Psyllid ID: psy6820
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 639 | 2.2.26 [Sep-21-2011] | |||||||
| B4GXC2 | 755 | Serine/threonine-protein | N/A | N/A | 0.837 | 0.708 | 0.467 | 1e-154 | |
| B5DK35 | 755 | Serine/threonine-protein | yes | N/A | 0.837 | 0.708 | 0.462 | 1e-153 | |
| B4IMC3 | 744 | Serine/threonine-protein | N/A | N/A | 0.826 | 0.709 | 0.464 | 1e-151 | |
| B4NSS9 | 743 | Serine/threonine-protein | N/A | N/A | 0.826 | 0.710 | 0.464 | 1e-151 | |
| B3NKK1 | 745 | Serine/threonine-protein | N/A | N/A | 0.826 | 0.708 | 0.465 | 1e-149 | |
| B4IT27 | 750 | Serine/threonine-protein | N/A | N/A | 0.826 | 0.704 | 0.465 | 1e-149 | |
| Q7PLI7 | 748 | Serine/threonine-protein | yes | N/A | 0.904 | 0.772 | 0.439 | 1e-148 | |
| Q8N568 | 766 | Serine/threonine-protein | yes | N/A | 0.841 | 0.702 | 0.453 | 1e-144 | |
| Q6PGN3 | 756 | Serine/threonine-protein | yes | N/A | 0.840 | 0.710 | 0.453 | 1e-143 | |
| D2I3C6 | 784 | Serine/threonine-protein | yes | N/A | 0.838 | 0.683 | 0.436 | 1e-138 |
| >sp|B4GXC2|DCLK_DROPE Serine/threonine-protein kinase GL21140 OS=Drosophila persimilis GN=GL21140 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 545 bits (1404), Expect = e-154, Method: Compositional matrix adjust.
Identities = 284/607 (46%), Positives = 383/607 (63%), Gaps = 72/607 (11%)
Query: 90 FTPSPLKSRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGV 149
T S +R+A RI+F NGD+F+ G+ + V ERYRSF+SL E+LTR L EN+ +P V
Sbjct: 146 ITSSRTPTRKAHRIKFYRNGDRFYPGITIPVSNERYRSFESLYEDLTRLLEENVKIPGAV 205
Query: 150 RILFTMDGQKVTNIDELEDGKFYICSSSGDQFKKVDY-------AILNNNNSSNTLPRSG 202
R ++ M G+K+T ++ELEDG+ Y+CS + + FKKVDY A L N+S T
Sbjct: 206 RTIYDMVGKKITALEELEDGQSYVCSCNNENFKKVDYNTSSQPLANLTLANNSRTSSHRL 265
Query: 203 KFITKSAPPRVNKTPTSF--------------------------VVRPRIIIVIRNGIRP 236
+ + A P N P S VV PRI+ +IRNG +P
Sbjct: 266 AKLQRPASPLKNGVPNSIAPVPVGGGAAANGSPLNTSRFSERDSVVHPRIVTLIRNGTKP 325
Query: 237 RKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFA 296
R+++R LLNKRN+PS D + IT +V+LDTG VRKV+TL+G + +LSDFF SDDVFFA
Sbjct: 326 RRIIRLLLNKRNSPSFDHVLTAITQVVRLDTGYVRKVFTLSGVSVLQLSDFFGSDDVFFA 385
Query: 297 YGSERV-LPDDFELDVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREVPKMPTKTSV 355
YG+ERV DDF+L+ EE +AI A++K LR +GT C PKMP K+
Sbjct: 386 YGTERVNTVDDFKLESEEQRAINAIRKTLR-------TAGTACKGPK----PKMPVKSKK 434
Query: 356 A--------------RCATATIKRREN------------LNIPSKLLQRYSVGQIIGDGN 389
A + + A E +P+ + Y++ QIIGDGN
Sbjct: 435 AYPPGELKAQAEAQLQASAAPANEDEEQAALLKSTGVEVAELPAAIRDNYTLSQIIGDGN 494
Query: 390 FAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNE 449
FA+V ++ D+ + ALKIIDKSK GK+ I+ EV +++ ++HP+II L+ + D +
Sbjct: 495 FAIVLKIKDRQTGIPHALKIIDKSKCKGKEHYIDAEVRVMKKLHHPHIISLIMDVDQDTN 554
Query: 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE 509
+YLV+E + GGDLFDAI++ +FSE S+ M + L SA+SYLH IVHRDIKPENLLVE
Sbjct: 555 MYLVLEYVSGGDLFDAITQVTRFSESQSRIMIRHLGSAMSYLHSMGIVHRDIKPENLLVE 614
Query: 510 MSG-CHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYI 568
+ +V LK+ DFGLA V P++ VCGTPTYVAPEIL E GYG+KIDVWAAG+ILYI
Sbjct: 615 LDDFGNVVQLKLADFGLACEVTEPLYAVCGTPTYVAPEILLEVGYGLKIDVWAAGIILYI 674
Query: 569 LLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAE 628
LLCGFPPFV+ N Q+ LFD I+SG Y FP PYW DI + ++LI++ML+S+PD+RF++E
Sbjct: 675 LLCGFPPFVAPDNQQEPLFDAIISGVYEFPDPYWSDIGDGVRDLIANMLQSDPDVRFTSE 734
Query: 629 DVLDHPW 635
D+LDH W
Sbjct: 735 DILDHYW 741
|
Drosophila persimilis (taxid: 7234) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|B5DK35|DCLK_DROPS Serine/threonine-protein kinase GA29083 OS=Drosophila pseudoobscura pseudoobscura GN=GA29083 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 541 bits (1393), Expect = e-153, Method: Compositional matrix adjust.
Identities = 281/607 (46%), Positives = 385/607 (63%), Gaps = 72/607 (11%)
Query: 90 FTPSPLKSRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGV 149
T S +R+A RI+F NGD+F+ G+ + V ERYRSF+SL E+LTR L EN+ +P V
Sbjct: 146 ITSSRTPTRKAHRIKFYRNGDRFYPGITIPVSNERYRSFESLYEDLTRLLEENVKIPGAV 205
Query: 150 RILFTMDGQKVTNIDELEDGKFYICSSSGDQFKKVDYAILNN--------NNSSNTLPRS 201
R ++ M G+K+T ++ELEDG+ Y+CS + + FKKVDY + NNS + R
Sbjct: 206 RTIYDMVGKKITALEELEDGQSYVCSCNNENFKKVDYNTSSQPLANLTLANNSRTSSHRL 265
Query: 202 GKFITKSAPPR-----------------VNKTPTSF--------VVRPRIIIVIRNGIRP 236
K ++P + N +P + VV PRI+ +IRNG +P
Sbjct: 266 AKLQRPASPLKNGVLNSIAPVPVGGGAAANGSPLNTSRFSERDSVVHPRIVTLIRNGTKP 325
Query: 237 RKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFA 296
R+++R LLNKRN+PS D + IT +V+LDTG VRKV+TL+G + +LSDFF SDDVFFA
Sbjct: 326 RRIIRLLLNKRNSPSFDHVLTAITQVVRLDTGYVRKVFTLSGVSVLQLSDFFGSDDVFFA 385
Query: 297 YGSERV-LPDDFELDVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREVPKMPTKTSV 355
YG+ERV +DF+L+ EE +AI A++K LR +GT C PKMP K+
Sbjct: 386 YGTERVNTVEDFKLESEEQRAINAIRKTLR-------TAGTACKGPK----PKMPVKSKK 434
Query: 356 A--------------RCATATIKRREN------------LNIPSKLLQRYSVGQIIGDGN 389
A + + A E +P+ + Y++ QIIGDGN
Sbjct: 435 AYPPGELKAQAEAQLQASAAPANEDEEQAALLKSTGVEVAELPAAIRDNYTLSQIIGDGN 494
Query: 390 FAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNE 449
FA+V ++ D+ + ALKIIDKSK GK+ I+ EV +++ ++HP+II L+ + D +
Sbjct: 495 FAIVLKIKDRQTGIPHALKIIDKSKCKGKEHYIDAEVRVMKKLHHPHIISLIMDVDQDTN 554
Query: 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE 509
+YLV+E + GGDLFDAI++ +FSE S+ M + L SA+SYLH IVHRDIKPENLLVE
Sbjct: 555 MYLVLEYVSGGDLFDAITQVTRFSESQSRIMIRHLGSAMSYLHSMGIVHRDIKPENLLVE 614
Query: 510 MSG-CHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYI 568
+ +V LK+ DFGLA V P++ VCGTPTYVAPEIL E GYG+KIDVWAAG+ILYI
Sbjct: 615 LDDFGNVVQLKLADFGLACEVTEPLYAVCGTPTYVAPEILLEVGYGLKIDVWAAGIILYI 674
Query: 569 LLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAE 628
LLCGFPPFV+ N Q+ LFD I+SG Y FP PYW DI + ++LI++ML+S+PD+RF++E
Sbjct: 675 LLCGFPPFVAPDNQQEPLFDAIISGVYEFPDPYWSDIGDGVRDLIANMLQSDPDVRFTSE 734
Query: 629 DVLDHPW 635
D+LDH W
Sbjct: 735 DILDHYW 741
|
Drosophila pseudoobscura pseudoobscura (taxid: 46245) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|B4IMC3|DCLK_DROSE Serine/threonine-protein kinase GM11705 OS=Drosophila sechellia GN=GM11705 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 536 bits (1382), Expect = e-151, Method: Compositional matrix adjust.
Identities = 275/592 (46%), Positives = 378/592 (63%), Gaps = 64/592 (10%)
Query: 97 SRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMD 156
+R+A RI+F NGD+F+ G+ + V ERYRSF+ L E+LTR L EN+ +P VR ++ M
Sbjct: 150 TRKALRIKFYRNGDRFYPGITIPVSNERYRSFERLFEDLTRLLEENVKIPGAVRTIYNMC 209
Query: 157 GQKVTNIDELEDGKFYICSSSGDQFKKVDY---------AILNNNNS------------- 194
G+K+T++DELEDG+ Y+CS + + FKKV+Y L N+ S
Sbjct: 210 GKKITSLDELEDGQSYVCSCNNENFKKVEYNTGSQPLSNLTLTNSRSNSHRLAKCRPSSP 269
Query: 195 --------SNTLPRSGKFITKSAPPRVNKTPTSF-VVRPRIIIVIRNGIRPRKVVRALLN 245
SN LP G +P +++ VV PRI+ +IR+G +PR+++R LLN
Sbjct: 270 LKNGLLAGSNPLPTCGGGTGNGSPHIASRSSDRVTVVHPRIVTLIRSGTKPRRIMRLLLN 329
Query: 246 KRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAYGSERV-LP 304
KRN+PS D + IT +V+LDTG VRKV+TL+G + RLSDFF SDDVFFAYG+ER+
Sbjct: 330 KRNSPSFDHVLTAITQVVRLDTGYVRKVFTLSGVSVVRLSDFFGSDDVFFAYGTERINTA 389
Query: 305 DDFELDVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREVPKMPTKTSVA-------- 356
+DF+L+ EE +AI ++K +R +GTTC PKMP K+
Sbjct: 390 EDFKLEAEEHRAINVIRKTMR-------TTGTTCKGPK----PKMPIKSKKVYPPVVDSE 438
Query: 357 ------------RCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMD 404
A T E +PS + Y++G+IIGDGNFA+V ++ +
Sbjct: 439 AFKAATTPEDDRHAALLTSTGMEINELPSNIRNTYTLGRIIGDGNFAIVFKIKHRQTGHS 498
Query: 405 CALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFD 464
ALKIIDK+K GK+ I+ EV +++ +NHP+II L+ D N +YLV+E + GGDLFD
Sbjct: 499 YALKIIDKNKCKGKEHYIDAEVRVMKKLNHPHIISLILSVDQNTNMYLVLEYVSGGDLFD 558
Query: 465 AISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM-SGCHVKVLKVGDF 523
AI++ +FSE S+ M + L +A++YLH IVHRDIKPENLLV++ HV LK+ DF
Sbjct: 559 AITQVTRFSESQSRIMIRHLGAAMTYLHSMGIVHRDIKPENLLVKLDEHGHVLELKLADF 618
Query: 524 GLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ 583
GLA V ++ VCGTPTYVAPEIL E GYG+KIDVWAAG+ILYILLCGFPPFV+ N Q
Sbjct: 619 GLACEVNDLLYAVCGTPTYVAPEILLEVGYGLKIDVWAAGIILYILLCGFPPFVAPDNQQ 678
Query: 584 DELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
+ LFD I+SG Y FP PYW DI + ++LI++ML+++PD+RF++ED+LDHPW
Sbjct: 679 EPLFDAIISGIYEFPDPYWSDIGDGVRDLIANMLQADPDVRFTSEDILDHPW 730
|
Drosophila sechellia (taxid: 7238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|B4NSS9|DCLK_DROSI Serine/threonine-protein kinase GD17699 OS=Drosophila simulans GN=GD17699 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 534 bits (1376), Expect = e-151, Method: Compositional matrix adjust.
Identities = 275/592 (46%), Positives = 381/592 (64%), Gaps = 64/592 (10%)
Query: 97 SRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMD 156
+R+A RI+F NGD+F+ G+ + V ERYRSF+ L E+LTR L EN+ +P VR ++ M
Sbjct: 150 TRKALRIKFYRNGDRFYPGITIPVSNERYRSFERLFEDLTRLLEENVKIPGAVRTIYNMC 209
Query: 157 GQKVTNIDELEDGKFYICSSSGDQFKKVDYAI----LNN-------NNS----------- 194
G+K+T++DELEDG+ Y+CS + + FKKV+Y L+N +NS
Sbjct: 210 GKKITSLDELEDGQSYVCSCNNENFKKVEYNTGSQPLSNLTLTSSRSNSHRLDKCRPSSP 269
Query: 195 --------SNTLPRSGKFITKSAPPRVNKTPTSF-VVRPRIIIVIRNGIRPRKVVRALLN 245
S+ LP G +P +++ VV PRI+ +IR+G +PR+++R LLN
Sbjct: 270 LKNGLLAGSSPLPTCGGGTGNGSPHIASRSSDRVTVVHPRIVTLIRSGTKPRRIMRLLLN 329
Query: 246 KRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAYGSERV-LP 304
KRN+PS D + IT +V+LDTG VRKV+TL+G + RLSDFF SDDVFFAYG+ER+
Sbjct: 330 KRNSPSFDHVLTAITQVVRLDTGYVRKVFTLSGVSVVRLSDFFGSDDVFFAYGTERINTA 389
Query: 305 DDFELDVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREVPKMPTKTSV--------- 355
+DF+L+ EE +AI ++K +R +GTTC PKMP K+
Sbjct: 390 EDFKLEAEEHRAINVIRKTMR-------TTGTTCKGPK----PKMPIKSKKVYPPVVDSE 438
Query: 356 -----------ARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMD 404
+ A T E +PS + Y++G+IIGDGNFA+V ++ +
Sbjct: 439 AFKAATTPEDDSHAALLTSTGMEINELPSNIRNTYTLGRIIGDGNFAIVFKIKHRQTGHS 498
Query: 405 CALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFD 464
ALKIIDK+K GK+ I+ EV +++ +NHP+II L+ D N +YLV+E + GGDLFD
Sbjct: 499 YALKIIDKNKCKGKEHYIDAEVRVMKKLNHPHIISLILSVDQNTNMYLVLEYVSGGDLFD 558
Query: 465 AISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM-SGCHVKVLKVGDF 523
AI++ +FSE S+ M + L +A++YLH IVHRDIKPENLLV++ HV LK+ DF
Sbjct: 559 AITQVTRFSESQSRIMIRHLGAAMTYLHSMGIVHRDIKPENLLVKLDEHGHVLELKLADF 618
Query: 524 GLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ 583
GLA V ++ VCGTPTYVAPEIL E GYG+KIDVWAAG+ILYILLCGFPPFV+ N Q
Sbjct: 619 GLACEVNDLLYAVCGTPTYVAPEILLEVGYGLKIDVWAAGIILYILLCGFPPFVAPDNQQ 678
Query: 584 DELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
+ LFD I+SG Y FP PYW DI + ++LI++ML+++PD+RF++ED+LDHPW
Sbjct: 679 EPLFDAIISGIYEFPDPYWSDIGDGVRDLIANMLQADPDVRFTSEDILDHPW 730
|
Drosophila simulans (taxid: 7240) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|B3NKK1|DCLK_DROER Serine/threonine-protein kinase GG21441 OS=Drosophila erecta GN=GG21441 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 529 bits (1362), Expect = e-149, Method: Compositional matrix adjust.
Identities = 276/593 (46%), Positives = 381/593 (64%), Gaps = 65/593 (10%)
Query: 97 SRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMD 156
+R+A RI+F NGD+F+ G+ + V ERYRSF+ L E+LTR L EN+ +P VR ++ M
Sbjct: 155 TRKALRIKFYRNGDRFYPGITIPVSNERYRSFERLYEDLTRLLEENVKIPGAVRTIYNMC 214
Query: 157 GQKVTNIDELEDGKFYICSSSGDQFKKVDY---------AILNNNNSSNT---------- 197
G+K+T++DELEDG+ Y+CS + + FKKV+Y L NN+ SN
Sbjct: 215 GKKITSLDELEDGQSYVCSCNNENFKKVEYNTGSQPLSNLTLTNNSRSNNQRLAKCRPAS 274
Query: 198 ------------LPRSGKFITKSAPPRVNKTPTSF-VVRPRIIIVIRNGIRPRKVVRALL 244
LP SG +P ++ VV PRI+ +IR+G +PR+++R LL
Sbjct: 275 PLKNGLLTGISPLPASGGGTGNGSPLIASRLSDRVSVVHPRIVTLIRSGTKPRRIMRLLL 334
Query: 245 NKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAYGSERV-L 303
NKRN+PS D + IT +V+LDTG VRKV+TL+G + +LSDFF SDDVFFAYG+ER+
Sbjct: 335 NKRNSPSFDHVLTAITQVVRLDTGYVRKVFTLSGISVVQLSDFFGSDDVFFAYGTERINY 394
Query: 304 PDDFELDVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREVPKMPTKT---------- 353
+DF+L+ EE +AI ++K +R +GTTC PKMP K+
Sbjct: 395 AEDFKLEAEEYRAINVIRKTMR-------TAGTTCKGPK----PKMPIKSKKVYPPLVDS 443
Query: 354 SVARCAT-------ATIKRRENLNI---PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDM 403
V + AT AT+ + I P + Y++G+IIGDGNFA+V ++ +
Sbjct: 444 EVLKAATSPEDDSHATLLTSTGIEINELPLNIRNTYTLGRIIGDGNFAIVFKIKHRQTGD 503
Query: 404 DCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLF 463
ALKIIDK+K GK+ I+ EV +++ +NHP+II L+ D N +YLV+E + GGDLF
Sbjct: 504 SYALKIIDKNKCKGKEHYIDAEVRVMKKLNHPHIISLILSVDQNTNMYLVLEYVSGGDLF 563
Query: 464 DAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM-SGCHVKVLKVGD 522
DAI++ +FSE S+ M + L +A++YLH IVHRDIKPENLLV++ +V LK+ D
Sbjct: 564 DAITQVTRFSESQSRIMIRHLGAAMTYLHSMGIVHRDIKPENLLVKLDEHGNVLELKLAD 623
Query: 523 FGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND 582
FGLA V ++ VCGTPTYVAPEIL E GYG+KIDVWAAG+ILYILLCGFPPFV+ N
Sbjct: 624 FGLACEVNDLLYAVCGTPTYVAPEILLEVGYGLKIDVWAAGIILYILLCGFPPFVAPDNQ 683
Query: 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
Q+ LFD I+SG Y FP PYW DI + ++LI++ML+S+PD+RF++ED+LDH W
Sbjct: 684 QEPLFDAIISGIYEFPDPYWSDIGDGVRDLIANMLQSDPDVRFTSEDILDHYW 736
|
Drosophila erecta (taxid: 7220) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|B4IT27|DCLK_DROYA Serine/threonine-protein kinase GE16371 OS=Drosophila yakuba GN=GE16371 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 528 bits (1361), Expect = e-149, Method: Compositional matrix adjust.
Identities = 276/593 (46%), Positives = 382/593 (64%), Gaps = 65/593 (10%)
Query: 97 SRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMD 156
+R+A RI+F NGD+F+ GV + V ERYRSF+ L E+LTR L EN+ +P VR ++ M
Sbjct: 155 TRKALRIKFYRNGDRFYPGVTIPVSNERYRSFERLFEDLTRLLEENVKIPGAVRTIYNMC 214
Query: 157 GQKVTNIDELEDGKFYICSSSGDQFKKVDY----------AILNNNNSSN--------TL 198
G+K+T++DELEDG+ Y+CS + + FKKV+Y + NN+ N
Sbjct: 215 GKKITSLDELEDGQSYVCSCNNENFKKVEYNPGSQPLSNLTLTNNSRPYNQRLAKHRPAS 274
Query: 199 PRSGKFITKSAPPRV------NKTP--------TSFVVRPRIIIVIRNGIRPRKVVRALL 244
P + S+P V N +P VV PRI+ +IR+G +PR+++R LL
Sbjct: 275 PLKNGLLVGSSPLAVCGGGTGNGSPLIASKSSDRVTVVHPRIVTLIRSGTKPRRIMRLLL 334
Query: 245 NKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAYGSERV-L 303
NKRN+PS D + IT +V+LDTG VRKV+TL+G + +LSDFF+SDDVFFAYG+ER+
Sbjct: 335 NKRNSPSFDHVLTAITQVVRLDTGYVRKVFTLSGISVVQLSDFFESDDVFFAYGTERINT 394
Query: 304 PDDFELDVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREVPKMPTKT---------- 353
+DF+L+ EE+KAI ++K +R +GTTC PKMP K+
Sbjct: 395 AEDFKLEPEELKAINVIRKTMR-------TAGTTCKGPK----PKMPIKSKKVYPPSVNS 443
Query: 354 SVARCATATIKRR----------ENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDM 403
+ ATA R E +PS + Y++G+IIGDGNFA+V ++ +
Sbjct: 444 EAFKAATAPEDDRHATLLTSTGIEINELPSNIRSTYTLGKIIGDGNFAIVFKIKHRQTGD 503
Query: 404 DCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLF 463
ALKIIDK+K GK+ I+ EV +++ +NHP+II L+ D N +YLV+E + GGDLF
Sbjct: 504 SYALKIIDKNKCKGKEHYIDAEVRVMKKLNHPHIISLILSVDQNTNMYLVLEYVSGGDLF 563
Query: 464 DAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM-SGCHVKVLKVGD 522
DAI++ +F+E S+ M + L +A++YLH IVHRDIKPENLLV++ +V LK+ D
Sbjct: 564 DAITQVTRFAESQSRIMIRHLGAAMTYLHSMGIVHRDIKPENLLVKLDEHGNVLELKLAD 623
Query: 523 FGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND 582
FGLA V ++ VCGTPTYVAPEIL E GYG+KIDVWAAG+ILYILLCGFPPFV+ N
Sbjct: 624 FGLACEVNDLLYAVCGTPTYVAPEILLEVGYGLKIDVWAAGIILYILLCGFPPFVAPDNQ 683
Query: 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
Q+ LFD I+SG Y FP PYW DI + ++LI++ML+S+PD+RF++ED+LDH W
Sbjct: 684 QEPLFDAIISGIYEFPDPYWSDIGDGVRDLIANMLQSDPDVRFTSEDILDHYW 736
|
Drosophila yakuba (taxid: 7245) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7PLI7|DCLK_DROME Serine/threonine-protein kinase CG17528 OS=Drosophila melanogaster GN=CG17528 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 526 bits (1354), Expect = e-148, Method: Compositional matrix adjust.
Identities = 286/651 (43%), Positives = 402/651 (61%), Gaps = 73/651 (11%)
Query: 39 LNHILANTSSVS-NRTMSMILGDTKSAMVLSQSTDPLKDQCNTVDMQRHFSDFTPSPLKS 97
LN + + TS S +T+ ++ ++ S P D +R S TP+
Sbjct: 103 LNGVYSITSVTSETKTLESVVTTNSASGSACLSNTPTADHIK----KRIPSSRTPT---- 154
Query: 98 RRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDG 157
R+A RI+F NGD+F+ G+ + V ERYRSF+ L E+LTR L EN+ +P VR ++ + G
Sbjct: 155 RKALRIKFYRNGDRFYPGITIPVSNERYRSFERLFEDLTRLLEENVKIPGAVRTIYNLCG 214
Query: 158 QKVTNIDELEDGKFYICSSSGDQFKKVDY----------AILNNNNSSNTL-------PR 200
+K+T++DELEDG+ Y+CS + + FKKV+Y + N+ ++S+ L P
Sbjct: 215 KKITSLDELEDGQSYVCSCNNENFKKVEYNTGSQPLSNLPLSNSRSNSHRLAKCRPSSPL 274
Query: 201 SGKFITKSAP-PRV-----NKTP--------TSFVVRPRIIIVIRNGIRPRKVVRALLNK 246
+ S+P P N +P VV PRI+ +IR+G +PR+++R LLNK
Sbjct: 275 KNGLLAGSSPFPACGGGTGNGSPLIASRLSDRVTVVHPRIVTLIRSGTKPRRIMRLLLNK 334
Query: 247 RNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAYGSERV-LPD 305
RN+PS D + IT +V+LDTG VRKV+TL+G + RLSDFF SDDVFFAYG+ER+ +
Sbjct: 335 RNSPSFDHVLTAITQVVRLDTGYVRKVFTLSGIPVVRLSDFFGSDDVFFAYGTERINTAE 394
Query: 306 DFELDVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREVPKMPTKTSVA--------- 356
DF+L+ EE +AI ++K +R +GTTC PKMP K+
Sbjct: 395 DFKLEAEEQRAINVIRKTMR-------TTGTTCKGPK----PKMPIKSKKVYPPLVDSEP 443
Query: 357 -----------RCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDC 405
A T E +PS + YS+G+IIGDGNFA+V ++ +
Sbjct: 444 FKAETTPEDDRHAALLTSTGMEINELPSNIRNTYSLGRIIGDGNFAIVFKIKHRQTGHSY 503
Query: 406 ALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDA 465
ALKIIDK+K GK+ I+ EV +++ +NHP+II L+ D N +YLV+E + GGDLFDA
Sbjct: 504 ALKIIDKNKCKGKEHYIDAEVRVMKKLNHPHIISLILSVDQNTNMYLVLEYVSGGDLFDA 563
Query: 466 ISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM-SGCHVKVLKVGDFG 524
I++ +FSE S+ M + L +A++YLH IVHRDIKPENLLV++ +V LK+ DFG
Sbjct: 564 ITQVTRFSENQSRIMIRHLGAAMTYLHSMGIVHRDIKPENLLVKLDEHGNVLELKLADFG 623
Query: 525 LAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD 584
LA V ++ VCGTPTYVAPEIL E GYG+KIDVWAAG+ILYILLCGFPPFV+ N Q+
Sbjct: 624 LACEVNDLLYAVCGTPTYVAPEILLEVGYGLKIDVWAAGIILYILLCGFPPFVAPDNQQE 683
Query: 585 ELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
LFD I+SG Y FP PYW DI + ++LI++ML+++PD+RF++ED+LDH W
Sbjct: 684 PLFDAIISGIYEFPDPYWSDIGDGVRDLIANMLQADPDVRFTSEDILDHSW 734
|
Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8N568|DCLK2_HUMAN Serine/threonine-protein kinase DCLK2 OS=Homo sapiens GN=DCLK2 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 514 bits (1323), Expect = e-144, Method: Compositional matrix adjust.
Identities = 265/584 (45%), Positives = 378/584 (64%), Gaps = 46/584 (7%)
Query: 98 RRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDG 157
++AK+ RF NGD++FKG+V A+ +R+RSFD+LL ELTR+L++N+NLP GVR ++T+DG
Sbjct: 69 KKAKKARFYRNGDRYFKGLVFAISSDRFRSFDALLIELTRSLSDNVNLPQGVRTIYTIDG 128
Query: 158 -QKVTNIDELEDGKFYICSSSGDQFKKVDYAI-LNNNNSSNTLPRSGKFITKSAPPRVNK 215
+KVT++DEL +G+ Y+C+S+ + F+KVDY +N N S N + + + ++ +
Sbjct: 129 SRKVTSLDELLEGESYVCASN-EPFRKVDYTKNINPNWSVNIKGGTSRALAAASSVKSEV 187
Query: 216 TPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYT 275
+ ++P+++ VIR+G++PRK VR LLNK+ A S +Q + IT+ +KLD+G V+++ T
Sbjct: 188 KESKDFIKPKLVTVIRSGVKPRKAVRILLNKKTAHSFEQVLTDITEAIKLDSGVVKRLCT 247
Query: 276 LNGNQLARLSDFFKSDDVFFAYGSE--RVLPDDFELDVEEVKAIQALKKDLRRPEHTKLK 333
L+G Q+ L DFF DDVF A G E R DDF LD E + +++ +++ K
Sbjct: 248 LDGKQVTCLQDFFGDDDVFIACGPEKFRYAQDDFVLDHSECRVLKSSYSRSSAVKYSGSK 307
Query: 334 S-----------------------------------------GTTCLDASGREVPKMPTK 352
S G + A GR +
Sbjct: 308 SPGPSRRSKSPASVNGTPSSQLSTPKSTKSSSSSPTSPGSFRGLKQISAHGRSSSNVNGG 367
Query: 353 TSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK 412
+ RC + + S LL++Y +G++IGDGNFAVV++ D+ + ALKIIDK
Sbjct: 368 PELDRCISPEGVNGNRCSESSTLLEKYKIGKVIGDGNFAVVKECIDRSTGKEFALKIIDK 427
Query: 413 SKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKF 472
+K GK+ +IENEV+ILR V HPNII L++E +T EL+LV+EL+KGGDLFDAI+ + K+
Sbjct: 428 AKCCGKEHLIENEVSILRRVKHPNIIMLVEEMETATELFLVMELVKGGDLFDAITSSTKY 487
Query: 473 SEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532
+E D M +LA+AL YLH IVHRDIKPENLLV K LK+GDFGLA V P
Sbjct: 488 TERDGSAMVYNLANALRYLHGLSIVHRDIKPENLLVCEYPDGTKSLKLGDFGLATVVEGP 547
Query: 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS 592
++TVCGTPTYVAPEI+ E+GYG+K+D+WAAGVI YILLCGFPPF S+ N Q++LFD IL+
Sbjct: 548 LYTVCGTPTYVAPEIIAETGYGLKVDIWAAGVITYILLCGFPPFRSENNLQEDLFDQILA 607
Query: 593 GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
G+ FP+PYWD+I++ AKELIS ML+ N + R +A +L HPW+
Sbjct: 608 GKLEFPAPYWDNITDSAKELISQMLQVNVEARCTAGQILSHPWV 651
|
Protein kinase with a significantly reduced C(a2+)/CAM affinity and dependence compared to other members of the CaMK family. May play a role in the down-regulation of CRE-dependent gene activation probably by phosphorylation of the CREB coactivator CRTC2/TORC2 and the resulting retention of TORC2 in the cytoplasm. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6PGN3|DCLK2_MOUSE Serine/threonine-protein kinase DCLK2 OS=Mus musculus GN=Dclk2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 510 bits (1313), Expect = e-143, Method: Compositional matrix adjust.
Identities = 265/584 (45%), Positives = 379/584 (64%), Gaps = 47/584 (8%)
Query: 98 RRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDG 157
++AK+ RF NGD++FKG+V A+ +R+RSFD+LL ELTR+L++N+NLP GVR ++T+DG
Sbjct: 69 KKAKKARFYRNGDRYFKGLVFAISNDRFRSFDALLIELTRSLSDNVNLPQGVRTIYTIDG 128
Query: 158 -QKVTNIDELEDGKFYICSSSGDQFKKVDYAI-LNNNNSSNTLPRSGKFITKSAPPRVNK 215
+KVT++DEL +G+ Y+C+S+ + F+KVDY +N N S N + + + ++ K
Sbjct: 129 SRKVTSLDELLEGESYVCASN-EPFRKVDYTKNVNPNWSVNIKGGTTRTLAVASAKSEVK 187
Query: 216 TPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYT 275
F+ +P+++ VIR+G++PRK VR LLNK+ A S +Q + IT+ +KLD+G V+++ T
Sbjct: 188 ESKDFI-KPKLVTVIRSGVKPRKAVRILLNKKTAHSFEQVLTDITEAIKLDSGVVKRLCT 246
Query: 276 LNGNQLARLSDFFKSDDVFFAYGSE--RVLPDDFELDVEEVKAIQALKKDLRRPEHTKLK 333
L+G Q+ L DFF DDVF A G E R DDF LD E + +++ +++ +
Sbjct: 247 LDGKQVTCLQDFFGDDDVFIACGPEKYRYAQDDFVLDHSECRVLKSSYSRASAAKYSGSR 306
Query: 334 S-----------------------------------------GTTCLDASGREVPKMPTK 352
S G + A GR +
Sbjct: 307 SPGFSRRSKSPASVNGTPSSQLSTPKSTKSSSSSPTSPGSFRGLKQISAQGRSSSNVNGG 366
Query: 353 TSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK 412
+ RC + + LL++Y +G++IGDGNFAVV++ D++ + ALKIIDK
Sbjct: 367 PELDRCLSPEGVNGNRCSESFPLLEKYRIGKVIGDGNFAVVKECVDRYTGKEFALKIIDK 426
Query: 413 SKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKF 472
+K GK+ +IENEV+ILR V HPNII L++E +T +L+LV+EL+KGGDLFDAI+ + K+
Sbjct: 427 AKCCGKEHLIENEVSILRRVKHPNIIMLVEEMETATDLFLVMELVKGGDLFDAITSSTKY 486
Query: 473 SEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532
+E D M +LA+AL YLH IVHRDIKPENLLV K LK+GDFGLA V P
Sbjct: 487 TERDGSAMVYNLANALRYLHSLSIVHRDIKPENLLVCEYPDGTKSLKLGDFGLATVVEGP 546
Query: 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS 592
++TVCGTPTYVAPEI+ E+GYG+K+DVWAAGVI YILLCGFPPF S+ N Q++LFD IL+
Sbjct: 547 LYTVCGTPTYVAPEIIAETGYGLKVDVWAAGVITYILLCGFPPFRSENNLQEDLFDQILA 606
Query: 593 GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
G+ FP+PYWD+I++ AKELIS ML+ N + R +A ++L HPW+
Sbjct: 607 GKLEFPAPYWDNITDSAKELISQMLQVNVEARCTAGEILSHPWV 650
|
Protein kinase with a significantly reduced Ca(2+)+/CAM affinity and dependence compared to other members of the CaMK family. May play a role in the down-regulation of CRE-dependent gene activation probably by phosphorylation of the CREB coactivator CRTC2/TORC2 and the resulting retention of TORC2 in the cytoplasm. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|D2I3C6|DCLK2_AILME Serine/threonine-protein kinase DCLK2 OS=Ailuropoda melanoleuca GN=DCLK2 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 491 bits (1265), Expect = e-138, Method: Compositional matrix adjust.
Identities = 263/603 (43%), Positives = 373/603 (61%), Gaps = 67/603 (11%)
Query: 98 RRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDG 157
++AK+ RF NGD++FKG+V A+ +R+RSFD+LL ELTR+L++N+NLP GVR ++T+DG
Sbjct: 69 KKAKKARFYRNGDRYFKGLVFAISSDRFRSFDALLMELTRSLSDNVNLPQGVRTIYTIDG 128
Query: 158 -QKVTNIDELEDGKFYICSSSGDQFKKVDYAILNNNNSSNTLPRSGKFITKSAPPRVN-- 214
+KVT++DEL +G+ Y+C+S+ + F+KVDY N N S + + G +AP V
Sbjct: 129 SRKVTSLDELLEGESYVCASN-EPFRKVDYTKNINPNWSVNI-KGGTARALAAPSSVKSE 186
Query: 215 -KTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKV 273
K F+ +P+++ VIR+G++PRK VR LLNK+ A S +Q + IT+ +KLD+G V+++
Sbjct: 187 VKESKDFI-KPKLVTVIRSGVKPRKAVRILLNKKTAHSFEQVLTDITEAIKLDSGVVKRL 245
Query: 274 YTLNGNQLARLSDF----------------FKSDDVFFAYGSERVL-------------- 303
TL+G Q+ L DF + DD + RVL
Sbjct: 246 CTLDGKQVTCLQDFFGDDDVFIACGPEKFRYAQDDFVLDHSECRVLKSSYSRSSAVKYSG 305
Query: 304 ------------PDDFELDVEEVKAIQALKKDLRRPEHTKLKS----------------- 334
P + A A + + ++L +
Sbjct: 306 SKSPGPSRRSKSPASVKRGGHHASAYSAARSPVNGTPSSQLSTPKSTKSSSSSPTSPGSF 365
Query: 335 -GTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVV 393
G + A GR + +ARC + + S LL++Y +G++IGDGNFAVV
Sbjct: 366 RGLKQISAHGRSSSNVNGGPELARCLSPEGVNGNRCSESSTLLEKYKIGKVIGDGNFAVV 425
Query: 394 RQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453
++ D+ + ALKIIDK+K GK+ +IENEV+ILR V HPNII L++E +T EL+LV
Sbjct: 426 KECMDRSTGKEFALKIIDKAKCCGKEHLIENEVSILRRVKHPNIIMLVEEMETATELFLV 485
Query: 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC 513
+EL+KGGDLFDAI+ + K++E D M +LA+AL YLH IVHRDIKPENLLV
Sbjct: 486 MELVKGGDLFDAITSSTKYTERDGSAMVYNLANALRYLHGLSIVHRDIKPENLLVCEYPD 545
Query: 514 HVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGF 573
K LK+GDFGLA V P++TVCGTPTYVAPEI+ E+GYG+K+D+WAAGVI YILLCGF
Sbjct: 546 GTKSLKLGDFGLATVVEGPLYTVCGTPTYVAPEIIAETGYGLKVDIWAAGVITYILLCGF 605
Query: 574 PPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633
PPF S+ N Q++LFD IL+G+ FP+PYWD+I++ AKELIS ML+ N + R +A ++L H
Sbjct: 606 PPFRSENNLQEDLFDQILAGKLEFPAPYWDNITDSAKELISQMLQVNVEARCTAGEILSH 665
Query: 634 PWL 636
PW+
Sbjct: 666 PWV 668
|
Protein kinase with a significantly reduced Ca(2+)/CAM affinity and dependence compared to other members of the CaMK family. May play a role in the down-regulation of CRE-dependent gene activation probably by phosphorylation of the CREB coactivator CRTC2/TORC2 and the resulting retention of TORC2 in the cytoplasm. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 639 | ||||||
| 193718327 | 576 | PREDICTED: serine/threonine-protein kina | 0.881 | 0.977 | 0.546 | 0.0 | |
| 322800372 | 1124 | hypothetical protein SINV_05308 [Solenop | 0.826 | 0.469 | 0.558 | 1e-175 | |
| 307178222 | 1102 | Serine/threonine-protein kinase DCLK2 [C | 0.823 | 0.477 | 0.552 | 1e-173 | |
| 383852278 | 1156 | PREDICTED: uncharacterized protein LOC10 | 0.821 | 0.454 | 0.558 | 1e-173 | |
| 307211379 | 1339 | Serine/threonine-protein kinase DCLK2 [H | 0.841 | 0.401 | 0.539 | 1e-172 | |
| 156548886 | 613 | PREDICTED: serine/threonine-protein kina | 0.816 | 0.851 | 0.550 | 1e-172 | |
| 328790668 | 674 | PREDICTED: serine/threonine-protein kina | 0.821 | 0.778 | 0.550 | 1e-171 | |
| 380014233 | 665 | PREDICTED: serine/threonine-protein kina | 0.821 | 0.789 | 0.550 | 1e-171 | |
| 91093116 | 581 | PREDICTED: similar to AGAP009034-PA [Tri | 0.812 | 0.893 | 0.559 | 1e-171 | |
| 350411796 | 666 | PREDICTED: serine/threonine-protein kina | 0.821 | 0.788 | 0.544 | 1e-170 |
| >gi|193718327|ref|XP_001951365.1| PREDICTED: serine/threonine-protein kinase GE16371-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 646 bits (1667), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/589 (54%), Positives = 427/589 (72%), Gaps = 26/589 (4%)
Query: 50 SNRTMSMILGDTKSAMVLSQSTDPLKDQCNTVDMQRHFSDFTPSPLKSRRAKRIRFLCNG 109
SN+++ M A+ L S ++C T R SD + +R+AKRIRFL NG
Sbjct: 9 SNKSIKM------QAVALRTSRSISNEECTT----RQKSDVGRA---ARKAKRIRFLVNG 55
Query: 110 DKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDGQKVTNIDELEDG 169
D+F KGVV+AV ERYRSFDSLL EL+ L+EN +LPSGVR LF++DG KV+ +D+LEDG
Sbjct: 56 DRFCKGVVVAVTHERYRSFDSLLAELSNMLSENKHLPSGVRALFSIDGHKVSQLDDLEDG 115
Query: 170 KFYICSSSGDQFKKVDYAILNNNNSSNTLPRSGKFITKSAPPRVNKTPTSFVVRPRIIIV 229
KFYICS + KK+DYA LNN S +L + T + P +K P +RP+II V
Sbjct: 116 KFYICSGGNNAIKKIDYAALNNVKPSRSLTKLQSTHTVLSSP--SKQPY-LNIRPKIIFV 172
Query: 230 IRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFK 289
+R+G RPRK++R LLNKRN+PS + + IT+ +KLDTGAVRKVY +G Q+ +L FF+
Sbjct: 173 VRSGTRPRKIIRMLLNKRNSPSFEHILTLITESIKLDTGAVRKVYVSSGCQITQLEQFFE 232
Query: 290 SDDVFFAYGSERVLPDDFELDVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREVPKM 349
DD+FF YGSER+ DD +LD EE+K +Q+ K+ LRRP + +LK+GT C+D SG+ VP++
Sbjct: 233 PDDLFFVYGSERISQDDLKLDFEEMKTVQSHKRGLRRPAN-ELKNGTHCMDESGKRVPQL 291
Query: 350 PTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKI 409
P T R T++I P+K+L RY++G +GDGNFAVV + +DK + + ALK+
Sbjct: 292 PKTTKANRSITSSI--------PTKVLNRYTIGDRLGDGNFAVVYRCFDKRTNSEYALKV 343
Query: 410 IDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN 469
I K ++ QMIENE++IL+S++HPNII L+ + TN ++YL+ EL+ GGDLF+AI++
Sbjct: 344 IKKIEVPQMSQMIENELSILKSISHPNIINLISDLVTNTDVYLITELVSGGDLFEAIARC 403
Query: 470 VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMS-GCHVKVLKVGDFGLAQR 528
FSE D + MT++LASAL+YLH IVHRD+KPENLLVE HV LK+ DFGL+Q+
Sbjct: 404 TDFSERDIRLMTRNLASALAYLHGLDIVHRDVKPENLLVEYDINGHVLHLKLADFGLSQK 463
Query: 529 VLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFD 588
V P++ VCGTPTYV+PEIL + GYGVKID+WAAGVILYILLCGFPPFVS+ N Q++LF+
Sbjct: 464 VNEPLYMVCGTPTYVSPEILTQDGYGVKIDIWAAGVILYILLCGFPPFVSENNIQEDLFN 523
Query: 589 DILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
DILSG YGFP PYWD++SEEAK+L+ ML+SNP LRFSAEDVLDHPW +
Sbjct: 524 DILSGTYGFPEPYWDNVSEEAKDLVCSMLQSNPSLRFSAEDVLDHPWCD 572
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|322800372|gb|EFZ21376.1| hypothetical protein SINV_05308 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1600), Expect = e-175, Method: Compositional matrix adjust.
Identities = 304/544 (55%), Positives = 391/544 (71%), Gaps = 16/544 (2%)
Query: 97 SRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMD 156
+++AKR+RF NGDK++ GVVMAV PERYRSFDSL +LTRAL N+ LP+GVR ++TMD
Sbjct: 57 TKKAKRVRFFRNGDKYYTGVVMAVTPERYRSFDSLATDLTRALVSNVTLPNGVRTIYTMD 116
Query: 157 GQKVTNIDELEDGKFYICSSSGDQFKKVDYAI--LNNNNSSNTLPRSGKFITKSAPPRVN 214
G+K+ + +LEDGK Y+ S G+ FKKV+Y+ + +S + LP+S +
Sbjct: 117 GRKIQTVSDLEDGKCYVVSGQGEIFKKVEYSASKVRRGSSLSGLPQSPATSSGGGGTGRQ 176
Query: 215 KTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVY 274
+ V+ RI+ +IR+G +PRKV+R LLNKRNAPSL+ IT+ VKLDTGAVRKVY
Sbjct: 177 ISAIPLCVKARIVTLIRHGTKPRKVMRLLLNKRNAPSLEHAMEAITEAVKLDTGAVRKVY 236
Query: 275 TLNGNQLARLSDFFKSDDVFFAYGSERVLPDDFELDVEEVKAIQALKKDLRRPEHTKLKS 334
TL+G Q+ L FF++DD+F AYG E+ + +DFELD EE K +Q+ + R P K +S
Sbjct: 237 TLSGQQVTSLEQFFENDDIFVAYGPEKSVQEDFELDFEESKCVQSFR---RCPWSFKRQS 293
Query: 335 GTTCLDASGREVPKMPTKTSVARCATATIK--RRENLNIPSKLLQRYSVGQIIGDGNFAV 392
G +P+MP K+ +T ++ +L +P L Y+VG IIGDGNFAV
Sbjct: 294 GP---------MPRMPRKSGKKTLSTPQVRTPSPSSLILPQPLRLHYTVGHIIGDGNFAV 344
Query: 393 VRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452
VR K + A+KI+DK K GK+ M+ +EV ILR V HPNII L+ E DT +L+L
Sbjct: 345 VRHCTHKSSGAEYAMKIVDKYKCQGKETMLASEVAILRQVCHPNIISLIAEQDTTEQLFL 404
Query: 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG 512
V+EL+KGGDLFDAI+ KFSE ++ M L SAL+YLH ++IVHRD+KPENLLVEM G
Sbjct: 405 VMELVKGGDLFDAIAVATKFSEAEASVMISHLTSALAYLHSHHIVHRDVKPENLLVEMDG 464
Query: 513 CHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCG 572
HV+ LK+GDFGLAQ V P++TVCGTPTYVAPEIL E+GYG+KIDVWAAGVILYILLCG
Sbjct: 465 SHVRCLKLGDFGLAQVVREPLYTVCGTPTYVAPEILAETGYGLKIDVWAAGVILYILLCG 524
Query: 573 FPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632
FPPFVS N+Q+ELF+ ILSGQY F SPYWD IS+ AK+LIS+ML++ P+LRFSAEDVLD
Sbjct: 525 FPPFVSVDNEQEELFERILSGQYEFTSPYWDTISDSAKQLISNMLQAQPELRFSAEDVLD 584
Query: 633 HPWL 636
HPWL
Sbjct: 585 HPWL 588
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307178222|gb|EFN67007.1| Serine/threonine-protein kinase DCLK2 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1589), Expect = e-173, Method: Compositional matrix adjust.
Identities = 301/545 (55%), Positives = 394/545 (72%), Gaps = 19/545 (3%)
Query: 97 SRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMD 156
+++AKR+RF NGDK++ GVVMAV PERYRSFDSL +LTRAL ++ LP+GVR ++TMD
Sbjct: 24 TKKAKRVRFFRNGDKYYTGVVMAVTPERYRSFDSLASDLTRALMSSVTLPNGVRAIYTMD 83
Query: 157 GQKVTNIDELEDGKFYICSSSGDQFKKVDYAI--LNNNNSSNTLPRSGKFITKSAPPR-V 213
G+KV ++ +LEDGK Y+ S G+ FKKV+Y+ + +S + LP+S + R +
Sbjct: 84 GRKVQSVSDLEDGKCYVVSGQGEIFKKVEYSASKVRRGSSLSGLPQSPAASSSGGTGRQI 143
Query: 214 NKTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKV 273
+ P V+ RI+ +IR+G +PRKV+R LLNKRNAPSL+ IT+ VKLD+GAVRKV
Sbjct: 144 SAIP--LCVKARIVTLIRHGTKPRKVMRLLLNKRNAPSLEHAMEAITEAVKLDSGAVRKV 201
Query: 274 YTLNGNQLARLSDFFKSDDVFFAYGSERVLPDDFELDVEEVKAIQALKKDLRRPEHTKLK 333
YTL+G + L FF +DD+F AYG E+ + +DFELD EE K +Q+ + R P +K +
Sbjct: 202 YTLSGQHITSLEQFFDNDDIFVAYGPEKSIQEDFELDFEESKCVQSFR---RCPWSSKRQ 258
Query: 334 SGTTCLDASGREVPKMPTKTSVARCATATIK--RRENLNIPSKLLQRYSVGQIIGDGNFA 391
SG +P+MP K+ T ++ +L +P L Y+VG +IGDGNFA
Sbjct: 259 SGP---------MPRMPKKSGKKMLTTPQVRTPSPSSLILPQPLRLHYTVGHVIGDGNFA 309
Query: 392 VVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451
VVR K + A+KI+DK K GK+ M+ +EV ILR V HPNII L+ E +T ++L+
Sbjct: 310 VVRHCIHKSTGAEYAMKIVDKYKCQGKETMLASEVAILRQVCHPNIISLIAEQETTDQLF 369
Query: 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMS 511
LV+EL+KGGDLFDAI+ KFSE ++ M L SAL+YLH ++IVHRD+KPENLLVEM
Sbjct: 370 LVMELVKGGDLFDAIAAATKFSEAEASVMIGHLTSALAYLHSHHIVHRDVKPENLLVEMD 429
Query: 512 GCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC 571
G HV+ LK+GDFGLAQ V P++TVCGTPTYVAPEIL E+GYG+KIDVWAAGVILYILLC
Sbjct: 430 GSHVRCLKLGDFGLAQVVREPLYTVCGTPTYVAPEILAETGYGLKIDVWAAGVILYILLC 489
Query: 572 GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVL 631
GFPPFVS N+Q+ELF+ ILSGQY F SPYWD +S+ AK+LIS+ML++ P+LRFSAEDVL
Sbjct: 490 GFPPFVSVENEQEELFERILSGQYEFTSPYWDTVSDSAKQLISNMLQAQPELRFSAEDVL 549
Query: 632 DHPWL 636
DHPWL
Sbjct: 550 DHPWL 554
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383852278|ref|XP_003701655.1| PREDICTED: uncharacterized protein LOC100875181 [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1581), Expect = e-173, Method: Compositional matrix adjust.
Identities = 306/548 (55%), Positives = 395/548 (72%), Gaps = 23/548 (4%)
Query: 94 PLKSRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILF 153
P +++AKR+RF NGDKF+ G+VMAV ERYRSFDSL +LTRAL ++ LP+GVR ++
Sbjct: 50 PPSTKKAKRVRFYRNGDKFYTGIVMAVTAERYRSFDSLTSDLTRALISSVTLPNGVRAIY 109
Query: 154 TMDGQKVTNIDELEDGKFYICSSSGDQFKKVDYAI--LNNNNSSNTLPRSGKFITKSAPP 211
TMDG+KV +I +LEDGK Y+ S G+ FKKV+Y+ + +S + LP+ S
Sbjct: 110 TMDGKKVQSISDLEDGKCYVVSGQGEMFKKVEYSSTKVRRGSSLSGLPQ----FPASTGR 165
Query: 212 RVNKTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVR 271
+++ P V+ +II +IR+G +PRKVVR LLNKRNAP+L+ IT+ VKLD+GAVR
Sbjct: 166 QISAIP--LCVKAKIITLIRHGTKPRKVVRLLLNKRNAPNLEHAMEAITEAVKLDSGAVR 223
Query: 272 KVYTLNGNQLARLSDFFKSDDVFFAYGSERVLPDDFELDVEEVKAIQALKKDLRRPEHTK 331
KVYT +G Q+ L FF+ DD+F AYGSE+ +DFELD EEVK+IQ+ K R P +K
Sbjct: 224 KVYTRSGQQVTCLEQFFEDDDIFIAYGSEKSSQEDFELDFEEVKSIQSFK---RCPWISK 280
Query: 332 LKSGTTCLDASGREVPKMPTKTSVARCATATIKRR---ENLNIPSKLLQRYSVGQIIGDG 388
+SG +PKMP K+ T + R +L +P L Y+VG++IGDG
Sbjct: 281 RQSGP---------MPKMPRKSGKKVLTTPHLVRTPSPSSLMLPQPLRLHYTVGRVIGDG 331
Query: 389 NFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN 448
NFAVVR K + A+KI+DK K GK+ M+ +EV ILR V HPNII L+ E +T +
Sbjct: 332 NFAVVRHCIHKSTGEEYAMKIVDKYKCQGKETMLASEVAILRQVCHPNIISLVAEQETTD 391
Query: 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLV 508
+L+LV+EL+KGGDLFDAI+ KFSE ++ M L SAL+YLH ++IVHRD+KPENLLV
Sbjct: 392 QLFLVMELVKGGDLFDAIAAATKFSEAEASVMIGHLTSALAYLHSHHIVHRDVKPENLLV 451
Query: 509 EMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYI 568
EM G HV+ LK+GDFGLAQ V P++TVCGTPTYVAPEIL E+GYG+KIDVWAAGVILYI
Sbjct: 452 EMDGNHVRCLKLGDFGLAQIVREPLYTVCGTPTYVAPEILAETGYGLKIDVWAAGVILYI 511
Query: 569 LLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAE 628
LLCGFPPFVS N+Q+ELF+ ILSGQY F PYWD +S+ AK+LIS+ML++ P+LRFSAE
Sbjct: 512 LLCGFPPFVSPENEQEELFERILSGQYEFTPPYWDSVSDSAKQLISNMLQAQPELRFSAE 571
Query: 629 DVLDHPWL 636
DVLDHPWL
Sbjct: 572 DVLDHPWL 579
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307211379|gb|EFN87506.1| Serine/threonine-protein kinase DCLK2 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1580), Expect = e-172, Method: Compositional matrix adjust.
Identities = 303/562 (53%), Positives = 400/562 (71%), Gaps = 24/562 (4%)
Query: 85 RHFSDFTPSPLKSRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENIN 144
RH + +PL +++AKR+RF NGDK++ GVVMAV PERYRSFDSL +LTRAL ++
Sbjct: 44 RHTLNVLRTPL-TKKAKRVRFFRNGDKYYTGVVMAVTPERYRSFDSLASDLTRALVSSVT 102
Query: 145 LPSGVRILFTMDGQKVTNIDELEDGKFYICSSSGDQFKKVDYAI--LNNNNSSNTLPRSG 202
LP+GVR ++TMDG+KV ++ +LEDGK Y+ S G+ FKKV+Y+ + +S + LP+S
Sbjct: 103 LPNGVRAIYTMDGRKVQSVSDLEDGKCYVVSGQGEIFKKVEYSSSKVRRGSSLSGLPQSP 162
Query: 203 KFITKSAPPRVNKTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDI 262
+ + V+ RI+ +IR+G +PRKV+R LLNKRNAPSL+ IT+
Sbjct: 163 AATGIGSGTGRQTSAIPLCVKARIVTLIRHGTKPRKVLRLLLNKRNAPSLEHAMEAITEA 222
Query: 263 VKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAYGSERVLPDDFELDVEEVKAIQALKK 322
VKLD+GAVRKVYTL+G Q+ L FF++DD+F AYG E+ +DFELD EE K +Q+ ++
Sbjct: 223 VKLDSGAVRKVYTLSGQQVTSLEQFFENDDIFVAYGPEKSAQEDFELDFEETKCVQSFRR 282
Query: 323 DLRRPEHTKLKSGTTCLDASGRE---VPKMPTKTSVARCATATIKR-RENLNI-PSKLLQ 377
CL +S R+ +P+MP K+ T ++ + +I P L
Sbjct: 283 ---------------CLWSSKRQSGPMPRMPRKSGKKTLTTPQVRTPSPSFSILPQPLRL 327
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
Y+VG IIG+GNFAVVR K ++ A+KI+D + GK +M+ +EV ILR V HPNI
Sbjct: 328 HYAVGHIIGEGNFAVVRHCIHKSTGVEYAVKIVDMYRCQGK-EMLASEVAILRQVCHPNI 386
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
I L+ E +T N+L+LV+EL+KGGDLFDAI+ KFSE ++ M L SAL+YLH ++IV
Sbjct: 387 ISLIAEQETANQLFLVMELVKGGDLFDAIAAATKFSEAEASVMIGHLTSALAYLHSHHIV 446
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKI 557
HRD+KPENLLVEM G HV+ LK+GDFGLAQ V P++TVCGTPTYVAPEIL E+GYG+KI
Sbjct: 447 HRDVKPENLLVEMDGSHVRCLKLGDFGLAQVVREPLYTVCGTPTYVAPEILAETGYGLKI 506
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
DVWAAGVILYILLCGFPPFVS N+Q+ELF+ ILSGQY F SPYWD IS+ AK+LIS+ML
Sbjct: 507 DVWAAGVILYILLCGFPPFVSPENEQEELFERILSGQYEFTSPYWDAISDSAKQLISNML 566
Query: 618 ESNPDLRFSAEDVLDHPWLERS 639
++ P+LRF+AEDVLDHPWL +S
Sbjct: 567 QAQPELRFTAEDVLDHPWLAQS 588
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156548886|ref|XP_001606514.1| PREDICTED: serine/threonine-protein kinase GA29083-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1573), Expect = e-172, Method: Compositional matrix adjust.
Identities = 301/547 (55%), Positives = 385/547 (70%), Gaps = 25/547 (4%)
Query: 97 SRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMD 156
+R+AKRIRF NGDKF+ GVV+AV PERYRSFDSL+ +LTRAL N+ LP+GVRI++TMD
Sbjct: 59 TRKAKRIRFFRNGDKFYNGVVIAVTPERYRSFDSLIADLTRALVSNVTLPNGVRIIYTMD 118
Query: 157 GQKVTNIDELEDGKFYICSSSGDQFKKVDYAI--LNNNNSSNTLPRSGKFITKSAPPRVN 214
G+KV +I +LEDGK Y+ S G+ FKKVDY+ + NS + LP S ++ ++N
Sbjct: 119 GKKVQDISDLEDGKCYVVSGQGEVFKKVDYSSSSVKRGNSLSGLPSSSTISSR----QIN 174
Query: 215 KTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVY 274
P V+ RII +IRNG +PRK+VR LLNKRN+PS++ IT+++KLD+GAVRKVY
Sbjct: 175 SIP--LCVKARIITLIRNGTKPRKIVRLLLNKRNSPSVEHVLGAITEVIKLDSGAVRKVY 232
Query: 275 TLNGNQLARLSDFFKSDDVFFAYGSERVLPDDFELDVEEVKAIQALKKDLRRPEHTKLKS 334
+L G Q+ L FF D++F YG E+ +DFELD EE K +Q +K
Sbjct: 233 SLAGQQITLLEQFFDEDEIFIVYGLEKPNHEDFELDFEESKCVQGFRK------------ 280
Query: 335 GTTCLDASGREVPKMPTKTSVARCATATIKRREN-----LNIPSKLLQRYSVGQIIGDGN 389
G + +PKMP + + + ++ T++ N P L YS+G IIGDGN
Sbjct: 281 GHCSIKKHNGPMPKMPARNKLDKRSSYTLQSARTPSPSASNFPIPLKFHYSIGHIIGDGN 340
Query: 390 FAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNE 449
FAVVRQ K ALKIIDK+K GK+ M+ EV ILR V HPNII L++E +TN+
Sbjct: 341 FAVVRQCVHKASGTSYALKIIDKNKCQGKESMLAREVAILRQVCHPNIISLIEEQETNDH 400
Query: 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE 509
L+L++ELIKGGDLFDAI+ KFSE D+ M L AL+YLH + IVHRD+KPENLLV+
Sbjct: 401 LFLIMELIKGGDLFDAIATATKFSEADASIMISHLCYALAYLHSHQIVHRDVKPENLLVQ 460
Query: 510 MSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYIL 569
+G + LK+ DFGLAQ V P++T+CGTPTYVAPEIL E GYG+KIDVWAAGVILYIL
Sbjct: 461 TNGNRIHCLKLADFGLAQVVQEPLYTICGTPTYVAPEILAEVGYGLKIDVWAAGVILYIL 520
Query: 570 LCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAED 629
LCGFPPFVS N+Q++LF+ IL GQY F SPYWD+IS+ AKELIS+ML++ P+LRFSAED
Sbjct: 521 LCGFPPFVSTDNEQEKLFERILCGQYEFTSPYWDNISQSAKELISNMLQAQPELRFSAED 580
Query: 630 VLDHPWL 636
VLDHPWL
Sbjct: 581 VLDHPWL 587
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328790668|ref|XP_394386.4| PREDICTED: serine/threonine-protein kinase GD17699-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1568), Expect = e-171, Method: Compositional matrix adjust.
Identities = 301/547 (55%), Positives = 397/547 (72%), Gaps = 22/547 (4%)
Query: 97 SRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMD 156
+++AKR+RF NGDKF+ G+VMAV PERYRSFDSL +LTRAL ++ LP+GVR ++TMD
Sbjct: 62 TKKAKRVRFFRNGDKFYTGIVMAVTPERYRSFDSLATDLTRALISSVTLPNGVRAIYTMD 121
Query: 157 GQKVTNIDELEDGKFYICSSSGDQFKKVDYAI--LNNNNSSNTLPRSGKFITKSAPPRVN 214
G+KV +I++LEDGK Y+ S G+ FKKV+Y+ + +S + LP+S + +++
Sbjct: 122 GKKVQSINDLEDGKCYVVSGQGEIFKKVEYSSTKVRRGSSLSGLPQSPAGTGR----QIS 177
Query: 215 KTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVY 274
P V+ +II +IR+G +PRKVVR LLNKRNAPSL+ IT+ VKLD+GAVRKVY
Sbjct: 178 AIP--LCVKAKIITLIRHGTKPRKVVRLLLNKRNAPSLEHALEAITEAVKLDSGAVRKVY 235
Query: 275 TLNGNQLARLSDFFKSDDVFFAYGSERVLPDDFELDVEEVKAIQALKKDLRRPEHTKLKS 334
TL+G Q+ L FF++DD+F AYG E+ +DFELD EE K++Q+ + R P +K +S
Sbjct: 236 TLSGQQVTSLEQFFENDDIFVAYGPEKSNQEDFELDFEESKSVQSFR---RCPWTSKRQS 292
Query: 335 GTTCLDASGREVPKMPTKTSVARCATATIK--RRENLNIPSKLLQRYSVGQIIGDGNFAV 392
G +P+MP K+ T ++ +L +P L Y+VG +IG+GNFAV
Sbjct: 293 GP---------MPRMPRKSGKKVLTTPQVRTPSPSSLILPQPLRLHYAVGHVIGEGNFAV 343
Query: 393 VRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452
VR K ++ A+KI+DK K GK+ M +EV+ILR V HPNII L+ E +T ++L+L
Sbjct: 344 VRHCSHKSTGVEYAMKIVDKYKCQGKETMWASEVSILRQVCHPNIINLIAEQETTDQLFL 403
Query: 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG 512
V+EL+KGGDLFDAI+ KFSE ++ M L SAL+YLH ++IVHRD+KPENLLVEM G
Sbjct: 404 VMELVKGGDLFDAIAAATKFSESEASVMIGHLTSALAYLHSHHIVHRDVKPENLLVEMDG 463
Query: 513 CHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCG 572
HV+ LK+ DFGLAQ V P++TVCGTPTYVAPEIL E+GYG+KIDVWAAGVILYILLCG
Sbjct: 464 NHVRCLKLCDFGLAQVVREPLYTVCGTPTYVAPEILAETGYGLKIDVWAAGVILYILLCG 523
Query: 573 FPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632
FPPF S N Q+ELF+ ILSGQY F SP+WDDIS+ AK+LIS+ML++ P+LRF AEDVLD
Sbjct: 524 FPPFASPENKQEELFERILSGQYDFRSPFWDDISDSAKQLISNMLQTQPELRFGAEDVLD 583
Query: 633 HPWLERS 639
HPWL +S
Sbjct: 584 HPWLAQS 590
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380014233|ref|XP_003691144.1| PREDICTED: serine/threonine-protein kinase GL21140-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1566), Expect = e-171, Method: Compositional matrix adjust.
Identities = 301/547 (55%), Positives = 397/547 (72%), Gaps = 22/547 (4%)
Query: 97 SRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMD 156
+++AKR+RF NGDKF+ G+VMAV PERYRSFDSL +LTRAL ++ LP+GVR ++TMD
Sbjct: 53 TKKAKRVRFFRNGDKFYTGIVMAVTPERYRSFDSLATDLTRALISSVTLPNGVRAIYTMD 112
Query: 157 GQKVTNIDELEDGKFYICSSSGDQFKKVDYAI--LNNNNSSNTLPRSGKFITKSAPPRVN 214
G+KV +I++LEDGK Y+ S G+ FKKV+Y+ + +S + LP+S + +++
Sbjct: 113 GKKVQSINDLEDGKCYVVSGQGEIFKKVEYSSTKVRRGSSLSGLPQSPAGTGR----QIS 168
Query: 215 KTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVY 274
P V+ +II +IR+G +PRKVVR LLNKRNAPSL+ IT+ VKLD+GAVRKVY
Sbjct: 169 AIP--LCVKAKIITLIRHGTKPRKVVRLLLNKRNAPSLEHALEAITEAVKLDSGAVRKVY 226
Query: 275 TLNGNQLARLSDFFKSDDVFFAYGSERVLPDDFELDVEEVKAIQALKKDLRRPEHTKLKS 334
TL+G Q+ L FF++DD+F AYG E+ +DFELD EE K++Q+ + R P +K +S
Sbjct: 227 TLSGQQVTSLEQFFENDDIFVAYGPEKSNQEDFELDFEESKSVQSFR---RCPWTSKRQS 283
Query: 335 GTTCLDASGREVPKMPTKTSVARCATATIK--RRENLNIPSKLLQRYSVGQIIGDGNFAV 392
G +P+MP K+ T ++ +L +P L Y+VG +IG+GNFAV
Sbjct: 284 GP---------MPRMPRKSGKKVLTTPQVRTPSPSSLILPQPLRLHYAVGHVIGEGNFAV 334
Query: 393 VRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452
VR K ++ A+KI+DK K GK+ M +EV+ILR V HPNII L+ E +T ++L+L
Sbjct: 335 VRHCSHKSTGVEYAMKIVDKYKCQGKETMWASEVSILRQVCHPNIINLIAEQETTDQLFL 394
Query: 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG 512
V+EL+KGGDLFDAI+ KFSE ++ M L SAL+YLH ++IVHRD+KPENLLVEM G
Sbjct: 395 VMELVKGGDLFDAIAAATKFSENEASVMIGHLTSALAYLHSHHIVHRDVKPENLLVEMDG 454
Query: 513 CHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCG 572
HV+ LK+ DFGLAQ V P++TVCGTPTYVAPEIL E+GYG+KIDVWAAGVILYILLCG
Sbjct: 455 NHVRCLKLCDFGLAQVVREPLYTVCGTPTYVAPEILAETGYGLKIDVWAAGVILYILLCG 514
Query: 573 FPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632
FPPF S N Q+ELF+ ILSGQY F SP+WDDIS+ AK+LIS+ML++ P+LRF AEDVLD
Sbjct: 515 FPPFASPENKQEELFERILSGQYDFRSPFWDDISDSAKQLISNMLQTQPELRFGAEDVLD 574
Query: 633 HPWLERS 639
HPWL +S
Sbjct: 575 HPWLAQS 581
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|91093116|ref|XP_967543.1| PREDICTED: similar to AGAP009034-PA [Tribolium castaneum] gi|270001184|gb|EEZ97631.1| hypothetical protein TcasGA2_TC016079 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1566), Expect = e-171, Method: Compositional matrix adjust.
Identities = 312/558 (55%), Positives = 386/558 (69%), Gaps = 39/558 (6%)
Query: 93 SPLKSRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRIL 152
S ++++AKRIRF NG+KFF GVV+ V PERYRSFDSL ELT L +N+ LPSGVR +
Sbjct: 43 STSRTQKAKRIRFYHNGNKFFNGVVIPVAPERYRSFDSLTTELTNILTKNVTLPSGVRNI 102
Query: 153 FTMDGQKVTNIDELEDGKFYICSSSGDQFKKVDYAI--------LNNNNSSNTLPRSGKF 204
++M+G+KV ++D+LEDGK Y+CS G+ FK+++Y L+N +N+L + +
Sbjct: 103 YSMEGKKVCSLDDLEDGKEYVCSGKGEMFKRIEYTKTDTLRSKKLSNTKFNNSLTHTPRI 162
Query: 205 ITKSAPPRVNKTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVK 264
I PP VRPRI+ +IRNGI+PRK++R L+NKRNA S++Q S +T+ +
Sbjct: 163 I----PPDC--------VRPRIVTIIRNGIKPRKIIRLLINKRNASSMEQALSALTEAAQ 210
Query: 265 LDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAYGSERVLPDDFELDVEEVKAIQALKKDL 324
LD+GAVRKV+TL+G + LS FF S+DVFF YG+ER DDFEL+ EE KAIQ KK
Sbjct: 211 LDSGAVRKVFTLSGQAVTNLSQFFSSEDVFFVYGNERFSQDDFELEFEESKAIQQYKK-- 268
Query: 325 RRPEHTKLKSGTTCLDASGREVPKMPTKT-----SVARCATATIKRRENLNIPSKLLQRY 379
T L PKMP K + + N+ +P L Q+Y
Sbjct: 269 -----------TPGLKNGAGPKPKMPKKELNRTYESSESLLRKLSEDNNIILPLSLRQKY 317
Query: 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439
+VG++IGDGNFAVVR D + ALKIIDKSK GK+ MIENEV ILR VNHPNI+
Sbjct: 318 TVGRMIGDGNFAVVRLCKSATSDEEFALKIIDKSKCKGKEDMIENEVKILRRVNHPNIMS 377
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
L+ E DT LYLV E +KGGDLFDAI+ KFSEE + M L SAL+YLH+ IVHR
Sbjct: 378 LIAEQDTKTMLYLVCEYVKGGDLFDAITVAQKFSEEQAALMINHLVSALAYLHNLNIVHR 437
Query: 500 DIKPENLLVEMSG-CHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKID 558
D+KPENLLVE G +K+LK+GDFGLA V RP+FTVCGTPTYVAPEIL ESGYG+KID
Sbjct: 438 DVKPENLLVEFDGENRIKLLKLGDFGLACEVTRPLFTVCGTPTYVAPEILAESGYGLKID 497
Query: 559 VWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLE 618
VWAAGVILYILLCG+PPFVS NDQ++LFD ILSGQY FP YW D+S AKELI +ML+
Sbjct: 498 VWAAGVILYILLCGYPPFVSQDNDQEKLFDCILSGQYDFPDEYWKDVSGLAKELIQNMLQ 557
Query: 619 SNPDLRFSAEDVLDHPWL 636
P+LRFSAEDVLDHPWL
Sbjct: 558 LAPELRFSAEDVLDHPWL 575
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350411796|ref|XP_003489455.1| PREDICTED: serine/threonine-protein kinase GD17699-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 604 bits (1558), Expect = e-170, Method: Compositional matrix adjust.
Identities = 298/547 (54%), Positives = 395/547 (72%), Gaps = 22/547 (4%)
Query: 97 SRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMD 156
+++AKR+RF NGDKF+ G+VMAV PERYRSFDSL +LTRAL ++ LP+GVR ++TMD
Sbjct: 54 TKKAKRVRFFRNGDKFYTGIVMAVTPERYRSFDSLASDLTRALISSVTLPNGVRAIYTMD 113
Query: 157 GQKVTNIDELEDGKFYICSSSGDQFKKVDYAI--LNNNNSSNTLPRSGKFITKSAPPRVN 214
G+KV +I++LEDGK Y+ S G+ FKKV+Y+ + +S + LP+S + +++
Sbjct: 114 GKKVQSINDLEDGKCYVVSGQGEIFKKVEYSSTKVRRGSSLSGLPQSPAGTGR----QIS 169
Query: 215 KTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVY 274
P V+ +I+ +IR+G +PRKVVR LLNKRNAPSL+ IT+ VKLD+GAVRKVY
Sbjct: 170 AIP--LCVKAKIVTLIRHGTKPRKVVRLLLNKRNAPSLEHAMEAITEAVKLDSGAVRKVY 227
Query: 275 TLNGNQLARLSDFFKSDDVFFAYGSERVLPDDFELDVEEVKAIQALKKDLRRPEHTKLKS 334
TL+G Q+ L FF++DD+F AYG E+ +DFELD EE K++Q+ + R P +K +
Sbjct: 228 TLSGQQVTSLEQFFENDDIFIAYGPEKSNQEDFELDFEESKSVQSFR---RCPWTSKRQI 284
Query: 335 GTTCLDASGREVPKMPTKTSVARCATATIK--RRENLNIPSKLLQRYSVGQIIGDGNFAV 392
G +P+MP K+ T ++ +L +P L Y+VG +IG+GNFA+
Sbjct: 285 GP---------MPRMPRKSGKKVLTTPQVRTPSPSSLILPQPLRLHYAVGHVIGEGNFAI 335
Query: 393 VRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452
VR K + A+KI+DK K GK+ M +EV+ILR V HPNII L+ E +T ++L+L
Sbjct: 336 VRHCSHKSTGAEYAMKIVDKYKCQGKETMWASEVSILRQVCHPNIINLIAEQETTDQLFL 395
Query: 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG 512
V+EL+KGGDLFDAI+ KFSE ++ M L SAL+YLH + IVHRD+KPENLLVEM G
Sbjct: 396 VMELVKGGDLFDAIAAATKFSESEASVMIGHLTSALAYLHSHQIVHRDVKPENLLVEMDG 455
Query: 513 CHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCG 572
HV+ LK+ DFGLAQ V P++TVCGTPTYVAPEIL E+GYG+KIDVWAAGVILYILLCG
Sbjct: 456 NHVRCLKLCDFGLAQVVREPLYTVCGTPTYVAPEILAETGYGLKIDVWAAGVILYILLCG 515
Query: 573 FPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632
FPPF S N Q+ELF+ ILSGQY F SP+WD+IS+ AK+LIS+ML++ P+LRFSAEDVLD
Sbjct: 516 FPPFASPENKQEELFERILSGQYDFRSPFWDEISDSAKQLISNMLQTQPELRFSAEDVLD 575
Query: 633 HPWLERS 639
HPWL +S
Sbjct: 576 HPWLAQS 582
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 639 | ||||||
| UNIPROTKB|B4NSS9 | 743 | GD17699 "Serine/threonine-prot | 0.619 | 0.532 | 0.506 | 8.7e-132 | |
| UNIPROTKB|B4IMC3 | 744 | GM11705 "Serine/threonine-prot | 0.622 | 0.534 | 0.506 | 1.1e-131 | |
| UNIPROTKB|B4IT27 | 750 | GE16371 "Serine/threonine-prot | 0.622 | 0.530 | 0.503 | 1.6e-130 | |
| ZFIN|ZDB-GENE-050420-170 | 810 | dclk2 "doublecortin-like kinas | 0.420 | 0.332 | 0.607 | 2e-130 | |
| FB|FBgn0261387 | 748 | CG17528 [Drosophila melanogast | 0.621 | 0.530 | 0.502 | 2.6e-130 | |
| UNIPROTKB|B3NKK1 | 745 | GG21441 "Serine/threonine-prot | 0.621 | 0.532 | 0.497 | 3e-129 | |
| UNIPROTKB|E1BLC5 | 706 | DCLK2 "Uncharacterized protein | 0.413 | 0.373 | 0.602 | 3e-129 | |
| RGD|1308384 | 767 | Dclk2 "doublecortin-like kinas | 0.472 | 0.393 | 0.546 | 3.8e-129 | |
| UNIPROTKB|Q5MPA9 | 767 | Dclk2 "Serine/threonine-protei | 0.472 | 0.393 | 0.546 | 3.8e-129 | |
| UNIPROTKB|Q8N568 | 766 | DCLK2 "Serine/threonine-protei | 0.472 | 0.394 | 0.543 | 1.3e-128 |
| UNIPROTKB|B4NSS9 GD17699 "Serine/threonine-protein kinase GD17699" [Drosophila simulans (taxid:7240)] | Back alignment and assigned GO terms |
|---|
Score = 1040 (371.2 bits), Expect = 8.7e-132, Sum P(2) = 8.7e-132
Identities = 208/411 (50%), Positives = 283/411 (68%)
Query: 238 KVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAY 297
+++R LLNKRN+PS D + IT +V+LDTG VRKV+TL+G + RLSDFF SDDVFFAY
Sbjct: 322 RIMRLLLNKRNSPSFDHVLTAITQVVRLDTGYVRKVFTLSGVSVVRLSDFFGSDDVFFAY 381
Query: 298 GSERV-LPDDFELDVEEVKAIQALKKDLRRPEHT--------KLKSGTT---CLDASGRE 345
G+ER+ +DF+L+ EE +AI ++K +R T +KS +D+ +
Sbjct: 382 GTERINTAEDFKLEAEEHRAINVIRKTMRTTGTTCKGPKPKMPIKSKKVYPPVVDSEAFK 441
Query: 346 VPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDC 405
P S A T+T E +PS + Y++G+IIGDGNFA+V ++ +
Sbjct: 442 AATTPEDDSHAALLTST--GMEINELPSNIRNTYTLGRIIGDGNFAIVFKIKHRQTGHSY 499
Query: 406 ALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDA 465
ALKIIDK+K GK+ I+ EV +++ +NHP+II L+ D N +YLV+E + GGDLFDA
Sbjct: 500 ALKIIDKNKCKGKEHYIDAEVRVMKKLNHPHIISLILSVDQNTNMYLVLEYVSGGDLFDA 559
Query: 466 ISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC-HVKVLKVGDFG 524
I++ +FSE S+ M + L +A++YLH IVHRDIKPENLLV++ HV LK+ DFG
Sbjct: 560 ITQVTRFSESQSRIMIRHLGAAMTYLHSMGIVHRDIKPENLLVKLDEHGHVLELKLADFG 619
Query: 525 LAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD 584
LA V ++ VCGTPTYVAPEIL E GYG+KIDVWAAG+ILYILLCGFPPFV+ N Q+
Sbjct: 620 LACEVNDLLYAVCGTPTYVAPEILLEVGYGLKIDVWAAGIILYILLCGFPPFVAPDNQQE 679
Query: 585 ELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
LFD I+SG Y FP PYW DI + ++LI++ML+++PD+RF++ED+LDHPW
Sbjct: 680 PLFDAIISGIYEFPDPYWSDIGDGVRDLIANMLQADPDVRFTSEDILDHPW 730
|
|
| UNIPROTKB|B4IMC3 GM11705 "Serine/threonine-protein kinase GM11705" [Drosophila sechellia (taxid:7238)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 1.1e-131, Sum P(2) = 1.1e-131
Identities = 207/409 (50%), Positives = 279/409 (68%)
Query: 238 KVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAY 297
+++R LLNKRN+PS D + IT +V+LDTG VRKV+TL+G + RLSDFF SDDVFFAY
Sbjct: 322 RIMRLLLNKRNSPSFDHVLTAITQVVRLDTGYVRKVFTLSGVSVVRLSDFFGSDDVFFAY 381
Query: 298 GSERV-LPDDFELDVEEVKAIQALKKDLRRPEHT--------KLKSGTTCLDASGREVPK 348
G+ER+ +DF+L+ EE +AI ++K +R T +KS E K
Sbjct: 382 GTERINTAEDFKLEAEEHRAINVIRKTMRTTGTTCKGPKPKMPIKSKKVYPPVVDSEAFK 441
Query: 349 MPTKTSVARCATATIKRRENLN-IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCAL 407
T R A +N +PS + Y++G+IIGDGNFA+V ++ + AL
Sbjct: 442 AATTPEDDRHAALLTSTGMEINELPSNIRNTYTLGRIIGDGNFAIVFKIKHRQTGHSYAL 501
Query: 408 KIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAIS 467
KIIDK+K GK+ I+ EV +++ +NHP+II L+ D N +YLV+E + GGDLFDAI+
Sbjct: 502 KIIDKNKCKGKEHYIDAEVRVMKKLNHPHIISLILSVDQNTNMYLVLEYVSGGDLFDAIT 561
Query: 468 KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC-HVKVLKVGDFGLA 526
+ +FSE S+ M + L +A++YLH IVHRDIKPENLLV++ HV LK+ DFGLA
Sbjct: 562 QVTRFSESQSRIMIRHLGAAMTYLHSMGIVHRDIKPENLLVKLDEHGHVLELKLADFGLA 621
Query: 527 QRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDEL 586
V ++ VCGTPTYVAPEIL E GYG+KIDVWAAG+ILYILLCGFPPFV+ N Q+ L
Sbjct: 622 CEVNDLLYAVCGTPTYVAPEILLEVGYGLKIDVWAAGIILYILLCGFPPFVAPDNQQEPL 681
Query: 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
FD I+SG Y FP PYW DI + ++LI++ML+++PD+RF++ED+LDHPW
Sbjct: 682 FDAIISGIYEFPDPYWSDIGDGVRDLIANMLQADPDVRFTSEDILDHPW 730
|
|
| UNIPROTKB|B4IT27 GE16371 "Serine/threonine-protein kinase GE16371" [Drosophila yakuba (taxid:7245)] | Back alignment and assigned GO terms |
|---|
Score = 1030 (367.6 bits), Expect = 1.6e-130, Sum P(2) = 1.6e-130
Identities = 206/409 (50%), Positives = 282/409 (68%)
Query: 238 KVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAY 297
+++R LLNKRN+PS D + IT +V+LDTG VRKV+TL+G + +LSDFF+SDDVFFAY
Sbjct: 328 RIMRLLLNKRNSPSFDHVLTAITQVVRLDTGYVRKVFTLSGISVVQLSDFFESDDVFFAY 387
Query: 298 GSERV-LPDDFELDVEEVKAIQALKKDLRRPEHT--------KLKSGTTCLDASGREVPK 348
G+ER+ +DF+L+ EE+KAI ++K +R T +KS + E K
Sbjct: 388 GTERINTAEDFKLEPEELKAINVIRKTMRTAGTTCKGPKPKMPIKSKKVYPPSVNSEAFK 447
Query: 349 MPTKTSVARCATATIKRRENLN-IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCAL 407
T R AT +N +PS + Y++G+IIGDGNFA+V ++ + AL
Sbjct: 448 AATAPEDDRHATLLTSTGIEINELPSNIRSTYTLGKIIGDGNFAIVFKIKHRQTGDSYAL 507
Query: 408 KIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAIS 467
KIIDK+K GK+ I+ EV +++ +NHP+II L+ D N +YLV+E + GGDLFDAI+
Sbjct: 508 KIIDKNKCKGKEHYIDAEVRVMKKLNHPHIISLILSVDQNTNMYLVLEYVSGGDLFDAIT 567
Query: 468 KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC-HVKVLKVGDFGLA 526
+ +F+E S+ M + L +A++YLH IVHRDIKPENLLV++ +V LK+ DFGLA
Sbjct: 568 QVTRFAESQSRIMIRHLGAAMTYLHSMGIVHRDIKPENLLVKLDEHGNVLELKLADFGLA 627
Query: 527 QRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDEL 586
V ++ VCGTPTYVAPEIL E GYG+KIDVWAAG+ILYILLCGFPPFV+ N Q+ L
Sbjct: 628 CEVNDLLYAVCGTPTYVAPEILLEVGYGLKIDVWAAGIILYILLCGFPPFVAPDNQQEPL 687
Query: 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
FD I+SG Y FP PYW DI + ++LI++ML+S+PD+RF++ED+LDH W
Sbjct: 688 FDAIISGIYEFPDPYWSDIGDGVRDLIANMLQSDPDVRFTSEDILDHYW 736
|
|
| ZFIN|ZDB-GENE-050420-170 dclk2 "doublecortin-like kinase 2" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 863 (308.9 bits), Expect = 2.0e-130, Sum P(2) = 2.0e-130
Identities = 164/270 (60%), Positives = 208/270 (77%)
Query: 368 NLNIP-SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEV 426
N N+ S +L +Y +G++IGDGNFAVV++ ++ + ALKIIDK+K GK+ +IENEV
Sbjct: 408 NRNLAASTILDKYKIGKVIGDGNFAVVKECVERSTGKEFALKIIDKNKCRGKEHLIENEV 467
Query: 427 NILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLAS 486
+LR V HPNII L++E DT ELYLV+EL+KGGDLFDAI+ + K++E+D+ M LA+
Sbjct: 468 AVLRRVKHPNIIMLIEEVDTPAELYLVMELVKGGDLFDAITSSTKYTEKDASVMVFDLAA 527
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPE 546
AL YLH IVHRDIKPENLLV K LK+GDFGLA V P++TVCGTPTYVAPE
Sbjct: 528 ALKYLHRMCIVHRDIKPENLLVCEYPNGTKSLKLGDFGLATVVEGPLYTVCGTPTYVAPE 587
Query: 547 ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606
I+ ESGYG+K+D+WAAGVI YILLCGFPPF S+ N Q++LFD IL G FPSP+WD+IS
Sbjct: 588 IIAESGYGLKVDIWAAGVITYILLCGFPPFRSENNLQEDLFDQILLGHLEFPSPFWDNIS 647
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWL 636
+ AKELI HML+ N + R++AEDVL HPW+
Sbjct: 648 DSAKELIGHMLQVNVEARYTAEDVLSHPWV 677
|
|
| FB|FBgn0261387 CG17528 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1026 (366.2 bits), Expect = 2.6e-130, Sum P(2) = 2.6e-130
Identities = 206/410 (50%), Positives = 280/410 (68%)
Query: 238 KVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAY 297
+++R LLNKRN+PS D + IT +V+LDTG VRKV+TL+G + RLSDFF SDDVFFAY
Sbjct: 326 RIMRLLLNKRNSPSFDHVLTAITQVVRLDTGYVRKVFTLSGIPVVRLSDFFGSDDVFFAY 385
Query: 298 GSERV-LPDDFELDVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREV-PKM----PT 351
G+ER+ +DF+L+ EE +AI ++K +R T K + ++V P + P
Sbjct: 386 GTERINTAEDFKLEAEEQRAINVIRKTMRTTG-TTCKGPKPKMPIKSKKVYPPLVDSEPF 444
Query: 352 KTSVA-----RCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCA 406
K A T E +PS + YS+G+IIGDGNFA+V ++ + A
Sbjct: 445 KAETTPEDDRHAALLTSTGMEINELPSNIRNTYSLGRIIGDGNFAIVFKIKHRQTGHSYA 504
Query: 407 LKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI 466
LKIIDK+K GK+ I+ EV +++ +NHP+II L+ D N +YLV+E + GGDLFDAI
Sbjct: 505 LKIIDKNKCKGKEHYIDAEVRVMKKLNHPHIISLILSVDQNTNMYLVLEYVSGGDLFDAI 564
Query: 467 SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC-HVKVLKVGDFGL 525
++ +FSE S+ M + L +A++YLH IVHRDIKPENLLV++ +V LK+ DFGL
Sbjct: 565 TQVTRFSENQSRIMIRHLGAAMTYLHSMGIVHRDIKPENLLVKLDEHGNVLELKLADFGL 624
Query: 526 AQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDE 585
A V ++ VCGTPTYVAPEIL E GYG+KIDVWAAG+ILYILLCGFPPFV+ N Q+
Sbjct: 625 ACEVNDLLYAVCGTPTYVAPEILLEVGYGLKIDVWAAGIILYILLCGFPPFVAPDNQQEP 684
Query: 586 LFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
LFD I+SG Y FP PYW DI + ++LI++ML+++PD+RF++ED+LDH W
Sbjct: 685 LFDAIISGIYEFPDPYWSDIGDGVRDLIANMLQADPDVRFTSEDILDHSW 734
|
|
| UNIPROTKB|B3NKK1 GG21441 "Serine/threonine-protein kinase GG21441" [Drosophila erecta (taxid:7220)] | Back alignment and assigned GO terms |
|---|
Score = 1019 (363.8 bits), Expect = 3.0e-129, Sum P(2) = 3.0e-129
Identities = 204/410 (49%), Positives = 281/410 (68%)
Query: 238 KVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAY 297
+++R LLNKRN+PS D + IT +V+LDTG VRKV+TL+G + +LSDFF SDDVFFAY
Sbjct: 328 RIMRLLLNKRNSPSFDHVLTAITQVVRLDTGYVRKVFTLSGISVVQLSDFFGSDDVFFAY 387
Query: 298 GSERV-LPDDFELDVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREVPKMPTKTSVA 356
G+ER+ +DF+L+ EE +AI ++K +R T K + ++V + V
Sbjct: 388 GTERINYAEDFKLEAEEYRAINVIRKTMRTAG-TTCKGPKPKMPIKSKKVYPPLVDSEVL 446
Query: 357 RCAT-------ATIKRRENLNI---PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCA 406
+ AT AT+ + I P + Y++G+IIGDGNFA+V ++ + A
Sbjct: 447 KAATSPEDDSHATLLTSTGIEINELPLNIRNTYTLGRIIGDGNFAIVFKIKHRQTGDSYA 506
Query: 407 LKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI 466
LKIIDK+K GK+ I+ EV +++ +NHP+II L+ D N +YLV+E + GGDLFDAI
Sbjct: 507 LKIIDKNKCKGKEHYIDAEVRVMKKLNHPHIISLILSVDQNTNMYLVLEYVSGGDLFDAI 566
Query: 467 SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC-HVKVLKVGDFGL 525
++ +FSE S+ M + L +A++YLH IVHRDIKPENLLV++ +V LK+ DFGL
Sbjct: 567 TQVTRFSESQSRIMIRHLGAAMTYLHSMGIVHRDIKPENLLVKLDEHGNVLELKLADFGL 626
Query: 526 AQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDE 585
A V ++ VCGTPTYVAPEIL E GYG+KIDVWAAG+ILYILLCGFPPFV+ N Q+
Sbjct: 627 ACEVNDLLYAVCGTPTYVAPEILLEVGYGLKIDVWAAGIILYILLCGFPPFVAPDNQQEP 686
Query: 586 LFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
LFD I+SG Y FP PYW DI + ++LI++ML+S+PD+RF++ED+LDH W
Sbjct: 687 LFDAIISGIYEFPDPYWSDIGDGVRDLIANMLQSDPDVRFTSEDILDHYW 736
|
|
| UNIPROTKB|E1BLC5 DCLK2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 843 (301.8 bits), Expect = 3.0e-129, Sum P(2) = 3.0e-129
Identities = 159/264 (60%), Positives = 205/264 (77%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV 432
S LL++Y +G++IGDGNFAVV++ D+ + ALKIIDK+K GK+ +IENEV+ILR V
Sbjct: 403 STLLEKYKIGKVIGDGNFAVVKECMDRSTGKEFALKIIDKAKCCGKEHLIENEVSILRRV 462
Query: 433 NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492
HPNII L++E +T EL+LV+EL+KGGDLFDAI+ + K++E D M +LA+AL YLH
Sbjct: 463 KHPNIIMLIEEMETATELFLVMELVKGGDLFDAITSSTKYTERDGSAMVYNLANALRYLH 522
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESG 552
IVHRDIKPENLLV K LK+GDFGLA V P++TVCGTPTYVAPEI+ E+G
Sbjct: 523 ALNIVHRDIKPENLLVCEYPDGTKSLKLGDFGLATVVEGPLYTVCGTPTYVAPEIIAETG 582
Query: 553 YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612
YG+K+DVWAAGVI YILLCGFPPF S+ N Q++LFD IL+G+ FP+PYWD+I++ AKEL
Sbjct: 583 YGLKVDVWAAGVITYILLCGFPPFRSENNLQEDLFDQILAGKLEFPAPYWDNITDSAKEL 642
Query: 613 ISHMLESNPDLRFSAEDVLDHPWL 636
IS ML+ N + R +A +L HPW+
Sbjct: 643 ISQMLQVNVEARCTAGQILSHPWV 666
|
|
| RGD|1308384 Dclk2 "doublecortin-like kinase 2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 851 (304.6 bits), Expect = 3.8e-129, Sum P(2) = 3.8e-129
Identities = 165/302 (54%), Positives = 216/302 (71%)
Query: 335 GTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVR 394
G + A GR + + RC + + LL++Y +G++IGDGNFAVV+
Sbjct: 365 GLKQISAQGRSSSNVNGGPELDRCMSPEGVNGNRCSESFTLLEKYRIGKVIGDGNFAVVK 424
Query: 395 QVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454
+ D+ + ALKIIDK+K GK+ +IENEV+ILR V HPNII L++E +T EL+LV+
Sbjct: 425 ECMDRSTGKEFALKIIDKAKCCGKEHLIENEVSILRRVKHPNIIMLVEEMETTTELFLVM 484
Query: 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH 514
EL+KGGDLFDAI+ + K++E D M +LASAL YLH IVHRDIKPENLLV
Sbjct: 485 ELVKGGDLFDAITSSTKYTERDGSAMVYNLASALRYLHGLSIVHRDIKPENLLVCEYPDG 544
Query: 515 VKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFP 574
K LK+GDFGLA V P++TVCGTPTYVAPEI+ E+GYG+K+DVWAAGVI YILLCGFP
Sbjct: 545 TKSLKLGDFGLATVVEGPLYTVCGTPTYVAPEIIAETGYGLKVDVWAAGVITYILLCGFP 604
Query: 575 PFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHP 634
PF S+ N Q++LFD IL+G+ FP+PYWD+I++ AKELIS ML+ N + R +A ++L HP
Sbjct: 605 PFRSENNLQEDLFDQILAGKLEFPAPYWDNITDSAKELISQMLQVNVEARCTAGEILSHP 664
Query: 635 WL 636
W+
Sbjct: 665 WV 666
|
|
| UNIPROTKB|Q5MPA9 Dclk2 "Serine/threonine-protein kinase DCLK2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 851 (304.6 bits), Expect = 3.8e-129, Sum P(2) = 3.8e-129
Identities = 165/302 (54%), Positives = 216/302 (71%)
Query: 335 GTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVR 394
G + A GR + + RC + + LL++Y +G++IGDGNFAVV+
Sbjct: 365 GLKQISAQGRSSSNVNGGPELDRCMSPEGVNGNRCSESFTLLEKYRIGKVIGDGNFAVVK 424
Query: 395 QVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454
+ D+ + ALKIIDK+K GK+ +IENEV+ILR V HPNII L++E +T EL+LV+
Sbjct: 425 ECMDRSTGKEFALKIIDKAKCCGKEHLIENEVSILRRVKHPNIIMLVEEMETTTELFLVM 484
Query: 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH 514
EL+KGGDLFDAI+ + K++E D M +LASAL YLH IVHRDIKPENLLV
Sbjct: 485 ELVKGGDLFDAITSSTKYTERDGSAMVYNLASALRYLHGLSIVHRDIKPENLLVCEYPDG 544
Query: 515 VKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFP 574
K LK+GDFGLA V P++TVCGTPTYVAPEI+ E+GYG+K+DVWAAGVI YILLCGFP
Sbjct: 545 TKSLKLGDFGLATVVEGPLYTVCGTPTYVAPEIIAETGYGLKVDVWAAGVITYILLCGFP 604
Query: 575 PFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHP 634
PF S+ N Q++LFD IL+G+ FP+PYWD+I++ AKELIS ML+ N + R +A ++L HP
Sbjct: 605 PFRSENNLQEDLFDQILAGKLEFPAPYWDNITDSAKELISQMLQVNVEARCTAGEILSHP 664
Query: 635 WL 636
W+
Sbjct: 665 WV 666
|
|
| UNIPROTKB|Q8N568 DCLK2 "Serine/threonine-protein kinase DCLK2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 849 (303.9 bits), Expect = 1.3e-128, Sum P(2) = 1.3e-128
Identities = 164/302 (54%), Positives = 216/302 (71%)
Query: 335 GTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVR 394
G + A GR + + RC + + S LL++Y +G++IGDGNFAVV+
Sbjct: 350 GLKQISAHGRSSSNVNGGPELDRCISPEGVNGNRCSESSTLLEKYKIGKVIGDGNFAVVK 409
Query: 395 QVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454
+ D+ + ALKIIDK+K GK+ +IENEV+ILR V HPNII L++E +T EL+LV+
Sbjct: 410 ECIDRSTGKEFALKIIDKAKCCGKEHLIENEVSILRRVKHPNIIMLVEEMETATELFLVM 469
Query: 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH 514
EL+KGGDLFDAI+ + K++E D M +LA+AL YLH IVHRDIKPENLLV
Sbjct: 470 ELVKGGDLFDAITSSTKYTERDGSAMVYNLANALRYLHGLSIVHRDIKPENLLVCEYPDG 529
Query: 515 VKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFP 574
K LK+GDFGLA V P++TVCGTPTYVAPEI+ E+GYG+K+D+WAAGVI YILLCGFP
Sbjct: 530 TKSLKLGDFGLATVVEGPLYTVCGTPTYVAPEIIAETGYGLKVDIWAAGVITYILLCGFP 589
Query: 575 PFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHP 634
PF S+ N Q++LFD IL+G+ FP+PYWD+I++ AKELIS ML+ N + R +A +L HP
Sbjct: 590 PFRSENNLQEDLFDQILAGKLEFPAPYWDNITDSAKELISQMLQVNVEARCTAGQILSHP 649
Query: 635 WL 636
W+
Sbjct: 650 WV 651
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| D2I3C6 | DCLK2_AILME | 2, ., 7, ., 1, 1, ., 1 | 0.4361 | 0.8388 | 0.6836 | yes | N/A |
| Q8N568 | DCLK2_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.4537 | 0.8419 | 0.7023 | yes | N/A |
| Q95QC4 | DCLK_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.3953 | 0.8122 | 0.6471 | yes | N/A |
| Q7PLI7 | DCLK_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.4393 | 0.9045 | 0.7727 | yes | N/A |
| B5DK35 | DCLK_DROPS | 2, ., 7, ., 1, 1, ., 1 | 0.4629 | 0.8372 | 0.7086 | yes | N/A |
| Q5MPA9 | DCLK2_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.4333 | 0.8403 | 0.7001 | yes | N/A |
| Q6PGN3 | DCLK2_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.4537 | 0.8403 | 0.7103 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 639 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-102 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-87 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-72 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-71 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-66 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-63 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-57 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-57 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-55 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-54 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-54 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-53 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-51 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-48 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-48 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-47 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-47 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-45 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-44 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-44 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-44 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-43 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-43 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-42 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-42 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-42 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-42 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-41 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-41 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-41 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-40 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-40 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-40 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-39 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-39 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-39 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-39 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-39 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-39 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-39 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-39 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-39 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-38 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-38 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-38 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-38 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-38 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-37 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-37 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-37 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-37 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-36 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-36 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-36 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-36 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-35 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-35 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-35 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-35 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-35 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-35 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-34 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-34 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-33 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-33 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-33 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-33 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-33 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-32 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-32 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-32 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-32 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-32 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-31 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-31 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-31 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-31 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-31 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-31 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-30 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-30 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-30 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-30 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-30 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-30 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-30 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-29 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-29 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-29 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-29 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-29 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-29 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-29 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-29 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-29 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-29 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-28 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-28 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-28 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-28 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-28 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-28 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-27 | |
| smart00537 | 89 | smart00537, DCX, Domain in the Doublecortin (DCX) | 3e-27 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-26 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-26 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-26 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-26 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-26 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-26 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-26 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-25 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-25 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-25 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-25 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-25 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-24 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-24 | |
| cd01617 | 80 | cd01617, DCX, Ubiquitin-like domain of DCX | 7e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-24 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-23 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-23 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-23 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-23 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-22 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-22 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-22 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-21 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-21 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-21 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-21 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-21 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-21 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-21 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-20 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-20 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-19 | |
| pfam03607 | 60 | pfam03607, DCX, Doublecortin | 1e-18 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-18 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-18 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-18 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-18 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-17 | |
| smart00537 | 89 | smart00537, DCX, Domain in the Doublecortin (DCX) | 3e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-16 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-15 | |
| cd01617 | 80 | cd01617, DCX, Ubiquitin-like domain of DCX | 8e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| pfam03607 | 60 | pfam03607, DCX, Doublecortin | 3e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 309 bits (795), Expect = e-102
Identities = 109/260 (41%), Positives = 161/260 (61%), Gaps = 8/260 (3%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNII 438
Y + + +G+G+F V DK A+K+I K K+ ++ I E+ IL+ + HPNI+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
+L D ++ ++LYLV+E +GGDLFD + K + SE++++F + + SAL YLH IVH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF--TVCGTPTYVAPEILNESGYGVK 556
RD+KPEN+L++ G +K+ DFGLA+++ T GTP Y+APE+L GYG
Sbjct: 121 RDLKPENILLDEDG----HVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 557 IDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616
+D+W+ GVILY LL G PPF + ELF I + FP P W DIS EAK+LI +
Sbjct: 177 VDIWSLGVILYELLTGKPPF-PGDDQLLELFKKIGKPKPPFPPPEW-DISPEAKDLIRKL 234
Query: 617 LESNPDLRFSAEDVLDHPWL 636
L +P+ R +AE+ L HP+
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 272 bits (697), Expect = 4e-87
Identities = 111/264 (42%), Positives = 160/264 (60%), Gaps = 10/264 (3%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNI 437
Y + + +G G+F V + K A+KI+ K K Q E+ ILR ++HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
++L+D ++ + LYLV+E +GGDLFD +S+ SE+++K + + L YLH N I+
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNES-GY 553
HRD+KPEN+L++ +G V+K+ DFGLA+++L+ + T GTP Y+APE+L GY
Sbjct: 121 HRDLKPENILLDENG----VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQYGFPSPYWDDISEEAKEL 612
G K+DVW+ GVILY LL G PPF + DQ +L IL F P W SEEAK+L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236
Query: 613 ISHMLESNPDLRFSAEDVLDHPWL 636
I L +P R +AE++L HPW
Sbjct: 237 IKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 8e-72
Identities = 99/266 (37%), Positives = 157/266 (59%), Gaps = 17/266 (6%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNH 434
+ + +G G+F V V K ALKI+ K+K++ KQ+ + NE IL+S+ H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494
P ++ L + ++ LYLV+E + GG+LF + K+ +F E ++F + AL YLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYG 554
IV+RD+KPENLL++ G + +K+ DFG A+RV +T+CGTP Y+APEI+ GYG
Sbjct: 121 DIVYRDLKPENLLLDSDG-Y---IKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYG 176
Query: 555 VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
+D WA G+++Y +L G+PPF D ++++ IL G+ FPS + S +AK+LI
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKILEGKVRFPSFF----SPDAKDLIR 230
Query: 615 HMLESNPDLRF-----SAEDVLDHPW 635
++L+ + R D+ +HPW
Sbjct: 231 NLLQVDLTKRLGNLKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (590), Expect = 2e-71
Identities = 104/261 (39%), Positives = 154/261 (59%), Gaps = 22/261 (8%)
Query: 385 IGDGNFAVVRQVYDKHKDMD--CALKIIDKSKLLGKKQ--MIENEVNILRSVNHPNIIKL 440
+G G+F V V + KD A+K++ K K++ +K+ E NIL +NHP I+KL
Sbjct: 1 LGKGSFGKVLLV--RKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ T +LYLV+E GG+LF +SK +FSEE ++F + AL YLH I++RD
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAPEILNESGYGVKI 557
+KPEN+L++ G H+K L DFGLA+ + T CGTP Y+APE+L GYG +
Sbjct: 119 LKPENILLDADG-HIK-LT--DFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
D W+ GV+LY +L G PPF D+ E+++ IL FP + +S EA++LIS +L
Sbjct: 175 DWWSLGVLLYEMLTGKPPF--YAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLL 228
Query: 618 ESNPDLRF---SAEDVLDHPW 635
+ +P R AE++ HP+
Sbjct: 229 QKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 6e-66
Identities = 98/268 (36%), Positives = 138/268 (51%), Gaps = 23/268 (8%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHPN 436
+Y + + IG G+F V V K LK ID S + K ++ NEV IL+ +NHPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISK----NVKFSEEDS-KFMTQSLASALSYL 491
IIK + ++ +L +V+E GGDL I K F EE + Q L AL YL
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ-LCLALKYL 119
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF----TVCGTPTYVAPEI 547
H I+HRDIKP+N+ + ++K+GDFG++ +VL TV GTP Y++PE+
Sbjct: 120 HSRKILHRDIKPQNIFL----TSNGLVKLGDFGIS-KVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 548 LNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG-FPSPYWDDIS 606
Y K D+W+ G +LY L PF + EL IL GQY PS Y S
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--LLELALKILKGQYPPIPSQY----S 228
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHP 634
E + L+S +L+ +P+ R S +L P
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 2e-63
Identities = 94/264 (35%), Positives = 142/264 (53%), Gaps = 19/264 (7%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ--MIENEVNILRSVNHPNIIKLLD 442
+G G F V V K K+ ALK + K ++ Q I +E IL NHP I+KL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
+ +Y+++E GG+L+ + F E ++F + A YLH+ I++RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRV--LRPMFTVCGTPTYVAPEILNESGYGVKIDVW 560
PENLL++ +G +K+ DFG A+++ + +T CGTP YVAPEI+ GY +D W
Sbjct: 121 PENLLLDSNG----YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 561 AAGVILYILLCGFPPFVSDTNDQDELFDDILSG--QYGFPSPYWDDISEEAKELISHMLE 618
+ G++LY LL G PPF D D E+++DIL G + FP+ I + AK+LI +L
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN----YIDKAAKDLIKQLLR 232
Query: 619 SNPDLRF-----SAEDVLDHPWLE 637
NP+ R +D+ H W
Sbjct: 233 RNPEERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 1e-60
Identities = 86/255 (33%), Positives = 129/255 (50%), Gaps = 45/255 (17%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G+G F V DK A+KII K + + E+ IL+ +NHPNI+KL +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 445 DTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKP 503
+ N LYLV+E +GG L D + +N K SE++ + + L YLH N I+HRD+KP
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 504 ENLLVEMSGCHVKVLKVGDFGLAQRV---LRPMFTVCGTPTYVAPEIL-NESGYGVKIDV 559
EN+L++ V K+ DFGL++ + + T+ GTP Y+APE+L + Y K D+
Sbjct: 121 ENILLDSDNGKV---KLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 560 WAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLES 619
W+ GVILY L E K+LI ML+
Sbjct: 178 WSLGVILYEL-------------------------------------PELKDLIRKMLQK 200
Query: 620 NPDLRFSAEDVLDHP 634
+P+ R SA+++L+H
Sbjct: 201 DPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 2e-57
Identities = 85/267 (31%), Positives = 138/267 (51%), Gaps = 15/267 (5%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM-IENEVNILRSVNHPN 436
++ G+++G G+F V DK A+K ++ S ++ +E E+ IL S+ HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 437 IIKLLDEY--DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494
I++ + N L + +E + GG L + K K E + T+ + L+YLH N
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-----LRPMFTVCGTPTYVAPEILN 549
IVHRDIK N+LV+ G V+K+ DFG A+R+ +V GTP ++APE++
Sbjct: 121 GIVHRDIKGANILVDSDG----VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 550 ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
YG D+W+ G + + G PP+ N L+ SG+ P + +SEEA
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE---PPEIPEHLSEEA 233
Query: 610 KELISHMLESNPDLRFSAEDVLDHPWL 636
K+ + L +P R +A+++L HP+L
Sbjct: 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 3e-57
Identities = 93/288 (32%), Positives = 139/288 (48%), Gaps = 42/288 (14%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQ---MIENEVNILRSVNH 434
+ G+IIG+G+F+ V +K + + A+KI+DK +L+ KK IE EV + R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLNGH 61
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494
P IIKL + LY V+E G+L I K E+ ++F + AL YLH
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ-------------------RVLRPMF- 534
I+HRD+KPEN+L++ H+K+ DFG A+ +
Sbjct: 122 GIIHRDLKPENILLDKDM-HIKIT---DFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 535 ---TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDIL 591
+ GT YV+PE+LNE G D+WA G I+Y +L G PPF + F IL
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYLTFQKIL 235
Query: 592 SGQYGFPSPYWDDISEEAKELISHMLESNPDLR----FSAEDVLDHPW 635
+Y FP + +AK+LI +L +P R +++ HP+
Sbjct: 236 KLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 1e-55
Identities = 88/260 (33%), Positives = 137/260 (52%), Gaps = 11/260 (4%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNII 438
+ + + IG G F V + K + A+K+I KK+ I NE+ IL+ HPNI+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIV 60
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
K Y +EL++V+E GG L D + S N +E ++ + L L YLH N I+
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGII 120
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV--LRPMFTVCGTPTYVAPEILNESGYGV 555
HRDIK N+L+ G +K+ DFGL+ ++ + T+ GTP ++APE++N Y
Sbjct: 121 HRDIKAANILLTSDG----EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
K D+W+ G+ L G PP+ S+ LF +G G +P S+E K+ +
Sbjct: 177 KADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPPGLRNPEK--WSDEFKDFLKK 233
Query: 616 MLESNPDLRFSAEDVLDHPW 635
L+ NP+ R +AE +L HP+
Sbjct: 234 CLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 4e-54
Identities = 91/265 (34%), Positives = 139/265 (52%), Gaps = 15/265 (5%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPN 436
+ + ++IG G F V V + A+K ++K K + K + + NE IL+ +NHP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
++ L + +YLV++L+ GGDL +S+ VKFSEE KF + AL YLH I
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGY 553
+HRDIKP+N+L++ G HV + DF +A + P + GTP Y+APE+L GY
Sbjct: 122 IHRDIKPDNILLDEQG-HV---HITDFNIA-TKVTPDTLTTSTSGTPGYMAPEVLCRQGY 176
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
V +D W+ GV Y L G P+ + + D I + Q Y S EA + I
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSR---TIRDQIRAKQETADVLYPATWSTEAIDAI 233
Query: 614 SHMLESNPDLRFS--AEDVLDHPWL 636
+ +LE +P R +D+ +HP+
Sbjct: 234 NKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 7e-54
Identities = 94/267 (35%), Positives = 153/267 (57%), Gaps = 17/267 (6%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVN 433
L + +G+ +G G+F VR K A+K + K ++L KQ+ + E +IL ++
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
HP I+ ++ + N +Y ++E + GG+LF + K +F + +KF L A YLH
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGY 553
I++RD+KPENLL++ G HVKV DFG A++V FT+CGTP Y+APE++ G+
Sbjct: 137 KDIIYRDLKPENLLLDNKG-HVKVT---DFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGH 192
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
G +D W GV+LY + G+PPF DT + +++ IL+G+ FP+ W D A++L+
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFR--IYEKILAGRLKFPN--WFD--GRARDLV 246
Query: 614 SHMLESNPDLRFSA-----EDVLDHPW 635
+L+++ R DV +HP+
Sbjct: 247 KGLLQTDHTKRLGTLKGGVADVKNHPY 273
|
Length = 329 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 2e-53
Identities = 82/248 (33%), Positives = 137/248 (55%), Gaps = 24/248 (9%)
Query: 406 ALKIIDKSKLLGK--KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLF 463
A+K+I K+ ++ K + E +IL P ++KL + LYLV+E + GGDL
Sbjct: 22 AIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLA 81
Query: 464 DAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523
+ E+ ++ + AL YLH N I+HRD+KP+N+L++ +G H LK+ DF
Sbjct: 82 SLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-H---LKLTDF 137
Query: 524 GLA------QRVLRPMFT-----VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCG 572
GL+ +++ + GTP Y+APE++ G+ +D W+ G ILY L G
Sbjct: 138 GLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
Query: 573 FPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF---SAED 629
PPF +T +E+F +IL+G+ +P ++S+EA +LIS +L +P+ R S E+
Sbjct: 198 IPPFHGET--PEEIFQNILNGKIEWPE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253
Query: 630 VLDHPWLE 637
+ +HP+ +
Sbjct: 254 IKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 2e-51
Identities = 89/260 (34%), Positives = 145/260 (55%), Gaps = 17/260 (6%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLD 442
+G G F V V D+ + ALK++ +++ KQ + NE +L+ V+HP II+L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
LY+++E + GG+LF + + +FS F + AL YLH IV+RD+K
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAA 562
PEN+L++ G H +K+ DFG A+++ +T+CGTP Y+APE++ G+ +D WA
Sbjct: 129 PENILLDKEG-H---IKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWAL 184
Query: 563 GVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPD 622
G+++Y +L G+PPF D +++ IL+G+ FP D+ AK+LI +L +
Sbjct: 185 GILIYEMLVGYPPFFDDN--PFGIYEKILAGKLEFPRHL--DLY--AKDLIKKLLVVDRT 238
Query: 623 LRF-----SAEDVLDHPWLE 637
R A+DV +H W +
Sbjct: 239 RRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 86/265 (32%), Positives = 145/265 (54%), Gaps = 17/265 (6%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHP 435
Y +G +IG G F VV + + A+K I K+ ++ + I E+++L+++ HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHP 59
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSE-EDSKFMTQSLASALSYLHDN 494
NI+K + +T++ LY+++E + G L I K F E + ++ Q L L+YLH+
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-QGLAYLHEQ 118
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVCGTPTYVAPEILNES 551
++HRDIK N+L G V+K+ DFG+A ++ + +V GTP ++APE++ S
Sbjct: 119 GVIHRDIKAANILTTKDG----VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 552 GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611
G D+W+ G + LL G PP+ D N LF I+ + P P + IS E K+
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPY-YDLNPMAALF-RIVQDDH-PPLP--EGISPELKD 229
Query: 612 LISHMLESNPDLRFSAEDVLDHPWL 636
+ + +P+LR +A+ +L HPW+
Sbjct: 230 FLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 6e-48
Identities = 103/274 (37%), Positives = 146/274 (53%), Gaps = 30/274 (10%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHPNI 437
Y V + IG G+F VR+V K K ID + K KQ + +EVNILR + HPNI
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 438 IKLLD-EYDTNNE-LYLVIELIKGGDLFDAISK---NVKFSEEDS--KFMTQSLASALSY 490
++ D D +N+ LY+V+E +GGDL I K K+ EE+ + +TQ L AL
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ-LLLALYE 120
Query: 491 LH-----DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--PMF--TVCGTPT 541
H N ++HRD+KP N+ ++ + +K+GDFGLA ++L F T GTP
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN----VKLGDFGLA-KILGHDSSFAKTYVGTPY 175
Query: 542 YVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG-FPSP 600
Y++PE LN Y K D+W+ G ++Y L PPF + N Q +L I G++ P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARN-QLQLASKIKEGKFRRIPYR 233
Query: 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLDHP 634
Y S E E+I ML +PD R S E++L P
Sbjct: 234 Y----SSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 95/293 (32%), Positives = 148/293 (50%), Gaps = 42/293 (14%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHP 435
+ V ++IG G F V V DK A+K++ KS ++ + Q+ + E +IL + P
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY 495
I+KL + LYLV+E + GGDL + + + F EE ++F L AL +H
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR--------------------------- 528
+HRDIKP+N+L++ G H+K+ DFGL ++
Sbjct: 122 FIHRDIKPDNILIDADG-HIKLA---DFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 529 ----VLRPMF-TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ 583
R + GTP Y+APE+L + YG++ D W+ GVILY +L GFPPF SDT
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL-- 235
Query: 584 DELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF-SAEDVLDHPW 635
E ++ I++ + P +S EA +LI +L +P+ R S E++ HP+
Sbjct: 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 3e-47
Identities = 96/284 (33%), Positives = 139/284 (48%), Gaps = 31/284 (10%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHP- 435
Y + + +G+G+F V D+ ALK++ K K++ E+ IL S+NHP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN---VKFSEEDSKFMTQSLASALSYLH 492
NI+KL D + LYLV+E + GG L D + K SE ++ F+ + SAL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA---------QRVLRPMFTVCGTPTYV 543
I+HRDIKPEN+L++ G VK++ DFGLA + T GTP Y+
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLI---DFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 544 APEIL---NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ--DELFDDILSGQYG-F 597
APE+L + + D+W+ G+ LY LL G PPF + N + IL
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 598 PSPYWDD----ISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
SP IS+ A +L+ +L +P R S+ L H L
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 8e-47
Identities = 94/301 (31%), Positives = 134/301 (44%), Gaps = 62/301 (20%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN---------EVNIL 429
Y + +G+G + VV + DK ALK I + E E+++L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--------RLDNEEEGIPSTALREISLL 52
Query: 430 RSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASAL 488
+ + HPNI+KLLD T +LYLV E DL + K S K + L L
Sbjct: 53 KELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----LRPMFTVCGTPTYVA 544
+Y H + I+HRD+KP+N+L+ G VLK+ DFGLA R LR T Y A
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDG----VLKLADFGLA-RAFGIPLRTYTHEVVTLWYRA 166
Query: 545 PEIL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFD--DILSGQYGFPS-- 599
PEIL Y +D+W+ G I ++ G P F D+ + D+LF IL G P+
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS-EIDQLFKIFQIL----GTPTEE 221
Query: 600 --------PYWDD----------------ISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
P + + E +L+S ML+ NP R SA++ L HP+
Sbjct: 222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
Query: 636 L 636
Sbjct: 282 F 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 4e-45
Identities = 88/263 (33%), Positives = 149/263 (56%), Gaps = 20/263 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN--EVNILRSVNHPNIIKL 440
+++G G F V V +K A+KI+ K ++ K ++ E +L++ HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ T++ L V+E GG+LF +S+ FSE+ ++F + SAL YLH +V+RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVCGTPTYVAPEILNESGYGVKI 557
+K ENL+++ G H+ K+ DFGL + + M T CGTP Y+APE+L ++ YG +
Sbjct: 121 LKLENLMLDKDG-HI---KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
D W GV++Y ++CG PF + D ++LF+ IL + FP +S EAK L++ +L
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLL 230
Query: 618 ESNPDLRF-----SAEDVLDHPW 635
+ +P R A+++++H +
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 83/270 (30%), Positives = 126/270 (46%), Gaps = 22/270 (8%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDC--ALKIIDKSKLLGKKQMIENEVNILRSVN 433
L+R V +G G+ VV +V +HK ALK I ++ + E+ LRS
Sbjct: 3 LERVKV---LGQGSSGVVYKV--RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH- 492
P ++K + E+ +V+E + GG L D + K K E ++ + + L YLH
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ---RVLRPMFTVCGTPTYVAPEILN 549
+I+HRDIKP NLL+ G +K+ DFG+++ L T GT TY++PE +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGE----VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 550 ESGYGVKIDVWAAGVILYILLCG-FPPFVSDTNDQDELFDDILSGQYGFPSPYWDD--IS 606
Y D+W+ G+ L G FP EL I G P P S
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG----PPPSLPAEEFS 229
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWL 636
E ++ IS L+ +P R SA ++L HP++
Sbjct: 230 PEFRDFISACLQKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 85/275 (30%), Positives = 148/275 (53%), Gaps = 22/275 (8%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL 429
P +L Y + IG+G V + D+ + A+K + L K+ I NE+ I+
Sbjct: 17 PREL---YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIM 69
Query: 430 RSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASAL 488
+ HPNI+ D Y +EL++V+E + GG L D I++N V+ +E ++ + + L
Sbjct: 70 KDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAP 545
YLH ++HRDIK +N+L+ G +K+ DFG A ++ + +V GTP ++AP
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDG----SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP-YWDD 604
E++ YG K+D+W+ G++ + G PP++ + + LF L G P +
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALF---LITTKGIPPLKNPEK 241
Query: 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
S E K+ ++ L +P+ R SAE++L HP+L+++
Sbjct: 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 9e-44
Identities = 92/265 (34%), Positives = 152/265 (57%), Gaps = 22/265 (8%)
Query: 383 QIIGDGNFA---VVRQVYDKHKDMDCALKIIDKSKLLGKKQM-IENEVNILRSVNHPNII 438
+++G G+F +VR++ A+K++ K+ L + ++ + E +IL VNHP I+
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
KL + T +LYL+++ ++GGDLF +SK V F+EED KF LA AL +LH I++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVCGTPTYVAPEILNESGYGV 555
RD+KPEN+L++ G H+K+ DFGL++ + + ++ CGT Y+APE++N G+
Sbjct: 122 RDLKPENILLDEEG-HIKLT---DFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
D W+ GV+++ +L G PF D+ E IL + G P +S EA+ L+
Sbjct: 178 SADWWSFGVLMFEMLTGSLPF--QGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRA 231
Query: 616 MLESNPDLRFSA-----EDVLDHPW 635
+ + NP R A E++ HP+
Sbjct: 232 LFKRNPANRLGAGPDGVEEIKRHPF 256
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 1e-43
Identities = 78/236 (33%), Positives = 125/236 (52%), Gaps = 13/236 (5%)
Query: 406 ALKIIDKSKLLGKKQMIE---NEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL 462
A+K++ KS ++ K Q+ ++ P + KL + + + LYLV+E + GGD
Sbjct: 25 AIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDC 84
Query: 463 FDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGD 522
I E+ +K + + LH I+HRDIKPENLL++ +G H LK+ D
Sbjct: 85 ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-H---LKLTD 140
Query: 523 FGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND 582
FGL++ L V GTP Y+APE + G D W+ G +++ L G+PPF ++T
Sbjct: 141 FGLSRNGLENKKFV-GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-- 197
Query: 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSA---EDVLDHPW 635
D +FD+ILS + +P + S EA +LI+ +L +P R A +++ HP+
Sbjct: 198 PDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 86/263 (32%), Positives = 143/263 (54%), Gaps = 18/263 (6%)
Query: 385 IGDGNFAVVRQVY-DKHKDMD--CALKIIDKSKL--LGKKQMIENEVNILRSVNHPNIIK 439
+G G + QV+ K KD ALK + KS L L + + + E +IL + ++K
Sbjct: 9 VGQGGYG---QVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
LL + + LYL +E + GGD ++ SE+ ++F + A+ LH+ +HR
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHR 125
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDV 559
D+KPEN L++ SG H+K+ DFGL++ ++ +V G+P Y+APE+L GY +D
Sbjct: 126 DLKPENFLIDASG-HIKLT---DFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDY 181
Query: 560 WAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD----ISEEAKELISH 615
W+ G +LY LCGFPPF T +E ++++ + P +DD +S+EA +LI+
Sbjct: 182 WSLGCMLYEFLCGFPPFSGST--PNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239
Query: 616 MLESNPDLRFSAEDVLDHPWLER 638
++ S ED+ +HP+ +
Sbjct: 240 LINDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 86/262 (32%), Positives = 139/262 (53%), Gaps = 21/262 (8%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSV-NHPNIIKL 440
++G G+F V K D A+K++ K +L + E +L HP + +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ T + L+ V+E + GGDL I ++ +F E ++F + L +LH+ I++RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVKI 557
+K +N+L++ G H+ K+ DFG+ + + T CGTP Y+APEIL+ YG +
Sbjct: 122 LKLDNVLLDSEG-HI---KIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAV 177
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
D WA GV+LY +L G PF + +D+DELF IL + +P W +S+EAK ++ L
Sbjct: 178 DWWALGVLLYEMLAGQSPF--EGDDEDELFQSILEDEVRYPR--W--LSKEAKSILKSFL 231
Query: 618 ESNPDLRFSA-----EDVLDHP 634
NP+ R +D+ HP
Sbjct: 232 TKNPEKRLGCLPTGEQDIKGHP 253
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 90/261 (34%), Positives = 147/261 (56%), Gaps = 20/261 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN--EVNILRSVNHPNIIKL 440
+++G G F V V +K A+KI+ K ++ K ++ E +L++ HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ T++ L V+E GG+LF +S+ F+EE ++F + SAL YLH +V+RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVCGTPTYVAPEILNESGYGVKI 557
IK ENL+++ G H+K+ DFGL + + M T CGTP Y+APE+L ++ YG +
Sbjct: 121 IKLENLMLDKDG-HIKIT---DFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
D W GV++Y ++CG PF + D + LF+ IL + FP +S EAK L++ +L
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYN--QDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 230
Query: 618 ESNPDLRF-----SAEDVLDH 633
+ +P R A++V++H
Sbjct: 231 KKDPKQRLGGGPSDAKEVMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 6e-42
Identities = 90/266 (33%), Positives = 143/266 (53%), Gaps = 22/266 (8%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNII 438
++IG G+F V K A+K++ K +L KK+ M E V +L++V HP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLV 59
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
L + T ++LY V++ + GG+LF + + F E ++F +ASAL YLH I++
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIY 119
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGV 555
RD+KPEN+L++ G HV VL DFGL + + T CGTP Y+APE+L + Y
Sbjct: 120 RDLKPENILLDSQG-HV-VLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
+D W G +LY +L G PPF S D E++D+IL+ +IS A+ L+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS--RDTAEMYDNILNKPLRLKP----NISVSARHLLEG 229
Query: 616 MLESNPDLRFSA----EDVLDHPWLE 637
+L+ + R A ++ +H +
Sbjct: 230 LLQKDRTKRLGAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 7e-42
Identities = 94/284 (33%), Positives = 131/284 (46%), Gaps = 39/284 (13%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNHPNIIKLLDE 443
IG+G + VV + DK A+K I G + E+ +L+ +NHPNIIKLLD
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 444 YDTNNELYLVIELIKGGDLFDAISKNVK-FSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
+ +LYLV E + DL+ I + E K L L++ H + I+HRD+K
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLK 125
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRVL----RPMFTVCGTPTYVAPEIL-NESGYGVKI 557
PENLL+ G VLK+ DFGLA R RP T Y APE+L + GY +
Sbjct: 126 PENLLINTEG----VLKLADFGLA-RSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDI----------------LSGQYGFPSPY 601
D+W+ G I LL P F ++ D+LF L+ Y F P
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGK-SEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239
Query: 602 WD---------DISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
+ S +A +L+S ML +P R +AE L HP+
Sbjct: 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 1e-41
Identities = 96/301 (31%), Positives = 138/301 (45%), Gaps = 61/301 (20%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE-----NEVNILRSVN 433
Y V + +GDG F V +K A+K K+ K E EV LR +N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIK-----KMKKKFYSWEECMNLREVKSLRKLN 55
Query: 434 -HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAIS--KNVKFSEEDSKFMTQSLASALSY 490
HPNI+KL + + N+ELY V E ++G +L+ + K FSE + + + L++
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 491 LHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL-RPMFTV-CGTPTYVAPEIL 548
+H + HRD+KPENLLV V+K+ DFGLA+ + RP +T T Y APEIL
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPE----VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEIL 170
Query: 549 NESG-YGVKIDVWAAGVI---LYILLCGFPPFVSDTNDQDELFD--DILSGQYGFPSP-Y 601
S Y +D+WA G I LY L FP +++ D+L+ +L G P+
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFP----GSSEIDQLYKICSVL----GTPTKQD 222
Query: 602 WDD--------------------------ISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
W + S EA +LI ML +P R +A L HP+
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
Query: 636 L 636
Sbjct: 283 F 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 87/262 (33%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN--EVNILRSVNHPNIIKLLD 442
IG G+F V QV + ALK I K+ ++ + ++ E +L VN P I+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
+ + +LYLV+ I GG+LF + + +F ++F T L AL LH +++RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVCGTPTYVAPEILNESGYGVKIDV 559
PEN+L++ G H+ + DFGL + ++ T CGTP Y+APE+L GY +D
Sbjct: 121 PENILLDYQG-HIALC---DFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 560 WAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLES 619
W GV+LY +L G PPF + + +E++ IL FP D +AK+L+ +L
Sbjct: 177 WTLGVLLYEMLTGLPPFYDE--NVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSR 230
Query: 620 NPDLRF---SAEDVLDHPWLER 638
+P R A+++ +HP+ +
Sbjct: 231 DPTRRLGYNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 89/269 (33%), Positives = 148/269 (55%), Gaps = 26/269 (9%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNII 438
+++G G+F V K A+K++ K +L M E + L + NHP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSL-ARNHPFLT 59
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
+L + T + L+ V+E + GGDL I K+ +F E ++F + SAL +LHD I++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 499 RDIKPENLLVEMSG-CHVKVLKVGDFGLAQRVLR---PMFTVCGTPTYVAPEILNESGYG 554
RD+K +N+L++ G C K+ DFG+ + + T CGTP Y+APEIL E YG
Sbjct: 120 RDLKLDNVLLDHEGHC-----KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 555 VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
+D WA GV+LY +LCG PF ++ +D+LF+ IL+ + +P+ W +S++A +++
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAILNDEVVYPT--W--LSQDAVDILK 228
Query: 615 HMLESNPDLRFSA------EDVLDHPWLE 637
+ NP +R + E +L HP+ +
Sbjct: 229 AFMTKNPTMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 85/271 (31%), Positives = 138/271 (50%), Gaps = 25/271 (9%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE--NEVNILRSVN 433
L + + + IG G F+VV + ALK + +++ K + E+++L+ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQ--------SLA 485
HPN+IK L + NNEL +V+EL GDL S+ +K ++ + + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL----SRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP----MFTVCGTPT 541
SAL ++H I+HRDIKP N+ + +G V+K+GD GL R ++ GTP
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATG----VVKLGDLGLG-RFFSSKTTAAHSLVGTPY 171
Query: 542 YVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY 601
Y++PE ++E+GY K D+W+ G +LY + PF D + L I Y P P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP-PLPA 230
Query: 602 WDDISEEAKELISHMLESNPDLRFSAEDVLD 632
D SEE ++L+S + +P+ R VL
Sbjct: 231 -DHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 3e-40
Identities = 89/264 (33%), Positives = 147/264 (55%), Gaps = 20/264 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN--EVNILRSVNHPNIIKL 440
+++G G F V V +K A+KI+ K ++ K ++ E +L++ HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ T + L V+E + GG+LF +S+ FSE+ ++F + SAL YLH IV+RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVCGTPTYVAPEILNESGYGVKI 557
+K ENL+++ G H+K+ DFGL + + M T CGTP Y+APE+L ++ YG +
Sbjct: 121 LKLENLMLDKDG-HIKIT---DFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
D W GV++Y ++CG PF + D ++LF+ IL FP +S +AK L+S +L
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILMEDIKFPR----TLSADAKSLLSGLL 230
Query: 618 ESNPDLRF-----SAEDVLDHPWL 636
+P+ R A++++ H +
Sbjct: 231 IKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 90/265 (33%), Positives = 150/265 (56%), Gaps = 22/265 (8%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN--EVNILRSV---NHPNIIK 439
IG G F V QV K A+K++ K +++ KK++ E NIL P I+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
L + T+++LYLV + + GG+LF + K +FSE+ +KF L AL +LH IV+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVCGTPTYVAPEI-LNESGYGV 555
D+KPEN+L++ +G H+ + DFGL++ L + T CGT Y+APE+ L+E GY
Sbjct: 121 DLKPENILLDATG-HIALC---DFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
+D W+ GV+++ + CG+ PF ++ D +++ +I G+ FP + +S+E ++ +
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPFYAE--DTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKG 231
Query: 616 MLESNPDLRFSA----EDVLDHPWL 636
+L NP R A ++ +HP+
Sbjct: 232 LLNRNPQHRLGAHRDAVELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 1e-39
Identities = 89/261 (34%), Positives = 146/261 (55%), Gaps = 21/261 (8%)
Query: 386 GDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ---MIENEVNILRSVNHPNIIKLLD 442
G G VR+V A+K++ K+ ++ ++ + E NIL +V HP I+ L+
Sbjct: 8 GYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIY 67
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
+ T +LYL++E + GG+LF + + F E+ + F ++ AL +LH I++RD+K
Sbjct: 68 AFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLK 127
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVKIDV 559
PEN+L++ G HVK+ DFGL + + T CGT Y+APEIL SG+G +D
Sbjct: 128 PENILLDAQG-HVKLT---DFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDW 183
Query: 560 WAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLES 619
W+ G ++Y +L G PPF ++ ++ + D IL G+ P PY ++ EA++L+ +L+
Sbjct: 184 WSLGALMYDMLTGAPPFTAE--NRKKTIDKILKGKLNLP-PY---LTPEARDLLKKLLKR 237
Query: 620 NPDLRF-----SAEDVLDHPW 635
NP R A +V HP+
Sbjct: 238 NPSSRLGAGPGDAAEVQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 89/262 (33%), Positives = 149/262 (56%), Gaps = 21/262 (8%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN--EVNILRSVNHPNIIKL 440
+++G G F V V +K A+KI+ K ++ K ++ E +L++ HP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH-DNYIVHR 499
+ T++ L V+E GG+LF +S+ FSE+ ++F + SAL YLH + +V+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVCGTPTYVAPEILNESGYGVK 556
D+K ENL+++ G H+K+ DFGL + ++ M T CGTP Y+APE+L ++ YG
Sbjct: 121 DLKLENLMLDKDG-HIKIT---DFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 557 IDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616
+D W GV++Y ++CG PF + D ++LF+ IL + FP +S EAK L+S +
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILMEEIRFPR----TLSPEAKSLLSGL 230
Query: 617 LESNPDLRF-----SAEDVLDH 633
L+ +P R A++++ H
Sbjct: 231 LKKDPKQRLGGGPDDAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 86/265 (32%), Positives = 137/265 (51%), Gaps = 24/265 (9%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVN---HPNII 438
++G G+F V K A+K + K ++ + ++ + E I + N HP ++
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
L + T + + V+E GGDL I +V FSE + F + L YLH+N IV+
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHENKIVY 124
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGV 555
RD+K +NLL++ G VK+ DFGL + + T CGTP ++APE+L E+ Y
Sbjct: 125 RDLKLDNLLLDTEG-FVKI---ADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
+D W GV++Y +L G PF D D++E+FD I++ + +P +S EA ++
Sbjct: 181 AVDWWGLGVLIYEMLVGESPFPGD--DEEEVFDSIVNDEVRYPR----FLSREAISIMRR 234
Query: 616 MLESNPDLRF-----SAEDVLDHPW 635
+L NP+ R AEDV P+
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPF 259
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 4e-39
Identities = 81/267 (30%), Positives = 141/267 (52%), Gaps = 17/267 (6%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALK--IIDKSKLLGKK--QMIENEVNILRSVN 433
R+ G+++G G+F V + + A+K + G++ + +E E+ +L +
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
HPNI++ L + LY+ +EL+ GG L + K F E + T+ + L YLHD
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV--LRPMFTVCGTPTYVAPEILNES 551
VHRDIK N+LV+ +G +K+ DFG+A++V + G+P ++APE++ +
Sbjct: 121 RNTVHRDIKGANILVDTNGV----VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 552 G-YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS-GQYGFPSPYWDDISEEA 609
G YG+ D+W+ G + + G PP+ Q E + G+ P D +S+EA
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPW-----SQLEGVAAVFKIGRSKELPPIPDHLSDEA 231
Query: 610 KELISHMLESNPDLRFSAEDVLDHPWL 636
K+ I L+ +P LR +A ++L+HP++
Sbjct: 232 KDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 94/289 (32%), Positives = 136/289 (47%), Gaps = 36/289 (12%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE----NEVNILRSVN 433
RY G+ +G+G +AVV + DK A+K I + K I E+ +L+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLH 492
HPNII LLD + + + LV E + DL I K++ + D K L YLH
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV---LRPMFTVCGTPTYVAPEIL- 548
N+I+HRD+KP NLL+ G VLK+ DFGLA+ R M T Y APE+L
Sbjct: 120 SNWILHRDLKPNNLLIASDG----VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLF 175
Query: 549 NESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQ------------DELFDDILSGQY 595
YGV +D+W+ G I LL P D++ DQ +E + + S
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235
Query: 596 G-----FPSPYWDDI----SEEAKELISHMLESNPDLRFSAEDVLDHPW 635
FP I S++A +L+ +L NP+ R +A L+HP+
Sbjct: 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 5e-39
Identities = 88/253 (34%), Positives = 144/253 (56%), Gaps = 16/253 (6%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ--MIENEVNIL-RSVNHPNIIK 439
++IG G+F V K ++ A+K++ K +L KK+ I +E N+L ++V HP ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
L + T ++LY V++ I GG+LF + + F E ++F +ASAL YLH IV+R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVK 556
D+KPEN+L++ G H+ + DFGL + + T CGTP Y+APE+L++ Y
Sbjct: 121 DLKPENILLDSQG-HIVLT---DFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 557 IDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616
+D W G +LY +L G PPF S + E++D+IL+ P +I+ A+ L+ +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYS--RNTAEMYDNILNK----PLQLKPNITNSARHLLEGL 230
Query: 617 LESNPDLRFSAED 629
L+ + R A+D
Sbjct: 231 LQKDRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 5e-39
Identities = 92/302 (30%), Positives = 148/302 (49%), Gaps = 55/302 (18%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLL 441
+IG G F VR V K A+K + KS++L K+Q+ + E +IL ++P ++KL
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 442 DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRD 500
+ N LYL++E + GGD+ + K F+EE+++F A+ +H YI HRD
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYI-HRD 126
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQ-----------RVL-------------RPM--- 533
IKP+NLL++ G H+ K+ DFGL R+L +PM
Sbjct: 127 IKPDNLLLDAKG-HI---KLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 534 --------------FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSD 579
++ GTP Y+APE+ ++GY + D W+ GVI+Y +L G+PPF SD
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242
Query: 580 TNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF---SAEDVLDHPWL 636
+ E + I++ + P +S EAK+LI + + R ++ HP+
Sbjct: 243 --NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFF 299
Query: 637 ER 638
+
Sbjct: 300 KG 301
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 88/297 (29%), Positives = 133/297 (44%), Gaps = 50/297 (16%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN----EVNILRSVN 433
RY + IG+G +V + D+ ALK + +L G I N E+ L++
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG---IPNQALREIKALQACQ 57
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK-FSEEDSKFMTQSLASALSYLH 492
HP ++KLLD + + LV+E + DL + + + E K + L ++Y+H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL-----RPMFTVCGTPTYVAPEI 547
N I+HRD+KP NLL+ G LK+ DFGLA R+ R T Y APE+
Sbjct: 117 ANGIMHRDLKPANLLISADGV----LKIADFGLA-RLFSEEEPRLYSHQVATRWYRAPEL 171
Query: 548 LNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY----- 601
L + Y +D+WA G I LL G P F + ND ++L I+ G P+
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE-NDIEQL--AIVFRTLGTPNEETWPGL 228
Query: 602 ------------------WDDI----SEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
++I S EA +L+ +L +P R SA + L HP+
Sbjct: 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 89/260 (34%), Positives = 142/260 (54%), Gaps = 14/260 (5%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMD---CALKIIDKSKLLGKKQM--IENEVNILRSVNHPNI 437
+ +G G+F R + +K+ D A+K +KSK++ +KQ+ + +E IL +NHP
Sbjct: 36 RTLGTGSFG--RVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
+ L + + LYLV+E + GG+ F + +N +F + F + YL IV
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKI 557
+RD+KPENLL++ G +K+ DFG A+ V +T+CGTP Y+APEIL G+G
Sbjct: 154 YRDLKPENLLLDKDG----FIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAA 209
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
D W G+ +Y +L G PPF + N+ ++ IL G FP ++ K+L+SH L
Sbjct: 210 DWWTLGIFIYEILVGCPPFYA--NEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDL 267
Query: 618 ESN-PDLRFSAEDVLDHPWL 636
+L+ A++V +HPW
Sbjct: 268 TKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 9e-39
Identities = 85/266 (31%), Positives = 132/266 (49%), Gaps = 21/266 (7%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHPN 436
+ V + +G G++ V +V + ALK +D + K ++ NE+ IL SVNHPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK----FSEEDS-KFMTQSLASALSYL 491
II + + N+L +V+E GDL AISK K E++ + Q L L L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ-LLRGLQAL 119
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF--TVCGTPTYVAPEILN 549
H+ I+HRD+K N+L+ ++K+GD G++ +VL+ T GTP Y+APE+
Sbjct: 120 HEQKILHRDLKSANILL----VANDLVKIGDLGIS-KVLKKNMAKTQIGTPHYMAPEVWK 174
Query: 550 ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY-GFPSPYWDDISEE 608
Y K D+W+ G +LY + PPF + +L + G+Y P Y D+
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPF--EARSMQDLRYKVQRGKYPPIPPIYSQDLQ-- 230
Query: 609 AKELISHMLESNPDLRFSAEDVLDHP 634
I ML+ P LR + + +L P
Sbjct: 231 --NFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 85/270 (31%), Positives = 141/270 (52%), Gaps = 25/270 (9%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNII 438
+++G G+F V K D A+K++ K +L M E + L + HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILAL-AAKHPFLT 59
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
L + T + L+ V+E + GGDL I ++ KF E S+F + AL +LH + +++
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGV 555
RD+K +N+L++ G H K+ DFG+ + + T CGTP Y+APEIL E YG
Sbjct: 120 RDLKLDNILLDAEG-HCKL---ADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
+D WA GV++Y ++ G PPF +D ++D+LF+ IL + P W +S+EA ++
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEAD--NEDDLFESILHDDVLY--PVW--LSKEAVSILKA 229
Query: 616 MLESNPDLRFSA-------EDVLDHPWLER 638
+ NP+ R + + HP+ +
Sbjct: 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 94/307 (30%), Positives = 135/307 (43%), Gaps = 61/307 (19%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKII---DKSKLLGKKQMIENEVNILRSVNH 434
RY + + IG G + VV DK A+K I + K+ I E+ +LR + H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR--ILREIKLLRHLRH 58
Query: 435 PNIIKLLD-----EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALS 489
NII LLD + N++Y+V EL DL I +++ ++ + L
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTEL-METDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT-YV----- 543
YLH ++HRD+KP N+LV S C LK+ DFGLA R + P G T YV
Sbjct: 118 YLHSANVIHRDLKPSNILVN-SNCD---LKICDFGLA-RGVDPDEDEKGFLTEYVVTRWY 172
Query: 544 -APEI-LNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELFDDILSGQYGFPSP 600
APE+ L+ S Y ID+W+ G I LL P F D DQ L ++L +P
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL------GTP 226
Query: 601 YWDDI------------------------------SEEAKELISHMLESNPDLRFSAEDV 630
+D+ S EA +L+ ML +P R +A++
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286
Query: 631 LDHPWLE 637
L HP+L
Sbjct: 287 LAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 81/223 (36%), Positives = 125/223 (56%), Gaps = 14/223 (6%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNII 438
++IG G+F V K A+K++ K +L KK+ M E V +L+++ HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
L + T +LY V++ + GG+LF + + F E ++F +ASA+ YLH I++
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGV 555
RD+KPEN+L++ G HV VL DFGL + + P T CGTP Y+APE+L + Y
Sbjct: 120 RDLKPENILLDSQG-HV-VLT--DFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598
+D W G +LY +L G PPF S D +++D+IL P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS--RDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 86/270 (31%), Positives = 138/270 (51%), Gaps = 20/270 (7%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPN 436
+ V ++G G+F V+ V +K A+K++ KS LL ++ + E E +IL N P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNY 495
I +L + + LYLV+E GGDL +++ +F E+ ++F L A+ +H
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTV----CGTPTYVAPEILN-- 549
VHRDIKPEN+L++ +G H+K+ DFG A R+ GTP Y+APE+L
Sbjct: 123 YVHRDIKPENVLIDRTG-HIKLA---DFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 550 ----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605
+ YGV+ D W+ GVI Y ++ G PF T+ + +++I++ Q P +
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--AKTYNNIMNFQRFLKFPEDPKV 236
Query: 606 SEEAKELISHMLESNPDLRFSAEDVLDHPW 635
S + +LI L R E + HP+
Sbjct: 237 SSDFLDLI-QSLLCGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 9e-38
Identities = 87/265 (32%), Positives = 139/265 (52%), Gaps = 14/265 (5%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHPN 436
RY + + IG+G+F + K C +K ID +K+ K K+ + EV +L + HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDN 494
I+ + N L++V+E GGDL I++ V FSE+ ++ L ++HD
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM---FTVCGTPTYVAPEILNES 551
I+HRDIK +N+ + +G V K+GDFG+A+++ M +T GTP Y++PEI
Sbjct: 121 KILHRDIKSQNIFLSKNG---MVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 552 GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611
Y K D+W+ G +LY L PF + N+ +L I G + SP + S + +
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPF--EGNNLHQLVLKICQGYFAPISPNF---SRDLRS 232
Query: 612 LISHMLESNPDLRFSAEDVLDHPWL 636
LIS + + +P R S +L P+L
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 88/261 (33%), Positives = 136/261 (52%), Gaps = 19/261 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNII 438
+++G G+F V K + A+K + K +L M+E V L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLT 59
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
L + T L+ V+E + GGDL I + +F E ++F + L +LH I++
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLA-QRVLRPMF--TVCGTPTYVAPEILNESGYGV 555
RD+K +N+L++ G H+ K+ DFG+ + + T CGTP Y+APEIL Y
Sbjct: 120 RDLKLDNVLLDKDG-HI---KIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
+D W+ GV+LY +L G PF + D+DELFD IL+ + FP W IS+EAK+ +S
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGE--DEDELFDSILNDRPHFPR--W--ISKEAKDCLSK 229
Query: 616 MLESNPDLRF-SAEDVLDHPW 635
+ E +P R D+ HP+
Sbjct: 230 LFERDPTKRLGVDGDIRQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 22/266 (8%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNII 438
++IG G+F V K A+K++ K +L +K+ M E V +L++V HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLV 59
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
L + T +LY V++ + GG+LF + + F E ++F +ASAL YLH IV+
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQR---VLRPMFTVCGTPTYVAPEILNESGYGV 555
RD+KPEN+L++ G HV VL DFGL + T CGTP Y+APE++ + Y
Sbjct: 120 RDLKPENILLDSQG-HV-VLT--DFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
+D W G +LY +L G PPF D E++D+IL P S A ++
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYC--RDVAEMYDNILHK----PLVLRPGASLTAWSILEE 229
Query: 616 MLESNPDLRFSAED----VLDHPWLE 637
+LE + R A++ + +HP+ E
Sbjct: 230 LLEKDRQRRLGAKEDFLEIQEHPFFE 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 378 RYSVGQIIGDGNFAVVRQVY--DKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVNH 434
R+ G IG G F V D + M A+K I K + I +E+ +L + H
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELM--AVKEIRIQDNDPKTIKEIADEMKVLELLKH 58
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494
PN++K ++Y+ +E GG L + + E + T L L+YLH +
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-------MFTVCGTPTYVAPEI 547
IVHRDIKP N+ ++ +G V+K+GDFG A ++ + ++ GTP Y+APE+
Sbjct: 119 GIVHRDIKPANIFLDHNG----VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 548 L---NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY--GF----P 598
+ G+G D+W+ G ++ + G P+ D+ + G P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPW--------SELDNEFQIMFHVGAGHKPP 226
Query: 599 SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
P +S E K+ + LES+P R +A ++L HP++
Sbjct: 227 IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 87/276 (31%), Positives = 138/276 (50%), Gaps = 30/276 (10%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE--NEVNILRSVNHPNIIKL 440
++I +G + V V K A+K I+K L+ + Q+ + E +IL +P ++ +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
++T L +V+E ++GGD + + ++ AL YLH+ IVHRD
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRD 126
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT------------------VCGTPTY 542
+KP+NLL+ G H+K+ DFGL++ L + T VCGTP Y
Sbjct: 127 LKPDNLLITSMG-HIKLT---DFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 543 VAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602
+APE++ GYG +D WA G+ILY L G PF DT +ELF ++S +P
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--PEELFGQVISDDIEWPEGD- 239
Query: 603 DDISEEAKELISHMLESNPDLRF---SAEDVLDHPW 635
+ + +A++LIS +L NP R A +V H +
Sbjct: 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 85/292 (29%), Positives = 136/292 (46%), Gaps = 50/292 (17%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLD 442
+G G+ V V K ALK++DK +++ K + + E IL +++HP + L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ T L LV++ GG+LF + + SEE ++F + AL YLH IV+RD
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRD 128
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLA-----------------------QRVLRPMFTVC 537
+KPEN+L+ SG H+ +L DF L+ + F
Sbjct: 129 LKPENILLHESG-HI-MLS--DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF-SE 183
Query: 538 ----------GTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF 587
GT Y+APE+++ G+G +D W G++LY +L G PF ++DE F
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS--NRDETF 241
Query: 588 DDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF----SAEDVLDHPW 635
+IL + FP +S A++LI +L +P R A ++ HP+
Sbjct: 242 SNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 82/273 (30%), Positives = 154/273 (56%), Gaps = 25/273 (9%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRS 431
P LL+ Y IG+G+ +V +KH A+K++D K +++++ NEV I+R
Sbjct: 19 PRSLLENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRD 74
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL 491
H N++++ Y EL++++E ++GG L D +S+ + +EE + +S+ AL YL
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYL 133
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM---FTVCGTPTYVAPEIL 548
H ++HRDIK +++L+ + G +K+ DFG ++ + + ++ GTP ++APE++
Sbjct: 134 HSQGVIHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 189
Query: 549 NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ--DELFDDILSGQYGFPSPYWDD-- 604
+ + YG ++D+W+ G+++ ++ G PP+ SD+ Q L D P P +
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS--------PPPKLKNAH 241
Query: 605 -ISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
IS ++ + ML P R +A+++LDHP+L
Sbjct: 242 KISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 77/220 (35%), Positives = 117/220 (53%), Gaps = 18/220 (8%)
Query: 424 NEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMT 481
NE+ IL + HPNII + + +N L + +E GG L+D I + F EE +
Sbjct: 48 NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL 107
Query: 482 QSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF----TVC 537
+ SA+SY+H I+HRDIK N+ + +G ++K+GDFG++ ++L + TV
Sbjct: 108 FQIVSAVSYIHKAGILHRDIKTLNIFLTKAG----LIKLGDFGIS-KILGSEYSMAETVV 162
Query: 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG- 596
GTP Y++PE+ Y K D+WA G +LY LL F D + L I+ G Y
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLVVKIVQGNYTP 220
Query: 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
S Y S E L+ +L+ +P+ R +A++VLD P L
Sbjct: 221 VVSVY----SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 74/256 (28%), Positives = 108/256 (42%), Gaps = 62/256 (24%)
Query: 425 EVNILRSVNHPNIIKLLDEY--DTNNELYLVIE--------LIKGGDLFDAISKNVKFSE 474
E+ +L+ + HPNI++L + +Y+V E L+ S VKF+E
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLD--------SPEVKFTE 99
Query: 475 EDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA---QRVLR 531
K + L L YLH N I+HRDIK N+L+ G VLK+ DFGLA +
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG----VLKLADFGLARPYTKRNS 155
Query: 532 PMFT--VCGTPTYVAPEIL-NESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELF 587
+T V T Y PE+L + YG ++D+W+ G IL L G P F S +Q E
Sbjct: 156 ADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214
Query: 588 DDILSGQYGFPSP-YWDD---------------------------ISEEAKELISHMLES 619
++ G P+ W I A +L+ +L
Sbjct: 215 FELC----GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL 270
Query: 620 NPDLRFSAEDVLDHPW 635
+P R SA+ L H +
Sbjct: 271 DPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 8e-36
Identities = 78/266 (29%), Positives = 134/266 (50%), Gaps = 14/266 (5%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+ +++ + IG G+F V + DK + A+K+ID + + + I+ E+ L P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
I K + ++L++++E GG D + K K E F+ + + L YLH+
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFG----LAQRVLRPMFTVCGTPTYVAPEILNESG 552
+HRDIK N+L+ G +K+ DFG L + + T GTP ++APE++ +SG
Sbjct: 120 IHRDIKAANILLSEEG----DVKLADFGVSGQLTSTMSK-RNTFVGTPFWMAPEVIKQSG 174
Query: 553 YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612
Y K D+W+ G+ L G PP SD + LF L + PS + S+ K+
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPL-SDLHPMRVLF---LIPKNNPPSLEGNKFSKPFKDF 230
Query: 613 ISHMLESNPDLRFSAEDVLDHPWLER 638
+S L +P R SA+++L H ++++
Sbjct: 231 VSLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 86/267 (32%), Positives = 133/267 (49%), Gaps = 23/267 (8%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNIIK 439
++G G+F V K D A+KI+ K ++ M+E V L P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-KPPFLTQ 65
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
L + T + LY V+E + GGDL I + KF E + F +A L +LH I++R
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVK 556
D+K +N++++ G H+K+ DFG+ + + T CGTP Y+APEI+ YG
Sbjct: 126 DLKLDNVMLDAEG-HIKI---ADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 557 IDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616
+D WA GV+LY +L G PPF D D+DELF I+ +P +S+EA + +
Sbjct: 182 VDWWAFGVLLYEMLAGQPPF--DGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGL 235
Query: 617 LESNPDLRFSA-----EDVLDHPWLER 638
L +P R D+ +H + R
Sbjct: 236 LTKHPAKRLGCGPTGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 77/266 (28%), Positives = 145/266 (54%), Gaps = 28/266 (10%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE---NEVNILRSVNHPNIIKLL 441
IG+G+ +V DK A+K +D L K+Q E NEV I+R HPNI+++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD----LRKQQRRELLFNEVVIMRDYQHPNIVEMY 82
Query: 442 DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
Y +EL++V+E ++GG L D ++ + +EE + ++ ALS+LH ++HRDI
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDI 141
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM---FTVCGTPTYVAPEILNESGYGVKID 558
K +++L+ G +K+ DFG +V + + ++ GTP ++APE+++ YG ++D
Sbjct: 142 KSDSILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVD 197
Query: 559 VWAAGVILYILLCGFPPFVSDTNDQ--DELFDDILSGQYGFPSPYWDD---ISEEAKELI 613
+W+ G+++ ++ G PP+ ++ Q + D+ P + +S + +
Sbjct: 198 IWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--------LPPKLKNLHKVSPRLRSFL 249
Query: 614 SHMLESNPDLRFSAEDVLDHPWLERS 639
ML +P R +A ++L+HP+L ++
Sbjct: 250 DRMLVRDPAQRATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 85/273 (31%), Positives = 144/273 (52%), Gaps = 27/273 (9%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL-RSVNHPNIIK 439
++IG G++A V V K + A+K++ K + + + ++ E ++ ++ NHP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
L + T + L+ VIE + GGDL + + K EE ++F + ++ AL+YLH+ I++R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTV---CGTPTYVAPEILNESGYGVK 556
D+K +N+L++ G H+K+ D+G+ + LRP T CGTP Y+APEIL YG
Sbjct: 121 DLKLDNVLLDSEG-HIKLT---DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 557 IDVWAAGVILYILLCGFPPF-------VSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
+D WA GV+++ ++ G PF D N +D LF IL Q P +S +A
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKA 232
Query: 610 KELISHMLESNPDLRFSA------EDVLDHPWL 636
++ L +P R D+ HP+
Sbjct: 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 78/264 (29%), Positives = 145/264 (54%), Gaps = 12/264 (4%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
++Y+ + IG G V D + A+K ++ + KK++I NE+ ++R HPN
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPN 77
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
I+ LD Y +EL++V+E + GG L D +++ E + + AL +LH N +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 136
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVCGTPTYVAPEILNESGY 553
+HRDIK +N+L+ M G +K+ DFG ++ T+ GTP ++APE++ Y
Sbjct: 137 IHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
G K+D+W+ G++ ++ G PP++++ N L+ +G +P + +S ++ +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGTPELQNP--EKLSAIFRDFL 249
Query: 614 SHMLESNPDLRFSAEDVLDHPWLE 637
+ LE + + R SA+++L HP+L+
Sbjct: 250 NRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 85/279 (30%), Positives = 142/279 (50%), Gaps = 41/279 (14%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNI----------LRSV 432
++IG G++A V V K A+K+I KK+++ ++ +I +
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVI-------KKELVNDDEDIDWVQTEKHVFETAS 53
Query: 433 NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492
NHP ++ L + T + L+ VIE + GGDL + + K EE ++F + ++ AL++LH
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH 113
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILN 549
+ I++RD+K +N+L++ G H+K+ D+G+ + +RP T CGTP Y+APEIL
Sbjct: 114 ERGIIYRDLKLDNVLLDAEG-HIKLT---DYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 550 ESGYGVKIDVWAAGVILYILLCGFPPF-------VSDTNDQDELFDDILSGQYGFPSPYW 602
YG +D WA GV+++ ++ G PF D N +D LF IL Q P
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--- 226
Query: 603 DDISEEAKELISHMLESNPDLRFSAE------DVLDHPW 635
+S +A ++ L +P R D+ HP+
Sbjct: 227 -SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 9e-35
Identities = 78/263 (29%), Positives = 131/263 (49%), Gaps = 15/263 (5%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHPN 436
+Y +++G G F +V K +K I ++ + +NE +L+ ++HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISK--NVKFSEEDS-KFMTQSLASALSYLHD 493
II+ + + + L +V+E GG L + I K N E+ F Q L AL ++H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL-ALHHVHT 119
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNES 551
I+HRD+K +N+L++ H V+K+GDFG+++ + +TV GTP Y++PE+
Sbjct: 120 KLILHRDLKTQNILLDK---HKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK 176
Query: 552 GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611
Y K D+WA G +LY L F + + L I+SG + +P D S + ++
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAF--EAANLPALVLKIMSGTF---APISDRYSPDLRQ 231
Query: 612 LISHMLESNPDLRFSAEDVLDHP 634
LI ML +P R ++ P
Sbjct: 232 LILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 87/290 (30%), Positives = 134/290 (46%), Gaps = 49/290 (16%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE----NEVNILRSVNHPNIIKL 440
I +G + VV + DK ALK K K+ +K+ E+NIL + HPNI+ +
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALK---KLKMEKEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 441 LDEY---DTNNELYLVIELIKGGDLFDAIS-KNVKFSEEDSKFMTQSLASALSYLHDNYI 496
E +++Y+V+E ++ DL + F + + K + L S +++LHDN+I
Sbjct: 70 -KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI 127
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLA---QRVLRPMFTVCGTPTYVAPEIL-NESG 552
+HRD+K NLL+ G +LK+ DFGLA L+P + T Y APE+L
Sbjct: 128 LHRDLKTSNLLLNNRG----ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 553 YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF----------DDILSGQYGFPS--- 599
Y ID+W+ G I LL P F ++ D+L + I G P
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPG-KSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242
Query: 600 ------PYW--------DDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
PY +S+ +L++ +L +P R SAED L HP+
Sbjct: 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 2e-34
Identities = 72/263 (27%), Positives = 129/263 (49%), Gaps = 18/263 (6%)
Query: 382 GQIIGDGNFAVVRQVYDKHKDMDCALKII----DKSKLLGKKQMIENEVNILRSVNHPNI 437
G+++G G F V YD + A+K + D + + +E E+ +L+++ H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
++ + L + +E + GG + D + +E ++ T+ + + YLH N IV
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV------LRPMFTVCGTPTYVAPEILNES 551
HRDIK N+L + +G +K+GDFG ++R+ M +V GTP +++PE+++
Sbjct: 127 HRDIKGANILRDSAGN----VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 552 GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611
GYG K DVW+ G + +L PP+ ++ +F I + P +S +A+
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPW-AEFEAMAAIF-KIATQPTNPQLP--SHVSPDARN 238
Query: 612 LISHMLESNPDLRFSAEDVLDHP 634
+ N R SAE++L H
Sbjct: 239 FLRRTFVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 79/265 (29%), Positives = 137/265 (51%), Gaps = 23/265 (8%)
Query: 388 GNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN---EVNILRSVNH-PNIIKLLDE 443
G +VR+V A+K++ K+ ++ K + E+ E +L +V P ++ L
Sbjct: 14 GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA 73
Query: 444 YDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKP 503
+ T+ +L+L+++ + GG+LF + + F+E + + + AL +LH I++RDIK
Sbjct: 74 FQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKL 133
Query: 504 ENLLVEMSGCHVKVLKVGDFGLAQRVLRP----MFTVCGTPTYVAPEILN--ESGYGVKI 557
EN+L++ G HV + DFGL++ L ++ CGT Y+APE++ G+ +
Sbjct: 134 ENILLDSEG-HV---VLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAV 189
Query: 558 DVWAAGVILYILLCGFPPFVSD--TNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
D W+ GV+ + LL G PF D N Q E+ IL + FP +S EA++ I
Sbjct: 190 DWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK----TMSAEARDFIQK 245
Query: 616 MLESNPDLRFSAEDVLD---HPWLE 637
+LE +P R A + HP+ +
Sbjct: 246 LLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 77/277 (27%), Positives = 123/277 (44%), Gaps = 35/277 (12%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNII 438
Y + ++IG G AVV + A+K ID K + EV + NHPN++
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLAS---ALSYLHDNY 495
K + +EL+LV+ + GG L D + + D + L L YLH N
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLA-------QRVLRPMFTVCGTPTYVAPEIL 548
+HRDIK N+L+ G +K+ DFG++ R + T GTP ++APE++
Sbjct: 123 QIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 549 NE-SGYGVKIDVWAAGVILYILLCGFPPF----------VSDTNDQDELFDDILSGQYGF 597
+ GY K D+W+ G+ L G P+ ++ ND L +Y
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY-- 236
Query: 598 PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHP 634
S+ +++IS L+ +P R +AE++L H
Sbjct: 237 --------SKSFRKMISLCLQKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 91/301 (30%), Positives = 133/301 (44%), Gaps = 57/301 (18%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKII----DKSKLLGKKQMIENEVNILRSV-- 432
Y IG+G + V + D + ALK + + G E+ +L+ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE---GIPLSTLREIALLKQLES 57
Query: 433 -NHPNIIKLLD-----EYDTNNELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMTQSL 484
HPNI++LLD D +L LV E + DL +SK K E K + + L
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 485 ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVCGTPT 541
+ +LH + IVHRD+KP+N+LV G +K+ DFGLA R+ + +V T
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLA-RIYSFEMALTSVVVTLW 171
Query: 542 YVAPEILNESGYGVKIDVWAAGVILYILLCGFPPF--VSDTNDQDELFDDILSGQYGFPS 599
Y APE+L +S Y +D+W+ G I L P F S+ + D++FD I G PS
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI-----GLPS 226
Query: 600 ----P-----YWD---------------DISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
P +I EE +L+ ML NP R SA + L HP+
Sbjct: 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
Query: 636 L 636
Sbjct: 287 F 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 74/262 (28%), Positives = 127/262 (48%), Gaps = 14/262 (5%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNII 438
+ + + +G+G++ V + K A+K++ + Q I E++IL+ + P I+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
K Y N +L++V+E G + D + N +EE+ + L YLH N +
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAPEILNESGYG 554
HRDIK N+L+ G K+ DFG++ ++ M TV GTP ++APE++ E GY
Sbjct: 122 HRDIKAGNILLNEEG----QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 555 VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
K D+W+ G+ + G PP+ SD + +F P + S E + +
Sbjct: 178 NKADIWSLGITAIEMAEGKPPY-SDIHPMRAIFMIPNKPPPTLSDP--EKWSPEFNDFVK 234
Query: 615 HMLESNPDLRFSAEDVLDHPWL 636
L +P+ R SA +L HP++
Sbjct: 235 KCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 80/269 (29%), Positives = 146/269 (54%), Gaps = 15/269 (5%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRS 431
P K RY + IG G V D + A+K I+ K KK++I NE+ +++
Sbjct: 17 PKKKYTRY---EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKE 72
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL 491
+ +PNI+ LD + +EL++V+E + GG L D +++ E + + AL +L
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFL 131
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVCGTPTYVAPEIL 548
H N ++HRDIK +N+L+ M G +K+ DFG ++ T+ GTP ++APE++
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 549 NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608
YG K+D+W+ G++ ++ G PP++++ N L+ +G +P + +S
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGTPELQNP--EKLSPI 244
Query: 609 AKELISHMLESNPDLRFSAEDVLDHPWLE 637
++ ++ LE + + R SA+++L HP+L+
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 95/308 (30%), Positives = 151/308 (49%), Gaps = 48/308 (15%)
Query: 371 IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALK-IIDKSKLLGKKQMIENEVNIL 429
I +L++Y + Q +G G + +V + D+ ALK I D + Q E+ L
Sbjct: 1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFL 60
Query: 430 RSV-NHPNIIKLLDEY--DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK-FMTQSLA 485
+ + +HPNI+KLL+ + + ++YLV E ++ DL I N+ E+ K ++ L
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANIL--EDVHKRYIMYQLL 117
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT---Y 542
AL Y+H ++HRD+KP N+L+ S C VK+ DFGLA R L + P Y
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLN-SDCRVKL---ADFGLA-RSLSELEENPENPVLTDY 172
Query: 543 VA------PEILNESG-YGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELF------- 587
VA PEIL S Y +D+W+ G IL +L G P F + T +Q E
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232
Query: 588 --DDILSGQYGFPSPYWDDI---------------SEEAKELISHMLESNPDLRFSAEDV 630
+DI S + F + D + S++A +L+ +L NP+ R +AE+
Sbjct: 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292
Query: 631 LDHPWLER 638
L+HP++ +
Sbjct: 293 LEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 3e-33
Identities = 84/267 (31%), Positives = 134/267 (50%), Gaps = 23/267 (8%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNIIK 439
++G G+F V K D A+KI+ K ++ M+E V L+ P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-KPPFLTQ 65
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
L + T + LY V+E + GGDL I + KF E + F ++ L +LH I++R
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTV---CGTPTYVAPEILNESGYGVK 556
D+K +N++++ G H+K+ DFG+ + + T CGTP Y+APEI+ YG
Sbjct: 126 DLKLDNVMLDSEG-HIKI---ADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 557 IDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616
+D WA GV+LY +L G PPF D D+DELF I+ +P +S+EA + +
Sbjct: 182 VDWWAYGVLLYEMLAGQPPF--DGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGL 235
Query: 617 LESNPDLRFSA-----EDVLDHPWLER 638
+ +P R D+ +H + R
Sbjct: 236 MTKHPSKRLGCGPEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 3e-33
Identities = 78/264 (29%), Positives = 145/264 (54%), Gaps = 12/264 (4%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
++Y+ + IG G V D + A+K ++ + KK++I NE+ ++R +PN
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPN 77
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
I+ LD Y +EL++V+E + GG L D +++ E + + AL +LH N +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQV 136
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVCGTPTYVAPEILNESGY 553
+HRDIK +N+L+ M G +K+ DFG ++ T+ GTP ++APE++ Y
Sbjct: 137 IHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
G K+D+W+ G++ ++ G PP++++ N L+ +G +P + +S ++ +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGTPELQNP--ERLSAVFRDFL 249
Query: 614 SHMLESNPDLRFSAEDVLDHPWLE 637
+ LE + D R SA+++L HP+L+
Sbjct: 250 NRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 82/266 (30%), Positives = 136/266 (51%), Gaps = 17/266 (6%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHPN 436
+Y + IG+G+F V K +K I+ SK+ K ++ EV +L ++ HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAIS--KNVKFSEEDSKFMTQSLASALSYLHDN 494
I++ + ++ N LY+V++ +GGDL+ I+ + V F E+ + AL ++HD
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF----TVCGTPTYVAPEILNE 550
I+HRDIK +N+ + G +K+GDFG+A RVL T GTP Y++PEI
Sbjct: 121 KILHRDIKSQNIFLTKDG----TIKLGDFGIA-RVLNSTVELARTCIGTPYYLSPEICEN 175
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610
Y K D+WA G +LY + F + + L I+ G Y S ++ S + +
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAF--EAGNMKNLVLKIIRGSYPPVSSHY---SYDLR 230
Query: 611 ELISHMLESNPDLRFSAEDVLDHPWL 636
L+S + + NP R S +L+ ++
Sbjct: 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 83/259 (32%), Positives = 135/259 (52%), Gaps = 17/259 (6%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVN 433
L + + + IG G F+ V + ALK + +++ K Q E+++L+ +N
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI---SKNVKFSEEDS--KFMTQSLASAL 488
HPN+IK LD + +NEL +V+EL GDL I K + E + K+ Q L SA+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ-LCSAV 119
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ---RVLRPMFTVCGTPTYVAP 545
++H ++HRDIKP N+ + +G V+K+GD GL + ++ GTP Y++P
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605
E ++E+GY K D+W+ G +LY + PF D + L I Q +P +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI--EQCDYPPLPTEHY 233
Query: 606 SEEAKELISHMLESNPDLR 624
SE+ +EL+S + +PD R
Sbjct: 234 SEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 78/264 (29%), Positives = 135/264 (51%), Gaps = 18/264 (6%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G GN VV +V + A+K I ++ I E++IL N P I+ +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHDNY-IVHRDI 501
N ++ + +E + GG L D I K V+ E + ++ L+YLH+ + I+HRD+
Sbjct: 69 YNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDV 127
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-FTVCGTPTYVAPEILNESGYGVKIDVW 560
KP N+LV G +K+ DFG++ +++ + T GT +Y+APE + + Y VK D+W
Sbjct: 128 KPSNILVNSRG----QIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIW 183
Query: 561 AAGVILYILLCG-FP-PFVSDTNDQD-ELFDDILSGQYGFPSPYW--DDISEEAKELISH 615
+ G+ L L G FP P +D D EL I++ P P S + ++ ++
Sbjct: 184 SLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE----PPPRLPSGKFSPDFQDFVNL 239
Query: 616 MLESNPDLRFSAEDVLDHPWLERS 639
L +P R S +++L+HP++++
Sbjct: 240 CLIKDPRERPSYKELLEHPFIKKY 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 85/296 (28%), Positives = 134/296 (45%), Gaps = 44/296 (14%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALK---IIDKSKLLGKKQMIENEVNILRSVN 433
+Y V ++G+G + VV + +K A+K + + + K + EV +LR +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL--REVKVLRQLR 58
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK-FSEEDSKFMTQSLASALSYLH 492
H NI+ L + + LYLV E + L + + + + + L A++Y H
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG----LAQRVLRPMFTVCGTPTYVAPEIL 548
+ I+HRDIKPEN+LV SG VLK+ DFG L R P+ T Y APE+L
Sbjct: 118 SHNIIHRDIKPENILVSESG----VLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173
Query: 549 -NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF--------------DDILSG 593
++ YG +DVWA G I+ LL G P F D +D D+L+ + S
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD-SDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 594 QY----GFPSPYWDD---------ISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
FP P + +S A + + L +P R + +++L HP+
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-32
Identities = 86/263 (32%), Positives = 131/263 (49%), Gaps = 21/263 (7%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPNIIKLLD 442
+G G F V K A K +DK +L +K QM NE IL V+ I+ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 443 EYDTNNELYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
++T ++L LV+ L+ GGDL I F E + F + L +LH IV+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNESGYGVKID 558
+KPEN+L++ G +V ++ D GLA + + + GTP Y+APE+L Y +D
Sbjct: 121 LKPENVLLDDHG-NV---RISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 559 VWAAGVILYILLCGFPPFVS--DTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616
+A G LY ++ G PF + +++EL L +P D S EAK+L +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP----DKFSPEAKDLCEAL 232
Query: 617 LESNPDLRF-----SAEDVLDHP 634
L+ +P+ R SA++V +HP
Sbjct: 233 LQKDPEKRLGCRGGSADEVREHP 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 91/306 (29%), Positives = 141/306 (46%), Gaps = 66/306 (21%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKL 440
++IG G F VR V K A+KI+ K+ +L K+Q+ I E +IL + ++K+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ LYL++E + GGD+ + K SEE ++F A+ +H +HRD
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRD 126
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLA---QRVLRPMF----------------------- 534
IKP+NLL++ G HV K+ DFGL ++ R F
Sbjct: 127 IKPDNLLLDAKG-HV---KLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 535 ------------TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND 582
+ GTP Y+APE+ ++GY D W+ GVI+Y +L G+PPF S+T
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET-- 240
Query: 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF-----------SAEDVL 631
E + +++ + P ISE+AK+LI LRF E++
Sbjct: 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLI---------LRFCTDSENRIGSNGVEEIK 291
Query: 632 DHPWLE 637
HP+ E
Sbjct: 292 SHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 1e-31
Identities = 79/257 (30%), Positives = 137/257 (53%), Gaps = 19/257 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL-RSVNHPNIIK 439
++IG G++A V V K D A+K++ K + + + ++ E ++ ++ ++P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
L + T + L+LVIE + GGDL + + K EE ++F + AL++LH+ I++R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVK 556
D+K +N+L++ G H+K+ D+G+ + L P T CGTP Y+APEIL YG
Sbjct: 121 DLKLDNVLLDADG-HIKLT---DYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176
Query: 557 IDVWAAGVILYILLCGFPPF-----VSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611
+D WA GV+++ ++ G PF D N +D LF IL P +S +A
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASH 232
Query: 612 LISHMLESNPDLRFSAE 628
++ L +P R +
Sbjct: 233 VLKGFLNKDPKERLGCQ 249
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 82/262 (31%), Positives = 131/262 (50%), Gaps = 23/262 (8%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNIIK 439
++G G+F V K D A+KI+ K ++ M+E V L S P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL-SGKPPFLTQ 65
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
L + T + LY V+E + GGDL I + +F E + F +A L +LH I++R
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTV---CGTPTYVAPEILNESGYGVK 556
D+K +N++++ G H+K+ DFG+ + + T CGTP Y+APEI+ YG
Sbjct: 126 DLKLDNVMLDSEG-HIKI---ADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181
Query: 557 IDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616
+D WA GV+LY +L G PF + D+DELF I+ +P +S+EA + +
Sbjct: 182 VDWWAFGVLLYEMLAGQAPF--EGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGL 235
Query: 617 LESNPDLRFSA-----EDVLDH 633
+ +P R D+ +H
Sbjct: 236 MTKHPGKRLGCGPEGERDIKEH 257
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 82/276 (29%), Positives = 150/276 (54%), Gaps = 28/276 (10%)
Query: 383 QIIGDGNFA---VVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN---EVNILRSVNH-P 435
+++G G + +VR+V A+K++ K+ ++ K + E+ E +L + P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY 495
++ L + T+ +L+L+++ I GG+LF +S+ +F E++ + + + AL +LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG 125
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP----MFTVCGTPTYVAPEIL--N 549
I++RDIK EN+L++ +G HV VL DFGL++ ++ CGT Y+AP+I+
Sbjct: 126 IIYRDIKLENILLDSNG-HV-VLT--DFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 550 ESGYGVKIDVWAAGVILYILLCGFPPFVSD--TNDQDELFDDILSGQYGFPSPYWDDISE 607
+ G+ +D W+ GV++Y LL G PF D N Q E+ IL + PY ++S
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----PPYPQEMSA 237
Query: 608 EAKELISHMLESNPDLRF-----SAEDVLDHPWLER 638
AK++I +L +P R A+++ HP+ ++
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 69/268 (25%), Positives = 126/268 (47%), Gaps = 27/268 (10%)
Query: 384 IIGDGNFAVVRQ--VYDKH-KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKL 440
+G+G F V + + K K + A+K + + +++ E +++ + HPN+++L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQS--------LASALSYL 491
L LYLV+E ++GGDL D + K+ F + ++ +A + YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV-----APE 546
VHRD+ N LV V+K+ DFGL++ V + T + APE
Sbjct: 122 ASKKFVHRDLAARNCLV----GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 547 ILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605
L + + K DVW+ GV+L+ I G P+ +N +E+ + + G Y P P +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRKG-YRLPKP--EYC 232
Query: 606 SEEAKELISHMLESNPDLRFSAEDVLDH 633
+E EL+ + +P+ R + ++++
Sbjct: 233 PDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 40/284 (14%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPN 436
+ + ++IG+G + V + K A+KI+D + +++ I+ E NILR NHPN
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPN 64
Query: 437 IIKLLDEYDTNN------ELYLVIELIKGGDLFD----AISKNVKFSEEDSKFMTQSLAS 486
I + N +L+LV+EL GG + D K + EE ++ +
Sbjct: 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYV 543
L+YLH+N ++HRDIK +N+L+ + VK++ DFG++ ++ + T GTP ++
Sbjct: 125 GLAYLHENKVIHRDIKGQNILLTKNA-EVKLV---DFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 544 APEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598
APE++ ++ Y + DVW+ G+ L G PP D + LF I P
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-CDMHPMRALF-KIPRN----P 234
Query: 599 SP------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
P W S++ + IS L N + R E++L+HP++
Sbjct: 235 PPTLKSPENW---SKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 86/274 (31%), Positives = 150/274 (54%), Gaps = 27/274 (9%)
Query: 383 QIIGDGNFA---VVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN---EVNILRSVNH-P 435
+++G G + +VR+V A+K++ K+ L+ K + +E+ E N+L V P
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY 495
++ L + T +L+L+++ + GG++F + + FSE++ +F + + AL +LH
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG 125
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP----MFTVCGTPTYVAPEIL-NE 550
IV+RDIK EN+L++ G HV VL DFGL++ L ++ CGT Y+APEI+ +
Sbjct: 126 IVYRDIKLENILLDSEG-HV-VLT--DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFV--SDTNDQDELFDDILSGQYGFPSPYWDDISEE 608
G+G +D W+ G++++ LL G PF + N Q E+ IL FPS I E
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS----FIGPE 237
Query: 609 AKELISHMLESNPDLRF-----SAEDVLDHPWLE 637
A++L+ +L +P R A ++ +HP+ +
Sbjct: 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 89/288 (30%), Positives = 138/288 (47%), Gaps = 51/288 (17%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE--------NEVNILR 430
+ V ++IG G F V+ V +HK K + KLL K +MI+ E +I+
Sbjct: 45 FDVIKVIGRGAFGEVQLV--RHKSS----KQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 431 SVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSY 490
N I++L + + LY+V+E + GGDL + +S N E+ ++F T + AL
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS-NYDIPEKWARFYTAEVVLALDA 157
Query: 491 LHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC----GTPTYVAPE 546
+H +HRD+KP+N+L++ SG H LK+ DFG ++ C GTP Y++PE
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSG-H---LKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213
Query: 547 ILNESG----YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG------ 596
+L G YG + D W+ GV LY +L G PF + D L G Y
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF----------YADSLVGTYSKIMDHK 263
Query: 597 ----FPSPYWDDISEEAKELISHMLESNPDL--RFSAEDVLDHPWLER 638
FP +IS++AK+LI L R +++ HP+ +
Sbjct: 264 NSLTFPDDI--EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 82/262 (31%), Positives = 130/262 (49%), Gaps = 17/262 (6%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDE 443
++G G + +V D + A+K I + + Q + E+ + + H NI++ L
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE-RDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 444 YDTNNELYLVIELIKGGDLFDAISKN---VKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
N + +E + GG L + +K +E+ F T+ + L YLHDN IVHRD
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133
Query: 501 IKPENLLVEM-SGCHVKVLKVGDFGLAQRV--LRPMF-TVCGTPTYVAPEILNES--GYG 554
IK +N+LV SG V+K+ DFG ++R+ + P T GT Y+APE++++ GYG
Sbjct: 134 IKGDNVLVNTYSG----VVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189
Query: 555 VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
D+W+ G + + G PPF+ Q +F G + + +S EAK I
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFK---VGMFKIHPEIPESLSAEAKNFIL 246
Query: 615 HMLESNPDLRFSAEDVLDHPWL 636
E +PD R SA D+L P+L
Sbjct: 247 RCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 75/261 (28%), Positives = 148/261 (56%), Gaps = 22/261 (8%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
IG+G+ +V +KH A+K +D K +++++ NEV I+R +H N++ + + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-QRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPE 504
+EL++V+E ++GG L D ++ + + +EE + S+ ALSYLH+ ++HRDIK +
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147
Query: 505 NLLVEMSGCHVKVLKVGDFGLAQRVLRPM---FTVCGTPTYVAPEILNESGYGVKIDVWA 561
++L+ G +K+ DFG +V + + ++ GTP ++APE+++ YG ++D+W+
Sbjct: 148 SILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203
Query: 562 AGVILYILLCGFPPFVSDTNDQ--DELFDDILSGQYGFPSPYWDD---ISEEAKELISHM 616
G+++ ++ G PP+ ++ Q + D++ P D +S + + M
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL--------PPRVKDSHKVSSVLRGFLDLM 255
Query: 617 LESNPDLRFSAEDVLDHPWLE 637
L P R +A+++L HP+L+
Sbjct: 256 LVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 382 GQIIGDGNFAVVRQ-VY---DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
G+ +G+G F V + K+++ A+K + + + + E I+R ++HPNI
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 438 IKLL-----DEYDTNNELYLVIELIKGGDLFDAI--SKNVKFSEED-SKFMTQSLASALS 489
+KLL +E L +V+E + GGDL D + ++ + S D F Q +A +
Sbjct: 64 VKLLGVCTEEE-----PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ-IARGME 117
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV-----A 544
YL +HRD+ N LV + V+K+ DFGL+ R L + A
Sbjct: 118 YLESKNFIHRDLAARNCLVGEN----LVVKISDFGLS-RDLYDDDYYKVKGGKLPIRWMA 172
Query: 545 PEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSG 593
PE L E + K DVW+ GV+L+ I G P+ +N E+ + + G
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN--AEVLEYLKKG 220
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 74/259 (28%), Positives = 125/259 (48%), Gaps = 31/259 (11%)
Query: 382 GQIIGDGNFAVVRQ-VY---DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
G+ +G+G F V + K ++ A+K + + + + E I+R ++HPN+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 438 IKLL-----DEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEED-SKFMTQSLASALSY 490
+KLL +E LY+V+E ++GGDL + KN K S D F Q +A + Y
Sbjct: 64 VKLLGVCTEEE-----PLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQ-IARGMEY 117
Query: 491 LHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-PMFTVCGTP---TYVAPE 546
L +HRD+ N LV + V+K+ DFGL++ + + G ++APE
Sbjct: 118 LESKNFIHRDLAARNCLVGEN----LVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173
Query: 547 ILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605
L E + K DVW+ GV+L+ I G P+ +N +E+ + + +G Y P P +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN--EEVLEYLKNG-YRLPQP--PNC 228
Query: 606 SEEAKELISHMLESNPDLR 624
E +L+ +P+ R
Sbjct: 229 PPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 88/286 (30%), Positives = 137/286 (47%), Gaps = 55/286 (19%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKL 440
++IG G F VR V K A+KI+ K+ +L K+Q+ I E +IL + ++K+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ LYL++E + GGD+ + K +EE+++F A+ +H +HRD
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRD 126
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLA---------------------------------- 526
IKP+NLL++ G HV K+ DFGL
Sbjct: 127 IKPDNLLLDSKG-HV---KLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 527 ---QRVLRPM-FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND 582
+R R + F+ GTP Y+APE+ ++GY D W+ GVI+Y +L G+PPF S+T
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET-- 240
Query: 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAE 628
E + +++ + P ISE+AK+LI LRF E
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLI---------LRFCCE 277
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 74/269 (27%), Positives = 132/269 (49%), Gaps = 29/269 (10%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN---EVNILRSVNHPNIIKLL 441
+GDG F V + K + A KII + ++ +E+ E++IL HPNI+ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQ----IESEEELEDFMVEIDILSECKHPNIVGLY 68
Query: 442 DEYDTNNELYLVIELIKGGDLFDAISKNVK-FSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ Y N+L+++IE GG L + + + +E +++ + + AL++LH + ++HRD
Sbjct: 69 EAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM---FTVCGTPTYVAPEILN-----ESG 552
+K N+L+ + G +K+ DFG++ + + T GTP ++APE++ ++
Sbjct: 129 LKAGNILLTLDG----DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 553 YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD---ISEEA 609
Y K D+W+ G+ L L PP + N L IL P D S
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPH-HELNPMRVLL-KILKS----EPPTLDQPSKWSSSF 238
Query: 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638
+ + L +PD R +A ++L HP++
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 89/314 (28%), Positives = 148/314 (47%), Gaps = 66/314 (21%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPN 436
+ ++IG G F VR V K A+K + KS++ K Q+ ++ E ++L + P
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
++ L + LYL++E + GGDL + K FSE+ ++F A+ +H
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF 122
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLA------------QRVL-------------- 530
+HRDIKP+N+L++ G H+ K+ DFGL+ Q++L
Sbjct: 123 IHRDIKPDNILIDRGG-HI---KLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178
Query: 531 -----------------------RPM-FTVCGTPTYVAPEILNESGYGVKIDVWAAGVIL 566
R M ++ GTP Y+APEI + GYG + D W+ G I+
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238
Query: 567 YILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI--SEEAKELISHMLESNPDLR 624
+ L G+PPF S+ + E + I++ + P DDI S EA++LI ++ +N + R
Sbjct: 239 FECLIGWPPFCSE--NSHETYRKIINWRETLYFP--DDIHLSVEAEDLIRRLI-TNAENR 293
Query: 625 F---SAEDVLDHPW 635
A ++ HP+
Sbjct: 294 LGRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 89/287 (31%), Positives = 140/287 (48%), Gaps = 45/287 (15%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN----EVNILRSVNHPNIIKL 440
IG+G + VV + DK ALK K +L + + + + E+++L+ +NHPNI++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALK---KIRLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 441 LDEYDTNNELYLVIELIKGGDL---FDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
LD + N+LYLV E + DL D+ ++ Q L ++Y H + ++
Sbjct: 64 LDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQ-LLQGIAYCHSHRVL 121
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYVAPEILNESG-Y 553
HRD+KP+NLL++ G LK+ DFGLA+ P+ T T Y APEIL S Y
Sbjct: 122 HRDLKPQNLLIDREG----ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQY 177
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF----------DDILSGQYGFPS---- 599
+D+W+ G I ++ P F D+ + D+LF +D+ G P
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDS-EIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236
Query: 600 -PYWD---------DISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
P W ++ E+ +L+S ML +P R SA+ L HP+
Sbjct: 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 83/261 (31%), Positives = 127/261 (48%), Gaps = 18/261 (6%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
+Y+V +++G+G+F V + D A+K I K + E +L + HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAIS-KNVKFSEEDS--KFMTQSLASALSYLHDN 494
+ + ++ + LY+V+E GGDL I + K ED+ ++ Q + + ++H+
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ-MCLGVQHIHEK 119
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC---GTPTYVAPEILNES 551
++HRDIK +N+ + +G +K+GDFG A+ + P C GTP YV PEI
Sbjct: 120 RVLHRDIKSKNIFLTQNG----KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 552 GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG-FPSPYWDDISEEAK 610
Y K D+W+ G ILY L PF N L + G Y PS Y S E +
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPF--QANSWKNLILKVCQGSYKPLPSHY----SYELR 229
Query: 611 ELISHMLESNPDLRFSAEDVL 631
LI M + NP R SA +L
Sbjct: 230 SLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 81/261 (31%), Positives = 128/261 (49%), Gaps = 21/261 (8%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHPNIIKLLDE 443
IG G+F VV +V K A+K ID SK+ + ++ +E +L ++ II+ +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 444 YDTNNELYLVIELIKGGDLFDAISKNVK--FSEEDS-KFMTQSLASALSYLHDNYIVHRD 500
+ +L +V+E + GDL + E+ +F Q L L++LH I+HRD
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-GLAHLHSKKILHRD 126
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--MF--TVCGTPTYVAPEILNESGYGVK 556
IK NL ++ + +VK+ GD G+A ++L F T+ GTP Y++PE+ + Y K
Sbjct: 127 IKSLNLFLD-AYDNVKI---GDLGVA-KLLSDNTNFANTIVGTPYYLSPELCEDKPYNEK 181
Query: 557 IDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG-FPSPYWDDISEEAKELISH 615
DVWA GV+LY G PF D N+Q L I+ G + Y ++ +LI
Sbjct: 182 SDVWALGVVLYECCTGKHPF--DANNQGALILKIIRGVFPPVSQMYSQQLA----QLIDQ 235
Query: 616 MLESNPDLRFSAEDVLDHPWL 636
L + R +L +P L
Sbjct: 236 CLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 74/264 (28%), Positives = 144/264 (54%), Gaps = 12/264 (4%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
++Y+ + IG G V D + A++ ++ + KK++I NE+ ++R +PN
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPN 78
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
I+ LD Y +EL++V+E + GG L D +++ E + + AL +LH N +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 137
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVCGTPTYVAPEILNESGY 553
+HRDIK +N+L+ M G +K+ DFG ++ T+ GTP ++APE++ Y
Sbjct: 138 IHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
G K+D+W+ G++ ++ G PP++++ N L+ +G +P + +S ++ +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPELQNP--EKLSAIFRDFL 250
Query: 614 SHMLESNPDLRFSAEDVLDHPWLE 637
+ L+ + + R SA+++L H +L+
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 74/266 (27%), Positives = 129/266 (48%), Gaps = 33/266 (12%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDE 443
+ G V+QV ++ A K + + ++ EV++L+S+ H NI++ L
Sbjct: 20 LTNQGQLIAVKQVELDTSNVLAAEK---------EYEKLQEEVDLLKSLKHVNIVQYLGT 70
Query: 444 YDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKP 503
+N + + +E + GG + +++ E T+ + ++YLH+N +VHRDIK
Sbjct: 71 CLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKG 130
Query: 504 ENLLVEMSGCHVKVLKVGDFGLAQRV------------LRPMFTVCGTPTYVAPEILNES 551
N+++ +G ++K+ DFG A+R+ L+ M GTP ++APE++NES
Sbjct: 131 NNVMLMPNG----IIKLIDFGCARRLAWVGLHGTHSNMLKSMH---GTPYWMAPEVINES 183
Query: 552 GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD-ISEEAK 610
GYG K D+W+ G ++ + G PP S D L G + P D S A
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLAS----MDRLAAMFYIGAHRGLMPRLPDSFSAAAI 239
Query: 611 ELISHMLESNPDLRFSAEDVLDHPWL 636
+ ++ L + R SA +L H +L
Sbjct: 240 DFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 91/273 (33%), Positives = 145/273 (53%), Gaps = 27/273 (9%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKL 440
++IG G F V V K+ A+KI++K ++L + + E ++L + + I L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHR 499
+ N LYLV++ GGDL +SK + E+ ++F + A+ +H VHR
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR 126
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTV-----CGTPTYVAPEILN--ESG 552
DIKP+N+L++ +G H+ ++ DFG R L TV GTP Y++PEIL E G
Sbjct: 127 DIKPDNVLLDKNG-HI---RLADFGSCLR-LLADGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 553 ---YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ--YGFPSPYWDDISE 607
YG + D W+ GV +Y +L G PF +++ E + I++ + + FP P D+SE
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHKEHFQFP-PDVTDVSE 238
Query: 608 EAKELISHMLESNPDLRF---SAEDVLDHPWLE 637
EAK+LI ++ S P+ R +D DHP+ E
Sbjct: 239 EAKDLIRRLICS-PETRLGRNGLQDFKDHPFFE 270
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 81/259 (31%), Positives = 133/259 (51%), Gaps = 17/259 (6%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE--NEVNILRSVN 433
L + + + IG G F+ V + + ALK + L+ K + E+++L+ +N
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI---SKNVKFSEEDS--KFMTQSLASAL 488
HPN+IK + +NEL +V+EL GDL I K + E + K+ Q L SAL
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ-LCSAL 119
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ---RVLRPMFTVCGTPTYVAP 545
++H ++HRDIKP N+ + +G V+K+GD GL + ++ GTP Y++P
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605
E ++E+GY K D+W+ G +LY + PF D + L I Q +P D
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCDYPPLPSDHY 233
Query: 606 SEEAKELISHMLESNPDLR 624
SEE ++L++ + +P+ R
Sbjct: 234 SEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVN 433
+ Y + Q IG G + V + D A+K+I KL ++I+ E+++L+
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECR 58
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK-FSEEDSKFMTQSLASALSYLH 492
HPNI+ Y ++L++V+E GG L D SE ++ + L+YLH
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAPEILN 549
+ +HRDIK N+L+ G +K+ DFG++ ++ + + GTP ++APE+
Sbjct: 119 ETGKIHRDIKGANILLTEDGD----VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 550 E---SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606
GY K D+WA G+ L PP D + LF L + FP P D
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPM-FDLHPMRALF---LISKSNFPPPKLKDKE 230
Query: 607 EEAKELISHM---LESNPDLRFSAEDVLDHP 634
+ + + L +P R +A +L HP
Sbjct: 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 20/267 (7%)
Query: 382 GQIIGDGNFAVVRQVYDKHKDMDCALKII-----DKSKLLGKKQMIENEVNILRSVNHPN 436
GQ +G G F+ Q D A+K + S+ + + E+ ++ +NHP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
II++L ++ L +E + GG + +SK F E T+ L LSYLH+N I
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT--------VCGTPTYVAPEIL 548
+HRD+K NLL++ +G L++ DFG A R L T + GT ++APE+L
Sbjct: 125 IHRDVKGANLLIDSTGQR---LRIADFGAAAR-LAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 549 NESGYGVKIDVWAAGVILYILLCGFPPFVSDT-NDQDELFDDILSGQYGFPSPYWDDISE 607
YG DVW+ G ++ + PP+ ++ ++ L I S P + +S
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP--EHLSP 238
Query: 608 EAKELISHMLESNPDLRFSAEDVLDHP 634
+++ LE P+ R + ++L HP
Sbjct: 239 GLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 93/306 (30%), Positives = 136/306 (44%), Gaps = 59/306 (19%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKII---DKSKLLGKKQMIENEVNILRSVN 433
RY IG+G + +V K + A+K I + Q E+ ILR
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC---QRTLREIKILRRFK 61
Query: 434 HPNIIKLLD-----EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASAL 488
H NII +LD +++ N++Y+V EL++ DL+ I K S + ++ + L
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGL 119
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-------MFTVCGTPT 541
Y+H ++HRD+KP NLL+ + C LK+ DFGLA R+ P + T
Sbjct: 120 KYIHSANVLHRDLKPSNLLLN-TNCD---LKICDFGLA-RIADPEHDHTGFLTEYVATRW 174
Query: 542 YVAPEI-LNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELFDDILSGQYGFPS 599
Y APEI LN GY ID+W+ G IL +L P F D Q L +L G PS
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL----GTPS 230
Query: 600 -------------------PY-----WDDI----SEEAKELISHMLESNPDLRFSAEDVL 631
P+ W+ + +A +L+ ML NP R + E+ L
Sbjct: 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL 290
Query: 632 DHPWLE 637
HP+LE
Sbjct: 291 AHPYLE 296
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 87/289 (30%), Positives = 151/289 (52%), Gaps = 24/289 (8%)
Query: 362 TIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ- 420
TI + +L + + + Y V ++IG G F V+ V K A+K++ K +++ +
Sbjct: 31 TINKIRDLRMKA---EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS 87
Query: 421 -MIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF 479
E +I+ N P +++L + + LY+V+E + GGDL + +S N E+ ++F
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARF 146
Query: 480 MTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC-- 537
T + AL +H +HRD+KP+N+L++ SG H LK+ DFG ++ + C
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-H---LKLADFGTCMKMNKEGMVRCDT 202
Query: 538 --GTPTYVAPEILNESG----YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDIL 591
GTP Y++PE+L G YG + D W+ GV LY +L G PF +D+ + I+
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIM 260
Query: 592 SGQYGFPSPYWDDISEEAKELISHMLESNPDLRF---SAEDVLDHPWLE 637
+ + P +DIS+EAK LI L ++ ++R E++ H + +
Sbjct: 261 NHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRNGVEEIKRHLFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 94/309 (30%), Positives = 131/309 (42%), Gaps = 60/309 (19%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE----NEVNILRS 431
+ ++ + IG+G + V + DK ALK K +L +K+ E+ ILR
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQ 62
Query: 432 VNHPNIIKL----------LDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFM 480
+NH NI+ L LD YLV E + DL + S V FSE+ K
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSF 121
Query: 481 TQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ----RVLRPMFTV 536
+ L L+Y H +HRDIK N+L+ G +K+ DFGLA+ RP
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG----QIKLADFGLARLYNSEESRPYTNK 177
Query: 537 CGTPTYVAPEIL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQ 594
T Y PE+L E YG IDVW+ G IL L P F ++ Q EL +
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC--- 234
Query: 595 YGFPSP-YWDDISE--------------------------EAKELISHMLESNPDLRFSA 627
G P P W D+ + A +L+ HML +P R +A
Sbjct: 235 -GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA 293
Query: 628 EDVLDHPWL 636
E+ L+ PWL
Sbjct: 294 EEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 88/269 (32%), Positives = 130/269 (48%), Gaps = 24/269 (8%)
Query: 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLL 441
IG G V +V + ALK+I + ++ I E+ ILR VNHPN++K
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 442 DEYDTNNELYLVIELIKGGDLFDA-ISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
D +D N E+ +++E + GG L I+ ++ + + + S ++YLH +IVHRD
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRHIVHRD 193
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC----GTPTYVAPEI----LNESG 552
IKP NLL+ + K +K+ DFG++ R+L C GT Y++PE LN
Sbjct: 194 IKPSNLLINSA----KNVKIADFGVS-RILAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248
Query: 553 Y-GVKIDVWAAGV-ILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610
Y G D+W+ GV IL L FP V D L I Q S E +
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPA---TASREFR 305
Query: 611 ELISHMLESNPDLRFSAEDVLDHPWLERS 639
IS L+ P R+SA +L HP++ R+
Sbjct: 306 HFISCCLQREPAKRWSAMQLLQHPFILRA 334
|
Length = 353 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 81/285 (28%), Positives = 130/285 (45%), Gaps = 52/285 (18%)
Query: 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKL 440
Q G + ++ + K ++ + E+ LR ++ HPNI++L
Sbjct: 18 AQSRKTGKYYAIKCMKKHFKSLEQVNNL--------------REIQALRRLSPHPNILRL 63
Query: 441 LD-EYD-TNNELYLVIELIKGGDLFDAISKNVK-FSEEDSK-FMTQSLASALSYLHDNYI 496
++ +D L LV EL+ +L++ I + E+ K +M Q L +L ++H N I
Sbjct: 64 IEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQ-LLKSLDHMHRNGI 121
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL-RPMFTV-CGTPTYVAPEILNESG-Y 553
HRDIKPEN+L+ +LK+ DFG + + +P +T T Y APE L G Y
Sbjct: 122 FHRDIKPENILI-----KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 554 GVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELFDDILSG---------------QYGF 597
G K+D+WA G + + +L FP F ++ DQ D+L Y F
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236
Query: 598 PS-------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
PS + S E +L+ +L +PD R +A+ L HP+
Sbjct: 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 81/263 (30%), Positives = 131/263 (49%), Gaps = 19/263 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNII 438
+++G G+F V K K A+K + K +L M+E V L N P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN-PFLT 59
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
L + T L+ V+E + GGDL I +F + F + L +LH I++
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIY 119
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVCGTPTYVAPEILNESGYGV 555
RD+K +N++++ G H+K+ DFG+ + + T CGTP Y+APEIL Y
Sbjct: 120 RDLKLDNVMLDRDG-HIKI---ADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
+D W+ GV+LY +L G PF D D+DELF+ I +P W I++E+K+++
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGD--DEDELFESIRVDTPHYPR--W--ITKESKDILEK 229
Query: 616 MLESNPDLRFSAE-DVLDHPWLE 637
+ E +P R ++ HP+ +
Sbjct: 230 LFERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 82/274 (29%), Positives = 141/274 (51%), Gaps = 21/274 (7%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ--MIENEVNILRSVNH 434
+ Y V ++IG G F V+ V K A+K++ K +++ + E +I+ N
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494
P +++L + + LY+V+E + GGDL + +S N E+ +KF T + AL +H
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS-NYDVPEKWAKFYTAEVVLALDAIHSM 161
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC----GTPTYVAPEILNE 550
++HRD+KP+N+L++ G H LK+ DFG ++ C GTP Y++PE+L
Sbjct: 162 GLIHRDVKPDNMLLDKHG-H---LKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 551 SG----YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606
G YG + D W+ GV L+ +L G PF +D+ + I+ + P +IS
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--LVGTYSKIMDHKNSLNFPEDVEIS 275
Query: 607 EEAKELISHMLESNPDLRF---SAEDVLDHPWLE 637
+ AK LI L ++ ++R E++ HP+ +
Sbjct: 276 KHAKNLICAFL-TDREVRLGRNGVEEIKQHPFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 90/299 (30%), Positives = 134/299 (44%), Gaps = 49/299 (16%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN------EVNILR 430
RY +G G + V +D A+K KL Q + E+ +L+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK-----KLSRPFQSAIHAKRTYRELRLLK 69
Query: 431 SVNHPNIIKLLDEY--DTNNE----LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSL 484
++H N+I LLD + ++ E +YLV L+ G DL + I K K S++ +F+ +
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQI 127
Query: 485 ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVA 544
L Y+H I+HRD+KP N+ V C +K+L DFGLA+ M T Y A
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKIL---DFGLARHTDDEMTGYVATRWYRA 183
Query: 545 PEI-LNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQ------------DELFDDI 590
PEI LN Y +D+W+ G I+ LL G F SD DQ +EL I
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243
Query: 591 LS--------GQYGFPSPYWDDI----SEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
S P + ++ + A +L+ ML +PD R +A + L HP+L
Sbjct: 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 84/264 (31%), Positives = 137/264 (51%), Gaps = 23/264 (8%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIID-KSKLLGKKQMIENEVNILRSVNHPNIIKLLDE 443
+GDG F V + +K + A K+ID KS+ + M+E ++IL S +HPNI+KLLD
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVE--IDILASCDHPNIVKLLDA 70
Query: 444 YDTNNELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
+ N L+++IE GG + DA+ ++ +E + + + AL+YLH+N I+HRD+
Sbjct: 71 FYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLA---QRVLRPMFTVCGTPTYVAPEIL-----NESGY 553
K N+L + G +K+ DFG++ R ++ + GTP ++APE++ + Y
Sbjct: 130 KAGNILFTLDG----DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY-WDDISEEAKEL 612
K DVW+ G+ L I + P + N L S P W S E K+
Sbjct: 186 DYKADVWSLGITL-IEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSEFKDF 241
Query: 613 ISHMLESNPDLRFSAEDVLDHPWL 636
+ LE N D R++ +L HP++
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 81/263 (30%), Positives = 129/263 (49%), Gaps = 19/263 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNII 438
+++G G+F V K + A+K + K +L M+E V L + HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL-AWEHPFLT 59
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
L + T L+ V+E + GGDL I KF + F + L +LH IV+
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVCGTPTYVAPEILNESGYGV 555
RD+K +N+L++ G H+ K+ DFG+ + + T CGTP Y+APEIL Y
Sbjct: 120 RDLKLDNILLDTDG-HI---KIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
+D W+ GV+LY +L G PF +D++ELF I +P W ++ EAK+++
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF--HGHDEEELFQSIRMDNPCYPR--W--LTREAKDILVK 229
Query: 616 MLESNPDLRFSAE-DVLDHPWLE 637
+ P+ R + D+ HP+
Sbjct: 230 LFVREPERRLGVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 87/268 (32%), Positives = 136/268 (50%), Gaps = 34/268 (12%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMD-CALKII------------DKSKLLGKKQMIENE 425
Y+V + +G G F V +V K+ + ALK I ++ K +G I +E
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGD---IVSE 58
Query: 426 VNILR-SVNHPNIIKLLDEYDTNNELYLVIELIKG---GDLFDAI-SKNVKFSEEDSKFM 480
V I++ + HPNI++ + N+ LY+V++LI+G G+ F+++ K +F+EE +
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 481 TQSLASALSYLH-DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--PMFTVC 537
+ AL YLH + IVHRD+ P N+ M G KV + DFGLA++ + +V
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNI---MLGEDDKVT-ITDFGLAKQKQPESKLTSVV 174
Query: 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597
GT Y PEI+ YG K DVWA G ILY + PPF S + L I+ Y
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS--TNMLSLATKIVEAVY-- 230
Query: 598 PSPYWDDI-SEEAKELISHMLESNPDLR 624
P + + SE+ ++I+ L + + R
Sbjct: 231 -EPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 83/285 (29%), Positives = 129/285 (45%), Gaps = 43/285 (15%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G+G +A V + ++ ALK I G E+++++ + H NI++L D
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 445 DTNNELYLVIELIKGGDL---FDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
T N+L LV E + DL D K T L +++ H+N ++HRD+
Sbjct: 68 HTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDL 126
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYVAPEILNES-GYGVKI 557
KP+NLL+ G LK+ DFGLA+ P+ T T Y AP++L S Y I
Sbjct: 127 KPQNLLINKRG----ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI 182
Query: 558 DVWAAGVILYILLCGFPPFV-SDTNDQDELFDDILSGQYGFPSPY-WDDISEEAK----- 610
D+W+ G I+ ++ G P F ++ DQ I+ G P+ W IS+ +
Sbjct: 183 DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM----GTPTESTWPGISQLPEYKPTF 238
Query: 611 --------------------ELISHMLESNPDLRFSAEDVLDHPW 635
+L+ +L+ NP+LR SA D L HPW
Sbjct: 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 83/304 (27%), Positives = 137/304 (45%), Gaps = 62/304 (20%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLD 442
IG G F V V + A+K + K+ +L + Q ++ E +IL ++ ++KL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
+ + LY V++ I GGD+ + + F E+ ++F L A+ +H +HRDIK
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIK 128
Query: 503 PENLLVEMSGCHVKVLKVGDFGLA------------------------------------ 526
P+N+L++ G H+K+ DFGL
Sbjct: 129 PDNILIDRDG-HIKLT---DFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184
Query: 527 ------------QRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFP 574
QR L ++ GTP Y+APE+L +GY D W+ GVILY +L G P
Sbjct: 185 LKPLERRRKRQHQRCL--AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 575 PFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF---SAEDVL 631
PF++DT + +L +++ + P +S EA +LI L + R A+++
Sbjct: 243 PFLADTPAETQL--KVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIK 299
Query: 632 DHPW 635
HP+
Sbjct: 300 AHPF 303
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 89/278 (32%), Positives = 147/278 (52%), Gaps = 29/278 (10%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPN 436
+ + ++IG G F V V KH + A+KI++K ++L + + E N+L + +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNY 495
I L + N LYLV++ GGDL +SK + E+ ++F + A+ +H +
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 496 IVHRDIKPENLLVEMSGCHVKV------LKVGDFGLAQRVLRPMFTVCGTPTYVAPEILN 549
VHRDIKP+N+L++M+G H+++ LK+ G Q + GTP Y++PEIL
Sbjct: 123 YVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDGTVQSSV-----AVGTPDYISPEILQ 176
Query: 550 --ESG---YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ--YGFPSPYW 602
E G YG + D W+ GV +Y +L G PF +++ E + I++ + + FPS +
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHEERFQFPS-HI 233
Query: 603 DDISEEAKELISHMLESNPDLRFSA---EDVLDHPWLE 637
D+SEEAK+LI ++ S + R ED H + E
Sbjct: 234 TDVSEEAKDLIQRLICSR-ERRLGQNGIEDFKKHAFFE 270
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 15/213 (7%)
Query: 382 GQIIGDGNFAVVRQ----VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
G+ +G+G F V + + + A+K + + +++ E +I++ ++HPNI
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
++LL LY+V E + GGDL D + K + +D M +A + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNF 123
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV-----APEILNES 551
VHRD+ N LV + V+K+ DFGL++ + + + APE L +
Sbjct: 124 VHRDLAARNCLVTENL----VVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 552 GYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
+ K DVW+ GV+L+ I G P+ +N++
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212
|
Length = 258 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 77/235 (32%), Positives = 119/235 (50%), Gaps = 21/235 (8%)
Query: 413 SKLLGKKQM-------IENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDA 465
KL +K + IE V+ L ++PN IKL T L+++ IK GDLFD
Sbjct: 41 QKLFVQKIIKAKNFNAIEPMVHQLMK-DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99
Query: 466 ISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525
+ K K SE + K + + L AL+ LH + I+H DIK EN+L + + + + D+GL
Sbjct: 100 LKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC---DYGL 156
Query: 526 AQRVLRPMFTVC--GTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ 583
+ + P C GT Y +PE + Y V D WA GV+ Y LL G PF D+
Sbjct: 157 CKIIGTPS---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK---EDE 210
Query: 584 DELFD-DILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSA-EDVLDHPWL 636
DE D + L + P+ ++S+ A + + ML+ N + R + +++ HP+L
Sbjct: 211 DEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 25/270 (9%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK---- 439
+G+G V + K+ M ALK I ++ I E+ I +S P I+K
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVK-----FSEEDSKFMTQSLASALSYLHDN 494
LDE ++ + + +E +GG L D+I K VK E+ + +S+ LSYLH
Sbjct: 68 FLDESSSS--IGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA-QRVLRPMFTVCGTPTYVAPEILNESGY 553
I+HRDIKP N+L+ G +K+ DFG++ + V T GT Y+APE + Y
Sbjct: 125 KIIHRDIKPSNILLTRKG----QVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPY 180
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD-------IS 606
+ DVW+ G+ L + PF + + ++LS P+P D S
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPE-GEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWL 636
EE K+ I LE +P R + D+L+HPW+
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|214711 smart00537, DCX, Domain in the Doublecortin (DCX) gene product | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-27
Identities = 47/89 (52%), Positives = 66/89 (74%), Gaps = 3/89 (3%)
Query: 98 RRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDG 157
+ KRIRF NGD+FFKGV + V +R++SF++LL++LT ++LP GVR L+T+DG
Sbjct: 3 VKPKRIRFYRNGDRFFKGVRLVVNRKRFKSFEALLQDLTE--VVKLDLPHGVRKLYTLDG 60
Query: 158 QKVTNIDELEDGKFYICSSSGDQFKKVDY 186
+KVT++DELEDG Y+ S + FKKVDY
Sbjct: 61 KKVTSLDELEDGGSYVA-SGTEAFKKVDY 88
|
Tandemly-repeated domain in doublin, the Doublecortin gene product. Proposed to bind tubulin. Doublecortin (DCX) is mutated in human X-linked neuronal migration defects. Length = 89 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 90/307 (29%), Positives = 129/307 (42%), Gaps = 59/307 (19%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVN 433
+Y IG G F V + K ALK + + +K+ E+ IL+ +
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV---LMENEKEGFPITALREIKILQLLK 69
Query: 434 HPNIIKLLDEYDT-----NN---ELYLVIELIKGGDLFDAIS-KNVKFSEEDSKFMTQSL 484
H N++ L++ T N YLV E + DL +S KNVKF+ + K + + L
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 485 ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-------MFTVC 537
+ L Y+H N I+HRD+K N+L+ G +LK+ DFGLA+
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDG----ILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 538 GTPTYVAPEI-LNESGYGVKIDVWAAGVI---------------------LYILLCG-FP 574
T Y PE+ L E YG ID+W AG I L LCG
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244
Query: 575 PFVSDTNDQDELFD--DILSGQYGFP----SPYWDDISEEAKELISHMLESNPDLRFSAE 628
P V D+ ELF ++ GQ PY D A +LI +L +P R A+
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKD--PHALDLIDKLLVLDPAKRIDAD 302
Query: 629 DVLDHPW 635
L+H +
Sbjct: 303 TALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 70/259 (27%), Positives = 144/259 (55%), Gaps = 14/259 (5%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
IG+G+ +V K A+K +D K +++++ NEV I+R H N++++ + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPE 504
+EL++V+E ++GG L D ++ + + +EE + ++ ALS LH ++HRDIK +
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145
Query: 505 NLLVEMSGCHVKVLKVGDFGLAQRVLRPM---FTVCGTPTYVAPEILNESGYGVKIDVWA 561
++L+ G +K+ DFG +V + + ++ GTP ++APE+++ YG ++D+W+
Sbjct: 146 SILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWS 201
Query: 562 AGVILYILLCGFPPFVSDTNDQD-ELFDDILSGQYGFPSPYWDDISEEAKELISHMLESN 620
G+++ ++ G PP+ ++ + ++ D L + +S K + +L +
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL----KNLHKVSPSLKGFLDRLLVRD 257
Query: 621 PDLRFSAEDVLDHPWLERS 639
P R +A ++L HP+L ++
Sbjct: 258 PAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 82/275 (29%), Positives = 137/275 (49%), Gaps = 36/275 (13%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG----KKQMIENEVNILRSVNH 434
Y +++G G++ V V +H+ D +I K L +++ E E +L + H
Sbjct: 2 YCFVRVVGKGSYGEVSLV--RHRT-DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH 58
Query: 435 PNIIKLLDEYDTNN-ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQS--------LA 485
PNI+ + ++ + LY+V+ +GGDL+ K E+ K + ++ +A
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYH------KLKEQKGKLLPENQVVEWFVQIA 112
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF----TVCGTPT 541
AL YLH+ +I+HRD+K +N+ + + ++KVGD G+A RVL T+ GTP
Sbjct: 113 MALQYLHEKHILHRDLKTQNVFLTRT----NIIKVGDLGIA-RVLENQCDMASTLIGTPY 167
Query: 542 YVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY 601
Y++PE+ + Y K DVWA G +Y + F + D + L I+ G+ P
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF--NAKDMNSLVYRIIEGKL---PPM 222
Query: 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
D S E ELI+ ML P+ R S + +L P++
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 86/305 (28%), Positives = 129/305 (42%), Gaps = 52/305 (17%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMD--CALK----IIDKSKLLGKKQMIENEVNILRS 431
RY + + +G G + +V + + A+K + K K+L K+ + E+ +LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRAL--RELKLLRH 57
Query: 432 V-NHPNIIKLLD----EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLAS 486
H NI L D NELYL EL++ DL I ++ + +
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILC 116
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT----- 541
L Y+H ++HRD+KP NLLV LK+ DFGLA+ G T
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCE----LKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 542 --YVAPEI-LNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQ-DELF-------DD 589
Y APEI L+ Y IDVW+ G IL LL P F D DQ +++ ++
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232
Query: 590 ILSG-------QYGFPSPY---------WDDISEEAKELISHMLESNPDLRFSAEDVLDH 633
LS Y P + + + A +L+ +L +P R S E+ L+H
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292
Query: 634 PWLER 638
P+L
Sbjct: 293 PYLAI 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 84/275 (30%), Positives = 145/275 (52%), Gaps = 21/275 (7%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNH 434
+ + + ++IG G F V V K+ D A+KI++K ++L + + E ++L + ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHD 493
I L + N LYLV++ GGDL +SK + E+ ++F + A+ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR----PMFTVCGTPTYVAPEILN 549
+ VHRDIKP+N+L++M+G H+ ++ DFG +++ GTP Y++PEIL
Sbjct: 121 LHYVHRDIKPDNILMDMNG-HI---RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 550 --ESG---YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW-D 603
E G YG + D W+ GV +Y +L G PF +++ E + I++ + F P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHKERFQFPAQVT 234
Query: 604 DISEEAKELISHMLESNPDL--RFSAEDVLDHPWL 636
D+SE+AK+LI ++ S + ED HP+
Sbjct: 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 85/290 (29%), Positives = 133/290 (45%), Gaps = 49/290 (16%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE----NEVNILRSVNHPNIIK 439
IG+G + +V + D ALK K ++ ++ I E+ +L ++ HPNI++
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALK---KVRMDNERDGIPISSLREITLLLNLRHPNIVE 70
Query: 440 LLDEYDTN--NELYLVIELIKG--GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY 495
L + + ++LV+E + L D + FSE K + L L YLH+N+
Sbjct: 71 LKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT--PFSESQVKCLMLQLLRGLQYLHENF 128
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR---VLRPMFTVCGTPTYVAPEIL-NES 551
I+HRD+K NLL+ GC LK+ DFGLA+ +PM T Y APE+L +
Sbjct: 129 IIHRDLKVSNLLLTDKGC----LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT 184
Query: 552 GYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILS----------------GQ 594
Y ID+WA G IL LL P + +Q +L +L G+
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244
Query: 595 YGFPS-PY--------WDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
+ P PY W +SE L++ +L +P R +AE+ L+ +
Sbjct: 245 FTLPKQPYNNLKHKFPW--LSEAGLRLLNFLLMYDPKKRATAEEALESSY 292
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 78/265 (29%), Positives = 123/265 (46%), Gaps = 21/265 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPNIIKL 440
+++G G F V + A K ++K ++ +K M NE IL VN ++ L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
Y+T + L LV+ L+ GGDL I N F EE + F + L LH IV+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNESGYGVK 556
RD+KPEN+L++ G H+++ D GLA + + GT Y+APE++ Y
Sbjct: 126 RDLKPENILLDDYG-HIRI---SDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181
Query: 557 IDVWAAGVILYILLCGFPPFVS--DTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
D W G ++Y ++ G PF + ++E+ + Q Y + SE A+ +
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----EEYSEKFSEAARSICR 237
Query: 615 HMLESNPDLRF-----SAEDVLDHP 634
+L +P R AE+V HP
Sbjct: 238 QLLTKDPGFRLGCRGEGAEEVKAHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 77/259 (29%), Positives = 123/259 (47%), Gaps = 17/259 (6%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNHPNIIKLLD 442
+G G F V V K+ A K +DK +L K ++M E IL VN P I+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK--FMTQSLASALSYLHDNYIVHRD 500
+++ L LV+ L+ GGDL I + E + + + + +LH IV+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 501 IKPENLLVEMSG-CHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNESGYGVKI 557
+KPEN+L++ G C ++ D GLA + + + GT Y+APEIL E Y +
Sbjct: 121 MKPENVLLDDQGNC-----RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 558 DVWAAGVILYILLCGFPPF--VSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
D +A G +Y ++ G PF + ++EL L + F + +EE+K++
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH---QNFTEESKDICRL 232
Query: 616 MLESNPDLRFSAEDVLDHP 634
L P+ R + + D P
Sbjct: 233 FLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 71/274 (25%), Positives = 130/274 (47%), Gaps = 30/274 (10%)
Query: 382 GQIIGDGNFAVVRQVYDKHKDMDCALK-----IIDKSKLLGKKQMIE---NEVNILRSVN 433
G +IG G+F V + A+K + S K+ M++ E+ +L+ +
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
H NI++ L + L + +E + GG + ++ F E + + + L+YLH+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-----------LRPMFTVCGTPTY 542
I+HRDIK N+LV+ G +K+ DFG+++++ RP G+ +
Sbjct: 125 RGIIHRDIKGANILVDNKG----GIKISDFGISKKLEANSLSTKTNGARPSLQ--GSVFW 178
Query: 543 VAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602
+APE++ ++ Y K D+W+ G ++ +L G PF D +F G+ P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF-PDCTQLQAIFK---IGENASPEIP- 233
Query: 603 DDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
+IS EA + + E + + R +A ++L HP+L
Sbjct: 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 87/282 (30%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIID-KSKLLGKKQMIENEVNILRSVNHPNIIKLLDE 443
IG+G + VV + +K ALK I ++ G E+++L+ +NHPNI+KLLD
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 444 YDTNNELYLVIELIKGGDL--FDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
T N+LYLV E + DL F S K L L++ H + ++HRD+
Sbjct: 68 IHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYVAPEILNESG-YGVKI 557
KP+NLL+ G +K+ DFGLA+ P+ T T Y APEIL Y +
Sbjct: 127 KPQNLLINTEG----AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 182
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELF----------DDILSGQYGFPS-----PYW 602
D+W+ G I ++ F D+ + D+LF + + G P P W
Sbjct: 183 DIWSLGCIFAEMVTRRALFPGDS-EIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKW 241
Query: 603 D---------DISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
+ E+ ++L+S ML +P+ R SA+ L HP+
Sbjct: 242 ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 87/302 (28%), Positives = 128/302 (42%), Gaps = 49/302 (16%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKS---KLLGKKQMIENEVNILRSVNH 434
RY + IG G + VV D A+K I + L K+ + E+ ILR H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL--RELKILRHFKH 63
Query: 435 PNIIKLLDEYDTNNEL----YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSY 490
NII + D Y+V++L+ DL I + +EE ++ L L Y
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKY 122
Query: 491 LHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL-------RPMFTVCGTPTYV 543
+H ++HRD+KP NLLV C L++GDFG+A+ + M T Y
Sbjct: 123 IHSANVIHRDLKPSNLLVN-EDCE---LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 544 APEILNESG-YGVKIDVWAAGVI---------------------LYILLCGFPPF-VSDT 580
APE+L Y ID+W+ G I L + + G P V +
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238
Query: 581 NDQDELFDDILSGQYGFPSPYWDDI----SEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
D + I + P P W I S EA +L+S ML+ +P+ R + E L HP+L
Sbjct: 239 IGSDRVRKYIQNLPRKQPVP-WSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
Query: 637 ER 638
+
Sbjct: 298 AQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 65/272 (23%), Positives = 129/272 (47%), Gaps = 24/272 (8%)
Query: 382 GQIIGDGNFAVVRQVYDKHKDMDCALKII---------DKSKLLGKKQMIENEVNILRSV 432
G++IG G + V + A+K + S+ + + +E+ L+ +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 433 NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492
+H NI++ L T L + +E + GG + + +F E+ +F T+ + L+YLH
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-----PMFTVCGTPTYVAPEI 547
I+HRD+K +NLLV+ G + K+ DFG++++ ++ G+ ++APE+
Sbjct: 126 SKGILHRDLKADNLLVDADG----ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 548 LNES--GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD--ELFDDILSGQYGFPSPYWD 603
++ GY K+D+W+ G ++ + G P+ + +L + P
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN--KRSAPPIPPDVSM 239
Query: 604 DISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
++S A + ++ NPD R +A ++L HP+
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 76/263 (28%), Positives = 122/263 (46%), Gaps = 25/263 (9%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
IG G+F V + D A+KIID + + + I+ E+ +L + P I + Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPE 504
+L++++E + GG D + K E + + + L YLH +HRDIK
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130
Query: 505 NLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAPEILNESGYGVKIDVWA 561
N+L+ G +K+ DFG+A ++ T GTP ++APE++ +S Y K D+W+
Sbjct: 131 NVLLSEQG----DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWS 186
Query: 562 AGVILYILLCGFPPFVSDTNDQDELF------DDILSGQYGFPSPYWDDISEEAKELISH 615
G+ L G PP SD + LF L GQY P KE +
Sbjct: 187 LGITAIELAKGEPPN-SDLHPMRVLFLIPKNSPPTLEGQYSKP----------FKEFVEA 235
Query: 616 MLESNPDLRFSAEDVLDHPWLER 638
L +P R +A+++L H ++ R
Sbjct: 236 CLNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 59/309 (19%)
Query: 385 IGDGNFAVVRQVYDKHKDM--DCALKII--DKSKLLGKKQMIENEVNILRSVNHPNIIKL 440
IG G + V + K+ + A+K DK + G Q E+ +LR + H N++ L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 441 LDEY--DTNNELYLVIELIKGGDLFDAI-----SKNVKFSEEDSKFMTQSLASALSYLHD 493
++ + + +YL+ + + DL+ I +K V K + + + + YLH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA---QRVLRPMFT---VCGTPTYVAPEI 547
N+++HRD+KP N+LV G V+K+GD GLA L+P+ V T Y APE+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPEL 186
Query: 548 LNESG-YGVKIDVWAAGVILYILLC------------------------------GFP-- 574
L + Y ID+WA G I LL G P
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTE 246
Query: 575 ---PFVSDTNDQDELFDDILSGQYGFPS-PYWDDI----SEEAKELISHMLESNPDLRFS 626
P + + D L D + Y S W + + +L+ +LE +P R +
Sbjct: 247 KDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306
Query: 627 AEDVLDHPW 635
AE+ L+HP+
Sbjct: 307 AEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 78/266 (29%), Positives = 135/266 (50%), Gaps = 23/266 (8%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIID-KSKLLGKKQMIENEVNILRSVNHPNIIKLLDE 443
+GDG F V + +K A K+I+ KS+ + M+E + IL + NHP I+KLL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVE--IEILATCNHPYIVKLLGA 77
Query: 444 YDTNNELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
+ + +L+++IE GG + DAI + +E + + + + AL YLH I+HRD+
Sbjct: 78 FYWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQ---RVLRPMFTVCGTPTYVAPEI-----LNESGY 553
K N+L+ + G +K+ DFG++ + L+ + GTP ++APE+ + ++ Y
Sbjct: 137 KAGNVLLTLDG----DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY-WDDISEEAKEL 612
K D+W+ G+ L I + P + N L S P W S E ++
Sbjct: 193 DYKADIWSLGITL-IEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW---SMEFRDF 248
Query: 613 ISHMLESNPDLRFSAEDVLDHPWLER 638
+ L+ +P+ R SA +L+HP++
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 79/314 (25%), Positives = 126/314 (40%), Gaps = 64/314 (20%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALK-IIDKSKLLGKKQMIENEVNILRSVNH 434
L+ Y + +G+G F V + ALK I+ ++ G E+ IL+ + H
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKH 66
Query: 435 PNIIKLLD--------EYDTNNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLA 485
PN++ L+D +Y+V + DL + +VK +E K L
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVCGTPT- 541
++YLH+N+I+HRDIK N+L++ G +LK+ DFGLA R P G
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQG----ILKIADFGLA-RPYDGPPPNPKGGGGGGT 180
Query: 542 -----------YVAPE-ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFD 588
Y PE +L E Y +D+W G + + P ++ DQ L
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240
Query: 589 DILSGQYGFPS----PYWDDI-----------------------SEEAKELISHMLESNP 621
+ G P+ P W + E +L+S +L +P
Sbjct: 241 KLC----GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296
Query: 622 DLRFSAEDVLDHPW 635
R +A D L+HP+
Sbjct: 297 YKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 74/256 (28%), Positives = 120/256 (46%), Gaps = 15/256 (5%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
IG G+F V + D A+KIID + + + I+ E+ +L + P + K Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPE 504
+L++++E + GG D + F E M + + L YLH +HRDIK
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130
Query: 505 NLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAPEILNESGYGVKIDVWA 561
N+L+ G +K+ DFG+A ++ T GTP ++APE++ +S Y K D+W+
Sbjct: 131 NVLLSEQG----DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWS 186
Query: 562 AGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW-DDISEEAKELISHMLESN 620
G+ L G PP SD + LF P + S+ KE I L +
Sbjct: 187 LGITAIELAKGEPP-NSDMHPMRVLFL-----IPKNNPPTLTGEFSKPFKEFIDACLNKD 240
Query: 621 PDLRFSAEDVLDHPWL 636
P R +A+++L H ++
Sbjct: 241 PSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 96/292 (32%), Positives = 124/292 (42%), Gaps = 46/292 (15%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDK--SKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
IG G F VV V D ALK + L+ K++ E+ +L H N++ LD
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66
Query: 443 -----EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
D E+Y+V EL++ DL I S + K + L YLH I+
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGIL 125
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESG 552
HRDIKP NLLV S C VLK+ DFGLA RV P M T Y APEIL S
Sbjct: 126 HRDIKPGNLLVN-SNC---VLKICDFGLA-RVEEPDESKHMTQEVVTQYYRAPEILMGSR 180
Query: 553 -YGVKIDVWAAGVI---------------------LYILLCGFPPFVSDTNDQDELFDDI 590
Y +D+W+ G I L L G P + + + I
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240
Query: 591 LSGQY---GFPSPYW--DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
L G + P Y + EA L+ ML +PD R SA D L HP+L+
Sbjct: 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 76/269 (28%), Positives = 127/269 (47%), Gaps = 19/269 (7%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH 434
L QR ++IG G + V + ALKII+ I+ EV +L +
Sbjct: 2 LYQRL---ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ 58
Query: 435 ---PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL 491
PNI K Y L++++E +GG + + K +E+ + + + AL Y+
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYI 117
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA---QRVLRPMFTVCGTPTYVAPEIL 548
H ++HRDIK N+LV +G +K+ DFG+A + T GTP ++APE++
Sbjct: 118 HKVGVIHRDIKAANILVTNTG----NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 549 NE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607
E Y K D+W+ G+ +Y + G PP+ +D D +L + P + S+
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPY----SDVDAFRAMMLIPKSKPPRLEDNGYSK 229
Query: 608 EAKELISHMLESNPDLRFSAEDVLDHPWL 636
+E ++ L+ P R SAE++L W+
Sbjct: 230 LLREFVAACLDEEPKERLSAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 74/241 (30%), Positives = 126/241 (52%), Gaps = 23/241 (9%)
Query: 404 DCALKIIDKSKLLGKKQMI---ENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGG 460
D K++ K +L ++ +E++ L + +H I+K D++ ++++L L++E GG
Sbjct: 91 DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150
Query: 461 DLFDAISKNVK----FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVK 516
DL I + +K F E + + + AL +H ++HRD+K N+ + +G
Sbjct: 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG---- 206
Query: 517 VLKVGDFGLAQRV-----LRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC 571
++K+GDFG +++ L + CGTP Y+APE+ Y K D+W+ GVILY LL
Sbjct: 207 IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
Query: 572 GFPPFVSDTNDQDELFDDILSGQYG-FPSPYWDDISEEAKELISHMLESNPDLRFSAEDV 630
PF + Q E+ +L G+Y FP P +S K L+ +L NP LR + + +
Sbjct: 267 LHRPFKGPS--QREIMQQVLYGKYDPFPCP----VSSGMKALLDPLLSKNPALRPTTQQL 320
Query: 631 L 631
L
Sbjct: 321 L 321
|
Length = 478 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 80/284 (28%), Positives = 130/284 (45%), Gaps = 38/284 (13%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIID-KSKLLGKKQMIENEVNILRSVNHPNIIKLLDE 443
IG+G + VV + +K A+K I +S+ G E+++L+ + HPNI+ L D
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 444 YDTNNELYLVIELIKGGDL---FDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ LYL+ E + DL D++ K E K + + + H ++HRD
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYVAPEILNESG-YGVK 556
+KP+NLL++ G +K+ DFGLA+ P+ T Y APE+L S Y
Sbjct: 127 LKPQNLLIDNKGV----IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTP 182
Query: 557 IDVWAAGVILYILLCGFPPFVSDTNDQDELF----------DDILSGQYGFPS-----PY 601
+D+W+ G I + P F D+ + D+LF +D+ G P P
Sbjct: 183 VDIWSIGTIFAEMATKKPLFHGDS-EIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPK 241
Query: 602 WD---------DISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
W ++ E+ +L+ ML +P R SA+ L+HP+
Sbjct: 242 WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-25
Identities = 81/284 (28%), Positives = 140/284 (49%), Gaps = 43/284 (15%)
Query: 377 QRYSVGQIIGDGNFAVV---RQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSV 432
++Y + +++G G V ++V D A+K++D + K + EV L +
Sbjct: 32 KKYWISRVLGSGATGTVLCAKRVSDGEP---FAVKVVDMEGMSEADKNRAQAEVCCLLNC 88
Query: 433 NHPNIIKLLDEY---DTNNE-----LYLVIELIKGGDLFDAISKNVK----FSEEDSKFM 480
+ +I+K +++ D N + LV++ GDL I K F E ++ +
Sbjct: 89 DFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLL 148
Query: 481 TQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF------ 534
+ A+ ++H +++HRDIK N+L+ C ++K+GDFG ++ M+
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILL----CSNGLVKLGDFGFSK-----MYAATVSD 199
Query: 535 ----TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDI 590
T CGTP YVAPEI Y K D+++ GV+LY LL PF D + +E+
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF--DGENMEEVMHKT 257
Query: 591 LSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHP 634
L+G+Y P IS E +E+++ +L S+P R S+ +L+ P
Sbjct: 258 LAGRY---DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 75/268 (27%), Positives = 133/268 (49%), Gaps = 21/268 (7%)
Query: 382 GQIIGDGNFAVVRQVYDKHKDMDCALKII----DKSKLLGKKQMIENEVNILRSVNHPNI 437
G+++G G F V YD + A K + + + + +E E+ +L+++ H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 438 IKLLDEYDTNNELYLVI--ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY 495
++ E L I E + GG + D + +E ++ T+ + +SYLH N
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL------RPMFTVCGTPTYVAPEILN 549
IVHRDIK N+L + +G +K+GDFG ++R+ + +V GTP +++PE+++
Sbjct: 127 IVHRDIKGANILRDSAGN----VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 550 ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
GYG K DVW+ G + +L PP+ ++ +F ++ Q P ISE A
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPW-AEYEAMAAIFK--IATQPTNP-QLPSHISEHA 238
Query: 610 KELISHMLESNPDLRFSAEDVLDHPWLE 637
++ + + R SAE++L HP+ +
Sbjct: 239 RDFLGCIF-VEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 72/271 (26%), Positives = 128/271 (47%), Gaps = 23/271 (8%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL--LGKKQMIEN--EVNILRSVN 433
RY + Q +G G+F V V DK + LK++ + + L + ++ E +L ++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALS 489
HP I+K + + ++ E +G DL + + SE L +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPE 546
Y+H I+HRD+K +N+ ++ + +LK+GDFG+++ ++ T GTP Y++PE
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-----LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175
Query: 547 ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD-I 605
L GY K D+W+ G ILY + C F F ++ P+P +
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEGPTPSLPETY 229
Query: 606 SEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
S + ++ ML +P LR SA ++L +P++
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 78/267 (29%), Positives = 128/267 (47%), Gaps = 21/267 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPNIIKL 440
+++G G F V + A K ++K ++ +K M NE IL VN ++ L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
Y+T + L LV+ ++ GGDL I N F EE + F + L LH V+
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--PMFTVCGTPTYVAPEILNESGYGVK 556
RD+KPEN+L++ G H+++ D GLA ++ + GT Y+APE+LN Y +
Sbjct: 126 RDLKPENILLDDYG-HIRI---SDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181
Query: 557 IDVWAAGVILYILLCGFPPFVS--DTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
D W G ++Y ++ G PF + ++E+ +L + + + + SEEAK +
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF----SEEAKSICK 237
Query: 615 HMLESNPDLRF-----SAEDVLDHPWL 636
+L +P R A +V HP+
Sbjct: 238 MLLTKDPKQRLGCQEEGAGEVKRHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 89/289 (30%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIID-KSKLLGKKQMIENEVNILRSV---NHPNIIKL 440
IG G + V + D H ALK + ++ G EV +L+ + +HPNI++L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 441 LD-----EYDTNNELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHD 493
+D D ++ LV E + DL + K E K + + L +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA-----QRVLRPMFTVCGTPTYVAPEIL 548
N IVHRD+KPEN+LV G +K+ DFGLA Q L P V T Y APE+L
Sbjct: 127 NCIVHRDLKPENILVTSGG----QVKLADFGLARIYSCQMALTP---VVVTLWYRAPEVL 179
Query: 549 NESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQ-DELFD------------DILSGQ 594
+S Y +D+W+ G I + P F ++ DQ ++FD D+ +
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239
Query: 595 YGF----PSPYWD---DISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
F P P +I E +L+ ML NP R SA L HP+
Sbjct: 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|176357 cd01617, DCX, Ubiquitin-like domain of DCX | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 7e-24
Identities = 37/84 (44%), Positives = 52/84 (61%), Gaps = 5/84 (5%)
Query: 101 KRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDGQKV 160
KR+ NGD FFKGV + V R++SFD+LL++LT + + P VR L+T+DG
Sbjct: 1 KRVVVYRNGDPFFKGVRLLVNRRRFKSFDALLDDLTEKVQLD---PGAVRKLYTLDGGHR 57
Query: 161 TN-IDELEDGKFYICSSSGDQFKK 183
+ +DELEDG Y+ S + FKK
Sbjct: 58 VSLLDELEDGGVYVA-SGREPFKK 80
|
DCX The ubiquitin-like DCX domain is present in tandem within the N-terminal half of the doublecortin protein. Doublecortin is expressed in migrating neurons. Mutations in the gene encoding doublecortin cause lissencephaly in males and 'double-cortex syndrome' in females. Length = 80 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 74/266 (27%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
IG G+F V + D A+KIID + + + I+ E+ +L + P + K Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPE 504
+ +L++++E + GG D + E + + + L YLH +HRDIK
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130
Query: 505 NLLVEMSGCHVKVLKVGDFGLA-----QRVLRPMFTVCGTPTYVAPEILNESGYGVKIDV 559
N+L+ G +K+ DFG+A ++ R F GTP ++APE++ +S Y K D+
Sbjct: 131 NVLLSEHG----EVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQSAYDSKADI 184
Query: 560 WAAGVILYILLCGFPPFVSDTNDQDELF------DDILSGQYGFPSPYWDDISEEAKELI 613
W+ G+ L G PP S+ + LF L G Y P KE +
Sbjct: 185 WSLGITAIELAKGEPPH-SELHPMKVLFLIPKNNPPTLEGNYSKP----------LKEFV 233
Query: 614 SHMLESNPDLRFSAEDVLDHPWLERS 639
L P R +A+++L H ++ R
Sbjct: 234 EACLNKEPSFRPTAKELLKHKFIVRF 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 93/289 (32%), Positives = 131/289 (45%), Gaps = 45/289 (15%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKII-DKSKLLGKKQMIENEVNILRSVNHPN 436
RY + ++IG G++ VV D H A+K I D + + I E+ +LR + HP+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 437 I-----IKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL 491
I I L ++Y+V EL+ DL I N + E +F L AL Y+
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT---------- 541
H + HRD+KP+N+L + C LK+ DFGLA R F TPT
Sbjct: 120 HTANVFHRDLKPKNILAN-ADCK---LKICDFGLA----RVAFN--DTPTAIFWTDYVAT 169
Query: 542 --YVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELFDDILSGQYG 596
Y APE+ S Y ID+W+ G I +L G P F + Q +L D+L G
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL----G 225
Query: 597 FPSPYWDDIS----EEAKELISHMLESNP---DLRFSAEDVLDHPWLER 638
PSP + IS E+A+ +S M + P +F D L LER
Sbjct: 226 TPSP--ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLER 272
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 85/307 (27%), Positives = 138/307 (44%), Gaps = 53/307 (17%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
RY + +G G+ +V D D A+K I + K + E+ I+R ++H NI
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR-EIKIIRRLDHDNI 64
Query: 438 IKLLD--------------EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQS 483
+K+ + N +Y+V E ++ DL + + + SEE ++
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQG-PLSEEHARLFMYQ 122
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG----- 538
L L Y+H ++HRD+KP N+ + VLK+GDFGLA R++ P ++ G
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDL---VLKIGDFGLA-RIVDPHYSHKGYLSEG 178
Query: 539 --TPTYVAPEI-LNESGYGVKIDVWAAGVILYILLCGFPPF-----------------VS 578
T Y +P + L+ + Y ID+WAAG I +L G P F V
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238
Query: 579 DTNDQDELFDDI---LSGQYGFP-SPYWD---DISEEAKELISHMLESNPDLRFSAEDVL 631
D++EL + I + G P P D ++ EA + + +L NP R +AE+ L
Sbjct: 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298
Query: 632 DHPWLER 638
HP++
Sbjct: 299 MHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 92/289 (31%), Positives = 136/289 (47%), Gaps = 38/289 (13%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK--SKLLGKKQMIENEVNILRSVNHP 435
RY Q +G G F +V D+ + A+K I K S + K+ E+ +L+ + H
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHE 69
Query: 436 NIIKLLDEYDTNNE-LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494
NII L D + + E +Y V EL+ G DL ++ + F+ Q L L Y+H
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQIL-RGLKYVHSA 127
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT-VCGTPTYVAPEI-LNESG 552
+VHRD+KP N+L+ C LK+ DFGLA R+ P T T Y APEI L
Sbjct: 128 GVVHRDLKPSNILIN-ENCD---LKICDFGLA-RIQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 553 YGVKIDVWAAGVILYILLCGFPPF-----------VSDT--NDQDELFDDILS-GQYGF- 597
Y V++D+W+AG I +L G P F ++D D++ + I S F
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242
Query: 598 -------PSPY---WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
P P+ + + A +L+ ML +P R SA + L HP+L
Sbjct: 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 78/265 (29%), Positives = 123/265 (46%), Gaps = 21/265 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPNIIKL 440
+++G G F V + A K ++K ++ +K M NE IL VN ++ L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
Y+T + L LV+ ++ GGDL I N F E+ + F L L L IV+
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNESGYGVK 556
RD+KPEN+L++ G H+ ++ D GLA ++ + GT Y+APE++N Y
Sbjct: 126 RDLKPENILLDDRG-HI---RISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 557 IDVWAAGVILYILLCGFPPF--VSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
D W G ++Y ++ G PF + ++E+ + Q Y + SE+AK +
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ----EEYSEKFSEDAKSICR 237
Query: 615 HMLESNPDLRF-----SAEDVLDHP 634
+L NP R A V HP
Sbjct: 238 MLLTKNPKERLGCRGNGAAGVKQHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 61/212 (28%), Positives = 110/212 (51%), Gaps = 20/212 (9%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKII----DKSKLLGKKQMIENEVNILRSVNH 434
+ +G+++G G F V YD + A+K + D + + +E E+ +L+++ H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 435 PNIIK----LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSY 490
I++ L D +L + +E + GG + D + +E ++ T+ + +SY
Sbjct: 64 DRIVQYYGCLRDP--EEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 491 LHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF------TVCGTPTYVA 544
LH N IVHRDIK N+L + +G +K+GDFG ++R+ +V GTP +++
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGN----VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 545 PEILNESGYGVKIDVWAAGVILYILLCGFPPF 576
PE+++ GYG K DVW+ + +L PP+
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 79/321 (24%), Positives = 142/321 (44%), Gaps = 61/321 (19%)
Query: 370 NIPSKLLQRYS-VGQIIGDGNFAVVRQVYDKHKDMDCA---LKIID-KSKLLGKKQMIEN 424
N+ + +RY G +G+G + V + YD A +KII+ + + +Q++
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM 60
Query: 425 ---------EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEE 475
E+ I+ + H NI+ L+D Y + + LV++++ DL + + ++ +E
Sbjct: 61 CGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTES 119
Query: 476 DSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-F 534
K + + + L+ LH Y +HRD+ P N+ + G + K+ DFGLA+R P
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG----ICKIADFGLARRYGYPPYS 175
Query: 535 TVCG----------------TPTYVAPEILNESG-YGVKIDVWAAGVILYILLCGFPPFV 577
T Y APE+L + Y +D+W+ G I LL G P F
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF- 234
Query: 578 SDTNDQDEL---FDDI---------------LSGQYGFPSP-----YWDDISEEAKELIS 614
N+ D+L F+ + L ++ P + + S++A +L+
Sbjct: 235 PGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQ 294
Query: 615 HMLESNPDLRFSAEDVLDHPW 635
+L+ NP R SA++ L H +
Sbjct: 295 SLLKLNPLERISAKEALKHEY 315
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 78/291 (26%), Positives = 116/291 (39%), Gaps = 51/291 (17%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G+G++A V + K ALK I G E ++L+ + H NI+ L D
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 445 DTNNELYLVIELIKGGDLFDAISK--------NVKFSEEDSKFMTQSLASALSYLHDNYI 496
T L LV E + DL + NV+ F+ Q L L+Y H +
Sbjct: 73 HTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRL------FLFQ-LLRGLAYCHQRRV 124
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYVAPEIL-NESG 552
+HRD+KP+NLL+ G LK+ DFGLA+ P T T Y P++L +
Sbjct: 125 LHRDLKPQNLLISERG----ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 553 YGVKIDVWAAGVILYILLCGFPPF--VSDTNDQDELFDDIL------------------S 592
Y +D+W G I Y + G P F +D DQ +L
Sbjct: 181 YSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240
Query: 593 GQYGFPSP-----YWDDIS--EEAKELISHMLESNPDLRFSAEDVLDHPWL 636
+ F P + + +EL L+ P R SA + + HP+
Sbjct: 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 6e-23
Identities = 76/273 (27%), Positives = 127/273 (46%), Gaps = 24/273 (8%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-----QMIENEVNILRS 431
+ ++ + IG G+F V D + A+K K GK+ Q I EV L+
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQQ 71
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKG--GDLFDAISKNVKFSEEDSKFMTQSLASALS 489
+ HPN I+ Y + +LV+E G D+ + K ++ E + + L+
Sbjct: 72 LRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQ--EVEIAAICHGALQGLA 129
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEI-- 547
YLH + +HRDIK N+L+ G +K+ DFG A ++ P + GTP ++APE+
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPG----TVKLADFGSAS-LVSPANSFVGTPYWMAPEVIL 184
Query: 548 -LNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606
++E Y K+DVW+ G+ L PP + N L+ Q P+ +D S
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYH---IAQNDSPTLSSNDWS 240
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
+ + + L+ P R S+E++L H ++ R
Sbjct: 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 7e-23
Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKS-KLLGKKQMIENEVNILRSVNHP 435
+RY +G G + V YD A+K + + + L + E+ +L+ + H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 436 NIIKLLDEY------DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALS 489
N+I LLD + + NE+YLV L+ G DL + I K K S+E +F+ L L
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLM-GADL-NNIVKCQKLSDEHVQFLIYQLLRGLK 132
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEI-L 548
Y+H I+HRD+KP N+ V C +++L DFGLA++ M T Y APEI L
Sbjct: 133 YIHSAGIIHRDLKPSNVAVN-EDCELRIL---DFGLARQADDEMTGYVATRWYRAPEIML 188
Query: 549 NESGYGVKIDVWAAGVILYILLCG---FPPFVSDTNDQDELFDDILSGQYGFPSP-YWDD 604
N Y +D+W+ G I+ LL G FP +D DQ + +++ G PSP
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPG--NDYIDQLKRIMEVV----GTPSPEVLKK 242
Query: 605 ISEE---------------------------AKELISHMLESNPDLRFSAEDVLDHPWL 636
IS E A +L+ ML + D R SA + L HP+
Sbjct: 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 75/285 (26%), Positives = 130/285 (45%), Gaps = 60/285 (21%)
Query: 406 ALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLF 463
A+K + K +L + Q+ ++ E +IL ++ ++KL + + LY V++ I GGD+
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 464 DAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523
+ + F E ++F L A+ +H +HRDIKP+N+L+++ G H+K+ DF
Sbjct: 90 SLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLT---DF 145
Query: 524 GLA---------------------------------------------QRVLRP-----M 533
GL QR +
Sbjct: 146 GLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLA 205
Query: 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG 593
++ GTP Y+APE+L GY D W+ GVIL+ +L G PPF++ T + +L +++
Sbjct: 206 HSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQL--KVINW 263
Query: 594 QYGFPSPYWDDISEEAKELISHMLESNPDL--RFSAEDVLDHPWL 636
+ P +S EA +LI+ + S + R A+D+ HP+
Sbjct: 264 ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 77/268 (28%), Positives = 121/268 (45%), Gaps = 27/268 (10%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPNIIKL 440
+++G G F V + A K ++K ++ +K M NE IL VN ++ L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
Y+T + L LV+ L+ GGDL I F E + F + L LH IV+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNESGYGVK 556
RD+KPEN+L++ G H+ ++ D GLA V + + GT Y+APE++ Y
Sbjct: 126 RDLKPENILLDDHG-HI---RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 557 IDVWAAGVILYILLCGFPPFVS-----DTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611
D WA G +LY ++ G PF + + L ++ Y + S +A+
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------QEEYSEKFSPDARS 234
Query: 612 LISHMLESNPDLRF-----SAEDVLDHP 634
L +L +P R A +V +HP
Sbjct: 235 LCKMLLCKDPKERLGCQGGGAREVKEHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 92/323 (28%), Positives = 145/323 (44%), Gaps = 83/323 (25%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN------EVNI 428
+L+RY + IG G +V YD + A+K KL Q + + E+ +
Sbjct: 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK-----KLSRPFQNVTHAKRAYRELVL 68
Query: 429 LRSVNHPNIIKLLD------EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQ 482
++ VNH NII LL+ + ++YLV+EL+ +L I ++ E S + Q
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLD-HERMSYLLYQ 126
Query: 483 SLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT- 541
L + +LH I+HRD+KP N++V+ S C +K+L DFGLA R F + TP
Sbjct: 127 MLC-GIKHLHSAGIIHRDLKPSNIVVK-SDCTLKIL---DFGLA-RTAGTSFMM--TPYV 178
Query: 542 ----YVAPEILNESGYGVKIDVWAAGVILYILLCG---FPPFVSDTNDQ----------- 583
Y APE++ GY +D+W+ G I+ ++ G FP +D DQ
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG--TDHIDQWNKIIEQLGTP 236
Query: 584 ---------------------------DELFDDILSGQYGFPSPYWDDI---SEEAKELI 613
+ELF D+L FP + +A++L+
Sbjct: 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVL-----FPPDSESHNKLKASQARDLL 291
Query: 614 SHMLESNPDLRFSAEDVLDHPWL 636
S ML +P+ R S +D L HP++
Sbjct: 292 SKMLVIDPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 61/212 (28%), Positives = 111/212 (52%), Gaps = 20/212 (9%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKII----DKSKLLGKKQMIENEVNILRSVNH 434
+ +G+++G G F V YD + A+K + + + + +E E+ +L+++ H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 435 PNIIK----LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSY 490
I++ L D + L + +E + GG + D + +E ++ T+ + +SY
Sbjct: 64 ERIVQYYGCLRDPMERT--LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 491 LHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL------RPMFTVCGTPTYVA 544
LH N IVHRDIK N+L + G +K+GDFG ++R+ M +V GTP +++
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGN----VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 545 PEILNESGYGVKIDVWAAGVILYILLCGFPPF 576
PE+++ GYG K D+W+ G + +L PP+
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 68/220 (30%), Positives = 118/220 (53%), Gaps = 18/220 (8%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKII---DKSKLLGKKQMIENEVNILRSVN 433
++Y ++G+G++ +V + K A+K + K++ K M E+ +L+ +
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM--REIRMLKQLR 58
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDS--KFMTQSLASALSYL 491
H N++ L++ + LYLV E + + D + K +E K++ Q L + +
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQIL-RGIEFC 116
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--MFT-VCGTPTYVAPEIL 548
H + I+HRDIKPEN+LV SG V+K+ DFG A+ + P ++T T Y APE+L
Sbjct: 117 HSHNIIHRDIKPENILVSQSG----VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL 172
Query: 549 -NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF 587
++ YG +D+WA G ++ +L G P F D+ D D+L+
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS-DIDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 75/258 (29%), Positives = 120/258 (46%), Gaps = 23/258 (8%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK----QMIENEVNILRSVNHPNIIKL 440
+G G F V + A K ++K +L +K M+E IL V+ I+ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR--ILAKVHSRFIVSL 58
Query: 441 LDEYDTNNELYLVIELIKGGDL----FDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
+ T +L LV+ ++ GGDL ++ +N F E + F T + S L +LH I
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTV---CGTPTYVAPEILNESGY 553
++RD+KPEN+L++ G +V ++ D GLA + GTP ++APE+L Y
Sbjct: 119 IYRDLKPENVLLDNDG-NV---RISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 554 GVKIDVWAAGVILYILLCGFPPFVS--DTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611
+D +A GV LY ++ PF + + + EL IL+ Y D S +K
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----SVTYPDKFSPASKS 230
Query: 612 LISHMLESNPDLRFSAED 629
+L +P+ R D
Sbjct: 231 FCEALLAKDPEKRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 81/293 (27%), Positives = 141/293 (48%), Gaps = 38/293 (12%)
Query: 367 ENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEV 426
E+L P+ + + + IG G + V +V +K A+KI+D + ++ IE E
Sbjct: 15 ESLGDPT---DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE--IEAEY 69
Query: 427 NILRSV-NHPNIIKLL------DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEE-DSK 478
NIL+S+ NHPN++K D+ +L+LV+EL GG + + + + + D
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKL-VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128
Query: 479 FMTQSLASAL---SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF- 534
++ L AL +LH+N I+HRD+K N+L+ G +K+ DFG++ ++
Sbjct: 129 MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTSTRLR 184
Query: 535 --TVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF 587
T GTP ++APE++ + Y + DVW+ G+ L G PP + D + LF
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP-LFDMHPVKTLF 243
Query: 588 DDILSGQYGFPSP---YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
+ P P + + IS L + + R S +L+HP+++
Sbjct: 244 KIPRN-----PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 78/268 (29%), Positives = 134/268 (50%), Gaps = 23/268 (8%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKS--KLLGKKQMIENEVNILRSVNH---PNII 438
IIG G F V A+K +DK K+ + + NE +L V+ P I+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
+ + T ++L +++L+ GGDL +S++ FSE + +F + L ++H+ ++V+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNES-GYGV 555
RD+KP N+L++ G HV ++ D GLA +P +V GT Y+APE+L + Y
Sbjct: 121 RDLKPANILLDEHG-HV---RISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDS 175
Query: 556 KIDVWAAGVILYILLCGFPPFVS-DTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
D ++ G +L+ LL G PF T D+ E+ L+ P D S E + L+
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLE 231
Query: 615 HMLESNPDLRF-----SAEDVLDHPWLE 637
+L+ + + R A++V +HP+
Sbjct: 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 86/291 (29%), Positives = 128/291 (43%), Gaps = 51/291 (17%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G+G++A V + + ALK+I G E ++L+ + H NI+ L D
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 445 DTNNELYLVIELIKGGDLFDAISK--------NVKFSEEDSKFMTQSLASALSYLHDNYI 496
T L V E + DL + + NV+ FM Q L L+Y+H +I
Sbjct: 73 HTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL------FMFQ-LLRGLAYIHGQHI 124
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYVAPEIL-NESG 552
+HRD+KP+NLL+ ++ LK+ DFGLA+ P T T Y P++L +
Sbjct: 125 LHRDLKPQNLLIS----YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 553 YGVKIDVWAAGVILYILLCGFPPF--VSDTNDQDELF--------DDILSGQYGFPS--- 599
Y +D+W AG I +L G P F VSD +Q E +D G P+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240
Query: 600 ------------PYWDDISE--EAKELISHMLESNPDLRFSAEDVLDHPWL 636
W +S +A++L S ML P R SA+D L HP+
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 74/287 (25%), Positives = 132/287 (45%), Gaps = 62/287 (21%)
Query: 406 ALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLF 463
A+K + K +L + Q+ ++ E +IL ++ +++L + + LY V++ I GGD+
Sbjct: 30 AMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 464 DAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523
+ + F E+ ++F L A+ +H +HRDIKP+N+L++ G H+K+ DF
Sbjct: 90 SLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLT---DF 145
Query: 524 GLAQRV-------------------------------------LRPM------------- 533
GL L+P+
Sbjct: 146 GLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLA 205
Query: 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG 593
++ GTP Y+APE+L +GY D W+ GVILY +L G PPF++ T + ++ +++
Sbjct: 206 HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQM--KVINW 263
Query: 594 QYGFPSPYWDDISEEAKELISHMLESNPDLRF---SAEDVLDHPWLE 637
Q P +S EA +LI + P+ R A+++ HP+ +
Sbjct: 264 QTSLHIPPQAKLSPEASDLIIKLCRG-PEDRLGKNGADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 83/296 (28%), Positives = 135/296 (45%), Gaps = 42/296 (14%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIID-KSKLLGKKQMIENEVNILRSVNH 434
+ +Y + IG+G + VV + D+ + ALK I + + G E+++L+ + H
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 435 PNIIKLLDEYDTNNELYLVIE-----LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALS 489
NI++L D + LYLV E L K D +KN + + ++ Q L ++
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIK---TYLYQIL-RGIA 116
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYVAPE 546
Y H + ++HRD+KP+NLL++ LK+ DFGLA+ P+ T T Y APE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRR---TNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPE 173
Query: 547 ILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF----------DDILSGQY 595
IL S Y +D+W+ G I ++ P F D+ + DELF ++ G
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS-EIDELFKIFRILGTPNEETWPGVT 232
Query: 596 GFPS-----PYWD---------DISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
P P W + +L+S ML +P R +A L+H + +
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 35/272 (12%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKII----DKSKLLGKKQMIENEVNILRSVNHPNIIKL 440
+G GN+ V +V + + A+K I D+SK I E++IL P I+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ----IIMELDILHKAVSPYIVDF 64
Query: 441 LDEYDTNNELYLVIELIKGGD---LFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY-I 496
+ +Y+ +E + G L+ E+ + +T ++ L +L + + I
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF-TVCGTPTYVAPEILNESG--- 552
+HRD+KP N+LV +G +K+ DFG++ ++ + T G +Y+APE + G
Sbjct: 125 IHRDVKPTNVLVNGNG----QVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 553 ---YGVKIDVWAAGVILYILLCG-----FPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604
Y V+ DVW+ G L IL +PP +F + + G P
Sbjct: 181 NPTYTVQSDVWSLG--LSILEMALGRYPYPPETYAN-----IFAQLSAIVDGDPPTLPSG 233
Query: 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
S++A++ ++ L P+ R + +L+HPWL
Sbjct: 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-21
Identities = 91/354 (25%), Positives = 156/354 (44%), Gaps = 61/354 (17%)
Query: 329 HTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDG 388
H K G+ + + +++ + + ++ + +I + Y +G IIG+G
Sbjct: 18 HKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNG 77
Query: 389 NFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT-- 446
+F VV + A+K K+L Q E+ I++++NH NII L D Y T
Sbjct: 78 SFGVVYEAICIDTSEKVAIK-----KVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132
Query: 447 --NNE----LYLVIELIKGGDLFDAISKNVKFSEEDS--------KFMTQSLASALSYLH 492
NE L +V+E I + K +K ++ K + L AL+Y+H
Sbjct: 133 FKKNEKNIFLNVVMEFIP-----QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVCGTPTYVAPEI-L 548
+I HRD+KP+NLL++ + LK+ DFG A+ +L R + +C + Y APE+ L
Sbjct: 188 SKFICHRDLKPQNLLIDP---NTHTLKLCDFGSAKNLLAGQRSVSYIC-SRFYRAPELML 243
Query: 549 NESGYGVKIDVWAAGVILYILLCGFPPF--------------VSDTNDQDELFDDILSGQ 594
+ Y ID+W+ G I+ ++ G+P F V T +D+L ++
Sbjct: 244 GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL--KEMNPN 301
Query: 595 YG---FPSPYWDDIS--------EEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
Y FP D+ ++A IS L+ P R + + L P+ +
Sbjct: 302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355
|
Length = 440 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 28/231 (12%)
Query: 406 ALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLF-- 463
A+KI+ KS L K+Q + EV L+ + H ++I L +Y++ EL++ G L
Sbjct: 34 AIKIL-KSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92
Query: 464 --DAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLV-EMSGCHVKVLKV 520
+ + + M +A ++YL + +HRD+ N+LV E C KV
Sbjct: 93 LRSPEGQVLPVAS--LIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVC-----KV 145
Query: 521 GDFGLAQRVLRPMFTVCGTPT---YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPF 576
DFGLA+ + ++ + APE + + K DVW+ G++LY + G P+
Sbjct: 146 ADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205
Query: 577 VSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLE---SNPDLR 624
N E++D I +G Y P P ++ +E+ MLE + P+ R
Sbjct: 206 PGMNN--HEVYDQITAG-YRMPCP-----AKCPQEIYKIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 71/247 (28%), Positives = 113/247 (45%), Gaps = 39/247 (15%)
Query: 425 EVNILRSVNHPNIIKLLD-----EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF 479
E+ +LR ++H N+I + D + N++Y+V EL+ DL I + S++ ++
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQY 112
Query: 480 MTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTV 536
L L Y+H ++HRD+KP NLL+ + C LK+ DFGLA+ M
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLN-ANCD---LKICDFGLARTTSEKGDFMTEY 168
Query: 537 CGTPTYVAPE-ILNESGYGVKIDVWAAGVILYILLCGFPPF--------------VSDTN 581
T Y APE +LN S Y IDVW+ G I LL P F + +
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228
Query: 582 DQDEL--FDDILSGQYGFPSPY---------WDDISEEAKELISHMLESNPDLRFSAEDV 630
+++L + + +Y PY + + A +L+ ML +P R + E+
Sbjct: 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288
Query: 631 LDHPWLE 637
L HP+L
Sbjct: 289 LAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 84/290 (28%), Positives = 124/290 (42%), Gaps = 50/290 (17%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G+G +A V + K D ALK I G EV++L+ + H NI+ L D
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVKFSEEDS---------KFMTQSLASALSYLHDNY 495
T L LV F+ + K++K +D K L L+Y H
Sbjct: 74 HTEKSLTLV---------FEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYVAPEI-LNES 551
++HRD+KP+NLL+ G LK+ DFGLA+ P T T Y P+I L +
Sbjct: 125 VLHRDLKPQNLLINERG----ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 552 GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ-------------DELFDDILSGQ---- 594
Y +ID+W G I Y + G P F T ++ +E + ILS +
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240
Query: 595 YGFPSPYWDDISEEAK-------ELISHMLESNPDLRFSAEDVLDHPWLE 637
Y +P D + A EL+S +L+ R SAE+ + HP+
Sbjct: 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 76/268 (28%), Positives = 138/268 (51%), Gaps = 23/268 (8%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENE---VNILRSVNHPNII 438
IIG G F V A+K +DK ++ K+ + NE ++++ + + P I+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
+ + T ++L +++L+ GGDL +S++ FSE++ +F + L ++H+ ++V+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRV--LRPMFTVCGTPTYVAPEILNE-SGYGV 555
RD+KP N+L++ G HV ++ D GLA +P +V GT Y+APE+L + + Y
Sbjct: 121 RDLKPANILLDEHG-HV---RISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAYDS 175
Query: 556 KIDVWAAGVILYILLCGFPPFVS-DTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
D ++ G +L+ LL G PF T D+ E+ L+ P D S E K L+
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP----DSFSPELKSLLE 231
Query: 615 HMLESNPDLRF-----SAEDVLDHPWLE 637
+L+ + R A++V +H + +
Sbjct: 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 73/264 (27%), Positives = 121/264 (45%), Gaps = 23/264 (8%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKII---DKSKLLGKKQMIENEVNILRSVNHPNIIKLL 441
+G GN V +V A K++ KS + +KQ I E+ I+ P I+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV--RKQ-ILRELQIMHECRSPYIVSFY 69
Query: 442 DEYDTNNELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHD-NYIVHR 499
+ N + + +E + G L D I K E + ++ L+YL++ + I+HR
Sbjct: 70 GAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR 128
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF-TVCGTPTYVAPEILNESGYGVKID 558
DIKP N+LV G +K+ DFG++ ++ + T GT TY++PE + Y VK D
Sbjct: 129 DIKPSNILVNSRG----QIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 559 VWAAGVILYILLCGFPPFVSDTNDQDELFD------DILSGQYGFPSPYW--DDISEEAK 610
VW+ G+ + L G PF + +N D+ D D+L P P D E+ +
Sbjct: 185 VWSLGISIIELALGKFPF-AFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243
Query: 611 ELISHMLESNPDLRFSAEDVLDHP 634
+ + L +P R + + + P
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAMP 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 6e-21
Identities = 80/284 (28%), Positives = 124/284 (43%), Gaps = 37/284 (13%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G+G++A V + K ALK+I + G E ++L+ + H NI+ L D
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVKFSEEDS-KFMTQSLASALSYLHDNYIVHRDIKP 503
T L LV E + DL + K+ ++ K L LSY+H YI+HRD+KP
Sbjct: 73 HTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKP 131
Query: 504 ENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYVAPEI-LNESGYGVKIDV 559
+NLL+ +G LK+ DFGLA+ P T T Y P++ L + Y +D+
Sbjct: 132 QNLLISDTG----ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187
Query: 560 WAAGVILYILLCGFPPFVSDTNDQDEL----------FDDILSGQYGFP----------- 598
W G I ++ G F + QD+L +D G + P
Sbjct: 188 WGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYS 247
Query: 599 ----SPYWDDIS--EEAKELISHMLESNPDLRFSAEDVLDHPWL 636
W+ +S A++L S +L+ P R SA+ L H +
Sbjct: 248 PKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 6e-21
Identities = 86/285 (30%), Positives = 132/285 (46%), Gaps = 40/285 (14%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLGKKQMIENEVNILRSV 432
L Y V + IG+G F V V KHK + C I + +K + EVN++R +
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLV--KHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL 69
Query: 433 NHPNIIKLLDEY--DTNNELYLVIELIKGGDLFDAISKNVKF----SEEDSKFMTQSLAS 486
H NI++ +D + N +LY+++E GDL I K K E +T+ L
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 487 ALSYLHD-------NYIVHRDIKPENLLVEMSGCHV-------------KVLKVGDFGLA 526
AL+Y H+ ++HRD+KP+N+ + H+ + K+GDFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 527 QRV-LRPMFTVC-GTPTYVAPEIL--NESGYGVKIDVWAAGVILYILLCGFPPFVSDTND 582
+ + + M C GTP Y +PE+L Y K D+WA G I+Y L G PF N+
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF-HKANN 248
Query: 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSA 627
+L ++ G P S+E LI ++L + R SA
Sbjct: 249 FSQLISELKRG----PDLPIKGKSKELNILIKNLLNLSAKERPSA 289
|
Length = 1021 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 77/285 (27%), Positives = 125/285 (43%), Gaps = 43/285 (15%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIID-KSKLLGKKQMIENEVNILRSVNHPNIIKLLDE 443
IG+G + V + ++ ALK + G E+ +L+ + H NI++L D
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 444 YDTNNELYLVIELIKGGDL---FDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
++ +L LV E DL FD+ + ++ S FM Q L L++ H + ++HRD
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKS-FMFQ-LLKGLAFCHSHNVLHRD 124
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYVAPEIL-NESGYGVK 556
+KP+NLL+ +G LK+ DFGLA+ P+ T Y P++L Y
Sbjct: 125 LKPQNLLINKNG----ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180
Query: 557 IDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS-PYWDDISE-------- 607
ID+W+AG I L P + D+L + G P+ W +S+
Sbjct: 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQL--KRIFRLLGTPTEESWPGVSKLPDYKPYP 238
Query: 608 -----------------EAKELISHMLESNPDLRFSAEDVLDHPW 635
++L+ ++L NP R SAE+ L HP+
Sbjct: 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-21
Identities = 83/296 (28%), Positives = 135/296 (45%), Gaps = 43/296 (14%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK---SKLLGKKQMIENEVNILRSVN 433
RY + +G G + V D+ A+K + + S+L K+ E+ +L+ +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMK 72
Query: 434 HPNIIKLLDEY--DTN----NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASA 487
H N+I LLD + D + ++ YLV+ + G DL + K+ K SE+ +F+ +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDL-GKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 488 LSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPE- 546
L Y+H I+HRD+KP NL V C +K+L DFGLA++ M T Y APE
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVN-EDCELKIL---DFGLARQTDSEMTGYVVTRWYRAPEV 186
Query: 547 ILNESGYGVKIDVWAAGVILYILLCGFPPF--------------VSDTNDQDEL----FD 588
ILN Y +D+W+ G I+ +L G P F V+ T ++ + +
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 589 DILSGQYGFPSPYWDD-------ISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
D + P D + A ++ ML + + R +A + L HP+ E
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 76/277 (27%), Positives = 133/277 (48%), Gaps = 29/277 (10%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNI 437
+ + + IG G + V +V +K A+KI+D + ++ IE E NIL+++ +HPN+
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE--IEAEYNILKALSDHPNV 77
Query: 438 IKLLDEY-----DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK----FMTQSLASAL 488
+K Y ++L+LV+EL GG + D + +K E + ++ L
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAP 545
+LH N +HRD+K N+L+ G +K+ DFG++ ++ T GTP ++AP
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 546 EILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
E++ +S Y + DVW+ G+ L G PP ++D + LF + P
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP-LADLHPMRALFKIPRNPPPTLHQP 252
Query: 601 -YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
W S E + I L + + R + D+L H ++
Sbjct: 253 ELW---SNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 9e-21
Identities = 87/311 (27%), Positives = 137/311 (44%), Gaps = 49/311 (15%)
Query: 365 RRENLNIPS-KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK---SKLLGKKQ 420
RE +N +L +RY+ + +G G + V DK A+K + + S++ K+
Sbjct: 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA 61
Query: 421 MIENEVNILRSVNHPNIIKLLD------EYDTNNELYLVIELIKGGDLFDAISK--NVKF 472
E+ +L+ + H N+I LLD D + YLV+ + + K
Sbjct: 62 Y--RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY-----MQTDLQKIMGHPL 114
Query: 473 SEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532
SE+ +++ + L Y+H I+HRD+KP NL V C +K+L DFGLA+
Sbjct: 115 SEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN-EDCELKIL---DFGLARHADAE 170
Query: 533 MFTVCGTPTYVAPE-ILNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQ------- 583
M T Y APE ILN Y +D+W+ G I+ +L G F D DQ
Sbjct: 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230
Query: 584 -----DEL---FDDILSGQY--GFP-------SPYWDDISEEAKELISHMLESNPDLRFS 626
E +D + Y P S + S +A +L+ MLE + D R +
Sbjct: 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT 290
Query: 627 AEDVLDHPWLE 637
A + L+HP+ +
Sbjct: 291 ATEALEHPYFD 301
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-20
Identities = 84/296 (28%), Positives = 132/296 (44%), Gaps = 45/296 (15%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK--SKLLGKKQMIENEVNILRSVNH 434
+RY +G G + V +D + A+K + + ++ K+ E+ +L+ + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 75
Query: 435 PNIIKLLD------EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASAL 488
N+I LLD + N++YLV L+ G DL + I K K +++ +F+ + L
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEI- 547
Y+H I+HRD+KP NL V C +K+L DFGLA+ M T Y APEI
Sbjct: 134 KYIHSADIIHRDLKPSNLAVN-EDCELKIL---DFGLARHTDDEMTGYVATRWYRAPEIM 189
Query: 548 LNESGYGVKIDVWAAGVILYILLCG---FPPFVSDTNDQ------------DELFDDI-- 590
LN Y +D+W+ G I+ LL G FP +D DQ EL I
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHIDQLKLILRLVGTPGAELLKKISS 247
Query: 591 ------LSGQYGFPSPYWDDI----SEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
+ P + ++ + A +L+ ML + D R +A L H +
Sbjct: 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 20/252 (7%)
Query: 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439
+ + +G G F VV + K D A+K+I + + + IE E ++ ++HPN+++
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKI-DVAIKMI-REGAMSEDDFIE-EAKVMMKLSHPNLVQ 63
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVH 498
L +++V E + G L + + + K E M + A+ YL N +H
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT-----YVAPEILNESGY 553
RD+ N LV V+KV DFGLA+ VL +T T + PE+ + S +
Sbjct: 124 RDLAARNCLVGEDN----VVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRF 178
Query: 554 GVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612
K DVW+ GV+++ + G P+ +N E+ + + +G Y P E +
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVVESVSAG-YRLYRPKL--APTEVYTI 233
Query: 613 ISHMLESNPDLR 624
+ P+ R
Sbjct: 234 MYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 79/287 (27%), Positives = 136/287 (47%), Gaps = 46/287 (16%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSK---LLGKKQMIENEVNILRSVNHPNIIKLL 441
IG+G++ VV + ++ A+K +S+ ++ K + E+ +L+ + HPN++ L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL--REIRMLKQLKHPNLVNLI 66
Query: 442 DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDS-KFMTQSLASALSYLHDNYIVHRD 500
+ + +L+LV E + + + KN + E K + A+++ H + +HRD
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRD 125
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVC-GTPTYVAPEIL-NESGYGV 555
+KPEN+L+ G +K+ DFG A R+L +T T Y APE+L ++ YG
Sbjct: 126 VKPENILITKQG----QIKLCDFGFA-RILTGPGDDYTDYVATRWYRAPELLVGDTQYGP 180
Query: 556 KIDVWAAGVILYILLCGFP--PFVSDTNDQ---------------DELF--DDILSGQYG 596
+DVWA G + LL G P P SD DQ ++F + G
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDV-DQLYLIRKTLGDLIPRHQQIFSTNQFFKG-LS 238
Query: 597 FPSP--------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
P P + +IS A + L+ +P R S E++L+HP+
Sbjct: 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 60/302 (19%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE----NEVNILRSVNH-PNI 437
+ IG+G + V + DK+ ALK K++L ++ I E+++L+ ++ I
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 438 IKLLDEYDTNNE-----LYLVIELIKGGDLFDAISKNVKFS----EEDS--KFMTQSLAS 486
++LLD + LYLV E + DL + N + + FM Q L
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ-LLK 121
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYV 543
+++ H + ++HRD+KP+NLLV+ +LK+ D GL + P+ + T Y
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQK---GLLKIADLGLGRAFSIPVKSYTHEIVTLWYR 178
Query: 544 APEI-LNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDEL--FDDILSGQYGFPS- 599
APE+ L + Y +D+W+ G I + P F D+ Q L F + G P+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL-----GTPTE 233
Query: 600 ---------------PYWD---------DISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
P W D+S E +L+ ML +P R SA+ L HP+
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
Query: 636 LE 637
+
Sbjct: 294 FD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 76/258 (29%), Positives = 119/258 (46%), Gaps = 19/258 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
+ IG GNF V + K + A+K + K+ E IL+ +HPNI+KL+
Sbjct: 1 EKIGKGNFGDVYKGVLKGN-TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSL--ASALSYLHDNYIVHRD 500
+Y+V+EL+ GG L + K K K + SL A+ + YL +HRD
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG----TPT-YVAPEILNESGYGV 555
+ N LV + VLK+ DFG+++ ++TV P + APE LN Y
Sbjct: 119 LAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 556 KIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
+ DVW+ G++L+ G P+ +N Q + I SG Y P+P EE L+
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTR--ERIESG-YRMPAP--QLCPEEIYRLML 229
Query: 615 HMLESNPDLRFSAEDVLD 632
+P+ R S ++ +
Sbjct: 230 QCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 8e-20
Identities = 86/314 (27%), Positives = 145/314 (46%), Gaps = 66/314 (21%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK---SKLLGKKQMIENEVNILRS 431
+L+RY + IG G +V +D ++ A+K + + ++ K+ E+ +L+
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY--RELVLLKC 76
Query: 432 VNHPNIIKLLDEYDTN------NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLA 485
VNH NII LL+ + ++YLV+EL+ +L I +++ E ++ +
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI--HMELDHERMSYLLYQML 133
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--MFTVCGTPTYV 543
+ +LH I+HRD+KP N++V+ S C +K+L DFGLA+ M T Y
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKIL---DFGLARTACTNFMMTPYVVTRYYR 189
Query: 544 APEILNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQ------------------- 583
APE++ GY +D+W+ G I+ L+ G F +D DQ
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249
Query: 584 -------------------DELFDDILSGQYGFPSPYWDD--ISEEAKELISHMLESNPD 622
+ELF D + FPS D + +A++L+S ML +PD
Sbjct: 250 QPTVRNYVENRPQYPGISFEELFPD-----WIFPSESERDKLKTSQARDLLSKMLVIDPD 304
Query: 623 LRFSAEDVLDHPWL 636
R S ++ L HP++
Sbjct: 305 KRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 8e-20
Identities = 77/279 (27%), Positives = 126/279 (45%), Gaps = 24/279 (8%)
Query: 366 RENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENE 425
R N +L+QR IG G + V + + + A+K+I K + +++ E
Sbjct: 4 RRNPQEDFELIQR------IGSGTYGDVYKARNVNTGELAAIKVI-KLEPGEDFAVVQQE 56
Query: 426 VNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLA 485
+ +++ H NI+ Y ++L++ +E GG L D SE ++++
Sbjct: 57 IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL 116
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV---LRPMFTVCGTPTY 542
L YLH +HRDIK N+L+ +G HV K+ DFG++ ++ + + GTP +
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLTDNG-HV---KLADFGVSAQITATIAKRKSFIGTPYW 172
Query: 543 VAPEIL---NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599
+APE+ + GY D+WA G I I L P + D + LF L + F
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVG-ITAIELAELQPPMFDLHPMRALF---LMTKSNFQP 228
Query: 600 PYWDD---ISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
P D S + L NP R +AE +L HP+
Sbjct: 229 PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 73/261 (27%), Positives = 124/261 (47%), Gaps = 18/261 (6%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKS--KLLGKKQMIENEVNILRSVNHPNIIKLLD 442
IG G+F V + H + A+K + S + K Q I EV L+ + HPN I+
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 443 EYDTNNELYLVIELIKGG--DLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
Y + +LV+E G DL + K ++ E + +T L+YLH + ++HRD
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ--EVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEI---LNESGYGVKI 557
IK N+L+ G +K+ DFG A P + GTP ++APE+ ++E Y K+
Sbjct: 147 IKAGNILLTEPG----QVKLADFGSAS-KSSPANSFVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
DVW+ G+ L PP + N L+ Q P+ ++ ++ + + + L
Sbjct: 202 DVWSLGITCIELAERKPPLF-NMNAMSALYH---IAQNDSPTLQSNEWTDSFRGFVDYCL 257
Query: 618 ESNPDLRFSAEDVLDHPWLER 638
+ P R ++ ++L H ++ R
Sbjct: 258 QKIPQERPASAELLRHDFVRR 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 24/264 (9%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-----QMIENEVNILRSVNHPNIIK 439
IG G+F V D A+K + S GK+ Q I EV L+ + HPN I+
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYS---GKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 440 LLDEYDTNNELYLVIELIKGG--DLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
Y + +LV+E G DL + K ++ E + +T L+YLH + ++
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ--EVEIAAVTHGALQGLAYLHSHNMI 137
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEI---LNESGYG 554
HRD+K N+L+ G ++K+GDFG A ++ P GTP ++APE+ ++E Y
Sbjct: 138 HRDVKAGNILLSEPG----LVKLGDFGSAS-IMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 555 VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
K+DVW+ G+ L PP + N L+ + S +W SE + +
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPALQSGHW---SEYFRNFVD 248
Query: 615 HMLESNPDLRFSAEDVLDHPWLER 638
L+ P R ++E +L H ++ R
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 89/299 (29%), Positives = 127/299 (42%), Gaps = 50/299 (16%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYD-KHKDMDCALKIID-KSKLLGKKQMIENEVNILR---S 431
Q+Y IG+G + V + D K+ ALK + ++ G EV +LR +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 432 VNHPNIIKLLD-----EYDTNNELYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSL 484
HPN+++L D D +L LV E + DL + K E K M L
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 485 ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT--VCGTPTY 542
L +LH + +VHRD+KP+N+LV SG +K+ DFGLA+ M V T Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSG----QIKLADFGLARIYSFQMALTSVVVTLWY 175
Query: 543 VAPEILNESGYGVKIDVWAAGVILYILLCGFPPFV--SDTNDQDELFDDILSGQYGFPSP 600
APE+L +S Y +D+W+ G I + P F SD + ++ D I G P
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-----GLPGE 230
Query: 601 ------------------------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
+ DI E K+L+ L NP R SA L HP+
Sbjct: 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 74/266 (27%), Positives = 118/266 (44%), Gaps = 18/266 (6%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
Y + Q +G G + V + + H A+KII K + +I+ E+ +++ H N
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKII-KLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
I+ Y + +L++ +E GG L D SE ++ + L+YLH
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAPEIL---NE 550
+HRDIK N+L+ +G +K+ DFG+A ++ + + GTP ++APE+
Sbjct: 128 MHRDIKGANILLTDNG----DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD---ISE 607
GY D+WA G I I L P + D + LF L + F P D S
Sbjct: 184 GGYNQLCDIWAVG-ITAIELAELQPPMFDLHPMRALF---LMSKSNFQPPKLKDKTKWSS 239
Query: 608 EAKELISHMLESNPDLRFSAEDVLDH 633
+ L NP R +AE +L H
Sbjct: 240 TFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|217637 pfam03607, DCX, Doublecortin | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-18
Identities = 31/65 (47%), Positives = 47/65 (72%), Gaps = 5/65 (7%)
Query: 118 MAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDGQKVTNIDELEDGKFYICSSS 177
+ V R++SFD+LL++LT E + LPSGVR L+T+DG +VT++DELEDG Y+ +
Sbjct: 1 LVVSRRRFKSFDALLDDLT----EKVKLPSGVRKLYTLDGHRVTSLDELEDGGSYVAAGR 56
Query: 178 GDQFK 182
++FK
Sbjct: 57 -ERFK 60
|
Length = 60 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 82/293 (27%), Positives = 137/293 (46%), Gaps = 45/293 (15%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN---EVNILRSVNH 434
++ V ++G+G + VV + K A+K S+ +++ E E+ +LR++
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE--ENEEVKETTLRELKMLRTLKQ 59
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGG--DLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492
NI++L + + +LYLV E ++ +L + + V E + L A+ + H
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCH 117
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFT-VCGTPTYVAPEIL 548
N IVHRDIKPENLL+ H VLK+ DFG A+ + +T T Y +PE+L
Sbjct: 118 KNDIVHRDIKPENLLIS----HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 549 NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFD------DILSGQYG------ 596
+ YG +D+W+ G IL L G P F ++ + D+LF + + Q
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQPLFPGES-EIDQLFTIQKVLGPLPAEQMKLFYSNP 232
Query: 597 ------FPS---------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHP 634
FP+ Y +S +L+ ++L+ NP R+ E L+HP
Sbjct: 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 15/217 (6%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
Q IG G F +V Y K A+K I + + ++ IE E ++ ++HP +++L
Sbjct: 10 QEIGSGQFGLVWLGYWLEKR-KVAIKTI-REGAMSEEDFIE-EAQVMMKLSHPKLVQLYG 66
Query: 443 EYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
+ + LV E ++ G L D + ++ KFS+E M + ++YL + ++HRD+
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC-GTP---TYVAPEILNESGYGVKI 557
N LV + +V+KV DFG+ + VL +T GT + +PE+ + S Y K
Sbjct: 127 AARNCLVGEN----QVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 558 DVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSG 593
DVW+ GV+++ + G P+ + +N E+ + I +G
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSN--SEVVETINAG 217
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-18
Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 8/158 (5%)
Query: 416 LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEE 475
+G+K E +L++VNHP++I++ D + +V+ DL+ ++K +
Sbjct: 98 IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPI 156
Query: 476 DSKFMTQ-SLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ-RVLRPM 533
D + + + L YLH I+HRD+K EN+ + V + +GD G AQ V+ P
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN----DVDQVCIGDLGAAQFPVVAPA 212
Query: 534 FT-VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILL 570
F + GT APE+L Y K D+W+AG++L+ +L
Sbjct: 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 72/294 (24%), Positives = 134/294 (45%), Gaps = 48/294 (16%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G GN VV +V + + A K+I + I E+ +L N P I+ +
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 445 DTNNELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNY-IVHRDIK 502
++ E+ + +E + GG L D + K + E ++ ++ L+YL + + I+HRD+K
Sbjct: 69 YSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVK 127
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF-TVCGTPTYVAPEILNESGYGVKIDVWA 561
P N+LV G +K+ DFG++ +++ M + GT +Y++PE L + Y V+ D+W+
Sbjct: 128 PSNILVNSRG----EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 562 AGVILYILLCG---------------FPPFVSDTNDQD-------------------ELF 587
G+ L + G F VS+ ++ EL
Sbjct: 184 LGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELL 243
Query: 588 DDILSGQYGFPSPYWDD--ISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
D I++ P P S+E ++ + L+ NP R +++ HP+++R+
Sbjct: 244 DYIVNE----PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 88/292 (30%), Positives = 122/292 (41%), Gaps = 56/292 (19%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G+G +A V + K + ALK I G EV++L+++ H NI+ L D
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 445 DTNNELYLVIELIKG---------GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY 495
T L LV E + G+L NVK FM Q L LSY H
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNLMSM--HNVKI------FMFQ-LLRGLSYCHKRK 123
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYVAPEI-LNES 551
I+HRD+KP+NLL+ G LK+ DFGLA+ P T T Y P++ L +
Sbjct: 124 ILHRDLKPQNLLINEKG----ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 552 GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ-------------DELFDDILSGQ---- 594
Y ID+W G ILY + G P F T + +E + I S +
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239
Query: 595 YGFP----------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
Y FP +P D + +L+S +L R SAE L H +
Sbjct: 240 YLFPQYRAQPLINHAPRLD---TDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 75/261 (28%), Positives = 121/261 (46%), Gaps = 18/261 (6%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKS--KLLGKKQMIENEVNILRSVNHPNIIKLLD 442
IG G+F V D + A+K + S + K Q I EV L+ + HPN I+
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 443 EYDTNNELYLVIELIKGG--DLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
Y + +LV+E G DL + K ++ E + +T L+YLH + ++HRD
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQ--EVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEI---LNESGYGVKI 557
IK N+L+ G +K+ DFG A + P + GTP ++APE+ ++E Y K+
Sbjct: 151 IKAGNILLTEPG----QVKLADFGSAS-IASPANSFVGTPYWMAPEVILAMDEGQYDGKV 205
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
DVW+ G+ L PP + N L+ + S W D + + L
Sbjct: 206 DVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPTLQSNEWSDY---FRNFVDSCL 261
Query: 618 ESNPDLRFSAEDVLDHPWLER 638
+ P R ++E++L H ++ R
Sbjct: 262 QKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 4e-18
Identities = 82/319 (25%), Positives = 146/319 (45%), Gaps = 76/319 (23%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK---SKLLGKKQMIENEVNILRS 431
+L+RY + IG G +V YD + + A+K + + ++ K+ E+ +++
Sbjct: 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKC 79
Query: 432 VNHPNIIKLLDEYDTN------NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLA 485
VNH NII LL+ + ++Y+V+EL+ +L I ++ E ++ +
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--QMELDHERMSYLLYQML 136
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR-----VLRPMFTVCGTP 540
+ +LH I+HRD+KP N++V+ S C +K+L DFGLA+ ++ P T
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKIL---DFGLARTAGTSFMMTPYVV---TR 189
Query: 541 TYVAPEILNESGYGVKIDVWAAGVILYILLCG---FPPFVSDTNDQ-------------- 583
Y APE++ GY +D+W+ G I+ ++ G FP +D DQ
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG--TDHIDQWNKVIEQLGTPCPE 247
Query: 584 ------------------------DELFDDILSGQYGFP--SPYWDDISEEAKELISHML 617
++LF D+L FP S + + +A++L+S ML
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL-----FPADSEHNKLKASQARDLLSKML 302
Query: 618 ESNPDLRFSAEDVLDHPWL 636
+ R S ++ L HP++
Sbjct: 303 VIDASKRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-18
Identities = 82/309 (26%), Positives = 138/309 (44%), Gaps = 56/309 (18%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK---SKLLGKKQMIENEVNILRS 431
+L+RY + IG G +V YD D + A+K + + ++ K+ E+ +++
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKC 72
Query: 432 VNHPNIIKLLDEYDTNNEL------YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLA 485
VNH NII LL+ + L YLV+EL+ +L I ++ E ++ +
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQML 129
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--MFTVCGTPTYV 543
+ +LH I+HRD+KP N++V+ S C +K+L DFGLA+ M T Y
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKIL---DFGLARTAGTSFMMTPYVVTRYYR 185
Query: 544 APEILNESGYGVKIDVWAAGVIL------YILLCG-----------------FPPFVSDT 580
APE++ GY +D+W+ G I+ IL G P F+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 581 NDQDELFDDILSGQYG--FPSPYWDDI-----------SEEAKELISHMLESNPDLRFSA 627
+ + G FP + D + + +A++L+S ML +P R S
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 628 EDVLDHPWL 636
++ L HP++
Sbjct: 306 DEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 8/243 (3%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G GN VV +V K + A K+I + I E+ +L N P I+ +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY-IVHRDIKP 503
++ E+ + +E + GG L + + + EE ++ ++ L+YL + + I+HRD+KP
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKP 132
Query: 504 ENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF-TVCGTPTYVAPEILNESGYGVKIDVWAA 562
N+LV G +K+ DFG++ +++ M + GT +Y++PE L + Y V+ D+W+
Sbjct: 133 SNILVNSRG----EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188
Query: 563 GVILYILLCG-FPPFVSDTNDQDELFD-DILSGQYGFPSPYWDDISEEAKELISHMLESN 620
G+ L L G +P D + + +F ++ G+ G P + + H ++S
Sbjct: 189 GLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSR 248
Query: 621 PDL 623
P +
Sbjct: 249 PAM 251
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 81/300 (27%), Positives = 126/300 (42%), Gaps = 52/300 (17%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP 435
++ Y + +G+G +A V + K + ALK I G EV++L+ + H
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK---------FSEEDSKFMTQSLAS 486
NI+ L D T+ L LV F+ + K++K S + K +
Sbjct: 65 NIVTLHDIVHTDKSLTLV---------FEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTYV 543
L+Y H ++HRD+KP+NLL+ G LK+ DFGLA+ P T T Y
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERG----ELKLADFGLARAKSVPTKTYSNEVVTLWYR 171
Query: 544 APEI-LNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF----------DDILS 592
P++ L S Y +ID+W G I + + G P F T +DEL ++
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV-EDELHLIFRLLGTPTEETWP 230
Query: 593 G--------QYGF----PSPYWDD---ISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
G Y F P P + + E EL++ L+ R SAE+ + H +
Sbjct: 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-17
Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 24/184 (13%)
Query: 417 GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEED 476
G++ E +ILR++NHP+II+L + N L++ K DL+ ++ + D
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICD 183
Query: 477 SKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG--CHVKVLKVGDFGLA----QRVL 530
+ +S+ A+ YLH+N I+HRDIK EN+ + G C +GDFG A
Sbjct: 184 ILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC------LGDFGAACFPVDINA 237
Query: 531 RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFD-D 589
+ GT APE+L YG +D+W+AG++L+ + D LF+ D
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC----------HDSLFEKD 287
Query: 590 ILSG 593
L G
Sbjct: 288 GLDG 291
|
Length = 391 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
IG GNF V + + A+K ++ K E IL+ +HPNI++L+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 445 DTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKP 503
+Y+V+EL++GGD + ++ + ++ M ++ A+ + YL + +HRD+
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAA 122
Query: 504 ENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG----TPT-YVAPEILNESGYGVKID 558
N LV VLK+ DFG+++ ++ G P + APE LN Y + D
Sbjct: 123 RNCLVTEK----NVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 559 VWAAGVILY-ILLCGFPPFVSDTNDQ 583
VW+ G++L+ G P+ + +N Q
Sbjct: 179 VWSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 16/193 (8%)
Query: 385 IGDGNFAVVRQ-VY--DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLL 441
+G GNF V + VY K+++ A+K + + + K+ E +++ ++HP I++L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 442 DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
L LV+EL G L + K + D K + +A ++YL + VHRD+
Sbjct: 63 G-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGT-PT-YVAPEILNESGYG 554
N+L+ K+ DFG++ R L T G P + APE +N +
Sbjct: 122 AARNVLLVNR----HQAKISDFGMS-RALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 555 VKIDVWAAGVILY 567
K DVW+ GV L+
Sbjct: 177 SKSDVWSYGVTLW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 16/215 (7%)
Query: 377 QRYSVGQIIGDGNFAVVRQ-VYDKHKD--MDCALKIIDKSKLLGKKQMIENEVNILRSVN 433
+ ++G+ IG+G F V Q VY ++ + A+K ++ E I+R +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQS--LASALSYL 491
HP+I+KL+ T N +++V+EL G+L + N K+S + + + S L++AL+YL
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYL 123
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTP-TYVAPEI 547
VHRDI N+LV C +K+GDFGL++ + + + P ++APE
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDC----VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179
Query: 548 LNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTN 581
+N + DVW GV ++ IL+ G PF N
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 58/212 (27%), Positives = 108/212 (50%), Gaps = 7/212 (3%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G GN VV +V K + A K+I + I E+ +L N P I+ +
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY-IVHRDIKP 503
++ E+ + +E + GG L + K + E+ ++ ++ L+YL + + I+HRD+KP
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 132
Query: 504 ENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF-TVCGTPTYVAPEILNESGYGVKIDVWAA 562
N+LV G +K+ DFG++ +++ M + GT +Y++PE L + Y V+ D+W+
Sbjct: 133 SNILVNSRG----EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188
Query: 563 GVILYILLCG-FPPFVSDTNDQDELFDDILSG 593
G+ L + G +P D + + +F + G
Sbjct: 189 GLSLVEMAIGRYPIPPPDAKELELMFGCPVEG 220
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 70/260 (26%), Positives = 121/260 (46%), Gaps = 16/260 (6%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
+I+G GN V + Y A+K+I + ++ I +E+ IL + P II
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 443 EYDTNNELYLVIELIKGG--DLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ N + + E + GG D++ I ++V + ++ L+YL I+HRD
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLGR------IAVAVVKGLTYLWSLKILHRD 120
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF-TVCGTPTYVAPEILNESGYGVKIDV 559
+KP N+LV G VK+ DFG++ +++ + T GT Y+APE ++ YG+ DV
Sbjct: 121 VKPSNMLVNTRG-QVKLC---DFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 560 WAAGVILYILLCGFPPFVSDTNDQDELFD-DILSGQYGFPSPYWDD--ISEEAKELISHM 616
W+ G+ L G P+ +Q L +L P SE+ I+
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQC 236
Query: 617 LESNPDLRFSAEDVLDHPWL 636
+ P R + E+++DHP++
Sbjct: 237 MRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|214711 smart00537, DCX, Domain in the Doublecortin (DCX) gene product | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-17
Identities = 28/84 (33%), Positives = 45/84 (53%), Gaps = 2/84 (2%)
Query: 222 VRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTG-AVRKVYTLNGNQ 280
V+P+ I RNG R K VR ++N++ S + +T++VKLD VRK+YTL+G +
Sbjct: 3 VKPKRIRFYRNGDRFFKGVRLVVNRKRFKSFEALLQDLTEVVKLDLPHGVRKLYTLDGKK 62
Query: 281 LARLSDFFKSDDVFFAYGSERVLP 304
+ L + + A G+E
Sbjct: 63 VTSLDELE-DGGSYVASGTEAFKK 85
|
Tandemly-repeated domain in doublin, the Doublecortin gene product. Proposed to bind tubulin. Doublecortin (DCX) is mutated in human X-linked neuronal migration defects. Length = 89 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
+++G GNF V + K K A+K + K +E IL+ +HPNI+KL+
Sbjct: 1 ELLGKGNFGEVFKGTLKDK-TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQ---SLASALSYLHDNYIVHR 499
+Y+V+EL+ GGD + K K E +K + + A+ ++YL +HR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRK--KKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTP----TYVAPEILNESGYGV 555
D+ N LV + VLK+ DFG++++ +++ G + APE LN Y
Sbjct: 118 DLAARNCLVGEN----NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 556 KIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
+ DVW+ G++L+ G P+ TN Q
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 4e-17
Identities = 70/276 (25%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH-PNI 437
+ + +++G+G + V + A+K++D + +++ I+ E+N+L+ +H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNI 65
Query: 438 IKLLDEYDTNN------ELYLVIELIKGGDLFDAISKNVK---FSEEDSKFMTQSLASAL 488
+ N +L+LV+E G + D I KN K EE ++ + + L
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGL 124
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM---FTVCGTPTYVAP 545
S+LH + ++HRDIK +N+L+ + +K+ DFG++ ++ R + T GTP ++AP
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
Query: 546 EILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
E++ ++ Y K D+W+ G+ + G PP + D + LF + S
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP-LCDMHPMRALFLIPRNPAPRLKSK 239
Query: 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
W S++ + I L N R + E ++ HP++
Sbjct: 240 KW---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G G + V + K + A+K + K + ++ ++ E +++ + HPN+++LL
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVC 71
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK---FMTQSLASALSYLHDNYIVHRDI 501
Y++ E + G+L D + + + E ++ +M ++SA+ YL +HRD+
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTY----VAPEILNESGYGVKI 557
N LV G + ++KV DFGL++ + +T + APE L + + +K
Sbjct: 131 AARNCLV---GEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 558 DVWAAGVILY-ILLCGFPPF 576
DVWA GV+L+ I G P+
Sbjct: 187 DVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 9e-17
Identities = 60/194 (30%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP 435
LQ+ ++G+IIG+G F V Q ++ A+K I K Q E ++ ++H
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQ--GEYTGQKVAVKNI---KCDVTAQAFLEETAVMTKLHHK 59
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSL--ASALSYLHD 493
N+++LL +N LY+V+EL+ G+L + + + + + SL A + YL
Sbjct: 60 NLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGY 553
+VHRD+ N+LV G V KV DFGLA+ + + APE L +
Sbjct: 119 KKLVHRDLAARNILVSEDG----VAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKF 174
Query: 554 GVKIDVWAAGVILY 567
K DVW+ GV+L+
Sbjct: 175 SSKSDVWSYGVLLW 188
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 66/280 (23%), Positives = 116/280 (41%), Gaps = 45/280 (16%)
Query: 383 QIIGDGNFA-VVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN---EVNILRSVNHPNII 438
+++G+G+F V YD D + + K +Q E+NIL+++ H NI+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 439 KLLD--EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
K L L++E + G L D + K+ K + Q + ++YLH +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHY 128
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-------------PMFTVCGTPTYV 543
+HRD+ N+L++ +++K+GDFGLA+ V P+F +
Sbjct: 129 IHRDLAARNVLLDND----RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-------WY 177
Query: 544 APEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFD------------DIL 591
A E L E+ + DVW+ GV LY LL S +E+ ++L
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237
Query: 592 SGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVL 631
P P + +E L+ + E+ R + ++
Sbjct: 238 ERGMRLPCP--KNCPQEVYILMKNCWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 53/164 (32%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNE-LYLVIELIKGGDLFDAISKNVKFSEEDS-KFMTQ 482
E + + HPNI+ LLD + L+ V E + G L + ++ + ++ + M Q
Sbjct: 28 ETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQ 87
Query: 483 SLASALSYLHDNYIVHRDIKPENLLVEMSGC--HVKVLKVGDFGL------AQRVLRPMF 534
L AL+ H+ IVHRD+KP+N++V +G H KVL DFG+ +
Sbjct: 88 VL-DALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVL---DFGIGTLLPGVRDADVATL 143
Query: 535 T----VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFP 574
T V GTPTY APE L D++A G+I L G
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G G F VV + + A+K I++ + ++ IE E ++ ++HP +++L
Sbjct: 12 LGSGQFGVVH-LGKWRAQIKVAIKAINEGAM-SEEDFIE-EAKVMMKLSHPKLVQLYGVC 68
Query: 445 DTNNELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKP 503
LY+V E ++ G L + + + K S++ M Q + + YL N +HRD+
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAA 128
Query: 504 ENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT-VCGTP---TYVAPEILNESGYGVKIDV 559
N LV +G V+KV DFG+ + VL +T G + PE+ N S Y K DV
Sbjct: 129 RNCLVSSTG----VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 560 WAAGVILY-ILLCGFPPFVSDTNDQ 583
W+ GV+++ + G PF +N +
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 62/257 (24%), Positives = 117/257 (45%), Gaps = 33/257 (12%)
Query: 405 CALKIIDKSKLLGKKQMIENEVN------------ILRSVNHPNIIKLLDEYDTNNELYL 452
++ ++ KQM +L+S + P I+K + T++++++
Sbjct: 32 YKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91
Query: 453 VIELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHDNY-IVHRDIKPENLLVE 509
+EL+ D + K ++ E+ MT ++ AL YL + + ++HRD+KP N+L++
Sbjct: 92 CMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD 149
Query: 510 MSGCHVKVLKVGDFGLAQRVLRPMFTV--CGTPTYVAPEILN----ESGYGVKIDVWAAG 563
SG +K+ DFG++ R++ G Y+APE ++ Y ++ DVW+ G
Sbjct: 150 ASGN----VKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG 205
Query: 564 VILYILLCGFPPFVSDTNDQD-ELFDDILSGQYGFPS-PYWDDISEEAKELISHMLESNP 621
+ L L G P+ + E+ IL Q PS P + S + + L +
Sbjct: 206 ISLVELATGQFPY--KNCKTEFEVLTKIL--QEEPPSLPPNEGFSPDFCSFVDLCLTKDH 261
Query: 622 DLRFSAEDVLDHPWLER 638
R ++L HP++ R
Sbjct: 262 RKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 27/246 (10%)
Query: 327 PEHTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIG 386
T + L + TS + + + R NI S L S G++
Sbjct: 55 THATDYDADEESLSPQTDVCQEPCETTSSS-DPASVV--RMQYNILSSLTPG-SEGEV-- 108
Query: 387 DGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT 446
F + + + +K + K G+ E++IL++++H II L+ Y
Sbjct: 109 ---FVCTK--HGDEQRKKVIVKAVTGGKTPGR------EIDILKTISHRAIINLIHAYRW 157
Query: 447 NNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENL 506
+ + +V+ K DLF + ++ E + + + L AL+YLH I+HRD+K EN+
Sbjct: 158 KSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENI 216
Query: 507 LVEMSGCHVKVLKVGDFGLAQRVLRPMFTV-----CGTPTYVAPEILNESGYGVKIDVWA 561
++ V +GDFG A ++ T GT +PE+L Y K D+W+
Sbjct: 217 FLDEPENAV----LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWS 272
Query: 562 AGVILY 567
AG++L+
Sbjct: 273 AGLVLF 278
|
Length = 392 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 385 IGDGNFAVVRQVYDKHK-DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDE 443
+G G F VV+ Y K + D A+K+I K + + + IE E ++ ++H +++L
Sbjct: 12 LGTGQFGVVK--YGKWRGQYDVAIKMI-KEGSMSEDEFIE-EAKVMMKLSHEKLVQLYGV 67
Query: 444 YDTNNELYLVIELIKGGDLFDAISKNVK-FSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
+Y+V E + G L + + ++ K F M + + ++YL +HRD+
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLA 127
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC-GTPTYV---APEILNESGYGVKID 558
N LV+ GC +KV DFGL++ VL +T G+ V PE+L S + K D
Sbjct: 128 ARNCLVDDQGC----VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 559 VWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSG 593
VWA GV+++ + G P+ + + E + + G
Sbjct: 184 VWAFGVLMWEVYSLGKMPY--ERFNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 42/212 (19%)
Query: 383 QIIGDGNFAVVRQV-YDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIK 439
Q +G GNF V YD +D + + K + + + E E+ IL+S+ H NI+K
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 440 LLDEYDT------NNELYLVIELIKGGDLFDAISKNVKFSEEDSKFM--TQSLASALSYL 491
Y L LV+E + G L D + K+ + + K + + + YL
Sbjct: 70 ----YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYL 124
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--------------RPMFTVC 537
VHRD+ N+LVE S VK+ GDFGL +VL P+F
Sbjct: 125 GSKRYVHRDLATRNILVE-SENRVKI---GDFGLT-KVLPQDKEYYKVREPGESPIF--- 176
Query: 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYIL 569
+ APE L ES + V DVW+ GV+LY L
Sbjct: 177 ----WYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 16/191 (8%)
Query: 406 ALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDA 465
A+K + K +K+ E +++ + NHPNI+KLL N Y+++EL++GGDL
Sbjct: 30 AVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSY 89
Query: 466 ISKNVKFSEEDSKFMTQS--------LASALSYLHDNYIVHRDIKPENLLV-EMSGCHVK 516
+ ++ + +T +A YL + +HRD+ N LV E +
Sbjct: 90 L-RDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADR 148
Query: 517 VLKVGDFGLAQRVLRP-MFTVCGT---PT-YVAPEILNESGYGVKIDVWAAGVILY-ILL 570
V+K+GDFGLA+ + + + G P ++APE L + + + DVW+ GV+++ IL
Sbjct: 149 VVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
Query: 571 CGFPPFVSDTN 581
G P+ + N
Sbjct: 209 LGQQPYPALNN 219
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 47/214 (21%)
Query: 385 IGDGNFAVVRQV-YDKHKDMDCALKIIDKSKLLGKKQMI---ENEVNILRSVNHPNIIKL 440
+G+G+F V YD D + G++Q E E+ ILR+++H NI+K
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 441 --LDEYDTNNELYLVIELIKGGDLFDAISKN---------VKFSEEDSKFMTQSLASALS 489
+ E L L++E + G L D + ++ + FS + + +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ--------ICKGMD 123
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ-----------RVLR--PMFTV 536
YL +HRD+ N+LVE ++K+ DFGLA+ + P+F
Sbjct: 124 YLGSQRYIHRDLAARNILVE----SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF-- 177
Query: 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILL 570
+ APE L S + DVW+ GV LY L
Sbjct: 178 -----WYAPECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 50/224 (22%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 385 IGDGNFAVV-----RQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439
+G G+F +V + V + A+K ++++ + ++ NE ++++ N ++++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF----------MTQSLASALS 489
LL T +V+EL+ GDL + +E + M +A ++
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-----LRP----MFTVCGTP 540
YL VHRD+ N +V +K+GDFG+ + + R + V
Sbjct: 134 YLAAKKFVHRDLAARNCMVA----EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 185
Query: 541 TYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
++APE L + + K DVW+ GV+L+ + P+ +N++
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 39/216 (18%)
Query: 385 IGDGNFAVVRQ---VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKL- 440
+GDG+F VVR+ K + A+K + KL E I+ S++H N+I+L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 441 ---LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDS---KFMTQSLASALSYLHDN 494
L L +V EL G L D + K+ S + Q +A+ + YL
Sbjct: 63 GVVLTH-----PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ-IANGMRYLESK 116
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV------------LRPMFTVCGTPTY 542
+HRD+ N+L+ +K+GDFGL + + L+ F C
Sbjct: 117 RFIHRDLAARNILLASD----DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC----- 167
Query: 543 VAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFV 577
APE L + DVW GV L+ + G P+
Sbjct: 168 -APESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 371 IPSKLLQRYSVGQIIGDGNFAVVRQ-VYDKHKDMDCALKII-DKSKLLGKKQMIENEVNI 428
I SK L+ +G IG G F V Y K A+K + D S Q E ++
Sbjct: 3 INSKELK---LGATIGKGEFGDVMLGDYRGQK---VAVKCLKDDSTA---AQAFLAEASV 53
Query: 429 LRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI---SKNVKFSEEDSKFMTQSLA 485
+ ++ HPN+++LL N LY+V E + G L D + + V + F +
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF-ALDVC 112
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT-YVA 544
+ YL + VHRD+ N+LV V KV DFGLA+ P + A
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFGLAKEA-SQGQDSGKLPVKWTA 167
Query: 545 PEILNESGYGVKIDVWAAGVILY 567
PE L E + K DVW+ G++L+
Sbjct: 168 PEALREKKFSTKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 59/235 (25%), Positives = 104/235 (44%), Gaps = 30/235 (12%)
Query: 371 IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKD-----MDCALKIIDKSKLLGKKQMIENE 425
+P + + +G G F V + + +D + A+K + +S + E
Sbjct: 3 VPRDSITL---LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLME 59
Query: 426 VNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-------VKFSEEDSK 478
I+ NH NI++L+ ++++EL+ GGDL + +N + +D
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 479 FMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR------- 531
F + +A YL +N+ +HRDI N L+ G +V K+ DFG+A+ + R
Sbjct: 120 FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPG-RVAKIADFGMARDIYRASYYRKG 178
Query: 532 --PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
M + P PE + + K DVW+ GV+L+ I G+ P+ TN +
Sbjct: 179 GRAMLPIKWMP----PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|176357 cd01617, DCX, Ubiquitin-like domain of DCX | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 8e-15
Identities = 31/77 (40%), Positives = 43/77 (55%)
Query: 225 RIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARL 284
+ ++V RNG K VR L+N+R S D +T+ V+LD GAVRK+YTL+G L
Sbjct: 1 KRVVVYRNGDPFFKGVRLLVNRRRFKSFDALLDDLTEKVQLDPGAVRKLYTLDGGHRVSL 60
Query: 285 SDFFKSDDVFFAYGSER 301
D + V+ A G E
Sbjct: 61 LDELEDGGVYVASGREP 77
|
DCX The ubiquitin-like DCX domain is present in tandem within the N-terminal half of the doublecortin protein. Doublecortin is expressed in migrating neurons. Mutations in the gene encoding doublecortin cause lissencephaly in males and 'double-cortex syndrome' in females. Length = 80 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 9e-15
Identities = 73/251 (29%), Positives = 112/251 (44%), Gaps = 33/251 (13%)
Query: 385 IGDGNFAVVRQVY--DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
+G G + V + D D D ALK I+ + G E+ +LR + HPN+I L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 65
Query: 443 EY--DTNNELYLVIE--------LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492
+ + +++L+ + +IK A K V+ K + + + YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV---LRPMFT---VCGTPTYVAPE 546
N+++HRD+KP N+LV G +K+ D G A+ L+P+ V T Y APE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 547 -ILNESGYGVKIDVWAAGVILYILLCGFPPF--------VSDTNDQDELFDDILSGQYGF 597
+L Y ID+WA G I LL P F S+ D+L D + GF
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL--DRIFNVMGF 243
Query: 598 PSPY-WDDISE 607
P+ W+DI +
Sbjct: 244 PADKDWEDIKK 254
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 54/213 (25%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 378 RYSVGQIIGDGNFAVVRQ--VYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSV 432
S G+ +G G F V + Y K M A+K++ + +++ + +E+ I+ +
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 433 -NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALS 489
NH NI+ LL + ++ E GDL + + + + ED + +A ++
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-FTVCGTP----TYVA 544
+L +HRD+ N+L+ H K++K+ DFGLA+ ++ + V G ++A
Sbjct: 156 FLASKNCIHRDLAARNVLL----THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211
Query: 545 PEILNESGYGVKIDVWAAGVILY-ILLCGFPPF 576
PE + Y + DVW+ G++L+ I G P+
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 67/272 (24%), Positives = 135/272 (49%), Gaps = 29/272 (10%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH-PNIIKLL 441
+++G+G + V + A+K++D ++ +++ I+ E+N+L+ +H NI
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYY 79
Query: 442 DEY------DTNNELYLVIELIKGGDLFDAISKNVK---FSEEDSKFMTQSLASALSYLH 492
+ +++L+LV+E G + D + KN K E+ ++ + + L++LH
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIAYICREILRGLAHLH 138
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM---FTVCGTPTYVAPEILN 549
+ ++HRDIK +N+L+ + +K+ DFG++ ++ R + T GTP ++APE++
Sbjct: 139 AHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 550 -----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604
++ Y + D+W+ G+ + G PP + D + LF + S W
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPP-LCDMHPMRALFLIPRNPPPKLKSKKW-- 251
Query: 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
S++ + I L N R S E +L HP++
Sbjct: 252 -SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-14
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 9/170 (5%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPNIIKLLD 442
I G F V K+ A+K++ K+ ++ K ++ E + L P I+ L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
+ N +YLV+E + GGD+ + F EE + +A AL YLH + I+HRD+K
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVCGTPTYVAPEILN 549
P+N+L+ G H+K+ DFGL++ L M + TP+ P+
Sbjct: 132 PDNMLISNEG-HIKLT---DFGLSKVTLNRELNMMDILTTPSMAKPKNDY 177
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNV--KFSEEDSKFMTQ 482
E I++ + HP +I+L +Y+V EL+K G L + + M
Sbjct: 51 EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 483 SLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---------PM 533
+AS ++YL +HRD+ N+LV + + KV DFGLA RV++
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENN----ICKVADFGLA-RVIKEDIYEAREGAK 165
Query: 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
F + + APE + + +K DVW+ G++L I+ G P+ TN +
Sbjct: 166 FPI----KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 73/261 (27%), Positives = 120/261 (45%), Gaps = 33/261 (12%)
Query: 384 IIGDGNFA-VVRQVYDKHKD-MDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKL 440
+IG+GNF V+R + K M+ A+K++ + + E+ +L + +HPNII L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQ-----------------S 483
L + LY+ IE G+L D + K+ + E D F +
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKS-RVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ-RVLRPMFTVCGTPT- 541
+A+ + YL + +HRD+ N+LV + K+ DFGL++ + T+ P
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGEN----LASKIADFGLSRGEEVYVKKTMGRLPVR 183
Query: 542 YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
++A E LN S Y K DVW+ GV+L+ I+ G P+ T EL++ + G Y P
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--AELYEKLPQG-YRMEKP 240
Query: 601 YWDDISEEAKELISHMLESNP 621
+ +E EL+ P
Sbjct: 241 --RNCDDEVYELMRQCWRDRP 259
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF----- 479
E N+++ + HP +++L T +Y++ E ++ G L D + + E K
Sbjct: 51 EANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLK-----TPEGIKLTINKL 104
Query: 480 --MTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTV- 536
M +A ++++ +HRD++ N+LV + C K+ DFGLA+ + +T
Sbjct: 105 IDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC----CKIADFGLARLIEDNEYTAR 160
Query: 537 --CGTP-TYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILS 592
P + APE +N + +K DVW+ G++L I+ G P+ TN E+ ++
Sbjct: 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNLER 218
Query: 593 GQYGFPSPYWDDISEEAKELISHMLESNPDLR 624
G Y P P D+ EE EL+ + P+ R
Sbjct: 219 G-YRMPRP--DNCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 37/272 (13%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ---MIENEVNILRSVNHPNIIKLL 441
IG G F V ++ K A+K I +S + K+Q +++ +V ++RS + P I+K
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDV-VMRSSDCPYIVKFY 69
Query: 442 DEYDTNNELYLVIELIKGGDL-FDAISK------NVKFSEEDSKFMTQSLASALSYLHDN 494
+ ++ +EL+ D+ D K EE + + AL+YL +
Sbjct: 70 GALFREGDCWICMELM---DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 495 Y-IVHRDIKPENLLVEMSGCHVKVLKVGDFG----LAQRVLRPMFTVCGTPTYVAPEILN 549
I+HRD+KP N+L++ +G +K+ DFG L + + C P Y+APE ++
Sbjct: 127 LKIIHRDVKPSNILLDRNGN----IKLCDFGISGQLVDSIAKTRDAGC-RP-YMAPERID 180
Query: 550 ES---GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP----SPYW 602
S GY V+ DVW+ G+ LY + G P+ + +FD + G P +
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPY----PKWNSVFDQLTQVVKGDPPILSNSEE 236
Query: 603 DDISEEAKELISHMLESNPDLRFSAEDVLDHP 634
+ S I+ L + R +++L+HP
Sbjct: 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHP 268
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 59/253 (23%), Positives = 113/253 (44%), Gaps = 31/253 (12%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G G F V Y + A+K + + Q E N+++++ H +++L
Sbjct: 14 LGAGQFGEVWMGY-YNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFM-------TQSLASALSYLHDNYIV 497
+Y++ E + G L D + S+E K + + +A ++Y+ +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLK-----SDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125
Query: 498 HRDIKPENLLV-EMSGCHVKVLKVGDFGLAQRVLRPMFTV---CGTP-TYVAPEILNESG 552
HRD++ N+LV E C K+ DFGLA+ + +T P + APE +N
Sbjct: 126 HRDLRAANVLVSESLMC-----KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 553 YGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611
+ +K DVW+ G++LY I+ G P+ +N D + + Q G+ P ++ +E +
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-----DVMSALQRGYRMPRMENCPDELYD 235
Query: 612 LISHMLESNPDLR 624
++ + + R
Sbjct: 236 IMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 385 IGDGNFAVVRQV-YDKHKDMDCALKIIDKSKLLGKKQMIEN---EVNILRSVNHPNIIKL 440
+G+G+F V YD D + K I + E+ ILR++ H NI+K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 441 --LDEYDTNNELYLVIELIKGGDLFDAISKNVKFS--EEDSKFMTQSLASALSYLHDNYI 496
+ D N + L++E + G L + + +N ++ K+ Q + + YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ-ICKGMDYLGSRQY 130
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTV---CGTPTY-VAPEILNE 550
VHRD+ N+LVE +K+GDFGL + + + +TV +P + APE L +
Sbjct: 131 VHRDLAARNVLVESEH----QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 551 SGYGVKIDVWAAGVILYILL--CG--------FPPFVSDTNDQDELFDDILSGQYGFPSP 600
S + + DVW+ GV LY LL C F + T+ Q + + + G P
Sbjct: 187 SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP 246
Query: 601 YWDDISEEAKELISHMLESNPDLRFSAEDVL 631
+ EE +L+ E P R + ++++
Sbjct: 247 RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 72/261 (27%), Positives = 115/261 (44%), Gaps = 33/261 (12%)
Query: 384 IIGDGNFA-VVRQVYDKHK-DMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKL 440
+IG+GNF V++ K MD A+K + + + E+ +L + +HPNII L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF-----------------MTQS 483
L + LYL IE G+L D + K+ + E D F
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ-RVLRPMFTVCGTPT- 541
+A + YL +HRD+ N+LV + K+ DFGL++ + + T+ P
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA----KIADFGLSRGQEVYVKKTMGRLPVR 176
Query: 542 YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
++A E LN S Y DVW+ GV+L+ I+ G P+ T EL++ + G Y P
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQG-YRLEKP 233
Query: 601 YWDDISEEAKELISHMLESNP 621
+ +E +L+ P
Sbjct: 234 --LNCDDEVYDLMRQCWREKP 252
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 82/272 (30%), Positives = 124/272 (45%), Gaps = 35/272 (12%)
Query: 384 IIGDGNFAVVRQVYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNIL-RSVNHPNIIK 439
+IG+GNF V + K KD MD A+K + + + E+ +L + +HPNII
Sbjct: 14 VIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF-MTQSLASALS--------- 489
LL + LYL IE G+L D + K+ + E D F + S AS LS
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 490 -------YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ-RVLRPMFTVCGTPT 541
YL +HRD+ N+LV + V K+ DFGL++ + + T+ P
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGEN----YVAKIADFGLSRGQEVYVKKTMGRLPV 187
Query: 542 -YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599
++A E LN S Y DVW+ GV+L+ I+ G P+ T EL++ + G Y
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQG-YRLEK 244
Query: 600 PYWDDISEEAKELISHMLESNPDLRFSAEDVL 631
P + +E +L+ P R S +L
Sbjct: 245 PL--NCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 72/251 (28%), Positives = 114/251 (45%), Gaps = 33/251 (13%)
Query: 385 IGDGNFAVVRQVY--DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
+G G + V + D + + ALK I+ + G E+ +LR + HPN+I L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQK 65
Query: 443 EY--DTNNELYLVIE--------LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492
+ ++ +++L+ + +IK A K ++ K + + + YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV---LRPMFT---VCGTPTYVAPE 546
N+++HRD+KP N+LV G +K+ D G A+ L+P+ V T Y APE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 547 -ILNESGYGVKIDVWAAGVILYILLCGFPPF--------VSDTNDQDELFDDILSGQYGF 597
+L Y ID+WA G I LL P F S+ D+L D I S GF
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL-DRIFS-VMGF 243
Query: 598 PSPY-WDDISE 607
P+ W+DI +
Sbjct: 244 PADKDWEDIRK 254
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 14/189 (7%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
Q IG G F V + ++ A+K I Q E +++ + H N+++LL
Sbjct: 12 QTIGKGEFGDV--MLGDYRGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 443 E-YDTNNELYLVIELIKGGDLFDAI---SKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
+ LY+V E + G L D + ++V + KF + + A+ YL N VH
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAMEYLEANNFVH 125
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKID 558
RD+ N+LV V KV DFGL + T + APE L E + K D
Sbjct: 126 RDLAARNVLVSED----NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 559 VWAAGVILY 567
VW+ G++L+
Sbjct: 182 VWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 59/288 (20%)
Query: 399 KHKDMD--CALKIID-KSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455
KHK + A+K I+ S ++++ E+ R + HPNI+ + + ++ELY+V
Sbjct: 20 KHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP 79
Query: 456 LIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC 513
L+ G D + + E F+ + + +AL Y+H +HR +K ++L+ G
Sbjct: 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG- 138
Query: 514 HVKVLKVGDFGLAQRVLRPMF-------TVCGTPTY-------VAPEIL--NESGYGVKI 557
KV GL R M V P ++PE+L N GY K
Sbjct: 139 -----KVVLSGL--RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKS 191
Query: 558 DVWAAGVILYILLCGFPPFVSDTN------------------------DQDELFDDILSG 593
D+++ G+ L G PF D +D + S
Sbjct: 192 DIYSVGITACELANGHVPF-KDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250
Query: 594 QYGFPS-----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
++ PY SE + + L+ +P+ R SA +L+H +
Sbjct: 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 60/252 (23%), Positives = 119/252 (47%), Gaps = 22/252 (8%)
Query: 385 IGDGNFAVV-RQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDE 443
+G G F V Y+KH + A+K + K + + + E N+++++ H ++KL
Sbjct: 14 LGAGQFGEVWMATYNKHTKV--AVKTM-KPGSMSVEAFLA-EANVMKTLQHDKLVKL-HA 68
Query: 444 YDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFM--TQSLASALSYLHDNYIVHRDI 501
T +Y++ E + G L D + + + K + + +A ++++ +HRD+
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTV---CGTP-TYVAPEILNESGYGVKI 557
+ N+LV V K+ DFGLA+ + +T P + APE +N + +K
Sbjct: 129 RAANILVSA----SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 558 DVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616
DVW+ G++L I+ G P+ +N + I + + G+ P ++ EE ++
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELYNIMMRC 239
Query: 617 LESNPDLRFSAE 628
++ P+ R + E
Sbjct: 240 WKNRPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 72/287 (25%), Positives = 126/287 (43%), Gaps = 48/287 (16%)
Query: 381 VGQIIGDGNFAVVRQVYDKHKD-----MDCALKIIDKSKLLGKKQMIENEVNILRSVNHP 435
+G+ +G+G F V + A+K++ ++ + + + +E N+L+ VNHP
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDL--FDAISKNVKFSEEDSKFMTQS---------- 483
++IKL + L L++E K G L F S+ V S S S
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 484 ------------LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531
++ + YL + +VHRD+ N+LV + +K+ DFGL++ V
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEG----RKMKISDFGLSRDVYE 179
Query: 532 PMFTVCGTP-----TYVAPEILNESGYGVKIDVWAAGVILY--ILLCGFP-PFVSDTNDQ 583
V + ++A E L + Y + DVW+ GV+L+ + L G P P ++
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-- 237
Query: 584 DELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDV 630
LF+ + +G Y P ++ SEE L+ + PD R + D+
Sbjct: 238 --LFNLLKTG-YRMERP--ENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 70/273 (25%), Positives = 128/273 (46%), Gaps = 36/273 (13%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNI-LRSVNHPNIIKLLDE 443
+G G + VV ++ A+K I + +++ + +++I +RSV+ P +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 444 YDTNNELYLVIELIKGG-DLF--DAISKNVKFSEEDSKFMTQSLASALSYLHDNY-IVHR 499
++++ +E++ D F K + E+ + S+ AL YLH ++HR
Sbjct: 69 LFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHR 128
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF-TV-CGTPTYVAPE----ILNESGY 553
D+KP N+L+ +G VK+ DFG++ ++ + T+ G Y+APE LN+ GY
Sbjct: 129 DVKPSNVLINRNG-QVKLC---DFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 184
Query: 554 GVKIDVWAAGVILYILLCG-FP------PFVSDTNDQDELFDDILSGQYGFPSPYW--DD 604
VK DVW+ G+ + L G FP PF + ++ PSP +
Sbjct: 185 DVKSDVWSLGITMIELATGRFPYDSWKTPF--------QQLKQVVEE----PSPQLPAEK 232
Query: 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
S E ++ ++ L+ N R + ++L HP+ E
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 3e-12
Identities = 65/263 (24%), Positives = 108/263 (41%), Gaps = 44/263 (16%)
Query: 334 SGTTCLDASGREVPKMPTK-TSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNF-- 390
SG DAS + + P A A +K + + L + V + G F
Sbjct: 110 SGAEDSDASHLDFDEAPPDAAGPVPLAQAKLKHDD------EFLAHFRVIDDLPAGAFGK 163
Query: 391 ----AVVRQVYD--KHKDMDCALKIIDKSKLLGKKQM---------IENEVNILRSVNHP 435
A+ + + ++ + K + L K++ +ENE+ L +NH
Sbjct: 164 IFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAIS--KNVKFSEEDSKFMTQS------LASA 487
NI+K+ + + Y++ + FD S + F +D + Q+ L A
Sbjct: 224 NILKIEEILRSEANTYMITQKYD----FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCA 279
Query: 488 LSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM----FTVCGTPTYV 543
+ Y+HD ++HRDIK EN+ + G V +GDFG A + + GT
Sbjct: 280 VEYIHDKKLIHRDIKLENIFLNCDGKIV----LGDFGTAMPFEKEREAFDYGWVGTVATN 335
Query: 544 APEILNESGYGVKIDVWAAGVIL 566
+PEIL GY D+W+ G+IL
Sbjct: 336 SPEILAGDGYCEITDIWSCGLIL 358
|
Length = 501 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 69/256 (26%), Positives = 106/256 (41%), Gaps = 41/256 (16%)
Query: 393 VRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452
V V D LK + KS + E I V PN++ L + + ++L
Sbjct: 9 VLLVMDTRTQQTFILKGLRKSSEYSR----ERLTIIPHCV--PNMVCLHKYIVSEDSVFL 62
Query: 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG 512
V++ +GG L+ ISK + EE K + AL LH IV RD+ P N+L++ G
Sbjct: 63 VLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG 122
Query: 513 CHVKVLKVGDFGLAQRVLRPMFTVCGTPT---YVAPEILNESGYGVKIDVWAAGVILYIL 569
H+++ + + + G Y APE+ S D W+ G IL+ L
Sbjct: 123 -HIQLTYFSRWSEVED------SCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFEL 175
Query: 570 LCGFP-----PFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLR 624
L G P +T+ + P W +SEEA+ L+ +L+ NP R
Sbjct: 176 LTGKTLVECHPSGINTHTTLNI-------------PEW--VSEEARSLLQQLLQFNPTER 220
Query: 625 FSA-----EDVLDHPW 635
A ED+ HP+
Sbjct: 221 LGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 65/241 (26%), Positives = 110/241 (45%), Gaps = 32/241 (13%)
Query: 378 RYSVGQIIGDGNFAVV---RQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH 434
+ ++IG G F V R +++ A+K + +++ +E +I+ +H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF-------MTQSLASA 487
PNII L + + +V E ++ G L + K+ D +F M + +AS
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH------DGQFTVIQLVGMLRGIASG 118
Query: 488 LSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR----PMFTVCGTPT-- 541
+ YL D VHRD+ N+LV + V KV DFGL+ RVL +T G
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSN----LVCKVSDFGLS-RVLEDDPEAAYTTRGGKIPI 173
Query: 542 -YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599
+ APE + + DVW+ G++++ ++ G P+ +N QD + I G Y P+
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QD-VIKAIEEG-YRLPA 230
Query: 600 P 600
P
Sbjct: 231 P 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-12
Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 37/233 (15%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK----SKLLGKKQMIENEVNILRS 431
+QRY + ++IG G V YD ALK I + + LL K+ + E I
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL--REAKIAAD 58
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQ--SLASALS 489
+ HP I+ + + +Y + I+G L ++ K+V E SK + + S+ + LS
Sbjct: 59 LIHPGIVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 490 ----------YLHDNYIVHRDIKPENLLVEMSGCHVKV-----------------LKVGD 522
Y+H ++HRD+KP+N+L+ + G V + + V +
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 523 FGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFP 574
+ + + GTP Y+APE L D++A GVILY +L FP
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-12
Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 424 NEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK-FSEEDSKFMTQ 482
+E +LR ++HP ++ LLD LV+ + DL+ + ++ + +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYLGARLRPLGLAQVTAVAR 267
Query: 483 SLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA-----QRVLRPMFTVC 537
L SA+ Y+H I+HRDIK EN+LV + + +GDFG A + +
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGP----EDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 538 GTPTYVAPEILNESGYGVKIDVWAAGVILY 567
GT APE+L Y +D+W+AG++++
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 64/232 (27%), Positives = 110/232 (47%), Gaps = 19/232 (8%)
Query: 380 SVGQIIGDGNFAVV---RQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
++ ++IG G F V R K++D A+K + ++ E +I+ +HPN
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNY 495
II+L + + ++ E ++ G L + +N KF+ M + +AS + YL +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVCG--TPT-YVAPEILN 549
VHRD+ N+LV + V KV DFGL+ R L +T G P + APE +
Sbjct: 127 YVHRDLAARNILVNSN----LVCKVSDFGLS-RRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 550 ESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
+ DVW+ G++++ ++ G P+ +N QD + + G Y P P
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVI-KAVEDG-YRLPPP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 20/154 (12%)
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF----- 479
E I++ + H +++L +Y+V E + G L D + S E K
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK-----SGEGKKLRLPQL 105
Query: 480 --MTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC 537
M +A ++YL +HRD+ N+LV + V K+ DFGLA+ + +T
Sbjct: 106 VDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN----LVCKIADFGLARLIEDDEYTAR 161
Query: 538 -GT--PT-YVAPEILNESGYGVKIDVWAAGVILY 567
G P + APE N + +K DVW+ G++L
Sbjct: 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 50/224 (22%), Positives = 90/224 (40%), Gaps = 23/224 (10%)
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQ-- 482
EV R +NHPN+++ L + + LV+E GDL + + N + ++
Sbjct: 45 EVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR 104
Query: 483 ---SLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGT 539
+AS L +LH +H D+ N + +K+GD+GLA + +
Sbjct: 105 MACEVASGLLWLHQADFIHSDLALRNCQL----TADLSVKIGDYGLALEQYPEDYYITKD 160
Query: 540 PTYV-----APEILNESGYGVKI-------DVWAAGVILYILL-CGFPPFVSDTNDQDEL 586
V APE++ G + ++W+ GV ++ L P+ D +D+ L
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSDEQVL 219
Query: 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDV 630
+ P P D + + +P+ R +AE+V
Sbjct: 220 KQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 58/278 (20%), Positives = 128/278 (46%), Gaps = 32/278 (11%)
Query: 377 QRYSVGQIIGDGNFAVV-----RQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRS 431
++ ++ + +G G+F +V + V + A+K ++++ + ++ NE ++++
Sbjct: 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 65
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF-----------M 480
N ++++LL +++EL+ GDL + ++++ E++ M
Sbjct: 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVQAPPSLKKMIQM 124
Query: 481 TQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTP 540
+A ++YL+ N VHRD+ N +V +K+GDFG+ + + + G
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAED----FTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 541 -----TYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQ 594
+++PE L + + DVW+ GV+L+ I P+ +N+Q F ++ G
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF--VMEGG 238
Query: 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632
P D+ + EL+ + NP +R S +++
Sbjct: 239 L-LDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 50/201 (24%), Positives = 97/201 (48%), Gaps = 32/201 (15%)
Query: 385 IGDGNFAVVRQVYDKHKDMD--CALKII--DKSKLLGKKQMIENEVNILRSVNHPNIIKL 440
+G GNF V++ K K + A+KI+ D + K +++ E N+++ +++P I+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR-EANVMQQLDNPYIVRM 61
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ + + LV+EL + G L + KN +E++ + ++ + YL + VHRD
Sbjct: 62 IGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--------------PMFTVCGTPTYVAPE 546
+ N+L+ K+ DFGL+ + L P+ + APE
Sbjct: 121 LAARNVLLVTQ----HYAKISDFGLS-KALGADENYYKAKTHGKWPV-------KWYAPE 168
Query: 547 ILNESGYGVKIDVWAAGVILY 567
+N + K DVW+ GV+++
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 383 QIIGDGNFAVV--RQVYDKHKDMDC---ALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
+ +G+G F V + Y + D A+K + ++ ++ E E +L + H NI
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLF--------DAI------SKNVKFSEEDSKFMTQS 483
+K + +V E ++ GDL DA S + + +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT-- 541
+AS + YL + VHRD+ N LV G + V+K+GDFG+++ V + G T
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLV---GYDL-VVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 542 ---YVAPEILNESGYGVKIDVWAAGVILY 567
++ PE + + + DVW+ GV+L+
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 382 GQIIGDGNFAVVRQVY-----DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+++G G F V + +K K + A+K++ + + I +E ++ SV+HP+
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVK-IPVAIKVLREETSPKANKEILDEAYVMASVDHPH 70
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFM---TQSLASALSYLHD 493
+++LL ++ ++ L+ +L+ G L D + + S+++ +A +SYL +
Sbjct: 71 VVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEE 127
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCG--TPT-YVAPEI 547
+VHRD+ N+LV+ + HVK+ DFGLA ++L + G P ++A E
Sbjct: 128 KRLVHRDLAARNVLVK-TPQHVKIT---DFGLA-KLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 548 LNESGYGVKIDVWAAGVILYILL 570
+ Y K DVW+ GV ++ L+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 53/239 (22%), Positives = 98/239 (41%), Gaps = 51/239 (21%)
Query: 385 IGDGNFAVVRQ-----VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439
IG G F V Q + A+K++ + + + E ++ +HPNI+K
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKN----------------------VKFSEEDS 477
LL + L+ E + GDL + + + S +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 478 KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-------- 529
+ + +A+ ++YL + VHRD+ N LV G ++ V+K+ DFGL++ +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENM-VVKIADFGLSRNIYSADYYKA 188
Query: 530 ----LRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
P+ ++ PE + + Y + DVWA GV+L+ I G P+ +++
Sbjct: 189 SENDAIPI-------RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 60/246 (24%), Positives = 105/246 (42%), Gaps = 41/246 (16%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVR----QVYDKHKDMDCALKIIDKSKLLGKKQMIE---- 423
P K L + + +G+G F V + +K D D +L + +L +M+
Sbjct: 3 PRKRL---TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN 59
Query: 424 --------NEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL----------FDA 465
E+ I+ + PNII+LL T++ L ++ E ++ GDL A
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 466 ISKNVKF-SEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524
+V S FM +AS + YL VHRD+ N LV + +K+ DFG
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN----YTIKIADFG 175
Query: 525 LAQRVLR-PMFTVCGTPT----YVAPEILNESGYGVKIDVWAAGVILY--ILLCGFPPFV 577
+++ + + + G +++ E + + DVWA GV L+ + LC P+
Sbjct: 176 MSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235
Query: 578 SDTNDQ 583
+++Q
Sbjct: 236 QLSDEQ 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|217637 pfam03607, DCX, Doublecortin | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 3e-10
Identities = 20/59 (33%), Positives = 35/59 (59%), Gaps = 2/59 (3%)
Query: 243 LLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAYGSER 301
++++R S D +T+ VKL +G VRK+YTL+G+++ L + + + A G ER
Sbjct: 2 VVSRRRFKSFDALLDDLTEKVKLPSG-VRKLYTLDGHRVTSLDE-LEDGGSYVAAGRER 58
|
Length = 60 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 5/98 (5%)
Query: 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597
GTP Y+APE+L +G +D WA GV L+ L G PPF +T Q +F +IL+
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQ--VFQNILNRD--I 597
Query: 598 PSPYWDD-ISEEAKELISHMLESNPDLRFSAEDVLDHP 634
P P ++ +S A+ I +L +P R +++ HP
Sbjct: 598 PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 38/246 (15%)
Query: 378 RYSVGQIIGDGNFA-VVRQVY---DKHKD-MDCALKIIDKSKLLGKKQMIE--NEVNILR 430
R ++G+ +G+G F VV+ D + A+K++ +K + + +E+ +++
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMK 70
Query: 431 SV-NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF--------MT 481
+ H NII LL LY+V+E G+L D + E S +T
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 482 Q--------SLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533
Q +A + +L +HRD+ N+LV V+K+ DFGLA+ +
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED----HVMKIADFGLARDIHHID 186
Query: 534 F---TVCG-TPT-YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELF 587
+ T G P ++APE L + Y + DVW+ GV+L+ I G P+ +ELF
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY--PGIPVEELF 244
Query: 588 DDILSG 593
+ G
Sbjct: 245 KLLKEG 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 61/269 (22%), Positives = 122/269 (45%), Gaps = 30/269 (11%)
Query: 385 IGDGNFAVV-----RQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439
+G G+F +V R + + A+K +++S L ++ NE ++++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDS-------KFMTQ---SLASALS 489
LL +V+EL+ GDL + +E + + M Q +A ++
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTP-----TYVA 544
YL+ VHRD+ N +V H +K+GDFG+ + + + G ++A
Sbjct: 134 YLNAKKFVHRDLAARNCMV----AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 545 PEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603
PE L + + D+W+ GV+L+ I P+ +N+Q F ++ G Y P D
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF--VMDGGY-LDQP--D 244
Query: 604 DISEEAKELISHMLESNPDLRFSAEDVLD 632
+ E +L+ + NP +R + ++++
Sbjct: 245 NCPERVTDLMRMCWQFNPKMRPTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 43/282 (15%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKD---MDCALKIIDKSKLLGKKQMIE--NEVNILRSVN 433
+++G+++G G F VR+ K +D A+K++ K+ + + E E ++ +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 434 HPNIIKLLD---EYDTNNEL---YLVIELIKGGDL--FDAISKNVKFSEEDSKFMTQSL- 484
HPN+IKL+ L +++ +K GDL F +S+ EE Q+L
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR---IGEEPFTLPLQTLV 116
Query: 485 ------ASALSYLHDNYIVHRDIKPENLLV--EMSGCHVKVLKVGDFGLAQRVLRPMFTV 536
AS + YL +HRD+ N ++ M+ C V DFGL++++ +
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC------VADFGLSKKIYSGDYYR 170
Query: 537 CGTPT-----YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDI 590
G + ++A E L ++ Y DVWA GV ++ I+ G P+ N E+++ +
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYL 228
Query: 591 LSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632
+ G P D E+ EL+ P R S + + D
Sbjct: 229 IKGNRLKQPP---DCLEDVYELMCQCWSPEPKCRPSFQHLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 60/238 (25%), Positives = 110/238 (46%), Gaps = 34/238 (14%)
Query: 383 QIIGDGNFAVVRQVYDKH---KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439
++IG G F V + K +++ A+K + +++ +E +I+ +HPNII
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF-------MTQSLASALSYLH 492
L + + ++ E ++ G L + +N D +F M + +A+ + YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQN------DGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-----PMFTVC---GTPT-YV 543
+ VHRD+ N+LV + V KV DFGL+ R L P +T P +
Sbjct: 124 EMNYVHRDLAARNILVNSN----LVCKVSDFGLS-RFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 544 APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
APE + + DVW+ G++++ ++ G P+ D ++QD + + + Y P P
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-WDMSNQDVI--NAIEQDYRLPPP 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 383 QIIGDGNFAVVRQ---VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439
++IG G+F V + + + CA+K +++ L + + E I++ +HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 440 LLD-EYDTNNELYLVIELIKGGDLFDAISK-----NVKFSEEDSKFMTQSLASALSYLHD 493
LL + +V+ +K GDL + I VK D +A + YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK----DLIGFGLQVAKGMEYLAS 116
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF------TVCGTPT-YVAPE 546
VHRD+ N +++ S +KV DFGLA+ + + T P ++A E
Sbjct: 117 KKFVHRDLAARNCMLDES----FTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 547 ILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQD 584
L + K DVW+ GV+L+ L+ G PP+ D + D
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-PDVDSFD 210
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 62/269 (23%), Positives = 107/269 (39%), Gaps = 54/269 (20%)
Query: 422 IENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK--FSEEDSKF 479
++ E+++ + NHPNI+ + +NEL++V + G D I + SE +
Sbjct: 46 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105
Query: 480 MTQSLASALSYLHDNYIVHRDIKPENLL------VEMSGCHVKVLKVGDFGLAQRVLR-- 531
+ Q + AL Y+H VHR +K ++L V +SG L + + G RV+
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR-SNLSMINHGQRLRVVHDF 164
Query: 532 PMFTVCGTPTYVAPEIL--NESGYGVKIDVWAAGVILYILLCGFPPF------------- 576
P ++V P +++PE+L N GY K D+++ G+ L G PF
Sbjct: 165 PKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 223
Query: 577 -------------------------VSDTNDQDELFDDILSGQYGFPS--PYWDDISEEA 609
+++ + G S PY S
Sbjct: 224 NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHF 283
Query: 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638
+ L+ NPD R SA +L+H + ++
Sbjct: 284 HHFVEQCLQRNPDARPSASTLLNHSFFKQ 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 46/192 (23%), Positives = 92/192 (47%), Gaps = 14/192 (7%)
Query: 385 IGDGNFAVVRQ-VYD-KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
+G GNF V++ VY + K +D A+K++ + + E I+ +++P I++++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 443 EYDTNNELYLVIELIKGGDLFDAIS-KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
+ L LV+E+ GG L +S K + + + + ++ + YL VHRD+
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRV-----LRPMFTVCGTP-TYVAPEILNESGYGV 555
N+L+ + K+ DFGL++ + + P + APE +N +
Sbjct: 122 AARNVLL----VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 556 KIDVWAAGVILY 567
+ DVW+ G+ ++
Sbjct: 178 RSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 54/223 (24%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 385 IGDGNFAVV--RQVYDKHKDMD---CALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439
+G+G F V + Y+ + D A+K + + +K E +L ++ H +I+K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDF-HREAELLTNLQHEHIVK 71
Query: 440 LLDEYDTNNELYLVIELIKGGDLF--------DAI-----SKNVKFSEEDSKFMTQSLAS 486
+ L +V E +K GDL DA+ ++ + ++ + Q +A+
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT----- 541
+ YL + VHRD+ N LV + ++K+GDFG+++ V + G T
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGEN----LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 542 YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
++ PE + + + DVW+ GV+L+ I G P+ +N++
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 29/231 (12%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
QR+ + ++G+G F V + +D+ + CA+KI+ + I E+ + V +
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKI--EIQFMEKVRQAD 186
Query: 437 I-----IKLLDEYDTNNELYLVIELIKGGD-LFDAISKNVKFSEEDSKFMTQSLASALSY 490
+ + Y N ++ I + K G L D I K+ FS + AL Y
Sbjct: 187 PADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDY 246
Query: 491 LHDN-YIVHRDIKPENLLVEMSG---------------CHVKVLKVGDFGLAQRVLRPMF 534
H +++H D+KPEN+L+E S C V++ +G +R R
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-CDERHSRT-- 303
Query: 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDE 585
+ T Y +PE++ G+ D+W+ G I+Y L G + DT+D E
Sbjct: 304 AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG--KLLYDTHDNLE 352
|
Length = 467 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 383 QIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439
++IG G F V + K K++ A+K + ++Q +E +I+ +H NII+
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF-------MTQSLASALSYLH 492
L ++ E ++ G A+ K ++ + D +F M + +A+ + YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENG----ALDKYLR--DHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL----RPMFTVCGTPT---YVAP 545
D VHRD+ N+LV + KV DFGL+ RVL +T G + AP
Sbjct: 125 DMNYVHRDLAARNILVNSN----LECKVSDFGLS-RVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 546 EILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
E + + DVW+ G++++ ++ G P+ +N E+ I G + P+P
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDG-FRLPAP 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 45/178 (25%), Positives = 81/178 (45%), Gaps = 23/178 (12%)
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFD-----------AISKNV-KF 472
E+ I+ + +PNII+LL +++ L ++ E ++ GDL + N+
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 473 SEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531
S + +M +AS + YL VHRD+ N LV +K+ DFG+++ +
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH----YTIKIADFGMSRNLYSG 182
Query: 532 PMFTVCGTPT----YVAPEILNESGYGVKIDVWAAGVILY--ILLCGFPPFVSDTNDQ 583
+ + G ++A E + + DVWA GV L+ LC P+ +++Q
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNE--LYLVIELIKGGDLFDAISKNVKFSEEDSKF--- 479
E I++ + H ++ L Y +E +Y+V E + G L D + E D K+
Sbjct: 51 EAQIMKKLRHDKLVPL---YAVVSEEPIYIVTEFMGKGSLLDFLK------EGDGKYLKL 101
Query: 480 -----MTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534
M +A ++Y+ +HRD++ N+LV + V K+ DFGLA+ + +
Sbjct: 102 PQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN----LVCKIADFGLARLIEDNEY 157
Query: 535 TV---CGTP-TYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDD 589
T P + APE + +K DVW+ G++L L+ G P+ N E+ +
Sbjct: 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQ 215
Query: 590 ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAE 628
+ G Y P P E EL+ + +PD R + E
Sbjct: 216 VERG-YRMPCP--QGCPESLHELMKLCWKKDPDERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 40/184 (21%), Positives = 83/184 (45%), Gaps = 27/184 (14%)
Query: 423 ENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI---------------S 467
+ E +++ ++HPNI+ LL + ++ E + GDL + +
Sbjct: 55 QQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114
Query: 468 KNVKFSEEDSKFMTQSL--ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525
VK S + F+ ++ A+ + YL ++ VH+D+ N+L+ G + V K+ D GL
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHV-KISDLGL 170
Query: 526 AQRVLRPMFTVCGTPT-----YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSD 579
++ + + + ++ PE + + D+W+ GV+L+ I G P+
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230
Query: 580 TNDQ 583
+N +
Sbjct: 231 SNQE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 34/229 (14%)
Query: 378 RYSVGQIIGDGNFAVVRQV----YDKHKDMDC---ALKIIDKSKLLGKKQMIENEVNILR 430
+ ++G+ +G+G F V DK K + A+K++ + +E+ +++
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 75
Query: 431 SV-NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-----------VKFSEEDSK 478
+ H NII LL + LY+++E G+L + + + +E
Sbjct: 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 479 FM-----TQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533
F T +A + YL +HRD+ N+LV + V+K+ DFGLA+ V
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN----NVMKIADFGLARDVNNID 191
Query: 534 F---TVCGT-PT-YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPF 576
+ T G P ++APE L + Y + DVW+ GV+++ I G P+
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 385 IGDGNFAVV--RQVYD---KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439
+G+G F V + Y+ M A+K + L +K + E +L ++ H +I+K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF-QREAELLTNLQHEHIVK 71
Query: 440 LLDEYDTNNELYLVIELIKGGDLF--------DAI--------SKNVKFSEEDSKFMTQS 483
+ L +V E +K GDL DA+ + +
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT-- 541
+AS + YL + VHRD+ N LV G ++ ++K+GDFG+++ V + G T
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLV---GANL-LVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 542 ---YVAPEILNESGYGVKIDVWAAGVILY 567
++ PE + + + DVW+ GVIL+
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 48/200 (24%), Positives = 88/200 (44%), Gaps = 26/200 (13%)
Query: 406 ALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDA 465
A+K + ++ +Q E ++ + HPNI+ LL ++ E + GDL +
Sbjct: 39 AIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEF 98
Query: 466 ISKN-----VKFSEED---------SKFMTQSL--ASALSYLHDNYIVHRDIKPENLLVE 509
+ +N V D S F+ ++ A+ + YL ++ VHRD+ N LV
Sbjct: 99 LVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV- 157
Query: 510 MSGCHVKVLKVGDFGLAQRV-----LRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGV 564
G + V K+ DFGL++ + R ++ PE + + + D+W+ GV
Sbjct: 158 --GEGLTV-KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214
Query: 565 ILY-ILLCGFPPFVSDTNDQ 583
+L+ I G P+ +N +
Sbjct: 215 VLWEIFSYGLQPYYGFSNQE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNE--LYLVIELIKGGDLFDAI----SKNVKFSEEDSK 478
E +++ + H +++L Y +E +Y+V E + G L D + K ++ +
Sbjct: 51 EAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD- 106
Query: 479 FMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTV-- 536
M +AS ++Y+ VHRD++ N+LV + V KV DFGLA+ + +T
Sbjct: 107 -MAAQIASGMAYVERMNYVHRDLRAANILVGEN----LVCKVADFGLARLIEDNEYTARQ 161
Query: 537 -CGTP-TYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSG 593
P + APE + +K DVW+ G++L L G P+ N E+ D + G
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG 219
Query: 594 QYGFPSPYWDDISEEAKELISHMLESNPDLRFSAE 628
Y P P + E +L+ P+ R + E
Sbjct: 220 -YRMPCP--PECPESLHDLMCQCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 39/230 (16%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP 435
LQ +S + N V A+K++ ++ EV IL ++ P
Sbjct: 29 LQDFSEKAFAENDNADAPVLV---------AVKVLRPDASDNAREDFLKEVKILSRLSDP 79
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNV---KFSEEDSKFMTQS--------L 484
NI +LL + L +++E ++ GDL + K+V +SK ++ S +
Sbjct: 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQI 139
Query: 485 ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT-----VCGT 539
AS + YL VHRD+ N LV G + + K+ DFG++ R +++ V G
Sbjct: 140 ASGMRYLESLNFVHRDLATRNCLV---GKNYTI-KIADFGMS----RNLYSSDYYRVQGR 191
Query: 540 PT----YVAPEILNESGYGVKIDVWAAGVILY-IL-LCGFPPFVSDTNDQ 583
++A E + + K DVWA GV L+ IL LC P+ T+ Q
Sbjct: 192 APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 424 NEVNILRSVNHPNIIKLLDEYDTNNE--LYLVIELIKGGDLFDAIS----KNVKFSEEDS 477
E I++ + H +++L Y +E +Y+V E + G L D + + +K
Sbjct: 50 EEAQIMKKLRHDKLVQL---YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD 106
Query: 478 KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTV- 536
M +A+ ++Y+ +HRD++ N+LV V K+ DFGLA+ + +T
Sbjct: 107 --MAAQVAAGMAYIERMNYIHRDLRSANILVGDG----LVCKIADFGLARLIEDNEYTAR 160
Query: 537 --CGTP-TYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILS 592
P + APE + +K DVW+ G++L L+ G P+ N E+ + +
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVER 218
Query: 593 GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAE 628
G Y P P D EL+ + +P+ R + E
Sbjct: 219 G-YRMPCP--QDCPISLHELMLQCWKKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 44/190 (23%), Positives = 84/190 (44%), Gaps = 33/190 (17%)
Query: 419 KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK 478
+Q + E +L + H +I++ L +V E ++ GDL ++ ++ D+K
Sbjct: 51 RQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL----NRFLRSHGPDAK 106
Query: 479 FMTQS-------------------LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLK 519
+ +AS + YL + VHRD+ N LV G + V+K
Sbjct: 107 ILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQGL-VVK 162
Query: 520 VGDFGLAQRVLRPMFTVCGTPT-----YVAPEILNESGYGVKIDVWAAGVILY-ILLCGF 573
+GDFG+++ + + G T ++ PE + + + D+W+ GV+L+ I G
Sbjct: 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
Query: 574 PPFVSDTNDQ 583
P+ +N +
Sbjct: 223 QPWYQLSNTE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 63/260 (24%), Positives = 117/260 (45%), Gaps = 47/260 (18%)
Query: 380 SVGQIIGDGNFAVVRQVYDKHKD--MDCALKIIDKSKLLGKKQMIE--NEVNILRSVNHP 435
++G+ +G+G F V + D + A+K + K + + +M + +E ++ +HP
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 436 NIIKLLDE--YDTNNELY----LVIELIKGGDL-----FDAISKNVKF--SEEDSKFMTQ 482
N+++L+ +E Y +++ +K GDL + + ++ ++ KFMT
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT- 119
Query: 483 SLASALSYLHDNYIVHRDIKPENLLVE--MSGCHVKVLKVGDFGLAQRVLRPMF----TV 536
+AS + YL +HRD+ N ++ M+ C V DFGL++++ + +
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCMLNENMNVC------VADFGLSKKIYNGDYYRQGRI 173
Query: 537 CGTPT-YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFD------ 588
P ++A E L + Y K DVW+ GV ++ I G P+ N E++D
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQGN 231
Query: 589 ------DILSGQYGFPSPYW 602
D L G Y S W
Sbjct: 232 RLKQPPDCLDGLYSLMSSCW 251
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 378 RYSVGQIIGDGNFAVVRQV----YDK---HKDMDCALKIIDKSKLLGKKQMIENEVNILR 430
R ++G+ +G+G F V DK +K + A+K++ + +E+ +++
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72
Query: 431 SV-NHPNIIKLLDEYDTNNELYLVIELIKGGDL-----------FDAISKNVKFSEEDSK 478
+ H NII LL + LY+++E G+L D K EE
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 479 FM-----TQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533
F +A + YL +HRD+ N+LV V+K+ DFGLA+ V
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED----NVMKIADFGLARDVHNID 188
Query: 534 FTVCGTP-----TYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPF 576
+ T ++APE L + Y + DVW+ GV+L+ I G P+
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 63/268 (23%), Positives = 110/268 (41%), Gaps = 36/268 (13%)
Query: 385 IGDGNFA-VVRQVYDKHKDMDCALKIIDKS---KLLGKKQMIENE----VNILRSVNHPN 436
+G G F + + V D+D + S K+LG +++ ++H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 437 IIKLL-----DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFM--TQSLASALS 489
++KL DE +V E +K G L D K + + + LASAL
Sbjct: 63 LVKLYGVCVRDEN------IMVEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASALH 115
Query: 490 YLHDNYIVHRDIKPENLLV---EMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPE 546
YL D +VH ++ +N+LV ++ +V +K+ D G+ VL V P ++APE
Sbjct: 116 YLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-WIAPE 174
Query: 547 ILNESGYGVKI--DVWAAGVILYILLCGFP-PFVSDTNDQDELFDDILSGQYGFPSPYWD 603
+ + I D W+ G L + P + ++ + E F Q+ P P
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF---YQDQHRLPMPDCA 231
Query: 604 DISEEAKELISHMLESNPDLRFSAEDVL 631
+++ LI+ +P R S +L
Sbjct: 232 ELA----NLINQCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 15/217 (6%)
Query: 423 ENEVNILRSVNHPNIIKL----LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK 478
ENE+ LR ++ NI+K+ +D D L L++E G L + + K S +
Sbjct: 66 ENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKL 125
Query: 479 FMTQSLASALSYLHDNY-IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC 537
M L L+ ++++ + LV + LK+ GL + + P F
Sbjct: 126 DMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY----KLKIICHGLEKILSSPPFKNV 181
Query: 538 GTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY 595
Y + ++LN+ S Y +K D+++ GV+L+ + G PF + E++D I++
Sbjct: 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF--ENLTTKEIYDLIINKNN 239
Query: 596 GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632
P D E K ++ + R + +++L
Sbjct: 240 SLKLPL--DCPLEIKCIVEACTSHDSIKRPNIKEILY 274
|
Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 36/241 (14%)
Query: 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKS-KLLGKKQM-IE---NEVNILRSVNH 434
+G+I+G+G F V + D LK+ K+ KL IE +E ++ +H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDD-GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 435 PNIIKLLDEYDTNNEL------YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSL---- 484
PN++KL+ + L +++ +K GDL + + + K Q+L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKFM 119
Query: 485 ---ASALSYLHDNYIVHRDIKPENLLV--EMSGCHVKVLKVGDFGLAQRVLRPMFTVCGT 539
A + YL + +HRD+ N ++ +M+ C V DFGL++++ + G
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC------VADFGLSKKIYSGDYYRQGR 173
Query: 540 PT-----YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSG 593
++A E L + Y K DVWA GV ++ I G P+ N E++D + G
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRHG 231
Query: 594 Q 594
Sbjct: 232 N 232
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 459 GGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVL 518
I+++ S D + +A+ + +L VHRD+ N+L+ C K++
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI----CEGKLV 278
Query: 519 KVGDFGLAQRVLRPMFTVCGTPTYV-----APEILNESGYGVKIDVWAAGVILY-ILLCG 572
K+ DFGLA+ ++R + T++ APE + + Y DVW+ G++L+ I G
Sbjct: 279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLG 338
Query: 573 FPPFVSDTNDQDELFDDILSGQYGFPSPYW--DDISEEAKELISHMLESNPDLRF 625
P+ +E F + + Y P D+I E ++ E PD
Sbjct: 339 GTPYPELP--MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQ 391
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 64/240 (26%), Positives = 110/240 (45%), Gaps = 27/240 (11%)
Query: 397 YDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456
Y K++ LK++D S E +++R V+H +I+ L + E +V E
Sbjct: 27 YSYEKEIKVILKVLDPSHRDISLAFFET-ASMMRQVSHKHIVLLYGVCVRDVENIMVEEF 85
Query: 457 IKGG--DLF-----DAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE 509
++ G DLF D ++ KF + + LASALSYL D +VH ++ +N+L+
Sbjct: 86 VEFGPLDLFMHRKSDVLTTPWKFK------VAKQLASALSYLEDKDLVHGNVCTKNILLA 139
Query: 510 MSGCHVK---VLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVI 565
G + +K+ D G+ VL V P ++APE + +S + D W+ G
Sbjct: 140 REGIDGECGPFIKLSDPGIPITVLSRQECVERIP-WIAPECVEDSKNLSIAADKWSFGTT 198
Query: 566 LY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLR 624
L+ I G P T + E F GQ +P +++ +L++H + +P+ R
Sbjct: 199 LWEICYNGEIPLKDKTLAEKERF---YEGQCMLVTPSCKELA----DLMTHCMNYDPNQR 251
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 378 RYSVGQIIGDGNFAVVRQV----YDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILR 430
R +G+ +G+G F V DK K A+K++ + +E+ +++
Sbjct: 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 78
Query: 431 SV-NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAIS----------------KNVKFS 473
+ H NII LL + LY+++E G+L + + + S
Sbjct: 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138
Query: 474 EEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533
+D +A + YL +HRD+ N+LV V+K+ DFGLA+ +
Sbjct: 139 FKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED----NVMKIADFGLARDIHHID 194
Query: 534 F---TVCGT-PT-YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPF 576
+ T G P ++APE L + Y + DVW+ GV+L+ I G P+
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 35/196 (17%)
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF----- 479
EV IL + PNII+LL + L ++ E ++ GDL +S + +E++
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 480 --------------MTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525
+ +AS + YL VHRD+ N LV + +K+ DFG+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGEN----LTIKIADFGM 184
Query: 526 AQRVLR-PMFTVCGTPT----YVAPEILNESGYGVKIDVWAAGVILY--ILLCGFPPFVS 578
++ + + + G ++A E + + DVWA GV L+ ++LC P+
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244
Query: 579 DTNDQ-----DELFDD 589
T++Q E F D
Sbjct: 245 LTDEQVIENAGEFFRD 260
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 51/226 (22%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL--FDAISKNVKFSEEDSKFMTQ 482
E+++ R ++H N+++LL Y+++E GDL F +K+ K + ++
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKS-KDEKLKPPPLST 116
Query: 483 S--------LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVG--------DFGLA 526
+A + +L + VHRD+ N LV S VKV + ++
Sbjct: 117 KQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEYYKL 175
Query: 527 QRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDE 585
+ L P+ ++APE + E + K DVW+ GV+++ + G PF ++ +E
Sbjct: 176 RNALIPL-------RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EE 226
Query: 586 LFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVL 631
+ + + +G+ P P + +L++ NP R S +++
Sbjct: 227 VLNRLQAGKLELPVP--EGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 34/230 (14%)
Query: 377 QRYSVGQIIGDGNFA-VVR-QVYDKHKD-----MDCALKIIDKSKLLGKKQMIENEVNIL 429
R +G+ +G+G F VVR + Y K + A+K++ + + +E+ ++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 430 RSVN-HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-----------VKFSEEDS 477
+ + H NII LL LY+++E G+L + + K EE
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 478 KF-----MTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532
F +A + YL +HRD+ N+LV V+K+ DFGLA+ V
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED----NVMKIADFGLARGVHDI 187
Query: 533 MF---TVCG-TPT-YVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPF 576
+ T G P ++APE L + Y + DVW+ G++++ I G P+
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 52/206 (25%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 383 QIIGDGNFAVVRQ---VYDKHK-DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNII 438
+++G G F V + + + K + A+K + ++ + I +E ++ SV++P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKF--SEEDSKFMTQSLASALSYLHDNYI 496
+LL T+ + L+ +L+ G L D + ++ S+ + Q +A ++YL + +
Sbjct: 73 RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ-IAKGMNYLEERRL 130
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPT---YVAPEILNES 551
VHRD+ N+LV+ HVK+ DFGLA+ + + G ++A E +
Sbjct: 131 VHRDLAARNVLVKTPQ-HVKIT---DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186
Query: 552 GYGVKIDVWAAGVILYILLC-GFPPF 576
Y + DVW+ GV ++ L+ G P+
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 20/155 (12%)
Query: 481 TQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTP 540
T +A + +L VHRD+ N+L+ K++K+ DFGLA+ ++ V
Sbjct: 243 TYQVARGMEFLASKNCVHRDLAARNVLL----AQGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 541 TYV-----APEILNESGYGVKIDVWAAGVILY-ILLCG---FPPFVSDTNDQDELFDDIL 591
T++ APE + ++ Y DVW+ G++L+ I G +P + D+ ++ I
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST----FYNKIK 354
Query: 592 SGQYGFPSPYWDDISEEAKELISHMLESNPDLRFS 626
SG Y P D ++E +++ S P+ R S
Sbjct: 355 SG-YRMAKP--DHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 43/203 (21%), Positives = 90/203 (44%), Gaps = 31/203 (15%)
Query: 406 ALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDA 465
A+K + ++ ++E + + HPNI+ LL L ++ DL +
Sbjct: 39 AIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEF 98
Query: 466 I--------------SKNVKFSEEDSKFM--TQSLASALSYLHDNYIVHRDIKPENLLV- 508
+ K VK + E + F+ +A+ + +L +++VH+D+ N+LV
Sbjct: 99 LVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158
Query: 509 -EMSGCHVKVLKVGDFGLAQRVLRP-MFTVCGTPT----YVAPEILNESGYGVKIDVWAA 562
+++ +K+ D GL + V + + G +++PE + + + D+W+
Sbjct: 159 DKLN------VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 563 GVILY-ILLCGFPPFVSDTNDQD 584
GV+L+ + G P+ +N QD
Sbjct: 213 GVVLWEVFSYGLQPYCGYSN-QD 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 13/167 (7%)
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQS 483
E L +H NI++L N + +V E + G L + K+ + M
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMS-GCHVKVLKVGDFGLAQR-VLRPMFTVCGTPT 541
LAS + YL + VH+ + +LV C K+ F Q ++T +
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVC-----KISGFRRLQEDKSEAIYTTMSGKS 170
Query: 542 YV---APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQD 584
V APE + + DVW+ G++++ ++ G P+ D + QD
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY-WDMSGQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 56/202 (27%), Positives = 106/202 (52%), Gaps = 23/202 (11%)
Query: 383 QIIGDGNFAVV-RQVYDKHKD---MDCALKIIDKSKLLGKKQMIE--NEVNILRSVNHPN 436
+++G G F V + ++ + + A+KI++++ G K +E +E I+ S++HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPH 70
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAIS--KNVKFSEEDSKFMTQSLASALSYLHDN 494
+++LL + + LV +L+ G L D + K+ S+ + Q +A + YL +
Sbjct: 71 LVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ-IAKGMMYLEER 128
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVCGTPT---YVAPEIL 548
+VHRD+ N+LV+ S HVK+ DFGLA R+L + G ++A E +
Sbjct: 129 RLVHRDLAARNVLVK-SPNHVKIT---DFGLA-RLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 549 NESGYGVKIDVWAAGVILYILL 570
+ + + DVW+ GV ++ L+
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 31/105 (29%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 478 KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-FTV 536
+F +Q +A + +L +HRD+ N+L+ +V K+ DFGLA+ ++ + V
Sbjct: 216 RFSSQ-VAQGMDFLASKNCIHRDVAARNVLLT----DGRVAKICDFGLARDIMNDSNYVV 270
Query: 537 CGTP----TYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPF 576
G ++APE + + Y V+ DVW+ G++L+ I G P+
Sbjct: 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 17/195 (8%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDE 443
+I G + M +K I+ + +E+ + + HPNI+KL+
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGL 751
Query: 444 YDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN---YIVHRD 500
+ YL+ E I+G +L + + S E + + +A AL +LH +V +
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVW 560
+ PE ++++ G L++ GL L + YVAPE K D++
Sbjct: 809 LSPEKIIID--GKDEPHLRLSLPGL----LCTDTKCFISSAYVAPETRETKDITEKSDIY 862
Query: 561 AAGVILYILLCGFPP 575
G+IL LL G P
Sbjct: 863 GFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 53/205 (25%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 383 QIIGDGNFAVVRQ---VYD-KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNII 438
+++G G F V + + D ++ + A+K++ ++ + I +E ++ V P +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIV 497
+LL T+ + LV +L+ G L D + +N + +D +A +SYL + +V
Sbjct: 73 RLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLV 131
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQ--RVLRPMFTVCGTPT---YVAPEILNESG 552
HRD+ N+LV+ S HVK+ DFGLA+ + + G ++A E +
Sbjct: 132 HRDLAARNVLVK-SPNHVKIT---DFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 553 YGVKIDVWAAGVILYILLC-GFPPF 576
+ + DVW+ GV ++ L+ G P+
Sbjct: 188 FTHQSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 13/155 (8%)
Query: 482 QSLASALSYLHDNYIVHRDIKPENLLVEMSGC---HVKVLKVGDFGLAQRVLRPMFTVCG 538
Q LASALSYL D +VH ++ +N+L+ G +K+ D G++ L V
Sbjct: 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVER 183
Query: 539 TPTYVAPEIL-NESGYGVKIDVWAAG-VILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596
P ++APE + + D W+ G +L I G P T + E F ++
Sbjct: 184 IP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF---YEKKHR 239
Query: 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVL 631
P P +++ LIS L P R S +L
Sbjct: 240 LPEPSCKELA----TLISQCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 46/176 (26%), Positives = 83/176 (47%), Gaps = 28/176 (15%)
Query: 420 QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF 479
+ ++NEV + HPNI+ + T + L+++ + G +++ K F E S+
Sbjct: 44 KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSA-NSLLKTY-FPEGMSEA 101
Query: 480 MTQSL----ASALSYLHDNYIVHRDIKPENL------LVEMSG-----CHVKVLKVGDFG 524
+ ++ L+YLH N +HR+IK ++ LV +SG V+ G
Sbjct: 102 LIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVR------NG 155
Query: 525 LAQRVLR--PMFTVCGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPF 576
+V+ P F+ P +++PE+L + GY VK D+++ G+ L G PF
Sbjct: 156 QKAKVVYDFPQFSTSVLP-WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 29/99 (29%), Positives = 53/99 (53%), Gaps = 10/99 (10%)
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-PMFTVCGTP-- 540
+A + +L +HRD+ N+L+ + V+K+ DFGLA+ + + P + G
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLSEN----NVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 541 --TYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPF 576
++APE + + Y ++ DVW+ GV+L+ I G P+
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 38/218 (17%)
Query: 378 RYSVGQIIGDGNFAVVRQ-VY---DKHKDMDCALK-IIDKSKLLGKKQMIENEVNILRSV 432
R ++ ++ +G F + + K+ + +K + D + + + ++ E +L +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-QVTLLLQESCLLYGL 65
Query: 433 NHPNIIKLL----DEYDT-----------NNELYLVIELIKGGDLFDAISKNVKFSEEDS 477
+H NI+ +L ++ + N +L+L + + A+S +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS------TQQL 119
Query: 478 KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC 537
M +A +SYLH ++H+DI N +++ +K+ D L+ R L PM C
Sbjct: 120 VHMAIQIACGMSYLHKRGVIHKDIAARNCVID----EELQVKITDNALS-RDLFPMDYHC 174
Query: 538 -----GTPT-YVAPEILNESGYGVKIDVWAAGVILYIL 569
P ++A E L Y DVW+ GV+L+ L
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 29/99 (29%), Positives = 53/99 (53%), Gaps = 10/99 (10%)
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-PMFTVCGTP-- 540
+A + +L +HRD+ N+L+ + V+K+ DFGLA+ + + P + G+
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSEN----NVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 541 --TYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPF 576
++APE + + Y + DVW+ GV+L+ I G P+
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 49/210 (23%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 382 GQIIGDGNFAVVRQ-VYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
+++G G F V + ++ D + A+K I Q I + + + S++H I
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQ--SLASALSYLHDNY 495
++LL L LV +L G L D + ++ + S + + + +A + YL ++
Sbjct: 72 VRLLG-ICPGASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGTP-TYVAPEILN 549
+VHR++ N+L++ ++++ DFG+A +L P ++ TP ++A E +
Sbjct: 130 MVHRNLAARNILLKSD----SIVQIADFGVAD-LLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 550 ESGYGVKIDVWAAGVILYILLC-GFPPFVS 578
Y + DVW+ GV ++ ++ G P+
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 23/194 (11%)
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-----SKNVKFSEEDSKF 479
E RS+ H N+++ L + LV+E GDL + ++ + +
Sbjct: 45 EAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR 104
Query: 480 MTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGT 539
M +A L +LH N +H D+ N L+ +K+GD+GL+ + + V
Sbjct: 105 MACEIALGLLHLHKNNFIHSDLALRNCLLTAD----LTVKIGDYGLSHNKYKEDYYVTPD 160
Query: 540 PTYV-----APEILNE-SGYGVKID------VWAAGVILYILL-CGFPPFVSDTNDQDEL 586
+V APE+++E G + +D VW+ GV ++ L G P+ +D+ L
Sbjct: 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY-RHLSDEQVL 219
Query: 587 FDDILSGQYGFPSP 600
+ Q P P
Sbjct: 220 TYTVREQQLKLPKP 233
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 58/257 (22%), Positives = 109/257 (42%), Gaps = 25/257 (9%)
Query: 385 IGDGNFAVV-----RQV--YDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
+G G F + R+V Y + + LK++DKS + E +++ ++H ++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFE-AASMMSQLSHKHL 61
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF-MTQSLASALSYLHDNYI 496
+ +E +V E +K G L + KN K + + LA AL +L D +
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGL 121
Query: 497 VHRDIKPENLLVEMSGCHVK----VLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNES- 551
H ++ +N+L+ +K+ D G++ VL + P +V PE +
Sbjct: 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-WVPPECIENPQ 180
Query: 552 GYGVKIDVWAAGVILYILLCG--FPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
+ D W+ G L+ + G P D+ + + ++D ++ P+P W E
Sbjct: 181 NLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED----RHQLPAPKW----TEL 232
Query: 610 KELISHMLESNPDLRFS 626
LI+ ++ PD R S
Sbjct: 233 ANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 30/222 (13%)
Query: 430 RSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNV-KFSEEDS---KFMTQSLA 485
R + HPNI++ L + LV E + GDL +S+ + M +A
Sbjct: 50 RILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIA 109
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVK---VLKVGDFGLAQRVLRPMFT-----VC 537
+ ++++H + +H D+ N C + +KVGD+G+ + + C
Sbjct: 110 AGVTHMHKHNFLHSDLALRN-------CFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKC 162
Query: 538 GTPTYVAPEILNESGYGVKI-------DVWAAGVILYILL-CGFPPFVSDTNDQDELFDD 589
++APE++ E G+ +VWA GV L+ L P+ S +D++ L
Sbjct: 163 VPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY-SHLSDREVLNHV 221
Query: 590 ILSGQYGFPSPYWD-DISEEAKELISHMLESNPDLRFSAEDV 630
I Q P + SE E++ S P+ R +AE+V
Sbjct: 222 IKDQQVKLFKPQLELPYSERWYEVLQFCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 30/76 (39%), Positives = 41/76 (53%), Gaps = 10/76 (13%)
Query: 478 KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-----LRP 532
K + + + + L LH IVHRDIKPENLLV + G VK++ DFG A + P
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKII---DFGAAVDMCTGINFNP 367
Query: 533 MFTVCGTPTYVAPEIL 548
++ + P Y PE L
Sbjct: 368 LYGML-DPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 10/99 (10%)
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-PMFTVCGTP-- 540
+A + +L +HRD+ N+L+ + V+K+ DFGLA+ + + P + G
Sbjct: 182 VARGMEFLASRKCIHRDLAARNILLSEN----NVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 541 --TYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPF 576
++APE + + Y + DVW+ GV+L+ I G P+
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 31/108 (28%), Positives = 54/108 (50%), Gaps = 10/108 (9%)
Query: 475 EDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM- 533
ED + +A +S+L +HRD+ N+L+ H ++ K+ DFGLA+ +
Sbjct: 214 EDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICDFGLARDIRNDSN 269
Query: 534 FTVCGTP----TYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPF 576
+ V G ++APE + Y + DVW+ G++L+ I G P+
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 38/128 (29%), Positives = 54/128 (42%), Gaps = 26/128 (20%)
Query: 477 SKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKV--------LKVG------D 522
M Q L AL LH IVHRD+KP+N++ K+ L+VG +
Sbjct: 258 QTIMRQIL-FALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKE 316
Query: 523 FGLAQRVLRPMFTVCGTPTYVAPE---------ILNESGYGVKIDVWAAGVILYILLCGF 573
F L R P + T T AP +L + + D+++AG+I L F
Sbjct: 317 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF--LQMAF 374
Query: 574 PPFVSDTN 581
P SD+N
Sbjct: 375 PNLRSDSN 382
|
Length = 566 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 17/134 (12%)
Query: 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNII- 438
S +++ G V + K +D LKI K E EV IL+ + +
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDY--VLKINPSR---EKGADREREVAILQLLARKGLPV 55
Query: 439 -KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH--DNY 495
K+L +++ YL++E I+G L + SEE+ + + + LA L+ LH
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETLD-------EVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 496 -IVHRDIKPENLLV 508
+ H D+ P N+LV
Sbjct: 109 VLCHGDLHPGNILV 122
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 639 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0612|consensus | 1317 | 100.0 | ||
| KOG3757|consensus | 301 | 100.0 | ||
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| KOG1989|consensus | 738 | 100.0 | ||
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| KOG0983|consensus | 391 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027|consensus | 903 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG0200|consensus | 609 | 99.97 | ||
| KOG0665|consensus | 369 | 99.97 | ||
| KOG2052|consensus | 513 | 99.97 | ||
| KOG0664|consensus | 449 | 99.97 | ||
| KOG3653|consensus | 534 | 99.97 | ||
| KOG1152|consensus | 772 | 99.97 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0576|consensus | 829 | 99.97 | ||
| KOG1025|consensus | 1177 | 99.97 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167|consensus | 418 | 99.96 | ||
| KOG0984|consensus | 282 | 99.96 | ||
| KOG1345|consensus | 378 | 99.96 | ||
| smart00537 | 89 | DCX Domain in the Doublecortin (DCX) gene product. | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1024|consensus | 563 | 99.95 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| cd01617 | 80 | DCX Ubiquitin-like domain of DCX. DCX The ubiquiti | 99.93 | |
| KOG1164|consensus | 322 | 99.93 | ||
| KOG0590|consensus | 601 | 99.93 | ||
| KOG0603|consensus | 612 | 99.92 | ||
| KOG1165|consensus | 449 | 99.91 | ||
| KOG1163|consensus | 341 | 99.91 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0606|consensus | 1205 | 99.88 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG1240|consensus | 1431 | 99.86 | ||
| KOG0195|consensus | 448 | 99.86 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG4158|consensus | 598 | 99.85 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| smart00537 | 89 | DCX Domain in the Doublecortin (DCX) gene product. | 99.8 | |
| PF03607 | 60 | DCX: Doublecortin; InterPro: IPR003533 X-linked li | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| cd01617 | 80 | DCX Ubiquitin-like domain of DCX. DCX The ubiquiti | 99.78 | |
| KOG1166|consensus | 974 | 99.77 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1033|consensus | 516 | 99.73 | ||
| KOG1023|consensus | 484 | 99.73 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG0590|consensus | 601 | 99.71 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0606|consensus | 1205 | 99.58 | ||
| PF03607 | 60 | DCX: Doublecortin; InterPro: IPR003533 X-linked li | 99.56 | |
| KOG0601|consensus | 524 | 99.52 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| KOG1243|consensus | 690 | 99.34 | ||
| KOG0601|consensus | 524 | 99.34 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG3757|consensus | 301 | 99.31 | ||
| KOG1266|consensus | 458 | 99.25 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG2137|consensus | 700 | 99.02 | ||
| KOG3087|consensus | 229 | 98.99 | ||
| KOG3741|consensus | 655 | 98.89 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.59 | |
| KOG0576|consensus | 829 | 98.53 | ||
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.39 | |
| KOG1035|consensus | 1351 | 98.38 | ||
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.12 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.12 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.08 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.86 | |
| KOG1235|consensus | 538 | 97.72 | ||
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.71 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.6 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.54 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.5 | |
| KOG1826|consensus | 2724 | 97.45 | ||
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.44 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.21 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.11 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.94 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.94 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.87 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.82 | |
| KOG2268|consensus | 465 | 96.77 | ||
| KOG2270|consensus | 520 | 96.65 | ||
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.56 | |
| PF11834 | 69 | DUF3354: Domain of unknown function (DUF3354); Int | 96.5 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.47 | |
| KOG1093|consensus | 725 | 96.39 | ||
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.23 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.18 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.07 | |
| PLN02236 | 344 | choline kinase | 95.91 | |
| PF11834 | 69 | DUF3354: Domain of unknown function (DUF3354); Int | 95.81 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.68 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.21 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.9 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-56 Score=461.20 Aligned_cols=267 Identities=39% Similarity=0.755 Sum_probs=240.2
Q ss_pred CCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh------HHHHHHHHHHHHhcCCCceeeeeee
Q psy6820 370 NIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK------KQMIENEVNILRSVNHPNIIKLLDE 443 (639)
Q Consensus 370 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~------~~~~~~Ei~iL~~l~HpnIv~l~~~ 443 (639)
..|....+.|.+.+.||+|+||.|.+|..+.+++.||||++++...... ...+.+|+++|++|+|||||+++++
T Consensus 165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred CccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 3445566889999999999999999999999999999999988776542 2345799999999999999999999
Q ss_pred eecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 444 YDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 444 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
|+.++..||||||++||+|++.+-.++.+.+...+.+++|++.|+.|||+.||+||||||+|||+..+..+ -.+||+||
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~-~llKItDF 323 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAED-CLLKITDF 323 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcc-eEEEeccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999877422 38999999
Q ss_pred ccccccc--CCCccccCCCcccCccccccCCC---ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy6820 524 GLAQRVL--RPMFTVCGTPTYVAPEILNESGY---GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598 (639)
Q Consensus 524 Gla~~~~--~~~~~~~GT~~Y~APE~l~~~~~---s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p 598 (639)
|+|+... .-+.+.||||.|.|||++.+.++ ..++|+|||||+||.++||.+||..... ...+.++|..+.+.+-
T Consensus 324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-DPSLKEQILKGRYAFG 402 (475)
T ss_pred chhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-CccHHHHHhcCccccc
Confidence 9999884 44779999999999999976543 4488999999999999999999965433 2347899999999999
Q ss_pred CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 599 SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 599 ~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++.|..+++++.+||.+||..||++|||++|+|+||||+.
T Consensus 403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 403 PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 9999999999999999999999999999999999999984
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=459.72 Aligned_cols=252 Identities=37% Similarity=0.715 Sum_probs=236.8
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.+|+.++.||+|||+.+|.+++..+|+.||+|++.+..+.. ..+.+.+|++|.+.|+|||||+++++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999998765543 3467889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---C
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---R 531 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---~ 531 (639)
|+|..++|..++++...++|.+++.++.||+.||.|||+++|+|||||..|+|++.+. +|||+|||+|+... +
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~----~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM----NVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC----cEEecccceeeeecCccc
Confidence 9999999999999999999999999999999999999999999999999999999886 89999999999887 4
Q ss_pred CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
...+.||||.|+|||++...+++..+||||+||+||.||+|++||. +.+..+.++.|...++.+|. .++.++++
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe--tk~vkety~~Ik~~~Y~~P~----~ls~~A~d 247 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE--TKTVKETYNKIKLNEYSMPS----HLSAEAKD 247 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc--cchHHHHHHHHHhcCccccc----ccCHHHHH
Confidence 4679999999999999999999999999999999999999999995 44678999999999998884 79999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
||.+||++||.+|||+++||.|+||.+
T Consensus 248 LI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 248 LIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 999999999999999999999999954
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-53 Score=435.95 Aligned_cols=254 Identities=38% Similarity=0.736 Sum_probs=234.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.++|+++++||+|+||+||.++.+++++.||+|++++..+... .....+|..||.+++||+||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 5789999999999999999999999999999999998877655 45678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--- 530 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~--- 530 (639)
+||+.||+|+.+|++++.|++..++.++.+|+.||.|||++|||||||||+|||+|.+| +++|+|||+++...
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G----Hi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG----HIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC----cEEEeccccchhcccCC
Confidence 99999999999999999999999999999999999999999999999999999999999 99999999998654
Q ss_pred CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 531 RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 531 ~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
....++|||+.|||||++.+.+|+..+||||||+++|||++|.+||.+ .+...+++.|..+....++ .-++.+++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~--~~~~~~~~~I~~~k~~~~p---~~ls~~ar 254 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA--EDVKKMYDKILKGKLPLPP---GYLSEEAR 254 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC--ccHHHHHHHHhcCcCCCCC---ccCCHHHH
Confidence 346678999999999999999999999999999999999999999965 4667888999988754443 34799999
Q ss_pred HHHHHhcccCCCCCC----CHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRF----SAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rp----ta~eiL~HP~f~~ 638 (639)
+|++++|..||++|. ++.+|-+||||.+
T Consensus 255 dll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 999999999999997 6899999999974
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-53 Score=422.41 Aligned_cols=254 Identities=39% Similarity=0.781 Sum_probs=239.4
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.+++|++.+.||.|+||.|.+++.+.++..||+|++++.....-+ +...+|..+|+.+.||+++++++.|.+.+.+||
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 357899999999999999999999999999999999987765443 456789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||++||.|+.++++.++|++..+++++.+|+.||+|||+++|++|||||+|||+|.+| .+||+|||+|+.+...
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G----~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG----HIKITDFGFAKRVSGR 197 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC----cEEEEeccceEEecCc
Confidence 999999999999999999999999999999999999999999999999999999999999 8999999999999999
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
..+.||||.|+|||++...+|+.++|+|||||++|||++|.+||.... ...+++.|+.+.+.+| +.+++++++|
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~--~~~iY~KI~~~~v~fP----~~fs~~~kdL 271 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN--PIQIYEKILEGKVKFP----SYFSSDAKDL 271 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC--hHHHHHHHHhCcccCC----cccCHHHHHH
Confidence 999999999999999999999999999999999999999999997654 4889999999999998 4789999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 613 ISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 613 I~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
|.++|+.|-.+|. ...+|.+||||..
T Consensus 272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999999995 5789999999974
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-52 Score=425.35 Aligned_cols=255 Identities=31% Similarity=0.486 Sum_probs=230.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCc-eEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNE-LYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-~~lV~E 455 (639)
.+.+.++.||+|+.|+||+|+++.+++.+|+|++...........+.+|+++++.++||+||.+||.|..+.. .+|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 4566788999999999999999999999999999766666667788999999999999999999999999984 999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-C
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-M 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-~ 533 (639)
||.+|||.+++...+++++.....++.++++||.|||+ ++||||||||+||||+..| .|||||||.+....+. .
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG----eVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG----EVKICDFGVSGILVNSIA 234 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC----CEEeccccccHHhhhhhc
Confidence 99999999999998999999999999999999999995 9999999999999999998 8999999999887655 4
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC---CCChHHHHHHHHcCCCCCCCCCcc-cccHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSD---TNDQDELFDDILSGQYGFPSPYWD-DISEEA 609 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~---~~~~~~l~~~i~~~~~~~p~~~~~-~l~~~l 609 (639)
.+++||..|||||.+.+..|+.++||||||++++|+++|+.||... ..+.-+++..|..+. |+.... .+++++
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p---pP~lP~~~fS~ef 311 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP---PPRLPEGEFSPEF 311 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC---CCCCCcccCCHHH
Confidence 7899999999999999999999999999999999999999999775 235566777777753 222234 489999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+++|..||++||.+||++.|+++|||+++
T Consensus 312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 312 RSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 99999999999999999999999999975
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=429.92 Aligned_cols=256 Identities=35% Similarity=0.674 Sum_probs=235.0
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHHHhc-CCCceeeeeeeeecCCc
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSV-NHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 449 (639)
.....+|.+++.||+|+|++|++|+++.+++.||||++.+..+.... ..+..|-.+|.+| .||.|++|+..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567899999999999999999999999999999999877654332 4577899999999 69999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
+|+|+||+++|+|.++|++.+.|++..++.++.+|+.||+|||++|||||||||+|||+|.++ ++||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm----hikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG----HIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC----cEEEeeccccccC
Confidence 999999999999999999999999999999999999999999999999999999999999998 8999999999765
Q ss_pred cC----------------CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC
Q psy6820 530 LR----------------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG 593 (639)
Q Consensus 530 ~~----------------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~ 593 (639)
.. ...+++||..|++||++..+..+..+|+|+|||+||+|+.|.+||.+ .++..+++.|+.-
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra--~NeyliFqkI~~l 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA--ANEYLIFQKIQAL 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc--ccHHHHHHHHHHh
Confidence 31 11458999999999999999999999999999999999999999965 4678899999999
Q ss_pred CCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 QYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 ~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+.+| +..++.++|||+++|..||.+|+|+++|.+||||.+
T Consensus 303 ~y~fp----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 303 DYEFP----EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred cccCC----CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 99888 478899999999999999999999999999999974
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=428.14 Aligned_cols=257 Identities=34% Similarity=0.663 Sum_probs=233.3
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
-.++|+++++||+|+||.||+|+.+.+|..||+|+++++.+.... +-+..|-.+|....+|+||+|+..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 358899999999999999999999999999999999998876544 346789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
||||++||++..+|.+.+.|++..+++++.+++.|++-||+.|+|||||||+|+|||..| ++||+||||++....
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G----HiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG----HIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC----CEeeccccccchhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999 999999999842200
Q ss_pred ------------------------C-------------------------CccccCCCcccCccccccCCCChhhhHHHH
Q psy6820 532 ------------------------P-------------------------MFTVCGTPTYVAPEILNESGYGVKIDVWAA 562 (639)
Q Consensus 532 ------------------------~-------------------------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSL 562 (639)
+ .+..+|||.|||||++.+.+|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 123579999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCC---HHHHHcCCcccC
Q psy6820 563 GVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFS---AEDVLDHPWLER 638 (639)
Q Consensus 563 GvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpt---a~eiL~HP~f~~ 638 (639)
|||+||||.|.+||.+. +..+.++.|.++...+..|....++++++|||.+||. ||++|.. ++||.+||||++
T Consensus 375 G~ImyEmLvGyPPF~s~--tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSE--TPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 99999999999999664 5688999999998666655557889999999999999 9999995 999999999975
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=419.98 Aligned_cols=255 Identities=40% Similarity=0.769 Sum_probs=232.6
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc----hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCC
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL----GKKQMIENEVNILRSVN-HPNIIKLLDEYDTNN 448 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~----~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 448 (639)
...++|.+++.||+|+||+|+.|.+..++..||+|++++.... ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567999999999999999999999999999999988775222 23456778999999999 999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccC-CceeeeEEEeeccccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMS-GCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~-g~~~~~vKL~DFGla~ 527 (639)
.+|+||||+.||+|++++.+.+++.+.+++.+++||+.|++|||++||+||||||+|||++.+ + .+||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~----~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEG----NLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC----CEEEecccccc
Confidence 999999999999999999999999999999999999999999999999999999999999998 6 89999999998
Q ss_pred ccc---CCCccccCCCcccCccccccCC-CC-hhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCc
Q psy6820 528 RVL---RPMFTVCGTPTYVAPEILNESG-YG-VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 528 ~~~---~~~~~~~GT~~Y~APE~l~~~~-~s-~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
... ....+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.. .+...++..|..+.+.+|.
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--~~~~~l~~ki~~~~~~~p~--- 244 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--SNVPNLYRKIRKGEFKIPS--- 244 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--ccHHHHHHHHhcCCccCCC---
Confidence 772 4467899999999999999977 85 899999999999999999999965 5667788889999888874
Q ss_pred ccc-cHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 603 DDI-SEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 603 ~~l-~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+ ++++++|+.+||+.||.+|+++.+|++||||+.
T Consensus 245 -~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 245 -YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 45 999999999999999999999999999999985
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=430.02 Aligned_cols=253 Identities=34% Similarity=0.647 Sum_probs=232.1
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHHHhcC-CCceeeeeeeeecCCceE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVN-HPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 451 (639)
.+++|.+.++||+|+||+|+++..+.+++.||||++++..+.... +....|.+|+.... ||.++.++.+|++.+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 458899999999999999999999999999999999998876544 45677888888776 999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc-
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL- 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~- 530 (639)
+||||+.||++ .++++.+.|++..++.|+.+++.||.|||++||||||||.+|||+|.+| ++||+|||+++...
T Consensus 446 fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG----h~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 446 FVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG----HVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC----cEEecccccccccCC
Confidence 99999999994 4455667899999999999999999999999999999999999999999 99999999998765
Q ss_pred --CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 --RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 --~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
..+.++||||.|||||++.+..|+.++|||||||+||||+.|+.||.++ +++++++.|++.++.+| ..++.+
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee~FdsI~~d~~~yP----~~ls~e 594 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEEEVFDSIVNDEVRYP----RFLSKE 594 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCCCCC----CcccHH
Confidence 4567899999999999999999999999999999999999999999654 67899999999988777 579999
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
+.++++++|.++|++|+. +++|..||||+.
T Consensus 595 a~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 595 AIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 999999999999999995 689999999974
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-49 Score=406.11 Aligned_cols=262 Identities=38% Similarity=0.665 Sum_probs=232.8
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
....+|.+.+.||.|+||+||+|+++.++..||||.+.+..... ..+.+..|+.+|+.++|||||.++++++.++.+||
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 34678999999999999999999999999999999998876433 34667899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccC-Cce-eeeEEEeecccccccc
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMS-GCH-VKVLKVGDFGLAQRVL 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~-g~~-~~~vKL~DFGla~~~~ 530 (639)
|||||.||||.++|++.+.+++..++.++.||+.||++||+++||||||||+||||+.. +.+ ...+||+|||+|+...
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999876 321 1589999999999876
Q ss_pred CC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 RP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 ~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
.. ..+.||+|-|||||++....|+.|+|+||+|++||+|++|..||.. ....+++..+..+....|. ....++..
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a--~t~~eL~~~~~k~~~~~~~-~~~~~s~~ 243 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA--ETPKELLLYIKKGNEIVPV-LPAELSNP 243 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc--cCHHHHHHHHhccccccCc-hhhhccCc
Confidence 44 3578999999999999999999999999999999999999999954 4567788888777644432 23467788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+|+...|+.+|..|.+..+-+.||++..
T Consensus 244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 244 LRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred hhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 889999999999999999999999999864
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=421.42 Aligned_cols=254 Identities=35% Similarity=0.671 Sum_probs=234.1
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL--LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..+-|++++.||.|+-|.|.+|++..+|+.+|||++.+... ......+++|+.||+.+.|||++++|++|++..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 34668999999999999999999999999999999987632 2223568999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|.||++||.|++++-+.+++++.++..+++||+.|+.|+|..+|+||||||+|+|+|..+ .+||+|||+|......
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~----nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN----NIKIADFGMASLEVPG 165 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc----CEeeeccceeecccCC
Confidence 999999999999999999999999999999999999999999999999999999999987 6999999999765432
Q ss_pred --CccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
..+.||+|.|.|||++.|..| +.++||||.|||||.||||.+||. +.+...++..+..|.+..| ..++.++
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--DdNir~LLlKV~~G~f~MP----s~Is~ea 239 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--DDNIRVLLLKVQRGVFEMP----SNISSEA 239 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--CccHHHHHHHHHcCcccCC----CcCCHHH
Confidence 468999999999999999988 689999999999999999999995 5577889999999999888 5899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++||.+||..||++|+|.+||+.|||+.+
T Consensus 240 QdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 240 QDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred HHHHHHHhccCccccccHHHHhhCchhhc
Confidence 99999999999999999999999999975
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=394.96 Aligned_cols=255 Identities=35% Similarity=0.674 Sum_probs=237.5
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHH--HHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~--~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
..+++|..+++||+|.||+|-+|+.+.+++.||+|++++..+..+.+. -..|-++|+..+||.+..+-..|+..+++|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 356889999999999999999999999999999999998887666544 346999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc-
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL- 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~- 530 (639)
+||||+.||.|+.+|++.+.|++..++++..+|+.||.|||+++||+||||.+|+|+|.+| ++||+|||+++...
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG----HIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG----HIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC----ceEeeecccchhccc
Confidence 9999999999999999999999999999999999999999999999999999999999999 89999999997653
Q ss_pred --CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 --RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 --~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
..+.++||||.|+|||++....|+.++|+|.+||++|||+||++||+. .+.+.+++.|+.+.+.+| ..++++
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn--~dh~kLFeLIl~ed~kFP----r~ls~e 394 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN--KDHEKLFELILMEDLKFP----RTLSPE 394 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc--cchhHHHHHHHhhhccCC----ccCCHH
Confidence 457789999999999999999999999999999999999999999965 467899999999999998 478999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
++.|+..+|.+||++|. .+.||.+|+||..
T Consensus 395 AktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 395 AKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 99999999999999999 4899999999963
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=387.36 Aligned_cols=261 Identities=43% Similarity=0.774 Sum_probs=237.8
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
+.++|.+.+.||+|.|+.||++.+..+|+.+|+|++....+.. .-+.+++|+.|.+.|+|||||++.+.+.+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3467899999999999999999999999999999997665543 346789999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
+|+|.|++|..-|-....+++..+-.+++||++||.|+|.+||||||+||+|+|+-..... .-+||+|||+|..+...
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~-A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKG-AAVKLADFGLAIEVNDGE 167 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCC-CceeecccceEEEeCCcc
Confidence 9999999998777666789999999999999999999999999999999999999655322 36999999999887633
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....|||.|||||++...+|+..+|||+-||+||.|+.|++||. ..++..+++.|..+.+.++.++|+.+++++++
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~--~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW--DEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC--CccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 345789999999999999999999999999999999999999995 45788999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
|+++||..||++|.|+.|+|+|||+.+
T Consensus 246 LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHhccChhhhccHHHHhCCchhcc
Confidence 999999999999999999999999976
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=406.20 Aligned_cols=263 Identities=43% Similarity=0.783 Sum_probs=242.1
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHHHhcC-CCceeeeeeeeecCCc
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVN-HPNIIKLLDEYDTNNE 449 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 449 (639)
......|++.+.||.|.||.||.|..+.+|+.+|+|++.+....+.. +.+.+|+.+|+++. |||||.++++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 45567899999999999999999999999999999999888776544 67899999999999 9999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
+++|||+|.||+|++.+.+. .+++..+..++.|++.|++|||+.|++||||||+|+|+.........+|++|||++...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999776 49999999999999999999999999999999999999766432347999999999887
Q ss_pred cC--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 530 LR--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 530 ~~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.. .....|||+.|+|||++....|+..+||||+|+++|.|++|.+||.+. .....+..+..+.+.++.+.|+.++.
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~--~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE--TEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC--ChhHHHHHHHcCCCCCCCCCccccCH
Confidence 65 456789999999999999999999999999999999999999999765 44567779999999999999999999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.++++|+.||..||.+|+|+.++|+|||++.
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKS 298 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence 9999999999999999999999999999975
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=372.02 Aligned_cols=254 Identities=34% Similarity=0.652 Sum_probs=236.1
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.+++|++++.||+|.||.||+|+.+.++-.+|+|++.++.+... ...+.+|++|.+.|+||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 35789999999999999999999999999999999988776433 4678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 453 VIELIKGGDLFDAIS--KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~--~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
++||.++|+|+..|+ ...++++..+..++.|++.||.|+|.+++|||||||+|+|++..+ .+||+|||.+....
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~----~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG----ELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC----CeeccCCCceeecC
Confidence 999999999999998 667899999999999999999999999999999999999999988 89999999997764
Q ss_pred -CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 531 -RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 531 -~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
+...+.|||..|.+||...+..++..+|+|++|++.||++.|.+||.... ..+.++.|....+.+| +.++.++
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~~~~~p----~~is~~a 249 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKVDLKFP----STISGGA 249 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHccccCC----cccChhH
Confidence 45678999999999999999999999999999999999999999997654 7889999999988888 5789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.|||.+||.++|.+|.+..|+++|||+..
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=388.85 Aligned_cols=252 Identities=34% Similarity=0.689 Sum_probs=226.8
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4789999999999999999999999999999999754332 22356788999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~ 534 (639)
||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~----~~kl~Dfg~~~~~~~~~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG----HIKLTDFGFAKKLRDRTW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC----CEEEEecCcchhccCCcc
Confidence 9999999999998888999999999999999999999999999999999999999887 799999999987766666
Q ss_pred cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHH
Q psy6820 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~ 614 (639)
..+||+.|+|||++.+..++.++|||||||++|+|++|..||... ....+++.+..+...++ ..++..+++||+
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 230 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD--NPFGIYEKILAGKLEFP----RHLDLYAKDLIK 230 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCcCCC----ccCCHHHHHHHH
Confidence 778999999999999999999999999999999999999999653 45667777777766555 356899999999
Q ss_pred HhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 615 HMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 615 ~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
+||+.||.+||+ ++++++||||+.
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 999999999995 999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=395.56 Aligned_cols=254 Identities=35% Similarity=0.717 Sum_probs=228.8
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..++|.+.+.||+|+||.||+|.++.+++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 357899999999999999999999999999999999765432 223567899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG----HVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC----CEEEeeccCceEcCCC
Confidence 999999999999999888999999999999999999999999999999999999999887 8999999999877666
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||... .....++.+..+...+| ..++..+++|
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~~p----~~~~~~~~~l 245 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD--TPFRIYEKILAGRLKFP----NWFDGRARDL 245 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCcCCC----CCCCHHHHHH
Confidence 66788999999999999999999999999999999999999999643 45566777777765554 3578999999
Q ss_pred HHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 613 ISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 613 I~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
|.+||+.||++||+ ++++++||||.+
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999999997 799999999975
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=403.13 Aligned_cols=251 Identities=37% Similarity=0.641 Sum_probs=230.4
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH-HHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~-~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.....++ ..+.+|++|++.++||||+.++++|++..++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5788999999999999999999999999999999887665433 568899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC--
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-- 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~-- 533 (639)
|+.| +|+.+|...+.++++.++.++.+++.||.|||+.+|+|||+||.|||++.++ ++|+||||+|+......
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~----~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG----TLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC----ceeechhhhhhhcccCcee
Confidence 9976 9999999999999999999999999999999999999999999999999998 89999999998876543
Q ss_pred -ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 534 -FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 534 -~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
....|||.|||||.+.+.+|+..+|+|||||++|||+.|++||... ...++.+.|..+...+| ..++.++.++
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--si~~Lv~~I~~d~v~~p----~~~S~~f~nf 230 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--SITQLVKSILKDPVKPP----STASSSFVNF 230 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--HHHHHHHHHhcCCCCCc----ccccHHHHHH
Confidence 3467999999999999999999999999999999999999999654 45677788888766655 4789999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 613 ISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++.+|.+||.+|.|-.+++.|||+++
T Consensus 231 l~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 231 LQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHHHhhcChhhcccHHHHhcChHHhh
Confidence 99999999999999999999999874
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=375.24 Aligned_cols=257 Identities=39% Similarity=0.731 Sum_probs=232.6
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc----hh---HHHHHHHHHHHHhcC-CCceeeeeeeeec
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL----GK---KQMIENEVNILRSVN-HPNIIKLLDEYDT 446 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~----~~---~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 446 (639)
....|.-.+.||.|..++|.+|..+.++..+|+|++...... .. .+.-.+|+.||+++. ||+|+++.++|++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345677788999999999999999999999999998643221 11 234567999999996 9999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 447 NNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
+..+++|+|.|+.|.|+|+|.+.-.+++..++.+++|+.+|++|||.++||||||||+|||+|++. .+||+|||+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~----~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM----NIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc----ceEEecccee
Confidence 999999999999999999999988999999999999999999999999999999999999999887 8999999999
Q ss_pred ccccC--CCccccCCCcccCccccc------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy6820 527 QRVLR--PMFTVCGTPTYVAPEILN------ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598 (639)
Q Consensus 527 ~~~~~--~~~~~~GT~~Y~APE~l~------~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p 598 (639)
+.... .....||||+|+|||.+. ..+|+..+|+|++||+||-|+.|.+||.. ..+.-+.+.|..|.+.+.
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--RkQmlMLR~ImeGkyqF~ 248 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--RKQMLMLRMIMEGKYQFR 248 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--HHHHHHHHHHHhcccccC
Confidence 98864 356789999999999984 35789999999999999999999999954 356778899999999999
Q ss_pred CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 599 SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 599 ~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
++-|.+++...+|||.+||+.||.+|.|++|+|+||||.
T Consensus 249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 999999999999999999999999999999999999994
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=389.81 Aligned_cols=254 Identities=31% Similarity=0.558 Sum_probs=214.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC--ceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN--ELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~lV~ 454 (639)
.+|..++.||+|+||.||++....++..+|+|.+....... .+.+++|+.+|++++|||||+++|...... .++++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 46778899999999999999999999999999998763322 566889999999999999999999754444 699999
Q ss_pred eeccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEcc-CCceeeeEEEeeccccccccC-
Q psy6820 455 ELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM-SGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~-~g~~~~~vKL~DFGla~~~~~- 531 (639)
||+++|+|.+++.+.+ .+++..++.+++||++||+|||++|||||||||+|||++. ++ .+||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~----~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG----DVKLADFGLAKKLESK 171 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC----eEEeccCccccccccc
Confidence 9999999999998876 8999999999999999999999999999999999999999 56 799999999976652
Q ss_pred -----CCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 532 -----PMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 532 -----~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
......||+.|||||++..+ ..+.++|||||||++.||+||..||.......+.++ .+.... ..| .+...+
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~-~ig~~~-~~P-~ip~~l 248 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALL-LIGRED-SLP-EIPDSL 248 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHH-HHhccC-CCC-CCCccc
Confidence 23457899999999999963 334599999999999999999999965311223333 333332 222 445679
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+++++|.+|++.||++||||+++|+|||.++
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 999999999999999999999999999999865
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=375.80 Aligned_cols=256 Identities=29% Similarity=0.510 Sum_probs=215.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
+.|+.+.++|+|+||.||+|+++.+|+.||||.+..+.. ..-+.-..+|+.+|++++|||+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 578888999999999999999999999999999875543 2234456799999999999999999999999999999999
Q ss_pred eccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 456 LIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
||+. ++.+-|.+ ...++.+.++.++.|++.|+.|+|++++|||||||+||||..+| .+||||||+|+....+
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g----vvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG----VVKLCDFGFARTLSAPGD 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC----cEEeccchhhHhhcCCcc
Confidence 9976 55555544 45689999999999999999999999999999999999999998 9999999999887643
Q ss_pred -CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc-------------CC---
Q psy6820 533 -MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS-------------GQ--- 594 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~-------------~~--- 594 (639)
.+.++.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+.|.+.+ +.++++..... ..
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S-DiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS-DIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc-hHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 345788999999999876 789999999999999999999999998765 44444332221 11
Q ss_pred --CCCCCC--------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 595 --YGFPSP--------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 595 --~~~p~~--------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+|.+ .+++++.-+.||+++||+.||++|++.+|+|.||||++
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 112211 23457888999999999999999999999999999963
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=385.75 Aligned_cols=256 Identities=33% Similarity=0.572 Sum_probs=228.7
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
-++.|++++.||.|.-|+||+|+.+.++..+|+|++.+..+.... .+.+.|.+||+.++||.++.||+.|+.++..|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 357799999999999999999999999999999999988765433 456679999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 453 VIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+||||+||+|..+++++ +.|+++.+++++.+++.||+|||-.|||+|||||+||||..+| ++.|+||.++....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG----HIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG----HIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC----cEEeeeccccccCC
Confidence 99999999999999775 5699999999999999999999999999999999999999999 89999999873210
Q ss_pred ------------------------------------C-------------------C----CccccCCCcccCccccccC
Q psy6820 531 ------------------------------------R-------------------P----MFTVCGTPTYVAPEILNES 551 (639)
Q Consensus 531 ------------------------------------~-------------------~----~~~~~GT~~Y~APE~l~~~ 551 (639)
. + ...++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0135689999999999999
Q ss_pred CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCC----H
Q psy6820 552 GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFS----A 627 (639)
Q Consensus 552 ~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpt----a 627 (639)
+.+.++|||+|||+||||+.|..||.+.+ .++.+..|+.....+|.. +.++..++|||+++|.+||.+|.. |
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~--~~~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSN--NKETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCC--chhhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhccccch
Confidence 99999999999999999999999997654 466778888888888764 478899999999999999999998 9
Q ss_pred HHHHcCCcccC
Q psy6820 628 EDVLDHPWLER 638 (639)
Q Consensus 628 ~eiL~HP~f~~ 638 (639)
+||.+||||++
T Consensus 387 ~eIK~HpFF~g 397 (459)
T KOG0610|consen 387 AEIKRHPFFEG 397 (459)
T ss_pred HHhhcCccccC
Confidence 99999999985
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=400.50 Aligned_cols=256 Identities=30% Similarity=0.574 Sum_probs=228.0
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..-...|.....||+|+.|.||.|+...+++.||||.+..... ..++.+.+|+.+|+..+|+|||.+++.|...+.+|+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 3445678889999999999999999999999999999987653 446778899999999999999999999988899999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
|||||+||+|.+.+... .+++.++..++++++.||+|||.+||+|||||.+|||+..+| .+||+|||++..+..
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g----~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG----SVKLTDFGFCAQISEE 422 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC----cEEEeeeeeeeccccc
Confidence 99999999999998654 599999999999999999999999999999999999999998 799999999987753
Q ss_pred --CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 --PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 --~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
...+.+|||+|||||++....|++++||||||++.+||+-|++||.... ...+++....++.+.+. .+..+++++
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-PlrAlyLIa~ng~P~lk--~~~klS~~~ 499 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-PLRALYLIATNGTPKLK--NPEKLSPEL 499 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-hHHHHHHHhhcCCCCcC--CccccCHHH
Confidence 3468899999999999999999999999999999999999999997533 34455555555554443 457899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
++++.+||+.|+++|++|.|+|+||||+
T Consensus 500 kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 500 KDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred HHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 9999999999999999999999999995
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=394.52 Aligned_cols=258 Identities=33% Similarity=0.528 Sum_probs=219.6
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCC-ceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNN-ELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~-~~~l 452 (639)
+.++|.+.+.||.|+||.||+|..+.++..||||.+++.-....+-.-.+|+..|++|+ ||||++|.+++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45789999999999999999999999999999999876655444445568999999999 999999999998888 9999
Q ss_pred EEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc-
Q psy6820 453 VIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL- 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~- 530 (639)
|||||+ .+|+++++. +..|++..++.|+.||++||+|+|.+|+.|||+||+|||+..+. .+||+|||+|+...
T Consensus 88 VfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~----~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND----VIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc----eeEeccccccccccc
Confidence 999994 599999965 45699999999999999999999999999999999999998654 89999999999875
Q ss_pred -CCCccccCCCcccCccccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHH------------------
Q psy6820 531 -RPMFTVCGTPTYVAPEILN-ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDI------------------ 590 (639)
Q Consensus 531 -~~~~~~~GT~~Y~APE~l~-~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i------------------ 590 (639)
.+.+.++.|.+|+|||++. .+.|+.+.||||+|||++|+++-++.|.+.+ +.+++++..
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s-E~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS-EIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc-HHHHHHHHHHHhCCCccccchhHHHHH
Confidence 4566789999999999975 5678999999999999999999999997654 333333221
Q ss_pred HcCCCCCCCC-------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 591 LSGQYGFPSP-------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 591 ~~~~~~~p~~-------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
....+.+|.- ..+..+.++.+||.+||.+||++||||+|+|+||||+-
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 1122333321 12347899999999999999999999999999999985
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=391.87 Aligned_cols=255 Identities=31% Similarity=0.577 Sum_probs=218.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++.+.||+|+||+||+|.+..+++.||+|++.+..... ....+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997654322 2345778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~----~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG----HVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC----CEEEeeccCccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999887 8999999998643211
Q ss_pred ------------------------------------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCC
Q psy6820 533 ------------------------------------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPF 576 (639)
Q Consensus 533 ------------------------------------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf 576 (639)
....+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 12458999999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCC---CCCCHHHHHcCCcccC
Q psy6820 577 VSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPD---LRFSAEDVLDHPWLER 638 (639)
Q Consensus 577 ~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~---~Rpta~eiL~HP~f~~ 638 (639)
... ...+.+..+......+..+....+++++++||.+|+. +|+ .||+++||++||||++
T Consensus 237 ~~~--~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 237 CSE--TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CCC--CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 653 4456667776643332222234578999999999775 444 4689999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=377.01 Aligned_cols=244 Identities=33% Similarity=0.543 Sum_probs=216.1
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh-HHHHHHHHHHHHhcCCCceeeeee-eeecCCc-eE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHPNIIKLLD-EYDTNNE-LY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~~-~~~~~~~-~~ 451 (639)
.+.+|.+.+.||+|+||+||++.+..+++.+|.|.++-..+..+ .+.+..|+.+|++|+|||||++++ .+.++.. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 35679999999999999999999999999999999986655544 366889999999999999999999 5555555 99
Q ss_pred EEEeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 452 LVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHD--NY--IVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~--~g--ivHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
||||||.+|+|...++. ...+++..++.++.|++.||.++|+ .+ |+||||||.||+++.+| .+||+||
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g----vvKLGDf 172 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG----VVKLGDF 172 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC----ceeeccc
Confidence 99999999999999853 4579999999999999999999999 45 99999999999999998 9999999
Q ss_pred cccccccCCC---ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC-CCC
Q psy6820 524 GLAQRVLRPM---FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG-FPS 599 (639)
Q Consensus 524 Gla~~~~~~~---~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~-~p~ 599 (639)
|+++...+.. .+.+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.++ +...+-+.|.++++. +|.
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCCCCCcH
Confidence 9998887553 4689999999999999999999999999999999999999999876 677888899998653 222
Q ss_pred CCcccccHHHHHHHHHhcccCCCCCCCH
Q psy6820 600 PYWDDISEEAKELISHMLESNPDLRFSA 627 (639)
Q Consensus 600 ~~~~~l~~~l~dLI~~~L~~dP~~Rpta 627 (639)
.-.|.++..||..|+..||+.||+.
T Consensus 251 ---~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 ---EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ---HHhhhHHHHHHHHHccCCcccCCCc
Confidence 4578999999999999999999984
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=388.77 Aligned_cols=246 Identities=35% Similarity=0.689 Sum_probs=218.9
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
+.||+|+||.||+|.+..+++.||+|++.+..... ....+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997654322 2245678999999999999999999999999999999999999
Q ss_pred ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---CCCcccc
Q psy6820 461 DLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTVC 537 (639)
Q Consensus 461 sL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---~~~~~~~ 537 (639)
+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... ......+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~----~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC----CEEEeeCCCCcccccCCCccccee
Confidence 9999998888999999999999999999999999999999999999999887 79999999987543 2234568
Q ss_pred CCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhc
Q psy6820 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617 (639)
Q Consensus 538 GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L 617 (639)
||+.|+|||++.+..++.++|||||||++|||++|..||.. .+...+...+..+...+| ..+++++.+||.+||
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~--~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L 230 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLL 230 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHc
Confidence 99999999999999999999999999999999999999964 355667777777766555 468999999999999
Q ss_pred ccCCCCCC-----CHHHHHcCCcccC
Q psy6820 618 ESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 618 ~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
+.||++|| ++.++++||||++
T Consensus 231 ~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 231 KKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred cCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99999999 8999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=390.07 Aligned_cols=254 Identities=33% Similarity=0.648 Sum_probs=225.9
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCC-eEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKD-MDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
..++|.+.+.||+|+||.||+|.+..++ ..+|+|++.+.... ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3578999999999999999999876654 68999998754432 22345778999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+||||+++|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~----~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG----FIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC----CEEEecCCCCeecCC
Confidence 9999999999999999888999999999999999999999999999999999999999887 899999999987766
Q ss_pred CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
...+.+||+.|+|||++.+..++.++|||||||++|||++|..||... +....+..+..+...+| ..+++++.+
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~--~~~~~~~~i~~~~~~~p----~~~~~~~~~ 257 (340)
T PTZ00426 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN--EPLLIYQKILEGIIYFP----KFLDNNCKH 257 (340)
T ss_pred CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC--CHHHHHHHHhcCCCCCC----CCCCHHHHH
Confidence 666778999999999999988999999999999999999999999643 45566777777766555 467899999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
+|++||+.||++|+ +++++++||||++
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99999999999996 8999999999974
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=386.10 Aligned_cols=256 Identities=30% Similarity=0.582 Sum_probs=224.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.... .....+.+|+.++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999999765432 22345778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~ 534 (639)
||++|++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kL~Dfg~a~~~~~~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG----HIKLTDFGLSKGIVTYAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC----CEEEEeCcCCcccccccC
Confidence 9999999999998888899999999999999999999999999999999999999887 899999999987666556
Q ss_pred cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCc----ccccHHHH
Q psy6820 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW----DDISEEAK 610 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~----~~l~~~l~ 610 (639)
..+||+.|+|||++.+..++.++|||||||++|||++|..||... +..+.+..+......+..+.+ ..++.++.
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS--TPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC--CHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 678999999999999999999999999999999999999999653 344555555543322222222 25789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||..+|++||+++++++||||.+
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=384.24 Aligned_cols=258 Identities=34% Similarity=0.643 Sum_probs=224.0
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh-------------HHHHHHHHHHHHhcCCCceee
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-------------KQMIENEVNILRSVNHPNIIK 439 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~-------------~~~~~~Ei~iL~~l~HpnIv~ 439 (639)
...+++|++.+.||+|.||.|.+|++..+++.||||++.+...... .+...+|+.+|++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3567899999999999999999999999999999999986554221 256789999999999999999
Q ss_pred eeeeeecC--CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeee
Q psy6820 440 LLDEYDTN--NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKV 517 (639)
Q Consensus 440 l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~ 517 (639)
|+++..+. +.+|||+|||..|.+...-.....+++.+++.|+++++.||+|||.+|||||||||+|+||+.+| +
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g----~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG----T 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC----c
Confidence 99998765 57999999999988865443333399999999999999999999999999999999999999998 8
Q ss_pred EEEeeccccccccC--------CCccccCCCcccCccccccCC----CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHH
Q psy6820 518 LKVGDFGLAQRVLR--------PMFTVCGTPTYVAPEILNESG----YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDE 585 (639)
Q Consensus 518 vKL~DFGla~~~~~--------~~~~~~GT~~Y~APE~l~~~~----~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~ 585 (639)
+||+|||.+..... ......|||.|+|||...++. -+.+.||||+||+||.|+.|+.||.+ +...+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~--~~~~~ 326 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD--DFELE 326 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc--chHHH
Confidence 99999999975521 122468999999999986522 37899999999999999999999954 46688
Q ss_pred HHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 586 LFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 586 l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+++.|.+..+.+|.. +.+.+.++|||.+||++||++|.+..+|..|||..+
T Consensus 327 l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 327 LFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 999999998888763 468999999999999999999999999999999865
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=389.75 Aligned_cols=255 Identities=33% Similarity=0.629 Sum_probs=221.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++.+.||+|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999999999999999999765432 22345778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
||+++|+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~----~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG----HIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC----CEEEeecccceecccccc
Confidence 9999999999998888899999999999999999999999999999999999999887 8999999998653211
Q ss_pred ---------------------------------------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCC
Q psy6820 533 ---------------------------------------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGF 573 (639)
Q Consensus 533 ---------------------------------------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~ 573 (639)
....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 11346999999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCC---HHHHHcCCcccC
Q psy6820 574 PPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFS---AEDVLDHPWLER 638 (639)
Q Consensus 574 ~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpt---a~eiL~HP~f~~ 638 (639)
.||... +..+....+......+..+....+++++++||++||. +|.+|++ ++|+++||||++
T Consensus 237 ~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 237 PPFCSD--NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCCC--CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999654 3455556666554444433334689999999999997 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=373.60 Aligned_cols=254 Identities=32% Similarity=0.440 Sum_probs=211.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
+++|.+.+.||.|+||.||+|.+..++..||+|++...........+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 46799999999999999999999999999999999765544445567789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 456 LIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|+++ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~----~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG----ELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC----CEEECcCcceeeccCCCc
Confidence 9965 999988654 3579999999999999999999999999999999999999887 7999999999754322
Q ss_pred -CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC---------------
Q psy6820 533 -MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY--------------- 595 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~--------------- 595 (639)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+. .+....+.....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV--KEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhhccccchh
Confidence 234568999999999865 5689999999999999999999999965432 222222221100
Q ss_pred ----CCCC-------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 596 ----GFPS-------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 596 ----~~p~-------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.++. .....++.++.+||++||+.||++|||++|+++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0110 0113468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=376.29 Aligned_cols=257 Identities=28% Similarity=0.479 Sum_probs=224.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.+.|++...||.|..++||+|+...+++.||||++..+......+.+.+|+..++.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 57899999999999999999999999999999999999888878889999999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 456 LIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
||.+||+.++++.. ..+++..+..+++++++||.|||++|.||||||+.||||+.+| .|||+|||.+..+...
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG----~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG----TVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC----cEEEcCceeeeeecccC
Confidence 99999999999764 3499999999999999999999999999999999999999999 8999999997654321
Q ss_pred ------CccccCCCcccCccccc--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC------CC
Q psy6820 533 ------MFTVCGTPTYVAPEILN--ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG------FP 598 (639)
Q Consensus 533 ------~~~~~GT~~Y~APE~l~--~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~------~p 598 (639)
..++.|||+|||||++. ..+|+.|+||||||++..||.+|..||.... ..++.-..+++.+. ++
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p--PmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP--PMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC--hHHHHHHHhcCCCCCcccccCC
Confidence 25678999999999964 3579999999999999999999999995432 23333344444332 22
Q ss_pred CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 599 SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 599 ~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.......+.+++.+|..||++||++||||+++|.|+||+.
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~ 298 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK 298 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence 2233457889999999999999999999999999999975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=373.31 Aligned_cols=253 Identities=30% Similarity=0.503 Sum_probs=216.0
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ....+.+|+.++++++|+||+++++++.+.+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3788999999999999999999999999999987654332 23456789999999999999999999999999999999
Q ss_pred eccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC--
Q psy6820 456 LIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-- 531 (639)
Q Consensus 456 ~~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-- 531 (639)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+|||++.++ .+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~----~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG----HIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC----CEEEeeCCCcEEcCCCC
Confidence 9999999988754 34689999999999999999999999999999999999999887 799999999976532
Q ss_pred CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC--hHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND--QDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~--~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .+.+...+..... .+...++.++
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~ 232 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE----EYSEKFSEDA 232 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc----cCCccCCHHH
Confidence 223467999999999999999999999999999999999999999764432 2233333333222 3345689999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
.+||++||+.||++||+ ++++++||||++
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 233 KSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 99999999999999997 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=388.01 Aligned_cols=255 Identities=29% Similarity=0.508 Sum_probs=216.2
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.|++++.||+|+||+||+|.+..+++.||+|++.+..... ..+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5889999999999999999999999999999997654322 23567899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC----
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---- 531 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---- 531 (639)
|++||+|.+++.+...+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~----~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC----CEEEeeCcCCccccccccc
Confidence 999999999998888899999999999999999999999999999999999999887 899999999753210
Q ss_pred ----------------------------------------------CCccccCCCcccCccccccCCCChhhhHHHHHHH
Q psy6820 532 ----------------------------------------------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVI 565 (639)
Q Consensus 532 ----------------------------------------------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvv 565 (639)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0123579999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcc--cCCCCCCCHHHHHcCCcccC
Q psy6820 566 LYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLE--SNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 566 L~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~--~dP~~Rpta~eiL~HP~f~~ 638 (639)
+|||++|..||.... ..+....+......+..+.+..+++++.+||.+||. .++..|++++++++||||++
T Consensus 238 l~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 238 LFEMLVGQPPFLAPT--PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHHHhCCCCCcCCC--HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 999999999996543 333334444433233333345689999999999654 45556999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=378.61 Aligned_cols=244 Identities=35% Similarity=0.686 Sum_probs=216.1
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCCh
Q psy6820 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL 462 (639)
Q Consensus 385 LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 462 (639)
||+|+||.||+|.+..+++.||+|++.+.... .....+.+|+.++++++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999754322 2234567899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---CCccccCC
Q psy6820 463 FDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVCGT 539 (639)
Q Consensus 463 ~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~~~~~GT 539 (639)
.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....+||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG----HIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC----cEEEEECcccccCccCCCccccccCC
Confidence 99998888899999999999999999999999999999999999999887 899999999975432 23356799
Q ss_pred CcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhccc
Q psy6820 540 PTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLES 619 (639)
Q Consensus 540 ~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~ 619 (639)
+.|+|||++.+..++.++|||||||++|+|++|..||... ...+.++.+......++ ..+++++.+||.+||+.
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~ 230 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE--NVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSR 230 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC--CHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCC
Confidence 9999999999999999999999999999999999999653 45667777777665554 46899999999999999
Q ss_pred CCCCCC---CHHHHHcCCcccC
Q psy6820 620 NPDLRF---SAEDVLDHPWLER 638 (639)
Q Consensus 620 dP~~Rp---ta~eiL~HP~f~~ 638 (639)
||++|| ++.|++.||||.+
T Consensus 231 dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 231 DPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred CHHHcCCCCCHHHHHcCCCcCC
Confidence 999997 5899999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=368.67 Aligned_cols=258 Identities=38% Similarity=0.716 Sum_probs=229.7
Q ss_pred ccCCCeeEE-EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeee----cC
Q psy6820 374 KLLQRYSVG-QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYD----TN 447 (639)
Q Consensus 374 ~~~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~----~~ 447 (639)
.+.++|.+. ++||-|-.|.|..|..+.+++.+|+|++... +..++|+++.-..+ |||||.++++|+ ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 355778774 5789999999999999999999999998653 34468888877665 999999999875 34
Q ss_pred CceEEEEeeccCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
..+.+|||.|+||+|++.++..+. |++.++..|++||+.|+.|||+.+|.||||||+|+|....+ .+..+||+|||+
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~-~na~lKLtDfGF 210 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS-PNAPLKLTDFGF 210 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC-CCcceEeccccc
Confidence 678999999999999999987665 99999999999999999999999999999999999998765 334899999999
Q ss_pred ccccc--CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--ChHHHHHHHHcCCCCCCCCC
Q psy6820 526 AQRVL--RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN--DQDELFDDILSGQYGFPSPY 601 (639)
Q Consensus 526 a~~~~--~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~--~~~~l~~~i~~~~~~~p~~~ 601 (639)
|+... ....+.|-||.|.|||++....|+...|+||+||++|.|+||++||++... -...+...|..+.+.||.+-
T Consensus 211 AK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 211 AKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred ccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 98776 456788999999999999998999999999999999999999999987543 23567889999999999999
Q ss_pred cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 602 ~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
|+.+|+.++|+|+.+|..+|.+|.|+.++++|||+.+
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 9999999999999999999999999999999999875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=388.40 Aligned_cols=255 Identities=31% Similarity=0.590 Sum_probs=217.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|.+++.||+|+||.||+|.+..+++.||+|++.+.... ...+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999999999999999998754332 22355778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
||++||+|.+++.....+++..++.++.|++.||+|||+.||+||||||+|||++.++ .+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~----~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG----HIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC----CEEEeecccccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999887 8999999998632110
Q ss_pred ------------------------------------------------CccccCCCcccCccccccCCCChhhhHHHHHH
Q psy6820 533 ------------------------------------------------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGV 564 (639)
Q Consensus 533 ------------------------------------------------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGv 564 (639)
....+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 01246999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCC---CCHHHHHcCCcccC
Q psy6820 565 ILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLR---FSAEDVLDHPWLER 638 (639)
Q Consensus 565 vL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~R---pta~eiL~HP~f~~ 638 (639)
++|||++|..||... .....+..+......+..+....++.++++||.+||+ +|.+| +++.|+++||||.+
T Consensus 237 il~elltG~~Pf~~~--~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 237 IMFECLIGWPPFCSE--NSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhhcCCCCCCCC--CHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999999654 3345566666544333333334689999999999998 77765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=388.70 Aligned_cols=254 Identities=30% Similarity=0.543 Sum_probs=218.5
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
+|++++.||+|+||.||+|++..+++.||+|++.+.... ...+.+.+|+.++++++||||+++++.+.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999765432 223567889999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC----
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---- 531 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---- 531 (639)
|+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g----~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG----HIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----CEEEeECCCCccccccccc
Confidence 999999999998888899999999999999999999999999999999999999887 899999999743210
Q ss_pred ----------------------------------------------CCccccCCCcccCccccccCCCChhhhHHHHHHH
Q psy6820 532 ----------------------------------------------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVI 565 (639)
Q Consensus 532 ----------------------------------------------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvv 565 (639)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0123579999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCC---HHHHHcCCcccC
Q psy6820 566 LYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFS---AEDVLDHPWLER 638 (639)
Q Consensus 566 L~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpt---a~eiL~HP~f~~ 638 (639)
+|||++|..||...+ ..+....+......++.+....+++++.++|.+|+ .+|++|++ ++++++||||++
T Consensus 238 l~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 238 LYEMLVGQPPFLAQT--PLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHhCCCCCCCCC--HHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999997543 33444455554444444444678999999999987 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=373.08 Aligned_cols=257 Identities=31% Similarity=0.480 Sum_probs=210.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+.+.||+|+||.||+|.++.+++.||+|++...........+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 36899999999999999999999999999999999765544444566789999999999999999999999999999999
Q ss_pred eccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---
Q psy6820 456 LIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--- 531 (639)
Q Consensus 456 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~--- 531 (639)
|+. ++|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG----ELKLADFGLARAKSVPSH 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----CEEECCCCcceeccCCCc
Confidence 995 688887755 35689999999999999999999999999999999999999887 799999999875432
Q ss_pred CCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC--CC------------C
Q psy6820 532 PMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG--QY------------G 596 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~--~~------------~ 596 (639)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......+.+ ..+... .. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL-ERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-HHHHHHhCCCChhhccchhhccc
Confidence 2234578999999999865 468999999999999999999999997654322222 222110 00 0
Q ss_pred C---------CCC---Cc--ccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 597 F---------PSP---YW--DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 597 ~---------p~~---~~--~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+ +.. .| ...++++.+||.+||+.||++|||+.|+++||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 0 000 00 124578999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=379.11 Aligned_cols=246 Identities=36% Similarity=0.689 Sum_probs=217.3
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
+.||+|+||.||++.+..++..||+|++....... ....+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997653322 2245668999999999999999999999999999999999999
Q ss_pred ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---CCcccc
Q psy6820 461 DLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVC 537 (639)
Q Consensus 461 sL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~~~~~ 537 (639)
+|..++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC----CEEecccHHhccccCCCCcccccc
Confidence 9999998888899999999999999999999999999999999999999887 899999999875432 223467
Q ss_pred CCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhc
Q psy6820 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617 (639)
Q Consensus 538 GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L 617 (639)
||+.|+|||++.+..++.++|||||||++|||++|..||... +.......+......+| ..+++++.+||.+||
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L 230 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFP----RTLSPEAKSLLAGLL 230 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHc
Confidence 999999999999999999999999999999999999999643 45566677776666555 467999999999999
Q ss_pred ccCCCCCC-----CHHHHHcCCcccC
Q psy6820 618 ESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 618 ~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
+.||++|+ ++.++++||||.+
T Consensus 231 ~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 231 KKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred cCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 99999998 8999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=388.32 Aligned_cols=255 Identities=30% Similarity=0.545 Sum_probs=219.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.+|++.+.||+|+||.||+|++..+++.||+|++.+..... ....+.+|+.+|+.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999997543322 2355778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--- 531 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~--- 531 (639)
||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~----~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG----HIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC----CEEEEeCCCCcccccccc
Confidence 9999999999998888899999999999999999999999999999999999999887 899999999742210
Q ss_pred -------------------------------------------CCccccCCCcccCccccccCCCChhhhHHHHHHHHHH
Q psy6820 532 -------------------------------------------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYI 568 (639)
Q Consensus 532 -------------------------------------------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~e 568 (639)
.....+||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0113579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCC---CHHHHHcCCcccC
Q psy6820 569 LLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF---SAEDVLDHPWLER 638 (639)
Q Consensus 569 LltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rp---ta~eiL~HP~f~~ 638 (639)
|++|..||.... ..+....+......++.+.+..+++++.++|.+|+ .+|.+|+ ++.++++||||++
T Consensus 237 ll~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 237 MLVGQPPFLADT--PAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hhhCCCCCCCCC--HHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 999999996543 34444555554444444445678999999999987 5999999 9999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=368.78 Aligned_cols=254 Identities=31% Similarity=0.484 Sum_probs=211.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
++|++.+.||+|+||.||+|+++.+++.+|+|++...... ...+.+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4799999999999999999999999999999999765332 224567789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
|++++++..+......+++..+..++.||+.||+|||+.|++||||||+||+++.++ .+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND----VLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC----cEEEeeccCcccccccccc
Confidence 999877766655556799999999999999999999999999999999999999887 8999999999765422
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC-----------------
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ----------------- 594 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~----------------- 594 (639)
.....||+.|+|||++.+..++.++|||||||++|||++|++||...+.. +... .+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-DQLF-TIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-HHHH-HHHHhhCCCCHHHHHhhhccchh
Confidence 23457899999999999888999999999999999999999999764321 1111 111100
Q ss_pred --CCCCC---------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 595 --YGFPS---------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 595 --~~~p~---------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
...+. .....++.++.+||++||+.||++|||++|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00110 1122478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=380.31 Aligned_cols=246 Identities=35% Similarity=0.695 Sum_probs=217.4
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
+.||+|+||.||+|.+..+++.||+|++.+..... ....+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997654322 2345678999999999999999999999999999999999999
Q ss_pred ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---CCcccc
Q psy6820 461 DLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVC 537 (639)
Q Consensus 461 sL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~~~~~ 537 (639)
+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~----~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG----HIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC----cEEEecCcCCccCCCccccccccc
Confidence 9999998888899999999999999999999999999999999999999887 799999999875432 233567
Q ss_pred CCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhc
Q psy6820 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617 (639)
Q Consensus 538 GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L 617 (639)
||+.|+|||++.+..++.++|||||||++|+|++|..||... +.......+......+| ..+++++.+||++||
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~--~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L 230 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEDIKFP----RTLSADAKSLLSGLL 230 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC--CHHHHHHHhccCCccCC----CCCCHHHHHHHHHHc
Confidence 999999999999999999999999999999999999999643 44566667766665555 468999999999999
Q ss_pred ccCCCCCC-----CHHHHHcCCcccC
Q psy6820 618 ESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 618 ~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
+.||++|+ ++.|+++||||..
T Consensus 231 ~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 231 IKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99999997 8999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=382.86 Aligned_cols=255 Identities=36% Similarity=0.660 Sum_probs=221.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|.+.+.||+|+||.||+|++..+++.||+|++.+.... .....+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4799999999999999999999999999999999765432 23456788999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC-
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM- 533 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~- 533 (639)
||+++++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~----~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG----HIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC----CEEeecCCCCccCcccCc
Confidence 9999999999998888899999999999999999999999999999999999999887 89999999997654322
Q ss_pred -------------------------------ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC
Q psy6820 534 -------------------------------FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND 582 (639)
Q Consensus 534 -------------------------------~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~ 582 (639)
....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-- 234 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT-- 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC--
Confidence 34568999999999999999999999999999999999999996543
Q ss_pred hHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCC-HHHHHcCCcccC
Q psy6820 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFS-AEDVLDHPWLER 638 (639)
Q Consensus 583 ~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpt-a~eiL~HP~f~~ 638 (639)
.......+......+..+....+++++.+||.+||. ||++||+ ++++++||||++
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 445556666632222222234589999999999998 9999999 999999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=379.90 Aligned_cols=248 Identities=28% Similarity=0.481 Sum_probs=210.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh-HHHHHHHHHHHHhcCCCceeeeeeeeecCC-ceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHPNIIKLLDEYDTNN-ELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-~~~lV~ 454 (639)
....+.+.||.|+||+||++....+. .||+|++........ .+.|.+|+.+|++++|||||+++|+|.++. .++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 34555667999999999998776553 299999986554332 467999999999999999999999998887 799999
Q ss_pred eeccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCceEEccCCceeeeEEEeecccccccc-
Q psy6820 455 ELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNY-IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL- 530 (639)
Q Consensus 455 E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~g-ivHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~- 530 (639)
||+++|+|.+++.+ ...++...+..++.||++||+|||+++ ||||||||+|||++.+. .++||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~---~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG---KTLKIADFGLSREKVI 196 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC---CEEEECCCccceeecc
Confidence 99999999999987 678999999999999999999999999 99999999999999885 489999999997665
Q ss_pred --CCCccccCCCcccCccccc--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 531 --RPMFTVCGTPTYVAPEILN--ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 531 --~~~~~~~GT~~Y~APE~l~--~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
.......||+.|||||++. ...|+.++||||||++||||+||..||..... .++...+.......+ ....++
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~Rp~--~p~~~~ 272 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGLRPP--IPKECP 272 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCCCCC--CCccCC
Confidence 3344478999999999999 67999999999999999999999999976654 344444443332222 224599
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+..||..||+.||++||++.+|+.
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999998873
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=374.89 Aligned_cols=251 Identities=33% Similarity=0.625 Sum_probs=219.7
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCC-CceeeeeeeeecCCceEEEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNH-PNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV~ 454 (639)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.... ...+.+..|..++..+.| ++|+.+++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 588999999999999999999999999999999765432 223556789999999976 56888999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---C
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---R 531 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---~ 531 (639)
||+++|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~----~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG----HIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC----CEEEeecCcceecCCCCC
Confidence 9999999999998888899999999999999999999999999999999999999887 79999999986532 2
Q ss_pred CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +..+....+......+| ..+++++.+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~--~~~~~~~~i~~~~~~~~----~~~~~~~~~ 230 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQSIMEHNVSYP----KSLSKEAVS 230 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence 234567999999999999999999999999999999999999999643 45667777777665544 468999999
Q ss_pred HHHHhcccCCCCCCCH-----HHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFSA-----EDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta-----~eiL~HP~f~~ 638 (639)
++.+||++||++|++. +++++||||++
T Consensus 231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999976 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=373.47 Aligned_cols=255 Identities=26% Similarity=0.427 Sum_probs=217.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||++.+..++..+|+|++...........+.+|+.++++++||||+++++++...+.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 47899999999999999999999999999999999765443445678899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEccCCceeeeEEEeeccccccccCC-C
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN-YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-M 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~-givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-~ 533 (639)
|+++++|.+++.....+++..+..++.+++.||+|||+. +|+||||||+|||++.++ .+||+|||++...... .
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~ 159 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG----EIKLCDFGVSGQLIDSMA 159 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC----cEEEccCccccccccccc
Confidence 999999999998888899999999999999999999986 699999999999999887 7999999999765432 3
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHH------------------------
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDD------------------------ 589 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~------------------------ 589 (639)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .++...
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA--KELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccccCCccccCccccccc
Confidence 346799999999999999999999999999999999999999954321 222111
Q ss_pred ----------------------HHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 590 ----------------------ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 590 ----------------------i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.... .+......+++++++||.+||++||++|||+.|+++||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEP--PPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCC--CcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 11110 011111246889999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=382.91 Aligned_cols=255 Identities=32% Similarity=0.611 Sum_probs=218.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4689999999999999999999999999999999754332 22356778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
||++||+|.+++.+...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~----~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG----HVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC----CEEEeeccCCcccccccc
Confidence 9999999999998888899999999999999999999999999999999999999887 8999999998643210
Q ss_pred ------------------------------------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCC
Q psy6820 533 ------------------------------------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPF 576 (639)
Q Consensus 533 ------------------------------------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf 576 (639)
....+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 12457999999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCC---CHHHHHcCCcccC
Q psy6820 577 VSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF---SAEDVLDHPWLER 638 (639)
Q Consensus 577 ~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rp---ta~eiL~HP~f~~ 638 (639)
... .....+..+......+..+....+++++++||.+|+. ||++|+ +++++++||||++
T Consensus 237 ~~~--~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 237 CSE--TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCC--CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 654 3455566666543222222223578999999999875 999999 4899999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=375.80 Aligned_cols=246 Identities=35% Similarity=0.697 Sum_probs=216.3
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.++.+++.||+|++.+.... ...+.+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999764322 2234566788888877 599999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---CCCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---~~~~~~ 536 (639)
|+|.+++.+...+++..+..++.|++.||+|||++|++||||||+|||++.++ .+||+|||++.... ......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~----~~kL~DfG~~~~~~~~~~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG----HCKLADFGMCKEGIFNGKTTSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC----cEEEeeCCCCeecCcCCCccccc
Confidence 99999998888999999999999999999999999999999999999999887 89999999987542 223456
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+||+.|+|||++.+..++.++|||||||++|+|++|..||... +...+.+.+..+...+| ..++.++.+||++|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~--~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~ 230 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE--NEDDLFEAILNDEVVYP----TWLSQDAVDILKAF 230 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC--CHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHH
Confidence 7999999999999999999999999999999999999999643 45677778877765554 35789999999999
Q ss_pred cccCCCCCCCH------HHHHcCCcccC
Q psy6820 617 LESNPDLRFSA------EDVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rpta------~eiL~HP~f~~ 638 (639)
|+.||++||++ +++++||||++
T Consensus 231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 231 MTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred cccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 99999999998 99999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=374.16 Aligned_cols=256 Identities=30% Similarity=0.487 Sum_probs=208.1
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----CceE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNHPNIIKLLDEYDTN-----NELY 451 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~~ 451 (639)
+|++.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 58999999999999999999999999999999874322 12234577899999999999999999987533 3589
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+||||+ +++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~----~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFN 155 (338)
T ss_pred EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----cEEEccCcccccccc
Confidence 999999 469999998888899999999999999999999999999999999999999887 899999999975432
Q ss_pred C------CccccCCCcccCcccccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChH-------------HHHHH-
Q psy6820 532 P------MFTVCGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD-------------ELFDD- 589 (639)
Q Consensus 532 ~------~~~~~GT~~Y~APE~l~~--~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~-------------~l~~~- 589 (639)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... .....
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 1 124579999999999875 6789999999999999999999999965432110 00000
Q ss_pred -----------HHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 590 -----------ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 590 -----------i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+...........++.+++++.++|.+||+.||++|||++|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 1111111111123457889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=372.20 Aligned_cols=254 Identities=35% Similarity=0.698 Sum_probs=234.6
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHH--HHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~--~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
..+..+|++.+.||+|.||.|-+|++...|+.||||.++++.+....+. +.+|++||+.|+||||+.++.+|+..+.+
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 3455789999999999999999999999999999999998887665543 67999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
.|||||..+|.|++++.+.+.+++.+++.+++||+.|+.|+|.++++|||||.+|||+|.++ ++||+|||++..+.
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~----NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN----NIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC----Ceeeeccchhhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999998 89999999997775
Q ss_pred CC--CccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 531 RP--MFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 531 ~~--~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.. ..++||+|-|.+||++.+.+| ++.+|.|||||+||.|..|.+||.+ .+...+.++|.++.+.-|. -|.
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG--~Dhk~lvrQIs~GaYrEP~-----~PS 277 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG--RDHKRLVRQISRGAYREPE-----TPS 277 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC--chHHHHHHHhhcccccCCC-----CCc
Confidence 44 458999999999999999998 7899999999999999999999955 4778899999999887764 478
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
.+.-||+.||..+|++|.|+.+|..|=|+.
T Consensus 278 dA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 278 DASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred hHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 899999999999999999999999998864
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=377.57 Aligned_cols=246 Identities=35% Similarity=0.692 Sum_probs=216.9
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
+.||+|+||.||+|.+..+++.||+|++.+..... ....+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997654322 2345668999999999999999999999999999999999999
Q ss_pred ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccC---CCccc
Q psy6820 461 DLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTV 536 (639)
Q Consensus 461 sL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~~~~ 536 (639)
+|.+++.+...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..... .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~----~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG----HIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC----CEEEecCCCCeecCCCCcccccc
Confidence 999999888889999999999999999999997 7999999999999999887 899999999875432 23356
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+||+.|+|||++.+..++.++|||||||++|+|++|..||... +.+.....+......+| ..+++++.+||++|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~--~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~ 230 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEEIRFP----RTLSPEAKSLLSGL 230 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC--CHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHH
Confidence 7999999999999999999999999999999999999999643 45666777777666555 46789999999999
Q ss_pred cccCCCCCC-----CHHHHHcCCcccC
Q psy6820 617 LESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
|+.||++|+ ++.++++||||.+
T Consensus 231 L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 231 LKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=376.46 Aligned_cols=255 Identities=33% Similarity=0.557 Sum_probs=218.8
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|.+.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4799999999999999999999999999999999865432 23356788999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 455 ELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 455 E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~----~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG----HIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC----CEEeccCCCCeECCCCC
Confidence 999999999999775 6799999999999999999999999999999999999999887 89999999997654321
Q ss_pred ----ccccCCCcccCccccc------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc
Q psy6820 534 ----FTVCGTPTYVAPEILN------ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 534 ----~~~~GT~~Y~APE~l~------~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
....||+.|+|||++. ...++.++|||||||++|||++|..||... .....+..+.........+...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~ 234 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG--TSAKTYNNIMNFQRFLKFPEDP 234 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC--CHHHHHHHHHcCCCccCCCCCC
Confidence 2347899999999986 456789999999999999999999999654 3344556665543222222234
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+++++.+||++||+ ||++||+++++++||||++
T Consensus 235 ~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 235 KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 689999999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=375.22 Aligned_cols=248 Identities=32% Similarity=0.625 Sum_probs=214.9
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.+..+++.||+|++++..... ....+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999998654322 234577899999998 699999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---CCCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---~~~~~~ 536 (639)
|+|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+|||++.... ......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~----~~kL~Dfg~~~~~~~~~~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG----HIKLTDYGMCKEGIRPGDTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC----CEEECcCccccccccCCCccccc
Confidence 99999998888999999999999999999999999999999999999999887 79999999987532 223456
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCC-------CChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDT-------NDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~-------~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
+||+.|+|||++.+..++.++|+|||||++|+|++|..||.... ...+...+.+......+| ..++.++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~ 232 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKA 232 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHH
Confidence 89999999999999999999999999999999999999995311 122345566666655554 4678999
Q ss_pred HHHHHHhcccCCCCCCC------HHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFS------AEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpt------a~eiL~HP~f~~ 638 (639)
.+||++||+.||++|++ ++++++||||..
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999999999997 789999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=373.30 Aligned_cols=253 Identities=31% Similarity=0.592 Sum_probs=216.0
Q ss_pred CeeEEEEEccCCceEEEEEEEc---CCCeEEEEEEEcccccc---hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCce
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLL---GKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiKv~~~~~~~---~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 450 (639)
+|++.+.||+|+||.||+|+.. .+++.||+|++.+.... ...+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999998764 46889999999764332 22345678999999995 99999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|+||||+++|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~----~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG----HVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC----CEEEeeCcCCcccc
Confidence 99999999999999998888899999999999999999999999999999999999999887 89999999997643
Q ss_pred C----CCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCC--CChHHHHHHHHcCCCCCCCCCcc
Q psy6820 531 R----PMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDT--NDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 531 ~----~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~--~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
. .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.... .....+...+......++ .
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~ 232 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----S 232 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----C
Confidence 2 22356799999999999765 47899999999999999999999996432 234455555555444333 5
Q ss_pred cccHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 604 DISEEAKELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
.+++.+.++|.+||+.||++|| +++++++||||++
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 6899999999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=381.26 Aligned_cols=257 Identities=30% Similarity=0.539 Sum_probs=220.7
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+.... .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 357899999999999999999999999999999999754322 223456789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~----~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG----HLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC----CEEEEeccceeeccCC
Confidence 9999999999998865 4689999999999999999999999999999999999999887 8999999999765432
Q ss_pred ----CccccCCCcccCccccccC----CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 533 ----MFTVCGTPTYVAPEILNES----GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 533 ----~~~~~GT~~Y~APE~l~~~----~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
....+||+.|+|||++.+. .++.++|||||||++|||++|..||... +....+..+......+..+....
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC--CHHHHHHHHHcCCCcCCCCCcCC
Confidence 2356799999999998653 4789999999999999999999999654 34566677766543333333346
Q ss_pred ccHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccC
Q psy6820 605 ISEEAKELISHMLESNPDL--RFSAEDVLDHPWLER 638 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~--Rpta~eiL~HP~f~~ 638 (639)
++.++++||++||+.+|++ |++++++++||||++
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 8999999999999999988 999999999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=373.47 Aligned_cols=246 Identities=34% Similarity=0.646 Sum_probs=216.3
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.+..+++.||+|++.+.... ...+.+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999999999999999999999765432 2234566788888876 699999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---CCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~~~~ 536 (639)
++|.+.+.+...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~----~~kL~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG----HCKLADFGMCKEGILNGVTTTTF 156 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC----CEEEeecccceecccCCcccccc
Confidence 99999998888999999999999999999999999999999999999999887 899999999875432 23356
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +....++.+..+...+| ..++.++.+||.+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~--~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~ 230 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD--NEDDLFESILHDDVLYP----VWLSKEAVSILKAF 230 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence 7999999999999999999999999999999999999999654 45667777877765554 35789999999999
Q ss_pred cccCCCCCC-------CHHHHHcCCcccC
Q psy6820 617 LESNPDLRF-------SAEDVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rp-------ta~eiL~HP~f~~ 638 (639)
|+.||++|| +++++++||||.+
T Consensus 231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 231 MTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred hccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 999999999 9999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=372.28 Aligned_cols=246 Identities=30% Similarity=0.589 Sum_probs=213.7
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEccccc--chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL--LGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.++.+++.||+|++.+... ....+.+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999976532 12234556788888765 799999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---CCCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---~~~~~~ 536 (639)
|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... ......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG----HIKIADFGMCKENVFGDNRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC----CEEeCccCCCeecccCCCceecc
Confidence 99999998888899999999999999999999999999999999999999887 79999999986432 233457
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+||+.|+|||++.+..++.++|||||||++|||++|..||... +...+.+.+......+| ..++.++++||++|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~ 230 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--DEDELFESIRVDTPHYP----RWITKESKDILEKL 230 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHH
Confidence 8999999999999999999999999999999999999999643 45666677766554444 35789999999999
Q ss_pred cccCCCCCCCH-HHHHcCCcccC
Q psy6820 617 LESNPDLRFSA-EDVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rpta-~eiL~HP~f~~ 638 (639)
|+.||++||++ +++++||||++
T Consensus 231 l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 231 FERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred ccCCHHHcCCChHHHHcCCCcCC
Confidence 99999999997 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=377.53 Aligned_cols=255 Identities=32% Similarity=0.499 Sum_probs=216.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC--CceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTN--NELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~l 452 (639)
.+.|+.+++||+|.||.||+|++..+|+.||+|.+...... +......+||.||++|.||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 46688899999999999999999999999999999766532 2234556999999999999999999987665 68999
Q ss_pred EEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
|+|||+. ||.-++.. .-.|++.+++.+++||+.||+|||++||+|||||.+|||||.+| .+||+|||+|+.+..
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G----~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG----VLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC----CEEeccccceeeccC
Confidence 9999966 99988866 45799999999999999999999999999999999999999998 999999999986642
Q ss_pred ----CCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc---
Q psy6820 532 ----PMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWD--- 603 (639)
Q Consensus 532 ----~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~--- 603 (639)
+.+..+-|.+|+|||.+.| ..|+.++|+||.||||.||++|++.|.+.++ .+..+.|....-.+...+|+
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE--veQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE--VEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH--HHHHHHHHHHhCCCChhcccccc
Confidence 3455677999999999876 5799999999999999999999999977643 33334444332222223332
Q ss_pred ----------------------cccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 604 ----------------------DISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 604 ----------------------~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
.+++.+.+|+..||..||.+|.||.++|+|+||.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 3688999999999999999999999999999994
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=371.26 Aligned_cols=251 Identities=31% Similarity=0.595 Sum_probs=219.6
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+|.+.+.||+|+||.||+|.+..+++.||+|++.+..... ..+.+..|..++..+. |++|+.+++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999999999999999997654322 2234567888887774 899999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--- 531 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~--- 531 (639)
||+++|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~----~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC----cEEEccCCCceecCCCCC
Confidence 9999999999998888899999999999999999999999999999999999999887 899999999975432
Q ss_pred CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||... +...+...+......+| ..++.++.+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~--~~~~~~~~i~~~~~~~p----~~~s~~~~~ 230 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHNVAYP----KSMSKEAVA 230 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCC----CcCCHHHHH
Confidence 233567999999999999999999999999999999999999999653 45667777777665555 468999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
|+.+||+.||++|++ ..++++||||+.
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999999999997 489999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=371.43 Aligned_cols=249 Identities=34% Similarity=0.632 Sum_probs=215.7
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHH---HhcCCCceeeeeeeeecCCceEEE
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNIL---RSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL---~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
|++.+.||+|+||.||+|.+..+++.||+|++.+..... ..+.+.+|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678999999999999999999999999999997654221 224566666655 456799999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--- 530 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~--- 530 (639)
|||+++++|...+.. ..+++..+..++.||+.||+|||+.|++||||||+||+++.++ .+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~----~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG----FVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC----cEEeCcccCCccCCCCC
Confidence 999999999988864 4799999999999999999999999999999999999999887 89999999987543
Q ss_pred CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 531 RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 531 ~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||... +..+....+......+| ..++.++.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~--~~~~~~~~i~~~~~~~p----~~~~~~~~ 229 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD--DEEEVFDSIVNDEVRYP----RFLSREAI 229 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCC----CCCCHHHH
Confidence 2234568999999999999999999999999999999999999999643 45666777777665554 46799999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
++|.+||+.||++|| ++.++++||||++
T Consensus 230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred HHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 999999999999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=372.20 Aligned_cols=246 Identities=35% Similarity=0.680 Sum_probs=215.3
Q ss_pred EEEccCCceEEEEEEEc---CCCeEEEEEEEcccccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 383 QIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLL---GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~---~~~~~vAiKv~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+.||+|+||.||+|+.. .+++.||+|++.+.... .....+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999864 46889999999765432 2234567899999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---CC
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PM 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~ 533 (639)
+++++|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG----HVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----CEEEeeCcCCeecccCCCcc
Confidence 99999999998888899999999999999999999999999999999999999887 899999999865432 23
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
...+||+.|+|||++.+..++.++|||||||++|||++|..||... +.......+..+...+| ..+++++.+||
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~li 231 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE--NRKKTIDKILKGKLNLP----PYLTPEARDLL 231 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 3467999999999999988999999999999999999999999653 44566677777765554 46789999999
Q ss_pred HHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 614 SHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 614 ~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
.+||+.||++|| +++++++||||..
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 999999999999 8999999999964
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=361.12 Aligned_cols=255 Identities=37% Similarity=0.724 Sum_probs=228.7
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEEeeccCC
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
.+.||+|+||.|-.|....++..||||++.+. .......+.+|++++.+++ |+||++|+++|+++..+|||||-|.||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 46799999999999999999999999999887 3344566779999999997 999999999999999999999999999
Q ss_pred ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc----------
Q psy6820 461 DLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---------- 530 (639)
Q Consensus 461 sL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---------- 530 (639)
+|..+|++..-|++.++.++.++|+.||.|||.+||.||||||+|||..... +..-||||||.+.....
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn-~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN-KVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC-CcCceeeeccccccccccCCCCCCCCC
Confidence 9999999999999999999999999999999999999999999999997664 33469999999975432
Q ss_pred CCCccccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-------------ChHHHHHHHHc
Q psy6820 531 RPMFTVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-------------DQDELFDDILS 592 (639)
Q Consensus 531 ~~~~~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-------------~~~~l~~~i~~ 592 (639)
....+.+|+..|||||+.. ...|+.+.|.|||||+||.|++|++||.+... .++.+++.|..
T Consensus 241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE 320 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE 320 (463)
T ss_pred ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence 1234678999999999863 34689999999999999999999999965322 25789999999
Q ss_pred CCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 593 GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 593 ~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+.+|...|..++.+++|||..+|..|+.+|.++.++++|||+++
T Consensus 321 GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 321 GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 9999999999999999999999999999999999999999999985
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=379.73 Aligned_cols=256 Identities=31% Similarity=0.555 Sum_probs=217.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.++|++.+.||+|+||.||+|.+..+++.+|+|++.+.... .....+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 46899999999999999999999999999999999754322 2234577899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~----~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG----HLKLADFGTCMKMDETG 196 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC----CEEEEecccceecccCC
Confidence 9999999999999654 689999999999999999999999999999999999999887 8999999999765432
Q ss_pred ---CccccCCCcccCccccccC----CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 533 ---MFTVCGTPTYVAPEILNES----GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~----~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
..+.+||+.|+|||++.+. .++.++|||||||++|+|++|..||... +....+..+......+..+....+
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~p~~~~~ 274 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD--SLVGTYSKIMDHKNSLNFPEDVEI 274 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCcccCCCCcccC
Confidence 2356799999999998754 3789999999999999999999999654 345556666654433333333467
Q ss_pred cHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccC
Q psy6820 606 SEEAKELISHMLESNPDL--RFSAEDVLDHPWLER 638 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~--Rpta~eiL~HP~f~~ 638 (639)
+..+++++.+||+.++.+ |++++|+++||||+.
T Consensus 275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred CHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 999999999999865544 889999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=348.01 Aligned_cols=255 Identities=33% Similarity=0.531 Sum_probs=214.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh-HHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.+|...+.||+|.||.||+|++..+|+.||||.++.....+. .....+|+..|+.++|+||+.++++|-..+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999999999999999999987654322 3456799999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc
Q psy6820 456 LIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534 (639)
Q Consensus 456 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~ 534 (639)
|++. +|...++.. ..++..+++.++.++++||+|||+++|+||||||.|+|++.+| .+||+|||+|+....+..
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g----~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG----QLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC----cEEeecccchhccCCCCc
Confidence 9964 999999654 5799999999999999999999999999999999999999998 899999999998875543
Q ss_pred c---ccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC----------
Q psy6820 535 T---VCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP---------- 600 (639)
Q Consensus 535 ~---~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~---------- 600 (639)
. .+-|.+|+|||.+.| ..|+..+||||.||++.||+-|.+-|.+.+ +.+++ ..|...--.....
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-DidQL-~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-DIDQL-SKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-hHHHH-HHHHHHcCCCCcccCcccccccc
Confidence 2 367999999998865 579999999999999999999988776544 44333 2222211111111
Q ss_pred --------------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 601 --------------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 601 --------------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+..+.++.||+.+||..||.+|+++.|+|+||||..
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 22346788999999999999999999999999999974
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=371.81 Aligned_cols=246 Identities=34% Similarity=0.662 Sum_probs=212.6
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHH-HHHHHhcCCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENE-VNILRSVNHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~E-i~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.+..+++.||+|++.+...... ...+..| ..+++.++||||+++++.+...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999976543221 1233344 4456789999999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---CCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~~~~ 536 (639)
|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~----~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG----HVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC----cEEEeccCCCcccccCCCccccc
Confidence 99999998888999999999999999999999999999999999999999887 899999999875432 23356
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+||+.|+|||++.+..++.++|||||||++|+|++|..||... +..++++.+......++ ..++.++.++|++|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~ 230 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--DTAEMYDNILNKPLRLK----PNISVSARHLLEGL 230 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC--CHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence 7999999999999999999999999999999999999999643 45667777777655544 46799999999999
Q ss_pred cccCCCCCCCH----HHHHcCCcccC
Q psy6820 617 LESNPDLRFSA----EDVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rpta----~eiL~HP~f~~ 638 (639)
|+.||++||++ .++++||||..
T Consensus 231 l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 231 LQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred hhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 99999999987 69999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=372.58 Aligned_cols=253 Identities=32% Similarity=0.463 Sum_probs=210.7
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
..++|+..+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++|+||+++++++...+.+|+||
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 35678899999999999999999999999999999976554444567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
||+++++|.+. ...++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK----NVKIADFGVSRILAQTMD 223 (353)
T ss_pred ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC----CEEEcccccceecccccc
Confidence 99999998653 2456788889999999999999999999999999999999887 8999999999765432
Q ss_pred -CccccCCCcccCcccccc-----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-ChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 533 -MFTVCGTPTYVAPEILNE-----SGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-----~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||..... +...+...+... .+......+
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 300 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS---QPPEAPATA 300 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc---CCCCCCCcc
Confidence 245679999999998743 2345789999999999999999999964322 222222222222 222333578
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.++.+||.+||+.||++||++.|+++||||.+
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 999999999999999999999999999999975
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=371.97 Aligned_cols=248 Identities=33% Similarity=0.638 Sum_probs=214.0
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.+..+++.+|+|++.+..... ....+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998654322 234567888888777 699999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---CCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~~~~ 536 (639)
|+|..++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~----~~kL~DfG~~~~~~~~~~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC----CEEEeeCCccccccCCCCccccc
Confidence 99999998888999999999999999999999999999999999999999887 899999999875432 23456
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC-------CCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSD-------TNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~-------~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
+||+.|+|||++.+..++.++|||||||++|+|++|..||... ......+.+.+......+| ..++.++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 232 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKA 232 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHH
Confidence 7999999999999999999999999999999999999999521 1122345556666655555 4678999
Q ss_pred HHHHHHhcccCCCCCCC------HHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFS------AEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpt------a~eiL~HP~f~~ 638 (639)
.+||++||+.||++||+ ++++++||||++
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999999999998 589999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=357.76 Aligned_cols=258 Identities=31% Similarity=0.488 Sum_probs=214.8
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec--CCce
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDT--NNEL 450 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 450 (639)
...++|..+..|++|+||.||+|+++.+++.||+|.++.+.-. +-.-.-.+|+.+|.+++|||||.+-.+... -+.+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3456799999999999999999999999999999999765421 111234689999999999999999987653 4579
Q ss_pred EEEEeeccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
|||||||+. +|..++..-. +|...+++.++.|+++||+|||.++|+||||||+|+|+...| .+||+|||+|+.+
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G----~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG----ILKIADFGLAREY 227 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC----cEEecccchhhhh
Confidence 999999976 9999997654 899999999999999999999999999999999999999998 8999999999999
Q ss_pred cCC---CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc--
Q psy6820 530 LRP---MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWD-- 603 (639)
Q Consensus 530 ~~~---~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~-- 603 (639)
..+ .+..+-|.+|+|||.+.+ ..|+.++||||+|||+.||+++.+.|.+.+.- ++ .+.|....-......|+
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQ-l~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQ-LDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HH-HHHHHHHhCCCccccCCCc
Confidence 876 566778999999999876 57999999999999999999999999876542 22 22222211111111111
Q ss_pred --------------------------cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 604 --------------------------DISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 604 --------------------------~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+++...+|+..+|..||++|.||.|.|.|+||.+
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 15689999999999999999999999999999986
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=368.53 Aligned_cols=246 Identities=34% Similarity=0.642 Sum_probs=211.6
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.+..+++.||+|++...... ...+.+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999765322 2223445666677654 799999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---CCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~~~~ 536 (639)
|+|.+++.....+++..+..++.||+.||+|||+.||+||||||+|||++.++ .+||+|||++..... .....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~----~~kL~Dfg~a~~~~~~~~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG----HIKIADFGMCKENMNGEGKASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC----CEEEccCcCCeECCCCCCccccc
Confidence 99999998888999999999999999999999999999999999999999887 799999999975432 23456
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+||+.|+|||++.+..++.++|||||||++|||++|..||... +..+++..+......+| ..++.++.+||.+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~ 230 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE--DEDELFDSILNDRPHFP----RWISKEAKDCLSKL 230 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence 7999999999999999999999999999999999999999654 44666666666544443 46789999999999
Q ss_pred cccCCCCCCCH-HHHHcCCcccC
Q psy6820 617 LESNPDLRFSA-EDVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rpta-~eiL~HP~f~~ 638 (639)
|+.||++||++ +++++||||..
T Consensus 231 l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 231 FERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred ccCCHHHcCCChHHHHcCcccCC
Confidence 99999999986 58999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=378.55 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=208.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
..+|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.++++++||||+++++++......++|||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 467999999999999999999999999999999754 2345789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC----
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---- 531 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---- 531 (639)
++ +++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 164 ~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~----~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 164 RY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG----DVCLGDFGAACFPVDINAN 238 (391)
T ss_pred cC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC----CEEEEeCCccccccccccc
Confidence 99 469999998888899999999999999999999999999999999999999887 799999999965322
Q ss_pred CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-----ChHHHHHHHHc--------------
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-----DQDELFDDILS-------------- 592 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-----~~~~l~~~i~~-------------- 592 (639)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||..... +.......+..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 23356899999999999999999999999999999999999988754221 01111111111
Q ss_pred ------------CCCCCC--CCCc---ccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 593 ------------GQYGFP--SPYW---DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 593 ------------~~~~~p--~~~~---~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.....+ .+.| ..++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 000000 1111 135778999999999999999999999999999975
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=368.79 Aligned_cols=246 Identities=35% Similarity=0.666 Sum_probs=216.2
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.+..+++.||+|++.+.... .....+.+|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999865432 2234566788898888 599999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---CCCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---~~~~~~ 536 (639)
|+|.+++.+...+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|||++.... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG----HIKIADFGMCKEGILGGVTTSTF 156 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC----cEEecccCCCeecCcCCCcccce
Confidence 99999998888999999999999999999999999999999999999999887 89999999986532 223346
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+||+.|+|||++.+..++.++|+|||||++|+|++|..||... +...+...+......+| ..++.++.+||++|
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~--~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~ 230 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD--DEDELFQSILEDEVRYP----RWLSKEAKSILKSF 230 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHH
Confidence 7999999999999999999999999999999999999999643 45666777777665544 46789999999999
Q ss_pred cccCCCCCCCH-----HHHHcCCcccC
Q psy6820 617 LESNPDLRFSA-----EDVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rpta-----~eiL~HP~f~~ 638 (639)
|+.||++||++ .++++||||..
T Consensus 231 l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 231 LTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred ccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999 99999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=361.18 Aligned_cols=260 Identities=32% Similarity=0.501 Sum_probs=215.4
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcc-cccchhHHHHHHHHHHHHhcCCCceeeeeeeeec-----C
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK-SKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT-----N 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~-~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-----~ 447 (639)
.+...|...+.||.|+||.|..+.++.+++.||||.+.. .......++..+|+.+|+.++|+||+.+++.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344567778999999999999999999999999998862 2222334566799999999999999999998754 3
Q ss_pred CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
+.+|+|+|+| +.+|...++.+..+++..+..++.||++||.|+|+.||+||||||.|+|++.+. .+||||||+|+
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c----~lKI~DFGLAR 173 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC----DLKICDFGLAR 173 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC----CEEecccccee
Confidence 5689999999 669999999888899999999999999999999999999999999999999987 78999999998
Q ss_pred ccc-----CCCccccCCCcccCccccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh-------------HHHHH
Q psy6820 528 RVL-----RPMFTVCGTPTYVAPEILN-ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ-------------DELFD 588 (639)
Q Consensus 528 ~~~-----~~~~~~~GT~~Y~APE~l~-~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~-------------~~l~~ 588 (639)
... ..++.++.|.+|.|||++. ...|+.++||||.||++.||++|++.|.+.+.-. ++...
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 873 3356788899999999875 5789999999999999999999999997754311 11111
Q ss_pred HHH--------cCCCCCCC----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 589 DIL--------SGQYGFPS----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 589 ~i~--------~~~~~~p~----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+. ......|. ..++..++.+.||+++||..||.+|+|++|+|+||||..
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 111 11111111 123578999999999999999999999999999999863
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.72 Aligned_cols=246 Identities=31% Similarity=0.587 Sum_probs=212.8
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEccccc--chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL--LGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.+..+++.||+|++..... ......+..|..+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999976532 12234455677788764 899999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---CCCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---~~~~~~ 536 (639)
|+|.+++.+...+++..+..++.|++.||+|||+.||+||||||+|||++.++ .+||+|||++.... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG----HIKIADFGMCKENMLGDAKTCTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC----CEEEccCCcceECCCCCCceeee
Confidence 99999998888899999999999999999999999999999999999999887 79999999987532 223456
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+||+.|+|||++.+..++.++|||||||++|||++|..||... +..++.+.+......+| ..++.+++++|.+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~ 230 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH--DEEELFQSIRMDNPCYP----RWLTREAKDILVKL 230 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHH
Confidence 7999999999999999999999999999999999999999654 44566666665544333 35789999999999
Q ss_pred cccCCCCCCCHH-HHHcCCcccC
Q psy6820 617 LESNPDLRFSAE-DVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rpta~-eiL~HP~f~~ 638 (639)
|+.||++||++. ++++||||++
T Consensus 231 l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 231 FVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred hccCHhhcCCChHHHHcCcccCC
Confidence 999999999996 9999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=368.23 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=216.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||++.+..++..+|+|++...........+.+|+.++++++||||++++++|.+.+.+|+|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 47899999999999999999999999999999998765444445678899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEccCCceeeeEEEeeccccccccCC-C
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN-YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-M 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~-givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-~ 533 (639)
|+++++|.+++.+...+++..+..++.+++.||+|||+. +++|+||||+|||++.++ .+||+|||++...... .
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~----~~kL~Dfg~~~~~~~~~~ 159 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG----EIKLCDFGVSGQLIDSMA 159 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC----CEEEeeCCcchhhhhhcc
Confidence 999999999998888899999999999999999999985 799999999999999887 7999999999765432 2
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHH----------------------------
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDE---------------------------- 585 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~---------------------------- 585 (639)
....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.........
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 3457999999999999988999999999999999999999999653321110
Q ss_pred --------------HHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 586 --------------LFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 586 --------------l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+...+.+... +.......+.++++||.+||++||++|||+.|++.||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 0011111100 00001235789999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.94 Aligned_cols=246 Identities=30% Similarity=0.492 Sum_probs=208.9
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCCh
Q psy6820 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL 462 (639)
Q Consensus 385 LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 462 (639)
||+|+||+||+|.+..+++.+|+|.+........ .+.+..|+.+++.++||||+++.+++......|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999999999999999999876543322 24567899999999999999999999999999999999999999
Q ss_pred HHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---Ccc
Q psy6820 463 FDAIS----KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFT 535 (639)
Q Consensus 463 ~~~l~----~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~~~ 535 (639)
.+++. ....+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++...... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG----NVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEeeCccceecCCCCccccc
Confidence 88774 245689999999999999999999999999999999999999877 7999999999765432 234
Q ss_pred ccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC--hHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 536 VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND--QDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 536 ~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~--~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
..||+.|+|||++.+..++.++|+|||||++|+|++|+.||...... .......+..... .+...++.++.+++
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li 232 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV----TYPDKFSPASKSFC 232 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC----CCcccCCHHHHHHH
Confidence 57899999999999999999999999999999999999999754332 2233333333322 33356899999999
Q ss_pred HHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 614 SHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 614 ~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
.+||+.||++|| +++++++||||++
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=366.46 Aligned_cols=251 Identities=32% Similarity=0.613 Sum_probs=218.8
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+|++.+.||+|+||.||+|.++.+++.||+|++.+.... ...+.+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478899999999999999999999999999999765332 22345667888888886 577888999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
||+++|+|.+++.+...+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~----~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG----HIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC----CEEEeccccccccCCCCc
Confidence 9999999999998888899999999999999999999999999999999999999887 7999999998754322
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||... ....+.+.+......+| ..++.++.+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~--~~~~~~~~i~~~~~~~p----~~~~~~~~~ 230 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE--DEDELFQSIMEHNVSYP----KSLSKEAVS 230 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCC----ccCCHHHHH
Confidence 23467999999999999999999999999999999999999999654 45666777777665554 467899999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
++.+||++||++|++ .+++++||||+.
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred HHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 999999999999997 579999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=375.47 Aligned_cols=253 Identities=30% Similarity=0.518 Sum_probs=224.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
..|+..+.||+|+||.||+|.+..+++.||+|++..+.....-+.+++|+.+|.+++++||.++|+.|.....+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35777799999999999999999999999999999888777778899999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---C
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---M 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~ 533 (639)
|.||++.+.++....+.+..+..++++++.||.|||.++.+|||||+.|||+..+| .+||+|||.+...... .
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g----~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG----DVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC----cEEEEecceeeeeechhhcc
Confidence 99999999999888889999999999999999999999999999999999999887 8999999999877532 3
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
.+++|||.|||||++.+..|+.++||||||++.+||++|.+||..... ..+.-.| .-..|+..-...++.++++|
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--mrvlflI---pk~~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--MRVLFLI---PKSAPPRLDGDFSPPFKEFV 243 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--ceEEEec---cCCCCCccccccCHHHHHHH
Confidence 689999999999999999999999999999999999999999965433 1111111 12233333347899999999
Q ss_pred HHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 614 SHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 614 ~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..||++||+.||+|.++|.|+|+++
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHh
Confidence 9999999999999999999999875
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=358.47 Aligned_cols=253 Identities=30% Similarity=0.510 Sum_probs=214.7
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.|++.+.||+|+||.||++.+..+++.||+|++....... ....+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4889999999999999999999999999999997644322 23456789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 456 LIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG----HIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC----CEEEeeCCCceecCCCC
Confidence 99999999888543 4689999999999999999999999999999999999999887 7999999999765422
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh--HHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ--DELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~--~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
....+|++.|+|||++.+..++.++|||||||++|||++|..||....... +.+...+.... ..+...++..+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 232 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----EEYSEKFSEAA 232 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc----cccCcccCHHH
Confidence 234578999999999998899999999999999999999999997543211 22223333322 22335689999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
.+||.+||+.||++|| +++++++||||.+
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 9999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=367.55 Aligned_cols=248 Identities=32% Similarity=0.604 Sum_probs=214.5
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|....+++.||+|++.+..... ..+.+.+|+.++.++ +||||+.+++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998654332 234577899999888 599999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---CCCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---~~~~~~ 536 (639)
|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~----~~kl~Dfg~~~~~~~~~~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG----HIKLTDYGMCKEGLGPGDTTSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC----CEEEeccccceeccCCCCceecc
Confidence 99999998888899999999999999999999999999999999999999887 79999999997532 223457
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCC-----CChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDT-----NDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~-----~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ...+.+...+......+| ..++..+.+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~ 232 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASH 232 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHH
Confidence 89999999999999999999999999999999999999995422 223445555655544444 468899999
Q ss_pred HHHHhcccCCCCCCC------HHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFS------AEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpt------a~eiL~HP~f~~ 638 (639)
+|.+||+.||++|++ +.++++||||+.
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 999999999999997 579999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=369.93 Aligned_cols=246 Identities=37% Similarity=0.665 Sum_probs=215.3
Q ss_pred EEEccCCceEEEEEEE---cCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeecc
Q psy6820 383 QIIGDGNFAVVRQVYD---KHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIK 458 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~---~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 458 (639)
+.||+|+||.||++++ ..+++.+|+|++....... ....+.+|+.++++++||||+++++++.+.+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 3578899999997654322 23456789999999999999999999999999999999999
Q ss_pred CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---Ccc
Q psy6820 459 GGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFT 535 (639)
Q Consensus 459 ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~~~ 535 (639)
+|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ...
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC----cEEEeeccCCcccCCCCCceec
Confidence 999999998888899999999999999999999999999999999999999887 7999999998765432 345
Q ss_pred ccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHH
Q psy6820 536 VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615 (639)
Q Consensus 536 ~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~ 615 (639)
.+||+.|+|||++.+..++.++|||||||++|||++|..||... +..+....+......+| ..+++++.+||++
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~--~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~ 231 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK--DRKETMTMILKAKLGMP----QFLSPEAQSLLRA 231 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC--CHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 67999999999999988999999999999999999999999643 45566677776665554 4678999999999
Q ss_pred hcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 616 MLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 616 ~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
||+.||++||+ +.+++.||||+.
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 99999999999 778999999964
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=373.53 Aligned_cols=256 Identities=32% Similarity=0.561 Sum_probs=218.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.++|++.+.||+|+||.||+|.++.+++.+|+|++.+.... .....+.+|+.+++.++||||+++++.+.+.+.+|+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 47899999999999999999999999999999998754322 2234577899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|||++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~----~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 122 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG----HLKLADFGTCMKMNKEG 196 (371)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC----CEEEEeCCceeEcCcCC
Confidence 9999999999998654 589999999999999999999999999999999999999887 8999999999765432
Q ss_pred ---CccccCCCcccCccccccC----CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 533 ---MFTVCGTPTYVAPEILNES----GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~----~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
....+||+.|+|||++.+. .++.++|||||||++|||++|..||... +....+..+......++.+....+
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~ 274 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMNHKNSLTFPDDNDI 274 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCcccCCCcCCC
Confidence 2356799999999998754 3789999999999999999999999653 445667777765433333444578
Q ss_pred cHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccC
Q psy6820 606 SEEAKELISHMLESNPDL--RFSAEDVLDHPWLER 638 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~--Rpta~eiL~HP~f~~ 638 (639)
+.++++||.+||..++.+ |++++++++||||++
T Consensus 275 s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred CHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 999999999999844433 789999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=381.80 Aligned_cols=258 Identities=23% Similarity=0.373 Sum_probs=205.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCC------CceeeeeeeeecC-C
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH------PNIIKLLDEYDTN-N 448 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~H------pnIv~l~~~~~~~-~ 448 (639)
.++|++.+.||+|+||+||+|.+..+++.||||+++.... .......|+.+++.++| .+++.+++++... .
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 4789999999999999999999999999999999964321 22345567777777754 4588899888754 5
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCce------------e
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCH------------V 515 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~------------~ 515 (639)
.+|+|||++ |++|.+++.+.+.+++..+..++.||+.||+|||+ .|||||||||+|||++.++.. .
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 789999998 77999999888889999999999999999999998 599999999999999876521 1
Q ss_pred eeEEEeeccccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC
Q psy6820 516 KVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY 595 (639)
Q Consensus 516 ~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~ 595 (639)
..+||+|||++..........+||+.|+|||++.+..|+.++|||||||++|||++|++||..... .+....+.....
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~g 362 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN--LEHLHLMEKTLG 362 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHcC
Confidence 149999999987665555678899999999999999999999999999999999999999965432 222111111100
Q ss_pred CCCCC-----------------------C-------------cc--cccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 596 GFPSP-----------------------Y-------------WD--DISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 596 ~~p~~-----------------------~-------------~~--~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
.+|.. . +. ..++.+.|||.+||+.||++|||++|+|+||||+
T Consensus 363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL 442 (467)
T ss_pred CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccc
Confidence 01000 0 00 0145678999999999999999999999999997
Q ss_pred C
Q psy6820 638 R 638 (639)
Q Consensus 638 ~ 638 (639)
+
T Consensus 443 ~ 443 (467)
T PTZ00284 443 K 443 (467)
T ss_pred c
Confidence 5
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=356.53 Aligned_cols=253 Identities=32% Similarity=0.459 Sum_probs=203.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcC-CCeEEEEEEEcccccch-hHHHHHHHHHHHHhc---CCCceeeeeeeee-----c
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKH-KDMDCALKIIDKSKLLG-KKQMIENEVNILRSV---NHPNIIKLLDEYD-----T 446 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~-----~ 446 (639)
++|++.+.||+|+||.||+|.+.. +++.+|+|++....... ....+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999998854 46889999987544322 223455677777766 6999999999874 3
Q ss_pred CCceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 447 NNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
...+++||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~----~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----QIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC----CEEEcccc
Confidence 456899999995 6999998653 4589999999999999999999999999999999999999887 89999999
Q ss_pred ccccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC-----
Q psy6820 525 LAQRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF----- 597 (639)
Q Consensus 525 la~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~----- 597 (639)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|.+||.... ..+....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~--~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhc
Confidence 99765432 335678999999999998899999999999999999999999996543 223333333211000
Q ss_pred ------CC------------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 598 ------PS------------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 598 ------p~------------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
+. ...+.+++.+++|+.+||+.||++|||+.|+++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 00 0123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=361.23 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=212.0
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+.+.||+|+||.||+|.++.++..+|+|.+...........+.+|+.++++++||||+++++++..++..|+|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 46899999999999999999999999999999999765544444567789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 456 LIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|+++ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG----ELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----CEEECccccceecCCCcc
Confidence 9965 888887654 4589999999999999999999999999999999999999887 7999999999754322
Q ss_pred -CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC-----------------
Q psy6820 533 -MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG----------------- 593 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~----------------- 593 (639)
.....+|+.|+|||++.+ ..++.++|||||||++|+|+||..||...+. .+....+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV--EDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 234568999999999865 5689999999999999999999999965432 2222222110
Q ss_pred --CCCCCC-------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 --QYGFPS-------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 --~~~~p~-------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...++. .....+++++.+||.+||+.||++|||++|+++||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 001111 111357889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=370.65 Aligned_cols=259 Identities=31% Similarity=0.529 Sum_probs=229.2
Q ss_pred CcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCc
Q psy6820 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 372 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 449 (639)
.....+.|..-++||+||||.||.|..+.+|+.||.|.+.+..+. ..+.+..+|-.||.+++.+.||.+-..|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 344567899999999999999999999999999999998765543 234567799999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
+|+||..|+||+|..+|...+ .|++..+++++.+|+.||++||+.+||+|||||+|||+|+.| +++|+|+|+|.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G----hvRISDLGLAv 335 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG----HVRISDLGLAV 335 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC----CeEeeccceEE
Confidence 999999999999999997655 799999999999999999999999999999999999999999 89999999999
Q ss_pred cccC--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--ChHHHHHHHHcCCCCCCCCCcc
Q psy6820 528 RVLR--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN--DQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 528 ~~~~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~--~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
.+.. +....+||.+|||||++.+..|+...|+|||||+||||+.|+.||..... ..+++-+.++.....++ +
T Consensus 336 ei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~ 411 (591)
T KOG0986|consen 336 EIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----D 411 (591)
T ss_pred ecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----c
Confidence 8864 44556899999999999999999999999999999999999999965433 23456666666655554 6
Q ss_pred cccHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 604 DISEEAKELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
..++++++|.+.+|++||++|. +++++.+||||+.
T Consensus 412 kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 412 KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 8899999999999999999999 5889999999974
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=368.40 Aligned_cols=246 Identities=34% Similarity=0.652 Sum_probs=211.9
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHH-HHHHhcCCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEV-NILRSVNHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei-~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.+..+++.+|+|++.+..... ....+..|. .+++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999997643221 123344444 457778999999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---CCCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RPMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---~~~~~~ 536 (639)
|+|..++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~----~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG----HVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC----CEEEeecCCcccCCCCCCCcccc
Confidence 99999998888999999999999999999999999999999999999999887 89999999987532 223456
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+||+.|+|||++.+..++.++|||||||++|+|++|..||... +..++++.+.......+ +.++.++.++|++|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~l 230 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR--DVAEMYDNILHKPLVLR----PGASLTAWSILEEL 230 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC--CHHHHHHHHHcCCccCC----CCCCHHHHHHHHHH
Confidence 7999999999999999999999999999999999999999653 45566777776654443 45789999999999
Q ss_pred cccCCCCCCCH----HHHHcCCcccC
Q psy6820 617 LESNPDLRFSA----EDVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rpta----~eiL~HP~f~~ 638 (639)
|+.||.+||++ .++++||||..
T Consensus 231 l~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 231 LEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred hccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 99999999976 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=379.23 Aligned_cols=253 Identities=30% Similarity=0.510 Sum_probs=203.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC--------
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN-------- 447 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-------- 447 (639)
.++|.+++.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 468999999999999999999999999999999885432 3345799999999999999998876322
Q ss_pred CceEEEEeeccCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 448 NELYLVIELIKGGDLFDAIS----KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
..+++||||+++ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~---~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT---HTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC---Cceeeecc
Confidence 247799999965 7777664 356799999999999999999999999999999999999998665 26999999
Q ss_pred cccccccC--CCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc--------
Q psy6820 524 GLAQRVLR--PMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS-------- 592 (639)
Q Consensus 524 Gla~~~~~--~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~-------- 592 (639)
|+|+.... ......||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+... .+.+...+..
T Consensus 216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-VDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHH
Confidence 99986543 2345678999999999865 4689999999999999999999999976432 2222221110
Q ss_pred --------CCCCCCCC--------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 593 --------GQYGFPSP--------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 593 --------~~~~~p~~--------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
....+|.. +....++++.+||.+||++||++|||+.|+++||||++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 01111110 11246789999999999999999999999999999963
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=366.34 Aligned_cols=245 Identities=34% Similarity=0.669 Sum_probs=210.2
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHH-HHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIE-NEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~-~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.+..+++.||+|++.+...... ...+. ++..+++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999976433211 12233 344457788999999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---CCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~~~~ 536 (639)
++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~----~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC----CEEEccCCCCcccccCCCCcccc
Confidence 99999998888899999999999999999999999999999999999999887 799999999975432 23456
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+||+.|+|||++.+..++.++|||||||++|+|++|..||... +..+.+..+......++ +.++.++.++|++|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~ 230 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--NTAEMYDNILNKPLQLK----PNITNSARHLLEGL 230 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC--CHHHHHHHHHhCCcCCC----CCCCHHHHHHHHHH
Confidence 7999999999999999999999999999999999999999643 44566666666544433 47899999999999
Q ss_pred cccCCCCCCCHH----HHHcCCccc
Q psy6820 617 LESNPDLRFSAE----DVLDHPWLE 637 (639)
Q Consensus 617 L~~dP~~Rpta~----eiL~HP~f~ 637 (639)
|+.||.+|+++. ++++|+||.
T Consensus 231 l~~~p~~R~~~~~~~~~i~~~~~~~ 255 (325)
T cd05602 231 LQKDRTKRLGAKDDFMEIKNHIFFS 255 (325)
T ss_pred cccCHHHCCCCCCCHHHHhcCcccC
Confidence 999999999865 899999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=351.62 Aligned_cols=254 Identities=40% Similarity=0.670 Sum_probs=215.8
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHH-HHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ-MIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~-~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
|++++.||+|+||+||++.+..+++.+|+|++.......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 789999999999999999999999999999998876544332 3356999999999999999999999999999999999
Q ss_pred cCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc---cCCCc
Q psy6820 458 KGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV---LRPMF 534 (639)
Q Consensus 458 ~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~---~~~~~ 534 (639)
.+++|.+++.....+++..+..++.||+.||++||+.|++|+||||+||+++.++ .++|+|||.+... .....
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~----~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG----EVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS----EEEESSGTTTEESTSTTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccc
Confidence 9999999999888899999999999999999999999999999999999999887 7899999999753 23344
Q ss_pred cccCCCcccCccccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCC-CChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 535 TVCGTPTYVAPEILN-ESGYGVKIDVWAAGVILYILLCGFPPFVSDT-NDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~-~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~-~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
...+++.|+|||++. +..++.++|+||||+++|+|++|..||.... .+.......................+.++.++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 577899999999998 8889999999999999999999999996541 12233333333322222222222335899999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 613 ISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
|.+||+.||++||++.++++||||
T Consensus 237 i~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHccCChhHCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=364.63 Aligned_cols=246 Identities=33% Similarity=0.633 Sum_probs=211.5
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHH-HHHHhcCCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEV-NILRSVNHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei-~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.+..+++.||+|++.+...... ...+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999976543221 22334444 467889999999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---CCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~~~~ 536 (639)
++|...+.+...+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++..... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG----HVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC----CEEEccCCCCccCCCCCCccccc
Confidence 99999998888899999999999999999999999999999999999999887 899999999875422 23346
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+||+.|+|||++.+..++.++|||||||++|||++|..||... +...+++.+......+| ...+.++.++|.+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~ 230 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR--DVSQMYDNILHKPLQLP----GGKTVAACDLLVGL 230 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC--CHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHH
Confidence 7999999999999989999999999999999999999999654 45666777776655444 46789999999999
Q ss_pred cccCCCCCCCH----HHHHcCCcccC
Q psy6820 617 LESNPDLRFSA----EDVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rpta----~eiL~HP~f~~ 638 (639)
|+.||++||++ .++++||||..
T Consensus 231 l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 231 LHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred ccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 99999999975 59999999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.89 Aligned_cols=255 Identities=33% Similarity=0.584 Sum_probs=213.8
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++.+.||+|+||.||++....+++.||+|++.+.... ...+.+.+|+.+++.++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999999999999999999753322 22345778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 455 ELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 455 E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
||++||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG----HIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC----CEEEEECCceeecCCCC
Confidence 99999999999976 45799999999999999999999999999999999999999887 89999999987654321
Q ss_pred ----ccccCCCcccCcccccc-----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC--CCCCCCCc
Q psy6820 534 ----FTVCGTPTYVAPEILNE-----SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ--YGFPSPYW 602 (639)
Q Consensus 534 ----~~~~GT~~Y~APE~l~~-----~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~--~~~p~~~~ 602 (639)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ...+.+..+.... ..++. ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~-~~ 233 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQFPP-DV 233 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCcccCCC-cc
Confidence 23569999999999863 45788999999999999999999999653 3344555555433 23332 23
Q ss_pred ccccHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccC
Q psy6820 603 DDISEEAKELISHMLESNPDL--RFSAEDVLDHPWLER 638 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~--Rpta~eiL~HP~f~~ 638 (639)
..++.++++||++||..++++ |++++++++||||.+
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 458999999999999764444 789999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=351.82 Aligned_cols=252 Identities=38% Similarity=0.754 Sum_probs=225.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|.+.+.||+|+||.||++.+..+++.+|+|++...... ...+.+.+|+.++++++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4799999999999999999999999999999998765432 22356788999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~ 534 (639)
||+++++|.+++.+...+++..+..++.||+.||+|||+.|++|+||+|.||+++.++ .+||+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~----~~kl~dfg~~~~~~~~~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG----YIKITDFGFAKRVKGRTY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC----CEEEeeCCCccccCCCCC
Confidence 9999999999998888999999999999999999999999999999999999999887 799999999987766666
Q ss_pred cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHH
Q psy6820 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~ 614 (639)
..+|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .....+.+..+...+| ..++..++++|+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~----~~~~~~l~~li~ 230 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKILEGKVRFP----SFFSPDAKDLIR 230 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCccCC----ccCCHHHHHHHH
Confidence 6789999999999988889999999999999999999999996543 4556666666655444 456899999999
Q ss_pred HhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 615 HMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 615 ~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
+||+.||.+|+ +++|+++||||+.
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCccccc
Confidence 99999999999 9999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=366.97 Aligned_cols=245 Identities=36% Similarity=0.690 Sum_probs=210.5
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHHHhc---CCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSV---NHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 385 LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
||+|+||.||+|++..+++.||+|++.+....... .....|..++..+ .||||+.+++.+.+.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999999754332222 2234566666655 699999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---CCccc
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTV 536 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~~~~ 536 (639)
|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~----~~kl~Dfg~a~~~~~~~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG----HIALCDFGLSKANLTDNKTTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC----CEEEecCCcCcCCCCCCCCccCc
Confidence 99999998888999999999999999999999999999999999999999887 799999999875432 23456
Q ss_pred cCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHH
Q psy6820 537 CGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~ 615 (639)
+||+.|+|||++.+. .++.++|||||||++|+|++|..||... +..+.+..+..+...++. ..+++++.+||++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~ 231 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE--DTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKG 231 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC--CHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHH
Confidence 899999999998754 5899999999999999999999999653 456677777777666654 3578999999999
Q ss_pred hcccCCCCCC----CHHHHHcCCcccC
Q psy6820 616 MLESNPDLRF----SAEDVLDHPWLER 638 (639)
Q Consensus 616 ~L~~dP~~Rp----ta~eiL~HP~f~~ 638 (639)
||+.||++|| ++.++++||||.+
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 9999999998 7999999999974
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.37 Aligned_cols=256 Identities=32% Similarity=0.554 Sum_probs=216.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|.+.+.||+|+||.||+++++.+++.||+|++.+.... .....+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999999764322 22345778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 455 ELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 455 E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
||++||+|.+++.+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~----~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG----HIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC----CEEEEeccceeeccCCC
Confidence 99999999999976 46799999999999999999999999999999999999999887 79999999997654322
Q ss_pred ----ccccCCCcccCcccccc-----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC-CCCcc
Q psy6820 534 ----FTVCGTPTYVAPEILNE-----SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP-SPYWD 603 (639)
Q Consensus 534 ----~~~~GT~~Y~APE~l~~-----~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p-~~~~~ 603 (639)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... +..+.+..+......++ +....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~p~~~~ 234 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHEERFQFPSHIT 234 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC--CHHHHHHHHHcCCCcccCCCccc
Confidence 23579999999999875 46789999999999999999999999653 34455566655433222 12335
Q ss_pred cccHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccC
Q psy6820 604 DISEEAKELISHMLESNPDL--RFSAEDVLDHPWLER 638 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~--Rpta~eiL~HP~f~~ 638 (639)
.++++++++|.+||..++++ |++++++++||||+.
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 68999999999999976654 568999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=344.43 Aligned_cols=252 Identities=27% Similarity=0.487 Sum_probs=215.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch----hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG----KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~----~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
++|.+.+.||+|++|.||.|.+..+++.+|+|.+....... ....+.+|+.++++++||||+++++++.+.+.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46899999999999999999999999999999987543221 12457889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||+++++|.+++.....+++..+..++.+++.||+|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~----~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG----NVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEeecccceecccc
Confidence 999999999999998888899999999999999999999999999999999999999887 7999999998754321
Q ss_pred ------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 533 ------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 533 ------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||.... .......+..... .......++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~--~~~~~~~~~ 233 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE--AMAAIFKIATQPT--NPQLPSHVS 233 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc--hHHHHHHHhccCC--CCCCCccCC
Confidence 134568889999999999889999999999999999999999996532 2222222322221 222335689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.++.++|++||..+|++|||+.++++||||
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 234 PDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.32 Aligned_cols=256 Identities=31% Similarity=0.567 Sum_probs=214.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++.+.||+|+||.||++..+.+++.+|+|++.+.... .....+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4799999999999999999999999999999999753322 12345778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 455 ELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
||+++|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~----~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG----HIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC----CEEEeecchheecccCC
Confidence 99999999999976 46799999999999999999999999999999999999999887 7999999998755322
Q ss_pred ---CccccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC-CCcc
Q psy6820 533 ---MFTVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS-PYWD 603 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~-~~~~ 603 (639)
....+||+.|+|||++. ...++.++|||||||++|||++|..||... +..+.+..+......++. ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~p~~~~ 234 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERFQFPAQVT 234 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC--CHHHHHHHHhCCCccccCCCccc
Confidence 22357999999999986 346889999999999999999999999654 445556666554332221 2235
Q ss_pred cccHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccC
Q psy6820 604 DISEEAKELISHMLESNPDL--RFSAEDVLDHPWLER 638 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~--Rpta~eiL~HP~f~~ 638 (639)
.+++++++||++||..++++ |++++|+++||||++
T Consensus 235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 68999999999999765544 689999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=351.22 Aligned_cols=247 Identities=30% Similarity=0.480 Sum_probs=207.9
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCCh
Q psy6820 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL 462 (639)
Q Consensus 385 LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 462 (639)
||+|+||.||++..+.+++.||+|.+....... ....+..|++++++++||||+++++.+.....+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999999999999999997544322 234456799999999999999999999999999999999999999
Q ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--CccccC
Q psy6820 463 FDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--MFTVCG 538 (639)
Q Consensus 463 ~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--~~~~~G 538 (639)
.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++...... .....|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~----~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG----NCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC----CEEEeeceeeeecCCCceeeccCC
Confidence 9888543 3588999999999999999999999999999999999999887 7999999998765432 234578
Q ss_pred CCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--ChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 539 TPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN--DQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 539 T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~--~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
++.|+|||++.+..++.++|+|||||++|||++|..||..... ....+...........+ ...+++++.+||.+|
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~ 233 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLF 233 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHH
Confidence 9999999999988899999999999999999999999965432 22334444444333322 246899999999999
Q ss_pred cccCCCCCCCH----HHHHcCCcccC
Q psy6820 617 LESNPDLRFSA----EDVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rpta----~eiL~HP~f~~ 638 (639)
|+.||++||++ ++++.||||+.
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcC
Confidence 99999999999 77889999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.39 Aligned_cols=256 Identities=29% Similarity=0.503 Sum_probs=207.0
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCC----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNN---- 448 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 448 (639)
.+.++|.+.+.||+|+||.||+|.+..++..+|+|++...... .....+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3568999999999999999999999999999999999754322 23456778999999999999999999886443
Q ss_pred --ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 449 --ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 449 --~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
.+|+||||+.+ +|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~----~~kl~Dfg~a 170 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLA 170 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC----CEEEecCCCc
Confidence 47999999965 67766643 488999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHH--------------
Q psy6820 527 QRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDI-------------- 590 (639)
Q Consensus 527 ~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i-------------- 590 (639)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ...+..+
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH--IDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCcHHHHHH
Confidence 765322 2345789999999999999999999999999999999999999975432 1111111
Q ss_pred --------HcCCCCCCC----------------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 591 --------LSGQYGFPS----------------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 591 --------~~~~~~~p~----------------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.......+. ......++++++||.+||+.||++|||++|+++||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 111111110 011124678999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=363.56 Aligned_cols=256 Identities=37% Similarity=0.670 Sum_probs=228.0
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH-HHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~-~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.+.+-|.+.+.||+|.|+.|.+|++-.+|..||||++++..+.... ..+.+|+.-|+.++|||||+||++..+...+||
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 4456699999999999999999999999999999999988775443 456789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc-
Q psy6820 453 VIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL- 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~- 530 (639)
|+|+-.+|+|+++|-+ ...+.++.+++++.||+.|+.|+|+..+|||||||+|+.+-..- ..|||.|||++..+.
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl---GlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL---GLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec---CceEeeeccccccCCC
Confidence 9999999999999954 45699999999999999999999999999999999999875442 389999999997664
Q ss_pred -CCCccccCCCcccCccccccCCCC-hhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 -RPMFTVCGTPTYVAPEILNESGYG-VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 -~~~~~~~GT~~Y~APE~l~~~~~s-~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
....+.||+..|.|||++.+..|+ +++|||||||+||.|.||++||.. .+..+.+..|+...+..| ..++.+
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe--ANDSETLTmImDCKYtvP----shvS~e 245 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE--ANDSETLTMIMDCKYTVP----SHVSKE 245 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc--ccchhhhhhhhcccccCc----hhhhHH
Confidence 446789999999999999998885 789999999999999999999954 344566677888887777 578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+++||..||+.||++|.+.++|..|+|+|.
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 999999999999999999999999999984
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=352.35 Aligned_cols=256 Identities=32% Similarity=0.492 Sum_probs=212.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhcCCCc-eeeeeeeeecCC-----
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNHPN-IIKLLDEYDTNN----- 448 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~----- 448 (639)
...|..++.||+|+||+||+|+.+.+|+.||+|.+..... ++......+|+.+|+.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456777889999999999999999999999999987654 344455679999999999999 999999998877
Q ss_pred -ceEEEEeeccCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 449 -ELYLVIELIKGGDLFDAISKNV----KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 449 -~~~lV~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
.+++|+||+ .-+|..++.... .++...++.+++||+.||+|||+++|+||||||+||||+.+| .+||+||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G----~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG----VLKLADF 164 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC----cEeeecc
Confidence 899999999 459999997654 577889999999999999999999999999999999999988 8999999
Q ss_pred cccccccCC---CccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy6820 524 GLAQRVLRP---MFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599 (639)
Q Consensus 524 Gla~~~~~~---~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~ 599 (639)
|+|+...-+ .....+|.+|+|||++.+. .|+...||||+||+++||++++.-|.+.+. .++ ...|..-.-....
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~q-l~~If~~lGtP~e 242 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQ-LFRIFRLLGTPNE 242 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHH-HHHHHHHcCCCCc
Confidence 999876533 3356789999999999876 799999999999999999999999987654 222 2233221111111
Q ss_pred CCc--------------------------ccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 600 PYW--------------------------DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 600 ~~~--------------------------~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..| +..+++..+++.+||+.+|++|.|++.+|+||||+.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE 307 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence 111 123458999999999999999999999999999975
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=352.14 Aligned_cols=254 Identities=30% Similarity=0.508 Sum_probs=213.4
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.|++.+.||+|+||.||++.+..+++.+|+|.+........ ...+.+|+.+++.++|+||+.+++.+.+.+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37788999999999999999999999999999876543322 2456789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 456 LIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~----~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG----HIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC----CEEEeeccceeecCCCc
Confidence 99999999988543 3589999999999999999999999999999999999999887 7999999998755322
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh-HHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ-DELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~-~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....||+.|+|||++.+..++.++|+||||+++|+|++|..||....... ......+.. ..+......+++++.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 233 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK---EVQEEYSEKFSPDAR 233 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh---hhhhhcCccCCHHHH
Confidence 234578999999999999899999999999999999999999997543321 111122211 112223356889999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
+|+++||+.||++||| ++|+++||||++
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.07 Aligned_cols=256 Identities=31% Similarity=0.481 Sum_probs=212.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
+++|.+.+.||.|+||.||+|.+..+++.||+|.+...........+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 57899999999999999999999999999999999765544445567789999999999999999999999999999999
Q ss_pred eccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 456 LIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|++ ++|.+++.. ...+++..+..++.||+.||+|||+.|++|+||||+||+++.++ .+||+|||++.....+
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~----~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG----ELKLADFGLARAKSIPTK 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC----cEEECcCcchhccCCCCC
Confidence 996 589888865 35689999999999999999999999999999999999999887 7999999999764422
Q ss_pred -CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC----------------
Q psy6820 533 -MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ---------------- 594 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~---------------- 594 (639)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+. .+....+....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--EEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChhhchhhhcccc
Confidence 223457899999999865 4578999999999999999999999965432 22222221110
Q ss_pred ---CCCCC-------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 595 ---YGFPS-------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 595 ---~~~p~-------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...+. .....+++++++||.+||+.||++|||++|+++||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01110 112357889999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=349.21 Aligned_cols=252 Identities=32% Similarity=0.483 Sum_probs=203.4
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhc---CCCceeeeeeeeec-----CC
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSV---NHPNIIKLLDEYDT-----NN 448 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~-----~~ 448 (639)
+|++.+.||+|+||.||+|.++.+++.+|+|.+....... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999999999999999987543222 223455677777665 69999999998754 34
Q ss_pred ceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
..+++|||+. ++|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~----~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG----QVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----CEEECccCcc
Confidence 5899999996 4898888653 3489999999999999999999999999999999999999887 7999999999
Q ss_pred ccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC----------
Q psy6820 527 QRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ---------- 594 (639)
Q Consensus 527 ~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~---------- 594 (639)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ......+....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH--HHHHHHHHHHhCCCChhhCcc
Confidence 765432 2345789999999999988999999999999999999999999965432 22222222100
Q ss_pred -CCCC------------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 595 -YGFP------------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 595 -~~~p------------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
...+ ....+.++.++.+||.+||++||++|||+.|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 01123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=355.10 Aligned_cols=253 Identities=33% Similarity=0.616 Sum_probs=228.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHHHhcC-CCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVN-HPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~l 452 (639)
..+|..+.+||+|+||.|.++..+.+.+.||||++++..+.+.. +.-..|-.+|.... -|.+++++.+|++-+++|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 35789999999999999999999999999999999988765443 22345777776554 7899999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc--
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL-- 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~-- 530 (639)
||||+.||+|...+++-+++.+..+.+++.+|+-||=+||++|||+||||.+|||+|.+| ++||+|||+++...
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG----HiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC----ceEeeecccccccccC
Confidence 999999999999999999999999999999999999999999999999999999999998 89999999997653
Q ss_pred -CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 531 -RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 531 -~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
....++||||.|+|||++.-.+|+.++||||+||+||||+.|++||.+ .+++++++.|......+| ..+|.++
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG--eDE~elF~aI~ehnvsyP----KslSkEA 577 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG--EDEDELFQAIMEHNVSYP----KSLSKEA 577 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHHHccCcCc----ccccHHH
Confidence 345689999999999999999999999999999999999999999965 477899999999888777 5799999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
.++++.+|.+.|.+|+. -.+|-+||||++
T Consensus 578 v~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 578 VAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 99999999999999995 478999999975
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=375.53 Aligned_cols=251 Identities=27% Similarity=0.522 Sum_probs=217.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCC-CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHK-DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
..|.+.+.||+|+||.||.|....+ +..+|+|.+.... ......+.+|+.+|+.++||||+++++++...+.+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 4599999999999999999988877 7889999775443 2334567789999999999999999999999999999999
Q ss_pred eccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 456 LIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 456 ~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
|++||+|.+++.. ..++++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~----~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC----cEEEEeCcCceecCC
Confidence 9999999987753 45689999999999999999999999999999999999999887 899999999986543
Q ss_pred C-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 532 P-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 532 ~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||... ...++...+..+.... ....++
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~--~~~~~~~~~~~~~~~~---~~~~~s 296 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP--SQREIMQQVLYGKYDP---FPCPVS 296 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCC---CCccCC
Confidence 2 33567999999999999999999999999999999999999999543 4566666666654432 224688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
.++.+||.+||+.||++||++++++.|||++
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence 9999999999999999999999999999985
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=364.96 Aligned_cols=254 Identities=35% Similarity=0.466 Sum_probs=209.4
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----ceE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN-----ELY 451 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~ 451 (639)
+|.+.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47789999999999999999999999999999865322 122356778999999999999999999998776 789
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+||||+. ++|.+.+.....+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~----~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC----VLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC----CEEeccccceeeccc
Confidence 9999995 68999888888899999999999999999999999999999999999999887 899999999975432
Q ss_pred C----CccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHH---------------
Q psy6820 532 P----MFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDIL--------------- 591 (639)
Q Consensus 532 ~----~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~--------------- 591 (639)
. .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+. ......+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP--IQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHHHhh
Confidence 1 2334679999999998774 579999999999999999999999965432 12222211
Q ss_pred --------cCCCCCCC-----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 592 --------SGQYGFPS-----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 592 --------~~~~~~p~-----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
......+. ......++++.+||.+||+.||++|||+.|+++||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 11111111 122346889999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=359.34 Aligned_cols=248 Identities=22% Similarity=0.409 Sum_probs=203.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEc-----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecC-Cc
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDK-----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTN-NE 449 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~-~~ 449 (639)
++|.+++.||+|+||.||+|.+. .++..||+|++...........+.+|+.++..+ +||||++++++|... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 68999999999999999999752 345679999997654444446688999999999 799999999988764 46
Q ss_pred eEEEEeeccCCChHHHHhhc------------------------------------------------------------
Q psy6820 450 LYLVIELIKGGDLFDAISKN------------------------------------------------------------ 469 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~------------------------------------------------------------ 469 (639)
+++||||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 89999999999999998642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-----CccccCCCcc
Q psy6820 470 --VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTY 542 (639)
Q Consensus 470 --~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y 542 (639)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... .....+++.|
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~----~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC----cEEEeecccccccccCcchhcccCCCCCccc
Confidence 2477888999999999999999999999999999999999887 7999999999765321 1223456789
Q ss_pred cCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCC
Q psy6820 543 VAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNP 621 (639)
Q Consensus 543 ~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP 621 (639)
+|||++.+..++.++|||||||+||||++ |..||...... +.+...+..+.. .+ ....+++++.+|+.+||+.||
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGTR-MR--APENATPEIYRIMLACWQGDP 318 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcCCC-CC--CCCCCCHHHHHHHHHHccCCh
Confidence 99999999999999999999999999997 99999764432 333344444332 11 125678999999999999999
Q ss_pred CCCCCHHHHHc
Q psy6820 622 DLRFSAEDVLD 632 (639)
Q Consensus 622 ~~Rpta~eiL~ 632 (639)
++|||+.|+++
T Consensus 319 ~~RPs~~el~~ 329 (338)
T cd05102 319 KERPTFSALVE 329 (338)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=355.86 Aligned_cols=251 Identities=29% Similarity=0.460 Sum_probs=194.3
Q ss_pred EEEEccCCceEEEEEEEc--CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec--CCceEEEEeec
Q psy6820 382 GQIIGDGNFAVVRQVYDK--HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT--NNELYLVIELI 457 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~--~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV~E~~ 457 (639)
++.||+|+||.||+|..+ .+++.+|+|.+..... ...+.+|+.++++++||||+++++++.. ....|++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999865 4678899999875432 3446789999999999999999998854 45689999998
Q ss_pred cCCChHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 458 KGGDLFDAISKN---------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 458 ~ggsL~~~l~~~---------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.....+||+|||++..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 5 5888887432 25899999999999999999999999999999999999954332223799999999976
Q ss_pred ccCC------CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh-------HHHHHHHHcCC
Q psy6820 529 VLRP------MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ-------DELFDDILSGQ 594 (639)
Q Consensus 529 ~~~~------~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~-------~~l~~~i~~~~ 594 (639)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.....+. ......+....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 5432 234678999999999876 468999999999999999999999996543211 11111111100
Q ss_pred CCC-----------C-----------------------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 595 YGF-----------P-----------------------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 595 ~~~-----------p-----------------------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
... + .......+.++.+||++||+.||++|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 0 00001235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=373.20 Aligned_cols=258 Identities=30% Similarity=0.471 Sum_probs=214.1
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-C-----CceeeeeeeeecC
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-H-----PNIIKLLDEYDTN 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-H-----pnIv~l~~~~~~~ 447 (639)
.+.-+|.+.++||+|+||.|.+|.+..+++.||||+++....- ......|+.+|..|+ | -|+|+++++|...
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f--~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF--LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH--HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 3445899999999999999999999999999999999865322 233456999999997 4 3799999999999
Q ss_pred CceEEEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
+++|||+|.+ ..+|+++|+.+. .++...++.++.||+.||.+||+.||||+||||+||||...+. ..|||+|||+
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r--~~vKVIDFGS 337 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR--SRIKVIDFGS 337 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc--CceeEEeccc
Confidence 9999999999 569999998764 5899999999999999999999999999999999999977652 2799999999
Q ss_pred cccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC------------
Q psy6820 526 AQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG------------ 593 (639)
Q Consensus 526 a~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~------------ 593 (639)
|+......++++.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.++ .++ +..|..-
T Consensus 338 Sc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne-~DQ-l~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 338 SCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE-YDQ-LARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH-HHH-HHHHHHHhCCCCHHHHHhc
Confidence 99998888899999999999999999999999999999999999999888866532 222 2222110
Q ss_pred ----------------------------------------CCCCCC--C----Ccc-cccHHHHHHHHHhcccCCCCCCC
Q psy6820 594 ----------------------------------------QYGFPS--P----YWD-DISEEAKELISHMLESNPDLRFS 626 (639)
Q Consensus 594 ----------------------------------------~~~~p~--~----~~~-~l~~~l~dLI~~~L~~dP~~Rpt 626 (639)
....|. + ... .-...+.|+|++||++||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 000010 0 000 12356899999999999999999
Q ss_pred HHHHHcCCcccC
Q psy6820 627 AEDVLDHPWLER 638 (639)
Q Consensus 627 a~eiL~HP~f~~ 638 (639)
+.++|+||||.+
T Consensus 496 p~qal~Hpfl~~ 507 (586)
T KOG0667|consen 496 PAQALNHPFLTG 507 (586)
T ss_pred HHHHhcCccccc
Confidence 999999999984
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=362.26 Aligned_cols=257 Identities=30% Similarity=0.491 Sum_probs=210.7
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTN----- 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 447 (639)
.+.++|.+.+.||.|+||.||+|.+..+++.||+|++...... .....+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999999999999999998754322 2234566899999999999999999987533
Q ss_pred -CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 448 -NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 448 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
...|++||++ +++|.+++. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~----~~kl~Dfg~~ 165 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC----ELRILDFGLA 165 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC----CEEEcCCccc
Confidence 4579999998 789988775 45799999999999999999999999999999999999999887 7999999999
Q ss_pred ccccCCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC------------
Q psy6820 527 QRVLRPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG------------ 593 (639)
Q Consensus 527 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~------------ 593 (639)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+...
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 166 RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND--YIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred eecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHhc
Confidence 877666667789999999999876 568999999999999999999999996532 22222222110
Q ss_pred -----------CCCCCC----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 -----------QYGFPS----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 -----------~~~~p~----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
....+. ..+...++.+.+||.+||+.||++|||+.|+++||||.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 001111 112345778999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=354.56 Aligned_cols=252 Identities=34% Similarity=0.596 Sum_probs=208.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC---C--ceE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN---N--ELY 451 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~---~--~~~ 451 (639)
-.|.-.+++|.|+||.||.|....+++.+|||.+-.+.. .-.+|+.+|+.+.|||||+|..+|... + ++.
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 458889999999999999999999999999998754432 234799999999999999999988432 2 456
Q ss_pred EEEeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 452 LVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
+||||++. +|++.++. +..++.-.++-++.||++||+|||+.||+||||||+|+|+|.+. ..+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t---g~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT---GVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC---CeEEeccCCcce
Confidence 89999975 99999974 57799999999999999999999999999999999999999885 389999999998
Q ss_pred ccc--CCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHH-----------HHcC
Q psy6820 528 RVL--RPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDD-----------ILSG 593 (639)
Q Consensus 528 ~~~--~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~-----------i~~~ 593 (639)
... ++..++..|..|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.+.+.. +++.+. |...
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHHhCCCCHHHHhhc
Confidence 775 45567788999999998865 67999999999999999999999999876532 222111 1111
Q ss_pred C-----CCCCC---C-----CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 Q-----YGFPS---P-----YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 ~-----~~~p~---~-----~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
. ..+|. . ....+++++.+|+.++|+.+|.+|.++.|++.||||++
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 1 11111 1 12457999999999999999999999999999999974
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=350.84 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=214.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||+|+||.||++.+..++..+|+|.+...........+.+|+.++++++||||+++++.+.+++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46999999999999999999999999999999987654333445678899999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-Cc
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-MF 534 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-~~ 534 (639)
+++++|.+++.+...+++..+..++.|++.||+|||+ .+++|+||||+|||++.++ .+||+|||++...... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG----EIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC----cEEEccCCCcccccccccc
Confidence 9999999999888889999999999999999999997 5899999999999999887 7999999998755432 33
Q ss_pred cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC------------------
Q psy6820 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG------------------ 596 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~------------------ 596 (639)
..+|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+ .......+......
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 5678999999999988889999999999999999999999995432 11111111110000
Q ss_pred ----------------CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 597 ----------------FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 597 ----------------~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.|......++.++.+|+.+||..||++||++.++++||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 000001236789999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=345.37 Aligned_cols=252 Identities=28% Similarity=0.452 Sum_probs=212.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|.+.+.||+|+||.||+|.+..+++.+|+|++...........+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788999999999999999999999999999997654444456688999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-Ccc
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-MFT 535 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-~~~ 535 (639)
+++++|..+ ..+++..+..++.|++.||+|||+.||+|+||||+||+++.++ .+||+|||++...... ...
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~----~~~l~dfg~~~~~~~~~~~~ 152 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG----QVKLCDFGVSTQLVNSIAKT 152 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC----CEEEeeCCcceecccccccC
Confidence 999998654 3578899999999999999999999999999999999999887 8999999999765433 345
Q ss_pred ccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh-----HHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 536 VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ-----DELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 536 ~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~-----~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.+||+.|+|||++.+..++.++|+||||+++|+|++|..||....... ......+..... +.......++++.
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 230 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSEKFV 230 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCCcCCHHHH
Confidence 679999999999999899999999999999999999999996432211 122223322211 1111245788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++|.+||+.||++||+++|+++||||+.
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 9999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=367.22 Aligned_cols=251 Identities=35% Similarity=0.684 Sum_probs=229.2
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH-HHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCC
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~-~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
.++||.|.||+||-|+++.+|+.||||++++..+..+. ..+++|++||+++.||.||.+.-.|++.+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 57899999999999999999999999999987776544 5688999999999999999999999999999999999954
Q ss_pred ChHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC--ccc
Q psy6820 461 DLFDAI--SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM--FTV 536 (639)
Q Consensus 461 sL~~~l--~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~--~~~ 536 (639)
++.+.| ++.+++++...++++.||+.||.|||.+||+|+||||+|||+.... .-..+||||||+|+...+.. .+.
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~-~FPQvKlCDFGfARiIgEksFRrsV 726 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS-PFPQVKLCDFGFARIIGEKSFRRSV 726 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC-CCCceeeccccceeecchhhhhhhh
Confidence 666655 4467899999999999999999999999999999999999997663 33479999999999887653 467
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+|||.|+|||++.+.+|+..-||||.||++|.-+.|..||. +.+++.++|.+..+.+|+.-|+.+++++.|||..+
T Consensus 727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN----EdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~L 802 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN----EDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNL 802 (888)
T ss_pred cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC----CccchhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence 89999999999999999999999999999999999999993 45678899999999999999999999999999999
Q ss_pred cccCCCCCCCHHHHHcCCcccC
Q psy6820 617 LESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
|+..-++|.+.+..+.|||+|+
T Consensus 803 LqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 803 LQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHhcchHhhccchhhhc
Confidence 9999999999999999999985
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=374.34 Aligned_cols=255 Identities=29% Similarity=0.509 Sum_probs=218.3
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCC----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNN---- 448 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 448 (639)
...++|.+.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34579999999999999999999999999999999997654432 2355778999999999999999988764332
Q ss_pred ----ceEEEEeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEE
Q psy6820 449 ----ELYLVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 449 ----~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL 520 (639)
.+++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+|||++.++ .+||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~----~vkL 184 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG----LVKL 184 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC----CEEE
Confidence 36899999999999998854 34689999999999999999999999999999999999999887 8999
Q ss_pred eeccccccccC-----CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC
Q psy6820 521 GDFGLAQRVLR-----PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY 595 (639)
Q Consensus 521 ~DFGla~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~ 595 (639)
+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||... +..++...+..+..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--NMEEVMHKTLAGRY 262 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHhcCCC
Confidence 99999876532 234568999999999999999999999999999999999999999643 45566666666543
Q ss_pred CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 596 GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 596 ~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
. +....+++++.+|+.+||+.||++||++.++++|||++
T Consensus 263 ~---~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~ 301 (496)
T PTZ00283 263 D---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301 (496)
T ss_pred C---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHH
Confidence 2 22357899999999999999999999999999999975
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=366.69 Aligned_cols=254 Identities=35% Similarity=0.545 Sum_probs=228.9
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH-HHHHHHHHHHHhcCCCceeeeeeeeecCCc-eEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVNHPNIIKLLDEYDTNNE-LYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~-~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-~~lV 453 (639)
+++|..++++|+|+||.+++++++..+..+++|.+......... +...+|+.++++++|||||.+.+.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 57899999999999999999999999999999999877665544 357799999999999999999999998888 9999
Q ss_pred EeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 454 IELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
|+||+||+|.+.|.+. .-|+++.+..++.|++.|+.|||+++|+|||||+.||++..++ .|||+|||+|+....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~----~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK----KVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC----ceeecchhhhhhcCC
Confidence 9999999999999664 4699999999999999999999999999999999999999887 789999999998875
Q ss_pred C---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 532 P---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 532 ~---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
+ ..+..|||.||+||++.+.+|+.++|||||||++|||++-+++|.+ .+...+...|.++.+. +.....+.+
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a--~~m~~Li~ki~~~~~~---Plp~~ys~e 233 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA--SNMSELILKINRGLYS---PLPSMYSSE 233 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc--cchHHHHHHHhhccCC---CCCccccHH
Confidence 5 3568899999999999999999999999999999999999999954 4667788888887632 233678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++.||..||+++|+.||++.++|.+|.+++
T Consensus 234 l~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 234 LRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 999999999999999999999999998763
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=361.19 Aligned_cols=256 Identities=27% Similarity=0.471 Sum_probs=207.9
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTN----- 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 447 (639)
.+.++|.+.+.||+|+||.||+|.+..+++.+|+|++...... .....+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3568999999999999999999999999999999999754322 2235567899999999999999999987543
Q ss_pred -CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 448 -NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 448 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
...|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~~kL~DfG~a 173 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLA 173 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC----cEEEEeCCCc
Confidence 35799999995 478877754 488999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC----------
Q psy6820 527 QRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ---------- 594 (639)
Q Consensus 527 ~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~---------- 594 (639)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+ ..+.+..+....
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD--HIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCCHHHHHh
Confidence 765432 234578999999999999999999999999999999999999996543 222222222110
Q ss_pred ------------CCCC----------------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 595 ------------YGFP----------------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 595 ------------~~~p----------------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+. .......+.++++||.+||+.||++|||+.|+|+||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0000 0011123568999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=347.08 Aligned_cols=253 Identities=30% Similarity=0.517 Sum_probs=213.9
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.|+..+.||+|+||+||+|.+..+++.+|+|.+........ ...+.+|+.+++.++|+||+.+++.+...+..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37788999999999999999999999999999876543322 3456789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC--
Q psy6820 456 LIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-- 531 (639)
Q Consensus 456 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-- 531 (639)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~----~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG----HIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC----CEEEecCCcceecCCCC
Confidence 99999999888543 4699999999999999999999999999999999999999887 799999999865532
Q ss_pred CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh--HHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ--DELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~--~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||....... +.+...+.... ..+...++.++
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 232 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----EVYSAKFSEEA 232 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----cccCccCCHHH
Confidence 2234578999999999998899999999999999999999999996543211 12222222222 23345788999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
.+|+.+||+.||++||+ ++++++||||..
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 99999999999999999 899999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=338.80 Aligned_cols=254 Identities=28% Similarity=0.487 Sum_probs=216.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||.|+||.||+|....++..+|+|++...........+.+|+.+++.++|+||+++++.+...+..|++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999998899999999998766555567788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 457 IKGGDLFDAISKN---VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~---~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~----~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG----SVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC----CEEEcccchHHHhccCc
Confidence 9999999999764 4589999999999999999999999999999999999999887 79999999987665322
Q ss_pred -------ccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC-CCCCC-Ccc
Q psy6820 534 -------FTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY-GFPSP-YWD 603 (639)
Q Consensus 534 -------~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~-~~p~~-~~~ 603 (639)
....|+..|+|||++... .++.++|+||||+++|+|++|..||..... ...+..+..... .++.. .+.
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP--MKVLMLTLQNDPPSLETGADYK 234 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh--hhhHHHHhcCCCCCcCCccccc
Confidence 234689999999998776 789999999999999999999999965432 233333333322 12111 124
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.+++++.+++.+||+.||++||++.+++.||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 678999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=360.23 Aligned_cols=255 Identities=29% Similarity=0.494 Sum_probs=206.8
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTN----- 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 447 (639)
...++|.+.+.||+|+||.||+|.+..+++.+|+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3568999999999999999999999999999999998764332 2235567899999999999999999988543
Q ss_pred -CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 448 -NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 448 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~----~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC----CEEEeeCccc
Confidence 357999999965 77777754 488999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc------------
Q psy6820 527 QRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS------------ 592 (639)
Q Consensus 527 ~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~------------ 592 (639)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+..
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHHh
Confidence 765433 2346789999999999999999999999999999999999999965431 111111100
Q ss_pred ----------CCC-----CCC-----------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 593 ----------GQY-----GFP-----------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 593 ----------~~~-----~~p-----------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
... .++ .......+.++++||.+||+.||++|||+.|+++||||+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 000 000 011122467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=335.11 Aligned_cols=250 Identities=29% Similarity=0.455 Sum_probs=216.9
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|.+.+.||+|+||.||+|....+++.|++|.+...... .....+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 488899999999999999999999999999998754432 3345678899999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 457 IKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
+++++|.+++... ..+++..+..++.+++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~----~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD----NVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC----CEEEcccccceeccCccc
Confidence 9999999999764 5789999999999999999999999999999999999999887 7999999998765432
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||... +.......+..+.... ....++.++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN--NQGALILKIIRGVFPP---VSQMYSQQLAQ 231 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCC---CccccCHHHHH
Confidence 23457899999999999999999999999999999999999999654 3455555555543222 22367899999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
++.+||+.+|++||++.++++|||+
T Consensus 232 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 232 LIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHccCCcccCcCHHHHhhCCCC
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.42 Aligned_cols=254 Identities=32% Similarity=0.579 Sum_probs=218.8
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++.+.||+|+||.||+|.+..+++.+|+|.+....... ....+.+|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765443 3456788999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 455 ELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||+.+++|.+++.+. ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG----HIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC----CEEEeecchhhccccc
Confidence 999999999998754 5689999999999999999999999999999999999999887 7999999998654211
Q ss_pred --------------------------------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCC
Q psy6820 533 --------------------------------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDT 580 (639)
Q Consensus 533 --------------------------------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~ 580 (639)
.....||..|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 112467889999999999889999999999999999999999996543
Q ss_pred CChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCC----HHHHHcCCcccC
Q psy6820 581 NDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFS----AEDVLDHPWLER 638 (639)
Q Consensus 581 ~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpt----a~eiL~HP~f~~ 638 (639)
....+..+......++.. ..++.++.++|.+||+.||++||+ ++|+++||||+.
T Consensus 237 --~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 237 --RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred --hHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 344445555544444332 347999999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=334.02 Aligned_cols=250 Identities=29% Similarity=0.552 Sum_probs=213.5
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec-CCceEEEEe
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDT-NNELYLVIE 455 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV~E 455 (639)
+|++.+.||+|++|.||++.++.+++.+|+|.+...... ...+.+.+|+.++++++|+|++++++.+.. ...+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 589999999999999999999999999999998765432 234567889999999999999999998764 446899999
Q ss_pred eccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 456 LIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|+++++|.+++.. ...+++.++..++.+++.||++||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~----~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN----IIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC----cEEEecccceEEecccC
Confidence 9999999999965 34589999999999999999999999999999999999999887 8999999999765422
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||... +.......+..+... .....+++++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK--DMNSLVYRIIEGKLP---PMPKDYSPELG 231 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhcCCC---CCccccCHHHH
Confidence 23456899999999999999999999999999999999999999643 334444455554331 22356889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
+++.+||+.||++||++.+++.||||
T Consensus 232 ~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 232 ELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=361.03 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=208.0
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcC--CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKH--KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
...+|.+++.||+|+||.||+|.... .+..+|+|.+... ....+|+.+|++++||||+++++++......|+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 34689999999999999999997643 4678999988653 234689999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
+||++. ++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~----~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE----NAVLGDFGAACKLDAH 238 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC----CEEEccCccccccCcc
Confidence 999995 69999997778899999999999999999999999999999999999999887 8999999999765432
Q ss_pred -----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh-HHHHHHHHcC----CCCCCC---
Q psy6820 533 -----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ-DELFDDILSG----QYGFPS--- 599 (639)
Q Consensus 533 -----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~-~~l~~~i~~~----~~~~p~--- 599 (639)
.....||+.|+|||++.+..|+.++|||||||++|||++|..||.+..... ...+..+... ...++.
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 234679999999999999999999999999999999999999996543211 1111111110 000000
Q ss_pred ----------------CC-------cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 600 ----------------PY-------WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 600 ----------------~~-------~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++ ...++.+++++|++||+.||++|||+.|+|.||||++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 00 0235778999999999999999999999999999975
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=338.59 Aligned_cols=250 Identities=26% Similarity=0.464 Sum_probs=213.0
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--------HHHHHHHHHHHHhcCCCceeeeeeeeecCCc
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--------KQMIENEVNILRSVNHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--------~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 449 (639)
+|.+++.||+|+||.||+|.+..+++.+|+|.+........ .+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47788999999999999999998899999999865433221 2457789999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
.+++|||+++++|.+++...+.+++..+..++.+++.||+|||+.|++||||+|+||+++.++ .+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~----~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG----GIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC----CEEecccCCCccc
Confidence 999999999999999998888899999999999999999999999999999999999999887 7999999998766
Q ss_pred cCC---------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy6820 530 LRP---------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600 (639)
Q Consensus 530 ~~~---------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~ 600 (639)
... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~---~~~~ 231 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--LQAIFKIGEN---ASPE 231 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--HHHHHHHhcc---CCCc
Confidence 421 1234688999999999988899999999999999999999999965322 2222222222 1122
Q ss_pred CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 601 ~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
....++.++.++|++||+.||++||++.++++||||
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 234688999999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.53 Aligned_cols=252 Identities=28% Similarity=0.495 Sum_probs=217.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|.+.+.||.|+||.||+|.+..+++.+|+|++...........+.+|+.+++.++||||+++++++.+...+|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999999999999999997665444456678999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---C
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---M 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~ 533 (639)
+++++|.+++... ++++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~----~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG----DVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC----CEEEcccccceeeccccccc
Confidence 9999999999765 899999999999999999999999999999999999999987 7999999999776533 2
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc-ccHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD-ISEEAKEL 612 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~-l~~~l~dL 612 (639)
....|++.|+|||.+.+..++.++||||||+++|+|+||..||.... .......+..... ...... ++.++.++
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 230 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH--PMRVLFLIPKNNP---PSLEGNKFSKPFKDF 230 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc--hHHHHHHhhhcCC---CCCcccccCHHHHHH
Confidence 34578899999999998889999999999999999999999996543 2333333333321 111122 78999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 613 ISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+||..||++|||++++++||||++
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcC
Confidence 99999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=362.23 Aligned_cols=242 Identities=25% Similarity=0.443 Sum_probs=210.0
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
.+++++.||+|.||.||.|....+. .||+|.++...+ ..+.|.+|+.+|++|+|+|||+++++|..++.+|||||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCC-cccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 4567889999999999999877653 699999976643 2567789999999999999999999999988999999999
Q ss_pred cCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCcc
Q psy6820 458 KGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT 535 (639)
Q Consensus 458 ~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~ 535 (639)
+.|+|.++|+. ...+...+...++.|||+||+||+++++|||||.+.||||+.+. .+||+|||+|+...+..++
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~----~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL----VVKISDFGLARLIGDDEYT 359 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc----eEEEcccccccccCCCcee
Confidence 99999999986 56799999999999999999999999999999999999999987 8999999999965544432
Q ss_pred c-cC---CCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 536 V-CG---TPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 536 ~-~G---T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
. .| ...|.|||.+..+.++.++|||||||+||||+| |+.||...+ ..++.+.+..|- .+|.| ..+|+++.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--n~ev~~~le~Gy-Rlp~P--~~CP~~vY 434 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--NEEVLELLERGY-RLPRP--EGCPDEVY 434 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--HHHHHHHHhccC-cCCCC--CCCCHHHH
Confidence 2 22 456999999999999999999999999999998 899996654 466777777764 34433 68999999
Q ss_pred HHHHHhcccCCCCCCCHHHHH
Q psy6820 611 ELISHMLESNPDLRFSAEDVL 631 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL 631 (639)
+|+..||..+|++|||++.+.
T Consensus 435 ~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 435 ELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHhhCCcccCCCHHHHH
Confidence 999999999999999998654
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=391.95 Aligned_cols=253 Identities=34% Similarity=0.611 Sum_probs=226.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|.++++||+|+||.|.+++.+.+++.||+|++++..+. .....|..|-.+|.--+.+.|++++..|+++.++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 6899999999999999999999999999999999886654 22356888999998888999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
||++||+|..++.+..++++..+++|+.+|+.||..||+.|+|||||||+|||||..| ++||+|||.+..+...
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G----HikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG----HIKLADFGSCLKMDADGT 230 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC----cEeeccchhHHhcCCCCc
Confidence 9999999999999988999999999999999999999999999999999999999999 9999999999777633
Q ss_pred --CccccCCCcccCccccc----c-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC--CCCCCCCCcc
Q psy6820 533 --MFTVCGTPTYVAPEILN----E-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG--QYGFPSPYWD 603 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~----~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~--~~~~p~~~~~ 603 (639)
....+|||.|++||++. + +.|++.+||||+||++|||+.|..||+.+ ...+.+-.|.+- .+.||.. .
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--slveTY~KIm~hk~~l~FP~~--~ 306 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--SLVETYGKIMNHKESLSFPDE--T 306 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--HHHHHHHHHhchhhhcCCCcc--c
Confidence 34578999999999984 3 57999999999999999999999999865 346677777776 5667633 4
Q ss_pred cccHHHHHHHHHhcccCCCCCCC---HHHHHcCCcccC
Q psy6820 604 DISEEAKELISHMLESNPDLRFS---AEDVLDHPWLER 638 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpt---a~eiL~HP~f~~ 638 (639)
.+|+++++||++++. +|+.|.+ ++++..||||.+
T Consensus 307 ~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 699999999999987 5888998 999999999975
|
|
| >KOG3757|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=347.50 Aligned_cols=216 Identities=46% Similarity=0.775 Sum_probs=186.4
Q ss_pred CceEEEEEecCCCCCCcEEEEECCccccCHHHHHHHHHHHHhhcCCCcccceEeecCCC-ceeccccccccCCeEEEecC
Q psy6820 99 RAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDG-QKVTNIDELEDGKFYICSSS 177 (639)
Q Consensus 99 ~~k~v~~~rNgd~~~~g~~~~v~~~~~~~~~~ll~~~t~~l~~~~~l~~~vr~~~t~~g-~~v~~l~~l~~g~~yv~~~~ 177 (639)
+||+|.||||||+||+|++++||+++|++||+||++||+. |+||+|||+|||++| |+|++||+|+||+.|||+|.
T Consensus 28 ~ak~i~fYrnGD~~~~Gv~~vv~~~rv~sfe~Ll~~lt~~----v~lp~Gvr~iyT~~G~~~I~sldeledG~sYV~ss~ 103 (301)
T KOG3757|consen 28 KAKRISFYRNGDPYFKGVKFVVNPRRVKSFEPLLEDLTRR----VQLPFGVRHIYTPDGGHRITSLDELEDGGSYVASSN 103 (301)
T ss_pred CceEEEEeccCCccCCceEEEecccccCchHHHHHhhccc----cCCCccceeeecCCCCceeccHHHhhcccceeccCc
Confidence 8999999999999999999999999999999999999976 679999999999998 99999999999999999995
Q ss_pred CCcccccccccccCCCCCCCCCCCCcc----cccCCCCCCCCCCCCccccceEEEEEEcCCCCcccEEEEecCCCCCCHH
Q psy6820 178 GDQFKKVDYAILNNNNSSNTLPRSGKF----ITKSAPPRVNKTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLD 253 (639)
Q Consensus 178 ~e~f~~~~y~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~p~~i~v~rng~~~~~~~~~~l~~~~~~~~~ 253 (639)
|.|++++|+....+.++|........ .+..+........+..+++|++|++++||+++++..++++|+++..+||
T Consensus 104 -~~Fkp~~Y~~~~~~~~~~~~~~~~~~~~~~~~a~s~~~a~~~~~~~~~~p~~v~~i~~~~k~R~~~r~~~n~~~~~Sfd 182 (301)
T KOG3757|consen 104 -ENFKPVDYSKIREPSWSPPSKNKSKYRDRSPLAVSRSVASARERVPFQRPRIVTVIREGVKPRRAVRLLLNKKTAMSFD 182 (301)
T ss_pred -ccccccccccccCCCcchhhhcccccCccchhhhccccccccccCCccceeeeeeecccccccchhhcccCcccccchh
Confidence 89999999987755555444433321 1111112233445678899999999999999999999999999999999
Q ss_pred HHHHhhhhhccCCCccccceeccCCccccccccccccCcEEEEc-CCccccC-CcccccHHHHHHHHH
Q psy6820 254 QCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAY-GSERVLP-DDFELDVEEVKAIQA 319 (639)
Q Consensus 254 ~~l~~it~~~~~~~g~v~~lyt~~g~~v~~~~~~~~~~d~yva~-G~e~~~~-dd~~~~~ee~~~i~~ 319 (639)
|+|.++|++|++.+|+|++|||++|+++.++++++-++|+|+|+ |.+++.- +|+..+.+++..+..
T Consensus 183 ~vl~~~t~~v~~~sg~~~kl~t~~~~~~~~l~~~~~~~~vf~a~gg~~~~~~~~d~~~~~~e~r~~~~ 250 (301)
T KOG3757|consen 183 QVLPDVTPAVRLDSGAVKKLYTLDGKRVLSLSDFFGDDDVFVAYGGAEFFRGVEDFLLDEEEVRSLKK 250 (301)
T ss_pred hccccccceeecccCccccccccccccccCHHHccccccEEEecCCCccccchhhhccchhhhccccC
Confidence 99999999999999999999999999999999988899999999 5555544 788888887775544
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.97 Aligned_cols=254 Identities=25% Similarity=0.498 Sum_probs=212.7
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc---------hhHHHHHHHHHHHHhcCCCceeeeeeeeecCC
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL---------GKKQMIENEVNILRSVNHPNIIKLLDEYDTNN 448 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 448 (639)
+|.+.+.||.|+||.||+|....+++.+|+|.+...... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588899999999999999999989999999988643211 11245778999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
..++||||+++++|.+++.+.+.+++..+..++.+|+.||.|||++|++||||+|+||+++.++ .++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~----~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG----ICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC----eEEEeecccccc
Confidence 9999999999999999998888899999999999999999999999999999999999999887 899999999976
Q ss_pred ccCC-----CccccCCCcccCccccccCC--CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc-CCCCCCCC
Q psy6820 529 VLRP-----MFTVCGTPTYVAPEILNESG--YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS-GQYGFPSP 600 (639)
Q Consensus 529 ~~~~-----~~~~~GT~~Y~APE~l~~~~--~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~-~~~~~p~~ 600 (639)
.... .....|+..|+|||.+.... ++.++|+||||+++|+|++|..||..... .....+.... ....++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-IAAMFKLGNKRSAPPIPPD 236 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-HHHHHHhhccccCCcCCcc
Confidence 5422 22356889999999987654 89999999999999999999999954322 2222222111 12233444
Q ss_pred CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 601 ~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
....++.++.++|.+||.+||++||+++++++||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 445679999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.89 Aligned_cols=250 Identities=25% Similarity=0.405 Sum_probs=202.4
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
.+|++.+.||+|+||.||+|.+..+++.||+|+..... ...|+.++++++||||+++++++...+..++|||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 47999999999999999999999999999999854332 24689999999999999999999999999999999
Q ss_pred ccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC--CC
Q psy6820 457 IKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--PM 533 (639)
Q Consensus 457 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~--~~ 533 (639)
+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... ..
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~----~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD----QVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----CEEEecCccccccccCccc
Confidence 95 588888854 46799999999999999999999999999999999999999887 799999999975332 23
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCC-CCCCCCh--------HHHHHHHHcCC---CCCC---
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPF-VSDTNDQ--------DELFDDILSGQ---YGFP--- 598 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf-~~~~~~~--------~~l~~~i~~~~---~~~p--- 598 (639)
....||+.|+|||++.+..++.++|||||||++|||+++..|+ ....... ..+...+.... ..++
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 4567999999999999999999999999999999999855444 3322111 11111111100 0111
Q ss_pred ------------------CC-----CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 599 ------------------SP-----YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 599 ------------------~~-----~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.. ....++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00 01245778889999999999999999999999999985
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.63 Aligned_cols=256 Identities=26% Similarity=0.462 Sum_probs=213.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||+|+||.||+|.+..+++.+|+|.+...........+.+|+.++++++||||+++++.+...+.+|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999999999999999987543333345678999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 457 IKGGDLFDAISKN---VKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 457 ~~ggsL~~~l~~~---~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
+++++|..++... ..+++..+..++.+++.||.|||+ .|++|+||||+||+++.++ .+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG----QVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC----CEEEeecCCcccccCC
Confidence 9999999988763 379999999999999999999997 5999999999999999876 7999999999765432
Q ss_pred -CccccCCCcccCccccccC------CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 533 -MFTVCGTPTYVAPEILNES------GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~------~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
.....|++.|+|||.+.+. .++.++|+|||||++|+|++|..||..... ......+.......+......+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHHHHHHhhcCCCCCCccc
Confidence 3345688999999998543 358899999999999999999999965322 2222222221112223334568
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.++.++|.+||+.+|++||+++++++||||.+
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence 999999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=341.32 Aligned_cols=255 Identities=27% Similarity=0.480 Sum_probs=217.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||.|+||.||+|.++.+++.+|+|.+...........+.+|+.+++.++||||+++++.+...+.+++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999999999999999998765545556788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-C
Q psy6820 457 IKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-M 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-~ 533 (639)
+++++|.+++... ..+++..+..++.+++.||+|||+ .|++|+||||+||+++.++ .++|+|||.+...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~----~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG----QIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC----CEEEeecccchhhHHHHh
Confidence 9999999999775 789999999999999999999999 9999999999999999887 7999999998765422 1
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC---ChHHHHHHHHcCCC-CCCCCCcccccHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN---DQDELFDDILSGQY-GFPSPYWDDISEEA 609 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~---~~~~l~~~i~~~~~-~~p~~~~~~l~~~l 609 (639)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+.+..... ..+. ..++.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 233 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS---GKFSPDF 233 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh---hhcCHHH
Confidence 236789999999999988999999999999999999999999965432 22233333333321 1111 2278999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.++|.+||..||++|||+.+++.||||++
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=343.62 Aligned_cols=255 Identities=33% Similarity=0.591 Sum_probs=219.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|.+.+.||+|+||.||++.+..+++.|++|.+...... .....+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3689999999999999999999999999999998765432 22356778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--- 531 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~--- 531 (639)
||++|++|.+++...+.+++..+..++.+++.||+|||+.|++||||||+||+++.++ .+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~----~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC----CEEEeeCCCccccCcCcc
Confidence 9999999999998888899999999999999999999999999999999999999887 899999999863210
Q ss_pred ---------------CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 532 ---------------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 532 ---------------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
......|+..|+|||.+.+..++.++|+||||+++|||++|..||.+. ...++...+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--~~~~~~~~~~~~~~~ 234 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQVISDDIE 234 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcccC
Confidence 011245788999999998888999999999999999999999999654 345666666666544
Q ss_pred CCCCCcccccHHHHHHHHHhcccCCCCCCC---HHHHHcCCcccC
Q psy6820 597 FPSPYWDDISEEAKELISHMLESNPDLRFS---AEDVLDHPWLER 638 (639)
Q Consensus 597 ~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpt---a~eiL~HP~f~~ 638 (639)
.+... ..++.++.++|.+||+.||++||+ +.++++||||..
T Consensus 235 ~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 235 WPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred CCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 44432 267899999999999999999997 799999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=339.42 Aligned_cols=255 Identities=28% Similarity=0.467 Sum_probs=211.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
++|++.+.||+|+||.||+|.++.+++.+|+|++...... ...+.+.+|+.++++++|||++++++.+...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4799999999999999999999999999999998654322 223567789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC--
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-- 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~-- 533 (639)
|+++++|..++.....+++..+..++.||+.||+|||+.|++|+||||+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG----QIKLCDFGFARILTGPGDD 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC----cEEECccccceecCCCccc
Confidence 999988888887777899999999999999999999999999999999999999887 79999999997664332
Q ss_pred -ccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHH--cC----------------
Q psy6820 534 -FTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDIL--SG---------------- 593 (639)
Q Consensus 534 -~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~--~~---------------- 593 (639)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .+....... ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD-VDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 24567889999999876 5578999999999999999999999975443 222221111 00
Q ss_pred CCCCCC--------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 594 QYGFPS--------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 594 ~~~~p~--------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
....+. ...+.++..+.+||.+||+.||++||++.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001111 1124578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=343.35 Aligned_cols=256 Identities=28% Similarity=0.534 Sum_probs=217.2
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
....+|++.+.||.|+||.||+|.+..++..+|+|.+...... ..+.+.+|+.+++.++||||+++++.+......|+|
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 3457899999999999999999999999999999998765543 245678899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|||+++++|.+++.+ ..+++.++..++.|++.||+|||+.||+||||||+||+++.++ .+||+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~----~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC----CEEECccccchhccccc
Confidence 999999999999864 4689999999999999999999999999999999999999887 7999999998765322
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|..||..... ............ .+.+....++..+.
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~l~ 247 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-LRALYLIATNGT--PELQNPEKLSAIFR 247 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-HHhHHHHhcCCC--CCCCCccccCHHHH
Confidence 2345789999999999988899999999999999999999999965432 222222222221 12222356889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++|.+||+.||++||++.++++||||..
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 9999999999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.85 Aligned_cols=252 Identities=26% Similarity=0.444 Sum_probs=211.8
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|.+.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|+.+++.++||||+++++.+...+..|++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 578899999999999999999999999999999876532 2234577899999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---C
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---M 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~ 533 (639)
+++++|.+++...+.+++.++..++.|++.||+|||+.|++|+||||+||+++.++ .+||+|||++...... .
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~----~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG----HVKLADFGVSAQITATIAKR 163 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----CEEECcceeeeEccCccccc
Confidence 99999999998888999999999999999999999999999999999999999887 7999999998755422 2
Q ss_pred ccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC-CCcccccHHH
Q psy6820 534 FTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS-PYWDDISEEA 609 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~-~~~~~l~~~l 609 (639)
....|++.|+|||++. ...++.++|+|||||++|+|++|..||...... ..+. .........+. .....++..+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALF-LMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-hhHH-hhhccCCCCCcccccCCCCHHH
Confidence 3457899999999974 456889999999999999999999999654321 2222 22222222111 1112468899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCc
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPW 635 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~ 635 (639)
.++|.+||+.||++||+++++++|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=342.44 Aligned_cols=240 Identities=21% Similarity=0.273 Sum_probs=207.1
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHhcCCCceeeeeeeeec----CCceEEEEee
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNHPNIIKLLDEYDT----NNELYLVIEL 456 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~lV~E~ 456 (639)
..||+|++|.||+|.. +++.||+|.+........ .+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999976 578999999976543322 3567799999999999999999999866 4578999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCcc
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT 535 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~ 535 (639)
+++|+|.+++.+...+++.....++.+++.||.|||+ .+++||||||+|||++.++ .+||+|||++.........
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~----~~kl~dfg~~~~~~~~~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY----KLKIICHGLEKILSSPPFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC----cEEEcccchHhhhcccccc
Confidence 9999999999888889999999999999999999998 4999999999999999887 8999999999876655556
Q ss_pred ccCCCcccCcccccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 536 VCGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 536 ~~GT~~Y~APE~l~~--~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
..|++.|+|||++.+ ..++.++|||||||++|||++|..||... +..+++..+......++.+ ..+++++++|+
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li 255 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL--TTKEIYDLIINKNNSLKLP--LDCPLEIKCIV 255 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence 678999999999976 68999999999999999999999999654 4456666666554443322 36899999999
Q ss_pred HHhcccCCCCCCCHHHHHc
Q psy6820 614 SHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 614 ~~~L~~dP~~Rpta~eiL~ 632 (639)
.+||+.||++|||++|+++
T Consensus 256 ~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHhcCCcccCcCHHHHHH
Confidence 9999999999999999985
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=340.32 Aligned_cols=253 Identities=29% Similarity=0.450 Sum_probs=206.4
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|++.+.||+|+||.||+|.+..++..||+|.+....... ....+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5889999999999999999999999999999987543322 235677899999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 457 IKGGDLFDAISKN---VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~~---~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
++ ++|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++.....+
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG----VIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC----cEEECcccceeecCCCc
Confidence 97 5898888542 4689999999999999999999999999999999999999887 7999999998755322
Q ss_pred --CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC----------------
Q psy6820 533 --MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG---------------- 593 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~---------------- 593 (639)
.....+++.|+|||++.+ ..++.++||||||+++|+|+||+.||..... ...........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE-IDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 123456899999998865 4578999999999999999999999975432 11111111000
Q ss_pred --------CCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 594 --------QYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 594 --------~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
...........+++++.++|++||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000011124578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=336.19 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=210.8
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-----hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-----GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
+|++++.||.|+||.||+|.. .++..+|+|.+...... .....+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478899999999999999976 46778999998654321 122457889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
+|||+++++|.+++.+...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRLAWV 155 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC----eEEeccchhhHhhhhc
Confidence 999999999999998878899999999999999999999999999999999999999887 899999999875421
Q ss_pred --------CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc
Q psy6820 532 --------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 532 --------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+...... ..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~-~~~~~~ 232 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR--LAAMFYIGAHRGL-MPRLPD 232 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh--HHHHHHhhhccCC-CCCCCC
Confidence 12245689999999999988899999999999999999999999965432 2222222222111 122335
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.++.++.++|++||+.+|++||++.++++||||
T Consensus 233 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 233 SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 689999999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=335.71 Aligned_cols=248 Identities=37% Similarity=0.694 Sum_probs=217.0
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCCh
Q psy6820 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL 462 (639)
Q Consensus 385 LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 462 (639)
||.|+||.||+|.+..+++.+|+|++.+.... ...+.+.+|+.+++.++||||+++++.+.+...+|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999998999999999765433 2346688999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--CccccCCC
Q psy6820 463 FDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--MFTVCGTP 540 (639)
Q Consensus 463 ~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--~~~~~GT~ 540 (639)
.+++.+...+++..+..++.+|+.||+|||+.|++|+||+|+||+++.++ .++|+|||++...... .....|++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG----YVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC----CEEEeeCCcccccCcccccccccCCc
Confidence 99998888899999999999999999999999999999999999999887 7999999999876543 34457899
Q ss_pred cccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccC
Q psy6820 541 TYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESN 620 (639)
Q Consensus 541 ~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~d 620 (639)
.|+|||.+.+..++.++|+||||+++|+|++|..||.....+.......+..+...... ...+++++.++|.+||+.|
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC--CcccCHHHHHHHHHHccCC
Confidence 99999999888899999999999999999999999977655566666666643222222 2345899999999999999
Q ss_pred CCCCCC-----HHHHHcCCcccC
Q psy6820 621 PDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 621 P~~Rpt-----a~eiL~HP~f~~ 638 (639)
|++||+ ++|+++||||..
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhC
Confidence 999999 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=345.60 Aligned_cols=251 Identities=28% Similarity=0.469 Sum_probs=192.9
Q ss_pred EEEEccCCceEEEEEEEcC--CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeee--cCCceEEEEeec
Q psy6820 382 GQIIGDGNFAVVRQVYDKH--KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYD--TNNELYLVIELI 457 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~--~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~lV~E~~ 457 (639)
+..||+|+||.||+|.... ++..+|+|.+..... ...+.+|+.++++++||||+++++++. ....+|+||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 4689999999999998654 567899999875432 345678999999999999999999884 456789999998
Q ss_pred cCCChHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 458 KGGDLFDAISK---------NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 458 ~ggsL~~~l~~---------~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+..++.....+||+|||++..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 5 588887742 124889999999999999999999999999999999999954332234899999999976
Q ss_pred ccCC------CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChH-------HHHHHHHcCC
Q psy6820 529 VLRP------MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD-------ELFDDILSGQ 594 (639)
Q Consensus 529 ~~~~------~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~-------~l~~~i~~~~ 594 (639)
.... .....||+.|+|||++.+ ..++.++|||||||++|||+||.+||.....+.. .....+....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 5432 234578999999999876 4589999999999999999999999965432110 0011111000
Q ss_pred C--------------CCC--------------------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 595 Y--------------GFP--------------------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 595 ~--------------~~p--------------------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
. .++ .......+..+.+||.+||+.||++|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000 00001235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=337.10 Aligned_cols=252 Identities=29% Similarity=0.515 Sum_probs=209.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc----hhHHHHHHHHHHHHhcCCCceeeeeeeeec--CCce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL----GKKQMIENEVNILRSVNHPNIIKLLDEYDT--NNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 450 (639)
.+|.+.+.||+|+||.||+|.+..++..+|+|.+...... .....+.+|+.++++++||||+++++.+.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999999999999999998654321 223567889999999999999999998865 3678
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+++|||+++++|.+++.....+++.....++.|++.||+|||+.+++||||||+||+++.++ .+||+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~----~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG----NVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC----CEEEccCCCccccc
Confidence 99999999999999998877899999999999999999999999999999999999999887 79999999987543
Q ss_pred CC------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 531 RP------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 531 ~~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
.. .....++..|+|||.+.+..++.++|+|||||++|||++|+.||..... ...+. .+..... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-~~~~~-~~~~~~~--~~~~~~~ 233 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-MAAIF-KIATQPT--NPQLPSH 233 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-HHHHH-HHhcCCC--CCCCchh
Confidence 21 1234588999999999988899999999999999999999999965432 22222 2222111 1122245
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
+++.+++++ +||..+|++||+++|+++||||+
T Consensus 234 ~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 234 ISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred cCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 788999999 67778999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=349.67 Aligned_cols=252 Identities=23% Similarity=0.396 Sum_probs=203.9
Q ss_pred EEEEEccC--CceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 381 VGQIIGDG--NFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 381 i~~~LG~G--~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
++++||+| +|++||++..+.+++.||+|.+...... ...+.+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7899999999999999999999765433 23456778999999999999999999999999999999999
Q ss_pred cCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 458 KGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 458 ~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .++++||+.+......
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~----~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG----KVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC----cEEEcccchhhcccccccc
Confidence 99999999965 34589999999999999999999999999999999999999887 7999999875433211
Q ss_pred -------CccccCCCcccCcccccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC-------
Q psy6820 533 -------MFTVCGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG------- 596 (639)
Q Consensus 533 -------~~~~~GT~~Y~APE~l~~--~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~------- 596 (639)
.....++..|+|||++.+ ..++.++|||||||++|||++|..||...... ........+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh--HHHHHHhcCCccccccccc
Confidence 112356778999999976 46899999999999999999999999643221 111111111110
Q ss_pred -----------------------------------CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 597 -----------------------------------FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 597 -----------------------------------~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...+....+++++.+||++||+.||++|||++|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000112245789999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=341.41 Aligned_cols=253 Identities=29% Similarity=0.469 Sum_probs=206.9
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... .....+.+|+.++++++||||+++++++.+.+.+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588999999999999999999999999999998754332 1234567899999999999999999999999999999999
Q ss_pred ccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 457 IKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
++ ++|.+++.. ...+++..++.++.||++||.|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~----~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG----ELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC----cEEECccchhhccCCCCCC
Confidence 96 588887754 56799999999999999999999999999999999999999887 8999999999765432
Q ss_pred CccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC----------------C
Q psy6820 533 MFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ----------------Y 595 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~----------------~ 595 (639)
.....+++.|+|||++.+. .++.++|||||||++|+|++|..||..... ..+..+.+.... .
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC-HHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2234678999999998764 479999999999999999999988754332 222222222110 0
Q ss_pred -CCC--------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 596 -GFP--------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 596 -~~p--------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.++ ....+.+++++.+||++||+.||.+|||+++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000 01123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=337.27 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=211.7
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
..++|++.+.||+|+||.||+|.+..+++.+|+|++..... .....+.+|+.++++++||||+++++++...+.+|+||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 34689999999999999999999999999999999865432 22346778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
||+++++|.+++.....+++..+..++.|++.||+|||+.||+||||||+||+++.++ .+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~----~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG----DVKLADFGVAAKITATIA 161 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC----CEEECcCccceeeccccc
Confidence 9999999999998888899999999999999999999999999999999999999887 7999999999765422
Q ss_pred -CccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC-CCcccccH
Q psy6820 533 -MFTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS-PYWDDISE 607 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~-~~~~~l~~ 607 (639)
.....|++.|+|||.+. ...++.++|+|||||++|||++|..||...... ... ..+.......+. .....++.
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RAL-FLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-hhh-eeeecCCCCCCCCccccccCH
Confidence 23456899999999884 445788999999999999999999999543221 111 111122222111 11135689
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCCc
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDHPW 635 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~HP~ 635 (639)
++.++|++||+.||++||+++++++|+|
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=338.11 Aligned_cols=254 Identities=25% Similarity=0.434 Sum_probs=208.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHH-HHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNI-LRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
++|++.+.||+|+||.||+|.+..+++.||+|.+...........+..|+.+ ++.++||||+++++++...+..|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4789999999999999999999999999999999765443333444456554 666789999999999999999999999
Q ss_pred eccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 456 LIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDN-YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 456 ~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~-givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|++ ++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++ .+||+|||++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~----~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG----QVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC----CEEEeecccccccc
Confidence 996 688877743 34689999999999999999999997 999999999999999887 89999999997654
Q ss_pred CCC--ccccCCCcccCcccccc----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 531 RPM--FTVCGTPTYVAPEILNE----SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 531 ~~~--~~~~GT~~Y~APE~l~~----~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
... ....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.......+.+...+......++. ..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 232 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA---EK 232 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc---cc
Confidence 322 23568899999998864 4578999999999999999999999965444444443333222222322 35
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++.++.++|.+||..+|++||+++++++||||++
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 7899999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.97 Aligned_cols=252 Identities=28% Similarity=0.447 Sum_probs=214.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||.|+||.||+|....+++.+++|++...... ..+.+.+|+.++++++||||+++++++...+.+|++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 6899999999999999999999988999999999765433 346778999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 457 IKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .+||+|||++......
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~----~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG----DVKLADFGVSAQLTATIAK 157 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC----CEEECccccchhhhhhhhc
Confidence 9999999999776 7899999999999999999999999999999999999999887 7999999999765432
Q ss_pred CccccCCCcccCccccccC---CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC-CCcccccHH
Q psy6820 533 MFTVCGTPTYVAPEILNES---GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS-PYWDDISEE 608 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~---~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~-~~~~~l~~~ 608 (639)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ......+....+..+. ......+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--MRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCCCccccchhhhhHH
Confidence 2345788999999999776 889999999999999999999999965432 2222223222221111 112346789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPW 635 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~ 635 (639)
+.+++++||+.||.+|||+.+++.|||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=335.48 Aligned_cols=255 Identities=28% Similarity=0.483 Sum_probs=214.2
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-----hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-----GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
+|+..+.||+|+||.||++.+..+++.+|+|++...... ...+.+.+|+.++++++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999999999999999998754321 123567899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||+++++|.+++.+..++++..+..++.|++.||+|||++|++|+||+|+||+++.++ ..+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~---~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG---QRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEEcccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998765 26999999998765432
Q ss_pred -------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-ChHHHHHHHHcCCCCCCCCCccc
Q psy6820 533 -------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 533 -------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........+.... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT--TAPSIPEH 235 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC--CCCCCchh
Confidence 1234678999999999888899999999999999999999999964332 1122222222111 12223346
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
+++++.+++.+||+.+|++||++.++++||||+
T Consensus 236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 789999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.31 Aligned_cols=250 Identities=31% Similarity=0.550 Sum_probs=216.6
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|++.+.||+|+||.+|.+.+..+++.+|+|.+...... .....+.+|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999999999999999998754332 2335678999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC-
Q psy6820 457 IKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM- 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~- 533 (639)
+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~----~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG----TIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC----CEEEeeccceeecCcchh
Confidence 9999999998654 3578999999999999999999999999999999999999877 79999999997654322
Q ss_pred --ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 534 --FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 534 --~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
....|++.|+|||++.+..++.++|+|||||++|+|++|..||... +..+....+..+.... ....++.++.+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--NMKNLVLKIIRGSYPP---VSSHYSYDLRN 231 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC--CHHHHHHHHhcCCCCC---CcccCCHHHHH
Confidence 2346889999999999888999999999999999999999999643 4455555665554321 22467899999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
+|.+||+.+|++||++.++++||||
T Consensus 232 li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 232 LVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHhhCChhhCcCHHHHhhCcCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=336.02 Aligned_cols=251 Identities=34% Similarity=0.606 Sum_probs=217.5
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
+|.+.+.||.|+||.||+|.+..+++.+|+|++.+.... .....+.+|+.++++++||||+++++.+.+...+++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 589999999999999999999999999999999765432 234668899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--C
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--M 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--~ 533 (639)
|+++++|.+++.....+++..+..++.+|++||.|||+.|++|+||+|+||+++.++ .++|+|||++...... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG----HVHITDFNIATKVTPDTLT 156 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC----CEEEeecccccccCCCccc
Confidence 999999999998878899999999999999999999999999999999999999887 7999999999765433 2
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc-CCCCCCCCCcccccHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS-GQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~-~~~~~p~~~~~~l~~~l~dL 612 (639)
....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..........+..... .... ....++.++.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 232 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL----YPATWSTEAIDA 232 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccccc----CcccCcHHHHHH
Confidence 34668899999999998889999999999999999999999997654322222222222 2222 234678999999
Q ss_pred HHHhcccCCCCCCCH--HHHHcCCcc
Q psy6820 613 ISHMLESNPDLRFSA--EDVLDHPWL 636 (639)
Q Consensus 613 I~~~L~~dP~~Rpta--~eiL~HP~f 636 (639)
|.+||+.||.+||++ +|+++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=337.08 Aligned_cols=250 Identities=25% Similarity=0.447 Sum_probs=207.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecC------Cc
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTN------NE 449 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~------~~ 449 (639)
+.|++.+.||+|+||.||+|....+++.+|+|++.... .....+.+|+.+++++ +||||+++++.+... ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 56888999999999999999999999999999987543 2345677899999998 699999999988643 46
Q ss_pred eEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
+|++|||+++++|.+++... ..+++..+..++.|++.||+|||+++|+|+||||+||+++.++ .+||+|||++.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~----~~~l~Dfg~~~ 159 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSA 159 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC----CEEEccCCCce
Confidence 89999999999999999763 4689999999999999999999999999999999999999887 79999999997
Q ss_pred cccC---CCccccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy6820 528 RVLR---PMFTVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599 (639)
Q Consensus 528 ~~~~---~~~~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~ 599 (639)
.... ......|++.|+|||++. +..++.++|||||||++|||++|..||..... ......+... ..+.
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~--~~~~~~~~~~--~~~~ 235 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--MRALFLIPRN--PAPR 235 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH--HHHHHHHhcC--CCCC
Confidence 6532 233567899999999986 34688899999999999999999999954332 2211122221 1222
Q ss_pred CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 600 PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 600 ~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.....++.++.+|+.+||+.||.+|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 2234678999999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=363.01 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=207.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
..+|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|++++||||+++++++...+..++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4579999999999999999999999999999996432 234689999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 456 LIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
++ .++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 241 ~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~----~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWS 315 (461)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC----CEEEcccCCceecccccc
Confidence 99 46898888653 5699999999999999999999999999999999999999887 7999999999765322
Q ss_pred ---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC------ChHHHHHHHHcCCCC---CC--
Q psy6820 533 ---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN------DQDELFDDILSGQYG---FP-- 598 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~------~~~~l~~~i~~~~~~---~p-- 598 (639)
....+||+.|+|||++.+..++.++|||||||+||||++|..|+..... ....+.+.+...... ++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 2245799999999999999999999999999999999998876543221 122333333322211 11
Q ss_pred ----------------------CCCcc---cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q psy6820 599 ----------------------SPYWD---DISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639 (639)
Q Consensus 599 ----------------------~~~~~---~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~~ 639 (639)
.+.|. .++.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~~ 461 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQSK 461 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCCC
Confidence 11121 356789999999999999999999999999999863
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.41 Aligned_cols=256 Identities=30% Similarity=0.543 Sum_probs=216.4
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
...++|++.+.||.|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3457899999999999999999999999999999999765433 346678899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|||+++++|.+++.+ ..+++..+..++.+++.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~----~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEECcCccceEccCCc
Confidence 999999999999865 4689999999999999999999999999999999999999887 7999999998765322
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.. .........+. .+......++..+.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~ 246 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RALYLIATNGT--PELQNPERLSAVFR 246 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-hheeeeccCCC--CCCCCccccCHHHH
Confidence 22456899999999999988999999999999999999999999654321 11111111111 11122356789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+|+.+||+.||++||+++++++||||+.
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 9999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=329.06 Aligned_cols=250 Identities=32% Similarity=0.529 Sum_probs=218.0
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|++.+.||.|+||.||.+++..++..+++|.+...... .....+.+|+.++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 589999999999999999999999999999998765432 3345677999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC-
Q psy6820 457 IKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM- 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~- 533 (639)
+++++|.+++.+. ..+++..+..++.+++.||+|||+.|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~----~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG----LIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC----CEEECcCcceEEcccccc
Confidence 9999999999764 5689999999999999999999999999999999999999887 79999999997664332
Q ss_pred --ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 534 --FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 534 --~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
....|++.|+|||.+.+..++.++|+||||+++|+|++|..||... +..+....+..+..... ...++.++.+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--NPLNLVVKIVQGNYTPV---VSVYSSELIS 231 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCC---ccccCHHHHH
Confidence 3467899999999999888999999999999999999999999643 34555556665543322 2567999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
+|.+||+.+|++||++.++++|||+
T Consensus 232 ~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 232 LVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHcccCcccCCCHHHHhhCcCC
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=339.27 Aligned_cols=254 Identities=29% Similarity=0.541 Sum_probs=216.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+.+.||.|+||.||+|.+..+++.+++|.+..... ...+.+.+|+.+++.++||||+++++++...+.+|+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4679999999999999999999999999999999875443 234667899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
|+++++|.+++... .+++.++..++.+++.||+|||+.|++|+||||+||+++.++ .+||+|||++......
T Consensus 97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~----~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 97 YLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG----SVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred ecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEccCccchhccccccc
Confidence 99999999988654 689999999999999999999999999999999999999887 7999999998765422
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+. ......+.... ..+......+++.+.++
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALYLIATNG-TPELQNPEKLSPIFRDF 248 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcC-CcccCCcccCCHHHHHH
Confidence 2245789999999999988899999999999999999999999965432 22222222221 11122335689999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 613 ISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
|++||+.||++||++.+++.||||+.
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhh
Confidence 99999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.64 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=206.9
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+.+.||+|+||.||+|.+..++..+|+|++...........+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 36899999999999999999999999999999999765544444566789999999999999999999999999999999
Q ss_pred eccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 456 LIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|+. ++|.+.+.. ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~----~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG----ELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC----cEEEeccccccccCCCCC
Confidence 995 677776644 35678899999999999999999999999999999999999887 7999999998754322
Q ss_pred -CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC-------------CCC
Q psy6820 533 -MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ-------------YGF 597 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~-------------~~~ 597 (639)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.......+.+.+.+.... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 233457899999999875 45789999999999999999999999755432222221110000 000
Q ss_pred ---------CC---CCcc--cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 598 ---------PS---PYWD--DISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 598 ---------p~---~~~~--~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
+. ..+. ..+.++.+++.+||+.||++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 0011 126789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=328.84 Aligned_cols=251 Identities=29% Similarity=0.524 Sum_probs=215.4
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|.+.+.||+|+||.||+|.+..+++.+|+|.+...... .....+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999999999999999999765433 2345688999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 457 IKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
+++++|.+++... ..+++..+..++.+++.||+|||++|++|+||+|+||+++.++ ..+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~---~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK---MVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEEccCCCceecCCCcc
Confidence 9999999999763 3589999999999999999999999999999999999998654 26899999999866533
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+ .......+...... +....++.++.++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~l~~l 232 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--LPALVLKIMSGTFA---PISDRYSPDLRQL 232 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--hHHHHHHHHhcCCC---CCCCCcCHHHHHH
Confidence 234578999999999998889999999999999999999999996543 33444444443321 2224689999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 613 ISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
+.+||+.||++|||+.|+++||||
T Consensus 233 i~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 233 ILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.41 Aligned_cols=252 Identities=27% Similarity=0.506 Sum_probs=210.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc----chhHHHHHHHHHHHHhcCCCceeeeeeeeecC--Cce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL----LGKKQMIENEVNILRSVNHPNIIKLLDEYDTN--NEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 450 (639)
.+|++.+.||+|+||.||.+.+..++..||+|.+..... ....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999999864321 12235678899999999999999999988664 468
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+++|||+++++|.+++.+...+++..+..++.+++.||+|||+.+++|+||||+||+++.++ .++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~----~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG----NVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC----CEEECcCccccccc
Confidence 89999999999999998877899999999999999999999999999999999999999887 79999999987543
Q ss_pred C------CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 531 R------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 531 ~------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.... ..... ..+..... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~-~~~~~~~~--~~~~~~~ 233 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-AMAAI-FKIATQPT--NPVLPPH 233 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-hHHHH-HHHhcCCC--CCCCchh
Confidence 2 2234568999999999998889999999999999999999999996432 22222 22322211 1122346
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
++..+.++|.+||. +|++||+++|+++|||+.
T Consensus 234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 78899999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=340.43 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=217.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||+|+||.||++.+..+++.+|+|++...........+.+|+.+++.++||||+++++.+...+.+|+||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57889999999999999999999999999999987654444456788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-Cc
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-MF 534 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-~~ 534 (639)
+++++|.+++.+.+.+++..+..++.+++.||.|||+ .+++|+||||+||+++.++ .++|+|||++...... ..
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~----~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG----QIKLCDFGVSGELINSIAD 160 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC----cEEEccCCcccchhhhccC
Confidence 9999999999888889999999999999999999997 6899999999999999887 7999999998654322 23
Q ss_pred cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC------h---HHHHHHHHcCCCCCCCCCcccc
Q psy6820 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND------Q---DELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~------~---~~l~~~i~~~~~~~p~~~~~~l 605 (639)
...|+..|+|||++.+..++.++|+|||||++|+|++|..||...... . .+....+..... +......+
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 238 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--PRLPSSDF 238 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--CCCCchhc
Confidence 457899999999998888999999999999999999999999754321 0 122233332211 11112347
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.++.+|+.+||+.||++|||+.|+++||||.+
T Consensus 239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 889999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.46 Aligned_cols=255 Identities=30% Similarity=0.491 Sum_probs=222.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|.+.+.||.|++|.||+|.+..+++.+++|++...........+.+|+..++.++|+|++++++++...+.+++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36889999999999999999999999999999998765444456788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC--
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-- 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~-- 533 (639)
+++++|.+++.....+++..+..++.+++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~----~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG----EVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC----CEEEccCccceecccCCCc
Confidence 9999999999887889999999999999999999999 9999999999999999887 79999999997664322
Q ss_pred -ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-ChHHHHHHHHcCCCCCCCCCccc-ccHHHH
Q psy6820 534 -FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQYGFPSPYWDD-ISEEAK 610 (639)
Q Consensus 534 -~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-~~~~l~~~i~~~~~~~p~~~~~~-l~~~l~ 610 (639)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...+....+...... ..... ++..+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~ 233 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP---SLPAEEFSPEFR 233 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC---CCCcccCCHHHH
Confidence 245688999999999988999999999999999999999999966542 344555555543221 11234 789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++|++||..+|++||++.++++||||++
T Consensus 234 ~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 234 DFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 9999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=330.10 Aligned_cols=253 Identities=30% Similarity=0.516 Sum_probs=215.5
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|.+.+.||+|+||.||+|....+++.+++|++...... .....+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999999989999999999766543 2446788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC---
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM--- 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~--- 533 (639)
+++++|.+++.+...+++..+..++.+++.||+|||+.|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~----~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG----VIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEcccccccccCCCCCcc
Confidence 99999999998877899999999999999999999999999999999999999877 79999999997654321
Q ss_pred ----ccccCCCcccCccccccCC---CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 534 ----FTVCGTPTYVAPEILNESG---YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 534 ----~~~~GT~~Y~APE~l~~~~---~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
....+++.|+|||++.+.. ++.++||||||+++|+|++|..||........ ....+..+ .....+.+..++
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~ 234 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFHVGAG-HKPPIPDSLQLS 234 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHHHhcC-CCCCCCcccccC
Confidence 2356789999999998765 89999999999999999999999965433222 22222222 122223334569
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
..+.++|.+||+.||++||++.+++.|||+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=331.41 Aligned_cols=250 Identities=28% Similarity=0.472 Sum_probs=213.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||.|+||.||+|....++..+++|.+..... .+.+.+|+.++++++||||+++++.+.....+|+++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 579999999999999999999998889999999875432 56788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC--
Q psy6820 457 IKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-- 533 (639)
Q Consensus 457 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~-- 533 (639)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+++|+||+|+||+++.++ .+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~----~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG----QAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC----cEEEcccccchhcccCccc
Confidence 999999999965 45789999999999999999999999999999999999999887 79999999997665332
Q ss_pred -ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 534 -FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 534 -~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
....|+..|+|||++.+..++.++||||||+++|+|++|..||...... .....+..... ........++.++.++
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 232 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--RAIFMIPNKPP-PTLSDPEKWSPEFNDF 232 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--hhhhhhccCCC-CCCCchhhcCHHHHHH
Confidence 2345889999999999989999999999999999999999999654322 11112211111 1111123578899999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 613 ISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
|.+||+.||++|||+.|+++||||
T Consensus 233 i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.06 Aligned_cols=252 Identities=30% Similarity=0.498 Sum_probs=211.4
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeecc
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIK 458 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 458 (639)
|++.+.||+|+||.||+|.+..++..+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..|+||||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 6788999999999999999999999999999865432 234567789999999999999999999999999999999999
Q ss_pred CCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---Cc
Q psy6820 459 GGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MF 534 (639)
Q Consensus 459 ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~~ 534 (639)
+++|..++.+ ...+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++...... ..
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~----~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG----DIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC----CEEEccccccccccccccccc
Confidence 9999988754 56799999999999999999999999999999999999999887 7999999998655322 23
Q ss_pred cccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 535 TVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
...|++.|+|||++. +..++.++|+|||||++|+|++|..||...+ ..+....+...... .......++.++
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSEPP-TLAQPSRWSSEF 238 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--HHHHHHHHhhcCCC-CCCCccccCHHH
Confidence 457899999999983 4557889999999999999999999996543 23333333333211 112234578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.++|.+||+.||.+||+++++++||||..
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 99999999999999999999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.10 Aligned_cols=253 Identities=32% Similarity=0.537 Sum_probs=210.4
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|++.+.||+|+||.||+|.+..++..+|+|++..... ......+.+|+.+++.++||||+++++++.....+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58999999999999999999999999999999876553 23346688999999999999999999999999999999999
Q ss_pred ccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 457 IKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
+ +++|.+++.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~----~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG----VLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC----cEEEeeeeecccccCCCCC
Confidence 9 9999999864 45699999999999999999999999999999999999999877 7999999999766433
Q ss_pred -CccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC----------------
Q psy6820 533 -MFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ---------------- 594 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~---------------- 594 (639)
.....|+..|+|||++.+. .++.++||||||+++|+|++|.+||..... ...+..+....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCcch
Confidence 2345689999999998654 468999999999999999999888855432 22222222110
Q ss_pred ---CCCCC-------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 595 ---YGFPS-------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 595 ---~~~p~-------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
..++. ...+..+.++.+||++||+.||++||+++++++||||.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00010 11235679999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.18 Aligned_cols=247 Identities=28% Similarity=0.492 Sum_probs=203.3
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHh---cCCCceeeeeeeeecCCceEEEEeecc
Q psy6820 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRS---VNHPNIIKLLDEYDTNNELYLVIELIK 458 (639)
Q Consensus 384 ~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~---l~HpnIv~l~~~~~~~~~~~lV~E~~~ 458 (639)
.||+|+||.||++.+..+++.+|+|.+.+...... ...+.+|..+++. ..||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 38999999999999999999999999876543222 2334455544443 469999999999999999999999999
Q ss_pred CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-Ccccc
Q psy6820 459 GGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-MFTVC 537 (639)
Q Consensus 459 ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-~~~~~ 537 (639)
+++|.+++.....+++..+..++.|++.||+|||+.|++||||||+|||++.++ .++|+|||++...... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG----HVRISDLGLACDFSKKKPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC----CEEEccCCcceeccccCccCcC
Confidence 999999998888899999999999999999999999999999999999999887 7999999998755432 23457
Q ss_pred CCCcccCccccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC-hHHHHHHHHcCCCCCCCCCcccccHHHHHHHHH
Q psy6820 538 GTPTYVAPEILN-ESGYGVKIDVWAAGVILYILLCGFPPFVSDTND-QDELFDDILSGQYGFPSPYWDDISEEAKELISH 615 (639)
Q Consensus 538 GT~~Y~APE~l~-~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~-~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~ 615 (639)
||+.|+|||.+. +..++.++|+|||||++|+|++|..||...... ...+........ ......++.++.++|++
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN----VELPDSFSPELKSLLEG 232 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCC----cCCccccCHHHHHHHHH
Confidence 899999999986 456899999999999999999999999654332 222222222222 22335689999999999
Q ss_pred hcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 616 MLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 616 ~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
||+.||++|| +++++++||||++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 9999999999 6999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.87 Aligned_cols=247 Identities=18% Similarity=0.285 Sum_probs=208.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEc---CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
++|++.+.||+|+||.||+|... ..+..+|+|.++..........+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 57999999999999999999765 446789999998765444456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++ .+|++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~----~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL----VCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC----cEEECCCccccccccc
Confidence 9999999999999764 5789999999999999999999999999999999999999887 8999999987654321
Q ss_pred ----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 533 ----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 533 ----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||... ...++.+.+..+. .. +....++.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~--~~~~~~~~~~~~~-~~--~~~~~~~~ 235 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM--SGQDVIKAVEDGF-RL--PAPRNCPN 235 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHHCCC-CC--CCCCCCCH
Confidence 112335678999999999999999999999999999775 99999644 3344555554432 22 23357899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+.+++.+||+.+|++||++++|++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.19 Aligned_cols=249 Identities=32% Similarity=0.552 Sum_probs=211.6
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHH-HhcCCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNIL-RSVNHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||.|+||.||+|.+..+++.+|+|++.+....... ..+..|..++ ...+|||++++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999999999999999999765432221 2234454443 445799999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCccccCC
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGT 539 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~~~GT 539 (639)
++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++..... .....|+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~~~~~~-~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG----HLKLTDFGLSRNGLE-NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----cEEEeecccceeccc-cccCCCC
Confidence 99999998888899999999999999999999999999999999999999887 799999999875443 3345689
Q ss_pred CcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhccc
Q psy6820 540 PTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLES 619 (639)
Q Consensus 540 ~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~ 619 (639)
+.|+|||.+.+..++.++||||||+++|+|++|..||... +....+..+.......+......+++++.++|.+||+.
T Consensus 157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE--TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 9999999998888999999999999999999999999643 34556666666665555555557899999999999999
Q ss_pred CCCCCCC---HHHHHcCCcccC
Q psy6820 620 NPDLRFS---AEDVLDHPWLER 638 (639)
Q Consensus 620 dP~~Rpt---a~eiL~HP~f~~ 638 (639)
||++||+ ++|++.||||.+
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 9999994 579999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.57 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=212.3
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCC-----eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKD-----MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|++.+.||+|+||.||+|.....+ ..+|+|.+...........+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 357889999999999999999876554 679999987655444556788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCce
Q psy6820 451 YLVIELIKGGDLFDAISKN----------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH 514 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~ 514 (639)
|++|||+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~-- 161 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL-- 161 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC--
Confidence 9999999999999999654 4578899999999999999999999999999999999999887
Q ss_pred eeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHH
Q psy6820 515 VKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFD 588 (639)
Q Consensus 515 ~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~ 588 (639)
.+||+|||++...... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.... ..++..
T Consensus 162 --~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~--~~~~~~ 237 (283)
T cd05048 162 --TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--NQEVIE 237 (283)
T ss_pred --cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHH
Confidence 7999999999754322 223456888999999998889999999999999999998 999996543 355666
Q ss_pred HHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 589 DILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 589 ~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+..+... +....++.++.+|+.+||+.||++||++.||+++
T Consensus 238 ~i~~~~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66554322 2235789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=333.46 Aligned_cols=258 Identities=29% Similarity=0.434 Sum_probs=214.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec--CCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT--NNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV~ 454 (639)
++|...+.||.|++|.||+|.+..+++.+|+|.+...........+.+|+++++.++||||++++++|.+ .+.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4689999999999999999999999999999999866544455678899999999999999999998854 34789999
Q ss_pred eeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 455 ELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 455 E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
||+++++|.+++.. ...+++..+..++.+|+.||+|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~----~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG----QVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC----eEEEeecccccccc
Confidence 99999999887743 35689999999999999999999999999999999999999887 79999999987554
Q ss_pred CCC-ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC---ChHHHHHHHHcCCC-CCCCC--Ccc
Q psy6820 531 RPM-FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN---DQDELFDDILSGQY-GFPSP--YWD 603 (639)
Q Consensus 531 ~~~-~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~---~~~~l~~~i~~~~~-~~p~~--~~~ 603 (639)
... ....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ...+....+..... .++.. ...
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred ccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 322 345678899999999998999999999999999999999999975521 22334444443221 11111 012
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..++++.++|.+||+.||++|||+.|++.||||++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 35789999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.01 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=201.9
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC----------------CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceee
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH----------------KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~----------------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~ 439 (639)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++...........+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3679999999999999999997532 345799999976554444567889999999999999999
Q ss_pred eeeeeecCCceEEEEeeccCCChHHHHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy6820 440 LLDEYDTNNELYLVIELIKGGDLFDAISKN-------------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500 (639)
Q Consensus 440 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-------------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrD 500 (639)
+++++.+.+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+.||+|||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 999999999999999999999999998543 1367788999999999999999999999999
Q ss_pred CCCCceEEccCCceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc--CC
Q psy6820 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC--GF 573 (639)
Q Consensus 501 LKp~NILld~~g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt--G~ 573 (639)
|||+|||++.++ .+||+|||++...... .....++..|+|||++.+..++.++||||||+++|||++ +.
T Consensus 164 lkp~Nill~~~~----~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 164 LATRNCLVGENL----TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cchhheEEcCCc----cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999887 8999999999765322 123345788999999998889999999999999999986 66
Q ss_pred CCCCCCCCChHHHHHHHH----cCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6820 574 PPFVSDTNDQDELFDDIL----SGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVL 631 (639)
Q Consensus 574 ~Pf~~~~~~~~~l~~~i~----~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL 631 (639)
.||.... ..+....+. ...........+.++..+.+|+.+||+.||++|||+.+|.
T Consensus 240 ~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 240 QPYGELT--DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCcCC--HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 7886432 222222221 1111111112246789999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=327.58 Aligned_cols=250 Identities=37% Similarity=0.562 Sum_probs=215.3
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec--CCceEEEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDT--NNELYLVI 454 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV~ 454 (639)
+|++.+.||.|+||.||+|.+..++..+|+|++...... ...+.+.+|+.+++.++||||+++++.+.. ....|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999999999999999998765443 334567889999999999999999997753 45689999
Q ss_pred eeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 455 ELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLH-----DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 455 E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH-----~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
||+++++|.+++.. ..++++..+..++.+|+.||+||| +.+++|+||+|+||+++.++ .+||+|||+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~----~~kl~d~g~ 156 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN----NVKLGDFGL 156 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC----CEEEecccc
Confidence 99999999999865 467899999999999999999999 88999999999999999877 899999999
Q ss_pred cccccCCC---ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCc
Q psy6820 526 AQRVLRPM---FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 526 a~~~~~~~---~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
+....... ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ...+.+.+..+... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~---~~~ 231 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGKFR---RIP 231 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCCCC---CCc
Confidence 98765322 34578999999999998889999999999999999999999996543 45566666555432 223
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
..++.++.+++.+||+.+|++||++.+|++|||+
T Consensus 232 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 5678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=353.96 Aligned_cols=248 Identities=22% Similarity=0.385 Sum_probs=205.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCC-----CeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHK-----DMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 450 (639)
++|.+++.||+|+||.||+|.+... +..||+|++.........+.+.+|+.+++.+ +||||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 5799999999999999999986433 3579999998665554556788999999999 799999999999999999
Q ss_pred EEEEeeccCCChHHHHhhc-------------------------------------------------------------
Q psy6820 451 YLVIELIKGGDLFDAISKN------------------------------------------------------------- 469 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~------------------------------------------------------------- 469 (639)
|+||||+++|+|.+++.+.
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999988542
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc-----c
Q psy6820 470 ---------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF-----T 535 (639)
Q Consensus 470 ---------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~-----~ 535 (639)
.++++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........ .
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~----~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR----VAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC----eEEEeeceeeeeccCCcceeeccC
Confidence 2478889999999999999999999999999999999999876 899999999976543211 2
Q ss_pred ccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHH
Q psy6820 536 VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614 (639)
Q Consensus 536 ~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~ 614 (639)
..+++.|+|||++.+..++.++|||||||++|||++ |..||....... .....+..+ ...+ ....+++++.+++.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~-~~~~--~~~~~~~~l~~li~ 349 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRG-YQMS--RPDFAPPEIYSIMK 349 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcc-cCcc--CCCCCCHHHHHHHH
Confidence 234567999999999999999999999999999997 999997644322 233333322 2222 22357899999999
Q ss_pred HhcccCCCCCCCHHHHHc
Q psy6820 615 HMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 615 ~~L~~dP~~Rpta~eiL~ 632 (639)
+||+.||++||++.++++
T Consensus 350 ~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 350 MCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.81 Aligned_cols=254 Identities=27% Similarity=0.473 Sum_probs=214.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|.+.+.||.|+||.||++.+..++..+|+|++..... ...+.+.+|+.++++++||||+++++.+......|+||||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 568999999999999999999988899999999875432 2335677899999999999999999999999999999999
Q ss_pred ccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 457 IKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
+++++|.+++.+ ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++ .++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~----~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG----DVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC----CEEEccCccchhhcccccc
Confidence 999999999866 35799999999999999999999999999999999999999887 8999999998655322
Q ss_pred CccccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 533 MFTVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.....|++.|+|||.+. ...++.++|+||||+++|+|++|..||... +.......+...... .......++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL--NPMRVLLKILKSEPP-TLDQPSKWSS 236 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC--CHHHHHHHHhcCCCC-CcCCcccCCH
Confidence 23456899999999974 345788999999999999999999999654 333344444443221 1112246789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++.++|.+||+.||++||++.++++||||.+
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 9999999999999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=335.68 Aligned_cols=255 Identities=29% Similarity=0.462 Sum_probs=207.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+.+.||.|++|.||+|.++.+++.||+|.+...........+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 47899999999999999999999989999999998765433333456789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 456 LIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|+.+ +|.+++.+. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++.....+
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~----~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG----ELKLADFGLARAKSVPSK 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC----CEEECccccccccCCCCc
Confidence 9974 999988654 4689999999999999999999999999999999999999887 7999999998654322
Q ss_pred -CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC---------------
Q psy6820 533 -MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY--------------- 595 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~--------------- 595 (639)
.....++..|+|||++.+ ..++.++||||||+++|+|++|..||....... +....+.....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhhhhhhccc
Confidence 122346889999999865 568999999999999999999999996543222 22221111000
Q ss_pred ----CC----CC---CCccccc--HHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 596 ----GF----PS---PYWDDIS--EEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 596 ----~~----p~---~~~~~l~--~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.. +. .....++ .++.+++.+||+.||++|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 00 0112344 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=335.76 Aligned_cols=253 Identities=26% Similarity=0.466 Sum_probs=212.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+.|++.+.||.|+||.||+|.+..+++.+++|++..... ...+.+.+|+.+++.++||||+++++.+..++.+|+||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 679999999999999999999999999999999875432 2345677899999999999999999999999999999999
Q ss_pred ccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 457 IKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
+++++|..++.+ ...+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++......
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG----DIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC----CEEEccCccceeccccccc
Confidence 999999888754 45789999999999999999999999999999999999998877 7999999998654322
Q ss_pred CccccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 533 MFTVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.....+++.|+|||++. ...++.++|+|||||++|+|++|..||.... .......+..... ........++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~ 243 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSEP-PTLSQPSKWSM 243 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc--HHHHHHHHhcCCC-ccCCCCcccCH
Confidence 23456889999999984 4457889999999999999999999996543 2333333333221 11112246788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
++.++|.+||+.||++||+++++++||||.
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 273 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEHPFVS 273 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 999999999999999999999999999996
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.70 Aligned_cols=254 Identities=28% Similarity=0.487 Sum_probs=210.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
++|++.+.||+|+||.||+|.+..+++.+|+|++....... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999999999899999999986543322 34567789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
|+++++|.++......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~----~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC----cEEEEeeeeeeeccCCccc
Confidence 999999988877766799999999999999999999999999999999999999887 8999999998765432
Q ss_pred CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC------------------
Q psy6820 533 MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG------------------ 593 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~------------------ 593 (639)
.....++..|+|||++.+ ..++.++||||||+++|||++|.+||..... .+ ....+...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-ID-QLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HH-HHHHHHHHhCCCchhhHHHhccchHh
Confidence 223568899999999875 4578899999999999999999999965432 11 11111110
Q ss_pred -CCCCCC--------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 594 -QYGFPS--------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 594 -~~~~p~--------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
....+. ..++.++..+.+|+.+||+.||++||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000110 1124678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.71 Aligned_cols=255 Identities=34% Similarity=0.554 Sum_probs=210.6
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc----hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL----GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.++++++|+||+++++++.+.+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999999999999999765543 1234567899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+ +++|.+++.... .+++..+..++.||++||+|||++|++|+||+|+||+++.++ .+||+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~----~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG----VLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC----CEEEccceeeeeccCC
Confidence 9999 889999997765 799999999999999999999999999999999999999887 8999999999766432
Q ss_pred ---CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC-----------
Q psy6820 533 ---MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF----------- 597 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~----------- 597 (639)
.....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||..... . +....+.......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-I-DQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-H-HHHHHHHHHcCCCchhhhhhcccc
Confidence 223356788999998854 4678999999999999999999888865432 2 2222222110000
Q ss_pred -------------CCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q psy6820 598 -------------PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639 (639)
Q Consensus 598 -------------p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~~ 639 (639)
........+.++.++|.+||++||++|||+.|+++||||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 001123457899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.05 Aligned_cols=252 Identities=28% Similarity=0.483 Sum_probs=216.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
..|+..+.||.|+||.||.|.+..++..+|+|++...........+.+|+.+++++.||||+++++.+.+....|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999999999999999998665545556788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---C
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---M 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~ 533 (639)
+++++|.+++.. .++++..+..++.+++.||+|||+.+++|+||+|+||+++.++ .++|+|||++...... .
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~----~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG----DVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC----CEEEcccccceeccCCcccc
Confidence 999999999865 5789999999999999999999999999999999999999887 7999999999765432 2
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
....++..|+|||++.+..++.++|+||||+++|||++|..||.... .......+... .+......++..+.+++
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~~~li 233 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH--PMRVLFLIPKN---NPPTLTGEFSKPFKEFI 233 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC--hHhHhhhhhcC---CCCCCchhhhHHHHHHH
Confidence 23467889999999998889999999999999999999999996543 22222222222 22333456789999999
Q ss_pred HHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 614 SHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 614 ~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+||+.+|++||++.+++.||||.+
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 234 DACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred HHHcccCcccCcCHHHHHhChHhhh
Confidence 9999999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=338.81 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=209.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E 455 (639)
++|...+.||+|+||.||++.+..+++.+|+|.+...........+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 356667889999999999999999999999999986655445567789999999996 9999999999999999999999
Q ss_pred eccCCChHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 456 LIKGGDLFDAIS-----KNVKFSEEDSKFMTQSLASALSYLHDN-YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 456 ~~~ggsL~~~l~-----~~~~l~~~~~~~i~~qI~~aL~yLH~~-givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
|+. ++|.++.. ....+++..+..++.+++.||+|||+. +++||||||+||+++.++ .+||+|||++...
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~----~~kl~dfg~~~~~ 158 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG----NIKLCDFGISGQL 158 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC----cEEEeecchhHHh
Confidence 985 46655432 246799999999999999999999974 999999999999999887 7999999999765
Q ss_pred cCC--CccccCCCcccCccccccC---CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC-CCCCCCCCcc
Q psy6820 530 LRP--MFTVCGTPTYVAPEILNES---GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG-QYGFPSPYWD 603 (639)
Q Consensus 530 ~~~--~~~~~GT~~Y~APE~l~~~---~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~-~~~~p~~~~~ 603 (639)
... .....|++.|+|||++.+. .++.++|||||||++|+|++|..||.......+.+ ..+..+ ...++...+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL-TQVVKGDPPILSNSEER 237 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHH-hhhcCCCCCcCCCcCCC
Confidence 433 2345689999999999766 68999999999999999999999996543222222 222222 2223333334
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.++.++.+||.+||+.||++|||+++++.||||++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 58999999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=377.46 Aligned_cols=262 Identities=31% Similarity=0.479 Sum_probs=215.5
Q ss_pred CCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeec--C
Q psy6820 371 IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDT--N 447 (639)
Q Consensus 371 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~ 447 (639)
..+...++|.+++.||+|+||.||+|.+..++..+|+|++....... ....+..|+.+|++|+|||||+++++|.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34456789999999999999999999999999999999987654332 34567889999999999999999998844 4
Q ss_pred CceEEEEeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCceEEccCCc---
Q psy6820 448 NELYLVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDN-------YIVHRDIKPENLLVEMSGC--- 513 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~-------givHrDLKp~NILld~~g~--- 513 (639)
..+||||||+++++|.++|.. ...+++..++.|+.||+.||+|||+. +||||||||+||||+.+..
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 568999999999999999865 35799999999999999999999984 4999999999999965321
Q ss_pred ----------eeeeEEEeeccccccccCC--CccccCCCcccCcccccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q psy6820 514 ----------HVKVLKVGDFGLAQRVLRP--MFTVCGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFVSD 579 (639)
Q Consensus 514 ----------~~~~vKL~DFGla~~~~~~--~~~~~GT~~Y~APE~l~~--~~~s~~sDVwSLGvvL~eLltG~~Pf~~~ 579 (639)
....+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||+||+|+||..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 1125899999999765422 234679999999999854 45899999999999999999999999654
Q ss_pred CCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 580 TNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 580 ~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
. ....+...+... ..++ ....+.++.+||..||+.+|.+||++.|+|.||||+
T Consensus 247 ~-~~~qli~~lk~~-p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 247 N-NFSQLISELKRG-PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred C-cHHHHHHHHhcC-CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 3 334444444333 2222 245789999999999999999999999999999996
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=339.14 Aligned_cols=258 Identities=30% Similarity=0.469 Sum_probs=209.0
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecC--CceE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTN--NELY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~ 451 (639)
..++|++.+.||+|+||.||+|.+..+++.||+|.+....... ....+.+|+.++++++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3578999999999999999999999999999999987543322 123456799999999999999999998654 5689
Q ss_pred EEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.|++||||||+||+++.++ .+||+|||++....
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~----~~kL~dfg~~~~~~ 159 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG----CLKIADFGLARTYG 159 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----CEEECccceeeecC
Confidence 9999996 488888865 36789999999999999999999999999999999999999887 89999999997665
Q ss_pred CC---CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC------------
Q psy6820 531 RP---MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ------------ 594 (639)
Q Consensus 531 ~~---~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~------------ 594 (639)
.. .....+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...+ ..+.+..+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--EIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCChhhchhhh
Confidence 32 223345788999999865 567999999999999999999999996543 233333333211
Q ss_pred -------CCCCCCC-------cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q psy6820 595 -------YGFPSPY-------WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639 (639)
Q Consensus 595 -------~~~p~~~-------~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~~ 639 (639)
...+... ....++++.+||.+||+.||++|||+.|+++||||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0111000 12358899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=327.34 Aligned_cols=247 Identities=31% Similarity=0.522 Sum_probs=213.6
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
+|++.+.||.|+||.||++.+..++..+|+|.+.........+.+.+|+.+++.++||||+++++.+.+.+.+|++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 58899999999999999999999999999999876554444567788999999999999999999999999999999999
Q ss_pred cCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 458 KGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 458 ~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
++++|.+++.. ...+++..+..++.+++.||.|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~----~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG----KVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC----cEEEcccCcceeecccccc
Confidence 99999998864 34589999999999999999999999999999999999999887 7999999999766432
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||... +.......+..+.... ....++..+.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 231 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN--SWKNLILKVCQGSYKP---LPSHYSYELRSL 231 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC--CHHHHHHHHhcCCCCC---CCcccCHHHHHH
Confidence 23456899999999999888999999999999999999999999643 3444455555554332 224678999999
Q ss_pred HHHhcccCCCCCCCHHHHHcC
Q psy6820 613 ISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~H 633 (639)
|.+||+.||++||++.+++.-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=327.20 Aligned_cols=251 Identities=32% Similarity=0.597 Sum_probs=213.0
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc----hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL----GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
+|+..+.||+|+||.||+|....++..+++|.+...... ...+.+.+|+.+++.++|+||+++++++...+.+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 477789999999999999999988999999998654321 1235678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|||+++++|.+++.+...+++..+..++.+++.||+|||+.|++|+||+|+||+++.++ .+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~----~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG----VVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEccCccceeccccc
Confidence 99999999999998888899999999999999999999999999999999999999887 8999999998765433
Q ss_pred -CccccCCCcccCccccccCC-CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESG-YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~-~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....|++.|+|||.+.... ++.++|+||||+++|+|++|..||.... ...... .+.... . .......+++++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~-~~~~~~-~-~~~~~~~~~~~~~ 232 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVF-KIGRSK-E-LPPIPDHLSDEAK 232 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHH-HHHhcc-c-CCCcCCCcCHHHH
Confidence 24566899999999987766 8999999999999999999999996543 222222 222211 1 1123356789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
+++.+||+.+|++||++.+++.|||+
T Consensus 233 ~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 233 DFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=328.40 Aligned_cols=251 Identities=31% Similarity=0.509 Sum_probs=213.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++.+.||+|+||.||+|....+++.+|+|.+...... .....+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 6899999999999999999999999999999988654332 22355788999999999999999999999999999999
Q ss_pred eeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 455 ELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 455 E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
||+++++|.+++.. ...+++..+..++.+++.||+|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~----~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC----CEEECccccceecc
Confidence 99999999988853 34589999999999999999999999999999999999999887 79999999987654
Q ss_pred CC---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 531 RP---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 531 ~~---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.. .....|++.|+|||.+.+..++.++|+||||+++|||++|..||.....+...+...+.... .+......++.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE 235 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence 32 22456889999999999888999999999999999999999999765545455555554432 22222346789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+.++|.+||+.+|++||++.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.79 Aligned_cols=246 Identities=34% Similarity=0.543 Sum_probs=208.6
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCCh
Q psy6820 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL 462 (639)
Q Consensus 385 LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 462 (639)
||+|+||+||+|.+..+++.+|+|++...... .....+.+|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998754332 2234567899999999999999999999999999999999999999
Q ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC--CCccccC
Q psy6820 463 FDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--PMFTVCG 538 (639)
Q Consensus 463 ~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~--~~~~~~G 538 (639)
.+++.+.. .+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .+||+|||++..... ......+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG----NVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC----CEEEccCcchhhhccCCccccccC
Confidence 99997655 799999999999999999999999999999999999999887 799999999876542 2234567
Q ss_pred CCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--ChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 539 TPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN--DQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 539 T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~--~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....+...+.. .+......+++++.++|.+|
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE----MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc----ccccCCccCCHHHHHHHHHH
Confidence 8899999999888899999999999999999999999965443 22333333322 23334456799999999999
Q ss_pred cccCCCCCC-----CHHHHHcCCcccC
Q psy6820 617 LESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 617 L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
|+.||++|| ++.++++||||.+
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhc
Confidence 999999999 8999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.65 Aligned_cols=249 Identities=22% Similarity=0.398 Sum_probs=205.8
Q ss_pred CCeeEEEEEccCCceEEEEEEE-----cCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYD-----KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 450 (639)
++|++++.||+|+||.||+|.. ..++..||+|+++........+.+.+|+.+++.+ +||||++++++|.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 5799999999999999999964 3456789999997655444556788999999999 799999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcC------------------------------------------------------------
Q psy6820 451 YLVIELIKGGDLFDAISKNV------------------------------------------------------------ 470 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~------------------------------------------------------------ 470 (639)
++||||+++|+|.+++.+..
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999885421
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC--
Q psy6820 471 ---------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-- 533 (639)
Q Consensus 471 ---------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~-- 533 (639)
.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~----~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR----ITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC----cEEEecCccceeccCcccc
Confidence 467888999999999999999999999999999999999876 79999999997654321
Q ss_pred ---ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 534 ---FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 534 ---~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
....++..|+|||++.+..++.++|||||||++|||++ |..||..... .....+.+..+. ... .....+.++
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-~~~~~~~~~~~~-~~~--~~~~~~~~l 346 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-DSKFYKMIKEGY-RML--SPECAPSEM 346 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-hHHHHHHHHhCc-cCC--CCCCCCHHH
Confidence 12234567999999999999999999999999999997 8999965432 233444444332 111 124568999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+||.+||+.||++||++.|+++.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.47 Aligned_cols=255 Identities=28% Similarity=0.446 Sum_probs=209.1
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecC-----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTN----- 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~----- 447 (639)
...++|.+.+.||+|+||.||+|....+++.+|+|++..... ....+.+|+.+++++ +|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 346789999999999999999999999999999999865432 245677899999999 799999999988653
Q ss_pred CceEEEEeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 448 NELYLVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
+.+|+||||+++++|.+++.. ...+++..++.++.+++.||+|||+.|++|+||||+||+++.++ .+||+||
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~----~~kl~df 172 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG----GVKLVDF 172 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC----CEEEeec
Confidence 358999999999999998853 45789999999999999999999999999999999999999887 7999999
Q ss_pred cccccccCC---CccccCCCcccCccccccC-----CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC
Q psy6820 524 GLAQRVLRP---MFTVCGTPTYVAPEILNES-----GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY 595 (639)
Q Consensus 524 Gla~~~~~~---~~~~~GT~~Y~APE~l~~~-----~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~ 595 (639)
|++...... .....|+..|+|||.+... .++.++|+|||||++|||++|+.||.... .......+.....
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~--~~~~~~~~~~~~~ 250 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH--PVKTLFKIPRNPP 250 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc--HHHHHHHHhcCCC
Confidence 998765422 2245688999999998543 36899999999999999999999996532 2222223333221
Q ss_pred CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 596 GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 596 ~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
.........+.++.+||.+||+.||++||++.|+++||||+
T Consensus 251 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 -PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 11111235678999999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=332.94 Aligned_cols=253 Identities=33% Similarity=0.510 Sum_probs=206.7
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|++.+.||.|+||.||+|.+..+++.+|+|.+...... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488999999999999999999999999999998754322 2235678899999999999999999999999999999999
Q ss_pred ccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 457 IKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
+. ++|.+++.. ...+++..+..++.+++.||+|||+.|++|+||+|+||+++.++ .+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~----~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----CEEEeeccchhhcccCcc
Confidence 95 689888855 35689999999999999999999999999999999999999887 7999999998755422
Q ss_pred -CccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC---------------
Q psy6820 533 -MFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY--------------- 595 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~--------------- 595 (639)
.....+++.|+|||.+.+. .++.++||||||+++|+|+||..||...+. .....+.+.....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2234578899999988764 468899999999999999999999975432 2222222111100
Q ss_pred --CCC-------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 596 --GFP-------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 596 --~~p-------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.++ ......++++++++|.+||+.||++|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000 01123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=356.07 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=211.7
Q ss_pred cccCCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeee
Q psy6820 367 ENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYD 445 (639)
Q Consensus 367 ~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 445 (639)
+.|+++ .++..++..||.|+||+||+|++-+ .||||++....... ..+.|++|+.+|++-+|.||+-++|+|.
T Consensus 385 ~~WeIp---~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 385 EEWEIP---PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred cccccC---HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 345444 3567789999999999999998766 59999998766543 3478999999999999999999999998
Q ss_pred cCCceEEEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 446 TNNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 446 ~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
.++. .||+.||+|-+|+.++.- ..+|.....+.|++||++|+.|||.++|||||||..||+++.++ .|||+|||
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~----kVkIgDFG 533 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL----KVKIGDFG 533 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC----cEEEeccc
Confidence 8777 999999999999999954 45799999999999999999999999999999999999999887 89999999
Q ss_pred cccccc-----CCCccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 525 LAQRVL-----RPMFTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 525 la~~~~-----~~~~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
++.... .......|...|||||+++ ..+|+..+||||||+++|||+||.+||. .+..++++-.+-.|-..
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys--i~~~dqIifmVGrG~l~ 611 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFMVGRGYLM 611 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC--CCChhheEEEecccccC
Confidence 997543 2334566888999999985 4679999999999999999999999997 34445554444444221
Q ss_pred C-CCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 597 F-PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 597 ~-p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
. +.....++++++++|+..||..++++||.+.+||.
T Consensus 612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1 12234678999999999999999999999999886
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=331.56 Aligned_cols=252 Identities=30% Similarity=0.521 Sum_probs=208.5
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
+|++.+.||.|++|.||+|.+..+++.||+|++...........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58899999999999999999999999999999987655444566778999999999999999999999999999999999
Q ss_pred cCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 458 KGGDLFDAISKN---VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 458 ~ggsL~~~l~~~---~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
++ +|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~----~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG----ELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC----cEEEeecchhhhhcCCcc
Confidence 75 898888653 3589999999999999999999999999999999999999887 7999999999755322
Q ss_pred -CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC----------------
Q psy6820 533 -MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ---------------- 594 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~---------------- 594 (639)
.....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+. .+....+....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN--EDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 223457899999998865 4578999999999999999999999976543 22222221110
Q ss_pred --CCCCC-------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 595 --YGFPS-------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 595 --~~~p~-------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
..++. ...+.++.++.++|.+||+.||++||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00000 0112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=333.35 Aligned_cols=255 Identities=32% Similarity=0.618 Sum_probs=229.8
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHHHhc-CCCceeeeeeeeecCCceE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSV-NHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 451 (639)
-+++|.++++||+|+|++|.+++.+.+.+.||+|++++.-....+ +-.+.|-.+..+- +||.+|.+..+|+++..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 468899999999999999999999999999999999877655443 2345666666666 5999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+|.||++||+|.-+++++++++++.++++-.+|+.||.|||++|||+||||.+|+|+|..| ++||.|+|+++....
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg----hikltdygmcke~l~ 403 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG----HIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC----ceeecccchhhcCCC
Confidence 9999999999999999999999999999999999999999999999999999999999998 899999999987654
Q ss_pred ---CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCC------CCCCChHHHHHHHHcCCCCCCCCCc
Q psy6820 532 ---PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFV------SDTNDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 532 ---~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~------~~~~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
...++||||.|+|||++.+..|+..+|+|+|||+++||+.|+.||. ...+..+.+++.|+..++.+|.
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--- 480 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--- 480 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc---
Confidence 3568999999999999999999999999999999999999999995 2334567789999999988884
Q ss_pred ccccHHHHHHHHHhcccCCCCCC------CHHHHHcCCccc
Q psy6820 603 DDISEEAKELISHMLESNPDLRF------SAEDVLDHPWLE 637 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rp------ta~eiL~HP~f~ 637 (639)
.++-.+..+++..|.+||++|. ...++..||||+
T Consensus 481 -slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr 520 (593)
T KOG0695|consen 481 -SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR 520 (593)
T ss_pred -eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence 6788899999999999999998 478999999996
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=328.11 Aligned_cols=251 Identities=31% Similarity=0.516 Sum_probs=206.5
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeecc
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIK 458 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 458 (639)
+.....||+|+||.||+|.+..++..+|+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 3445689999999999999999999999999875543 234568899999999999999999999999999999999999
Q ss_pred CCChHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 459 GGDLFDAISKN-VKF--SEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 459 ggsL~~~l~~~-~~l--~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
+++|.+++... ..+ ++..+..++.||+.||+|||+.||+||||||+||+++.+. ..++|+|||++......
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~---~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS---GVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC---CeEEEecchhheecccCCCc
Confidence 99999999754 445 8888999999999999999999999999999999998633 27999999998755321
Q ss_pred CccccCCCcccCccccccC--CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNES--GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~--~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....|++.|+|||.+.+. .++.++|+||||+++|+|++|..||................. ........+++++.
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 242 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK---IHPEIPESLSAEAK 242 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc---cCCCCCcccCHHHH
Confidence 2234689999999998654 378999999999999999999999965433222222221111 11223356889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
+++++||+.+|++|||+.|++.||||
T Consensus 243 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 243 NFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=356.37 Aligned_cols=253 Identities=36% Similarity=0.659 Sum_probs=231.0
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH-HHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~-~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
-...|.+.+.||+|.|+.|.++++..++..||||++++....... +.+.+|+++|+.++|||||+++.+.+.+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346799999999999999999999999999999999987765443 4578999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC--
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-- 531 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-- 531 (639)
|||+.+|.+++++.+.++..+..++.++.|++.|++|||+++|+|||||++|||++.+. ++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m----nikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM----NIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc----ceeeeccccceeecccc
Confidence 99999999999999999999999999999999999999999999999999999999886 799999999987753
Q ss_pred CCccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
...+.||++.|.|||++.+..| ++.+|+||+|++||-|++|.+||.+. ....+....+.+.+.+|. .++-+++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~--~lk~Lr~rvl~gk~rIp~----~ms~dce 283 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ--NLKELRPRVLRGKYRIPF----YMSCDCE 283 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc--ccccccchheeeeecccc----eeechhH
Confidence 3568999999999999998877 68999999999999999999999653 456677778888887774 5789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
+||+++|.++|.+|++.++++.|.|..
T Consensus 284 ~lLrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 284 DLLRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred HHHHHhhccCccccCCHHHhhhhcccc
Confidence 999999999999999999999999974
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=332.62 Aligned_cols=251 Identities=25% Similarity=0.441 Sum_probs=207.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeee------cCC
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYD------TNN 448 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~------~~~ 448 (639)
.+.|++.+.||.|+||.||+|.+..+++.+|+|++..... ....+..|+.+++++ +||||+++++++. ...
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 3679999999999999999999999999999999865432 234577899999998 5999999999884 346
Q ss_pred ceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
.+|++|||+++|+|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~----~~~l~dfg~~ 168 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA----EVKLVDFGVS 168 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEeeCcch
Confidence 789999999999999999653 4588999999999999999999999999999999999999887 7999999998
Q ss_pred ccccC---CCccccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy6820 527 QRVLR---PMFTVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598 (639)
Q Consensus 527 ~~~~~---~~~~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p 598 (639)
..... ......|++.|+|||.+. +..++.++|+|||||++|||++|..||..... ...... +... ..+
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-~~~~~~-~~~~--~~~ 244 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-MRALFL-IPRN--PPP 244 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-Hhhhhh-HhhC--CCC
Confidence 75532 233467899999999985 34678899999999999999999999965332 222221 2111 112
Q ss_pred CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 599 SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 599 ~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
......++.++.+||.+||+.||.+||++.|+++||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 22224678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=325.65 Aligned_cols=251 Identities=33% Similarity=0.611 Sum_probs=214.2
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|.+.+.||+|+||.||+|..+.++..+|+|.+...... ...+.+.+|+.+++.++|+||+++++.+...+..|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588999999999999999999999999999998765432 2335678999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC-
Q psy6820 457 IKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM- 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~- 533 (639)
+++++|.+++.+.. .+++..+..++.+++.||+|||+.+++|+||||+||+++.++ ..+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~---~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG---MVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC---CeEEecccccchhccCCcc
Confidence 99999999996643 579999999999999999999999999999999999998775 257999999997664322
Q ss_pred --ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 534 --FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 534 --~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||... +..+....+...... +..+.++.++.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--NLHQLVLKICQGYFA---PISPNFSRDLRS 232 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHhcccCC---CCCCCCCHHHHH
Confidence 2346899999999998888999999999999999999999999643 333444444443321 222467899999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
+|.+||+.+|++|||+.+++.||||
T Consensus 233 ~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 233 LISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHhccChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=332.57 Aligned_cols=255 Identities=33% Similarity=0.527 Sum_probs=211.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
++|++.+.||+|+||.||+|.+..+++.||+|.++..... ...+.+.+|+.++++++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4799999999999999999999999999999998754332 224667899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
|++++.+..+..+...+++..+..++.+|+.||+|||+.|++|+||+|+||+++.++ .+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~----~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG----VLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----CEEEEeeecccccCCCccc
Confidence 999877777676667799999999999999999999999999999999999999887 8999999998766532
Q ss_pred -CccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc-C----------------
Q psy6820 533 -MFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS-G---------------- 593 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~-~---------------- 593 (639)
.....++..|+|||++.+. .++.++|+||||+++|+|++|..||..... .+.+...... +
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-IDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 2346688999999999887 889999999999999999999999965432 2222111100 0
Q ss_pred -CCCCCC---------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 594 -QYGFPS---------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 594 -~~~~p~---------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
...++. .+...++.++.+||++||+.+|++||++++++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000100 1112358999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=330.59 Aligned_cols=251 Identities=27% Similarity=0.487 Sum_probs=214.6
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
-|++.+.||.|+||.||+|.+..++..+|+|++...........+.+|+.++++++||||+++++++...+..|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 36778899999999999999998999999999876655444567889999999999999999999999999999999999
Q ss_pred cCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---Cc
Q psy6820 458 KGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MF 534 (639)
Q Consensus 458 ~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~~ 534 (639)
++++|.+++.. ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...... ..
T Consensus 85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~----~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG----EVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC----CEEEeecccceecccchhhhc
Confidence 99999999864 4689999999999999999999999999999999999999887 7999999998655432 22
Q ss_pred cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHH
Q psy6820 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~ 614 (639)
...|+..|+|||.+.+..++.++|+|||||++|+|++|..||.... .......+.... +......++.++.+++.
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~ 234 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--PMKVLFLIPKNN---PPTLEGNYSKPLKEFVE 234 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--hHHHHHHHhcCC---CCCCCcccCHHHHHHHH
Confidence 3468899999999988889999999999999999999999995432 233333333322 12223467899999999
Q ss_pred HhcccCCCCCCCHHHHHcCCcccC
Q psy6820 615 HMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 615 ~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||+.+|++||++.++++||||.+
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 235 ACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred HHccCChhhCcCHHHHHhCHHHhh
Confidence 999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=331.77 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=211.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|.+.+.||+|+||.||+|.... ++..+|+|.+.........+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568899999999999999997743 35789999997665544567788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceee
Q psy6820 451 YLVIELIKGGDLFDAISKN--------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVK 516 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~--------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~ 516 (639)
|++|||+++++|.+++... ..+++..+..++.+++.||+|||++|++||||||+||+++.++
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~---- 159 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL---- 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC----
Confidence 9999999999999999654 3478899999999999999999999999999999999999887
Q ss_pred eEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHH
Q psy6820 517 VLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDI 590 (639)
Q Consensus 517 ~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i 590 (639)
.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|||++ |..||... +.......+
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~--~~~~~~~~~ 237 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL--SNEEVIECI 237 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHH
Confidence 8999999999754321 123345788999999999999999999999999999998 99999643 345566666
Q ss_pred HcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 591 LSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 591 ~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
..+....+ ...++.++.+++.+||+.||++||++.|+++
T Consensus 238 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 65544332 2468999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=330.58 Aligned_cols=254 Identities=29% Similarity=0.475 Sum_probs=206.8
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeee-----cC
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYD-----TN 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~-----~~ 447 (639)
...++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 34578999999999999999999999999999999986532 2235677899999999 6999999999873 44
Q ss_pred CceEEEEeeccCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 448 NELYLVIELIKGGDLFDAIS----KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
+.+++||||+++++|.+++. ....+++..+..++.+++.||.|||+.+++||||||+||+++.++ .+||+||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~----~~kl~df 168 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG----GVKLVDF 168 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC----CEEEccC
Confidence 67899999999999998874 235688999999999999999999999999999999999999887 7999999
Q ss_pred cccccccCC---CccccCCCcccCcccccc-----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC
Q psy6820 524 GLAQRVLRP---MFTVCGTPTYVAPEILNE-----SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY 595 (639)
Q Consensus 524 Gla~~~~~~---~~~~~GT~~Y~APE~l~~-----~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~ 595 (639)
|++...... .....|++.|+|||++.. ..++.++|||||||++|||++|..||..... ...+. .+....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-~~~~~-~~~~~~- 245 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-MRALF-KIPRNP- 245 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-hHHHh-hccccC-
Confidence 998765432 234568999999999853 4578999999999999999999999965432 12221 111111
Q ss_pred CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 596 GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 596 ~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.........++.++.+||.+||+.||++|||+.|+++||||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 11111123467899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=336.85 Aligned_cols=251 Identities=27% Similarity=0.471 Sum_probs=213.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+.|+..+.||+|+||.||+|.+..++..+|+|.+.........+.+.+|+.++++++||||+++++.+...+..|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34667788999999999999999999999999987665544556788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---C
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---M 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~ 533 (639)
+++++|.+++.. ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++ .++|+|||++...... .
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~----~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG----DVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC----CEEEccccccccccCcchhh
Confidence 999999998864 5789999999999999999999999999999999999999887 7999999999765432 1
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
....|+..|+|||++.+..++.++|+||||+++|||++|..||..... ......+.... +......++.++.++|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~~li 233 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP--MRVLFLIPKNS---PPTLEGQYSKPFKEFV 233 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch--hhHHhhhhcCC---CCCCCcccCHHHHHHH
Confidence 234688999999999998899999999999999999999999954322 22222222221 1222245788999999
Q ss_pred HHhcccCCCCCCCHHHHHcCCccc
Q psy6820 614 SHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 614 ~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
.+||+.+|++||++.++++||||.
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 234 EACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred HHHccCCcccCcCHHHHHHhHHHH
Confidence 999999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=329.64 Aligned_cols=250 Identities=30% Similarity=0.503 Sum_probs=204.7
Q ss_pred CCeeEEEEE--ccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQII--GDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~L--G~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 453 (639)
++|++.+.+ |+|+||.||++..+.++..+|+|++....... .|+.....+ +||||+++++.+...+.+|+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 456666666 99999999999999999999999987543321 122233323 699999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|||+++++|.+++..+..+++..+..++.|++.||+|||+.|++||||||+||+++.++ ..++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~---~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK---DRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC---CeEEEecCccceecCCC-
Confidence 99999999999998877899999999999999999999999999999999999998775 26999999998765432
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
....|+..|+|||++.+..++.++||||||+++|+|++|..||......... ...+.... ..+.+.++.+++.+.++|
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li 241 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-LESLLKRQ-QKKLPFIKNVSKNANDFV 241 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-HHHHHHhh-cccCCcccccCHHHHHHH
Confidence 3456899999999999989999999999999999999999999744322111 11111111 222234457899999999
Q ss_pred HHhcccCCCCCCC-HHHHHcCCcccC
Q psy6820 614 SHMLESNPDLRFS-AEDVLDHPWLER 638 (639)
Q Consensus 614 ~~~L~~dP~~Rpt-a~eiL~HP~f~~ 638 (639)
.+||+.||.+||+ ++++++||||+.
T Consensus 242 ~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 242 QSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHhccChhhCCchHHHHhcCCcccC
Confidence 9999999999996 699999999973
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=328.37 Aligned_cols=252 Identities=30% Similarity=0.489 Sum_probs=208.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCC------
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNN------ 448 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~------ 448 (639)
.++|++.+.||.|+||.||+|.++.+++.+++|++..... ..+.+.+|+.+++++ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4789999999999999999999998899999999876543 346688999999999 6999999999986544
Q ss_pred ceEEEEeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 449 ELYLVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
.+|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .+||+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~----~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC----eEEECCCc
Confidence 48999999999999998864 35799999999999999999999999999999999999999887 79999999
Q ss_pred ccccccCC---CccccCCCcccCcccccc-----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 525 LAQRVLRP---MFTVCGTPTYVAPEILNE-----SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 525 la~~~~~~---~~~~~GT~~Y~APE~l~~-----~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
++...... .....|++.|+|||++.. ..++.++||||||+++|+|++|..||.... ..... ..+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~-~~~~~~~~~ 236 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-PMRAL-FKIPRNPPP 236 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-hHHHH-HHhhccCCC
Confidence 98755322 234568999999998753 346889999999999999999999996432 22222 233332211
Q ss_pred CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 597 ~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.......++.++++||++||..||++|||+.++++|||+
T Consensus 237 -~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 -TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 111113468899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=330.42 Aligned_cols=250 Identities=36% Similarity=0.663 Sum_probs=219.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 453 (639)
++|.+.+.||.|+||.||+|....+++.+|+|++...... .....+.+|+.++++++ ||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999999999999999999764432 22356778999999999 99999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|||+++++|.+++.+.+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~----~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM----HIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC----CEEecCCccccccCCcc
Confidence 99999999999999888899999999999999999999999999999999999999887 79999999987554321
Q ss_pred -----------------------ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHH
Q psy6820 534 -----------------------FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDI 590 (639)
Q Consensus 534 -----------------------~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i 590 (639)
....|+..|+|||++.+..++.++|+||||+++++|++|..||.... ....+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~ 234 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYLTFQKI 234 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHH
Confidence 13457899999999988889999999999999999999999996543 44455555
Q ss_pred HcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCH----HHHHcCCcc
Q psy6820 591 LSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSA----EDVLDHPWL 636 (639)
Q Consensus 591 ~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta----~eiL~HP~f 636 (639)
......++ ..+++.+.++|++||+.||++||++ +++++||||
T Consensus 235 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 235 LKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 55544444 4568999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.43 Aligned_cols=254 Identities=29% Similarity=0.432 Sum_probs=204.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCc-----
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNE----- 449 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~----- 449 (639)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4699999999999999999999999999999998654322 12345778999999996 6999999999877665
Q ss_pred eEEEEeeccCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEcc-CCceeeeEEEeec
Q psy6820 450 LYLVIELIKGGDLFDAISKN-----VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM-SGCHVKVLKVGDF 523 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~-~g~~~~~vKL~DF 523 (639)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++. ++ .+||+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~----~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG----LLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC----eEEEeec
Confidence 8999999975 898887542 35799999999999999999999999999999999999998 55 7999999
Q ss_pred cccccccCC---CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC----
Q psy6820 524 GLAQRVLRP---MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY---- 595 (639)
Q Consensus 524 Gla~~~~~~---~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~---- 595 (639)
|++.....+ .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+. ...... +.....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-~~~~~~-~~~~~~~~~~ 233 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-LQQLLH-IFKLLGTPTE 233 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHH-HHHHhCCCCh
Confidence 998765322 123356889999998865 5679999999999999999999999975432 222221 111000
Q ss_pred --------------------CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 596 --------------------GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 596 --------------------~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
..+....+.++.++.++|.+||+.||++||++.|++.||||+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000011135789999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.97 Aligned_cols=253 Identities=29% Similarity=0.449 Sum_probs=223.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+.|.-++.||.|+||.||-|++..+.+.||||.+..+.....+ +.+..|+..|++++|||++.+-|+|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3466678899999999999999999999999999876655433 56889999999999999999999999999999999
Q ss_pred eeccCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 455 ELIKGGDLFDAIS-KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 455 E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|||- |+-.|++. ...++.+.++..|+.+.+.||+|||+++.||||||..|||+...| .|||+|||.|.. ..|.
T Consensus 106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g----~VKLaDFGSAsi-~~PA 179 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG----LVKLADFGSASI-MAPA 179 (948)
T ss_pred HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC----eeeeccccchhh-cCch
Confidence 9995 58777774 345799999999999999999999999999999999999999998 999999999954 4677
Q ss_pred ccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 534 FTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.+++|||.|||||++. .+.|+-++||||||++..||.-.++|+.. .+....++....+..+.++.. ..+..+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn-MNAMSALYHIAQNesPtLqs~---eWS~~F~ 255 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPTLQSN---EWSDYFR 255 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC-chHHHHHHHHHhcCCCCCCCc---hhHHHHH
Confidence 8899999999999974 57899999999999999999999999854 345667777777777777764 4589999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccCC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLERS 639 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~~ 639 (639)
.++..||++-|.+|||++++|.|+|+.++
T Consensus 256 ~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 256 NFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 99999999999999999999999999874
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=330.87 Aligned_cols=252 Identities=28% Similarity=0.464 Sum_probs=212.0
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC---CCceeeeeeeeecCCceEEEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN---HPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.|++.+.||.|+||.||+|.+..+++.+|+|.+...........+.+|+.++++++ |||++++++++...+..|++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 47788999999999999999999999999999876544444566788999999997 999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
||+++++|.+++.. ..+++..+..++.+++.||+|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~----~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG----NVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC----CEEEccCCceeecCCCcc
Confidence 99999999999865 4789999999999999999999999999999999999999877 8999999999766432
Q ss_pred -CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.... .......+... ..+.......+.++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~ 232 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD--AFRAMMLIPKS--KPPRLEDNGYSKLLR 232 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC--hhhhhhccccC--CCCCCCcccCCHHHH
Confidence 234568999999999865 457899999999999999999999996543 22222222121 112211224789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+++.+||+.||++||++.+++.||||++
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 9999999999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=333.47 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=202.9
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCC----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNN---- 448 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 448 (639)
...++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 3457899999999999999999999999999999998654322 22334568999999999999999999886554
Q ss_pred ----ceEEEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 449 ----ELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 449 ----~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
..++||||+. ++|.+.+... ..+++.++..++.||+.||+|||++|++|+||||+||+++.++ .+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~----~~kl~df 163 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG----ILKLADF 163 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC----cEEECcC
Confidence 4599999995 5888887654 3689999999999999999999999999999999999999887 8999999
Q ss_pred cccccccCC-------CccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC
Q psy6820 524 GLAQRVLRP-------MFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY 595 (639)
Q Consensus 524 Gla~~~~~~-------~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~ 595 (639)
|++...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... .....+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~ 241 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCG 241 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC
Confidence 999755322 1234578899999988654 4789999999999999999999999654322 11111111000
Q ss_pred C-------------------CCCCC---------cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 596 G-------------------FPSPY---------WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 596 ~-------------------~p~~~---------~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
. ++... ....+..+.+||.+||+.||++|||++++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 11000 00135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.44 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=210.0
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|.+.+.||+|+||.||+|.... ++..+|+|.+...........+.+|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999999877 77889999987554444456688899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 451 YLVIELIKGGDLFDAISKNV-------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
++||||+++++|.+++.... .+++..+..++.+|+.||+|||+++++||||||+||+++.++. ...+||+||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~-~~~~kl~df 163 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGP-GRVAKIADF 163 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCC-CcceEeccC
Confidence 99999999999999996543 4899999999999999999999999999999999999987642 236999999
Q ss_pred cccccccCCCc-----cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCC
Q psy6820 524 GLAQRVLRPMF-----TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGF 597 (639)
Q Consensus 524 Gla~~~~~~~~-----~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~ 597 (639)
|++........ ...++..|+|||++.+..++.++|||||||++|||++ |..||.... ...+...+..... .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~--~~~~~~~~~~~~~-~ 240 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT--NQEVMEFVTGGGR-L 240 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHcCCc-C
Confidence 99976532211 2223567999999998889999999999999999997 999996543 3444444444321 1
Q ss_pred CCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 598 PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 598 p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.....++.++.+++.+||+.||++||++.++++|
T Consensus 241 --~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 --DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1224678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.20 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=207.4
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
++|++.+.||+|++|.||+|.++.+++.+|+|.+...... .....+.+|+.++++++||||+++++++...+..|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6799999999999999999999999999999998765432 223567789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 456 LIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|++ ++|.+.+.... .+++..+..++.||+.||+|||++|++|+||+|+||+++.++ ..+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~---~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT---NALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC---CEEEEcccccccccCCCc
Confidence 995 58888876543 357888999999999999999999999999999999998654 26899999999755322
Q ss_pred --CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC-------------
Q psy6820 533 --MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG------------- 596 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~------------- 596 (639)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... .+.+.+ +......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-IDELFK-IFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH-HHHHhCCCChhhccccccch
Confidence 223457899999998866 4579999999999999999999999975432 222222 2110000
Q ss_pred --------CCC----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 597 --------FPS----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 597 --------~p~----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+. ...+.+++++.+++.+||+.||++||++.++++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 000 012357889999999999999999999999999999975
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=329.42 Aligned_cols=250 Identities=31% Similarity=0.513 Sum_probs=202.7
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecC--CceEEEEe
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTN--NELYLVIE 455 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~--~~~~lV~E 455 (639)
|++.+.||+|+||.||+|.+..++..+|+|.+.............+|+.++.++. |+|++++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6789999999999999999999999999999876533333333457888898886 99999999999887 88999999
Q ss_pred eccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 456 LIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|++ ++|.+.+.. ...+++..+..++.|++.||+|||+.|++||||+|+||+++. + .+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~----~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D----ILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C----CeEEEecccccccccCCC
Confidence 996 588888865 357899999999999999999999999999999999999998 6 7999999999765432
Q ss_pred CccccCCCcccCccccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC------------------
Q psy6820 533 MFTVCGTPTYVAPEILN-ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG------------------ 593 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~-~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~------------------ 593 (639)
.....+++.|+|||.+. +..++.++|||||||++|||++|..||...+. .+....+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 23456899999999765 45578999999999999999999999965432 2222222110
Q ss_pred CCCCCCCC-------cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 594 QYGFPSPY-------WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 594 ~~~~p~~~-------~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
...++... ...++.++.+||.+||++||++||+++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11111110 13568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.10 Aligned_cols=254 Identities=21% Similarity=0.383 Sum_probs=210.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|++.+.||+|+||.||+|..+. .+..+|+|.+...........+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 4689999999999999999997653 35579999987654444445677899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEE
Q psy6820 451 YLVIELIKGGDLFDAISKN----------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~----------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL 520 (639)
|+||||+++|+|.+++.+. ..++...+..++.+++.||.|||++|++||||||+||+++.++ .+||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~----~~~L 160 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF----TVKI 160 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC----cEEE
Confidence 9999999999999999642 2346678899999999999999999999999999999999887 7999
Q ss_pred eeccccccccCCC-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCC
Q psy6820 521 GDFGLAQRVLRPM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQ 594 (639)
Q Consensus 521 ~DFGla~~~~~~~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~ 594 (639)
+|||++....... ....++..|+|||.+.+..++.++|+|||||++|||++ |..||... ..++....+..+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~~ 238 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--SNEQVLKFVMDGG 238 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC
Confidence 9999987553221 12345678999999998889999999999999999998 78999543 3455555555443
Q ss_pred CCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc------CCcccC
Q psy6820 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD------HPWLER 638 (639)
Q Consensus 595 ~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~------HP~f~~ 638 (639)
... ....+++++.+++.+||+.||++|||+.++++ ||||..
T Consensus 239 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 239 YLD---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 211 12456899999999999999999999999987 999974
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=354.30 Aligned_cols=259 Identities=32% Similarity=0.586 Sum_probs=232.3
Q ss_pred CcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHHHhcCCCceeeeeeeeecCCc
Q psy6820 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 372 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 449 (639)
+...+.+++++..||-||||.|-++........+|+|++++..+...+ +.+..|-.||..++.|.||++|..|.++++
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 344567788899999999999999877766666899999887765444 447789999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
.||+||-|-||.|+..+...+.|++..+++++.++++|++|||++|||+|||||+|++++.+| .+||.|||+|+..
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G----y~KLVDFGFAKki 570 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG----YLKLVDFGFAKKI 570 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC----ceEEeehhhHHHh
Confidence 999999999999999999999999999999999999999999999999999999999999998 8999999999987
Q ss_pred c--CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 530 L--RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 530 ~--~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
. ..+.++||||.|.|||++.+.+.+.++|.||||+++|||++|.+||.+. ++...++.|+.+--.+.-| ..++.
T Consensus 571 ~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~--dpmktYn~ILkGid~i~~P--r~I~k 646 (732)
T KOG0614|consen 571 GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV--DPMKTYNLILKGIDKIEFP--RRITK 646 (732)
T ss_pred ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC--chHHHHHHHHhhhhhhhcc--cccch
Confidence 6 4567899999999999999999999999999999999999999999654 6677888898885333222 57899
Q ss_pred HHHHHHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 608 EAKELISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
.+.+||++++..+|.+|.. +.+|-.|-||..
T Consensus 647 ~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 647 TATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred hHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 9999999999999999995 899999999974
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=360.30 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=197.2
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCC-eEEEEEE--------------Ecccc--cchhHHHHHHHHHHHHhcCCC
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKD-MDCALKI--------------IDKSK--LLGKKQMIENEVNILRSVNHP 435 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAiKv--------------~~~~~--~~~~~~~~~~Ei~iL~~l~Hp 435 (639)
....++|++++.||+|+||+||+|..+... ...+.|. +.+.. .......+.+|+.+|++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 445689999999999999999998765432 1222221 11100 111234578999999999999
Q ss_pred ceeeeeeeeecCCceEEEEeeccCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEcc
Q psy6820 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-----VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM 510 (639)
Q Consensus 436 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~ 510 (639)
||+++++++...+..|+++|++ +++|.+++... .......++.++.||+.||+|||++||+||||||+|||++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 9999999999999999999998 45888777432 23456778899999999999999999999999999999998
Q ss_pred CCceeeeEEEeeccccccccCC----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCC-CCCCCCCh-H
Q psy6820 511 SGCHVKVLKVGDFGLAQRVLRP----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPP-FVSDTNDQ-D 584 (639)
Q Consensus 511 ~g~~~~~vKL~DFGla~~~~~~----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~P-f~~~~~~~-~ 584 (639)
++ .+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..+ |....... .
T Consensus 303 ~~----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 303 DG----KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred CC----CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 87 7999999999766432 2346799999999999999999999999999999999998754 43322222 2
Q ss_pred HHHHHHHcC---CCCCCCC------------------------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 585 ELFDDILSG---QYGFPSP------------------------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 585 ~l~~~i~~~---~~~~p~~------------------------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
.+.+.+... ...+|.. ....++.++.++|.+||+.||++|||+.|+|+||||.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 222222110 0011110 0013567888999999999999999999999999997
Q ss_pred C
Q psy6820 638 R 638 (639)
Q Consensus 638 ~ 638 (639)
.
T Consensus 459 ~ 459 (501)
T PHA03210 459 A 459 (501)
T ss_pred c
Confidence 5
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.13 Aligned_cols=247 Identities=25% Similarity=0.418 Sum_probs=210.3
Q ss_pred ccccCCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeee
Q psy6820 366 RENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYD 445 (639)
Q Consensus 366 ~~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 445 (639)
.+.|++|-+.+ .-++-||.|+.|.||+|+.. ++.||||.++ +.-+.+|.=|++|+||||+.+.|+|.
T Consensus 116 ~e~WeiPFe~I---sELeWlGSGaQGAVF~Grl~--netVAVKKV~--------elkETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 116 EELWEIPFEEI---SELEWLGSGAQGAVFLGRLH--NETVAVKKVR--------ELKETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred hhhccCCHHHh---hhhhhhccCcccceeeeecc--CceehhHHHh--------hhhhhhHHHHHhccCcceeeEeeeec
Confidence 35566664333 23577999999999998665 4589999874 33356788899999999999999999
Q ss_pred cCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 446 TNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 446 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
....+|||||||..|-|+.+|+....+.......+..+||.|+.|||.+.|||||||.-||||..+. .|||+|||-
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d----~VKIsDFGT 258 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD----VVKISDFGT 258 (904)
T ss_pred CCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc----eEEeccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999887 899999999
Q ss_pred cccccC--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc
Q psy6820 526 AQRVLR--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 526 a~~~~~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
++.... ....++||..|||||++.+.+.++|+|||||||+|||||||..||..- +...++--+-...+.+ +...
T Consensus 259 S~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV--dssAIIwGVGsNsL~L--pvPs 334 (904)
T KOG4721|consen 259 SKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV--DSSAIIWGVGSNSLHL--PVPS 334 (904)
T ss_pred hHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc--chheeEEeccCCcccc--cCcc
Confidence 987653 345689999999999999999999999999999999999999999532 2233322222223333 3447
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+|+.++-||++||+..|..||++.+|+.|
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 899999999999999999999999999988
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=326.24 Aligned_cols=246 Identities=34% Similarity=0.656 Sum_probs=214.1
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCCh
Q psy6820 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL 462 (639)
Q Consensus 385 LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 462 (639)
||.|+||.||+|.+..+++.+++|++...... ...+.+.+|+.++++++||||+++++.+...+..|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999765442 2345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC----------
Q psy6820 463 FDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---------- 532 (639)
Q Consensus 463 ~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---------- 532 (639)
.+++.+...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG----HLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC----CEEEEecccchhcccCcccccccccc
Confidence 99998877899999999999999999999999999999999999999887 8999999998755322
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||... .....+..+..+....+.. ..++.++.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE--TPEEIFQNILNGKIEWPED--VEVSDEAID 232 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCcCCCcc--ccCCHHHHH
Confidence 22346788999999998888999999999999999999999999544 4556666676655444432 235899999
Q ss_pred HHHHhcccCCCCCCCH---HHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFSA---EDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta---~eiL~HP~f~~ 638 (639)
++.+||+.+|++|||+ .++++||||.+
T Consensus 233 ~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 233 LISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 9999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.40 Aligned_cols=247 Identities=28% Similarity=0.508 Sum_probs=203.8
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHH---HHHhcCCCceeeeeeeeecCCceEEEEeecc
Q psy6820 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVN---ILRSVNHPNIIKLLDEYDTNNELYLVIELIK 458 (639)
Q Consensus 384 ~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~---iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 458 (639)
.||+|+||.||+|.+..+++.||+|++.+...... ...+.+|.. .++...||+|+.+++.+...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 38999999999999999999999999876543211 222334443 3444579999999999999999999999999
Q ss_pred CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-CCcccc
Q psy6820 459 GGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-PMFTVC 537 (639)
Q Consensus 459 ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-~~~~~~ 537 (639)
|++|.+++.....+++..+..++.|++.||+|||+.+++||||||+||+++.++ .+||+|||++..... .....+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~----~~kl~dfg~~~~~~~~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG----HVRISDLGLACDFSKKKPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC----CEEEccCcCccccCccCCcCcC
Confidence 999999998888899999999999999999999999999999999999999887 799999999875542 223467
Q ss_pred CCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCC-ChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHH
Q psy6820 538 GTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615 (639)
Q Consensus 538 GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~ 615 (639)
|+..|+|||.+.++ .++.++|+||+|+++|+|++|..||..... ........+...... .+..++.++.+++.+
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~ 232 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPELRSLLEG 232 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC----CCCcCCHHHHHHHHH
Confidence 99999999998754 689999999999999999999999965432 223333333332222 234578999999999
Q ss_pred hcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 616 MLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 616 ~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
||..||++|| ++.++++||||.+
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 9999999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=356.24 Aligned_cols=249 Identities=33% Similarity=0.579 Sum_probs=218.7
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCCh
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL 462 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 462 (639)
=+||+|.||+||.|++..+....|||-+..... ...+-+.+|+.+.+.|+|.|||+++|.+.+++++-|.||-++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 368999999999999999999999999864432 2345678999999999999999999999999999999999999999
Q ss_pred HHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc--CC-Cccc
Q psy6820 463 FDAISKN-VKF--SEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RP-MFTV 536 (639)
Q Consensus 463 ~~~l~~~-~~l--~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~--~~-~~~~ 536 (639)
.++|... +++ .+..+-++.+||++||.|||++.|||||||-+|+||+.-. +.+||+|||-++... ++ +.++
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTyS---GvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYS---GVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeecc---ceEEecccccchhhccCCcccccc
Confidence 9999654 667 8899999999999999999999999999999999998664 389999999998875 33 4578
Q ss_pred cCCCcccCcccccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHH
Q psy6820 537 CGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614 (639)
Q Consensus 537 ~GT~~Y~APE~l~~--~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~ 614 (639)
.||..|||||++.. .+|+.++|||||||++.||.||++||..-...+..+++ -|.+..-++++..++.+++.+|.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---VGmyKvHP~iPeelsaeak~Fil 813 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---VGMYKVHPPIPEELSAEAKNFIL 813 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---hcceecCCCCcHHHHHHHHHHHH
Confidence 89999999999975 47999999999999999999999999876666666553 34455555666889999999999
Q ss_pred HhcccCCCCCCCHHHHHcCCcccC
Q psy6820 615 HMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 615 ~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+|+.+||..||+|.++|+.||++-
T Consensus 814 rcFepd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 814 RCFEPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred HHcCCCcccCccHHHhccCccccc
Confidence 999999999999999999999974
|
|
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=364.44 Aligned_cols=244 Identities=31% Similarity=0.485 Sum_probs=211.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeee-eec------CC
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDE-YDT------NN 448 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~-~~~------~~ 448 (639)
.+++|.++|.+|||+.||+|.+...+..||+|.+-.. .....+.+.+|+.+|++|+ |+|||.+++. ... .-
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 4688999999999999999999988889999998665 3445677889999999998 9999999993 211 13
Q ss_pred ceEEEEeeccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 449 ELYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNY--IVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~g--ivHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
+++|+||||.||.|-+++.+ +..|++.++++|+.++|+|+++||... |||||||-+||||+.+| ..||||||
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g----~~KLCDFG 191 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG----NYKLCDFG 191 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC----CEEeCccc
Confidence 57899999999999999974 456999999999999999999999998 99999999999999998 89999999
Q ss_pred ccccccCCC------------ccccCCCcccCcccc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHH
Q psy6820 525 LAQRVLRPM------------FTVCGTPTYVAPEIL---NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDD 589 (639)
Q Consensus 525 la~~~~~~~------------~~~~GT~~Y~APE~l---~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~ 589 (639)
.|+...... ....-|+.|+|||++ .+.+.++|+|||+|||+||-|+....||+.... -.
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------la 265 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------LA 265 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------ee
Confidence 997654222 123459999999987 578899999999999999999999999965422 36
Q ss_pred HHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 590 ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 590 i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
|+++.+.+|+. +.++..+.+||+.||+.||++||++-+++.+
T Consensus 266 Ilng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 266 ILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred EEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 88999998864 6789999999999999999999999998864
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=318.99 Aligned_cols=252 Identities=34% Similarity=0.552 Sum_probs=217.0
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC--CceEEEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTN--NELYLVI 454 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV~ 454 (639)
+|.+.+.||+|++|.||+|.+..+++.+++|++...... ...+.+.+|+.++++++||||+++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 478899999999999999999989999999998765432 2346788999999999999999999999888 8899999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
||+++++|.+++.+...+++..+..++.+++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~----~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG----VVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC----CEEEcccccEEecccccc
Confidence 9999999999998877999999999999999999999999999999999999999877 7999999999876543
Q ss_pred ---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 ---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .......+... .........++.++
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~l 233 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-PMAALYKIGSS--GEPPEIPEHLSEEA 233 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHhcccc--CCCcCCCcccCHHH
Confidence 2346789999999999888899999999999999999999999976542 22222222221 11222335679999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.++|.+||+.||++||++.+++.||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.58 Aligned_cols=256 Identities=28% Similarity=0.389 Sum_probs=204.8
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 453 (639)
-...|+++++||.||.+.||++...+++..++.|+...........-+.+|+..|.+|+ |.+||+|+++-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34679999999999999999998776665444455444433444566889999999997 99999999999999999999
Q ss_pred EeeccCCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKNVK-FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||= ..+|..+|++... ++...++.+..|++.|+.++|++||||.||||.|+|+-.. .+||+|||+|......
T Consensus 439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG-----~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG-----RLKLIDFGIANAIQPD 512 (677)
T ss_pred eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee-----eEEeeeechhcccCcc
Confidence 9985 6799999977654 4446889999999999999999999999999999999754 7999999999877654
Q ss_pred C-----ccccCCCcccCccccccCC-----------CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 533 M-----FTVCGTPTYVAPEILNESG-----------YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 533 ~-----~~~~GT~~Y~APE~l~~~~-----------~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
. .+.+||+.||+||.+.... .++++|||||||+||+|+.|+.||..-. +...-+..|......
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-NQIAKLHAITDPNHE 591 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-HHHHHHHhhcCCCcc
Confidence 3 3568999999999985433 4678999999999999999999995432 222333444444332
Q ss_pred CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 597 ~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++.+..+. ..++.++++.||..||++||++.++|+|||++-
T Consensus 592 Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 592 IEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 23222211 234999999999999999999999999999873
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=319.92 Aligned_cols=250 Identities=37% Similarity=0.611 Sum_probs=217.8
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|.+.+.||.|+||.||++.+..++..+++|++...... .....+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 588999999999999999999989999999999765443 3345678999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 457 IKGGDLFDAISKN----VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 457 ~~ggsL~~~l~~~----~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
+++++|.+++.+. ..+++..+..++.+++.||+|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~----~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG----LVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC----cEEECCccceeecccC
Confidence 9999999999763 6799999999999999999999999999999999999999876 7999999999766443
Q ss_pred ---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 ---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||... +...+...+...... +....++.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE--NLLELALKILKGQYP---PIPSQYSSEL 231 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC--cHHHHHHHHhcCCCC---CCCCCCCHHH
Confidence 23457899999999998888999999999999999999999999554 345555555544322 2224688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.+++.+||..+|++||++.++++||||
T Consensus 232 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 232 RNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=340.63 Aligned_cols=256 Identities=32% Similarity=0.493 Sum_probs=205.4
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Cc
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN-----NE 449 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 449 (639)
+.++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3478999999999999999999999999999999987543333345677899999999999999999876544 35
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
.|++|||+. ++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~----~~kl~dfg~~~~~ 156 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC----DLKICDFGLARIA 156 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC----CEEECcccceeec
Confidence 899999995 588887754 5799999999999999999999999999999999999999887 7999999998765
Q ss_pred cCC------CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHH------------
Q psy6820 530 LRP------MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDI------------ 590 (639)
Q Consensus 530 ~~~------~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i------------ 590 (639)
... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.... .......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~--~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD--YLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCCHHHH
Confidence 321 123578999999998754 568999999999999999999999996432 11111111
Q ss_pred ---HcC--------CCCCCC----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 591 ---LSG--------QYGFPS----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 591 ---~~~--------~~~~p~----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
... ....+. ...+..++++.++|.+||+.||++|||+.|+++||||..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 000 000000 011346788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=355.13 Aligned_cols=253 Identities=26% Similarity=0.458 Sum_probs=214.4
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+.|.|+..||.|+||.||+|..+.++...|.|++.... ....+.+.-|+.||..+.||+||+|++.|..++.+||+.||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 45778888999999999999999999888999986433 22345667899999999999999999999999999999999
Q ss_pred ccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---CC
Q psy6820 457 IKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---RP 532 (639)
Q Consensus 457 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---~~ 532 (639)
|.||-...++-. ...+++.++..++++++.||.|||+++|||||||..|||+..+| .++|+|||.+.... ..
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG----dirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG----DIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC----cEeeecccccccchhHHhh
Confidence 999988877754 56799999999999999999999999999999999999999998 79999999986554 23
Q ss_pred CccccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC-CCCCCCCccccc
Q psy6820 533 MFTVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ-YGFPSPYWDDIS 606 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~-~~~p~~~~~~l~ 606 (639)
..++.|||+|||||+.. ..+|+.++||||||++|.||..+.+|-..- +...++-.|.... +.+-. ++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel--npMRVllKiaKSePPTLlq--PS~Ws 262 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL--NPMRVLLKIAKSEPPTLLQ--PSHWS 262 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc--chHHHHHHHhhcCCCcccC--cchhh
Confidence 45789999999999874 568999999999999999999999997432 3334444443332 22222 25678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+.|++.+||.+||+.||+++++++||||+.
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 99999999999999999999999999999983
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=342.55 Aligned_cols=255 Identities=29% Similarity=0.516 Sum_probs=207.0
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecC------
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNHPNIIKLLDEYDTN------ 447 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 447 (639)
+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.+... ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 46889999999999999999999999999999999865322 22234566899999999999999999988543
Q ss_pred CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
...|+||||+. ++|.+.+... +++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~----~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC----CEEEccCccce
Confidence 35799999995 5898888654 89999999999999999999999999999999999999887 79999999997
Q ss_pred cccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC------------
Q psy6820 528 RVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG------------ 593 (639)
Q Consensus 528 ~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~------------ 593 (639)
..... .....+++.|+|||.+.+..++.++|||||||++|+|++|..||...+. ...+..+...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH--IDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhcCCCCHHHHHHh
Confidence 65433 2345688999999999999999999999999999999999999965432 2222222110
Q ss_pred ----------CCC--------------CCC---CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 ----------QYG--------------FPS---PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 ----------~~~--------------~p~---~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
... ++. ......++++.++|.+||+.||++|||+.|+|+||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 000 000 001234678999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.29 Aligned_cols=249 Identities=18% Similarity=0.357 Sum_probs=208.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEE----cCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYD----KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
+++|++.+.||+|+||.||+|.. ...+..+|+|.+...........+.+|+.+++.++||||+++++++...+..|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 36789999999999999999985 34567899999976544444467889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCce
Q psy6820 452 LVIELIKGGDLFDAISKN-----------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH 514 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~-----------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~ 514 (639)
++|||+++++|.+++... ..+++.++..++.+++.||+|||++|++||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~-- 161 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL-- 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC--
Confidence 999999999999998532 2478889999999999999999999999999999999999876
Q ss_pred eeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHH
Q psy6820 515 VKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFD 588 (639)
Q Consensus 515 ~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~ 588 (639)
.+||+|||++...... .....++..|+|||++.+..++.++||||||+++|||++ |..||... ....+.+
T Consensus 162 --~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~--~~~~~~~ 237 (283)
T cd05090 162 --HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF--SNQEVIE 237 (283)
T ss_pred --cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHH
Confidence 7999999999765322 223445778999999998889999999999999999998 99999653 2344455
Q ss_pred HHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 589 DILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 589 ~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+..... + +.+..+++.+.+++.+||+.||++||++.+|+++
T Consensus 238 ~~~~~~~-~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRKRQL-L--PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCCc-C--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5544332 1 2335789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=319.46 Aligned_cols=250 Identities=32% Similarity=0.591 Sum_probs=216.5
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|++.+.||+|++|.||++.+..+++.+++|.+...... ...+.+.+|+.++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588999999999999999999989999999999776542 2345688999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC---
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM--- 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~--- 533 (639)
+++++|.+++.....+++..+..++.+++.||.|||+.|++||||+|+||+++.++ .++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~----~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG----VVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC----CEEEeccccceecCCCcccc
Confidence 99999999998888899999999999999999999999999999999999999876 79999999998665432
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... .............. .....++..+.+++
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~~~i 231 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-PMAALFRIVQDDHP----PLPEGISPELKDFL 231 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhccCCC----CCCCCCCHHHHHHH
Confidence 24578999999999988889999999999999999999999996543 22223332222222 22356899999999
Q ss_pred HHhcccCCCCCCCHHHHHcCCcc
Q psy6820 614 SHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 614 ~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.+||..+|++||++.+++.||||
T Consensus 232 ~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 232 MQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHhCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=335.97 Aligned_cols=253 Identities=28% Similarity=0.551 Sum_probs=212.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+.|.....||+|+||.||++.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 44556678999999999999999999999999986543 23345678999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---C
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---M 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~ 533 (639)
+++++|.+++.. ..+++..+..++.+|+.||+|||++||+||||||+||+++.++ .++|+|||++...... .
T Consensus 101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~----~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG----RIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC----CEEEccCcchhhcccccccC
Confidence 999999998854 4689999999999999999999999999999999999999887 7999999998754322 2
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
....|++.|+|||.+.+..++.++|+||||+++|||++|..||.... .......+.... ....+....++..+.+++
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP--PLQAMRRIRDNL-PPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcC-CCccccccccCHHHHHHH
Confidence 34568999999999998889999999999999999999999996543 233333333221 111122235788999999
Q ss_pred HHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 614 SHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 614 ~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+||+.||++|||++++++||||+.
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHHccCChhHCcCHHHHhhChhhhc
Confidence 9999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=316.61 Aligned_cols=250 Identities=34% Similarity=0.588 Sum_probs=213.8
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
+|.+.+.||.|++|.||++.+..++..+++|++..... .....+.+|+.++++++|||++++++.+......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 47889999999999999999998899999999976554 34567889999999999999999999999999999999999
Q ss_pred cCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC--c
Q psy6820 458 KGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM--F 534 (639)
Q Consensus 458 ~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~--~ 534 (639)
++++|.+++... ..+++..+..++.+++.||++||+.|++|+||+|+||+++.++ .++|+|||.+....... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~----~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG----EVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC----eEEEeecccccccccccccc
Confidence 999999999775 6799999999999999999999999999999999999999877 79999999997765443 5
Q ss_pred cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHH
Q psy6820 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~ 614 (639)
...|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.. ..............+. ...++.++.++|.
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~ 232 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-KALFKIATNGPPGLRN--PEKWSDEFKDFLK 232 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhcCCCCcCc--ccccCHHHHHHHH
Confidence 667899999999998888999999999999999999999999654322 2222222111112221 1234899999999
Q ss_pred HhcccCCCCCCCHHHHHcCCc
Q psy6820 615 HMLESNPDLRFSAEDVLDHPW 635 (639)
Q Consensus 615 ~~L~~dP~~Rpta~eiL~HP~ 635 (639)
+||+.||++|||+.|+++|||
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=328.23 Aligned_cols=253 Identities=28% Similarity=0.555 Sum_probs=213.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
..|...+.||+|++|.||++.+..++..+++|.+..... ...+.+.+|+.+++.++||||+++++++...+..++++||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 345556899999999999999998999999999864432 2345577899999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---C
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---M 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~ 533 (639)
+++++|.+++.. .++++..+..++.+++.||+|||++|++||||+|+||+++.++ .++|+|||++...... .
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG----RVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC----cEEEcccccchhhccCCccc
Confidence 999999999977 6789999999999999999999999999999999999999887 8999999988655432 2
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
....|++.|+|||.+.+..++.++|+||||+++|+|++|..||... +.......+....... ......++..+.++|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 249 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE--PPLQAMKRIRDNLPPK-LKNLHKVSPRLRSFL 249 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC--CHHHHHHHHHhcCCCC-CcccccCCHHHHHHH
Confidence 2356899999999999888999999999999999999999999653 3334444444432111 112234789999999
Q ss_pred HHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 614 SHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 614 ~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++||+.+|++||++.++++||||++
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred HHHcccChhhCcCHHHHccCccccc
Confidence 9999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.06 Aligned_cols=256 Identities=30% Similarity=0.549 Sum_probs=214.7
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
...++|.+.+.||.|+||.||++.+..++..+|+|.+..... ...+.+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 345789999999999999999999988899999999865432 2346678899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
+||+++++|.+++.+. .+++..+..++.+++.||+|||++|++|+||||+||+++.++ .+||+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~----~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC----CEEEccCcceecccccc
Confidence 9999999999998654 588999999999999999999999999999999999999887 7999999998655422
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ..+......+... ...+..++..+.
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~l~ 246 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RALYLIATNGTPE--LQNPEKLSAIFR 246 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-hheeehhcCCCCC--CCCccccCHHHH
Confidence 22346889999999998888999999999999999999999999654321 2211111112111 122346788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++|++||+.+|++||++.+++.||||+.
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 9999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.14 Aligned_cols=249 Identities=21% Similarity=0.359 Sum_probs=206.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|++.+.||+|+||.||+|.+.. .+..+|+|.+...........+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 4679999999999999999997653 35679999986544433445678999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEE
Q psy6820 451 YLVIELIKGGDLFDAISKNV----------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL 520 (639)
++||||+++++|.+++.+.. .+++..+..++.+++.||+|||+.|++|+||||+||+++.++ .+||
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~----~~~l 160 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF----TVKI 160 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC----CEEE
Confidence 99999999999999986532 357788899999999999999999999999999999999887 7999
Q ss_pred eeccccccccCCC-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCC
Q psy6820 521 GDFGLAQRVLRPM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQ 594 (639)
Q Consensus 521 ~DFGla~~~~~~~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~ 594 (639)
+|||++....... ....+++.|+|||++.+..++.++|||||||++|||++ |..||... ......+.+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~~ 238 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM--SNEQVLRFVMEGG 238 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCC
Confidence 9999987543221 12345778999999998889999999999999999999 78999643 3345555555443
Q ss_pred CCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 595 ~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
... ....++.++.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 221 124678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=321.22 Aligned_cols=241 Identities=26% Similarity=0.429 Sum_probs=201.9
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCCh
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL 462 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 462 (639)
+.||+|+||.||+|.+..+++.+|+|.+...........+.+|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999999999999999987554444456788999999999999999999999999999999999999999
Q ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCccc-----
Q psy6820 463 FDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTV----- 536 (639)
Q Consensus 463 ~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~~----- 536 (639)
.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++..........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN----VLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC----cEEECccccCcccccccccccCCCC
Confidence 9999654 4689999999999999999999999999999999999999887 79999999987544322111
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHH
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~ 615 (639)
.++..|+|||.+.+..++.++|+||||+++|||++ |..||.... .......+... .+.+....++..+.+|+.+
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~ 231 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS--NQQTREAIEQG---VRLPCPELCPDAVYRLMER 231 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC--HHHHHHHHHcC---CCCCCcccCCHHHHHHHHH
Confidence 22456999999998889999999999999999997 999995432 23333334332 1222335678999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q psy6820 616 MLESNPDLRFSAEDVLD 632 (639)
Q Consensus 616 ~L~~dP~~Rpta~eiL~ 632 (639)
||+.||++|||+.++++
T Consensus 232 ~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=320.53 Aligned_cols=244 Identities=25% Similarity=0.428 Sum_probs=205.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||+|+||.||++..+. +..+|+|.+...... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 568999999999999999997764 457999998654332 45678899999999999999999999999999999999
Q ss_pred ccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc-
Q psy6820 457 IKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF- 534 (639)
Q Consensus 457 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~- 534 (639)
+++|+|.+++.. ...+++..+..++.+++.||+|||++|++||||||+||+++.++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~----~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG----VVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC----eEEECCCCCccccCCCcee
Confidence 999999999865 35689999999999999999999999999999999999999887 799999999976543221
Q ss_pred ---cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 535 ---TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 535 ---~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
...++..|+|||.+.+..++.++|+||||+++|||++ |+.||... +..+....+..+..... ....+.++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~--~~~~~~~~i~~~~~~~~---~~~~~~~~~ 231 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEMISRGFRLYR---PKLASMTVY 231 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCCCCC---CCCCCHHHH
Confidence 2234568999999998889999999999999999999 99999543 34555566655432221 134688999
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q psy6820 611 ELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+++.+||+.||++||+++++++
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.19 Aligned_cols=252 Identities=33% Similarity=0.491 Sum_probs=206.6
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
|++.+.||.|++|.||+|.+..++..||+|++....... ....+.+|+.+++.++|||++++++++.+.+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 667899999999999999999999999999987654322 2355778999999999999999999999999999999999
Q ss_pred cCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 458 KGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 458 ~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
+ ++|.+++.... .+++..+..++.|++.||+|||+++++||||+|+||+++.++ .++|+|||++......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG----ALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC----cEEEeecccccccCCCccc
Confidence 4 69999997765 789999999999999999999999999999999999999877 8999999999755322
Q ss_pred CccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc-------------------
Q psy6820 533 MFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS------------------- 592 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~------------------- 592 (639)
.....+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+. .....+....
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 1233568899999988654 578999999999999999999999965432 2222211110
Q ss_pred -----CCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 593 -----GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 593 -----~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
............++.++.++|.+||+.||++|||++|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00001111234577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.41 Aligned_cols=250 Identities=31% Similarity=0.523 Sum_probs=212.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++.+.||.|+||.||+|....++..+|+|.+....... ....+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57889999999999999999999899999999887544322 2356778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 455 ELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 455 E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
||+++++|.+++.. ...+++..+..++.+|+.||+|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~----~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC----CEEECcchhhhccc
Confidence 99999999998863 35689999999999999999999999999999999999999887 79999999987654
Q ss_pred CC---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 531 RP---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 531 ~~---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.. .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....+.......+.... .+...+..+++
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSE 235 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccH
Confidence 32 22457899999999999888999999999999999999999999765544445555554432 22222356889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++.+++.+||+.||++|||+.+|++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.41 Aligned_cols=254 Identities=31% Similarity=0.495 Sum_probs=206.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecC--CceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTN--NELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~l 452 (639)
.++|++.+.||.|+||.||+|.+..+++.+|+|.++...... ....+.+|+.++++++||||+++++++... +..|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 467999999999999999999999999999999997554332 223456899999999999999999998777 89999
Q ss_pred EEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
||||+. ++|.+++... ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++ .+||+|||++.....
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~----~~~l~d~g~~~~~~~ 158 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG----ILKICDFGLAREYGS 158 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC----cEEEeecCceeeccC
Confidence 999996 5999988664 3589999999999999999999999999999999999999887 899999999976654
Q ss_pred C---CccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC-----------
Q psy6820 532 P---MFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG----------- 596 (639)
Q Consensus 532 ~---~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~----------- 596 (639)
. .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||..... ......+......
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE--IDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchHHHHHhhc
Confidence 3 2334578899999998754 468999999999999999999999975432 2222222111000
Q ss_pred CC---------------CCCccc--ccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 597 FP---------------SPYWDD--ISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 597 ~p---------------~~~~~~--l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
++ ....+. +++.+.++|++||+.||++|||+.|+++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00 000111 58899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.08 Aligned_cols=258 Identities=29% Similarity=0.504 Sum_probs=203.9
Q ss_pred CeeEEEEEccCCceEEEEEEEcC--CCeEEEEEEEccccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecC--CceE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKH--KDMDCALKIIDKSKL--LGKKQMIENEVNILRSVNHPNIIKLLDEYDTN--NELY 451 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~--~~~~vAiKv~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~ 451 (639)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ....+.+.+|+.+++.++||||+++++++.+. +.+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 889999999986431 12235567899999999999999999999888 8899
Q ss_pred EEEeeccCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 452 LVIELIKGGDLFDAISKN-----VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
+||||+++ +|.+.+... ..+++..++.++.||+.||+|||+.+++||||||+||+++.++.....+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999964 777766422 368999999999999999999999999999999999999983333348999999998
Q ss_pred ccccCC------CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh-------HHHHHHHHc
Q psy6820 527 QRVLRP------MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ-------DELFDDILS 592 (639)
Q Consensus 527 ~~~~~~------~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~-------~~l~~~i~~ 592 (639)
...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|++||....... ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 765432 224567899999998866 458999999999999999999999997544322 001111100
Q ss_pred --------------------------CCCCCCC-------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 593 --------------------------GQYGFPS-------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 593 --------------------------~~~~~p~-------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
....++. +.+...+.++.+++.+||+.||++|||+.|+++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000110 0011467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.59 Aligned_cols=254 Identities=32% Similarity=0.495 Sum_probs=212.7
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----ceE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN-----ELY 451 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~ 451 (639)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+..... ....+.+.+|+.+++.++||||+++++++...+ .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58899999999999999999998899999999876432 233456788999999999999999999987775 789
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
++|||++ ++|.+++.+...+++..+..++.+|+.||+|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~----~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC----DLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEcccCceEeecc
Confidence 9999996 58999998878999999999999999999999999999999999999999887 899999999986653
Q ss_pred C------CccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC-----
Q psy6820 532 P------MFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS----- 599 (639)
Q Consensus 532 ~------~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~----- 599 (639)
. .....+++.|+|||++.+. .++.++|+||||+++|+|++|.+||.... ..+.+..+.......+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD--YIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHhcCCCChhHhhh
Confidence 3 2345678999999999877 88999999999999999999999996543 22333333221110000
Q ss_pred ----------------------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 600 ----------------------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 600 ----------------------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.....++.++.++|.+||++||++||+++++++||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 011346889999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.32 Aligned_cols=248 Identities=25% Similarity=0.405 Sum_probs=205.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCe--EEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDM--DCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 453 (639)
++|++.+.||+|+||.||+|..+.++. .+++|.++........+.+.+|+.+++++ +||||+++++++...+.+|++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999998877654 46888876443333446678899999999 699999999999999999999
Q ss_pred EeeccCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeee
Q psy6820 454 IELIKGGDLFDAISKNV----------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKV 517 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~ 517 (639)
|||+++++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+|||++.++ .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~----~ 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL----A 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC----e
Confidence 99999999999996532 488899999999999999999999999999999999999876 7
Q ss_pred EEEeeccccccccCCCcc--ccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCC
Q psy6820 518 LKVGDFGLAQRVLRPMFT--VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQ 594 (639)
Q Consensus 518 vKL~DFGla~~~~~~~~~--~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~ 594 (639)
+||+|||++......... ...+..|+|||++.+..++.++|||||||++|||++ |..||... ....+...+..+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~--~~~~~~~~~~~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM--TCAELYEKLPQGY 235 (297)
T ss_pred EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhcCC
Confidence 999999998644322111 223557999999998889999999999999999997 99999654 3445555554432
Q ss_pred CCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 595 ~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
. .+....++.++.+|+.+||+.||.+||+++++++.
T Consensus 236 -~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 -R--MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred -C--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 12224688999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=322.23 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=209.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCC---CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
++|++.+.||+|+||.||+|..... ...+|+|++...........+.+|+.+++.++||||+++++.+...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5799999999999999999987644 4579999987665555556788899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+++++|.+++... +.+++..+..++.+++.||+|||++||+|+||||+||+++.++ .++|+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~----~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL----VCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC----CEEECccchhhccccc
Confidence 9999999999999663 4789999999999999999999999999999999999999887 7999999999876421
Q ss_pred C-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 533 M-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 533 ~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
. ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ........+.... ..+. ...++
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~~-~~~~--~~~~~ 234 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM--SNQDVIKAVEDGY-RLPP--PMDCP 234 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHcCC-CCCC--CCCCC
Confidence 1 12234678999999998899999999999999999998 99999543 3444555554432 2222 24679
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+.+.+|+.+||+.+|++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.43 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=205.3
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeE--EEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMD--CALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 452 (639)
.++|++.+.||+|+||.||+|.++.++.. +|+|.+...........+.+|+.++.++ +||||+++++++...+.+|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 56899999999999999999998777654 5777765443333446678899999999 79999999999999999999
Q ss_pred EEeeccCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceee
Q psy6820 453 VIELIKGGDLFDAISKNV----------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVK 516 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~ 516 (639)
||||+++++|.+++.+.. .+++..+..++.||+.||+|||++|++||||||+|||++.++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~---- 161 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY---- 161 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC----
Confidence 999999999999996542 478999999999999999999999999999999999999887
Q ss_pred eEEEeeccccccccCCCc--cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcC
Q psy6820 517 VLKVGDFGLAQRVLRPMF--TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSG 593 (639)
Q Consensus 517 ~vKL~DFGla~~~~~~~~--~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~ 593 (639)
.+||+|||++........ ...++..|+|||.+.+..++.++|||||||++|||+| |..||.... ..+..+.+..+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~ 239 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQG 239 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--hHHHHHHHhcC
Confidence 799999999864322111 1234667999999988889999999999999999998 999996543 34444444332
Q ss_pred CCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 594 QYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 594 ~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
...+.+..+++++.+|+.+||+.+|++||++++++++
T Consensus 240 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 ---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1122234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.63 Aligned_cols=253 Identities=29% Similarity=0.579 Sum_probs=213.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
..|.....||+|+||.||+|.+..+++.+|+|++...... ..+.+.+|+.+++.++||||+++++.+...+..|++|||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 4455566899999999999999989999999998654332 345677899999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---C
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---M 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~ 533 (639)
+++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++...... .
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~----~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC----cEEEeechhHhhcccccccc
Confidence 999999987754 5689999999999999999999999999999999999999887 8999999998654322 2
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
....|++.|+|||++.+..++.++|||||||++|||++|..||.... .......+..... .....+..++.++.++|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i 251 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--PVQAMKRLRDSPP-PKLKNAHKISPVLRDFL 251 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhccCC-CCccccCCCCHHHHHHH
Confidence 34678999999999998889999999999999999999999996543 2333333333221 12223356789999999
Q ss_pred HHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 614 SHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 614 ~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+||+.+|++||+++++++||||.+
T Consensus 252 ~~~l~~~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 252 ERMLTREPQERATAQELLDHPFLLQ 276 (297)
T ss_pred HHHhcCCcccCcCHHHHhhChhhcc
Confidence 9999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=335.64 Aligned_cols=249 Identities=26% Similarity=0.464 Sum_probs=217.8
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
-|.++.+||+|+||.||+|.++.+|..+|||.+... .+.+.+..|+.|++++..|++|++||.|.....+|||||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 478899999999999999999999999999998654 34677889999999999999999999999999999999999
Q ss_pred cCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---C
Q psy6820 458 KGGDLFDAIS-KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---M 533 (639)
Q Consensus 458 ~ggsL~~~l~-~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~ 533 (639)
..|++.+++. ++.++++.++..+++..+.||+|||...-||||||..|||++.+| +.||+|||.|-.+... .
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G----~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG----IAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc----hhhhhhccccchhhhhHHhh
Confidence 9999999995 467899999999999999999999999999999999999999998 8999999999777643 4
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC--CcccccHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP--YWDDISEEAKE 611 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~--~~~~l~~~l~d 611 (639)
.+..|||.|||||++..-+|+.++||||||++..||..|++||..-.. .+.|..-.-..|+. .....+.++.|
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP-----MRAIFMIPT~PPPTF~KPE~WS~~F~D 261 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP-----MRAIFMIPTKPPPTFKKPEEWSSEFND 261 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc-----cceeEeccCCCCCCCCChHhhhhHHHH
Confidence 578999999999999999999999999999999999999999954322 12222222222222 22346899999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++++||.+.|++|-||.++++|||++.
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 999999999999999999999999874
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.55 Aligned_cols=256 Identities=31% Similarity=0.577 Sum_probs=218.4
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
...+.|++.+.||+|+||.||+|.+..++..+++|++..... ..+.+.+|+.+++.++|+|++++++.+...+..|++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 455779999999999999999999998899999999976543 356678899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
+||+++++|.+++.... .+++..+..++.+++.||+|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~----~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG----SVKLADFGFAAQLTKE 169 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC----CEEECccchhhhhccc
Confidence 99999999999998776 899999999999999999999999999999999999999887 7999999998655432
Q ss_pred ---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 ---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+..... .+......++.++
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~l 246 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP--PLRALFLITTKGI-PPLKNPEKWSPEF 246 (286)
T ss_pred hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCC-CCCcchhhCCHHH
Confidence 234457899999999998889999999999999999999999996432 2233333333221 1112223478999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.++|++||+.+|.+||++.++++||||.+
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=330.68 Aligned_cols=254 Identities=28% Similarity=0.413 Sum_probs=209.6
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..+.|.+.+.||+|+||.||+|....+++.||+|.+...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 346799999999999999999999989999999998654332 223567889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
||||+. |+|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++....
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~----~~kL~dfg~~~~~~- 166 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG----TVKLADFGSASLVS- 166 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC----CEEEeecCcceecC-
Confidence 999996 577777643 45799999999999999999999999999999999999999887 79999999986543
Q ss_pred CCccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 532 PMFTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
......|++.|+|||++. ...++.++||||||+++|||++|..||.... ................+ ...++.+
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~ 242 (307)
T cd06607 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNDSPTLS---SNDWSDY 242 (307)
T ss_pred CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcCCCCCCC---chhhCHH
Confidence 334567899999999874 4568899999999999999999999995432 12222222212222222 2346889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.++|.+||+.||++||++.+++.||||.+
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=320.90 Aligned_cols=245 Identities=23% Similarity=0.419 Sum_probs=209.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
.+|.+.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++.++||||+++++++...+.++++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch--HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 568999999999999999999999999999999875432 245677899999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc
Q psy6820 457 IKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534 (639)
Q Consensus 457 ~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~ 534 (639)
+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~----~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC----cEEeCCCcccccccccee
Confidence 9999999999653 3589999999999999999999999999999999999998887 899999999976654322
Q ss_pred ----cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 535 ----TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 535 ----~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
...++..|+|||.+.+..++.++|||||||++|||++ |..||... +.++....+.... ..+....++.++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKGY---RMERPEGCPPKV 234 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCC---CCCCCCCCCHHH
Confidence 1234568999999998899999999999999999998 99999653 4455555555431 222335689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHc
Q psy6820 610 KELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+++.+||+.||++||++.++++
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=321.40 Aligned_cols=251 Identities=27% Similarity=0.506 Sum_probs=210.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccc----cchhHHHHHHHHHHHHhcCCCceeeeeeeeecC--Cce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSK----LLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN--NEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 450 (639)
.+|.+.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875432 122335678999999999999999999988654 468
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+++|||+++++|.+++.....+++..+..++.+++.||.|||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~----~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG----NVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC----CEEECccccccccc
Confidence 99999999999999998877899999999999999999999999999999999999999887 79999999997653
Q ss_pred CC------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 531 RP------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 531 ~~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
.. .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.... ....+ ..+.... .+...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~-~~~~~~~--~~~~~p~~ 233 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-AMAAI-FKIATQP--TKPMLPDG 233 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-HHHHH-HHHHcCC--CCCCCCcc
Confidence 21 123568999999999998889999999999999999999999996432 22222 2332221 12223467
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
+++++.++|++||+ +|..||++.+++.|||.
T Consensus 234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 234 VSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred cCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 89999999999999 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=319.11 Aligned_cols=250 Identities=32% Similarity=0.528 Sum_probs=213.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++.+.||+|+||.||+|....+++.+|+|.++..... ...+.+.+|+.++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999999989999999998753332 22456889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 455 ELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 455 E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
||+++++|.+++.. ...+++..+..++.+++.||+|||+.|++||||+|+||+++.++ .++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~----~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG----VVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC----cEEEeccceeeecc
Confidence 99999999998853 34589999999999999999999999999999999999999887 79999999987554
Q ss_pred CC---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 531 RP---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 531 ~~---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.. .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||........++.+.+..+... ......++.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP--PLPADHYSE 235 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC--CCChhhcCH
Confidence 32 2345689999999999988899999999999999999999999976555545555555544321 111236788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++.++|.+||..+|++||++.+|++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=318.85 Aligned_cols=242 Identities=27% Similarity=0.453 Sum_probs=210.1
Q ss_pred EEEccCCceEEEEEEEcCC---CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|..... +..+++|++.........+.+.+|+.+++.++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999999998866 8899999998766554467788999999999999999999999999999999999999
Q ss_pred CChHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 460 GDLFDAISKN---------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 460 gsL~~~l~~~---------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
++|.+++... ..+++..+..++.+++.||+|||++|++|+||||+||+++.++ .+||+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~----~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL----VVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC----cEEEcccccccccc
Confidence 9999999875 7799999999999999999999999999999999999999987 89999999997765
Q ss_pred CC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 531 RP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 531 ~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
.. .....+++.|+|||.+....++.++|+||||+++|+|++ |..||... ....+.+.+..+.. ......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~---~~~~~~ 231 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEYLRKGYR---LPKPEY 231 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCC---CCCCcc
Confidence 32 234567889999999988889999999999999999999 69999654 34555566654321 122356
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
++.++.+++.+||+.||++||++.|++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 79999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=323.72 Aligned_cols=251 Identities=32% Similarity=0.510 Sum_probs=206.7
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccc-cchhHHHHHHHHHHHHhcCCCceeeeeeeeecC--CceEEEEe
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSK-LLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN--NELYLVIE 455 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV~E 455 (639)
|++.+.||.|+||.||+|....+++.+|+|.+.... .......+.+|+.++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678999999999999999999999999999998664 122235577899999999999999999999888 89999999
Q ss_pred eccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 456 LIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|+++ +|.+++... ..+++..+..++.+|+.||+|||+.|++|+||+|+||+++.++ .+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~----~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG----VLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC----CEEEccccceeeccCCCc
Confidence 9964 899888665 5799999999999999999999999999999999999999887 8999999999766543
Q ss_pred --CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC---------
Q psy6820 533 --MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP--------- 600 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~--------- 600 (639)
.....++..|+|||.+.+ ..++.++||||||+++|||++|..||.... .......+..........
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST--ELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCchhhccccccch
Confidence 233456889999998765 467999999999999999999999996543 233333332211000000
Q ss_pred -----------------Cccc-ccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 601 -----------------YWDD-ISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 601 -----------------~~~~-l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.... ++.++.+++++||+.||++||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0112 38899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=332.48 Aligned_cols=247 Identities=21% Similarity=0.301 Sum_probs=205.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCe----EEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDM----DCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.+|++.+.||+|+||.||+|.+..++. .||+|++.........+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 579999999999999999998765544 48999987654444556788999999999999999999998764 5789
Q ss_pred EEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
++||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~----~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC----cEEEccccccccccC
Confidence 99999999999999764 4688999999999999999999999999999999999999887 799999999986543
Q ss_pred CC-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 532 PM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 532 ~~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
.. ....++..|+|||.+.+..++.++||||||+++|||++ |..||... ...++.. +......++.+ ..+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~--~~~~~~~-~~~~~~~~~~~--~~~ 236 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISS-ILEKGERLPQP--PIC 236 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHH-HHhCCCCCCCC--CCC
Confidence 21 12234678999999999999999999999999999997 99999643 2333333 33333333322 457
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+.++.+++.+||+.||++||++.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=326.19 Aligned_cols=246 Identities=21% Similarity=0.377 Sum_probs=207.0
Q ss_pred CCeeEEEEEccCCceEEEEEEE-----cCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYD-----KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
++|.+.+.||+|+||.||++.. ..++..+|+|.+.... ......+.+|+.++++++||||+++++++...+.++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 5799999999999999999975 2345678999986543 233456889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeE
Q psy6820 452 LVIELIKGGDLFDAISKNV-------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVL 518 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~-------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~v 518 (639)
+||||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~----~~ 159 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL----LV 159 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC----cE
Confidence 9999999999999996543 489999999999999999999999999999999999999887 89
Q ss_pred EEeeccccccccCCC-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHc
Q psy6820 519 KVGDFGLAQRVLRPM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILS 592 (639)
Q Consensus 519 KL~DFGla~~~~~~~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~ 592 (639)
||+|||++....... ....+++.|+|||++.+..++.++|+|||||++|+|++ |..||... ...+....+..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~--~~~~~~~~i~~ 237 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--SNNEVIECITQ 237 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHc
Confidence 999999997553221 22335778999999998899999999999999999998 99999544 34556666666
Q ss_pred CCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 593 GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 593 ~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+..... ...++.++.+|+.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 543221 2457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.90 Aligned_cols=256 Identities=31% Similarity=0.489 Sum_probs=208.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec----CCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDT----NNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~ 450 (639)
.++|++.+.||.|+||.||+|.+..+++.||+|++...... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36899999999999999999999999999999998754321 223556789999999999999999998753 3568
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|+||||+. ++|.+++.....+++..+..++.||+.||+|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~----~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC----ELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC----cEEecccccceeec
Confidence 99999995 69999998778899999999999999999999999999999999999999887 79999999997653
Q ss_pred CC-------CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc----------
Q psy6820 531 RP-------MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS---------- 592 (639)
Q Consensus 531 ~~-------~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~---------- 592 (639)
.. .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+... ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QLKLILSVLGSPSEEVL 236 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HHHHHHHHhCCChhHhh
Confidence 22 124578999999999865 568999999999999999999999996543211 1111110
Q ss_pred -------------CCCCCCC----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 593 -------------GQYGFPS----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 593 -------------~~~~~p~----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.....+. ...+.++.++.++|++||+.||++||++++++.||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 0000000 112457899999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.15 Aligned_cols=244 Identities=33% Similarity=0.533 Sum_probs=201.8
Q ss_pred eEEEEEccCCceEEEEEEEc----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 380 SVGQIIGDGNFAVVRQVYDK----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 380 ~i~~~LG~G~fG~Vy~a~~~----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
++.+.||.|.||.||+|... ..+..|+||+++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999887 45678999999665444446778899999999999999999999998888999999
Q ss_pred eccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 456 LIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++++|+||+++||+++.++ .+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~----~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG----QVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT----EEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccc
Confidence 99999999999876 7799999999999999999999999999999999999999987 8999999999776321
Q ss_pred ----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 533 ----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 533 ----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.....+...|+|||.+.+..++.++||||||+++|||++ |..||... +..++...+..+.. .+ ....++.
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~~~~~~~~~-~~--~~~~~~~ 232 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEIIEKLKQGQR-LP--IPDNCPK 232 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHHHHHHTTEE-TT--SBTTSBH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ce--eccchhH
Confidence 223456778999999998889999999999999999999 78998544 45566666655433 22 2256899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+.++|.+||..||++||++.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=322.82 Aligned_cols=248 Identities=21% Similarity=0.378 Sum_probs=208.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCC-----CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHK-----DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|.+.+.||+|+||.||+|..... +..+|+|.+...........+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 46899999999999999999987654 3789999987665444456678999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEE
Q psy6820 451 YLVIELIKGGDLFDAISKN----------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~----------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL 520 (639)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++ .+||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~----~~kl 160 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL----TVKI 160 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC----CEEE
Confidence 9999999999999998642 2367889999999999999999999999999999999999887 7999
Q ss_pred eeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCC
Q psy6820 521 GDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQ 594 (639)
Q Consensus 521 ~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~ 594 (639)
+|||++...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||... ......+.+..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~ 238 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--SNEEVLKFVIDGG 238 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC--CHHHHHHHHhcCC
Confidence 999998765322 223456789999999988889999999999999999998 99999643 3445555555332
Q ss_pred CCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 595 ~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
. . .....++.++.+++.+||+.+|++|||+.++++
T Consensus 239 ~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 H-L--DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C-C--CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2 1 122456899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=335.91 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=211.4
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCC----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNN---- 448 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 448 (639)
.+.++|++.+.||+|+||.||+|.+..++..||+|++...... .....+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999999999999999998653322 22345778999999999999999999887554
Q ss_pred --ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 449 --ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 449 --~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
.+++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ .+||+|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~----~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC----ELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEeecccc
Confidence 458999998 7799888864 5799999999999999999999999999999999999999887 7999999999
Q ss_pred ccccCCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC--------
Q psy6820 527 QRVLRPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF-------- 597 (639)
Q Consensus 527 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~-------- 597 (639)
...........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ......+.......
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 166 RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH--LDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHHHHhh
Confidence 876655556678999999999876 4589999999999999999999999965432 22222221111000
Q ss_pred ------------C-------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 598 ------------P-------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 598 ------------p-------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+ ...+..+++++.++|.+||+.||++|||+.+++.||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 0 0122467889999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.47 Aligned_cols=257 Identities=29% Similarity=0.455 Sum_probs=209.1
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----C
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNHPNIIKLLDEYDTN-----N 448 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~ 448 (639)
+.++|.+.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 34689999999999999999999999999999999875321 22234566899999999999999999987644 3
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
..|++|||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||++..
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~----~~kL~Dfg~~~~ 157 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC----DLKICDFGLART 157 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC----CEEECcCccccc
Confidence 5899999995 69999998888899999999999999999999999999999999999999887 799999999976
Q ss_pred ccCC---CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc------------
Q psy6820 529 VLRP---MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS------------ 592 (639)
Q Consensus 529 ~~~~---~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~------------ 592 (639)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+. ......+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCChHHhhh
Confidence 5432 234568899999998865 4689999999999999999999999965421 111111110
Q ss_pred -----------CCCCCC----CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 593 -----------GQYGFP----SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 593 -----------~~~~~p----~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.....+ ....+.+++++.+||++||+.||++|||++++++||||..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000000 1123467899999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=325.97 Aligned_cols=253 Identities=29% Similarity=0.578 Sum_probs=213.0
Q ss_pred CeeEEEEEccCCceEEEEEEEc---CCCeEEEEEEEcccccc---hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCce
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLL---GKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiKv~~~~~~~---~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 450 (639)
+|++.+.||+|+||.||.|.+. .++..||+|++...... ...+.+.+|+.+++++. |+||+.+++.++....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4789999999999999999874 46889999998754332 22356778999999995 99999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|+||||+++++|.+++.....+++..+..++.|++.||+|||+.|++||||+|+|||++.++ .+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~----~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC----CEEEeeCccceecc
Confidence 99999999999999998888899999999999999999999999999999999999999887 89999999987653
Q ss_pred CC----CccccCCCcccCcccccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCC--CChHHHHHHHHcCCCCCCCCCc
Q psy6820 531 RP----MFTVCGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFVSDT--NDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 531 ~~----~~~~~GT~~Y~APE~l~~--~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~--~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
.. .....|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.... .....+...+......+ .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~ 232 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----P 232 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----C
Confidence 21 234568999999999875 347889999999999999999999996422 22344444444443322 2
Q ss_pred ccccHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 603 DDISEEAKELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
..+++.+.+++++||+.||++|| ++++++.||||++
T Consensus 233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 46889999999999999999997 8999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=326.63 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=207.3
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCC----------------eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceee
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKD----------------MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~----------------~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~ 439 (639)
.++|++++.||+|+||.||+|.....+ ..+|+|.+.........+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 468999999999999999998876543 5689999887655555667889999999999999999
Q ss_pred eeeeeecCCceEEEEeeccCCChHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q psy6820 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNV-----------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLV 508 (639)
Q Consensus 440 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILl 508 (639)
+++++...+..+++|||+++++|.+++.+.. .+++..+..++.|++.||+|||++|++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999999999999999999999999997655 68999999999999999999999999999999999999
Q ss_pred ccCCceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc--CCCCCCCCCC
Q psy6820 509 EMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC--GFPPFVSDTN 581 (639)
Q Consensus 509 d~~g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt--G~~Pf~~~~~ 581 (639)
+.++ .++|+|||++...... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 164 ~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~- 238 (296)
T cd05051 164 GKNY----TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT- 238 (296)
T ss_pred cCCC----ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-
Confidence 9887 8999999998754322 223456788999999988889999999999999999998 778885432
Q ss_pred ChHHHHHHHHcC----CCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 582 DQDELFDDILSG----QYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 582 ~~~~l~~~i~~~----~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
....+..+... ......+....++.++.+|+.+||+.||++|||+.|+++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 239 -DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred -hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 23333333322 111111122457899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=343.75 Aligned_cols=249 Identities=26% Similarity=0.429 Sum_probs=205.9
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCC-----CeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCc
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHK-----DMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNE 449 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 449 (639)
.++|.+++.||+|+||.||+|.+... +..||+|++.........+.+.+|+.+|+++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 46899999999999999999986432 35799999976555445567889999999996 9999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhc------------------------------------------------------------
Q psy6820 450 LYLVIELIKGGDLFDAISKN------------------------------------------------------------ 469 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~------------------------------------------------------------ 469 (639)
.|||||||++|+|.+++.++
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999988542
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCc
Q psy6820 470 ------------------------------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC 513 (639)
Q Consensus 470 ------------------------------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~ 513 (639)
..+++..+..++.||+.||+|||+.+|+||||||+|||++.++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~- 274 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK- 274 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC-
Confidence 2367788899999999999999999999999999999999887
Q ss_pred eeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHH
Q psy6820 514 HVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELF 587 (639)
Q Consensus 514 ~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~ 587 (639)
.+||+|||++...... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.....+ ....
T Consensus 275 ---~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-~~~~ 350 (400)
T cd05105 275 ---IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-STFY 350 (400)
T ss_pred ---EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-HHHH
Confidence 7999999999765322 123346788999999999899999999999999999997 99999654322 2333
Q ss_pred HHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 588 DDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 588 ~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
..+..+ ... +....++.++.+++.+||+.||++||++.++.+
T Consensus 351 ~~~~~~-~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSG-YRM--AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcC-CCC--CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 334333 222 223568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=334.03 Aligned_cols=257 Identities=27% Similarity=0.493 Sum_probs=208.9
Q ss_pred cCCCee-EEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh-------------HHHHHHHHHHHHhcCCCceeee
Q psy6820 375 LLQRYS-VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-------------KQMIENEVNILRSVNHPNIIKL 440 (639)
Q Consensus 375 ~~~~y~-i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~-------------~~~~~~Ei~iL~~l~HpnIv~l 440 (639)
+.++|. +.+.||.|+||.||+|.+..+++.||+|++........ ...+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 346675 45789999999999999999999999999875433221 1246789999999999999999
Q ss_pred eeeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEE
Q psy6820 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 441 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL 520 (639)
++++...+..|++|||+. ++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .+||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~----~~kl 160 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG----ICKI 160 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC----CEEE
Confidence 999999999999999996 69999998888899999999999999999999999999999999999999887 8999
Q ss_pred eeccccccccC-----------------CCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCC
Q psy6820 521 GDFGLAQRVLR-----------------PMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTND 582 (639)
Q Consensus 521 ~DFGla~~~~~-----------------~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~ 582 (639)
+|||++..... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~- 239 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE- 239 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 99999875541 11223468889999998764 479999999999999999999999965432
Q ss_pred hHHHHHHHHcCCCCCCC------------------------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 583 QDELFDDILSGQYGFPS------------------------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 583 ~~~l~~~i~~~~~~~p~------------------------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+....+.......+. ......+.++.++|.+||+.||++||+++|++.||||++
T Consensus 240 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 240 -IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred -HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 2222222211000000 011345788999999999999999999999999999986
|
|
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.46 Aligned_cols=251 Identities=25% Similarity=0.506 Sum_probs=219.0
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCc--eEEEE
Q psy6820 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL---GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNE--LYLVI 454 (639)
Q Consensus 380 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~--~~lV~ 454 (639)
+...+||+|+|-+||+|.+..+|..||--.++..... ...++|..|+.+|+.|+||||+++|++|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4567899999999999999999999987655544433 334778899999999999999999999987765 88999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY--IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~g--ivHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|.+..|+|..|+++.++.+...++.|++||++||.|||++. |||||||.+||+|+.+. +.|||+|+|+|+.....
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~---G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL---GEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCc---CceeecchhHHHHhhcc
Confidence 99999999999999999999999999999999999999986 99999999999998764 48999999999888765
Q ss_pred Cc-cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 MF-TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 ~~-~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.. ...|||.|||||.+. ..|+..+||||||++++||+|+..||. ...+..++++.+..|.. |..+..--.+++++
T Consensus 200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-EC~n~AQIYKKV~SGiK--P~sl~kV~dPevr~ 275 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-ECTNPAQIYKKVTSGIK--PAALSKVKDPEVRE 275 (632)
T ss_pred ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-hhCCHHHHHHHHHcCCC--HHHhhccCCHHHHH
Confidence 54 468999999999998 569999999999999999999999995 34567889999988843 32222334799999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+|.+||.. .++|||+.|+|.||||+.
T Consensus 276 fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 276 FIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HHHHHhcC-chhccCHHHHhhChhhcc
Confidence 99999999 999999999999999975
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=317.45 Aligned_cols=242 Identities=41% Similarity=0.758 Sum_probs=213.6
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCCh
Q psy6820 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL 462 (639)
Q Consensus 385 LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 462 (639)
||.|+||.||++.+..+++.+|+|++....... ....+.+|+.++++++||||+++++.+...+..|++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999999889999999987765432 345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---CccccCC
Q psy6820 463 FDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGT 539 (639)
Q Consensus 463 ~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~~~~~GT 539 (639)
.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++...... .....++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC----cEEEeecCcceecccCCCcccCCcCC
Confidence 99998888899999999999999999999999999999999999999887 7999999999766542 3456789
Q ss_pred CcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhccc
Q psy6820 540 PTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLES 619 (639)
Q Consensus 540 ~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~ 619 (639)
..|+|||.+.+...+.++|+||||+++|+|++|..||... +.......+......++ ..++.++.++|++||..
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~ 230 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE--DRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQK 230 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcC
Confidence 9999999999888899999999999999999999999543 34556666666444443 45689999999999999
Q ss_pred CCCCCCCH---HHHHcCCcc
Q psy6820 620 NPDLRFSA---EDVLDHPWL 636 (639)
Q Consensus 620 dP~~Rpta---~eiL~HP~f 636 (639)
||++||++ +++++||||
T Consensus 231 ~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 231 DPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CHhhCCCcccHHHHHhCCCC
Confidence 99999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.36 Aligned_cols=251 Identities=27% Similarity=0.364 Sum_probs=201.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC-ceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN-ELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-~~~lV~ 454 (639)
.++|.-...||+|+||.||+|....+ ..||||.+....... ...|.+|+.++.+++|||+|+|+|+|.+.+ ..+||+
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY 151 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY 151 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence 37888889999999999999987765 789999887655443 445999999999999999999999999888 499999
Q ss_pred eeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 455 ELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNY---IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~g---ivHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
|||++|+|.++|.... .++|..+..|+.++|.||+|||... ||||||||+|||+|.+. .+||+|||+|...
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~----~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF----NAKLSDFGLAKLG 227 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC----CEEccCccCcccC
Confidence 9999999999997654 8999999999999999999999854 99999999999999887 8999999999766
Q ss_pred cC-CCcc--c-cCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-Ch---HHH-HHHHHcCCC-CCCC
Q psy6820 530 LR-PMFT--V-CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQ---DEL-FDDILSGQY-GFPS 599 (639)
Q Consensus 530 ~~-~~~~--~-~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-~~---~~l-~~~i~~~~~-~~p~ 599 (639)
.. .... . .||.+|+|||++..+..+.++|||||||+|.||+||+.|...... .. .+. ...+..+.. .+..
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred CccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 54 3222 2 799999999999999999999999999999999999988864321 11 111 112222111 1111
Q ss_pred CC-c-ccc-----cHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 600 PY-W-DDI-----SEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 600 ~~-~-~~l-----~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+. . ... -..+..+..+|++.+|++||++.|+++
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11 1 122 233667889999999999999999753
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.55 Aligned_cols=258 Identities=28% Similarity=0.468 Sum_probs=212.9
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCc--
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNE-- 449 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-- 449 (639)
..+.++|.+.+.||+|+||.||+|.+..++..||+|++...... .....+.+|+.++++++||||+++++++...+.
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 44568899999999999999999999999999999998654221 223456789999999999999999998766554
Q ss_pred ----eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 450 ----LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 450 ----~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
.|+|+||+ +++|.+++.. ..+++..+..++.+++.||+|||+.|++||||||+||+++.++ .+||+|||+
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~----~~kL~dfg~ 164 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDFGL 164 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----CEEEccccc
Confidence 89999998 6799998865 4799999999999999999999999999999999999999887 799999999
Q ss_pred cccccCCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC------
Q psy6820 526 AQRVLRPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP------ 598 (639)
Q Consensus 526 a~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p------ 598 (639)
+...........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ......+.......+
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 165 ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred cccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCHHHHhh
Confidence 9877666666778999999999865 4678999999999999999999999965432 222333322111000
Q ss_pred -----------------C----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 599 -----------------S----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 599 -----------------~----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
. .....++.++.++|.+||+.||++|||+.++++||||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 0 011245889999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.73 Aligned_cols=247 Identities=21% Similarity=0.294 Sum_probs=205.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCe----EEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDM----DCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
.++|++.+.||+|+||.||+|....++. .||+|++...........+.+|+.+++.+.||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 3679999999999999999998776655 4899998766555556678899999999999999999999865 4578
Q ss_pred EEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
++|||+++|+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++ .+||+|||++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~----~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN----HVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC----cEEECCCCceeecc
Confidence 99999999999999976 45699999999999999999999999999999999999998877 79999999997654
Q ss_pred CCCc-----cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 531 RPMF-----TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 531 ~~~~-----~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
.... ...+++.|+|||.+.+..++.++|||||||++|||++ |..||... ....+...+..+.. .+ ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~-~~--~~~~ 235 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI--PAREIPDLLEKGER-LP--QPPI 235 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCc-CC--CCcc
Confidence 2211 1234678999999998899999999999999999998 99999543 33444444444322 22 2356
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++.++.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.15 Aligned_cols=245 Identities=22% Similarity=0.402 Sum_probs=206.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||+|+||.||.+.... +..+|+|.+..... ..+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 578999999999999999997654 34699999875443 245678999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc-
Q psy6820 457 IKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF- 534 (639)
Q Consensus 457 ~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~- 534 (639)
+++++|.+++... ..+++..+..++.+|+.||+|||+.|++|+||||+||+++.++ .+||+|||.+........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~----~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG----CVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC----CEEECCCccceecCCCcee
Confidence 9999999999764 4689999999999999999999999999999999999999887 799999999876543221
Q ss_pred ---cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 535 ---TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 535 ---~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
...++..|+|||.+.+..++.++|+||||+++|+|++ |..||... ........+..+..... ....+..+.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF--NNSETVEKVSQGLRLYR---PHLASEKVY 231 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHhcCCCCCC---CCCCCHHHH
Confidence 1234567999999998889999999999999999998 99999543 33455566655533222 234689999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+++.+||+.||.+||++.+++.+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=327.70 Aligned_cols=248 Identities=23% Similarity=0.390 Sum_probs=206.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcC-------CCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKH-------KDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNN 448 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 448 (639)
++|.+++.||+|+||.||+|.+.. +...+|+|.+...........+.+|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 679999999999999999997643 23469999998654333445677899999999 6999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC
Q psy6820 449 ELYLVIELIKGGDLFDAISKN----------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG 512 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g 512 (639)
..|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+.|++||||||+||+++.++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence 999999999999999999653 2478899999999999999999999999999999999999887
Q ss_pred ceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHH
Q psy6820 513 CHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDEL 586 (639)
Q Consensus 513 ~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l 586 (639)
.+||+|||++...... .....+++.|+|||++.+..++.++|+|||||++|||++ |..||... ..+++
T Consensus 178 ----~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~--~~~~~ 251 (307)
T cd05098 178 ----VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEEL 251 (307)
T ss_pred ----cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--CHHHH
Confidence 7999999998765421 111234568999999998889999999999999999998 88999543 44555
Q ss_pred HHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 587 ~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
...+..... .+....++.++.+|+.+||+.+|++||++.+++++
T Consensus 252 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 252 FKLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHcCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 555554431 12235678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=326.46 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=209.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+...........+..|+.++.++. ||||+++++++.+....|++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4789999999999999999999999899999999986654444455666777776665 999999999999999999999
Q ss_pred eeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 455 ELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||+. ++|.+++.. ...+++..+..++.+++.||+|||+ .||+||||+|+||+++.++ .+||+|||++......
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~----~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG----NVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC----CEEECccccchhccCC
Confidence 9984 577777754 4578999999999999999999997 6999999999999999877 8999999998765432
Q ss_pred --CccccCCCcccCccccccCC----CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC-CCCCCCcccc
Q psy6820 533 --MFTVCGTPTYVAPEILNESG----YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY-GFPSPYWDDI 605 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~----~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~-~~p~~~~~~l 605 (639)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...... .+....+..... ..+ ....+
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~ 245 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQEEPPSLP--PNEGF 245 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcCCCCCCC--CCCCC
Confidence 22345788999999987543 789999999999999999999999653322 233444444322 222 12357
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.++.+|+.+||+.||++||+++++++||||+.
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 899999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.87 Aligned_cols=245 Identities=20% Similarity=0.391 Sum_probs=206.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||+|... .+..+|+|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 468999999999999999999865 455799999865433 24677899999999999999999999999999999999
Q ss_pred eccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 456 LIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|+++++|.+++.+ ...+++..+..++.+++.||+|||+.+++||||||+||+++.++ .+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~----~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL----MCKIADFGLARVIEDNE 157 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC----cEEECCCccceecCCCc
Confidence 9999999999965 35688999999999999999999999999999999999999887 79999999997654322
Q ss_pred ----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 534 ----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 534 ----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
....++..|+|||.+.+..++.++|+|||||++|+|++ |..||... ........+.... .. +....++.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~~-~~--~~~~~~~~~ 232 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM--SNSDVMSALQRGY-RM--PRMENCPDE 232 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC--CHHHHHHHHHcCC-CC--CCCCCCCHH
Confidence 12335678999999998889999999999999999998 99999653 3344555554432 22 233568999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+++.+||..+|++||+++++++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=336.77 Aligned_cols=249 Identities=22% Similarity=0.377 Sum_probs=203.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeec-CCc
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDT-NNE 449 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~-~~~ 449 (639)
++|++.+.||+|+||.||+|.... +++.||+|++.........+.+.+|+.++.++ +||||++++++|.. ...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 589999999999999999997543 35789999997554333345677899999999 79999999998764 457
Q ss_pred eEEEEeeccCCChHHHHhhc------------------------------------------------------------
Q psy6820 450 LYLVIELIKGGDLFDAISKN------------------------------------------------------------ 469 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~------------------------------------------------------------ 469 (639)
++++|||+++++|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 89999999999999988532
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-----CccccCCCccc
Q psy6820 470 -VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYV 543 (639)
Q Consensus 470 -~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~ 543 (639)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... .....++..|+
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~----~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC----cEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 2578899999999999999999999999999999999999877 7999999999765322 12234567899
Q ss_pred CccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCC
Q psy6820 544 APEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPD 622 (639)
Q Consensus 544 APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~ 622 (639)
|||++.+..++.++|||||||++|||++ |..||..... .+.+...+..+.. .. .....++++.+++.+||+.+|+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~-~~--~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-DEEFCRRLKEGTR-MR--APEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc-cHHHHHHHhccCC-CC--CCccCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999999997 9999965432 2233333333322 11 1245789999999999999999
Q ss_pred CCCCHHHHHcC
Q psy6820 623 LRFSAEDVLDH 633 (639)
Q Consensus 623 ~Rpta~eiL~H 633 (639)
+||++.|+++|
T Consensus 319 ~RPs~~ell~~ 329 (337)
T cd05054 319 DRPTFSELVEI 329 (337)
T ss_pred hCcCHHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=331.47 Aligned_cols=258 Identities=31% Similarity=0.485 Sum_probs=209.2
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec-CCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDT-NNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~l 452 (639)
..++|.+.+.||.|+||.||+|.+..+++.+|+|.+.+.... ...+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 457899999999999999999999999999999998654322 234567789999999999999999998865 567899
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
+|||+ +++|.+++.. ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++ .+||+|||++......
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~----~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC----DLKICDFGLARIQDPQ 161 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC----CEEeCccccccccCCC
Confidence 99998 6689888864 4688999999999999999999999999999999999999877 7999999999766554
Q ss_pred CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh-------------HHHHHHHHc------
Q psy6820 533 MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ-------------DELFDDILS------ 592 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~-------------~~l~~~i~~------ 592 (639)
.....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ++....+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 455678899999998865 568999999999999999999999996543210 001110000
Q ss_pred ---CCC--CCC-CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 593 ---GQY--GFP-SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 593 ---~~~--~~p-~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
... ..+ ....+.++.++.++|++||+.+|++||++++++.||||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 000 001 1112357899999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.93 Aligned_cols=248 Identities=19% Similarity=0.306 Sum_probs=208.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCC-----CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHK-----DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
.+|.+.+.||+|+||.||+|....+ ++.+|+|++.........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4577889999999999999987543 57899999976544334466889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCcee
Q psy6820 452 LVIELIKGGDLFDAISK----------------NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHV 515 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~----------------~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~ 515 (639)
+++||+.+++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~--- 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL--- 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC---
Confidence 99999999999999842 23478889999999999999999999999999999999999876
Q ss_pred eeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHH
Q psy6820 516 KVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDD 589 (639)
Q Consensus 516 ~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~ 589 (639)
.+||+|||++...... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||... ...++.+.
T Consensus 162 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~~ 238 (283)
T cd05091 162 -NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVIEM 238 (283)
T ss_pred -ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHH
Confidence 7999999998765322 123345789999999988889999999999999999998 88898653 34566666
Q ss_pred HHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 590 ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 590 i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+...... +....++.++.+|+.+||+.+|++||++++|+..
T Consensus 239 i~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 6665432 2235789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.75 Aligned_cols=249 Identities=21% Similarity=0.411 Sum_probs=206.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEE-----cCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCc
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYD-----KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 449 (639)
.++|.+.+.||+|+||.||++.+ ..++..+|+|++.........+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35799999999999999999975 2345679999987655444456788999999999 79999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
.|++|||+++++|.+++.... .+++.++..++.+++.||+|||+++++|+||||+|||++.++ .+||+|||++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK----IVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC----eEEECCCcccc
Confidence 999999999999999997543 389999999999999999999999999999999999998776 89999999997
Q ss_pred cccCCC-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy6820 528 RVLRPM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPY 601 (639)
Q Consensus 528 ~~~~~~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~ 601 (639)
...... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||..... .......+..+ ... ..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-~~~~~~~~~~~-~~~--~~ 265 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-DSKFYKLIKEG-YRM--AQ 265 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-hHHHHHHHHcC-CcC--CC
Confidence 654321 12345778999999999889999999999999999998 9999965432 22233333322 222 12
Q ss_pred cccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 602 WDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 602 ~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
....++++.+++.+||+++|++|||+.|+++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=334.92 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=209.5
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTN----- 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 447 (639)
...++|.+.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 3458899999999999999999999999999999998754322 2235577899999999999999999987533
Q ss_pred -CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 448 -NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 448 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
...|++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~----~~kl~dfg~~ 167 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC----ELKILDFGLA 167 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC----CEEEeccccc
Confidence 3478899987 7899888765 4699999999999999999999999999999999999999887 7999999999
Q ss_pred ccccCCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC-----------
Q psy6820 527 QRVLRPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ----------- 594 (639)
Q Consensus 527 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~----------- 594 (639)
...........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... ......+....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 168 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHhhc
Confidence 876655556678999999999866 5689999999999999999999999965432 22212211110
Q ss_pred ------------CCCCC----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 595 ------------YGFPS----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 595 ------------~~~p~----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...+. ..+...++++.++|.+||+.||.+||++.++++||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 01111 111245889999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=344.63 Aligned_cols=254 Identities=31% Similarity=0.578 Sum_probs=221.0
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHH--HHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ--MIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~--~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.|..++.||-|+||+|.++...++...||+|.+.+.......+ -++.|-.||..-..+.||+||..|++.+.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4888999999999999999999999999999998776654443 36689999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc-----
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL----- 530 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~----- 530 (639)
|++||++..+|-+-+.|.+..+++++.++.+|+++.|..|+|||||||+|||||.+| ++||.||||++-+.
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG----HIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG----HIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC----ceeeeeccccccceecccc
Confidence 999999999999999999999999999999999999999999999999999999999 99999999996331
Q ss_pred --------------C---------C-----------------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHH
Q psy6820 531 --------------R---------P-----------------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILL 570 (639)
Q Consensus 531 --------------~---------~-----------------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLl 570 (639)
+ + ....+||+.|+|||++...+|+..+|+||.||+||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 0 0 11356999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCC---CHHHHHcCCcccC
Q psy6820 571 CGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF---SAEDVLDHPWLER 638 (639)
Q Consensus 571 tG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rp---ta~eiL~HP~f~~ 638 (639)
.|++||...+..... ..+.+++-.+..++-.++++++.+||.+++. +++.|+ .++||..||||+.
T Consensus 866 ~g~~pf~~~tp~~tq--~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQ--YKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hCCCCccCCCCCcce--eeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 999999876654332 3455555455555567899999999998765 578888 4788999999974
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.07 Aligned_cols=250 Identities=31% Similarity=0.496 Sum_probs=215.2
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+|++.+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.+++.++|+||+++++.+.+....|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999999999999999998765432 2345567899999999999999999999999999999999
Q ss_pred ccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 457 IKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 457 ~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
+++++|.+++.+ ...+++..+..++.+++.||+|||+.|++|+||+|+||+++.++ .+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~----~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC----cEEEeeccchhhhccC
Confidence 999999999865 35689999999999999999999999999999999999999876 7999999999766543
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||... +...+...+....... ....++.++.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR--SMQDLRYKVQRGKYPP---IPPIYSQDLQN 231 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCCCC---CchhhCHHHHH
Confidence 22356889999999999999999999999999999999999999654 3444555554443321 22467899999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
++.+||+.+|++||++.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.06 Aligned_cols=248 Identities=24% Similarity=0.404 Sum_probs=207.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCC-----CeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHK-----DMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 450 (639)
++|++.+.||+|+||.||++..... ...+|+|.+...........+.+|+.+++++ +||||+++++++...+.+
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 5799999999999999999987643 3789999987654444445678899999999 799999999999999999
Q ss_pred EEEEeeccCCChHHHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCce
Q psy6820 451 YLVIELIKGGDLFDAISK----------------NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH 514 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~----------------~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~ 514 (639)
+++|||+++|+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||+++.++
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~-- 169 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-- 169 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC--
Confidence 999999999999999854 24588999999999999999999999999999999999999887
Q ss_pred eeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHH
Q psy6820 515 VKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFD 588 (639)
Q Consensus 515 ~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~ 588 (639)
.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..||... ...+++.
T Consensus 170 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~ 245 (293)
T cd05053 170 --VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEELFK 245 (293)
T ss_pred --eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC--CHHHHHH
Confidence 8999999999765432 112234678999999998899999999999999999997 99999643 3445555
Q ss_pred HHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 589 DILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 589 ~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+..+. .. .....++.++.+|+.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGY-RM--EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCC-cC--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 554442 11 1224678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.83 Aligned_cols=239 Identities=24% Similarity=0.357 Sum_probs=199.9
Q ss_pred EEccCCceEEEEEEE--cCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCC
Q psy6820 384 IIGDGNFAVVRQVYD--KHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 384 ~LG~G~fG~Vy~a~~--~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
.||+|+||.||+|.. ..++..+|+|+++..... ...+.+.+|+.+++.+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 456788999998754332 23456788999999999999999999885 45679999999999
Q ss_pred ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC------c
Q psy6820 461 DLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM------F 534 (639)
Q Consensus 461 sL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~------~ 534 (639)
+|.+++.+...+++..+..++.|++.||+|||++|++||||||.||+++.++ .+||+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH----YAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC----eEEECCCccccccCCCCCeeeecC
Confidence 9999998888899999999999999999999999999999999999999876 79999999997654321 1
Q ss_pred cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
...+++.|+|||.+....++.++|+|||||++|||++ |..||... ...++...+..+.. . +....+++++.++|
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~i~~~~~-~--~~~~~~~~~l~~li 231 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM--KGNEVTQMIESGER-M--ECPQRCPPEMYDLM 231 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHCCCC-C--CCCCCCCHHHHHHH
Confidence 2234578999999988889999999999999999997 99999653 34455566655432 1 22356899999999
Q ss_pred HHhcccCCCCCCCHHHHHc
Q psy6820 614 SHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 614 ~~~L~~dP~~Rpta~eiL~ 632 (639)
.+||+.||++||++++|.+
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 9999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.56 Aligned_cols=243 Identities=24% Similarity=0.356 Sum_probs=205.0
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeee-ecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY-DTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~lV~ 454 (639)
.++|.+.+.||+|+||.||++... +..+|+|.+.... ..+.+.+|+.++++++|+|++++++++ ...+..+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 357999999999999999998665 5679999986543 245678999999999999999999975 4556789999
Q ss_pred eeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 455 ELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||+++++|.+++.+.. .+++..+..++.+++.||+|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~----~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC----cEEecCCccceecccc
Confidence 9999999999997643 488999999999999999999999999999999999999887 8999999999766554
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||... +...+...+..+. +......+++.+.+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 230 (256)
T cd05082 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGY---KMDAPDGCPPVVYD 230 (256)
T ss_pred CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCC---CCCCCCCCCHHHHH
Confidence 445556778999999998899999999999999999997 99999643 3444555554432 22233578999999
Q ss_pred HHHHhcccCCCCCCCHHHHHc
Q psy6820 612 LISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~ 632 (639)
++.+||+.||++|||++++++
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.91 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=201.6
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCe--EEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC------Cc
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDM--DCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTN------NE 449 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~--~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~ 449 (639)
|.+++.||+|+||.||+|....++. .+|+|.++..... ...+.+.+|+.+++.++||||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998877764 6899998765322 2345678899999999999999999976422 35
Q ss_pred eEEEEeeccCCChHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 450 LYLVIELIKGGDLFDAISK------NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~------~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
.+++|||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM----NVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC----CEEECCC
Confidence 7899999999999988732 23488999999999999999999999999999999999999877 7999999
Q ss_pred cccccccCCC-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCC
Q psy6820 524 GLAQRVLRPM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGF 597 (639)
Q Consensus 524 Gla~~~~~~~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~ 597 (639)
|++....... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||... ....+.+.+..+...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~- 233 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--ENSEIYDYLRQGNRL- 233 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCCC-
Confidence 9998654321 22345778999999999999999999999999999999 89999653 345566666655321
Q ss_pred CCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 598 PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 598 p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+....++..+.++|.+||+.||++|||+++++++
T Consensus 234 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 --KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1224688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=334.29 Aligned_cols=255 Identities=29% Similarity=0.487 Sum_probs=207.3
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNN----- 448 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 448 (639)
+.++|.+.+.||+|+||.||+|.+..+++.+|+|++.+.... .....+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 457899999999999999999999999999999998754322 22345678999999999999999999886543
Q ss_pred -ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 449 -ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 449 -~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
.+|+||||+. .+|..++. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++.
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~----~~kL~dfg~~~ 165 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC----ELKILDFGLAR 165 (342)
T ss_pred ceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEeeCCCCc
Confidence 4699999995 47776653 3689999999999999999999999999999999999999887 89999999998
Q ss_pred cccCCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC------------
Q psy6820 528 RVLRPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ------------ 594 (639)
Q Consensus 528 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~------------ 594 (639)
..........+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.... ....+..+....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 166 HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCCHHHHHHhc
Confidence 76555555678999999999876 468999999999999999999999997543 222222222110
Q ss_pred -----------CCCCCC----CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 595 -----------YGFPSP----YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 595 -----------~~~p~~----~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...+.. .++..+.++.+||++||+.||++||++++++.||||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 001110 12356788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=348.90 Aligned_cols=245 Identities=34% Similarity=0.613 Sum_probs=215.1
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 453 (639)
..+.|.+...+|.|+|+.|-.|.+..+++.+++|++.+... ...+|+.++... +||||+++.+.+.+..+.|+|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 45788899999999999999999999999999999987622 223566666555 599999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEc-cCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE-MSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld-~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||.+.|+.|.+.+.....+. .++..|+.+|+.|+.|||++|+|||||||+|||++ ..+ +++|+|||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g----~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG----HLRLTYFGFWSELERS 469 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC----cEEEEEechhhhCchh
Confidence 99999999999887776665 88888999999999999999999999999999995 555 8999999999988777
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
..+.|-|..|.|||++...+|++++||||||++||+|+||+.||.....+ .++...+..+.+. ..+|.++++|
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~~~s------~~vS~~AKdL 542 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMPKFS------ECVSDEAKDL 542 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCCccc------cccCHHHHHH
Confidence 66778899999999999999999999999999999999999999765443 5566566554332 5799999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 613 ISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
|++||+.||.+||++.+++.||||
T Consensus 543 l~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHhccCChhhCcChhhhccCcch
Confidence 999999999999999999999999
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=315.89 Aligned_cols=240 Identities=24% Similarity=0.377 Sum_probs=202.5
Q ss_pred EEEccCCceEEEEEEEcCCC---eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~---~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||.||+|.....+ ..+|+|.+.........+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999876554 7899999987766555667889999999999999999999876 4568999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc-----
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF----- 534 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~----- 534 (639)
++|.+++.....+++..+..++.|++.||+|||+.+++|+||||+|||++.++ .+||+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~----~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH----QAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC----cEEeccccccceeecCCcccccc
Confidence 99999998887899999999999999999999999999999999999999887 899999999976643221
Q ss_pred -cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 535 -TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 535 -~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||... +..++...+..... .+....++..+.++
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~l~~l 230 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM--KGAEVIAMLESGER---LPRPEECPQEIYSI 230 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHcCCc---CCCCCCCCHHHHHH
Confidence 1123467999999998899999999999999999998 99999643 33455555544432 22335688999999
Q ss_pred HHHhcccCCCCCCCHHHHHc
Q psy6820 613 ISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~ 632 (639)
|.+||..||++||++.++++
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.85 Aligned_cols=255 Identities=31% Similarity=0.457 Sum_probs=205.9
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNN----- 448 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 448 (639)
..++|++.+.||+|+||.||+|.++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 457899999999999999999999999999999998754322 22345678999999999999999999887654
Q ss_pred -----ceEEEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEee
Q psy6820 449 -----ELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGD 522 (639)
Q Consensus 449 -----~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~D 522 (639)
.+|+|+||+++ +|...+.. ...+++..+..++.||+.||+|||+.||+|+||||+||+++.++ .+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~----~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG----QIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----cEEeCc
Confidence 79999999976 77777754 34689999999999999999999999999999999999999887 899999
Q ss_pred ccccccccCCC----ccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC
Q psy6820 523 FGLAQRVLRPM----FTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597 (639)
Q Consensus 523 FGla~~~~~~~----~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~ 597 (639)
||++....... ....++..|+|||.+.+ ..++.++|||||||++|+|++|++||.... .......+.......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--ELAQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCC
Confidence 99997654322 22346788999998865 457899999999999999999999996533 222222222210000
Q ss_pred CC--------------------------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 598 PS--------------------------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 598 p~--------------------------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
+. ..+..++..+.++|.+||+.||++||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 00 1123478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.07 Aligned_cols=249 Identities=28% Similarity=0.519 Sum_probs=207.8
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc----chhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL----LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
+|.+.+.||+|+||.||++.+...+..+++|+++.... ......+..|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58899999999999999999988777777777654322 12234466799999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 454 IELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ .+||+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~-----~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-----LLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC-----CEeecccCceeec
Confidence 999999999988853 4568999999999999999999999999999999999999754 5999999998765
Q ss_pred cCC---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 530 LRP---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 530 ~~~---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||... ........+..+.. ......++
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~ 230 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--NFLSVVLRIVEGPT---PSLPETYS 230 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHcCCC---CCCcchhc
Confidence 432 22456889999999998888999999999999999999999999543 33344444443321 12224678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.++.++|.+||+.||++||++.++++||||
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 231 RQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=313.83 Aligned_cols=244 Identities=24% Similarity=0.374 Sum_probs=208.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+.+.||.|+||.||+|... ++.+|+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 357899999999999999999764 67899999976543 35667889999999999999999999998999999999
Q ss_pred eccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 456 LIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~----~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFGLAKEASQGQ 156 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC----CEEEccccccccccccc
Confidence 999999999997655 699999999999999999999999999999999999999887 79999999998775443
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||... ....+...+.... +......+++++.++
T Consensus 157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~l 231 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPHVEKGY---RMEAPEGCPPEVYKV 231 (256)
T ss_pred ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhcCC---CCCCccCCCHHHHHH
Confidence 34445677999999988889999999999999999997 99999544 3445544444331 112224678999999
Q ss_pred HHHhcccCCCCCCCHHHHHc
Q psy6820 613 ISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~ 632 (639)
|.+||+.+|++||++.++++
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=360.98 Aligned_cols=249 Identities=25% Similarity=0.361 Sum_probs=203.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
+++|.+.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999999754322 2245678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEee
Q psy6820 454 IELIKGGDLFDAISKN-----------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGD 522 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~-----------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~D 522 (639)
|||++|++|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg----~vKLiD 156 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG----EVVILD 156 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC----CEEEEe
Confidence 9999999999988531 2355677889999999999999999999999999999999887 799999
Q ss_pred ccccccccC---------------------CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC
Q psy6820 523 FGLAQRVLR---------------------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN 581 (639)
Q Consensus 523 FGla~~~~~---------------------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~ 581 (639)
||++..... .....+||+.|+|||++.+..++.++|||||||++|||+||..||.....
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 999975510 01135699999999999999999999999999999999999999965332
Q ss_pred ChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6820 582 DQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVL 631 (639)
Q Consensus 582 ~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL 631 (639)
. .............. ..+..+++.+.+++.+||+.||++||+..+.+
T Consensus 237 ~-ki~~~~~i~~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 237 R-KISYRDVILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred h-hhhhhhhccChhhc--cccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 1 11111111111111 11346899999999999999999998765544
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=356.05 Aligned_cols=246 Identities=24% Similarity=0.426 Sum_probs=216.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
.+-...+.||+|.||+||+|+... ..+.||||.++........+.|++|++++..++|||||+|+|+|..++.+|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 456678899999999999997543 357899999998877777889999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeee
Q psy6820 452 LVIELIKGGDLFDAISKN--------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKV 517 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~--------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~ 517 (639)
||+|||..|||.++|... .+++..+...||.|||.||+||-++.+|||||-+.|+||..+- .
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l----~ 641 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL----V 641 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce----E
Confidence 999999999999999432 1288899999999999999999999999999999999998775 9
Q ss_pred EEEeeccccccccCCCccccC-----CCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHH
Q psy6820 518 LKVGDFGLAQRVLRPMFTVCG-----TPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDIL 591 (639)
Q Consensus 518 vKL~DFGla~~~~~~~~~~~G-----T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~ 591 (639)
|||+|||+++..-...+-..+ ..+|||||.+..+.|+.++||||+||+|||+++ |..||++.++ +++++.|.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--~EVIe~i~ 719 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--QEVIECIR 719 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--HHHHHHHH
Confidence 999999999876543332222 568999999999999999999999999999997 9999987654 67889999
Q ss_pred cCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6820 592 SGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVL 631 (639)
Q Consensus 592 ~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL 631 (639)
+++. ++.+ .++|.++.+||..||+.+|++||++.||-
T Consensus 720 ~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 720 AGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 9987 5443 78999999999999999999999999884
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=334.15 Aligned_cols=257 Identities=30% Similarity=0.529 Sum_probs=207.2
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeecC--Cc
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSV-NHPNIIKLLDEYDTN--NE 449 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~--~~ 449 (639)
.+.++|++.+.||.|+||.||+|.+..+++.+|+|.+..... ......+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 456789999999999999999999998899999998864321 12234566899999999 999999999988654 36
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
+|+||||+. ++|.+++... .+++..+..++.||+.||+|||+.||+||||||+||+++.++ .+||+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~----~~kl~d~g~~~~~ 157 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC----RVKLADFGLARSL 157 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC----cEEEeeccchhcc
Confidence 899999996 5999998765 789999999999999999999999999999999999999888 8999999999755
Q ss_pred cCC--------CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc--------
Q psy6820 530 LRP--------MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS-------- 592 (639)
Q Consensus 530 ~~~--------~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~-------- 592 (639)
... .....||+.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... +....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL--NQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHH
Confidence 321 123568999999998754 56789999999999999999999999654321 11111111
Q ss_pred -------------------CCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 593 -------------------GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 593 -------------------~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..........+.++.++.++|.+||+.||++|||+.++++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 1111111222347899999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.90 Aligned_cols=246 Identities=22% Similarity=0.368 Sum_probs=205.8
Q ss_pred CCeeEEEEEccCCceEEEEEEEc-----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDK-----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
.+|.+.+.||+|+||.||+|... .++..+++|.+..... .....+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 56899999999999999999754 3456688999865433 23356789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCcee
Q psy6820 452 LVIELIKGGDLFDAISKN----------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHV 515 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~ 515 (639)
+||||+++++|.+++... ..+++..+..++.+|+.||+|||++|++||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~--- 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL--- 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC---
Confidence 999999999999999653 2378999999999999999999999999999999999999887
Q ss_pred eeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHH
Q psy6820 516 KVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDD 589 (639)
Q Consensus 516 ~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~ 589 (639)
.++|+|||++...... .....+++.|+|||++.+..++.++||||||+++|||+| |..||... ...+..+.
T Consensus 161 -~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~~~ 237 (291)
T cd05094 161 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL--SNTEVIEC 237 (291)
T ss_pred -cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHH
Confidence 8999999999755432 123446788999999999899999999999999999998 99999554 33445555
Q ss_pred HHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 590 ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 590 i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+..+.... ....++..+.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 55543322 22457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.19 Aligned_cols=246 Identities=21% Similarity=0.348 Sum_probs=202.6
Q ss_pred eeEEEEEccCCceEEEEEEEcCC---CeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCc-----
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNE----- 449 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----- 449 (639)
|.+++.||+|+||.||.|....+ +..+|+|.+....... ....+.+|+..++.++||||+++++.+...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999987653 4789999987654332 23567889999999999999999998765544
Q ss_pred -eEEEEeeccCCChHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEee
Q psy6820 450 -LYLVIELIKGGDLFDAISKN------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGD 522 (639)
Q Consensus 450 -~~lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~D 522 (639)
.+++|||+++++|..++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~----~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM----TVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC----eEEECC
Confidence 79999999999999888432 3589999999999999999999999999999999999999887 799999
Q ss_pred ccccccccCCC-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 523 FGLAQRVLRPM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 523 FGla~~~~~~~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
||++....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..++.+.+..+..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--~~~~~~~~~~~~~- 233 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NHEIYDYLRHGNR- 233 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC-
Confidence 99997654322 12335678999999988889999999999999999999 999996543 3455555555432
Q ss_pred CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 597 ~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
......++.++.+++.+||+.||++||++.|++.+
T Consensus 234 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 --LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12224688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.23 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=204.7
Q ss_pred CeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
+|.+.+.||+|+||.||+|.... ....+++|.+.........+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998653 2356899998765544445678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q psy6820 453 VIELIKGGDLFDAISKN------------------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLV 508 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~------------------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILl 508 (639)
+|||+.+++|.+++... ..+++..+..++.+++.||+|||+.|++||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999988542 247889999999999999999999999999999999999
Q ss_pred ccCCceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q psy6820 509 EMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTND 582 (639)
Q Consensus 509 d~~g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~ 582 (639)
+.++ .+||+|||++...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||... .
T Consensus 161 ~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~ 234 (290)
T cd05045 161 AEGR----KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--A 234 (290)
T ss_pred cCCC----cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC--C
Confidence 9877 8999999999754321 122345778999999988889999999999999999998 99999543 3
Q ss_pred hHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 583 ~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
...+.+.+... ...+ ....++.++.+++.+||+.||++||+++++++
T Consensus 235 ~~~~~~~~~~~-~~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTG-YRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCC-CCCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 44555544433 2222 23568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.83 Aligned_cols=245 Identities=24% Similarity=0.403 Sum_probs=204.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
.+|++.+.||+|+||.||+|.++. +..+|+|++...... ...+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 458889999999999999998764 567999998654332 34577899999999999999999999999999999999
Q ss_pred ccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc-
Q psy6820 457 IKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF- 534 (639)
Q Consensus 457 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~- 534 (639)
+++++|.+++.. ...+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~----~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN----VVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC----cEEECCcccceeccccccc
Confidence 999999999965 34689999999999999999999999999999999999999887 799999999976543221
Q ss_pred cc---cCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 535 TV---CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 535 ~~---~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.. .++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... ..+....+.... +.+....++.++.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~ 231 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS--NSEVVESVSAGY---RLYRPKLAPTEVY 231 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC--HHHHHHHHHcCC---cCCCCCCCCHHHH
Confidence 11 23457999999998899999999999999999999 899996433 344444544431 1222246799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+++.+||..+|++|||+.|+++.
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=313.92 Aligned_cols=245 Identities=23% Similarity=0.395 Sum_probs=206.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||+|.... ++.+|+|.++.... ..+.+.+|+.++++++||||+++++++...+..|++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3679999999999999999998654 46799999876543 24567889999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 456 LIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|+++++|.+++.... .+++..+..++.+++.||.|||+.|++||||||+||+++.++ .+||+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN----ICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC----CEEECCcceEEEccCCc
Confidence 999999999997643 689999999999999999999999999999999999999887 79999999997665321
Q ss_pred c-ccc---CCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 534 F-TVC---GTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 534 ~-~~~---GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
. ... ++..|+|||.+.+..++.++|+||||+++|||++ |+.||... ....+...+... ...+ ....++..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~-~~~~--~~~~~~~~ 232 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM--TNAEVLQQVDQG-YRMP--CPPGCPKE 232 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcC-CCCC--CCCcCCHH
Confidence 1 122 2457999999998889999999999999999999 99999643 334455555433 2222 23467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+++.+||+.||++||++.++++
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=316.66 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=206.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCC---eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.+|++.+.||+|+||.||+|.+..++ ..+|+|.+.........+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57899999999999999999876443 479999987654444456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+++++|.+++.+. ..+++.++..++.|++.||+|||+.|++||||||+|||++.++ .++|+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~----~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL----VCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC----eEEeCCCCcccccccc
Confidence 9999999999999764 4689999999999999999999999999999999999999887 8999999999765432
Q ss_pred Cc------cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 533 MF------TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 533 ~~------~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
.. ...++..|+|||.+.+..++.++|+||||+++||+++ |..||.... ..+....+..+ ...+ ....+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~--~~~~~~~~~~~-~~~~--~~~~~ 234 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS--NQDVIKAIEEG-YRLP--APMDC 234 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC--HHHHHHHHhCC-CcCC--CCCCC
Confidence 11 1123567999999998889999999999999999886 999996543 33445555543 2222 23568
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++.+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=315.15 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=207.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCe---EEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDM---DCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
++|+..+.||+|+||.||+|..+.++. .+|+|.+.........+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 578899999999999999998876544 68999987654444456688999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+++++|.+++.. .+.+++..+..++.+++.||+|||+.|++|+||||+||+++.++ .+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~----~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL----ECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC----cEEECCCccceecccc
Confidence 999999999999965 35789999999999999999999999999999999999999876 7999999999765422
Q ss_pred Cc------cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 533 MF------TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 533 ~~------~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
.. ....++.|+|||++.+..++.++|||||||++|||++ |..||... ........+.... .. +....+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~--~~~~~~~~i~~~~-~~--~~~~~~ 235 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM--SNHEVMKAINDGF-RL--PAPMDC 235 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC--CHHHHHHHHhcCC-CC--CCCCCC
Confidence 11 1123457999999998889999999999999999997 99999543 3455666665432 22 223468
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.++.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.45 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=202.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecC-------
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTN------- 447 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------- 447 (639)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+....... ....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 589999999999999999999999999999999986543322 123457899999999999999999876433
Q ss_pred -CceEEEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 448 -NELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 448 -~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
..+|+||||+.+ +|...+.. ...+++..+..++.|+++||+|||++|++|+||||+||+++.++ .+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG----ILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----CEEECcCcc
Confidence 357999999854 77777654 45799999999999999999999999999999999999999887 899999999
Q ss_pred cccccCCC--------------ccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHH
Q psy6820 526 AQRVLRPM--------------FTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDI 590 (639)
Q Consensus 526 a~~~~~~~--------------~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i 590 (639)
+....... ....|++.|+|||.+.+ ..++.++||||||+++|||++|.+||...+. ....+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~--~~~~~~~ 239 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD--IDQLHLI 239 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence 97543211 22356888999998865 4589999999999999999999999965432 2222222
Q ss_pred HcCCCCC-----------------------CC---CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 591 LSGQYGF-----------------------PS---PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 591 ~~~~~~~-----------------------p~---~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
....... +. ..+..+++.+.++|.+||+.||++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 2110000 00 0112355789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.24 Aligned_cols=256 Identities=30% Similarity=0.469 Sum_probs=204.5
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC-------
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN------- 447 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------- 447 (639)
+..+|.+.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 35789999999999999999999999999999999876544 2345577899999999999999999876543
Q ss_pred -------CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEE
Q psy6820 448 -------NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 448 -------~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL 520 (639)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.|++||||||+||+++..+ ..+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~---~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED---LVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC---ceEEE
Confidence 35799999996 599888864 4689999999999999999999999999999999999998554 26899
Q ss_pred eeccccccccCC------CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC
Q psy6820 521 GDFGLAQRVLRP------MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG 593 (639)
Q Consensus 521 ~DFGla~~~~~~------~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~ 593 (639)
+|||++...... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ......+...
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~~~~~ 234 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE--LEQMQLILES 234 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHh
Confidence 999999754321 122357889999998754 5688999999999999999999999965432 1111111110
Q ss_pred C-------------------------CCCC-CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 Q-------------------------YGFP-SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 ~-------------------------~~~p-~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
. ...+ ......++.++.+||.+||+.||++|||+.+++.||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 0 0000 0112357889999999999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=312.47 Aligned_cols=245 Identities=26% Similarity=0.442 Sum_probs=209.8
Q ss_pred eeEEEEEccCCceEEEEEEEcCCC----eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKD----MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+++.+.||.|+||.||++.+...+ ..+|+|++...........+.+|+.+++.++|+||+++++++.+.+..|++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 356789999999999999988766 8899999976655445667889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 455 ELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||+++++|.+++..... +++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~----~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC----eEEEcccCCceecccc
Confidence 99999999999976544 99999999999999999999999999999999999999887 8999999999766543
Q ss_pred Cc----cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 533 MF----TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 533 ~~----~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.. ...+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.. .....+.+.+..+.... ....++.
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG--MSNEEVLEYLKKGYRLP---KPENCPP 231 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhcCCCCC---CCCcCCH
Confidence 21 1236789999999988889999999999999999998 8899865 34455566665554322 2245899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++.+++.+||..||++|||+.|+++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.51 Aligned_cols=250 Identities=20% Similarity=0.287 Sum_probs=201.8
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCC--------------CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHK--------------DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~--------------~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 442 (639)
++|.+.+.||+|+||.||+|....+ ...||+|.+...........+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999977543 23589999876544444567889999999999999999999
Q ss_pred eeecCCceEEEEeeccCCChHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEcc
Q psy6820 443 EYDTNNELYLVIELIKGGDLFDAISKNV------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM 510 (639)
Q Consensus 443 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~ 510 (639)
++...+..++||||+++++|.+++.... .+++..+..++.+++.||+|||+.|++|+||||+||+++.
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence 9999999999999999999999985432 3678899999999999999999999999999999999998
Q ss_pred CCceeeeEEEeeccccccccCCC-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc--CCCCCCCCCCCh
Q psy6820 511 SGCHVKVLKVGDFGLAQRVLRPM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC--GFPPFVSDTNDQ 583 (639)
Q Consensus 511 ~g~~~~~vKL~DFGla~~~~~~~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt--G~~Pf~~~~~~~ 583 (639)
++ .+||+|||++....... ....++..|+|||++.+..++.++|+||||+++|+|++ |..||.....
T Consensus 165 ~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-- 238 (295)
T cd05097 165 HY----TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-- 238 (295)
T ss_pred CC----cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence 76 79999999997543221 12334678999999998889999999999999999988 6778865432
Q ss_pred HHHHHHHHc----CCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 584 DELFDDILS----GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 584 ~~l~~~i~~----~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+....+.. ..........+.+++.+.+|+.+||+.||++||++++|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 333222211 1111111123457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=315.12 Aligned_cols=243 Identities=23% Similarity=0.362 Sum_probs=202.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||+|+||.||+|.+..+. .+|+|++..... ..+.+.+|+.+++.++||||+++++.+. .+..|+||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 57999999999999999999887664 599999976443 2356788999999999999999999875 4568999999
Q ss_pred ccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc
Q psy6820 457 IKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534 (639)
Q Consensus 457 ~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~ 534 (639)
+++|+|.+++.+. ..+++..+..++.+++.||+|||+.+++|+||||+||+++.++ .+||+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~----~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC----cEEeccCCceeecccccc
Confidence 9999999999753 4588999999999999999999999999999999999999887 799999999976543221
Q ss_pred ----cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 535 ----TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 535 ----~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
...++..|+|||+..+..++.++|+||||+++|+|++ |..||.... .......+.... +.+....++..+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~l 232 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGY---RMPCPPECPESL 232 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--hHHHHHHHhcCC---CCCCccccCHHH
Confidence 2345678999999998889999999999999999999 889996543 334445554432 112235689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHc
Q psy6820 610 KELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+++.+||+.||++||+++++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 233 HDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=331.00 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=199.2
Q ss_pred EEccC--CceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCC
Q psy6820 384 IIGDG--NFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 384 ~LG~G--~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
.||+| +||+||++.+..+++.||+|++....... ..+.+.+|+.+++.++||||++++++|...+..|+||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 45655 99999999999999999999987654332 2367889999999999999999999999999999999999999
Q ss_pred ChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC------
Q psy6820 461 DLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP------ 532 (639)
Q Consensus 461 sL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~------ 532 (639)
+|.+++.+. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++++||+.+......
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~----~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG----LVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC----cEEEechHHHhhhhccCccccc
Confidence 999998764 3589999999999999999999999999999999999999887 7999999865432211
Q ss_pred ----CccccCCCcccCcccccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC----------
Q psy6820 533 ----MFTVCGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG---------- 596 (639)
Q Consensus 533 ----~~~~~GT~~Y~APE~l~~--~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~---------- 596 (639)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||...... ............
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccch
Confidence 011234667999999976 35789999999999999999999999654322 222122111110
Q ss_pred ---------------------------------CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 597 ---------------------------------FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 597 ---------------------------------~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...+....+++.+.+||++||+.||++|||+.|+++||||.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 001112346778999999999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.27 Aligned_cols=249 Identities=23% Similarity=0.388 Sum_probs=207.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEc-------CCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDK-------HKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTN 447 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 447 (639)
.++|.+.+.||+|+||.||+|... ..+..+|+|.+...........+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 468999999999999999999753 234579999987554344456688999999999 799999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccC
Q psy6820 448 NELYLVIELIKGGDLFDAISKN----------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMS 511 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~ 511 (639)
+..|+||||+++++|.+++.+. ..++...+..++.||+.||+|||++|++||||||+||+++.+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~ 173 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCC
Confidence 9999999999999999999653 246788899999999999999999999999999999999987
Q ss_pred CceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHH
Q psy6820 512 GCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDE 585 (639)
Q Consensus 512 g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~ 585 (639)
+ .+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||... ...+
T Consensus 174 ~----~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~ 247 (304)
T cd05101 174 N----VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEE 247 (304)
T ss_pred C----cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--CHHH
Confidence 7 8999999999765422 122345678999999998889999999999999999998 88888543 4456
Q ss_pred HHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 586 LFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 586 l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+.+.+..+... .....++.++.+|+.+||+.+|++||++.|+++.
T Consensus 248 ~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 248 LFKLLKEGHRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHcCCcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 66666544321 1224688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=317.83 Aligned_cols=251 Identities=33% Similarity=0.505 Sum_probs=204.1
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhc---CCCceeeeeeeeecCCc-----
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSV---NHPNIIKLLDEYDTNNE----- 449 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~----- 449 (639)
|++.+.||.|+||.||+|.++.+++.+|+|.+...... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67899999999999999999988999999999754332 2234456788777766 59999999999988776
Q ss_pred eEEEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
.+++|||+. ++|.+++.... .+++..+..++.+++.||+|||+.+++|+||+|+||+++.++ .+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~----~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC----CEEEeccCcce
Confidence 999999996 48999886643 589999999999999999999999999999999999999887 89999999997
Q ss_pred cccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC-----CCCC--
Q psy6820 528 RVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ-----YGFP-- 598 (639)
Q Consensus 528 ~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~-----~~~p-- 598 (639)
..... .....++..|+|||++.+..++.++|+|||||++|+|++|.+||.... ..+....+.... ...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS--EADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC--hHHHHHHHHHHcCCCChHhcCCC
Confidence 66432 234457889999999999889999999999999999999999996543 223333332210 0000
Q ss_pred ----------------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 599 ----------------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 599 ----------------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
....+.+++.+.++|.+||+.||++||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 01112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.16 Aligned_cols=245 Identities=26% Similarity=0.469 Sum_probs=208.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
.+|++.+.||.|+||.||+|.+.. +..+|+|++...... ....+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL-KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh-hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 568999999999999999999888 788999998765432 245678899999999999999999999999999999999
Q ss_pred ccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc
Q psy6820 457 IKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534 (639)
Q Consensus 457 ~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~ 534 (639)
+++++|.+++.+ ...+++..+..++.+|+.||.|||++|++|+||||+||+++.++ .+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~----~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL----VCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc----eEEEccccchhhcCCccc
Confidence 999999999975 34689999999999999999999999999999999999999887 899999999976643322
Q ss_pred ---cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 535 ---TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 535 ---~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
...++..|+|||.+.+..++.++|+||||+++|+|++ |..||... ...+.+..+..+ ... +....+++++.
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~-~~~--~~~~~~~~~~~ 234 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM--NNHEVYDQITAG-YRM--PCPAKCPQEIY 234 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC--CHHHHHHHHHhC-CcC--CCCCCCCHHHH
Confidence 2345678999999998889999999999999999998 89999653 344555555543 222 22357899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q psy6820 611 ELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+++.+||+.||++|||++++++
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 235 KIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=324.06 Aligned_cols=247 Identities=23% Similarity=0.390 Sum_probs=205.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcC-------CCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKH-------KDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNN 448 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 448 (639)
++|.+++.||+|+||.||+|.+.. ....+|+|.+...........+.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 589999999999999999997532 34578999987654444445678899999999 5999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC
Q psy6820 449 ELYLVIELIKGGDLFDAISKN----------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG 512 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g 512 (639)
.+|++|||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN 171 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence 999999999999999999653 3488899999999999999999999999999999999999887
Q ss_pred ceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHH
Q psy6820 513 CHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDEL 586 (639)
Q Consensus 513 ~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l 586 (639)
.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||... ...++
T Consensus 172 ----~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~--~~~~~ 245 (314)
T cd05099 172 ----VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI--PVEEL 245 (314)
T ss_pred ----cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC--CHHHH
Confidence 7999999999765421 112234567999999998889999999999999999999 89999543 34555
Q ss_pred HHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 587 ~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+..+..+.. ......++.++.+++.+||+.||++||++.++++
T Consensus 246 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 665555432 1122567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=319.94 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=207.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++...........+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3679999999999999999998753 57789999987655444456688999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhc----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q psy6820 451 YLVIELIKGGDLFDAISKN----------------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLV 508 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~----------------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILl 508 (639)
|++|||+++++|.+++... ..+++..+..++.+++.||+|||++|++||||||+||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 9999999999999999643 246788899999999999999999999999999999999
Q ss_pred ccCCceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q psy6820 509 EMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTND 582 (639)
Q Consensus 509 d~~g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~ 582 (639)
+.++ .++|+|||++...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||... .
T Consensus 164 ~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~--~ 237 (288)
T cd05050 164 GENM----VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM--A 237 (288)
T ss_pred cCCC----ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--C
Confidence 9887 8999999998754322 112234667999999998899999999999999999997 88898543 3
Q ss_pred hHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 583 ~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
..+....+..+... + ....++.++.+||.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVL-S--CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCC-C--CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 45555666555432 1 12467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=314.09 Aligned_cols=239 Identities=22% Similarity=0.352 Sum_probs=196.9
Q ss_pred EEccCCceEEEEEEEc--CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCC
Q psy6820 384 IIGDGNFAVVRQVYDK--HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGD 461 (639)
Q Consensus 384 ~LG~G~fG~Vy~a~~~--~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs 461 (639)
.||+|+||.||+|... ..+..+|+|++.........+.+.+|+.++++++||||++++++++ .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999765 4456799999876544444567889999999999999999999885 457899999999999
Q ss_pred hHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC------c
Q psy6820 462 LFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM------F 534 (639)
Q Consensus 462 L~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~------~ 534 (639)
|.+++.. ...+++..+..++.+++.||+|||++|++||||||+||+++.++ .+||+|||++....... .
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH----YAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC----cEEeccCCccccccCCccceeccC
Confidence 9999864 45789999999999999999999999999999999999999887 89999999997543221 1
Q ss_pred cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
...+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ....+...+..+.. ......+++++.++|
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~l~~li 231 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM--KGPEVMSFIEQGKR---LDCPAECPPEMYALM 231 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHHCCCC---CCCCCCCCHHHHHHH
Confidence 1223578999999988889999999999999999996 99999654 33444444544332 122246789999999
Q ss_pred HHhcccCCCCCCCHHHHHc
Q psy6820 614 SHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 614 ~~~L~~dP~~Rpta~eiL~ 632 (639)
.+||+.||++||++.++++
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=318.21 Aligned_cols=246 Identities=19% Similarity=0.290 Sum_probs=200.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCe----EEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDM----DCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
++|++.+.||+|+||.||+|....++. .+++|.+...........+..|+.+++.+.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 578899999999999999999876665 477777754332223355678888999999999999999875 456789
Q ss_pred EEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
++||+++|+|.+++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+|||++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~----~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS----IVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC----cEEEcCCccceeccC
Confidence 9999999999999975 45789999999999999999999999999999999999999887 899999999975532
Q ss_pred C-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 532 P-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 532 ~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||... ......+.+..+.. .+. ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~~-~~~--~~~~ 236 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM--RPHEVPDLLEKGER-LAQ--PQIC 236 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCc-CCC--CCCC
Confidence 1 123456778999999998889999999999999999998 99999654 23334344443332 221 2356
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.++.+++.+||..||++|||+.|+++
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=319.05 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=200.1
Q ss_pred CCe-eEEEEEccCCceEEEEEE----EcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC--Cc
Q psy6820 377 QRY-SVGQIIGDGNFAVVRQVY----DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN--NE 449 (639)
Q Consensus 377 ~~y-~i~~~LG~G~fG~Vy~a~----~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~ 449 (639)
++| .+.+.||+|+||+||++. ...++..+|+|++...........+.+|+.+|++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 899999999999998764 33467789999997654433456678999999999999999999987653 46
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
++++|||+++++|.+++... .+++..+..++.+++.||+|||++|++||||||+||+++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~~l~dfg~~~~~ 157 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR----LVKIGDFGLAKAV 157 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC----cEEEeeccccccc
Confidence 89999999999999999764 599999999999999999999999999999999999999876 8999999999765
Q ss_pred cCCC------ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHH------------HHHH
Q psy6820 530 LRPM------FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF------------DDIL 591 (639)
Q Consensus 530 ~~~~------~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~------------~~i~ 591 (639)
.... ....++..|+|||.+.+..++.++||||||+++|||++|..||........+.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 4321 122456679999999988899999999999999999999999854332211111 0111
Q ss_pred cCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 592 SGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 592 ~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
...... +....++.++.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111111 123467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=319.97 Aligned_cols=263 Identities=29% Similarity=0.457 Sum_probs=210.1
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCC----eEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec-CC
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKD----MDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDT-NN 448 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~ 448 (639)
.+..|++...||+|.||.||+|..+.++ +.+|||.++-.... +-....-+|+.+++.++|||++.|..++-. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3567999999999999999999665543 36899998755322 223455689999999999999999998876 78
Q ss_pred ceEEEEeeccCCChHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 449 ELYLVIELIKGGDLFDAISK-----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~-----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
.+++++||.+. +|+.+|+- ...++...++.++.||+.|+.|||++.|+||||||.|||+..+|.+...|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 89999999976 99998842 3469999999999999999999999999999999999999988766669999999
Q ss_pred cccccccCCCc------cccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC-------hHHHHHH
Q psy6820 524 GLAQRVLRPMF------TVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTND-------QDELFDD 589 (639)
Q Consensus 524 Gla~~~~~~~~------~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~-------~~~l~~~ 589 (639)
|+++.+.++.. ..+-|.+|+|||.+.+ ..|+.+.|||++||++.||+|-.+.|.+...+ +.+....
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99998876533 3456899999999876 57999999999999999999999988654321 1122233
Q ss_pred HHcCCCCCCCCCc---------------------cc------------ccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 590 ILSGQYGFPSPYW---------------------DD------------ISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 590 i~~~~~~~p~~~~---------------------~~------------l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
|..-.-......| .+ -++.+.+|+.+||+.||.+|.|++++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 3321111111111 11 25568899999999999999999999999999
Q ss_pred cC
Q psy6820 637 ER 638 (639)
Q Consensus 637 ~~ 638 (639)
.+
T Consensus 341 ~~ 342 (438)
T KOG0666|consen 341 TE 342 (438)
T ss_pred cc
Confidence 86
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.32 Aligned_cols=249 Identities=23% Similarity=0.425 Sum_probs=202.1
Q ss_pred CCeeEEEEEccCCceEEEEEEE-----cCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecC-Cc
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYD-----KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTN-NE 449 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~-~~ 449 (639)
++|++.+.||+|+||.||+|.+ ..+++.||+|++...........+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5899999999999999999974 3457789999997654444445678899999999 589999999987654 56
Q ss_pred eEEEEeeccCCChHHHHhhc------------------------------------------------------------
Q psy6820 450 LYLVIELIKGGDLFDAISKN------------------------------------------------------------ 469 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~------------------------------------------------------------ 469 (639)
.+++|||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 89999999999999998542
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-----Ccccc
Q psy6820 470 -------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-----MFTVC 537 (639)
Q Consensus 470 -------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-----~~~~~ 537 (639)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC----cEEEEecccccccccCcchhhcCCCC
Confidence 1367788899999999999999999999999999999999877 8999999999765321 11234
Q ss_pred CCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 538 GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ......+..+. ..+.+ ..+++++.+++.+|
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~c 318 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGT-RMRAP--DYTTPEMYQTMLDC 318 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhccC-CCCCC--CCCCHHHHHHHHHH
Confidence 5678999999998899999999999999999996 99999654332 23333333332 22222 34688999999999
Q ss_pred cccCCCCCCCHHHHHcC
Q psy6820 617 LESNPDLRFSAEDVLDH 633 (639)
Q Consensus 617 L~~dP~~Rpta~eiL~H 633 (639)
|+.||++||++.++++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.94 Aligned_cols=251 Identities=35% Similarity=0.578 Sum_probs=207.9
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
|++.+.||.|++|.||+|....+++.+++|.+...... .....+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56788999999999999999989999999998765433 33456778999999999999999999999999999999999
Q ss_pred cCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC---
Q psy6820 458 KGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM--- 533 (639)
Q Consensus 458 ~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~--- 533 (639)
++ +|.+.+.. ...+++..+..++.+++.||+|||+.|++|+||||+||+++.++ .+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~----~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG----VLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC----cEEEeeeeeeEecCCCcccc
Confidence 65 88888865 46899999999999999999999999999999999999999877 79999999997665432
Q ss_pred ccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC------------------
Q psy6820 534 FTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ------------------ 594 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~------------------ 594 (639)
....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+. .+....+....
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 234578899999998776 789999999999999999999999965432 22222211110
Q ss_pred -CCCC-------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 595 -YGFP-------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 595 -~~~p-------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
..++ ...++.++.++.++|.+||++||.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0000 01223578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=320.04 Aligned_cols=253 Identities=29% Similarity=0.578 Sum_probs=210.9
Q ss_pred CeeEEEEEccCCceEEEEEEEc---CCCeEEEEEEEcccccc---hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCce
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLL---GKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiKv~~~~~~~---~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 450 (639)
+|++.+.||+|+||.||++.+. .+++.+|+|++.+.... ...+.+.+|+.++.+++ ||||+++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999764 45678999998754332 22345778999999995 99999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|+||||+++++|.+++.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++ .++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~----~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG----HVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC----CEEEEECccccccc
Confidence 99999999999999998777899999999999999999999999999999999999999887 79999999987654
Q ss_pred CCC----ccccCCCcccCccccccCC--CChhhhHHHHHHHHHHHHcCCCCCCCCCC--ChHHHHHHHHcCCCCCCCCCc
Q psy6820 531 RPM----FTVCGTPTYVAPEILNESG--YGVKIDVWAAGVILYILLCGFPPFVSDTN--DQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 531 ~~~----~~~~GT~~Y~APE~l~~~~--~s~~sDVwSLGvvL~eLltG~~Pf~~~~~--~~~~l~~~i~~~~~~~p~~~~ 602 (639)
... ....|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||..... ...++.+.+.......+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 232 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP---- 232 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCC----
Confidence 322 2356899999999987654 78899999999999999999999954322 22344444444433332
Q ss_pred ccccHHHHHHHHHhcccCCCCCCC---HHHHHcCCcccC
Q psy6820 603 DDISEEAKELISHMLESNPDLRFS---AEDVLDHPWLER 638 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpt---a~eiL~HP~f~~ 638 (639)
..++.++.++|.+||+.||++||| +.++++||||+.
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 457899999999999999999998 567899999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=322.72 Aligned_cols=252 Identities=27% Similarity=0.439 Sum_probs=208.4
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+.|...+.||+|+||.||+|.+..+++.+++|++....... ..+.+.+|+.+++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 34667788999999999999999999999999987544322 2245778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 455 ELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 455 E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
||+. ++|.+.+.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++ .+||+|||++.... ..
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~----~~kL~dfg~~~~~~-~~ 174 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG----QVKLADFGSASKSS-PA 174 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC----CEEEeecCCCcccC-CC
Confidence 9995 578777754 45789999999999999999999999999999999999999887 79999999986543 23
Q ss_pred ccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 534 FTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
....|+..|+|||.+. ...++.++||||||+++|+|++|..||.... ............. +......++..++
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~l~ 250 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNDS---PTLQSNEWTDSFR 250 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCC---CCCCccccCHHHH
Confidence 4567899999999984 4568899999999999999999999996542 2233332222222 2222245678999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+|+.+||+.+|.+||++.+++.||||+.
T Consensus 251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 251 GFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=316.42 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=209.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
++|.+.+.||.|+||.||+|+.+. ..+.+++|.+.........+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578899999999999999998654 346799999876544334567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEee
Q psy6820 452 LVIELIKGGDLFDAISKNV---------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGD 522 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~---------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~D 522 (639)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++|+|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~----~~~l~~ 160 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR----EVKVSL 160 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC----cEEEcc
Confidence 9999999999999997655 689999999999999999999999999999999999999887 799999
Q ss_pred ccccccccCC----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCC
Q psy6820 523 FGLAQRVLRP----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGF 597 (639)
Q Consensus 523 FGla~~~~~~----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~ 597 (639)
||++...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||... ........+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~--~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL--SDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc--chHHHHHHHHcCCcCC
Confidence 9998654322 223356778999999988889999999999999999998 88999543 3344555555554433
Q ss_pred CCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 598 PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 598 p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+. ...++..+.+++.+||+.||++||++.|++.+
T Consensus 239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 32 24688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.35 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=203.0
Q ss_pred CeeEEEEEccCCceEEEEEEE----cCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC--CceE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYD----KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN--NELY 451 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~ 451 (639)
-|++.+.||+|+||.||+|.. ..++..||+|.+...........+.+|+.+++.++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478899999999999999974 4567889999987554444456788999999999999999999998765 5689
Q ss_pred EEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+||||++|++|.+++.+. ..+++..+..++.+++.||+|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~----~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----QVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC----CEEECCCccccccc
Confidence 999999999999999664 3589999999999999999999999999999999999999887 79999999997654
Q ss_pred CCC------ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-------------ChHHHHHHHH
Q psy6820 531 RPM------FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-------------DQDELFDDIL 591 (639)
Q Consensus 531 ~~~------~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-------------~~~~l~~~i~ 591 (639)
... ....++..|+|||.+.+..++.++||||||+++|||+++..|+..... ........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 321 234567789999999988899999999999999999998776532211 1111122222
Q ss_pred cCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 592 SGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 592 ~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+. ..+.+..++.++.+|+.+||+.||++||++.+++++
T Consensus 241 ~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 241 EGK---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cCc---cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 221 122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=318.51 Aligned_cols=251 Identities=35% Similarity=0.536 Sum_probs=205.4
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEEeec
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
|.+.+.||.|+||.||+|....+++.+++|.+.............+|+..+++++ ||||+++++++...+..|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6788999999999999999998999999999876543333344567999999999 999999999999999999999999
Q ss_pred cCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--C
Q psy6820 458 KGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--M 533 (639)
Q Consensus 458 ~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--~ 533 (639)
+++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++...... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~----~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE----VVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC----CEEEeecccceeccCCCCc
Confidence 789999887654 789999999999999999999999999999999999999887 8999999999766432 2
Q ss_pred ccccCCCcccCccccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC-------------------
Q psy6820 534 FTVCGTPTYVAPEILN-ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG------------------- 593 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~-~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~------------------- 593 (639)
....++..|+|||++. ...++.++|+||||+++|+|++|.+||..... .+.. ..+...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE-IDQL-YKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh-HHHH-HHHHHhcCCCChhhhhhHhhhhccc
Confidence 3456889999999885 45679999999999999999999999965432 1111 111100
Q ss_pred CCCCC-------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 594 QYGFP-------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 594 ~~~~p-------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
....+ .......+..+.++|++||+.||++|||+.|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00000 00112336889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=314.92 Aligned_cols=247 Identities=21% Similarity=0.347 Sum_probs=206.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCe---EEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDM---DCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
..|++.+.||+|+||.||+|..+.++. .||+|++...........+..|+.+++.++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 568999999999999999999876654 69999987654444456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+++++|.+++.. .+.+++.++..++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~----~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL----VCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC----cEEECCCccccccccC
Confidence 999999999999865 45689999999999999999999999999999999999998876 7999999998654321
Q ss_pred Cc-----ccc---CCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc
Q psy6820 533 MF-----TVC---GTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 533 ~~-----~~~---GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
.. ... .+..|+|||.+.+..++.++|||||||++|||++ |..||... ........+... ...+ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~--~~~~~~~~i~~~-~~~~--~~~ 234 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVINAIEQD-YRLP--PPM 234 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC--CHHHHHHHHHcC-CcCC--Ccc
Confidence 11 111 1457999999999999999999999999999886 99999543 334444555332 2222 235
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.++..+.+++.+||+.+|++||++++++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.74 Aligned_cols=248 Identities=28% Similarity=0.527 Sum_probs=208.8
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCC
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGD 461 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs 461 (639)
...||+|+||.||++....++..+|+|.+.... ......+.+|+.+++.++|+||+++++.+...+..+++|||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 467999999999999999999999999986433 2334567889999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---CccccC
Q psy6820 462 LFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCG 538 (639)
Q Consensus 462 L~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~~~~~G 538 (639)
|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++...... .....|
T Consensus 104 L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 104 LTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----CEEEcccccceeccccccccccccc
Confidence 9998754 4689999999999999999999999999999999999999887 7999999998655432 233568
Q ss_pred CCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcc
Q psy6820 539 TPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLE 618 (639)
Q Consensus 539 T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~ 618 (639)
++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+.... .........++..+.+++.+||+
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNL-PPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhC-CcccCCcccCCHHHHHHHHHHHh
Confidence 999999999988889999999999999999999999996532 233333332221 11111234678999999999999
Q ss_pred cCCCCCCCHHHHHcCCcccC
Q psy6820 619 SNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 619 ~dP~~Rpta~eiL~HP~f~~ 638 (639)
.||.+||++.++++||||.+
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~ 275 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAK 275 (292)
T ss_pred CCcccCcCHHHHhcChHHhc
Confidence 99999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.35 Aligned_cols=246 Identities=21% Similarity=0.344 Sum_probs=204.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEc-----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDK-----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
.+|.+.+.||+|+||.||++... .++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 56788999999999999999643 346678999876543 233467889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceee
Q psy6820 452 LVIELIKGGDLFDAISKNV---------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVK 516 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~---------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~ 516 (639)
++|||+++++|.+++.... .+++..+..++.||+.||+|||+.|++||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~---- 159 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL---- 159 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC----
Confidence 9999999999999986542 478999999999999999999999999999999999999876
Q ss_pred eEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHH
Q psy6820 517 VLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDI 590 (639)
Q Consensus 517 ~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i 590 (639)
.+||+|||++...... .....+++.|+|||.+.+..++.++|||||||++|||++ |.+||... ........+
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~ 237 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL--SNTEAIECI 237 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC--CHHHHHHHH
Confidence 8999999998755322 122335678999999999899999999999999999998 99999543 334444445
Q ss_pred HcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 591 LSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 591 ~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
..+.. ......+++.+.+||.+||+.||.+||+++++++
T Consensus 238 ~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCcc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 44422 1222468899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.59 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=205.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCC-------CeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHK-------DMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNN 448 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~-------~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 448 (639)
.+|++++.||+|+||.||+|.+... ...+|+|++.........+.+.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 5799999999999999999976432 2368999887554444456778999999999 7999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC
Q psy6820 449 ELYLVIELIKGGDLFDAISKN----------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG 512 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g 512 (639)
..+++|||+++|+|.+++.+. ..++...+..++.|++.||+|||++|++||||||+|||++.++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~ 171 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN 171 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence 999999999999999999653 2477888999999999999999999999999999999999887
Q ss_pred ceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHH
Q psy6820 513 CHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDEL 586 (639)
Q Consensus 513 ~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l 586 (639)
.+||+|||+++..... .....++..|+|||++.+..++.++||||||+++|||++ |..||... +.++.
T Consensus 172 ----~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~ 245 (334)
T cd05100 172 ----VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEEL 245 (334)
T ss_pred ----cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC--CHHHH
Confidence 7999999999765432 122234567999999999999999999999999999998 89999543 44556
Q ss_pred HHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 587 ~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
...+..... .+....++.++.+|+.+||+.+|++||++.|++++
T Consensus 246 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 246 FKLLKEGHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHcCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 665554422 12224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=355.63 Aligned_cols=148 Identities=30% Similarity=0.499 Sum_probs=135.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
+++|.+.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+.++..++||||+++++++...+.+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999997654322 235678899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
|||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g----~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG----HIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC----CEEEEeCCCCc
Confidence 99999999999998888899999999999999999999999999999999999999887 79999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=315.70 Aligned_cols=240 Identities=28% Similarity=0.426 Sum_probs=198.1
Q ss_pred EEccCCceEEEEEEEcCCCe--EEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEEEeeccCC
Q psy6820 384 IIGDGNFAVVRQVYDKHKDM--DCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 384 ~LG~G~fG~Vy~a~~~~~~~--~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
.||+|+||.||+|..+.++. .+++|.+.........+.+.+|+.+++++ +||||+++++++...+..|++|||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999999887765 46888887544334456788999999999 6999999999999999999999999999
Q ss_pred ChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 461 DLFDAISKNV----------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 461 sL~~~l~~~~----------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
+|.+++.... .+++..+..++.+++.||+|||+.|++||||||+||+++.++ .+||+|||
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~----~~kl~dfg 157 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY----VAKIADFG 157 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC----eEEECCCC
Confidence 9999996532 478999999999999999999999999999999999999887 89999999
Q ss_pred ccccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy6820 525 LAQRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPY 601 (639)
Q Consensus 525 la~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~ 601 (639)
++...... ......+..|+|||++....++.++|+||||+++|||++ |..||... +....+..+.... .. +.
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~--~~~~~~~~~~~~~-~~--~~ 232 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKLPQGY-RL--EK 232 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc--CHHHHHHHHhCCC-CC--CC
Confidence 98543211 112234567999999988889999999999999999997 99999543 3344555554431 11 12
Q ss_pred cccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 602 WDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 602 ~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
...++.++.+|+.+||+.||.+|||+++++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=311.06 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=211.0
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Cce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN-----NEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~ 450 (639)
-++|.+.+.||+|||+.||+++.-.++..||+|.+.... ....+...+|++..++++|||+++++++...+ ...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 378999999999999999999999999999999998766 34456677999999999999999999876433 458
Q ss_pred EEEEeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 451 YLVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNY--IVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~g--ivHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
||++.|...|+|.+.+.. +..+++.++.+|+.+|++||++||+.. +.||||||.|||+...+ .++|.|||
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~----~~vl~D~G 174 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG----LPVLMDLG 174 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC----ceEEEecc
Confidence 999999999999999854 336999999999999999999999999 99999999999999876 89999999
Q ss_pred ccccccCC------------CccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHH
Q psy6820 525 LAQRVLRP------------MFTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDD 589 (639)
Q Consensus 525 la~~~~~~------------~~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~ 589 (639)
.++...-. ...-..|..|+|||.+. +...++++|||||||+||+|+.|..||...-..-..+.-.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 99765311 12234689999999985 4456899999999999999999999995432222233344
Q ss_pred HHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 590 ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 590 i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+.++++.+|.. ..+++.+.+||+.||+.||.+||++.+++.+
T Consensus 255 v~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 255 VQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 56667777765 3489999999999999999999999999865
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=311.60 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=202.7
Q ss_pred EEEccCCceEEEEEEEcC-CC--eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKH-KD--MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~-~~--~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|++|.||+|.+.. ++ ..+|+|.+.........+.+.+|+.++++++||||+++++.+.. ..++++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998765 33 36899999877664445678899999999999999999999988 889999999999
Q ss_pred CChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-----
Q psy6820 460 GDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP----- 532 (639)
Q Consensus 460 gsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~----- 532 (639)
++|.+++.+.. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD----KVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC----EEEecccccccccccccccee
Confidence 99999997654 689999999999999999999999999999999999999887 8999999999766432
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||... ...+....+.......+ ....++..+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 231 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--SGSQILKKIDKEGERLE--RPEACPQDIY 231 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence 112456788999999998899999999999999999998 99999543 33445455543222222 2246789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q psy6820 611 ELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+++.+||+.+|++||+++++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=335.70 Aligned_cols=249 Identities=24% Similarity=0.433 Sum_probs=205.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEc-----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDK-----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 450 (639)
++|.+++.||+|+||.||+|.+. .+++.||+|++.........+.+.+|+.+|.++. ||||++++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 56888999999999999999854 3456899999986554444456889999999997 99999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcC------------------------------------------------------------
Q psy6820 451 YLVIELIKGGDLFDAISKNV------------------------------------------------------------ 470 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~------------------------------------------------------------ 470 (639)
++||||+++|+|.+++.+..
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999986431
Q ss_pred --------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC
Q psy6820 471 --------------------------------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG 512 (639)
Q Consensus 471 --------------------------------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g 512 (639)
.+++..+..++.||+.||+|||+.+++||||||+|||++.++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence 356677888999999999999999999999999999999876
Q ss_pred ceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHH
Q psy6820 513 CHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDEL 586 (639)
Q Consensus 513 ~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l 586 (639)
.+||+|||++...... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.... ..+..
T Consensus 277 ----~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~-~~~~~ 351 (401)
T cd05107 277 ----LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP-MNEQF 351 (401)
T ss_pred ----EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC-chHHH
Confidence 8999999999764321 123456788999999998889999999999999999998 899996433 22333
Q ss_pred HHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 587 ~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
...+..+ ..+ +.+..++.++.+|+.+||+.+|++||++++|++.
T Consensus 352 ~~~~~~~-~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRG-YRM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcC-CCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3334333 222 2234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.51 Aligned_cols=243 Identities=23% Similarity=0.369 Sum_probs=202.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|.+.+.||+|+||.||+|.+..+. .+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 57999999999999999999877664 589998765432 2456788999999999999999999885 4568999999
Q ss_pred ccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC-
Q psy6820 457 IKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM- 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~- 533 (639)
+++++|.+++.+. ..+++..+..++.+++.||+|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~----~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL----VCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC----eEEECCCccceEccCCcc
Confidence 9999999999653 3478999999999999999999999999999999999999887 79999999997653321
Q ss_pred ---ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 534 ---FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 534 ---~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... ..+....+... . +.+....++..+
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~-~--~~~~~~~~~~~~ 232 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NREVLEQVERG-Y--RMPCPQGCPESL 232 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcC-C--CCCCCcccCHHH
Confidence 12345678999999998889999999999999999999 999996532 33444444443 2 222335789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHc
Q psy6820 610 KELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+++.+||++||++||+++++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=319.57 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=201.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcC----------------CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKH----------------KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKL 440 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~----------------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 440 (639)
++|++.+.||+|+||.||++.... ++..+|+|++...........+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 579999999999999999985432 3456899999765444445678899999999999999999
Q ss_pred eeeeecCCceEEEEeeccCCChHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEc
Q psy6820 441 LDEYDTNNELYLVIELIKGGDLFDAISKNV-----------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE 509 (639)
Q Consensus 441 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld 509 (639)
++++...+..+++|||+++++|.+++.... .+++..+..++.+++.||+|||+.|++|+||||+|||++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence 999999999999999999999999986532 366778999999999999999999999999999999998
Q ss_pred cCCceeeeEEEeeccccccccCCC-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc--CCCCCCCCCCC
Q psy6820 510 MSGCHVKVLKVGDFGLAQRVLRPM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC--GFPPFVSDTND 582 (639)
Q Consensus 510 ~~g~~~~~vKL~DFGla~~~~~~~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt--G~~Pf~~~~~~ 582 (639)
.++ .++|+|||++....... ....+++.|+|||...+..++.++|+|||||++|||++ |..||.....
T Consensus 165 ~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 165 KNY----TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred CCC----CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 876 79999999997653221 12334678999999888889999999999999999998 7789864332
Q ss_pred hHHHHHHHH----cCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 583 QDELFDDIL----SGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 583 ~~~l~~~i~----~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+...... ........+....+++.+.+|+.+||+.||++||++.++++
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 240 -EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred -HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 22222111 11011111122457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.18 Aligned_cols=251 Identities=22% Similarity=0.407 Sum_probs=197.7
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEEcccc-cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSK-LLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 381 i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+++.+|.| |.||.++...+++.||+|++.... .......+.+|+.+++.++||||+++++++...+..|++|||+++
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 33444444 455556667789999999997653 233446788999999999999999999999999999999999999
Q ss_pred CChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-----
Q psy6820 460 GDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP----- 532 (639)
Q Consensus 460 gsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~----- 532 (639)
++|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++ .+||+|||.+......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~----~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG----KVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC----ceEEecCccceeecccccccc
Confidence 9999999753 4689999999999999999999999999999999999999887 7999999998654321
Q ss_pred -----CccccCCCcccCcccccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC----------
Q psy6820 533 -----MFTVCGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY---------- 595 (639)
Q Consensus 533 -----~~~~~GT~~Y~APE~l~~--~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~---------- 595 (639)
.....++..|+|||++.+ ..++.++|+|||||++|||++|..||..... .....+.+.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA-TQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCccccccCchhh
Confidence 123456788999999876 4588999999999999999999999975432 2222222211100
Q ss_pred -------------------CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 596 -------------------GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 596 -------------------~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+......++.++.+|+.+||+.||++|||++++++||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 0000111234578999999999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=314.80 Aligned_cols=248 Identities=20% Similarity=0.298 Sum_probs=206.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec-CCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT-NNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~ 450 (639)
.++|.+.+.||+|+||.||+|.+.. ++..+++|.+.........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4689999999999999999998876 3578999998765444455678899999999999999999998765 5678
Q ss_pred EEEEeeccCCChHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEee
Q psy6820 451 YLVIELIKGGDLFDAISKN--------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGD 522 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~--------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~D 522 (639)
++++||+++++|.+++... ..+++..+..++.+++.||+|||+.+++|+||||+||+++.++ .+||+|
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~----~~kl~d 160 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL----QVKITD 160 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC----cEEECC
Confidence 9999999999999998653 4589999999999999999999999999999999999998876 899999
Q ss_pred ccccccccCCC-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 523 FGLAQRVLRPM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 523 FGla~~~~~~~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
||+++...... ....++..|+|||++.+..++.++||||||+++||+++ |..||... +..++...+..+ ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~-~~ 237 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEMAAYLKDG-YR 237 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHHHHHHHcC-CC
Confidence 99997653221 12345678999999998889999999999999999998 99999543 334444444443 22
Q ss_pred CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 597 ~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++ ....+++++.+++.+||+.||++|||+.++++
T Consensus 238 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22 23467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=322.08 Aligned_cols=252 Identities=28% Similarity=0.430 Sum_probs=209.4
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
..|+..+.||+|+||.||++.+..++..+|+|.+....... ....+.+|+.+++.++|||++++++++.+....|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45888999999999999999999999999999987543322 2345778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 455 ELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 455 E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
||+.| +|.+.+.. ..++++..+..++.+++.||.|||+.|++||||+|+||+++.++ .+||+|||++.... ..
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~----~~kl~dfg~~~~~~-~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG----QVKLADFGSASIAS-PA 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC----CEEEecCCCccccC-Cc
Confidence 99965 78777743 56789999999999999999999999999999999999999887 79999999986543 33
Q ss_pred ccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 534 FTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
....|++.|+|||.+. ...++.++|||||||++|+|++|..||... +.......+..... +......+++.+.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 254 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNES--PTLQSNEWSDYFR 254 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHhccC--CCCCCccccHHHH
Confidence 4567899999999974 456899999999999999999999999653 22333333433322 1112245788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++|.+||+.+|.+||++.++++|||+..
T Consensus 255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 255 NFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 9999999999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=311.62 Aligned_cols=244 Identities=22% Similarity=0.371 Sum_probs=203.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||+|.... +..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....|++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 3579999999999999999997664 45699999876543 2456889999999999999999999885 456899999
Q ss_pred eccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 456 LIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|+++++|.+++... ..+++..+..++.+++.||+|||+.|++||||||+||+++.++ .++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~----~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL----VCKIADFGLARLIEDNE 156 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc----eEEeCCceeeeeccCcc
Confidence 99999999999653 4589999999999999999999999999999999999999887 89999999997654322
Q ss_pred ----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 534 ----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 534 ----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||... +..+....+... . +.+.....+.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~-~--~~~~~~~~~~~ 231 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--NNREVLEQVERG-Y--RMPCPQDCPIS 231 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcC-C--CCCCCCcCCHH
Confidence 12234567999999988889999999999999999999 89999643 334455555443 1 22233578899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+|+.+||++||++|||++++.+
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHH
Confidence 999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=325.63 Aligned_cols=253 Identities=30% Similarity=0.445 Sum_probs=203.8
Q ss_pred CeeEEEEEccCCceEEEEEEEcCC--CeEEEEEEEcccccc-hhHHHHHHHHHHHHhcC-CCceeeeeeeeec----CCc
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHK--DMDCALKIIDKSKLL-GKKQMIENEVNILRSVN-HPNIIKLLDEYDT----NNE 449 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~--~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~----~~~ 449 (639)
+|++.+.||+|+||.||++.+..+ +..+|+|.+...... ...+.+.+|+.+++++. ||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 588999999999999999999888 889999998643222 12355678999999995 9999999986532 246
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
.|+++||+. ++|.+++.....+++..++.++.||+.||+|||+.|++||||||+||+++.++ .+||+|||++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~----~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC----CEEeCcCCCceec
Confidence 789999985 69999998888899999999999999999999999999999999999999887 7999999999765
Q ss_pred cCC-------CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC--------
Q psy6820 530 LRP-------MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG-------- 593 (639)
Q Consensus 530 ~~~-------~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~-------- 593 (639)
... .....||+.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+ ....+..+...
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD--YVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC--HHHHHHHHHHHhCCCCHHH
Confidence 321 223568999999998765 568999999999999999999999996533 11111111110
Q ss_pred -------------------CCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 594 -------------------QYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 594 -------------------~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
........+..++.++.+++.+||+.||++|||+.+++.||||+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 00000112245688999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=317.35 Aligned_cols=251 Identities=35% Similarity=0.541 Sum_probs=207.3
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
|++.+.||+|+||.||+|....+++.+|+|++..... ....+.+.+|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5678899999999999999999999999999986542 222355678999999999999999999999999999999999
Q ss_pred cCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC---
Q psy6820 458 KGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM--- 533 (639)
Q Consensus 458 ~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~--- 533 (639)
+ ++|.+++.+. ..+++..+..++.+++.||+|||+.|++||||+|+||+++.++ .+||+|||++.......
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~----~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG----VLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC----CEEEecCCcccccCCCcccc
Confidence 7 5999999776 5799999999999999999999999999999999999999887 89999999997654322
Q ss_pred ccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC------------------C
Q psy6820 534 FTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG------------------Q 594 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~------------------~ 594 (639)
....++..|+|||.+.+. .++.++|+||||+++|||++|..||..... ......+... .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 234567889999998766 789999999999999999999999965432 2222222110 0
Q ss_pred CCCCC-------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 595 YGFPS-------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 595 ~~~p~-------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
..++. ...+.++.++.++|++||+.||++||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00000 1123457899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.42 Aligned_cols=245 Identities=26% Similarity=0.422 Sum_probs=205.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
.+|++.+.||.|+||.||++.+.. +..+|+|.+...... ...+.+|+.++++++|||++++++++......|++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 478899999999999999998754 567999998755432 45678899999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc-
Q psy6820 457 IKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF- 534 (639)
Q Consensus 457 ~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~- 534 (639)
+++++|.+++... ..+++..+..++.+++.||+|||+.+++|+||||+||+++.++ .+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~----~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ----VVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC----eEEECCCcceeecccCccc
Confidence 9999999998653 5689999999999999999999999999999999999999877 799999999876543221
Q ss_pred ---cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 535 ---TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 535 ---~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
...++..|+|||.+.+..++.++|+||||+++|||++ |..||... ......+.+..+..... ....+.++.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR--SNSEVVETINAGFRLYK---PRLASQSVY 231 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC--CHHHHHHHHhCCCCCCC---CCCCCHHHH
Confidence 2234578999999998889999999999999999998 99999543 34455555544322221 134689999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+|+.+||+.+|++||++.+++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.13 Aligned_cols=245 Identities=22% Similarity=0.367 Sum_probs=206.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+.+.||+|+||.||+|.... ++.+|+|.+...... ...+.+|+.++++++||||+++++++......+++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccC--HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4789999999999999999998764 467999998765432 4567899999999999999999999999899999999
Q ss_pred eccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 456 LIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|+++++|.+++... ..+++..+..++.+++.||+|||++|++|+||||+||+++.++ .+||+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~----~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL----VCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC----CEEECccccceeccchh
Confidence 99999999999764 3689999999999999999999999999999999999999887 89999999987654321
Q ss_pred ----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 534 ----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 534 ----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||... ......+.+..+. . .+.....+.+
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~~~~~-~--~~~~~~~~~~ 232 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--TNREVLEQVERGY-R--MPRPPNCPEE 232 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC-C--CCCCCCCCHH
Confidence 12234568999999998889999999999999999998 99999543 3344555554432 1 2222456899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=312.95 Aligned_cols=229 Identities=28% Similarity=0.385 Sum_probs=194.9
Q ss_pred CCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCChHHHHh
Q psy6820 388 GNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAIS 467 (639)
Q Consensus 388 G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~ 467 (639)
|.||.||+|.+..+++.||+|.+.... ...+|...+....||||+++++++.+.+..|+||||++||+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999999999999999997643 22345555556679999999999999999999999999999999998
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCccccCCCcccCccc
Q psy6820 468 KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEI 547 (639)
Q Consensus 468 ~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~ 547 (639)
+...+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||.+...........++..|+|||.
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~ 153 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG----HIQLTYFSRWSEVEDSCDGEAVENMYCAPEV 153 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC----CEEEecccchhccccccccCCcCccccCCcc
Confidence 877899999999999999999999999999999999999999887 7999999998766655555667888999999
Q ss_pred cccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCH
Q psy6820 548 LNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSA 627 (639)
Q Consensus 548 l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta 627 (639)
+.+..++.++|+||+|+++|||++|..||...... .. ......+| ..+++.+.++|.+||+.||++||++
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~~---~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG---IN---THTTLNIP----EWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---cc---cccccCCc----ccCCHHHHHHHHHHccCCHHHhcCC
Confidence 98888999999999999999999999987432111 00 00111222 4578999999999999999999985
Q ss_pred -----HHHHcCCcc
Q psy6820 628 -----EDVLDHPWL 636 (639)
Q Consensus 628 -----~eiL~HP~f 636 (639)
+++++||||
T Consensus 224 ~~~~~~~~~~h~~~ 237 (237)
T cd05576 224 GVAGVEDIKSHPFF 237 (237)
T ss_pred CccchHHHHcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=313.55 Aligned_cols=244 Identities=23% Similarity=0.320 Sum_probs=193.9
Q ss_pred EEEccCCceEEEEEEEc--CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCC
Q psy6820 383 QIIGDGNFAVVRQVYDK--HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~--~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
+.||+|+||.||+|... .++..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999754 3456799999876554444456788999999999999999999999999999999999999
Q ss_pred ChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 461 DLFDAISKN-----VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 461 sL~~~l~~~-----~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
+|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .+||+|||++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~----~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL----TVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC----cEEECCccccccccCccee
Confidence 999999643 2456778889999999999999999999999999999999876 8999999999654322
Q ss_pred --CccccCCCcccCccccccC-------CCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCc
Q psy6820 533 --MFTVCGTPTYVAPEILNES-------GYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~-------~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
.....|++.|+|||++.+. .++.++|+||||+++|||++ |..||...... +.....+.......+.+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE-QVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHhhcccCCCCCCcc
Confidence 1234578889999998642 35789999999999999996 99999654332 2222223333333333322
Q ss_pred -ccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 603 -DDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 603 -~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
...++.+.+++++|+ .+|++|||++||+.
T Consensus 236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 246889999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.52 Aligned_cols=244 Identities=23% Similarity=0.421 Sum_probs=203.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+.++||+|+||.||+|.... ++.+|+|.+...... .+.+.+|+.++++++||||+++++++. .+..|++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 3679999999999999999998654 567999998765432 456889999999999999999999874 467899999
Q ss_pred eccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 456 LIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|+++++|.+++... ..+++.++..++.+++.||+|||+.|++||||||+||+++.++ .++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~----~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL----CCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC----CEEEccCcceeecCCCC
Confidence 99999999998653 4689999999999999999999999999999999999999887 79999999997655221
Q ss_pred ----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 534 ----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 534 ----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
....++..|+|||++....++.++|+||||+++|||++ |.+||...+ ..+....+... . +.+.....+.+
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~-~--~~~~~~~~~~~ 231 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNLERG-Y--RMPRPDNCPEE 231 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHcC-C--CCCCCCCCCHH
Confidence 12345678999999998889999999999999999999 999996543 33444444333 1 22333568899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+++.+||+.+|++||+++++++
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.95 Aligned_cols=240 Identities=24% Similarity=0.417 Sum_probs=200.4
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCCh
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL 462 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 462 (639)
++||+|+||.||+|... ++..+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999865 57789999987655444455688999999999999999999999999999999999999999
Q ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc----ccc
Q psy6820 463 FDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF----TVC 537 (639)
Q Consensus 463 ~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~----~~~ 537 (639)
.+++.. ...+++..+..++.+++.||.|||++|++||||||+||+++.++ .+||+|||++........ ...
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~----~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN----VLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC----eEEECCCccceeccccccccCCCCC
Confidence 999865 34689999999999999999999999999999999999999887 799999999865432221 223
Q ss_pred CCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 538 GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
++..|+|||++.+..++.++|+||||+++|+|++ |..||... ........+.... .......++..+.+++.+|
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM--TNQQAREQVEKGY---RMSCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHHcCC---CCCCCCCCCHHHHHHHHHH
Confidence 4667999999998889999999999999999998 99999654 3334444444332 1122346889999999999
Q ss_pred cccCCCCCCCHHHHHc
Q psy6820 617 LESNPDLRFSAEDVLD 632 (639)
Q Consensus 617 L~~dP~~Rpta~eiL~ 632 (639)
|+.+|++||++.++++
T Consensus 231 l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 231 WDYKPENRPKFSELQK 246 (250)
T ss_pred cccCcccCCCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=310.36 Aligned_cols=242 Identities=28% Similarity=0.418 Sum_probs=202.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||++. .+++.+|+|.+.... ..+.+.+|+.+++.++|||++++++++... ..+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 3679999999999999999985 466789999986542 245678899999999999999999998654 5799999
Q ss_pred eccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 456 LIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|+++++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++.......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~----~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG----VAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC----cEEECCCccceeccccC
Confidence 999999999997543 588999999999999999999999999999999999999887 79999999997654333
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.... ..+....+..+. ..+ ....++.++.++
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~-~~~--~~~~~~~~~~~l 229 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--LKEVKECVEKGY-RME--PPEGCPADVYVL 229 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--HHHHHHHHhCCC-CCC--CCCcCCHHHHHH
Confidence 33445678999999998899999999999999999997 999996543 344555554432 221 225688999999
Q ss_pred HHHhcccCCCCCCCHHHHHc
Q psy6820 613 ISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+||+.+|++||+++++++
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.77 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=206.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCe----EEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDM----DCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
..+|.+.+.||+|+||.||+|..+.++. .+|+|.............+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3678999999999999999998766543 5899998766554455678899999999999999999999987 7899
Q ss_pred EEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~----~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC----eEEECCCccccccc
Confidence 999999999999999764 4689999999999999999999999999999999999998877 79999999997654
Q ss_pred CCCc-----cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 531 RPMF-----TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 531 ~~~~-----~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
.... ...++..|+|||.+....++.++|+||||+++|||++ |..||... ..+++...+..+.. .+. ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~-~~~--~~~ 235 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI--PAVEIPDLLEKGER-LPQ--PPI 235 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHhCCCC-CCC--CCC
Confidence 2211 1223568999999988889999999999999999998 99999654 34555555554432 222 235
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+..+.+++.+||..||++||++.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 7889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.35 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=204.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCC---CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
++|.+.+.||+|+||.||+|.+... ...+|+|...........+.+.+|+.+++.++||||+++++++.+ +..|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 5689999999999999999987544 456899998765544455678899999999999999999998875 457899
Q ss_pred EeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+++++|.+++.+. ..+++..+..++.+++.||+|||+.|++|+||||+||+++.++ .+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~----~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD----CVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC----CeEEccCceeeecccc
Confidence 9999999999999764 3589999999999999999999999999999999999999887 8999999998765432
Q ss_pred C----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 533 M----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 533 ~----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
. ....+++.|+|||.+....++.++||||||+++|||++ |..||.... ..+....+..+.. . +....++.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--~~~~~~~~~~~~~-~--~~~~~~~~ 235 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK--NNDVIGRIENGER-L--PMPPNCPP 235 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCc-C--CCCCCCCH
Confidence 1 12234567999999988889999999999999999986 999996543 2333444444321 1 22357899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
++.++|.+||..+|++|||+.+++..
T Consensus 236 ~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 236 TLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=355.79 Aligned_cols=253 Identities=24% Similarity=0.444 Sum_probs=216.0
Q ss_pred CCcccCCCeeEEEEEccCCceEEEEEEEcCCC-----eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeee
Q psy6820 371 IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKD-----MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYD 445 (639)
Q Consensus 371 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 445 (639)
+|......-+..+.||+|.||.||.|...... ..||+|.+.+....+....|.+|..+|+.++|||||+++|.+-
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 33444567888999999999999999776543 3499999988877777888999999999999999999999999
Q ss_pred cCCceEEEEeeccCCChHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeE
Q psy6820 446 TNNELYLVIELIKGGDLFDAISKN-------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVL 518 (639)
Q Consensus 446 ~~~~~~lV~E~~~ggsL~~~l~~~-------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~v 518 (639)
+....+|++|||+||+|..+|++. ..++..+...++.+||+|+.||+++++|||||...|+|++... .|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r----~V 841 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR----VV 841 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC----cE
Confidence 999999999999999999999775 3589999999999999999999999999999999999999885 99
Q ss_pred EEeeccccccccC-CCccccC----CCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHc
Q psy6820 519 KVGDFGLAQRVLR-PMFTVCG----TPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILS 592 (639)
Q Consensus 519 KL~DFGla~~~~~-~~~~~~G----T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~ 592 (639)
||+|||+|+.... ..+...| ...|||||.+..+.++.++|||||||+|||+++ |..||...++ .+++..++.
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--~~v~~~~~~ 919 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--FEVLLDVLE 919 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--HHHHHHHHh
Confidence 9999999995543 2333223 357999999999999999999999999999998 8999976543 455554444
Q ss_pred CCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 593 GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 593 ~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+. .++.| ..+|..+.+||..||+.+|++||++..|++
T Consensus 920 gg-RL~~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 920 GG-RLDPP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CC-ccCCC--CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 43 33333 579999999999999999999999999885
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.36 Aligned_cols=241 Identities=24% Similarity=0.377 Sum_probs=194.6
Q ss_pred EEEccCCceEEEEEEEcC---CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeee-cCCceEEEEeecc
Q psy6820 383 QIIGDGNFAVVRQVYDKH---KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYD-TNNELYLVIELIK 458 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~---~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~ 458 (639)
+.||+|+||.||+|.... ....+|+|.+.........+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998643 346799999865443334566778999999999999999999765 4566899999999
Q ss_pred CCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-----
Q psy6820 459 GGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP----- 532 (639)
Q Consensus 459 ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~----- 532 (639)
+++|.+++.+. ..+++..+..++.+++.||+|||+.+++||||||+|||++.++ .+||+|||++......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~----~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF----TVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC----cEEECCccccccccCCcceee
Confidence 99999999754 4567888899999999999999999999999999999999887 7999999999754321
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcC-CCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCG-FPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG-~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.....+++.|+|||.+.+..++.++||||||+++|||++| .+||... +.......+..+.... ....++..+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVYLLQGRRLL---QPEYCPDPL 231 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhcCCCCC---CCCcCCHHH
Confidence 1233457789999999888999999999999999999995 6666432 3344444554443211 124578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHc
Q psy6820 610 KELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+++.+||+.+|++||++.++++
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.94 Aligned_cols=240 Identities=28% Similarity=0.448 Sum_probs=202.2
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCCh
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL 462 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 462 (639)
++||.|+||.||+|.+.. ++.+|+|.+...........+.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 368999999999999887 8899999987665544456788999999999999999999999999999999999999999
Q ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc-----cc
Q psy6820 463 FDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF-----TV 536 (639)
Q Consensus 463 ~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~-----~~ 536 (639)
.+++.+ ...+++..+..++.+++.||+|||+++++||||||+||+++.++ .+||+|||++........ ..
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~----~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC----cEEEeeccccccccCCcceeccccC
Confidence 999965 45689999999999999999999999999999999999999887 899999999976542221 12
Q ss_pred cCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHH
Q psy6820 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615 (639)
Q Consensus 537 ~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~ 615 (639)
.++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... .......+... ... +....++.++.+++.+
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--~~~~~~~~~~~-~~~--~~~~~~~~~~~~li~~ 230 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS--NQQTRERIESG-YRM--PAPQLCPEEIYRLMLQ 230 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC--HHHHHHHHhcC-CCC--CCCccCCHHHHHHHHH
Confidence 23567999999998889999999999999999998 899995543 23344444332 222 2235688999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q psy6820 616 MLESNPDLRFSAEDVLD 632 (639)
Q Consensus 616 ~L~~dP~~Rpta~eiL~ 632 (639)
||+.+|++|||+.|+++
T Consensus 231 ~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 231 CWAYDPENRPSFSEIYN 247 (251)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.76 Aligned_cols=243 Identities=23% Similarity=0.322 Sum_probs=193.2
Q ss_pred EEccCCceEEEEEEEcC--CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCC
Q psy6820 384 IIGDGNFAVVRQVYDKH--KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGD 461 (639)
Q Consensus 384 ~LG~G~fG~Vy~a~~~~--~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs 461 (639)
.||+|+||.||+|.... ....+|+|.+...........+.+|+.+++.++||||+++++.+.+...+|+||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996433 3457888887655444444567889999999999999999999999999999999999999
Q ss_pred hHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC----
Q psy6820 462 LFDAISKNV-----KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---- 532 (639)
Q Consensus 462 L~~~l~~~~-----~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---- 532 (639)
|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~----~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL----SVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC----cEEEeccccccccccchhee
Confidence 999996542 246788899999999999999999999999999999999887 8999999998654221
Q ss_pred -CccccCCCcccCcccccc-------CCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCC-c
Q psy6820 533 -MFTVCGTPTYVAPEILNE-------SGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPY-W 602 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-------~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~-~ 602 (639)
.....+++.|+|||++.. ..++.++|||||||++|||++ |..||.... +.+.+...+......++.+. .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-DEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC-HHHHHHHHhhccCccCCCCccc
Confidence 123345778999998743 356889999999999999999 788885432 23333333444444444432 2
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
..++..+.+++..|| .||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 467889999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.04 Aligned_cols=253 Identities=29% Similarity=0.419 Sum_probs=208.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
...|+..+.||+|+||.||+|++..++..+|+|.+...... .....+.+|+.+++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34588889999999999999999999999999998653222 2234567899999999999999999999999999999
Q ss_pred EeeccCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAIS-KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+. |+|.+.+. ....+++..+..++.+++.||.|||+.+++||||+|+||+++.++ .+||+|||++.... .
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~kl~dfg~~~~~~-~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMA-P 167 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC----cEEECCcccceeec-C
Confidence 99996 58877764 345689999999999999999999999999999999999999877 79999999986553 3
Q ss_pred CccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 MFTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.....|++.|+|||.+. ...++.++|||||||++|+|++|..||.... .......+..... +......++.++
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~ 243 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNES--PALQSGHWSEYF 243 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--HHHHHHHHhhcCC--CCcCcccccHHH
Confidence 34567899999999974 3567889999999999999999999985432 2222222332221 211124678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+||++||+.+|++||+++++++|||+.+
T Consensus 244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 99999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=367.47 Aligned_cols=253 Identities=28% Similarity=0.545 Sum_probs=219.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
-+|.-+..||.|.||.||.|...++|...|+|-+....... .-..+.+|+.+|..|+|||+|+++|+-.+.+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 45667889999999999999999999999999886554431 12457789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC--
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-- 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~-- 533 (639)
||++|+|.+.+...+..++...+.+..|++.|++|||++|||||||||+||+++.+| .+|++|||.|.....+.
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g----~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG----LIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC----cEEeecccceeEecCchhc
Confidence 999999999999988899999999999999999999999999999999999999998 89999999998776543
Q ss_pred -----ccccCCCcccCcccccc---CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 534 -----FTVCGTPTYVAPEILNE---SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 534 -----~~~~GT~~Y~APE~l~~---~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
....||+.|||||++.+ .+...++|||||||++.||+||+.||...+++-.-++.--....+.+| ..+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P----~~l 1466 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP----ERL 1466 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc----hhh
Confidence 34679999999999965 456789999999999999999999997666555444444444444444 459
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
+.+..|+|.+||+.||++|.++.|+++|-|-+
T Consensus 1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred hHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 99999999999999999999999999998854
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=306.80 Aligned_cols=255 Identities=22% Similarity=0.394 Sum_probs=213.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E 455 (639)
++.+.+..||.|+.|.|++++.+.+|...|||.+.+........++...+.++.+.. .|+||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 445567889999999999999999999999999988776666667777888877665 8999999999999999999999
Q ss_pred eccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 456 LIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
.|. ..+..++.+ .+++++..+-.+...++.||.||.+ +||+|||+||+|||+|..| .+||||||++-.+...
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G----niKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG----NIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC----CEEeecccccceeeccc
Confidence 984 355555544 4679999999999999999999986 6899999999999999998 8999999999776543
Q ss_pred -CccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 533 -MFTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
.....|-+.|||||.+. ...|+.++||||||+.|+||.||+.||.....+.+ +...+++..+ ...+.....++.
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-~ltkvln~eP-P~L~~~~gFSp~ 324 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-VLTKVLNEEP-PLLPGHMGFSPD 324 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-HHHHHHhcCC-CCCCcccCcCHH
Confidence 34567889999999985 45799999999999999999999999987655444 4455555433 222223458999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+++++..||++|+.+||...++|+|||+.+
T Consensus 325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 999999999999999999999999999863
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.59 Aligned_cols=268 Identities=29% Similarity=0.477 Sum_probs=218.4
Q ss_pred cCCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-C-Cc----eeeeee
Q psy6820 369 LNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-H-PN----IIKLLD 442 (639)
Q Consensus 369 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-H-pn----Iv~l~~ 442 (639)
....+.+..+|.+++.+|+|.||.|..|.+..++..+|||+++.. ....+...-|+.+|.++. + |+ +|.+.+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 344556678999999999999999999999999999999998643 233455667999999994 2 33 888889
Q ss_pred eeecCCceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC--------
Q psy6820 443 EYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG-------- 512 (639)
Q Consensus 443 ~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g-------- 512 (639)
+|+-.++.|||+|.+ |-|+++++..+ .+++...++.|++|+++++++||+.+++|.||||+|||+....
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999998 77999999775 4699999999999999999999999999999999999984321
Q ss_pred --------ceeeeEEEeeccccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC-h
Q psy6820 513 --------CHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND-Q 583 (639)
Q Consensus 513 --------~~~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~-~ 583 (639)
.....+||+|||.|+.......+.+.|..|+|||++.+-+++..+||||+||||+|++||...|...++. +
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 0123689999999998888888899999999999999999999999999999999999999999765532 2
Q ss_pred HHHHHHHHcC------------------CCCCCCCCcc---------------------cccHHHHHHHHHhcccCCCCC
Q psy6820 584 DELFDDILSG------------------QYGFPSPYWD---------------------DISEEAKELISHMLESNPDLR 624 (639)
Q Consensus 584 ~~l~~~i~~~------------------~~~~p~~~~~---------------------~l~~~l~dLI~~~L~~dP~~R 624 (639)
-++.+.|+.. .+..+....+ .-..++.|||++||..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 2344444331 1111110000 012368899999999999999
Q ss_pred CCHHHHHcCCcccCC
Q psy6820 625 FSAEDVLDHPWLERS 639 (639)
Q Consensus 625 pta~eiL~HP~f~~~ 639 (639)
+|+.|+|.||||.++
T Consensus 398 iTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 398 ITLREALSHPFFARL 412 (415)
T ss_pred ccHHHHhcCHHhhcC
Confidence 999999999999864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.62 Aligned_cols=248 Identities=26% Similarity=0.370 Sum_probs=198.9
Q ss_pred CCeeEEEEEccCCceEEEEEEE----cCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec--CCce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYD----KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT--NNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 450 (639)
++|++.+.||+|+||.||.|.. ..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 4789999999999999999873 45688999999875432 234567899999999999999999997643 3568
Q ss_pred EEEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
++||||+++++|.+++.+. ..+++..+..++.+++.||+|||++|++||||||+||+++.++ .+||+|||++...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~----~~~l~dfg~~~~~ 158 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN----RVKIGDFGLTKVL 158 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC----eEEECCCcccccc
Confidence 9999999999999999754 4689999999999999999999999999999999999999887 7999999999865
Q ss_pred cCCCc------cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh--------------HHHHHH
Q psy6820 530 LRPMF------TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ--------------DELFDD 589 (639)
Q Consensus 530 ~~~~~------~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~--------------~~l~~~ 589 (639)
..... ...++..|+|||++.+..++.++|+||||+++|||++|..|+....... ..+. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 237 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI-E 237 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH-H
Confidence 43221 1123446999999998889999999999999999999887764322110 0111 1
Q ss_pred HHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 590 ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 590 i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+......++ ....++.++.+|+.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 238 LLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 122222222 22568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.93 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=208.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCC----eEEEEEEEccc--ccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKD----MDCALKIIDKS--KLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiKv~~~~--~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
++-.+.++||+|+||.||+|..+..+ ..||+|..... ........+.+|++++++++|||||++||++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34456699999999999999876542 23899998752 2233446678999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
++|||+|+||+|.++|++.+ .++..+...++.+.++||+|||++++|||||-..|+|++.++ .+||+|||+++..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~----~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG----VVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC----eEEeCccccccCC
Confidence 99999999999999999877 499999999999999999999999999999999999999887 7899999998765
Q ss_pred cCC--Cccc-cCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 530 LRP--MFTV-CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 530 ~~~--~~~~-~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
..- .... --...|+|||.+....|+.++|||||||++||+++ |..||.+.. ..++...|....+..+.+ ...
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~--~~~v~~kI~~~~~r~~~~--~~~ 388 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK--NYEVKAKIVKNGYRMPIP--SKT 388 (474)
T ss_pred cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC--HHHHHHHHHhcCccCCCC--CCC
Confidence 411 1111 23568999999999999999999999999999998 888996653 356667775655544443 478
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
|.++..++.+||..||+.||++.++.+
T Consensus 389 p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 389 PKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHHhccCChhhccCHHHHHH
Confidence 999999999999999999999988763
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=307.32 Aligned_cols=239 Identities=23% Similarity=0.294 Sum_probs=194.1
Q ss_pred EEEccCCceEEEEEEEcCCC----------eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 383 QIIGDGNFAVVRQVYDKHKD----------MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~----------~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
+.||+|+||.||+|....++ ..+++|++...... ...+.+|+.++++++||||+++++++.. +..++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 36899999999999988766 45788887654332 5677899999999999999999999988 78899
Q ss_pred EEeeccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCc---eeeeEEEeecccccc
Q psy6820 453 VIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC---HVKVLKVGDFGLAQR 528 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~---~~~~vKL~DFGla~~ 528 (639)
||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++. ....+||+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 999999999999998765 7899999999999999999999999999999999999987651 123699999999976
Q ss_pred ccCCCccccCCCcccCccccccC--CCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 529 VLRPMFTVCGTPTYVAPEILNES--GYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 529 ~~~~~~~~~GT~~Y~APE~l~~~--~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
... .....++..|+|||++.+. .++.++|+||||+++|+|++ |..||...... ....... .....+. ..
T Consensus 158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~-~~~~~~~----~~ 229 (259)
T cd05037 158 VLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQ-DQHRLPM----PD 229 (259)
T ss_pred ccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHh-cCCCCCC----CC
Confidence 544 2334577889999999876 78999999999999999999 68888654321 1111111 1112221 12
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
...+.++|.+||..+|.+|||+.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHH
Confidence 389999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.84 Aligned_cols=242 Identities=22% Similarity=0.316 Sum_probs=192.9
Q ss_pred EEEccCCceEEEEEEEcC------------CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 383 QIIGDGNFAVVRQVYDKH------------KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~------------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
+.||+|+||.||+|.... ....+++|++..... .....+.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 368999999999997432 234588898765432 2345677899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCc---eeeeEEEeecccc
Q psy6820 451 YLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC---HVKVLKVGDFGLA 526 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~---~~~~vKL~DFGla 526 (639)
+++|||+++++|..++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++. ....+|++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 999999999999988865 456899999999999999999999999999999999999986541 1124899999998
Q ss_pred ccccCCCccccCCCcccCccccc-cCCCChhhhHHHHHHHHHHHH-cCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 527 QRVLRPMFTVCGTPTYVAPEILN-ESGYGVKIDVWAAGVILYILL-CGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 527 ~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~~sDVwSLGvvL~eLl-tG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
..... .....++..|+|||.+. +..++.++|||||||++|||+ +|..||..... .+. ........... ..
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~-~~~~~~~~~~~----~~ 231 (262)
T cd05077 160 ITVLS-RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--AEK-ERFYEGQCMLV----TP 231 (262)
T ss_pred ccccC-cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--hHH-HHHHhcCccCC----CC
Confidence 65532 23456888999999886 567899999999999999997 68898854322 221 22223322222 23
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+.++.+||.+||+.||++||++.+|+++
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 46889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.90 Aligned_cols=244 Identities=25% Similarity=0.429 Sum_probs=199.5
Q ss_pred EEccCCceEEEEEEEcCCC------eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 384 IIGDGNFAVVRQVYDKHKD------MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 384 ~LG~G~fG~Vy~a~~~~~~------~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
.||+|+||.||+|...... +.+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 5899999999999876543 6899999876544444567889999999999999999999999999999999999
Q ss_pred cCCChHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC-ceeeeEEEeeccccccc
Q psy6820 458 KGGDLFDAISKN-------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG-CHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 458 ~ggsL~~~l~~~-------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g-~~~~~vKL~DFGla~~~ 529 (639)
++++|.+++... ..+++..+..++.+++.||+|||+.+++|+||||+||+++.++ .....++|+|||++...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~ 161 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence 999999999642 3478899999999999999999999999999999999998754 11236999999998755
Q ss_pred cCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc
Q psy6820 530 LRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 530 ~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||... ...+....+..+. ......
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~---~~~~~~ 236 (269)
T cd05044 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL--NNQEVLQHVTAGG---RLQKPE 236 (269)
T ss_pred ccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc--CHHHHHHHHhcCC---ccCCcc
Confidence 322 122345788999999999999999999999999999998 99999643 2334444443322 112235
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.++..+.++|.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 237 NCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 68899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=314.20 Aligned_cols=249 Identities=14% Similarity=0.162 Sum_probs=193.3
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCC---CeEEEEEEEcccccchhHH----------HHHHHHHHHHhcCCCceeee
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLGKKQ----------MIENEVNILRSVNHPNIIKL 440 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~~~~----------~~~~Ei~iL~~l~HpnIv~l 440 (639)
...++|.+.+.||+|+||.||+|....+ +..+|+|+..........+ ....+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3447899999999999999999998877 6677888754332111111 11233445566789999999
Q ss_pred eeeeecCC----ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceee
Q psy6820 441 LDEYDTNN----ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVK 516 (639)
Q Consensus 441 ~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~ 516 (639)
++++.... ..++++|++ ..++.+.+......++..+..++.|++.||+|||+++|+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~---- 163 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN---- 163 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----
Confidence 98765443 347888887 447777777666678899999999999999999999999999999999998876
Q ss_pred eEEEeeccccccccC----------CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChH--
Q psy6820 517 VLKVGDFGLAQRVLR----------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD-- 584 (639)
Q Consensus 517 ~vKL~DFGla~~~~~----------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~-- 584 (639)
.++|+|||+|+.... ......||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 799999999976531 12234699999999999999999999999999999999999999976533322
Q ss_pred -----HHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 585 -----ELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 585 -----~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+....+..+...+ ..+++++.++++.||..+|++||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1223333332222 356899999999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=311.09 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=204.4
Q ss_pred CCeeEEEEEccCCceEEEEEEEc----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec--CCce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDK----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT--NNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 450 (639)
+.|++.+.||+|+||.||+|... .+++.+|+|++.........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999864 34788999999866544345678899999999999999999999877 5679
Q ss_pred EEEEeeccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
+++|||+++++|.+++.... .+++..+..++.+++.||+|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED----LVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC----CEEEccccccccc
Confidence 99999999999999997654 699999999999999999999999999999999999999887 8999999999776
Q ss_pred cCCCc------cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh-------------HHHHHHH
Q psy6820 530 LRPMF------TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ-------------DELFDDI 590 (639)
Q Consensus 530 ~~~~~------~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~-------------~~l~~~i 590 (639)
..... ...++..|+|||.+.+..++.++|+||||+++|||++|..||....... ..+.+ .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 238 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-L 238 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH-H
Confidence 52211 1234567999999988889999999999999999999999986432221 11222 2
Q ss_pred HcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 591 LSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 591 ~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.......+. ...++.++.+|+.+||+.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 239 LKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222222222 2467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=311.72 Aligned_cols=242 Identities=20% Similarity=0.298 Sum_probs=194.2
Q ss_pred EEEccCCceEEEEEEEcCCCe-------EEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDM-------DCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~-------~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
+.||.|+||.||+|.....+. .+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 368999999999998765443 48888876443 2234567789999999999999999999999899999999
Q ss_pred eccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCc----eeeeEEEeecccccccc
Q psy6820 456 LIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC----HVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~----~~~~vKL~DFGla~~~~ 530 (639)
|+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++. ....++++|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 999999999997644 5899999999999999999999999999999999999987651 11247999999986554
Q ss_pred CCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcC-CCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 RPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCG-FPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 ~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG-~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
. .....+++.|+|||.+.+ ..++.++||||||+++|+|++| ..||..... .. ...+......+|. ..+.+
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--~~-~~~~~~~~~~~~~----~~~~~ 231 (258)
T cd05078 160 P-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--QK-KLQFYEDRHQLPA----PKWTE 231 (258)
T ss_pred C-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--HH-HHHHHHccccCCC----CCcHH
Confidence 3 334568899999999976 4579999999999999999998 466643321 11 1223333333443 45688
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+.+||.+||+.||++|||++++++.
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHh
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=354.49 Aligned_cols=257 Identities=28% Similarity=0.516 Sum_probs=210.8
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec------
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT------ 446 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------ 446 (639)
+....+|+..+.||+||||.||+|+.+-+|+.||||.+...........+.+|+..|.+|+|||||+++..|.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34567899999999999999999999999999999999876533344567899999999999999999954300
Q ss_pred ------------------------------------------------------------------------C-------
Q psy6820 447 ------------------------------------------------------------------------N------- 447 (639)
Q Consensus 447 ------------------------------------------------------------------------~------- 447 (639)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CceEEEEeeccCCChHHHHhhcCCC-CHHHHHHHHHHHHHHHHHHH
Q psy6820 448 ----------------------------------NELYLVIELIKGGDLFDAISKNVKF-SEEDSKFMTQSLASALSYLH 492 (639)
Q Consensus 448 ----------------------------------~~~~lV~E~~~ggsL~~~l~~~~~l-~~~~~~~i~~qI~~aL~yLH 492 (639)
-.+||-||||+..+|.+++.++... ....+++++++|++||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1368999999998888888776544 57889999999999999999
Q ss_pred HCCceeccCCCCceEEccCCceeeeEEEeecccccccc---------------------CCCccccCCCcccCccccccC
Q psy6820 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---------------------RPMFTVCGTPTYVAPEILNES 551 (639)
Q Consensus 493 ~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---------------------~~~~~~~GT~~Y~APE~l~~~ 551 (639)
+.|||||||||.||+++.++ .|||+|||+|+... ...+..+||.-|+|||++.+.
T Consensus 715 ~~giIHRDLKP~NIFLd~~~----~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRN----SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred hCceeeccCCcceeEEcCCC----CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99999999999999999887 89999999998721 023457899999999999765
Q ss_pred C---CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHH
Q psy6820 552 G---YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAE 628 (639)
Q Consensus 552 ~---~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~ 628 (639)
. |+.|+||||||++|+||+. ||.... +...+...+..+.+..+..++..--+.-..+|+.||+.||.+||||.
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH-HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 4 9999999999999999985 574322 34455566666665555444555667788999999999999999999
Q ss_pred HHHcCCccc
Q psy6820 629 DVLDHPWLE 637 (639)
Q Consensus 629 eiL~HP~f~ 637 (639)
|+|++.||.
T Consensus 867 eLL~s~llp 875 (1351)
T KOG1035|consen 867 ELLNSELLP 875 (1351)
T ss_pred HHhhccCCC
Confidence 999999986
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=304.05 Aligned_cols=244 Identities=21% Similarity=0.390 Sum_probs=202.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+.+.||+|+||.||++.... +..+|+|.+..... ..+.+.+|+.++++++|+||+++++.+.+ ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChh--HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4789999999999999999997554 45699998875432 24567889999999999999999999877 78899999
Q ss_pred eccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 456 LIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|+++++|.+++.+ ...+++..+..++.+++.||+|||+.|++|+||||+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~----~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC----cEEECCCcceeeccCCC
Confidence 9999999999975 34578889999999999999999999999999999999999887 89999999997654321
Q ss_pred c----cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 534 F----TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 534 ~----~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
. ...++..|+|||++....++.++|+|||||++|+|++ |..||... +...+...+..+. . .+.....+.+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~~-~--~~~~~~~~~~ 231 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRALERGY-R--MPRPENCPEE 231 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhCCC-C--CCCcccCCHH
Confidence 1 2234577999999998889999999999999999998 99999653 3334444444432 2 2233578899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+++.+||+++|++||++.++++
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHH
Confidence 999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=313.83 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=202.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCe----EEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDM----DCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
++|++.+.||+|+||.||+|.+..++. .+|+|.+...........+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 578899999999999999998876665 57889887654444445678899999999999999999998654 5679
Q ss_pred EEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
++||+++|+|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++ .+||+|||++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~----~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN----HVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC----ceEEccccccccccC
Confidence 99999999999998764 3689999999999999999999999999999999999998876 799999999976542
Q ss_pred C-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 532 P-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 532 ~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||... ........+..+ ..++. ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~-~~~~~--~~~~ 236 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--PTREIPDLLEKG-ERLPQ--PPIC 236 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHCC-CCCCC--CCCC
Confidence 2 122345778999999998999999999999999999997 99999543 233333333332 22222 2457
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+..+.+++.+||..+|++||+++++++.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=311.29 Aligned_cols=241 Identities=22% Similarity=0.290 Sum_probs=191.9
Q ss_pred EEccCCceEEEEEEEcC------------------------CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceee
Q psy6820 384 IIGDGNFAVVRQVYDKH------------------------KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439 (639)
Q Consensus 384 ~LG~G~fG~Vy~a~~~~------------------------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~ 439 (639)
.||+|+||.||+|.... ....+++|++..... .....+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 58999999999987421 124588898865432 22345678899999999999999
Q ss_pred eeeeeecCCceEEEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCc---ee
Q psy6820 440 LLDEYDTNNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC---HV 515 (639)
Q Consensus 440 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~---~~ 515 (639)
+++++.+.+..++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+. ..
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 99999999999999999999999999865 467899999999999999999999999999999999999986531 12
Q ss_pred eeEEEeeccccccccCCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHH-HcCCCCCCCCCCChHHHHHHHHcC
Q psy6820 516 KVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYIL-LCGFPPFVSDTNDQDELFDDILSG 593 (639)
Q Consensus 516 ~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eL-ltG~~Pf~~~~~~~~~l~~~i~~~ 593 (639)
..+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|..||....... .. .....
T Consensus 161 ~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~-~~~~~ 236 (274)
T cd05076 161 PFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--KE-RFYEK 236 (274)
T ss_pred ceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--HH-HHHHh
Confidence 35899999998654322 23457888999998865 5689999999999999998 47999996543322 21 22222
Q ss_pred CCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 594 QYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 594 ~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
....+ ...++++.++|.+||+.+|++||++.+++++
T Consensus 237 ~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 237 KHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred ccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22333 2346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=284.56 Aligned_cols=255 Identities=29% Similarity=0.480 Sum_probs=210.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.+|.-.++||+|.||+||+++.+++++.||+|.+...... +......+|+-+|+.++|.|||++++....++.+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 3566678999999999999999999999999998765432 334556799999999999999999999999999999999
Q ss_pred eccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC-
Q psy6820 456 LIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM- 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~- 533 (639)
|| ..+|..+... ++.++.+.++.++.|+++||.++|++++.|||+||+|+||+.+| .+||+|||+|+...-+.
T Consensus 82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng----elkladfglarafgipvr 156 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG----ELKLADFGLARAFGIPVR 156 (292)
T ss_pred Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC----cEEecccchhhhcCCceE
Confidence 99 4588888754 67899999999999999999999999999999999999999998 89999999998877554
Q ss_pred --ccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCC--------
Q psy6820 534 --FTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPY-------- 601 (639)
Q Consensus 534 --~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~-------- 601 (639)
...+-|.+|.+|.++-+ .-|+...|+||.||++.|+.. |++.|.+. +.++....|..-.-.+....
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~--dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC--cHHHHHHHHHHHhCCCccccCCccccCC
Confidence 23456999999999876 568999999999999999986 66767554 33333344432111111111
Q ss_pred -------------c----ccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 602 -------------W----DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 602 -------------~----~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
| +.++..-+||++++|.-+|.+|.+++++++||||.+
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 1 234567889999999999999999999999999976
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.65 Aligned_cols=248 Identities=32% Similarity=0.490 Sum_probs=204.6
Q ss_pred CeeEEEEEccCCceEEEEEEEcC-CCeEEEEEEEccccc---------chhHHHHHHHHHHHHh-cCCCceeeeeeeeec
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKH-KDMDCALKIIDKSKL---------LGKKQMIENEVNILRS-VNHPNIIKLLDEYDT 446 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiKv~~~~~~---------~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~ 446 (639)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ......+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999887 678899998864321 1112345678888765 689999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEe
Q psy6820 447 NNELYLVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVG 521 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~ 521 (639)
.+..+++|||+++++|.+++.. ...+++..++.++.+++.||.|||+ .|++|+||+|+||+++.++ .+||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~----~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD----KVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC----cEEEe
Confidence 9999999999999999988743 3568999999999999999999996 7899999999999999887 79999
Q ss_pred eccccccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy6820 522 DFGLAQRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599 (639)
Q Consensus 522 DFGla~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~ 599 (639)
|||++...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||... +.......+.........
T Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~ 234 (269)
T cd08528 157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST--NMLSLATKIVEAVYEPLP 234 (269)
T ss_pred cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc--CHHHHHHHHhhccCCcCC
Confidence 99999765433 23456899999999999888999999999999999999999999543 334444455444332211
Q ss_pred CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 600 PYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 600 ~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
...+++++.++|.+||+.||++||++.|+.++
T Consensus 235 --~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 --EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred --cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 23578999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.19 Aligned_cols=242 Identities=22% Similarity=0.298 Sum_probs=190.9
Q ss_pred EEccCCceEEEEEEEcCC--CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCC
Q psy6820 384 IIGDGNFAVVRQVYDKHK--DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGD 461 (639)
Q Consensus 384 ~LG~G~fG~Vy~a~~~~~--~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs 461 (639)
.||+|+||.||++..... ...+++|.+.........+.+.+|+.+++.++||||+++++.+.+....|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999865433 345677777655444445678899999999999999999999999999999999999999
Q ss_pred hHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-----C
Q psy6820 462 LFDAISKN----VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-----P 532 (639)
Q Consensus 462 L~~~l~~~----~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-----~ 532 (639)
|.+++.+. ..+++..+..++.||+.||+|||+.+++||||||+|||++.++ .+||+|||++..... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~----~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL----TVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc----cEEecccccccccCcchhhhc
Confidence 99999753 3466778889999999999999999999999999999999887 799999999864321 1
Q ss_pred CccccCCCcccCcccccc-------CCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcC-CCCCCCC-Cc
Q psy6820 533 MFTVCGTPTYVAPEILNE-------SGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSG-QYGFPSP-YW 602 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~-------~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~-~~~~p~~-~~ 602 (639)
....+|+..|+|||++.. ..++.++||||||+++|||++ |..||... ...+.+..+..+ ....+.+ ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL--SDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhhcccccCCCccC
Confidence 234568899999999753 245789999999999999996 57788543 233344443333 3332222 22
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
..+++.+.+++..|| .+|++||+++++++
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 457889999999999 67999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.00 Aligned_cols=246 Identities=22% Similarity=0.391 Sum_probs=199.4
Q ss_pred eeEEEEEccCCceEEEEEEEc---CCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNN------ 448 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 448 (639)
|.+.+.||+|+||.||+|... .++..+|+|++...... ...+.+.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667889999999999999864 35788999998764432 23456788999999999999999999875432
Q ss_pred ceEEEEeeccCCChHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEee
Q psy6820 449 ELYLVIELIKGGDLFDAISKN------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGD 522 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~D 522 (639)
..++++||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~----~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM----TVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC----CEEECc
Confidence 347899999999998887432 2478999999999999999999999999999999999998876 799999
Q ss_pred ccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 523 FGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 523 FGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
||++...... .....+++.|++||.+.+..++.++||||||+++|+|++ |.+||... +...+...+......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~ 234 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV--ENSEIYNYLIKGNRL 234 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC--CHHHHHHHHHcCCcC
Confidence 9999765322 123345678999999999889999999999999999999 89999643 344555555544321
Q ss_pred CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 597 ~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
. .....+..+.+++.+||+.+|++||++.+++++
T Consensus 235 ~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 K---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 124578999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.19 Aligned_cols=242 Identities=44% Similarity=0.772 Sum_probs=210.1
Q ss_pred CceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCChHHHHhh
Q psy6820 389 NFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISK 468 (639)
Q Consensus 389 ~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~ 468 (639)
+||.||+|....+++.+|+|++.........+.+.+|+..+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999989999999998765544357788999999999999999999999998999999999999999999987
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC--CCccccCCCcccCcc
Q psy6820 469 NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--PMFTVCGTPTYVAPE 546 (639)
Q Consensus 469 ~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~--~~~~~~GT~~Y~APE 546 (639)
...++...+..++.+++.++.+||+.+++|+||+|.||+++.++ .++|+|||.+..... ......++..|+|||
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG----HVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC----cEEEccccceeeeccccccccccCCcCCCCHH
Confidence 76689999999999999999999999999999999999999887 899999999987754 345567899999999
Q ss_pred ccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCC
Q psy6820 547 ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFS 626 (639)
Q Consensus 547 ~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpt 626 (639)
.+.+..++.++|+||||+++|+|++|..||... .+...+.+.+........ ..+..++.++.+++.+||..+|++||+
T Consensus 157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-DQLLELFKKIGKPKPPFP-PPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhccCCCCc-cccccCCHHHHHHHHHHccCCchhccC
Confidence 999888999999999999999999999999653 344555555554443332 222238899999999999999999999
Q ss_pred HHHHHcCCcc
Q psy6820 627 AEDVLDHPWL 636 (639)
Q Consensus 627 a~eiL~HP~f 636 (639)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=298.68 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=205.9
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcc-cccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC-------
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK-SKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN------- 447 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~-~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------- 447 (639)
...|.-..+||+|.||.||+|+.+.+++.||+|++-- ....+-.....+|+.+|..++|+|++.+++.|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3557777899999999999999999999999876532 22223334456899999999999999999987432
Q ss_pred -CceEEEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 448 -NELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 448 -~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
..+|+|+.+|+. +|+-+|... .+++..++..++.++..||.|+|+..|+|||+|++|+||+.+| .+||+|||+
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg----ilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG----ILKLADFGL 170 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc----eEEeecccc
Confidence 348999999976 999999664 6899999999999999999999999999999999999999998 999999999
Q ss_pred cccccCC-------CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC
Q psy6820 526 AQRVLRP-------MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597 (639)
Q Consensus 526 a~~~~~~-------~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~ 597 (639)
++..... ....+-|.+|++||.+.+ ..|+++.|||+.||++.||+||.+.|.++++.+.-.+-..+.+.+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~-- 248 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI-- 248 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC--
Confidence 9765422 123345999999998865 689999999999999999999999998766544332223333321
Q ss_pred CCCCccc-------------------------------ccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 598 PSPYWDD-------------------------------ISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 598 p~~~~~~-------------------------------l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+.|++ -++++.+|+.+||..||.+|++++++++|.||..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 1122221 1458889999999999999999999999999964
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=333.07 Aligned_cols=254 Identities=22% Similarity=0.269 Sum_probs=178.3
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCC----CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeee------
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHK----DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDE------ 443 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~------ 443 (639)
...++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .+...+| .++...+.++..++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 3457899999999999999999999988 89999998764321 1111111 1122222233222221
Q ss_pred eecCCceEEEEeeccCCChHHHHhhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q psy6820 444 YDTNNELYLVIELIKGGDLFDAISKNVK--------------------FSEEDSKFMTQSLASALSYLHDNYIVHRDIKP 503 (639)
Q Consensus 444 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp 503 (639)
......+++||||+.+++|.+++..... .....+..++.||+.||+|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 2456789999999999999999865321 12344668999999999999999999999999
Q ss_pred CceEEccCCceeeeEEEeeccccccccC----CCccccCCCcccCccccccC----------------------CCChhh
Q psy6820 504 ENLLVEMSGCHVKVLKVGDFGLAQRVLR----PMFTVCGTPTYVAPEILNES----------------------GYGVKI 557 (639)
Q Consensus 504 ~NILld~~g~~~~~vKL~DFGla~~~~~----~~~~~~GT~~Y~APE~l~~~----------------------~~s~~s 557 (639)
+|||++.+. ..+||+|||+|+.... .....+||+.|+|||.+... .++.++
T Consensus 284 ~NILl~~~~---~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 284 QNIIFSEGS---GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHEEEeCCC---CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999998642 2799999999975532 23456889999999976432 234567
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC-------CC----------CCcccccHHHHHHHHHhcccC
Q psy6820 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF-------PS----------PYWDDISEEAKELISHMLESN 620 (639)
Q Consensus 558 DVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~-------p~----------~~~~~l~~~l~dLI~~~L~~d 620 (639)
|||||||+||||+++..|+.. +.......+......+ +. ...+..+....+||.+||++|
T Consensus 361 DVwSlGviL~el~~~~~~~~~---~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDS---NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCch---HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 999999999999998776532 1222222221111100 00 011122345679999999999
Q ss_pred CCCCCCHHHHHcCCcccC
Q psy6820 621 PDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 621 P~~Rpta~eiL~HP~f~~ 638 (639)
|++|||+.|+|+||||++
T Consensus 438 P~kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 438 GRQRISAKAALAHPYFDR 455 (566)
T ss_pred cccCCCHHHHhCCcCcCC
Confidence 999999999999999975
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.70 Aligned_cols=247 Identities=29% Similarity=0.461 Sum_probs=200.8
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC------Cce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN------NEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~~ 450 (639)
.-|...+.||+|+||.||+++.+.+|+.+|||.+.........+..-+|+++|++++|||||++++.-++. +..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 34566788999999999999999999999999998876666667778999999999999999999976543 356
Q ss_pred EEEEeeccCCChHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 451 YLVIELIKGGDLFDAISK---NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~---~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
.++||||.||||+..+.+ ...+++.+.+.++.+++.||.|||++||+||||||.||++-........-||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 899999999999999965 34699999999999999999999999999999999999996654344578999999999
Q ss_pred cccC--CCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh---HHHHHHHHc---------
Q psy6820 528 RVLR--PMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ---DELFDDILS--------- 592 (639)
Q Consensus 528 ~~~~--~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~---~~l~~~i~~--------- 592 (639)
.... ......||+.|++||.+.. ..|+..+|.|||||++|+.+||..||.+..... +-.+..+..
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~ 252 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA 252 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence 8864 3567899999999999984 889999999999999999999999997654432 233333221
Q ss_pred -----CC----CCCCCCCccccc----HHHHHHHHHhcccCCCCCC
Q psy6820 593 -----GQ----YGFPSPYWDDIS----EEAKELISHMLESNPDLRF 625 (639)
Q Consensus 593 -----~~----~~~p~~~~~~l~----~~l~dLI~~~L~~dP~~Rp 625 (639)
+. ..+|. ...++ ..+...+..+|..+|++|.
T Consensus 253 ~~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 253 QEEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ecccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11 11111 12233 3455678889999999998
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=298.22 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=207.0
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEEEeec
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
..-+..||.|+||+|++-.++.+|+..|||.+..........++..|.+...+- +.||||++||.+..++..||.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 334677999999999999999999999999998877766667777888776666 4999999999999999999999999
Q ss_pred cCCChHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 458 KGGDLFDAIS-----KNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 458 ~ggsL~~~l~-----~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
..||..+.+ ++..++++..-.|+...+.||.||-. ..|||||+||+|||+|..| .+||||||++-.+..
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G----~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG----DVKLCDFGICGQLVD 220 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC----CEeeecccchHhHHH
Confidence 557755442 34679999999999999999999985 6899999999999999998 799999999976654
Q ss_pred CC--ccccCCCcccCccccc--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCC--cccc
Q psy6820 532 PM--FTVCGTPTYVAPEILN--ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY--WDDI 605 (639)
Q Consensus 532 ~~--~~~~GT~~Y~APE~l~--~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~--~~~l 605 (639)
.. ..-.|-..|||||.+. +.+|+.++||||||++|||+.||..|+..++.-.+ ....+..+.+..-... .-..
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe-ql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE-QLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH-HHHHHHcCCCCeecCccccccc
Confidence 32 2345778899999985 45699999999999999999999999977654222 2333444432221111 1237
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+..+..+|..||-+|-+.||...+++.+||++.
T Consensus 300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred CHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 899999999999999999999999999999863
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=320.77 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=215.3
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeee-----cCCc
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYD-----TNNE 449 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~-----~~~~ 449 (639)
.+.|++.+.||.|.+|.||+++.+.+++..|+|+....... .+.++.|.++|+... |||++.++|+|. .++.
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 35789999999999999999999999999999998765433 566788999999886 999999999884 4568
Q ss_pred eEEEEeeccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 450 LYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
+|||||||.|||..|+++. ..++.|+.+..|++.++.||.+||...++|||||-.|||+..++ .|||+|||.+.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~----~VKLvDFGvSa 171 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA----EVKLVDFGVSA 171 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC----cEEEeeeeeee
Confidence 9999999999999999964 56799999999999999999999999999999999999999998 89999999998
Q ss_pred cccC---CCccccCCCcccCcccccc-----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy6820 528 RVLR---PMFTVCGTPTYVAPEILNE-----SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599 (639)
Q Consensus 528 ~~~~---~~~~~~GT~~Y~APE~l~~-----~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~ 599 (639)
.... ...+..|||.|||||++.. ..|+.++|+||||++-.||.-|.+|+.+... .-.++....+..+ ..
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-mraLF~IpRNPPP--kL 248 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-MRALFLIPRNPPP--KL 248 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-hhhhccCCCCCCc--cc
Confidence 7753 3568899999999999854 3578899999999999999999999965432 2223222222111 11
Q ss_pred CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 600 PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 600 ~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..|...+.++.++|..||.+|-++||+..++|+|||+.+
T Consensus 249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 225677999999999999999999999999999999874
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=306.06 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=205.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+...++++||+|-||.|.+|.... +..||+|.++..........|..|+.+|.+|+||||++++|+|..++.+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 557789999999999999996544 7899999998877776678899999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-CC
Q psy6820 457 IKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-PM 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~--l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-~~ 533 (639)
+++|+|.+++.+... .......+|+.||+.||+||.+.++|||||.+.|+|++.+. ++||+|||+++..-. +.
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~----~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF----TIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc----cEEecCcccccccccCCc
Confidence 999999999987632 35566778999999999999999999999999999999887 899999999986543 22
Q ss_pred ccc----cCCCcccCccccccCCCChhhhHHHHHHHHHHH--HcCCCCCCCCCCChHHHHHHHHc---CCC-CCCCCCcc
Q psy6820 534 FTV----CGTPTYVAPEILNESGYGVKIDVWAAGVILYIL--LCGFPPFVSDTNDQDELFDDILS---GQY-GFPSPYWD 603 (639)
Q Consensus 534 ~~~----~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eL--ltG~~Pf~~~~~~~~~l~~~i~~---~~~-~~p~~~~~ 603 (639)
+.. +-..+|||||.+..+.++.++|+|+||+++||+ +|...||...+. +++.+.... ... ..-...+.
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HHHHHhhhhhcCCCCcceeccCCC
Confidence 322 236789999999999999999999999999986 578999965432 233222211 110 00112235
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
-+|.++.+||.+||..|-++||+++++..
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 68999999999999999999999999853
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=281.82 Aligned_cols=257 Identities=26% Similarity=0.476 Sum_probs=211.2
Q ss_pred CCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecC--
Q psy6820 371 IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTN-- 447 (639)
Q Consensus 371 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~-- 447 (639)
+.....++|++.+++|+|.++.||.|....+++.++||+++.. +...+.+|+.||..|+ ||||+.+++...++
T Consensus 32 i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred eeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 4445678999999999999999999999999999999999754 3567889999999998 99999999998765
Q ss_pred CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
....+|+||+.+.+...+.. .++.-+++.++.+++.||.|+|+.||+|||+||.|++||... ..++|+|+|+|.
T Consensus 108 ktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~---rkLrlIDWGLAE 181 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAE 181 (338)
T ss_pred cCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh---ceeeeeecchHh
Confidence 45789999998877665553 478889999999999999999999999999999999999775 579999999997
Q ss_pred cccCC--CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHH------------HHHc
Q psy6820 528 RVLRP--MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFD------------DILS 592 (639)
Q Consensus 528 ~~~~~--~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~------------~i~~ 592 (639)
.+-.. ....+.+..|-.||.+-. ..|+.+-|+|||||+|..|+..+.||-....+.+++.+ .+..
T Consensus 182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 66432 234456788899999865 56899999999999999999999999776655554322 2222
Q ss_pred CCCCCCCCC-----------cc---------cccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 593 GQYGFPSPY-----------WD---------DISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 593 ~~~~~p~~~-----------~~---------~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
-.+.+++.+ |. -+++++.||+.++|..|..+|+||.|++.||||.
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 222333221 11 1479999999999999999999999999999995
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=306.26 Aligned_cols=245 Identities=24% Similarity=0.440 Sum_probs=213.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
.+..+..+||-|.||.||.|.++.-.-.||||.++.+.+. .+.|..|+.+|+.++|||+|+|+|+|..+..+|||+||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 4566788999999999999999998889999999877654 57788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc
Q psy6820 457 IKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534 (639)
Q Consensus 457 ~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~ 534 (639)
|..|+|.++|.+.. .++.-...+|+.||..|++||..+++|||||...|+|+..+. .||++|||+++.+....+
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh----iVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH----IVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc----eEEeeccchhhhhcCCce
Confidence 99999999997653 377788899999999999999999999999999999999886 899999999998877665
Q ss_pred cc-cC---CCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 535 TV-CG---TPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 535 ~~-~G---T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
+. .| ...|.|||-+.-+.++.++|||+|||+|||+.| |-.||.+- +..+++..+..+ +.. .....||+.+
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--dlSqVY~LLEkg-yRM--~~PeGCPpkV 495 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYGLLEKG-YRM--DGPEGCPPKV 495 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--cHHHHHHHHhcc-ccc--cCCCCCCHHH
Confidence 43 34 457999999999999999999999999999988 88999654 455666666554 222 2236899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHc
Q psy6820 610 KELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
..|+++||++.|..||+++|+-+
T Consensus 496 YeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHHHH
Confidence 99999999999999999998853
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=304.37 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=215.2
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc--chhHH----HHHHHHHHHHhcCCCceeeeeeeee-cC
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL--LGKKQ----MIENEVNILRSVNHPNIIKLLDEYD-TN 447 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~--~~~~~----~~~~Ei~iL~~l~HpnIv~l~~~~~-~~ 447 (639)
+-++|-++.+||+|||+.||+|.+...++.||+|+-..... ..+++ ..-+|..|.+.|.||.||++|++|. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 44678899999999999999999999999999999654432 22222 2347999999999999999999985 56
Q ss_pred CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY--IVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~g--ivHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
+.+|-|+|||+|.+|..+|+....+++.+++.|+.||+.||.||.+.. |||-||||.|||+.... ....+||.|||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt-acGeIKITDFGL 619 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT-ACGEIKITDFGL 619 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc-ccceeEeeecch
Confidence 779999999999999999999999999999999999999999999865 99999999999996543 445899999999
Q ss_pred cccccCC----------CccccCCCcccCcccccc----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHH--H
Q psy6820 526 AQRVLRP----------MFTVCGTPTYVAPEILNE----SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFD--D 589 (639)
Q Consensus 526 a~~~~~~----------~~~~~GT~~Y~APE~l~~----~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~--~ 589 (639)
++.+... .....||.+|++||.+-- ...+.++||||.||++|..+.|+.||..+... .++++ .
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-QdILqeNT 698 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-QDILQENT 698 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-HHHHhhhc
Confidence 9877543 234678999999998742 24688999999999999999999999765433 33322 2
Q ss_pred HH-cCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 590 IL-SGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 590 i~-~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
|+ ..+..||.. +.++.+++++|++||++--+.|....++..||||.
T Consensus 699 IlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 699 ILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 22 334556553 67999999999999999999999999999999984
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=306.40 Aligned_cols=242 Identities=25% Similarity=0.426 Sum_probs=204.5
Q ss_pred eEEEEEccCCceEEEEEEEc----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 380 SVGQIIGDGNFAVVRQVYDK----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 380 ~i~~~LG~G~fG~Vy~a~~~----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
++.+.||.|.||.||.|... +..-.||||..+.+-...+.+.|.+|..+++.++||||++++|.|.+. ..|||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 44678999999999999653 334568999998877677788999999999999999999999999654 6899999
Q ss_pred eccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc
Q psy6820 456 LIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534 (639)
Q Consensus 456 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~ 534 (639)
.++-|.|..+|+.+ ..++......++.||+.||+|||+.++|||||...|||+.... -|||+|||+++......+
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~----CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ----CVKLADFGLSRYLEDDAY 546 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc----eeeecccchhhhccccch
Confidence 99999999999765 4699999999999999999999999999999999999999886 699999999998875533
Q ss_pred c--ccC--CCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 535 T--VCG--TPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 535 ~--~~G--T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
- ..| ...|||||-+.-..++.++|||.|||++||++. |..||.+-.+. +++-.+.+|. ..|.++.+|+.+
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs--DVI~~iEnGe---RlP~P~nCPp~L 621 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS--DVIGHIENGE---RLPCPPNCPPAL 621 (974)
T ss_pred hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc--ceEEEecCCC---CCCCCCCCChHH
Confidence 2 122 346999999999999999999999999999775 99999775543 2333344443 334457999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHH
Q psy6820 610 KELISHMLESNPDLRFSAEDVL 631 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL 631 (639)
..|+.+||..||.+||.+.+|.
T Consensus 622 YslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHH
Confidence 9999999999999999988765
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.67 Aligned_cols=248 Identities=24% Similarity=0.411 Sum_probs=216.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCC---eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
...+|.++||.|.||.||.|+.+..+ ..||||.++..........|..|+.||-+++||||++|.|+........||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34678999999999999999887654 469999999888777778899999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
+|||++|+|..+|.+ .+.|+..+...|++.|+.||.||-+.|+|||||...|||++.+- .+|++|||+++...+.
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL----vCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL----VCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce----EEEeccccceeecccC
Confidence 999999999999965 57899999999999999999999999999999999999999886 8999999999877543
Q ss_pred C---ccccC---CCcccCccccccCCCChhhhHHHHHHHHHHHH-cCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 533 M---FTVCG---TPTYVAPEILNESGYGVKIDVWAAGVILYILL-CGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 533 ~---~~~~G---T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLl-tG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
. ++..| ..+|.|||.+....++.++||||+|++|||.+ .|..||-..+ ..++++.|..+ +.+|+| .++
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--NQdVIkaIe~g-yRLPpP--mDC 859 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVIKAIEQG-YRLPPP--MDC 859 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc--hHHHHHHHHhc-cCCCCC--CCC
Confidence 3 22222 45799999999999999999999999999866 4999995443 35666777654 556655 589
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
|..+-.|+..||++|-.+||.++||+.+
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999999999998753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=309.41 Aligned_cols=257 Identities=23% Similarity=0.290 Sum_probs=189.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEc----------------CCCeEEEEEEEcccccchh-------------HHHHHHHH
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDK----------------HKDMDCALKIIDKSKLLGK-------------KQMIENEV 426 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~----------------~~~~~vAiKv~~~~~~~~~-------------~~~~~~Ei 426 (639)
.++|++.++||+|+||.||+|... ..++.||||.+........ .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 578999999999999999999642 2346799999865432111 12233477
Q ss_pred HHHHhcCCCce-----eeeeeeeec--------CCceEEEEeeccCCChHHHHhhc------------------------
Q psy6820 427 NILRSVNHPNI-----IKLLDEYDT--------NNELYLVIELIKGGDLFDAISKN------------------------ 469 (639)
Q Consensus 427 ~iL~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~------------------------ 469 (639)
.++.+++|.++ ++++++|.. .+..|+||||+++++|.+++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77778876554 667777643 35689999999999999988532
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--Ccc--ccCCCcccCc
Q psy6820 470 VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--MFT--VCGTPTYVAP 545 (639)
Q Consensus 470 ~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--~~~--~~GT~~Y~AP 545 (639)
..+++..++.++.+++.||+|||+.+|+||||||+|||++.++ .+||+|||++...... ... ..+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG----QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC----cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1235677889999999999999999999999999999999887 7999999999654322 112 2348899999
Q ss_pred cccccCC--------------------C--ChhhhHHHHHHHHHHHHcCCC-CCCCCCC---------ChHHHHHHHHcC
Q psy6820 546 EILNESG--------------------Y--GVKIDVWAAGVILYILLCGFP-PFVSDTN---------DQDELFDDILSG 593 (639)
Q Consensus 546 E~l~~~~--------------------~--s~~sDVwSLGvvL~eLltG~~-Pf~~~~~---------~~~~l~~~i~~~ 593 (639)
|.+.... | ..+.||||+||++|+|++|.. ||..... .....++.+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9885432 1 134799999999999999986 6642110 001112222233
Q ss_pred CCCCCCCCcccccHHHHHHHHHhcccCC---CCCCCHHHHHcCCcccC
Q psy6820 594 QYGFPSPYWDDISEEAKELISHMLESNP---DLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 ~~~~p~~~~~~l~~~l~dLI~~~L~~dP---~~Rpta~eiL~HP~f~~ 638 (639)
.+.+ +.++.+++.++||+.+||..+| .+|+|++|+|+||||..
T Consensus 460 ~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 3333 3467789999999999999876 78999999999999964
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=307.19 Aligned_cols=260 Identities=30% Similarity=0.448 Sum_probs=214.8
Q ss_pred CCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCC------Cceeeeeeee
Q psy6820 371 IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH------PNIIKLLDEY 444 (639)
Q Consensus 371 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~H------pnIv~l~~~~ 444 (639)
+.+.+-.+|.+....|+|-|++|..|.+...+..||||++.......+ .=..|++||++|+. -|+++|+..|
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K--tGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK--TGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh--hhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 445566789999999999999999999999999999999987654322 22479999999952 4899999999
Q ss_pred ecCCceEEEEeeccCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEe
Q psy6820 445 DTNNELYLVIELIKGGDLFDAISKNV---KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVG 521 (639)
Q Consensus 445 ~~~~~~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~ 521 (639)
...+++|||+|-+ ..+|.++|++.+ .|....++.|+.|+..||..|-..||+|.||||+|||++... ..+|||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k---~iLKLC 579 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK---NILKLC 579 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc---ceeeec
Confidence 9999999999998 459999998754 488999999999999999999999999999999999998765 489999
Q ss_pred eccccccccCC-CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy6820 522 DFGLAQRVLRP-MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600 (639)
Q Consensus 522 DFGla~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~ 600 (639)
|||.|...... ...+.-+..|.|||++.|.+|+...|+||.||+||||+||+..|.+.++++.--+..-+.| .+|..
T Consensus 580 DfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG--k~p~K 657 (752)
T KOG0670|consen 580 DFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG--KFPNK 657 (752)
T ss_pred cCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC--CCcHH
Confidence 99999877644 3345567789999999999999999999999999999999999999887664322221111 11110
Q ss_pred Cc--------------------------------------------------------ccccHHHHHHHHHhcccCCCCC
Q psy6820 601 YW--------------------------------------------------------DDISEEAKELISHMLESNPDLR 624 (639)
Q Consensus 601 ~~--------------------------------------------------------~~l~~~l~dLI~~~L~~dP~~R 624 (639)
.. ..+-.++++|+.+||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 00 0123468899999999999999
Q ss_pred CCHHHHHcCCcccC
Q psy6820 625 FSAEDVLDHPWLER 638 (639)
Q Consensus 625 pta~eiL~HP~f~~ 638 (639)
.|..++|.||||++
T Consensus 738 it~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 738 ITVNQALKHPFITE 751 (752)
T ss_pred CCHHHHhcCCcccC
Confidence 99999999999986
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=311.89 Aligned_cols=245 Identities=24% Similarity=0.405 Sum_probs=209.6
Q ss_pred CeeEEEEEccCCceEEEEEEEcCC---CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+.++.+.||+|+||.|++|.++.- ...||||.+...........|.+|+.+|.+|+|||+++|||+..+ ....|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 345568899999999999987643 356899999888777677889999999999999999999999877 6788999
Q ss_pred eeccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 455 ELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 455 E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
|++++|+|.+.|.+ ...|-......++.||+.||.||.++++|||||-..|+|+-... .|||||||+.+.+..
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr----tVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR----TVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc----eeeeecccceeccCCC
Confidence 99999999999976 35688999999999999999999999999999999999998764 899999999987764
Q ss_pred -CCccccC----CCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 532 -PMFTVCG----TPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 532 -~~~~~~G----T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
.++.+.+ ...|+|||.+....++.++|||++||+||||++ |+.||.+- ...++++.|-.++ .++.+ +.+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--~g~qIL~~iD~~e-rLpRP--k~c 340 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--RGIQILKNIDAGE-RLPRP--KYC 340 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--CHHHHHHhccccc-cCCCC--CCC
Confidence 3443333 456999999999999999999999999999998 89999664 3456666666443 33333 679
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++.+.++++.||..+|++|||+..|.+
T Consensus 341 sedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHH
Confidence 999999999999999999999988864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=334.09 Aligned_cols=243 Identities=22% Similarity=0.309 Sum_probs=189.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
..|...+.||+|+||.||+|....+++.||+|.+..... ....|+.++++++|||||+++++|.+.+..|+||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 346667899999999999999999999999999864332 123568899999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH---DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH---~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
+++|+|.++++. +++..+..++.+++.||+||| +.+|+||||||+||+++.++ ..++. ||.+..... .
T Consensus 765 ~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~----~~~~~-~~~~~~~~~-~ 835 (968)
T PLN00113 765 IEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD----EPHLR-LSLPGLLCT-D 835 (968)
T ss_pred CCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC----ceEEE-ecccccccc-C
Confidence 999999999963 889999999999999999999 66999999999999999776 44443 555433222 2
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHH---HHHHcC-------CCCC--CCCC
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF---DDILSG-------QYGF--PSPY 601 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~---~~i~~~-------~~~~--p~~~ 601 (639)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.........+. +..... .... ..+.
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 234689999999999999999999999999999999999999954322111111 111100 0000 0011
Q ss_pred cccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 602 ~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
......++.+++.+||+.||++|||++|+++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11223467889999999999999999999853
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.87 Aligned_cols=247 Identities=31% Similarity=0.456 Sum_probs=195.2
Q ss_pred eeEEEEEccCCceE-EEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEEee
Q psy6820 379 YSVGQIIGDGNFAV-VRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 379 y~i~~~LG~G~fG~-Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
|.-.+++|.|+-|+ ||+|.. .++.||||.+-.+ -.....+|+..|+..+ |||||++++.-.+....||..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 44456789999985 577754 4669999987432 2346679999999986 99999999999999999999999
Q ss_pred ccCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC-ceeeeEEEeeccccccccC
Q psy6820 457 IKGGDLFDAISKNV----KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG-CHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 457 ~~ggsL~~~l~~~~----~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g-~~~~~vKL~DFGla~~~~~ 531 (639)
|. .+|.+++.... .......+.+..|++.||++||+.+||||||||+||||.... .....++|+|||+++....
T Consensus 585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 95 59999997631 112245678899999999999999999999999999998742 2235899999999988753
Q ss_pred C------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcC-CCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 532 P------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCG-FPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 532 ~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG-~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
. ..+..||-+|+|||++....-+.++|||||||++|+.++| .+||.....- ...|+.+...+..-. +.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R----~~NIl~~~~~L~~L~-~~ 738 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER----QANILTGNYTLVHLE-PL 738 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh----hhhhhcCccceeeec-cC
Confidence 2 3456799999999999988888899999999999998886 9999654322 224555554332210 11
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
-..++.|||.+|+.+||..||+|.++|.||||=
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 112999999999999999999999999999983
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=284.60 Aligned_cols=266 Identities=27% Similarity=0.467 Sum_probs=204.1
Q ss_pred cCCCcccC-CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-----C---Cceee
Q psy6820 369 LNIPSKLL-QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-----H---PNIIK 439 (639)
Q Consensus 369 ~~~~~~~~-~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-----H---pnIv~ 439 (639)
..+.+..- .+|.+.++||-|.|++||+|.+..+.+.||+|+.+... ...+....||.+|++++ | .+||+
T Consensus 69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 34444454 78999999999999999999999999999999997543 22455678999999985 2 36999
Q ss_pred eeeeeecC----CceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccC-
Q psy6820 440 LLDEYDTN----NELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMS- 511 (639)
Q Consensus 440 l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~- 511 (639)
|++.|... .++|||+|++ |.+|..+|.+. +.++...++.|++||+.||.|||. .||||.||||+|||+..+
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e 225 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTE 225 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccc
Confidence 99999644 5799999999 77999999764 569999999999999999999996 689999999999996211
Q ss_pred --------------------------------------------------------------------------------
Q psy6820 512 -------------------------------------------------------------------------------- 511 (639)
Q Consensus 512 -------------------------------------------------------------------------------- 511 (639)
T Consensus 226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~ 305 (590)
T KOG1290|consen 226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN 305 (590)
T ss_pred cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence
Q ss_pred -----Cc-------------------------------------------------------------------------
Q psy6820 512 -----GC------------------------------------------------------------------------- 513 (639)
Q Consensus 512 -----g~------------------------------------------------------------------------- 513 (639)
+.
T Consensus 306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~ 385 (590)
T KOG1290|consen 306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP 385 (590)
T ss_pred ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence 00
Q ss_pred ---eeeeEEEeeccccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC----hHHH
Q psy6820 514 ---HVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND----QDEL 586 (639)
Q Consensus 514 ---~~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~----~~~l 586 (639)
....+||+|||-|+......+.-..|..|+|||++.+.+|+..+||||++|++|||+||...|...+.+ .++-
T Consensus 386 ~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 386 LPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred CCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 001356677777766555555556788999999999999999999999999999999999999654321 1111
Q ss_pred HHHHHcCCCCCCC-------------------------CCcc-------------cccHHHHHHHHHhcccCCCCCCCHH
Q psy6820 587 FDDILSGQYGFPS-------------------------PYWD-------------DISEEAKELISHMLESNPDLRFSAE 628 (639)
Q Consensus 587 ~~~i~~~~~~~p~-------------------------~~~~-------------~l~~~l~dLI~~~L~~dP~~Rpta~ 628 (639)
+..|..-...+|. .+|+ .-..++.++|.-||+.+|++||||+
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 1111110001110 1121 1245788999999999999999999
Q ss_pred HHHcCCccc
Q psy6820 629 DVLDHPWLE 637 (639)
Q Consensus 629 eiL~HP~f~ 637 (639)
++|+|||+.
T Consensus 546 ~cl~hPwLn 554 (590)
T KOG1290|consen 546 QCLKHPWLN 554 (590)
T ss_pred HHhcCcccc
Confidence 999999996
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=301.73 Aligned_cols=254 Identities=25% Similarity=0.477 Sum_probs=211.2
Q ss_pred ccCCCcccCCCeeEEEEEccCCceEEEEEEEcC-------CCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceee
Q psy6820 368 NLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKH-------KDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIK 439 (639)
Q Consensus 368 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~ 439 (639)
.|+++... ..+.+.||+|.||.|++|.... ....||+|.++........+.+..|+.+|+.+. ||||+.
T Consensus 290 ~~e~~~~~---l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 290 KWEIPREN---LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred ceeechhh---ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhh
Confidence 45555443 3566699999999999986431 256799999988777767788999999999996 999999
Q ss_pred eeeeeecCCceEEEEeeccCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q psy6820 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNV----------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKP 503 (639)
Q Consensus 440 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp 503 (639)
++|+|...+.+++|+||+..|+|.+++.+.+ .++..+...++.||+.|++||++.++|||||-.
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa 446 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA 446 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence 9999999999999999999999999997665 388899999999999999999999999999999
Q ss_pred CceEEccCCceeeeEEEeeccccccccCCC-cccc---C--CCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCC
Q psy6820 504 ENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-FTVC---G--TPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPF 576 (639)
Q Consensus 504 ~NILld~~g~~~~~vKL~DFGla~~~~~~~-~~~~---G--T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf 576 (639)
.|||+..+. .+||+|||+|+...... +... | ...|||||.+....|+.++||||||++||||++ |..||
T Consensus 447 RNVLi~~~~----~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 447 RNVLITKNK----VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hhEEecCCC----EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 999999886 89999999998655432 2212 2 235999999999999999999999999999998 88999
Q ss_pred CCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 577 VSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 577 ~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+-. ...++++.+..|.. ... +..+++++.++++.||+.+|++||++.++.+
T Consensus 523 p~~~-~~~~l~~~l~~G~r-~~~--P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 523 PGIP-PTEELLEFLKEGNR-MEQ--PEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCC-cHHHHHHHHhcCCC-CCC--CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 6532 24555666666543 222 2567999999999999999999999998864
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=275.48 Aligned_cols=252 Identities=29% Similarity=0.500 Sum_probs=201.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC------C
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTN------N 448 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~ 448 (639)
..+|.-++.+|.|.- .|..+.+.-.++.||+|.+...... .......+|...+..+.|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 467888889999998 7778888888999999987654221 1224567899999999999999999988433 3
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
..|+|||+| ..+|...+. -.++-+.+.++..|+++|+.|||+.||+||||||+||++..++ .+||.|||+|..
T Consensus 95 e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~----~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC----TLKILDFGLART 167 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh----heeeccchhhcc
Confidence 579999999 569998887 4578899999999999999999999999999999999999887 899999999976
Q ss_pred ccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc--------------
Q psy6820 529 VLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS-------------- 592 (639)
Q Consensus 529 ~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~-------------- 592 (639)
.... +..++.|..|.|||++.+..|.+.+||||+||++.||++|...|.+.+. -+.+..+..
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~--idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH--IDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH--HHHHHHHHHHhcCCCHHHHHHhh
Confidence 6543 4567889999999999998899999999999999999999999975432 111111100
Q ss_pred --------C---------CCCCCCCCcc-------cccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 593 --------G---------QYGFPSPYWD-------DISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 593 --------~---------~~~~p~~~~~-------~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
. .-.+|...|. .-...+++|+.+||..||++|.+++++|.||||+
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 0011221121 1245689999999999999999999999999985
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=274.99 Aligned_cols=245 Identities=26% Similarity=0.405 Sum_probs=190.9
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHH--hcCCCceeeeeeeeecC----C
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILR--SVNHPNIIKLLDEYDTN----N 448 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~--~l~HpnIv~l~~~~~~~----~ 448 (639)
+.++..+.+.||+|.||.||+|.++ |+.||||++.... ++...+|.+|.+ .|+|+||+.+++.-..+ .
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 3467788999999999999998665 5589999997543 344455555554 56999999999875433 3
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-----CC---ceeccCCCCceEEccCCceeeeEEE
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-----NY---IVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-----~g---ivHrDLKp~NILld~~g~~~~~vKL 520 (639)
++|||++|.+.|||+|+|++ ..++.+...+++..++.||+|||. +| |.|||||..||||..++ ..-|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~----~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC----cEEE
Confidence 68999999999999999988 578999999999999999999995 23 99999999999999998 8999
Q ss_pred eeccccccccC-------CCccccCCCcccCccccccCC------CChhhhHHHHHHHHHHHHcC----------CCCCC
Q psy6820 521 GDFGLAQRVLR-------PMFTVCGTPTYVAPEILNESG------YGVKIDVWAAGVILYILLCG----------FPPFV 577 (639)
Q Consensus 521 ~DFGla~~~~~-------~~~~~~GT~~Y~APE~l~~~~------~s~~sDVwSLGvvL~eLltG----------~~Pf~ 577 (639)
+|+|+|..... +....+||.+|||||++.+.- --..+||||||+++||++.. ++||+
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 99999976543 345678999999999996542 13479999999999999853 67886
Q ss_pred C---CCCChHHHHHHHHcCCCCCCCC-Ccccc--cHHHHHHHHHhcccCCCCCCCHHHH
Q psy6820 578 S---DTNDQDELFDDILSGQYGFPSP-YWDDI--SEEAKELISHMLESNPDLRFSAEDV 630 (639)
Q Consensus 578 ~---~~~~~~~l~~~i~~~~~~~p~~-~~~~l--~~~l~dLI~~~L~~dP~~Rpta~ei 630 (639)
. .++..+++.+-+.-..+.++.+ .|... -..+-.||+.||..+|.-|.||--|
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 4 3445566655554444443332 34332 2456788999999999999987544
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=270.60 Aligned_cols=259 Identities=33% Similarity=0.489 Sum_probs=206.0
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccc-ccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKS-KLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN----- 448 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 448 (639)
...+..-.+.||.|+||.||.+.+..+++.||+|.+... ........+-+|+.+|...+|.|++..++..+-..
T Consensus 51 qq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 51 QQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred ccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 334455678999999999999999999999999887432 22223455678999999999999999988765442
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
.+|+++|.| ..+|..+|-.-..++...++-++.||++||.|||+.||.||||||.|+|++.|. .+||||||+|+.
T Consensus 131 EiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC----vLKICDFGLARv 205 (449)
T KOG0664|consen 131 ELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC----ILKICDFGLART 205 (449)
T ss_pred HHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc----eEEecccccccc
Confidence 578999999 459999998888899999999999999999999999999999999999999987 899999999986
Q ss_pred ccC----CCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChH-HH----------------
Q psy6820 529 VLR----PMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD-EL---------------- 586 (639)
Q Consensus 529 ~~~----~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~-~l---------------- 586 (639)
... .+...+-|..|.|||++++ ..|+.++||||.||++.||+..+..|...+.-+. ++
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 642 3445567889999999987 4689999999999999999999999965543221 11
Q ss_pred ----HHHHHcCCCCCCCC---C----cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 587 ----FDDILSGQYGFPSP---Y----WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 587 ----~~~i~~~~~~~p~~---~----~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...++.+....|.. | ...-..+..+++..+|..||++|.+.++.+.|+|+.+
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 11122232222211 0 0123457889999999999999999999999999876
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=278.03 Aligned_cols=242 Identities=27% Similarity=0.393 Sum_probs=189.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc--CCCceeeeeeeeecCC----ce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV--NHPNIIKLLDEYDTNN----EL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~~~~~~~~----~~ 450 (639)
....+.++||+|.||.||+|... ++.||||++... ..+.+.+|-+|.+.. +|+||+++++.-+... .+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 44566789999999999998655 479999999754 356677777777664 6999999999866555 89
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCceEEccCCceeeeEEEe
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN---------YIVHRDIKPENLLVEMSGCHVKVLKVG 521 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~---------givHrDLKp~NILld~~g~~~~~vKL~ 521 (639)
+||+||.+.|+|.++|+.+ .+++....+++.-+++||+|||+. .|+|||||..||||..|. +..|+
T Consensus 284 wLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl----TccIa 358 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL----TCCIA 358 (534)
T ss_pred eEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC----cEEee
Confidence 9999999999999999765 689999999999999999999962 399999999999999998 89999
Q ss_pred eccccccccC-----CCccccCCCcccCccccccCC-C-----ChhhhHHHHHHHHHHHHcCC------------CCCC-
Q psy6820 522 DFGLAQRVLR-----PMFTVCGTPTYVAPEILNESG-Y-----GVKIDVWAAGVILYILLCGF------------PPFV- 577 (639)
Q Consensus 522 DFGla~~~~~-----~~~~~~GT~~Y~APE~l~~~~-~-----s~~sDVwSLGvvL~eLltG~------------~Pf~- 577 (639)
|||+|..+.. +....+||.+|||||++.+.- + -.+.||||+|.+||||++.. +||+
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 9999987752 233478999999999997642 2 24799999999999999753 3343
Q ss_pred --CCCCChHHHHHHHHcCC--CCCCCCCcc-cccHHHHHHHHHhcccCCCCCCCHHH
Q psy6820 578 --SDTNDQDELFDDILSGQ--YGFPSPYWD-DISEEAKELISHMLESNPDLRFSAED 629 (639)
Q Consensus 578 --~~~~~~~~l~~~i~~~~--~~~p~~~~~-~l~~~l~dLI~~~L~~dP~~Rpta~e 629 (639)
+.....+++.+.+.... +.+|..... .-...+++.+..||+.||+.|+||.=
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 22233455555555443 333332111 12457889999999999999999853
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=286.20 Aligned_cols=197 Identities=35% Similarity=0.614 Sum_probs=179.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHH-------HHHHHHHHHhcC---CCceeeeeeeeec
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM-------IENEVNILRSVN---HPNIIKLLDEYDT 446 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~-------~~~Ei~iL~~l~---HpnIv~l~~~~~~ 446 (639)
..|+..+.+|.|+||.|++|.++.+...|+||.+.++.+..+... +--|++||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 469999999999999999999999999999999988776544322 345999999997 9999999999999
Q ss_pred CCceEEEEeec-cCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 447 NNELYLVIELI-KGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 447 ~~~~~lV~E~~-~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
++++||+||-. +|.+|+++|.....+++.++..|++|++.|+++||+.||||||||-+|+.++.+| -+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g----~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG----FVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC----eEEEeeccc
Confidence 99999999965 5779999999999999999999999999999999999999999999999999999 799999999
Q ss_pred ccccc-CCCccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCC
Q psy6820 526 AQRVL-RPMFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFV 577 (639)
Q Consensus 526 a~~~~-~~~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~ 577 (639)
|.... .+...+.||..|.|||++.+..| +..-|||+||++||-++....||+
T Consensus 717 aa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 97765 57788999999999999998877 778999999999999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=245.78 Aligned_cols=209 Identities=41% Similarity=0.708 Sum_probs=189.2
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCChHH
Q psy6820 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFD 464 (639)
Q Consensus 385 LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ 464 (639)
||+|++|.||++....+++.+++|++.........+.+.+|+..++.++|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999876543334678899999999999999999999999999999999999899999
Q ss_pred HHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEcc-CCceeeeEEEeeccccccccCC---CccccCC
Q psy6820 465 AISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM-SGCHVKVLKVGDFGLAQRVLRP---MFTVCGT 539 (639)
Q Consensus 465 ~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~-~g~~~~~vKL~DFGla~~~~~~---~~~~~GT 539 (639)
++... ..++...+..++.+++.+|++||+.|++|+||+|.||+++. ++ .++|+|||.+...... .....+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG----KVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC----cEEEecCCceEEccCCcchhhcccCC
Confidence 99765 57899999999999999999999999999999999999998 55 7999999999876554 3456688
Q ss_pred CcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcc
Q psy6820 540 PTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLE 618 (639)
Q Consensus 540 ~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~ 618 (639)
..|++||.+... .++.++|+|+||+++++| ..+.+++.+||+
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhh
Confidence 999999999877 889999999999999999 688899999999
Q ss_pred cCCCCCCCHHHHHcCC
Q psy6820 619 SNPDLRFSAEDVLDHP 634 (639)
Q Consensus 619 ~dP~~Rpta~eiL~HP 634 (639)
.||++||++.+++.|+
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 9999999999999886
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=291.69 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=217.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+...+|.|++|.||+++++.+++..|+|+++...-. .-..+.+|+-+++.++||||+.+++.|-..+.+|+.||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 46899999999999999999999999999999999865432 23456789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---C
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---P 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~ 532 (639)
||.||+|.+.-+-.+++++.++..++++.++||+|||+.|-+|||||-.|||+.+.| .+|++|||.+..+.. .
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g----DvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG----DVKLADFGVSAQITATIAK 168 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC----ceeecccCchhhhhhhhhh
Confidence 999999999998889999999999999999999999999999999999999999988 799999999977653 3
Q ss_pred CccccCCCcccCcccc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC-CCcccccHH
Q psy6820 533 MFTVCGTPTYVAPEIL---NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS-PYWDDISEE 608 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l---~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~-~~~~~l~~~ 608 (639)
...+.|||.|||||+. ..++|...+|+|++|+.-.|+---++|..... ............+..|. ......++.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--pmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--PMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--hHHHHHHhhccCCCCCcccCCccchHH
Confidence 4578899999999986 46789999999999999999988888864332 22222222223333332 222346889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+-++++.+|.++|++||+++.+|.|||+..
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 999999999999999999999999999865
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=284.25 Aligned_cols=243 Identities=23% Similarity=0.346 Sum_probs=206.1
Q ss_pred eeEEEEEccCCceEEEEEEEcCC----CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHK----DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~----~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.+.+++||.|+||+||+|.+--. +.+||+|++.......+...+..|+-+|.+++|||+++|+++|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34478999999999999977544 45689999988877777788899999999999999999999998765 88999
Q ss_pred eeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 455 ELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 455 E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
+|+++|+|.++++.. ..+..+....|..||++||.|||.++++||||-..||||.... ++||.|||+|+......
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~----hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN----HVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC----eEEEEecchhhccCccc
Confidence 999999999999764 5788999999999999999999999999999999999999887 89999999998765332
Q ss_pred c---cccC--CCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 534 F---TVCG--TPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 534 ~---~~~G--T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
. ...| .+.|||-|.+....|+.++|||||||++||++| |..|+.+. ..+++-+.+..++- ++.| +.++-
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi--~~~eI~dlle~geR-LsqP--piCti 927 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI--PAEEIPDLLEKGER-LSQP--PICTI 927 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC--CHHHhhHHHhcccc-CCCC--CCccH
Confidence 2 1222 456999999999999999999999999999988 99999654 34555555555543 4433 67899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVL 631 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL 631 (639)
++..++.+||..|+..||+++++.
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHH
Confidence 999999999999999999998875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-29 Score=246.16 Aligned_cols=212 Identities=42% Similarity=0.712 Sum_probs=187.7
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeecc
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIK 458 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 458 (639)
|.+.+.||.|++|.||++....+++.+|+|.+...........+.+|+..++.++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56789999999999999999988899999999866543245678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC----
Q psy6820 459 GGDLFDAISKNVK-FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM---- 533 (639)
Q Consensus 459 ggsL~~~l~~~~~-l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~---- 533 (639)
+++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++ .++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~----~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG----LVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEeeCceeeEecCcccccc
Confidence 9999999987766 89999999999999999999999999999999999999886 89999999998776543
Q ss_pred ccccCCCcccCcccc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC
Q psy6820 534 FTVCGTPTYVAPEIL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ 594 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l-~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~ 594 (639)
....++..|++||.+ ....++.++|+|+||+++++|++|+.||....++...+.+.+..+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 456788999999998 6777888999999999999999999999653456667777777765
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=271.63 Aligned_cols=256 Identities=34% Similarity=0.489 Sum_probs=205.1
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcC---CCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCc
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKH---KDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNE 449 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 449 (639)
.+.+.|.++++||+|+|++||++.+.. .++.||+|.+..... ..++.+|+++|..+. +.||+++.+++..++.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 445779999999999999999998877 788999999876543 466889999999997 9999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
..+||||++..+-.++... ++...+++++++++.||+++|.+|||||||||+|+|.+... ..-.|+|||+|...
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t---~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT---QRGVLVDFGLAQRY 183 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccccc---CCceEEechhHHHH
Confidence 9999999999888877754 67899999999999999999999999999999999998765 36789999999621
Q ss_pred c-----------------C----------------C--------------CccccCCCcccCcccccc-CCCChhhhHHH
Q psy6820 530 L-----------------R----------------P--------------MFTVCGTPTYVAPEILNE-SGYGVKIDVWA 561 (639)
Q Consensus 530 ~-----------------~----------------~--------------~~~~~GT~~Y~APE~l~~-~~~s~~sDVwS 561 (639)
. . + .....||++|.|||++.. ..-+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 0 0 0 012358999999999864 55688999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCChHHHHHHH-------------HcCC---------------------------CC-----
Q psy6820 562 AGVILYILLCGFPPFVSDTNDQDELFDDI-------------LSGQ---------------------------YG----- 596 (639)
Q Consensus 562 LGvvL~eLltG~~Pf~~~~~~~~~l~~~i-------------~~~~---------------------------~~----- 596 (639)
-||++.-+++++.||.....+.+.+.+.. ..+. ..
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 99999999999999965444333222111 0011 00
Q ss_pred CCCCCc-ccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 597 FPSPYW-DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 597 ~p~~~~-~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.....| +..+..+.+|+++||+.||.+|.||+++|.||||.+
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 000111 224568999999999999999999999999999964
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=241.88 Aligned_cols=208 Identities=24% Similarity=0.394 Sum_probs=174.7
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEEeecc
Q psy6820 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVIELIK 458 (639)
Q Consensus 380 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 458 (639)
..+..||+|++|.|-+.++..+|+..|+|.+...........+..|+.+..+.. .|.+|.++|.+.++...||.||.|
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M- 127 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM- 127 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-
Confidence 346779999999999999999999999999987665555566778888877764 999999999999999999999999
Q ss_pred CCChHHH----HhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 459 GGDLFDA----ISKNVKFSEEDSKFMTQSLASALSYLHDN-YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 459 ggsL~~~----l~~~~~l~~~~~~~i~~qI~~aL~yLH~~-givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
..||..+ +.+.+..++..+-+|+..++.||.|||++ .+||||+||+||||+.+| .||+||||++-.+.+..
T Consensus 128 ~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G----qVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 128 DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG----QVKICDFGISGYLVDSI 203 (282)
T ss_pred hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC----cEEEcccccceeehhhh
Confidence 4577544 45677899999999999999999999974 799999999999999999 89999999997765543
Q ss_pred c-c-ccCCCcccCccccc----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc
Q psy6820 534 F-T-VCGTPTYVAPEILN----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS 592 (639)
Q Consensus 534 ~-~-~~GT~~Y~APE~l~----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~ 592 (639)
. + -.|-..|||||.+. ...|+.++||||||+.+.||.+++.||..+....+++.+-+..
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 2 2 35777899999874 4479999999999999999999999998776655555444433
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=248.92 Aligned_cols=255 Identities=23% Similarity=0.379 Sum_probs=199.4
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeee-eeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLD-EYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~-~~~~~~~~~l 452 (639)
+.+.|.|.+.||+|.||.+.+|+++.+++.+++|.+.+... ....|.+|...--.|. |.||+.-|+ .|++.+.+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 45789999999999999999999999999999999987643 3566788887766665 899998776 5788899999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
+|||++.|+|.+-+... .+.+.....++.|++.|+.|+|++++||||||.+||||-.... ..+||||||+.......
T Consensus 100 ~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df--~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF--YRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc--cEEEeeecccccccCce
Confidence 99999999999888654 4788899999999999999999999999999999999954432 37999999999776554
Q ss_pred CccccCCCcccCccccccC-----CCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh--HHHHHHHHcC-CCCCCCCCccc
Q psy6820 533 MFTVCGTPTYVAPEILNES-----GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ--DELFDDILSG-QYGFPSPYWDD 604 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~-----~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~--~~l~~~i~~~-~~~~p~~~~~~ 604 (639)
.....-+..|.+||..... ..++.+|+|.||+++|..+||.+||....-+. ..-+.....+ ....|. ....
T Consensus 177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~-~F~~ 255 (378)
T KOG1345|consen 177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK-KFNP 255 (378)
T ss_pred ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch-hhcc
Confidence 4444456789999986432 34789999999999999999999997432221 1122333333 223332 3356
Q ss_pred ccHHHHHHHHHhcccCCCCC---CCHHHHHcCCc
Q psy6820 605 ISEEAKELISHMLESNPDLR---FSAEDVLDHPW 635 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~R---pta~eiL~HP~ 635 (639)
+++.+..+.++-|..+|++| -++......-|
T Consensus 256 fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 256 FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 78999999999999999999 34444433333
|
|
| >smart00537 DCX Domain in the Doublecortin (DCX) gene product | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=212.79 Aligned_cols=88 Identities=53% Similarity=0.972 Sum_probs=81.8
Q ss_pred ccCceEEEEEecCCCCCCcEEEEECCccccCHHHHHHHHHHHHhhcCCCcccceEeecCCCceeccccccccCCeEEEec
Q psy6820 97 SRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDGQKVTNIDELEDGKFYICSS 176 (639)
Q Consensus 97 ~~~~k~v~~~rNgd~~~~g~~~~v~~~~~~~~~~ll~~~t~~l~~~~~l~~~vr~~~t~~g~~v~~l~~l~~g~~yv~~~ 176 (639)
.++||+|+||||||+||+|++++||+++++|||+||++||+++. +.+|+|||+|||++|++|++++||+||+.|||||
T Consensus 2 ~~k~k~i~~~rNGD~~~~g~~~~v~~~~~~s~d~lL~~lt~~v~--l~~~~~Vr~lyt~~G~~v~~l~~l~~g~~yVa~g 79 (89)
T smart00537 2 LVKPKRIRFYRNGDRFFKGVRLVVNRKRFKSFEALLQDLTEVVK--LDLPHGVRKLYTLDGKKVTSLDELEDGGSYVASG 79 (89)
T ss_pred CccceEEEEEeCCCCCCCCEEEEEChhhcCCHHHHHHHHhhhcc--cCCCCCeeEEEcCCCCEECCHHHhCcCCEEEEEc
Confidence 46999999999999999999999999999999999999999533 3477789999999999999999999999999999
Q ss_pred CCCcccccccc
Q psy6820 177 SGDQFKKVDYA 187 (639)
Q Consensus 177 ~~e~f~~~~y~ 187 (639)
+ |+||+++|.
T Consensus 80 ~-e~fk~~~Y~ 89 (89)
T smart00537 80 T-EAFKKVDYG 89 (89)
T ss_pred C-CcceeCCCC
Confidence 6 999999994
|
Tandemly-repeated domain in doublin, the Doublecortin gene product. Proposed to bind tubulin. Doublecortin (DCX) is mutated in human X-linked neuronal migration defects. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=295.05 Aligned_cols=200 Identities=16% Similarity=0.206 Sum_probs=151.1
Q ss_pred hcCC-Cceeeeeeee-------ecCCceEEEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q psy6820 431 SVNH-PNIIKLLDEY-------DTNNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501 (639)
Q Consensus 431 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDL 501 (639)
.++| +||+.++++| ...+.++++|||+ +++|+++|.. ...+++.++..++.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 5777788876 2334678889988 6699999965 456999999999999999999999999999999
Q ss_pred CCCceEEccCC---------------ceeeeEEEeeccccccccC-------------------CCccccCCCcccCccc
Q psy6820 502 KPENLLVEMSG---------------CHVKVLKVGDFGLAQRVLR-------------------PMFTVCGTPTYVAPEI 547 (639)
Q Consensus 502 Kp~NILld~~g---------------~~~~~vKL~DFGla~~~~~-------------------~~~~~~GT~~Y~APE~ 547 (639)
||+||||+..+ .....+|++|||+++.... .....+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996432 0112578888888754211 0112468999999999
Q ss_pred cccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCH
Q psy6820 548 LNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSA 627 (639)
Q Consensus 548 l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta 627 (639)
+.+..|+.++|||||||+||||++|..|+.... .....+.... ++... ....+...+++.+||++||.+||++
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHRV--LPPQI-LLNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHhh--cChhh-hhcCHHHHHHHHHhCCCChhhCcCh
Confidence 999999999999999999999999999874321 1222222211 12111 1224567789999999999999999
Q ss_pred HHHHcCCcccC
Q psy6820 628 EDVLDHPWLER 638 (639)
Q Consensus 628 ~eiL~HP~f~~ 638 (639)
.|+++||||.+
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 99999999964
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=246.29 Aligned_cols=247 Identities=20% Similarity=0.323 Sum_probs=203.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCC-----eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeee-ecCCce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKD-----MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY-DTNNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~ 450 (639)
.++.....+-+|.||.||.|.+++.+ +.+-+|.++....+-.-..+.+|.-.+..+.|||+..+.+++ ++....
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 56888888999999999999776543 335566665554444456788899999999999999999987 455677
Q ss_pred EEEEeeccCCChHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEee
Q psy6820 451 YLVIELIKGGDLFDAISKN--------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGD 522 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~--------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~D 522 (639)
++++.++.-|+|..++... ..++..+...++.|++.|++|||++|+||.||...|.+||+.- .+||+|
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L----qVkltD 439 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL----QVKLTD 439 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe----eEEecc
Confidence 8899999889999999621 2477788899999999999999999999999999999999774 899999
Q ss_pred ccccccccCCCccccC-----CCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 523 FGLAQRVLRPMFTVCG-----TPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 523 FGla~~~~~~~~~~~G-----T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
=.+++......+...| ...||+||.+.+..|+.++|+|||||+||||+| |+.|+.. -+..++...+..| ++
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae--IDPfEm~~ylkdG-yR 516 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE--IDPFEMEHYLKDG-YR 516 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc--cCHHHHHHHHhcc-ce
Confidence 9999888765555544 567999999999999999999999999999988 8999954 3556666666555 33
Q ss_pred CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 597 ~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+-.| -++|+++..++..||..+|++||+++|+..
T Consensus 517 laQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 LAQP--FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 3333 479999999999999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=225.09 Aligned_cols=163 Identities=22% Similarity=0.283 Sum_probs=130.3
Q ss_pred CChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCccccC
Q psy6820 460 GDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG 538 (639)
Q Consensus 460 gsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~~~G 538 (639)
|+|.+++.. ...+++.+++.++.||+.||+|||+.+ ||+|||++.++ .+|+ ||++....... ..|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~----~~~~--fG~~~~~~~~~--~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG----LLKL--DGSVAFKTPEQ--SRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc----ceee--ccceEeecccc--CCC
Confidence 689999976 456999999999999999999999998 99999999887 7888 99987654332 368
Q ss_pred CCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC-CC--CCcccccH--HHHHHH
Q psy6820 539 TPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF-PS--PYWDDISE--EAKELI 613 (639)
Q Consensus 539 T~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~-p~--~~~~~l~~--~l~dLI 613 (639)
|+.|+|||++.+..|+.++|||||||++|||++|..||..... .......+....... +. +....++. ++.++|
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 9999999999999999999999999999999999999965432 222333333222111 10 11223444 699999
Q ss_pred HHhcccCCCCCCCHHHHHcCCccc
Q psy6820 614 SHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 614 ~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
.+||+.||++||++.|+++|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-24 Score=219.94 Aligned_cols=253 Identities=38% Similarity=0.608 Sum_probs=208.8
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHhcCCC-ceeeeeeeeecCCceEEEEe
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNHP-NIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~lV~E 455 (639)
|.+.+.||.|+||.||.+.+. ..+++|.+........ ...+.+|+.++..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999887 6789999987666543 56788999999999988 79999999977777899999
Q ss_pred eccCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 456 LIKGGDLFDAISKNV---KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~---~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
++.++++.+++.... .++......++.+++.++.|+|+.+++|||+||+||+++..+ ..++++|||++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~---~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG---RVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC---CeEEEeccCcceecCCC
Confidence 999999998777664 799999999999999999999999999999999999999875 15899999999755432
Q ss_pred ---------CccccCCCcccCcccccc---CCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--ChHHHHHHHHcCCCC-C
Q psy6820 533 ---------MFTVCGTPTYVAPEILNE---SGYGVKIDVWAAGVILYILLCGFPPFVSDTN--DQDELFDDILSGQYG-F 597 (639)
Q Consensus 533 ---------~~~~~GT~~Y~APE~l~~---~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~--~~~~l~~~i~~~~~~-~ 597 (639)
.....||..|+|||.+.+ ..++...|+||+|++++++++|..||..... ........+...... .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 356789999999999987 5789999999999999999999999866543 134444444444332 2
Q ss_pred CCCCcccc----cHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 598 PSPYWDDI----SEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 598 p~~~~~~l----~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
........ ...+.+++..++..+|..|.+..+...++|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence 22221222 26899999999999999999999988876653
|
|
| >cd01617 DCX Ubiquitin-like domain of DCX | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=194.29 Aligned_cols=78 Identities=50% Similarity=0.893 Sum_probs=74.5
Q ss_pred eEEEEEecCCCCCCcEEEEECCccccCHHHHHHHHHHHHhhcCCC-cccceEeecCCC-ceeccccccccCCeEEEecCC
Q psy6820 101 KRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINL-PSGVRILFTMDG-QKVTNIDELEDGKFYICSSSG 178 (639)
Q Consensus 101 k~v~~~rNgd~~~~g~~~~v~~~~~~~~~~ll~~~t~~l~~~~~l-~~~vr~~~t~~g-~~v~~l~~l~~g~~yv~~~~~ 178 (639)
|+|+||||||+||+|++++||+++++|||+||++||+.|+ | |.|||+|||+|| +.|++++||++|+.|||||.
T Consensus 1 k~I~~~rNGD~~~~g~~~~i~~~~~~sfd~lL~~lt~~l~----l~~~~Vr~lyt~~g~~~v~~~~~l~~g~~yVa~g~- 75 (80)
T cd01617 1 KRVVVYRNGDPFFKGVRLLVNRRRFKSFDALLDDLTEKVQ----LDPGAVRKLYTLDGGHRVSLLDELEDGGVYVASGR- 75 (80)
T ss_pred CEEEEEECCCCCCCCEEEEEChhhhCCHHHHHHHHHHHhC----CCCCcEEEEEcCCCCeEeccHHHhcCCCEEEEECC-
Confidence 7999999999999999999999999999999999999987 6 778999999998 99999999999999999995
Q ss_pred Ccccc
Q psy6820 179 DQFKK 183 (639)
Q Consensus 179 e~f~~ 183 (639)
|+||+
T Consensus 76 e~fk~ 80 (80)
T cd01617 76 EPFKK 80 (80)
T ss_pred CCCCC
Confidence 99985
|
DCX The ubiquitin-like DCX domain is present in tandem within the N-terminal half of the doublecortin protein. Doublecortin is expressed in migrating neurons. Mutations in the gene encoding doublecortin cause lissencephaly in males and 'double-cortex syndrome' in females. |
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-25 Score=232.36 Aligned_cols=250 Identities=26% Similarity=0.321 Sum_probs=197.2
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCC-eEEEEEEEcccccchhHHHHHHHHHHHHhcCC----Cceeeeeeee-ecCCceE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKD-MDCALKIIDKSKLLGKKQMIENEVNILRSVNH----PNIIKLLDEY-DTNNELY 451 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~H----pnIv~l~~~~-~~~~~~~ 451 (639)
+|++.+.||+|+||.||.|.+...+ ..+|+|+.......... .+..|..++..+.. +++..+++.. .....-|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 8999999999999999999987774 67899998765433333 67788889888873 6899999998 5778899
Q ss_pred EEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC-ceeeeEEEeeccccc-
Q psy6820 452 LVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG-CHVKVLKVGDFGLAQ- 527 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g-~~~~~vKL~DFGla~- 527 (639)
+||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.|++||||||+|+++...+ .....+.|.|||+++
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 999998 88999988543 5799999999999999999999999999999999999998764 223479999999998
Q ss_pred -cccC----------C-CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC-hHHHHHHHHcCC
Q psy6820 528 -RVLR----------P-MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND-QDELFDDILSGQ 594 (639)
Q Consensus 528 -~~~~----------~-~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~-~~~l~~~i~~~~ 594 (639)
.... + ...+.||..|++++++.+.+.+++.|+||++.++.+|+.|.+||...... ....+.......
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~ 256 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL 256 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence 3211 1 12345999999999999999999999999999999999999999654422 222222222221
Q ss_pred CCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6820 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVL 631 (639)
Q Consensus 595 ~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL 631 (639)
.... .....+.++.++...+-..+...+|....+.
T Consensus 257 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 257 LTDR--FGDLKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred cccc--ccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 1111 2234567888888888888999999877664
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=263.71 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=202.8
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEEcc----cccchhH-HHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK----SKLLGKK-QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 380 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~----~~~~~~~-~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
....++|.|++|.|+.+......+.++.|.+.. ....... ..+..|+-+-..+.|||++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456889999999888887766666566665442 1111111 12556777788889999998888777776666669
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|||++ +|+..+.....+...++..+++|++.|++|||+.||.|||+|++|+++..+| .+||+|||.+.....+
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g----~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG----ILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC----ceEEeecCcceeeccCcc
Confidence 99999 9999999888999999999999999999999999999999999999999998 8999999999766433
Q ss_pred -----CccccCCCcccCccccccCCCCh-hhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC---CCCCCCCcc
Q psy6820 533 -----MFTVCGTPTYVAPEILNESGYGV-KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ---YGFPSPYWD 603 (639)
Q Consensus 533 -----~~~~~GT~~Y~APE~l~~~~~s~-~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~---~~~p~~~~~ 603 (639)
....+|+..|+|||++.+..|++ ..||||.|+++..|++|+.||.................. ..-+...+.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 23578999999999999999975 589999999999999999999765544332211111111 122334456
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.++.+.+.+|.+||++||.+|.|+++|++.+||+.
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 78999999999999999999999999999999974
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-26 Score=251.15 Aligned_cols=237 Identities=34% Similarity=0.595 Sum_probs=207.7
Q ss_pred EccCCceEEEEEEE---cCCCeEEEEEEEcccccchhH-HHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEEeeccC
Q psy6820 385 IGDGNFAVVRQVYD---KHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 385 LG~G~fG~Vy~a~~---~~~~~~vAiKv~~~~~~~~~~-~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+|+|+||.|++++. .+.+..||+|+..+....... .....|..++..++ ||.+|++...++.+..+++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999988743 345778999998765543322 23446888888887 99999999999999999999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCccccCC
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGT 539 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~~~GT 539 (639)
|+|+..+.+...+.+.....+..+++-|++++|+.+++|||+|++||+++.+| ++++.|||+++........ |||
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G----hi~~tdfglske~v~~~~~-cgt 156 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG----HIKLTDFGLSKEAVKEKIA-CGT 156 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC----ccccCCchhhhHhHhhhhc-ccc
Confidence 99999999999999999999999999999999999999999999999999999 8999999999876544434 999
Q ss_pred CcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhccc
Q psy6820 540 PTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLES 619 (639)
Q Consensus 540 ~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~ 619 (639)
..|||||++. +...++|+||||++++||+||..||.. ++...|....+..| ..++..+++++..++..
T Consensus 157 ~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il~~~~~~p----~~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 157 YEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKRILKAELEMP----RELSAEARSLFRQLFKR 224 (612)
T ss_pred hhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHHHHhhhccCCc----hhhhHHHHHHHHHHHhh
Confidence 9999999998 568899999999999999999999954 67778888777776 46789999999999999
Q ss_pred CCCCCCC-----HHHHHcCCcccC
Q psy6820 620 NPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 620 dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
+|..|.. +.|+++|+||+.
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred CHHHHhccCcchhHHHhccchhee
Confidence 9999995 589999999974
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=214.85 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=196.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.-.|+++++||+|+||.++.|...-+++.||||.-.... ....+..|....+.|. .++|...+.+.....+-.|||
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 357999999999999999999999999999999965432 2345678999999886 799999999888888888999
Q ss_pred eeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC-ceeeeEEEeeccccccccCC
Q psy6820 455 ELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG-CHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g-~~~~~vKL~DFGla~~~~~~ 532 (639)
|++ |.||.|+..-. ++|+..++..+|.|++.-++|+|++.+|+|||||+|+||...+ .+...+.|+|||+|+.+..+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 998 88999988654 5799999999999999999999999999999999999998665 23347999999999987644
Q ss_pred ----------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC-hHHHHHHHHcCCCCCC-CC
Q psy6820 533 ----------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND-QDELFDDILSGQYGFP-SP 600 (639)
Q Consensus 533 ----------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~-~~~l~~~i~~~~~~~p-~~ 600 (639)
.....||.+||+-..+.+.+-+.+.|+-|||-++.++|-|.+||.+-..+ -.+-++.|-......| ..
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~ 262 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV 262 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH
Confidence 33567999999999999999999999999999999999999999764332 2333444433222111 11
Q ss_pred CcccccHHHHHHHHHhcccCCCCCCC
Q psy6820 601 YWDDISEEAKELISHMLESNPDLRFS 626 (639)
Q Consensus 601 ~~~~l~~~l~dLI~~~L~~dP~~Rpt 626 (639)
...++|.++-.-++-.-..+-.+-|.
T Consensus 263 Lc~g~P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 263 LCEGFPEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred HHhcCHHHHHHHHHHHHhcCcccCCC
Confidence 22345666666666555555555554
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=205.70 Aligned_cols=247 Identities=19% Similarity=0.246 Sum_probs=202.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.+.|++++.||.|+||.+|+|....+|..||||+-+.... ...+..|..+.+.|+ ...|..+..+..+..+-.+||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4789999999999999999999999999999999765432 344667999999998 477888888888888889999
Q ss_pred eeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 455 ELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
+.+ |.||.++.+- .+.++..++.-++-|++.-++|+|.+++|||||||+|+|+..+. +...+.|+|||+|+.+.+.
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr-h~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR-HCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc-ccceEEEEeccchhhhcccc
Confidence 998 8899998853 45799999999999999999999999999999999999997664 3347999999999876432
Q ss_pred ---------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCC-CChHHHHHHHHcCCCCCCC-CC
Q psy6820 533 ---------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDT-NDQDELFDDILSGQYGFPS-PY 601 (639)
Q Consensus 533 ---------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~-~~~~~l~~~i~~~~~~~p~-~~ 601 (639)
.....||..|.+-..+.+..-+.+.|+-|+|.+|.++.-|.+||.+-. +...+-++.|.......|. ..
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~L 248 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVL 248 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHH
Confidence 234679999999999988888999999999999999999999997643 3344556666655444332 22
Q ss_pred cccccHHHHHHHHHhcccCCCCCCCH
Q psy6820 602 WDDISEEAKELISHMLESNPDLRFSA 627 (639)
Q Consensus 602 ~~~l~~~l~dLI~~~L~~dP~~Rpta 627 (639)
-...|.++.-.+.-|-..--++-|..
T Consensus 249 C~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 249 CKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred hCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 35678888888888877777777754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=223.04 Aligned_cols=161 Identities=23% Similarity=0.213 Sum_probs=127.7
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcC-CCeEEEEEEEcccc----cchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCc
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKH-KDMDCALKIIDKSK----LLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiKv~~~~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 449 (639)
+.++|.+.+.||+|+||+||+|.++. +++.+|||++.... .....+.+.+|+.+|++++|+|++..+..+ +.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CC
Confidence 45789999999999999999998876 67778999875331 122345688999999999999998533322 45
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEEccCCceeeeEEEeecccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI-KPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDL-Kp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
.|+||||++|++|... .. .. ...++.++++||+|||++||+|||| ||+|||++.++ .+||+|||+|+.
T Consensus 93 ~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~----~ikLiDFGlA~~ 161 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG----EAAVIDFQLASV 161 (365)
T ss_pred cEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC----CEEEEECcccee
Confidence 7999999999999732 11 11 1467889999999999999999999 99999998776 799999999985
Q ss_pred ccCC-----------CccccCCCcccCccccc
Q psy6820 529 VLRP-----------MFTVCGTPTYVAPEILN 549 (639)
Q Consensus 529 ~~~~-----------~~~~~GT~~Y~APE~l~ 549 (639)
.... .....+++.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 5422 13456888999999984
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-23 Score=234.24 Aligned_cols=218 Identities=35% Similarity=0.632 Sum_probs=177.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
..+|+.++.|..|++|.||.++++.+.+.+|+|+= +... .+++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l-----ilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL-----ILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccc-ccch-----hhhc---cccccCCccee-----------------
Confidence 36789999999999999999999999999999553 2211 1111 23323344444
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC----
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---- 531 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---- 531 (639)
|+=...++.-+.++... +.+++|||+-||+|||+||+|++|..-| ++|+.|||+.+....
T Consensus 136 ----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mG----hiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMG----HIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecc----cccccchhhhhhhhhhccc
Confidence 45455555555565443 7899999999999999999999999887 899999999865421
Q ss_pred --------------CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC
Q psy6820 532 --------------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597 (639)
Q Consensus 532 --------------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~ 597 (639)
.....||||.|+|||++...+|+..+|||++|+++||.+-|..||.++ ..++++..++...+.+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd--tpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQVISDDIEW 277 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC--CHHHHHhhhhhhhccc
Confidence 123569999999999999999999999999999999999999999665 4688999999999888
Q ss_pred CCCCcccccHHHHHHHHHhcccCCCCCC---CHHHHHcCCcccC
Q psy6820 598 PSPYWDDISEEAKELISHMLESNPDLRF---SAEDVLDHPWLER 638 (639)
Q Consensus 598 p~~~~~~l~~~l~dLI~~~L~~dP~~Rp---ta~eiL~HP~f~~ 638 (639)
|.. ...++++++++|.++|+.+|..|. .+-++.+|+||+.
T Consensus 278 pE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 278 PEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred ccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 877 457899999999999999999998 5788999999974
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=203.81 Aligned_cols=232 Identities=25% Similarity=0.398 Sum_probs=151.1
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCC----------Cceeeeeee--
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNH----------PNIIKLLDE-- 443 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~H----------pnIv~l~~~-- 443 (639)
....++.||.|+|+.||.+.+.++++.+|+|++....... ..+.+++|......+.+ -.++-.++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4577899999999999999999999999999986544222 23445555544433322 112222221
Q ss_pred -------eecC---C-----ceEEEEeeccCCChHHHHhh---cC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q psy6820 444 -------YDTN---N-----ELYLVIELIKGGDLFDAISK---NV----KFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501 (639)
Q Consensus 444 -------~~~~---~-----~~~lV~E~~~ggsL~~~l~~---~~----~l~~~~~~~i~~qI~~aL~yLH~~givHrDL 501 (639)
+... . ..+++|+-+ .+||.+++.. .. .+.......+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1111 1 346788887 4588887632 11 1233344556689999999999999999999
Q ss_pred CCCceEEccCCceeeeEEEeeccccccccCCCccccCCCcccCcccccc--------CCCChhhhHHHHHHHHHHHHcCC
Q psy6820 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNE--------SGYGVKIDVWAAGVILYILLCGF 573 (639)
Q Consensus 502 Kp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~--------~~~s~~sDVwSLGvvL~eLltG~ 573 (639)
+|+|++++.+| .++|+||+..............+..|.+||.... -.++.+.|.|+||+++|.|+||.
T Consensus 172 ~~~nfll~~~G----~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDG----GVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-----EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCC----CEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999998 8999999998776554333445678999997743 24789999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCC
Q psy6820 574 PPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLR 624 (639)
Q Consensus 574 ~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~R 624 (639)
.||.......... ..+. .. .++|+.+++||+++|+.||++|
T Consensus 248 lPf~~~~~~~~~~--------~~f~-~C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPE--------WDFS-RC-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSG--------GGGT-TS-S---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccccc--------ccch-hc-CCcCHHHHHHHHHHccCCcccC
Confidence 9996543211110 0111 11 2789999999999999999988
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=231.59 Aligned_cols=242 Identities=24% Similarity=0.336 Sum_probs=185.2
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHH---HHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN---EVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~---Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+|...+.||.+.|=+|.+|++.+. .+++|++-+....-..+.+.+ |+. ...+++||++++.-+-......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 788899999999999999877654 499999976654433333333 444 45568999999999988888999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc----
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---- 530 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---- 530 (639)
+|+.. +|+|.+....-+..-+.++|+.||+.||.-+|..||+|||||.+||||..-+ .+.|+||...+..-
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN----W~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN----WLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec----hhhhhcccccCCccCCCC
Confidence 99965 9999999888899999999999999999999999999999999999999876 89999998875332
Q ss_pred CC--C----ccccCCCcccCccccccC----------C-CChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHc
Q psy6820 531 RP--M----FTVCGTPTYVAPEILNES----------G-YGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILS 592 (639)
Q Consensus 531 ~~--~----~~~~GT~~Y~APE~l~~~----------~-~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~ 592 (639)
+| . .+...-.+|+|||.+-.. . .+++.||||+||+++||++ |++||. ..+++..-..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-----LSQL~aYr~~ 250 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-----LSQLLAYRSG 250 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-----HHHHHhHhcc
Confidence 11 1 122234579999987431 1 5789999999999999988 688883 2233322222
Q ss_pred CCCCCCCCCccc-ccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 593 GQYGFPSPYWDD-ISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 593 ~~~~~p~~~~~~-l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+. ..+...... -+..++.||..|++.||++|.+|++.|+-
T Consensus 251 ~~-~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NA-DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred Cc-cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11 111111111 13578999999999999999999999964
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-22 Score=197.06 Aligned_cols=243 Identities=14% Similarity=0.258 Sum_probs=189.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh-HHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
....+..+|.+...|..|+|+++.+ .+++|++........ ...|..|.-.|+...||||+.+++.|..+.++.+|..
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 3455667788999999999987766 578888876554432 3568889999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 456 LIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNY--IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~g--ivHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
||+-|+|+..+..+. ..+..++.+++.++++|++|||+.. |.---|....++||.+-. ..+-.+|--++....
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlt--arismad~kfsfqe~- 344 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLT--ARISMADTKFSFQEV- 344 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhh--hheecccceeeeecc-
Confidence 999999999997764 3678899999999999999999975 445568889999998751 123334433332221
Q ss_pred CCccccCCCcccCccccccCCCC---hhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYG---VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s---~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
...-.|.||+||.+...+.+ .++|+|||+++||||.|...||...++.+-.+.-.+..-...+| +.++..
T Consensus 345 ---gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip----pgis~h 417 (448)
T KOG0195|consen 345 ---GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP----PGISRH 417 (448)
T ss_pred ---ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC----CCccHH
Confidence 12246899999999876543 57999999999999999999997766544433333332233343 689999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHH
Q psy6820 609 AKELISHMLESNPDLRFSAEDVL 631 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL 631 (639)
+..|+.-|+..||.+||.++.|+
T Consensus 418 m~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999987764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-21 Score=190.15 Aligned_cols=141 Identities=23% Similarity=0.193 Sum_probs=111.0
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh-------------------------HHHHHHHHHHHHhcCCCc
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-------------------------KQMIENEVNILRSVNHPN 436 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~-------------------------~~~~~~Ei~iL~~l~Hpn 436 (639)
...||+|+||.||+|.+. +|+.||+|+++....... .....+|+.++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999887 889999999975432110 112345999999998877
Q ss_pred eeeeeeeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceEEccCCcee
Q psy6820 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL-HDNYIVHRDIKPENLLVEMSGCHV 515 (639)
Q Consensus 437 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yL-H~~givHrDLKp~NILld~~g~~~ 515 (639)
+........ ...+|||||++|+++...+.....+++..+..++.|++.+|.+| |+.||+||||||+|||++. +
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--- 154 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--- 154 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C---
Confidence 644333222 22389999999887776654567899999999999999999999 7999999999999999984 3
Q ss_pred eeEEEeecccccccc
Q psy6820 516 KVLKVGDFGLAQRVL 530 (639)
Q Consensus 516 ~~vKL~DFGla~~~~ 530 (639)
.++|+|||+|....
T Consensus 155 -~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 -KLYIIDVSQSVEHD 168 (190)
T ss_pred -cEEEEEccccccCC
Confidence 69999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=202.45 Aligned_cols=189 Identities=25% Similarity=0.390 Sum_probs=145.8
Q ss_pred CCCceeeeeeeee---------------------------cCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHH
Q psy6820 433 NHPNIIKLLDEYD---------------------------TNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLA 485 (639)
Q Consensus 433 ~HpnIv~l~~~~~---------------------------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~ 485 (639)
+|||||+++++|- +...+|+||.... .+|..++-.+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 5999999998662 2335899999885 4999999654 457778888999999
Q ss_pred HHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---------CCCccccCCCcccCccccccCC----
Q psy6820 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL---------RPMFTVCGTPTYVAPEILNESG---- 552 (639)
Q Consensus 486 ~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~---------~~~~~~~GT~~Y~APE~l~~~~---- 552 (639)
+|+.|||.+||.|||+|.+|||+..+.+....+.|+|||.+-... .......|...-||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999998776666789999999874322 2223456788899999985432
Q ss_pred --CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCH
Q psy6820 553 --YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSA 627 (639)
Q Consensus 553 --~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta 627 (639)
.-.++|.|+.|.+-||+++...||+......-+... .... .+| ...+.+++.+++|+..+|+.||++|+++
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe~--qLP-alp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQES--QLP-ALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hhhh--hCC-CCcccCChHHHHHHHHHhcCCccccCCc
Confidence 135899999999999999999999874432222111 1111 222 2346899999999999999999999984
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.8e-21 Score=192.24 Aligned_cols=172 Identities=20% Similarity=0.210 Sum_probs=133.4
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--------HHHHHHHHHHHhcCCCceeeeeeeeec
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--------QMIENEVNILRSVNHPNIIKLLDEYDT 446 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--------~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 446 (639)
+.++|++.++||.|+||.||++.. ++..+|+|++......... +.+++|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 457899999999999999999654 3557999999754432221 126789999999999999999987653
Q ss_pred C--------CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeE
Q psy6820 447 N--------NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVL 518 (639)
Q Consensus 447 ~--------~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~v 518 (639)
. +..+|+|||++|.+|.++.. +++ ....+++.+|..||+.|++|||+||+||+++.+| +
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-----i 173 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-----L 173 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-----E
Confidence 3 35899999999999988742 333 2456899999999999999999999999998765 8
Q ss_pred EEeeccccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHH
Q psy6820 519 KVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILL 570 (639)
Q Consensus 519 KL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLl 570 (639)
+|+|||........... ..++....|+.++|+||||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988654321110 11445566778999999999987664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=182.72 Aligned_cols=142 Identities=20% Similarity=0.157 Sum_probs=112.6
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-------------------------hHHHHHHHHHHHHhcCCCc
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-------------------------KKQMIENEVNILRSVNHPN 436 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-------------------------~~~~~~~Ei~iL~~l~Hpn 436 (639)
.+.||+|+||.||+|.+. +|+.||+|++....... ....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999887 89999999997653210 0123467999999999998
Q ss_pred eeeeeeeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCcee
Q psy6820 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHV 515 (639)
Q Consensus 437 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~ 515 (639)
+.....+... ..||||||++|+++.........++...+..++.+++.+|.+||+ .||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~--- 154 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG--- 154 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC---
Confidence 7544433322 248999999888665443345678899999999999999999999 9999999999999998 54
Q ss_pred eeEEEeeccccccccC
Q psy6820 516 KVLKVGDFGLAQRVLR 531 (639)
Q Consensus 516 ~~vKL~DFGla~~~~~ 531 (639)
.++|+|||++.....
T Consensus 155 -~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 -KPYIIDVSQAVELDH 169 (190)
T ss_pred -CEEEEEcccceecCC
Confidence 799999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=178.70 Aligned_cols=184 Identities=18% Similarity=0.160 Sum_probs=141.3
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc---hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEEe
Q psy6820 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL---GKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 380 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~---~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++..|+.|+||+||.+.. .+.+++.+.+.....- -....+.+|+++|++|. |+++++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3568899999999997644 5667887777655442 11236789999999996 5889999886 45799999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEEccCCceeeeEEEeeccccccccCCCc
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI-KPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDL-Kp~NILld~~g~~~~~vKL~DFGla~~~~~~~~ 534 (639)
|+.|.+|.+.+... ...++.+++.+|+++|++||+|||| ||+|||++.++ .++|+|||+|........
T Consensus 79 yI~G~~L~~~~~~~-------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g----~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 79 YLAGAAMYQRPPRG-------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG----SPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eecCccHHhhhhhh-------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC----CEEEEECCCceecCCcch
Confidence 99999997654221 2357789999999999999999999 79999998877 799999999975432210
Q ss_pred ----------------cccCCCcccCccccccC-CCC-hhhhHHHHHHHHHHHHcCCCCCCCCC
Q psy6820 535 ----------------TVCGTPTYVAPEILNES-GYG-VKIDVWAAGVILYILLCGFPPFVSDT 580 (639)
Q Consensus 535 ----------------~~~GT~~Y~APE~l~~~-~~s-~~sDVwSLGvvL~eLltG~~Pf~~~~ 580 (639)
-...++.|++|+...-. ..+ .+.++++.|+.+|.++|+..++..+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 11257888888865432 233 67899999999999999999986544
|
|
| >smart00537 DCX Domain in the Doublecortin (DCX) gene product | Back alignment and domain information |
|---|
Probab=99.80 E-value=8e-20 Score=156.75 Aligned_cols=83 Identities=34% Similarity=0.560 Sum_probs=77.3
Q ss_pred cccceEEEEEEcCCCCcccEEEEecCCCCCCHHHHHHhhhhhccCCCc-cccceeccCCccccccccccccCcEEEEcCC
Q psy6820 221 VVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTG-AVRKVYTLNGNQLARLSDFFKSDDVFFAYGS 299 (639)
Q Consensus 221 ~~~p~~i~v~rng~~~~~~~~~~l~~~~~~~~~~~l~~it~~~~~~~g-~v~~lyt~~g~~v~~~~~~~~~~d~yva~G~ 299 (639)
..+||+|+||||||.+++|++++||++.++|||++|++||+++.++.| +||+|||++|++|.++++ |++++.|||+|.
T Consensus 2 ~~k~k~i~~~rNGD~~~~g~~~~v~~~~~~s~d~lL~~lt~~v~l~~~~~Vr~lyt~~G~~v~~l~~-l~~g~~yVa~g~ 80 (89)
T smart00537 2 LVKPKRIRFYRNGDRFFKGVRLVVNRKRFKSFEALLQDLTEVVKLDLPHGVRKLYTLDGKKVTSLDE-LEDGGSYVASGT 80 (89)
T ss_pred CccceEEEEEeCCCCCCCCEEEEEChhhcCCHHHHHHHHhhhcccCCCCCeeEEEcCCCCEECCHHH-hCcCCEEEEEcC
Confidence 357999999999999999999999999999999999999998777776 799999999999999999 778999999999
Q ss_pred ccccC
Q psy6820 300 ERVLP 304 (639)
Q Consensus 300 e~~~~ 304 (639)
|+|.+
T Consensus 81 e~fk~ 85 (89)
T smart00537 81 EAFKK 85 (89)
T ss_pred Cccee
Confidence 98764
|
Tandemly-repeated domain in doublin, the Doublecortin gene product. Proposed to bind tubulin. Doublecortin (DCX) is mutated in human X-linked neuronal migration defects. |
| >PF03607 DCX: Doublecortin; InterPro: IPR003533 X-linked lissencephaly is a severe brain malformation affecting males | Back alignment and domain information |
|---|
Probab=99.79 E-value=8e-20 Score=144.98 Aligned_cols=60 Identities=50% Similarity=0.968 Sum_probs=53.1
Q ss_pred EEECCccccCHHHHHHHHHHHHhhcCCCcccceEeecCCCceeccccccccCCeEEEecCCCccc
Q psy6820 118 MAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDGQKVTNIDELEDGKFYICSSSGDQFK 182 (639)
Q Consensus 118 ~~v~~~~~~~~~~ll~~~t~~l~~~~~l~~~vr~~~t~~g~~v~~l~~l~~g~~yv~~~~~e~f~ 182 (639)
++||+++++|||+||++||++|. ||+|||+|||++|++|++++||+||+.|||||+ |+||
T Consensus 1 ~~i~~r~~~s~e~lL~~it~~v~----l~~gVr~lyt~~G~~V~~l~~l~dg~~yVa~g~-e~fk 60 (60)
T PF03607_consen 1 VVINPRRFRSFEQLLDEITEKVQ----LPSGVRKLYTLDGKRVKSLDELEDGGSYVASGR-EPFK 60 (60)
T ss_dssp EEESTTTHSSHHHHHHHHHHSSS----STTS-SEEEETTSSEESSGGGS-TTEEEEEESS-SS--
T ss_pred CeEChhhhcCHHHHHHHHHhhcC----CCcccceEECCCCCEeCCHHHHCCCCEEEEEcC-CcCC
Confidence 68999999999999999998655 999999999999999999999999999999985 9997
|
Recently it has been demonstrated that the doublecortin gene is implicated in this disorder []. Doublecortin was found to bind to the microtubule cytoskeleton. In vivo and in vitro assays show that Doublecortin stabilises microtubules and causes bundling []. Doublecortin is a basic protein with an iso-electric point of 10, typical of microtubule-binding proteins. However, its sequence contains no known microtubule-binding domain(s). The detailed sequence analysis of Doublecortin and Doublecortin-like proteins allowed the identification of an evolutionarily conserved Doublecortin (DC) domain. This domain is found in the N terminus of proteins and consists of one or two tandemly repeated copies of an around 80 amino acids region. It has been suggested that the first DC domain of Doublecortin binds tubulin and enhances microtubule polymerisation []. Some proteins known to contain a DC domain are listed below: Doublecortin. It is required for neuronal migration []. A large number of point mutations in the human DCX gene leading to lissencephaly are located within the DC domains []. Human serine/threonine-protein kinase DCAMKL1. It is a probable kinase that may be involved in a calcium-signaling pathway controling neuronal migration in the developing brain []. Retinitis pigmentosa 1 protein. It could play a role in the differentiation of photoreceptor cells. Mutation in the human RP1 gene cause retinitis pigmentosa of type 1 []. ; GO: 0035556 intracellular signal transduction; PDB: 1UF0_A 1MG4_A 1MFW_A 2DNF_A 2XRP_I 2BQQ_A 1MJD_A. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=174.00 Aligned_cols=138 Identities=17% Similarity=0.194 Sum_probs=108.5
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-----CCCceeeeeeeeecCC---c-eEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-----NHPNIIKLLDEYDTNN---E-LYL 452 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-----~HpnIv~l~~~~~~~~---~-~~l 452 (639)
.+.||+|+||.||. +..++.. +||++...... ..+.+.+|+.+++.+ .||||++++++++++. . +.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 47899999999995 6666655 69998764332 346688999999999 5799999999998874 3 337
Q ss_pred EEee--ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 453 VIEL--IKGGDLFDAISKNVKFSEEDSKFMTQSLASAL-SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 453 V~E~--~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL-~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
|||| +.+++|.+++++. .+++. ..++.+++.++ +|||+++|+||||||+|||++..+.....++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 5579999999764 46665 35577777777 99999999999999999999865422347999995544
|
|
| >cd01617 DCX Ubiquitin-like domain of DCX | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-19 Score=150.50 Aligned_cols=78 Identities=38% Similarity=0.594 Sum_probs=73.5
Q ss_pred eEEEEEEcCCCCcccEEEEecCCCCCCHHHHHHhhhhhccCCCccccceeccCC-ccccccccccccCcEEEEcCCcccc
Q psy6820 225 RIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNG-NQLARLSDFFKSDDVFFAYGSERVL 303 (639)
Q Consensus 225 ~~i~v~rng~~~~~~~~~~l~~~~~~~~~~~l~~it~~~~~~~g~v~~lyt~~g-~~v~~~~~~~~~~d~yva~G~e~~~ 303 (639)
|+|+||||||.+++|+++++++++.+|||++|++||+++++..|+||+|||++| +.|.++++ ++++++|||+|.|+|.
T Consensus 1 k~I~~~rNGD~~~~g~~~~i~~~~~~sfd~lL~~lt~~l~l~~~~Vr~lyt~~g~~~v~~~~~-l~~g~~yVa~g~e~fk 79 (80)
T cd01617 1 KRVVVYRNGDPFFKGVRLLVNRRRFKSFDALLDDLTEKVQLDPGAVRKLYTLDGGHRVSLLDE-LEDGGVYVASGREPFK 79 (80)
T ss_pred CEEEEEECCCCCCCCEEEEEChhhhCCHHHHHHHHHHHhCCCCCcEEEEEcCCCCeEeccHHH-hcCCCEEEEECCCCCC
Confidence 589999999999999999999999999999999999999999999999999999 77777666 9999999999999874
|
DCX The ubiquitin-like DCX domain is present in tandem within the N-terminal half of the doublecortin protein. Doublecortin is expressed in migrating neurons. Mutations in the gene encoding doublecortin cause lissencephaly in males and 'double-cortex syndrome' in females. |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=202.43 Aligned_cols=194 Identities=22% Similarity=0.271 Sum_probs=159.0
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC---CCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN---HPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~l 452 (639)
...|.|.+.||+|+||.||.|.... ++.+|+|+-+....- .|.=-.+++.+|+ -+.|..+...+.-.+.-++
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3579999999999999999998877 899999997654321 1111222333443 3456666666677778899
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC---ceeeeEEEeeccccccc
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG---CHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g---~~~~~vKL~DFGla~~~ 529 (639)
|+||.+.|+|.++++..+.+++..+..+..|++..+++||..+|||+||||+|+||...- .....++|+|||-+..+
T Consensus 772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 999999999999999889999999999999999999999999999999999999994321 12357999999999766
Q ss_pred c-----CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCC
Q psy6820 530 L-----RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFP 574 (639)
Q Consensus 530 ~-----~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~ 574 (639)
. ......++|-.+-.+|+..|.+++..+|.|.|+.+++-||.|+.
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 4 12445788999999999999999999999999999999999863
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-18 Score=173.80 Aligned_cols=145 Identities=22% Similarity=0.212 Sum_probs=115.5
Q ss_pred CeeEEEEEccCCceEEEEEE-EcCCCeEEEEEEEcccccch-----------------------hHHHHHHHHHHHHhcC
Q psy6820 378 RYSVGQIIGDGNFAVVRQVY-DKHKDMDCALKIIDKSKLLG-----------------------KKQMIENEVNILRSVN 433 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~-~~~~~~~vAiKv~~~~~~~~-----------------------~~~~~~~Ei~iL~~l~ 433 (639)
-|.+.+.||+|+||.||+|. +..+++.||+|++....... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999998 66789999999987543110 1123568999999997
Q ss_pred CC--ceeeeeeeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCceEEcc
Q psy6820 434 HP--NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY-IVHRDIKPENLLVEM 510 (639)
Q Consensus 434 Hp--nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~g-ivHrDLKp~NILld~ 510 (639)
+. .+.++++. ...++||||++|++|.........+....+..++.+++.+|.+||+.| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34455543 235899999999888776645556777778899999999999999999 99999999999998
Q ss_pred CCceeeeEEEeeccccccccC
Q psy6820 511 SGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 511 ~g~~~~~vKL~DFGla~~~~~ 531 (639)
++ .++|+|||.+.....
T Consensus 184 ~~----~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 DG----KVVIIDVSQSVELDH 200 (237)
T ss_pred CC----CEEEEEChhhhccCC
Confidence 44 699999999865543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=162.73 Aligned_cols=135 Identities=19% Similarity=0.270 Sum_probs=112.2
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-------hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-------KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-------~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
+.||+|++|.||+|.. .+..+++|+........ ....+.+|+.++..+.|+++.....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999976 56679999865432211 12356789999999999998877777777788999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
|++|++|.+++..... ....++.+++.+|.+||+.|++|+|++|.|||++ ++ .++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~----~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG----KIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC----CEEEEECCcccC
Confidence 9999999999865432 7889999999999999999999999999999998 44 689999999854
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-18 Score=187.80 Aligned_cols=175 Identities=30% Similarity=0.451 Sum_probs=140.8
Q ss_pred CceEEEEeeccCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 448 NELYLVIELIKGGDLFDAISKN---VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
.++||.|++|.-.+|.++|.+. ...+......++.|++.|++| +|.+|+|+||.||+...+. .+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~----q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD----QLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch----hhhhhhhh
Confidence 3689999999999999999654 346778889999999999999 9999999999999998886 79999999
Q ss_pred ccccccC---------CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCC
Q psy6820 525 LAQRVLR---------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQ 594 (639)
Q Consensus 525 la~~~~~---------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~ 594 (639)
+.+.... .+..-.||..||+||++.+..|+.++||||||++|+||+. =..+| .....+..+..+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~-----er~~t~~d~r~g~ 476 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF-----ERIATLTDIRDGI 476 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH-----HHHHhhhhhhcCC
Confidence 9976643 2345679999999999999999999999999999999997 22222 2233344444443
Q ss_pred CCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 595 ~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
+|+..+.+. ++-.+|+++||.+.|.+||++.+.--|+|.+
T Consensus 477 --ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 477 --IPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred --CChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 343344343 4456899999999999999999988898864
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-17 Score=181.88 Aligned_cols=199 Identities=27% Similarity=0.400 Sum_probs=158.2
Q ss_pred HHhcCCCceeeeeeeeecCCceEEEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCce
Q psy6820 429 LRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYI-VHRDIKPENL 506 (639)
Q Consensus 429 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gi-vHrDLKp~NI 506 (639)
|+.+.|.|+.+++|.+.+++..++|.+||..|+|.+.+.. ...++.--...+.++|+.||+|||+..| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3568899999999999999999999999999999999976 4567888888899999999999998776 9999999999
Q ss_pred EEccCCceeeeEEEeeccccccccC-----CCccccCCCcccCccccccCC-------CChhhhHHHHHHHHHHHHcCCC
Q psy6820 507 LVEMSGCHVKVLKVGDFGLAQRVLR-----PMFTVCGTPTYVAPEILNESG-------YGVKIDVWAAGVILYILLCGFP 574 (639)
Q Consensus 507 Lld~~g~~~~~vKL~DFGla~~~~~-----~~~~~~GT~~Y~APE~l~~~~-------~s~~sDVwSLGvvL~eLltG~~ 574 (639)
++|.. +.+||+|||+...... ......-..-|.|||.+.+.. .+.+.|+||||++++|+++...
T Consensus 81 lvd~~----w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 81 LVDSR----WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred eeeee----EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99976 4999999999866542 111112234599999987631 4678999999999999999999
Q ss_pred CCCCCC--CChHHHHHHHHc-CCCCCCCCCc--ccccHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6820 575 PFVSDT--NDQDELFDDILS-GQYGFPSPYW--DDISEEAKELISHMLESNPDLRFSAEDVL 631 (639)
Q Consensus 575 Pf~~~~--~~~~~l~~~i~~-~~~~~p~~~~--~~l~~~l~dLI~~~L~~dP~~Rpta~eiL 631 (639)
||.... .+.+++...+.. +...+.+..+ ..+++++..+++.||..+|++||+++++-
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 997633 233456666665 3322332222 14667899999999999999999998774
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-17 Score=160.03 Aligned_cols=131 Identities=21% Similarity=0.261 Sum_probs=104.7
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEEcccccch-------hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-------KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 384 ~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-------~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
.||+|+||.||++.. .+..+++|+........ ....+.+|+.+++.++|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999974 56789999865432211 124567899999999988765555455566677999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++ .++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~----~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD----KLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC----cEEEEECCCCcC
Confidence 999999998765321 7889999999999999999999999999998 44 699999999854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.8e-19 Score=201.49 Aligned_cols=258 Identities=30% Similarity=0.519 Sum_probs=207.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcC-CCeEEEEEEEcccc-cchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKH-KDMDCALKIIDKSK-LLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiKv~~~~~-~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 453 (639)
..|.+.+.||+|+|+.|-.+.... ....+|.|.+.... .......+..|..+-+.+. |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456777889999999998776543 34456777765543 2222344556888888887 99999999999999999999
Q ss_pred EeeccCCChHHHH-hhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 454 IELIKGGDLFDAI-SKNV-KFSEEDSKFMTQSLASALSYLH-DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 454 ~E~~~ggsL~~~l-~~~~-~l~~~~~~~i~~qI~~aL~yLH-~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+||..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.|+|+||+|.+++..+. .++++|||+|+...
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~---~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS---ALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC---cccCCCchhhcccc
Confidence 9999999999999 5554 6788899999999999999999 999999999999999987763 68999999998776
Q ss_pred C-C-----CccccC-CCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCc
Q psy6820 531 R-P-----MFTVCG-TPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 531 ~-~-----~~~~~G-T~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
. . ....+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||........... ........+-...|
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-SWKSNKGRFTQLPW 255 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-eecccccccccCcc
Confidence 5 2 234678 9999999999884 457889999999999999999999965443332222 22222222234457
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..++....+++.++|..+|..|.+.+++..+||+..
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCChhhhhcccccccCCchhccccccccccccccc
Confidence 889999999999999999999999999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=157.71 Aligned_cols=137 Identities=21% Similarity=0.223 Sum_probs=108.0
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc---------------------hhHHHHHHHHHHHHhcCCCc-
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL---------------------GKKQMIENEVNILRSVNHPN- 436 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~---------------------~~~~~~~~Ei~iL~~l~Hpn- 436 (639)
|.+.+.||+|+||.||++... +++.+|||++...... ........|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777899999999999999775 6889999997653310 01123567899999998774
Q ss_pred -eeeeeeeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCcee
Q psy6820 437 -IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHV 515 (639)
Q Consensus 437 -Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~ 515 (639)
++..++. ...++||||++|++|...... .....++.+++.++.++|+.|++||||||+||+++.++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~--- 162 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE--- 162 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC---
Confidence 4444442 355899999999998765431 34567889999999999999999999999999999876
Q ss_pred eeEEEeecccccccc
Q psy6820 516 KVLKVGDFGLAQRVL 530 (639)
Q Consensus 516 ~~vKL~DFGla~~~~ 530 (639)
.++|+|||++....
T Consensus 163 -~~~liDfg~~~~~~ 176 (198)
T cd05144 163 -KIYIIDWPQMVSTD 176 (198)
T ss_pred -cEEEEECCccccCC
Confidence 89999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=179.40 Aligned_cols=145 Identities=21% Similarity=0.241 Sum_probs=113.7
Q ss_pred cCCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-------hhHHHHHHHHHHHHhcCCCceeeee
Q psy6820 369 LNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-------GKKQMIENEVNILRSVNHPNIIKLL 441 (639)
Q Consensus 369 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~ 441 (639)
|.........|...+.||+|+||.||++...... +++|+....... ...+.+.+|+.+++.++|++++...
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3333444456677899999999999998765543 444432211111 1124578999999999999998887
Q ss_pred eeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEe
Q psy6820 442 DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVG 521 (639)
Q Consensus 442 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~ 521 (639)
.++......++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||++ ++ .++|+
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~----~~~li 469 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD----RLYLI 469 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC----cEEEE
Confidence 77777778899999999999999885 3567899999999999999999999999999994 33 69999
Q ss_pred ecccccc
Q psy6820 522 DFGLAQR 528 (639)
Q Consensus 522 DFGla~~ 528 (639)
|||++..
T Consensus 470 DFGla~~ 476 (535)
T PRK09605 470 DFGLGKY 476 (535)
T ss_pred eCccccc
Confidence 9999954
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=147.44 Aligned_cols=137 Identities=26% Similarity=0.299 Sum_probs=98.9
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHH---------------------HHHHHHHHHhcCCCc--
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQM---------------------IENEVNILRSVNHPN-- 436 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~---------------------~~~Ei~iL~~l~Hpn-- 436 (639)
++.||+|+||.||+|.+. +++.||||++........ ... ...|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 788999999875432111 111 135666666665432
Q ss_pred eeeeeeeeecCCceEEEEeeccCCChHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCce
Q psy6820 437 IIKLLDEYDTNNELYLVIELIKGGDLFD-AISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCH 514 (639)
Q Consensus 437 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~ 514 (639)
+.++++. ...+++|||++++++.. .+... ... ..+..++.+++.++.++|. .||+|+||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-- 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-- 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC--
Confidence 4445543 24689999999854432 12111 111 6788999999999999999 9999999999999999 54
Q ss_pred eeeEEEeecccccccc
Q psy6820 515 VKVLKVGDFGLAQRVL 530 (639)
Q Consensus 515 ~~~vKL~DFGla~~~~ 530 (639)
.++|+|||.+....
T Consensus 152 --~~~liDfg~a~~~~ 165 (187)
T cd05119 152 --KVYIIDVPQAVEID 165 (187)
T ss_pred --cEEEEECccccccc
Confidence 79999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-15 Score=139.38 Aligned_cols=132 Identities=28% Similarity=0.342 Sum_probs=111.7
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCC--CceeeeeeeeecCCceEEEEeecc
Q psy6820 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH--PNIIKLLDEYDTNNELYLVIELIK 458 (639)
Q Consensus 381 i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ 458 (639)
+++.||.|.++.||++.... ..+++|....... ...+.+|+.+++.+++ .++++++.++...+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 45789999999999998755 5799999865533 4567889999999986 589999998888889999999998
Q ss_pred CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 459 GGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN---YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 459 ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~---givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
|+++..+ +......++.+++.+|++||.. +++|+|++|+||+++..+ .++++|||.+..
T Consensus 77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~----~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK----ILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc----EEEEEecccccC
Confidence 8777654 5567778899999999999985 699999999999999755 799999999853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=148.35 Aligned_cols=135 Identities=19% Similarity=0.272 Sum_probs=102.4
Q ss_pred EEEc-cCCceEEEEEEEcCCCeEEEEEEEccccc------------chhHHHHHHHHHHHHhcCCCce--eeeeeeeecC
Q psy6820 383 QIIG-DGNFAVVRQVYDKHKDMDCALKIIDKSKL------------LGKKQMIENEVNILRSVNHPNI--IKLLDEYDTN 447 (639)
Q Consensus 383 ~~LG-~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~------------~~~~~~~~~Ei~iL~~l~HpnI--v~l~~~~~~~ 447 (639)
..|| .||.|+||.+... +..++||.+..... ......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7888888887654 56799998864321 0122456789999999998775 6777664332
Q ss_pred -Cc---eEEEEeeccC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEee
Q psy6820 448 -NE---LYLVIELIKG-GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGD 522 (639)
Q Consensus 448 -~~---~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~D 522 (639)
.. .++|||+++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||.|||++.++ .++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~----~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG----KFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC----CEEEEE
Confidence 22 3599999997 689888865 3455543 56899999999999999999999999998876 799999
Q ss_pred cccccc
Q psy6820 523 FGLAQR 528 (639)
Q Consensus 523 FGla~~ 528 (639)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999854
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.1e-16 Score=177.11 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=208.1
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..+.+.+.+-+-.|+++.++.+....++...++|+......... .+.+..+-.++-...+|.++.....+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 35678888899999999999988877787777777654433221 2333344444444566888877766666678999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc--
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL-- 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~-- 530 (639)
+++|+.+++|...++..+..+.+.++.+...+..++++||+..+.|+|++|.|+++..++ ..+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g----h~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG----HRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC----CcccCccccccccccc
Confidence 999999999999999888889999999999999999999999999999999999999888 78999998432110
Q ss_pred --------------------------------CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q psy6820 531 --------------------------------RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVS 578 (639)
Q Consensus 531 --------------------------------~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~ 578 (639)
.......||+.|.+||.+.+......+|+|++|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 002245689999999999999999999999999999999999999954
Q ss_pred CCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHH---HHHcCCcccC
Q psy6820 579 DTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAE---DVLDHPWLER 638 (639)
Q Consensus 579 ~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~---eiL~HP~f~~ 638 (639)
...+.+++.+.++....|.- ....+.++++++..+|..+|.+|.++. ++-.||||+.
T Consensus 1038 --~tpq~~f~ni~~~~~~~p~g-~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~ 1097 (1205)
T KOG0606|consen 1038 --ETPQQIFENILNRDIPWPEG-PEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQD 1097 (1205)
T ss_pred --cchhhhhhccccCCCCCCCC-ccccChhhhhhhhhhhccCchhccCcccccccccCCccCC
Confidence 45677888888887666542 246789999999999999999999887 9999999985
|
|
| >PF03607 DCX: Doublecortin; InterPro: IPR003533 X-linked lissencephaly is a severe brain malformation affecting males | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.5e-15 Score=118.40 Aligned_cols=59 Identities=34% Similarity=0.612 Sum_probs=54.4
Q ss_pred EEecCCCCCCHHHHHHhhhhhccCCCccccceeccCCccccccccccccCcEEEEcCCccc
Q psy6820 242 ALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAYGSERV 302 (639)
Q Consensus 242 ~~l~~~~~~~~~~~l~~it~~~~~~~g~v~~lyt~~g~~v~~~~~~~~~~d~yva~G~e~~ 302 (639)
++||+|..+|||++|++||+++++++| ||+|||++|++|+++++ |++++.|||+|.|+|
T Consensus 1 ~~i~~r~~~s~e~lL~~it~~v~l~~g-Vr~lyt~~G~~V~~l~~-l~dg~~yVa~g~e~f 59 (60)
T PF03607_consen 1 VVINPRRFRSFEQLLDEITEKVQLPSG-VRKLYTLDGKRVKSLDE-LEDGGSYVASGREPF 59 (60)
T ss_dssp EEESTTTHSSHHHHHHHHHHSSSSTTS--SEEEETTSSEESSGGG-S-TTEEEEEESSSS-
T ss_pred CeEChhhhcCHHHHHHHHHhhcCCCcc-cceEECCCCCEeCCHHH-HCCCCEEEEEcCCcC
Confidence 578999999999999999999999999 99999999999999999 999999999999986
|
Recently it has been demonstrated that the doublecortin gene is implicated in this disorder []. Doublecortin was found to bind to the microtubule cytoskeleton. In vivo and in vitro assays show that Doublecortin stabilises microtubules and causes bundling []. Doublecortin is a basic protein with an iso-electric point of 10, typical of microtubule-binding proteins. However, its sequence contains no known microtubule-binding domain(s). The detailed sequence analysis of Doublecortin and Doublecortin-like proteins allowed the identification of an evolutionarily conserved Doublecortin (DC) domain. This domain is found in the N terminus of proteins and consists of one or two tandemly repeated copies of an around 80 amino acids region. It has been suggested that the first DC domain of Doublecortin binds tubulin and enhances microtubule polymerisation []. Some proteins known to contain a DC domain are listed below: Doublecortin. It is required for neuronal migration []. A large number of point mutations in the human DCX gene leading to lissencephaly are located within the DC domains []. Human serine/threonine-protein kinase DCAMKL1. It is a probable kinase that may be involved in a calcium-signaling pathway controling neuronal migration in the developing brain []. Retinitis pigmentosa 1 protein. It could play a role in the differentiation of photoreceptor cells. Mutation in the human RP1 gene cause retinitis pigmentosa of type 1 []. ; GO: 0035556 intracellular signal transduction; PDB: 1UF0_A 1MG4_A 1MFW_A 2DNF_A 2XRP_I 2BQQ_A 1MJD_A. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.5e-15 Score=160.33 Aligned_cols=251 Identities=21% Similarity=0.247 Sum_probs=198.7
Q ss_pred CCeeEEEEEcc--CCceEEEEEEE--cCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCce
Q psy6820 377 QRYSVGQIIGD--GNFAVVRQVYD--KHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~--G~fG~Vy~a~~--~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 450 (639)
..|.+.+.+|. |.+|.||.+.. ...+..+|+|.-+..... .....-.+|+...+.+. |+|.++.+..++..+.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45777888999 99999999988 788889999884322211 11122246777777776 99999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVK-FSEEDSKFMTQSLAS----ALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qI~~----aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
++-+|+| +.+|..+...-.. ++...++....+... ||.++|+.+++|-|+||.||++..+. ...+++|||+
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~---~s~~~~df~~ 269 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW---TSCKLTDFGL 269 (524)
T ss_pred eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc---ceeecCCcce
Confidence 9999998 5788888766544 888999999999999 99999999999999999999998883 2789999999
Q ss_pred cccccCCC--------ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC
Q psy6820 526 AQRVLRPM--------FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597 (639)
Q Consensus 526 a~~~~~~~--------~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~ 597 (639)
........ ....|...|++||...+. ++...|+|+||.++.+..++..+........ +..+.+ ..+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~---W~~~r~--~~i 343 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSS---WSQLRQ--GYI 343 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCC---cccccc--ccC
Confidence 98775432 122577889999998765 7999999999999999999887765442211 111111 225
Q ss_pred CCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 598 PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 598 p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
+.++....+.++..++..|++.+|..|++++.+++|+++.
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 6666667788888899999999999999999999999875
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.2e-12 Score=144.70 Aligned_cols=149 Identities=15% Similarity=0.232 Sum_probs=98.6
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc---------------------------------hhHH
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL---------------------------------GKKQ 420 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~---------------------------------~~~~ 420 (639)
.....|+. +.||.|++|.||+|+.+.+|+.||||+.+..... .-.+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 44566776 8999999999999999988999999999754210 0011
Q ss_pred H------HHHHHHHHHhcC----CCceeeeeeee-ecCCceEEEEeeccCCChHHH--HhhcC----CCCHHHHHHHHHH
Q psy6820 421 M------IENEVNILRSVN----HPNIIKLLDEY-DTNNELYLVIELIKGGDLFDA--ISKNV----KFSEEDSKFMTQS 483 (639)
Q Consensus 421 ~------~~~Ei~iL~~l~----HpnIv~l~~~~-~~~~~~~lV~E~~~ggsL~~~--l~~~~----~l~~~~~~~i~~q 483 (639)
. +.+|+..+.+++ +.+.+.+-.++ +-....+|||||+.|+.+.+. +...+ .+.+..+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 1 334555555552 33323222222 224556899999999999774 33322 1333333333333
Q ss_pred HHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 484 I~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+...|++|+|+||.||+++.++.....++++|||++....
T Consensus 276 -------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 -------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4569999999999999998876444579999999996553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.8e-11 Score=135.26 Aligned_cols=145 Identities=20% Similarity=0.270 Sum_probs=99.4
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--------------------------------------
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-------------------------------------- 418 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~-------------------------------------- 418 (639)
..|+ .+.||.|++|.||+|+.+ +|+.||||+.+......-
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred hhCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 3444 367999999999999875 578999999865421100
Q ss_pred -HHHHHHHHHHHHhcC-----CCceeeeeeeeecCCceEEEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHH-HHHH
Q psy6820 419 -KQMIENEVNILRSVN-----HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLAS-ALSY 490 (639)
Q Consensus 419 -~~~~~~Ei~iL~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~-aL~y 490 (639)
+-.+.+|+..+.++. ++++.-..-+.......+|||||++|++|.++.... ... ....++..++. .+..
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQ 272 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHH
Confidence 001345666666653 344322112223344578999999999998876432 112 23456666655 5788
Q ss_pred HHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 491 LHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 491 LH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+|..|++|+|++|.||+++.++ .++|+|||++....
T Consensus 273 l~~~g~~H~D~hPgNilv~~~g----~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLRDGFFHADLHPGNIFVLKDG----KIIALDFGIVGRLS 308 (437)
T ss_pred HHhCCceeCCCCcccEEECCCC----cEEEEeCCCeeECC
Confidence 9999999999999999998887 79999999996553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.9e-12 Score=122.66 Aligned_cols=140 Identities=19% Similarity=0.234 Sum_probs=103.4
Q ss_pred EEEccCCceEEEEEEEcC------CCeEEEEEEEccccc---------------------chhHHHHH----HHHHHHHh
Q psy6820 383 QIIGDGNFAVVRQVYDKH------KDMDCALKIIDKSKL---------------------LGKKQMIE----NEVNILRS 431 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~------~~~~vAiKv~~~~~~---------------------~~~~~~~~----~Ei~iL~~ 431 (639)
..||.|.-+.||.|.... .+..+|||+.+.... ......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997654 357899999753221 01122333 79999999
Q ss_pred cCC--CceeeeeeeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceEE
Q psy6820 432 VNH--PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL-HDNYIVHRDIKPENLLV 508 (639)
Q Consensus 432 l~H--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yL-H~~givHrDLKp~NILl 508 (639)
+.. -++..++++ ..-+|||||+.+..+..-.-+...++..++..+..+++.+|..| |+.|+||+||++.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 963 466677764 45689999997654432222333466677788889999999999 89999999999999999
Q ss_pred ccCCceeeeEEEeeccccccccC
Q psy6820 509 EMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 509 d~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+.+ .+.|+|||.+.....
T Consensus 159 ~~~-----~v~iIDF~qav~~~h 176 (197)
T cd05146 159 HDG-----KVWFIDVSQSVEPTH 176 (197)
T ss_pred ECC-----cEEEEECCCceeCCC
Confidence 754 589999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.4e-11 Score=136.82 Aligned_cols=166 Identities=23% Similarity=0.349 Sum_probs=130.7
Q ss_pred EEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccCCChHHHHhhcCCCCHH
Q psy6820 396 VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEE 475 (639)
Q Consensus 396 a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~ 475 (639)
|..+.++.++.+.+.+...- ...+...+.+.-|+.++||||+++++.++.++.+|||+|.+ -.|..++++.+ ..
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~---~~ 104 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG---KE 104 (690)
T ss_pred cceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH---HH
Confidence 55667777888888876554 34566788899999999999999999999999999999998 36777887644 77
Q ss_pred HHHHHHHHHHHHHHHHH-HCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC---ccccCCCcccCccccccC
Q psy6820 476 DSKFMTQSLASALSYLH-DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM---FTVCGTPTYVAPEILNES 551 (639)
Q Consensus 476 ~~~~i~~qI~~aL~yLH-~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~---~~~~GT~~Y~APE~l~~~ 551 (639)
....-+.||+.||.||| +.+++|++|.-+.|+++..| ..||++|.++....... ....---.|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G----eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG----EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC----cEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence 88888999999999998 57799999999999999998 89999999986543211 111112235666655433
Q ss_pred CCChhhhHHHHHHHHHHHHcCC
Q psy6820 552 GYGVKIDVWAAGVILYILLCGF 573 (639)
Q Consensus 552 ~~s~~sDVwSLGvvL~eLltG~ 573 (639)
. -..|.|.||+++++++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 2 4579999999999999993
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.3e-13 Score=146.66 Aligned_cols=252 Identities=21% Similarity=0.216 Sum_probs=192.5
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEc-CCCeEEEEEEEcccccchhHHH-HHHHHHHHHhcC-CCceeeeeeeeecCCce
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDK-HKDMDCALKIIDKSKLLGKKQM-IENEVNILRSVN-HPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAiKv~~~~~~~~~~~~-~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 450 (639)
....+|..+..||.|.|+.|+.+..+ .++..|++|.+.........+. -..|+.+...+. |.+++..+..|...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 45678999999999999999988755 6777899998765544333222 235777777775 99999999888888888
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|+-.|||+++++...+.-...+.+...+.+..+++.++.++|+..++|+|+||+||++..++ ...++.|||.++.+.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~---~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG---FFSKLGDFGCWTRLA 418 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch---hhhhccccccccccc
Confidence 99999999999887775555688899999999999999999999999999999999998864 378999999997644
Q ss_pred CCCccccCCCccc--CccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 RPMFTVCGTPTYV--APEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 ~~~~~~~GT~~Y~--APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
-......+.-++. +++......+..++|++|||..+.+.++|..--....+ ...+..+.... ......+
T Consensus 419 ~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----~~~i~~~~~p~----~~~~~~~ 489 (524)
T KOG0601|consen 419 FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----SLTIRSGDTPN----LPGLKLQ 489 (524)
T ss_pred eecccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----ceeeecccccC----CCchHHh
Confidence 3333333444454 55555677889999999999999999998754322211 11223332211 1345589
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
++.+.+.+..+|+..|+.+.++..|+=|.
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhh
Confidence 99999999999999999999998887553
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.6e-12 Score=119.37 Aligned_cols=127 Identities=21% Similarity=0.178 Sum_probs=95.2
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCcee-eeeeeeecCCceEEEEeeccCC
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNII-KLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~gg 460 (639)
.+.|+.|.++.||++... +..+++|+...... ....+.+|+.+++.+.+.+++ +++.... ...++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence 467899999999998754 66899999765432 123457899999998755544 4554432 3457999999998
Q ss_pred ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 461 DLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI-----VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 461 sL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~gi-----vHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
++.+.. .....++.+++.+|+.||+.++ +|+|++|.||+++ ++ .++++|||.+.
T Consensus 77 ~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~----~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG----RLWLIDWEYAG 135 (170)
T ss_pred cccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC----eEEEEeccccc
Confidence 876430 1123456789999999999885 9999999999998 43 58999999984
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3757|consensus | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-12 Score=132.22 Aligned_cols=82 Identities=28% Similarity=0.446 Sum_probs=77.0
Q ss_pred cceEEEEEEcCCCCcccEEEEecCCCCCCHHHHHHhhhhhccCCCccccceeccCC-ccccccccccccCcEEEEcCCcc
Q psy6820 223 RPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNG-NQLARLSDFFKSDDVFFAYGSER 301 (639)
Q Consensus 223 ~p~~i~v~rng~~~~~~~~~~l~~~~~~~~~~~l~~it~~~~~~~g~v~~lyt~~g-~~v~~~~~~~~~~d~yva~G~e~ 301 (639)
..|.|.+|||||.+++|++++||.+.+++||.+|+.||+.|+|+.| ||+|||.+| +.|+++.+ |++++.|||.+.+.
T Consensus 28 ~ak~i~fYrnGD~~~~Gv~~vv~~~rv~sfe~Ll~~lt~~v~lp~G-vr~iyT~~G~~~I~slde-ledG~sYV~ss~~~ 105 (301)
T KOG3757|consen 28 KAKRISFYRNGDPYFKGVKFVVNPRRVKSFEPLLEDLTRRVQLPFG-VRHIYTPDGGHRITSLDE-LEDGGSYVASSNEN 105 (301)
T ss_pred CceEEEEeccCCccCCceEEEecccccCchHHHHHhhccccCCCcc-ceeeecCCCCceeccHHH-hhcccceeccCccc
Confidence 4569999999999999999999999999999999999999999999 999999999 99999999 99999999999997
Q ss_pred ccCCc
Q psy6820 302 VLPDD 306 (639)
Q Consensus 302 ~~~dd 306 (639)
|.+-+
T Consensus 106 Fkp~~ 110 (301)
T KOG3757|consen 106 FKPVD 110 (301)
T ss_pred ccccc
Confidence 76643
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.9e-12 Score=127.30 Aligned_cols=199 Identities=20% Similarity=0.276 Sum_probs=143.1
Q ss_pred HHHHHHhcCCCceeeeeeeeecC-----CceEEEEeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy6820 425 EVNILRSVNHPNIIKLLDEYDTN-----NELYLVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNY 495 (639)
Q Consensus 425 Ei~iL~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~g 495 (639)
-...|-++-|-|||+++.+|.+. ....++.||++.|+|..+|++ +..+......+|+-||+.||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34445566799999999988554 457899999999999999965 345888899999999999999999876
Q ss_pred --ceeccCCCCceEEccCCceeeeEEEeecccccccc--------CCCccccCCCcccCccccccCCCChhhhHHHHHHH
Q psy6820 496 --IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--------RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVI 565 (639)
Q Consensus 496 --ivHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~--------~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvv 565 (639)
|+|+++..+-|++..+| .+|+.- +.-.... .....-.+-++|.|||.=.....+-++|||+||..
T Consensus 197 PpiihgnlTc~tifiq~ng----LIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNG----LIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC 271 (458)
T ss_pred CccccCCcchhheeecCCc----eEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence 99999999999999887 566532 1111000 01112346789999998666666789999999999
Q ss_pred HHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 566 LYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 566 L~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
..+|..+..--.. +......-..+.+..+.+. ..--++++.+||+..|..||++.+++.||-+
T Consensus 272 AlemailEiq~tn-seS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 272 ALEMAILEIQSTN-SESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred HHHHHHheeccCC-Ccceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 9999988765321 1111112222222222211 1223468999999999999999999999964
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=4e-10 Score=111.88 Aligned_cols=141 Identities=22% Similarity=0.295 Sum_probs=107.2
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCC--CceeeeeeeeecC---CceEEEEeec
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH--PNIIKLLDEYDTN---NELYLVIELI 457 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~---~~~~lV~E~~ 457 (639)
+.|+.|..+.||++.... +..+++|+............+.+|+.+++.+.+ ..+.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678999999999997644 578999998654432234567899999999975 3456777776654 3678999999
Q ss_pred cCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q psy6820 458 KGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-------------------------------------------- 493 (639)
Q Consensus 458 ~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-------------------------------------------- 493 (639)
+|.++.+.+.. ..+++.....++.+++.+|+.||+
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 99988776532 456777778888888888888884
Q ss_pred ------------CCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 494 ------------NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 494 ------------~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
..++|+|++|.||+++.++. ..+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~--~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEP--RVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCC--cEEEEEeccccc
Confidence 23699999999999987310 268899999884
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.7e-09 Score=103.99 Aligned_cols=131 Identities=21% Similarity=0.249 Sum_probs=97.4
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEE-cccc----cchh--HHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKII-DKSK----LLGK--KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~-~~~~----~~~~--~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
..+++|+-+.+|.+... +..+++|.= .+.- .... .+...+|+.++.++.--.|...+=+..+++...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999988543 334666652 2211 1111 2345689999999986666655555567778889999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
|++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++...+ +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-----i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-----IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-----EEEEECCccc
Confidence 99999999888765 245666777777889999999999999999998764 8999999985
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.4e-10 Score=129.41 Aligned_cols=152 Identities=22% Similarity=0.371 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc------c------ccCCCcccCcccc
Q psy6820 482 QSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF------T------VCGTPTYVAPEIL 548 (639)
Q Consensus 482 ~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~------~------~~GT~~Y~APE~l 548 (639)
.+++.||.|+|. .++||++|.|++|.++.++ ..||+.|+++.....+.. + ..-...|.|||++
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~----~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANG----DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCc----ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 344599999996 5799999999999999998 899999999866543211 1 1235679999999
Q ss_pred ccCCCChhhhHHHHHHHHHHHH-cCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCH
Q psy6820 549 NESGYGVKIDVWAAGVILYILL-CGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSA 627 (639)
Q Consensus 549 ~~~~~s~~sDVwSLGvvL~eLl-tG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta 627 (639)
.+...+.++|+||||+++|.+. .|..-+.........-+.....+... ..+-..+|.++++=+.++|..++..||++
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~--~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA--FGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc--ccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 9988899999999999999999 67766655443333222222221111 12226799999999999999999999999
Q ss_pred HHHHcCCcccCC
Q psy6820 628 EDVLDHPWLERS 639 (639)
Q Consensus 628 ~eiL~HP~f~~~ 639 (639)
.+++.-|||+++
T Consensus 260 ~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 260 DLLLSIPFFSDP 271 (700)
T ss_pred hhhhcccccCCc
Confidence 999999999874
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.3e-09 Score=100.82 Aligned_cols=145 Identities=21% Similarity=0.230 Sum_probs=104.9
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEE-ccc----ccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKII-DKS----KLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 381 i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~-~~~----~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
....|-+|+-+.|+++. ..|+.++||.= .+. .... ...+..+|+..|.++.--.|.-..-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 56788999999999874 45667777752 221 1111 134567899999998755555444445556666799
Q ss_pred EeeccC-CChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 454 IELIKG-GDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 454 ~E~~~g-gsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
|||++| .++.+++.... .........++..|-+.+.-||..+|+|+||.++||++..++.+ ..+-++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~-~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQ-ITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCc-CceEEEeecchhc
Confidence 999976 47888886532 22333336788999999999999999999999999999988744 3568999999854
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.2e-08 Score=105.21 Aligned_cols=212 Identities=17% Similarity=0.176 Sum_probs=152.2
Q ss_pred eEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeee----cCCceEEEEeeccC-CChHHH
Q psy6820 391 AVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYD----TNNELYLVIELIKG-GDLFDA 465 (639)
Q Consensus 391 G~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~----~~~~~~lV~E~~~g-gsL~~~ 465 (639)
.+.|+|....+|..|++|.+......... ..-.-+++++++.|+|+|++.+++. .+..+++|++|.++ ++|.++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 47899999999999999999443322211 1123577899999999999999876 33468999999875 577765
Q ss_pred Hh---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 466 IS---------------KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 466 l~---------------~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
-- .+...+++.+|.++.|++.||.++|+.|+.-+-|.|.+||++.+. +++|+.-|......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~----RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM----RIRISGCGIMDVLQ 444 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc----eEEEecccceeeec
Confidence 51 223478899999999999999999999999999999999998764 68888777664433
Q ss_pred CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 531 RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 531 ~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
... -|-+.+ -.+-|.=.||.+++.|.||..--...+..+..-.+.| ....+.+++
T Consensus 445 ~d~-----------~~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-----------~~~yS~D~r 499 (655)
T KOG3741|consen 445 EDP-----------TEPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-----------TTTYSTDLR 499 (655)
T ss_pred CCC-----------CcchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-----------hhhhhHHHH
Confidence 221 011222 3467999999999999999654222222222212222 135688999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
++|.-+...++++ -++.+++.|
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHH
Confidence 9999998888886 667777643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.8e-08 Score=101.93 Aligned_cols=134 Identities=13% Similarity=0.060 Sum_probs=93.9
Q ss_pred EEEEEEEcCCCeEEEEEEEcccccch----------hHHHHHHHHHHHHhcCCCce--eeeeeeeec-----CCceEEEE
Q psy6820 392 VVRQVYDKHKDMDCALKIIDKSKLLG----------KKQMIENEVNILRSVNHPNI--IKLLDEYDT-----NNELYLVI 454 (639)
Q Consensus 392 ~Vy~a~~~~~~~~vAiKv~~~~~~~~----------~~~~~~~Ei~iL~~l~HpnI--v~l~~~~~~-----~~~~~lV~ 454 (639)
.|+.+. ..|+.|.||......... ....+.+|...+.+|..-+| +.++++.+. ...-+|||
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 455543 345678888764333110 11136788988888853333 344444432 23478999
Q ss_pred eeccCC-ChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccC---CceeeeEEEeeccccc
Q psy6820 455 ELIKGG-DLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMS---GCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 455 E~~~gg-sL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~---g~~~~~vKL~DFGla~ 527 (639)
|++++. +|.+++.. ....+......++.+++..++-||+.||+|+|+++.|||++.+ +.....+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999875 79888853 3456677888999999999999999999999999999999852 1112379999999885
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.7e-08 Score=97.52 Aligned_cols=128 Identities=23% Similarity=0.260 Sum_probs=82.1
Q ss_pred EEEEEEEcCCCeEEEEEEEccccc-------------------------chhHHHHHHHHHHHHhcCCC--ceeeeeeee
Q psy6820 392 VVRQVYDKHKDMDCALKIIDKSKL-------------------------LGKKQMIENEVNILRSVNHP--NIIKLLDEY 444 (639)
Q Consensus 392 ~Vy~a~~~~~~~~vAiKv~~~~~~-------------------------~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~ 444 (639)
.||.|.. ..+..+|+|+...... .......++|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888866 4456899999754211 00123456899999999865 466776553
Q ss_pred ecCCceEEEEeecc--CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCceEEccCCceeeeEEEe
Q psy6820 445 DTNNELYLVIELIK--GGDLFDAISKNVKFSEEDSKFMTQSLASALSY-LHDNYIVHRDIKPENLLVEMSGCHVKVLKVG 521 (639)
Q Consensus 445 ~~~~~~~lV~E~~~--ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~y-LH~~givHrDLKp~NILld~~g~~~~~vKL~ 521 (639)
.-+|||||++ |..+..+.... ++.+....++.+++..+.. +|..||+|+||.+.||+++.++ +.|+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~-----~~iI 148 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGK-----VYII 148 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTC-----EEE-
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecce-----EEEE
Confidence 3469999998 55554433221 2245567777788885555 5799999999999999998774 8999
Q ss_pred eccccccccC
Q psy6820 522 DFGLAQRVLR 531 (639)
Q Consensus 522 DFGla~~~~~ 531 (639)
|||.+.....
T Consensus 149 Df~qav~~~~ 158 (188)
T PF01163_consen 149 DFGQAVDSSH 158 (188)
T ss_dssp -GTTEEETTS
T ss_pred ecCcceecCC
Confidence 9999976543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.9e-07 Score=99.17 Aligned_cols=237 Identities=18% Similarity=0.189 Sum_probs=153.1
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeee------e-ecCCceEE
Q psy6820 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDE------Y-DTNNELYL 452 (639)
Q Consensus 381 i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~------~-~~~~~~~l 452 (639)
.++.||+|+-+.+|..-.- ...+.|++.........+ -+..|... .||-+-.-+.+ . .......+
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aq----k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQ----KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchHHHH----HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 3577999999999975322 245778887655432222 12223333 35543321211 1 12233678
Q ss_pred EEeeccCCC-hHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 453 VIELIKGGD-LFDAI------SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 453 V~E~~~ggs-L~~~l------~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
+|..++|.. +..++ +...-..+.-+.+.++.++.+.+.||..|.+-+|+.++|+|+.+++ .|.|.|-..
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~----~V~LVdsDs 163 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS----KVVLVDSDS 163 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc----eEEEEcccc
Confidence 898887642 22222 1123367888999999999999999999999999999999999887 678887554
Q ss_pred cccccC--CCccccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcC-CCCCCCCCC---ChHHHHHHHHcCC
Q psy6820 526 AQRVLR--PMFTVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCG-FPPFVSDTN---DQDELFDDILSGQ 594 (639)
Q Consensus 526 a~~~~~--~~~~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG-~~Pf~~~~~---~~~~l~~~i~~~~ 594 (639)
-....+ .....+|.+.|.+||.-. +.+-+...|.|.||+++++++.| ++||.+-.. ...-....|..+.
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 433222 233457899999999643 45567889999999999998876 999954211 0000111222221
Q ss_pred C---------CCC---CCCcccccHHHHHHHHHhcccC--CCCCCCHH
Q psy6820 595 Y---------GFP---SPYWDDISEEAKELISHMLESN--PDLRFSAE 628 (639)
Q Consensus 595 ~---------~~p---~~~~~~l~~~l~dLI~~~L~~d--P~~Rpta~ 628 (639)
+ ..| ..-|.-++++++.|..+|+... +.-|||++
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 1 111 1235678999999999998754 46899875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.5e-07 Score=93.72 Aligned_cols=108 Identities=20% Similarity=0.264 Sum_probs=84.8
Q ss_pred HHHHHHHHHHHhcCCC--ceeeeeeeeecC----CceEEEEeeccCC-ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Q psy6820 420 QMIENEVNILRSVNHP--NIIKLLDEYDTN----NELYLVIELIKGG-DLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492 (639)
Q Consensus 420 ~~~~~Ei~iL~~l~Hp--nIv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH 492 (639)
....+|...+..|..- .+.+.+++.+.. ...++|+|++++. +|.+++.....++......++.+++..++-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 4466788888777532 244555555432 2358999999874 89999987555778888999999999999999
Q ss_pred HCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 493 ~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
+.||+|+|+++.|||++.++ ....+.|+||+-+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~-~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDD-GQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCC-CceeEEEEcchhcee
Confidence 99999999999999999875 334799999998854
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.7e-07 Score=93.79 Aligned_cols=138 Identities=22% Similarity=0.244 Sum_probs=103.0
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc---------------------chhHHHHHHHHHHHHhcCCC--
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL---------------------LGKKQMIENEVNILRSVNHP-- 435 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~---------------------~~~~~~~~~Ei~iL~~l~Hp-- 435 (639)
+.++..||-|.-+.||.|.+. .+.++|+|.-..... .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999776 567899998532211 01123356899999999754
Q ss_pred ceeeeeeeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCcee
Q psy6820 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHV 515 (639)
Q Consensus 436 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~ 515 (639)
.+.+.+++ +...+|||+++|-.|...- ++.+.+..++..|++-+.-+-..|+||+|+++-||+++.+|
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg--- 239 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG--- 239 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC---
Confidence 67777754 5667999999987665432 24555666677777777666699999999999999999997
Q ss_pred eeEEEeecccccccc
Q psy6820 516 KVLKVGDFGLAQRVL 530 (639)
Q Consensus 516 ~~vKL~DFGla~~~~ 530 (639)
.+.++||--+....
T Consensus 240 -~~~vIDwPQ~v~~~ 253 (304)
T COG0478 240 -DIVVIDWPQAVPIS 253 (304)
T ss_pred -CEEEEeCcccccCC
Confidence 69999998875543
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.53 E-value=8.2e-09 Score=114.25 Aligned_cols=234 Identities=19% Similarity=0.262 Sum_probs=163.6
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc-eeeeeeeeecCCceEEEEeeccCC-
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN-IIKLLDEYDTNNELYLVIELIKGG- 460 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~gg- 460 (639)
.-+++|+.+++++.+...+.... .+++... ....-++++|.+++||| .+..++.++.++..++.|+++.++
T Consensus 248 h~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 44689999999998766665444 5555432 33345889999999999 788888888889999999999876
Q ss_pred ChHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--Ccccc
Q psy6820 461 DLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--MFTVC 537 (639)
Q Consensus 461 sL~~~l-~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--~~~~~ 537 (639)
+-.... .....+..-+...+.+.-+++|++||+.-=+|+| ||+.... ..|..||+.+..+... ..+..
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~-----~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE-----EVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc-----ccccccccCCcccCcccccccCC
Confidence 222111 1122234444555667778899999998778998 8887654 4899999999877655 55678
Q ss_pred CCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC--CCCCC-CCcccccHHHHHHHH
Q psy6820 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ--YGFPS-PYWDDISEEAKELIS 614 (639)
Q Consensus 538 GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~--~~~p~-~~~~~l~~~l~dLI~ 614 (639)
+|+.++|||+..++.+....|.|++|+--.+|.-|.+|-...... .-.+-.+. ..+-. ..|... .-.++..
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~----~~~~g~~p~s~~L~~~~aw~~~--~~~~~~~ 465 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV----LPMIGNGPNSPMLTDKSAWSPV--FHRDFPA 465 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc----cCCCCCCCCccccchhhhcCcc--cccCCcc
Confidence 999999999999999999999999998877888787775331110 00000000 00000 111111 1114777
Q ss_pred HhcccCCCCCCCHHHHHcCCcccC
Q psy6820 615 HMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 615 ~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.|+...|..|+....++-|.+|.+
T Consensus 466 ~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 466 PCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred cccCCCCCCCcchhhHHHHHHhcc
Confidence 899999999999999999988865
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.8e-06 Score=84.79 Aligned_cols=137 Identities=17% Similarity=0.197 Sum_probs=91.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--------HHHHHHHHHHHhcCC---Cceeeeeeee
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--------QMIENEVNILRSVNH---PNIIKLLDEY 444 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--------~~~~~Ei~iL~~l~H---pnIv~l~~~~ 444 (639)
-.+|++.+++-......|.+. .-++..+++|..........+ ....+++..+.+++. -....++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 367888899988887777654 445578999998654432111 112234444444432 2222323222
Q ss_pred -----ecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEE
Q psy6820 445 -----DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLK 519 (639)
Q Consensus 445 -----~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vK 519 (639)
.-....+|+|||++|..|.+... +++ .++..+.+++.-||+.|+.|+|..|.|+++..++ ++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-----i~ 174 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-----IR 174 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-----EE
Confidence 22345678999999988876542 222 2446677889999999999999999999999775 89
Q ss_pred Eeeccccc
Q psy6820 520 VGDFGLAQ 527 (639)
Q Consensus 520 L~DFGla~ 527 (639)
++||+...
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.4e-06 Score=102.72 Aligned_cols=196 Identities=22% Similarity=0.254 Sum_probs=143.8
Q ss_pred HHHHHHHHHhcCCCceeeeeeeeecCCc----eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy6820 422 IENEVNILRSVNHPNIIKLLDEYDTNNE----LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497 (639)
Q Consensus 422 ~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~giv 497 (639)
.+-|...+.++.|+|++.++.+-..... ..+..|+|+.-++...++.-...+....+.+..++.+||+|+|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 3456677778889999999987644432 345568899999999999999999999999999999999999999666
Q ss_pred eccCCCC---ceEEccCCceeeeEEEe--eccccccccCCCc--cccCCCcccCccccccCCCChh--hhHHHHHHHHHH
Q psy6820 498 HRDIKPE---NLLVEMSGCHVKVLKVG--DFGLAQRVLRPMF--TVCGTPTYVAPEILNESGYGVK--IDVWAAGVILYI 568 (639)
Q Consensus 498 HrDLKp~---NILld~~g~~~~~vKL~--DFGla~~~~~~~~--~~~GT~~Y~APE~l~~~~~s~~--sDVwSLGvvL~e 568 (639)
|.-+..+ +..++..+ .+.++ ||+.......... ....+..|.++|......++.+ .|+|.+|..+..
T Consensus 309 ~v~L~~s~~~~~~~~~e~----~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEG----VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred eeEEecccccccccCccc----eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 5555444 33333333 55555 8888877654432 3345677889998877766544 799999999999
Q ss_pred HHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc-HHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 569 LLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS-EEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 569 LltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~-~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
+..|..+-.-. .. +..+....+ .+..+++.+|+.-++++|+++.+++.|||..
T Consensus 385 ~~~~~~i~~~~-----~~-----------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 385 LSQGEDISEKS-----AV-----------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLR 438 (1351)
T ss_pred hhhcCcccccc-----cc-----------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence 99876553111 11 111111222 2788999999999999999999999999975
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=8.6e-06 Score=80.96 Aligned_cols=140 Identities=17% Similarity=0.148 Sum_probs=99.4
Q ss_pred ccCCceEEEEEEEcCCCeEEEEEEEccccc-----chhHHHHHHHHHHHHhcCCC--ceeeeeeeeec----CCceEEEE
Q psy6820 386 GDGNFAVVRQVYDKHKDMDCALKIIDKSKL-----LGKKQMIENEVNILRSVNHP--NIIKLLDEYDT----NNELYLVI 454 (639)
Q Consensus 386 G~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-----~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~~~----~~~~~lV~ 454 (639)
|.||.+.|+.....+. .+-+|.-..... ......|.+|+..|..|..- .+.++...... .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688888887643333 577776531110 22356788999999999632 24444422111 12357999
Q ss_pred eeccC-CChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 455 ELIKG-GDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 455 E~~~g-gsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
|-+.| .||.+++.+. .+.+......++.+++.+++-||+.|+.|+|+.+.||+++.++ ...++++||.-++..
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g--~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG--KAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC--CeeEEEEEhhccchh
Confidence 98753 5888888653 3567888889999999999999999999999999999998665 135999999987543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1e-05 Score=81.74 Aligned_cols=140 Identities=20% Similarity=0.163 Sum_probs=96.8
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH-------------------HH----HHHHHHHHHhcC--CCc
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-------------------QM----IENEVNILRSVN--HPN 436 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~-------------------~~----~~~Ei~iL~~l~--Hpn 436 (639)
...|..|.-+.||+|.. ..+..+|+|++......... +. ...|...|+++. +=.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34677888889999864 55678999998654432111 11 235888888875 444
Q ss_pred eeeeeeeeecCCceEEEEeeccCCCh-HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCce
Q psy6820 437 IIKLLDEYDTNNELYLVIELIKGGDL-FDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCH 514 (639)
Q Consensus 437 Iv~l~~~~~~~~~~~lV~E~~~ggsL-~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~ 514 (639)
+.+.+++. .-.|||||+....+ .-.|+ .-.+..+++..+..++++.+.-|-. .++||+||+.-|||+..+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~--- 203 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDG--- 203 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECC---
Confidence 55666554 23599999954311 11222 2234444788888899998888877 899999999999999944
Q ss_pred eeeEEEeeccccccccCC
Q psy6820 515 VKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 515 ~~~vKL~DFGla~~~~~~ 532 (639)
.+.|+|||-|.....+
T Consensus 204 --~p~iID~~QaV~~~hp 219 (268)
T COG1718 204 --EPYIIDVSQAVTIDHP 219 (268)
T ss_pred --eEEEEECccccccCCC
Confidence 6899999999766544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=2e-05 Score=79.79 Aligned_cols=72 Identities=24% Similarity=0.236 Sum_probs=54.4
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc--eeeeeeeeecCCceEEEEeeccCC
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN--IIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
..||.|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ +.+.+++....+..++|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 56899999999984 23467889876533 2345688999999986433 467788877778889999999886
Q ss_pred C
Q psy6820 461 D 461 (639)
Q Consensus 461 s 461 (639)
+
T Consensus 80 ~ 80 (226)
T TIGR02172 80 R 80 (226)
T ss_pred c
Confidence 4
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.4e-05 Score=76.69 Aligned_cols=78 Identities=22% Similarity=0.253 Sum_probs=56.4
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCC--ceeeeeeee---ecCCceEEEEee
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP--NIIKLLDEY---DTNNELYLVIEL 456 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~---~~~~~~~lV~E~ 456 (639)
++.|+.|..+.||.+.... + .+++|+.... .....+.+|..+++.+... .+.+++... ......+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 4689999999999987766 3 8999997654 3356677899998888633 355666533 233457899999
Q ss_pred ccCCChHH
Q psy6820 457 IKGGDLFD 464 (639)
Q Consensus 457 ~~ggsL~~ 464 (639)
++|.++..
T Consensus 77 i~g~~~~~ 84 (239)
T PF01636_consen 77 IPGRPLDD 84 (239)
T ss_dssp ESSEEHHH
T ss_pred eccccccc
Confidence 99987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.8e-05 Score=91.98 Aligned_cols=81 Identities=17% Similarity=0.246 Sum_probs=59.8
Q ss_pred EEEEccCCceEEEEEEEcCCC--eEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCce--eeeeeeeecC---CceEEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKD--MDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNI--IKLLDEYDTN---NELYLV 453 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~--~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnI--v~l~~~~~~~---~~~~lV 453 (639)
.+.|+.|.++.+|+......+ ..+++|+............+.+|+.+|+.+. |+++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 577899999999998665432 4678887655433333456789999999996 6665 7888887664 467899
Q ss_pred EeeccCCCh
Q psy6820 454 IELIKGGDL 462 (639)
Q Consensus 454 ~E~~~ggsL 462 (639)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.1e-05 Score=88.35 Aligned_cols=140 Identities=19% Similarity=0.204 Sum_probs=94.7
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh---------------------------------HH------HHH
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK---------------------------------KQ------MIE 423 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~---------------------------------~~------~~~ 423 (639)
+.|+.++-|.||.|+.+. |+.||||+........- .+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 679999999999998776 88999999754321000 01 133
Q ss_pred HHHHHHHhcC-----CCceeeeeeeeecCCceEEEEeeccCCChHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy6820 424 NEVNILRSVN-----HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI--SKNVKFSEEDSKFMTQSLASALSYLHDNYI 496 (639)
Q Consensus 424 ~Ei~iL~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l--~~~~~l~~~~~~~i~~qI~~aL~yLH~~gi 496 (639)
+|+..+.+++ .|++.-..=+++-...-.|+|||+.|..+.+.. +. ..++...+.....++ -+..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 5666666663 344433333344456678999999999888874 33 345533333222222 2344445899
Q ss_pred eeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 497 vHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+|.|..|.||+++.+| .+-+.|||+.....
T Consensus 287 fHaDpHpGNi~v~~~g----~i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVRSDG----RIVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEecCC----cEEEEcCcceecCC
Confidence 9999999999999997 78899999997654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.07 E-value=9e-05 Score=73.40 Aligned_cols=132 Identities=23% Similarity=0.312 Sum_probs=95.2
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccc---------------cchhHHHHHHHHHHHHhcC------CCceeeee
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSK---------------LLGKKQMIENEVNILRSVN------HPNIIKLL 441 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~---------------~~~~~~~~~~Ei~iL~~l~------HpnIv~l~ 441 (639)
..||+|+.-.||. +..+ ...+||+..... .........+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--CCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5789999999997 3443 357899987665 0112244556666666665 78899999
Q ss_pred eeeecCCceEEEEeeccC------CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCcee
Q psy6820 442 DEYDTNNELYLVIELIKG------GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHV 515 (639)
Q Consensus 442 ~~~~~~~~~~lV~E~~~g------gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~ 515 (639)
|+.+++-.+.+|+|.+.+ .+|.+++.+. .+++ .. ...+-+-..||-+.+|+.+|++|.||++...+...
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998653 2678888544 4555 33 33444556788899999999999999998776444
Q ss_pred eeEEEee
Q psy6820 516 KVLKVGD 522 (639)
Q Consensus 516 ~~vKL~D 522 (639)
..+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 4677777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.5e-05 Score=77.57 Aligned_cols=75 Identities=19% Similarity=0.207 Sum_probs=52.6
Q ss_pred EEccCCc-eEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEEeeccCCC
Q psy6820 384 IIGDGNF-AVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVIELIKGGD 461 (639)
Q Consensus 384 ~LG~G~f-G~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggs 461 (639)
.|-.|.. +.||++... +..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 3444555 788987543 3578889876543 234567899988885 4446677887776677899999999987
Q ss_pred hHH
Q psy6820 462 LFD 464 (639)
Q Consensus 462 L~~ 464 (639)
|..
T Consensus 79 l~~ 81 (244)
T cd05150 79 AAA 81 (244)
T ss_pred HhH
Confidence 764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.0001 Score=74.64 Aligned_cols=73 Identities=10% Similarity=0.108 Sum_probs=47.0
Q ss_pred EEEccCCce-EEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCC---ceeeeeeeeecC---CceEEEEe
Q psy6820 383 QIIGDGNFA-VVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP---NIIKLLDEYDTN---NELYLVIE 455 (639)
Q Consensus 383 ~~LG~G~fG-~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~~~---~~~~lV~E 455 (639)
+.|+.|+.. .||+. +..+++|+..... ....+.+|..++..+... -+..+++..... ...+++||
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 457767766 58875 1257788765422 245678899999888632 344555544332 24589999
Q ss_pred eccCCChH
Q psy6820 456 LIKGGDLF 463 (639)
Q Consensus 456 ~~~ggsL~ 463 (639)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00025 Score=79.66 Aligned_cols=209 Identities=17% Similarity=0.165 Sum_probs=119.8
Q ss_pred ccccCcEEEEcCCccccCCcccccHHHHHHHHHhhhhcCCccccccCCCCcccCCCCCCCCCCCCccccccchhhhhhcc
Q psy6820 287 FFKSDDVFFAYGSERVLPDDFELDVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRR 366 (639)
Q Consensus 287 ~~~~~d~yva~G~e~~~~dd~~~~~ee~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~~~~~~~~ 366 (639)
++.+|.+||-.|----.-.|+ +..|++++++.+.+..-. .|... .+.. -..
T Consensus 101 ~~~nGg~yIKlGQ~lst~~dl-lP~Eyv~~L~~LqD~~Pp----------------------~~~ee---~~~i---~e~ 151 (538)
T KOG1235|consen 101 FLRNGGTYIKLGQHLSTRPDL-LPKEYVKTLSELQDQAPP----------------------FPWEE---AFKI---FEE 151 (538)
T ss_pred HHHcCCeEEEechhhcccccc-CcHHHHHHHHHHhccCCC----------------------CCHHH---HHHH---HHH
Confidence 356788888888754433333 446888988887765311 00000 0000 000
Q ss_pred cccCCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh----------------------------
Q psy6820 367 ENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK---------------------------- 418 (639)
Q Consensus 367 ~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~---------------------------- 418 (639)
+--..++++...|. -+.||.-+.|.||+|+.+. |+.||||+-+..-...-
T Consensus 152 ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvd 229 (538)
T KOG1235|consen 152 ELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVD 229 (538)
T ss_pred HhCCCHHHHHHhcC-cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHH
Confidence 11111223333332 3679999999999998887 88999999654321100
Q ss_pred --HH------HHHHHHHHHHhc----CCCc------eeeeeeeeecCCceEEEEeeccCCChHHHH--hhcCCCCHHHHH
Q psy6820 419 --KQ------MIENEVNILRSV----NHPN------IIKLLDEYDTNNELYLVIELIKGGDLFDAI--SKNVKFSEEDSK 478 (639)
Q Consensus 419 --~~------~~~~Ei~iL~~l----~Hpn------Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l--~~~~~l~~~~~~ 478 (639)
.+ .|.+|++...++ .|-+ |.+++-.+ .....|+||||+|..+.|.- .+. .++...+.
T Consensus 230 E~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~ 306 (538)
T KOG1235|consen 230 EIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDIL 306 (538)
T ss_pred HHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHH
Confidence 00 133455444443 3444 34444333 34578999999998776543 333 35554333
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 479 FMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 479 ~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
.-+.++. ++-|=..|++|+|-.|.||++..++.....+.+-|||+......
T Consensus 307 ~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 307 NKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3333222 12233578999999999999996432224788999999876543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00024 Score=68.45 Aligned_cols=129 Identities=19% Similarity=0.194 Sum_probs=90.1
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceee-eeeeeecCCceEEEEeecc
Q psy6820 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK-LLDEYDTNNELYLVIELIK 458 (639)
Q Consensus 380 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~~~~~~~~lV~E~~~ 458 (639)
...+.||+|.+|.||+|..... .+|+|+-..+. ....++.|+.+|..+.-.++.+ ++.+..+ .+.|||+.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~--~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG--EVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc--eEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 3467899999999999876544 78999866543 3567889999999998766654 4444322 35599999
Q ss_pred CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-C-CceEEccCCceeeeEEEeeccccccc
Q psy6820 459 GGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIK-P-ENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 459 ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLK-p-~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
|-.|.+..... +..+. ..++++---|-..||-|+.|. | .||++..+ .+.|+||..|+..
T Consensus 96 G~~L~~~~~~~---~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-----~~~iIDFd~At~k 156 (201)
T COG2112 96 GRPLGKLEIGG---DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-----DVYIIDFDSATFK 156 (201)
T ss_pred Ccchhhhhhcc---cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCC-----cEEEEEccchhhc
Confidence 88887765422 22232 334455445667899999987 3 56666554 4899999999744
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0011 Score=65.74 Aligned_cols=126 Identities=20% Similarity=0.218 Sum_probs=87.8
Q ss_pred CCeeEEEEEccCCc-eEEEEEEEcCCCeEEEEEEEcccc----------cc----------hhHHHHHHHHHHHHhcC--
Q psy6820 377 QRYSVGQIIGDGNF-AVVRQVYDKHKDMDCALKIIDKSK----------LL----------GKKQMIENEVNILRSVN-- 433 (639)
Q Consensus 377 ~~y~i~~~LG~G~f-G~Vy~a~~~~~~~~vAiKv~~~~~----------~~----------~~~~~~~~Ei~iL~~l~-- 433 (639)
..++..+.||.|.- |.||+++.. |+.||+|++..-. .. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67899999999999 999998654 5599999942211 11 01123667777776665
Q ss_pred -CCce--eeeeeeeecC------------------CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Q psy6820 434 -HPNI--IKLLDEYDTN------------------NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492 (639)
Q Consensus 434 -HpnI--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH 492 (639)
+.++ |+++|+..-. ....||.||++... .++... +.+|.+-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 4556 8999986211 12467888876533 233333 345666778899
Q ss_pred HCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 493 ~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
..||+-+|+++.|.. +| ||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~G------~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---GG------KLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---CC------EEEecccC
Confidence 999999999999986 33 89999975
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0018 Score=70.79 Aligned_cols=78 Identities=18% Similarity=0.101 Sum_probs=54.6
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccc------cchhHHHHHHHHHHHHhcC---CCceeeeeeeeecCCceEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSK------LLGKKQMIENEVNILRSVN---HPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~------~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~l 452 (639)
.+.||.|.+..||++.....++.++||.-.... ..-..++...|.+.|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 467899999999999887555689999853111 1123456667888888764 2456777766 3455789
Q ss_pred EEeeccCCC
Q psy6820 453 VIELIKGGD 461 (639)
Q Consensus 453 V~E~~~ggs 461 (639)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0012 Score=66.50 Aligned_cols=75 Identities=19% Similarity=0.201 Sum_probs=49.1
Q ss_pred EEEEccCCceEEEEEEEcC-CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc-eeeeeeeeecCCceEEEEeeccC
Q psy6820 382 GQIIGDGNFAVVRQVYDKH-KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN-IIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~-~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~g 459 (639)
++.|..|-...+|++.... .+..|++|+....... ....++|+.+++.+...+ .+++++.+.. .++|||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCC
Confidence 4677888888999986543 3567899987543211 122347888998886333 4455544332 389999998
Q ss_pred CCh
Q psy6820 460 GDL 462 (639)
Q Consensus 460 gsL 462 (639)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.45 E-value=5.1e-05 Score=91.52 Aligned_cols=219 Identities=18% Similarity=0.098 Sum_probs=146.7
Q ss_pred EEEEEEcccccchh----HHHHHHHHHHHHhcCCCceeeeeeeee--cCCceEEEEeeccCCChHHHHhhc----CCCCH
Q psy6820 405 CALKIIDKSKLLGK----KQMIENEVNILRSVNHPNIIKLLDEYD--TNNELYLVIELIKGGDLFDAISKN----VKFSE 474 (639)
Q Consensus 405 vAiKv~~~~~~~~~----~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~ggsL~~~l~~~----~~l~~ 474 (639)
+.+|+.+....+.- .++...|...++...|+++.....-.. +....|..++|+.+|.+++.|-++ ..+..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 46666654433221 244556777777788999887666543 345678999999999999999543 23334
Q ss_pred HHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEEccCCceeeeEEEeeccccccccC---CCccccCCCcccCcc
Q psy6820 475 EDSKFMTQSLASALSYLHDNY-----IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVCGTPTYVAPE 546 (639)
Q Consensus 475 ~~~~~i~~qI~~aL~yLH~~g-----ivHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~~~~~~GT~~Y~APE 546 (639)
.-+.....+.+.+..-+|+.. .+|++||+-|.+|..+- .+|++++|+.+.... -.....+++.|++|+
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny----~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~ql 1410 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY----NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQL 1410 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCC----cccccccccccccCchHhhhhhhhCCHHHHHHH
Confidence 344444444466777777542 78999999999998775 799999999983322 233567889999999
Q ss_pred ccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC----CCCCCCcccccHHHHHHHHHhcccCCC
Q psy6820 547 ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY----GFPSPYWDDISEEAKELISHMLESNPD 622 (639)
Q Consensus 547 ~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~----~~p~~~~~~l~~~l~dLI~~~L~~dP~ 622 (639)
+...-.++.++|+|..|+.+|+...|..+|. ...+.++.+.. ....++ -.|.++......+|-..-.
T Consensus 1411 i~N~ik~t~rsdilr~s~~ly~rs~~n~~fi-------~flq~~Lkgiidn~tf~sIe~--l~pgdaNve~~~~Ll~K~~ 1481 (2724)
T KOG1826|consen 1411 IKNEIKFTKRSDILRRSLSLYLRSDGNAYFI-------FFLQPALKGIIDNHTFFSIEK--LKPGDANVEALHRLLWKYM 1481 (2724)
T ss_pred HHHHHhhhhHHHHHHHHHHHHHHhcccHHHH-------HHHHHHHcCcccccccccccc--cCCCcccHHHHHHHHHHhh
Confidence 9999999999999999999999999888872 22222222221 111111 1234444555555555566
Q ss_pred CCCCHHHHHcCCcc
Q psy6820 623 LRFSAEDVLDHPWL 636 (639)
Q Consensus 623 ~Rpta~eiL~HP~f 636 (639)
.||.-..++.-+.|
T Consensus 1482 ~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1482 ERPGQYISLSRDHF 1495 (2724)
T ss_pred hcchhhhhcccccc
Confidence 78887777766554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00047 Score=67.76 Aligned_cols=99 Identities=23% Similarity=0.306 Sum_probs=80.2
Q ss_pred HHHHHHHHhcCC-CceeeeeeeeecCCceEEEEeeccCCChHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q psy6820 423 ENEVNILRSVNH-PNIIKLLDEYDTNNELYLVIELIKGGDLFDA---ISKNVKFSEEDSKFMTQSLASALSYLHD---NY 495 (639)
Q Consensus 423 ~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~---l~~~~~l~~~~~~~i~~qI~~aL~yLH~---~g 495 (639)
.+|..+++.+.+ +++++++|+|.+ +++.||...+++... +..-...++..+..++.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 368889999985 799999999933 578899987766421 2222346899999999999999999997 45
Q ss_pred ceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 496 ivHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
+.-.|++++|+-++.++ .+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~----~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDG----RLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCC----cEEEEechhcchh
Confidence 88999999999999887 7999999987544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0026 Score=66.52 Aligned_cols=137 Identities=16% Similarity=0.134 Sum_probs=82.9
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc--eeeeeee------eecCCceEEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN--IIKLLDE------YDTNNELYLV 453 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~------~~~~~~~~lV 453 (639)
.+.|..|....+|++... +..+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..++|
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 466777877899987543 33689998764 12455677888888885322 4455442 1234567899
Q ss_pred EeeccCCChHH-----------HH---hh-cCCC----------CHHHH----------HHHHHHHHHHHHHHHH-----
Q psy6820 454 IELIKGGDLFD-----------AI---SK-NVKF----------SEEDS----------KFMTQSLASALSYLHD----- 493 (639)
Q Consensus 454 ~E~~~ggsL~~-----------~l---~~-~~~l----------~~~~~----------~~i~~qI~~aL~yLH~----- 493 (639)
++|++|..+.. .+ +. ...+ .+... ......+..++.++.+
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99999876532 11 00 0000 00000 0011122334455543
Q ss_pred --CCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 494 --NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 494 --~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
.+++|+|+.|.||+++.++ .+.|+||+.+..
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~----~~~iIDfe~a~~ 205 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDE----LSGVIDFYFACT 205 (296)
T ss_pred CCCcCCccCcCcccEEEeCCc----eEEEeehhhhcC
Confidence 4699999999999999765 568999998853
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0021 Score=65.94 Aligned_cols=132 Identities=15% Similarity=0.138 Sum_probs=75.6
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCce-eeeeeeeecCCceEEEEeeccCCChH
Q psy6820 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI-IKLLDEYDTNNELYLVIELIKGGDLF 463 (639)
Q Consensus 385 LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ggsL~ 463 (639)
+..|-.+.+|+.. .++..+++|+.......- .-...+|..+++.+...++ .+++.... -++||||++|..+.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 4567777889875 345678888865432111 0124678899998864333 34444432 36999999987653
Q ss_pred HH--------------Hh---hc----CCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCceeccCCCC
Q psy6820 464 DA--------------IS---KN----VKFSEE-DSKFMTQSL---------ASALSYLHD--------NYIVHRDIKPE 504 (639)
Q Consensus 464 ~~--------------l~---~~----~~l~~~-~~~~i~~qI---------~~aL~yLH~--------~givHrDLKp~ 504 (639)
.. +. .. .+++.. .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 11 11 111211 111221111 111222222 24899999999
Q ss_pred ceEEccCCceeeeEEEeecccccc
Q psy6820 505 NLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 505 NILld~~g~~~~~vKL~DFGla~~ 528 (639)
||+++.++ +.|+||+.|..
T Consensus 157 Nil~~~~~-----~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-----LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-----CEEEeccccCc
Confidence 99998765 68999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0061 Score=64.03 Aligned_cols=76 Identities=18% Similarity=0.090 Sum_probs=49.1
Q ss_pred EEEEccCCceEEEEEEEcC------CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc-eeeeeeeeecCCceEEEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKH------KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN-IIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~ 454 (639)
++.|..|-...+|++.... .++.+++|+...... ......+|..++..+...+ ..++++.+.. .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 3556677777899886543 257899999765421 1234467888888886333 3455655532 3689
Q ss_pred eeccCCChH
Q psy6820 455 ELIKGGDLF 463 (639)
Q Consensus 455 E~~~ggsL~ 463 (639)
||++|..+.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.016 Score=61.31 Aligned_cols=137 Identities=12% Similarity=0.156 Sum_probs=75.4
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc--eeeeeee------eecCCceEEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN--IIKLLDE------YDTNNELYLV 453 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~------~~~~~~~~lV 453 (639)
.+.|+.|....+|.+... ++ .+++|++.. . ..+.+..|+.++..|...+ +.+++.. ....+..+++
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~-~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER-L---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI 100 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEecc-C---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence 345677777899987643 33 689998752 1 1233445566666653211 3343321 1234567899
Q ss_pred EeeccCCChH-----------HHHh---h-cCCC--------C--H-HH-HHH-----------HH-HHHHHHHHHHH--
Q psy6820 454 IELIKGGDLF-----------DAIS---K-NVKF--------S--E-ED-SKF-----------MT-QSLASALSYLH-- 492 (639)
Q Consensus 454 ~E~~~ggsL~-----------~~l~---~-~~~l--------~--~-~~-~~~-----------i~-~qI~~aL~yLH-- 492 (639)
+||++|..+. ..+. . ...+ . . .. ... .. ..+...++.+.
T Consensus 101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (319)
T PRK05231 101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA 180 (319)
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence 9999887541 1111 0 0001 0 1 00 000 11 11112223332
Q ss_pred -----HCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 493 -----DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 493 -----~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
..+++|+|+.|.||+++.+. ..-|+||+.+..
T Consensus 181 ~~~~lp~~liHgD~~~~Nil~~~~~----~~~iIDf~~~~~ 217 (319)
T PRK05231 181 AWPALPRGVIHADLFRDNVLFEGDR----LSGFIDFYFACN 217 (319)
T ss_pred ccccCCcccCCCCCCCCcEEEECCc----eEEEEecccccC
Confidence 24799999999999998654 457999999854
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.016 Score=61.14 Aligned_cols=138 Identities=19% Similarity=0.221 Sum_probs=81.5
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc--eeeeeeee------ecCCceEE
Q psy6820 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN--IIKLLDEY------DTNNELYL 452 (639)
Q Consensus 381 i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~------~~~~~~~l 452 (639)
..+.++.|....+|++.. .++ .+++|+..... ..+.+..|.+++..|...+ +.+++... ...+..++
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~---~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV---KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCCC---CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 356677887789998754 333 68889875532 1334456777777774222 44544422 22456789
Q ss_pred EEeeccCCChH-----------HHH---hh-cCCC--------CHHH-----HH----------HHHHHHHHHHHHHHH-
Q psy6820 453 VIELIKGGDLF-----------DAI---SK-NVKF--------SEED-----SK----------FMTQSLASALSYLHD- 493 (639)
Q Consensus 453 V~E~~~ggsL~-----------~~l---~~-~~~l--------~~~~-----~~----------~i~~qI~~aL~yLH~- 493 (639)
++||++|.++. ..+ +. ...+ .... .. .....+...++++..
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99999886532 111 10 0001 0000 00 011123345555543
Q ss_pred ------CCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 494 ------NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 494 ------~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
.+++|+|+.+.||+++.++ .+.|+||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~----~~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDS----VKGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCc----eEEEeeccccc
Confidence 6799999999999998875 56899999984
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.011 Score=63.77 Aligned_cols=75 Identities=20% Similarity=0.199 Sum_probs=48.3
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEEccc------ccchhHHHHHHHHHHHHhcC--CCc-eeeeeeeeecCCceEEEE
Q psy6820 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKS------KLLGKKQMIENEVNILRSVN--HPN-IIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 384 ~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~------~~~~~~~~~~~Ei~iL~~l~--Hpn-Iv~l~~~~~~~~~~~lV~ 454 (639)
.||.|....||++.....++.++||.-... ...-..++..-|...|+... -|. +++++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999987654468999984311 12222344556777777664 354 4445443 455567999
Q ss_pred eeccCC
Q psy6820 455 ELIKGG 460 (639)
Q Consensus 455 E~~~gg 460 (639)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0011 Score=69.33 Aligned_cols=136 Identities=23% Similarity=0.270 Sum_probs=94.5
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-----chh----------------HHHHHHHHHHHHhcC-CCc
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-----LGK----------------KQMIENEVNILRSVN-HPN 436 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-----~~~----------------~~~~~~Ei~iL~~l~-Hpn 436 (639)
+.+++.||-|.-+.||.+.+. .|++.++|+-..... ..+ .-...+|...|+.|. |..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567899999999999998654 456788887432211 000 112346888888886 332
Q ss_pred -eeeeeeeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCcee
Q psy6820 437 -IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHV 515 (639)
Q Consensus 437 -Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~ 515 (639)
+.+.++ .+..++|||++.|..|...-+ ...+..+...+..-+.-|-.+|+||+|..--||+++.++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~--- 239 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD--- 239 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC---
Confidence 344444 356789999999988765432 123334455566666777889999999999999999776
Q ss_pred eeEEEeeccccccc
Q psy6820 516 KVLKVGDFGLAQRV 529 (639)
Q Consensus 516 ~~vKL~DFGla~~~ 529 (639)
.++++||--....
T Consensus 240 -~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 240 -KIVVIDFPQMVST 252 (465)
T ss_pred -CEEEeechHhhcc
Confidence 7999999776544
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.014 Score=62.27 Aligned_cols=142 Identities=21% Similarity=0.193 Sum_probs=96.1
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch---------------------hHHH----HHHHHHHHHhcCCC
Q psy6820 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG---------------------KKQM----IENEVNILRSVNHP 435 (639)
Q Consensus 381 i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~---------------------~~~~----~~~Ei~iL~~l~Hp 435 (639)
+-..|..|.-+.||.|... +|..+|||+++.+.+.- ...+ .+.|++.|.+|...
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4566889999999998654 45669999986443211 1122 34688999998765
Q ss_pred ceeeeeeeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEEccCCce
Q psy6820 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH-DNYIVHRDIKPENLLVEMSGCH 514 (639)
Q Consensus 436 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH-~~givHrDLKp~NILld~~g~~ 514 (639)
.|.-.--... ....|||+|+....-..=.-+...++...+..+-.+++.-+.-|- ..++||.||+--|+|+..+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG--- 301 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG--- 301 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC---
Confidence 5432211111 234699999953222211223456777888888888888877775 5789999999999999765
Q ss_pred eeeEEEeecccccccc
Q psy6820 515 VKVLKVGDFGLAQRVL 530 (639)
Q Consensus 515 ~~~vKL~DFGla~~~~ 530 (639)
.+.|+|-+-+....
T Consensus 302 --~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 302 --KLYIIDVSQSVEHD 315 (520)
T ss_pred --EEEEEEccccccCC
Confidence 59999998876554
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.018 Score=62.85 Aligned_cols=76 Identities=22% Similarity=0.279 Sum_probs=50.4
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcc-----cccchhHHHHHHHHHHHHhcC--CCc-eeeeeeeeecCCceEEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDK-----SKLLGKKQMIENEVNILRSVN--HPN-IIKLLDEYDTNNELYLV 453 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~-----~~~~~~~~~~~~Ei~iL~~l~--Hpn-Iv~l~~~~~~~~~~~lV 453 (639)
.+.||.|.-.-||++.+...+..++||.-.. ....-..++..-|.+.|+... -|. +++++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5778999999999998754356799997431 112223455566778887764 454 4455543 45566799
Q ss_pred EeeccC
Q psy6820 454 IELIKG 459 (639)
Q Consensus 454 ~E~~~g 459 (639)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PF11834 DUF3354: Domain of unknown function (DUF3354); InterPro: IPR021789 Potassium channels take part in important processes of higher plants, including opening and closing of stomatal pores and leaf movement | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.013 Score=47.73 Aligned_cols=64 Identities=22% Similarity=0.361 Sum_probs=52.6
Q ss_pred ceEEEEEecCCCCC---CcEEEEECCccccCHHHHHHHHHHHHhhcCCCcccceEeecCCCceeccccccccCCeEE
Q psy6820 100 AKRIRFLCNGDKFF---KGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDGQKVTNIDELEDGKFYI 173 (639)
Q Consensus 100 ~k~v~~~rNgd~~~---~g~~~~v~~~~~~~~~~ll~~~t~~l~~~~~l~~~vr~~~t~~g~~v~~l~~l~~g~~yv 173 (639)
+|||++|+|+-+-- .|+-+.+. .||+.||.-..++++ . ...+||+.||..|.+++-+.||+.-+
T Consensus 1 ~~RVtI~~~~~~~~~~~~GKvi~lP----~SleeLl~ia~~kfg----~--~~~~v~~~dgaeIdDI~~IRDgD~L~ 67 (69)
T PF11834_consen 1 PKRVTIFPNHPPEKGRRAGKVIWLP----DSLEELLKIASEKFG----F--SATKVLNEDGAEIDDIDVIRDGDHLY 67 (69)
T ss_pred CcEEEEecCCCCcccCcCCEEEEcC----ccHHHHHHHHHHHhC----C--CceEEEcCCCCEEeEEEEEEcCCEEE
Confidence 58999998887653 47766655 599999999988855 4 38999999999999999999999754
|
Inward rectifying potassium (K(+)in) channels play an important role in turgor regulation and ion uptake in higher plants. All of them comprise, from their N-terminal to their C-terminal ends: a short hydrophilic region, a hydrophobic region structurally analogous and partially homologous to the transmembrane domain of voltage-gated animal channels from the Shaker superfamily, a putative cyclic nucleotide-binding domain, and a conserved C-terminal KHA domain. Between these last two regions, some of them (AKT1, AKT2 and SKT1) contain an ankyrin-repeat domain with six repeats homologous to those of human erythrocyte ankyrin. This entry represents the KHA domain which is unique to plant K(+)in channels. The KHA domain contains two high-homology blocks enriched for hydrophobic and acidic residues, respectively. The KHA domain is essential for interaction of plant K(+)in channels. The KHA domain mediates tetramerization and/or stabilisation of the heteromers [, , ]. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.022 Score=60.00 Aligned_cols=103 Identities=12% Similarity=0.124 Sum_probs=73.5
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCC---Cceeeeeeeeec---CCceEEEEe
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH---PNIIKLLDEYDT---NNELYLVIE 455 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~---~~~~~lV~E 455 (639)
.+.||.|..+.||.....+ + .+.+|..+.. .....+..|...|+.|.. -.+.++++++.. .+..+||||
T Consensus 19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ-G-NPMPLMARSF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eeecCCccceeEEEEEcCC-C-CEEEEEeccc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 5779999999999975433 3 4677775331 124678899999999863 367888887754 366899999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~ 494 (639)
+++|+++.+. ..+......++.+++++|+-||+.
T Consensus 94 ~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 94 RLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred ccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9999887651 123444556667778888888863
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.0086 Score=66.26 Aligned_cols=163 Identities=20% Similarity=0.232 Sum_probs=100.2
Q ss_pred HHHHHHHHHHHhcCCCceeeeeeeeecC-CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy6820 420 QMIENEVNILRSVNHPNIIKLLDEYDTN-NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498 (639)
Q Consensus 420 ~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givH 498 (639)
..+.-...+++.+.|+|....+++-... ....+|||++ +.+|++.+.... +..... + .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~----------~----~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESL----------L----AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhh----------c----ccccce
Confidence 4455678899999999999999876543 3478899999 669999886643 211111 1 112221
Q ss_pred ccCCCCceEEccCCceeeeEEEeeccccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q psy6820 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVS 578 (639)
Q Consensus 499 rDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~ 578 (639)
.| .++.+| -++... ... ..+++||||+|.++.++.-|...|..
T Consensus 91 -----~~-----------~~~~td-~~~t~~----~~~----------------~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 91 -----LN-----------IIYITD-HFLTKY----PSP----------------IGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred -----eh-----------hhhccc-cccccC----CCC----------------CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 11 234444 111111 011 12499999999999999998777633
Q ss_pred CCCChHHHHHHHHcCCCCCCCC---------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 579 DTNDQDELFDDILSGQYGFPSP---------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 579 ~~~~~~~l~~~i~~~~~~~p~~---------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
... .+..+.+. .-+..+.. ....++.-..+++..|+-..|..||...++.+++-|.+
T Consensus 134 ~~~--s~~l~~i~-k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 134 LTE--SEYLEILL-KYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHH--HHHHHHHH-HhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 221 11111111 11111111 01235777889999999999999999999999987753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.033 Score=58.16 Aligned_cols=30 Identities=27% Similarity=0.514 Sum_probs=24.7
Q ss_pred ceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 496 ivHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
++|+|++|.||+++.++ ...-|+||+.+..
T Consensus 187 lvHGD~~~~Nilv~~~~---~~~gviDWe~a~i 216 (276)
T cd05152 187 LVHGDLHPGHILIDEDA---RVTGLIDWTEAKV 216 (276)
T ss_pred eEeCCCCCCcEEEeCCC---CEEEEECcHhccc
Confidence 89999999999998643 2467999999843
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.05 Score=57.77 Aligned_cols=143 Identities=15% Similarity=0.208 Sum_probs=78.8
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCC--CceeeeeeeeecCC--ceEEEEee
Q psy6820 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH--PNIIKLLDEYDTNN--ELYLVIEL 456 (639)
Q Consensus 381 i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~--~~~lV~E~ 456 (639)
+++.+-.|..-.+|..... ++.+++..-.............+|..+++.+.- --+...++.|.++. ..|.||+|
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3344433333344444333 667888822222333334556788888888753 23445566666555 67999999
Q ss_pred ccCCChHHHHhhc-----------------------------CC---CCHHHHHHHHHH--------------HHHHHHH
Q psy6820 457 IKGGDLFDAISKN-----------------------------VK---FSEEDSKFMTQS--------------LASALSY 490 (639)
Q Consensus 457 ~~ggsL~~~l~~~-----------------------------~~---l~~~~~~~i~~q--------------I~~aL~y 490 (639)
++|..+.+.+... +. +...+...+..+ ...-..+
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 9885332221100 00 001111111111 1122334
Q ss_pred HHHC--------CceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 491 LHDN--------YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 491 LH~~--------givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
|+.+ .++|+|+.+.|++++.++ -+=+.||+++...
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~----~~gVlDwe~~~lG 229 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGR----PTGVLDWELATLG 229 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCC----eeEEEeccccccC
Confidence 4432 289999999999999887 4778999998643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.12 Score=56.68 Aligned_cols=74 Identities=15% Similarity=0.060 Sum_probs=49.7
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEccccc------chhHHHHHHHHHHHHhcC---CCceeeeeeeeecCCceEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL------LGKKQMIENEVNILRSVN---HPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~------~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~l 452 (639)
.+.||.|....||++.+. +..++||.-..... .-...+...|+..|+.+. ..++.+++.++. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 578899999999998763 34689998652111 012233334566666654 347888888876 44678
Q ss_pred EEeeccC
Q psy6820 453 VIELIKG 459 (639)
Q Consensus 453 V~E~~~g 459 (639)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999977
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.088 Score=56.73 Aligned_cols=137 Identities=14% Similarity=0.139 Sum_probs=78.2
Q ss_pred EEEEccCCceEEEEEEEcC----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCce-eeeeeeeecCCceEEEEee
Q psy6820 382 GQIIGDGNFAVVRQVYDKH----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI-IKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~ 456 (639)
.+.|-.|-...+|++.... .++.+++|+....... .-...+|..+++.+..-++ .++++.+... .|+||
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~--~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ef 114 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL--FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEF 114 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe--eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEe
Confidence 3455557778999986432 2467899988654211 1112578888888864333 3556655332 58999
Q ss_pred ccCCChHHH--------------H---hhcC-C----CC-HHHHHHHHHH-----------------HHHHHHHH----H
Q psy6820 457 IKGGDLFDA--------------I---SKNV-K----FS-EEDSKFMTQS-----------------LASALSYL----H 492 (639)
Q Consensus 457 ~~ggsL~~~--------------l---~~~~-~----l~-~~~~~~i~~q-----------------I~~aL~yL----H 492 (639)
+++.+|... + ++.. + +. ...+..+..+ +...+..| .
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 987766321 0 1100 0 11 1222222211 11112122 1
Q ss_pred ----HCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 493 ----DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 493 ----~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
...++|+|+++.|||++..+ ..+.++||..|.
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~---~~~~lID~Eya~ 230 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEET---RAITIIDYEYAS 230 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCC---CcEEEEeehhcc
Confidence 23589999999999998642 269999999885
|
|
| >PF11834 DUF3354: Domain of unknown function (DUF3354); InterPro: IPR021789 Potassium channels take part in important processes of higher plants, including opening and closing of stomatal pores and leaf movement | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.024 Score=46.24 Aligned_cols=64 Identities=17% Similarity=0.333 Sum_probs=48.2
Q ss_pred ceEEEEEEcCCCCcc----cEEEEecCCCCCCHHHHHHhhhhhccCCCccccceeccCCccccccccccccCcEEE
Q psy6820 224 PRIIIVIRNGIRPRK----VVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFF 295 (639)
Q Consensus 224 p~~i~v~rng~~~~~----~~~~~l~~~~~~~~~~~l~~it~~~~~~~g~v~~lyt~~g~~v~~~~~~~~~~d~yv 295 (639)
|++++||.|+ ...+ |.-+.|+ . |||.+|+..++|.+.. ..++++-||-.|.++.-...++..|+
T Consensus 1 ~~RVtI~~~~-~~~~~~~~GKvi~lP-~---SleeLl~ia~~kfg~~---~~~v~~~dgaeIdDI~~IRDgD~L~~ 68 (69)
T PF11834_consen 1 PKRVTIFPNH-PPEKGRRAGKVIWLP-D---SLEELLKIASEKFGFS---ATKVLNEDGAEIDDIDVIRDGDHLYL 68 (69)
T ss_pred CcEEEEecCC-CCcccCcCCEEEEcC-c---cHHHHHHHHHHHhCCC---ceEEEcCCCCEEeEEEEEEcCCEEEE
Confidence 6789999887 3433 5444455 3 9999999999999993 58999999999999877434444443
|
Inward rectifying potassium (K(+)in) channels play an important role in turgor regulation and ion uptake in higher plants. All of them comprise, from their N-terminal to their C-terminal ends: a short hydrophilic region, a hydrophobic region structurally analogous and partially homologous to the transmembrane domain of voltage-gated animal channels from the Shaker superfamily, a putative cyclic nucleotide-binding domain, and a conserved C-terminal KHA domain. Between these last two regions, some of them (AKT1, AKT2 and SKT1) contain an ankyrin-repeat domain with six repeats homologous to those of human erythrocyte ankyrin. This entry represents the KHA domain which is unique to plant K(+)in channels. The KHA domain contains two high-homology blocks enriched for hydrophobic and acidic residues, respectively. The KHA domain is essential for interaction of plant K(+)in channels. The KHA domain mediates tetramerization and/or stabilisation of the heteromers [, , ]. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.12 Score=55.43 Aligned_cols=75 Identities=16% Similarity=0.260 Sum_probs=46.1
Q ss_pred EEEEccCCceEEEEEEEcCC---CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCce-eeeeeeeecCCceEEEEeec
Q psy6820 382 GQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI-IKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~ 457 (639)
.+.|..|-...+|++..... +..|++|+....... --.-.+|..+++.+..-++ .++++++. .+ +|.+|+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~--~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi 92 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY--VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI 92 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe--EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence 34555577778898864432 347889987643211 1112578888888875444 35565553 22 589999
Q ss_pred cCCCh
Q psy6820 458 KGGDL 462 (639)
Q Consensus 458 ~ggsL 462 (639)
+|.+|
T Consensus 93 ~g~~l 97 (330)
T PLN02421 93 NARTL 97 (330)
T ss_pred cCCCC
Confidence 87665
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.22 Score=52.25 Aligned_cols=29 Identities=24% Similarity=0.303 Sum_probs=24.7
Q ss_pred CCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 494 ~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
.+++|+|+.+.||+++.+ .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~-----~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDN-----EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCC-----cEEEEECcccc
Confidence 578999999999999874 47899999774
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.15 Score=53.65 Aligned_cols=74 Identities=14% Similarity=0.254 Sum_probs=49.2
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC---CCceeeeeeeeecCCceEEEEeec
Q psy6820 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN---HPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 381 i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
-.+.|+.|....+|... .+++.+-+|+-.. ....++..|..-|+.|. --.+.+++++....+.-+|||||+
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 35678989999999875 6667899999762 23467889999999984 345778888887777789999999
Q ss_pred cCC
Q psy6820 458 KGG 460 (639)
Q Consensus 458 ~gg 460 (639)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 639 | ||||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-59 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-59 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-59 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-59 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-58 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-58 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-56 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-54 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-54 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-54 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-54 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-53 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-53 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-53 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-53 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-53 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-53 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-51 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-51 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-51 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-51 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-50 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-50 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-50 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-50 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-50 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-50 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-49 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-49 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-49 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-49 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-49 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-49 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-49 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-48 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-48 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-48 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-48 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-48 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-47 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-46 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-46 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-45 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-45 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-45 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-45 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-45 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-45 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-44 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-44 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-44 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-44 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-44 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-44 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-44 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-44 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-44 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-44 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-44 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-44 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-44 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-44 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-44 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-44 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-44 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-44 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-44 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-44 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-44 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-44 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-44 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-44 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-44 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-44 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-44 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-44 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-44 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-44 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-44 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-44 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-44 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-44 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-43 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-43 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-43 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-43 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-43 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-43 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-43 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-43 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-43 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-43 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-43 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-43 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-43 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-43 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-43 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-43 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-43 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-43 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-43 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-43 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-43 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-43 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-43 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-43 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-43 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-43 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-43 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-43 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-43 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-43 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-43 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-43 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-43 | ||
| 4atu_I | 373 | Human Doublecortin N-Dc Repeat Plus Linker, And Tub | 7e-43 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-43 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-43 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-43 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-43 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-43 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-43 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-42 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-42 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-42 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-42 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-42 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-41 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-41 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-41 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-41 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-41 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-41 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-41 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-41 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-41 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-41 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-41 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-41 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-40 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-40 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-40 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-40 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-40 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-40 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-40 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-40 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-40 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-40 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-40 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-40 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-40 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-40 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-39 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-39 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-39 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-39 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-39 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-39 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-39 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-39 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-39 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-39 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-39 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-39 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-39 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-39 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-39 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-39 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-39 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-39 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-39 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-39 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-39 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-38 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-38 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-38 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-38 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-38 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-38 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-38 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-38 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-38 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-38 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-38 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-38 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-38 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-38 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-38 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-38 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-38 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-37 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-37 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-37 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-37 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-37 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-37 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-37 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-37 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-37 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-37 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-37 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-37 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-37 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-37 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-37 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-37 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-37 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-37 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-36 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-36 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-36 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-36 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-36 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-36 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-36 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-36 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-36 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-36 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-35 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-35 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-35 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-35 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-35 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-35 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-34 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-34 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-34 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-34 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-34 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-33 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-33 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-33 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-33 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-33 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-33 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-33 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-33 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-33 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-33 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-33 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-33 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-32 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-32 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-31 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-31 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-31 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-30 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-30 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-30 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-30 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-30 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-30 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-30 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-30 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-30 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-30 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-30 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-30 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-30 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-30 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-30 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-30 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-30 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-30 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-30 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-30 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-30 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-30 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-30 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-30 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-30 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-30 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-30 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-30 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-30 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-30 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-30 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-30 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-30 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-30 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-29 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-29 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-29 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-29 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-29 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-29 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-29 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-29 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-29 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-29 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-29 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-29 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-29 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-28 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-28 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-28 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-28 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-28 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-28 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-28 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-28 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-28 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-28 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-28 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-28 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-27 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-27 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-27 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-27 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-27 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-27 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-26 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-26 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-26 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-26 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-25 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-25 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-25 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-25 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-25 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-25 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-25 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-25 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-25 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-25 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-25 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-25 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-25 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-25 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-24 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-24 | ||
| 2xrp_I | 95 | Human Doublecortin N-Dc Repeat (1mjd) And Mammalian | 2e-24 | ||
| 1mjd_A | 113 | Structure Of N-Terminal Domain Of Human Doublecorti | 3e-24 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-24 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-23 | ||
| 1uf0_A | 116 | Solution Structure Of The N-Terminal Dcx Domain Of | 3e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-23 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-23 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-23 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-23 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-23 | ||
| 2bqq_A | 113 | X-Ray Strucure Of The N-Terminal Domain Of Human Do | 6e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-23 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-23 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-23 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-23 | ||
| 1mg4_A | 113 | Structure Of N-Terminal Doublecortin Domain From Dc | 9e-23 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-22 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-22 | ||
| 1mfw_A | 107 | Structure Of N-Terminal Doublecortin Domain From Dc | 2e-22 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-22 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-22 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-22 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-22 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-22 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-22 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-22 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-22 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-22 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-22 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-22 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-22 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-22 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-22 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-22 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-22 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-22 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-22 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-22 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-22 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-22 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-22 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-22 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-22 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-22 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-22 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-22 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-21 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-21 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-21 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-21 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-21 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-21 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-21 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-21 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-21 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-20 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-20 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-20 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-19 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-19 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-19 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-19 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-19 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-19 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-19 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-19 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-19 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-19 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-19 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-19 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-19 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-19 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-19 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-19 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-19 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-19 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-19 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-19 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-19 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-19 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-19 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-19 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-19 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-19 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-19 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-19 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-19 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-19 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-19 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-19 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-19 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-19 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-19 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-19 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-19 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-19 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-19 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-19 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-19 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-19 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-19 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-19 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-19 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-19 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-19 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-19 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-19 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-19 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-19 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-19 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-19 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-19 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-19 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-19 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-19 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-19 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-19 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-19 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-19 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-19 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-18 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-18 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-18 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-18 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-18 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-18 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-18 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-18 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-18 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-18 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-18 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-18 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-18 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-18 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-18 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-18 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-18 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-18 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-18 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-18 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-18 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-18 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-18 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-18 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-18 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-18 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-18 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-18 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-18 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-18 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-18 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-17 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-17 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-17 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-16 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-15 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-15 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-15 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-15 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-15 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-15 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-14 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-14 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-12 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-12 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-12 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-12 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-11 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-11 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-11 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 |
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4ATU|I Chain I, Human Doublecortin N-Dc Repeat Plus Linker, And Tubulin (2xrp) Docked Into An 8a Cryo-Em Map Of Doublecortin-Stabilised Microtubules Reconstructed In Absence Of Kinesin Length = 373 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XRP|I Chain I, Human Doublecortin N-Dc Repeat (1mjd) And Mammalian Tubulin (1jff And 3hke) Docked Into The 8-Angstrom Cryo-Em Map Of Doublecortin-Stabilised Microtubules Length = 95 | Back alignment and structure |
|
| >pdb|1MJD|A Chain A, Structure Of N-Terminal Domain Of Human Doublecortin Length = 113 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1UF0|A Chain A, Solution Structure Of The N-Terminal Dcx Domain Of Human Doublecortin-Like Kinase Length = 116 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2BQQ|A Chain A, X-Ray Strucure Of The N-Terminal Domain Of Human Doublecortin Length = 113 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1MG4|A Chain A, Structure Of N-Terminal Doublecortin Domain From Dclk: Wild Type Protein Length = 113 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1MFW|A Chain A, Structure Of N-Terminal Doublecortin Domain From Dclk: Selenomethionine Labeled Protein Length = 107 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 379 bits (976), Expect = e-128
Identities = 111/267 (41%), Positives = 167/267 (62%), Gaps = 7/267 (2%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRS 431
+ + + + +++G G F+ V V + ALK I KS + +ENE+ +L+
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKK 62
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL 491
+ H NI+ L D Y++ YLV++L+ GG+LFD I + ++E+D+ + Q + SA+ YL
Sbjct: 63 IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--MFTVCGTPTYVAPEILN 549
H+N IVHRD+KPENLL + K + + DFGL+ ++ + M T CGTP YVAPE+L
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSK-IMITDFGLS-KMEQNGIMSTACGTPGYVAPEVLA 180
Query: 550 ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
+ Y +D W+ GVI YILLCG+PPF +T + +LF+ I G Y F SP+WDDISE A
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPPFYEET--ESKLFEKIKEGYYEFESPFWDDISESA 238
Query: 610 KELISHMLESNPDLRFSAEDVLDHPWL 636
K+ I H+LE +P+ R++ E L HPW+
Sbjct: 239 KDFICHLLEKDPNERYTCEKALSHPWI 265
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-126
Identities = 108/267 (40%), Positives = 153/267 (57%), Gaps = 6/267 (2%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRS 431
+K Y V + +G G F+VVR+ K ++ A KII+ KL + Q +E E I R
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL 491
+ HPNI++L D + YLV +L+ GG+LF+ I +SE D+ Q + +++Y
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILN 549
H N IVHR++KPENLL+ S +K+ DFGLA V GTP Y++PE+L
Sbjct: 122 HSNGIVHRNLKPENLLLA-SKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 550 ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
+ Y +D+WA GVILYILL G+PPF + Q L+ I +G Y +PSP WD ++ EA
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYPSPEWDTVTPEA 238
Query: 610 KELISHMLESNPDLRFSAEDVLDHPWL 636
K LI ML NP R +A+ L PW+
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWI 265
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 372 bits (958), Expect = e-125
Identities = 111/293 (37%), Positives = 159/293 (54%), Gaps = 9/293 (3%)
Query: 347 PKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCA 406
P M + T + + +K Y V + +G G F+VVR+ K ++ A
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNA---STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA 58
Query: 407 LKIIDKSKLLGK-KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDA 465
KII+ KL + Q +E E I R + HPNI++L D + YLV +L+ GG+LF+
Sbjct: 59 AKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFED 118
Query: 466 ISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525
I +SE D+ Q + +++Y H N IVHR++KPENLL+ S +K+ DFGL
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA-SKAKGAAVKLADFGL 177
Query: 526 AQRVL--RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ 583
A V GTP Y++PE+L + Y +D+WA GVILYILL G+PPF + Q
Sbjct: 178 AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--Q 235
Query: 584 DELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
L+ I +G Y +PSP WD ++ EAK LI ML NP R +A+ L PW+
Sbjct: 236 HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 371 bits (955), Expect = e-124
Identities = 114/315 (36%), Positives = 175/315 (55%), Gaps = 14/315 (4%)
Query: 326 RPEHTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRRENL--NIPSKLLQRYSVGQ 383
+ + GT M + T+ A TA++ + + L + V
Sbjct: 5 HHHSSGVDLGT-----ENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVES 59
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDE 443
+G G ++V + K ALK++ K+ K+++ E+ +L ++HPNIIKL +
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 444 YDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKP 503
++T E+ LV+EL+ GG+LFD I + +SE D+ + + A++YLH+N IVHRD+KP
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKP 176
Query: 504 ENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNESGYGVKIDVWA 561
ENLL LK+ DFGL++ V M TVCGTP Y APEIL YG ++D+W+
Sbjct: 177 ENLLYATPAPDAP-LKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWS 235
Query: 562 AGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNP 621
G+I YILLCGF PF + DQ +F IL+ +Y F SP+WD++S AK+L+ ++ +P
Sbjct: 236 VGIITYILLCGFEPFYDERGDQ-FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDP 294
Query: 622 DLRFSAEDVLDHPWL 636
R + L HPW+
Sbjct: 295 KKRLTTFQALQHPWV 309
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-124
Identities = 104/280 (37%), Positives = 157/280 (56%), Gaps = 17/280 (6%)
Query: 370 NIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-------QMI 422
P L Y + + +G G V+ +++ A+KII K K +
Sbjct: 3 VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV 62
Query: 423 ENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQ 482
E E+ IL+ +NHP IIK+ + +D + Y+V+EL++GG+LFD + N + E K
Sbjct: 63 ETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 483 SLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGT 539
+ A+ YLH+N I+HRD+KPEN+L+ + K+ DFG + ++L M T+CGT
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHS-KILGETSLMRTLCGT 179
Query: 540 PTYVAPEILNES---GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596
PTY+APE+L GY +D W+ GVIL+I L G+PPF S+ Q L D I SG+Y
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-SEHRTQVSLKDQITSGKYN 238
Query: 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
F W ++SE+A +L+ +L +P RF+ E+ L HPWL
Sbjct: 239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 368 bits (946), Expect = e-123
Identities = 116/369 (31%), Positives = 190/369 (51%), Gaps = 25/369 (6%)
Query: 287 FFKSDDVFFAYGSERVLPDDFELDVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREV 346
S V + ER E+ + + +R +S +A
Sbjct: 5 HHHSSGVDNKFNKERR-RARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63
Query: 347 PKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCA 406
+ ++ + + + Q+Y +IG G +VVR+ + + A
Sbjct: 64 AQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123
Query: 407 LKIIDKSKLLGKKQMIE-------NEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIK 458
+KI++ + + +E E +ILR V HP+II L+D Y++++ ++LV +L++
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
Query: 459 GGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVL 518
G+LFD +++ V SE++++ + +SL A+S+LH N IVHRD+KPEN+L++ + +
Sbjct: 184 KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN----MQI 239
Query: 519 KVGDFGLAQRVLRP---MFTVCGTPTYVAPEIL------NESGYGVKIDVWAAGVILYIL 569
++ DFG + L P + +CGTP Y+APEIL GYG ++D+WA GVIL+ L
Sbjct: 240 RLSDFGFS-CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298
Query: 570 LCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAED 629
L G PPF Q + I+ GQY F SP WDD S K+LIS +L+ +P+ R +AE
Sbjct: 299 LAGSPPFWHRR--QILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356
Query: 630 VLDHPWLER 638
L HP+ ER
Sbjct: 357 ALQHPFFER 365
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-123
Identities = 101/270 (37%), Positives = 155/270 (57%), Gaps = 12/270 (4%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNIL-RS 431
+ Y V + IG G+++V ++ K +M+ A+KIIDKSK + E+ IL R
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRY 72
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL 491
HPNII L D YD +Y+V EL+KGG+L D I + FSE ++ + ++ + YL
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP----MFTVCGTPTYVAPEI 547
H +VHRD+KP N+L + + +++ DFG A + LR + T C T +VAPE+
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA-KQLRAENGLLMTPCYTANFVAPEV 191
Query: 548 LNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND-QDELFDDILSGQYGFPSPYWDDIS 606
L GY D+W+ GV+LY +L G+ PF + +D +E+ I SG++ YW+ +S
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWL 636
+ AK+L+S ML +P R +A VL HPW+
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 363 bits (933), Expect = e-122
Identities = 108/276 (39%), Positives = 164/276 (59%), Gaps = 7/276 (2%)
Query: 364 KRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMI 422
RENL +RY++ ++G G+F V + D+ + A+K+I+K+ K I
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 423 ENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQ 482
EV +L+ ++HPNI+KL + + ++ Y+V EL GG+LFD I K +FSE D+ + +
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK 128
Query: 483 SLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTP 540
+ S ++Y+H + IVHRD+KPEN+L+E S +K+ DFGL+ M GT
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLE-SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187
Query: 541 TYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
Y+APE+L + Y K DVW+AGVILYILL G PPF + ++ + +G+Y F P
Sbjct: 188 YYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYAFDLP 244
Query: 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
W IS++AK+LI ML +P LR +A L+HPW+
Sbjct: 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 365 bits (940), Expect = e-121
Identities = 104/268 (38%), Positives = 152/268 (56%), Gaps = 7/268 (2%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRS 431
++ + Y + + +G G F+VVR+ + A II+ KL + Q +E E I R
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL 491
+ HPNI++L D YL+ +L+ GG+LF+ I +SE D+ Q + A+ +
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEIL 548
H +VHR++KPENLL+ +K+ DFGLA V F GTP Y++PE+L
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAA-VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 549 NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608
+ YG +D+WA GVILYILL G+PPF + Q L+ I +G Y FPSP WD ++ E
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQIKAGAYDFPSPEWDTVTPE 243
Query: 609 AKELISHMLESNPDLRFSAEDVLDHPWL 636
AK+LI+ ML NP R +A + L HPW+
Sbjct: 244 AKDLINKMLTINPSKRITAAEALKHPWI 271
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-121
Identities = 102/286 (35%), Positives = 158/286 (55%), Gaps = 15/286 (5%)
Query: 363 IKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--- 419
+ + P L Y + + +G G V+ +++ A++II K K
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180
Query: 420 ----QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEE 475
+E E+ IL+ +NHP IIK+ + +D + Y+V+EL++GG+LFD + N + E
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEA 239
Query: 476 DSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPM 533
K + A+ YLH+N I+HRD+KPEN+L+ + K+ DFG ++ + M
Sbjct: 240 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLM 298
Query: 534 FTVCGTPTYVAPEILNES---GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDI 590
T+CGTPTY+APE+L GY +D W+ GVIL+I L G+PPF S+ Q L D I
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-SEHRTQVSLKDQI 357
Query: 591 LSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
SG+Y F W ++SE+A +L+ +L +P RF+ E+ L HPWL
Sbjct: 358 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-121
Identities = 93/271 (34%), Positives = 151/271 (55%), Gaps = 9/271 (3%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-----KQMIENEVN 427
S + Y +G+ +G G FA+VR+ K + A K I K +L ++ IE EVN
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 428 ILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASA 487
ILR + HPNII L D ++ ++ L++EL+ GG+LFD +++ +E+++ + +
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 488 LSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAP 545
+ YLH I H D+KPEN+++ +K+ DFG+A ++ + GTP +VAP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605
EI+N G++ D+W+ GVI YILL G PF+ +T + E +I + Y F Y+ +
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--KQETLTNISAVNYDFDEEYFSNT 238
Query: 606 SEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
SE AK+ I +L +P R + L+H W+
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 358 bits (922), Expect = e-119
Identities = 91/271 (33%), Positives = 144/271 (53%), Gaps = 15/271 (5%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK----KQMIENEVNILRSV 432
Y + ++IG G F+VVR+ ++ A+KI+D +K + ++ E +I +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 433 NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI----SKNVKFSEEDSKFMTQSLASAL 488
HP+I++LL+ Y ++ LY+V E + G DL I +SE + + + AL
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAP 545
Y HDN I+HRD+KP +L+ +K+G FG+A ++ GTP ++AP
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605
E++ YG +DVW GVIL+ILL G PF ++ LF+ I+ G+Y W I
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYG---TKERLFEGIIKGKYKMNPRQWSHI 259
Query: 606 SEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
SE AK+L+ ML +P R + + L+HPWL
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWL 290
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-119
Identities = 95/283 (33%), Positives = 158/283 (55%), Gaps = 15/283 (5%)
Query: 361 ATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-- 418
T+ R+EN++ Y G+ +G G FAVV++ +K + A K I K +
Sbjct: 1 GTVFRQENVD------DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR 54
Query: 419 ---KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEE 475
++ IE EV+IL+ + HPN+I L + Y+ ++ L++EL+ GG+LFD +++ +EE
Sbjct: 55 GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE 114
Query: 476 DSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPM 533
++ + + + + YLH I H D+KPEN+++ +K+ DFGLA ++
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG 593
+ GTP +VAPEI+N G++ D+W+ GVI YILL G PF+ DT + E ++ +
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANVSAV 232
Query: 594 QYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
Y F Y+ + S AK+ I +L +P R + +D L HPW+
Sbjct: 233 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-119
Identities = 94/270 (34%), Positives = 151/270 (55%), Gaps = 9/270 (3%)
Query: 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-----KQMIENEVNI 428
K+ Y +G+ +G G FA+V++ +K ++ A K I K + ++ IE EV+I
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 429 LRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASAL 488
LR V H N+I L D Y+ ++ L++EL+ GG+LFD +++ SEE++ + + +
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPE 546
+YLH I H D+KPEN+++ + +K+ DFGLA + + GTP +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 547 ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606
I+N G++ D+W+ GVI YILL G PF+ DT + E +I S Y F ++ S
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANITSVSYDFDEEFFSHTS 246
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWL 636
E AK+ I +L R + ++ L HPW+
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWI 276
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 353 bits (908), Expect = e-118
Identities = 108/282 (38%), Positives = 162/282 (57%), Gaps = 25/282 (8%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--------GKKQMIEN 424
+ Y +I+G G +VVR+ K + A+KIID + ++
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 425 EVNILRSVN-HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQS 483
EV+ILR V+ HPNII+L D Y+TN +LV +L+K G+LFD +++ V SE++++ + ++
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTP 540
L + LH IVHRD+KPEN+L++ +K+ DFG + L P + VCGTP
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMN----IKLTDFGFS-CQLDPGEKLREVCGTP 187
Query: 541 TYVAPEIL------NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ 594
+Y+APEI+ N GYG ++D+W+ GVI+Y LL G PPF Q + I+SG
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMIMSGN 245
Query: 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
Y F SP WDD S+ K+L+S L P R++AE+ L HP+
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 354 bits (911), Expect = e-118
Identities = 95/270 (35%), Positives = 152/270 (56%), Gaps = 9/270 (3%)
Query: 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-----KQMIENEVNI 428
K+ Y +G+ +G G FA+V++ +K ++ A K I K + ++ IE EV+I
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 429 LRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASAL 488
LR V HPNII L D Y+ ++ L++EL+ GG+LFD +++ SEE++ + + +
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPE 546
+YLH I H D+KPEN+++ + +K+ DFGLA + + GTP +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 547 ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606
I+N G++ D+W+ GVI YILL G PF+ DT + E +I + Y F ++ S
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANITAVSYDFDEEFFSQTS 246
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWL 636
E AK+ I +L R + ++ L HPW+
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWI 276
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-116
Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 7/266 (2%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV 432
+ Q Y++ IG G++ V+ K + A K I K + + E+ I++S+
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-DRFKQEIEIMKSL 63
Query: 433 NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492
+HPNII+L + ++ N ++YLV+EL GG+LF+ + F E D+ + + + SA++Y H
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNE 550
+ HRD+KPEN L + LK+ DFGLA R + M T GTP YV+P++L
Sbjct: 124 KLNVAHRDLKPENFLFL-TDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 182
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610
YG + D W+AGV++Y+LLCG+PPF + T E+ I G + FP W ++S +A+
Sbjct: 183 L-YGPECDEWSAGVMMYVLLCGYPPFSAPT--DSEVMLKIREGTFTFPEKDWLNVSPQAE 239
Query: 611 ELISHMLESNPDLRFSAEDVLDHPWL 636
LI +L +P R ++ L+H W
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWF 265
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-115
Identities = 93/268 (34%), Positives = 144/268 (53%), Gaps = 16/268 (5%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNI 437
+ +G+G+F++ R+ K + A+KII K + E+ L+ HPNI
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME----ANTQKEITALKLCEGHPNI 68
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
+KL + + +LV+EL+ GG+LF+ I K FSE ++ ++ + L SA+S++HD +V
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVV 128
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP----MFTVCGTPTYVAPEILNESGY 553
HRD+KPENLL +K+ DFG A R+ P + T C T Y APE+LN++GY
Sbjct: 129 HRDLKPENLLFT-DENDNLEIKIIDFGFA-RLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTND-----QDELFDDILSGQYGFPSPYWDDISEE 608
D+W+ GVILY +L G PF S E+ I G + F W ++S+E
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE 246
Query: 609 AKELISHMLESNPDLRFSAEDVLDHPWL 636
AK+LI +L +P+ R + + WL
Sbjct: 247 AKDLIQGLLTVDPNKRLKMSGLRYNEWL 274
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 345 bits (886), Expect = e-115
Identities = 97/296 (32%), Positives = 150/296 (50%), Gaps = 32/296 (10%)
Query: 371 IPSKLLQRYSVG-QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNIL 429
+ Y + ++G+G A V+ + + A+KII+K + ++ EV +L
Sbjct: 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-FREVEML 64
Query: 430 RSV-NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASAL 488
H N+++L++ ++ + YLV E ++GG + I K F+E ++ + Q +ASAL
Sbjct: 65 YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----------LRPMFTVCG 538
+LH+ I HRD+KPEN+L E V +K+ DF L + + T CG
Sbjct: 125 DFLHNKGIAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 539 TPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTND----------- 582
+ Y+APE++ S Y + D+W+ GVILYILL G+PPFV
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243
Query: 583 --QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
Q+ LF+ I G+Y FP W IS AK+LIS +L + R SA VL HPW+
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-112
Identities = 81/280 (28%), Positives = 146/280 (52%), Gaps = 11/280 (3%)
Query: 366 RENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENE 425
RENL + + + +G G F V V ++ ++ +K I+K + + IE E
Sbjct: 11 RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE 70
Query: 426 VNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI----SKNVKFSEEDSKFMT 481
+ +L+S++HPNIIK+ + ++ + +Y+V+E +GG+L + I ++ SE +
Sbjct: 71 IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM 130
Query: 482 QSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGT 539
+ + +AL+Y H ++VH+D+KPEN+L + +K+ DFGLA+ GT
Sbjct: 131 KQMMNALAYFHSQHVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKSDEHSTNAAGT 189
Query: 540 PTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599
Y+APE+ K D+W+AGV++Y LL G PF + +E+ + +
Sbjct: 190 ALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTS--LEEVQQKATYKEPNYAV 246
Query: 600 PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
++ +A +L+ ML +P+ R SA VL H W +++
Sbjct: 247 E-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-112
Identities = 97/278 (34%), Positives = 158/278 (56%), Gaps = 18/278 (6%)
Query: 373 SKLLQRYSVG-QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNIL-R 430
+ Y + Q++G G V + + + CALK++ S + EV+ +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ------EVDHHWQ 77
Query: 431 SVNHPNIIKLLDEYDTNNE----LYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSL 484
+ P+I+ +LD Y+ + L +++E ++GG+LF I + + F+E ++ + + +
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 485 ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-PMFTVCGTPTYV 543
+A+ +LH + I HRD+KPENLL S VLK+ DFG A+ + + T C TP YV
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYT-SKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYV 196
Query: 544 APEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND--QDELFDDILSGQYGFPSPY 601
APE+L Y D+W+ GVI+YILLCGFPPF S+T + I GQYGFP+P
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
W ++SE+AK+LI +L+++P R + ++HPW+ +S
Sbjct: 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 336 bits (865), Expect = e-111
Identities = 68/266 (25%), Positives = 134/266 (50%), Gaps = 9/266 (3%)
Query: 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN 433
+L ++Y + + +G G F +V + + K + + +++ E++IL
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIAR 59
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLH 492
H NI+ L + +++ EL ++ E I G D+F+ I + + +E + + AL +LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNE 550
+ I H DI+PEN++ + +K+ +FG A+++ + P Y APE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSST--IKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610
D+W+ G ++Y+LL G PF+++T ++ ++I++ +Y F + +IS EA
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 611 ELISHMLESNPDLRFSAEDVLDHPWL 636
+ + +L R +A + L HPWL
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWL 261
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-111
Identities = 98/319 (30%), Positives = 167/319 (52%), Gaps = 13/319 (4%)
Query: 326 RPEHTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSK---LLQRYSVG 382
R H + K + D + R K +++A A ++ + +K + Y+V
Sbjct: 33 RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92
Query: 383 Q--IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKL 440
+ I+G G F V + + + A KII + K + ++NE++++ ++H N+I+L
Sbjct: 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK-EEVKNEISVMNQLDHANLIQL 151
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
D +++ N++ LV+E + GG+LFD I ++ +E D+ + + + ++H YI+H
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNESGYGVKI 557
D+KPEN+L +K+ DFGLA+R + GTP ++APE++N
Sbjct: 212 DLKPENILCVNRDAKQ--IKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPT 269
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
D+W+ GVI Y+LL G PF+ D E ++IL+ ++ + DISEEAKE IS +L
Sbjct: 270 DMWSVGVIAYMLLSGLSPFLGDN--DAETLNNILACRWDLEDEEFQDISEEAKEFISKLL 327
Query: 618 ESNPDLRFSAEDVLDHPWL 636
R SA + L HPWL
Sbjct: 328 IKEKSWRISASEALKHPWL 346
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 336 bits (863), Expect = e-110
Identities = 82/263 (31%), Positives = 137/263 (52%), Gaps = 8/263 (3%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
Y + + +G G F VV + +K K I+ L K ++NE++I+ ++HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK-YTVKNEISIMNQLHHPK 109
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNY 495
+I L D ++ E+ L++E + GG+LFD I +++ K SE + + L ++H++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNESGY 553
IVH DIKPEN++ E +K+ DFGLA ++ + T + APEI++
Sbjct: 170 IVHLDIKPENIMCETKKASS--VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
G D+WA GV+ Y+LL G PF + E ++ + F + +S EAK+ I
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGED--DLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285
Query: 614 SHMLESNPDLRFSAEDVLDHPWL 636
++L+ P R + D L+HPWL
Sbjct: 286 KNLLQKEPRKRLTVHDALEHPWL 308
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-110
Identities = 108/283 (38%), Positives = 164/283 (57%), Gaps = 7/283 (2%)
Query: 357 RCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL 416
RENL +RY++ ++G G+F V + D+ + A+K+I+K+
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 417 GK-KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEE 475
K I EV +L+ ++HPNI+KL + + ++ Y+V EL GG+LFD I K +FSE
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH 121
Query: 476 DSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPM 533
D+ + + + S ++Y+H + IVHRD+KPEN+L+E S +K+ DFGL+ M
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLE-SKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG 593
GT Y+APE+L + Y K DVW+AGVILYILL G PPF + ++ + +G
Sbjct: 181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETG 237
Query: 594 QYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
+Y F P W IS++AK+LI ML +P LR +A L+HPW+
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 335 bits (862), Expect = e-110
Identities = 97/301 (32%), Positives = 154/301 (51%), Gaps = 18/301 (5%)
Query: 347 PKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCA 406
P P + +K + + + Q++G G V Q+++K A
Sbjct: 32 PAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFA 91
Query: 407 LKIIDKSKLLGKKQMIENEVNIL-RSVNHPNIIKLLDEYDT----NNELYLVIELIKGGD 461
LK++ + EV + R+ P+I++++D Y+ L +V+E + GG+
Sbjct: 92 LKMLQDCPKARR------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 145
Query: 462 LFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLK 519
LF I + F+E ++ + +S+ A+ YLH I HRD+KPENLL S +LK
Sbjct: 146 LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT-SKRPNAILK 204
Query: 520 VGDFGLAQRVL--RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFV 577
+ DFG A+ + T C TP YVAPE+L Y D+W+ GVI+YILLCG+PPF
Sbjct: 205 LTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264
Query: 578 SDTND--QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
S+ + I GQY FP+P W ++SEE K LI ++L++ P R + + ++HPW
Sbjct: 265 SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324
Query: 636 L 636
+
Sbjct: 325 I 325
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 328 bits (843), Expect = e-108
Identities = 84/285 (29%), Positives = 140/285 (49%), Gaps = 16/285 (5%)
Query: 362 TIKRRENLNIPSKLLQRYSV-GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-K 419
+ EN N Y + + +G G FAVVRQ K + A K + K + +
Sbjct: 19 YFQSMENFN------NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR 72
Query: 420 QMIENEVNILRSVNH-PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK--FSEED 476
I +E+ +L P +I L + Y+ +E+ L++E GG++F + SE D
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND 132
Query: 477 SKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMF 534
+ + + + YLH N IVH D+KP+N+L+ S + +K+ DFG+++++ +
Sbjct: 133 VIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS-SIYPLGDIKIVDFGMSRKIGHACELR 191
Query: 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ 594
+ GTP Y+APEILN D+W G+I Y+LL PFV + E + +I
Sbjct: 192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--NQETYLNISQVN 249
Query: 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
+ + +S+ A + I +L NP+ R +AE L H WL++
Sbjct: 250 VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = e-105
Identities = 106/267 (39%), Positives = 156/267 (58%), Gaps = 8/267 (2%)
Query: 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRS 431
RY +++G G+F V DK +CA+K+I K ++ K K+ + EV +L+
Sbjct: 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL 491
++HPNI+KL + ++ YLV E+ GG+LFD I +FSE D+ + + + S ++Y+
Sbjct: 83 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILN 549
H N IVHRD+KPENLL+E S +++ DFGL+ + M GT Y+APE+L+
Sbjct: 143 HKNKIVHRDLKPENLLLE-SKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH 201
Query: 550 ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
+ Y K DVW+ GVILYILL G PPF + ++ + G+Y F P W +SE A
Sbjct: 202 GT-YDEKCDVWSTGVILYILLSGCPPFNGAN--EYDILKKVEKGKYTFELPQWKKVSESA 258
Query: 610 KELISHMLESNPDLRFSAEDVLDHPWL 636
K+LI ML P +R SA D LDH W+
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWI 285
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-105
Identities = 82/319 (25%), Positives = 151/319 (47%), Gaps = 12/319 (3%)
Query: 325 RRPEHTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPS----KLLQRYS 380
P + + +D G+ V T +S I ++ +L Y
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD 160
Query: 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKL 440
+ + +G G F VV +V ++ + A K + K+ + E+ + + HP ++ L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNL 219
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
D ++ +NE+ ++ E + GG+LF+ + ++ K SE+++ + + L ++H+N VH
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 279
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNESGYGVKI 557
D+KPEN++ + LK+ DFGL + + + GT + APE+ G
Sbjct: 280 DLKPENIMFTTKRSNE--LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 337
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
D+W+ GV+ YILL G PF + DE ++ S + + ISE+ K+ I +L
Sbjct: 338 DMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 395
Query: 618 ESNPDLRFSAEDVLDHPWL 636
++P+ R + L+HPWL
Sbjct: 396 LADPNTRMTIHQALEHPWL 414
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-104
Identities = 106/266 (39%), Positives = 158/266 (59%), Gaps = 7/266 (2%)
Query: 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSV 432
L + Y + +G G + V DK ++ A+KII K+ + + EV +L+ +
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 433 NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492
+HPNI+KL D ++ YLV+E KGG+LFD I +KF+E D+ + + + S ++YLH
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNE 550
+ IVHRD+KPENLL+E S ++K+ DFGL+ + M GT Y+APE+L +
Sbjct: 154 KHNIVHRDLKPENLLLE-SKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK 212
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610
Y K DVW+ GVIL+ILL G+PPF T E+ + G+Y F SP W ++SE AK
Sbjct: 213 K-YDEKCDVWSIGVILFILLAGYPPFGGQT--DQEILRKVEKGKYTFDSPEWKNVSEGAK 269
Query: 611 ELISHMLESNPDLRFSAEDVLDHPWL 636
+LI ML+ + R SA+ L+HPW+
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWI 295
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 319 bits (818), Expect = e-104
Identities = 94/317 (29%), Positives = 153/317 (48%), Gaps = 57/317 (17%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL----GKKQMIENEVNI 428
+L ++Y + IG G++ VVR + A+KI++K+K+ + I+ EV +
Sbjct: 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL 81
Query: 429 LRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK----------------- 471
++ ++HPNI +L + Y+ + LV+EL GG L D ++ +
Sbjct: 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 472 -----------------------FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLV 508
E+ + + + SAL YLH+ I HRDIKPEN L
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 509 EMSGCHVKVLKVGDFGLAQRVLRP-------MFTVCGTPTYVAPEILNESG--YGVKIDV 559
+ +K+ DFGL++ + M T GTP +VAPE+LN + YG K D
Sbjct: 202 STNKSFE--IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 560 WAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLES 619
W+AGV+L++LL G PF + +L+ + F +P ++ +S A++L+S++L
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVN--DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNR 317
Query: 620 NPDLRFSAEDVLDHPWL 636
N D RF A L HPW+
Sbjct: 318 NVDERFDAMRALQHPWI 334
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = e-103
Identities = 101/278 (36%), Positives = 156/278 (56%), Gaps = 18/278 (6%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL------------GKKQ 420
K+ + Y + +G G + V +K+ + A+K+I KS+ +
Sbjct: 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 421 MIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFM 480
I NE+++L+S++HPNIIKL D ++ YLV E +GG+LF+ I KF E D+ +
Sbjct: 92 EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 481 TQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCG 538
+ + S + YLH + IVHRDIKPEN+L+E + + +K+ DFGL+ + G
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLE-NKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 539 TPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598
T Y+APE+L + Y K DVW+ GVI+YILLCG+PPF ++ + G+Y F
Sbjct: 211 TAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQN--DQDIIKKVEKGKYYFD 267
Query: 599 SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
W +IS+EAKELI ML + + R +AE+ L+ W+
Sbjct: 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 2e-96
Identities = 63/299 (21%), Positives = 120/299 (40%), Gaps = 40/299 (13%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+ + I+G G A V + K A+K+ + L + E +L+ +NH N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 437 IIKLLD--EYDTNNELYLVIELIKGGDLFDAISKN---VKFSEEDSKFMTQSLASALSYL 491
I+KL E T L++E G L+ + + E + + + + +++L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEIL 548
+N IVHR+IKP N++ + V K+ DFG A R L ++ GT Y+ P++
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA-RELEDDEQFVSLYGTEEYLHPDMY 187
Query: 549 --------NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD--ELFDDILSGQY--- 595
++ YG +D+W+ GV Y G PF + E+ I++G+
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 596 --------------GFPSPYWDDISEEAKE----LISHMLESNPDLRFSAEDVLDHPWL 636
P +S + +++++LE++ + + +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 4e-96
Identities = 85/269 (31%), Positives = 134/269 (49%), Gaps = 35/269 (13%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNIL-RSVNHP 435
Q++G G V Q+++K ALK++ EV + R+ P
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA------RREVELHWRASQCP 71
Query: 436 NIIKLLDEYDT----NNELYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALS 489
+I++++D Y+ L +V+E + GG+LF I + F+E ++ + +S+ A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILN 549
YLH I HRD+KPENLL + +LK+ DFG A E
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFA------------------KETTG 172
Query: 550 ESGYGVKIDVWAAGVILYILLCGFPPFVSDTND--QDELFDDILSGQYGFPSPYWDDISE 607
E Y D+W+ GVI+YILLCG+PPF S+ + I GQY FP+P W ++SE
Sbjct: 173 E-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231
Query: 608 EAKELISHMLESNPDLRFSAEDVLDHPWL 636
E K LI ++L++ P R + + ++HPW+
Sbjct: 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWI 260
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = 4e-95
Identities = 85/300 (28%), Positives = 149/300 (49%), Gaps = 15/300 (5%)
Query: 341 ASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKH 400
A + A A K + + + +RY G+ +G G FA ++ D
Sbjct: 5 ADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDAD 64
Query: 401 KDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIK 458
A KI+ KS LL Q + E++I RS+ H +++ ++ N+ +++V+EL +
Sbjct: 65 TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124
Query: 459 GGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVL 518
L + + +E ++++ + + YLH N ++HRD+K NL + +
Sbjct: 125 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL----EV 180
Query: 519 KVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPP 575
K+GDFGLA +V +CGTP Y+APE+L++ G+ ++DVW+ G I+Y LL G PP
Sbjct: 181 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
Query: 576 FVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
F +T+ E + I +Y P I+ A LI ML+++P R + ++L+ +
Sbjct: 241 F--ETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARPTINELLNDEF 294
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 4e-95
Identities = 81/270 (30%), Positives = 143/270 (52%), Gaps = 15/270 (5%)
Query: 371 IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNI 428
+ + +RY G+ +G G FA ++ D A KI+ KS LL Q + E++I
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 429 LRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASAL 488
RS+ H +++ ++ N+ +++V+EL + L + + +E ++++ + +
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAP 545
YLH N ++HRD+K NL + +K+GDFGLA +V +CGTP Y+AP
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLE----VKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605
E+L++ G+ ++DVW+ G I+Y LL G PPF +T+ E + I +Y P I
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF--ETSCLKETYLRIKKNEYSIPK----HI 238
Query: 606 SEEAKELISHMLESNPDLRFSAEDVLDHPW 635
+ A LI ML+++P R + ++L+ +
Sbjct: 239 NPVAASLIQKMLQTDPTARPTINELLNDEF 268
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 7e-94
Identities = 89/265 (33%), Positives = 141/265 (53%), Gaps = 17/265 (6%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVN 433
L+ + +G+ +G G F V +K ALK++ K++L + EV I +
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
HPNI++L + +YL++E G ++ + K KF E+ + LA+ALSY H
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNE 550
++HRDIKPENLL+ +G LK+ DFG + V P +CGT Y+ PE++
Sbjct: 128 KRVIHRDIKPENLLLGSAGE----LKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610
+ K+D+W+ GV+ Y L G PPF + N E + I ++ FP + ++E A+
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYKRISRVEFTFPD--F--VTEGAR 235
Query: 611 ELISHMLESNPDLRFSAEDVLDHPW 635
+LIS +L+ NP R +VL+HPW
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPW 260
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 1e-93
Identities = 92/270 (34%), Positives = 154/270 (57%), Gaps = 16/270 (5%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL 429
+ ++ + VG ++G G+FA V + H ++ A+K+IDK + + ++NEV I
Sbjct: 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 430 RSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK-FSEEDSKFMTQSLASAL 488
+ HP+I++L + ++ +N +YLV+E+ G++ + VK FSE +++ + + +
Sbjct: 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAP 545
YLH + I+HRD+ NLL+ + +K+ DFGLA ++ P +T+CGTP Y++P
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNM----NIKIADFGLATQLKMPHEKHYTLCGTPNYISP 181
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605
EI S +G++ DVW+ G + Y LL G PPF DT+ + ++ Y PS +
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPF--DTDTVKNTLNKVVLADYEMPS----FL 235
Query: 606 SEEAKELISHMLESNPDLRFSAEDVLDHPW 635
S EAK+LI +L NP R S VLDHP+
Sbjct: 236 SIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 3e-93
Identities = 87/269 (32%), Positives = 141/269 (52%), Gaps = 17/269 (6%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL 429
+ + +G+ +G G F V +K ALK++ KS+L + + E+ I
Sbjct: 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQ 68
Query: 430 RSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALS 489
+ HPNI+++ + + +YL++E G+L+ + K+ +F E+ S + LA AL
Sbjct: 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPE 546
Y H+ ++HRDIKPENLL+ G LK+ DFG + V P T+CGT Y+ PE
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKG----ELKIADFGWS--VHAPSLRRRTMCGTLDYLPPE 182
Query: 547 ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606
++ + K+D+W AGV+ Y L G PPF D+ E I++ FP +S
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPF--DSPSHTETHRRIVNVDLKFPP----FLS 236
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPW 635
+ +K+LIS +L +P R + V++HPW
Sbjct: 237 DGSKDLISKLLRYHPPQRLPLKGVMEHPW 265
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 4e-91
Identities = 70/297 (23%), Positives = 131/297 (44%), Gaps = 44/297 (14%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV 432
+ + ++G G F V + + A+K I ++ K I +EV +L S+
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASL 59
Query: 433 NHPNIIKLLDEY-------------DTNNELYLVIELIKGGDLFDAISKNVKFSEEDS-- 477
NH +++ + + L++ +E + G L+D I + D
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 478 KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA----------- 526
+ Q + ALSY+H I+HRD+KP N+ ++ S +K+GDFGLA
Sbjct: 120 RLFRQ-ILEALSYIHSQGIIHRDLKPMNIFIDESR----NVKIGDFGLAKNVHRSLDILK 174
Query: 527 ------QRVLRPMFTVCGTPTYVAPEILNESG-YGVKIDVWAAGVILYILLCGFPPFVSD 579
+ + GT YVA E+L+ +G Y KID+++ G+I + ++ F
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG--- 231
Query: 580 TNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
++ + + S FP + D+ + K++I +++ +P+ R A +L+ WL
Sbjct: 232 -MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 7e-91
Identities = 64/302 (21%), Positives = 121/302 (40%), Gaps = 40/302 (13%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV 432
S + + I+G G A V + K A+K+ + L + E +L+ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 433 NHPNIIKLLD--EYDTNNELYLVIELIKGGDLFDAISKN---VKFSEEDSKFMTQSLASA 487
NH NI+KL E T L++E G L+ + + E + + + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 488 LSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVA 544
+++L +N IVHR+IKP N++ + V K+ DFG A R L ++ GT Y+
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA-RELEDDEQFVSLYGTEEYLH 183
Query: 545 PEIL--------NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD--ELFDDILSGQ 594
P++ ++ YG +D+W+ GV Y G PF + E+ I++G+
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 595 Y-----------------GFPSPYWDDISEEAKE----LISHMLESNPDLRFSAEDVLDH 633
P +S + +++++LE++ + + +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 634 PW 635
Sbjct: 304 TS 305
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 7e-90
Identities = 78/268 (29%), Positives = 129/268 (48%), Gaps = 13/268 (4%)
Query: 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN 433
++ + + Q +G+G + V+ ++ + A+KI+D + + + I+ E+ I + +N
Sbjct: 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
H N++K N YL +E GG+LFD I ++ E D++ L + + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA-----QRVLRPMFTVCGTPTYVAPEIL 548
I HRDIKPENLL++ LK+ DFGLA R + +CGT YVAPE+L
Sbjct: 124 IGITHRDIKPENLLLDERDN----LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 549 NESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607
+ +DVW+ G++L +L G P+ +D + + D + W I
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPW-DQPSDSCQEYSDWKEKKTYLNP--WKKIDS 236
Query: 608 EAKELISHMLESNPDLRFSAEDVLDHPW 635
L+ +L NP R + D+ W
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRW 264
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 3e-88
Identities = 78/268 (29%), Positives = 129/268 (48%), Gaps = 13/268 (4%)
Query: 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN 433
++ + + Q +G+G + V+ ++ + A+KI+D + + + I+ E+ I + +N
Sbjct: 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
H N++K N YL +E GG+LFD I ++ E D++ L + + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA-----QRVLRPMFTVCGTPTYVAPEIL 548
I HRDIKPENLL++ LK+ DFGLA R + +CGT YVAPE+L
Sbjct: 124 IGITHRDIKPENLLLDERDN----LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 549 NESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607
+ +DVW+ G++L +L G P+ +D + + D + W I
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPW-DQPSDSCQEYSDWKEKKTYLNP--WKKIDS 236
Query: 608 EAKELISHMLESNPDLRFSAEDVLDHPW 635
L+ +L NP R + D+ W
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRW 264
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 1e-85
Identities = 90/270 (33%), Positives = 137/270 (50%), Gaps = 13/270 (4%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRS 431
RY + IG GNF V R + DK A+K I++ + + ++ E+ RS
Sbjct: 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--VQREIINHRS 72
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL 491
+ HPNI++ + T L +++E GG+L++ I +FSE++++F Q L S +SY
Sbjct: 73 LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF--TVCGTPTYVAPEILN 549
H I HRD+K EN L++ G LK+ DFG ++ + + GTP Y+APE+L
Sbjct: 133 HSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190
Query: 550 ESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQD---ELFDDILSGQYGFPSPYWDDI 605
Y G DVW+ GV LY++L G PF D + + ILS +Y P I
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYSIPDDIR--I 247
Query: 606 SEEAKELISHMLESNPDLRFSAEDVLDHPW 635
S E LIS + ++P R S ++ H W
Sbjct: 248 SPECCHLISRIFVADPATRISIPEIKTHSW 277
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 3e-85
Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 29/279 (10%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHP 435
+ YS+ + IG G + V QV ++ K + A+K ++ + + NE+ L +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 436 N--IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
+ II+L D T+ +Y+V+E DL + K + K +++ A+ +H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-----LRPMFTVCGTPTYVAPEIL 548
+ IVH D+KP N L+ +LK+ DFG+A ++ + GT Y+ PE +
Sbjct: 146 HGIVHSDLKPANFLI-----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 549 NESG-----------YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597
+ K DVW+ G ILY + G PF N +L I
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NH 257
Query: 598 PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
+ D ++ ++++ L+ +P R S ++L HP++
Sbjct: 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 5e-85
Identities = 90/268 (33%), Positives = 144/268 (53%), Gaps = 14/268 (5%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRS 431
+ Y + + IG GNFA V+ + A+KIIDK++L Q + EV I++
Sbjct: 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI 70
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL 491
+NHPNI+KL + +T LYL++E GG++FD + + + E++++ + + SA+ Y
Sbjct: 71 LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF--TVCGTPTYVAPEILN 549
H IVHRD+K ENLL++ +K+ DFG + CG P Y APE+
Sbjct: 131 HQKRIVHRDLKAENLLLDADMN----IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ 186
Query: 550 ESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608
Y G ++DVW+ GVILY L+ G PF D + EL + +L G+Y P++ +S +
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPF--DGQNLKELRERVLRGKY--RIPFY--MSTD 240
Query: 609 AKELISHMLESNPDLRFSAEDVLDHPWL 636
+ L+ L NP R + E ++ W+
Sbjct: 241 CENLLKRFLVLNPIKRGTLEQIMKDRWI 268
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 6e-85
Identities = 66/308 (21%), Positives = 125/308 (40%), Gaps = 54/308 (17%)
Query: 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM------------ 421
K + Y + + + G F + + + ALK +KS L K+
Sbjct: 28 KYINDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKS 85
Query: 422 ----IENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK------ 471
+NE+ I+ + + + +E+Y++ E ++ +
Sbjct: 86 KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 472 --FSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528
+ K + +S+ ++ SY+H+ I HRD+KP N+L++ +G +K+ DFG +
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG----RVKLSDFGES-- 199
Query: 529 VLRP---MFTVCGTPTYVAPEILN--ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ 583
+ GT ++ PE + S G K+D+W+ G+ LY++ PF +
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS-L 258
Query: 584 DELFDDILSGQYGFPS---------------PYWDDISEEAKELISHMLESNPDLRFSAE 628
ELF++I + +P + +S E + + L NP R ++E
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318
Query: 629 DVLDHPWL 636
D L H WL
Sbjct: 319 DALKHEWL 326
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 4e-84
Identities = 87/270 (32%), Positives = 144/270 (53%), Gaps = 15/270 (5%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL 429
+ Y +G +G G F V+ + A+KI+++ K+ + I+ E+ L
Sbjct: 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 430 RSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALS 489
+ HP+IIKL T + ++V+E + GG+LFD I K+ + E +++ + Q + SA+
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA--QRVLRPMFTVCGTPTYVAPEI 547
Y H + +VHRD+KPEN+L++ K+ DFGL+ + T CG+P Y APE+
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMN----AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181
Query: 548 LNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606
++ Y G ++D+W+ GVILY LLCG PF D LF I G + P + ++
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPF--DDEHVPTLFKKIRGGVFYIPE--Y--LN 235
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWL 636
L+ HML+ +P R + +D+ +H W
Sbjct: 236 RSVATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 9e-84
Identities = 91/300 (30%), Positives = 148/300 (49%), Gaps = 42/300 (14%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM---------- 421
L +Y++ IG G++ VV+ Y+++ + A+K++ K KL+ +
Sbjct: 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTR 67
Query: 422 ---------------IENEVNILRSVNHPNIIKLLD--EYDTNNELYLVIELIKGGDLFD 464
+ E+ IL+ ++HPN++KL++ + + LY+V EL+ G + +
Sbjct: 68 PAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME 127
Query: 465 AISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524
+ SE+ ++F Q L + YLH I+HRDIKP NLLV G +K+ DFG
Sbjct: 128 VPTLK-PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFG 182
Query: 525 LAQRVLRP---MFTVCGTPTYVAPEILNES--GY-GVKIDVWAAGVILYILLCGFPPFVS 578
++ + GTP ++APE L+E+ + G +DVWA GV LY + G PF
Sbjct: 183 VSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF-- 240
Query: 579 DTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
L I S FP DI+E+ K+LI+ ML+ NP+ R ++ HPW+ R
Sbjct: 241 MDERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 262 bits (673), Expect = 4e-83
Identities = 85/278 (30%), Positives = 138/278 (49%), Gaps = 25/278 (8%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM---IENEVNIL 429
+KL+ +Y +G ++G+G++ V++V D A+KI+ K KL ++ E+ +L
Sbjct: 1 AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 430 RSVNHPNIIKLLD--EYDTNNELYLVIELIKGG--DLFDAISKNVKFSEEDSKFMTQSLA 485
R + H N+I+L+D + ++Y+V+E G ++ D++ + +F + L
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLI 119
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA-----QRVLRPMFTVCGTP 540
L YLH IVH+DIKP NLL+ G LK+ G+A T G+P
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGT----LKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 541 TYVAPEILN-ESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598
+ PEI N + G K+D+W+AGV LY + G PF + ++ +LF++I G Y P
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF--EGDNIYKLFENIGKGSYAIP 233
Query: 599 SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
D +L+ MLE P RFS + H W
Sbjct: 234 ----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 267 bits (683), Expect = 5e-83
Identities = 73/309 (23%), Positives = 127/309 (41%), Gaps = 47/309 (15%)
Query: 364 KRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVY-DKHKDMDCALKIIDKSKLLGKKQMI 422
+ N L +I+G G+ V V+ + A+K + +
Sbjct: 2 RIANIPNFEQSLKNLVVSEKILGYGSSGTV--VFQGSFQGRPVAVKRMLIDFC----DIA 55
Query: 423 ENEVNILR-SVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFS-------E 474
E+ +L S +HPN+I+ T+ LY+ +EL +L D + E
Sbjct: 56 LMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKE 114
Query: 475 EDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKV---------LKVGDFGL 525
+ + + +AS +++LH I+HRD+KP+N+LV S + + DFGL
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 526 AQRV-------LRPMFTVCGTPTYVAPEILNES-------GYGVKIDVWAAGVILYILLC 571
+++ + GT + APE+L ES ID+++ G + Y +L
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 572 -GFPPFVSDTNDQDELFDDILSGQYGFP---SPYWDDISEEAKELISHMLESNPDLRFSA 627
G PF + + I+ G + + + EA +LIS M++ +P R +A
Sbjct: 235 KGKHPFGDKYSRESN----IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA 290
Query: 628 EDVLDHPWL 636
VL HP
Sbjct: 291 MKVLRHPLF 299
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 9e-83
Identities = 69/279 (24%), Positives = 126/279 (45%), Gaps = 29/279 (10%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHP 435
+ YS+ + IG G + V QV ++ K + A+K ++ + + NE+ L +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 436 N--IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
+ II+L D T+ +Y+V+E DL + K + K +++ A+ +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-----LRPMFTVCGTPTYVAPEIL 548
+ IVH D+KP N L+ +LK+ DFG+A ++ + GT Y+ PE +
Sbjct: 127 HGIVHSDLKPANFLI-----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 549 NESG-----------YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597
+ K DVW+ G ILY + G PF N +L I+ +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-AIIDPNH-- 238
Query: 598 PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
+ D ++ ++++ L+ +P R S ++L HP++
Sbjct: 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 9e-83
Identities = 94/284 (33%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILR 430
PS+ + Y V IG G++ +++ K K +D + KQM+ +EVN+LR
Sbjct: 2 PSRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 431 SVNHPNIIKLLDEY--DTNNELYLVIELIKGGDLFDAISK----NVKFSEED-SKFMTQS 483
+ HPNI++ D TN LY+V+E +GGDL I+K EE + MTQ
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ- 119
Query: 484 LASALSYLHD-----NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---- 534
L AL H + ++HRD+KP N+ ++ +K+GDFGLA R+L
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ----NVKLGDFGLA-RILNHDTSFAK 174
Query: 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ 594
T GTP Y++PE +N Y K D+W+ G +LY L PPF Q EL I G+
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF--TAFSQKELAGKIREGK 232
Query: 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
+ S+E E+I+ ML R S E++L++P +
Sbjct: 233 F---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 3e-82
Identities = 84/277 (30%), Positives = 140/277 (50%), Gaps = 19/277 (6%)
Query: 370 NIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNI 428
N+ + +++Y Q IG+G+F V +K I+ S++ K ++ EV +
Sbjct: 17 NLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV 76
Query: 429 LRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAIS--KNVKFSEED-SKFMTQSLA 485
L ++ HPNI++ + ++ N LY+V++ +GGDLF I+ K V F E+ + Q +
Sbjct: 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ-IC 135
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF----TVCGTPT 541
AL ++HD I+HRDIK +N+ + G +++GDFG+A RVL GTP
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDG----TVQLGDFGIA-RVLNSTVELARACIGTPY 190
Query: 542 YVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY 601
Y++PEI Y K D+WA G +LY L F + L I+SG + P
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF--EAGSMKNLVLKIISGSF---PPV 245
Query: 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
S + + L+S + + NP R S +L+ ++ +
Sbjct: 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 4e-82
Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 27/274 (9%)
Query: 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM-------IENEV 426
+ Q+YS +G G F V DK K+ + +K I K K+L + + E+
Sbjct: 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 427 NILRSVNHPNIIKLLDEYDTNNELYLVIEL-IKGGDLFDAISKNVKFSEEDSKFMTQSLA 485
IL V H NIIK+LD ++ LV+E G DLF I ++ + E + ++ + L
Sbjct: 81 AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA--QRVLRPMFTVCGTPTYV 543
SA+ YL I+HRDIK EN+++ +K+ DFG A + +T CGT Y
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFT----IKLIDFGSAAYLERGKLFYTFCGTIEYC 196
Query: 544 APEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602
APE+L + Y G ++++W+ GV LY L+ PF E ++ + P
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF-------CE-LEETVEAAIHPPYL-- 246
Query: 603 DDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
+S+E L+S +L+ P+ R + E ++ PW+
Sbjct: 247 --VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 9e-82
Identities = 80/301 (26%), Positives = 142/301 (47%), Gaps = 27/301 (8%)
Query: 347 PKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCA 406
+P + +A C + L +Y VG ++G G F V ++ A
Sbjct: 13 GLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 72
Query: 407 LKIIDKSKL-----LGKKQMIENEVNILRSVNH--PNIIKLLDEYDTNNELYLVIELIKG 459
+K ++K ++ L + EV +L+ V+ +I+LLD ++ + L++E +
Sbjct: 73 IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 132
Query: 460 -GDLFDAISKNVKFSEEDS-KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKV 517
DLFD I++ EE + F Q + A+ + H+ ++HRDIK EN+L++++ +K+
Sbjct: 133 VQDLFDFITERGALQEELARSFFWQ-VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 191
Query: 518 LKVGDFGLAQRVLRPMF-TVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPP 575
+ DFG + ++ GT Y PE + Y G VW+ G++LY ++CG P
Sbjct: 192 I---DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
Query: 576 FVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
F D ++I+ GQ F +S E + LI L P R + E++ +HPW
Sbjct: 249 FEHD--------EEIIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296
Query: 636 L 636
+
Sbjct: 297 M 297
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 262 bits (670), Expect = 1e-81
Identities = 70/330 (21%), Positives = 132/330 (40%), Gaps = 29/330 (8%)
Query: 326 RPEHTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQII 385
+ G+ + + + + + S + YS+ + I
Sbjct: 5 HHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQI 64
Query: 386 GDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVNHPN--IIKLLD 442
G G + V QV ++ K + A+K ++ + + NE+ L + + II+L D
Sbjct: 65 GSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
T+ +Y+V+E DL + K + K +++ A+ +H + IVH D+K
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRV-----LRPMFTVCGTPTYVAPEILNESG----- 552
P N L+ +LK+ DFG+A ++ + G Y+ PE + +
Sbjct: 183 PANFLI-----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 553 ------YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606
K DVW+ G ILY + G PF N +L I + D
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NHEIEFPDIPE 294
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWL 636
++ ++++ L+ +P R S ++L HP++
Sbjct: 295 KDLQDVLKCCLKRDPKQRISIPELLAHPYV 324
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 6e-81
Identities = 78/276 (28%), Positives = 129/276 (46%), Gaps = 27/276 (9%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM-----IENEVN 427
Y +G ++G G F V + + A+K+I ++++LG + EV
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 428 ILRSVN----HPNIIKLLDEYDTNNELYLVIEL-IKGGDLFDAISKNVKFSEEDSKFMTQ 482
+L V HP +I+LLD ++T LV+E + DLFD I++ E S+
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 483 SLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF-TVCGTPT 541
+ +A+ + H +VHRDIK EN+L+++ K++ DFG + + GT
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI---DFGSGALLHDEPYTDFDGTRV 203
Query: 542 YVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
Y PE ++ Y + VW+ G++LY ++CG PF D +IL + FP+
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--------QEILEAELHFPAH 255
Query: 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
+S + LI L P R S E++L PW+
Sbjct: 256 ----VSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 2e-80
Identities = 88/270 (32%), Positives = 146/270 (54%), Gaps = 15/270 (5%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL 429
+ Y +G +G G F V+ + A+KI+++ K+ + I E+ L
Sbjct: 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 430 RSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALS 489
+ HP+IIKL T +++++V+E + GG+LFD I KN + E++S+ + Q + S +
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA--QRVLRPMFTVCGTPTYVAPEI 547
Y H + +VHRD+KPEN+L++ K+ DFGL+ + T CG+P Y APE+
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMN----AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186
Query: 548 LNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606
++ Y G ++D+W++GVILY LLCG PF D + LF I G + P ++
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPF--DDDHVPTLFKKICDGIFYTPQ----YLN 240
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWL 636
L+ HML+ +P R + +D+ +H W
Sbjct: 241 PSVISLLKHMLQVDPMKRATIKDIREHEWF 270
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 3e-80
Identities = 87/264 (32%), Positives = 141/264 (53%), Gaps = 16/264 (6%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHP 435
Y + + +G+G+F V+ ALK I + L +E E++ L+ + HP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY 495
+IIKL D T ++ +VIE GG+LFD I + + +E++ + Q + A+ Y H +
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLA--QRVLRPMFTVCGTPTYVAPEILNESGY 553
IVHRD+KPENLL++ + +K+ DFGL+ + T CG+P Y APE++N Y
Sbjct: 129 IVHRDLKPENLLLDDNLN----VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 554 -GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612
G ++DVW+ G++LY++L G PF D LF + S Y P +S A+ L
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPF--DDEFIPNLFKKVNSCVYVMPD----FLSPGAQSL 238
Query: 613 ISHMLESNPDLRFSAEDVLDHPWL 636
I M+ ++P R + +++ PW
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWF 262
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 3e-80
Identities = 75/274 (27%), Positives = 118/274 (43%), Gaps = 26/274 (9%)
Query: 378 RYSVGQIIGDGNFAVVRQVY-DKHKDMDCALKIIDKSKLLGKKQMIENEVNILR-SVNHP 435
+ ++G G + VY + D A+K I + EV +LR S HP
Sbjct: 25 SFCPKDVLGHGAEGTI--VYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHP 78
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDN 494
N+I+ Y+ IEL L + + K+ + + Q S L++LH
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 495 YIVHRDIKPENLLVEMSGCHVKV-LKVGDFGLA------QRVLRPMFTVCGTPTYVAPEI 547
IVHRD+KP N+L+ M H K+ + DFGL + V GT ++APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 548 LNES---GYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPY-W 602
L+E +D+++AG + Y ++ G PF + + IL G +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-GKSLQRQAN---ILLGACSLDCLHPE 253
Query: 603 DDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
A+ELI M+ +P R SA+ VL HP+
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 265 bits (677), Expect = 1e-79
Identities = 66/300 (22%), Positives = 129/300 (43%), Gaps = 36/300 (12%)
Query: 370 NIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNIL 429
++P++ + + + +G G F V + + A+K + ++ E+ I+
Sbjct: 7 SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIM 66
Query: 430 RSVNHPNIIKLLDEYDTNNEL------YLVIELIKGGDLFDAISKN---VKFSEEDSKFM 480
+ +NHPN++ + D +L L +E +GGDL +++ E + +
Sbjct: 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 481 TQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVC 537
++SAL YLH+N I+HRD+KPEN++++ G + K+ D G A + L
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQ-PGPQRLIHKIIDLGYA-KELDQGELCTEFV 184
Query: 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597
GT Y+APE+L + Y V +D W+ G + + + GF PF+ N Q + + +
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP--NWQPVQWHGKVREKSNE 242
Query: 598 PSPYWDDIS--------------------EEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
+DD++ + + + ML + R + + +
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 2e-77
Identities = 73/317 (23%), Positives = 116/317 (36%), Gaps = 19/317 (5%)
Query: 327 PEHTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIG 386
L + + + P+ + T + S Q + +G
Sbjct: 8 SSGVDLGTENLYFQSMHQLQPRRVSFRG-EASETLQSPGYDPSRPESFFQQSFQRLSRLG 66
Query: 387 DGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSV-NHPNIIKLLDEY 444
G++ V +V K A+K K + EV V HP ++L +
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126
Query: 445 DTNNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKP 503
+ LYL EL G L E + AL++LH +VH D+KP
Sbjct: 127 EEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKP 185
Query: 504 ENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF--TVCGTPTYVAPEILNESGYGVKIDVWA 561
N+ + G K+GDFGL + G P Y+APE+L YG DV++
Sbjct: 186 ANIFLGPRG----RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFS 240
Query: 562 AGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNP 621
G+ + + C +L L P + +S E + ++ MLE +P
Sbjct: 241 LGLTILEVACNMELP-HGGEGWQQLRQGYL------PPEFTAGLSSELRSVLVMMLEPDP 293
Query: 622 DLRFSAEDVLDHPWLER 638
LR +AE +L P L +
Sbjct: 294 KLRATAEALLALPVLRQ 310
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 7e-77
Identities = 97/302 (32%), Positives = 168/302 (55%), Gaps = 17/302 (5%)
Query: 341 ASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKH 400
A+ + + K +A+ +K+ E + + L ++ + +G G+F V V K
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 401 KDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIK 458
A+KI+DK K++ KQ+ NE IL++VN P ++KL + N+ LY+V+E +
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 459 GGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVL 518
GG++F + + +FSE ++F + YLH +++RD+KPENLL++ G +++V
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVT 183
Query: 519 KVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVS 578
DFG A+RV +T+CGTP +APEI+ GY +D WA GV++Y + G+PPF +
Sbjct: 184 ---DFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 579 DTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF-----SAEDVLDH 633
D ++++ I+SG+ FPS S + K+L+ ++L+ + RF D+ +H
Sbjct: 241 D--QPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294
Query: 634 PW 635
W
Sbjct: 295 KW 296
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 1e-76
Identities = 80/301 (26%), Positives = 147/301 (48%), Gaps = 24/301 (7%)
Query: 349 MPTKTSVARCATATIKRRENLNIPSKL-LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCAL 407
M + R +++ + P K + + G+I+G+G+F+ V + + A+
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60
Query: 408 KIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDA 465
KI++K ++ + ++ + E +++ ++HP +KL + + +LY + K G+L
Sbjct: 61 KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120
Query: 466 ISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525
I K F E ++F T + SAL YLH I+HRD+KPEN+L+ H+ ++ DFG
Sbjct: 121 IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HI---QITDFGT 176
Query: 526 AQRVLRPM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDT 580
A+ + + GT YV+PE+L E D+WA G I+Y L+ G PPF +
Sbjct: 177 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG- 235
Query: 581 NDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF------SAEDVLDHP 634
++ +F I+ +Y FP + +A++L+ +L + R + HP
Sbjct: 236 -NEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 290
Query: 635 W 635
+
Sbjct: 291 F 291
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 2e-76
Identities = 87/309 (28%), Positives = 141/309 (45%), Gaps = 26/309 (8%)
Query: 339 LDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYD 398
+D + + P + A ++ L + + + IG G F+ V +
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRP-------DMGYNTLANFRIEKKIGRGQFSEVYRAAC 53
Query: 399 KHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456
+ ALK + L+ K E+++L+ +NHPN+IK + +NEL +V+EL
Sbjct: 54 LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113
Query: 457 IKGGDLFDAI----SKNVKFSEED-SKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMS 511
GDL I + E K+ Q L SAL ++H ++HRDIKP N+ + +
Sbjct: 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ-LCSALEHMHSRRVMHRDIKPANVFITAT 172
Query: 512 GCHVKVLKVGDFGLAQRVLRPMF----TVCGTPTYVAPEILNESGYGVKIDVWAAGVILY 567
G V+K+GD GL R ++ GTP Y++PE ++E+GY K D+W+ G +LY
Sbjct: 173 G----VVKLGDLGLG-RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 227
Query: 568 ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSA 627
+ PF D + L I Y P P D SEE ++L++ + +P+ R
Sbjct: 228 EMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPS-DHYSEELRQLVNMCINPDPEKRPDV 285
Query: 628 EDVLDHPWL 636
V D
Sbjct: 286 TYVYDVAKR 294
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 1e-75
Identities = 58/290 (20%), Positives = 113/290 (38%), Gaps = 43/290 (14%)
Query: 371 IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILR 430
+ + + ++IG G F V + + +K + + E EV L
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY-----NNEKAEREVKALA 59
Query: 431 SVNHPNIIKLLD----------------EYDTNNELYLVIELIKGGDLFDAISK--NVKF 472
++H NI+ L++ +E G L I K K
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 473 SEEDS-KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531
+ + + Q + + Y+H +++RD+KP N+ + + +K+GDFGL L+
Sbjct: 120 DKVLALELFEQ-ITKGVDYIHSKKLINRDLKPSNIFLVDTK----QVKIGDFGLV-TSLK 173
Query: 532 P---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFD 588
GT Y++PE ++ YG ++D++A G+IL LL + + F
Sbjct: 174 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA----FETSKFFT 229
Query: 589 DILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
D+ G + ++ K L+ +L P+ R + ++L + +
Sbjct: 230 DLRDGI--ISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 3e-75
Identities = 67/298 (22%), Positives = 117/298 (39%), Gaps = 37/298 (12%)
Query: 366 RENLNIPSKLLQ----RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM 421
RENL ++ Y Q +G+G F+ V V H ALK I + ++
Sbjct: 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-QDREE 72
Query: 422 IENEVNILRSVNHPNIIKLLD----EYDTNNELYLVIELIKGGDLFDAI----SKNVKFS 473
+ E ++ R NHPNI++L+ E +E +L++ K G L++ I K +
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 474 EEDS-KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532
E+ + + L +H HRD+KP N+L+ G + D G +
Sbjct: 133 EDQILWLLLG-ICRGLEAIHAKGYAHRDLKPTNILLGDEG----QPVLMDLGSMNQACIH 187
Query: 533 MF------------TVCGTPTYVAPEILNESGYGV---KIDVWAAGVILYILLCGFPPFV 577
+ T +Y APE+ + + V + DVW+ G +LY ++ G P+
Sbjct: 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY- 246
Query: 578 SDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
+ + + Q P S +L++ M+ +P R +L
Sbjct: 247 DMVFQKGDSVALAVQNQLSIPQS--PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 4e-75
Identities = 83/267 (31%), Positives = 151/267 (56%), Gaps = 17/267 (6%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVN 433
LQ + + + +G G+F V + +H A+K++ K ++ KQ+ +E +L V
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
HP II++ + +++++++ I+GG+LF + K+ +F +KF + AL YLH
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGY 553
I++RD+KPEN+L++ +G H+ K+ DFG A+ V +T+CGTP Y+APE+++ Y
Sbjct: 125 KDIIYRDLKPENILLDKNG-HI---KITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPY 180
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
ID W+ G+++Y +L G+ PF + + ++ IL+ + FP +E+ K+L+
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAELRFPP----FFNEDVKDLL 234
Query: 614 SHMLESNPDLRF-----SAEDVLDHPW 635
S ++ + R EDV +HPW
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 5e-71
Identities = 68/296 (22%), Positives = 126/296 (42%), Gaps = 43/296 (14%)
Query: 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN 433
+ L + Q +G G F VV + +K D + A+K I ++ + EV L +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 434 HPNIIKLLDEYDTNNE------------LYLVIELIKGGDLFDAIS--KNVKFSEEDS-- 477
HP I++ + + N LY+ ++L + +L D ++ ++ E
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 478 KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA----------- 526
Q +A A+ +LH ++HRD+KP N+ M V+KVGDFGL
Sbjct: 122 HIFLQ-IAEAVEFLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQT 176
Query: 527 ----QRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND 582
GT Y++PE ++ + Y K+D+++ G+IL+ LL F S +
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPF----STQME 232
Query: 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
+ D+ + ++ P + ++ ML +P R A +++++ E
Sbjct: 233 RVRTLTDVRNLKF---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 9e-71
Identities = 80/261 (30%), Positives = 135/261 (51%), Gaps = 17/261 (6%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLD 442
IG G+F V V A+K ++K K + + ++ + E+ I++ + HP ++ L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
+ ++++V++L+ GGDL + +NV F EE K L AL YL + I+HRD+K
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMK 142
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNE---SGYGVKI 557
P+N+L++ G HV + DF +A + + T+ GT Y+APE+ + +GY +
Sbjct: 143 PDNILLDEHG-HV---HITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAV 198
Query: 558 DVWAAGVILYILLCGFPPF-VSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616
D W+ GV Y LL G P+ + + E+ + +PS S+E L+ +
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWSQEMVSLLKKL 254
Query: 617 LESNPDLRF-SAEDVLDHPWL 636
LE NPD RF DV + P++
Sbjct: 255 LEPNPDQRFSQLSDVQNFPYM 275
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 9e-69
Identities = 50/343 (14%), Positives = 96/343 (27%), Gaps = 48/343 (13%)
Query: 340 DASGREVPKMPTKTS--VARCATATIKRRENLNIPSKLLQR---YSVGQIIGDGNFAVVR 394
+ G + + + V + + S L Q + + + G+ +VV
Sbjct: 20 ELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVF 79
Query: 395 QVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLD---------- 442
V D + D ALK+ + ++ + + + + D
Sbjct: 80 LVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139
Query: 443 ----------------EYDTNNELYLVIELIKG------GDLFDAISKNVKFSEEDSKFM 480
+ L++ L +
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199
Query: 481 TQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTP 540
T L + L +VH P+NL + G L +GD +V
Sbjct: 200 TAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG----RLMLGDVSALWKVGTRGPASSVPV 255
Query: 541 TYVAPEIL--NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598
TY E L + + + ++ W G+ +Y + C F PF T + G
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD 315
Query: 599 S---PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
S + + K LI L + R + ++ P +
Sbjct: 316 SLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-65
Identities = 80/265 (30%), Positives = 137/265 (51%), Gaps = 21/265 (7%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLL 441
+IG G F V+ V K A+K++ K +++ + E +I+ N P +++L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 442 DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
+ + LY+V+E + GGDL + +S E+ ++F T + AL +H +HRD+
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDV 194
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM----FTVCGTPTYVAPEILNESG----Y 553
KP+N+L++ SG H+ K+ DFG ++ + T GTP Y++PE+L G Y
Sbjct: 195 KPDNMLLDKSG-HL---KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 250
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
G + D W+ GV LY +L G PF +D + I++ + P +DIS+EAK LI
Sbjct: 251 GRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 308
Query: 614 SHMLESNPDLRF---SAEDVLDHPW 635
L ++ ++R E++ H +
Sbjct: 309 CAFL-TDREVRLGRNGVEEIKRHLF 332
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 5e-65
Identities = 83/265 (31%), Positives = 141/265 (53%), Gaps = 24/265 (9%)
Query: 385 IGDGNFA---VVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN---EVNILRSVNHPNII 438
+G G + VR+V + A+K++ K+ ++ + + E NIL V HP I+
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
L+ + T +LYL++E + GG+LF + + F E+ + F ++ AL +LH I++
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIY 144
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGV 555
RD+KPEN+++ G HV K+ DFGL + + T CGT Y+APEIL SG+
Sbjct: 145 RDLKPENIMLNHQG-HV---KLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
+D W+ G ++Y +L G PPF + ++ + D IL + P +++EA++L+
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGE--NRKKTIDKILKCKLNLPP----YLTQEARDLLKK 254
Query: 616 MLESNPDLRF-----SAEDVLDHPW 635
+L+ N R A +V HP+
Sbjct: 255 LLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 6e-65
Identities = 90/261 (34%), Positives = 146/261 (55%), Gaps = 20/261 (7%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLD 442
+G G F V V +K A+KI+ K ++ K ++ E +L++ HP + L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
+ T++ L V+E GG+LF +S+ F+EE ++F + SAL YLH +V+RDIK
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVKIDV 559
ENL+++ G H+ K+ DFGL + + M T CGTP Y+APE+L ++ YG +D
Sbjct: 133 LENLMLDKDG-HI---KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 560 WAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLES 619
W GV++Y ++CG PF + D + LF+ IL + FP +S EAK L++ +L+
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 242
Query: 620 NPDLRF-----SAEDVLDHPW 635
+P R A++V++H +
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRF 263
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 9e-65
Identities = 89/263 (33%), Positives = 147/263 (55%), Gaps = 22/263 (8%)
Query: 385 IGDGNFA---VVRQVYDKHKDMDCALKIIDKSKLLGKKQM-IENEVNILRSVNHPNIIKL 440
+G G+F +V+++ A+K++ K+ L + ++ + E +IL VNHP I+KL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ T +LYL+++ ++GGDLF +SK V F+EED KF LA AL +LH I++RD
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 151
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVKI 557
+KPEN+L++ G H+ K+ DFGL++ + ++ CGT Y+APE++N G+
Sbjct: 152 LKPENILLDEEG-HI---KLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 207
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
D W+ GV+++ +L G PF D+ E IL + G P +S EA+ L+ +
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGK--DRKETMTMILKAKLGMPQ----FLSPEAQSLLRMLF 261
Query: 618 ESNPDLRF-----SAEDVLDHPW 635
+ NP R E++ H +
Sbjct: 262 KRNPANRLGAGPDGVEEIKRHSF 284
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 1e-64
Identities = 86/261 (32%), Positives = 143/261 (54%), Gaps = 20/261 (7%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL-RSVNHPNIIKLL 441
IG G+F V K +++ A+K++ K +L KK+ I +E N+L ++V HP ++ L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 442 DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
+ T ++LY V++ I GG+LF + + F E ++F +ASAL YLH IV+RD+
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVKID 558
KPEN+L++ G H+ + DFGL + + T CGTP Y+APE+L++ Y +D
Sbjct: 166 KPENILLDSQG-HI---VLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVD 221
Query: 559 VWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLE 618
W G +LY +L G PPF S + E++D+IL+ +I+ A+ L+ +L+
Sbjct: 222 WWCLGAVLYEMLYGLPPFYSR--NTAEMYDNILNKPLQLKP----NITNSARHLLEGLLQ 275
Query: 619 SNPDLRF----SAEDVLDHPW 635
+ R ++ H +
Sbjct: 276 KDRTKRLGAKDDFMEIKSHVF 296
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-64
Identities = 64/293 (21%), Positives = 116/293 (39%), Gaps = 33/293 (11%)
Query: 370 NIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNI 428
+ S+ + + IG G F V + + A+K K +Q EV
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63
Query: 429 LRSV-NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK----FSEEDSKFMTQS 483
+ H ++++ + ++ + + E GG L DAIS+N + F E + K +
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHV---------------KVLKVGDFGLAQR 528
+ L Y+H +VH DIKP N+ + + + K+GD G R
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 529 VLRPMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF 587
+ P G ++A E+L E+ + K D++A + + P + +
Sbjct: 184 ISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP-----RNGDQW 237
Query: 588 DDILSGQY-GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
+I G+ P S+E EL+ M+ +P+ R SA ++ H L +
Sbjct: 238 HEIRQGRLPRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-64
Identities = 34/307 (11%), Positives = 87/307 (28%), Gaps = 61/307 (19%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM---------------- 421
G ++G + + D+ + + ++ +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 422 -----------IENEVNILRSVNHPNIIKLLDEYDTNN--ELYLVIELIK------GGDL 462
++++ +I++ + + + ++ G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 463 FDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGD 522
S + +T + L+ LH +VH ++P +++++ G + +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG----GVFLTG 249
Query: 523 FGLAQRVLRPMFTVCGTPTYVAPEILNESG-----------YGVKIDVWAAGVILYILLC 571
F R + + + PE+ D WA G+++Y + C
Sbjct: 250 FEHLVRDGARV-VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 572 GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVL 631
P D + I +I + + L+ L + R +
Sbjct: 309 ADLPITKDA--ALGGSEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358
Query: 632 DHPWLER 638
+ P E+
Sbjct: 359 ETPEYEQ 365
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 5e-64
Identities = 78/258 (30%), Positives = 122/258 (47%), Gaps = 17/258 (6%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL-RSVNHPNIIKLL 441
+G G+F V K + A+K + K +L + E +L + HP + +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 442 DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
+ T L+ V+E + GGDL I KF + F + L +LH IV+RD+
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVKID 558
K +N+L++ G H+ K+ DFG+ + + T CGTP Y+APEIL Y +D
Sbjct: 145 KLDNILLDKDG-HI---KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVD 200
Query: 559 VWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLE 618
W+ GV+LY +L G PF D++ELF I +P + +EAK+L+ +
Sbjct: 201 WWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFV 254
Query: 619 SNPDLRF-SAEDVLDHPW 635
P+ R D+ HP
Sbjct: 255 REPEKRLGVRGDIRQHPL 272
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 8e-64
Identities = 81/271 (29%), Positives = 129/271 (47%), Gaps = 25/271 (9%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKL 440
++IG G F+ V V K A+KI++K +L + ++ E ++L + + I +L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
+ N LYLV+E GGDL +SK + E ++F + A+ +H VHR
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM----FTVCGTPTYVAPEILNESG--- 552
DIKP+N+L++ G H+ ++ DFG ++ GTP Y++PEIL G
Sbjct: 187 DIKPDNILLDRCG-HI---RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 553 ----YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP-YWDDISE 607
YG + D WA GV Y + G PF +D E + I+ + P + + E
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STAETYGKIVHYKEHLSLPLVDEGVPE 300
Query: 608 EAKELISHMLESNPDLRF---SAEDVLDHPW 635
EA++ I +L P+ R A D HP+
Sbjct: 301 EARDFIQRLL-CPPETRLGRGGAGDFRTHPF 330
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-63
Identities = 79/290 (27%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPN 436
R V +++ +G FA V + D + ALK + ++ K + I EV ++ + HPN
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE-KNRAIIQEVCFMKKLSGHPN 87
Query: 437 IIKLLD-------EYDTNNELYLVIELIKGGDLFDAISK---NVKFSEEDS-KFMTQSLA 485
I++ E DT +L++ + G L + + K S + K Q
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ-TC 146
Query: 486 SALSYLHDN--YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA---------------QR 528
A+ ++H I+HRD+K ENLL+ G +K+ DFG A +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQG----TIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 529 VLRPMFTVCGTPTYVAPEILNESG---YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDE 585
++ T TP Y PEI++ G K D+WA G ILY+L PF +D
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF------EDG 256
Query: 586 LFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
I++G+Y P D LI ML+ NP+ R S +V+
Sbjct: 257 AKLRIVNGKYSIPP--HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 215 bits (548), Expect = 3e-63
Identities = 84/269 (31%), Positives = 138/269 (51%), Gaps = 23/269 (8%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKL 440
++IG G F V V K+ D A+KI++K ++L + + E ++L + + I L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
+ +N LYLV++ GGDL +SK + EE ++F + A+ +H + VHR
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR 199
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP----MFTVCGTPTYVAPEILNE----- 550
DIKP+N+L++M+G H+ ++ DFG +++ GTP Y++PEIL
Sbjct: 200 DIKPDNILMDMNG-HI---RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP-YWDDISEEA 609
YG + D W+ GV +Y +L G PF ++ E + I++ + F P D+SE A
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERFQFPTQVTDVSENA 313
Query: 610 KELISHMLESNPDLRF---SAEDVLDHPW 635
K+LI ++ S R ED HP+
Sbjct: 314 KDLIRRLICSREH-RLGQNGIEDFKKHPF 341
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-62
Identities = 88/262 (33%), Positives = 146/262 (55%), Gaps = 21/262 (8%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVNHPNIIKLLD 442
+G G F V V +K A+KI+ K ++ K ++ E +L++ HP + L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY-IVHRDI 501
+ T++ L V+E GG+LF +S+ FSE+ ++F + SAL YLH +V+RD+
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVKID 558
K ENL+++ G H+K+ DFGL + ++ M T CGTP Y+APE+L ++ YG +D
Sbjct: 276 KLENLMLDKDG-HIKI---TDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 331
Query: 559 VWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLE 618
W GV++Y ++CG PF + D ++LF+ IL + FP + EAK L+S +L+
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLK 385
Query: 619 SNPDLRF-----SAEDVLDHPW 635
+P R A++++ H +
Sbjct: 386 KDPKQRLGGGSEDAKEIMQHRF 407
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 4e-62
Identities = 86/264 (32%), Positives = 141/264 (53%), Gaps = 24/264 (9%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNIIKL 440
+G G+F V K A+K++ K +L M E + + + NHP + +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRI-LSLARNHPFLTQL 89
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRD 500
+ T + L+ V+E + GGDL I K+ +F E ++F + SAL +LHD I++RD
Sbjct: 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRD 149
Query: 501 IKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVKI 557
+K +N+L++ G H K+ DFG+ + + T CGTP Y+APEIL E YG +
Sbjct: 150 LKLDNVLLDHEG-HC---KLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAV 205
Query: 558 DVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617
D WA GV+LY +LCG PF ++ ++D+LF+ IL+ + +P+ + E+A ++ +
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAE--NEDDLFEAILNDEVVYPT----WLHEDATGILKSFM 259
Query: 618 ESNPDLR------FSAEDVLDHPW 635
NP +R +L HP+
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPF 283
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-62
Identities = 79/271 (29%), Positives = 143/271 (52%), Gaps = 28/271 (10%)
Query: 385 IGDGNFA---VVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE---NEVNILRSVNH-PNI 437
+G G + +VR++ A+K++ K+ ++ K + E E +L + P +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
+ L + T +L+L+++ I GG+LF +S+ +F+E + + + AL +LH I+
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII 181
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM----FTVCGTPTYVAPEIL--NES 551
+RDIK EN+L++ +G HV + DFGL++ + + CGT Y+AP+I+ +S
Sbjct: 182 YRDIKLENILLDSNG-HV---VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 237
Query: 552 GYGVKIDVWAAGVILYILLCGFPPFVSDT--NDQDELFDDILSGQYGFPSPYWDDISEEA 609
G+ +D W+ GV++Y LL G PF D N Q E+ IL + +P ++S A
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ----EMSALA 293
Query: 610 KELISHMLESNPDLRF-----SAEDVLDHPW 635
K+LI +L +P R A+++ +H +
Sbjct: 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 5e-62
Identities = 86/272 (31%), Positives = 144/272 (52%), Gaps = 27/272 (9%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL-RSVNHPNIIK 439
++IG G++A V V K D A+K++ K + + + ++ E ++ ++ NHP ++
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
L + T + L+ VIE + GGDL + + K EE ++F + ++ AL+YLH+ I++R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVK 556
D+K +N+L++ G H+ K+ D+G+ + LRP T CGTP Y+APEIL YG
Sbjct: 135 DLKLDNVLLDSEG-HI---KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 190
Query: 557 IDVWAAGVILYILLCGFPPF-------VSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
+D WA GV+++ ++ G PF D N +D LF IL Q P +S +A
Sbjct: 191 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKA 246
Query: 610 KELISHMLESNPDLRF------SAEDVLDHPW 635
++ L +P R D+ HP+
Sbjct: 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 8e-62
Identities = 78/262 (29%), Positives = 128/262 (48%), Gaps = 21/262 (8%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL-RSVNHPNIIKLL 441
+G G+F V K D A+KI+ K ++ + E +L P + +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 442 DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
+ T + LY V+E + GGDL I + +F E + F +A L +L I++RD+
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVKID 558
K +N++++ G H+ K+ DFG+ + + T CGTP Y+APEI+ YG +D
Sbjct: 148 KLDNVMLDSEG-HI---KIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 203
Query: 559 VWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLE 618
WA GV+LY +L G PF + D+DELF I+ +P +S+EA + ++
Sbjct: 204 WWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMT 257
Query: 619 SNPDLRF-----SAEDVLDHPW 635
+P R D+ +H +
Sbjct: 258 KHPGKRLGCGPEGERDIKEHAF 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-61
Identities = 47/281 (16%), Positives = 88/281 (31%), Gaps = 33/281 (11%)
Query: 377 QRYSVGQIIGDGNFAVVRQVY-----DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRS 431
+ V ++G+G FA V + D LK+ + + + + L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGTQLMERLKP 123
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISK-----NVKFSEEDSKFMTQSLAS 486
+K + N LV EL G L +AI+ + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHV-------KVLKVGDFGLA--QRVLRP---MF 534
+ +HD I+H DIKP+N ++ L + D G + ++
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ 594
C T + E+L+ + +ID + +Y +L G V + + +
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF---- 299
Query: 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
+ E ML + D+L
Sbjct: 300 ----RRLPH--LDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 4e-61
Identities = 85/272 (31%), Positives = 144/272 (52%), Gaps = 27/272 (9%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL-RSVNHPNIIK 439
++IG G++A V V K D A++++ K + + + ++ E ++ ++ NHP ++
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
L + T + L+ VIE + GGDL + + K EE ++F + ++ AL+YLH+ I++R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGVK 556
D+K +N+L++ G H+ K+ D+G+ + LRP T CGTP Y+APEIL YG
Sbjct: 178 DLKLDNVLLDSEG-HI---KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 233
Query: 557 IDVWAAGVILYILLCGFPPF-------VSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
+D WA GV+++ ++ G PF D N +D LF IL Q P +S +A
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKA 289
Query: 610 KELISHMLESNPDLRF------SAEDVLDHPW 635
++ L +P R D+ HP+
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-60
Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 24/268 (8%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ--MIENEVNILRSVNHPNIIKLL 441
++G G F V K A K ++K +L +K E IL V+ I+ L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 442 DEYDTNNELYLVIELIKGGDLF----DAISKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
++T +L LV+ ++ GGD+ + N F E + F T + S L +LH I+
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYG 554
+RD+KPEN+L++ G +V++ D GLA + GTP ++APE+L Y
Sbjct: 312 YRDLKPENVLLDDDG-NVRI---SDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 555 VKIDVWAAGVILYILLCGFPPFVSD--TNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612
+D +A GV LY ++ PF + + EL +L +P D S +K+
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDF 423
Query: 613 ISHMLESNPDLRF-----SAEDVLDHPW 635
+L+ +P+ R S + + HP
Sbjct: 424 CEALLQKDPEKRLGFRDGSCDGLRTHPL 451
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 212 bits (540), Expect = 5e-60
Identities = 76/265 (28%), Positives = 130/265 (49%), Gaps = 21/265 (7%)
Query: 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ--MIENEVNILRSVN---HPNII 438
IIG G F V A+K +DK ++ K+ + NE +L V+ P I+
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
+ + T ++L +++L+ GGDL +S++ FSE D +F + L ++H+ ++V+
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-PMFTVCGTPTYVAPEILN-ESGYGVK 556
RD+KP N+L++ G HV ++ D GLA + GT Y+APE+L Y
Sbjct: 316 RDLKPANILLDEHG-HV---RISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 557 IDVWAAGVILYILLCGFPPFVSD-TNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
D ++ G +L+ LL G PF T D+ E+ L+ P D S E + L+
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEG 427
Query: 616 MLESNPDLRF-----SAEDVLDHPW 635
+L+ + + R A++V + P+
Sbjct: 428 LLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-59
Identities = 79/265 (29%), Positives = 130/265 (49%), Gaps = 23/265 (8%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNII 438
++G G+F V K D A+KI+ K ++ M+E V + P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLT 405
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
+L + T + LY V+E + GGDL I + +F E + F +A L +L I++
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 465
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGYGV 555
RD+K +N++++ G H+ K+ DFG+ + + T CGTP Y+APEI+ YG
Sbjct: 466 RDLKLDNVMLDSEG-HI---KIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 521
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISH 615
+D WA GV+LY +L G PF + D+DELF I+ +P +S+EA +
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHNVAYPK----SMSKEAVAICKG 575
Query: 616 MLESNPDLRF-----SAEDVLDHPW 635
++ +P R D+ +H +
Sbjct: 576 LMTKHPGKRLGCGPEGERDIKEHAF 600
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 3e-58
Identities = 83/288 (28%), Positives = 130/288 (45%), Gaps = 28/288 (9%)
Query: 368 NLNIPSKLLQRYSVG-------QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ 420
N + K L+R V +++G G F V + A K ++K ++ +K
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 227
Query: 421 --MIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISK--NVKFSEED 476
M NE IL VN ++ L Y+T + L LV+ L+ GGDL I F E
Sbjct: 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR 287
Query: 477 SKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMF 534
+ F + L LH IV+RD+KPEN+L++ G H+++ D GLA V + +
Sbjct: 288 AVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRI---SDLGLAVHVPEGQTIK 343
Query: 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSD--TNDQDELFDDILS 592
GT Y+APE++ Y D WA G +LY ++ G PF ++E+ +
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403
Query: 593 GQYGFPSPYWDDISEEAKELISHMLESNPDLRF-----SAEDVLDHPW 635
+ + S +A+ L S +L +P R SA +V +HP
Sbjct: 404 VPEEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 7e-54
Identities = 41/373 (10%), Positives = 103/373 (27%), Gaps = 69/373 (18%)
Query: 321 KKDLRRPEHTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIP-------- 372
+++L G ++ +P+ +T+ +A
Sbjct: 11 RENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVE 70
Query: 373 SKLLQRY---SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM-------- 421
S+L +R G ++G + + D+ + + ++ +
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 422 -------------------IENEVNILRSVNHPNIIKLLDEYDTNN--ELYLVIELIKG- 459
++++ +I++ + + + ++
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 460 -----GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH 514
L S + +T + L+ LH +VH ++P +++++ G
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-- 248
Query: 515 VKVLKVGDFGLAQRVLRPMFT----VCGTPTYVAPEILNESG-----YGVKIDVWAAGVI 565
+ + F R + P A +L D W G+
Sbjct: 249 --GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 566 LYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF 625
+Y + C P D + I +I + + L+ L + R
Sbjct: 307 IYWIWCADLPNTDDA--ALGGSEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRL 356
Query: 626 SAEDVLDHPWLER 638
++ P E+
Sbjct: 357 LPLQAMETPEYEQ 369
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-52
Identities = 60/323 (18%), Positives = 116/323 (35%), Gaps = 20/323 (6%)
Query: 323 DLRRPEHTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVG 382
+ + L S + ++ ++ +T T K + + + +
Sbjct: 4 SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ 63
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
+G G+F V ++ DK CA+K + E+ ++ P I+ L
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYG 117
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
+ + +EL++GG L I + E+ + + L YLH I+H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRV--------LRPMFTVCGTPTYVAPEILNESGYG 554
+N+L+ G + DFG A + L + GT T++APE++
Sbjct: 178 ADNVLLSSDGSRA---ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 555 VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
K+D+W++ ++ +L G P+ + P + + I
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPW-TQYFRGPLCLKIASEPPPIREIP--PSCAPLTAQAIQ 291
Query: 615 HMLESNPDLRFSAEDVLDHPWLE 637
L P R SA ++
Sbjct: 292 EGLRKEPVHRASAMELRRKVGKA 314
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-51
Identities = 53/293 (18%), Positives = 108/293 (36%), Gaps = 31/293 (10%)
Query: 364 KRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE 423
K + +KL V + + +
Sbjct: 50 KVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPS 109
Query: 424 NEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDS----KF 479
++ + + N + L LY+ ++L + +L D +++ + +
Sbjct: 110 VKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHI 169
Query: 480 MTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA------------- 526
Q +A A+ +LH ++HRD+KP N+ M V+KVGDFGL
Sbjct: 170 FIQ-IAEAVEFLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQTVL 224
Query: 527 --QRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD 584
GT Y++PE ++ + Y K+D+++ G+IL+ LL F ++
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ----MERV 280
Query: 585 ELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
+ D+ + ++ + + ++ ML +P R A D++++ E
Sbjct: 281 RIITDVRNLKF---PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 24/143 (16%), Positives = 49/143 (34%), Gaps = 1/143 (0%)
Query: 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV 432
S+ L + Q +G G F VV + +K D + A+K I ++ + EV L +
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 433 NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQ-SLASALSYL 491
HP I++ + + E+ + ++ + + S
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 492 HDNYIVHRDIKPENLLVEMSGCH 514
+ + L ++M C
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCR 144
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 7e-51
Identities = 69/268 (25%), Positives = 122/268 (45%), Gaps = 16/268 (5%)
Query: 378 RYS-VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHP 435
R+ IG G+F V + D ++ A + KL +Q + E +L+ + HP
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85
Query: 436 NIIKLLDEY----DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYL 491
NI++ D + + LV EL+ G L + + + + + + L +L
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 492 HDN--YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-FTVCGTPTYVAPEIL 548
H I+HRD+K +N+ + VK+ GD GLA V GTP ++APE+
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKI---GDLGLATLKRASFAKAVIGTPEFMAPEMY 202
Query: 549 NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608
E Y +DV+A G+ + + P+ S+ + +++ + SG P+ + E
Sbjct: 203 EE-KYDESVDVYAFGMCMLEMATSEYPY-SECQNAAQIYRRVTSGV--KPASFDKVAIPE 258
Query: 609 AKELISHMLESNPDLRFSAEDVLDHPWL 636
KE+I + N D R+S +D+L+H +
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 6e-47
Identities = 74/304 (24%), Positives = 127/304 (41%), Gaps = 56/304 (18%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN----EVNILR 430
++++Y IG+G++ VV + ++ A+K K +I+ E+ +L+
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLK 57
Query: 431 SVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALS 489
+ HPN++ LL+ + L+LV E + + E K +T A++
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVCGTPTYV--- 543
+ H + +HRD+KPEN+L+ V+K+ DFG A R+L + V
Sbjct: 117 FCHKHNCIHRDVKPENILITKHS----VIKLCDFGFA-RLLTGPSDYYD-----DEVATR 166
Query: 544 ---APEIL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF----------DD 589
+PE+L ++ YG +DVWA G + LL G P + +D D+L+
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK-SDVDQLYLIRKTLGDLIPR 225
Query: 590 ILSG--------QYGFPSPYWD--------DISEEAKELISHMLESNPDLRFSAEDVLDH 633
P P +IS A L+ L +P R + E +L H
Sbjct: 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285
Query: 634 PWLE 637
P+ E
Sbjct: 286 PYFE 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 80/273 (29%), Positives = 130/273 (47%), Gaps = 17/273 (6%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP 435
++G G + +V D + A+K I + + + E+ + + + H
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHK 79
Query: 436 NIIKLLDEYDTNNELYLVIELIKGG---DLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492
NI++ L + N + + +E + GG L + +K +E+ F T+ + L YLH
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 493 DNYIVHRDIKPENLLV-EMSGCHVKVLKVGDFGLAQRVLRPM---FTVCGTPTYVAPEIL 548
DN IVHRDIK +N+L+ SG VLK+ DFG ++R+ T GT Y+APEI+
Sbjct: 140 DNQIVHRDIKGDNVLINTYSG----VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 195
Query: 549 NES--GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606
++ GYG D+W+ G + + G PPF Q +F + + P + +S
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIP--ESMS 252
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
EAK I E +PD R A D+L +L+ S
Sbjct: 253 AEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-46
Identities = 72/267 (26%), Positives = 145/267 (54%), Gaps = 14/267 (5%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
IG+G+ +V +KH A+K++D K +++++ NEV I+R H N
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFN 103
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
++++ Y EL++++E ++GG L D I V+ +EE + +++ AL+YLH +
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAPEILNESGY 553
+HRDIK +++L+ + G V K+ DFG ++ + + ++ GTP ++APE+++ S Y
Sbjct: 163 IHRDIKSDSILLTLDG-RV---KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS-PYWDDISEEAKEL 612
++D+W+ G+++ ++ G PP+ + + P +S ++
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPY-FSDSPVQAMK---RLRDSPPPKLKNSHKVSPVLRDF 274
Query: 613 ISHMLESNPDLRFSAEDVLDHPWLERS 639
+ ML +P R +A+++LDHP+L ++
Sbjct: 275 LERMLVRDPQERATAQELLDHPFLLQT 301
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-46
Identities = 75/273 (27%), Positives = 128/273 (46%), Gaps = 27/273 (9%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+ ++ + IG G+F V + D A+KIID + + + I+ E+ +L + P
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
+ K Y + +L++++E + GG D + + E + + + L YLH
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAPEILNESGY 553
+HRDIK N+L+ G V K+ DFG+A ++ T GTP ++APE++ +S Y
Sbjct: 141 IHRDIKAANVLLSEHG-EV---KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 196
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDI-------LSGQYGFPSPYWDDIS 606
K D+W+ G+ L G PP S+ + LF I L G Y S
Sbjct: 197 DSKADIWSLGITAIELARGEPPH-SELHPMKVLF-LIPKNNPPTLEGNY----------S 244
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
+ KE + L P R +A+++L H ++ R+
Sbjct: 245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 77/267 (28%), Positives = 142/267 (53%), Gaps = 14/267 (5%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
++Y+ + IG G V D + A++ ++ + KK++I NE+ ++R +PN
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPN 78
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
I+ LD Y +EL++V+E + GG L D +++ E + + AL +LH N +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAPEILNESGY 553
+HRDIK +N+L+ M G V K+ DFG ++ T+ GTP ++APE++ Y
Sbjct: 138 IHRDIKSDNILLGMDG-SV---KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS-PYWDDISEEAKEL 612
G K+D+W+ G++ ++ G PP+ + N L+ L G P + +S ++
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPY-LNENPLRALY---LIATNGTPELQNPEKLSAIFRDF 249
Query: 613 ISHMLESNPDLRFSAEDVLDHPWLERS 639
++ LE + + R SA+++L H +L+ +
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLKIA 276
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-45
Identities = 86/354 (24%), Positives = 130/354 (36%), Gaps = 58/354 (16%)
Query: 326 RPEHTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQII 385
RP T + M T+ Y+ ++I
Sbjct: 4 RPRTTSFAESCKPVQQPS-AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVI 62
Query: 386 GDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYD 445
G+G+F VV Q A+K K+L K+ E+ I+R ++H NI++L +
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 446 TNNE------LYLVIELIKGGDLFDAI----SKNVKFSEEDSKFMTQSLASALSYLHDNY 495
++ E L LV++ + ++ K L +L+Y+H
Sbjct: 118 SSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTP--TYV------APE- 546
I HRDIKP+NLL++ VLK+ DFG A + L G P +Y+ APE
Sbjct: 177 ICHRDIKPQNLLLDPD-TA--VLKLCDFGSA-KQLVR-----GEPNVSYICSRYYRAPEL 227
Query: 547 ILNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQ------------DELFDDILSG 593
I + Y IDVW+AG +L LL G P F DQ E ++
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287
Query: 594 QYGFPSPYWD----------DISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
F P EA L S +LE P R + + H + +
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-45
Identities = 73/307 (23%), Positives = 128/307 (41%), Gaps = 56/307 (18%)
Query: 370 NIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN----E 425
N+ + +++Y ++G+G++ +V + +K A+K K +M++ E
Sbjct: 18 NLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMRE 74
Query: 426 VNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSL 484
+ +L+ + H N++ LL+ YLV E + + D + + + +
Sbjct: 75 IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI 133
Query: 485 ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---PMFTVCGTPT 541
+ + + H + I+HRDIKPEN+LV SG V+K+ DFG A R L ++
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFA-RTLAAPGEVYD-----D 183
Query: 542 YV------APEIL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF------- 587
V APE+L + YG +DVWA G ++ + G P F D +D D+L+
Sbjct: 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD-SDIDQLYHIMMCLG 242
Query: 588 ---DDILSGQYGFPS------PYWD----------DISEEAKELISHMLESNPDLRFSAE 628
P P +SE +L L +PD R
Sbjct: 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCA 302
Query: 629 DVLDHPW 635
++L H +
Sbjct: 303 ELLHHDF 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-44
Identities = 70/269 (26%), Positives = 120/269 (44%), Gaps = 22/269 (8%)
Query: 371 IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILR 430
I K ++ V +++G G F VV + K + D A+K I+ + E+ L
Sbjct: 5 IDYKEIE---VEEVVGRGAFGVVCKA--KWRAKDVAIKQIESESER---KAFIVELRQLS 56
Query: 431 SVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQ---SLASA 487
VNHPNI+KL N + LV+E +GG L++ + + +
Sbjct: 57 RVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 488 LSYLHD---NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVA 544
++YLH ++HRD+KP NLL+ G VLK+ DFG A + M G+ ++A
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGG---TVLKICDFGTACDIQTHMTNNKGSAAWMA 171
Query: 545 PEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604
PE+ S Y K DV++ G+IL+ ++ PF + + P +
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPF-DEIGGPAFRIMWAVHNGTRPPLI--KN 228
Query: 605 ISEEAKELISHMLESNPDLRFSAEDVLDH 633
+ + + L++ +P R S E+++
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-44
Identities = 84/300 (28%), Positives = 138/300 (46%), Gaps = 43/300 (14%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN----EVN 427
+ + RY +G+G + V + D + A+K + +L +++ + EV+
Sbjct: 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGTAIREVS 85
Query: 428 ILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK-FMTQSLAS 486
+L+ + H NII+L N+ L+L+ E + DL + KN S K F+ Q L +
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ-LIN 143
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHVK-VLKVGDFGLAQRV----LRPMFTVCGTPT 541
+++ H +HRD+KP+NLL+ +S VLK+GDFGLA R +R T
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA-RAFGIPIRQFTHEIITLW 202
Query: 542 YVAPEIL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF----------DDI 590
Y PEIL Y +D+W+ I +L P F D+ + D+LF D
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS-EIDQLFKIFEVLGLPDDTT 261
Query: 591 LSG-------QYGFP--------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
G + FP + +E +L++ MLE +P R SA++ L+HP+
Sbjct: 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 88/310 (28%), Positives = 138/310 (44%), Gaps = 59/310 (19%)
Query: 368 NLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN--- 424
L++ S+ +RY +G+G FA V + DK+ + A+K K KL + + +
Sbjct: 2 ALDVKSRA-KRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---KIKLGHRSEAKDGINR 57
Query: 425 ----EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSK- 478
E+ +L+ ++HPNII LLD + + + LV + ++ DL I ++ + K
Sbjct: 58 TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKA 116
Query: 479 FMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----LRPMF 534
+M L YLH ++I+HRD+KP NLL++ +G LK+ DFGLA + R
Sbjct: 117 YMLM-TLQGLEYLHQHWILHRDLKPNNLLLDENGV----LKLADFGLA-KSFGSPNRAY- 169
Query: 535 TVCGTPT-----YVAPEIL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF- 587
T Y APE+L YGV +D+WA G IL LL P D+ D D+L
Sbjct: 170 ----THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTR 224
Query: 588 ---------DDI------LSGQYGFPS-PYWD------DISEEAKELISHMLESNPDLRF 625
++ L F S P ++ +LI + NP R
Sbjct: 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284
Query: 626 SAEDVLDHPW 635
+A L +
Sbjct: 285 TATQALKMKY 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 64/287 (22%), Positives = 119/287 (41%), Gaps = 19/287 (6%)
Query: 359 ATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK 418
+ + + ++ + IG G F +V + A+K + G+
Sbjct: 4 GGSEFPKSRLPTLADNEIE---YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 419 KQMIE------NEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVK 471
+MIE EV I+ ++NHPNI+KL +N +V+E + GDL+ + K
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHP 118
Query: 472 FSEEDSKFMTQSLASALSYLHDN--YIVHRDIKPENLLVEMSGCHVKV-LKVGDFGLAQR 528
+ +A + Y+ + IVHRD++ N+ ++ + V KV DFGL+Q+
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
Query: 529 VLRPMFTVCGTPTYVAPEILNESG--YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDEL 586
+ + + G ++APE + Y K D ++ +ILY +L G PF + + +
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238
Query: 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633
+ I P +D + +I +P R ++
Sbjct: 239 INMIREEGLRPTIP--EDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 73/267 (27%), Positives = 133/267 (49%), Gaps = 14/267 (5%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+ + V + +G+G++ V + K A+K + + Q I E++I++ + P+
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKEISIMQQCDSPH 85
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNY 495
++K Y N +L++V+E G + D I +N +E++ + QS L YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAPEILNESG 552
+HRDIK N+L+ G H K+ DFG+A ++ M TV GTP ++APE++ E G
Sbjct: 146 KIHRDIKAGNILLNTEG-HA---KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 201
Query: 553 YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612
Y D+W+ G+ + G PP+ +D + +F + F P + S+ +
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPY-ADIHPMRAIFMIPTNPPPTFRKP--ELWSDNFTDF 258
Query: 613 ISHMLESNPDLRFSAEDVLDHPWLERS 639
+ L +P+ R +A +L HP++ +
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRSA 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 84/315 (26%), Positives = 139/315 (44%), Gaps = 49/315 (15%)
Query: 357 RCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL 416
RENL + ++Y + +G+G + VV + D + ALK I +L
Sbjct: 2 HHHHHHSSGRENLYFQGLM-EKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRI---RLD 56
Query: 417 GKKQMIEN----EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVK 471
+ + I + E+++L+ ++HPNI+ L+D + L LV E ++ DL +
Sbjct: 57 AEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG 115
Query: 472 FSEEDSK-FMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV- 529
+ K ++ Q L +++ H + I+HRD+KP+NLL+ G LK+ DFGLA R
Sbjct: 116 LQDSQIKIYLYQ-LLRGVAHCHQHRILHRDLKPQNLLINSDGA----LKLADFGLA-RAF 169
Query: 530 ---LRPMFTVCGTPTYVAPEIL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDE 585
+R T Y AP++L Y +D+W+ G I ++ G P F T D D+
Sbjct: 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT-DDDQ 228
Query: 586 LF----------DDILSG--------QYGFPSPY-------WDDISEEAKELISHMLESN 620
L Q F +E +L+S+ML +
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFD 288
Query: 621 PDLRFSAEDVLDHPW 635
P+ R SA D ++HP+
Sbjct: 289 PNKRISARDAMNHPY 303
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 80/295 (27%), Positives = 133/295 (45%), Gaps = 47/295 (15%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN----EVNILRS 431
+++Y + IG+G + VV + + + + ALK K +L + + I + E++IL+
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGET-FALK---KIRLEKEDEGIPSTTIREISILKE 56
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSK-FMTQSLASALS 489
+ H NI+KL D T L LV E + DL + +K F+ Q L + ++
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ-LLNGIA 114
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----LRPMFTVCGTPTYVAP 545
Y HD ++HRD+KP+NLL+ G LK+ DFGLA R +R T Y AP
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGE----LKIADFGLA-RAFGIPVRKYTHEIVTLWYRAP 169
Query: 546 EIL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF----------DDILSG- 593
++L Y ID+W+ G I ++ G P F ++ D+L
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV-SEADQLMRIFRILGTPNSKNWPNV 228
Query: 594 ------QYGFPSP-------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
F + + E +L+S ML+ +P+ R +A+ L+H +
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 80/302 (26%), Positives = 127/302 (42%), Gaps = 60/302 (19%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN----------E 425
++ Y +G+G +A V + K D ALK + +L E+ E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALK---EIRL-------EHEEGAPCTAIRE 50
Query: 426 VNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSK-FMTQS 483
V++L+ + H NI+ L D T L LV E + DL + + + K F+ Q
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ- 108
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----LRPMFTVCGT 539
L L+Y H ++HRD+KP+NLL+ G LK+ DFGLA R + T
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLLINERGE----LKLADFGLA-RAKSIPTKTYDNEVVT 163
Query: 540 PTYVAPEIL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF----------D 588
Y P+IL + Y +ID+W G I Y + G P F T +++L +
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-VEEQLHFIFRILGTPTE 222
Query: 589 DILSG--------QYGFPSPY-------WDDISEEAKELISHMLESNPDLRFSAEDVLDH 633
+ G Y +P + + +L++ +L+ R SAED + H
Sbjct: 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282
Query: 634 PW 635
P+
Sbjct: 283 PF 284
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 27/283 (9%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
Y + ++IG G AVV+ Y K A+K I+ K + E+ + +HPNI
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAI--------SKNVKFSEEDSKFMTQSLASALS 489
+ + +EL+LV++L+ GG + D I K+ E + + + L
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG----LAQRVLRPMF----TVCGTPT 541
YLH N +HRD+K N+L+ G V ++ DFG LA T GTP
Sbjct: 136 YLHKNGQIHRDVKAGNILLGEDG-SV---QIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 542 YVAPE-ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
++APE + GY K D+W+ G+ L G P+ L + + +
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY-HKYPPMKVLMLTLQNDPPSLETG 250
Query: 601 YWDDI-----SEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
D + +++IS L+ +P+ R +A ++L H + ++
Sbjct: 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 83/299 (27%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
Y+ ++IG+G+F VV Q D A+K K+L K+ E+ I+R V HPN+
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIK-----KVLQDKRFKNRELQIMRIVKHPNV 94
Query: 438 IKLLD------EYDTNNELYLVIELIKGGDLFDAI----SKNVKFSEEDSK-FMTQSLAS 486
+ L + L LV+E + ++ A K +M Q L
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQ-LLR 152
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT----VCGTPTY 542
+L+Y+H I HRDIKP+NLL+ VLK+ DFG A ++L +C + Y
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLL-DPPSG--VLKLIDFGSA-KILIAGEPNVSYIC-SRYY 207
Query: 543 VAPE-ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQ------------DELFD 588
APE I + Y ID+W+ G ++ L+ G P F ++ DQ E
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267
Query: 589 DILSGQYGFPSPYWD----------DISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
+ P +A +LIS +LE P R +A + L HP+ +
Sbjct: 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 85/302 (28%), Positives = 129/302 (42%), Gaps = 55/302 (18%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK---SKLLGKKQMIENEVNILRSVN 433
+RY +G G + V +D + A+K + + S + K+ E+ +L+ +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR--TYRELRLLKHMK 86
Query: 434 HPNIIKLLD------EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASA 487
H N+I LLD + N++YLV L+ G DL + I K K +++ +F+ +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 488 LSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT--VCGTPTYVAP 545
L Y+H I+HRD+KP NL V C LK+ DFGLA R T V T Y AP
Sbjct: 145 LKYIHSADIIHRDLKPSNLAV-NEDCE---LKILDFGLA-RHTADEMTGYVA-TRWYRAP 198
Query: 546 EI-LNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELFDDILSGQYGFPS---- 599
EI LN Y +D+W+ G I+ LL G F +D DQ +L ++ G P
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV----GTPGAELL 254
Query: 600 ---------------PYWD---------DISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
+ A +L+ ML + D R +A L H +
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314
Query: 636 LE 637
Sbjct: 315 FA 316
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 69/273 (25%), Positives = 134/273 (49%), Gaps = 19/273 (6%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+ + + +GDG F V + +K A K+I+ + + E+ IL + +HP
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPY 77
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNY 495
I+KLL Y + +L+++IE GG + + + +E + + + + AL++LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF---TVCGTPTYVAPEI----- 547
I+HRD+K N+L+ + G + ++ DFG++ + L+ + + GTP ++APE+
Sbjct: 138 IIHRDLKAGNVLMTLEG-DI---RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 548 LNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS-PYWDDIS 606
+ ++ Y K D+W+ G+ L + PP + N L + P+ S
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLL---KIAKSDPPTLLTPSKWS 249
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
E ++ + L+ NP+ R SA +L+HP++
Sbjct: 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-42
Identities = 79/311 (25%), Positives = 130/311 (41%), Gaps = 55/311 (17%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALK-IIDKSKLLGKKQMIENEVNILRSVN 433
L RY + +G G +V D D A+K I+ K E+ I+R ++
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH--ALREIKIIRRLD 66
Query: 434 HPNIIKLLD--------------EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF 479
H NI+K+ + N +Y+V E + DL + + + EE ++
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQG-PLLEEHARL 124
Query: 480 MTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGT 539
L L Y+H ++HRD+KP NL + LK+GDFGLA R++ P ++ G
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV---LKIGDFGLA-RIMDPHYSHKGH 180
Query: 540 PT-YV------APEI-LNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQ------- 583
+ + +P + L+ + Y ID+WAAG I +L G F + +Q
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240
Query: 584 -----DELFDDILSG--QYGFPSPYWD---------DISEEAKELISHMLESNPDLRFSA 627
+E ++LS Y IS EA + + +L +P R +A
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300
Query: 628 EDVLDHPWLER 638
E+ L HP++
Sbjct: 301 EEALSHPYMSI 311
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-42
Identities = 67/295 (22%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY 444
+G GN VV +V K + A K+I + I E+ +L N P I+ +
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 445 DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY-IVHRDIKP 503
++ E+ + +E + GG L + K + E+ ++ ++ L+YL + + I+HRD+KP
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 160
Query: 504 ENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-FTVCGTPTYVAPEILNESGYGVKIDVWAA 562
N+LV G +K+ DFG++ +++ M + GT +Y++PE L + Y V+ D+W+
Sbjct: 161 SNILVNSRG----EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 563 GVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW-------------------- 602
G+ L + G P + EL +P
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276
Query: 603 ------------------DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
S E ++ ++ L NP R + ++ H +++RS
Sbjct: 277 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 82/320 (25%), Positives = 129/320 (40%), Gaps = 17/320 (5%)
Query: 325 RRPEHTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQI 384
H TT + MP + + P KL +S +
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKL---FSDLRE 61
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIID--KSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
IG G+F V D A+K + + K Q I EV L+ + HPN I+
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIK 502
Y + +LV+E G E + +T L+YLH + ++HRD+K
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181
Query: 503 PENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEI---LNESGYGVKIDV 559
N+L+ G V K+GDFG A + P + GTP ++APE+ ++E Y K+DV
Sbjct: 182 AGNILLSEPG-LV---KLGDFGSASI-MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 236
Query: 560 WAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLES 619
W+ G+ L PP + N L+ + S +W SE + + L+
Sbjct: 237 WSLGITCIELAERKPPL-FNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSCLQK 292
Query: 620 NPDLRFSAEDVLDHPWLERS 639
P R ++E +L H ++ R
Sbjct: 293 IPQDRPTSEVLLKHRFVLRE 312
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 76/295 (25%), Positives = 128/295 (43%), Gaps = 45/295 (15%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN----EVNILRS 431
+Q+Y + IG+G + V + ++ ALK + +L + + + E+ +L+
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKE 57
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSK-FMTQSLASALS 489
+ H NI++L D ++ +L LV E DL S N E K F+ Q L L
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ-LLKGLG 115
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----LRPMFTVCGTPTYVAP 545
+ H ++HRD+KP+NLL+ +G LK+ +FGLA R +R T Y P
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGE----LKLANFGLA-RAFGIPVRCYSAEVVTLWYRPP 170
Query: 546 EIL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF----------DDILSG- 593
++L Y ID+W+AG I L P + D+L ++
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 594 ----------QYGFPSP---YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635
Y + ++ ++L+ ++L+ NP R SAE+ L HP+
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 85/316 (26%), Positives = 136/316 (43%), Gaps = 67/316 (21%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIID--KSKLLGKKQMIENEVNILRSV 432
+ + + ++G+G + VV K A+K I+ L + E+ IL+
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR--TLREIKILKHF 66
Query: 433 NHPNIIKLLD-----EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK-FMTQSLAS 486
H NII + + ++ NE+Y++ EL+ DL IS S++ + F+ Q+L
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ-MLSDDHIQYFIYQTL-R 123
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT----- 541
A+ LH + ++HRD+KP NLL+ S C LKV DFGLA R++ PT
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLIN-SNCD---LKVCDFGLA-RIIDESAADNSEPTGQQSG 178
Query: 542 ---YV------APEI-LNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELFDDI 590
+V APE+ L + Y +DVW+ G IL L P F D Q L I
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238
Query: 591 LSGQYGFPSPYWD-----------------------------DISEEAKELISHMLESNP 621
+ G P D ++ + +L+ ML +P
Sbjct: 239 I----GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 622 DLRFSAEDVLDHPWLE 637
R +A++ L+HP+L+
Sbjct: 295 AKRITAKEALEHPYLQ 310
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 78/278 (28%), Positives = 116/278 (41%), Gaps = 25/278 (8%)
Query: 369 LNIPSKLLQRYSVGQIIGDGNFAVV-RQVYDKHKDMDCALKIIDKSKLLGKKQMIEN--- 424
L I L + +IIG G F V R + + A+K Q IEN
Sbjct: 2 LEIDFAELT---LEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSL 484
E + + HPNII L L LV+E +GG L +S + + +
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQI 114
Query: 485 ASALSYLHDN---YIVHRDIKPENLLV----EMSGCHVKVLKVGDFGLAQRVLRP--MFT 535
A ++YLHD I+HRD+K N+L+ E K+LK+ DFGLA R +
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTKMS 173
Query: 536 VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY 595
G ++APE++ S + DVW+ GV+L+ LL G PF + + +
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--VAYGVAMNKL 231
Query: 596 GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633
P P E +L+ +P R S ++LD
Sbjct: 232 ALPIP--STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 86/309 (27%), Positives = 124/309 (40%), Gaps = 56/309 (18%)
Query: 371 IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN------ 424
+ S RY IG G + V + D H ALK ++
Sbjct: 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK---SVRVPNGGGGGGGLPISTV 59
Query: 425 -EVNILRSVN---HPNIIKLLD-----EYDTNNELYLVIELIKGGDLFDAI--SKNVKFS 473
EV +LR + HPN+++L+D D ++ LV E + DL + +
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 474 EEDSK-FMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532
E K M Q L +LH N IVHRD+KPEN+LV G +K+ DFGLA+
Sbjct: 119 AETIKDLMRQ-FLRGLDFLHANCIVHRDLKPENILVTSGGT----VKLADFGLARIYSYQ 173
Query: 533 M-FT---VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF- 587
M T V T Y APE+L +S Y +D+W+ G I + P F ++ + D+L
Sbjct: 174 MALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-EADQLGK 230
Query: 588 ---------DDILSG-----QYGFPSPYWDD-------ISEEAKELISHMLESNPDLRFS 626
+D + FP + E +L+ ML NP R S
Sbjct: 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 627 AEDVLDHPW 635
A L H +
Sbjct: 291 AFRALQHSY 299
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 63/285 (22%), Positives = 124/285 (43%), Gaps = 25/285 (8%)
Query: 368 NLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVN 427
++ + + L+ +G G + VV ++ A+K I + +++ + +++
Sbjct: 1 SMEVKADDLEPIME---LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD 57
Query: 428 I-LRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK-----FSEEDSKFMT 481
I +R+V+ P + ++++ +EL+ D K V E+ +
Sbjct: 58 ISMRTVDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIA 115
Query: 482 QSLASALSYLHDNY-IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF--TVCG 538
S+ AL +LH ++HRD+KP N+L+ G VK+ DFG++ ++ + G
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKM---CDFGISGYLVDDVAKDIDAG 171
Query: 539 TPTYVAPE----ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ 594
Y+APE LN+ GY VK D+W+ G+ + L P+ S +L +
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231
Query: 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
P+ + S E + S L+ N R + +++ HP+
Sbjct: 232 PQLPADKF---SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 81/304 (26%), Positives = 124/304 (40%), Gaps = 56/304 (18%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK---SKLLGKKQMIENEVNILRS 431
L + Y +G G + V DK A+K + + S++ K+ E+ +L+
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR--AYRELLLLKH 79
Query: 432 VNHPNIIKLLD------EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLA 485
+ H N+I LLD + YLV+ + DL + FSEE +++ +
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQML 136
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAP 545
L Y+H +VHRD+KP NL V C LK+ DFGLA+ M T Y AP
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVN-EDCE---LKILDFGLARHADAEMTGYVVTRWYRAP 192
Query: 546 EI-LNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELFDDILSGQYGFPSPYWD 603
E+ L+ Y +D+W+ G I+ +L G F D DQ + G P +
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT----GVPGT--E 246
Query: 604 DI------------------------------SEEAKELISHMLESNPDLRFSAEDVLDH 633
+ S +A +L+ MLE + D R +A L H
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306
Query: 634 PWLE 637
P+ E
Sbjct: 307 PFFE 310
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 80/313 (25%), Positives = 131/313 (41%), Gaps = 77/313 (24%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN----------EVN 427
++ + +G+G +A V + +K + ALK + KL ++ E++
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KL-------DSEEGTPSTAIREIS 55
Query: 428 ILRSVNHPNIIKLLDEYDTNNELYLVIE-----LIKGGDLFDAISKNVKFSEEDSK-FMT 481
+++ + H NI++L D T N+L LV E L K D + K F
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 482 QSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----LRPMFTVC 537
Q L L++ H+N I+HRD+KP+NLL+ G LK+GDFGLA R +
Sbjct: 116 Q-LLQGLAFCHENKILHRDLKPQNLLINKRGQ----LKLGDFGLA-RAFGIPVNTF---- 165
Query: 538 GTP---T--YVAPEIL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF---- 587
+ T Y AP++L Y ID+W+ G IL ++ G P F D+++L
Sbjct: 166 -SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-DEEQLKLIFD 223
Query: 588 ------DDILSGQYGFPS-----PYW--------------DDISEEAKELISHMLESNPD 622
+ + P + + + + +L+ NPD
Sbjct: 224 IMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283
Query: 623 LRFSAEDVLDHPW 635
+R SA+ L HPW
Sbjct: 284 MRLSAKQALHHPW 296
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 92/308 (29%), Positives = 130/308 (42%), Gaps = 63/308 (20%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIID--KSKLLGKKQMIENEVNILRSVNH 434
RY+ IG+G + +V YD + A+K I + + ++ E+ IL H
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLRFRH 84
Query: 435 PNIIKLLD-----EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK-FMTQSLASAL 488
NII + D + ++Y+V +L+ DL+ + S + F+ Q L L
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYFLYQIL-RGL 141
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT-YV---- 543
Y+H ++HRD+KP NLL+ + C LK+ DFGLA RV P G T YV
Sbjct: 142 KYIHSANVLHRDLKPSNLLLN-TTCD---LKICDFGLA-RVADPDHDHTGFLTEYVATRW 196
Query: 544 --APEI-LNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELFDDILSGQYGFPS 599
APEI LN GY ID+W+ G IL +L P F DQ IL G PS
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL----GSPS 252
Query: 600 PYWDDI------------------------------SEEAKELISHMLESNPDLRFSAED 629
+D+ +A +L+ ML NP R E
Sbjct: 253 Q--EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310
Query: 630 VLDHPWLE 637
L HP+LE
Sbjct: 311 ALAHPYLE 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 70/277 (25%), Positives = 123/277 (44%), Gaps = 24/277 (8%)
Query: 367 ENLNIPSKLLQRYSVGQIIGDGNFAVV-RQVYDKHKDMDCALKIIDKSKLLGKK-QMIEN 424
++++IP L + + IG G+F V R + D A+KI+ + ++
Sbjct: 30 DDMDIPWCDLN---IKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLR 83
Query: 425 EVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN---VKFSEEDSKFMT 481
EV I++ + HPNI+ + L +V E + G L+ + K+ + E M
Sbjct: 84 EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 482 QSLASALSYLHDN--YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA---QRVLRPMFTV 536
+A ++YLH+ IVHR++K NLLV+ +KV DFGL+ +
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK----YTVKVCDFGLSRLKASTFLSSKSA 199
Query: 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596
GTP ++APE+L + K DV++ GVIL+ L P+ + Q + +
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFKCKR 257
Query: 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633
P +++ + +I + P R S ++D
Sbjct: 258 LEIP--RNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 76/319 (23%), Positives = 123/319 (38%), Gaps = 73/319 (22%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALK-IIDKSKLLGKKQMIEN--------- 424
+ Y+V + I G++ V D A+K + + ++ +
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 425 EVNILRSVNHPNIIKLLD-----EYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSK 478
E+ +L +HPNI+ L D E ++LYLV EL+ DL I + + S + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQ 137
Query: 479 -FMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC 537
FM L L LH+ +VHRD+ P N+L+ + + DF LA R
Sbjct: 138 YFMYHIL-LGLHVLHEAGVVHRDLHPGNILLA-DNND---ITICDFNLA----REDTADA 188
Query: 538 GTPTYV------APEI-LNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELFDD 589
YV APE+ + G+ +D+W+AG ++ + F S +Q +
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 590 ILSGQYGFPSPYWDDI-------------------------------SEEAKELISHMLE 618
++ G P +D+ A +LI+ MLE
Sbjct: 249 VV----GTPKI--EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLE 302
Query: 619 SNPDLRFSAEDVLDHPWLE 637
NP R S E L HP+ E
Sbjct: 303 FNPQRRISTEQALRHPYFE 321
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 82/304 (26%), Positives = 127/304 (41%), Gaps = 55/304 (18%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK---SKLLGKKQMIENEVNILRS 431
+ Y Q +G G + V D A+K + + S+L K+ E+ +L+
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR--AYRELRLLKH 80
Query: 432 VNHPNIIKLLD------EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLA 485
+ H N+I LLD D + YLV+ + G DL + K+ K E+ +F+ +
Sbjct: 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQML 138
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAP 545
L Y+H I+HRD+KP NL V C LK+ DFGLA++ M T Y AP
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVN-EDCE---LKILDFGLARQADSEMTGYVVTRWYRAP 194
Query: 546 EI-LNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELFDDILSGQYGFPSPYWD 603
E+ LN Y +D+W+ G I+ ++ G F SD DQ + + G P +
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT----GTPPA--E 248
Query: 604 DI------------------------------SEEAKELISHMLESNPDLRFSAEDVLDH 633
+ S A L+ ML + + R +A + L H
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308
Query: 634 PWLE 637
P+ E
Sbjct: 309 PYFE 312
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 68/266 (25%), Positives = 125/266 (46%), Gaps = 20/266 (7%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE---NEVNILRSVNH 434
RY + +G G + V D ++ A+K I K++ ++ EV+ ++H
Sbjct: 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSH 70
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494
NI+ ++D + ++ YLV+E I+G L + I + S + + T + + + HD
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT----VCGTPTYVAPEILNE 550
IVHRDIKP+N+L++ + LK+ DFG+A+ + T V GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNK----TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ---DELFDDILSGQYGFPSPYWDDISE 607
D+++ G++LY +L G PPF +T + D + + + DI +
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN----VTTDVRKDIPQ 242
Query: 608 EAKELISHMLESNPDLRF-SAEDVLD 632
+I E + R+ + +++ D
Sbjct: 243 SLSNVILRATEKDKANRYKTIQEMKD 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 63/326 (19%), Positives = 125/326 (38%), Gaps = 55/326 (16%)
Query: 341 ASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVV-RQVYDK 399
S R P+ ++TS+ + +IP + L+ +G++IG G F V +
Sbjct: 9 LSARSFPRKASQTSIFL---------QEWDIPFEQLE---IGELIGKGRFGQVYHGRWHG 56
Query: 400 HKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIK 458
+ A+++ID + + + + EV R H N++ + + L ++ L K
Sbjct: 57 ----EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112
Query: 459 GGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKV 517
G L+ + + ++ + Q + + YLH I+H+D+K +N+ +
Sbjct: 113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-----GK 167
Query: 518 LKVGDFGLA--------QRVLRPMFTVCGTPTYVAPEILNESG---------YGVKIDVW 560
+ + DFGL R + G ++APEI+ + + DV+
Sbjct: 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227
Query: 561 AAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF---PSPYWDDISEEAKELISHML 617
A G I Y L PF + + + Q G P+ + +E +++
Sbjct: 228 ALGTIWYELHAREWPFKTQPAEA-------IIWQMGTGMKPNLSQIGMGKEISDILLFCW 280
Query: 618 ESNPDLRFSAEDVLDH----PWLERS 639
+ R + ++D P R
Sbjct: 281 AFEQEERPTFTKLMDMLEKLPKRNRR 306
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-40
Identities = 77/324 (23%), Positives = 128/324 (39%), Gaps = 64/324 (19%)
Query: 364 KRRENLNIPS-KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ-- 420
K+ +++ P + +Y IG G F V + + ALK K + +K+
Sbjct: 3 KQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGF 59
Query: 421 --MIENEVNILRSVNHPNIIKLLD--------EYDTNNELYLVIELI----KGGDLFDAI 466
E+ IL+ + H N++ L++ +YLV + G L
Sbjct: 60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLS-- 115
Query: 467 SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526
+ VKF+ + K + Q L + L Y+H N I+HRD+K N+L+ G LK+ DFGLA
Sbjct: 116 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLA 171
Query: 527 QRVLRPMFTVCGTPT-------YVAPEIL-NESGYGVKIDVWAAGVILYILLCGFPPFVS 578
+ + T Y PE+L E YG ID+W AG I+ + P
Sbjct: 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231
Query: 579 DTNDQDELF----------DDI--------LSGQYGFPSPYWDDI---------SEEAKE 611
+T +Q +L ++ L + + A +
Sbjct: 232 NT-EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 290
Query: 612 LISHMLESNPDLRFSAEDVLDHPW 635
LI +L +P R ++D L+H +
Sbjct: 291 LIDKLLVLDPAQRIDSDDALNHDF 314
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 70/302 (23%), Positives = 138/302 (45%), Gaps = 27/302 (8%)
Query: 354 SVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKS 413
S+ I ++ + ++ L+ IG G + V ++ K A+K I +
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGE---IGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 414 KLLGKKQMIENEVNI-LRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK- 471
+++ + ++++ +RS + P I++ + ++ +EL+ FD K V
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYS 116
Query: 472 -----FSEEDSKFMTQSLASALSYLHDNY-IVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525
EE +T + AL++L +N I+HRDIKP N+L++ SG ++K+ DFG+
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKL---CDFGI 172
Query: 526 AQRVLRPM---FTVCGTPTYVAPEILNES----GYGVKIDVWAAGVILYILLCGFPPFVS 578
+ +++ + G Y+APE ++ S GY V+ DVW+ G+ LY L G P+
Sbjct: 173 SGQLVDSIAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 579 DTNDQDELFDDILSGQY-GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
+ D+L ++ G + + S ++ L + R +++L HP++
Sbjct: 232 WNSVFDQLTQ-VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290
Query: 638 RS 639
Sbjct: 291 MY 292
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 71/282 (25%), Positives = 128/282 (45%), Gaps = 27/282 (9%)
Query: 368 NLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE---N 424
++ PS L RY +G+I+G G + V D D A+K++ ++ L
Sbjct: 3 HMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRR 61
Query: 425 EVNILRSVNHPNIIKLLD----EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFM 480
E ++NHP I+ + D E Y+V+E + G L D + + + + +
Sbjct: 62 EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 481 TQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT----- 535
AL++ H N I+HRD+KP N+++ + +KV DFG+A+ + +
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATN----AVKVMDFGIARAIADSGNSVTQTA 177
Query: 536 -VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ---DELFDDIL 591
V GT Y++PE + DV++ G +LY +L G PPF D+ + +D +
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237
Query: 592 SGQYGFPSPYWDDISEEAKELISHMLESNPDLRF-SAEDVLD 632
PS + +S + ++ L NP+ R+ +A ++
Sbjct: 238 P-----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 70/308 (22%), Positives = 142/308 (46%), Gaps = 33/308 (10%)
Query: 349 MPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALK 408
M + + + + P+ + + + +++G+G + V + A+K
Sbjct: 2 MASDSPARSLDEIDLSALRD---PAGI---FELVELVGNGTYGQVYKGRHVKTGQLAAIK 55
Query: 409 IIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEY------DTNNELYLVIELIKGGD 461
++D + +++ I+ E+N+L+ +H NI + +++L+LV+E G
Sbjct: 56 VMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGS 113
Query: 462 LFDAI--SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLK 519
+ D I +K EE ++ + + LS+LH + ++HRDIK +N+L+ + V K
Sbjct: 114 VTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EV---K 169
Query: 520 VGDFGLAQRVLRPMF---TVCGTPTYVAPEIL-----NESGYGVKIDVWAAGVILYILLC 571
+ DFG++ ++ R + T GTP ++APE++ ++ Y K D+W+ G+ +
Sbjct: 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 572 GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVL 631
G PP D + LF L + P S++ + I L N R + E ++
Sbjct: 230 GAPPL-CDMHPMRALF---LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLM 285
Query: 632 DHPWLERS 639
HP++
Sbjct: 286 KHPFIRDQ 293
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 58/272 (21%), Positives = 117/272 (43%), Gaps = 31/272 (11%)
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNIL-RSVNHPNIIKLLDE 443
+G G V ++ + A+K + +S + + I +++++ +S + P I++
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 444 YDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY-IVHRDIK 502
+ TN ++++ +EL+ E MT ++ AL YL + + ++HRD+K
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK 152
Query: 503 PENLLVEMSGCHVKVLKVGDFG----LAQRVLRPMFTVCGTPTYVAPEIL-----NESGY 553
P N+L++ G +K+ DFG L + G Y+APE + + Y
Sbjct: 153 PSNILLDERG----QIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTKPDY 206
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP------YWDDISE 607
++ DVW+ G+ L L G P+ + D + L +L P + S
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCKTDFEVLT-KVLQE----EPPLLPGHMGF---SG 258
Query: 608 EAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
+ + + L + R +L+H +++R
Sbjct: 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 66/276 (23%), Positives = 120/276 (43%), Gaps = 30/276 (10%)
Query: 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKL 440
G+++G G F +V + +K + + ++ ++ EV ++R + HPN++K
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK-EVKVMRCLEHPNVLKF 72
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499
+ + L + E IKGG L I S + ++ + +AS ++YLH I+HR
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132
Query: 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVL------------------RPMFTVCGTPT 541
D+ N LV + K + V DFGLA R++ + +TV G P
Sbjct: 133 DLNSHNCLVREN----KNVVVADFGLA-RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 542 YVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY 601
++APE++N Y K+DV++ G++L ++ D + F + G P
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD-PDYLPRTMDFGLNVRGFLDRYCP- 245
Query: 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
+ + + +P+ R S + WLE
Sbjct: 246 -PNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE 278
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 69/322 (21%), Positives = 123/322 (38%), Gaps = 52/322 (16%)
Query: 360 TATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK 419
+ K + R+ V ++ G G F V+ +K M A+K + + +
Sbjct: 6 MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RN 64
Query: 420 QMIENEVNILRSVNHPNIIKLLDEYDTNNE-------LYLVIELIKGGDLFDAISKNVKF 472
+ ++ + L ++HPNI++L + T E L +V+E + L +
Sbjct: 65 RELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRR 122
Query: 473 SEEDSKFMTQS----LASALSYLHDNY--IVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526
+ + L ++ LH + HRDIKP N+LV + LK+ DFG A
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG---TLKLCDFGSA 179
Query: 527 QRVLRPMFT----VCGTPTYVAPE-ILNESGYGVKIDVWAAGVILYILLCGFPPFV-SDT 580
+ L P +C + Y APE I Y +D+W+ G I ++ G P F ++
Sbjct: 180 -KKLSPSEPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237
Query: 581 NDQ------------DELFDDILSGQYGFPSPYWD-------------DISEEAKELISH 615
Q E+ + ++EA +L+S
Sbjct: 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297
Query: 616 MLESNPDLRFSAEDVLDHPWLE 637
+L+ P+ R + L HP+ +
Sbjct: 298 LLQYLPEERMKPYEALCHPYFD 319
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-39
Identities = 78/315 (24%), Positives = 133/315 (42%), Gaps = 66/315 (20%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK---SKLLGKKQMIENEVNILRS 431
+L+RY + IG G +V YD + + A+K + + ++ K+ E+ +++
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR--AYRELVLMKC 80
Query: 432 VNHPNIIKLLD------EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLA 485
VNH NII LL+ + ++Y+V+EL+ +L I E ++ +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQML 137
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTY 542
+ +LH I+HRD+KP N++V+ S C LK+ DFGLA R F + T Y
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVK-SDCT---LKILDFGLA-RTAGTSFMMTPYVVTRYY 192
Query: 543 VAPEILNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELFDDILSGQYGFPSP- 600
APE++ GY +D+W+ G I+ ++ G F +D DQ + L G P P
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPCPE 248
Query: 601 YWDDISEEAKE--------------------------------------LISHMLESNPD 622
+ + + L+S ML +
Sbjct: 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308
Query: 623 LRFSAEDVLDHPWLE 637
R S ++ L HP++
Sbjct: 309 KRISVDEALQHPYIN 323
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 72/311 (23%), Positives = 130/311 (41%), Gaps = 52/311 (16%)
Query: 367 ENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEV 426
E+ + Y + + +G G ++ V + + + +KI+ K + KK+ I+ E+
Sbjct: 26 ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKK-IKREI 81
Query: 427 NILRSV-NHPNIIKLLD--EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQS 483
IL ++ PNII L D + + LV E + D ++ D +F
Sbjct: 82 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYE 138
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM--FTV-CGTP 540
+ AL Y H I+HRD+KP N++++ L++ D+GLA P + V +
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHR---KLRLIDWGLA-EFYHPGQEYNVRVASR 194
Query: 541 TYVAPEIL-NESGYGVKIDVWAAGVILYILLCGFPPFV--SDTNDQ-------------- 583
+ PE+L + Y +D+W+ G +L ++ PF D DQ
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254
Query: 584 ----------DELFDDILSGQYG-------FPSPYWDDISEEAKELISHMLESNPDLRFS 626
D F+DIL G++ S +S EA + + +L + R +
Sbjct: 255 DYIDKYNIELDPRFNDIL-GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313
Query: 627 AEDVLDHPWLE 637
A + ++HP+
Sbjct: 314 AREAMEHPYFY 324
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 87/315 (27%), Positives = 129/315 (40%), Gaps = 72/315 (22%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYD-KHKDMDCALKIIDKSKLLGKKQMIEN------ 424
+ Q+Y IG+G + V + D K+ ALK + ++ +
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRV-------QTGEEGMP 55
Query: 425 -----EVNILRSVN---HPNIIKLLD-----EYDTNNELYLVIELI----KGGDLFDAIS 467
EV +LR + HPN+++L D D +L LV E + D +
Sbjct: 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKV- 112
Query: 468 KNVKFSEEDSK-FMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526
E K M Q L L +LH + +VHRD+KP+N+LV SG +K+ DFGLA
Sbjct: 113 PEPGVPTETIKDMMFQ-LLRGLDFLHSHRVVHRDLKPQNILVTSSGQ----IKLADFGLA 167
Query: 527 QRVLRPM-FT---VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND 582
+ M T V T Y APE+L +S Y +D+W+ G I + P F +D
Sbjct: 168 RIYSFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SD 224
Query: 583 QDELF----------DDILSG-----QYGFPSP-------YWDDISEEAKELISHMLESN 620
D+L ++ + F S + DI E K+L+ L N
Sbjct: 225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284
Query: 621 PDLRFSAEDVLDHPW 635
P R SA L HP+
Sbjct: 285 PAKRISAYSALSHPY 299
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-38
Identities = 79/317 (24%), Positives = 127/317 (40%), Gaps = 75/317 (23%)
Query: 385 IGDGNFAVVRQVYDKHK--DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
+G G + V + K D D ALK + + G E+ +LR + HPN+I L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALK---QIEGTGISMSACREIALLRELKHPNVISLQK 85
Query: 443 --EYDTNNELYLVIE--------LIKGGDLFDAISKNVKFSEEDSK-FMTQSLASALSYL 491
+ +++L+ + +IK A K V+ K + Q + + YL
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-ILDGIHYL 144
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----LRPMFTVCG---TPTYVA 544
H N+++HRD+KP N+LV G +K+ D G A R+ L+P+ + T Y A
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDPVVVTFWYRA 203
Query: 545 PEIL-NESGYGVKIDVWAAGVILYILLCGFPPF--------VSDTNDQDELFD--DILSG 593
PE+L Y ID+WA G I LL P F S+ D+L +++
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM-- 261
Query: 594 QYGFPSP-YWDDIS----------------------------------EEAKELISHMLE 618
GFP+ W+DI +A L+ +L
Sbjct: 262 --GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 319
Query: 619 SNPDLRFSAEDVLDHPW 635
+P R ++E + P+
Sbjct: 320 MDPIKRITSEQAMQDPY 336
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 63/275 (22%), Positives = 111/275 (40%), Gaps = 32/275 (11%)
Query: 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILR--- 430
Y + +++G G V + D ++ ALK++ + + + V R
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLM-------SETLSSDPVFRTRMQR 83
Query: 431 ------SVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSL 484
+ P+++ + D + + +LY+ + LI G DL + + + + + + +
Sbjct: 84 EARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQI 143
Query: 485 ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT----VCGTP 540
SAL H HRD+KPEN+LV + DFG+A T GT
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADD----FAYLVDFGIASATTDEKLTQLGNTVGTL 199
Query: 541 TYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ--DELFDDILSGQYGFP 598
Y+APE +ES + D++A +LY L G PP+ D + I P
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPR-----P 254
Query: 599 SPYWDDISEEAKELISHMLESNPDLRF-SAEDVLD 632
S I +I+ + NP+ R+ + D+
Sbjct: 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-38
Identities = 81/315 (25%), Positives = 133/315 (42%), Gaps = 66/315 (20%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK---SKLLGKKQMIENEVNILRS 431
+L+RY + IG G +V YD D + A+K + + ++ K+ E+ +++
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR--AYRELVLMKC 117
Query: 432 VNHPNIIKLLD------EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLA 485
VNH NII LL+ + ++YLV+EL+ +L I + E ++ +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMEL--DHERMSYLLYQML 174
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG---TPTY 542
+ +LH I+HRD+KP N++V+ S C LK+ DFGLA R F + T Y
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVK-SDCT---LKILDFGLA-RTAGTSFMMTPYVVTRYY 229
Query: 543 VAPEILNESGYGVKIDVWAAGVILYILLCGFPPFV-SDTNDQDELFDDILSGQYGFPSP- 600
APE++ GY +D+W+ G I+ ++ F D DQ + L G P P
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL----GTPCPE 285
Query: 601 YWDDISEEAKE--------------------------------------LISHMLESNPD 622
+ + + L+S ML +P
Sbjct: 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345
Query: 623 LRFSAEDVLDHPWLE 637
R S +D L HP++
Sbjct: 346 KRISVDDALQHPYIN 360
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 77/331 (23%), Positives = 126/331 (38%), Gaps = 81/331 (24%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
++YS+G+ +G G+F +V +V+D ALK K+L + E++I++ ++H N
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQDPRYKNRELDIMKVLDHVN 61
Query: 437 IIKLLD--------------------------------------EYDTNNELYLVIELIK 458
IIKL+D N L +++E +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120
Query: 459 GGDLFDAISKNVK----FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH 514
L + ++ L A+ ++H I HRDIKP+NLLV
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN- 179
Query: 515 VKVLKVGDFGLAQRVLRPMFT----VCGTPTYVAPE-ILNESGYGVKIDVWAAGVILYIL 569
LK+ DFG A + L P +C + Y APE +L + Y ID+W+ G + L
Sbjct: 180 --TLKLCDFGSA-KKLIPSEPSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 570 LCGFPPFV-SDTNDQ------------DELFDDILSGQYGFPSPYWDDIS---------- 606
+ G P F + DQ E + P
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
A +L+ +L PDLR + + + HP+ +
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 76/328 (23%), Positives = 138/328 (42%), Gaps = 73/328 (22%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN---- 433
RY + + +G G+F+ V D + A+KI+ + + + + E+ +L+ VN
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAED-EIKLLQRVNDADN 77
Query: 434 -------HPNIIKLLDEYDTNNE----LYLVIELIKGGDLFDAISKN--VKFSEEDSKFM 480
+I+KLLD ++ + +V E++ G +L I K K +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI 136
Query: 481 TQSLASALSYLHDNY-IVHRDIKPENLLVEMSGC--HVKVLKVGDFGLAQRVLRPMFTVC 537
++ L L Y+H I+H DIKPEN+L+E+ ++ +K+ D G A
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPF-----VSDTNDQDEL------ 586
T Y +PE+L + +G D+W+ +++ L+ G F S T D D +
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256
Query: 587 ------------------FD-----------------DILSGQYGFPSPYWDDISEEAKE 611
F+ D+L+ +Y F D ++E +
Sbjct: 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS----KDEAKEISD 312
Query: 612 LISHMLESNPDLRFSAEDVLDHPWLERS 639
+S ML+ +P R A +++HPWL+ +
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDT 340
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-37
Identities = 72/332 (21%), Positives = 128/332 (38%), Gaps = 33/332 (9%)
Query: 310 DVEEVKAIQALKKDLRRPEHTKLKSGTTCLDASGREVPKMPTKTSV--ARCATATIKRRE 367
++ ++AL + PE + C GR + + C + +
Sbjct: 14 RAPDIDPLEALMTNPVVPESKRFCWN--CGRPVGRSDSETKGASEGWCPYCGSPYSFLPQ 71
Query: 368 NLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDM-DCALKIIDKSKLLGKKQMIENEV 426
LN + +Y V I G + D++ + LK + S + M E
Sbjct: 72 -LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAER 130
Query: 427 NILRSVNHPNIIKLLD-----EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMT 481
L V HP+I+++ + + + Y+V+E + G L + + K ++
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYL 188
Query: 482 QSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT 541
+ ALSYLH +V+ D+KPEN+++ LK+ D G R+ + GTP
Sbjct: 189 LEILPALSYLHSIGLVYNDLKPENIMLTEEQ-----LKLIDLGAVSRINSFG-YLYGTPG 242
Query: 542 YVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY 601
+ APEI+ +G V D++ G L L P D L +D P
Sbjct: 243 FQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRY--VDGLPEDD-------PVL- 291
Query: 602 WDDISEEAKELISHMLESNPDLRF-SAEDVLD 632
+ L+ ++ +P RF +AE++
Sbjct: 292 --KTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 71/274 (25%), Positives = 129/274 (47%), Gaps = 27/274 (9%)
Query: 364 KRRENLNIPSKLLQRYSVGQIIGDGNFAVV-RQVYDKHKDMDCALKIIDKSKLLGKK-QM 421
++ IP + VGQ IG G+F V + + D A+K+++ + ++ Q
Sbjct: 14 DAADDWEIPDGQIT---VGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQA 66
Query: 422 IENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFM 480
+NEV +LR H NI+ + Y T +L +V + +G L+ + + KF + +
Sbjct: 67 FKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDI 125
Query: 481 TQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL------RPMF 534
+ A + YLH I+HRD+K N+ + +K+GDFGLA
Sbjct: 126 ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN----TVKIGDFGLA-TEKSRWSGSHQFE 180
Query: 535 TVCGTPTYVAPEILNESG---YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDIL 591
+ G+ ++APE++ Y + DV+A G++LY L+ G P+ S+ N++D++ + +
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-SNINNRDQIIEMVG 239
Query: 592 SGQ-YGFPSPYWDDISEEAKELISHMLESNPDLR 624
G S + + K L++ L+ D R
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 42/280 (15%), Positives = 97/280 (34%), Gaps = 49/280 (17%)
Query: 367 ENLNIPSKLLQRYSVGQIIGDGNFAVV-RQVYDKHKDMDCALKIIDKSKLLGKK-QMIEN 424
++ I K L + + + + + + + D +K++ +K +
Sbjct: 3 KHSGIDFKQLN---FLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWSTRKSRDFNE 56
Query: 425 EVNILRSVNHPNIIKLL----DEYDTNNELYLVIELIKGGDLFDAI--SKNVKFSEEDSK 478
E LR +HPN++ +L + L+ + G L++ + N + +
Sbjct: 57 ECPRLRIFSHPNVLPVLGACQSPPAPH--PTLITHWMPYGSLYNVLHEGTNFVVDQSQAV 114
Query: 479 FMTQSLASALSYLH--DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTV 536
+A +++LH + I + +++++ ++ + +
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED----MTARISMADVK-FSFQ-SPGR 168
Query: 537 CGTPTYVAPEILNESGYGV---KIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG 593
P +VAPE L + D+W+ V+L+ L+ P F D+ +
Sbjct: 169 MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP-----------FADLSNM 217
Query: 594 QYGF---------PSPYWDDISEEAKELISHMLESNPDLR 624
+ G P IS +L+ + +P R
Sbjct: 218 EIGMKVALEGLRPTIP--PGISPHVSKLMKICMNEDPAKR 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 79/324 (24%), Positives = 130/324 (40%), Gaps = 68/324 (20%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH 434
+ RY V ++IG G+F V + YD ALK++ +++ +Q E+ IL +
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQ-AAEEIRILEHLRK 152
Query: 435 ------PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLAS 486
N+I +L+ + N + + EL+ +L++ I KN FS + S+
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 487 ALSYLHDNYIVHRDIKPEN-LLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAP 545
L LH N I+H D+KPEN LL + +KV+ DFG + + ++T + Y AP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVI---DFGSSCYEHQRVYTYIQSRFYRAP 268
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILS------------ 592
E++ + YG+ ID+W+ G IL LL G+P + DQ ++L
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR 328
Query: 593 -----GQYGFPSPYWDDISEEAKE-----------------------------------L 612
G+P +
Sbjct: 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDF 388
Query: 613 ISHMLESNPDLRFSAEDVLDHPWL 636
+ LE +P +R + L HPWL
Sbjct: 389 LKQCLEWDPAVRMTPGQALRHPWL 412
|
| >1uf0_A Serine/threonine-protein kinase dcamkl1; structural genomics, ubiquitin-like fold, microtubule- binding; NMR {Homo sapiens} SCOP: d.15.11.1 Length = 116 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-35
Identities = 50/112 (44%), Positives = 82/112 (73%), Gaps = 2/112 (1%)
Query: 93 SPLKSRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRIL 152
S ++AK++RF NGD++FKG+V A+ P+R+RSF++LL +LTR L++N+NLP GVR +
Sbjct: 3 SGSSGKKAKKVRFYRNGDRYFKGIVYAISPDRFRSFEALLADLTRTLSDNVNLPQGVRTI 62
Query: 153 FTMDG-QKVTNIDELEDGKFYICSSSGDQFKKVDYAILNNNNSSNTLPRSGK 203
+T+DG +K++++D+L +G+ Y+C S + FKK++Y N N S + SG
Sbjct: 63 YTIDGLKKISSLDQLVEGESYVC-GSIEPFKKLEYTKNVNPNWSVNVKTSGP 113
|
| >1uf0_A Serine/threonine-protein kinase dcamkl1; structural genomics, ubiquitin-like fold, microtubule- binding; NMR {Homo sapiens} SCOP: d.15.11.1 Length = 116 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 2e-04
Identities = 14/88 (15%), Positives = 33/88 (37%), Gaps = 3/88 (3%)
Query: 223 RPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTG---AVRKVYTLNGN 279
+ + + RNG R K + ++ S + + +T + + VR +YT++G
Sbjct: 9 KAKKVRFYRNGDRYFKGIVYAISPDRFRSFEALLADLTRTLSDNVNLPQGVRTIYTIDGL 68
Query: 280 QLARLSDFFKSDDVFFAYGSERVLPDDF 307
+ D + + E ++
Sbjct: 69 KKISSLDQLVEGESYVCGSIEPFKKLEY 96
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 59/293 (20%), Positives = 108/293 (36%), Gaps = 52/293 (17%)
Query: 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLL 441
+ +G G + V + + + A+KI K E E+ + H NI+ +
Sbjct: 13 LECVGKGRYGEVWRG--SWQGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFI 68
Query: 442 ----DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY-- 495
++ +L+L+ + G L+D + + S+AS L++LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 496 ------IVHRDIKPENLLVEMSGCHVKVLKVGDFGLA-------QRVLRPMFTVCGTPTY 542
I HRD+K +N+LV+ +G + D GLA ++ GT Y
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNG----QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 543 VAPEILNES------GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596
+APE+L+E+ ++D+WA G++L+ + D F D++
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVVPNDPS 242
Query: 597 F-----------------PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632
F + D +L+ NP R +A +
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 59/305 (19%), Positives = 115/305 (37%), Gaps = 55/305 (18%)
Query: 370 NIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNIL 429
++ + + + IG G F V + K + + A+KI + + E E+
Sbjct: 38 RTIARTIV---LQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREE--RSWFREAEIYQT 90
Query: 430 RSVNHPNIIKLL----DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLA 485
+ H NI+ + + T +L+LV + + G LFD +++ + E + S A
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTA 149
Query: 486 SALSYLHDNY--------IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR-------VL 530
S L++LH I HRD+K +N+LV+ +G + D GLA R +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT----CCIADLGLAVRHDSATDTID 205
Query: 531 RPMFTVCGTPTYVAPEILNESG------YGVKIDVWAAGVILYILLCGFPPFVSDTNDQD 584
GT Y+APE+L++S + D++A G++ + + + Q
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265
Query: 585 ELFDDILSGQYGF-----------------PSPYWDDISEEAKELISHMLESNPDLRFSA 627
+ D++ + +++ +N R +A
Sbjct: 266 P-YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 628 EDVLD 632
+
Sbjct: 325 LRIKK 329
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 60/305 (19%), Positives = 114/305 (37%), Gaps = 55/305 (18%)
Query: 370 NIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNIL 429
+K +Q + + IG G + V K + A+K+ ++ + E E+
Sbjct: 33 RTIAKQIQ---MVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEASWFR--ETEIYQT 85
Query: 430 RSVNHPNIIKLL----DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLA 485
+ H NI+ + + +LYL+ + + G L+D + + + S
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSV 144
Query: 486 SALSYLHDNY--------IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR------ 531
S L +LH I HRD+K +N+LV+ +G + D GLA + +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG----TCCIADLGLAVKFISDTNEVD 200
Query: 532 -PMFTVCGTPTYVAPEILNESG------YGVKIDVWAAGVILYILLCGFPPFVSDTNDQD 584
P T GT Y+ PE+L+ES + D+++ G+IL+ + +
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQ 259
Query: 585 ELFDDILSGQYGF-----------------PSPYWDDISEEAKELISHMLESNPDLRFSA 627
+ D++ + D+ + +L++ NP R +A
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
Query: 628 EDVLD 632
V
Sbjct: 320 LRVKK 324
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 61/318 (19%), Positives = 109/318 (34%), Gaps = 61/318 (19%)
Query: 379 YSVGQIIGDG--NFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVNHP 435
Y + +IG G + V K ++ I+ + ++ E+++ + NHP
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAI--SKNVKFSEEDSKFMTQSLASALSYLHD 493
NI+ + +NEL++V + G D I +E ++ Q + AL Y+H
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM----------FTVCGTPTYV 543
VHR +K ++L+ + G V + ++ ++
Sbjct: 147 MGYVHRSVKASHILISVDG-KV---YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 544 APEIL--NESGYGVKIDVWAAGVILYILLCGFPPF------------------------- 576
+PE+L N GY K D+++ G+ L G PF
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262
Query: 577 ---------------VSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNP 621
S +D S PY S + L+ NP
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322
Query: 622 DLRFSAEDVLDHPWLERS 639
D R SA +L+H + ++
Sbjct: 323 DARPSASTLLNHSFFKQI 340
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 74/334 (22%), Positives = 128/334 (38%), Gaps = 75/334 (22%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH 434
+ RY + +IG G+F V + YD+ + A+KII K+K Q + EV +L +N
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQ-AQIEVRLLELMNK 109
Query: 435 P------NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLAS 486
I+ L + N L LV E++ +L+D + S ++ Q + +
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 487 ALSYLHDNY--IVHRDIKPEN-LLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV 543
AL +L I+H D+KPEN LL +K++ DFG + ++ + ++ + Y
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV---DFGSSCQLGQRIYQYIQSRFYR 225
Query: 544 APEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQ------------------- 583
+PE+L Y + ID+W+ G IL + G P F DQ
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285
Query: 584 ---DELFDDILSGQY-----------------------------GFPSPYWDDISEEAKE 611
+ F+ + G + G + +
Sbjct: 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVAD 345
Query: 612 ------LISHMLESNPDLRFSAEDVLDHPWLERS 639
LI ML+ +P R L H + +++
Sbjct: 346 YLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 82/359 (22%), Positives = 136/359 (37%), Gaps = 110/359 (30%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK---SKLLGKKQMIENEVNILRS 431
+ Y + +IG G++ V YDK+ + + A+K +++ + K+ I E+ IL
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR--ILREITILNR 81
Query: 432 VNHPNIIKLLD-----EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK-FMTQSLA 485
+ II+L D + +ELY+V+E+ DL + +EE K + L
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLL- 139
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT---- 541
+++H++ I+HRD+KP N L+ C +KV DFGLA R +
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLN-QDCS---VKVCDFGLA-RTINSEKDTNIVNDLEEN 194
Query: 542 ----------------YV------APEI-LNESGYGVKIDVWAAGVILYILLCG------ 572
+V APE+ L + Y ID+W+ G I LL
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
Query: 573 --------FP---------------PFVSDTNDQDELFDDILSGQYGFPSPYWDDI---- 605
FP DQ + +I+ G P+ DD+
Sbjct: 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNII----GTPTE--DDLKNIN 308
Query: 606 --------------------------SEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
S++ L+ ML+ NP+ R + + LDHP+L+
Sbjct: 309 KPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 66/306 (21%), Positives = 120/306 (39%), Gaps = 53/306 (17%)
Query: 367 ENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEV 426
ENL S LQ + ++ G F V + + + A+KI + E EV
Sbjct: 17 ENLYFQSMPLQ---LLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQN--EYEV 69
Query: 427 NILRSVNHPNIIKLL--DEYDTNN--ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQ 482
L + H NI++ + ++ T+ +L+L+ + G L D + NV S + + +
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAE 128
Query: 483 SLASALSYLHDNY----------IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531
++A L+YLH++ I HRDIK +N+L++ + + DFGLA +
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL----TACIADFGLALKFEAG 184
Query: 532 ----PMFTVCGTPTYVAPEILNES-----GYGVKIDVWAAGVILYILLCGFPPFVSDTND 582
GT Y+APE+L + ++ID++A G++L+ L ++
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 583 QDELFDDILSGQYGF----------------PSPYWDDISEEA-KELISHMLESNPDLRF 625
F++ + + E I + + + R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 626 SAEDVL 631
SA V
Sbjct: 305 SAGCVG 310
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 84/337 (24%), Positives = 136/337 (40%), Gaps = 84/337 (24%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDK---SKLLGKKQMIENEVNILRS 431
+L++Y + + +G G + +V + D+ A+K I + ++ E+ IL
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR--TFREIMILTE 64
Query: 432 VN-HPNIIKLLD--EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK-FMTQSLASA 487
++ H NI+ LL+ D + ++YLV + + DL I N+ + + Q +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI-LEPVHKQYVVYQLI-KV 121
Query: 488 LSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT------ 541
+ YLH ++HRD+KP N+L+ + CH +KV DFGL+ R + V
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLN-AECH---VKVADFGLS-RSFVNIRRVTNNIPLSINEN 176
Query: 542 -------------YV------APEI-LNESGYGVKIDVWAAGVILYILLCGFPPFV-SDT 580
YV APEI L + Y ID+W+ G IL +LCG P F S T
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236
Query: 581 NDQ---------------------------------------DELFDDILSGQYGFPSPY 601
+Q D +
Sbjct: 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296
Query: 602 -WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
D +EEA +L+ +L+ NP+ R SA D L HP++
Sbjct: 297 PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-33
Identities = 92/413 (22%), Positives = 149/413 (36%), Gaps = 114/413 (27%)
Query: 325 RRPEHTKLKSGTTCLDASGREVPKMPTKTSVARCATATIKRRENLNIPSKLLQRYSVGQI 384
+ SGT + ++ + + ++ + + + IP RY + +
Sbjct: 5 EAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD----RYEIRHL 60
Query: 385 IGDGNFAVVRQVYDKHKDMDCALKIIDK--SKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
IG G++ V + YDK + A+K I + L+ K+++ E+ IL +NH +++K+LD
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLD 119
Query: 443 -----EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK-FMTQSLASALSYLHDNYI 496
+ + +ELY+V+E+ D V +E K + L + Y+H I
Sbjct: 120 IVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLL-VGVKYVHSAGI 177
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT--------------- 541
+HRD+KP N LV C +KV DFGLA+ V P P
Sbjct: 178 LHRDLKPANCLVN-QDCS---VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 542 ---------YV------APEI-LNESGYGVKIDVWAAGVIL-----------YILLCGFP 574
+V APE+ L + Y IDVW+ G I P
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
Query: 575 PF---------------------VSDTNDQDELFDDILSGQYGFPS-------------- 599
F DQ + +IL G PS
Sbjct: 294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL----GTPSEEDIEALEKEDAKR 349
Query: 600 -----PYWD---------DISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
P + S +A L+ ML NP+ R + + L HP+ +
Sbjct: 350 YIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >1mg4_A Doublecortin, doublecortin-like kinase (N-terminal domain); DCX domain, microtubule bundling, cortex development, transferase; 1.50A {Homo sapiens} SCOP: d.15.11.1 PDB: 1mfw_A 1mjd_A 2bqq_A 2xrp_I* Length = 113 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 45/96 (46%), Positives = 76/96 (79%), Gaps = 2/96 (2%)
Query: 97 SRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMD 156
++AK++RF NGD++FKG+V A+ P+R+RSF++LL +LTR L++N+NLP GVR ++T+D
Sbjct: 12 EKKAKKVRFYRNGDRYFKGIVYAISPDRFRSFEALLADLTRTLSDNVNLPQGVRTIYTID 71
Query: 157 G-QKVTNIDELEDGKFYICSSSGDQFKKVDYAILNN 191
G +K++++D+L +G+ Y+C S + FKK++Y N
Sbjct: 72 GLKKISSLDQLVEGESYVC-GSIEPFKKLEYTKNVN 106
|
| >1mg4_A Doublecortin, doublecortin-like kinase (N-terminal domain); DCX domain, microtubule bundling, cortex development, transferase; 1.50A {Homo sapiens} SCOP: d.15.11.1 PDB: 1mfw_A 1mjd_A 2bqq_A 2xrp_I* Length = 113 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 3e-04
Identities = 15/97 (15%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 214 NKTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDT---GAV 270
+ S + + + RNG R K + ++ S + + +T + + V
Sbjct: 5 PEFTLSSEKKAKKVRFYRNGDRYFKGIVYAISPDRFRSFEALLADLTRTLSDNVNLPQGV 64
Query: 271 RKVYTLNGNQLARLSDFFKSDDVFFAYGSERVLPDDF 307
R +YT++G + D + + E ++
Sbjct: 65 RTIYTIDGLKKISSLDQLVEGESYVCGSIEPFKKLEY 101
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 68/332 (20%), Positives = 124/332 (37%), Gaps = 73/332 (21%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ-MIENEVNILRSVN 433
L + V + +GDG F V A+K++ ++ + IE +IL+ +
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIE--ADILKKIQ 89
Query: 434 H-----PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLAS 486
+ NI+K ++ + + L+ E + G L++ I++N F ED K +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHVKV---------------------LKVGDFGL 525
AL+YL + H D+KPEN+L++ + +K+ DFG
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 526 AQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN---- 581
A ++ T Y APE++ G+ V D+W+ G +L L G F + +
Sbjct: 209 ATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268
Query: 582 --------------------DQDELFDDILSGQYGFPSPYWDDIS--------------- 606
+ + + +P S
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328
Query: 607 -EEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
E + + +L+ +P LR S ++L H +LE
Sbjct: 329 HELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 75/327 (22%), Positives = 129/327 (39%), Gaps = 67/327 (20%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYD-KHKDMDCALKIIDKSKLLGKKQ-MIENEVNILRSV 432
L RY + +G+G F V + D K A+KI+ K+ + E + +L +
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSE--IQVLEHL 68
Query: 433 NHP------NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSL 484
N +++L+ ++ + + +V EL+ G +D I +N + F + + M +
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 485 ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKV---------------LKVGDFGLAQRV 529
++++LH N + H D+KPEN+L S +KV DFG A
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 530 LRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFD 588
T+ T Y APE++ G+ DVW+ G IL GF F + + + + +
Sbjct: 188 DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 589 DIL-----------------------------SGQYGFPS--------PYWDDISEEAKE 611
IL +G+Y + D E +
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 612 LISHMLESNPDLRFSAEDVLDHPWLER 638
LI MLE +P R + + L HP+ +
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 74/326 (22%), Positives = 128/326 (39%), Gaps = 65/326 (19%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKD-MDCALKIIDKSKLLGKKQMIENEVNILRSVN 433
L +RY + +G+G F V + D + ALKII + +E +N+L+ +
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE--INVLKKIK 74
Query: 434 HP------NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLA 485
+ + D ++ + + + EL+ G + F+ + +N + + M L
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKV---------------LKVGDFGLAQRVL 530
AL +LH+N + H D+KPEN+L S ++V DFG A
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 531 RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDD 589
T+ T Y PE++ E G+ DVW+ G IL+ GF F + N + + +
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253
Query: 590 IL-----------------------------SGQYGFPS--PYWDDISEEAKE------L 612
IL G+Y + P + +++ E L
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313
Query: 613 ISHMLESNPDLRFSAEDVLDHPWLER 638
+ MLE +P R + + L HP+
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 47/254 (18%), Positives = 81/254 (31%), Gaps = 33/254 (12%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHP 435
RY + G Q D D AL +D +L Q + L ++ P
Sbjct: 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY 495
+ ++LD T +V E I+GG L + + S + QSLA+A H
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP--SPVGAIRAMQSLAAAADAAHRAG 149
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGV 555
+ P + V + G V + P +
Sbjct: 150 VALSIDHPSRVRVSIDG-DVVL--------------------AYPATMPDA-------NP 181
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQD-ELFDDILSGQYGFPSPYWDDISEEAKELIS 614
+ D+ G LY LL P + +GQ P+ DI + + +
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 615 HMLESNPDLRFSAE 628
++ + +R ++
Sbjct: 242 RSVQGDGGIRSAST 255
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 61/319 (19%), Positives = 111/319 (34%), Gaps = 68/319 (21%)
Query: 367 ENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEV 426
++ L+ + ++IG G + V + + A+K+ +Q NE
Sbjct: 6 SEPSLDLDNLK---LLELIGRGRYGAVYKG--SLDERPVAVKVFSF----ANRQNFINEK 56
Query: 427 NI--LRSVNHPNIIKLL-----DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKF 479
NI + + H NI + + D E LV+E G L +S + S
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCR 115
Query: 480 MTQSLASALSYLHDNY---------IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530
+ S+ L+YLH I HRD+ N+LV+ G + DFGL+ R+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG----TCVISDFGLSMRLT 171
Query: 531 R-----------PMFTVCGTPTYVAPEILNES-------GYGVKIDVWAAGVILYILLCG 572
+ GT Y+APE+L + ++D++A G+I + +
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 573 FPPFVSDTNDQDEL--FDDILSGQYGF-------------PS--PYWDDISEEAKELISH 615
+ + F + F P W + S + L
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 616 MLE---SNPDLRFSAEDVL 631
+ + + + R +A+
Sbjct: 292 IEDCWDQDAEARLTAQXAE 310
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 76/366 (20%), Positives = 133/366 (36%), Gaps = 109/366 (29%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-- 432
RY V + +G G+F+ V +D A+K++ KS + +E+ +L+SV
Sbjct: 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTET-ALDEIRLLKSVRN 92
Query: 433 ---NHPN---IIKLLDEYDTNNE----LYLVIELIKGGDLFDAI--SKNVKFSEEDSKFM 480
N PN +++LLD++ + + +V E++ G L I S K +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 481 TQSLASALSYLH-DNYIVHRDIKPENLLVEMSGCHVK----------------------- 516
Q + L YLH I+H DIKPEN+L+ ++ +++
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 517 ----------------------VLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYG 554
+K+ D G A V + T Y + E+L SGY
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYN 271
Query: 555 VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS------GQYGFP---------- 598
D+W+ + + L G F + ++ +D ++ G+ P
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK--VPRKLIVAGKYS 329
Query: 599 SPYWD------------------------DISEEAKE----LISHMLESNPDLRFSAEDV 630
++ + S+E + MLE P+ R +A +
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389
Query: 631 LDHPWL 636
L HPWL
Sbjct: 390 LRHPWL 395
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 64/260 (24%), Positives = 109/260 (41%), Gaps = 16/260 (6%)
Query: 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK 439
+G+ IG GNF V + + A+K ++ K E IL+ +HPNI++
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 440 LLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVH 498
L+ +Y+V+EL++GGD + + + M A+ + YL +H
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV-----APEILNESGY 553
RD+ N LV VLK+ DFG+++ ++ G V APE LN Y
Sbjct: 237 RDLAARNCLVTEKN----VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 554 GVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612
+ DVW+ G++L+ G P+ + +N + + + G P P + + L
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEKG-GRLPCP--ELCPDAVFRL 347
Query: 613 ISHMLESNPDLRFSAEDVLD 632
+ P R S +
Sbjct: 348 MEQCWAYEPGQRPSFSTIYQ 367
|
| >2dnf_A Doublecortin domain-containing protein 2; structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} Length = 108 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-26
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 98 RRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSG-VRILFTMD 156
+ I + NGD + + + +D +L+ +T E I L SG V L+T++
Sbjct: 12 QEPCTIFLIANGDLINPASRLLIPRKTLNQWDHVLQMVT----EKITLRSGAVHRLYTLE 67
Query: 157 GQKVTNIDELEDGKFYICSSSGDQFKKVDY 186
G+ V + ELE+G+FY+ D+FKK+ Y
Sbjct: 68 GKLVESGAELENGQFYVA-VGRDKFKKLPY 96
|
| >2dnf_A Doublecortin domain-containing protein 2; structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} Length = 108 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-21
Identities = 21/97 (21%), Positives = 43/97 (44%), Gaps = 2/97 (2%)
Query: 221 VVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQ 280
+ P I +I NG R L+ ++ D +T+ + L +GAV ++YTL G
Sbjct: 11 LQEPCTIFLIANGDLINPASRLLIPRKTLNQWDHVLQMVTEKITLRSGAVHRLYTLEGKL 70
Query: 281 LARLSDFFKSDDVFFAYGSERVLPDDF-ELDVEEVKA 316
+ ++ ++ + A G ++ + EL + +
Sbjct: 71 VESGAE-LENGQFYVAVGRDKFKKLPYGELLFDSGPS 106
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 51/235 (21%), Positives = 101/235 (42%), Gaps = 36/235 (15%)
Query: 380 SVGQIIGDGNFAVVRQ----VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP 435
+++G G F V + + + A+K + ++ + I +E ++ SV++P
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 436 NIIKLLDEYD---TNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYL 491
++ +LL + + L+ +L+ G L D + ++ + +A ++YL
Sbjct: 78 HVCRLL----GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV-------- 543
D +VHRD+ N+LV+ + HV K+ DFGLA ++L Y
Sbjct: 134 EDRRLVHRDLAARNVLVK-TPQHV---KITDFGLA-KLLGA-----EEKEYHAEGGKVPI 183
Query: 544 ---APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQ 594
A E + Y + DVW+ GV ++ ++ G P+ E+ + G+
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGE 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 60/251 (23%), Positives = 116/251 (46%), Gaps = 18/251 (7%)
Query: 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKL 440
+ +G G + V + K + A+K + K + ++ ++ E +++ + HPN+++L
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK-EAAVMKEIKHPNLVQL 281
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVH 498
L Y++ E + G+L D + + + S +M ++SA+ YL +H
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTY----VAPEILNESGYG 554
R++ N LV G + ++KV DFGL++ + +T + APE L + +
Sbjct: 342 RNLAARNCLV---GEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 555 VKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
+K DVWA GV+L+ I G P+ ++++ + Y P + E+ EL+
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKD-YRMERP--EGCPEKVYELM 452
Query: 614 SHMLESNPDLR 624
+ NP R
Sbjct: 453 RACWQWNPSDR 463
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 29/204 (14%)
Query: 382 GQIIGDGNFAVVRQ-VYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
+ +G+G+F V YD D A+K + + + E++ILR++ H +I
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 438 IKLLD--EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY 495
IK E L LV+E + G L D + ++ Q + ++YLH +
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV------------ 543
+HRD+ N+L++ + V K+GDFGLA + + G Y
Sbjct: 155 YIHRDLAARNVLLD-NDRLV---KIGDFGLA-KAVPE-----GHEYYRVREDGDSPVFWY 204
Query: 544 APEILNESGYGVKIDVWAAGVILY 567
APE L E + DVW+ GV LY
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLY 228
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 65/253 (25%), Positives = 96/253 (37%), Gaps = 39/253 (15%)
Query: 382 GQIIGDGNFAVVRQ-VYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
Q +G GNF V YD +D A+K + S + E+ IL+S+ H NI
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER-EIEILKSLQHDNI 73
Query: 438 IKLLD--EYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDN 494
+K L L++E + G L D + K+ + T + + YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV----------- 543
+HRD+ N+LVE + V K+GDFGL +VL +
Sbjct: 134 RYIHRDLATRNILVE-NENRV---KIGDFGLT-KVLP-----QDKEFFKVKEPGESPIFW 183
Query: 544 -APEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602
APE L ES + V DVW+ GV+LY L T + +
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELF---------TYIEKSKSPPAEFMRMIGNDKQG 234
Query: 603 DDISEEAKELISH 615
I EL+ +
Sbjct: 235 QMIVFHLIELLKN 247
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 44/222 (19%), Positives = 90/222 (40%), Gaps = 28/222 (12%)
Query: 382 GQIIGDGNFAVVRQ-------VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH 434
+ +G G F + + Y + + + LK++DK+ + E +++ ++H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-AASMMSKLSH 71
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHD 493
+++ +E LV E +K G L + KN + + + LA+A+ +L +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 494 NYIVHRDIKPENLLVEMSGCHVK----VLKVGDFGLAQRVLRPMFTVCGTPTY------V 543
N ++H ++ +N+L+ +K+ D G++ VL V
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-------KDILQERIPWV 184
Query: 544 APE-ILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
PE I N + D W+ G L+ I G P + + +
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/253 (26%), Positives = 96/253 (37%), Gaps = 39/253 (15%)
Query: 382 GQIIGDGNFAVVRQ-VYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
Q +G GNF V YD +D A+K + S + E+ IL+S+ H NI
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER-EIEILKSLQHDNI 104
Query: 438 IKLLD--EYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDN 494
+K L L++E + G L D + K+ + T + + YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV----------- 543
+HRD+ N+LVE + V K+GDFGL +VL Y
Sbjct: 165 RYIHRDLATRNILVE-NENRV---KIGDFGLT-KVLPQ-----DKEYYKVKEPGESPIFW 214
Query: 544 -APEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602
APE L ES + V DVW+ GV+LY L T + +
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELF---------TYIEKSKSPPAEFMRMIGNDKQG 265
Query: 603 DDISEEAKELISH 615
I EL+ +
Sbjct: 266 QMIVFHLIELLKN 278
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 56/252 (22%), Positives = 93/252 (36%), Gaps = 41/252 (16%)
Query: 382 GQIIGDGNFAVVRQ-VYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
+ +G+G+F V YD D A+K + ++ E+ ILR++ H NI
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 438 IKLLD--EYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDN 494
+K D N + L++E + G L + + KN K + + + + YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV----------- 543
VHRD+ N+LVE +K+GDFGL + + Y
Sbjct: 146 QYVHRDLAARNVLVE----SEHQVKIGDFGLT-KAIE-----TDKEYYTVKDDRDSPVFW 195
Query: 544 -APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY 601
APE L +S + + DVW+ GV L+ +L D + +
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYC-----------DSDSSPMALFLKMIGPTH 244
Query: 602 WDDISEEAKELI 613
+
Sbjct: 245 GQMTVTRLVNTL 256
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 57/251 (22%), Positives = 100/251 (39%), Gaps = 20/251 (7%)
Query: 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKL 440
+ +G G F V A+K + + + E +++ + H +++L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL 244
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVH 498
+ +Y+V E + G L D + M +AS ++Y+ VH
Sbjct: 245 Y-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTY----VAPEILNESGYG 554
RD++ N+LV + V KV DFGLA+ + +T + APE +
Sbjct: 304 RDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 555 VKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
+K DVW+ G++L + G P+ N E+ D + G Y P P + E +L+
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG-YRMPCP--PECPESLHDLM 414
Query: 614 SHMLESNPDLR 624
P+ R
Sbjct: 415 CQCWRKEPEER 425
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 51/232 (21%), Positives = 101/232 (43%), Gaps = 30/232 (12%)
Query: 380 SVGQIIGDGNFAVVRQ----VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP 435
+++G G F V + + + A+K + ++ + I +E ++ SV++P
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDN 494
++ +LL + + L+ +L+ G L D + ++ + +A ++YL D
Sbjct: 78 HVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV----------- 543
+VHRD+ N+LV+ + HV K+ DFGLA ++L Y
Sbjct: 137 RLVHRDLAARNVLVK-TPQHV---KITDFGLA-KLLGA-----EEKEYHAEGGKVPIKWM 186
Query: 544 APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQ 594
A E + Y + DVW+ GV ++ ++ G P+ E+ + G+
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGE 236
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 49/222 (22%), Positives = 97/222 (43%), Gaps = 33/222 (14%)
Query: 381 VGQIIGDGNFAVVRQ-VY-DKHKDMDCALKII--DKSKLLGKKQMIENEVNILRSVNHPN 436
+ +G GNF V++ Y K A+KI+ + + K +++ E N+++ +++P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPY 79
Query: 437 IIKLLDEYD--TNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494
I+++ LV+E+ + G L + +N +++ + ++ + YL ++
Sbjct: 80 IVRM---IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV----------- 543
VHRD+ N+L+ K+ DFGL+ + LR Y
Sbjct: 137 NFVHRDLAARNVLLVTQHY----AKISDFGLS-KALRA-----DENYYKAQTHGKWPVKW 186
Query: 544 -APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
APE +N + K DVW+ GV+++ G P+ +
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 382 GQIIGDGNFAVVRQ-VYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
+G GNF V YD D A+K + S ++ E+ IL++++ I
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR-EIQILKALHSDFI 86
Query: 438 IKLLD--EYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDN 494
+K L LV+E + G L D + ++ + + + + YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV----------- 543
VHRD+ N+LVE S HV K+ DFGLA ++L YV
Sbjct: 147 RCVHRDLAARNILVE-SEAHV---KIADFGLA-KLLPL-----DKDYYVVREPGQSPIFW 196
Query: 544 -APEILNESGYGVKIDVWAAGVILY-ILLCGFPPF 576
APE L+++ + + DVW+ GV+LY +
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 63/234 (26%), Positives = 95/234 (40%), Gaps = 37/234 (15%)
Query: 371 IPSKLLQRYSVGQIIGDGNFAVVRQ-VY--DKHKDMDCALKIIDKSKLLGKKQMIE--NE 425
I K L+ + +GDG+F VVR+ + K + A+K + L + M + E
Sbjct: 15 IGEKDLRL---LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 426 VNILRSVNHPNIIKLLDEYD--TNNELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQ 482
VN + S++H N+I+L Y + +V EL G L D + K+ F
Sbjct: 72 VNAMHSLDHRNLIRL---YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 483 SLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTY 542
+A + YL +HRD+ NLL+ +K+GDFGL R L Y
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDL----VKIGDFGLM-RALPQ-----NDDHY 178
Query: 543 V------------APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
V APE L + D W GV L+ + G P++ Q
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 380 SVGQIIGDGNFAVVRQ---VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+ +I+G+G F V + K + ++ A+K K L K+ +E I+++++HP+
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 437 IIKLLDEYD--TNNELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHD 493
I+KL ++++EL G+L + +N + + A++YL
Sbjct: 75 IVKL---IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV---------- 543
VHRDI N+LV C +K+GDFGL+ R + Y
Sbjct: 132 INCVHRDIAVRNILVASPEC----VKLGDFGLS-RYIE------DEDYYKASVTRLPIKW 180
Query: 544 -APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
+PE +N + DVW V ++ IL G PF N
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 57/251 (22%), Positives = 100/251 (39%), Gaps = 20/251 (7%)
Query: 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKL 440
+ +G G F V A+K + + + E +++ + H +++L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL 327
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVH 498
+ +Y+V E + G L D + M +AS ++Y+ VH
Sbjct: 328 Y-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTY----VAPEILNESGYG 554
RD++ N+LV + V KV DFGLA+ + +T + APE +
Sbjct: 387 RDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 555 VKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
+K DVW+ G++L + G P+ N E+ D + G Y P P + E +L+
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG-YRMPCP--PECPESLHDLM 497
Query: 614 SHMLESNPDLR 624
P+ R
Sbjct: 498 CQCWRKEPEER 508
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 53/235 (22%), Positives = 96/235 (40%), Gaps = 29/235 (12%)
Query: 365 RRENLNIPSKLLQRYSVGQIIGDGNFAVVRQ-VYDKHK-DMDCALKIIDKSKLLGKKQMI 422
+ + L + L +G GNF VRQ VY K +D A+K++ + + +
Sbjct: 326 KDKKLFLKRDNLLI--ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM 383
Query: 423 ENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMT 481
E I+ +++P I++L+ L LV+E+ GG L + + + +
Sbjct: 384 MREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442
Query: 482 QSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT 541
++ + YL + VHR++ N+L+ K+ DFGL+ + L
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY----AKISDFGLS-KALGA-----DDSY 492
Query: 542 YV------------APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
Y APE +N + + DVW+ GV ++ L G P+ +
Sbjct: 493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 57/233 (24%), Positives = 102/233 (43%), Gaps = 21/233 (9%)
Query: 380 SVGQIIGDGNF-----AVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH 434
++ + +G G F V + + + A+K + + + E I+ NH
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSL-------ASA 487
NI++ + + ++++EL+ GGDL + + + S L A
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 488 LSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV---- 543
YL +N+ +HRDI N L+ G +V K+GDFG+A+ + R + G +
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 544 -APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQ 594
PE E + K D W+ GV+L+ I G+ P+ S +N E+ + + SG
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGG 262
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 56/241 (23%), Positives = 102/241 (42%), Gaps = 42/241 (17%)
Query: 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKII-----DKSKLLGKKQMIENEVNILRSVNH 434
++ +G G + V + K + A+K + + + L E +++ + H
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-------KEAAVMKEIKH 68
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAI--SKNVKFSEEDSKFMTQSLASALSYLH 492
PN+++LL Y++ E + G+L D + + S +M ++SA+ YL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV--------- 543
+HRD+ N LV + ++KV DFGL+ R++ TY
Sbjct: 129 KKNFIHRDLAARNCLVGENH----LVKVADFGLS-RLMT-------GDTYTAHAGAKFPI 176
Query: 544 ---APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599
APE L + + +K DVWA GV+L+ I G P+ ++++ + Y
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKD-YRMER 233
Query: 600 P 600
P
Sbjct: 234 P 234
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 51/238 (21%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 380 SVGQIIGDGNFAVVRQVYDKHKD---MDCALKIIDKSKLLGKKQMIE--NEVNILRSVNH 434
++G+++G G F VR+ K +D + A+K++ K+ ++ + E E ++ +H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDH 84
Query: 435 PNIIKLL------DEYDTNNELYLVIELIKGGDLFD------AISKNVKFSEEDSKFMTQ 482
P++ KL+ +++ +K GDL +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 483 SLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTY 542
+A + YL +HRD+ N ++ + V DFGL++++ + G +
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCML----AEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 543 V-----APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQ 594
+ A E L ++ Y V DVWA GV ++ I+ G P+ N E+++ ++ G
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEIYNYLIGGN 256
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-22
Identities = 51/237 (21%), Positives = 95/237 (40%), Gaps = 36/237 (15%)
Query: 380 SVGQIIGDGNFAVVRQ-VYDKHKDMDCALKII-----DKSKLLGKKQMIENEVNILRSVN 433
++ + +G G F VV+ + D A+K+I + + E + ++
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQ--YDVAVKMIKEGSMSEDEFF-------QEAQTMMKLS 61
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLH 492
HP ++K +Y+V E I G L + + + M + +++L
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG--------TPTYVA 544
+ +HRD+ N LV+ +KV DFG+ + VL + + A
Sbjct: 122 SHQFIHRDLAARNCLVDRDL----CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----A 173
Query: 545 PEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
PE+ + Y K DVWA G++++ + G P+ TN E+ + G + P
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEVVLKVSQG-HRLYRP 227
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 58/238 (24%), Positives = 106/238 (44%), Gaps = 31/238 (13%)
Query: 380 SVGQIIGDGNFAVVRQVYDKHKD---MDCALKIIDKSKLLGKKQMIE--NEVNILRSVNH 434
+G+I+G+G F V + K +D + A+K + K ++++ E +E ++ +H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 435 PNIIKLL-----DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDS-------KFMTQ 482
PN+I+LL + +++ +K GDL + + + KFM
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 483 SLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTY 542
+A + YL + +HRD+ N ++ + V DFGL++++ + G
Sbjct: 156 -IALGMEYLSNRNFLHRDLAARNCML----RDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 543 V-----APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQ 594
+ A E L + Y K DVWA GV ++ I G P+ N E++D +L G
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMYDYLLHGH 266
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 9e-22
Identities = 57/233 (24%), Positives = 102/233 (43%), Gaps = 21/233 (9%)
Query: 380 SVGQIIGDGNF-----AVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH 434
++ + +G G F V + + + A+K + + + E I+ NH
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSL-------ASA 487
NI++ + + ++++EL+ GGDL + + + S L A
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 488 LSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV---- 543
YL +N+ +HRDI N L+ G +V K+GDFG+A+ + R + G +
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 544 -APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQ 594
PE E + K D W+ GV+L+ I G+ P+ S +N E+ + + SG
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGG 303
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 57/237 (24%), Positives = 102/237 (43%), Gaps = 36/237 (15%)
Query: 380 SVGQIIGDGNFAVVRQ-VYDKHKDMDCALKII-----DKSKLLGKKQMIENEVNILRSVN 433
+ Q IG G F +V + A+K I + + E ++ ++
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNK--DKVAIKTIREGAMSEEDFIE-------EAEVMMKLS 61
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLH 492
HP +++L + LV E ++ G L D + F+ E M + ++YL
Sbjct: 62 HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG--------TPTYVA 544
+ ++HRD+ N LV + V+KV DFG+ + VL +T +
Sbjct: 122 EACVIHRDLAARNCLVGENQ----VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----S 173
Query: 545 PEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
PE+ + S Y K DVW+ GV+++ + G P+ + +N E+ +DI +G + P
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTG-FRLYKP 227
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 27/215 (12%)
Query: 385 IGDGNFAVVRQ-VY-DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
+G GNF VRQ VY + K +D A+K++ + + + E I+ +++P I++L+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 443 EYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
L LV+E+ GG L + + + + ++ + YL + VHRD+
Sbjct: 78 -VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 136
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV------------APEILN 549
N+L+ K+ DFGL+ + L Y APE +N
Sbjct: 137 AARNVLLVNRH----YAKISDFGLS-KALGA-----DDSYYTARSAGKWPLKWYAPECIN 186
Query: 550 ESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
+ + DVW+ GV ++ L G P+ +
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 52/220 (23%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 380 SVGQIIGDGNFAVVRQ-VYDKHKDMDCALKII-----DKSKLLGKKQMIENEVNILRSVN 433
+ + +G G F VV+ + D A+K+I + + + E ++ +++
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQ--YDVAIKMIKEGSMSEDEFI-------EEAKVMMNLS 77
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLH 492
H +++L ++++ E + G L + + + +F + M + + A+ YL
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG--------TPTYVA 544
+HRD+ N LV G V+KV DFGL++ VL +T +
Sbjct: 138 SKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----P 189
Query: 545 PEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
PE+L S + K D+WA GV+++ I G P+ TN +
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 380 SVGQIIGDGNFAVVRQ---VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+G+ IG+G F V Q + ++ + A+K ++ E +R +HP+
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNY 495
I+KL+ T N +++++EL G+L + L++AL+YL
Sbjct: 78 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV-----------A 544
VHRDI N+LV + C +K+GDFGL+ R + + Y A
Sbjct: 137 FVHRDIAARNVLVSSNDC----VKLGDFGLS-RYME------DSTYYKASKGKLPIKWMA 185
Query: 545 PEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
PE +N + DVW GV ++ IL+ G PF N+
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 55/238 (23%), Positives = 101/238 (42%), Gaps = 38/238 (15%)
Query: 380 SVGQIIGDGNFAVVRQ-VYDKHKDMDCALKII-----DKSKLLGKKQMIENEVNILRSVN 433
+ + +G G F V Y+ H A+K + L E N+++ +
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGH--TKVAVKSLKQGSMSPDAFL-------AEANLMKQLQ 66
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYL 491
H +++L T +Y++ E ++ G L D + +K + M +A ++++
Sbjct: 67 HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG--------TPTYV 543
+ +HRD++ N+LV K+ DFGLA+ + +T T
Sbjct: 126 EERNYIHRDLRAANILV---SDT-LSCKIADFGLARLIEDNEYTAREGAKFPIKWT---- 177
Query: 544 APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
APE +N + +K DVW+ G++L I+ G P+ TN E+ ++ G Y P
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLERG-YRMVRP 232
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 381 VGQIIGDGNFAVVR----QVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
++IG G F V + K++ A+K + ++ E I+ +H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNY 495
II+L + ++ E ++ G L + + +FS M + +A+ + YL +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR----PMFTVCGTPTYV---APEIL 548
VHRD+ N+LV + V KV DFGL+ RVL +T G + APE +
Sbjct: 168 YVHRDLAARNILVNSNL----VCKVSDFGLS-RVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 549 NESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
+ + DVW+ G++++ ++ G P+ +N +
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 381 VGQIIGDGNFAVVRQ---VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
+ +IIG G+ V +D+ A+K + +++ +E +I+ +HPNI
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYI 496
I+L +V E ++ G L + + +F+ M + + + + YL D
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV------------A 544
VHRD+ N+LV+ + V KV DFGL+ RVL A
Sbjct: 173 VHRDLAARNVLVDSNL----VCKVSDFGLS-RVLED-----DPDAAYTTTGGKIPIRWTA 222
Query: 545 PEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
PE + + DVW+ GV+++ +L G P+ + TN
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 34/258 (13%)
Query: 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKL 440
+ + +G G F V K A+K + K + + + E N+++++ H ++KL
Sbjct: 192 LEKKLGAGQFGEVWMATYN-KHTKVAVKTM-KPGSMSVEAFLA-EANVMKTLQHDKLVKL 248
Query: 441 LDEYDTNNELYLVIELIKGGDLFDAI--SKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
T +Y++ E + G L D + + K + +A ++++ +H
Sbjct: 249 H-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 307
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG--------TPTYVAPEILNE 550
RD++ N+LV V K+ DFGLA+ + +T T APE +N
Sbjct: 308 RDLRAANILV---SAS-LVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINF 359
Query: 551 SGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
+ +K DVW+ G++L I+ G P+ +N E+ + G Y P P ++ EE
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERG-YRMPRP--ENCPEEL 414
Query: 610 KELISHMLE---SNPDLR 624
+ M+ + P+ R
Sbjct: 415 YNI---MMRCWKNRPEER 429
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 48/231 (20%), Positives = 98/231 (42%), Gaps = 32/231 (13%)
Query: 382 GQIIGDGNFAVVR----QVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
+++G G F V + + +K+I+ Q + + + + S++H +I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYI 496
++LL + L LV + + G L D + ++ + +A + YL ++ +
Sbjct: 78 VRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM 136
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV------------A 544
VHR++ N+L++ S V +V DFG+A +L P + A
Sbjct: 137 VHRNLAARNVLLK-SPSQV---QVADFGVA-DLLPP------DDKQLLYSEAKTPIKWMA 185
Query: 545 PEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQ 594
E ++ Y + DVW+ GV ++ ++ G P+ E+ D + G+
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEKGE 234
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-20
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 382 GQIIGDGNFAVVRQ---VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNII 438
G+ IG+G F V Q + ++ M A+K ++ E +R +HP+I+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIV 497
KL+ T N +++++EL G+L + L++AL+YL V
Sbjct: 455 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV 513
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV-----APEILNESG 552
HRDI N+LV + C +K+GDFGL+ R + + + APE +N
Sbjct: 514 HRDIAARNVLVSSNDC----VKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 553 YGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
+ DVW GV ++ IL+ G PF N+
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 17/216 (7%)
Query: 380 SVGQIIGDGNFAVVRQ---VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
S+ +++G G F V K++ A+K + +++ E +I+ +HPN
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNY 495
II+L + + +V E ++ G L + K+ +F+ M + +AS + YL D
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR----PMFTVCGTPTYV---APEIL 548
VHRD+ N+L+ + V KV DFGL RVL +T G + +PE +
Sbjct: 168 YVHRDLAARNILINSNL----VCKVSDFGLG-RVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 549 NESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQ 583
+ DVW+ G++L+ ++ G P+ +N
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 48/234 (20%), Positives = 100/234 (42%), Gaps = 27/234 (11%)
Query: 382 GQIIGDGNF-----AVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+ +G G+F V + V + A+K ++++ + ++ NE ++++ N +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSL----------AS 486
+++LL +++EL+ GDL + + SL A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV--- 543
++YL+ N VHRD+ N +V +K+GDFG+ + + + G +
Sbjct: 150 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 544 --APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQ 594
+PE L + + DVW+ GV+L+ I P+ +N +++ ++ G
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLRFVMEGG 257
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 19/227 (8%)
Query: 380 SVGQIIGDGNFAVVRQ---VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
++IG G+F V + + K + CA+K +++ +G+ E I++ +HPN
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 437 IIKLLDE-YDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDN 494
++ LL + +V+ +K GDL + I + +D +A + YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV-------APEI 547
VHRD+ N +++ +KV DFGLA+ + + T A E
Sbjct: 148 KFVHRDLAARNCMLDEKF----TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 548 LNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSG 593
L + K DVW+ GV+L+ ++ G PP+ ++ +L G
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQG 248
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-20
Identities = 62/259 (23%), Positives = 100/259 (38%), Gaps = 40/259 (15%)
Query: 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKII----DKSKLLGKKQMIENEVNILRSVNHPN 436
+ Q IG G F V ++ A+K I L E +++ + H N
Sbjct: 197 LLQTIGKGEFGDVML--GDYRGNKVAVKCIKNDATAQAFL-------AEASVMTQLRHSN 247
Query: 437 IIKLL----DEYDTNNELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSY 490
+++LL +E LY+V E + G L D + + + + + A+ Y
Sbjct: 248 LVQLLGVIVEEKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 491 LHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP----MFTVCGTPTYVAPE 546
L N VHRD+ N+LV V KV DFGL + V T APE
Sbjct: 305 LEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APE 356
Query: 547 ILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605
L E + K DVW+ G++L+ I G P+ ++ + G Y +P D
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKG-YKMDAP--DGC 411
Query: 606 SEEAKELISHMLESNPDLR 624
+++ + + R
Sbjct: 412 PPAVYDVMKNCWHLDAATR 430
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 19/228 (8%)
Query: 380 SVGQIIGDGNFAVVRQ---VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
++IG G+F V + + K + CA+K +++ +G+ E I++ +HPN
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 437 IIKLLDE-YDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDN 494
++ LL + +V+ +K GDL + I + +D +A + +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV-------APEI 547
VHRD+ N +++ +KV DFGLA+ + F T A E
Sbjct: 212 KFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 548 LNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQ 594
L + K DVW+ GV+L+ ++ G PP+ ++ +L G+
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGR 313
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 19/225 (8%)
Query: 382 GQIIGDGNFAVVRQ---VYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNII 438
++IG G+F VV + + CA+K + + + + + E ++R +NHPN++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 439 KLLDE-YDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
L+ ++++ + GDL I S + +D +A + YL +
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF 145
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV-------APEILN 549
VHRD+ N +++ S +KV DFGLA+ +L + + A E L
Sbjct: 146 VHRDLAARNCMLDESF----TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 550 ESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSG 593
+ K DVW+ GV+L+ +L G PP+ +L + G
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLAQG 244
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 58/240 (24%), Positives = 93/240 (38%), Gaps = 46/240 (19%)
Query: 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKII----DKSKLLGKKQMIENEVNILRSVNHP 435
+ Q IG G F V + ++ A+K I L E +++ + H
Sbjct: 24 KLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQAFL-------AEASVMTQLRHS 74
Query: 436 NIIKLL----DEYDTNNELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALS 489
N+++LL +E LY+V E + G L D + + + + + A+
Sbjct: 75 NLVQLLGVIVEEKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV------ 543
YL N VHRD+ N+LV V KV DFGL + +
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLT----KEAS----STQDTGKLPVK 179
Query: 544 --APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
APE L E + K DVW+ G++L+ I G P+ ++ + G Y +P
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKG-YKMDAP 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 53/241 (21%), Positives = 93/241 (38%), Gaps = 33/241 (13%)
Query: 380 SVGQIIGDGNF-----AVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH 434
+ +G+G F A + + M A+K + K +Q + E +L + H
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQH 102
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDL---------------FDAISKNVKFSEEDSKF 479
+I++ L +V E ++ GDL
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 480 MTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGT 539
+ +A+ + YL + VHRD+ N LV V+K+GDFG+++ + + G
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLV----GQGLVVKIGDFGMSRDIYSTDYYRVGG 218
Query: 540 PTYV-----APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSG 593
T + PE + + + DVW+ GV+L+ I G P+ +N E D I G
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAIDCITQG 276
Query: 594 Q 594
+
Sbjct: 277 R 277
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 79/277 (28%)
Query: 366 RENLNIPSKLLQRYSVGQIIGDGNF-----AVVRQVYDKHKDMDCALKII-------DKS 413
R+NL + G+ +G+G F A + + A+K++ +
Sbjct: 22 RKNLVL----------GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELR 71
Query: 414 KLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDL----------- 462
LL +E N+L+ VNHP++IKL + L L++E K G L
Sbjct: 72 DLL-------SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124
Query: 463 -----FDAISKNVKFSEEDSKFMTQS--------LASALSYLHDNYIVHRDIKPENLLVE 509
+ D + +T ++ + YL + +VHRD+ N+LV
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV- 183
Query: 510 MSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV------------APEILNESGYGVKI 557
+ +K+ DFGL+ R ++ +YV A E L + Y +
Sbjct: 184 ---AEGRKMKISDFGLS----RDVYE---EDSYVKRSQGRIPVKWMAIESLFDHIYTTQS 233
Query: 558 DVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSG 593
DVW+ GV+L+ I+ G P+ + LF+ + +G
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPP--ERLFNLLKTG 268
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 49/218 (22%)
Query: 384 IIGDGNFAVV--------RQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP 435
+IG G F V +V ALK G ++ E E+ L HP
Sbjct: 46 LIGHGVFGKVYKGVLRDGAKV---------ALKRRTPESSQGIEEF-ETEIETLSFCRHP 95
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMT--QSL------ASA 487
+++ L+ D NE+ L+ + ++ G+L + S+ + M+ Q L A
Sbjct: 96 HLVSLIGFCDERNEMILIYKYMENGNLKRHLYG----SDLPTMSMSWEQRLEICIGAARG 151
Query: 488 LSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT-----VCGTPTY 542
L YLH I+HRD+K N+L++ + V K+ DFG++++ T V GT Y
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDEN----FVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 543 VAPE-----ILNESGYGVKIDVWAAGVILYILLCGFPP 575
+ PE L E K DV++ GV+L+ +LC
Sbjct: 208 IDPEYFIKGRLTE-----KSDVYSFGVVLFEVLCARSA 240
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 33/215 (15%)
Query: 382 GQIIGDGNF-----AVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHP 435
G+ +G G F A + M A+K++ S L +++ + +E+ +L + NH
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDL----------FDAISKNVKFSEEDSKFMTQS-- 483
NI+ LL ++ E GDL F + E+D +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 484 ------LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC 537
+A +++L +HRD+ N+L+ H ++ K+ DFGLA+ + V
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILL----THGRITKICDFGLARDIKNDSNYVV 203
Query: 538 GTPTYV-----APEILNESGYGVKIDVWAAGVILY 567
+ APE + Y + DVW+ G+ L+
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 57/241 (23%), Positives = 101/241 (41%), Gaps = 34/241 (14%)
Query: 382 GQIIGDGNF-----AVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+ +G+G F A + M A+K + K L ++ + E +L ++ H +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEH 78
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFD---------AISKNVKFSEEDSKFMTQSL--- 484
I+K + L +V E +K GDL I + + + + +
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 485 ----ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTP 540
AS + YL + VHRD+ N LV + ++K+GDFG+++ V + G
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGAN----LLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 541 TYV-----APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQ 594
T + PE + + + DVW+ GVIL+ I G P+ +N E+ + I G+
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--TEVIECITQGR 252
Query: 595 Y 595
Sbjct: 253 V 253
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 56/261 (21%), Positives = 107/261 (40%), Gaps = 55/261 (21%)
Query: 366 RENLNIPSKLLQRYSVGQIIGDGNF-----AVVRQVYDKHKDMDCALKIIDKSKLLGKKQ 420
R NL G+ +G G F A + + + A+K++ + +K+
Sbjct: 45 RNNLQF----------GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 421 MIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKGGDLFD-------AISKNVKF 472
+ +E+ I+ + H NI+ LL + ++ E GDL + + + F
Sbjct: 95 ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 473 SEEDSKFMTQSL-------ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525
+ +S T+ L A +++L +HRD+ N+L+ + V K+GDFGL
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL----TNGHVAKIGDFGL 210
Query: 526 AQRVLRPMFTVCGTPTYV------------APEILNESGYGVKIDVWAAGVILY-ILLCG 572
A+ ++ Y+ APE + + Y V+ DVW+ G++L+ I G
Sbjct: 211 ARDIMN-------DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 263
Query: 573 FPPFVSDTNDQDELFDDILSG 593
P+ + + + + G
Sbjct: 264 LNPYPGILVNS-KFYKLVKDG 283
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 57/255 (22%), Positives = 99/255 (38%), Gaps = 62/255 (24%)
Query: 382 GQIIGDGNF-----AVVRQVYDKHKDMDCALKII-------DKSKLLGKKQMIENEVNIL 429
G+ +G G F A + A+K++ + L+ +E+ IL
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-------SELKIL 84
Query: 430 RSV-NHPNIIKLLDE-YDTNNELYLVIELIKGGDLFD--------AISKNVKFSEEDSKF 479
+ +H N++ LL L +++E K G+L + V + F
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 480 MTQS--------LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531
+T +A + +L +HRD+ N+L+ V+K+ DFGLA R
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLA----R 196
Query: 532 PMFTVCGTPTYV------------APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVS 578
++ P YV APE + + Y ++ DVW+ GV+L+ I G P+
Sbjct: 197 DIYK---DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 579 DTNDQDELFDDILSG 593
D+ E + G
Sbjct: 254 VKIDE-EFCRRLKEG 267
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 424 NEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMT-- 481
E+ ++ H N+++LL ++L LV + G L D + + + ++
Sbjct: 79 QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-----SCLDGTPPLSWH 133
Query: 482 ------QSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT 535
Q A+ +++LH+N+ +HRDIK N+L++ K+ DFGLA+ F
Sbjct: 134 MRCKIAQGAANGINFLHENHHIHRDIKSANILLD-EAFTA---KISDFGLAR--ASEKFA 187
Query: 536 -------VCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF 587
+ GT Y+APE L G K D+++ GV+L ++ G P V + + L
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPA-VDEHREPQLLL 244
Query: 588 D 588
D
Sbjct: 245 D 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 69/257 (26%), Positives = 97/257 (37%), Gaps = 72/257 (28%)
Query: 382 GQIIGDGNFAVVRQ--VYDKHKDMDCALKII-------DKSKLLGKKQMIENEVNILRSV 432
+IG+GNF V + + MD A+K + D E+ +L +
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-------GELEVLCKL 82
Query: 433 -NHPNIIKLL-----DEYDTNNELYLVIELIKGGDLFD---------AISKNVKFSEEDS 477
+HPNII LL Y LYL IE G+L D + S
Sbjct: 83 GHHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 478 KFMTQSL-------ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530
+Q L A + YL +HRD+ N+LV V K+ DFGL++
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLSR--- 190
Query: 531 RPMFTVCGTPTYV------------APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFV 577
G YV A E LN S Y DVW+ GV+L+ I+ G P+
Sbjct: 191 -------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243
Query: 578 SDTNDQDELFDDILSGQ 594
T EL++ + G
Sbjct: 244 GMTC--AELYEKLPQGY 258
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 44/249 (17%), Positives = 89/249 (35%), Gaps = 47/249 (18%)
Query: 380 SVGQIIGDGNF-----AVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH 434
+ +G+ F + + A+K + ++ +E + + H
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDL----------------FDAISKNVKFSEEDSK 478
PN++ LL + L ++ GDL D + D
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 479 FMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG 538
+ +A+ + YL +++VH+D+ N+LV +K+ D GL R +
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLV----YDKLNVKISDLGLF-REVY------A 180
Query: 539 TPTYV------------APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDE 585
Y APE + + + D+W+ GV+L+ + G P+ +N +
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QD 238
Query: 586 LFDDILSGQ 594
+ + I + Q
Sbjct: 239 VVEMIRNRQ 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 54/260 (20%), Positives = 95/260 (36%), Gaps = 65/260 (25%)
Query: 382 GQIIGDGNF-----AVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+ IG+G F A + A+K++ + + + E ++ ++PN
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 437 IIKLL-----DEYDTNNELYLVIELIKGGDL------------FDAISKNVKFSEEDSKF 479
I+KLL + + L+ E + GDL ++ S
Sbjct: 112 IVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 480 MTQSL------------ASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527
L A+ ++YL + VHRD+ N LV V+K+ DFGL+
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV----GENMVVKIADFGLS- 221
Query: 528 RVLRPMFTVCGTPTYV------------APEILNESGYGVKIDVWAAGVILY-ILLCGFP 574
R +++ Y PE + + Y + DVWA GV+L+ I G
Sbjct: 222 ---RNIYS---ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 575 PFVSDTNDQDELFDDILSGQ 594
P+ + +E+ + G
Sbjct: 276 PYYGMAH--EEVIYYVRDGN 293
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 65/270 (24%), Positives = 109/270 (40%), Gaps = 64/270 (23%)
Query: 366 RENLNIPSKLLQRYSVGQIIGDGNF-----AVVRQVYDKHKDMDCALKII-------DKS 413
RENL G+++G G F A + + A+K++ ++
Sbjct: 44 RENLEF----------GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE 93
Query: 414 KLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKGGDL---------- 462
L+ +E+ ++ + +H NI+ LL + +YL+ E GDL
Sbjct: 94 ALM-------SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 146
Query: 463 -----FDAISKNVKFSEEDSKFMTQS--------LASALSYLHDNYIVHRDIKPENLLVE 509
+ ++ EED +T +A + +L VHRD+ N+LV
Sbjct: 147 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV- 205
Query: 510 MSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV-----APEILNESGYGVKIDVWAAGV 564
H KV+K+ DFGLA+ ++ V + APE L E Y +K DVW+ G+
Sbjct: 206 ---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
Query: 565 ILY-ILLCGFPPFVSDTNDQDELFDDILSG 593
+L+ I G P+ D + I +G
Sbjct: 263 LLWEIFSLGVNPYPGIPVDA-NFYKLIQNG 291
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 36/214 (16%)
Query: 384 IIGDGNFAVV--------RQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP 435
I+G G F V V A+K + + + G + + EV ++ H
Sbjct: 37 ILGRGGFGKVYKGRLADGTLV---------AVKRLKEERTQGGELQFQTEVEMISMAVHR 87
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGD----LFDAISKNVKFSEEDSKFMTQSLASALSYL 491
N+++L T E LV + G L + + + A L+YL
Sbjct: 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 147
Query: 492 HDN---YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT-----VCGTPTYV 543
HD+ I+HRD+K N+L++ VGDFGLA +++ T V GT ++
Sbjct: 148 HDHCDPKIIHRDVKAANILLD-EEFEA---VVGDFGLA-KLMDYKDTHVTTAVRGTIGHI 202
Query: 544 APEILNESGY-GVKIDVWAAGVILYILLCGFPPF 576
APE L+ +G K DV+ GV+L L+ G F
Sbjct: 203 APEYLS-TGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 63/273 (23%), Positives = 104/273 (38%), Gaps = 76/273 (27%)
Query: 366 RENLNIPSKLLQRYSVGQIIGDGNFAVVRQ-------VYDKHKDMDCALKII-------D 411
R+ L + G+ +G+G F V + + A+K++ D
Sbjct: 34 RDKLTL----------GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD 83
Query: 412 KSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIELIKGGDL-------- 462
S L+ +E+ +++ + H NII LL + LY+++E G+L
Sbjct: 84 LSDLV-------SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 463 --FDAISKNVKFSEEDS-------KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC 513
S ++ E+ Q LA + YL +HRD+ N+LV
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQ-LARGMEYLASQKCIHRDLAARNVLV----T 191
Query: 514 HVKVLKVGDFGLAQRVLRPMFTVCGTPTYV------------APEILNESGYGVKIDVWA 561
V+K+ DFGLA R + Y APE L + Y + DVW+
Sbjct: 192 ENNVMKIADFGLA----RDINN---IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 562 AGVILY-ILLCGFPPFVSDTNDQDELFDDILSG 593
GV+++ I G P+ +ELF + G
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPV--EELFKLLKEG 275
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 39/159 (24%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH--- 434
Y VG+ IG+G+F V+ + + + A+K + +E + +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAPQLRDEYRTYKLLAGCTG 67
Query: 435 -PNIIKLLDEYDTNNELYLVIELIKG---GDLFDAISKNVKFSEEDSKFMTQSLASALSY 490
PN+ E N LVI+L+ G DL D + KFS + + + + +
Sbjct: 68 IPNVYYFGQEGLHN---VLVIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQS 121
Query: 491 LHDNYIVHRDIKPENLLV-EMSGCHVKVLKVGDFGLAQR 528
+H+ +V+RDIKP+N L+ + + ++ V DFG+ +
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 60/256 (23%), Positives = 101/256 (39%), Gaps = 64/256 (25%)
Query: 382 GQIIGDGNFAVVRQ-------VYDKHKDMDCALKII-------DKSKLLGKKQMIENEVN 427
G+ +G+G F V + + A+K++ D S L+ +E+
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-------SEME 138
Query: 428 ILRSV-NHPNIIKLLDEYDTNNELYLVIELIKGGDLFD--------AISKNVKFSEEDSK 478
+++ + H NII LL + LY+++E G+L + + + + +
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 479 FMTQS--------LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530
MT LA + YL +HRD+ N+LV V+K+ DFGLA
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLA---- 250
Query: 531 RPMFTVCGTPTYV------------APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFV 577
R + Y APE L + Y + DVW+ GV+++ I G P+
Sbjct: 251 RDINN---IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307
Query: 578 SDTNDQDELFDDILSG 593
+ELF + G
Sbjct: 308 GIPV--EELFKLLKEG 321
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 37/172 (21%), Positives = 72/172 (41%), Gaps = 26/172 (15%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVNHP 435
++ +G+ IG G F ++ + +K A ++ K+ ++ + +E+ + V
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV---KVEYQENGPLFSELKFYQRVAKK 93
Query: 436 NIIKLLDEYDTNNEL-------------------YLVIELIKGGDLFDAISKNVKFSEED 476
+ IK E + L ++V+E + G DL +N F +
Sbjct: 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKST 152
Query: 477 SKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528
+ + L Y+H+N VH DIK NLL + + + + D+GL+ R
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLL--LGYKNPDQVYLADYGLSYR 202
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 19/160 (11%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH--- 434
+ VG+ IG GNF +R + + + A+K+ + + + E + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 435 -PNIIKLLDEYDTNNELYLVIELIKGG----DLFDAISKNVKFSEEDSKFMTQSLASALS 489
P + N +V+EL+ G DLFD + FS + + L S +
Sbjct: 67 IPQVYYFGPCGKYN---AMVLELL--GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRME 119
Query: 490 YLHDNYIVHRDIKPENLLVEMSG-CHVKVLKVGDFGLAQR 528
Y+H +++RD+KPEN L+ G +V+ + DF LA+
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 64/256 (25%)
Query: 382 GQIIGDGNFAVVRQ--VYDKHKD-----MDCALKII-------DKSKLLGKKQMIENEVN 427
G+ +G+G F V KD A+K++ D S L+ +E+
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-------SEME 126
Query: 428 ILRSV-NHPNIIKLLDEYDTNNELYLVIELIKGGDLFD----------------AISKNV 470
+++ + H NII LL + LY+++E G+L + + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 471 KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530
+ S +D +A + YL +HRD+ N+LV V+K+ DFGLA
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV----TEDNVMKIADFGLA---- 238
Query: 531 RPMFTVCGTPTYV------------APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFV 577
R + Y APE L + Y + DVW+ GV+L+ I G P+
Sbjct: 239 RDIHH---IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295
Query: 578 SDTNDQDELFDDILSG 593
+ELF + G
Sbjct: 296 GVPV--EELFKLLKEG 309
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH--- 434
RY +G+ IG G+F + D + A+K+ + K + E I + +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVG 66
Query: 435 -PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLH 492
P I E D N +V+EL+ G L D + + KFS + + + S + Y+H
Sbjct: 67 IPTIRWCGAEGDYN---VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528
+HRD+KP+N L+ G ++ + DFGLA++
Sbjct: 123 SKNFIHRDVKPDNFLMG-LGKKGNLVYIIDFGLAKK 157
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 75.7 bits (185), Expect = 3e-14
Identities = 92/596 (15%), Positives = 191/596 (32%), Gaps = 148/596 (24%)
Query: 4 HIEEHSLEEEYKAHPLVILVILDLIFSFYMTCHPRLNHILANTSSV-SNRTMSMIL--GD 60
H++ + E +Y+ ++ + + +F C + S+ S + I+ D
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNF--DC----KDVQDMPKSILSKEEIDHIIMSKD 59
Query: 61 TKSA------MVLSQSTDPLKDQCNTVDMQRHFSDFTPSPL----KSRRAKRIRFLCNGD 110
S +LS+ + ++ V + F SP+ + ++ D
Sbjct: 60 AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY--KFLMSPIKTEQRQPSMMTRMYIEQRD 117
Query: 111 KFFKGVVMAVGPERYRSFDSLLEELTRALAENINL-PSGVRILFTMDG-----------Q 158
+ + V + S +L +AL E L P+ ++ + G
Sbjct: 118 RLYNDNQ--VFAKYNVSRLQPYLKLRQALLE---LRPAKNVLIDGVLGSGKTWVALDVCL 172
Query: 159 KVTNIDELEDGKFYI----CSSSGDQFKKVD---YAILNNNNSSNTLPRSGKFITKSAPP 211
+++ F++ C+S + + Y I N S + + K S
Sbjct: 173 SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 212 RVNKTPTSFVVR--PRIIIVIRNGIRPRKVVRA-------LLNKRNAPSLDQCFSTITDI 262
+ + + ++V+ N ++ K A LL R +TD
Sbjct: 233 ELRRL---LKSKPYENCLLVLLN-VQNAKAWNAFNLSCKILLTTRFK--------QVTDF 280
Query: 263 VKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAYGSERV--LPDDFELDVEEVKAI--- 317
+ A +L+ + + D + + Y R LP EV
Sbjct: 281 LS---AATTTHISLDHHSMTLTPD--EVKSLLLKYLDCRPQDLP-------REVLTTNPR 328
Query: 318 ------QALKKDLRRPEHTKLKSGTTCLDASGREVPKMPT--KTSVARCATATIKR---- 365
++++ L ++ K K+ T ++S+ A ++
Sbjct: 329 RLSIIAESIRDGLATWDNWKH-----------VNCDKLTTIIESSLNVLEPAEYRKMFDR 377
Query: 366 ----RENLNIPSKLLQRY-------SVGQIIGDGNFAVVRQVYDKHKD------MDCALK 408
+ +IP+ LL V ++ N + +K L+
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVV---NKLHKYSLVEKQPKESTISIPSIYLE 434
Query: 409 IIDKSKLLGKKQM---IENEVNILRSVNHPNIIKL-LDEYDTNNELYLV-----IELIKG 459
+ K KL + + I + NI ++ + ++I LD+Y + ++ IE +
Sbjct: 435 L--KVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYS---HIGHHLKNIEHPER 489
Query: 460 GDLFDAISKNVKFSE---EDSKFMTQSLASALSYLHD-----NYIVHRDIKPENLL 507
LF + + +F E + S L+ L YI D K E L+
Sbjct: 490 MTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV 545
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 7e-10
Identities = 64/472 (13%), Positives = 135/472 (28%), Gaps = 153/472 (32%)
Query: 203 KFITKSAPPRVNKTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDI 262
I S V+ T R+ + + + ++V+ + + + S I
Sbjct: 52 DHIIMS-KDAVSGTL-------RLFWTLLS--KQEEMVQKFVEEVLRINYKFLMSPIKTE 101
Query: 263 VKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAYGSERVLPDDFELDVEEVKAIQALKK 322
+ + ++Y Q RL Y +V V ++ L++
Sbjct: 102 QR-QPSMMTRMYI---EQRDRL------------YNDNQVFAKYN---VSRLQPYLKLRQ 142
Query: 323 DLR--RPE-----HTKLKSGTTCLDA----SGREVPKMPTKT---SVARCAT--ATIKRR 366
L RP L SG T + S + KM K ++ C + ++
Sbjct: 143 ALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML 202
Query: 367 ENL--NIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIEN 424
+ L I R D + + +++ I + + L K + EN
Sbjct: 203 QKLLYQIDPNWTSR-------SDHSSNIKLRIHS----------IQAELRRLLKSKPYEN 245
Query: 425 EVNILRSVNHPNIIK--------LL--------DEYDTNNELYLVIELIKGGDLFDAISK 468
+ +L +V + LL D ++ ++
Sbjct: 246 CLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT-------- 297
Query: 469 NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528
+ ++ K + L L D +P++L E+ + + L + + R
Sbjct: 298 ---LTPDEVKSL---LLKYL-----------DCRPQDLPREVLTTNPRRLSI--IAESIR 338
Query: 529 VLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFD 588
+ L ++ I+ L P + ++FD
Sbjct: 339 -----------------DGLATWDNWKHVNCDKLTTIIESSLNVLEP-----AEYRKMFD 376
Query: 589 D--ILSGQYGFPS----P------YWDDISEEAKELISH------MLESNPD 622
+ FP P W D+ + ++ + ++E P
Sbjct: 377 RLSV------FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH--- 434
++ +G+ IG G+F + + + + A+K+ + K + E I R +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTG 64
Query: 435 -PNIIKLLDEYDTNNELYLVIELIKG---GDLFDAISKNVKFSEEDSKFMTQSLASALSY 490
PN+ E D N LV++L+ G DLF+ S+ K S + + + + + +
Sbjct: 65 IPNVRWFGVEGDYN---VLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEF 118
Query: 491 LHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528
+H +HRDIKP+N L+ G + + DFGLA++
Sbjct: 119 VHSKSFLHRDIKPDNFLMG-LGRRANQVYIIDFGLAKK 155
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 36/204 (17%), Positives = 67/204 (32%), Gaps = 29/204 (14%)
Query: 350 PTKTSVARCATATIKRRENLNIPSKLL----QRYSVGQIIGDGNFAVVRQVYDKHKDMDC 405
R ++A E + + + VG IG G F + +
Sbjct: 4 VKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSE-SV 62
Query: 406 ALKIIDKSKLLGKKQM-IENEVNILRSVNHPNIIKLLDEYDTNNEL-------------- 450
K+ + E+ + P I+ L
Sbjct: 63 GSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKN 122
Query: 451 -----YLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPE 504
+++++ G DL N +FS + ++ + L Y+H++ VH DIK
Sbjct: 123 GKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKAS 181
Query: 505 NLLVEMSGCHVKVLKVGDFGLAQR 528
NLL ++ + + + D+GLA R
Sbjct: 182 NLL--LNYKNPDQVYLVDYGLAYR 203
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 30/176 (17%), Positives = 58/176 (32%), Gaps = 31/176 (17%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYD--------KHKDMDCALKIIDKSKLL----------GK 418
+++ + N ++ + + +LK+ K L K
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 419 KQMIENEVNILRSVNHPNIIKL----LDEYDTNNELYLVIELIKGGDLFDAISKNVK--F 472
+ L S I + + +LV+ + G L A+ + K
Sbjct: 102 PLQVNKW-KKLYSTPLLAIPTCMGFGVHQDKYR---FLVLPSL-GRSLQSALDVSPKHVL 156
Query: 473 SEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528
SE + L AL +LH+N VH ++ EN+ + + + +G A R
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIF--VDPEDQSQVTLAGYGFAFR 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.7 bits (146), Expect = 5e-10
Identities = 34/203 (16%), Positives = 65/203 (32%), Gaps = 57/203 (28%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKII---DKSKLLGKKQM----IENEVNIL 429
++ + IG+G F V Q H + A+KII + G Q I E+ I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPV--AIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 430 RSV---------NHPNIIKLLDEY------------------------------DTNNEL 450
+ + I L + +++L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY-IVHRDIKPENLLVE 509
++V+E GG + + + + Q L ++L+ + HRD+ N+L++
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQ-LTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 510 MSGCHV-------KVLKVGDFGL 525
+ K + GL
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGL 219
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 26/129 (20%)
Query: 478 KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC 537
+ Q +A + +L +HRD+ N+L+ V+K+ DFGLA+ + +
Sbjct: 197 CYSFQ-VAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYK------ 245
Query: 538 GTPTYV------------APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQD 584
P YV APE + + Y ++ DVW+ GV+L+ I G P+ D+
Sbjct: 246 -DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 303
Query: 585 ELFDDILSG 593
E + G
Sbjct: 304 EFCRRLKEG 312
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 27/153 (17%), Positives = 54/153 (35%), Gaps = 21/153 (13%)
Query: 366 RENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKD-----MDCALKIIDKSKLLGKKQ 420
R+ L +G+ +G G F V + D A+K++ + + +
Sbjct: 21 RDRL----------KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 70
Query: 421 MIENEVNILRSV-NHPNIIKLLDEY-DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSK 478
+ +E+ IL + +H N++ LL L +++E K G+L + K
Sbjct: 71 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN-EFVPYK 129
Query: 479 FMTQSLASALSYLHDNYIVHRDIKPENLLVEMS 511
Y+ + D+K + S
Sbjct: 130 TKGARFRQGKDYVG---AIPVDLKRRLDSITSS 159
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 639 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4atu_I | 373 | Neuronal migration protein doublecortin; hydrolase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1mg4_A | 113 | Doublecortin, doublecortin-like kinase (N-terminal | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 2dnf_A | 108 | Doublecortin domain-containing protein 2; structur | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 2dnf_A | 108 | Doublecortin domain-containing protein 2; structur | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 1mg4_A | 113 | Doublecortin, doublecortin-like kinase (N-terminal | 99.75 | |
| 4atu_I | 373 | Neuronal migration protein doublecortin; hydrolase | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.14 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.84 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.64 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.54 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.42 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.17 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.01 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.9 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.84 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.83 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.63 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.63 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.49 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.0 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.9 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.51 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=491.67 Aligned_cols=252 Identities=31% Similarity=0.626 Sum_probs=231.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++++.||+|+||+||+|+++.+++.||||++.+.... ...+.+.+|+.+|++++|||||+++++|++++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999999999999999999865432 23467889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--- 531 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~--- 531 (639)
|||+||+|++++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g----~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM----HIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS----CEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC----CEEEEEcCCceecCCCCC
Confidence 9999999999999989999999999999999999999999999999999999999988 899999999986532
Q ss_pred --CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 --PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 --~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
...+.|||+.|||||++.+..|+.++|||||||+||||+||.+||.+ .+..+++..|..+.+.+| ..+++++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~--~~~~~~~~~i~~~~~~~p----~~~s~~~ 261 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA--GNEGLIFAKIIKLEYDFP----EKFFPKA 261 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCC----TTCCHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCC----cccCHHH
Confidence 24567999999999999999999999999999999999999999964 467888899999887766 4689999
Q ss_pred HHHHHHhcccCCCCCCCHHH------HHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAED------VLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~e------iL~HP~f~~ 638 (639)
++||.+||++||++|||++| |++||||++
T Consensus 262 ~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 99999999999999999987 689999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=492.52 Aligned_cols=255 Identities=27% Similarity=0.499 Sum_probs=228.6
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
..+.|++.+.||+|+||+||+|+++.+++.||||+++..... ..+.+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 346799999999999999999999999999999999765433 3456789999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|||+||+|.+++.+ +.+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g----~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG----RVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----CEEECCCTTCEECCSSSC
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC----CEEEecCcCceecCCCCC
Confidence 99999999999976 5799999999999999999999999999999999999999988 8999999999876532
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
..+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+. +..+++..+.... ....+.+..+++++++
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~-~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNL-PPRLKNLHKVSPSLKG 302 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSS-CCCCSCGGGSCHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCC-CCCCCccccCCHHHHH
Confidence 45789999999999999999999999999999999999999999653 4566666666543 3334556789999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
||.+||++||++|||++|+|+||||++
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 999999999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=491.46 Aligned_cols=254 Identities=30% Similarity=0.544 Sum_probs=223.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+++|++++.||+|+||+||+|+++.+++.||||++.+..... ..+.+.+|+.+|++|+|||||++++++++++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999998765443 3467889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 455 ELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+||+|.++|... ..+++.+++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g----~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG----TVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC----CEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC----CEEEcccccceeecCC
Confidence 999999999999654 4579999999999999999999999999999999999999988 8999999999876532
Q ss_pred ---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 ---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
..+.+||+.|||||++.+..|+.++|||||||+||||+||+.||.+. +..+++..+..+.+. +.+..+|+++
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~~~~---~~~~~~s~~~ 253 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--SMKNLVLKIISGSFP---PVSLHYSYDL 253 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCC---CCCTTSCHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCC---CCCccCCHHH
Confidence 34678999999999999999999999999999999999999999653 567778888887643 3346789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++||.+||++||++|||++|+|+||||++
T Consensus 254 ~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 99999999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-58 Score=475.59 Aligned_cols=253 Identities=38% Similarity=0.678 Sum_probs=215.0
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.+++|++++.||+|+||+||+|+++.+++.||+|++++..... ....+.+|+.+|++++|||||++++++++++.+||
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999998765432 24568899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
||||| +|+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~----~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL----NVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC----CEEECCSSCC------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC----CEEEeecCCCeecCCC
Confidence 99999 689999999999999999999999999999999999999999999999999887 899999999986643
Q ss_pred -CCccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 -PMFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 -~~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
...+.+||+.|||||++.+..| +.++|||||||++|+|+||+.||.. .+..++++.+..+.+.+| ..+|+++
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~--~~~~~~~~~i~~~~~~~p----~~~s~~~ 239 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD--ESIPVLFKNISNGVYTLP----KFLSPGA 239 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCC----TTSCHHH
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHH
Confidence 3456899999999999998876 6899999999999999999999964 456788888888876665 4689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++||.+||++||++|||++|+++||||+.
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 99999999999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-57 Score=470.56 Aligned_cols=254 Identities=27% Similarity=0.490 Sum_probs=220.7
Q ss_pred CCe-eEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeec----CCce
Q psy6820 377 QRY-SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDT----NNEL 450 (639)
Q Consensus 377 ~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~ 450 (639)
.+| ++.+.||+|+||+||+|.++.++..||+|++....... ..+.+.+|+.+|++++|||||+++++|.+ .+.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 78889999999999999999999999999997655432 34678899999999999999999999865 4568
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEcc-CCceeeeEEEeeccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY--IVHRDIKPENLLVEM-SGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~g--ivHrDLKp~NILld~-~g~~~~~vKL~DFGla~ 527 (639)
|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+|||++. ++ .+||+|||+|+
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g----~vKl~DFGla~ 180 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG----SVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS----CEEECCTTGGG
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC----CEEEEeCcCCE
Confidence 999999999999999999899999999999999999999999999 999999999999975 55 79999999997
Q ss_pred cccC-CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 528 RVLR-PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 528 ~~~~-~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
.... ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||... .+...++..+..+.. |...+..++
T Consensus 181 ~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~-~~~~~~~~~i~~~~~--~~~~~~~~~ 256 (290)
T 3fpq_A 181 LKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-QNAAQIYRRVTSGVK--PASFDKVAI 256 (290)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-SSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred eCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC-CcHHHHHHHHHcCCC--CCCCCccCC
Confidence 6543 3456799999999999875 5999999999999999999999999653 345566666665532 333446688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+++++||.+||++||++|||++|+|+||||++
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-57 Score=491.88 Aligned_cols=256 Identities=27% Similarity=0.498 Sum_probs=228.6
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
...+.|++.+.||+|+||.||+|+++.+++.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 3456799999999999999999999999999999999765433 345678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC--
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-- 531 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-- 531 (639)
||||+||+|.+++.. +.+++.+++.++.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+....
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g----~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG----RVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC----CEEECCCTTCEECCSSC
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC----CEEEecCccceECCCCC
Confidence 999999999999965 5699999999999999999999999999999999999999988 899999999987643
Q ss_pred -CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 532 -PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 532 -~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
...+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+. +..+++..+.... ....+.+..++++++
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~-~~~~~~~~~~s~~~~ 378 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNL-PPRLKNLHKVSPSLK 378 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSC-CCCCSCTTSSCHHHH
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCC-CCCCcccccCCHHHH
Confidence 345789999999999999999999999999999999999999999653 4556666666543 233345678999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||++||++|||++|+|+||||++
T Consensus 379 dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 379 GFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 9999999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-58 Score=478.75 Aligned_cols=252 Identities=35% Similarity=0.646 Sum_probs=221.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEc---CCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
++|++++.||+|+||+||+|++. .+++.||+|++++..... ....+.+|+.+|++++|||||++++++++++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999874 467899999997655432 23457789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc--
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL-- 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~-- 530 (639)
|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g----~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS----CEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC----CEEecccccceeccCC
Confidence 999999999999999989999999999999999999999999999999999999999988 89999999998653
Q ss_pred -CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 531 -RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 531 -~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+ .+..+++..+..+.+.+| ..+|+++
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~--~~~~~~~~~i~~~~~~~p----~~~s~~~ 253 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG--KDRKETMTMILKAKLGMP----QFLSPEA 253 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC--cCHHHHHHHHHcCCCCCC----CcCCHHH
Confidence 234578999999999999999999999999999999999999999965 456778888888876665 4689999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
++||++||++||++||| ++|+++||||++
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 99999999999999998 589999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=472.36 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=220.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.+.|++.++||+|+||.||+|+++.+++.||||+++..... .+|+.+|+.++|||||++++++.+.+.+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46799999999999999999999999999999999865432 479999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
||+||+|.+++++.+.+++..++.++.||+.||+|||++|||||||||+||||+.+| ..+||+|||+|+.....
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g---~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG---SRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS---CCEEECCCTTCEEC------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC---CEEEEeeCCCCeEccCCCcc
Confidence 999999999999888999999999999999999999999999999999999999886 25999999999865421
Q ss_pred -----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 533 -----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 533 -----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
....+||+.|||||++.+..|+.++|||||||+||||+||++||...+. .++...+..+...+ ...++.+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~~~~~~-~~~~~~~s~ 284 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR--GPLCLKIASEPPPI-REIPPSCAP 284 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC--SCCHHHHHHSCCGG-GGSCTTSCH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHHHHHHcCCCCc-hhcCccCCH
Confidence 2346899999999999999999999999999999999999999976443 34555666654322 234568999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHH-------------HcCCcccC
Q psy6820 608 EAKELISHMLESNPDLRFSAEDV-------------LDHPWLER 638 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~ei-------------L~HP~f~~ 638 (639)
++.+||.+||++||++|||+.|+ ++|||+.+
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 99999999999999999999998 57999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-54 Score=468.00 Aligned_cols=258 Identities=28% Similarity=0.446 Sum_probs=219.6
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec------
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDT------ 446 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------ 446 (639)
.+.++|++++.||+|+||+||+|+++.+++.||||++.+.... ...+.+.+|+.+|+.++|||||++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 4557899999999999999999999999999999999765433 234567899999999999999999998753
Q ss_pred CCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 447 NNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
.+.+|||||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~----~~Ki~DFGla 205 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC----ELKIGDFGMA 205 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC----CEEECCCTTC
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC----CEEEeeccee
Confidence 467899999995 68999999999999999999999999999999999999999999999999988 8999999999
Q ss_pred ccccC-------CCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy6820 527 QRVLR-------PMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598 (639)
Q Consensus 527 ~~~~~-------~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p 598 (639)
+.... ...+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+. +..+.+..|......++
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~--~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK--NYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS--SHHHHHHHHHHHHCCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC--CHHHHHHHHHHhcCCCC
Confidence 76532 24567999999999998875 5699999999999999999999999654 34455555544322221
Q ss_pred CC---------------------------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 599 SP---------------------------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 599 ~~---------------------------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.. .++.+++++.|||.+||++||++|||++|+|+||||++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 11 12357899999999999999999999999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=453.82 Aligned_cols=251 Identities=27% Similarity=0.470 Sum_probs=205.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC--------
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN-------- 448 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-------- 448 (639)
++|++++.||+|+||+||+|+++.+++.||||+++........+.+.+|+.+|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 469999999999999999999999999999999987665555677889999999999999999999986544
Q ss_pred ----ceEEEEeeccCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEe
Q psy6820 449 ----ELYLVIELIKGGDLFDAISKNVK---FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVG 521 (639)
Q Consensus 449 ----~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~ 521 (639)
.+|||||||+||+|.+++..... .++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~----~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD----VVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----CEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC----cEEEc
Confidence 37999999999999999987654 44567889999999999999999999999999999999888 89999
Q ss_pred eccccccccCC---------------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHH
Q psy6820 522 DFGLAQRVLRP---------------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDEL 586 (639)
Q Consensus 522 DFGla~~~~~~---------------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l 586 (639)
|||+|+..... ..+.+||+.|||||++.+..|+.++|||||||++|||++ ||.... +....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-~~~~~ 236 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-ERVRT 236 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-HHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-HHHHH
Confidence 99999765421 234689999999999999999999999999999999996 774321 11222
Q ss_pred HHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 587 ~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...+... .+| +.+...++++.+||++||++||++|||+.|+++||||++
T Consensus 237 ~~~~~~~--~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 237 LTDVRNL--KFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHTT--CCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHhcC--CCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 3333332 223 234566788999999999999999999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=452.66 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=210.6
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEc---CCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCc
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 449 (639)
.+.++|++.+.||+|+||+||+|+++ .+++.||+|++.... ....+.+|+.+|+.+ +||||++++++|++.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 34578999999999999999999875 457889999986543 245677899999998 59999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
+|||||||+||+|.+++. .+++.+++.++.||+.||+|||++||+||||||+|||++.+. ..+||+|||+|+..
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~---~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL---KKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT---TEEEECCCTTCEEC
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC---CeEEECcCCCCccc
Confidence 999999999999999984 599999999999999999999999999999999999998763 27999999999644
Q ss_pred cC-------------------------------CCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCC
Q psy6820 530 LR-------------------------------PMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFV 577 (639)
Q Consensus 530 ~~-------------------------------~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~ 577 (639)
.. ...+.+||+.|+|||++.+. .|+.++||||+||++|||+||+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 21 12346899999999999775 58999999999999999999999997
Q ss_pred CCCCChHHHHHHHHc--------------------------------------CCC------------CCCCCCcccccH
Q psy6820 578 SDTNDQDELFDDILS--------------------------------------GQY------------GFPSPYWDDISE 607 (639)
Q Consensus 578 ~~~~~~~~l~~~i~~--------------------------------------~~~------------~~p~~~~~~l~~ 607 (639)
....+.+.+ ..|.. ... ....+.|..+++
T Consensus 249 ~~~~~~~~l-~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 249 KASDDLTAL-AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp CCSSHHHHH-HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCHHHHH-HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 655433322 22211 000 011234567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+++|||++||+.||++|||++|+|+||||++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=481.15 Aligned_cols=257 Identities=28% Similarity=0.508 Sum_probs=226.3
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHH---HHHHHHhcCCCceeeeeeeeecCC
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIEN---EVNILRSVNHPNIIKLLDEYDTNN 448 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~---Ei~iL~~l~HpnIv~l~~~~~~~~ 448 (639)
..+++|+++++||+|+||+||+|+++.+++.||||++.+..... ....+.+ ++.+++.++|||||+++++|++.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 34688999999999999999999999999999999997654322 1233334 456666778999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
.+|||||||+||+|+++|.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G----~vKL~DFGlA~~ 341 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG----HVRISDLGLACD 341 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS----CEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC----CEEecccceeee
Confidence 9999999999999999999999999999999999999999999999999999999999999998 899999999987
Q ss_pred ccC-CCccccCCCcccCccccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCC-CChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 529 VLR-PMFTVCGTPTYVAPEILN-ESGYGVKIDVWAAGVILYILLCGFPPFVSDT-NDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 529 ~~~-~~~~~~GT~~Y~APE~l~-~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~-~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
... ...+.|||+.|||||++. +..|+.++|||||||+||||++|.+||.+.. .+..++...+....+.+| ..+
T Consensus 342 ~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~ 417 (689)
T 3v5w_A 342 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSF 417 (689)
T ss_dssp CSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTS
T ss_pred cCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccC
Confidence 653 356789999999999996 4579999999999999999999999997643 345567777777766555 578
Q ss_pred cHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 606 SEEAKELISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
++++++||.+||++||++|++ ++||++||||++
T Consensus 418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 999999999999999999998 899999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=443.13 Aligned_cols=245 Identities=22% Similarity=0.370 Sum_probs=212.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEc-----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDK-----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
++|.+.+.||+|+||+||+|+.. .+++.||||+++... ....+.|.+|+.+|++++|||||+++++|.+++.+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 57999999999999999999865 357889999997653 234567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeE
Q psy6820 452 LVIELIKGGDLFDAISKN-------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVL 518 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~-------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~v 518 (639)
||||||++|+|.++|.+. ..+++.++..++.||+.||+|||+++||||||||+|||++.++ .+
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~----~~ 167 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL----LV 167 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG----CE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC----cE
Confidence 999999999999999754 3699999999999999999999999999999999999999887 89
Q ss_pred EEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHc
Q psy6820 519 KVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILS 592 (639)
Q Consensus 519 KL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~ 592 (639)
||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||... ...++...+..
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~--~~~~~~~~i~~ 245 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--SNNEVIECITQ 245 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHc
Confidence 99999999765432 223568999999999999999999999999999999998 99999654 45677777877
Q ss_pred CCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6820 593 GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVL 631 (639)
Q Consensus 593 ~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL 631 (639)
+... +.+..+|+++.+||.+||+.||++|||++||+
T Consensus 246 ~~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 246 GRVL---QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 6532 22357899999999999999999999999994
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=477.06 Aligned_cols=261 Identities=29% Similarity=0.608 Sum_probs=236.7
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
+.++++|++++.||+|+||.||+|.++.+++.||+|++..... ...+.+.+|+.+|+.++|||||+++++|++.+.+||
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3456899999999999999999999999999999999976543 335678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
|||||+||+|+++|.+ .+.+++.+++.++.||+.||+|||++||+||||||+|||++.+.. ..+||+|||+|+....
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~--~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC--CCEEECCCSSCEECCT
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCC--CCEEEeeccceeEccC
Confidence 9999999999999964 468999999999999999999999999999999999999986521 2799999999987653
Q ss_pred C--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 P--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 ~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
. ..+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+ .+..+.+..+....+.++.+.+..+++++
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG--ENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC--SSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--cCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 3 4567999999999999999999999999999999999999999964 45677888999998888888888999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++||.+||+.||++|||++|+|+||||+.
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 99999999999999999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=438.26 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=210.3
Q ss_pred ccCCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec
Q psy6820 368 NLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDT 446 (639)
Q Consensus 368 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 446 (639)
.|+++ .+++.+++.||+|+||+||+|+... .||||+++..... ...+.|.+|+.+|++++|||||++++++.+
T Consensus 30 ~Wei~---~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 103 (307)
T 3omv_A 30 YWEIE---ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103 (307)
T ss_dssp CCBCC---TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CcEEc---HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence 35544 4678999999999999999997543 5999999755433 334678999999999999999999998854
Q ss_pred CCceEEEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 447 NNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
+.+|||||||+||+|.++|.. ..++++.++..++.||+.||+|||+++||||||||+|||++.++ .+||+|||+
T Consensus 104 -~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~----~~Ki~DFGl 178 (307)
T 3omv_A 104 -DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL----TVKIGDFGL 178 (307)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE----EEEECCCSS
T ss_pred -CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC----cEEEeeccC
Confidence 578999999999999999965 46799999999999999999999999999999999999999887 899999999
Q ss_pred cccccC-----CCccccCCCcccCcccccc---CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC
Q psy6820 526 AQRVLR-----PMFTVCGTPTYVAPEILNE---SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597 (639)
Q Consensus 526 a~~~~~-----~~~~~~GT~~Y~APE~l~~---~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~ 597 (639)
|+.... ...+.+||+.|||||++.+ ..|+.++|||||||+||||+||+.||...+ ....+...+..+....
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-~~~~~~~~~~~~~~~p 257 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-NRDQIIFMVGRGYASP 257 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHTTCCCC
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcCCCCC
Confidence 976532 2345789999999999963 469999999999999999999999996543 3444444444443221
Q ss_pred -CCCCcccccHHHHHHHHHhcccCCCCCCCHHHH------HcCCcc
Q psy6820 598 -PSPYWDDISEEAKELISHMLESNPDLRFSAEDV------LDHPWL 636 (639)
Q Consensus 598 -p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~ei------L~HP~f 636 (639)
....+..+|+++.+||.+||+.||++|||+.|| |+||+-
T Consensus 258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 234557899999999999999999999999976 467664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=439.44 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=216.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEc-----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDK-----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
..++++.+.||+|+||+||+|... .+++.||||+++........+.|.+|+.++++++|||||+++|+|.+++.+
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 457889999999999999999853 467889999997665555567899999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCce
Q psy6820 451 YLVIELIKGGDLFDAISKN----------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH 514 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~ 514 (639)
|||||||++|+|.++|... ..+++.++..++.||+.||+|||+++||||||||+||||+.++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~-- 182 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL-- 182 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC--
Confidence 9999999999999999542 3589999999999999999999999999999999999999887
Q ss_pred eeeEEEeeccccccccC-----CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHH
Q psy6820 515 VKVLKVGDFGLAQRVLR-----PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFD 588 (639)
Q Consensus 515 ~~~vKL~DFGla~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~ 588 (639)
.+||+|||+|+.... .....+||+.|||||++.+..|+.++|||||||+||||+| |..||.+. ...++..
T Consensus 183 --~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--~~~~~~~ 258 (308)
T 4gt4_A 183 --NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVVE 258 (308)
T ss_dssp --CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--CHHHHHH
T ss_pred --CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--CHHHHHH
Confidence 899999999976532 2345689999999999999999999999999999999998 89999654 4566777
Q ss_pred HHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 589 DILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 589 ~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+..+... +.++.+|+++.+|+.+||+.||++|||+.||+++
T Consensus 259 ~i~~~~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77766432 2336799999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=438.88 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=209.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEc-----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDK-----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|.+.+.||+|+||+||+|+.. .+++.||||+++... ....+.|.+|+.+|++++|||||+++++|.+.+.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357899999999999999999865 357899999997643 33456789999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCcee
Q psy6820 451 YLVIELIKGGDLFDAISKN---------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHV 515 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~ 515 (639)
|||||||++|+|.+++.+. .++++.++..++.||+.||+|||+++||||||||+||||+.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~--- 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL--- 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT---
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC---
Confidence 9999999999999999653 3589999999999999999999999999999999999999887
Q ss_pred eeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHH
Q psy6820 516 KVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDD 589 (639)
Q Consensus 516 ~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~ 589 (639)
.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||... ...++...
T Consensus 196 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~--~~~~~~~~ 272 (329)
T 4aoj_A 196 -VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNTEAIDC 272 (329)
T ss_dssp -EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS--CHHHHHHH
T ss_pred -cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC--CHHHHHHH
Confidence 8999999999865322 234679999999999999999999999999999999999 99999654 44566777
Q ss_pred HHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 590 ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 590 i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+..+.. .+.+..+|+++.+||.+||+.||++|||++||+++
T Consensus 273 i~~g~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCC---CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCC---CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 766542 22336789999999999999999999999999864
|
| >4atu_I Neuronal migration protein doublecortin; hydrolase, microtubule-associated protein; HET: GDP GTP; 8.30A {Homo sapiens} PDB: 1uf0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=445.26 Aligned_cols=224 Identities=44% Similarity=0.797 Sum_probs=92.4
Q ss_pred CCCccCceEEEEEecCCCCCCcEEEEECCccccCHHHHHHHHHHHHhhcCCCcccceEeecCCC-ceeccccccccCCeE
Q psy6820 94 PLKSRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDG-QKVTNIDELEDGKFY 172 (639)
Q Consensus 94 ~~~~~~~k~v~~~rNgd~~~~g~~~~v~~~~~~~~~~ll~~~t~~l~~~~~l~~~vr~~~t~~g-~~v~~l~~l~~g~~y 172 (639)
..+++|||+|+||||||+||+|++|+|++++|+|||+||++||+.|+++|+||+|||+|||++| |+|++||||+||+.|
T Consensus 59 ~~~~~kAKrV~fyrNGD~~f~G~~~~V~~~r~~tfd~lL~~lT~~Ls~~v~LP~GVR~i~tp~G~~~i~~ld~LedG~~Y 138 (373)
T 4atu_I 59 LSNEKKAKKVRFYRNGDRYFKGIVYAVSSDRFRSFDALLADLTRSLSDNINLPQGVRYIYTIDGSRKIGSMDELEEGESY 138 (373)
T ss_dssp -----CCEEEEEEESSCSSCCCEEEEECTTTCSSHHHHHHHHHHHSCCSSSCTTSCSEEEETTSSSEECSGGGCCTTEEE
T ss_pred cCCCccceEEEEEeCCCCCCCCeEEEECCcccCCHHHHHHHHHHHhhccCCCCceeEEEEcCCCCeecCcHHHhccCCEE
Confidence 5688999999999999999999999999999999999999999999999999999999999987 999999999999999
Q ss_pred EEecCCCcccccccccccCCCCCCCCCCCCccc-----ccCCCCCCCCCCCCccccceEEEEEEcCCCCcccEEEEecCC
Q psy6820 173 ICSSSGDQFKKVDYAILNNNNSSNTLPRSGKFI-----TKSAPPRVNKTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKR 247 (639)
Q Consensus 173 v~~~~~e~f~~~~y~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~p~~i~v~rng~~~~~~~~~~l~~~ 247 (639)
||||+ |+||+++|..+. .|.|...+..... ..........++.+.+++||+|+||||||.++++++++||++
T Consensus 139 V~s~~-e~fKki~Y~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~kPk~I~V~rNGd~~~~~~rvlLn~r 215 (373)
T 4atu_I 139 VCSSD-NFFKKVEYTKNV--NPNWSVNVKTSANMKAPQSLASSNSAQARENKDFVRPKLVTIIRSGVKPRKAVRVLLNKK 215 (373)
T ss_dssp EEESS-CCCCCCCCCCCC--CTTTTCCCCCCCCC----------------------------------------------
T ss_pred EEeCC-CCcccccccccc--CCccccccCcCccccCCccccCCCCCcccccccCCCccEEEEEeCCCCCCCCEEEEECCc
Confidence 99995 999999998643 3445443322111 111112233345567788999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhhccCCCccccceeccCCccccccccccccCcEEEEcCCcccc--CCcccccHHHHHHHHHh
Q psy6820 248 NAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVFFAYGSERVL--PDDFELDVEEVKAIQAL 320 (639)
Q Consensus 248 ~~~~~~~~l~~it~~~~~~~g~v~~lyt~~g~~v~~~~~~~~~~d~yva~G~e~~~--~dd~~~~~ee~~~i~~~ 320 (639)
+++|||+||++|||+|++++||||||||++|++|.++.++|+++++|||+|.|+|. ++|+.++.++.......
T Consensus 216 ~~~sfe~vL~~ite~l~l~~GaVrkLyT~~G~~v~~l~d~l~~~~~yVA~G~E~Fk~~~~d~~~~~~~~~~~~~~ 290 (373)
T 4atu_I 216 TAHSFEQVLTDITEAIKLETGVVKKLYTLDGKQVTCLHDFFGDDDVFIACGPEKFRYAQDDFSLDENECRVMKGN 290 (373)
T ss_dssp ---------------------------------------------------------------------------
T ss_pred cccCHHHHHHHHHhhcCCCCCceeEEEcCCCCEecCHHHHhcCCCEEEEecCCcCcccccccccccccccccccc
Confidence 99999999999999999999999999999999999999999999999999999885 46777776666555433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=434.98 Aligned_cols=255 Identities=22% Similarity=0.382 Sum_probs=217.0
Q ss_pred ccCCCcccCCCeeEEEEEccCCceEEEEEEEcCC-----CeEEEEEEEcccccchhHHHHHHHHHHHHhcCC-Cceeeee
Q psy6820 368 NLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHK-----DMDCALKIIDKSKLLGKKQMIENEVNILRSVNH-PNIIKLL 441 (639)
Q Consensus 368 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~ 441 (639)
.|+++ .++|++++.||+|+||+||+|..... ++.||+|++.........+.+.+|+.+|++++| ||||+++
T Consensus 58 ~wEi~---~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 58 KWEFP---RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHBCC---GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccEec---HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 35555 36899999999999999999987654 367999999877666666778999999999975 8999999
Q ss_pred eeeecC-CceEEEEeeccCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q psy6820 442 DEYDTN-NELYLVIELIKGGDLFDAISKN----------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPE 504 (639)
Q Consensus 442 ~~~~~~-~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~ 504 (639)
++|.+. +.+|||||||++|+|.++|++. ..+++.++..++.||+.||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 998654 5789999999999999999653 34899999999999999999999999999999999
Q ss_pred ceEEccCCceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q psy6820 505 NLLVEMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVS 578 (639)
Q Consensus 505 NILld~~g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~ 578 (639)
|||++.++ .+||+|||+|+..... ..+.+||+.|||||++.+..|+.++|||||||+||||+| |..||.+
T Consensus 215 NILl~~~~----~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 215 NILLSEKN----VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp GEEECGGG----CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ceeeCCCC----CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99999887 8999999999866432 234678999999999999999999999999999999998 9999976
Q ss_pred CCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 579 DTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 579 ~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.... +.+...+..+. .++ .++.+++++.+||.+||+.||++|||++||++|
T Consensus 291 ~~~~-~~~~~~i~~g~-~~~--~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 291 VKID-EEFCRRLKEGT-RMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCCS-HHHHHHHHHTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHH-HHHHHHHHcCC-CCC--CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 5433 34555555543 222 235789999999999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=425.52 Aligned_cols=263 Identities=35% Similarity=0.673 Sum_probs=238.1
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-----hHHHHHHHHHHHHhcCCCceeeeeeeeecCC
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-----KKQMIENEVNILRSVNHPNIIKLLDEYDTNN 448 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 448 (639)
.+.++|++++.||+|+||.||+|.++.+++.||+|++.+..... ..+.+.+|+.+|++++||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 45578999999999999999999999999999999998665432 2467889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
.+|+||||++||+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.....+||+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999999998889999999999999999999999999999999999999987763333699999999987
Q ss_pred ccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 529 VLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 529 ~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
.... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+ .+..+.+..+....+.++.+.|..++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--DTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC--SSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhcCCCCCchhccCCC
Confidence 6532 4567899999999999999999999999999999999999999965 35677888898888888877788999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+++++||.+||+.||++|||++|+++||||+.
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 99999999999999999999999999999973
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=414.17 Aligned_cols=254 Identities=35% Similarity=0.642 Sum_probs=229.6
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
..++|.+.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 357899999999999999999999999999999999765443 2345678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC--
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-- 531 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-- 531 (639)
|||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~----~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM----NIKIADFGFSNEFTVGG 168 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS----CEEECSTTCCGGGSSSC
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC----CEEEeeccCceecCCCC
Confidence 99999999999998888999999999999999999999999999999999999999887 899999999976543
Q ss_pred CCccccCCCcccCccccccCCCC-hhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYG-VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s-~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.. .+..++...+..+...+| ..+++++.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~ 242 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVLRGKYRIP----FYMSTDCE 242 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCC----CCCCHHHH
Confidence 34567899999999999888775 899999999999999999999954 456778888888877666 35799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||++||+.||++|||++|+++||||+.
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred HHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 9999999999999999999999999974
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=412.68 Aligned_cols=254 Identities=31% Similarity=0.695 Sum_probs=232.3
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..++|++.+.||+|+||.||+|+++.+++.||+|++.+.... ...+.+.+|..+++.++||||+++++++.+.+.+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 357899999999999999999999999999999999765432 234567789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||++||+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g----~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG----HIKITDFGFAKYVPDV 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS----CEEECCCSSCEECSSC
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC----CEEEeecCcceecCCc
Confidence 999999999999999888999999999999999999999999999999999999999888 8999999999887777
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
..+.+||+.|+|||++.+..++.++|||||||++|||++|..||.. .+....+..+......+| ..+++++.+|
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 233 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD--SNTMKTYEKILNAELRFP----PFFNEDVKDL 233 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 7788999999999999999999999999999999999999999965 356677888888876665 4689999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 613 ISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 613 I~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
|.+||+.||++|| +++|+++||||++
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999999 8999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=414.62 Aligned_cols=253 Identities=35% Similarity=0.667 Sum_probs=229.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL--LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.++|++.+.||+|+||.||+|+++.+++.||+|++.+... ......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999976532 22345678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--- 530 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~--- 530 (639)
|||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g----~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS----CEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC----CEEEeeccchhhcccCC
Confidence 99999999999999888999999999999999999999999999999999999999888 89999999997643
Q ss_pred CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 531 RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 531 ~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.. .+...++..+......+| ..+++++.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~ 233 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHERLFELILMEEIRFP----RTLSPEAK 233 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 234567899999999999999999999999999999999999999964 456778888888776665 46899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
+||.+||+.||++|| +++|+++||||+.
T Consensus 234 ~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 999999999999999 8999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=419.39 Aligned_cols=253 Identities=34% Similarity=0.670 Sum_probs=224.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 452 (639)
.++|++.+.||+|+||.||+|+++.+++.||+|++.+.... ...+.+.+|..+++.+ +||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 57899999999999999999999999999999999765322 2235577899999988 69999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc--
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL-- 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~-- 530 (639)
||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g----~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG----HCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS----CEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC----CEEEccccceeecccC
Confidence 999999999999999888999999999999999999999999999999999999999988 89999999997543
Q ss_pred -CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 531 -RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 531 -~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.. .+..+++..+..+...+| ..+++++
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~~ 251 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA--ENEDDLFEAILNDEVVYP----TWLHEDA 251 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHH
Confidence 234567899999999999999999999999999999999999999965 456788889998877766 3589999
Q ss_pred HHHHHHhcccCCCCCCCH------HHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSA------EDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta------~eiL~HP~f~~ 638 (639)
.+||++||++||++||++ +|+++||||++
T Consensus 252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 252 TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 999999999999999998 89999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=419.04 Aligned_cols=262 Identities=41% Similarity=0.753 Sum_probs=236.4
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.+.++|.+.+.||+|+||.||+|.++.+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34568999999999999999999999999999999998665432 33568899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||++||+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++. ...+||+|||++......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~-~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK-GAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSST-TCCEEECCCTTCBCCTTC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCC-CCCEEEeecCcceEecCC
Confidence 9999999999999988888999999999999999999999999999999999999986541 126999999999776532
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.. .+...+...+..+...++.+.|..++++++
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--EDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 3457899999999999999999999999999999999999999954 456778888999988888888899999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||+.||++|||+.|+|+||||+.
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999999963
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=427.25 Aligned_cols=261 Identities=40% Similarity=0.738 Sum_probs=234.8
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
+.++|++.+.||+|+||.||+|.+..+++.+|+|++....... ..+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4468999999999999999999999999999999998765433 345688999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|||++||+|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.+.. ...+||+|||++......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~-~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLK-GAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSST-TCCEEECCCSSCBCCCTTC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCC-CCcEEEccCceeEEecCCC
Confidence 999999999999998889999999999999999999999999999999999999985321 127999999999766533
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.. .+...++..+..+...++.+.|..++++++
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 245 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD--EDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC--ccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 3457899999999999999999999999999999999999999954 467788899999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||+.||++|||+.|+|+||||++
T Consensus 246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 9999999999999999999999999963
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=411.75 Aligned_cols=259 Identities=26% Similarity=0.580 Sum_probs=231.9
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 35689999999999999999999999999999999997543 3346688999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||++|++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ..+||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~--~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS--STIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC--CCEEECCCTTCEECCTT
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCC--CCEEEEECCCCeECCCC
Confidence 9999999999999765 47999999999999999999999999999999999999987311 27999999999876432
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.. .....+...+..+...++...+..+++++.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA--ETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC--CCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 3456799999999999998899999999999999999999999965 356677888888888777767778999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||+.||++|||+.|+++||||++
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 9999999999999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=414.65 Aligned_cols=255 Identities=35% Similarity=0.702 Sum_probs=233.5
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
...++|++.+.||+|+||.||+|.++.+++.||+|++.+.... ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 4568999999999999999999999999999999999765432 23456788999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g----~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG----YIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTTCEECSS
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC----CEEEcccccceeccC
Confidence 9999999999999999888999999999999999999999999999999999999999888 899999999988877
Q ss_pred CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
...+.+||+.|+|||++.+..++.++|||||||++|||++|..||... +..+++..+..+...+| ..+++++.+
T Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~p----~~~~~~~~~ 267 (350)
T 1rdq_E 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKVRFP----SHFSSDLKD 267 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC----TTCCHHHHH
T ss_pred CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC--CHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence 777889999999999999999999999999999999999999999653 56778888888876665 468999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
||.+||+.||++||+ ++|+++||||+.
T Consensus 268 li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 999999999999998 999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=409.26 Aligned_cols=262 Identities=34% Similarity=0.677 Sum_probs=233.8
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-----hHHHHHHHHHHHHhcCCCceeeeeeeeecCCc
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-----KKQMIENEVNILRSVNHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 449 (639)
+.++|.+.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4467999999999999999999999999999999997654322 35678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
+|+||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.....+||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 99999999999999999888899999999999999999999999999999999999999877633347999999999876
Q ss_pred c--CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 530 L--RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 530 ~--~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||... ...+....+......++...+..++.
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC--CHHHHHHHHHhcCCCcCccccccCCH
Confidence 4 2344678999999999999999999999999999999999999999653 45666777777777777666778999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++.+||.+||+.||++|||++|+++||||+.
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 9999999999999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=420.80 Aligned_cols=255 Identities=33% Similarity=0.635 Sum_probs=226.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH--HHHHHHHHHHHhc-CCCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSV-NHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~--~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 452 (639)
.++|++++.||+|+||.||+|+++.+++.||+|++.+....... +.+.+|..++.++ +||||+++++++.+.+.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 57899999999999999999999999999999999876543322 4577899999887 79999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc--
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL-- 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~-- 530 (639)
||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g----~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS----CEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC----CEEEeecceeeecccC
Confidence 999999999999999888999999999999999999999999999999999999999988 89999999997633
Q ss_pred -CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCC-------CChHHHHHHHHcCCCCCCCCCc
Q psy6820 531 -RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDT-------NDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 531 -~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~-------~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.... .....+++.+......+|
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p---- 282 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---- 282 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----
Confidence 33557899999999999999999999999999999999999999996432 234557778888777666
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCH------HHHHcCCcccC
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSA------EDVLDHPWLER 638 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta------~eiL~HP~f~~ 638 (639)
..+++++++||++||+.||++||++ +|+++||||++
T Consensus 283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 4689999999999999999999985 89999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=409.62 Aligned_cols=247 Identities=24% Similarity=0.334 Sum_probs=196.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC----ceEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN----ELYL 452 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~~l 452 (639)
++|.+.+.||+|+||+||+|+. +|+.||||+++.... .....+.|+..+.+++|||||+++++|.+++ .+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 5689999999999999999976 578999999975432 2333456777778899999999999997654 5899
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN--------YIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~--------givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
|||||++|+|.+++++. .++++.+..++.|++.||+|||++ +||||||||+|||++.++ .+||+|||
T Consensus 79 V~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~----~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS----CEEECCCT
T ss_pred EecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC----CEEEEeCC
Confidence 99999999999999764 689999999999999999999987 999999999999999988 89999999
Q ss_pred ccccccCC-------CccccCCCcccCccccccC------CCChhhhHHHHHHHHHHHHcCCCCCCCCC-----------
Q psy6820 525 LAQRVLRP-------MFTVCGTPTYVAPEILNES------GYGVKIDVWAAGVILYILLCGFPPFVSDT----------- 580 (639)
Q Consensus 525 la~~~~~~-------~~~~~GT~~Y~APE~l~~~------~~s~~sDVwSLGvvL~eLltG~~Pf~~~~----------- 580 (639)
+|+..... ....+||+.|||||++.+. .|+.++|||||||+||||+||..||....
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 99765432 2245899999999999764 36789999999999999999987663221
Q ss_pred --CChHHHHHHHHcCCCCCCCCC-c--ccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 581 --NDQDELFDDILSGQYGFPSPY-W--DDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 581 --~~~~~l~~~i~~~~~~~p~~~-~--~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
...+.+...+......++.+. + ...+..+.+|+.+||+.||++|||+.||++
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 123444445544433322211 1 124568899999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=412.82 Aligned_cols=254 Identities=30% Similarity=0.562 Sum_probs=228.2
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc--chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL--LGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 451 (639)
..++|.+.+.||+|+||.||+|+++.+++.||+|++.+... ....+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 35789999999999999999999999999999999976532 22345677899999887 8999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc-
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL- 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~- 530 (639)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g----~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENML 170 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS----CEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC----CEEEeEChhhhhccc
Confidence 9999999999999999888999999999999999999999999999999999999999988 89999999997643
Q ss_pred --CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 --RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 --~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||.. .+..+++..+..+...+| ..++++
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~ 244 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--QDEEELFHSIRMDNPFYP----RWLEKE 244 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC--CCHHHHHHHHHhCCCCCC----cccCHH
Confidence 234567899999999999999999999999999999999999999964 356778888888776655 468999
Q ss_pred HHHHHHHhcccCCCCCCCHH-HHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAE-DVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~-eiL~HP~f~~ 638 (639)
+.+||.+||+.||++||++. ++++||||++
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 99999999999999999998 9999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=408.83 Aligned_cols=255 Identities=33% Similarity=0.631 Sum_probs=227.0
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 452 (639)
.++|++.+.||+|+||.||+|+++.+++.||+|++.+..... ..+.+.+|..+++++ +||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 578999999999999999999999999999999998765433 235577899999988 79999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc--
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL-- 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~-- 530 (639)
||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g----~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS----CEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC----CEEEEeccccccccCC
Confidence 999999999999998888999999999999999999999999999999999999999888 89999999997643
Q ss_pred -CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCC-------CChHHHHHHHHcCCCCCCCCCc
Q psy6820 531 -RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDT-------NDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 531 -~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~-------~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||.... .....++..+......+|
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p---- 239 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---- 239 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----
Confidence 23456789999999999999999999999999999999999999996421 234556777777766665
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCH------HHHHcCCcccC
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSA------EDVLDHPWLER 638 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta------~eiL~HP~f~~ 638 (639)
..++.++.+||.+||+.||++||++ +|+++||||++
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 4689999999999999999999995 89999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=413.83 Aligned_cols=259 Identities=37% Similarity=0.720 Sum_probs=231.1
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 453 (639)
+.++|++.+.||+|+||.||+|.++.+++.||+|++.+.... ..+|+.++.++ +||||+++++++.+.+.+|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 446899999999999999999999999999999999765432 34688888888 699999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||+..+......+||+|||++......
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 9999999999999988899999999999999999999999999999999999998654322236999999999865432
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCC-CChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDT-NDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~-~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
..+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.... ....++...+..+.+.++...|..+++++
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 254 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHH
Confidence 346789999999999998889999999999999999999999997532 45677888899998888888889999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++||++||+.||++|||++|+++||||.+
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 99999999999999999999999999953
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=405.10 Aligned_cols=257 Identities=30% Similarity=0.566 Sum_probs=221.3
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
..++|++++.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 46899999999999999999999999999999999976655444567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--- 531 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~--- 531 (639)
||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD----NLKISDFGLATVFRYNNR 160 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----CEEECCCTTCEECEETTE
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC----CEEEEEeeccceeccCCc
Confidence 9999999999998888899999999999999999999999999999999999999887 899999999975532
Q ss_pred --CCccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 532 --PMFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 532 --~~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... +..+...... ...+..++++
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~ 237 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTY--LNPWKKIDSA 237 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTTCTT--STTGGGSCHH
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhccccc--CCccccCCHH
Confidence 2345689999999999987765 78999999999999999999999765543333 3333333222 2335789999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+||.+||+.||++|||++|+++||||++
T Consensus 238 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 238 PLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 999999999999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=390.68 Aligned_cols=262 Identities=41% Similarity=0.753 Sum_probs=235.9
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 45689999999999999999999999999999999997655432 33667899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||+++++|.+.+.....+++..+..++.|++.||+|||++||+||||||+||+++.++. ...+||+|||++......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK-GAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSST-TCCEEECCCTTCEECCSS
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCC-CCcEEEeeceeeEEcccC
Confidence 9999999999999988888999999999999999999999999999999999999987651 125999999999766533
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.. .+.......+..+....+.+.+..+++++.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--EDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC--CchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 2356799999999999999999999999999999999999999954 456778888888888888888889999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||+.||++|||++|+++||||++
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred HHHHHHcccChhhCCCHHHHhcCccccC
Confidence 9999999999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=410.50 Aligned_cols=254 Identities=31% Similarity=0.579 Sum_probs=228.4
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 451 (639)
..++|++.+.||+|+||.||+|+++.+++.||+|++.+.... ...+.+.+|..++..+ +||||+++++++++.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 357899999999999999999999999999999999765432 2345677899999888 6999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc-
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL- 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~- 530 (639)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g----~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS----CEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC----cEEEEeCCccccccc
Confidence 9999999999999999888999999999999999999999999999999999999999988 89999999997643
Q ss_pred --CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 --RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 --~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.. .+..++++.+......+| ..++++
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~ 247 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG--EDEDELFQSIMEHNVAYP----KSMSKE 247 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC--CCHHHHHHHHHhCCCCCC----CCCCHH
Confidence 234567899999999999999999999999999999999999999964 456778888888877665 468999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
+.+||.+||+.||++|| +++++++||||+.
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99999999999999999 4799999999974
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=396.99 Aligned_cols=256 Identities=29% Similarity=0.541 Sum_probs=221.8
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 3457899999999999999999999999999999999755432 356788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|||+++|+|.+++.+. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----CEEECCCTTCEECCSTT
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC----CEEEeeCCCceecCCcc
Confidence 9999999999999765 699999999999999999999999999999999999999887 8999999999765432
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ...............+ .....+++.+.
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 247 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-PLRALYLIATNGTPEL--QNPEKLSAIFR 247 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHHCSCCC--SCGGGSCHHHH
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCCC--CCccccCHHHH
Confidence 345689999999999999999999999999999999999999996543 2222222222332222 23467899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||+.||++|||++|+++||||+.
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 9999999999999999999999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=409.52 Aligned_cols=259 Identities=36% Similarity=0.683 Sum_probs=228.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc----hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL----GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
.++|++.+.||+|+||.||+|.++.+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 36799999999999999999999999999999999754322 13567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 452 LVIELIKGGDLFDAISKN----VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
+||||++|++|.+.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ...+||+|||++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~-~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKEN-SAPVKLGGFGVAI 181 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSST-TCCEEECCCTTCE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCC-CCcEEEecCccee
Confidence 999999999999888543 35899999999999999999999999999999999999987651 1259999999998
Q ss_pred cccCC---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 528 RVLRP---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 528 ~~~~~---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.. ....++..+..+...++...|..
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~---~~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG---TKERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS---SHHHHHHHHHHTCCCCCHHHHTT
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC---cHHHHHHHHHcCCCCCCcccccc
Confidence 76543 3356899999999999999999999999999999999999999965 34667778888877777666778
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+++++++||.+||+.||++|||+.|+++||||++
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 9999999999999999999999999999999974
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=405.64 Aligned_cols=257 Identities=41% Similarity=0.769 Sum_probs=217.3
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 45578999999999999999999999999999999997643 245678899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEcc---CCceeeeEEEeecccccccc
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM---SGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~---~g~~~~~vKL~DFGla~~~~ 530 (639)
|||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++. ++ .+||+|||++....
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~----~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA----PLKIADFGLSKIVE 202 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTC----CEEECCCC------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCC----CEEEccCccccccC
Confidence 999999999999988888999999999999999999999999999999999999975 44 79999999997654
Q ss_pred CC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 RP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 ~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|..||.... .....+..+......++.+.+..++.+
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER-GDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT-CHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc-ccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 32 345689999999999999999999999999999999999999996543 345577788888877777888899999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+||++||+.||++|||+.|+++||||++
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=420.93 Aligned_cols=254 Identities=34% Similarity=0.666 Sum_probs=220.6
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 347899999999999999999999999999999999764322 223456789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeecccccccc-
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL- 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~- 530 (639)
||||+++|+|.+++.+...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|....
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~----~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG----HIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS----CEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC----CEEEccCCCceeccC
Confidence 99999999999999988899999999999999999999998 9999999999999999887 89999999997643
Q ss_pred --CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 --RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 --~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||.. .+...+...+......+| ..++++
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~ 375 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILMEEIRFP----RTLGPE 375 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC--CCHHHHHHHHHhCCCCCC----ccCCHH
Confidence 234567899999999999999999999999999999999999999954 456778888888776665 468999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
+.+||.+||+.||++|| +++|+++||||++
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 99999999999999999 9999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=419.18 Aligned_cols=256 Identities=32% Similarity=0.569 Sum_probs=224.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.++|++.+.||+|+||.||+|+++.+++.||+|++.+..... ..+.+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997643221 123477899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|||++||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|......
T Consensus 148 ~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g----~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG----HLKLADFGTCMKMNKEG 222 (410)
T ss_dssp ECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTTCEECCTTS
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC----CEEEeccceeEeeccCC
Confidence 999999999999975 4699999999999999999999999999999999999999988 8999999999766533
Q ss_pred ---CccccCCCcccCccccccCC----CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 533 ---MFTVCGTPTYVAPEILNESG----YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~~----~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
..+.+||+.|+|||++.+.. |+.++|||||||++|||++|..||.. .+....+..+..+...+..+.+..+
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--~~~~~~~~~i~~~~~~~~~p~~~~~ 300 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA--DSLVGTYSKIMNHKNSLTFPDDNDI 300 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC--CChhhHHHHHHhccccccCCCcccc
Confidence 34678999999999998765 88999999999999999999999965 3567777788775433333444679
Q ss_pred cHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccC
Q psy6820 606 SEEAKELISHMLESNPDL--RFSAEDVLDHPWLER 638 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~--Rpta~eiL~HP~f~~ 638 (639)
++++++||++||+.+|++ |++++||++||||++
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 999999999999999988 999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=391.34 Aligned_cols=257 Identities=28% Similarity=0.430 Sum_probs=215.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 368999999999999999999999999999999997655433 3466789999999999999999999999999999999
Q ss_pred eeccCCChHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 455 ELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 455 E~~~ggsL~~~l-~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
||+++ +|.+.+ ...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....+
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~----~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG----ELKLANFGLARAFGIPV 155 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTTCEECCSCC
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEeecccceecCCcc
Confidence 99976 555555 4467899999999999999999999999999999999999999887 8999999999866432
Q ss_pred --CccccCCCcccCccccccCC-CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC----------
Q psy6820 533 --MFTVCGTPTYVAPEILNESG-YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS---------- 599 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~-~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~---------- 599 (639)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... +..+....+.......+.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-SHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC-CHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 34567899999999997765 8999999999999999999888865443 334444444332111111
Q ss_pred ---------------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 600 ---------------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 600 ---------------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...+.+++++++||++||+.||++|||++|+++||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 112357899999999999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=410.52 Aligned_cols=255 Identities=33% Similarity=0.646 Sum_probs=221.4
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHH-HHhcCCCceeeeeeeeecCCce
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNI-LRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~ 450 (639)
...++|++.+.||+|+||.||+|+++.+++.||+|++.+...... ...+.+|..+ ++.++||||+++++++.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 345789999999999999999999999999999999987654322 2345566666 5678899999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g----~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----CEEECCCCBCGGGB
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC----CEEEeeCccccccc
Confidence 99999999999999999888999999999999999999999999999999999999999988 89999999997643
Q ss_pred ---CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 531 ---RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 531 ---~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||.. .+..++++.+......++ ..++.
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~--~~~~~~~~~i~~~~~~~~----~~~~~ 264 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--RNTAEMYDNILNKPLQLK----PNITN 264 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC--SBHHHHHHHHHHSCCCCC----SSSCH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHHhcccCCC----CCCCH
Confidence 234567899999999999999999999999999999999999999964 456778888888766655 46899
Q ss_pred HHHHHHHHhcccCCCCCCCH----HHHHcCCcccC
Q psy6820 608 EAKELISHMLESNPDLRFSA----EDVLDHPWLER 638 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta----~eiL~HP~f~~ 638 (639)
++++||.+||+.||++||++ .++++||||+.
T Consensus 265 ~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 265 SARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999999999999986 69999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=392.12 Aligned_cols=255 Identities=36% Similarity=0.692 Sum_probs=216.8
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-------------------------hHHHHHHHHHHH
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-------------------------KKQMIENEVNIL 429 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-------------------------~~~~~~~Ei~iL 429 (639)
..++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3578999999999999999999999999999999997654321 124578999999
Q ss_pred HhcCCCceeeeeeeeec--CCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q psy6820 430 RSVNHPNIIKLLDEYDT--NNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLL 507 (639)
Q Consensus 430 ~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NIL 507 (639)
++++||||+++++++.+ .+.+|+||||+++++|.+++. ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99999999999999976 568999999999999988764 457999999999999999999999999999999999999
Q ss_pred EccCCceeeeEEEeeccccccccCC---CccccCCCcccCccccccCC---CChhhhHHHHHHHHHHHHcCCCCCCCCCC
Q psy6820 508 VEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESG---YGVKIDVWAAGVILYILLCGFPPFVSDTN 581 (639)
Q Consensus 508 ld~~g~~~~~vKL~DFGla~~~~~~---~~~~~GT~~Y~APE~l~~~~---~s~~sDVwSLGvvL~eLltG~~Pf~~~~~ 581 (639)
++.++ .+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 170 ~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-- 243 (298)
T 2zv2_A 170 VGEDG----HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE-- 243 (298)
T ss_dssp ECTTS----CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred ECCCC----CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc--
Confidence 99887 8999999999876533 23567999999999998765 488999999999999999999999643
Q ss_pred ChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 582 DQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 582 ~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
....+...+......++. ...+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp SHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred cHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 445566666666554443 3578999999999999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=397.45 Aligned_cols=263 Identities=35% Similarity=0.669 Sum_probs=233.5
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-----hHHHHHHHHHHHHhcCCCceeeeeeeeecCC
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-----KKQMIENEVNILRSVNHPNIIKLLDEYDTNN 448 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 448 (639)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34567999999999999999999999999999999997654322 3567889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
.+|+||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+||+++.++.....+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 99999999999999999998888999999999999999999999999999999999999988763333699999999977
Q ss_pred ccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 529 VLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 529 ~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||... ...+....+......++...+..++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhcccccChhhhcccC
Confidence 6533 34567999999999999999999999999999999999999999653 4566777777777666655567789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+.+||.+||+.||++|||++|+++||||+.
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 99999999999999999999999999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=408.18 Aligned_cols=260 Identities=32% Similarity=0.607 Sum_probs=231.5
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|++..... .....+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 456789999999999999999999999999999999976543 2345688999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ..+||+|||++......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~--~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC--CCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCC--CceEEEecccceecCCC
Confidence 9999999999999765 47999999999999999999999999999999999999975421 26999999999876533
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||... +..+....+......++...+..+++++.
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 33567999999999999999999999999999999999999999653 45667777877777777777788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||+.||++|||+.|+++||||++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 9999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=396.84 Aligned_cols=264 Identities=37% Similarity=0.702 Sum_probs=224.6
Q ss_pred cccCCCeeEE-EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCce
Q psy6820 373 SKLLQRYSVG-QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 373 ~~~~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 450 (639)
....++|.+. +.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++.++ +||||+++++++.+.+.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 3456789985 789999999999999999999999999976532 3356778999999985 699999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|+||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++. ...+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQ-VSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSS-SCSEEECCTTCCC---
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCC-cCceEEEEccCccccc
Confidence 999999999999999988888999999999999999999999999999999999999987761 1249999999987543
Q ss_pred C----------CCccccCCCcccCcccccc-----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC-------------
Q psy6820 531 R----------PMFTVCGTPTYVAPEILNE-----SGYGVKIDVWAAGVILYILLCGFPPFVSDTND------------- 582 (639)
Q Consensus 531 ~----------~~~~~~GT~~Y~APE~l~~-----~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~------------- 582 (639)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 1 1234569999999999875 55889999999999999999999999765432
Q ss_pred hHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 583 ~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...+...+..+...++...+..+++++++||.+||+.||++|||++|+++||||++
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 35567778888777776556678999999999999999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=388.58 Aligned_cols=267 Identities=30% Similarity=0.569 Sum_probs=223.1
Q ss_pred ccCCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q psy6820 368 NLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN 447 (639)
Q Consensus 368 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 447 (639)
++.....+.++|.+.+.||+|+||.||+|.+..++..+|+|++.........+.+.+|+.++++++||||+++++++.+.
T Consensus 13 ~~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 13 NLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp CCEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred cCCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence 34445566788999999999999999999999999999999998776555567889999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 448 NELYLVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
+..|+||||+++++|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++ ....+||+||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~-~~~~~kl~Df 171 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-PHSPIKIIDF 171 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS-TTCCEEECCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC-CCCCEEEEee
Confidence 999999999999999998854 36799999999999999999999999999999999999995432 1127999999
Q ss_pred cccccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy6820 524 GLAQRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY 601 (639)
Q Consensus 524 Gla~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~ 601 (639)
|++...... ....+||+.|+|||++. ..++.++||||||+++|+|++|..||... ........+......++..
T Consensus 172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~- 247 (285)
T 3is5_A 172 GLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVE- 247 (285)
T ss_dssp CCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCC--
T ss_pred ecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC--CHHHHHhhhccCCcccccc-
Confidence 999765432 34567999999999986 46899999999999999999999999654 4455555555544443322
Q ss_pred cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q psy6820 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639 (639)
Q Consensus 602 ~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~~ 639 (639)
...+++++.+||.+||+.||++|||+.|+++||||++.
T Consensus 248 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp -CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 23579999999999999999999999999999999873
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=409.00 Aligned_cols=255 Identities=34% Similarity=0.633 Sum_probs=220.2
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
....++|.+.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 445689999999999999999999999999999999997543221 135688999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|+||||+ +|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~----~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL----NVKIADFGLSNIMT 159 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC----CEEECCSSCTBTTT
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC----CEEEEEeccceecc
Confidence 9999999 789999998888999999999999999999999999999999999999999887 89999999997654
Q ss_pred CC--CccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 531 RP--MFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 531 ~~--~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.. ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ..+...+..+...+ ...+++
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~~----p~~~s~ 233 (336)
T 3h4j_B 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI--PNLFKKVNSCVYVM----PDFLSP 233 (336)
T ss_dssp TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS--TTCBCCCCSSCCCC----CTTSCH
T ss_pred CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH--HHHHHHHHcCCCCC----cccCCH
Confidence 32 356789999999999988776 7899999999999999999999965432 22222222222222 246899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++.+||++||+.||++|||++|+++||||+.
T Consensus 234 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 234 GAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 9999999999999999999999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=397.54 Aligned_cols=253 Identities=32% Similarity=0.625 Sum_probs=217.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEc---CCCeEEEEEEEcccccch---hHHHHHHHHHHHHhcCCCceeeeeeeeecCCc
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLLG---KKQMIENEVNILRSVNHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiKv~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 449 (639)
.++|++.+.||+|+||.||+|++. .+++.||+|++.+..... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 468999999999999999999885 678999999998754322 23456789999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
+|+||||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS----CEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC----cEEEEeCCccccc
Confidence 999999999999999999888899999999999999999999999999999999999999887 8999999999754
Q ss_pred cC---CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 530 LR---PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 530 ~~---~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
.. .....+||+.|+|||++.+..++.++||||||+++|+|++|..||... +.......+......+| ..++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~p----~~~~ 245 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE--NRKKTIDKILKCKLNLP----PYLT 245 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCCCC----TTSC
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCC----CCCC
Confidence 32 234568999999999999999999999999999999999999999653 45667777877766655 4689
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 607 EEAKELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
+++.+||.+||+.||++|| +++|+++||||++
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 9999999999999999999 8999999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=407.47 Aligned_cols=256 Identities=31% Similarity=0.604 Sum_probs=226.9
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.+.... ...+.+.+|+.+|+.++||||++++++|.+.+.+|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 357899999999999999999999999999999999765422 223567899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
||||+.||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g----~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG----HVHITDFNIAAMLPRE 168 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC----CEEEeccceeeeccCC
Confidence 999999999999999888999999999999999999999999999999999999999988 899999999986643
Q ss_pred -CCccccCCCcccCcccccc---CCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-ChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 532 -PMFTVCGTPTYVAPEILNE---SGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 532 -~~~~~~GT~~Y~APE~l~~---~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
...+.+||+.|+|||++.+ ..|+.++|||||||++|||++|..||..... ....+...+......+| ..++
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s 244 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWS 244 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSC
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCC
Confidence 3456789999999999963 4689999999999999999999999975433 44556666666655554 4689
Q ss_pred HHHHHHHHHhcccCCCCCCC-HHHHHcCCcccC
Q psy6820 607 EEAKELISHMLESNPDLRFS-AEDVLDHPWLER 638 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpt-a~eiL~HP~f~~ 638 (639)
+++.+||.+||+.||++||+ ++++++||||++
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 99999999999999999998 999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=401.72 Aligned_cols=257 Identities=37% Similarity=0.675 Sum_probs=209.9
Q ss_pred CCeeEE---EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEE
Q psy6820 377 QRYSVG---QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 377 ~~y~i~---~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~l 452 (639)
++|++. +.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+. ||||+++++++.+.+..|+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 456664 7899999999999999999999999999754 2456778999999997 9999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
||||+++|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++. ...+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 84 VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEND-NLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----CEEEECCCTTCEECCC-
T ss_pred EEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCC-cccEEEeccccceecCCC
Confidence 9999999999999999889999999999999999999999999999999999999986642 23799999999976543
Q ss_pred --CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-----ChHHHHHHHHcCCCCCCCCCccc
Q psy6820 532 --PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-----DQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 532 --~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-----~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...++...+..+...++.+.|..
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccC
Confidence 23456789999999999999999999999999999999999999975432 34567788888888777777788
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+++++++||.+||+.||++|||++|+++||||++
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred CCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 9999999999999999999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=404.81 Aligned_cols=257 Identities=35% Similarity=0.593 Sum_probs=215.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+.+.||+|+||.||+|.+..+++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 47899999999999999999999999999999999765432 3567899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc--CCC
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPM 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~--~~~ 533 (639)
|+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||++.... ...
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~--~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSS--CCEEECCCCCC---------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--ceEEEeecCccccccccCCC
Confidence 9999999999988889999999999999999999999999999999999999987651 249999999997443 233
Q ss_pred ccccCCCcccCccccccCCCChh-hhHHHHHHHHHHHHcCCCCCCCCCC--ChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVK-IDVWAAGVILYILLCGFPPFVSDTN--DQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~-sDVwSLGvvL~eLltG~~Pf~~~~~--~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
...+||+.|+|||++.+..++.+ +|||||||++|+|++|..||..... ........+......+|. ...+++++.
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~ 252 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIRISPECC 252 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSCCCHHHH
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCCCCHHHH
Confidence 45689999999999988887665 8999999999999999999975432 334556666666555543 346899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||+.||++|||+.|+++||||.+
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 253 HLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 9999999999999999999999999954
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=387.44 Aligned_cols=257 Identities=37% Similarity=0.709 Sum_probs=229.5
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.+.++|++.+.||+|+||.||+|.+..++..+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 345689999999999999999999999999999999976543 2356788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE---ccCCceeeeEEEeecccccccc
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLV---EMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILl---d~~g~~~~~vKL~DFGla~~~~ 530 (639)
|||+++++|.+++.....+++..+..++.|++.||+|||++||+||||||+||++ +.++ .+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~----~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS----PLKLIDFGLAARFK 160 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC----CEEECCCTTCEECC
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC----cEEEEecccceecc
Confidence 9999999999999888889999999999999999999999999999999999999 5454 79999999997654
Q ss_pred C--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 R--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 ~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
. ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.. ....+....+..+...++...+..++++
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA--PTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC--CCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 3 23456799999999998765 89999999999999999999999965 3556777788888777776666689999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+||.+||+.||++|||+.++++||||++
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 999999999999999999999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=392.44 Aligned_cols=258 Identities=29% Similarity=0.469 Sum_probs=210.7
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
..+.++|++.+.||+|+||.||+|.+.. ++.||+|++....... ....+.+|+.++++++||||+++++++.+.+.+|
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 4567899999999999999999998854 7899999997554322 2356789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+||||+++ +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~----~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG----ALKLADFGLARAFG 170 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEECCCTTCEETT
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC----CEEEccCcCceecC
Confidence 99999975 888887654 4599999999999999999999999999999999999999887 89999999998764
Q ss_pred C---CCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC------
Q psy6820 531 R---PMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP------ 600 (639)
Q Consensus 531 ~---~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~------ 600 (639)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+.......+..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--QLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--HHHHHHHHHCCCCTTTSGGGT
T ss_pred CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHHCCCChHHhhhhh
Confidence 3 2345678999999999876 568999999999999999999999997654332 222222110001110
Q ss_pred --------------------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 601 --------------------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 601 --------------------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+.+++++.+||.+||+.||++|||++|+++||||++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 11246789999999999999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=420.53 Aligned_cols=262 Identities=39% Similarity=0.702 Sum_probs=231.4
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc------------hhHHHHHHHHHHHHhcCCCceeee
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL------------GKKQMIENEVNILRSVNHPNIIKL 440 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~------------~~~~~~~~Ei~iL~~l~HpnIv~l 440 (639)
..+.++|.+++.||+|+||.||+|.++.+++.+|+|++...... ...+.+.+|+.++++++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 34568999999999999999999999999999999999765432 224668899999999999999999
Q ss_pred eeeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEE
Q psy6820 441 LDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 441 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL 520 (639)
++++.+.+.+|+|||||+||+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++. ...+||
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~-~~~~kl 190 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS-LLNIKI 190 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTC-CSSEEE
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCC-CccEEE
Confidence 9999999999999999999999999988889999999999999999999999999999999999999987752 236999
Q ss_pred eeccccccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy6820 521 GDFGLAQRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598 (639)
Q Consensus 521 ~DFGla~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p 598 (639)
+|||++...... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+..++...+..+.+.++
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGG--QNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCC
Confidence 999999866533 346789999999999874 599999999999999999999999965 456778888888888887
Q ss_pred CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 599 SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 599 ~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+.|..+++++++||++||+.||++|||++|+|+||||++
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 7778899999999999999999999999999999999964
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=416.49 Aligned_cols=256 Identities=32% Similarity=0.587 Sum_probs=223.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.++|++.++||+|+||.||+|+++.+++.||+|++.+...... ...+.+|..++..++||||++++++|.+.+.+|+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 4789999999999999999999999999999999976433221 23377899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|......
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g----~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG----HIRLADFGSCLKLMED 228 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC----CEEEcchhhhhhcccC
Confidence 999999999999987 57899999999999999999999999999999999999999988 8999999999765432
Q ss_pred ----CccccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC--CCCCCCC
Q psy6820 533 ----MFTVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ--YGFPSPY 601 (639)
Q Consensus 533 ----~~~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~--~~~p~~~ 601 (639)
....+||+.|+|||++. ...|+.++|||||||++|||++|..||... +..+.+..+.... +.+|. .
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~~~p~-~ 305 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERFQFPT-Q 305 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHHCCCCS-S
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC--ChhHHHHhhhhccccccCCc-c
Confidence 23468999999999987 567899999999999999999999999653 5566777776543 33432 2
Q ss_pred cccccHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccC
Q psy6820 602 WDDISEEAKELISHMLESNPDL--RFSAEDVLDHPWLER 638 (639)
Q Consensus 602 ~~~l~~~l~dLI~~~L~~dP~~--Rpta~eiL~HP~f~~ 638 (639)
+..+++++++||++||+.+|++ |++++|+++||||++
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 3568999999999999988888 999999999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=409.55 Aligned_cols=258 Identities=36% Similarity=0.712 Sum_probs=216.7
Q ss_pred ccCCCeeEE-EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHh-cCCCceeeeeeeeec----C
Q psy6820 374 KLLQRYSVG-QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRS-VNHPNIIKLLDEYDT----N 447 (639)
Q Consensus 374 ~~~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~----~ 447 (639)
...++|.+. +.||+|+||.||+|.++.+++.||||++... ..+.+|+.++.+ .+||||++++++|.. .
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 456788887 7999999999999999999999999999642 345678888744 579999999998865 6
Q ss_pred CceEEEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
+.+||||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++. ...+||+|||+
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~-~~~~kl~DFG~ 210 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP-NAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSST-TCCEEECCCTT
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCC-CccEEEEeccc
Confidence 67999999999999999997653 5999999999999999999999999999999999999987320 12799999999
Q ss_pred cccccC--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh--HHHHHHHHcCCCCCCCCC
Q psy6820 526 AQRVLR--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ--DELFDDILSGQYGFPSPY 601 (639)
Q Consensus 526 a~~~~~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~--~~l~~~i~~~~~~~p~~~ 601 (639)
+..... ...+.+||+.|+|||++.+..|+.++|||||||++|||++|..||....... ......+..+.+.++.+.
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 986643 2456789999999999999999999999999999999999999997643321 235566777888888888
Q ss_pred cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 602 ~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
|..+++++.+||++||+.||++|||+.|+++||||.+
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 8899999999999999999999999999999999965
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=418.77 Aligned_cols=261 Identities=39% Similarity=0.734 Sum_probs=232.0
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.+.++|.+++.||+|+||.||+|.+..+++.||+|++.+... ......+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 455789999999999999999999999999999999965432 2235678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
||||+.+++|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++..+. ...+||+|||++.....
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~-~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK-DCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSST-TCCEEECSCSCTTTBCCC
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCC-CCCEEEEECCcCeECCCC
Confidence 9999999999999988889999999999999999999999999999999999999965431 12799999999976543
Q ss_pred -CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 532 -PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 532 -~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. ....++...+..+.+.++.+.|..++++++
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG--KNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 2345689999999999976 499999999999999999999999965 356778888888888888888899999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||+.||++|||+.|+|+||||++
T Consensus 255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 9999999999999999999999999974
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=394.09 Aligned_cols=256 Identities=29% Similarity=0.502 Sum_probs=203.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||+|.++.+++.||+|++.........+.+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46899999999999999999999999999999999766544445677899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 456 LIKGGDLFDAISKN------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 456 ~~~ggsL~~~l~~~------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
|++ ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~----~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG----QLKLGDFGLARAF 158 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEECCCSSCEET
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC----CEEECcCccceec
Confidence 997 5999998653 3589999999999999999999999999999999999999887 8999999999866
Q ss_pred cCC---CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC------
Q psy6820 530 LRP---MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS------ 599 (639)
Q Consensus 530 ~~~---~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~------ 599 (639)
..+ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... +..+....+.......+.
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT--NDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCChhHhhhh
Confidence 432 345678999999999976 46899999999999999999999999654 333444444321111000
Q ss_pred ------------------------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 600 ------------------------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 600 ------------------------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.....++.++.+||.+||+.||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 011257889999999999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=389.06 Aligned_cols=258 Identities=43% Similarity=0.818 Sum_probs=229.3
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 345689999999999999999999999999999999986532 2345678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE---ccCCceeeeEEEeecccccccc
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLV---EMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILl---d~~g~~~~~vKL~DFGla~~~~ 530 (639)
|||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+||++ +.++ .+||+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~----~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS----KIMITDFGLSKMEQ 160 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC----CEEBCSCSTTCCCC
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC----CEEEccCCcceecC
Confidence 9999999999999888889999999999999999999999999999999999999 4444 79999999997554
Q ss_pred CC-CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 531 RP-MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 531 ~~-~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.. ....+||+.|+|||++.+..++.++||||||+++|+|++|..||... ....+...+..+...++.+.+..+++++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (304)
T 2jam_A 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFWDDISESA 238 (304)
T ss_dssp CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCCccccccCCHHH
Confidence 32 33467999999999999999999999999999999999999999653 4567778888888777777788999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+||.+||+.||++|||++|+++||||++
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=419.87 Aligned_cols=261 Identities=40% Similarity=0.735 Sum_probs=233.4
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL--LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.+... ....+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 345789999999999999999999999999999999976543 234577889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+||||+.+|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++..+ ....+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS-KDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCTTHHHHBCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCC-CCCcEEEEeeeeeEEccc
Confidence 9999999999999998888999999999999999999999999999999999999995322 112799999999976643
Q ss_pred C--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 P--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 ~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
. ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.. .+..++...+..+.+.++.+.|..+++++
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG--ANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 3 345689999999999876 699999999999999999999999965 45677888888888888888889999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++||.+||+.||++|||+.|+|+||||++
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 99999999999999999999999999963
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=384.82 Aligned_cols=254 Identities=35% Similarity=0.646 Sum_probs=223.6
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..++|++++.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3578999999999999999999999999999999996544322 24568899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~----~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG----ELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS----CEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC----CEEEEeccccccCCcc
Confidence 999999999999998888899999999999999999999999999999999999999887 8999999998655432
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.. .........+......+| ..+++++.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 236 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA--NTYQETYKRISRVEFTFP----DFVTEGARD 236 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHTCCCCC----TTSCHHHHH
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC--CcHHHHHHHHHhCCCCCC----CcCCHHHHH
Confidence 3456899999999999999999999999999999999999999964 355666677776665554 468899999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
||.+||+.||++|||+.|+++||||+.
T Consensus 237 li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHhccChhhCCCHHHHhhCccccC
Confidence 999999999999999999999999964
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=385.65 Aligned_cols=261 Identities=35% Similarity=0.686 Sum_probs=228.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-----hHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-----KKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999999999999999997654322 356788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
++||||+++++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.....+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888899999999999999999999999999999999999998775333479999999997654
Q ss_pred C--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 R--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 ~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ...+....+......++...+..+++.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE--TKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc--chHHHHHHhHhcccCCcchhcccCCHH
Confidence 3 234567999999999999999999999999999999999999999653 456666777777666665556778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+||.+||+.||++|||+.|+++||||++
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 999999999999999999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=384.99 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=210.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+++|++.+.||+|+||.||+|.+ .+++.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 36899999999999999999988 568899999997654322 2356779999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 455 ELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
||+++ +|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPV 154 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS----CEEECCTTHHHHHCC--
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC----CEEEeECccccccCccc
Confidence 99975 999988764 6799999999999999999999999999999999999999887 8999999999765432
Q ss_pred --CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC-----------
Q psy6820 533 --MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP----------- 598 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p----------- 598 (639)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+.......+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHHCCCChhhchhhhccc
Confidence 334578999999999976 458999999999999999999999996543 3333333322100000
Q ss_pred --------------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 599 --------------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 599 --------------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
......+++++.+||.+||+.||++|||++|+++||||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0112457899999999999999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=388.02 Aligned_cols=259 Identities=32% Similarity=0.460 Sum_probs=210.5
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch----hHHHHHHHHHHHHhcC---CCceeeeeeeee
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG----KKQMIENEVNILRSVN---HPNIIKLLDEYD 445 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~----~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~ 445 (639)
+...++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 345689999999999999999999999999999999987443211 1234567777777664 999999999987
Q ss_pred cCC-----ceEEEEeeccCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeE
Q psy6820 446 TNN-----ELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVL 518 (639)
Q Consensus 446 ~~~-----~~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~v 518 (639)
... .+++||||+. ++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~----~~ 159 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG----TV 159 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS----CE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC----CE
Confidence 655 5899999996 599999977654 99999999999999999999999999999999999999887 89
Q ss_pred EEeeccccccccC--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 519 KVGDFGLAQRVLR--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 519 KL~DFGla~~~~~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||... ...+....+......
T Consensus 160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN--SEADQLGKIFDLIGL 237 (308)
T ss_dssp EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS--SHHHHHHHHHHHHCC
T ss_pred EEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCC
Confidence 9999999976543 334578999999999999999999999999999999999999999654 334444444332111
Q ss_pred CCCCC-----------------------cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 597 FPSPY-----------------------WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 597 ~p~~~-----------------------~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+... .+.+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 11111 1357899999999999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=379.68 Aligned_cols=257 Identities=30% Similarity=0.561 Sum_probs=224.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46899999999999999999999999999999999866555556788999999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC----
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---- 531 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---- 531 (639)
|+++++|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD----NLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----CEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC----CEEEeeCCCccccCCCcch
Confidence 999999999998888899999999999999999999999999999999999999887 799999999976532
Q ss_pred -CCccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 -PMFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 -~~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ .+..+....... ..+..+++++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~ 238 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTYL--NPWKKIDSAP 238 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTCTTS--TTGGGSCHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhccccc--CchhhcCHHH
Confidence 2345679999999999987765 7899999999999999999999976544332 233343332222 2356789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLERS 639 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~~ 639 (639)
.+||.+||+.||++|||++|+++||||++.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 999999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=393.37 Aligned_cols=253 Identities=26% Similarity=0.474 Sum_probs=213.1
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN------ 448 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 448 (639)
..++|++.+.||+|+||.||+|.++.+++.||||++.........+.+.+|+.++++++||||++++++|.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 45689999999999999999999999999999999987665556678899999999999999999999885543
Q ss_pred ---------------------------------------------------ceEEEEeeccCCChHHHHhhcCC---CCH
Q psy6820 449 ---------------------------------------------------ELYLVIELIKGGDLFDAISKNVK---FSE 474 (639)
Q Consensus 449 ---------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~~---l~~ 474 (639)
.+++||||+++++|.+++.+... .++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999977543 566
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---------------CccccCC
Q psy6820 475 EDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---------------MFTVCGT 539 (639)
Q Consensus 475 ~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---------------~~~~~GT 539 (639)
..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ....+||
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC----CEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 67899999999999999999999999999999999887 8999999999766432 2345799
Q ss_pred CcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhccc
Q psy6820 540 PTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLES 619 (639)
Q Consensus 540 ~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~ 619 (639)
+.|+|||++.+..++.++|||||||++|||++|..|+. ........+.... .+ ..+...++++.+||.+||+.
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~----~~~~~~~~~~~~~--~~-~~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM----ERVRIITDVRNLK--FP-LLFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH----HHHHHHHHHHTTC--CC-HHHHHHCHHHHHHHHHHHCS
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh----HHHHHHHHhhccC--CC-cccccCChhHHHHHHHHccC
Confidence 99999999999999999999999999999999987762 1223333333332 22 22345678999999999999
Q ss_pred CCCCCCCHHHHHcCCcccC
Q psy6820 620 NPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 620 dP~~Rpta~eiL~HP~f~~ 638 (639)
||++|||++|+++||||++
T Consensus 313 ~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 313 SPTERPEATDIIENAIFEN 331 (332)
T ss_dssp SGGGSCCHHHHHHSTTCCC
T ss_pred CCCcCCCHHHHhhchhhhc
Confidence 9999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=416.36 Aligned_cols=260 Identities=40% Similarity=0.728 Sum_probs=228.6
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
+.++|.+++.||+|+||.||+|.++.++..+|+|++.+.... .....+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 446799999999999999999999999999999999765432 2346678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC--
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-- 531 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-- 531 (639)
|||+++|+|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++..+. ...+||+|||++.....
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~-~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK-DALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSST-TCCEEECCCTTCEECBTTB
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCC-CCcEEEEECCCCeECCCCc
Confidence 999999999999988889999999999999999999999999999999999999986541 12699999999976653
Q ss_pred CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. ....++...+..+...++.+.|..+++++++
T Consensus 194 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG--QTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 234678999999999986 4699999999999999999999999965 4567788889999888888888999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
||++||+.||++|||+.|+|+||||++
T Consensus 271 li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHCCCChhhCccHHHHhcCccccc
Confidence 999999999999999999999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=397.27 Aligned_cols=264 Identities=26% Similarity=0.364 Sum_probs=219.6
Q ss_pred cCCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-----CCceeeeeee
Q psy6820 369 LNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-----HPNIIKLLDE 443 (639)
Q Consensus 369 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l~~~ 443 (639)
+.....+.++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.++ ||||++++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 3444556789999999999999999999999999999999997532 23455678999999997 9999999999
Q ss_pred eecCCceEEEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC---------
Q psy6820 444 YDTNNELYLVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG--------- 512 (639)
Q Consensus 444 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g--------- 512 (639)
+...+..|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence 99999999999999 899999997654 599999999999999999999999999999999999997511
Q ss_pred ------------ceeeeEEEeeccccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCC
Q psy6820 513 ------------CHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDT 580 (639)
Q Consensus 513 ------------~~~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~ 580 (639)
.....+||+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~- 262 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH- 262 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS-
T ss_pred cccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC-
Confidence 0013799999999987776667788999999999999999999999999999999999999999654
Q ss_pred CChHHHHHHHHcCCCCCCCCC------------------------------------------cccccHHHHHHHHHhcc
Q psy6820 581 NDQDELFDDILSGQYGFPSPY------------------------------------------WDDISEEAKELISHMLE 618 (639)
Q Consensus 581 ~~~~~l~~~i~~~~~~~p~~~------------------------------------------~~~l~~~l~dLI~~~L~ 618 (639)
+..+....+......+|... ....++.+.+||.+||+
T Consensus 263 -~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 263 -EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp -SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred -cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 33334343333222222100 00123778899999999
Q ss_pred cCCCCCCCHHHHHcCCccc
Q psy6820 619 SNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 619 ~dP~~Rpta~eiL~HP~f~ 637 (639)
.||++|||++|+|+||||+
T Consensus 342 ~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 342 IDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGC
T ss_pred CChhhCCCHHHHhcCcccC
Confidence 9999999999999999996
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=381.32 Aligned_cols=260 Identities=40% Similarity=0.741 Sum_probs=231.1
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc--------chhHHHHHHHHHHHHhcC-CCceeeeeee
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL--------LGKKQMIENEVNILRSVN-HPNIIKLLDE 443 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~--------~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~ 443 (639)
....++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 3457899999999999999999999999999999999975531 122356778999999996 9999999999
Q ss_pred eecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 444 YDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 444 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
+...+..++||||+++++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~kl~df 168 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM----NIKLTDF 168 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----CEEECCC
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC----cEEEecc
Confidence 999999999999999999999998888899999999999999999999999999999999999999887 7999999
Q ss_pred cccccccC--CCccccCCCcccCccccc------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC
Q psy6820 524 GLAQRVLR--PMFTVCGTPTYVAPEILN------ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY 595 (639)
Q Consensus 524 Gla~~~~~--~~~~~~GT~~Y~APE~l~------~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~ 595 (639)
|++..... ......||+.|+|||++. ...++.++||||||+++|+|++|..||... ........+..+..
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGNY 246 (298)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCC
T ss_pred cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc--cHHHHHHHHhcCCc
Confidence 99976543 234567999999999985 456899999999999999999999999543 45667777888887
Q ss_pred CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 596 GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 596 ~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.++.+.+..++.++.+||.+||+.||++|||++|+++||||++
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence 7777777889999999999999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=411.54 Aligned_cols=263 Identities=38% Similarity=0.736 Sum_probs=220.6
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-------hHHHHHHHHHHHHhcCCCceeeeeeeee
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-------KKQMIENEVNILRSVNHPNIIKLLDEYD 445 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-------~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 445 (639)
..+.++|.+.+.||+|+||.||+|.+..+++.||+|++.+..... ....+.+|+.+|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345689999999999999999999999999999999997654321 1124779999999999999999999986
Q ss_pred cCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 446 TNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 446 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
. +..|+||||+++|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++. ...+||+|||+
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~-~~~~kl~DFG~ 288 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE-DCLIKITDFGH 288 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSS-SCCEEECCSST
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCC-cceEEEeeccc
Confidence 5 458999999999999999988889999999999999999999999999999999999999976541 12699999999
Q ss_pred cccccCC--CccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy6820 526 AQRVLRP--MFTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600 (639)
Q Consensus 526 a~~~~~~--~~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~ 600 (639)
+...... ....+||+.|+|||++. ...|+.++|||||||++|+|++|..||.... ....+...+..+...++.+
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR-TQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS-SSCCHHHHHHTTCCCCCHH
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc-chHHHHHHHhcCCCCCCch
Confidence 9876533 34678999999999985 3678899999999999999999999997543 3344556677777766666
Q ss_pred CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 601 ~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+..+++++.+||.+||+.||++|||++|+++||||++
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 67789999999999999999999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=401.35 Aligned_cols=255 Identities=35% Similarity=0.675 Sum_probs=220.8
Q ss_pred CCeeE--EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSV--GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i--~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
..|.+ .+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 34554 6789999999999999999999999999986543 33567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEc--cCCceeeeEEEeeccccccccC
Q psy6820 455 ELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE--MSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 455 E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld--~~g~~~~~vKL~DFGla~~~~~ 531 (639)
||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+. .++ .+||+|||++.....
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~----~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK----QIKIIDFGLARRYKP 241 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTT----EEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCC----cEEEEeCCCceecCC
Confidence 999999999988654 4699999999999999999999999999999999999994 344 799999999987643
Q ss_pred C--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 P--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 ~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||... +..+....+......++...+..+++++
T Consensus 242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 242 REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD--NDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 2 34567999999999999999999999999999999999999999654 4566777888877777777778899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++||.+||+.||++|||++|+++||||++
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999999999999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=395.79 Aligned_cols=260 Identities=36% Similarity=0.651 Sum_probs=223.3
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc----chhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL----LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 34789999999999999999999999999999999976532 23346788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh----------------------------------------cCCCCHHHHHHHHHHHHHHHHH
Q psy6820 451 YLVIELIKGGDLFDAISK----------------------------------------NVKFSEEDSKFMTQSLASALSY 490 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~----------------------------------------~~~l~~~~~~~i~~qI~~aL~y 490 (639)
|+||||++||+|.+++.. ...+++..++.++.||+.||+|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999999999999852 1124678889999999999999
Q ss_pred HHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-------CCccccCCCcccCcccccc--CCCChhhhHHH
Q psy6820 491 LHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-------PMFTVCGTPTYVAPEILNE--SGYGVKIDVWA 561 (639)
Q Consensus 491 LH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-------~~~~~~GT~~Y~APE~l~~--~~~s~~sDVwS 561 (639)
||++||+||||||+|||++.++. ..+||+|||++..... ......||+.|+|||++.+ ..++.++||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKS--FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSS--CCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCC--ceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 99999999999999999986642 2699999999976532 1345679999999999975 67899999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 562 AGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 562 LGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
||+++|||++|..||... ...+....+......++.+.+..+++++.+||.+||+.||++||++.|+++||||++
T Consensus 262 lG~il~el~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGV--NDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHCCCCCCCC--ChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 999999999999999543 456667777777777777777789999999999999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=401.10 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=214.5
Q ss_pred CCCeeEEEEEccC--CceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDG--NFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G--~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.++|++++.||+| +||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999999999999999997655433 23667889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 453 VIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~----~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG----KVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----CEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEcccccceeec
Confidence 99999999999999765 6799999999999999999999999999999999999999887 89999999986542
Q ss_pred C----------CCccccCCCcccCcccccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC---
Q psy6820 531 R----------PMFTVCGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY--- 595 (639)
Q Consensus 531 ~----------~~~~~~GT~~Y~APE~l~~--~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~--- 595 (639)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||........ + ..+..+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~-~~~~~~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-L-LEKLNGTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH-H-HHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH-H-HHHhcCCCCcc
Confidence 1 1223578999999999987 6799999999999999999999999976443221 1 11111110
Q ss_pred ---------------------------------------CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 596 ---------------------------------------GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 596 ---------------------------------------~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
....+.+..+++++.+||++||+.||++|||++|+|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 00112345688999999999999999999999999999999
Q ss_pred cC
Q psy6820 637 ER 638 (639)
Q Consensus 637 ~~ 638 (639)
++
T Consensus 338 ~~ 339 (389)
T 3gni_B 338 KQ 339 (389)
T ss_dssp GG
T ss_pred HH
Confidence 75
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=414.25 Aligned_cols=255 Identities=35% Similarity=0.668 Sum_probs=228.3
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
...++|.+++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3458899999999999999999999999999999999765432 22456889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~----~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM----NAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC----CEEECCCSSCEECCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC----CeEEEeccchhhccc
Confidence 9999999999999999888999999999999999999999999999999999999999887 799999999987643
Q ss_pred C--CccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 532 P--MFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 532 ~--~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
. ..+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||... ....++..+..+....| ..++++
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~p----~~~s~~ 242 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD--HVPTLFKKICDGIFYTP----QYLNPS 242 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS--SSHHHHHHHHTTCCCCC----TTCCHH
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC--CHHHHHHHHhcCCcCCC----ccCCHH
Confidence 2 346789999999999988765 78999999999999999999999643 45667778887766554 468999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+||.+||+.||++|||++|+++||||++
T Consensus 243 ~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 243 VISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred HHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 999999999999999999999999999964
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=409.06 Aligned_cols=255 Identities=31% Similarity=0.534 Sum_probs=219.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.++|++.+.||+|+||.||+|+++.+++.||+|++.+..... ..+.+.+|..++..++||||+++++++++.+.+|+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 478999999999999999999999999999999997643321 123477899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||++||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g----~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG----HIRLADFGSCLKLRAD 215 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTTCEECCTT
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC----CEEEeechhheeccCC
Confidence 9999999999999775 4799999999999999999999999999999999999999988 8999999999776432
Q ss_pred ----CccccCCCcccCccccc-------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC--CCCCC
Q psy6820 533 ----MFTVCGTPTYVAPEILN-------ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ--YGFPS 599 (639)
Q Consensus 533 ----~~~~~GT~~Y~APE~l~-------~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~--~~~p~ 599 (639)
....+||+.|+|||++. ...|+.++|||||||++|||++|..||... +..+.+..+.... ..+|.
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHHCCCC-
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC--CHHHHHHHHHhcccCcCCCc
Confidence 23468999999999997 356899999999999999999999999653 4566666776532 33332
Q ss_pred CCcccccHHHHHHHHHhcccCCCCC---CCHHHHHcCCcccC
Q psy6820 600 PYWDDISEEAKELISHMLESNPDLR---FSAEDVLDHPWLER 638 (639)
Q Consensus 600 ~~~~~l~~~l~dLI~~~L~~dP~~R---pta~eiL~HP~f~~ 638 (639)
....+++++++||++||+ +|++| |+++|+++||||++
T Consensus 294 -~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 294 -VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred -cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 235789999999999999 99998 59999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=393.46 Aligned_cols=262 Identities=29% Similarity=0.420 Sum_probs=209.9
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
...++|.+.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 44678999999999999999999999999999999997654332 23456789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC-ceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG-CHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g-~~~~~vKL~DFGla~~~~~ 531 (639)
||||++ |+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .....+||+|||++.....
T Consensus 111 v~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 999997 59999999888999999999999999999999999999999999999996544 2233799999999976542
Q ss_pred ---CCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCc-----
Q psy6820 532 ---PMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW----- 602 (639)
Q Consensus 532 ---~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~----- 602 (639)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ..+....+.......+...|
T Consensus 190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--EIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC--HHHHHHHHHHHhCCCchhhhhhhhh
Confidence 23456789999999999874 58999999999999999999999996543 33333333322111111111
Q ss_pred ---------------------ccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 603 ---------------------DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 603 ---------------------~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+++++.+||.+||+.||++|||++|+++||||++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 116899999999999999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=381.07 Aligned_cols=254 Identities=34% Similarity=0.670 Sum_probs=226.4
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..++|.+.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 457899999999999999999999999999999999754332 224668899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
||||+++++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG----ELKIADFGWSVHAPSL 167 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC----CEEECCCTTCEECSSS
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC----CEEEecccccccCccc
Confidence 999999999999998888899999999999999999999999999999999999999887 799999999976543
Q ss_pred CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....+||+.|+|||++.+..++.++||||||+++|+|++|..||... ........+......+| ..++.++.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~ 241 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP--SHTETHRRIVNVDLKFP----PFLSDGSKD 241 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTCCCCC----TTSCHHHHH
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC--CHhHHHHHHhccccCCC----CcCCHHHHH
Confidence 234567999999999999999999999999999999999999999643 45566667776665554 468999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
||.+||+.||++|||++++++||||+.
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 999999999999999999999999964
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=396.33 Aligned_cols=258 Identities=41% Similarity=0.777 Sum_probs=229.0
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-------hhHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-------GKKQMIENEVNILRSV-NHPNIIKLLDEYDT 446 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-------~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 446 (639)
..++|.+.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 346799999999999999999999999999999998754321 1134577899999999 79999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 447 NNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
.+..|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~----~ikl~DfG~~ 247 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM----QIRLSDFGFS 247 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----CEEECCCTTC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----CEEEEecCcc
Confidence 999999999999999999998888899999999999999999999999999999999999999887 8999999999
Q ss_pred ccccC--CCccccCCCcccCcccccc------CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy6820 527 QRVLR--PMFTVCGTPTYVAPEILNE------SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598 (639)
Q Consensus 527 ~~~~~--~~~~~~GT~~Y~APE~l~~------~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p 598 (639)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.. .........+..+...++
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~--~~~~~~~~~i~~~~~~~~ 325 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH--RRQILMLRMIMEGQYQFS 325 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCC
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC--CCHHHHHHHHHhCCCCCC
Confidence 76653 2345789999999999863 3588999999999999999999999954 345667777878777777
Q ss_pred CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 599 SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 599 ~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+.|..++.++.+||.+||+.||++|||++|+++||||++
T Consensus 326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 6667789999999999999999999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=384.98 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=213.0
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.++|++++.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 578999999999999999999999999999999987654332 2456779999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
||+++++|.+++.....+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS----VIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC----CEEEeeCCCchhccCccc
Confidence 9999999999998888899999999999999999999999999999999999999887 8999999999765432
Q ss_pred -CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC-----------------
Q psy6820 533 -MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG----------------- 593 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~----------------- 593 (639)
....+||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... .+....+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD--VDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhcccccccccccccccc
Confidence 345679999999999976 6789999999999999999999999965432 2222222110
Q ss_pred --CCCCCCC--------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 --QYGFPSP--------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 --~~~~p~~--------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
....+.+ .++.+++++.+||.+||+.||++|||++|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 0111111 12467899999999999999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=393.25 Aligned_cols=256 Identities=30% Similarity=0.453 Sum_probs=208.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
+++|.+++.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 36899999999999999999999999999999999765433222344579999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 456 LIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|++ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~----~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG----ELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC----CEEECSSSEEECC-----
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC----CEEEccCcccccccCCcc
Confidence 996 5999988764 4599999999999999999999999999999999999999887 8999999999765432
Q ss_pred -CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCc--------
Q psy6820 533 -MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW-------- 602 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~-------- 602 (639)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ...+....+.......+...|
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS--TVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 334578999999999876 67899999999999999999999999654 334444444332111111111
Q ss_pred ------------------ccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 603 ------------------DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 603 ------------------~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+++++.+||.+||+.||++|||++|+++||||.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 246889999999999999999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=410.71 Aligned_cols=260 Identities=30% Similarity=0.423 Sum_probs=199.1
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeee-----cC
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYD-----TN 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-----~~ 447 (639)
.+.++|++++.||+|+||.||+|.++.+++.||||++...... ...+.+.+|+.+|+.++||||+++++++. ..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 3457899999999999999999999999999999999654322 23466889999999999999999999984 33
Q ss_pred CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
..+|+||||+ +++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~----~~kl~DFGla~ 204 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC----SVKVCDFGLAR 204 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC----CEEECCCTTCB
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC----CEeecccccch
Confidence 5799999998 579999999888899999999999999999999999999999999999999987 89999999997
Q ss_pred cccC------------------------------CCccccCCCcccCcccc-ccCCCChhhhHHHHHHHHHHHHc-----
Q psy6820 528 RVLR------------------------------PMFTVCGTPTYVAPEIL-NESGYGVKIDVWAAGVILYILLC----- 571 (639)
Q Consensus 528 ~~~~------------------------------~~~~~~GT~~Y~APE~l-~~~~~s~~sDVwSLGvvL~eLlt----- 571 (639)
.... .....+||++|+|||++ .+..|+.++|||||||+||||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 6531 12346789999999986 56679999999999999999999
Q ss_pred ------CCCCCCCCCCC------------------hHHHHHHHHc-----------------------CCC----CCCCC
Q psy6820 572 ------GFPPFVSDTND------------------QDELFDDILS-----------------------GQY----GFPSP 600 (639)
Q Consensus 572 ------G~~Pf~~~~~~------------------~~~l~~~i~~-----------------------~~~----~~p~~ 600 (639)
|.++|.+.+.. .......+.. ... .....
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 67777553310 0011111110 000 00011
Q ss_pred CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 601 ~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.++.+++++.+||++||+.||++|||++|+|+||||++
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 23457999999999999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=426.85 Aligned_cols=254 Identities=31% Similarity=0.579 Sum_probs=229.3
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 451 (639)
..++|++++.||+|+||.||+|.++.+++.||||++.+.... ...+.+..|..++..+ +||+|+.+++++++.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999999999999999999764322 2235567899999887 5999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc-
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL- 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~- 530 (639)
|||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+...
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g----~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS----CEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC----cEEEeecceeecccc
Confidence 9999999999999999888999999999999999999999999999999999999999988 89999999998643
Q ss_pred --CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 531 --RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 531 --~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
....+.+||+.|+|||++.+..|+.++|||||||+||||++|..||.. .+..++++.|......+| ..++++
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~ 568 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG--EDEDELFQSIMEHNVAYP----KSMSKE 568 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHSSCCCCC----TTSCHH
T ss_pred CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC--CCHHHHHHHHHhCCCCCC----ccCCHH
Confidence 234567899999999999999999999999999999999999999965 466788899998887766 468999
Q ss_pred HHHHHHHhcccCCCCCCCH-----HHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSA-----EDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta-----~eiL~HP~f~~ 638 (639)
+.+||++||+.||++||++ +||++||||+.
T Consensus 569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 9999999999999999997 99999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=418.69 Aligned_cols=257 Identities=30% Similarity=0.482 Sum_probs=227.3
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
...++|.+.+.||+|+||.||+|.++.+++.||+|++.+.... .....+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 3457899999999999999999999999999999999765432 23456789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 452 LVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g----~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG----HIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS----CEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC----CeEEEecccceec
Confidence 9999999999999997654 499999999999999999999999999999999999999888 8999999999876
Q ss_pred cCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--ChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 530 LRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN--DQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 530 ~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~--~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||..... ....+...+......++ ..+
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~ 412 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERF 412 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTS
T ss_pred ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccC
Confidence 432 3457899999999999999999999999999999999999999976533 34566666766554444 578
Q ss_pred cHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 606 SEEAKELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
++++++||.+||+.||++|| +++|+++||||++
T Consensus 413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 99999999999999999999 8999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=400.93 Aligned_cols=257 Identities=31% Similarity=0.529 Sum_probs=204.9
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhcC-CCceeeeeeeeecCC--
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNN-- 448 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~-- 448 (639)
..+.++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 4456899999999999999999999999999999999865432 223456778999999998 999999999997544
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
.+|+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+|+.
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~----~~kl~DFG~a~~ 158 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC----HVKVADFGLSRS 158 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEECCCTTCEE
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC----CEEecCCccccc
Confidence 7899999996 599999876 4799999999999999999999999999999999999999887 899999999975
Q ss_pred ccC------------------------CCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh
Q psy6820 529 VLR------------------------PMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ 583 (639)
Q Consensus 529 ~~~------------------------~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~ 583 (639)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+. +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~--~~ 236 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS--ST 236 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC--CH
Confidence 421 1234689999999999976 67999999999999999999999999654 33
Q ss_pred HHHHHHHHcCCCCCCC-------------------------------C-------------CcccccHHHHHHHHHhccc
Q psy6820 584 DELFDDILSGQYGFPS-------------------------------P-------------YWDDISEEAKELISHMLES 619 (639)
Q Consensus 584 ~~l~~~i~~~~~~~p~-------------------------------~-------------~~~~l~~~l~dLI~~~L~~ 619 (639)
...+..+... ...|. . .+..+++++.+||.+||+.
T Consensus 237 ~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 MNQLERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 3333443321 11111 0 0126789999999999999
Q ss_pred CCCCCCCHHHHHcCCcccC
Q psy6820 620 NPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 620 dP~~Rpta~eiL~HP~f~~ 638 (639)
||++|||++|+|+||||+.
T Consensus 316 dP~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 316 NPNKRISANDALKHPFVSI 334 (388)
T ss_dssp SGGGSCCHHHHTTSTTTTT
T ss_pred CcccCCCHHHHhCCHHHHH
Confidence 9999999999999999863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=389.10 Aligned_cols=262 Identities=31% Similarity=0.553 Sum_probs=226.1
Q ss_pred ccCCCeeEE-EEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCce
Q psy6820 374 KLLQRYSVG-QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 374 ~~~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 450 (639)
.+.++|.+. +.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 344678887 8999999999999999999999999999765432 23467889999999996 79999999999999999
Q ss_pred EEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 451 YLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++... ....+||+|||++..
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~-~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY-PLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT-TBCCEEECCGGGCEE
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC-CCCcEEEeeCccccc
Confidence 9999999999999998553 6799999999999999999999999999999999999998721 012799999999987
Q ss_pred ccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 529 VLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 529 ~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
.... ....+||+.|+|||++.+..++.++||||||+++|+|++|..||... +..+....+.......+.+.+..++
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE--DNQETYLNISQVNVDYSEETFSSVS 261 (327)
T ss_dssp C---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred cCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CchHHHHHHHhcccccCchhhcccC
Confidence 6533 34568999999999999999999999999999999999999999653 4566667777777777777778899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+.+||.+||+.||++|||++|+++||||++
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence 99999999999999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=379.84 Aligned_cols=255 Identities=31% Similarity=0.596 Sum_probs=226.8
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
...++|.+.+.||+|+||.||+|.+..+++.+|+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 4457899999999999999999999999999999999765432 23466889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+||||+++++|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL----EVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC----CEEEEeccCceeccc
Confidence 9999999999999998888899999999999999999999999999999999999999887 799999999976542
Q ss_pred ---CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 532 ---PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 532 ---~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
......||+.|+|||++.+..++.++||||||+++|+|++|..||... ...+....+......++ ..++++
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~----~~~~~~ 241 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYSIP----KHINPV 241 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTCCCCC----TTSCHH
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhhccCCCc----cccCHH
Confidence 234467999999999999989999999999999999999999999643 44556666666655544 468899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+||.+||+.||++|||++|+++||||.+
T Consensus 242 ~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 242 AASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 999999999999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=383.34 Aligned_cols=252 Identities=29% Similarity=0.572 Sum_probs=220.0
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeec
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELI 457 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 457 (639)
.|+..+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 47888999999999999999999999999999975543 33566789999999999999999999999999999999999
Q ss_pred cCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---Cc
Q psy6820 458 KGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MF 534 (639)
Q Consensus 458 ~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~~ 534 (639)
++++|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ..
T Consensus 125 ~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 125 QGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----CEEECCCTTCEECCSSSCCBC
T ss_pred CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----cEEEeeeeeeeecccCccccc
Confidence 99999999865 4799999999999999999999999999999999999999887 7999999999766432 34
Q ss_pred cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHH
Q psy6820 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~ 614 (639)
...||+.|+|||++.+..++.++||||||+++|+|++|..||... ........+...... .......+++++.+||.
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD--SPVQAMKRLRDSPPP-KLKNSHKVSPVLRDFLE 276 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSSCC-CCTTGGGSCHHHHHHHH
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCCC-CcCccccCCHHHHHHHH
Confidence 568999999999999999999999999999999999999999654 344455555544321 12234568999999999
Q ss_pred HhcccCCCCCCCHHHHHcCCcccC
Q psy6820 615 HMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 615 ~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||+.||++|||++|+++||||.+
T Consensus 277 ~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 277 RMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred HHccCChhhCcCHHHHhcChhhcc
Confidence 999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=397.03 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=212.4
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCC----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNN---- 448 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 448 (639)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 4567899999999999999999999999999999998654322 23456789999999999999999999987653
Q ss_pred --ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 449 --ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 449 --~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a 175 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC----ELKILDFGLA 175 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEECCCTTC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC----CEEEEeeecc
Confidence 469999999 8899999876 5799999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC----------
Q psy6820 527 QRVLRPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY---------- 595 (639)
Q Consensus 527 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~---------- 595 (639)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+ ..+....+.....
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 176 RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--HLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp EECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCCHHHHHHh
Confidence 887766777889999999999887 679999999999999999999999996543 3333333322111
Q ss_pred -------------CCCC----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 596 -------------GFPS----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 596 -------------~~p~----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+. ..+..+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 1111 123467899999999999999999999999999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=379.59 Aligned_cols=254 Identities=35% Similarity=0.681 Sum_probs=197.6
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..++|.+.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 357899999999999999999999999999999999754322 123668899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~----~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM----NIKIADFGLATQLKM 164 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC----CEEECCCTTCEECC-
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC----CEEEEeecceeeccC
Confidence 99999999999999765 6799999999999999999999999999999999999999887 799999999976542
Q ss_pred ---CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 532 ---PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 532 ---~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+....... ...++.+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~----~~~~~~~ 238 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV--KNTLNKVVLADYEM----PSFLSIE 238 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC--C-----CCSSCCCC----CTTSCHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH--HHHHHHHhhcccCC----ccccCHH
Confidence 23456799999999999998999999999999999999999999965432 22223333333322 2468999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+||.+||+.||++|||++++++||||++
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 999999999999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=384.44 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=209.2
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 452 (639)
..++|++.+.||+|+||+||+|.+..+++.||||++....... .......|+..+.++ +||||++++++|.+.+.+|+
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999999999999999986543322 223344555555555 89999999999999999999
Q ss_pred EEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~----~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG----RCKLGDFGLLVELGT 209 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG----CEEECCCTTCEECC-
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC----CEEEccceeeeeccc
Confidence 99999 6799988865 44699999999999999999999999999999999999999887 899999999976643
Q ss_pred C--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 P--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 ~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
. .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.. ......+..+. .+...+..+++++
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~-----~~~~~~~~~~~--~~~~~~~~~~~~l 281 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG-----GEGWQQLRQGY--LPPEFTAGLSSEL 281 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS-----HHHHHHHTTTC--CCHHHHTTSCHHH
T ss_pred CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC-----ccHHHHHhccC--CCcccccCCCHHH
Confidence 2 335679999999999886 699999999999999999999776632 22333443332 2333446789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLERS 639 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~~ 639 (639)
.+||.+||+.||++|||++|+++||||+++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~p 311 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLALPVLRQP 311 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTSGGGSCC
T ss_pred HHHHHHHcCCChhhCcCHHHHHhCccccCC
Confidence 999999999999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=393.96 Aligned_cols=259 Identities=26% Similarity=0.418 Sum_probs=220.9
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 34578999999999999999999999999999999998765555567788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN-YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~-givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
|||+++++|.+++.+...+++..+..++.+++.||+|||+. ||+||||||+|||++.++ .+||+|||++.....
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG----EIKLCDFGVSGQLIDS 185 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC----CEEECCCCCCHHHHHH
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC----CEEEEECCCCcccccc
Confidence 99999999999999888999999999999999999999996 999999999999999887 799999999975532
Q ss_pred CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh----------------------------
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ---------------------------- 583 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~---------------------------- 583 (639)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 3345689999999999999999999999999999999999999996543211
Q ss_pred ------------HHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 584 ------------DELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 584 ------------~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+....+..... +......++.++.+||.+||+.||++|||++|+++||||++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp --------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 111222222221 11112457899999999999999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=408.70 Aligned_cols=256 Identities=28% Similarity=0.485 Sum_probs=206.3
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTN----- 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 447 (639)
.+.++|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+|+.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4568999999999999999999999999999999999765322 2345678999999999999999999998654
Q ss_pred -CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 448 -NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 448 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
..+|+||||+++ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~----~~kl~DFG~a 211 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLA 211 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----CEEECCCCCC
T ss_pred CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC----CEEEEEEEee
Confidence 357999999965 67777754 499999999999999999999999999999999999999987 8999999999
Q ss_pred ccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC----------
Q psy6820 527 QRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ---------- 594 (639)
Q Consensus 527 ~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~---------- 594 (639)
...... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+ ..+.+..+....
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~--~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCSCCHHHHTT
T ss_pred eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCCHHHHHH
Confidence 876543 345789999999999999999999999999999999999999996543 333333332211
Q ss_pred ------------CCCCCCCc-----c-----------cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 595 ------------YGFPSPYW-----D-----------DISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 595 ------------~~~p~~~~-----~-----------~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.......+ . ..++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00000000 0 11678999999999999999999999999999973
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=388.60 Aligned_cols=255 Identities=31% Similarity=0.596 Sum_probs=227.2
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
...++|.+.+.||+|+||.||+|.+..+++.+|+|++...... ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 4457899999999999999999999999999999999765432 23466889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~----~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL----EVKIGDFGLATKVEY 193 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC----CEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC----CEEEeeccCceeccc
Confidence 9999999999999998888899999999999999999999999999999999999999887 799999999976542
Q ss_pred ---CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 532 ---PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 532 ---~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
......||+.|+|||++.+..++.++||||||+++|+|++|..||... ...+....+......++ ..++++
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~----~~~~~~ 267 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYSIP----KHINPV 267 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCCC----TTSCHH
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC--CHHHHHHHHhcCCCCCC----ccCCHH
Confidence 234567999999999999999999999999999999999999999643 44556666666665554 467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+||.+||+.||++|||++|+++||||..
T Consensus 268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 268 AASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 999999999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=388.64 Aligned_cols=263 Identities=38% Similarity=0.743 Sum_probs=221.6
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-------hhHHHHHHHHHHHHhcCCCceeeeeeeee
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-------GKKQMIENEVNILRSVNHPNIIKLLDEYD 445 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 445 (639)
..+.++|.+.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 34557899999999999999999999999999999999765431 11234779999999999999999999987
Q ss_pred cCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 446 TNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 446 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
..+ .|+||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++. ...+||+|||+
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~-~~~~kl~Dfg~ 163 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE-DCLIKITDFGH 163 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSS-SCCEEECCCTT
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCC-CCeEEEccCcc
Confidence 655 8999999999999999988889999999999999999999999999999999999999987651 12599999999
Q ss_pred cccccCC--CccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy6820 526 AQRVLRP--MFTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600 (639)
Q Consensus 526 a~~~~~~--~~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~ 600 (639)
+...... ....+||+.|+|||++. ...++.++|||||||++|+|++|..||..... ...+...+..+...+...
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC-SSCHHHHHHHTCCCCCHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-HHHHHHHHHhCccccCch
Confidence 9876543 23467999999999974 56789999999999999999999999975433 233455566666555545
Q ss_pred CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 601 ~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+..+++++.+||.+||+.||++|||++++++||||++
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 55678999999999999999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=412.55 Aligned_cols=257 Identities=28% Similarity=0.454 Sum_probs=227.8
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
...++|.+.+.||+|+||.||+|+++.+++.||+|++.+.... ...+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 4457899999999999999999999999999999999765432 22356788999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 452 LVIELIKGGDLFDAISKN----VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g----~vkL~DFGla~ 337 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAV 337 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS----CEEECCCTTCE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC----CEEEeecceee
Confidence 999999999999999653 3699999999999999999999999999999999999999988 89999999998
Q ss_pred cccCC---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--ChHHHHHHHHcCCCCCCCCCc
Q psy6820 528 RVLRP---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN--DQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 528 ~~~~~---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~--~~~~l~~~i~~~~~~~p~~~~ 602 (639)
..... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||..... ....+...+......+|
T Consensus 338 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p---- 413 (543)
T 3c4z_A 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP---- 413 (543)
T ss_dssp ECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----
T ss_pred eccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----
Confidence 76432 2346899999999999999999999999999999999999999976533 45677777877766555
Q ss_pred ccccHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 603 DDISEEAKELISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
..+++++++||++||+.||++||+ ++++++||||+.
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 578999999999999999999995 589999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=398.55 Aligned_cols=260 Identities=29% Similarity=0.469 Sum_probs=210.0
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTN----- 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 447 (639)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|+.++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3457999999999999999999999999999999999754322 2346688999999999999999999998766
Q ss_pred CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
+.+|+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~----~~kL~DFGla~ 177 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC----SVKVCDFGLAR 177 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEECCCTTCE
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC----CEEEccCCCcc
Confidence 57999999985 59999999888899999999999999999999999999999999999999887 89999999997
Q ss_pred cccCC-------------------------CccccCCCcccCcccc-ccCCCChhhhHHHHHHHHHHHHcCCC-------
Q psy6820 528 RVLRP-------------------------MFTVCGTPTYVAPEIL-NESGYGVKIDVWAAGVILYILLCGFP------- 574 (639)
Q Consensus 528 ~~~~~-------------------------~~~~~GT~~Y~APE~l-~~~~~s~~sDVwSLGvvL~eLltG~~------- 574 (639)
..... ....+||++|+|||++ .+..|+.++|||||||++|||++|..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 65421 2567899999999986 56679999999999999999998544
Q ss_pred ----CCCCCCC---------------------------------------ChHHHHHHHHcCCCCCCCC---CcccccHH
Q psy6820 575 ----PFVSDTN---------------------------------------DQDELFDDILSGQYGFPSP---YWDDISEE 608 (639)
Q Consensus 575 ----Pf~~~~~---------------------------------------~~~~l~~~i~~~~~~~p~~---~~~~l~~~ 608 (639)
+|.+.+. ........+.......+.+ .++.++++
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 4433221 0001111111111111111 12468999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+||++||+.||++|||++|+|+||||++
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 999999999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=374.00 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=215.5
Q ss_pred CcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCc
Q psy6820 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 372 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 449 (639)
.....++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+..+..+ +||||+++++++.+.+.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 344557899999999999999999999999999999999865332 2345677899999999 89999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCc------------
Q psy6820 450 LYLVIELIKGGDLFDAISKN----VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC------------ 513 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~------------ 513 (639)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999999764 67999999999999999999999999999999999999985531
Q ss_pred ---eeeeEEEeeccccccccCCCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHH
Q psy6820 514 ---HVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDD 589 (639)
Q Consensus 514 ---~~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~ 589 (639)
....+||+|||++...... ....||+.|+|||++.+. .++.++||||||+++|+|++|.+|+... .....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~ 239 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----DQWHE 239 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----HHHHH
T ss_pred ccCCceEEEEcccccccccCCc-cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----hHHHH
Confidence 2237999999999876543 345699999999999876 6678999999999999999999877432 23344
Q ss_pred HHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 590 ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 590 i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+..+... .....+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 240 ~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 240 IRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 4444332 223578999999999999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=374.09 Aligned_cols=254 Identities=34% Similarity=0.663 Sum_probs=217.4
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
..++|.+++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 457899999999999999999999999999999999754322 224567899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||+++++|.+++.....+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM----NAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS----CEEECCCCGGGCCCC-
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC----CEEEeecccccccCCC
Confidence 999999999999998888899999999999999999999999999999999999999887 7999999999766433
Q ss_pred --CccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.. .....+.+.+..+...+| ..++.++
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~----~~~~~~l 238 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD--EHVPTLFKKIRGGVFYIP----EYLNRSV 238 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC--CcHHHHHHHhhcCcccCc----hhcCHHH
Confidence 235678999999999988765 6899999999999999999999954 345666777776655444 4678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+||.+||+.||++|||+.|+++||||++
T Consensus 239 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 99999999999999999999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=389.17 Aligned_cols=262 Identities=26% Similarity=0.441 Sum_probs=219.7
Q ss_pred CCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q psy6820 370 NIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTN 447 (639)
Q Consensus 370 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 447 (639)
..+..+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 345667789999999999999999999999999999999997654332 235678999999999999999999998765
Q ss_pred Cc----eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 448 NE----LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 448 ~~----~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
.. .|+||||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Df 160 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN----AVKVMDF 160 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS----CEEECCC
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC----CEEEeec
Confidence 54 499999999999999998888999999999999999999999999999999999999999887 7999999
Q ss_pred cccccccCC------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC
Q psy6820 524 GLAQRVLRP------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597 (639)
Q Consensus 524 Gla~~~~~~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~ 597 (639)
|++...... ....+||+.|+|||++.+..++.++||||||+++|+|++|..||... ........+.......
T Consensus 161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVSVAYQHVREDPIP 238 (311)
T ss_dssp SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHCCCCC
T ss_pred cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHhcCCCCC
Confidence 999765422 23457999999999999999999999999999999999999999654 3444444555554444
Q ss_pred CCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 598 PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 598 p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
+...+..+++++.+||.+||+.||++||++.+++.|+|++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 4334456899999999999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=378.94 Aligned_cols=255 Identities=24% Similarity=0.423 Sum_probs=214.1
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeec--CCce
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDT--NNEL 450 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--~~~~ 450 (639)
...++|++++.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.++++++ ||||+++++++.+ ....
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 34578999999999999999999999999999999997533 466889999999997 9999999999987 6678
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
++||||+++++|.+++.. +++..+..++.||+.||+|||++||+||||||+|||++.++ ..+||+|||++....
T Consensus 109 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~---~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH---RKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT---TEEEECCCTTCEECC
T ss_pred EEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC---CEEEEEeCCCceEcC
Confidence 999999999999998853 89999999999999999999999999999999999998665 279999999997654
Q ss_pred C--CCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHH------------HHHcCCC
Q psy6820 531 R--PMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFD------------DILSGQY 595 (639)
Q Consensus 531 ~--~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~------------~i~~~~~ 595 (639)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......+.+.. .+.....
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 2 3345679999999999977 67899999999999999999999999655443322221 1111111
Q ss_pred CCC--------------------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 596 GFP--------------------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 596 ~~p--------------------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+ ......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 111 1122337999999999999999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=373.92 Aligned_cols=255 Identities=26% Similarity=0.477 Sum_probs=218.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec----CCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDT----NNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~ 450 (639)
.+.|.+.+.||+|+||.||+|.+..++..||+|++...... ...+.+.+|+.++++++||||+++++++.. ...+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 35689999999999999999999999999999999765543 334668899999999999999999998864 4568
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEc-cCCceeeeEEEeeccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY--IVHRDIKPENLLVE-MSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~g--ivHrDLKp~NILld-~~g~~~~~vKL~DFGla~ 527 (639)
|+||||+++++|.+++.....+++..+..++.+|+.||+|||++| |+||||||+|||++ .++ .+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~----~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG----SVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS----CEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC----CEEEeeCCCcc
Confidence 999999999999999998888999999999999999999999999 99999999999997 555 79999999997
Q ss_pred cccCC-CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 528 RVLRP-MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 528 ~~~~~-~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ........+..+.. +.......+
T Consensus 181 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~--~~~~~~~~~ 256 (290)
T 1t4h_A 181 LKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVK--PASFDKVAI 256 (290)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred cccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC-cHHHHHHHHhccCC--ccccCCCCC
Confidence 65433 345679999999998875 58999999999999999999999996543 44555555554422 223345678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+++.+||.+||+.||++|||++|+++||||++
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 99999999999999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=397.95 Aligned_cols=259 Identities=30% Similarity=0.496 Sum_probs=216.0
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc------CCCceeeeeeeeec
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV------NHPNIIKLLDEYDT 446 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l------~HpnIv~l~~~~~~ 446 (639)
..+..+|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ .|+||+++++++..
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 345678999999999999999999999999999999997542 2235567888888887 56799999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 447 NNELYLVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
.+.+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~--~~vkL~DFG 247 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR--SGIKVIDFG 247 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS--CCEEECCCT
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC--cceEEeecc
Confidence 999999999995 69999997653 4999999999999999999999999999999999999998871 139999999
Q ss_pred ccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC------
Q psy6820 525 LAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP------ 598 (639)
Q Consensus 525 la~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p------ 598 (639)
++........+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+ ..+....+.......+
T Consensus 248 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~--~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 248 SSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED--EGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp TCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHT
T ss_pred cceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCCHHHHHh
Confidence 99887777778899999999999999999999999999999999999999996543 3333333322100000
Q ss_pred --------------------------------------------CCC-----cccccHHHHHHHHHhcccCCCCCCCHHH
Q psy6820 599 --------------------------------------------SPY-----WDDISEEAKELISHMLESNPDLRFSAED 629 (639)
Q Consensus 599 --------------------------------------------~~~-----~~~l~~~l~dLI~~~L~~dP~~Rpta~e 629 (639)
... ....++++.+||++||+.||++|||++|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 000 0123788999999999999999999999
Q ss_pred HHcCCcccC
Q psy6820 630 VLDHPWLER 638 (639)
Q Consensus 630 iL~HP~f~~ 638 (639)
+|+||||++
T Consensus 406 ~L~Hpw~~~ 414 (429)
T 3kvw_A 406 ALRHPWLRR 414 (429)
T ss_dssp HHTSTTTC-
T ss_pred HhCChhhcc
Confidence 999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=391.44 Aligned_cols=249 Identities=34% Similarity=0.557 Sum_probs=216.9
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-------hHHHHHHHHHHHHhcCCCceeeeeeeeec
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-------KKQMIENEVNILRSVNHPNIIKLLDEYDT 446 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-------~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 446 (639)
...++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 44578999999999999999999999999999999998664321 22346689999999999999999999999
Q ss_pred CCceEEEEeeccCC-ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 447 NNELYLVIELIKGG-DLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 447 ~~~~~lV~E~~~gg-sL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
.+.+++||||+.+| +|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~ 176 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF----TIKLIDFGS 176 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS----CEEECCCTT
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC----cEEEeeccc
Confidence 99999999999766 9999999888999999999999999999999999999999999999999887 899999999
Q ss_pred cccccCC--CccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCc
Q psy6820 526 AQRVLRP--MFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 526 a~~~~~~--~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
+...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ........ .
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~----~ 244 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHP----P 244 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCC----S
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCC----C
Confidence 9866533 345789999999999988876 8999999999999999999999954211 11122222 2
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+++++.+||.+||+.||++|||++++++||||++
T Consensus 245 ~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 458999999999999999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=387.91 Aligned_cols=257 Identities=28% Similarity=0.436 Sum_probs=214.4
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeec-------
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDT------- 446 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------- 446 (639)
..++|++++.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 3578999999999999999999999999999999986554322 23567789999999999999999999876
Q ss_pred -CCceEEEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 447 -NNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 447 -~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
.+.+|+||||+++ +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~----~~kl~Dfg 169 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG----VLKLADFG 169 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC----CEEEccch
Confidence 4468999999975 77777754 46799999999999999999999999999999999999999887 89999999
Q ss_pred cccccc-------CCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 525 LAQRVL-------RPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 525 la~~~~-------~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
++.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ........+......
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN--TEQHQLALISQLCGS 247 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCC
Confidence 997653 12345678999999999876 56899999999999999999999999654 344444444443333
Q ss_pred CCCCCcccc----------------------------cHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 597 FPSPYWDDI----------------------------SEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 597 ~p~~~~~~l----------------------------~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++...|+.. ++++.+||.+||+.||++|||++|+++||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 343333332 678999999999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=378.23 Aligned_cols=262 Identities=39% Similarity=0.735 Sum_probs=230.6
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
....++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 34557899999999999999999999999999999999765432 33567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+||||+++++|.+.+.....+++..+..++.||+.||+|||++|++||||||+||+++.++. ...+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~-~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK-DCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST-TCCEEECSTTGGGTBCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCC-cccEEEeccCcceeecC
Confidence 99999999999999988888999999999999999999999999999999999999976541 12699999999976543
Q ss_pred C--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 P--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 ~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
. .....||+.|+|||++.+. ++.++||||||+++|+|++|..||... ....+...+..+...++.+.+..+++++
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred CCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence 2 2345689999999998764 899999999999999999999999653 4566777788887777766677899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+||.+||+.||++|||+.|+++||||++
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 99999999999999999999999999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=384.53 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=210.6
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCC--CceeeeeeeeecCCceE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNH--PNIIKLLDEYDTNNELY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~ 451 (639)
..++|++.+.||+|+||.||+|.+. +++.||+|++....... ..+.+.+|+.+|++++| |||+++++++.+.+.+|
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 3567999999999999999999874 57889999997654432 23668899999999986 99999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+|||+ .+++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++. + .+||+|||++.....
T Consensus 86 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~----~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G----MLKLIDFGIANQMQP 159 (343)
T ss_dssp EEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T----EEEECCCSSSCCC--
T ss_pred EEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C----cEEEeecccccccCc
Confidence 99995 58899999999889999999999999999999999999999999999999974 4 699999999976643
Q ss_pred C-----CccccCCCcccCcccccc-----------CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC
Q psy6820 532 P-----MFTVCGTPTYVAPEILNE-----------SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY 595 (639)
Q Consensus 532 ~-----~~~~~GT~~Y~APE~l~~-----------~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~ 595 (639)
. ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||..... .......+.....
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIIDPNH 238 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-HHHHHHHHHCTTS
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-HHHHHHHHhcCCc
Confidence 2 235679999999999865 6789999999999999999999999975443 3333344443322
Q ss_pred CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 596 GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 596 ~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.. ......+.++.+||.+||+.||++|||+.|+++||||+.
T Consensus 239 ~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 239 EI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred cc--CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 22 223456889999999999999999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=374.48 Aligned_cols=255 Identities=23% Similarity=0.351 Sum_probs=204.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH-HHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~-~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.++|++.+.||+|+||.||+|.+..+++.||+|++......... +.+.++...++.++||||+++++++.+.+..|+||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 47899999999999999999999999999999999765443333 33445555678889999999999999999999999
Q ss_pred eeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 455 ELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDN-YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 455 E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~-givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
||++ |+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG----QVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC----CEEBCCC------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC----CEEEeecCCcccc
Confidence 9996 488777643 56799999999999999999999998 999999999999999887 8999999999766
Q ss_pred cCC--CccccCCCcccCcccc----ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc
Q psy6820 530 LRP--MFTVCGTPTYVAPEIL----NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 530 ~~~--~~~~~GT~~Y~APE~l----~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||.........+...+.......+ ..
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~ 237 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP---AD 237 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC---TT
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc---cc
Confidence 433 2345799999999996 56678999999999999999999999997655544555444444433333 25
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+++++.+||.+||+.||++|||++|+++||||+.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 68999999999999999999999999999999963
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=380.92 Aligned_cols=260 Identities=22% Similarity=0.406 Sum_probs=216.1
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC--ceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN--ELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~l 452 (639)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.++++++||||+++++++...+ ..|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 34689999999999999999999999999999999987665555677889999999999999999999987665 7899
Q ss_pred EEeeccCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 453 VIELIKGGDLFDAISKNVK---FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
||||+++++|.+++..... +++..+..++.||+.||+|||++||+||||||+|||+..+......+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999999999999976443 9999999999999999999999999999999999998222111237999999999876
Q ss_pred cCC--CccccCCCcccCccccc--------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--ChHHHHHHHHcCCC--
Q psy6820 530 LRP--MFTVCGTPTYVAPEILN--------ESGYGVKIDVWAAGVILYILLCGFPPFVSDTN--DQDELFDDILSGQY-- 595 (639)
Q Consensus 530 ~~~--~~~~~GT~~Y~APE~l~--------~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~--~~~~l~~~i~~~~~-- 595 (639)
... ....+||+.|+|||++. +..++.++|||||||++|||++|..||..... ...++...+..+..
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (319)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred CCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence 433 34567999999999986 57789999999999999999999999964332 22444455554432
Q ss_pred -------------------CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q psy6820 596 -------------------GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHP 634 (639)
Q Consensus 596 -------------------~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP 634 (639)
..+......++..+.+||++||+.||++|||++|+++||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 111122345678999999999999999999999999997
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=396.97 Aligned_cols=257 Identities=19% Similarity=0.237 Sum_probs=198.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhc--CCCceeeee-------eeee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSV--NHPNIIKLL-------DEYD 445 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l--~HpnIv~l~-------~~~~ 445 (639)
.+|.+.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999876542 2345677885555555 699988755 3333
Q ss_pred cC-----------------CceEEEEeeccCCChHHHHhhc-CCCCHHHH------HHHHHHHHHHHHHHHHCCceeccC
Q psy6820 446 TN-----------------NELYLVIELIKGGDLFDAISKN-VKFSEEDS------KFMTQSLASALSYLHDNYIVHRDI 501 (639)
Q Consensus 446 ~~-----------------~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~------~~i~~qI~~aL~yLH~~givHrDL 501 (639)
.. ..+|+||||++ |+|.+++... ..+++... ..++.||+.||+|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 22 34899999998 8999999763 34555555 677899999999999999999999
Q ss_pred CCCceEEccCCceeeeEEEeeccccccccCCCccccCCCcccCcccccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q psy6820 502 KPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFVSD 579 (639)
Q Consensus 502 Kp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~--~~~s~~sDVwSLGvvL~eLltG~~Pf~~~ 579 (639)
||+|||++.++ .+||+|||++...........||+.|+|||++.+ ..++.++|||||||++|||+||..||...
T Consensus 221 kp~NIll~~~~----~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDG----RLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTS----CEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCC----CEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999887 8999999999877655545677899999999987 67999999999999999999999999765
Q ss_pred CCChHHHHHH---HHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 580 TNDQDELFDD---ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 580 ~~~~~~l~~~---i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.......+.. .......+..+.+..+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 4322111111 1111223333444688999999999999999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=384.58 Aligned_cols=258 Identities=31% Similarity=0.480 Sum_probs=209.0
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh----HHHHHHHHHHHHhcCCCceeeeeeeeecCCc
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK----KQMIENEVNILRSVNHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~----~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 449 (639)
...++|++.+.||+|+||.||+|.+..+++.||+|++........ .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345789999999999999999999999999999999975433221 2356789999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
.++||||+++ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~----~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----CEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC----CEEEEeccccee
Confidence 9999999975 898888654 4699999999999999999999999999999999999999887 899999999987
Q ss_pred ccCC---CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCC---
Q psy6820 529 VLRP---MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY--- 601 (639)
Q Consensus 529 ~~~~---~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~--- 601 (639)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||... ...+....+.......+...
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~--~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD--SDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCTTTSSS
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHHHcCCCChhhhhh
Confidence 6432 345689999999999975 45899999999999999999999999654 33344444443211111111
Q ss_pred ---------------------cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 602 ---------------------WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 602 ---------------------~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+..++.++.+||.+||+.||++|||++|+++||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 1456799999999999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=380.08 Aligned_cols=262 Identities=27% Similarity=0.437 Sum_probs=216.5
Q ss_pred CcccCCCeeEEEEEccCCceEEEEEEE-cCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCC------ceeeeeeee
Q psy6820 372 PSKLLQRYSVGQIIGDGNFAVVRQVYD-KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP------NIIKLLDEY 444 (639)
Q Consensus 372 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hp------nIv~l~~~~ 444 (639)
...+.++|++.+.||+|+||.||+|.+ ..+++.||+|++.... ...+.+.+|+.+++.++|+ +++++++++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 445668999999999999999999998 5678999999997542 2346678899999998765 499999999
Q ss_pred ecCCceEEEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCce--------
Q psy6820 445 DTNNELYLVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH-------- 514 (639)
Q Consensus 445 ~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~-------- 514 (639)
...+.+|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++..+..
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999999 889999997765 68999999999999999999999999999999999999874311
Q ss_pred -------eeeEEEeeccccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHH
Q psy6820 515 -------VKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF 587 (639)
Q Consensus 515 -------~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~ 587 (639)
...+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||...+ ..+..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~ 243 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD--SKEHL 243 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC--HHHHH
T ss_pred cccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--hHHHH
Confidence 126999999999877666677889999999999999999999999999999999999999996543 22222
Q ss_pred HHHHcCCCCCCC----------------------------------------CCcccccHHHHHHHHHhcccCCCCCCCH
Q psy6820 588 DDILSGQYGFPS----------------------------------------PYWDDISEEAKELISHMLESNPDLRFSA 627 (639)
Q Consensus 588 ~~i~~~~~~~p~----------------------------------------~~~~~l~~~l~dLI~~~L~~dP~~Rpta 627 (639)
..+......+|. ......++++.+||.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 222211111110 0012346789999999999999999999
Q ss_pred HHHHcCCcccC
Q psy6820 628 EDVLDHPWLER 638 (639)
Q Consensus 628 ~eiL~HP~f~~ 638 (639)
+|+++||||++
T Consensus 324 ~ell~hp~f~~ 334 (339)
T 1z57_A 324 REALKHPFFDL 334 (339)
T ss_dssp HHHTTSGGGGG
T ss_pred HHHhcCHHHHH
Confidence 99999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=388.87 Aligned_cols=267 Identities=26% Similarity=0.429 Sum_probs=216.6
Q ss_pred cCCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC--------CCceeee
Q psy6820 369 LNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN--------HPNIIKL 440 (639)
Q Consensus 369 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~--------HpnIv~l 440 (639)
+.+...+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++ ||||+++
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 3444556689999999999999999999999999999999997542 23466789999999996 7889999
Q ss_pred eeeee----cCCceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEccCCc
Q psy6820 441 LDEYD----TNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDN-YIVHRDIKPENLLVEMSGC 513 (639)
Q Consensus 441 ~~~~~----~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~-givHrDLKp~NILld~~g~ 513 (639)
++++. ....+|+||||+ +++|.+.+.+. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 99987 567899999999 66777776543 5699999999999999999999998 9999999999999986641
Q ss_pred ---------------------------------------------eeeeEEEeeccccccccCCCccccCCCcccCcccc
Q psy6820 514 ---------------------------------------------HVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEIL 548 (639)
Q Consensus 514 ---------------------------------------------~~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l 548 (639)
....+||+|||++..........+||+.|+|||++
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHH
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhh
Confidence 11269999999998877666777899999999999
Q ss_pred ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh----HHHHHHHHcCCCCCCC-------------------------
Q psy6820 549 NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ----DELFDDILSGQYGFPS------------------------- 599 (639)
Q Consensus 549 ~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~----~~l~~~i~~~~~~~p~------------------------- 599 (639)
.+..++.++|||||||++|||++|..||...+... ......+.......|.
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99999999999999999999999999997644321 1112222110000000
Q ss_pred -------------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 600 -------------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 600 -------------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
......++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 112345678999999999999999999999999999973
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=386.00 Aligned_cols=255 Identities=30% Similarity=0.498 Sum_probs=213.3
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Cce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN-----NEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~ 450 (639)
.++|++++.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999999999999999998655555557788999999999999999999998655 468
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|+||||+. ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 106 ~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~----~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEECCCTTCEECC
T ss_pred EEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC----CEEEEeCcceEecC
Confidence 99999996 599999865 4699999999999999999999999999999999999999887 79999999997654
Q ss_pred CC------CccccCCCcccCccccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC--------
Q psy6820 531 RP------MFTVCGTPTYVAPEILN-ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY-------- 595 (639)
Q Consensus 531 ~~------~~~~~GT~~Y~APE~l~-~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~-------- 595 (639)
.. ....+||+.|+|||++. +..++.++|||||||++|+|++|..||..... .+....+.....
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG--GGHHHHHHHHHCSCCHHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHH
Confidence 22 23458999999999875 45689999999999999999999999965432 222222221100
Q ss_pred ------------CCCC-------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 596 ------------GFPS-------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 596 ------------~~p~-------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+. .....+++++.+||.+||+.||++|||++|+++||||++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 0000 012457899999999999999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=387.18 Aligned_cols=256 Identities=29% Similarity=0.579 Sum_probs=219.3
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEc---CCCeEEEEEEEcccccc---hhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLL---GKKQMIENEVNILRSV-NHPNIIKLLDEYDTN 447 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiKv~~~~~~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 447 (639)
..++|++.+.||+|+||.||+|++. .+++.||+|++...... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 3478999999999999999999884 57899999999764421 2234566899999999 699999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
+.+|+||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~a~ 207 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSK 207 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----CEEESCSSEEE
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----cEEEeeCCCCe
Confidence 99999999999999999998888999999999999999999999999999999999999999887 89999999997
Q ss_pred cccC----CCccccCCCcccCcccccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCC--CChHHHHHHHHcCCCCCCC
Q psy6820 528 RVLR----PMFTVCGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPFVSDT--NDQDELFDDILSGQYGFPS 599 (639)
Q Consensus 528 ~~~~----~~~~~~GT~~Y~APE~l~~--~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~--~~~~~l~~~i~~~~~~~p~ 599 (639)
.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.... .....+...+......++
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 286 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP- 286 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC-
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC-
Confidence 6532 2335689999999999985 457899999999999999999999996533 234555666665544443
Q ss_pred CCcccccHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 600 PYWDDISEEAKELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 600 ~~~~~l~~~l~dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
..++..+.+||.+||+.||++|| +++|+++||||++
T Consensus 287 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 287 ---QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ---cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 57899999999999999999999 9999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=372.82 Aligned_cols=253 Identities=27% Similarity=0.468 Sum_probs=223.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.+.|.+.+.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 46799999999999999999999999999999999877655566788999999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
|+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG----EVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTTCEECBTTBCC
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC----CEEEeecccceecCccccc
Confidence 9999999999865 5799999999999999999999999999999999999999887 7999999999766432
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||... ........+..... ......++.++.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~l~~l 250 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL--HPMKVLFLIPKNNP---PTLEGNYSKPLKEF 250 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCC---CCCCSSCCHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc--CHHHHHHHhhcCCC---CCCccccCHHHHHH
Confidence 34567999999999999999999999999999999999999999643 33444444444332 22335789999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 613 ISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
|.+||+.||++|||+.++++||||.+
T Consensus 251 i~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred HHHHcCCChhhCcCHHHHhhChhhhc
Confidence 99999999999999999999999953
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=384.71 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=215.2
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
-...++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 345689999999999999999999999999999999986554332 2355779999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFARTLAA 176 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----CEEECCCTTC-----
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC----cEEEEeCCCceeecC
Confidence 9999999999999888778899999999999999999999999999999999999999887 899999999976543
Q ss_pred C---CccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC--------------
Q psy6820 532 P---MFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG-------------- 593 (639)
Q Consensus 532 ~---~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~-------------- 593 (639)
. .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ..+....+...
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS--DIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCChhhhhHhhh
Confidence 2 3456799999999999875 78999999999999999999999996543 22222222210
Q ss_pred -----CCCCCC--------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 -----QYGFPS--------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 -----~~~~p~--------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
....+. ..++.+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 011110 012357899999999999999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=376.90 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=213.0
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 34557899999999999999999999999999999998654432 2336688999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|+||||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~----~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK----TLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----CEEECCCSSSTTC-
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEEeCCCccccc
Confidence 99999999999999999888999999999999999999999999999999999999999887 89999999997654
Q ss_pred CC----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC-CCCCCCCCcccc
Q psy6820 531 RP----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG-QYGFPSPYWDDI 605 (639)
Q Consensus 531 ~~----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~-~~~~p~~~~~~l 605 (639)
.. ....+||+.|+|||++.+..++.++||||||+++|+|++|..||.... ........... ....+......+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--AVSIAIKHIQDSVPNVTTDVRKDI 240 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--HHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhhccCCCcchhcccCC
Confidence 32 234679999999999999999999999999999999999999996543 33333333333 222223344678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcCCc
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDHPW 635 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~ 635 (639)
++.+.++|.+||+.||++||+..+.+.+.|
T Consensus 241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 241 PQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp CHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 999999999999999999995545444443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=387.90 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=204.7
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCC----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNN---- 448 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 448 (639)
.+.++|.+++.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3568999999999999999999999999999999999764332 23456789999999999999999999987655
Q ss_pred --ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 449 --ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 449 --~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
..|+||||++ ++|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~----~~kl~Dfg~a 174 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLA 174 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS----CEEECCCCC-
T ss_pred ccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC----CEEEEEeecc
Confidence 7899999996 48888886 3589999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC-----
Q psy6820 527 QRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS----- 599 (639)
Q Consensus 527 ~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~----- 599 (639)
...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +..+.+..+.........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT--DHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHC-CCCCCHHHHTT
T ss_pred cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCCHHHHHH
Confidence 766533 34568999999999999999999999999999999999999999654 334444444432111100
Q ss_pred -----------------CC----------------cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 600 -----------------PY----------------WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 600 -----------------~~----------------~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.. ....+.++++||.+||+.||++|||++|+++||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00 0112678999999999999999999999999999964
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=390.99 Aligned_cols=257 Identities=28% Similarity=0.482 Sum_probs=197.0
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNHPNIIKLLDEYDTN----- 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 447 (639)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 445899999999999999999999999999999999975432 22345677999999999999999999998654
Q ss_pred -CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 448 -NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 448 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
...|+|||++ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~----~~kL~DFG~a 179 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC----ELKILDFGLA 179 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----CEEECC----
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC----CEEEeecccc
Confidence 5689999999 7899998865 5799999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC------------
Q psy6820 527 QRVLRPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG------------ 593 (639)
Q Consensus 527 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~------------ 593 (639)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+ .......+...
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 180 RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCHHHHTTC
T ss_pred ccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHHh
Confidence 887666667889999999999877 679999999999999999999999996543 33333333221
Q ss_pred -----------CCCCCCC----CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 -----------QYGFPSP----YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 -----------~~~~p~~----~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
....+.. .+..+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 0111111 12356899999999999999999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=388.49 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=212.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcC--CCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVN--HPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~~~~lV 453 (639)
++|.+.+.||+|+||.||+|.+.. ++.||||++...... ...+.+.+|+.+|++++ ||||+++++++...+.+|+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 569999999999999999998765 889999999765443 23467889999999997 59999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
||+ .+++|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++. + .+||+|||++......
T Consensus 135 ~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~----~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 135 MEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G----MLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S----CEEECCCSSSCCC----
T ss_pred Eec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C----eEEEEecCccccccCCC
Confidence 994 58899999998889999999999999999999999999999999999999964 4 6999999999866432
Q ss_pred ----CccccCCCcccCcccccc-----------CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC
Q psy6820 533 ----MFTVCGTPTYVAPEILNE-----------SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597 (639)
Q Consensus 533 ----~~~~~GT~~Y~APE~l~~-----------~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~ 597 (639)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.... +.......+......+
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-NQISKLHAIIDPNHEI 287 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHCTTSCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-HHHHHHHHHhCccccC
Confidence 235689999999999865 468999999999999999999999996543 3334445555544333
Q ss_pred CCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 598 PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 598 p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.+ ...+.++.+||.+||+.||++|||+.|+++||||+.
T Consensus 288 ~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 288 EFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp CCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 322 345899999999999999999999999999999963
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=381.17 Aligned_cols=253 Identities=28% Similarity=0.416 Sum_probs=216.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.+.|.+.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 356999999999999999999999999999999997654332 235678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAIS-KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+. |+|.+++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAP- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT----EEEECCCTTCBSSSS-
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC----CEEEeeccCceecCC-
Confidence 99996 58888875 456799999999999999999999999999999999999999887 899999999976543
Q ss_pred CccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 MFTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
....+||+.|+|||++. +..++.++|||||||++|||++|..||.... .......+..... +......+++.+
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~--~~~~~~~~~~~l 282 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNES--PALQSGHWSEYF 282 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCC--CCCCCTTSCHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCC--CCCCCCCCCHHH
Confidence 34568999999999984 5678999999999999999999999996542 3333334444322 222235689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+||.+||+.||++|||++++++||||.+
T Consensus 283 ~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 99999999999999999999999999965
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=369.07 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=214.7
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
...++|++.+.||+|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 345789999999999999999999999999999999875432 2346678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc--
Q psy6820 454 IELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL-- 530 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~-- 530 (639)
|||+++++|.+++.. ...+++..+..++.+|+.||+|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG----DIRLADFGVSAKNLKT 170 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS----CEEECCCHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC----CEEEEECCCCcccccc
Confidence 999999999998865 56799999999999999999999999999999999999999887 79999999986432
Q ss_pred -CCCccccCCCcccCcccc-----ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 531 -RPMFTVCGTPTYVAPEIL-----NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 531 -~~~~~~~GT~~Y~APE~l-----~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
.......||+.|+|||++ .+..++.++||||||+++|+|++|..||... +.......+...... .......
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~ 247 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL--NPMRVLLKIAKSDPP-TLLTPSK 247 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCC-CCSSGGG
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC--CHHHHHHHHhccCCc-ccCCccc
Confidence 223456799999999998 4677899999999999999999999999654 334444444444321 1122357
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++.++.+||.+||+.||++|||++++++||||+.
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 8999999999999999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=385.52 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=211.3
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCce-
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL- 450 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~- 450 (639)
..+.++|.+.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++...+..
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 345689999999999999999999999999999999997654322 245678999999999999999999999877655
Q ss_pred -----EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 451 -----YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 451 -----~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
|+||||+. ++|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~----~~kL~Dfg~ 190 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC----ELKILDFGL 190 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CEEECSTTC
T ss_pred cceeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC----CEEEEecCc
Confidence 99999996 689888743 499999999999999999999999999999999999999887 899999999
Q ss_pred cccccCCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC----------
Q psy6820 526 AQRVLRPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ---------- 594 (639)
Q Consensus 526 a~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~---------- 594 (639)
+..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... +..+....+....
T Consensus 191 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 191 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK--DYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp C--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCcHHHHHH
Confidence 9887777777889999999999987 78999999999999999999999999654 3333333332210
Q ss_pred -------------CCCCC----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 595 -------------YGFPS----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 595 -------------~~~p~----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...+. ..++.+++++.+||.+||+.||++|||++|+++||||+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 01111 112356899999999999999999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=368.21 Aligned_cols=255 Identities=34% Similarity=0.545 Sum_probs=218.9
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeee--ecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEY--DTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~--~~~~~~~l 452 (639)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.++++++||||+++++++ ...+.+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 57899999999999999999999999999999999865543 3346788999999999999999999987 44678999
Q ss_pred EEeeccCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 453 VIELIKGGDLFDAISKN----VKFSEEDSKFMTQSLASALSYLHDNY-----IVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qI~~aL~yLH~~g-----ivHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
||||+++++|.+++... ..+++..++.++.|++.||+|||+.| |+||||||+||+++.++ .+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~----~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ----NVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS----CEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC----CEEEecC
Confidence 99999999999999653 34999999999999999999999999 99999999999999887 8999999
Q ss_pred cccccccCCC---ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy6820 524 GLAQRVLRPM---FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600 (639)
Q Consensus 524 Gla~~~~~~~---~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~ 600 (639)
|++....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||... ....+...+..+... .
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~i~~~~~~---~ 235 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFR---R 235 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCC---C
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc--CHHHHHHHHhhcccc---c
Confidence 9997664332 2457899999999999999999999999999999999999999654 455666667666542 2
Q ss_pred CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q psy6820 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639 (639)
Q Consensus 601 ~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~~ 639 (639)
....+++++.++|.+||+.||++|||++|+++|||+.++
T Consensus 236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 224689999999999999999999999999999999763
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=375.22 Aligned_cols=258 Identities=26% Similarity=0.495 Sum_probs=196.9
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 57899999999999999999999889999999998765544445667899999999999999999999999999999999
Q ss_pred eccCCChHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 456 LIKGGDLFDAISK--------NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 456 ~~~ggsL~~~l~~--------~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
|+++++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|||++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~kl~dfg~~~ 169 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG----SVQIADFGVSA 169 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC----CEEECCCHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC----CEEEEeccchh
Confidence 9999999999963 45699999999999999999999999999999999999999887 79999999987
Q ss_pred cccCC--------CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy6820 528 RVLRP--------MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598 (639)
Q Consensus 528 ~~~~~--------~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p 598 (639)
..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... ......+........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-KVLMLTLQNDPPSLE 248 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHHTSSCCCTT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-hHHHHHhccCCCccc
Confidence 55321 234579999999999875 56899999999999999999999999764332 222222222221111
Q ss_pred -----CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 599 -----SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 599 -----~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
......+++++.+||.+||+.||++|||+.++++||||++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 1233568899999999999999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=397.04 Aligned_cols=247 Identities=15% Similarity=0.226 Sum_probs=203.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc--chhHHHHHHHH---HHHHhcCCCceeeee-------ee
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL--LGKKQMIENEV---NILRSVNHPNIIKLL-------DE 443 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~--~~~~~~~~~Ei---~iL~~l~HpnIv~l~-------~~ 443 (639)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+ .+++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4689999999999999999999999999999999975432 23346788999 455555799999998 55
Q ss_pred eecCC-----------------ceEEEEeeccCCChHHHHhhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCceec
Q psy6820 444 YDTNN-----------------ELYLVIELIKGGDLFDAISKNVKFSE-------EDSKFMTQSLASALSYLHDNYIVHR 499 (639)
Q Consensus 444 ~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~~l~~-------~~~~~i~~qI~~aL~yLH~~givHr 499 (639)
+.+.+ ..|+||||+ +|+|.+++...+.+++ ..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 55543 389999999 6799999987655555 7888899999999999999999999
Q ss_pred cCCCCceEEccCCceeeeEEEeeccccccccCCCccccCCCcccCccccccC-----------CCChhhhHHHHHHHHHH
Q psy6820 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNES-----------GYGVKIDVWAAGVILYI 568 (639)
Q Consensus 500 DLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~-----------~~s~~sDVwSLGvvL~e 568 (639)
||||+|||++.++ .+||+|||++..........+| +.|+|||++.+. .++.++|||||||++||
T Consensus 231 Dikp~NIll~~~~----~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRG----GVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTC----CEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCC----CEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999887 8999999999876666667788 999999999887 89999999999999999
Q ss_pred HHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 569 LLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 569 LltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
|++|..||...... .....+ ...+..+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 306 lltg~~Pf~~~~~~--~~~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 306 IWCADLPITKDAAL--GGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHSSCCC--------CCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHCCCCCcccccc--cchhhh--------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999653321 111111 1123578999999999999999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=375.64 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=213.7
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN----- 447 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 447 (639)
..+.++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 345689999999999999999999999999999999997655444456678999999999999999999987654
Q ss_pred CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
...|+||||+. ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~----~~kl~Dfg~a~ 160 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC----DLKVCDFGLAR 160 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC----CEEECCCTTCE
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC----cEEEEeccccc
Confidence 67899999996 599999876 4799999999999999999999999999999999999999887 79999999997
Q ss_pred cccCC-------------CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc-
Q psy6820 528 RVLRP-------------MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS- 592 (639)
Q Consensus 528 ~~~~~-------------~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~- 592 (639)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+ .......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~ 238 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD--YRHQLLLIFGI 238 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHH
Confidence 65421 223578999999998764 778999999999999999999999996543 2222222111
Q ss_pred -----------------------CCCCCCC----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 593 -----------------------GQYGFPS----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 593 -----------------------~~~~~p~----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.....+. ..++.+++++.+||.+||+.||++|||++|+++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0001111 112468999999999999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=385.29 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=214.6
Q ss_pred CCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CC-----ceeeeeeee
Q psy6820 371 IPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HP-----NIIKLLDEY 444 (639)
Q Consensus 371 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIv~l~~~~ 444 (639)
......++|.+.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.+++.++ |+ +|+++++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 34556789999999999999999999999999999999997542 22455678899988886 55 499999999
Q ss_pred ecCCceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCceEEccCCceeeeEEE
Q psy6820 445 DTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLH--DNYIVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 445 ~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH--~~givHrDLKp~NILld~~g~~~~~vKL 520 (639)
...+.+|+||||+. ++|.+++... ..+++..++.++.||+.||+||| +.||+||||||+|||++.++. ..+||
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~--~~~kL 202 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR--SAIKI 202 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS--CCEEE
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC--CcEEE
Confidence 99999999999995 5999999765 46999999999999999999999 579999999999999964321 27999
Q ss_pred eeccccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC--
Q psy6820 521 GDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP-- 598 (639)
Q Consensus 521 ~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p-- 598 (639)
+|||++..........+||+.|+|||++.+..++.++|||||||++|||+||..||... +..+....+.......+
T Consensus 203 ~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 203 VDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA--NEVDQMNKIVEVLGIPPAH 280 (382)
T ss_dssp CCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCSCCHH
T ss_pred EeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCCHH
Confidence 99999988877777789999999999999999999999999999999999999999654 33344444432111000
Q ss_pred ----------------C-----------------CCccc-------------------------ccHHHHHHHHHhcccC
Q psy6820 599 ----------------S-----------------PYWDD-------------------------ISEEAKELISHMLESN 620 (639)
Q Consensus 599 ----------------~-----------------~~~~~-------------------------l~~~l~dLI~~~L~~d 620 (639)
. +.... .++++.+||.+||+.|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 0 00000 1147899999999999
Q ss_pred CCCCCCHHHHHcCCcccC
Q psy6820 621 PDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 621 P~~Rpta~eiL~HP~f~~ 638 (639)
|++|||++|+|+||||++
T Consensus 361 P~~Rpta~e~L~hp~f~~ 378 (382)
T 2vx3_A 361 PKTRIQPYYALQHSFFKK 378 (382)
T ss_dssp TTTSCCHHHHTTSGGGCC
T ss_pred hhhCCCHHHHhcCccccc
Confidence 999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=380.05 Aligned_cols=259 Identities=25% Similarity=0.491 Sum_probs=223.8
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh----------------HHHHHHHHHHHHhcCCCc
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK----------------KQMIENEVNILRSVNHPN 436 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~----------------~~~~~~Ei~iL~~l~Hpn 436 (639)
....++|.+.+.||+|+||.||+|.+ +++.||+|++........ .+.+.+|+.++++++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34568999999999999999999988 889999999975433211 167889999999999999
Q ss_pred eeeeeeeeecCCceEEEEeeccCCChHHH------Hhh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceE
Q psy6820 437 IIKLLDEYDTNNELYLVIELIKGGDLFDA------ISK--NVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLL 507 (639)
Q Consensus 437 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~--~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NIL 507 (639)
|+++++++.+.+..|+||||+++++|.++ +.. ...+++..++.++.||+.||+|||+ +||+||||||+||+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 665 5779999999999999999999999 99999999999999
Q ss_pred EccCCceeeeEEEeeccccccccC-CCccccCCCcccCccccccC-CCCh-hhhHHHHHHHHHHHHcCCCCCCCCCCChH
Q psy6820 508 VEMSGCHVKVLKVGDFGLAQRVLR-PMFTVCGTPTYVAPEILNES-GYGV-KIDVWAAGVILYILLCGFPPFVSDTNDQD 584 (639)
Q Consensus 508 ld~~g~~~~~vKL~DFGla~~~~~-~~~~~~GT~~Y~APE~l~~~-~~s~-~sDVwSLGvvL~eLltG~~Pf~~~~~~~~ 584 (639)
++.++ .+||+|||++..... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||..... ..
T Consensus 185 ~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~ 259 (348)
T 2pml_X 185 MDKNG----RVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS-LV 259 (348)
T ss_dssp ECTTS----CEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC-SH
T ss_pred EcCCC----cEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc-HH
Confidence 99887 899999999987543 33456799999999999877 6766 99999999999999999999976543 25
Q ss_pred HHHHHHHcCCCCCCCCC---------------cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 585 ELFDDILSGQYGFPSPY---------------WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 585 ~l~~~i~~~~~~~p~~~---------------~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+....+..+...++... ...+++++.+||.+||+.||++|||++|+++||||++
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 66677777665555311 1468999999999999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=371.15 Aligned_cols=253 Identities=33% Similarity=0.632 Sum_probs=215.9
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc---hhHHHHHHHHHHHHhcCCCceeeeeeee--ecCCc
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL---GKKQMIENEVNILRSVNHPNIIKLLDEY--DTNNE 449 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~--~~~~~ 449 (639)
+.++|.+.+.||+|+||.||+|.+..+++.+|+|++...... ...+.+.+|+.++++++||||+++++++ .+.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 568999999999999999999999999999999999765432 3356788999999999999999999998 45568
Q ss_pred eEEEEeeccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 450 LYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
.|+||||++++ |.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~----~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG----TLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----CEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC----cEEeecccccc
Confidence 99999999775 7777754 45799999999999999999999999999999999999999887 89999999997
Q ss_pred cccC-----CCccccCCCcccCccccccCC--CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy6820 528 RVLR-----PMFTVCGTPTYVAPEILNESG--YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600 (639)
Q Consensus 528 ~~~~-----~~~~~~GT~~Y~APE~l~~~~--~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~ 600 (639)
.... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.. .+.......+..+...++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--~~~~~~~~~i~~~~~~~~-- 233 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG--DNIYKLFENIGKGSYAIP-- 233 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHCCCCCC--
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC--chHHHHHHHHhcCCCCCC--
Confidence 6532 123457899999999997654 38899999999999999999999964 355667777777765554
Q ss_pred CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 601 ~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+++++.+||.+||+.||++|||++|+++||||++
T Consensus 234 --~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 234 --GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp --SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred --CccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 468999999999999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=385.67 Aligned_cols=252 Identities=29% Similarity=0.517 Sum_probs=205.7
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec--------
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT-------- 446 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-------- 446 (639)
..++|++++.||+|+||.||+|.+..+++.||+|++..... ...+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 35789999999999999999999999999999999865432 22479999999999999999998833
Q ss_pred ------------------------------CCceEEEEeeccCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHH
Q psy6820 447 ------------------------------NNELYLVIELIKGGDLFDAIS----KNVKFSEEDSKFMTQSLASALSYLH 492 (639)
Q Consensus 447 ------------------------------~~~~~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~qI~~aL~yLH 492 (639)
...+++||||++ ++|.+.+. ....+++..++.++.||+.||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 344899999997 47776664 4578999999999999999999999
Q ss_pred HCCceeccCCCCceEEcc-CCceeeeEEEeecccccccc--CCCccccCCCcccCccccccC-CCChhhhHHHHHHHHHH
Q psy6820 493 DNYIVHRDIKPENLLVEM-SGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYI 568 (639)
Q Consensus 493 ~~givHrDLKp~NILld~-~g~~~~~vKL~DFGla~~~~--~~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~e 568 (639)
++||+||||||+|||++. ++ .+||+|||+|.... .......||+.|+|||++.+. .++.++|||||||++||
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDN----TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTT----EEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCC----cEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 999999999999999984 55 79999999998654 334567889999999998764 58999999999999999
Q ss_pred HHcCCCCCCCCCCChHHHHHHHHcC-----------------CCCCCC---C-----CcccccHHHHHHHHHhcccCCCC
Q psy6820 569 LLCGFPPFVSDTNDQDELFDDILSG-----------------QYGFPS---P-----YWDDISEEAKELISHMLESNPDL 623 (639)
Q Consensus 569 LltG~~Pf~~~~~~~~~l~~~i~~~-----------------~~~~p~---~-----~~~~l~~~l~dLI~~~L~~dP~~ 623 (639)
|++|..||...+ ..+....+... ...++. . ....+++++.+||.+||+.||++
T Consensus 235 ll~g~~pf~~~~--~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 235 LILGKPLFSGET--SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999996543 33333333221 111111 0 12347899999999999999999
Q ss_pred CCCHHHHHcCCcccC
Q psy6820 624 RFSAEDVLDHPWLER 638 (639)
Q Consensus 624 Rpta~eiL~HP~f~~ 638 (639)
|||+.|+++||||++
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999963
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=370.34 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=213.5
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 445789999999999999999999999999999999976432 35678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAIS-KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+++++|.+++. ....+++..+..++.+|+.||.|||+.|++|+||||+||+++.++ .+||+|||++......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG----HAKLADFGVAGQLTDT 178 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----CEEECCCTTCEECBTT
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC----CEEEeecccchhhhhh
Confidence 99999999999996 456799999999999999999999999999999999999999887 7999999999765432
Q ss_pred ---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 ---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+.... .........++.++
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~l 255 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH--PMRAIFMIPTNP-PPTFRKPELWSDNF 255 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSC-CCCCSSGGGSCHHH
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCC-CcccCCcccCCHHH
Confidence 345679999999999999999999999999999999999999996533 222222332222 11112235679999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+||.+||+.||++|||+.++++||||+.
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence 99999999999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=377.55 Aligned_cols=264 Identities=27% Similarity=0.436 Sum_probs=214.7
Q ss_pred CCCcccCCCeeEEEEEccCCceEEEEEEEcCCC-eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc------eeeeee
Q psy6820 370 NIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKD-MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN------IIKLLD 442 (639)
Q Consensus 370 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~~ 442 (639)
.+...+.++|++.+.||+|+||.||+|.+..++ +.||+|++.... ...+.+.+|+.+++.++|++ ++.+++
T Consensus 12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence 344556789999999999999999999998776 789999997542 33466788999999997665 899999
Q ss_pred eeecCCceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC--------
Q psy6820 443 EYDTNNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG-------- 512 (639)
Q Consensus 443 ~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g-------- 512 (639)
++...+..|+||||+ +++|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 999999999999999 66887777654 3699999999999999999999999999999999999994321
Q ss_pred -------ceeeeEEEeeccccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHH
Q psy6820 513 -------CHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDE 585 (639)
Q Consensus 513 -------~~~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~ 585 (639)
.....+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||.... ..+
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~ 246 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE--NRE 246 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHH
T ss_pred ccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHH
Confidence 11237999999999877666677889999999999999999999999999999999999999996543 222
Q ss_pred HHHHHHcCCCCCCC----------------------------------------CCcccccHHHHHHHHHhcccCCCCCC
Q psy6820 586 LFDDILSGQYGFPS----------------------------------------PYWDDISEEAKELISHMLESNPDLRF 625 (639)
Q Consensus 586 l~~~i~~~~~~~p~----------------------------------------~~~~~l~~~l~dLI~~~L~~dP~~Rp 625 (639)
....+......+|. ......+.++.+||.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 22222211111110 00112356899999999999999999
Q ss_pred CHHHHHcCCcccC
Q psy6820 626 SAEDVLDHPWLER 638 (639)
Q Consensus 626 ta~eiL~HP~f~~ 638 (639)
|++|+++||||++
T Consensus 327 t~~e~l~hp~f~~ 339 (355)
T 2eu9_A 327 TLAEALLHPFFAG 339 (355)
T ss_dssp CHHHHTTSGGGGG
T ss_pred CHHHHhcChhhcC
Confidence 9999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=381.45 Aligned_cols=259 Identities=36% Similarity=0.719 Sum_probs=191.6
Q ss_pred ccCCCeeEEE-EEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec----CC
Q psy6820 374 KLLQRYSVGQ-IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT----NN 448 (639)
Q Consensus 374 ~~~~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~ 448 (639)
.+.++|.+.+ .||+|+||.||+|.++.+++.||+|++.... ....+....++.+.||||+++++++.. ..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 4567899955 6999999999999999999999999996532 222233344667789999999999876 45
Q ss_pred ceEEEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
.+++||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++. ...+||+|||++
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~-~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEK-DAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSST-TCCEEECCCTTC
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCC-CceEEEeccccc
Confidence 6899999999999999997653 6999999999999999999999999999999999999986541 126999999999
Q ss_pred ccccCC-CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh--HHHHHHHHcCCCCCCCCCcc
Q psy6820 527 QRVLRP-MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ--DELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 527 ~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~--~~l~~~i~~~~~~~p~~~~~ 603 (639)
...... ....+||+.|+|||++.+..++.++||||||+++|+|++|..||....... ......+......++.+.+.
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (336)
T 3fhr_A 179 KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 258 (336)
T ss_dssp EEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTST
T ss_pred eeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhc
Confidence 766533 345678999999999998889999999999999999999999996543321 12234455556667777778
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+++++.+||.+||+.||++|||++|+++||||++
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 89999999999999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=368.19 Aligned_cols=253 Identities=28% Similarity=0.520 Sum_probs=213.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec---------
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT--------- 446 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--------- 446 (639)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 46799999999999999999999999999999999643 2334667899999999999999999998754
Q ss_pred ----CCceEEEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEe
Q psy6820 447 ----NNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVG 521 (639)
Q Consensus 447 ----~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~ 521 (639)
.+..|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~----~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR----NVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS----CEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC----CEEEe
Confidence 45789999999999999999754 4688999999999999999999999999999999999999887 79999
Q ss_pred eccccccccC-----------------CCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh
Q psy6820 522 DFGLAQRVLR-----------------PMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ 583 (639)
Q Consensus 522 DFGla~~~~~-----------------~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~ 583 (639)
|||++..... ......||+.|+|||++.+. .++.++||||||+++|+|++ ||... .+.
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-~~~ 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-MER 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-HHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-hhH
Confidence 9999976532 12345789999999999864 68999999999999999998 55322 133
Q ss_pred HHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 584 DELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 584 ~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
......+......+|.......++.+.+||.+||+.||++|||++++++||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 4556666666777777777788999999999999999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=380.22 Aligned_cols=249 Identities=23% Similarity=0.395 Sum_probs=214.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEc-------CCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDK-------HKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTN 447 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 447 (639)
.++|++++.||+|+||.||+|.+. .++..||+|++.........+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999864 345679999998765555556788999999999 799999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccC
Q psy6820 448 NELYLVIELIKGGDLFDAISKNV----------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMS 511 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~ 511 (639)
+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC
Confidence 99999999999999999997643 47899999999999999999999999999999999999988
Q ss_pred CceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHH
Q psy6820 512 GCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDE 585 (639)
Q Consensus 512 g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~ 585 (639)
+ .+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||... ...+
T Consensus 240 ~----~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~--~~~~ 313 (370)
T 2psq_A 240 N----VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEE 313 (370)
T ss_dssp C----CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGG
T ss_pred C----CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC--CHHH
Confidence 7 8999999999865432 233457889999999999999999999999999999999 99999654 3455
Q ss_pred HHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 586 LFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 586 l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+...+..+.. ......++.++.+||.+||+.||++||++.|++++
T Consensus 314 ~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 314 LFKLLKEGHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHTTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5556655532 12235789999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=384.33 Aligned_cols=257 Identities=22% Similarity=0.352 Sum_probs=218.7
Q ss_pred ccCCCeeEEEEEccCCceEEEEEE-----EcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVY-----DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN 448 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 448 (639)
...++|++.+.||+|+||.||+|. +..+++.||+|++...........+.+|+.++++++||||+++++++.+.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 345789999999999999999998 445678899999976655555667889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEe
Q psy6820 449 ELYLVIELIKGGDLFDAISKN-------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVG 521 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~-------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~ 521 (639)
..|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.. ..+||+
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~-~~~kL~ 226 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG-RVAKIG 226 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT-CCEEEC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC-ceEEEC
Confidence 999999999999999999764 358999999999999999999999999999999999999866521 369999
Q ss_pred ecccccccc-----CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCC
Q psy6820 522 DFGLAQRVL-----RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQY 595 (639)
Q Consensus 522 DFGla~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~ 595 (639)
|||+++... .......||+.|+|||++.+..++.++|||||||++|||++ |..||... ...++...+..+..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~--~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVTSGGR 304 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC
Confidence 999997543 22334568999999999999999999999999999999998 99999653 45666666766543
Q ss_pred CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 596 GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 596 ~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
..+ ...++.++.+||.+||+.||++|||+.++++|.|+
T Consensus 305 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 305 MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 222 25789999999999999999999999999998664
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=371.57 Aligned_cols=255 Identities=25% Similarity=0.434 Sum_probs=210.8
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeec------
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDT------ 446 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~------ 446 (639)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 456889999999999999999999999999999999975432 346678999999999 79999999999876
Q ss_pred CCceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 447 NNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
.+.+|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~----~~kl~Dfg 174 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFG 174 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC----CEEECCCT
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC----CEEEeeCc
Confidence 46799999999999999999764 5799999999999999999999999999999999999999887 79999999
Q ss_pred ccccccCC---CccccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 525 LAQRVLRP---MFTVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 525 la~~~~~~---~~~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
++...... .....||+.|+|||++. +..++.++|||||||++|+|++|..||.... .......+.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~- 251 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPA- 251 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCC-
T ss_pred CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHhhcCcc-
Confidence 99765432 34567999999999986 5678999999999999999999999996432 3333333433322
Q ss_pred CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 597 ~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+......+++++.+||.+||+.||++||+++++++||||++
T Consensus 252 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 252 -PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp -CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred -ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 22223568999999999999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=382.10 Aligned_cols=260 Identities=28% Similarity=0.488 Sum_probs=212.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-----------CCceeeeeeee
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-----------HPNIIKLLDEY 444 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~~~~ 444 (639)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.++++++ ||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc--chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 4689999999999999999999999999999999975432 3456788999999886 79999999998
Q ss_pred ecCC----ceEEEEeeccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEccCC--cee
Q psy6820 445 DTNN----ELYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDN-YIVHRDIKPENLLVEMSG--CHV 515 (639)
Q Consensus 445 ~~~~----~~~lV~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~-givHrDLKp~NILld~~g--~~~ 515 (639)
...+ .+++||||+ +++|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ ...
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 7654 789999999 8899999976 34599999999999999999999998 999999999999996433 223
Q ss_pred eeEEEeeccccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC----hHHHHHHHH
Q psy6820 516 KVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND----QDELFDDIL 591 (639)
Q Consensus 516 ~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~----~~~l~~~i~ 591 (639)
..+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..||...... .......+.
T Consensus 175 ~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254 (373)
T ss_dssp EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred ceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence 4799999999988776666778999999999999999999999999999999999999999754321 112222222
Q ss_pred cCCCCCCC--------------------------------------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 592 SGQYGFPS--------------------------------------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 592 ~~~~~~p~--------------------------------------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.....+|. .....+++++.+||.+||+.||++|||++|+++|
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 11000100 1123567899999999999999999999999999
Q ss_pred CcccC
Q psy6820 634 PWLER 638 (639)
Q Consensus 634 P~f~~ 638 (639)
|||++
T Consensus 335 p~f~~ 339 (373)
T 1q8y_A 335 PWLKD 339 (373)
T ss_dssp GGGTT
T ss_pred hhhhc
Confidence 99986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=390.41 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=194.2
Q ss_pred CCeeE-EEEEccCCceEEEEEEEc--CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeee--ecCCceE
Q psy6820 377 QRYSV-GQIIGDGNFAVVRQVYDK--HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY--DTNNELY 451 (639)
Q Consensus 377 ~~y~i-~~~LG~G~fG~Vy~a~~~--~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~--~~~~~~~ 451 (639)
+.|.+ +++||+|+||.||+|..+ .+++.||+|++..... ...+.+|+.+|++++||||+++++++ .....+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 45666 568999999999999966 4688999999976543 24567899999999999999999999 4577899
Q ss_pred EEEeeccCCChHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEee
Q psy6820 452 LVIELIKGGDLFDAISKN---------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGD 522 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~D 522 (639)
+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+..++.....+||+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999996 5888887532 24999999999999999999999999999999999999943211112899999
Q ss_pred ccccccccC------CCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC-------hHHHHH
Q psy6820 523 FGLAQRVLR------PMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTND-------QDELFD 588 (639)
Q Consensus 523 FGla~~~~~------~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~-------~~~l~~ 588 (639)
||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....+ ..+...
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999976543 2345689999999999987 45899999999999999999999999755432 122333
Q ss_pred HHHcCCCCCCCCCccc----------------------------------ccHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q psy6820 589 DILSGQYGFPSPYWDD----------------------------------ISEEAKELISHMLESNPDLRFSAEDVLDHP 634 (639)
Q Consensus 589 ~i~~~~~~~p~~~~~~----------------------------------l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP 634 (639)
.+.......+...|.. .++++.+||.+||+.||++|||++|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 3332221222222222 267899999999999999999999999999
Q ss_pred cccC
Q psy6820 635 WLER 638 (639)
Q Consensus 635 ~f~~ 638 (639)
||++
T Consensus 336 ~f~~ 339 (405)
T 3rgf_A 336 YFLE 339 (405)
T ss_dssp GGTS
T ss_pred hhcc
Confidence 9975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=371.35 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=204.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.++|++.+.||+|+||.||+|.+ ++..||+|++....... ..+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 46899999999999999999976 57789999997665432 2356789999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 455 ELIKGGDLFDAISKNVK---FSEEDSKFMTQSLASALSYLHDNY--IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qI~~aL~yLH~~g--ivHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
||+++|+|.+++.+... +++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~----~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY----TVKVCDFGLSRLK 189 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC----CEEECCCC-----
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC----cEEECCCCCCccc
Confidence 99999999999977543 999999999999999999999999 99999999999999887 8999999999755
Q ss_pred cCC---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 530 LRP---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 530 ~~~---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||... ...+....+....... +....++
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~--~~~~~~~~~~~~~~~~--~~~~~~~ 265 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL--NPAQVVAAVGFKCKRL--EIPRNLN 265 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS--CHHHHHHHHHHSCCCC--CCCTTSC
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCCC--CCCccCC
Confidence 432 34567999999999999999999999999999999999999999654 3444444443332222 2235789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+++.+||.+||+.||++|||++++++
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=377.75 Aligned_cols=250 Identities=22% Similarity=0.392 Sum_probs=212.3
Q ss_pred CCCeeEEEEEccCCceEEEEEE-----EcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCc
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVY-----DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 449 (639)
.++|.+++.||+|+||.||+|. ...+++.||+|++.........+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 4689999999999999999998 55667899999998766555567789999999999 69999999999877654
Q ss_pred -eEEEEeeccCCChHHHHhhcCC---------------------------------------------------------
Q psy6820 450 -LYLVIELIKGGDLFDAISKNVK--------------------------------------------------------- 471 (639)
Q Consensus 450 -~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------------- 471 (639)
+++||||+++|+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 8999999999999999976433
Q ss_pred ---------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-----Ccccc
Q psy6820 472 ---------FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-----MFTVC 537 (639)
Q Consensus 472 ---------l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-----~~~~~ 537 (639)
+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... .....
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN----VVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG----CEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC----cEEEEeccceeeecccccchhccccC
Confidence 89999999999999999999999999999999999999887 8999999999765322 23456
Q ss_pred CCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHh
Q psy6820 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHM 616 (639)
Q Consensus 538 GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~ 616 (639)
||+.|+|||++.+..++.++||||||+++|||++ |..||...... ..+...+..+.. . .....+++++.++|.+|
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTR-M--RAPDYTTPEMYQTMLDC 332 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHHTCC-C--CCCTTCCHHHHHHHHHH
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-HHHHHHHHcCCC-C--CCCCCCCHHHHHHHHHH
Confidence 8899999999999999999999999999999998 99999765443 333344444322 1 12256899999999999
Q ss_pred cccCCCCCCCHHHHHcC
Q psy6820 617 LESNPDLRFSAEDVLDH 633 (639)
Q Consensus 617 L~~dP~~Rpta~eiL~H 633 (639)
|+.||++|||+.|+++|
T Consensus 333 l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 333 WHGEPSQRPTFSELVEH 349 (359)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCCCHHHHHHH
Confidence 99999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=375.04 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=210.3
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCc---
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNE--- 449 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~--- 449 (639)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++...+.
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 3457899999999999999999999999999999999765432 224567899999999999999999999977654
Q ss_pred ---eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 450 ---LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 450 ---~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
+|+||||+. ++|.+++.. .+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~----~~kl~Dfg~~ 173 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC----ELKILDFGLA 173 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC----CEEECSTTCT
T ss_pred ceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC----cEEEeecccc
Confidence 499999996 599888753 599999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC------------
Q psy6820 527 QRVLRPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG------------ 593 (639)
Q Consensus 527 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~------------ 593 (639)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+ ..+....+...
T Consensus 174 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 174 RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp TC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC--HHHHHHHHHHHHCBCCHHHHTTC
T ss_pred cCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHHH
Confidence 877666666789999999999877 678999999999999999999999996543 22333322211
Q ss_pred -----------CC----CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 -----------QY----GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 -----------~~----~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.. ......+..+++++.+||.+||+.||++|||++|+++||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00 0011233567999999999999999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=388.74 Aligned_cols=251 Identities=29% Similarity=0.484 Sum_probs=204.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec------CCce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT------NNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~~~ 450 (639)
.+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++||||++++++|.. ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 47999999999999999999999999999999986542 223479999999999999999998743 2247
Q ss_pred EEEEeeccCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 451 YLVIELIKGGDLFDAIS----KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
++||||+++ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~---~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT---AVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT---TEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC---CeEEeccchhh
Confidence 899999965 6766654 356799999999999999999999999999999999999999664 26899999999
Q ss_pred cccc--CCCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc-----------
Q psy6820 527 QRVL--RPMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS----------- 592 (639)
Q Consensus 527 ~~~~--~~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~----------- 592 (639)
+... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+ ..+.+..+..
T Consensus 205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~--~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCSCCHHHHH
T ss_pred hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHH
Confidence 8654 234467899999999999764 79999999999999999999999997643 2222222221
Q ss_pred ------CCCCCCCC--------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 593 ------GQYGFPSP--------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 593 ------~~~~~p~~--------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+.++.. +...+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 11122210 11356899999999999999999999999999999964
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=360.99 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=217.8
Q ss_pred CcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH------HHHHHHHHHHHhcCCCceeeeeeeee
Q psy6820 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK------QMIENEVNILRSVNHPNIIKLLDEYD 445 (639)
Q Consensus 372 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~------~~~~~Ei~iL~~l~HpnIv~l~~~~~ 445 (639)
+....++|++.+.||+|+||.||+|.+..+++.||+|++......... +.+.+|+.++++++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 344568999999999999999999999999999999998655433222 56789999999999999999999997
Q ss_pred cCCceEEEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEccCC-ceeeeEEEe
Q psy6820 446 TNNELYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNY--IVHRDIKPENLLVEMSG-CHVKVLKVG 521 (639)
Q Consensus 446 ~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~g--ivHrDLKp~NILld~~g-~~~~~vKL~ 521 (639)
+.. ++||||+++++|.+.+.+ ...+++..+..++.|++.||+|||++| |+||||||+|||++.++ .....+||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 665 699999999999988855 457999999999999999999999999 99999999999998766 112249999
Q ss_pred eccccccccCCCccccCCCcccCcccc--ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy6820 522 DFGLAQRVLRPMFTVCGTPTYVAPEIL--NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599 (639)
Q Consensus 522 DFGla~~~~~~~~~~~GT~~Y~APE~l--~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~ 599 (639)
|||++...........||+.|+|||++ ....++.++||||||+++|+|++|..||.............+..... +.
T Consensus 172 Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~ 249 (287)
T 4f0f_A 172 DFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--RP 249 (287)
T ss_dssp CCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC--CC
T ss_pred CCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC--CC
Confidence 999998777666678899999999998 45567999999999999999999999998766655555555554433 22
Q ss_pred CCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 600 PYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 600 ~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.....+++++.+||.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 334678999999999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=364.50 Aligned_cols=254 Identities=31% Similarity=0.521 Sum_probs=211.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|.....||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 344445689999999999999999999999999976532 3346688999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEcc-CCceeeeEEEeeccccccccCC
Q psy6820 457 IKGGDLFDAISKN---VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM-SGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 457 ~~ggsL~~~l~~~---~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~-~g~~~~~vKL~DFGla~~~~~~ 532 (639)
+++++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++. ++ .+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG----VLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC----CEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC----CEEEeecccccccCCC
Confidence 9999999999764 24678999999999999999999999999999999999987 55 7999999999765432
Q ss_pred ---CccccCCCcccCccccccC--CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 533 ---MFTVCGTPTYVAPEILNES--GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~--~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.....||+.|+|||++.+. .++.++||||||+++|+|++|..||................. ........+++
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 253 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK---VHPEIPESMSA 253 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC---CCCCCCTTSCH
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc---ccccccccCCH
Confidence 3456799999999999764 389999999999999999999999965443333332222211 12233357899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++.+||.+||+.||++||+++++++||||+.
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 9999999999999999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=371.53 Aligned_cols=246 Identities=23% Similarity=0.379 Sum_probs=209.9
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 468999999999999999999999999999999986532 3345678899999999999999999999999999999999
Q ss_pred eccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC-
Q psy6820 456 LIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM- 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~- 533 (639)
|+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK----NVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS----CEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC----CEEEeecccceecccccc
Confidence 9999999999977 56799999999999999999999999999999999999999887 79999999997653221
Q ss_pred ----------------ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHH---HHHHHHcCC
Q psy6820 534 ----------------FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDE---LFDDILSGQ 594 (639)
Q Consensus 534 ----------------~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~---l~~~i~~~~ 594 (639)
...+||+.|+|||++.+..++.++||||||+++|||++|..||......... ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 1567999999999999999999999999999999999999998653322110 01111111
Q ss_pred CCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 595 ~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
. ....+++++.+||.+||+.||++|||+.++++
T Consensus 243 -~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 243 -Y----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp -T----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -c----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 12467899999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=371.06 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=213.5
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCC---eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
..++|.+.+.||+|+||.||+|.+..++ ..||+|++.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3478999999999999999999987554 4599999987655555677889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+||||+++++|.+++... ..+++..+..++.+|+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL----VCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----CEEECCCSSCEECC
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC----CEEECCCCcccccc
Confidence 999999999999999654 6799999999999999999999999999999999999999887 89999999998664
Q ss_pred CC------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc
Q psy6820 531 RP------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 531 ~~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
.. .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ...++...+..+. .. +...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~~~-~~--~~~~ 277 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM--TNRDVISSVEEGY-RL--PAPM 277 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHHHHHTTC-CC--CCCT
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHcCC-CC--CCCC
Confidence 32 122345778999999999999999999999999999999 99999543 4455666665542 22 2235
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+++++.+||.+||+.||++|||+.++++
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 78999999999999999999999999885
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=373.72 Aligned_cols=250 Identities=30% Similarity=0.538 Sum_probs=215.9
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-----hHHHHHHHHHHHHhcC--CCceeeeeeeee
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-----KKQMIENEVNILRSVN--HPNIIKLLDEYD 445 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-----~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~ 445 (639)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 456688999999999999999999999999999999997654322 1234567999999996 599999999999
Q ss_pred cCCceEEEEeeccC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEc-cCCceeeeEEEeec
Q psy6820 446 TNNELYLVIELIKG-GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE-MSGCHVKVLKVGDF 523 (639)
Q Consensus 446 ~~~~~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld-~~g~~~~~vKL~DF 523 (639)
..+..++|||++.+ ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ .++ .+||+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~----~~kL~Df 194 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG----ELKLIDF 194 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT----EEEECCC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC----CEEEeeC
Confidence 99999999999976 89999998888999999999999999999999999999999999999998 555 7999999
Q ss_pred cccccccCC-CccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy6820 524 GLAQRVLRP-MFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY 601 (639)
Q Consensus 524 Gla~~~~~~-~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~ 601 (639)
|++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|..||... . .+......++
T Consensus 195 g~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~----~~~~~~~~~~--- 263 (320)
T 3a99_A 195 GSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E----EIIRGQVFFR--- 263 (320)
T ss_dssp TTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H----HHHHCCCCCS---
T ss_pred ccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----h----hhhccccccc---
Confidence 999876543 345679999999999987665 78899999999999999999999532 1 2333333333
Q ss_pred cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 602 ~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+++++.+||.+||+.||++|||++|+++||||++
T Consensus 264 -~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 264 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp -SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred -ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 568999999999999999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=368.44 Aligned_cols=256 Identities=32% Similarity=0.437 Sum_probs=211.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEc-CCCeEEEEEEEcccccch-hHHHHHHHHHHHHhc---CCCceeeeeeeee-----
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDK-HKDMDCALKIIDKSKLLG-KKQMIENEVNILRSV---NHPNIIKLLDEYD----- 445 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~----- 445 (639)
.++|++.+.||+|+||.||+|.+. .+++.||+|++....... ....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 478999999999999999999985 678899999987543221 123455777777766 8999999999986
Q ss_pred cCCceEEEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 446 TNNELYLVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 446 ~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
.....++||||+. |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~----~~kl~Df 164 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----QIKLADF 164 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----CEEECSC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC----CEEEecC
Confidence 5678999999997 69999997643 499999999999999999999999999999999999999887 8999999
Q ss_pred cccccccC--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC-----
Q psy6820 524 GLAQRVLR--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG----- 596 (639)
Q Consensus 524 Gla~~~~~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~----- 596 (639)
|++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ........+......
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--SDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCGGG
T ss_pred cccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHHcCCCCccc
Confidence 99976542 234567899999999999999999999999999999999999999654 333344444321000
Q ss_pred ------------------CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 597 ------------------FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 597 ------------------~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.....+..++.++.+||.+||+.||++|||+.|+++||||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 001123568999999999999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=374.98 Aligned_cols=257 Identities=24% Similarity=0.390 Sum_probs=193.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHH-HHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVN-ILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.++|++.+.||+|+||.||+|.+..+++.||+|++...........+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 4789999999999999999999999999999999986654444444555555 677788999999999999999999999
Q ss_pred eeccCCChHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 455 ELIKGGDLFDAISK-----NVKFSEEDSKFMTQSLASALSYLHDN-YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 455 E~~~ggsL~~~l~~-----~~~l~~~~~~~i~~qI~~aL~yLH~~-givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
||+++ +|.+++.. ...+++..+..++.+++.||.|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~~~~ 175 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG----NIKLCDFGISGQ 175 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT----EEEECCCSSSCC
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC----CEEEccCCCcee
Confidence 99975 88887753 56799999999999999999999998 999999999999999887 899999999976
Q ss_pred ccCC--CccccCCCcccCcccc----ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC-CCCCCCCC
Q psy6820 529 VLRP--MFTVCGTPTYVAPEIL----NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG-QYGFPSPY 601 (639)
Q Consensus 529 ~~~~--~~~~~GT~~Y~APE~l----~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~-~~~~p~~~ 601 (639)
.... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||.......+.+ ..+..+ ...++...
T Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~ 254 (327)
T 3aln_A 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL-TQVVKGDPPQLSNSE 254 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCCCCSCCCCCCCCS
T ss_pred cccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH-HHHhcCCCCCCCCcc
Confidence 6433 2334799999999998 46678999999999999999999999996543222211 112222 22233333
Q ss_pred cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 602 ~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+..+++++.+||.+||+.||++|||+.++++||||.+
T Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 4568999999999999999999999999999999963
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=356.18 Aligned_cols=245 Identities=24% Similarity=0.400 Sum_probs=213.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 689999999999999999998874 667999999865443 46688999999999999999999999999999999999
Q ss_pred ccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC----
Q psy6820 457 IKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---- 531 (639)
Q Consensus 457 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---- 531 (639)
+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ----VIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG----CEEECCTTGGGGBCCHHHH
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC----CEEeccccccccccccccc
Confidence 999999999965 45699999999999999999999999999999999999998887 899999999976543
Q ss_pred CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 532 PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 532 ~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
......+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ...+....+..+.... ....+++++.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~ 237 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLY---KPRLASTHVY 237 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCC---CCTTSCHHHH
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHhcCccCC---CCCcCCHHHH
Confidence 2334557888999999999999999999999999999999 99999653 4556666666653222 2246799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+++.+||+.||++|||+.++++|
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=367.56 Aligned_cols=257 Identities=30% Similarity=0.458 Sum_probs=206.8
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeee--------
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYD-------- 445 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-------- 445 (639)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh-HHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 456899999999999999999999999999999999875532 33456789999999999999999998873
Q ss_pred ------cCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEE
Q psy6820 446 ------TNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLK 519 (639)
Q Consensus 446 ------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vK 519 (639)
+....|+||||++ |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~~k 161 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED---LVLK 161 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT---TEEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC---CeEE
Confidence 4467899999997 599999864 5799999999999999999999999999999999999998543 2799
Q ss_pred EeeccccccccC------CCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc
Q psy6820 520 VGDFGLAQRVLR------PMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS 592 (639)
Q Consensus 520 L~DFGla~~~~~------~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~ 592 (639)
|+|||++..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.... ..+....+..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~~~~ 239 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH--ELEQMQLILE 239 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHH
Confidence 999999976532 2234567999999998865 678999999999999999999999996543 3333333332
Q ss_pred CCCCC----------------------CC----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 593 GQYGF----------------------PS----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 593 ~~~~~----------------------p~----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..... +. ..++.++.++.+||.+||+.||++|||++|+++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 21110 10 112457999999999999999999999999999999974
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=370.56 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=216.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 4789999999999999999999874 45889999998765555567789999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q psy6820 451 YLVIELIKGGDLFDAISKN------------------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENL 506 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~------------------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NI 506 (639)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 205 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 205 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceE
Confidence 9999999999999999763 5699999999999999999999999999999999999
Q ss_pred EEccCCceeeeEEEeeccccccccC-----CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCC
Q psy6820 507 LVEMSGCHVKVLKVGDFGLAQRVLR-----PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDT 580 (639)
Q Consensus 507 Lld~~g~~~~~vKL~DFGla~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~ 580 (639)
|++.++ .+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 206 l~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~- 280 (343)
T 1luf_A 206 LVGENM----VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM- 280 (343)
T ss_dssp EECGGG----CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred EECCCC----eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC-
Confidence 999887 899999999976532 2234568899999999999999999999999999999999 99999653
Q ss_pred CChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 581 NDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 581 ~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
...++...+..+.... ....+++++.+||.+||+.||++||++.+++++
T Consensus 281 -~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 281 -AHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp -CHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -ChHHHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 4556666666654322 235789999999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=382.62 Aligned_cols=251 Identities=31% Similarity=0.510 Sum_probs=201.6
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN------ 448 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 448 (639)
...+|++.+.||+|+||.||+|.+..++. +|+|.+..... ...+|+.+++.++||||+++++++...+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 34679999999999999999999888776 78877754322 2247999999999999999999985433
Q ss_pred ceEEEEeeccCCChHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEc-cCCceeeeEEEeec
Q psy6820 449 ELYLVIELIKGGDLFDAI----SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE-MSGCHVKVLKVGDF 523 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l----~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld-~~g~~~~~vKL~DF 523 (639)
.+|+||||+++ ++.+.+ .....+++..++.++.||+.||+|||++||+||||||+|||++ .++ .+||+||
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~----~~kL~DF 186 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG----VLKLIDF 186 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT----EEEECCC
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC----cEEEeeC
Confidence 38899999976 444433 2356799999999999999999999999999999999999998 566 8999999
Q ss_pred ccccccc--CCCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC-------
Q psy6820 524 GLAQRVL--RPMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG------- 593 (639)
Q Consensus 524 Gla~~~~--~~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~------- 593 (639)
|+|+... .......||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+ ..+....+...
T Consensus 187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES--GIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp TTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHH
T ss_pred CCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHH
Confidence 9997653 334567899999999998764 58999999999999999999999997543 22222222221
Q ss_pred ----------CCCCCC--------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 ----------QYGFPS--------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 ----------~~~~p~--------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...++. .+...+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 011111 112347899999999999999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=377.75 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=196.5
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCc-----
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNE----- 449 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----- 449 (639)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+|+..++.++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 457999999999999999999999999999999998654322 2344578888899999999999999865433
Q ss_pred --eEEEEeeccCCChHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCceEEcc-CCceeeeEEE
Q psy6820 450 --LYLVIELIKGGDLFDAI----SKNVKFSEEDSKFMTQSLASALSYLH--DNYIVHRDIKPENLLVEM-SGCHVKVLKV 520 (639)
Q Consensus 450 --~~lV~E~~~ggsL~~~l----~~~~~l~~~~~~~i~~qI~~aL~yLH--~~givHrDLKp~NILld~-~g~~~~~vKL 520 (639)
+++||||+++ +|.+.+ .....+++..+..++.|++.||.||| ++||+||||||+|||++. ++ .+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~----~~kl 173 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG----TLKL 173 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT----EEEE
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC----cEEE
Confidence 8899999976 554443 35677999999999999999999999 999999999999999986 65 8999
Q ss_pred eeccccccccC--CCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC
Q psy6820 521 GDFGLAQRVLR--PMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597 (639)
Q Consensus 521 ~DFGla~~~~~--~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~ 597 (639)
+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||... +.......+.......
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD--NSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCC
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC--ChHHHHHHHHHHcCCC
Confidence 99999986653 23456799999999998665 4899999999999999999999999654 3333444443211000
Q ss_pred C----------------------------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 598 P----------------------------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 598 p----------------------------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+ .......++++.+||.+||+.||++|||+.|+++||||++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 0 0011235789999999999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=364.93 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=215.0
Q ss_pred CCCeeEEEEEccCCceEEEEEEEc-----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDK-----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|.+.+.||+|+||.||+|.+. .++..||+|++.........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 468999999999999999999873 455889999998665545557788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q psy6820 451 YLVIELIKGGDLFDAISKNVK------------------------FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENL 506 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~------------------------l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NI 506 (639)
|+||||+++++|.+++..... +++..+..++.||+.||+|||++||+||||||+||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI 181 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence 999999999999999976533 89999999999999999999999999999999999
Q ss_pred EEccCCceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCC
Q psy6820 507 LVEMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDT 580 (639)
Q Consensus 507 Lld~~g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~ 580 (639)
+++.++ .+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 182 li~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 182 LVAEGR----KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp EEETTT----EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEcCCC----CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999887 8999999999765432 234467889999999999999999999999999999999 999996543
Q ss_pred CChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 581 NDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 581 ~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
...+...+..+.. .+....+++++.+||.+||+.||++||++.+++++
T Consensus 258 --~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 --PERLFNLLKTGHR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp --GGGHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --HHHHHHHhhcCCc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3445555555432 22335789999999999999999999999999865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=367.78 Aligned_cols=254 Identities=22% Similarity=0.391 Sum_probs=196.3
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCe---EEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce-
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDM---DCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL- 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~- 450 (639)
.++|++.+.||+|+||.||+|.+..++. .||+|++...... ...+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4689999999999999999998877764 7999999765432 3346788999999999999999999999877655
Q ss_pred -----EEEEeeccCCChHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEE
Q psy6820 451 -----YLVIELIKGGDLFDAISKNV------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLK 519 (639)
Q Consensus 451 -----~lV~E~~~ggsL~~~l~~~~------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vK 519 (639)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~----~~k 177 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM----TVC 177 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS----CEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC----CEE
Confidence 99999999999999996533 599999999999999999999999999999999999999887 899
Q ss_pred EeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcC
Q psy6820 520 VGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSG 593 (639)
Q Consensus 520 L~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~ 593 (639)
|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.... ..++...+..+
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~~~~~ 255 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE--NAEIYNYLIGG 255 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTT
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC--hHHHHHHHhcC
Confidence 9999999765432 223456789999999999999999999999999999999 999996543 34455555554
Q ss_pred CCCCCCCCcccccHHHHHHHHHhcccCCCCCCC-------HHHHHcCCcccC
Q psy6820 594 QYGFPSPYWDDISEEAKELISHMLESNPDLRFS-------AEDVLDHPWLER 638 (639)
Q Consensus 594 ~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpt-------a~eiL~HP~f~~ 638 (639)
... +....+++++.+||.+||+.||++||| ++++++|||+..
T Consensus 256 ~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 256 NRL---KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp CCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred CCC---CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 321 223578999999999999999999999 788899999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=356.50 Aligned_cols=246 Identities=23% Similarity=0.384 Sum_probs=211.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||+|... ++..||+|++...... .+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 468999999999999999999776 5678999999865443 4568899999999999999999999999999999999
Q ss_pred eccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 456 LIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~----~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS----CEEECSTTGGGGBCCHHH
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC----CEEEcccccccccccccc
Confidence 9999999999976 56799999999999999999999999999999999999999887 8999999999765432
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.....+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ........+..+..... ...+++++
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~l 250 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--TNSETAEHIAQGLRLYR---PHLASEKV 250 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHTTCCCCC---CTTCCHHH
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc--ChhHHHHHHhcccCCCC---CCcCCHHH
Confidence 234457888999999999999999999999999999998 99999654 44556666665533222 24678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+||.+||+.||++|||++++++|
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=354.24 Aligned_cols=246 Identities=22% Similarity=0.371 Sum_probs=212.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||+|... ++..||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 468999999999999999999776 4667999999765443 4568899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC-
Q psy6820 456 LIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM- 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~- 533 (639)
|+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~----~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL----CVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC----CEEECCTTCEEECCTTCE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC----CEEEccCccceecchhhh
Confidence 999999999997654 599999999999999999999999999999999999999887 89999999997664332
Q ss_pred ---ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 534 ---FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 534 ---~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
....+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ........+..+.....+ ..+++++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~~---~~~~~~l 234 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY--TNSEVVLKVSQGHRLYRP---HLASDTI 234 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc--ChHHHHHHHHcCCCCCCC---CcChHHH
Confidence 23456778999999999889999999999999999999 99999543 344555555555432222 4578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.++|.+||+.||++|||+.++++|
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 235 YQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=368.09 Aligned_cols=250 Identities=32% Similarity=0.585 Sum_probs=207.2
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-----hHHHHHHHHHHHHhc----CCCceeeeeee
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-----KKQMIENEVNILRSV----NHPNIIKLLDE 443 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-----~~~~~~~Ei~iL~~l----~HpnIv~l~~~ 443 (639)
..+.++|.+.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 445688999999999999999999999999999999997654322 123355799999999 89999999999
Q ss_pred eecCCceEEEEee-ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEc-cCCceeeeEEEe
Q psy6820 444 YDTNNELYLVIEL-IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE-MSGCHVKVLKVG 521 (639)
Q Consensus 444 ~~~~~~~~lV~E~-~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld-~~g~~~~~vKL~ 521 (639)
+...+..++|||+ +.+++|.+++.+...+++..+..++.||+.||+|||++||+||||||+||+++ .++ .+||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~----~~kl~ 182 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG----CAKLI 182 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT----EEEEC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC----eEEEE
Confidence 9999999999999 78999999998888899999999999999999999999999999999999998 565 79999
Q ss_pred eccccccccC-CCccccCCCcccCccccccCCCC-hhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy6820 522 DFGLAQRVLR-PMFTVCGTPTYVAPEILNESGYG-VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599 (639)
Q Consensus 522 DFGla~~~~~-~~~~~~GT~~Y~APE~l~~~~~s-~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~ 599 (639)
|||++..... ......||+.|+|||++.+..+. .++||||||+++|+|++|..||... . .+......++
T Consensus 183 dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~----~~~~~~~~~~- 253 (312)
T 2iwi_A 183 DFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----Q----EILEAELHFP- 253 (312)
T ss_dssp CCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H----HHHHTCCCCC-
T ss_pred EcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----H----HHhhhccCCc-
Confidence 9999986653 33456799999999999877664 5999999999999999999999532 1 2333333333
Q ss_pred CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 600 PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 600 ~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..++.++.+||.+||+.||++|||++|+++||||++
T Consensus 254 ---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 254 ---AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred ---ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 568999999999999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=371.04 Aligned_cols=253 Identities=20% Similarity=0.260 Sum_probs=211.9
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 453 (639)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.+++++ +||||+++++++...+..|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 34789999999999999999999999999999999875432 23577899999999 899999999999999999999
Q ss_pred EeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCc-eeeeEEEeeccccccccC
Q psy6820 454 IELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC-HVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~-~~~~vKL~DFGla~~~~~ 531 (639)
|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. ....+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999 9999999976 468999999999999999999999999999999999999988761 111299999999986543
Q ss_pred C----------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-ChHHHHHHHHcCCCCCCCC
Q psy6820 532 P----------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQYGFPSP 600 (639)
Q Consensus 532 ~----------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-~~~~l~~~i~~~~~~~p~~ 600 (639)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+.+..+.......+..
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 2 2457899999999999999999999999999999999999999976543 3344455554433322221
Q ss_pred C-cccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 601 Y-WDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 601 ~-~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
. ...+| ++.+||..||+.||.+||+++++++
T Consensus 243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 12345 9999999999999999999998875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=361.68 Aligned_cols=250 Identities=23% Similarity=0.406 Sum_probs=214.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEE-----cCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCc
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYD-----KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 449 (639)
.++|.+.+.||+|+||.||+|.+ ..+++.||+|++.........+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 36899999999999999999985 4567899999998766555567788999999999 89999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccC
Q psy6820 450 LYLVIELIKGGDLFDAISKNV------------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMS 511 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~------------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~ 511 (639)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC
Confidence 999999999999999997653 48999999999999999999999999999999999999988
Q ss_pred CceeeeEEEeeccccccccCCC-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHH
Q psy6820 512 GCHVKVLKVGDFGLAQRVLRPM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDE 585 (639)
Q Consensus 512 g~~~~~vKL~DFGla~~~~~~~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~ 585 (639)
+ .+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++ |..||...... ..
T Consensus 182 ~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~ 256 (313)
T 1t46_A 182 R----ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SK 256 (313)
T ss_dssp T----EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HH
T ss_pred C----CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-hH
Confidence 7 89999999997665332 23457889999999999999999999999999999999 99999765433 33
Q ss_pred HHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 586 LFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 586 l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
....+... ... .....++.++.+||.+||+.||++|||+.|++++
T Consensus 257 ~~~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 257 FYKMIKEG-FRM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHT-CCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccC-CCC--CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 33333333 222 2235689999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=372.42 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=203.1
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch----------hHHHHHHHHHHHHhcCCCceeeeeee
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG----------KKQMIENEVNILRSVNHPNIIKLLDE 443 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~----------~~~~~~~Ei~iL~~l~HpnIv~l~~~ 443 (639)
.+.++|.+.+.||+|+||.||+|.+.. ++.||+|++....... ..+.+.+|+.++++++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 456899999999999999999998765 8899999986533221 12668899999999999999999999
Q ss_pred ee-----cCCceEEEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeee
Q psy6820 444 YD-----TNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKV 517 (639)
Q Consensus 444 ~~-----~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~ 517 (639)
+. ....+|+||||+. |+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~----~ 172 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN----D 172 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----C
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC----C
Confidence 83 3346899999997 5888887654 4799999999999999999999999999999999999999887 7
Q ss_pred EEEeeccccccccC--CCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC-
Q psy6820 518 LKVGDFGLAQRVLR--PMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG- 593 (639)
Q Consensus 518 vKL~DFGla~~~~~--~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~- 593 (639)
+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+...
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~ 250 (362)
T 3pg1_A 173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST--FYNQLNKIVEVV 250 (362)
T ss_dssp EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHH
T ss_pred EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHc
Confidence 99999999975443 2345679999999999876 679999999999999999999999996543 33333333211
Q ss_pred -----------------------CCCCCCCC----cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 -----------------------QYGFPSPY----WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 -----------------------~~~~p~~~----~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
....+... .+.+++.+.+||.+||+.||++|||+.|+++||||++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 11111111 1346889999999999999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=373.20 Aligned_cols=249 Identities=23% Similarity=0.392 Sum_probs=216.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC-------CCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH-------KDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTN 447 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 447 (639)
.++|.+++.||+|+||.||+|.+.. .+..||+|++...........+.+|+.+++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 3689999999999999999998754 33579999998765555557788999999999 899999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccC
Q psy6820 448 NELYLVIELIKGGDLFDAISKNV----------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMS 511 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~ 511 (639)
+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 227 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC
Confidence 99999999999999999997643 49999999999999999999999999999999999999988
Q ss_pred CceeeeEEEeeccccccccC-----CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHH
Q psy6820 512 GCHVKVLKVGDFGLAQRVLR-----PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDE 585 (639)
Q Consensus 512 g~~~~~vKL~DFGla~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~ 585 (639)
+ .+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||... ...+
T Consensus 228 ~----~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~--~~~~ 301 (382)
T 3tt0_A 228 N----VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEE 301 (382)
T ss_dssp C----CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHH
T ss_pred C----cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHH
Confidence 7 899999999976542 2234567889999999999999999999999999999999 99999643 4566
Q ss_pred HHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 586 LFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 586 l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+...+..+... .....+++++.+||.+||+.||++|||+.|++++
T Consensus 302 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66666665322 2235789999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.43 Aligned_cols=250 Identities=23% Similarity=0.392 Sum_probs=209.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEE-----cCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCc
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYD-----KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 449 (639)
.++|.+.+.||+|+||.||+|.+ ..++..||+|++.........+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46899999999999999999987 3456789999998654444456788999999999 89999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q psy6820 450 LYLVIELIKGGDLFDAISKNV-----------------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENL 506 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~-----------------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NI 506 (639)
.|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 999999999999999997643 379999999999999999999999999999999999
Q ss_pred EEccCCceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCC
Q psy6820 507 LVEMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDT 580 (639)
Q Consensus 507 Lld~~g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~ 580 (639)
|++.++ .+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|+| |..||....
T Consensus 204 ll~~~~----~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 204 LVTHGK----VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp EEETTT----EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred EEcCCC----cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999887 8999999999765432 123457889999999999999999999999999999998 999997654
Q ss_pred CChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 581 NDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 581 ~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.. ......+..+ ...+ ....+++++.+||.+||+.||++|||+.++++|
T Consensus 280 ~~-~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 280 VD-ANFYKLIQNG-FKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CS-HHHHHHHHTT-CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cH-HHHHHHHhcC-CCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 33 3333333333 2222 235689999999999999999999999999976
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=377.98 Aligned_cols=248 Identities=24% Similarity=0.410 Sum_probs=213.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 36899999999999999999999999999999999765443344567899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc
Q psy6820 456 LIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534 (639)
Q Consensus 456 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~ 534 (639)
|+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~----~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN----VLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----CEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC----cEEECcCCCceecCCCce
Confidence 99999999999764 4699999999999999999999999999999999999999887 899999999976543322
Q ss_pred -----cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 535 -----TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 535 -----~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
...+++.|+|||++.+..++.++|||||||++|||++ |..||... ...++.+.+..+. ..+ ....++++
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~-~~~--~~~~~~~~ 343 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL--SNQQTREFVEKGG-RLP--CPELCPDA 343 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS--CHHHHHHHHHTTC-CCC--CCTTCCHH
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC-CCC--CCCCCCHH
Confidence 2235678999999998899999999999999999998 99999654 3344445554442 222 23568999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+||.+||+.||++|||++++++
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.70 Aligned_cols=257 Identities=23% Similarity=0.391 Sum_probs=199.4
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH-HHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~-~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
..++|++.+.||+|+||.||+|.+..+++.||+|++......... +.+.++..+++.++||||+++++++.+.+..|+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 357899999999999999999999999999999999866543333 3444566678888999999999999999999999
Q ss_pred EeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 454 IELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDN-YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~-givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
|||+ ++.+..+... ...+++..+..++.+|+.||+|||++ |++||||||+||+++.++ .+||+|||++.....
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~----~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG----QIKLCDFGISGRLVD 177 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS----CEEECCCTTC-----
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC----CEEEEECCCchhccC
Confidence 9999 5556555543 56799999999999999999999995 999999999999999887 899999999976543
Q ss_pred C--CccccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 532 P--MFTVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 532 ~--~~~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
. .....||+.|+|||++. ...++.++||||||+++|+|++|..||..... ..+....+....... .+....
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~-~~~~~~ 255 (318)
T 2dyl_A 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-DFEVLTKVLQEEPPL-LPGHMG 255 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-HHHHHHHHHHSCCCC-CCSSSC
T ss_pred CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cHHHHHHHhccCCCC-CCccCC
Confidence 2 33457999999999994 56789999999999999999999999975433 344455555543222 122346
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+++++.+||.+||+.||++||+++++++||||++
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 8999999999999999999999999999999964
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=362.23 Aligned_cols=253 Identities=27% Similarity=0.411 Sum_probs=209.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcC--CCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVN--HPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~~~~l 452 (639)
.++|++.+.||+|+||.||+|.+.. ++.||+|++...... ...+.+.+|+.++++++ ||||+++++++...+..|+
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 4679999999999999999998754 788999999765433 23467889999999997 5999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+ .+++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++. + .+||+|||++......
T Consensus 106 v~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~----~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 106 VMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G----MLKLIDFGIANQMQPD 179 (313)
T ss_dssp EECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T----EEEECCCSSSCC----
T ss_pred EEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C----eEEEeeccccccccCc
Confidence 9995 58899999998889999999999999999999999999999999999999964 4 7999999999765432
Q ss_pred -----CccccCCCcccCcccccc-----------CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 533 -----MFTVCGTPTYVAPEILNE-----------SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 533 -----~~~~~GT~~Y~APE~l~~-----------~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
....+||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... ......+......
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~ 258 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHE 258 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHHHHHHHCTTSC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-HHHHHHHHhcccc
Confidence 234579999999999875 47899999999999999999999999754433 3333444443322
Q ss_pred CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 597 ~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
. ......+.++.+||.+||+.||++||+++|+++||||+.
T Consensus 259 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 259 I--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp C--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred c--CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 2 222456899999999999999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=357.13 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=203.2
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCC---CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
..++|++.+.||+|+||.||+|.+..+ +..+|+|++.........+.+.+|+.++++++||||+++++++. .+..|
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 347899999999999999999988654 45799999876655555677889999999999999999999984 56789
Q ss_pred EEEeeccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----EEEECC--------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC----CEEECccccccccC
Confidence 9999999999999997654 699999999999999999999999999999999999999887 89999999997664
Q ss_pred CC----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 531 RP----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 531 ~~----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
.. .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.... ..+....+..+.. .+....+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~--~~~~~~~i~~~~~---~~~~~~~ 242 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGER---LPMPPNC 242 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTCC---CCCCTTC
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC--HHHHHHHHHcCCC---CCCCCCC
Confidence 32 223456789999999999999999999999999999996 999996543 3445555655432 2233678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
++++.++|.+||+.||++|||+.|++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=350.99 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=201.0
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL---GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
..++|++.+.||+|+||.||+|.+. +..+|+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 3578999999999999999999875 778999998754332 22356889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCceEEccCCc----eeeeEEEeecc
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY---IVHRDIKPENLLVEMSGC----HVKVLKVGDFG 524 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~g---ivHrDLKp~NILld~~g~----~~~~vKL~DFG 524 (639)
+||||+++++|.+++. ...+++..+..++.|++.||+|||++| |+||||||+|||++.+.. ....+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999999985 457999999999999999999999999 899999999999986311 11379999999
Q ss_pred ccccccCC-CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc
Q psy6820 525 LAQRVLRP-MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 525 la~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||... +.......+.......+ ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~--~~~ 237 (271)
T 3dtc_A 162 LAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--DGLAVAYGVAMNKLALP--IPS 237 (271)
T ss_dssp C-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS--CHHHHHHHHHTSCCCCC--CCT
T ss_pred cccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHhhhcCCCCCC--CCc
Confidence 99765433 33567999999999999999999999999999999999999999654 33444444444433332 336
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+++++.++|.+||+.||++|||+.|+++|
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 789999999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.51 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=215.4
Q ss_pred cccCCCeeEEEEEccCCceEEEEEE-----EcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVY-----DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN 447 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 447 (639)
....++|++.+.||+|+||.||+|. +..++..||+|++...........+.+|+.++++++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 3445789999999999999999998 55678899999997655555566788999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEE
Q psy6820 448 NELYLVIELIKGGDLFDAISKN-------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~-------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL 520 (639)
+..|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.. ..+||
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~-~~~kl 184 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG-RVAKI 184 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT-CCEEE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc-ceEEE
Confidence 9999999999999999999765 348999999999999999999999999999999999999855411 36999
Q ss_pred eeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCC
Q psy6820 521 GDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQ 594 (639)
Q Consensus 521 ~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~ 594 (639)
+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|+| |..||... ....+...+..+.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVTSGG 262 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc--CHHHHHHHHhcCC
Confidence 999999754322 234567999999999999999999999999999999998 99999653 4455666666554
Q ss_pred CCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 595 ~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
... ....++.++.+||.+||+.||++||++.++++|.|+
T Consensus 263 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 263 RMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 322 225789999999999999999999999999999775
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=360.51 Aligned_cols=250 Identities=22% Similarity=0.392 Sum_probs=212.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEE-----cCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCC-
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYD-----KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNN- 448 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~- 448 (639)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++.........+.+.+|+.+++++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999985 3567899999998765555556788999999999 6999999999987654
Q ss_pred ceEEEEeeccCCChHHHHhhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVK----------------FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG 512 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~----------------l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g 512 (639)
.+++||||+++++|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence 59999999999999999976543 89999999999999999999999999999999999999877
Q ss_pred ceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHH
Q psy6820 513 CHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDEL 586 (639)
Q Consensus 513 ~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l 586 (639)
.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++ |..||...... ..+
T Consensus 186 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~ 260 (316)
T 2xir_A 186 ----VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEF 260 (316)
T ss_dssp ----CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HHH
T ss_pred ----CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh-HHH
Confidence 8999999999765432 123567899999999999999999999999999999998 99999765443 334
Q ss_pred HHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 587 ~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
...+..+.. . .....+++++.++|.+||+.||++|||+.|+++|
T Consensus 261 ~~~~~~~~~-~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEGTR-M--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTCC-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCcc-C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444444322 1 1224689999999999999999999999999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=364.10 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=214.3
Q ss_pred cCCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEE--EEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q psy6820 369 LNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDC--ALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYD 445 (639)
Q Consensus 369 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~v--AiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 445 (639)
...|....++|++.+.||+|+||.||+|.+..++..+ |+|.+.........+.+.+|+.+++++ +||||+++++++.
T Consensus 17 ~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 17 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp CCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 3455556689999999999999999999998888765 999987654444456788999999999 8999999999999
Q ss_pred cCCceEEEEeeccCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEc
Q psy6820 446 TNNELYLVIELIKGGDLFDAISKNV----------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE 509 (639)
Q Consensus 446 ~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld 509 (639)
+.+..|+||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 9999999999999999999997653 699999999999999999999999999999999999999
Q ss_pred cCCceeeeEEEeeccccccccC--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHH
Q psy6820 510 MSGCHVKVLKVGDFGLAQRVLR--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDEL 586 (639)
Q Consensus 510 ~~g~~~~~vKL~DFGla~~~~~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l 586 (639)
.++ .+||+|||++..... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||... ...++
T Consensus 177 ~~~----~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--~~~~~ 250 (327)
T 1fvr_A 177 ENY----VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAEL 250 (327)
T ss_dssp GGG----CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHH
T ss_pred CCC----eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC--cHHHH
Confidence 887 899999999975432 2234457889999999999889999999999999999998 99999654 44555
Q ss_pred HHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 587 ~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
...+..+. .......+++++.+||.+||+.||++|||++|+++|
T Consensus 251 ~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 251 YEKLPQGY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHGGGTC---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhcCC---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55555542 122235789999999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=360.98 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=207.1
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
....++|++.+.||+|+||.||+|.+..+++.||+|++........ .+.+.+|+.++++++||||+++++++...+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 4456899999999999999999999999999999999976543322 36688999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|+||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~----~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD----FAYLVDFGIASATT 185 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS----CEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC----CEEEecCccCcccc
Confidence 99999999999999998888899999999999999999999999999999999999999887 89999999997654
Q ss_pred CC----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 531 RP----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 531 ~~----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..............+......++
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 262 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---LSVMGAHINQAIPRPSTVRPGIP 262 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---HHHHHHHHHSCCCCGGGTSTTCC
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---HHHHHHHhccCCCCccccCCCCC
Confidence 32 234578999999999999999999999999999999999999996532 22333444444444444556789
Q ss_pred HHHHHHHHHhcccCCCCCC-CHHHHHc
Q psy6820 607 EEAKELISHMLESNPDLRF-SAEDVLD 632 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rp-ta~eiL~ 632 (639)
+++.+||.+||+.||++|| +++++++
T Consensus 263 ~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 263 VAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp THHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999999999 8888764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=357.91 Aligned_cols=255 Identities=20% Similarity=0.261 Sum_probs=213.5
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 452 (639)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.+++.+ +|+|++++++++......++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 345789999999999999999999999999999999865432 34567899999999 69999999999999999999
Q ss_pred EEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCc-eeeeEEEeecccccccc
Q psy6820 453 VIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC-HVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~-~~~~vKL~DFGla~~~~ 530 (639)
||||+ +++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ....+||+|||++....
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999 99999999764 46999999999999999999999999999999999999987651 12249999999997664
Q ss_pred CC----------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-ChHHHHHHHHcCCCCCC-
Q psy6820 531 RP----------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQYGFP- 598 (639)
Q Consensus 531 ~~----------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-~~~~l~~~i~~~~~~~p- 598 (639)
.. .....||+.|+|||++.+..++.++||||||+++|||++|..||..... .....+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 32 2356799999999999999999999999999999999999999976443 33444444433322111
Q ss_pred CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 599 SPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 599 ~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
......+++++.+||.+||+.||++||+++++++
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1122468999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=364.28 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=202.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeE----EEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMD----CALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~----vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
.++|++.+.||+|+||.||+|.+..+++. +|+|.+...........+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 36799999999999999999998877655 47777765444445577889999999999999999999998754 78
Q ss_pred EEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+|+||+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT----EEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC----CEEEccCcceeEcc
Confidence 99999999999999976 45799999999999999999999999999999999999999887 89999999997654
Q ss_pred CC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 531 RP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 531 ~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
.. .....||+.|+|||++.+..++.++|||||||++|||++ |..||.... ...+...+..+.. .+ ....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~~-~~--~~~~ 243 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGER-LP--QPPI 243 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTCC-CC--CCTT
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC--HHHHHHHHHcCCC-CC--CCcc
Confidence 32 223456889999999999999999999999999999999 999996543 3344444444432 22 2356
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
++.++.+|+.+||+.||++||++.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 89999999999999999999999999865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=355.90 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=204.6
Q ss_pred cCCCeeEEEEEccCCceEEEEEE----EcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec--CC
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVY----DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT--NN 448 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~ 448 (639)
..++|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 34789999999999999999998 56788999999997543 2334668899999999999999999998854 35
Q ss_pred ceEEEEeeccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
.+++||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~----~~kl~Dfg~~~ 162 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTK 162 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----EEEECCCCSCC
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC----eEEEccCcccc
Confidence 6899999999999999997654 599999999999999999999999999999999999999887 89999999997
Q ss_pred cccCC------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC-----------h---HHHH
Q psy6820 528 RVLRP------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND-----------Q---DELF 587 (639)
Q Consensus 528 ~~~~~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~-----------~---~~l~ 587 (639)
..... .....+|+.|+|||++.+..++.++||||||+++|+|+||..||...... . ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 65432 22345778899999999999999999999999999999999998532110 0 0122
Q ss_pred HHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 588 DDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 588 ~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
..+... .. .+....+++++.+||.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~-~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 243 ELLKNN-GR--LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHTT-CC--CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhcc-Cc--CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 222222 12 2233678999999999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=356.13 Aligned_cols=254 Identities=31% Similarity=0.518 Sum_probs=207.7
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 4457899999999999999999999999999999999764332 23456789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 452 LVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
+||||+++++|.+++.. ...+++..+..++.+|+.||+|||++|++||||||+||+++.++ .+||+|||++.
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~----~~kl~Dfg~~~ 184 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGR 184 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----CEEECCC----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC----CEEEEecccee
Confidence 99999999999999864 45699999999999999999999999999999999999999887 89999999997
Q ss_pred cccCC---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 528 RVLRP---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 528 ~~~~~---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.........+...+..... +......
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 262 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDH 262 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS--CCCCTTT
T ss_pred eecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC--CCCcccc
Confidence 65432 234578999999999999999999999999999999999999998766555666666655433 2222357
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+++++.+||.+||+.||++|||+.+++++
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 89999999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=356.22 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=207.2
Q ss_pred CCCeeEEEEEccCCceEEEEEE----EcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC--Cc
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVY----DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN--NE 449 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~ 449 (639)
.++|++.+.||+|+||.||+|. +..+++.||+|++.........+.+.+|+.+++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3569999999999999999998 56789999999998665545557788999999999999999999999876 67
Q ss_pred eEEEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 450 LYLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
+++||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~----~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----QVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT----EEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC----CEEECccccccc
Confidence 8999999999999999954 46799999999999999999999999999999999999999887 899999999976
Q ss_pred ccCC------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCC-------------CChHHHHHH
Q psy6820 529 VLRP------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDT-------------NDQDELFDD 589 (639)
Q Consensus 529 ~~~~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~-------------~~~~~l~~~ 589 (639)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..|+.... .....+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6432 234568889999999999999999999999999999999999863211 011222233
Q ss_pred HHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 590 ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 590 i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+..+. ..+....+++++.+||.+||+.||++|||+.++++
T Consensus 256 ~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 256 LKEGK---RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHTTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HhccC---CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 33322 22234678999999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=346.84 Aligned_cols=245 Identities=24% Similarity=0.397 Sum_probs=213.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 68999999999999999999886 5678999999865543 46788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 457 IKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~----~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ----VIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG----CEEECCTTGGGGBCCHHHH
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC----CEEEccccccccccccccc
Confidence 9999999999764 5689999999999999999999999999999999999998887 8999999999765432
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....||+.|+|||++.+..++.++||||||+++|+|++ |..||... ........+..+.... ....+++++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~i~~~~~~~---~~~~~~~~l~ 235 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLY---KPRLASTHVY 235 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCC---CCTTSCHHHH
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC--CHHHHHHHHhcCCcCC---CCccCcHHHH
Confidence 234567889999999999999999999999999999999 89999653 4556666666653222 2246799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+++.+||+.||++|||+.+++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.37 Aligned_cols=248 Identities=19% Similarity=0.272 Sum_probs=206.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeE----EEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMD----CALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~----vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
.++|++.+.||+|+||.||+|.+..+++. +|+|.+...........+.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 46899999999999999999999887765 77777754433333345678999999999999999999986 56789
Q ss_pred EEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~----~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS----QVQVADFGVADLLP 166 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS----CEEECSCSGGGGSC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC----eEEECCCCcccccC
Confidence 999999999999999764 5799999999999999999999999999999999999999887 79999999998764
Q ss_pred CC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 531 RP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 531 ~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
.. .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.... ...+...+..+.... ....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~~---~~~~ 241 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--LAEVPDLLEKGERLA---QPQI 241 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--TTHHHHHHHTTCBCC---CCTT
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC--HHHHHHHHHcCCCCC---CCCc
Confidence 32 234567889999999999999999999999999999999 999997643 344455555543221 1245
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
++.++.+||.+||+.||++|||+.++++|
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78899999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=375.54 Aligned_cols=258 Identities=22% Similarity=0.410 Sum_probs=212.7
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC--ceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN--ELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~l 452 (639)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.++++++||||+++++++...+ ..|+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 35689999999999999999999999999999999987665555677889999999999999999999987665 7899
Q ss_pred EEeeccCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 453 VIELIKGGDLFDAISKNVK---FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
||||+++|+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||+..+......+||+|||++...
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 9999999999999976433 9999999999999999999999999999999999998222111237999999999766
Q ss_pred cCC--CccccCCCcccCcccccc--------CCCChhhhHHHHHHHHHHHHcCCCCCCCCC--CChHHHHHHHHcCCCC-
Q psy6820 530 LRP--MFTVCGTPTYVAPEILNE--------SGYGVKIDVWAAGVILYILLCGFPPFVSDT--NDQDELFDDILSGQYG- 596 (639)
Q Consensus 530 ~~~--~~~~~GT~~Y~APE~l~~--------~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~--~~~~~l~~~i~~~~~~- 596 (639)
... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.... ....+....+..+...
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred cCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 432 345679999999999865 567889999999999999999999996432 2334455555554321
Q ss_pred --------------------CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 597 --------------------FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 597 --------------------~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+......++..+.++|++||+.||++||+++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 111122456788999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=360.47 Aligned_cols=250 Identities=20% Similarity=0.381 Sum_probs=212.3
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCe-----EEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCc
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDM-----DCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 449 (639)
.++|.+.+.||+|+||.||+|.+..++. .||+|++.........+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4789999999999999999999876654 79999998766555567788999999999 89999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCcee
Q psy6820 450 LYLVIELIKGGDLFDAISKN--------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHV 515 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~--------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~ 515 (639)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--- 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH--- 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG---
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC---
Confidence 99999999999999999653 3589999999999999999999999999999999999999887
Q ss_pred eeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHH
Q psy6820 516 KVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDD 589 (639)
Q Consensus 516 ~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~ 589 (639)
.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++ |..||...... ......
T Consensus 202 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~ 279 (333)
T 2i1m_A 202 -VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYKL 279 (333)
T ss_dssp -EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHHHHH
T ss_pred -eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-HHHHHH
Confidence 8999999999765432 123456889999999999999999999999999999998 99999765433 233333
Q ss_pred HHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 590 ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 590 i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+.. ....+ ....+++++.+||.+||+.||++|||+.|++++
T Consensus 280 ~~~-~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 280 VKD-GYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHH-TCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hhc-CCCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 333 22222 224678999999999999999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=355.69 Aligned_cols=250 Identities=19% Similarity=0.289 Sum_probs=207.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCC-------eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKD-------MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN 448 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-------~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 448 (639)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 468999999999999999999988776 5799999965432 34567889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCce----eeeEEEeec
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVK-FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH----VKVLKVGDF 523 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~----~~~vKL~DF 523 (639)
..++||||+++++|.+++.+... +++..+..++.||+.||+|||++||+||||||+|||++.++.. ...+||+||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 99999999999999999977654 9999999999999999999999999999999999999887611 112999999
Q ss_pred cccccccCCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCc
Q psy6820 524 GLAQRVLRPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 524 Gla~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
|++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..|+.... +.... .........++
T Consensus 166 g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-~~~~~-~~~~~~~~~~~---- 238 (289)
T 4fvq_A 166 GISITVLP-KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-DSQRK-LQFYEDRHQLP---- 238 (289)
T ss_dssp CSCTTTSC-HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHHH-HHHHHTTCCCC----
T ss_pred cccccccC-ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-chHHH-HHHhhccCCCC----
Confidence 99965533 234568999999999987 779999999999999999999654443332 22222 23333333333
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
...++++.+||.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 239 APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3467899999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=360.03 Aligned_cols=249 Identities=21% Similarity=0.361 Sum_probs=215.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEc-----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDK-----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|++.+.||+|+||.||+|.+. .+++.||+|++...........+.+|+.+++.++||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 468999999999999999999876 357789999998665555556788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEE
Q psy6820 451 YLVIELIKGGDLFDAISKN----------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~----------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL 520 (639)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~----~~kl 179 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF----TVKI 179 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC----CEEE
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC----eEEE
Confidence 9999999999999999652 3579999999999999999999999999999999999999887 8999
Q ss_pred eeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCC
Q psy6820 521 GDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQ 594 (639)
Q Consensus 521 ~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~ 594 (639)
+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++ |..||... ....+...+..+.
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFVMEGG 257 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CHHHHHHHHHTTC
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC--CHHHHHHHHHcCC
Confidence 999999765432 223456889999999999999999999999999999999 89999653 4556666666654
Q ss_pred CCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 595 ~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
... ....++.++.+||.+||+.||++|||+.|+++|
T Consensus 258 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 322 225789999999999999999999999999976
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=361.20 Aligned_cols=249 Identities=23% Similarity=0.394 Sum_probs=213.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEc-------CCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDK-------HKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTN 447 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 447 (639)
.++|++++.||+|+||.||+|.+. .++..||+|++.........+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 368999999999999999999875 356789999998765545556788999999999 899999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccC
Q psy6820 448 NELYLVIELIKGGDLFDAISKNV----------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMS 511 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~ 511 (639)
+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 193 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC
Confidence 99999999999999999997653 38999999999999999999999999999999999999988
Q ss_pred CceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHH
Q psy6820 512 GCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDE 585 (639)
Q Consensus 512 g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~ 585 (639)
+ .+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ...+
T Consensus 194 ~----~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~ 267 (334)
T 2pvf_A 194 N----VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEE 267 (334)
T ss_dssp C----CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHH
T ss_pred C----CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC--CHHH
Confidence 7 8999999999765432 233457889999999998889999999999999999999 99999653 4556
Q ss_pred HHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 586 LFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 586 l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+...+..+... .....++.++.++|.+||+.||++|||+.|++++
T Consensus 268 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66666555321 2235789999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=352.30 Aligned_cols=247 Identities=23% Similarity=0.390 Sum_probs=214.3
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
..++|++.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 35789999999999999999999999999999999976432 3567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 455 ELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||+++++|.+++... ..+++..+..++.+|+.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~----~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG----CEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC----CEEEccCccceeccCC
Confidence 999999999999763 4599999999999999999999999999999999999998887 8999999999866533
Q ss_pred C----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 533 M----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 533 ~----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
. ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... ...+...+..... .+....+++
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~--~~~~~~~~~~~~~---~~~~~~~~~ 239 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYR---MERPEGCPE 239 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTTCC---CCCCTTCCH
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhccCC---CCCCCCCCH
Confidence 2 23456889999999999999999999999999999999 999996543 3444444544321 222357899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++.+||.+||+.||++|||++++++
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.90 Aligned_cols=244 Identities=27% Similarity=0.486 Sum_probs=202.0
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||+|... ++.||+|++... ...+.+.+|+.++++++||||+++++++.+ ..|+|||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 468999999999999999999775 678999998653 235678899999999999999999998874 4899999
Q ss_pred eccCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 456 LIKGGDLFDAISKNV---KFSEEDSKFMTQSLASALSYLHD---NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~---~l~~~~~~~i~~qI~~aL~yLH~---~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
|+++++|.+++.... .++...+..++.|++.||+|||+ +||+||||||+|||++.++ ..+||+|||++...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG---TVLKICDFGTACDI 156 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT---TEEEECCCCC----
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC---CEEEEccccccccc
Confidence 999999999997654 47899999999999999999999 8999999999999998876 24899999999877
Q ss_pred cCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 530 LRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 530 ~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
........||+.|+|||++.+..++.++||||||+++|||++|..||.........+...+..+. ..+....+++++
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 233 (307)
T 2eva_A 157 QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIKNLPKPI 233 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCBTTCCHHH
T ss_pred ccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCcccccCHHH
Confidence 66556677999999999999999999999999999999999999999765555444444444432 223346789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHc
Q psy6820 610 KELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+||.+||+.||++|||++++++
T Consensus 234 ~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 234 ESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.09 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=211.6
Q ss_pred CCeeEEE-EEccCCceEEEEEEEc--CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQ-IIGDGNFAVVRQVYDK--HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~-~LG~G~fG~Vy~a~~~--~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
++|.+.+ .||+|+||.||+|.+. .++..||+|++.........+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5677776 9999999999999854 467889999998765555567788999999999999999999999 45679999
Q ss_pred EeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT----EEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC----CEEECcccceeeeccC
Confidence 9999999999999653 5699999999999999999999999999999999999999887 8999999999766422
Q ss_pred ------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 533 ------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 533 ------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
.....||+.|+|||++.+..++.++||||||+++|+|++ |..||.... ..++...+..+.. .+....+
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~i~~~~~---~~~~~~~ 238 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKR---MECPPEC 238 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTCC---CCCCTTC
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHhcCCc---CCCCCCc
Confidence 223456899999999998889999999999999999998 999996543 3455556655432 2223578
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDHP 634 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~HP 634 (639)
++++.+||.+||+.||++||++.++++|.
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=350.56 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=208.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC---CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH---KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++.........+.+.+|+.+++.++||||+++++++.+ +..|+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4789999999999999999998654 3456999999876555556778899999999999999999999865 45789
Q ss_pred EEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
||||+++++|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE----CVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT----EEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC----cEEeCccCCCccccc
Confidence 99999999999999764 4599999999999999999999999999999999999999887 899999999976643
Q ss_pred C----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 532 P----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 532 ~----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
. .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+..+.. . +....++
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--~~~~~~~~~~~~-~--~~~~~~~ 240 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVLEKGDR-L--PKPDLCP 240 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--GGHHHHHHHTCC-C--CCCTTCC
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--HHHHHHHhcCCC-C--CCCCCCC
Confidence 2 233457889999999999999999999999999999998 9999965432 334444444322 1 2225689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+.+.+||.+||+.||++|||+.|++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 999999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=346.92 Aligned_cols=246 Identities=15% Similarity=0.215 Sum_probs=207.8
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC--CceE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTN--NELY 451 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~ 451 (639)
..++|.+.+.||+|+||.||+|.+. +..+|+|++...... ...+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 3578999999999999999999875 778999999866533 3345688999999999999999999999877 7889
Q ss_pred EEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 452 LVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNY--IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~g--ivHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++| ++||||||+||+++.++ .++|+|||++.
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~----~~~l~~~~~~~ 161 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM----TARISMADVKF 161 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS----CEEEEGGGSCC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc----ceeEEecccee
Confidence 9999999999999998765 4899999999999999999999999 99999999999999887 78899888875
Q ss_pred cccCCCccccCCCcccCccccccCCCC---hhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 528 RVLRPMFTVCGTPTYVAPEILNESGYG---VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 528 ~~~~~~~~~~GT~~Y~APE~l~~~~~s---~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
... .....||+.|+|||++.+..++ .++||||||+++|||++|..||... ........+....... .....
T Consensus 162 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~~--~~~~~ 235 (271)
T 3kmu_A 162 SFQ--SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL--SNMEIGMKVALEGLRP--TIPPG 235 (271)
T ss_dssp TTS--CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS--CHHHHHHHHHHSCCCC--CCCTT
T ss_pred eec--ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc--ChHHHHHHHHhcCCCC--CCCCC
Confidence 433 2345789999999999876544 4899999999999999999999654 3344444444443222 23467
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+++++.++|.+||+.||++|||++++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8999999999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=375.28 Aligned_cols=243 Identities=23% Similarity=0.359 Sum_probs=207.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC-ceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN-ELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-~~~lV~ 454 (639)
.++|++.+.||+|+||.||+|... ++.||||+++... ..+.+.+|+.++++++||||+++++++...+ .+|+||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 468999999999999999999775 6799999997654 3467889999999999999999999976654 799999
Q ss_pred eeccCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 455 ELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||+++|+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASST 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS----CEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC----CEEEeeCCCccccccc
Confidence 99999999999976543 79999999999999999999999999999999999999887 8999999999866554
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....+++.|+|||++.+..++.++||||||+++|||++ |..||..... .++...+..+. .. +....+++++.+
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~-~~--~~p~~~~~~l~~ 417 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGY-KM--DAPDGCPPAVYD 417 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--TTHHHHHHTTC-CC--CCCTTCCHHHHH
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC-CC--CCCCcCCHHHHH
Confidence 445578899999999999999999999999999999998 9999976543 33445555542 22 223678999999
Q ss_pred HHHHhcccCCCCCCCHHHHHc
Q psy6820 612 LISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~ 632 (639)
||.+||+.||++|||+.++++
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=350.38 Aligned_cols=247 Identities=21% Similarity=0.322 Sum_probs=208.2
Q ss_pred CCCeeEEE-EEccCCceEEEEEEE--cCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 376 LQRYSVGQ-IIGDGNFAVVRQVYD--KHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 376 ~~~y~i~~-~LG~G~fG~Vy~a~~--~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
.++|.+.+ .||+|+||.||+|.+ ..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 36799988 999999999999954 5667899999997654322 246788999999999999999999999 567789
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~----~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT----EEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC----cEEEccCCcceeecc
Confidence 9999999999999999888899999999999999999999999999999999999999887 899999999976643
Q ss_pred C------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 532 P------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 532 ~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
. .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ....+...+..+.. ......
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~---~~~~~~ 244 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGER---MGCPAG 244 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCC---CCCCTT
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCC---CCCCCC
Confidence 2 123346789999999998889999999999999999999 99999654 44555555655432 222357
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+++++.++|.+||+.||++||++.++++
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=350.44 Aligned_cols=249 Identities=28% Similarity=0.463 Sum_probs=200.2
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
..++|++.+.||+|+||.||+|.... .+|+|++...... ...+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34789999999999999999997544 5999999765433 3346788999999999999999999965 55678999
Q ss_pred EeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 454 IELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
|||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN----TVKIGDFGLATEKSRW 173 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT----EEEECCCC--------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC----CEEEccceeccccccc
Confidence 999999999999954 45799999999999999999999999999999999999999887 899999999975432
Q ss_pred ----CCccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC-CCCcc
Q psy6820 532 ----PMFTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP-SPYWD 603 (639)
Q Consensus 532 ----~~~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p-~~~~~ 603 (639)
......||+.|+|||++. +..++.++||||||+++|+|++|..||.... ..+.+...+..+....+ .....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-CHHHHHHHHHHTSCCCCTTSSCT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-hHHHHHHHhcccccCcchhhccc
Confidence 223467999999999986 6678999999999999999999999996543 44555555555544332 23345
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+++++.+||.+||+.||++|||++++++
T Consensus 253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 78999999999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=353.99 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=198.8
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHh--cCCCceeeeeeeeec----C
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRS--VNHPNIIKLLDEYDT----N 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~----~ 447 (639)
.+.++|++.+.||+|+||.||+|.. +++.||+|++.... ...+.+|.+++.. ++||||+++++++.. .
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 4557899999999999999999977 57899999986542 3444566666666 789999999998643 3
Q ss_pred CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCceEEccCCceeeeEE
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH--------DNYIVHRDIKPENLLVEMSGCHVKVLK 519 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH--------~~givHrDLKp~NILld~~g~~~~~vK 519 (639)
..+|+||||+++|+|.++++. ..+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+|
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~----~~k 153 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG----QCC 153 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS----CEE
T ss_pred ceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC----CEE
Confidence 568999999999999999954 57999999999999999999999 99999999999999999887 899
Q ss_pred EeeccccccccCC-------CccccCCCcccCccccccC------CCChhhhHHHHHHHHHHHHcC----------CCCC
Q psy6820 520 VGDFGLAQRVLRP-------MFTVCGTPTYVAPEILNES------GYGVKIDVWAAGVILYILLCG----------FPPF 576 (639)
Q Consensus 520 L~DFGla~~~~~~-------~~~~~GT~~Y~APE~l~~~------~~s~~sDVwSLGvvL~eLltG----------~~Pf 576 (639)
|+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999999765432 2234799999999999876 455799999999999999999 8888
Q ss_pred CCCCC---ChHHHHHHHHcCCCCCCCC---CcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 577 VSDTN---DQDELFDDILSGQYGFPSP---YWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 577 ~~~~~---~~~~l~~~i~~~~~~~p~~---~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
..... ........+.........+ ....+++++.+||.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 65322 2233333332222211111 11236789999999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=348.60 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=207.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCC---eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce-EE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL-YL 452 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~-~l 452 (639)
..|.+.+.||+|+||.||+|....++ ..+|+|++.........+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35788899999999999999875544 379999998765555567788999999999999999999999776665 99
Q ss_pred EEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
||||+.+++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++ .+||+|||++.....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~----~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF----TVKVADFGLARDILD 176 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC----CEEECCTTSSCTTTT
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC----cEEeCcCCCcccccC
Confidence 9999999999999976 45789999999999999999999999999999999999999887 899999999975432
Q ss_pred -------CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 532 -------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 532 -------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.... +...+...+...... +....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~ 252 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQGRRL---PQPEY 252 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHHTTCCC---CCCTT
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhhcCCCC---CCCcc
Confidence 2234567899999999999999999999999999999999655543332 334444455444321 22356
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+++++.+||.+||+.||++|||+.++++
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=352.05 Aligned_cols=245 Identities=24% Similarity=0.420 Sum_probs=211.6
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec------
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT------ 446 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------ 446 (639)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 445578999999999999999999999999999999997543 345689999999999999999998854
Q ss_pred ----------CCceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCce
Q psy6820 447 ----------NNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH 514 (639)
Q Consensus 447 ----------~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~ 514 (639)
...+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-- 159 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-- 159 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC--
Confidence 45589999999999999999654 5799999999999999999999999999999999999999887
Q ss_pred eeeEEEeeccccccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc
Q psy6820 515 VKVLKVGDFGLAQRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS 592 (639)
Q Consensus 515 ~~~vKL~DFGla~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~ 592 (639)
.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.. .......+..
T Consensus 160 --~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~----~~~~~~~~~~ 233 (284)
T 2a19_B 160 --QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE----TSKFFTDLRD 233 (284)
T ss_dssp --EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH----HHHHHHHHHT
T ss_pred --CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh----HHHHHHHhhc
Confidence 8999999999776532 3456799999999999999999999999999999999999998832 2333444443
Q ss_pred CCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 593 GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 593 ~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
.. ++ ..++.++.+||.+||+.||++|||+.|+++|.|.
T Consensus 234 ~~--~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 234 GI--IS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp TC--CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cc--cc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 32 12 4578999999999999999999999999999764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=356.97 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=208.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCC----eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKD----MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
.++|++.+.||+|+||.||+|....++ ..||+|++...........+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 478999999999999999999876553 4599999986655445567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~----~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL----VCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC----cEEECCCCcchhhc
Confidence 999999999999999764 6799999999999999999999999999999999999999887 89999999997654
Q ss_pred CC------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc
Q psy6820 531 RP------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 531 ~~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
.. .....+|+.|+|||++.+..++.++||||||+++|||++ |..||... ...++...+..+. ..+ ...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--~~~~~~~~~~~~~-~~~--~~~ 273 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGF-RLP--TPM 273 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTC-CCC--CCT
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHCCC-cCC--Ccc
Confidence 32 112345788999999999999999999999999999999 99999643 4455666665542 222 235
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+++++.+||.+||+.||++||++.+++++
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999998864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=361.70 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=201.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC----ceE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN----ELY 451 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~~ 451 (639)
.++|++.+.||+|+||.||+|.+. ++.||+|++..... .....++|+.++++++||||+++++++.... .+|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch--HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 368999999999999999999775 68999999965432 2344567999999999999999999997754 479
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCceEEccCCceeeeEEEe
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN----------YIVHRDIKPENLLVEMSGCHVKVLKVG 521 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~----------givHrDLKp~NILld~~g~~~~~vKL~ 521 (639)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+. ||+||||||+|||++.++ .+||+
T Consensus 99 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~----~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL----TACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC----CEEEC
T ss_pred EEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC----eEEEc
Confidence 999999999999999764 599999999999999999999999 999999999999999887 89999
Q ss_pred eccccccccCC-----CccccCCCcccCccccccC-----CCChhhhHHHHHHHHHHHHcCCCCCCCCCC----------
Q psy6820 522 DFGLAQRVLRP-----MFTVCGTPTYVAPEILNES-----GYGVKIDVWAAGVILYILLCGFPPFVSDTN---------- 581 (639)
Q Consensus 522 DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~-----~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~---------- 581 (639)
|||++...... ....+||+.|+|||++.+. .++.++|||||||++|||++|..||.....
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999765432 2346799999999999863 456789999999999999999999965432
Q ss_pred ----ChHHHHHHHHcCCCCCCCC-Cc--ccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 582 ----DQDELFDDILSGQYGFPSP-YW--DDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 582 ----~~~~l~~~i~~~~~~~p~~-~~--~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
....+...+.........+ .+ ...++++.+||.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2233333333333222111 11 124567999999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.20 Aligned_cols=247 Identities=21% Similarity=0.287 Sum_probs=204.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEE----EEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDC----ALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~v----AiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
.++|++.+.||+|+||.||+|.+..+++.+ |+|.+.........+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 478999999999999999999988777654 6777665544555678889999999999999999999998754 88
Q ss_pred EEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+|+||+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~----~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT----EEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC----CEEEccCcceeEcc
Confidence 99999999999999976 45799999999999999999999999999999999999999887 89999999997654
Q ss_pred CC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 531 RP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 531 ~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
.. .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.... ...+...+..+.. .+ ....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~~~~~~~-~~--~~~~ 243 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGER-LP--QPPI 243 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTCC-CC--CCTT
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCC-CC--CCcc
Confidence 22 223456889999999999999999999999999999999 999996543 3444444544432 22 2356
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++.++.+||.+||+.||++||++.|+++
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=368.71 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=202.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEc---CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.++|++.+.||+|+||.||+|... .++..||+|++.........+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999876 45678999999866544556778899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL----VCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC----CEEECcCcccccccc
Confidence 99999999999999765 4699999999999999999999999999999999999999887 899999999976643
Q ss_pred CC------ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCccc
Q psy6820 532 PM------FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604 (639)
Q Consensus 532 ~~------~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~ 604 (639)
.. ....+|+.|+|||++.+..++.++||||||+++|||++ |..||... ...++...+..+. ..+ ....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~--~~~~~~~~i~~~~-~~~--~~~~ 274 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM--SNQDVIKAVDEGY-RLP--PPMD 274 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC--CHHHHHHHHHTTE-ECC--CCTT
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC-CCC--CCcc
Confidence 21 12235778999999999999999999999999999998 99999654 4455555555542 222 2257
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++.++.+||.+||+.||++||++.++++
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 8999999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=375.50 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=200.2
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 452 (639)
.+.+.|.+.+.||+|+||+||.+ ...+++.||||++.... .+.+.+|+.+++++ +||||+++++++.+.+.+|+
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 44567788899999999999865 45678899999986532 35567899999886 79999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCC-------CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC---------ceee
Q psy6820 453 VIELIKGGDLFDAISKNVKF-------SEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG---------CHVK 516 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l-------~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g---------~~~~ 516 (639)
||||+. |+|.+++...... ++..+..++.||+.||+|||++||+||||||+|||++.++ ....
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999995 6999999765433 2334578999999999999999999999999999997642 1224
Q ss_pred eEEEeeccccccccCC-------CccccCCCcccCcccccc-------CCCChhhhHHHHHHHHHHHHc-CCCCCCCCCC
Q psy6820 517 VLKVGDFGLAQRVLRP-------MFTVCGTPTYVAPEILNE-------SGYGVKIDVWAAGVILYILLC-GFPPFVSDTN 581 (639)
Q Consensus 517 ~vKL~DFGla~~~~~~-------~~~~~GT~~Y~APE~l~~-------~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~ 581 (639)
.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||+| |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 7999999999866432 224579999999999975 678999999999999999999 9999965433
Q ss_pred ChHHHHHHHHcCCCCCCC---CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 582 DQDELFDDILSGQYGFPS---PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 582 ~~~~l~~~i~~~~~~~p~---~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.. ..+..+....+. .....+++++.+||.+||+.||++|||+.|+++||||..
T Consensus 246 ~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 246 RE----SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HH----HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hH----HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 22 233444333322 112356789999999999999999999999999999963
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=360.56 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=210.8
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
....++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 345689999999999999999999864 578999999876533 345678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 453 VIELIKGGDLFDAISKNV----KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF----VPKITDFGISKK 188 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC----CEEECCCTTCEE
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC----CEEEeecccccc
Confidence 999999999999996543 589999999999999999999999999999999999999887 899999999976
Q ss_pred ccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh----HHH-HHHHHcCCC---
Q psy6820 529 VLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ----DEL-FDDILSGQY--- 595 (639)
Q Consensus 529 ~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~----~~l-~~~i~~~~~--- 595 (639)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... ......+..
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 4321 234568999999999999999999999999999999999999996543221 110 111111111
Q ss_pred ---CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 596 ---GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 596 ---~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
..+......++.++.+++.+||+.||++|||+.|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11222334567889999999999999999999999976
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=364.75 Aligned_cols=255 Identities=18% Similarity=0.197 Sum_probs=203.1
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcC---CCeEEEEEEEcccccchh----------HHHHHHHHHHHHhcCCCceeeee
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKH---KDMDCALKIIDKSKLLGK----------KQMIENEVNILRSVNHPNIIKLL 441 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAiKv~~~~~~~~~----------~~~~~~Ei~iL~~l~HpnIv~l~ 441 (639)
..++|.+.+.||+|+||.||+|.+.. ++..+|+|++........ ...+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34789999999999999999999987 788999999876542211 12355788999999999999999
Q ss_pred eeeec----CCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeee
Q psy6820 442 DEYDT----NNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKV 517 (639)
Q Consensus 442 ~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~ 517 (639)
+++.. ....|+||||+ +++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++. ..
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~~ 191 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP--DQ 191 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST--TS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC--Cc
Confidence 99877 77899999999 9999999988889999999999999999999999999999999999999987642 16
Q ss_pred EEEeeccccccccCC----------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHH
Q psy6820 518 LKVGDFGLAQRVLRP----------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF 587 (639)
Q Consensus 518 vKL~DFGla~~~~~~----------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~ 587 (639)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.....+.....
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999999765321 2456799999999999999999999999999999999999999965444443333
Q ss_pred HHHHcCCCCCCCCC-----cccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 588 DDILSGQYGFPSPY-----WDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 588 ~~i~~~~~~~p~~~-----~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.........++... ...+++++.+||.+||+.||++||+++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 22222211222110 1268899999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.71 Aligned_cols=243 Identities=24% Similarity=0.364 Sum_probs=200.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecC-CceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTN-NELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-~~~~lV~ 454 (639)
.++|++.+.||+|+||.||+|... ++.||+|++.... ..+.+.+|+.++++++||||+++++++.+. +..|+||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 478999999999999999999764 7799999997543 356788999999999999999999986544 5799999
Q ss_pred eeccCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 455 ELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||+++++|.+++.+... +++..+..++.+++.||+|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS----CEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC----cEEEeecccccccccc
Confidence 99999999999976543 89999999999999999999999999999999999999887 8999999999877665
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....+++.|+|||++.+..++.++||||||+++|+|++ |..||... ...++...+..+. .......+++++.+
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~l~~ 245 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGY---KMDAPDGCPPAVYE 245 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTC---CCCCCTTCCHHHHH
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCC---CCCCcccCCHHHHH
Confidence 556678999999999999999999999999999999998 99999654 3344555554442 22233678999999
Q ss_pred HHHHhcccCCCCCCCHHHHHc
Q psy6820 612 LISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~ 632 (639)
+|.+||+.||++|||+.|+++
T Consensus 246 li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 246 VMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCChhhCCCHHHHHH
Confidence 999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=349.07 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=206.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCC---CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeee-ecCCceE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY-DTNNELY 451 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~ 451 (639)
..+|.+.+.||+|+||.||+|....+ ...+|+|.+.........+.+.+|+.++++++||||+++++++ ...+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35799999999999999999986543 3468999998765555567788999999999999999999985 5567889
Q ss_pred EEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~----~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF----TVKVADFGLARDMY 179 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC----CEEECSCGGGCCCS
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC----CEEECccccccccc
Confidence 99999999999999975 45689999999999999999999999999999999999999887 89999999997653
Q ss_pred CC-------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCc
Q psy6820 531 RP-------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 531 ~~-------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
.. .....||+.|+|||++.+..++.++||||||+++|+|++ |.+||.... ..+....+..+..... .
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~---~ 254 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRLLQ---P 254 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC--TTTHHHHHHTTCCCCC---C
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC--HHHHHHHHhcCCCCCC---C
Confidence 22 234567889999999999999999999999999999999 566665433 2334444555443322 2
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
..+++++.++|.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 467999999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=356.66 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=204.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeee----cCCceE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYD----TNNELY 451 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~----~~~~~~ 451 (639)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. .....|
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 367999999999999999999999999999999986543 234566889999999999999999999986 345789
Q ss_pred EEEeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 452 LVIELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~----~~kl~dfg~~~ 182 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG----QPVLMDLGSMN 182 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS----CEEECCCSSCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC----CEEEEecCcch
Confidence 99999999999999965 46799999999999999999999999999999999999999887 79999999986
Q ss_pred cccCC------------CccccCCCcccCccccccCC---CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHc
Q psy6820 528 RVLRP------------MFTVCGTPTYVAPEILNESG---YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILS 592 (639)
Q Consensus 528 ~~~~~------------~~~~~GT~~Y~APE~l~~~~---~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~ 592 (639)
..... .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||.............+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 54311 12345799999999987654 6899999999999999999999995311111112222222
Q ss_pred CCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 593 GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 593 ~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
...++ ....+++++.+||.+||+.||++|||+.+++++
T Consensus 263 -~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 -QLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -C--CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -cCCCC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 22222 235789999999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.20 Aligned_cols=251 Identities=20% Similarity=0.261 Sum_probs=201.6
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeee-ecCCceEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY-DTNNELYL 452 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~l 452 (639)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++|++++..+..+ ...+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 4457899999999999999999999999999999987654332 3467899999999988777666554 67778899
Q ss_pred EEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE---ccCCceeeeEEEeecccccc
Q psy6820 453 VIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLV---EMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILl---d~~g~~~~~vKL~DFGla~~ 528 (639)
||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++ .+||+|||++..
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~----~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN----LVYIIDFGLAKK 157 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT----CEEECCCTTCEE
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC----eEEEecCcccee
Confidence 99999 9999999974 5679999999999999999999999999999999999999 5555 799999999986
Q ss_pred ccCC----------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC-hHHHHHHHHcCCCCC
Q psy6820 529 VLRP----------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND-QDELFDDILSGQYGF 597 (639)
Q Consensus 529 ~~~~----------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~-~~~l~~~i~~~~~~~ 597 (639)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 6432 23567999999999999999999999999999999999999999764322 122222332222222
Q ss_pred CC-CCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 598 PS-PYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 598 p~-~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+. .....+++++.+||.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 21 112457899999999999999999999999885
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=349.04 Aligned_cols=251 Identities=20% Similarity=0.264 Sum_probs=206.7
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeee-ecCCceEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY-DTNNELYL 452 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~l 452 (639)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.+++.++|++++..+..+ ...+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 456899999999999999999999999999999999876543 24578999999999988866656554 66778899
Q ss_pred EEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEc---cCCceeeeEEEeecccccc
Q psy6820 453 VIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE---MSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld---~~g~~~~~vKL~DFGla~~ 528 (639)
||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++ .++ .+||+|||++..
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~----~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN----LVYIIDFGLAKK 157 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT----CEEECCCTTCEE
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC----eEEEeeCCCccc
Confidence 99999 8999999974 56799999999999999999999999999999999999994 555 799999999976
Q ss_pred ccCC----------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-ChHHHHHHHHcCCCCC
Q psy6820 529 VLRP----------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQYGF 597 (639)
Q Consensus 529 ~~~~----------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-~~~~l~~~i~~~~~~~ 597 (639)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+..+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 5432 2356799999999999999999999999999999999999999975332 2222333333322222
Q ss_pred C-CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 598 P-SPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 598 p-~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+ ......+++++.+||.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 2 1112467899999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=342.44 Aligned_cols=244 Identities=21% Similarity=0.369 Sum_probs=208.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||+|... ++..||+|++..... ..+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 368999999999999999999875 466899999976543 3567889999999999999999999986 456899999
Q ss_pred eccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 456 LIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++.......
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~----~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL----SCKIADFGLARLIEDNE 163 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS----CEEECCCTTCEECSSSC
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC----CEEECCCcccccccCcc
Confidence 999999999997543 799999999999999999999999999999999999999887 89999999998665332
Q ss_pred ----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 534 ----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 534 ----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
....+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ...++...+..+.. ......++++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~ 238 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNLERGYR---MVRPDNCPEE 238 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCC---CCCCTTCCHH
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc--CHHHHHHHHhcccC---CCCcccccHH
Confidence 23456789999999998889999999999999999999 99999653 34555555555422 1223578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+||.+||+.||++|||++++++
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=360.46 Aligned_cols=254 Identities=25% Similarity=0.326 Sum_probs=205.8
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
..++|.+.+.||+|+||.||+|... +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 106 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 106 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEE
Confidence 4578999999999999999999744 578899999987654444446889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 455 ELIKGGDLFDAISKNV----KFSEEDSKFMTQSLASALSYLHDN---YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~----~l~~~~~~~i~~qI~~aL~yLH~~---givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~----~~kl~Dfg~~~ 182 (326)
T 3uim_A 107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDFGLAK 182 (326)
T ss_dssp ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC----CEEECCCSSCE
T ss_pred EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC----CEEeccCcccc
Confidence 9999999999997543 499999999999999999999999 999999999999999887 89999999997
Q ss_pred cccCC----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCC----CCC--ChHHHHHHHHcC----
Q psy6820 528 RVLRP----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVS----DTN--DQDELFDDILSG---- 593 (639)
Q Consensus 528 ~~~~~----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~----~~~--~~~~l~~~i~~~---- 593 (639)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.. ... ............
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence 65422 2345699999999999988899999999999999999999999941 100 111111111111
Q ss_pred ---CCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 594 ---QYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 594 ---~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
............+.++.+++.+||+.||++|||+.|+++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 305 (326)
T 3uim_A 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305 (326)
T ss_dssp TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHH
Confidence 0111112234456889999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=365.14 Aligned_cols=253 Identities=18% Similarity=0.197 Sum_probs=200.2
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCC-----CeEEEEEEEcccccchhH----------HHHHHHHHHHHhcCCCceee
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHK-----DMDCALKIIDKSKLLGKK----------QMIENEVNILRSVNHPNIIK 439 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiKv~~~~~~~~~~----------~~~~~Ei~iL~~l~HpnIv~ 439 (639)
..++|.+++.||+|+||.||+|.+..+ ++.||+|++......... ..+.+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 346899999999999999999988765 578999998765421111 12335666777888999999
Q ss_pred eeeeeecC----CceEEEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEc--cCC
Q psy6820 440 LLDEYDTN----NELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE--MSG 512 (639)
Q Consensus 440 l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld--~~g 512 (639)
+++++... ...||||||+ |++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998664 4589999999 99999999765 6799999999999999999999999999999999999998 555
Q ss_pred ceeeeEEEeeccccccccCC----------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC
Q psy6820 513 CHVKVLKVGDFGLAQRVLRP----------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND 582 (639)
Q Consensus 513 ~~~~~vKL~DFGla~~~~~~----------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~ 582 (639)
.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||+||..||.....+
T Consensus 192 ----~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 192 ----QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp ----CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred ----eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 7999999999765321 23456999999999999999999999999999999999999999754443
Q ss_pred hHHHHHHHHcCCCCCC---CC--CcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 583 QDELFDDILSGQYGFP---SP--YWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 583 ~~~l~~~i~~~~~~~p---~~--~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
..............++ .. ....+++++.++|..||+.||++||+++++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 3222111111000000 00 01467899999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=369.80 Aligned_cols=244 Identities=21% Similarity=0.386 Sum_probs=209.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||+|.... +..||||++..... ..+.+.+|+.+|++++||||+++++++. .+.+|+|||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred hHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 4689999999999999999998764 56899999986543 3567889999999999999999999986 567899999
Q ss_pred eccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 456 LIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC----CEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC----cEEEeeCCCceEcCCCc
Confidence 99999999999754 3689999999999999999999999999999999999999887 8999999999865432
Q ss_pred ---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 533 ---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
.....+|+.|+|||++....++.++|||||||+||||+| |..||... ...++...+..+. ..+ ....++++
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~-~~~--~~~~~~~~ 413 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRALERGY-RMP--RPENCPEE 413 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHHTC-CCC--CCTTSCHH
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC-CCC--CCCCCCHH
Confidence 223456788999999999999999999999999999999 99999654 3455666665542 222 23578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+||.+||+.||++|||+++|++
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=376.61 Aligned_cols=246 Identities=22% Similarity=0.397 Sum_probs=213.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
..+|++.+.||+|+||.||+|.++.++..||+|++..... ..+.+.+|+.+|++++||||++++++|.+.+.+|+|||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 4679999999999999999999999899999999976543 35678899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 456 LIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 456 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~----~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH----LVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG----CEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC----cEEEeecccceeccCCc
Confidence 99999999999763 4589999999999999999999999999999999999999887 89999999998664322
Q ss_pred ----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 534 ----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 534 ----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
....+++.|+|||++.+..++.++|||||||+||||++ |..||.... ..++.+.+..+. .. +....++++
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~-~~--~~~~~~~~~ 447 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDY-RM--ERPEGCPEK 447 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTTC-CC--CCCTTCCHH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-CC--CCCCCCCHH
Confidence 23446788999999999999999999999999999999 999997643 344555554432 22 233678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+||.+||+.||++|||+.++++
T Consensus 448 l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 448 VYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=356.04 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=208.9
Q ss_pred CCeeEEEEEccCCceEEEEEE----EcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeee--cCCce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVY----DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYD--TNNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~ 450 (639)
++|++.+.||+|+||.||+|. +..+++.||+|++..... ...+.+.+|+.++++++||||+++++++. +...+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 689999999999999999998 567889999999976532 33456889999999999999999999875 45678
Q ss_pred EEEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 451 YLVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
|+||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~----~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA----HVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT----EEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC----CEEEcccccceec
Confidence 999999999999999976 45699999999999999999999999999999999999999887 8999999999865
Q ss_pred cCC------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-------------ChHHHHHHH
Q psy6820 530 LRP------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-------------DQDELFDDI 590 (639)
Q Consensus 530 ~~~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-------------~~~~l~~~i 590 (639)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ....+...+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 432 2335678889999999999999999999999999999999999853221 112222333
Q ss_pred HcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 591 LSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 591 ~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
..+. ..+....+++++.+||.+||+.||++|||+.|++++
T Consensus 258 ~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EEGQ---RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccc---CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3322 222346789999999999999999999999999754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=354.44 Aligned_cols=240 Identities=35% Similarity=0.704 Sum_probs=194.5
Q ss_pred cccCCCeeEE-EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHH-HhcCCCceeeeeeeeec----
Q psy6820 373 SKLLQRYSVG-QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNIL-RSVNHPNIIKLLDEYDT---- 446 (639)
Q Consensus 373 ~~~~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~---- 446 (639)
..+.++|.+. +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 3456788887 8899999999999999999999999999642 3456788887 55689999999999876
Q ss_pred CCceEEEEeeccCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 447 NNELYLVIELIKGGDLFDAISKNV--KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
...+|+||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++. ...+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~~~kl~Dfg 165 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP-NAILKLTDFG 165 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSST-TCCEEECCCT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCC-CCcEEEeccc
Confidence 678999999999999999997754 6999999999999999999999999999999999999997320 1279999999
Q ss_pred ccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChH--HHHHHHHcCCCCCCCCCc
Q psy6820 525 LAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD--ELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 525 la~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~--~l~~~i~~~~~~~p~~~~ 602 (639)
++.... +..++.++|||||||++|+|++|..||........ .....+......++.+.+
T Consensus 166 ~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (299)
T 3m2w_A 166 FAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226 (299)
T ss_dssp TCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHH
T ss_pred cccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhc
Confidence 985432 24578899999999999999999999965432110 000111122223333334
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 578999999999999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=371.23 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=198.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEEEe
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.+|.+.+.||+|+||+||. ....+++.||||++...... .+.+|+.+|+.+ +||||+++++++.+.+..|+|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 4699999999999999763 45567889999999764432 245799999999 79999999999999999999999
Q ss_pred eccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC-ceeeeEEEeeccccccccC--
Q psy6820 456 LIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG-CHVKVLKVGDFGLAQRVLR-- 531 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g-~~~~~vKL~DFGla~~~~~-- 531 (639)
|+. |+|.+++.... .+.+..+..++.||+.||+|||++||+||||||+|||++.++ .....+||+|||++.....
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 995 59999997653 466667889999999999999999999999999999996432 1223689999999976642
Q ss_pred ----CCccccCCCcccCccccc---cCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc
Q psy6820 532 ----PMFTVCGTPTYVAPEILN---ESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 532 ----~~~~~~GT~~Y~APE~l~---~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
.....+||+.|+|||++. ...++.++|||||||++|||++ |..||..... ... ..+.............
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--~~~-~~~~~~~~~~~~~~~~ 254 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--RQA-NILLGACSLDCLHPEK 254 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--HHH-HHHTTCCCCTTSCTTC
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--HHH-HHHhccCCccccCccc
Confidence 234567999999999997 4567889999999999999999 9999954332 222 2222221111111123
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+..+.+||.+||+.||++|||++|+++||||..
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 45778999999999999999999999999999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=353.85 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=206.4
Q ss_pred cCCCe-eEEEEEccCCceEEEEEEE----cCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec--C
Q psy6820 375 LLQRY-SVGQIIGDGNFAVVRQVYD----KHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT--N 447 (639)
Q Consensus 375 ~~~~y-~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~ 447 (639)
+.++| ++++.||+|+||.||++.. ..+++.||+|++.........+.+.+|+.++++++||||+++++++.+ .
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 33455 9999999999999988753 457889999999876555556778999999999999999999999977 4
Q ss_pred CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
..+++||||+++++|.+++.+. .+++..+..++.||+.||+|||+.||+||||||+|||++.++ .+||+|||++.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~----~~kl~Dfg~a~ 182 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR----LVKIGDFGLAK 182 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----CEEECCGGGCE
T ss_pred ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC----CEEECCccccc
Confidence 6789999999999999999765 599999999999999999999999999999999999999887 89999999998
Q ss_pred cccCC------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC----------h---HHHHH
Q psy6820 528 RVLRP------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND----------Q---DELFD 588 (639)
Q Consensus 528 ~~~~~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~----------~---~~l~~ 588 (639)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...... . ..+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 76432 23456788999999999999999999999999999999999999542111 0 11222
Q ss_pred HHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 589 DILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 589 ~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+.... ..+....+++++.+||++||+.||++|||++|+++
T Consensus 263 ~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 263 LLERGE---RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhccc---CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 222221 22233678999999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=349.77 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=201.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC---CCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCC---
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH---KDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNN--- 448 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 448 (639)
.++|.+.+.||+|+||.||+|.... ++..||+|++...... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4689999999999999999998765 4568999998765433 23356889999999999999999999987655
Q ss_pred --ceEEEEeeccCCChHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEE
Q psy6820 449 --ELYLVIELIKGGDLFDAIS------KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 449 --~~~lV~E~~~ggsL~~~l~------~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL 520 (639)
..++||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~----~~kl 188 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM----TVCV 188 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS----CEEE
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC----cEEE
Confidence 3599999999999999983 335699999999999999999999999999999999999999887 7999
Q ss_pred eeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCC
Q psy6820 521 GDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQ 594 (639)
Q Consensus 521 ~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~ 594 (639)
+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.... .......+..+.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~~ 266 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ--NHEMYDYLLHGH 266 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTTC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC--HHHHHHHHHcCC
Confidence 999999765432 223457889999999999999999999999999999999 999996543 344555555543
Q ss_pred CCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 595 ~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
. ......+++++.+||.+||+.||++|||+.+++++
T Consensus 267 ~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 R---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp C---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred C---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 22336789999999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=358.81 Aligned_cols=248 Identities=17% Similarity=0.240 Sum_probs=205.4
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC--------CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceee--------
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH--------KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIK-------- 439 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~--------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~-------- 439 (639)
.++|.+.+.||+|+||.||+|.+.. .++.||+|++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 4789999999999999999999987 4789999998754 35678999999999999988
Q ss_pred -------eeeeeec-CCceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEc
Q psy6820 440 -------LLDEYDT-NNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVE 509 (639)
Q Consensus 440 -------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld 509 (639)
+++++.. .+..|+||||+ +++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 5666654 67899999999 99999999875 7899999999999999999999999999999999999998
Q ss_pred cCCceeeeEEEeeccccccccCC----------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q psy6820 510 MSGCHVKVLKVGDFGLAQRVLRP----------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSD 579 (639)
Q Consensus 510 ~~g~~~~~vKL~DFGla~~~~~~----------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~ 579 (639)
.++. ..+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 194 ~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 PEDQ--SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp TTEE--EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCC--ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 7641 27999999999765421 13457999999999999999999999999999999999999999765
Q ss_pred CCChHHHHHHHH---cCCCCCC--CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 580 TNDQDELFDDIL---SGQYGFP--SPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 580 ~~~~~~l~~~i~---~~~~~~p--~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
......+..... .....++ ...+..+++++.+||.+||+.||++|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 544444433332 2222221 1223467999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=362.55 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=199.7
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCC---CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeee-cCCceEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYD-TNNELYL 452 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~l 452 (639)
..|.+.+.||+|+||.||+|....+ ...+|+|.+.........+.+.+|+.++++++||||+++++++. ..+..|+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4588999999999999999987543 34689999876555555677889999999999999999999864 4568899
Q ss_pred EEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF----TVKVADFGLARDMYD 244 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CEEECCC--------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC----CEEEeeccccccccc
Confidence 99999999999999764 4589999999999999999999999999999999999999887 899999999976532
Q ss_pred C-------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc
Q psy6820 532 P-------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 532 ~-------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
. .....+|+.|+|||++.+..++.++|||||||++|||++ |.+||..... .++...+..+..... ..
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~--~~~~~~~~~~~~~~~---p~ 319 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRRLLQ---PE 319 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS--SCHHHHHHTTCCCCC---CT
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH--HHHHHHHHcCCCCCC---CC
Confidence 2 123457889999999999999999999999999999999 7788865433 233344554432222 25
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+++++.++|.+||+.||++|||+.|++++
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 689999999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=344.46 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=201.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC-CC--eEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH-KD--MDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~--~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|++.+.||+|+||.||+|.+.. ++ ..||+|++...... ...+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3689999999999999999998643 33 36899998765432 33467889999999999999999999997765 8
Q ss_pred EEEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
++||||+++++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~----~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT----EEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC----CEEEccccccccc
Confidence 9999999999999999764 5799999999999999999999999999999999999999887 8999999999766
Q ss_pred cCC------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCc
Q psy6820 530 LRP------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 530 ~~~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||... +..++...+......++ ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~--~~ 247 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLP--RP 247 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTSCCCCC--CC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC--CHHHHHHHHHccCCCCC--CC
Confidence 432 123457889999999999889999999999999999999 99999654 45566666666544433 23
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
..++.++.++|.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 5789999999999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=350.54 Aligned_cols=243 Identities=32% Similarity=0.494 Sum_probs=188.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeee--------ecC
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEY--------DTN 447 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~--------~~~ 447 (639)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++++. ||||+++++++ ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 57999999999999999999999999999999985543 233456789999999996 99999999988 344
Q ss_pred CceEEEEeeccCCChHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEccCCceeeeEEEee
Q psy6820 448 NELYLVIELIKGGDLFDAISK---NVKFSEEDSKFMTQSLASALSYLHDNY--IVHRDIKPENLLVEMSGCHVKVLKVGD 522 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~---~~~l~~~~~~~i~~qI~~aL~yLH~~g--ivHrDLKp~NILld~~g~~~~~vKL~D 522 (639)
..++++|||+. |+|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~----~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG----TIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS----CEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC----CEEEec
Confidence 56899999995 699998864 467999999999999999999999999 99999999999999887 899999
Q ss_pred ccccccccCCC---------------ccccCCCcccCcccc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChH
Q psy6820 523 FGLAQRVLRPM---------------FTVCGTPTYVAPEIL---NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD 584 (639)
Q Consensus 523 FGla~~~~~~~---------------~~~~GT~~Y~APE~l---~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~ 584 (639)
||++....... ...+||+.|+|||++ .+..++.++||||||+++|+|++|..||..... .
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~ 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--L 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH--H
Confidence 99997654321 145699999999998 567789999999999999999999999954321 1
Q ss_pred HHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 585 ELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 585 ~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.+.......+. ....+..+.+||.+||+.||++|||+.|+++|
T Consensus 260 ----~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 260 ----RIVNGKYSIPP--HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ----------CCCCT--TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----HhhcCcccCCc--ccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12222222222 35677889999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=365.64 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=205.3
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||+|.+..+ ..||||++..... ..+.+.+|+.+|++++||||+++++++.+ +..|+|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 36799999999999999999988764 5699999986543 24678899999999999999999999876 67899999
Q ss_pred eccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 456 LIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG----CEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC----CEEECCCccceecCCCc
Confidence 9999999999964 35699999999999999999999999999999999999999877 8999999999765432
Q ss_pred ---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 533 ---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
.....+|+.|+|||++.+..++.++||||||+++|||++ |..||... ...++...+..+. .. +....++++
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~-~~--~~~~~~~~~ 409 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGY-RM--PCPPECPES 409 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTC-CC--CCCTTSCHH
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC-CC--CCCCCCCHH
Confidence 123456789999999999999999999999999999999 99999654 3455666665542 22 223578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+.+||.+||+.||++|||++++++
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=347.34 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=198.3
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHh--cCCCceeeeeeeeecC----
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRS--VNHPNIIKLLDEYDTN---- 447 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~---- 447 (639)
.+.++|++.+.||+|+||.||+|.+. ++.||+|++.... ......|.+++.. ++||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 34578999999999999999999875 7899999986432 2333445555544 4899999999998776
Q ss_pred CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEEccCCceeeeEE
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN--------YIVHRDIKPENLLVEMSGCHVKVLK 519 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~--------givHrDLKp~NILld~~g~~~~~vK 519 (639)
..+|+||||+++|+|.+++... .+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+|
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~----~~k 182 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG----TCC 182 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS----CEE
T ss_pred CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC----CEE
Confidence 7899999999999999999654 699999999999999999999999 999999999999999887 899
Q ss_pred EeeccccccccCC-------CccccCCCcccCccccccCCCChh------hhHHHHHHHHHHHHcC----------CCCC
Q psy6820 520 VGDFGLAQRVLRP-------MFTVCGTPTYVAPEILNESGYGVK------IDVWAAGVILYILLCG----------FPPF 576 (639)
Q Consensus 520 L~DFGla~~~~~~-------~~~~~GT~~Y~APE~l~~~~~s~~------sDVwSLGvvL~eLltG----------~~Pf 576 (639)
|+|||++...... ....+||+.|+|||++.+..++.. +|||||||++|||++| ..||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999999765422 224579999999999987766554 9999999999999999 7777
Q ss_pred CCCCC---ChHHHHHHHHcCCCCCCCCC---cccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 577 VSDTN---DQDELFDDILSGQYGFPSPY---WDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 577 ~~~~~---~~~~l~~~i~~~~~~~p~~~---~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
..... ........+.........+. ...+++++.+||.+||+.||++|||+.|+++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 54322 22333333333222221111 12577889999999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=392.83 Aligned_cols=266 Identities=24% Similarity=0.392 Sum_probs=211.8
Q ss_pred CcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec-----
Q psy6820 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT----- 446 (639)
Q Consensus 372 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----- 446 (639)
+....++|.+.+.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.++++++||||+++++++..
T Consensus 9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 344568999999999999999999999999999999999766555556778899999999999999999998765
Q ss_pred -CCceEEEEeeccCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEee
Q psy6820 447 -NNELYLVIELIKGGDLFDAISKNV---KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGD 522 (639)
Q Consensus 447 -~~~~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~D 522 (639)
.+..|+||||++||+|.+++.... .+++..++.++.+++.||+|||+.||+||||||+||+++.++. ...+||+|
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~-~~~vKL~D 167 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ-RLIHKIID 167 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSS-SCEEEECS
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCC-ceeEEEcc
Confidence 677899999999999999997644 6999999999999999999999999999999999999997762 23699999
Q ss_pred ccccccccCC--CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChH-------HHHHH----
Q psy6820 523 FGLAQRVLRP--MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQD-------ELFDD---- 589 (639)
Q Consensus 523 FGla~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~-------~l~~~---- 589 (639)
||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........ .....
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 9999876533 3456899999999999999999999999999999999999999965311000 00000
Q ss_pred -HHcCCC------CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 590 -ILSGQY------GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 590 -i~~~~~------~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...+.. ..+......+++.+.+||.+||+.||++|||++|+++||||+.
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 011111 1122334557899999999999999999999999999999963
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=345.74 Aligned_cols=249 Identities=27% Similarity=0.355 Sum_probs=206.0
Q ss_pred CCCeeEEEEEccCCceEEEEEE----EcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC--c
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVY----DKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN--E 449 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~ 449 (639)
.++|++++.||+|+||.||+|. +..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 4679999999999999999998 45678999999997643 334467889999999999999999999886654 7
Q ss_pred eEEEEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~----~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKV 194 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT----EEEECCCTTCEE
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC----cEEEecCcchhh
Confidence 89999999999999999775 4699999999999999999999999999999999999999887 899999999986
Q ss_pred ccCC------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCC----------CC-h---HHHHH
Q psy6820 529 VLRP------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDT----------ND-Q---DELFD 588 (639)
Q Consensus 529 ~~~~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~----------~~-~---~~l~~ 588 (639)
.... .....++..|+|||++.+..++.++||||||+++|+|+||..||.... .. . ..+.+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6432 123456788999999999889999999999999999999999985321 00 0 01122
Q ss_pred HHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 589 DILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 589 ~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+..+ ... +....+++++.+||.+||+.||++|||+.|+++
T Consensus 275 ~~~~~-~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 275 LLKNN-GRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHTT-CCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhcC-CCC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22222 122 223578999999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=375.82 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=206.8
Q ss_pred CCeeEEE-EEccCCceEEEEEEEc--CCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQ-IIGDGNFAVVRQVYDK--HKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~-~LG~G~fG~Vy~a~~~--~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
+++.+.+ .||+|+||.||+|..+ .++..||||+++........+.+.+|+.+|++++||||+++++++.. +.+|+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4566666 8999999999999775 35667999999876555556788999999999999999999999976 569999
Q ss_pred EeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~----~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH----YAKISDFGLSKALGAD 489 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----EEEECCCSTTTTCC--
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC----cEEEeeccCcccccCC
Confidence 9999999999999654 5699999999999999999999999999999999999999887 8999999999865422
Q ss_pred C------ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 533 M------FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 533 ~------~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
. ....+|+.|+|||++.+..++.++|||||||+||||++ |..||.... ..++...+..+.. .+....+
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~~~~~---~~~p~~~ 564 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKR---MECPPEC 564 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--SHHHHHHHHTTCC---CCCCTTC
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCC---CCCCCcC
Confidence 1 12345689999999999999999999999999999998 999997643 3456666666532 1223578
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++++.+||.+||+.||++||++.++++
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.90 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=194.8
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeee-----ecCC
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEY-----DTNN 448 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-----~~~~ 448 (639)
...++|++.+.||+|+||.||+|.. +++.||+|++...... ....+.|+..+..++||||+++++.+ ....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ--NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh--hHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3468999999999999999999965 6789999999754321 12223444445568999999999754 2334
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCceEEccCCceeeeEE
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN---------YIVHRDIKPENLLVEMSGCHVKVLK 519 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~---------givHrDLKp~NILld~~g~~~~~vK 519 (639)
.+|+||||+++|+|.+++... ..++..+..++.||+.||+|||+. ||+||||||+|||++.++ .+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~----~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG----TCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS----CEE
T ss_pred eEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC----cEE
Confidence 679999999999999999665 458999999999999999999999 999999999999999887 899
Q ss_pred EeeccccccccCC-----------CccccCCCcccCcccccc-------CCCChhhhHHHHHHHHHHHHcCCCCCCCCCC
Q psy6820 520 VGDFGLAQRVLRP-----------MFTVCGTPTYVAPEILNE-------SGYGVKIDVWAAGVILYILLCGFPPFVSDTN 581 (639)
Q Consensus 520 L~DFGla~~~~~~-----------~~~~~GT~~Y~APE~l~~-------~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~ 581 (639)
|+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 9999999765321 224579999999999986 4567899999999999999999777643221
Q ss_pred ----------------ChHHHHHHHHcCC--CCCCCC--CcccccHHHHHHHHHhcccCCCCCCCHHHHH------cCCc
Q psy6820 582 ----------------DQDELFDDILSGQ--YGFPSP--YWDDISEEAKELISHMLESNPDLRFSAEDVL------DHPW 635 (639)
Q Consensus 582 ----------------~~~~l~~~i~~~~--~~~p~~--~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL------~HP~ 635 (639)
........+.... ..++.. ....+++++.+||.+||+.||++|||++|++ .++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 1111211222211 122211 1123667899999999999999999999994 5666
Q ss_pred ccC
Q psy6820 636 LER 638 (639)
Q Consensus 636 f~~ 638 (639)
-++
T Consensus 321 ~~~ 323 (336)
T 3g2f_A 321 ERN 323 (336)
T ss_dssp CC-
T ss_pred Hhc
Confidence 543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=355.99 Aligned_cols=238 Identities=20% Similarity=0.253 Sum_probs=197.0
Q ss_pred CCCeeEEEEEccCCceEEEEE-----EEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC---CCceeeeeeeeecC
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQV-----YDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN---HPNIIKLLDEYDTN 447 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a-----~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~ 447 (639)
.++|.+.+.||+|+||.||+| .+..+++.||+|++.... ...+..|+.+++.++ |+||+.+++++...
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 467999999999999999999 467788999999997643 455678888888887 89999999999999
Q ss_pred CceEEEEeeccCCChHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEcc-----------C
Q psy6820 448 NELYLVIELIKGGDLFDAISK-----NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEM-----------S 511 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~-----~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~-----------~ 511 (639)
+..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++. +
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999999973 457999999999999999999999999999999999999987 4
Q ss_pred CceeeeEEEeecccccccc-----CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHH
Q psy6820 512 GCHVKVLKVGDFGLAQRVL-----RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDEL 586 (639)
Q Consensus 512 g~~~~~vKL~DFGla~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l 586 (639)
+ .+||+|||+|.... ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.........
T Consensus 220 ~----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~- 294 (365)
T 3e7e_A 220 A----GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK- 294 (365)
T ss_dssp T----TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred C----CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence 4 89999999996543 1234568999999999999999999999999999999999999999654322110
Q ss_pred HHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6820 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVL 631 (639)
Q Consensus 587 ~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL 631 (639)
....++ .. ..++.+.+++..||+.+|.+|++..+.+
T Consensus 295 ------~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l 330 (365)
T 3e7e_A 295 ------PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLL 330 (365)
T ss_dssp ------ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred ------echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence 001111 11 2478899999999999999997644444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=339.91 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=202.5
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL---LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
|..++.||+|+||.||+|.. +++.+|+|++..... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44458999999999999975 577899999875432 2335678899999999999999999999999999999999
Q ss_pred eccCCChHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 456 LIKGGDLFDAISK---NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~---~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|+++++|.+++.. ...+++..+..++.+|+.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF----TAKISDFGLARASEKF 186 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC----CEEECCCTTCEECCSC
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC----cEEEeecccccccccc
Confidence 9999999999863 34699999999999999999999999999999999999999887 8999999999765432
Q ss_pred -----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh--HHHHHHHHcCCCC-------CC
Q psy6820 533 -----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ--DELFDDILSGQYG-------FP 598 (639)
Q Consensus 533 -----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~--~~l~~~i~~~~~~-------~p 598 (639)
.....||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ..+...+...... ..
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 234579999999999875 48999999999999999999999997543321 2222322222110 01
Q ss_pred CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 599 SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 599 ~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.......+..+.+++.+||+.||++|||+.+++++
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11224567889999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=375.78 Aligned_cols=241 Identities=22% Similarity=0.337 Sum_probs=204.3
Q ss_pred EEEEccCCceEEEEEEE--cCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeecc
Q psy6820 382 GQIIGDGNFAVVRQVYD--KHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIK 458 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~--~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 458 (639)
.+.||+|+||.||+|.. +.+++.||||+++..... ...+.+.+|+.+|++++||||+++++++.. +.+++||||++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 35899999999999955 456788999999765432 235678899999999999999999999965 56899999999
Q ss_pred CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC------
Q psy6820 459 GGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP------ 532 (639)
Q Consensus 459 ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~------ 532 (639)
+|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----EEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC----CEEEEEcCCccccccCcccccc
Confidence 999999999888999999999999999999999999999999999999999887 8999999999765422
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....+|+.|+|||++.+..++.++|||||||++|||++ |..||... ...++...+..+... +....+++++.+
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--~~~~~~~~i~~~~~~---~~p~~~~~~l~~ 603 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERM---GCPAGCPREMYD 603 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCC---CCCTTCCHHHHH
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC---CCCCCCCHHHHH
Confidence 223456789999999999999999999999999999998 99999654 445666666665422 223578999999
Q ss_pred HHHHhcccCCCCCCCHHHHHc
Q psy6820 612 LISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~ 632 (639)
||.+||+.||++||+++++++
T Consensus 604 li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 604 LMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=345.25 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=204.5
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHh--cCCCceeeeeeeeecCC----
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRS--VNHPNIIKLLDEYDTNN---- 448 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~---- 448 (639)
+.++|.+.+.||+|+||.||+|.+ +++.||+|++... ....+.+|+.++.. ++||||+++++++...+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 346899999999999999999987 4789999999653 24556788888888 68999999999998776
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCceEEccCCceeeeEEE
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH--------DNYIVHRDIKPENLLVEMSGCHVKVLKV 520 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH--------~~givHrDLKp~NILld~~g~~~~~vKL 520 (639)
.+|+||||+++|+|.+++.+. .+++..+..++.|++.||+||| +.||+||||||+|||++.++ .+||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~----~~kL 188 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCI 188 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS----CEEE
T ss_pred eeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC----CEEE
Confidence 799999999999999999764 6999999999999999999999 89999999999999999887 8999
Q ss_pred eeccccccccCC-------CccccCCCcccCccccccCC------CChhhhHHHHHHHHHHHHcC----------CCCCC
Q psy6820 521 GDFGLAQRVLRP-------MFTVCGTPTYVAPEILNESG------YGVKIDVWAAGVILYILLCG----------FPPFV 577 (639)
Q Consensus 521 ~DFGla~~~~~~-------~~~~~GT~~Y~APE~l~~~~------~s~~sDVwSLGvvL~eLltG----------~~Pf~ 577 (639)
+|||++...... .....||+.|+|||++.+.. ++.++||||||+++|||++| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 999999766432 23457999999999997652 34789999999999999999 88986
Q ss_pred CCCC---ChHHHHHHHHcCCCCCCCCC---cccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 578 SDTN---DQDELFDDILSGQYGFPSPY---WDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 578 ~~~~---~~~~l~~~i~~~~~~~p~~~---~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
.... ....+...+.........+. ...++..+.+||.+||+.||++|||+.++++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 5432 33444454544433222111 12456789999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=368.65 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=209.9
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||.||+|.+..+ ..||||++..... ..+.+.+|+.+|++++||||+++++++.+ +.+|||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 36799999999999999999988764 5699999986543 24678899999999999999999999876 67899999
Q ss_pred eccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 456 LIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
|+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~----~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG----CEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC----cEEEcccccceecCCCc
Confidence 99999999999743 5699999999999999999999999999999999999998876 8999999999765432
Q ss_pred ---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 533 ---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
.....++..|+|||++.+..++.++|||||||+||||++ |..||... ...++...+..+. .. +....++.+
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~--~~~~~~~~i~~~~-~~--~~~~~~~~~ 492 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGY-RM--PCPPECPES 492 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC--CHHHHHHHHHTTC-CC--CCCTTCCHH
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC-CC--CCCCCCCHH
Confidence 223456789999999999999999999999999999999 99999654 3455666665542 22 223578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+.+||.+||+.||++|||+++|++.
T Consensus 493 l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 493 LHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=356.17 Aligned_cols=250 Identities=20% Similarity=0.245 Sum_probs=196.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc-------chhHHHHHHHHHHHHhcC---------CCceee
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-------LGKKQMIENEVNILRSVN---------HPNIIK 439 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~-------~~~~~~~~~Ei~iL~~l~---------HpnIv~ 439 (639)
.++|++.+.||+|+||.||+|++ +++.||||++..... ....+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 36799999999999999999987 678999999986542 222367789999999886 666655
Q ss_pred eeee-----------------eec-------------CCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHH
Q psy6820 440 LLDE-----------------YDT-------------NNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALS 489 (639)
Q Consensus 440 l~~~-----------------~~~-------------~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~ 489 (639)
+.+. +.+ .+.+||||||+++|++.+.+.+ ..+++..++.++.||+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 5554 433 7889999999999987777754 57899999999999999999
Q ss_pred HHH-HCCceeccCCCCceEEccCCcee----------------eeEEEeeccccccccCCCccccCCCcccCccccccCC
Q psy6820 490 YLH-DNYIVHRDIKPENLLVEMSGCHV----------------KVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESG 552 (639)
Q Consensus 490 yLH-~~givHrDLKp~NILld~~g~~~----------------~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~~ 552 (639)
||| ++||+||||||+|||++.++... ..+||+|||+|+..... ..+||+.|+|||++.+..
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~g~~ 253 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFTGDG 253 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGCCCS
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhhcCCC
Confidence 999 99999999999999999875211 27999999999876543 458999999999998776
Q ss_pred CChhhhHHHHHHH-HHHHHcCCCCCCCCCCChHHHHHHHHcC---CCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHH
Q psy6820 553 YGVKIDVWAAGVI-LYILLCGFPPFVSDTNDQDELFDDILSG---QYGFPSPYWDDISEEAKELISHMLESNPDLRFSAE 628 (639)
Q Consensus 553 ~s~~sDVwSLGvv-L~eLltG~~Pf~~~~~~~~~l~~~i~~~---~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~ 628 (639)
+.++||||||++ .+++++|..||.... ....+...+... ....+.+.+..+++++++||++||+.| |++
T Consensus 254 -~~~~Diwsl~~~~~~~~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 254 -DYQFDIYRLMKKENNNRWGEYHPYSNVL-WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp -SHHHHHHHHHHHHHTTCTTSCCTHHHHH-HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred -ccceehhhhhCCCCcccccccCCCcchh-hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 999999998777 778999999993210 001233333321 112222334568999999999999987 999
Q ss_pred HHH-cCCccc
Q psy6820 629 DVL-DHPWLE 637 (639)
Q Consensus 629 eiL-~HP~f~ 637 (639)
|+| +||||+
T Consensus 327 e~l~~Hp~f~ 336 (336)
T 2vuw_A 327 DLLCQHSLFK 336 (336)
T ss_dssp HHHHHCGGGC
T ss_pred HHHhcCCCcC
Confidence 999 999996
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=363.48 Aligned_cols=251 Identities=18% Similarity=0.233 Sum_probs=207.9
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCC-CceeeeeeeeecCCceEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH-PNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~l 452 (639)
.+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| +++..+..++...+..+|
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 4568999999999999999999999999999999998755432 346789999999986 556666667778888999
Q ss_pred EEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE---ccCCceeeeEEEeecccccc
Q psy6820 453 VIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLV---EMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILl---d~~g~~~~~vKL~DFGla~~ 528 (639)
||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||| +.++ .+||+|||++..
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~----~vkL~DFGla~~ 155 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDFGLAKK 155 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT----CEEECCCTTCEE
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC----eEEEEeCCccee
Confidence 99999 9999999975 5679999999999999999999999999999999999999 4555 899999999986
Q ss_pred ccCCC----------ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-ChHHHHHHHHcCCCCC
Q psy6820 529 VLRPM----------FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQYGF 597 (639)
Q Consensus 529 ~~~~~----------~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~-~~~~l~~~i~~~~~~~ 597 (639)
..... ...+||+.|+|||++.+..++.++|||||||+||||++|..||..... .....+..+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 65322 256899999999999999999999999999999999999999976443 3333444433322111
Q ss_pred -CCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 598 -PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 598 -p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.......++.++.+||..||+.||++||++++|++
T Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11122467899999999999999999999988764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.04 Aligned_cols=247 Identities=15% Similarity=0.192 Sum_probs=195.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHhcCC-Cceee-------------
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNH-PNIIK------------- 439 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~l~H-pnIv~------------- 439 (639)
...|..++.||+|+||.||+|.+..+++.||||++........ .+.+.+|+.+++.++| +|...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3468899999999999999999999999999999874433322 3568899999999987 22111
Q ss_pred --------eeeeeec-----CCceEEEEeeccCCChHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy6820 440 --------LLDEYDT-----NNELYLVIELIKGGDLFDAISK-------NVKFSEEDSKFMTQSLASALSYLHDNYIVHR 499 (639)
Q Consensus 440 --------l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~-------~~~l~~~~~~~i~~qI~~aL~yLH~~givHr 499 (639)
+..++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111 22467888876 6799998841 3457888999999999999999999999999
Q ss_pred cCCCCceEEccCCceeeeEEEeeccccccccCCCccccCCCcccCcccc----------ccCCCChhhhHHHHHHHHHHH
Q psy6820 500 DIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEIL----------NESGYGVKIDVWAAGVILYIL 569 (639)
Q Consensus 500 DLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l----------~~~~~s~~sDVwSLGvvL~eL 569 (639)
||||+|||++.++ .+||+|||+++.........+| +.|+|||++ .+..++.++|||||||++|||
T Consensus 236 DiKp~NILl~~~~----~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 236 YLRPVDIVLDQRG----GVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCCGGGEEECTTC----CEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCC----eEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 9999999999998 7999999999877666667788 999999999 555688999999999999999
Q ss_pred HcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 570 LCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 570 ltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||+.||..... ......+. ..+..+|+++.+||.+||+.||++||++.++++||||++
T Consensus 311 ltg~~Pf~~~~~--~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 311 WCADLPNTDDAA--LGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHSSCCCCTTGG--GSCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHCCCCCCCcch--hhhHHHHH--------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 999999965422 11111111 122467899999999999999999999999999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=344.82 Aligned_cols=245 Identities=21% Similarity=0.350 Sum_probs=203.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.++|++.+.||+|+||.||+|.+.. .+|+|++....... ..+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 5789999999999999999998764 49999987543321 2245678999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc---
Q psy6820 455 ELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--- 530 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~--- 530 (639)
||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++ ++ .+||+|||++....
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~----~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG----KVVITDFGLFSISGVLQ 183 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-------CCEECCCSCCC------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC----CEEEeecCCcccccccc
Confidence 9999999999997754 699999999999999999999999999999999999998 33 69999999986542
Q ss_pred -----CCCccccCCCcccCcccccc---------CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCC
Q psy6820 531 -----RPMFTVCGTPTYVAPEILNE---------SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596 (639)
Q Consensus 531 -----~~~~~~~GT~~Y~APE~l~~---------~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~ 596 (639)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|..||... ........+..+...
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--PAEAIIWQMGTGMKP 261 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC--CHHHHHHHHHTTCCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHhccCCCC
Confidence 12234568999999999864 45799999999999999999999999643 445555555554322
Q ss_pred CCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 597 ~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
......++.++.+||.+||+.||++|||+.++++
T Consensus 262 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 262 --NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp --CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred --CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2222468899999999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=370.36 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=209.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCC---CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.++|++++.||+|+||.||+|.+..+ +..+|+|.+.........+.+.+|+.++++++||||+++++++. .+..|+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 46799999999999999999988643 56799999876555555577889999999999999999999985 467899
Q ss_pred EEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~----~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMED 543 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----EEEECCCCCCCSCCC
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC----CEEEEecCCCeecCC
Confidence 99999999999999764 3699999999999999999999999999999999999999887 899999999986643
Q ss_pred CC----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCccccc
Q psy6820 532 PM----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDIS 606 (639)
Q Consensus 532 ~~----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~ 606 (639)
.. ....+|+.|+|||++.+..++.++||||||+++|||++ |..||... ...++...+..+... +....++
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~--~~~~~~~~i~~~~~~---~~~~~~~ 618 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGERL---PMPPNCP 618 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHHTCCC---CCCTTCC
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCC---CCCcccc
Confidence 22 23456789999999999999999999999999999997 99999653 445566666655321 2235789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 607 EEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 607 ~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
+++.+||.+||+.||++|||+.++++
T Consensus 619 ~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 619 PTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=372.95 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=205.3
Q ss_pred CCCcccCCCeeEEEEEccCCceEEEEEEEcC-CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC
Q psy6820 370 NIPSKLLQRYSVGQIIGDGNFAVVRQVYDKH-KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN 448 (639)
Q Consensus 370 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 448 (639)
.....+.++|++.+.||+|+||.||+|.+.. +++.||||++...........+.+|+.++++++||||+++++++...+
T Consensus 73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 3444566899999999999999999999976 789999999876554445567889999999999999999999998766
Q ss_pred c-----eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeec
Q psy6820 449 E-----LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDF 523 (639)
Q Consensus 449 ~-----~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DF 523 (639)
. .||||||++|++|.+++.. .+++.++..++.||+.||+|||++||+||||||+|||++.+ .+||+||
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-----~~kl~DF 225 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-----QLKLIDL 225 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-----CEEECCC
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-----cEEEEec
Confidence 5 7999999999999998765 79999999999999999999999999999999999999875 5899999
Q ss_pred cccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC-CCc
Q psy6820 524 GLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS-PYW 602 (639)
Q Consensus 524 Gla~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~-~~~ 602 (639)
|++...... ...+||+.|+|||++.+. ++.++|||||||++|+|++|..||...... ..+. ...
T Consensus 226 G~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------~~~~~~~~ 290 (681)
T 2pzi_A 226 GAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-------------GLPEDDPV 290 (681)
T ss_dssp TTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-------------SCCTTCHH
T ss_pred ccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-------------cccccccc
Confidence 999876543 556799999999999775 499999999999999999999998542111 1111 111
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
...++.+.+||.+||+.||++||+..+.+.|+|+
T Consensus 291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 2357899999999999999999999999988876
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=333.27 Aligned_cols=227 Identities=21% Similarity=0.188 Sum_probs=186.7
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 4578999999999999999999999999999999998665432 23668899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||++|++|.+++.+. ....++..++.||+.||+|||++||+||||||+|||++.++ .+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g----~~kl~~~~-------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG----DVVLAYPA-------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS----CEEECSCC--------
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC----CEEEEecc--------
Confidence 99999999999999653 46667899999999999999999999999999999999887 78887443
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHH-HHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDE-LFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~-l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
|++ .++.++|||||||++|||+||..||...+..... .......+....+......+++++.+
T Consensus 175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence 444 3799999999999999999999999764432100 00001111111111233568999999
Q ss_pred HHHHhcccCCCCCCCHHHHHc
Q psy6820 612 LISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~ 632 (639)
||.+||+.||++| |+.|+++
T Consensus 239 li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHHHcccCCccC-CHHHHHH
Confidence 9999999999999 9999985
|
| >1mg4_A Doublecortin, doublecortin-like kinase (N-terminal domain); DCX domain, microtubule bundling, cortex development, transferase; 1.50A {Homo sapiens} SCOP: d.15.11.1 PDB: 1mfw_A 1mjd_A 2bqq_A 2xrp_I* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=246.99 Aligned_cols=103 Identities=44% Similarity=0.898 Sum_probs=91.6
Q ss_pred CCCCCccCceEEEEEecCCCCCCcEEEEECCccccCHHHHHHHHHHHHhhcCCCcccceEeecCCC-ceeccccccccCC
Q psy6820 92 PSPLKSRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDG-QKVTNIDELEDGK 170 (639)
Q Consensus 92 ~~~~~~~~~k~v~~~rNgd~~~~g~~~~v~~~~~~~~~~ll~~~t~~l~~~~~l~~~vr~~~t~~g-~~v~~l~~l~~g~ 170 (639)
....++++||+|+||||||+||+|++|+|++++|+|||+||++||+.|+++|+||+|||+|||+|| |+|++++||+||+
T Consensus 7 ~~~~~~~kak~I~~yrNGD~~~~G~~~~v~~~~~~tfd~LL~~lT~~Ls~~v~lp~GVR~lyt~~G~~~I~sl~dL~dG~ 86 (113)
T 1mg4_A 7 FTLSSEKKAKKVRFYRNGDRYFKGIVYAISPDRFRSFEALLADLTRTLSDNVNLPQGVRTIYTIDGLKKISSLDQLVEGE 86 (113)
T ss_dssp ------CCSEEEEEEETTCSSCCCEEEEECTTTCSSHHHHHHHHHHHHCCSSSSTTCCCEEEETTSSCBCCSGGGCCTTC
T ss_pred cccCCCCCceEEEEEECCCCCCCCEEEEECccccCCHHHHHHHHHHHHhhcCCCCcceeEEEcCCCCeEcCCHHHhhCCC
Confidence 345678999999999999999999999999999999999999999999999999999999999998 9999999999999
Q ss_pred eEEEecCCCcccccccccccCCCCCCC
Q psy6820 171 FYICSSSGDQFKKVDYAILNNNNSSNT 197 (639)
Q Consensus 171 ~yv~~~~~e~f~~~~y~~~~~~~~~~~ 197 (639)
.|||||. |+||+++|..+. .|.|.
T Consensus 87 ~YVc~~~-e~fk~i~Y~~~~--~p~w~ 110 (113)
T 1mg4_A 87 SYVCGSI-EPFKKLEYTKNV--NPNWS 110 (113)
T ss_dssp EEEEESS-SCCCCCCTTTTC--CGGGG
T ss_pred EEEEeCC-CCceecCcCccC--CCCcc
Confidence 9999985 999999998743 45553
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=302.36 Aligned_cols=184 Identities=17% Similarity=0.108 Sum_probs=135.7
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEEccccc---------chhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEEE
Q psy6820 384 IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL---------LGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 384 ~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~---------~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 453 (639)
..+.|++|.+..++....++.+++|++.+... ....+.+.+|+++|+++ .|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46778888887777777888999999976532 12235688999999999 599999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC--
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-- 531 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-- 531 (639)
|||++|++|.++|.+.+++++. .|+.||+.||+|||++|||||||||+|||++.+| .+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg----~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ----HARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS----CEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC----CEEEeecccCeeCCCCC
Confidence 9999999999999998888765 4789999999999999999999999999999988 899999999986653
Q ss_pred -CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCC
Q psy6820 532 -PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPP 575 (639)
Q Consensus 532 -~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~P 575 (639)
...+.+||+.|||||++.+. +...+|+||+|+++++|.++..+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 24567899999999999764 67789999999998877665443
|
| >2dnf_A Doublecortin domain-containing protein 2; structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=215.77 Aligned_cols=95 Identities=28% Similarity=0.479 Sum_probs=89.1
Q ss_pred CCCCCCccCceEEEEEecCCCCCCcEEEEECCccccCHHHHHHHHHHHHhhcCCCccc-ceEeecCCCceeccccccccC
Q psy6820 91 TPSPLKSRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSG-VRILFTMDGQKVTNIDELEDG 169 (639)
Q Consensus 91 ~~~~~~~~~~k~v~~~rNgd~~~~g~~~~v~~~~~~~~~~ll~~~t~~l~~~~~l~~~-vr~~~t~~g~~v~~l~~l~~g 169 (639)
+...++..+||+|+||||||++|+|++++|++++++|||+||++||++|. ||+| ||+|||++|++|++|+||+||
T Consensus 5 ~~~~~~~~~pk~I~v~rNGD~~~~g~~v~i~~~~~~sfe~lL~~lT~~v~----l~~GaVr~Lyt~~G~~V~~l~dl~dg 80 (108)
T 2dnf_A 5 SSGRKPLQEPCTIFLIANGDLINPASRLLIPRKTLNQWDHVLQMVTEKIT----LRSGAVHRLYTLEGKLVESGAELENG 80 (108)
T ss_dssp SCSSCCCCCCEEEEECBTTCSSSCCEEEEECHHHHTCHHHHHHHHHHHCC----CTTSSCCEEEETTCCEESSTTSCCSS
T ss_pred cccCcCCCcceEEEEEeCCCCCCCCEEEEECCccccCHHHHHHHHHHhhC----CCCCCEEEEEcCCCCEeCCHHHhCCC
Confidence 34467789999999999999999999999999999999999999999876 9998 999999999999999999999
Q ss_pred CeEEEecCCCccccccccccc
Q psy6820 170 KFYICSSSGDQFKKVDYAILN 190 (639)
Q Consensus 170 ~~yv~~~~~e~f~~~~y~~~~ 190 (639)
+.||||| .|+||+++|....
T Consensus 81 ~~YVa~g-~E~fk~~~Y~~~~ 100 (108)
T 2dnf_A 81 QFYVAVG-RDKFKKLPYGELL 100 (108)
T ss_dssp CBEEEEC-SSCCCCCCCHHHH
T ss_pred CEEEEeC-CCcceecccCccc
Confidence 9999999 4999999999854
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=261.30 Aligned_cols=182 Identities=20% Similarity=0.184 Sum_probs=144.2
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-------hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-------KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-------~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
+...+.||+|+||.||+| ...+..+++|......... ..+.+.+|+.++++++||||+++..++...+..|
T Consensus 338 ~~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ----------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred CCCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 345678999999999999 4456788999865433211 1245789999999999999996666666777889
Q ss_pred EEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 452 LVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
|||||++|++|.+++.+ +..++.|++.||+|||++||+||||||+|||++. .+||+|||+++....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~------~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK------DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS------SEEECCCTTCEECCC
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC------eEEEEECccCEECCC
Confidence 99999999999999976 5689999999999999999999999999999986 499999999987654
Q ss_pred C----------CccccCCCcccCcccccc--CCCChhhhHHHHHHHHHHHHcCCCCC
Q psy6820 532 P----------MFTVCGTPTYVAPEILNE--SGYGVKIDVWAAGVILYILLCGFPPF 576 (639)
Q Consensus 532 ~----------~~~~~GT~~Y~APE~l~~--~~~s~~sDVwSLGvvL~eLltG~~Pf 576 (639)
. ....+||+.|||||++.+ ..|+...|+|+..+-..+.+-++-+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2 135789999999999987 67888999999998888888777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.6e-24 Score=218.46 Aligned_cols=146 Identities=20% Similarity=0.274 Sum_probs=119.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-----------------hhHHHHHHHHHHHHhcCCCceee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-----------------GKKQMIENEVNILRSVNHPNIIK 439 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-----------------~~~~~~~~Ei~iL~~l~HpnIv~ 439 (639)
..|.+++.||+|+||.||+|.+ .+++.||+|++...... .....+.+|+.++++++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 3466779999999999999999 88999999999653321 12456789999999999 4 66
Q ss_pred eeeeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEE
Q psy6820 440 LLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLK 519 (639)
Q Consensus 440 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vK 519 (639)
+.+++.. +..|+||||++|++|.+ +.. .....++.|++.||+|||++||+||||||+|||++ ++ .+|
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~----~vk 232 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE----GIW 232 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT----EEE
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC----cEE
Confidence 6665543 56799999999999988 422 34567999999999999999999999999999999 76 899
Q ss_pred EeeccccccccCCCccccCCCcccCccccc
Q psy6820 520 VGDFGLAQRVLRPMFTVCGTPTYVAPEILN 549 (639)
Q Consensus 520 L~DFGla~~~~~~~~~~~GT~~Y~APE~l~ 549 (639)
|+|||+|. .+..|+|||.+.
T Consensus 233 l~DFG~a~----------~~~~~~a~e~l~ 252 (282)
T 1zar_A 233 IIDFPQSV----------EVGEEGWREILE 252 (282)
T ss_dssp ECCCTTCE----------ETTSTTHHHHHH
T ss_pred EEECCCCe----------ECCCCCHHHHHH
Confidence 99999995 345678999874
|
| >2dnf_A Doublecortin domain-containing protein 2; structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.6e-22 Score=174.47 Aligned_cols=91 Identities=21% Similarity=0.378 Sum_probs=84.4
Q ss_pred CCCCCccccceEEEEEEcCCCCcccEEEEecCCCCCCHHHHHHhhhhhccCCCccccceeccCCccccccccccccCcEE
Q psy6820 215 KTPTSFVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDTGAVRKVYTLNGNQLARLSDFFKSDDVF 294 (639)
Q Consensus 215 ~~~~~~~~~p~~i~v~rng~~~~~~~~~~l~~~~~~~~~~~l~~it~~~~~~~g~v~~lyt~~g~~v~~~~~~~~~~d~y 294 (639)
.+++....+||+|+||||||.+++|++++|+++..+|||++|++||+++++++||||+|||++|++|.++++ |+++++|
T Consensus 5 ~~~~~~~~~pk~I~v~rNGD~~~~g~~v~i~~~~~~sfe~lL~~lT~~v~l~~GaVr~Lyt~~G~~V~~l~d-l~dg~~Y 83 (108)
T 2dnf_A 5 SSGRKPLQEPCTIFLIANGDLINPASRLLIPRKTLNQWDHVLQMVTEKITLRSGAVHRLYTLEGKLVESGAE-LENGQFY 83 (108)
T ss_dssp SCSSCCCCCCEEEEECBTTCSSSCCEEEEECHHHHTCHHHHHHHHHHHCCCTTSSCCEEEETTCCEESSTTS-CCSSCBE
T ss_pred cccCcCCCcceEEEEEeCCCCCCCCEEEEECCccccCHHHHHHHHHHhhCCCCCCEEEEEcCCCCEeCCHHH-hCCCCEE
Confidence 445667888999999999999999999999999999999999999999999999999999999999999999 6799999
Q ss_pred EEcCCccccCCc
Q psy6820 295 FAYGSERVLPDD 306 (639)
Q Consensus 295 va~G~e~~~~dd 306 (639)
||+|.|+|..-+
T Consensus 84 Va~g~E~fk~~~ 95 (108)
T 2dnf_A 84 VAVGRDKFKKLP 95 (108)
T ss_dssp EEECSSCCCCCC
T ss_pred EEeCCCcceecc
Confidence 999999887533
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=183.87 Aligned_cols=139 Identities=18% Similarity=0.135 Sum_probs=109.0
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeE--EEEEEEcccccc-----------------------hhHHHHHHHHHHHHhc
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMD--CALKIIDKSKLL-----------------------GKKQMIENEVNILRSV 432 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAiKv~~~~~~~-----------------------~~~~~~~~Ei~iL~~l 432 (639)
-|.+.+.||+|+||.||+|.+..+++. ||||++...... .....+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998778888 999997643211 1123577899999999
Q ss_pred CCCce--eeeeeeeecCCceEEEEeeccC-C----ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCC
Q psy6820 433 NHPNI--IKLLDEYDTNNELYLVIELIKG-G----DLFDAISKNVKFSEEDSKFMTQSLASALSYLH-DNYIVHRDIKPE 504 (639)
Q Consensus 433 ~HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH-~~givHrDLKp~ 504 (639)
.|+++ +.+++. +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.||+||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88754 344432 367899999942 4 66665432 235678899999999999999 999999999999
Q ss_pred ceEEccCCceeeeEEEeeccccccc
Q psy6820 505 NLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 505 NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
|||++. .++|+|||+|...
T Consensus 201 NILl~~------~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID------KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS------SEEECCCTTCEET
T ss_pred HEEEcC------cEEEEECcccccC
Confidence 999986 3899999999654
|
| >1mg4_A Doublecortin, doublecortin-like kinase (N-terminal domain); DCX domain, microtubule bundling, cortex development, transferase; 1.50A {Homo sapiens} SCOP: d.15.11.1 PDB: 1mfw_A 1mjd_A 2bqq_A 2xrp_I* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.6e-18 Score=153.03 Aligned_cols=84 Identities=20% Similarity=0.289 Sum_probs=76.3
Q ss_pred ccccceEEEEEEcCCCCcccEEEEecCCCCCCHHHHHHhhhh----hccCCCccccceeccCC-ccccccccccccCcEE
Q psy6820 220 FVVRPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITD----IVKLDTGAVRKVYTLNG-NQLARLSDFFKSDDVF 294 (639)
Q Consensus 220 ~~~~p~~i~v~rng~~~~~~~~~~l~~~~~~~~~~~l~~it~----~~~~~~g~v~~lyt~~g-~~v~~~~~~~~~~d~y 294 (639)
...++|+|.||||||.+++|++++|+++..+|||++|++||+ +|.++.| ||+|||++| ++|+++++ |++++.|
T Consensus 11 ~~~kak~I~~yrNGD~~~~G~~~~v~~~~~~tfd~LL~~lT~~Ls~~v~lp~G-VR~lyt~~G~~~I~sl~d-L~dG~~Y 88 (113)
T 1mg4_A 11 SEKKAKKVRFYRNGDRYFKGIVYAISPDRFRSFEALLADLTRTLSDNVNLPQG-VRTIYTIDGLKKISSLDQ-LVEGESY 88 (113)
T ss_dssp --CCSEEEEEEETTCSSCCCEEEEECTTTCSSHHHHHHHHHHHHCCSSSSTTC-CCEEEETTSSCBCCSGGG-CCTTCEE
T ss_pred CCCCceEEEEEECCCCCCCCEEEEECccccCCHHHHHHHHHHHHhhcCCCCcc-eeEEEcCCCCeEcCCHHH-hhCCCEE
Confidence 455688999999999999999999999999999999999976 4589999 999999998 99999999 8999999
Q ss_pred EEcCCccccCC
Q psy6820 295 FAYGSERVLPD 305 (639)
Q Consensus 295 va~G~e~~~~d 305 (639)
||+|.|+|..=
T Consensus 89 Vc~~~e~fk~i 99 (113)
T 1mg4_A 89 VCGSIEPFKKL 99 (113)
T ss_dssp EEESSSCCCCC
T ss_pred EEeCCCCceec
Confidence 99999988653
|
| >4atu_I Neuronal migration protein doublecortin; hydrolase, microtubule-associated protein; HET: GDP GTP; 8.30A {Homo sapiens} PDB: 1uf0_A | Back alignment and structure |
|---|
Probab=99.67 E-value=4.7e-18 Score=180.01 Aligned_cols=91 Identities=25% Similarity=0.446 Sum_probs=0.0
Q ss_pred CCCccCceEEEEEecCCCCCCcEEEEECCccccCHHHHHHHHHHHHhhcCCCccc-ceEeecCCCceeccccc-cccCCe
Q psy6820 94 PLKSRRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSG-VRILFTMDGQKVTNIDE-LEDGKF 171 (639)
Q Consensus 94 ~~~~~~~k~v~~~rNgd~~~~g~~~~v~~~~~~~~~~ll~~~t~~l~~~~~l~~~-vr~~~t~~g~~v~~l~~-l~~g~~ 171 (639)
.....++|+|+||||||.++++++++||++.++|||+||++||++|. ||+| ||+|||++|++|.++.| |+||+.
T Consensus 186 ~~~~~kPk~I~V~rNGd~~~~~~rvlLn~r~~~sfe~vL~~ite~l~----l~~GaVrkLyT~~G~~v~~l~d~l~~~~~ 261 (373)
T 4atu_I 186 NKDFVRPKLVTIIRSGVKPRKAVRVLLNKKTAHSFEQVLTDITEAIK----LETGVVKKLYTLDGKQVTCLHDFFGDDDV 261 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccCCCccEEEEEeCCCCCCCCEEEEECCccccCHHHHHHHHHhhcC----CCCCceeEEEcCCCCEecCHHHHhcCCCE
Confidence 34556899999999999999999999999999999999999999987 9998 99999999999999988 779999
Q ss_pred EEEecCCCcccccccccc
Q psy6820 172 YICSSSGDQFKKVDYAIL 189 (639)
Q Consensus 172 yv~~~~~e~f~~~~y~~~ 189 (639)
|||||. |+||.++|...
T Consensus 262 yVA~G~-E~Fk~~~~d~~ 278 (373)
T 4atu_I 262 FIACGP-EKFRYAQDDFS 278 (373)
T ss_dssp ------------------
T ss_pred EEEecC-CcCcccccccc
Confidence 999995 99999999743
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=6.5e-17 Score=173.66 Aligned_cols=141 Identities=18% Similarity=0.185 Sum_probs=102.6
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc------------h-hH--------HHHHHHHHHHHhcCCCce
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL------------G-KK--------QMIENEVNILRSVNHPNI 437 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~------------~-~~--------~~~~~Ei~iL~~l~HpnI 437 (639)
|.+++.||.|+||.||+|.+. +|+.||||+++..... . .. -....|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999875 5889999998643211 0 00 112356777777754443
Q ss_pred e--eeeeeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCc--
Q psy6820 438 I--KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC-- 513 (639)
Q Consensus 438 v--~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~-- 513 (639)
. ..++. ...+|||||++|++|..+.. ...+..++.||+.+|.+||+.|||||||||.|||++.++.
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 2 22222 23479999999988866542 2345678899999999999999999999999999987651
Q ss_pred ----eeeeEEEeecccccccc
Q psy6820 514 ----HVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 514 ----~~~~vKL~DFGla~~~~ 530 (639)
....+.|+||+-+....
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETT
T ss_pred cccccccceEEEEeCCcccCC
Confidence 12248899999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=5.7e-12 Score=127.37 Aligned_cols=140 Identities=16% Similarity=0.174 Sum_probs=112.3
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+..|++...++.|+.+.||++... +..+++|+...... .....+.+|+.+++.+. +..+.++++++.+.+..|+||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 457899999999999999998643 56899999875321 12345789999999995 677889999998888999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD----------------------------------------- 493 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~----------------------------------------- 493 (639)
||++|.+|.+.+. +......++.+++++|+.||+
T Consensus 90 e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 90 SEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred EecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999999887632 223345788899999999998
Q ss_pred ------------------CCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 494 ------------------NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 494 ------------------~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
..++|+|++|.||+++.++ .+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~----~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK----VSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE----EEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc----EEEEEEchhcc
Confidence 4489999999999997643 56799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=6.2e-11 Score=118.62 Aligned_cols=134 Identities=19% Similarity=0.124 Sum_probs=99.1
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc--eeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN--IIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~lV~ 454 (639)
..|.+....+.|..+.||++.. .++..+++|+..... ...+.+|+.+++.+.+.+ +.+++++....+..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 4566644444666799999854 456679999976541 234678999999886444 556888888888899999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------------
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY--------------------------------------- 495 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~g--------------------------------------- 495 (639)
||++|.+|. ... .+ ...++.+++..|+.||+..
T Consensus 95 e~i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 95 GEVPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp ECCSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred EecCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999998884 211 11 2356777888888888653
Q ss_pred -------------------ceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 496 -------------------IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 496 -------------------ivHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
++|+|++|.||+++.++ .+.|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~----~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR----FSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE----EEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc----EEEEEcchhcc
Confidence 99999999999997654 56799999984
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=3.2e-10 Score=120.22 Aligned_cols=142 Identities=19% Similarity=0.295 Sum_probs=107.1
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEEc--ccccchhHHHHHHHHHHHHhcC--CCceeeeeeeeecC---CceEEE
Q psy6820 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIID--KSKLLGKKQMIENEVNILRSVN--HPNIIKLLDEYDTN---NELYLV 453 (639)
Q Consensus 381 i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~--~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~---~~~~lV 453 (639)
..+.|+.|.++.||++... +..+++|+.. ..........+.+|+.+++.+. +..+++++.++.+. +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3678999999999998654 3578899876 4332223456788999999997 45578899888776 458999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD---------------------------------------- 493 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~---------------------------------------- 493 (639)
|||++|..+.+.. ...++..+...++.+++.+|+.||+
T Consensus 120 me~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 120 MEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp EECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9999998875422 1246788889999999999999997
Q ss_pred ------------------CCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 494 ------------------NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 494 ------------------~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
..++|+|+++.|||++.++. ..+.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~--~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP--RVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS--CEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC--cEEEEECcccccc
Confidence 35899999999999987652 2578999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=4.1e-10 Score=116.65 Aligned_cols=180 Identities=21% Similarity=0.272 Sum_probs=124.7
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCc--eeeeeeeeecCC---ceEEEEee
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPN--IIKLLDEYDTNN---ELYLVIEL 456 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~E~ 456 (639)
+.++.|....||++. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++......+ ..|+|||+
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 458999999999863 36899986533 23467889999999884 332 445555544333 35899999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD------------------------------------------- 493 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~------------------------------------------- 493 (639)
++|.+|.+... ..++.++...++.+++..|+.||+
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99988875433 347788888899999999999996
Q ss_pred ---------------CCceeccCCCCceEEccC-CceeeeEEEeeccccccccCCCccccCCCcc---cCcccccc----
Q psy6820 494 ---------------NYIVHRDIKPENLLVEMS-GCHVKVLKVGDFGLAQRVLRPMFTVCGTPTY---VAPEILNE---- 550 (639)
Q Consensus 494 ---------------~givHrDLKp~NILld~~-g~~~~~vKL~DFGla~~~~~~~~~~~GT~~Y---~APE~l~~---- 550 (639)
..++|+|++|.||+++.+ + ..+.|+||+.+... .+.........+ ..|+....
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~---~~~~~iD~~~~~~~-~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKN---TICGIIDFGDAAIS-DPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTT---EEEEECCCTTCEEE-CTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCC---CEEEEEeCCCCccC-ChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 136999999999999874 3 26889999998653 222211111111 23332211
Q ss_pred -CCC---------ChhhhHHHHHHHHHHHHcCCCCC
Q psy6820 551 -SGY---------GVKIDVWAAGVILYILLCGFPPF 576 (639)
Q Consensus 551 -~~~---------s~~sDVwSLGvvL~eLltG~~Pf 576 (639)
+.. ....+.|+++.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 001 22368999999999999998887
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=2e-06 Score=89.15 Aligned_cols=137 Identities=15% Similarity=0.212 Sum_probs=96.1
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCC---ceeeeeeeee-cCCceEEEEeec
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP---NIIKLLDEYD-TNNELYLVIELI 457 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~-~~~~~~lV~E~~ 457 (639)
.+.++.|....||+. +..+++|+.... .....+.+|..+|+.+.+. .+.+++.++. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ---QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH---HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc---hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456789999999987 456899985321 2346788999999999742 3556666663 456678999999
Q ss_pred cCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------------
Q psy6820 458 KGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN------------------------------------------- 494 (639)
Q Consensus 458 ~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~------------------------------------------- 494 (639)
+|.+|.+..- ..++..+...++.++...|+.||+.
T Consensus 96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9988876321 1245556666666666666666642
Q ss_pred -----------------CceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 495 -----------------YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 495 -----------------givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
.++|+|++|.||+++.++.+...+.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2599999999999987211112568999998854
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=3.4e-06 Score=84.98 Aligned_cols=132 Identities=18% Similarity=0.227 Sum_probs=96.2
Q ss_pred EEccCCce-EEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEEeeccCCC
Q psy6820 384 IIGDGNFA-VVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVIELIKGGD 461 (639)
Q Consensus 384 ~LG~G~fG-~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggs 461 (639)
.+..|..| .||+......+..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..|+|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34445554 7898877777788999987533 3456788999999886 3336788888888899999999999988
Q ss_pred hHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q psy6820 462 LFDAISKNVKFSEEDSKFMTQSLASALSYLHDN----------------------------------------------- 494 (639)
Q Consensus 462 L~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~----------------------------------------------- 494 (639)
+.+..... ......++.+++..|+-||+.
T Consensus 107 ~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 107 AFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 87665331 222334555566666666631
Q ss_pred -----------CceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 495 -----------YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 495 -----------givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
.++|+|+.+.|||++.++ .+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~----~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGK----LIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTE----EEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCe----EEEEEECcccc
Confidence 168999999999998664 56799999984
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=6e-06 Score=88.44 Aligned_cols=77 Identities=21% Similarity=0.183 Sum_probs=49.8
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEccccc------chhHHHHHHHHHHHHhcCC--Cc-eeeeeeeeecCCceEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL------LGKKQMIENEVNILRSVNH--PN-IIKLLDEYDTNNELYL 452 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~------~~~~~~~~~Ei~iL~~l~H--pn-Iv~l~~~~~~~~~~~l 452 (639)
.+.||.|.++.||++.....++.+++|....... ....+.+..|..+|+.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5789999999999997666677899998653221 0112445678888888742 33 4455544 3445689
Q ss_pred EEeeccCC
Q psy6820 453 VIELIKGG 460 (639)
Q Consensus 453 V~E~~~gg 460 (639)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=4.7e-06 Score=87.72 Aligned_cols=83 Identities=7% Similarity=0.061 Sum_probs=56.7
Q ss_pred EEEEE-ccCCceEEEEEEEc---C---CCeEEEEEEEccccc--chhHHHHHHHHHHHHhcC-C--CceeeeeeeeecC-
Q psy6820 381 VGQII-GDGNFAVVRQVYDK---H---KDMDCALKIIDKSKL--LGKKQMIENEVNILRSVN-H--PNIIKLLDEYDTN- 447 (639)
Q Consensus 381 i~~~L-G~G~fG~Vy~a~~~---~---~~~~vAiKv~~~~~~--~~~~~~~~~Ei~iL~~l~-H--pnIv~l~~~~~~~- 447 (639)
..+.| +.|....+|++... . ++..+++|+...... ......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 45778 88999999987653 1 156789998754320 001234678888888885 3 3467788877655
Q ss_pred --CceEEEEeeccCCChH
Q psy6820 448 --NELYLVIELIKGGDLF 463 (639)
Q Consensus 448 --~~~~lV~E~~~ggsL~ 463 (639)
+..|+||||++|.++.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3578999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.84 E-value=9.1e-05 Score=76.67 Aligned_cols=74 Identities=18% Similarity=0.205 Sum_probs=43.3
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC--CCceeeeeee------eecCCceEEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN--HPNIIKLLDE------YDTNNELYLV 453 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~------~~~~~~~~lV 453 (639)
.+.|+.|..+.||++... + ..+++|+.... ...+..|..+++.|. .-.+.+++.. ....+..+++
T Consensus 37 ~~~l~gG~~n~~~~v~~~-~-~~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-S-GAVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC----CEEEEEEET-T-EEEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeeccccccCcEEEEEeC-C-CCEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 456777788999998653 3 35999998752 233445566666553 1123444431 1345678999
Q ss_pred EeeccCCCh
Q psy6820 454 IELIKGGDL 462 (639)
Q Consensus 454 ~E~~~ggsL 462 (639)
|||++|.++
T Consensus 110 ~~~i~G~~~ 118 (346)
T 2q83_A 110 YDWIEGRPF 118 (346)
T ss_dssp EECCCCBCC
T ss_pred EEeecCccC
Confidence 999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00016 Score=78.03 Aligned_cols=75 Identities=12% Similarity=0.024 Sum_probs=46.8
Q ss_pred HCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC--ccccC--CCcccCccccccCC---CChhhhHHHHHHH
Q psy6820 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM--FTVCG--TPTYVAPEILNESG---YGVKIDVWAAGVI 565 (639)
Q Consensus 493 ~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~--~~~~G--T~~Y~APE~l~~~~---~s~~sDVwSLGvv 565 (639)
...++|+|++|.|||++.++ ++|+||+.+....... ....+ ...|++|+...... -....++.+....
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-----~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-----TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-----EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-----CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence 46699999999999998664 8999999986442110 00111 23466666553211 1234555677888
Q ss_pred HHHHHcC
Q psy6820 566 LYILLCG 572 (639)
Q Consensus 566 L~eLltG 572 (639)
+|+.+++
T Consensus 306 ~~~~y~~ 312 (420)
T 2pyw_A 306 TWNLFNK 312 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8877664
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.0006 Score=70.88 Aligned_cols=75 Identities=15% Similarity=0.211 Sum_probs=60.4
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC---CCceeeeeeeeecCCceEEEEeecc
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN---HPNIIKLLDEYDTNNELYLVIELIK 458 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~ 458 (639)
.+.|+.|....+|+... .+..+++|+.... ....+..|...|+.|. ...+++++.++...+..++||||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 57789999999999864 3567899987643 3567889999999885 3568888888888888999999999
Q ss_pred CCCh
Q psy6820 459 GGDL 462 (639)
Q Consensus 459 ggsL 462 (639)
|..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0015 Score=64.01 Aligned_cols=135 Identities=19% Similarity=0.127 Sum_probs=89.7
Q ss_pred CChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCcccc
Q psy6820 460 GDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC 537 (639)
Q Consensus 460 gsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~~~~ 537 (639)
-+|.++|+. +.+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+| .|-+.+ +.+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG----~V~f~~-~~s~---------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG----AVTLAP-AADD---------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS----CEEECC-C-------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC----ceeccc-cccc---------c
Confidence 378898864 6789999999999999999877622 1212344457889999888 444432 1110 1
Q ss_pred CCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhc
Q psy6820 538 GTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHML 617 (639)
Q Consensus 538 GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L 617 (639)
....+.|||... ...+.+.=|||||++||..+--..| ..-...+|+.+.+||..|.
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-----------------------e~eE~eLS~~LE~LL~~Mt 154 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-----------------------ENEERELSPPLEQLIDHMA 154 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-----------------------TTEEECCCHHHHHHHHHHT
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-----------------------cccchhhCHHHHHHHHHHH
Confidence 233466888763 3457889999999999998853222 2222578999999999998
Q ss_pred cc-------------------------CCCCCCCHHHHHc
Q psy6820 618 ES-------------------------NPDLRFSAEDVLD 632 (639)
Q Consensus 618 ~~-------------------------dP~~Rpta~eiL~ 632 (639)
.- .+..|.+.++|++
T Consensus 155 ~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 155 NTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp TCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred hcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 66 2467888988874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00061 Score=70.19 Aligned_cols=140 Identities=16% Similarity=0.154 Sum_probs=79.6
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc--eeeeeee------eecCCceE
Q psy6820 380 SVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN--IIKLLDE------YDTNNELY 451 (639)
Q Consensus 380 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~------~~~~~~~~ 451 (639)
.-.+.|+.|....+|++.... + .+++|+..... ..+.+..|+.+++.+...+ +.+++.. ....+..+
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEEEECC---EEEEEEEESS-C-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 345678889889999986543 3 68999987531 1234566788877775222 3344422 12235678
Q ss_pred EEEeeccCCChHH-----------H---Hhhc-CCC--------CHHHHHH---------------HHHHHHHHHHHHHH
Q psy6820 452 LVIELIKGGDLFD-----------A---ISKN-VKF--------SEEDSKF---------------MTQSLASALSYLHD 493 (639)
Q Consensus 452 lV~E~~~ggsL~~-----------~---l~~~-~~l--------~~~~~~~---------------i~~qI~~aL~yLH~ 493 (639)
++|+|++|..+.. . ++.. ..+ ....... +...+...++.+.+
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999998865421 1 1110 000 1000000 01123445555653
Q ss_pred -------CCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 494 -------NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 494 -------~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
.+++|+|+.+.|||++.++ .+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~----~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDE----LSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTE----EEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCc----eEEEecchhccC
Confidence 3599999999999998664 557999998854
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00083 Score=68.82 Aligned_cols=71 Identities=17% Similarity=0.035 Sum_probs=45.4
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCce-eeeeeeeecCCceEEEEeec-cC
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI-IKLLDEYDTNNELYLVIELI-KG 459 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~-~g 459 (639)
.+.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++ .++++.+ .+.-++++||+ +|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 678999999999998 46899998653211 0112468888877752222 4566544 33457899999 66
Q ss_pred CCh
Q psy6820 460 GDL 462 (639)
Q Consensus 460 gsL 462 (639)
.+|
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0016 Score=69.45 Aligned_cols=140 Identities=11% Similarity=0.070 Sum_probs=80.8
Q ss_pred EEEccCCceEEEEEEEcC-------CCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEE
Q psy6820 383 QIIGDGNFAVVRQVYDKH-------KDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~-------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+.|..|-...+|++.... .+..+++|+.... ......+.+|..+++.+. +.-..++++.+.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 567777788899887642 3468999986331 122345568999998886 3334567776654 2999
Q ss_pred eeccCCChHH--------------HH---hhc-----CCCC--HHHHHHHHHHHHH-------------------HHHHH
Q psy6820 455 ELIKGGDLFD--------------AI---SKN-----VKFS--EEDSKFMTQSLAS-------------------ALSYL 491 (639)
Q Consensus 455 E~~~ggsL~~--------------~l---~~~-----~~l~--~~~~~~i~~qI~~-------------------aL~yL 491 (639)
||++|.+|.. .| ... .... +.++..+..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998865531 11 111 1111 3444545443321 23333
Q ss_pred H----HC----CceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 492 H----DN----YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 492 H----~~----givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
. .. .++|+|+.+.||+++.+......+.|+||..|..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 22 3899999999999987611112689999999854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0035 Score=67.92 Aligned_cols=74 Identities=14% Similarity=0.031 Sum_probs=50.6
Q ss_pred EEEEccCCceEEEEEEEcC-------CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc-eeeeeeeeecCCceEEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKH-------KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN-IIKLLDEYDTNNELYLV 453 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~-------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV 453 (639)
.+.|+.|....+|++.... .+..+++|+.... ...+.+.+|..+++.+...+ ..++++.+.+ .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 5678889999999997653 2568999998432 11134457999998886333 3567776543 389
Q ss_pred EeeccCCCh
Q psy6820 454 IELIKGGDL 462 (639)
Q Consensus 454 ~E~~~ggsL 462 (639)
+||++|.+|
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.011 Score=60.06 Aligned_cols=80 Identities=9% Similarity=-0.026 Sum_probs=56.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-C--CceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-H--PNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-H--pnIv~l~~~~~~~~~~~lV 453 (639)
....-++.+|.|..+.||++.. .+|+.+.+|+..... .....++..|+..|+.|. . --+.+++++. .-++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 3456678899999999999865 456789999865432 222456889999999985 2 1245555542 34789
Q ss_pred EeeccCCCh
Q psy6820 454 IELIKGGDL 462 (639)
Q Consensus 454 ~E~~~ggsL 462 (639)
|||+.++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0019 Score=67.04 Aligned_cols=139 Identities=14% Similarity=0.122 Sum_probs=70.4
Q ss_pred EEccCCceE-EEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-C-CceeeeeeeeecCCceEEEEeeccCC
Q psy6820 384 IIGDGNFAV-VRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-H-PNIIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 384 ~LG~G~fG~-Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-H-pnIv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
.|+.|.... +|+... .++..+++|...... .+.+..|+.+++.+. + -.+.+++.+....+ +++||++.+.
T Consensus 25 ~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 25 PLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp C--------CCEEEEC-TTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred ECCCCCCCceEEEEEc-CCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 454454444 556543 224567777654321 023356777777764 2 23556666543333 7899999776
Q ss_pred ChHHHHhhc--------------------------CCCCHHHHH--------HHH------------HHHHHHHHHH---
Q psy6820 461 DLFDAISKN--------------------------VKFSEEDSK--------FMT------------QSLASALSYL--- 491 (639)
Q Consensus 461 sL~~~l~~~--------------------------~~l~~~~~~--------~i~------------~qI~~aL~yL--- 491 (639)
.+.+.+... ..++..... ++. ..+...++.|
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 665443211 012221110 000 0111222333
Q ss_pred ---HHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 492 ---HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 492 ---H~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
+...++|+|+.+.|||++.+......+.|+||+.+...
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 12469999999999999864100126899999998644
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0057 Score=64.41 Aligned_cols=75 Identities=17% Similarity=0.083 Sum_probs=44.8
Q ss_pred EEEEccCCceEEEEEEEcC--------CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc-eeeeeeeeecCCceEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKH--------KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN-IIKLLDEYDTNNELYL 452 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~--------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~l 452 (639)
.+.|+.|....+|++.... .+..+++|+....... ......|..+++.+...+ +.++++.. . -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 4677888888999987543 1257899987543211 111357888888876333 44666554 2 368
Q ss_pred EEeeccCCCh
Q psy6820 453 VIELIKGGDL 462 (639)
Q Consensus 453 V~E~~~ggsL 462 (639)
||||++|.++
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0071 Score=62.27 Aligned_cols=76 Identities=11% Similarity=0.093 Sum_probs=48.3
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc--eeeeeee-----eecCCceEEEEe
Q psy6820 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN--IIKLLDE-----YDTNNELYLVIE 455 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~-----~~~~~~~~lV~E 455 (639)
..|+ |....||++.. .+++.+++|+...... ....+..|..+++.+...+ +++++.. ....+..+++||
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 77889998743 3455799999864322 2455667888888875222 4444443 122456688999
Q ss_pred eccCCCh
Q psy6820 456 LIKGGDL 462 (639)
Q Consensus 456 ~~~ggsL 462 (639)
|++|..+
T Consensus 108 ~i~G~~~ 114 (328)
T 1zyl_A 108 SVGGRQF 114 (328)
T ss_dssp CCCCEEC
T ss_pred ecCCCCC
Confidence 9987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.012 Score=61.57 Aligned_cols=72 Identities=15% Similarity=0.101 Sum_probs=45.1
Q ss_pred EEEEc--cCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC---CCceeeeeee------eecCCce
Q psy6820 382 GQIIG--DGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN---HPNIIKLLDE------YDTNNEL 450 (639)
Q Consensus 382 ~~~LG--~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~------~~~~~~~ 450 (639)
.+.+. .|....||++... ++ .+++|+...... ..|+.+++.|. -|++++++.. ....+..
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~-------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~ 96 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSE-SK-SYFIKLKYGYHD-------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFK 96 (339)
T ss_dssp EEEETTTSCSSCEEEEEECS-SC-EEEEEEEECSSC-------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEE
T ss_pred eEEeeccCccccceEEEEeC-CC-CEEEEEecCccc-------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEE
Confidence 34453 3336799998643 34 899999876542 34566666553 2335555543 2345678
Q ss_pred EEEEeeccCCCh
Q psy6820 451 YLVIELIKGGDL 462 (639)
Q Consensus 451 ~lV~E~~~ggsL 462 (639)
+++|+|++|..+
T Consensus 97 ~~l~~~i~G~~~ 108 (339)
T 3i1a_A 97 IIAYPFIHAPNG 108 (339)
T ss_dssp EEEEECCCCCBT
T ss_pred EEEEeccCCCcC
Confidence 999999998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.00 E-value=0.035 Score=60.68 Aligned_cols=75 Identities=23% Similarity=0.172 Sum_probs=49.2
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCce-eeeeeeeecCCceEEEEeeccCC
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI-IKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~gg 460 (639)
.+.|+.|-...+|++.....+..+++|+....... .-...+|..+++.|...++ .++++.+. + .+||||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 56788899999999977654578999987542211 0012579999999975444 56777663 2 2599999875
Q ss_pred Ch
Q psy6820 461 DL 462 (639)
Q Consensus 461 sL 462 (639)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.90 E-value=0.062 Score=58.07 Aligned_cols=75 Identities=15% Similarity=0.051 Sum_probs=48.1
Q ss_pred EEEEccCCceEEEEEEEcCC-------CeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKHK-------DMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~-------~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 453 (639)
++.|..|-...+|++..... +..+++++....... .-...+|..+++.+. +.-..++++.+. -++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~--~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK--FYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C--CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch--hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 46677788889999876521 467999996542211 111257888888885 333456665442 2789
Q ss_pred EeeccCCCh
Q psy6820 454 IELIKGGDL 462 (639)
Q Consensus 454 ~E~~~ggsL 462 (639)
|||++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.51 E-value=0.37 Score=51.23 Aligned_cols=34 Identities=21% Similarity=0.245 Sum_probs=25.4
Q ss_pred ceeccCCCCceEEccCC--ceeeeEEEeeccccccc
Q psy6820 496 IVHRDIKPENLLVEMSG--CHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 496 ivHrDLKp~NILld~~g--~~~~~vKL~DFGla~~~ 529 (639)
++|+|+.+.|||+..+. .+...+.++||..|...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 67999999999995421 11237999999998643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 639 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-83 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-80 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-78 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-78 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-78 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-77 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-77 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-77 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-75 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-74 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-74 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-73 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-72 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-71 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-69 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-67 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-66 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-64 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-64 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-64 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-64 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-63 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-60 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-58 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-58 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-57 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-57 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-57 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-57 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-56 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-56 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-55 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-54 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-54 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-48 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-46 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-43 | |
| d1mg4a_ | 101 | d.15.11.1 (A:) Doublecortin-like kinase Dclk {Huma | 2e-30 | |
| d1mg4a_ | 101 | d.15.11.1 (A:) Doublecortin-like kinase Dclk {Huma | 8e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-21 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 261 bits (669), Expect = 4e-83
Identities = 113/275 (41%), Positives = 164/275 (59%), Gaps = 11/275 (4%)
Query: 364 KRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE 423
K+ E++ Y ++G G F+ V DK A+K I K L GK+ +E
Sbjct: 2 KQAEDIR------DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME 55
Query: 424 NEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQS 483
NE+ +L + HPNI+ L D Y++ LYL+++L+ GG+LFD I + ++E D+ +
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ 115
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV--LRPMFTVCGTPT 541
+ A+ YLHD IVHRD+KPENLL K+ + DFGL++ + T CGTP
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI-MISDFGLSKMEDPGSVLSTACGTPG 174
Query: 542 YVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY 601
YVAPE+L + Y +D W+ GVI YILLCG+PPF + + +LF+ IL +Y F SPY
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLFEQILKAEYEFDSPY 232
Query: 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
WDDIS+ AK+ I H++E +P+ RF+ E L HPW+
Sbjct: 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (646), Expect = 2e-80
Identities = 90/264 (34%), Positives = 143/264 (54%), Gaps = 13/264 (4%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVN 433
L+ + +G+ +G G F V +K ALK++ K++L G + + EV I +
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
HPNI++L + +YL++E G ++ + K KF E+ + LA+ALSY H
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-LRPMFTVCGTPTYVAPEILNESG 552
++HRDIKPENLL+ +G LK+ DFG + T+CGT Y+ PE++
Sbjct: 125 KRVIHRDIKPENLLLGSAGE----LKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 553 YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612
+ K+D+W+ GV+ Y L G PPF + N E + I ++ FP D ++E A++L
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYKRISRVEFTFP----DFVTEGARDL 234
Query: 613 ISHMLESNPDLRFSAEDVLDHPWL 636
IS +L+ NP R +VL+HPW+
Sbjct: 235 ISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 251 bits (643), Expect = 1e-78
Identities = 75/265 (28%), Positives = 138/265 (52%), Gaps = 8/265 (3%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH 434
+L Y + + +G G F VV +V ++ + A K + K+ + E+ + + H
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRH 82
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHD 493
P ++ L D ++ +NE+ ++ E + GG+LF+ + ++ K SE+++ + + L ++H+
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV--LRPMFTVCGTPTYVAPEILNES 551
N VH D+KPEN++ + LK+ DFGL + + + GT + APE+
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNE--LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 552 GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611
G D+W+ GV+ YILL G PF + +D E ++ S + + ISE+ K+
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKSCDWNMDDSAFSGISEDGKD 258
Query: 612 LISHMLESNPDLRFSAEDVLDHPWL 636
I +L ++P+ R + L+HPWL
Sbjct: 259 FIRKLLLADPNTRMTIHQALEHPWL 283
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 250 bits (639), Expect = 4e-78
Identities = 82/269 (30%), Positives = 140/269 (52%), Gaps = 8/269 (2%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRS 431
+ Y + + +G G F VV + +K K I+ L K ++NE++I+
Sbjct: 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT-VKNEISIMNQ 82
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSY 490
++HP +I L D ++ E+ L++E + GG+LFD I +++ K SE + + L +
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 491 LHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL--RPMFTVCGTPTYVAPEIL 548
+H++ IVH DIKPEN++ E +K+ DFGLA ++ + T + APEI+
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKAS--SVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200
Query: 549 NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608
+ G D+WA GV+ Y+LL G PF + + E ++ + F + +S E
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWEFDEDAFSSVSPE 258
Query: 609 AKELISHMLESNPDLRFSAEDVLDHPWLE 637
AK+ I ++L+ P R + D L+HPWL+
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLK 287
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 5e-78
Identities = 69/268 (25%), Positives = 138/268 (51%), Gaps = 9/268 (3%)
Query: 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN 433
+L ++Y + + +G G F +V + + K + + +++ E++IL
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIAR 59
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLH 492
H NI+ L + +++ EL ++ E I G D+F+ I+ + + +E + + AL +LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV--LRPMFTVCGTPTYVAPEILNE 550
+ I H DI+PEN++ + +K+ +FG A+++ + P Y APE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRS--STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610
D+W+ G ++Y+LL G PF+++TN ++ ++I++ +Y F + +IS EA
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638
+ + +L R +A + L HPWL++
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (629), Expect = 2e-77
Identities = 95/282 (33%), Positives = 157/282 (55%), Gaps = 15/282 (5%)
Query: 362 TIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-- 419
T+ R+EN++ Y G+ +G G FAVV++ +K + A K I K + +
Sbjct: 1 TVFRQENVD------DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG 54
Query: 420 ---QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEED 476
+ IE EV+IL+ + HPN+I L + Y+ ++ L++EL+ GG+LFD +++ +EE+
Sbjct: 55 VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 114
Query: 477 SKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV--LRPMF 534
+ + + + + YLH I H D+KPEN+++ +K+ DFGLA ++
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ 594
+ GTP +VAPEI+N G++ D+W+ GVI YILL G PF+ DT E ++ +
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVSAVN 232
Query: 595 YGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
Y F Y+ + S AK+ I +L +P R + +D L HPW+
Sbjct: 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 244 bits (625), Expect = 4e-77
Identities = 106/279 (37%), Positives = 164/279 (58%), Gaps = 23/279 (8%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--------GKKQMIENEVNI 428
+ Y +I+G G +VVR+ K + A+KIID + ++ EV+I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 429 LRSVN-HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASA 487
LR V+ HPNII+L D Y+TN +LV +L+K G+LFD +++ V SE++++ + ++L
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 488 LSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV--LRPMFTVCGTPTYVAP 545
+ LH IVHRD+KPEN+L++ +K+ DFG + ++ + VCGTP+Y+AP
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDM----NIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 546 EIL------NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599
EI+ N GYG ++D+W+ GVI+Y LL G PPF Q + I+SG Y F S
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQFGS 236
Query: 600 PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
P WDD S+ K+L+S L P R++AE+ L HP+ ++
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (624), Expect = 5e-77
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 13/269 (4%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP 435
++ + + Q +G+G + V+ ++ + A+KI+D + + + I+ E+ I + +NH
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY 495
N++K N YL +E GG+LFD I ++ E D++ L + + YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL-----RPMFTVCGTPTYVAPEILNE 550
I HRDIKPENLL++ LK+ DFGLA R + +CGT YVAPE+L
Sbjct: 124 ITHRDIKPENLLLDERD----NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 551 SGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
+ +DVW+ G++L +L G P+ +D + + D W I
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQP-SDSCQEYSDWKEK--KTYLNPWKKIDSAP 236
Query: 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638
L+ +L NP R + D+ W +
Sbjct: 237 LALLHKILVENPSARITIPDIKKDRWYNK 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 4e-75
Identities = 74/266 (27%), Positives = 143/266 (53%), Gaps = 12/266 (4%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
++Y+ + IG G V D + A++ ++ + KK++I NE+ ++R +PN
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPN 78
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
I+ LD Y +EL++V+E + GG L D +++ E + + AL +LH N +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNESGY 553
+HRDIK +N+L+ M G +K+ DFG ++ T+ GTP ++APE++ Y
Sbjct: 138 IHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
G K+D+W+ G++ ++ G PP+ + N L+ +G +P + +S ++ +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNP--EKLSAIFRDFL 250
Query: 614 SHMLESNPDLRFSAEDVLDHPWLERS 639
+ L+ + + R SA+++L H +L+ +
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLKIA 276
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 239 bits (610), Expect = 2e-74
Identities = 71/267 (26%), Positives = 118/267 (44%), Gaps = 14/267 (5%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNILRSVNH 434
+ +S + IG G+F V D A+K + S + Q I EV L+ + H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494
PN I+ Y + +LV+E G E + +T L+YLH +
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEIL---NES 551
++HRD+K N+L+ G ++K+GDFG A ++ P + GTP ++APE++ +E
Sbjct: 135 NMIHRDVKAGNILLSEPG----LVKLGDFGSA-SIMAPANSFVGTPYWMAPEVILAMDEG 189
Query: 552 GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611
Y K+DVW+ G+ L PP + I + P+ SE +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNES--PALQSGHWSEYFRN 245
Query: 612 LISHMLESNPDLRFSAEDVLDHPWLER 638
+ L+ P R ++E +L H ++ R
Sbjct: 246 FVDSCLQKIPQDRPTSEVLLKHRFVLR 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 2e-74
Identities = 76/266 (28%), Positives = 135/266 (50%), Gaps = 17/266 (6%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHP 435
+ G+I+G+G+F+ V + + A+KI++K ++ K + E +++ ++HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY 495
+KL + + +LY + K G+L I K F E ++F T + SAL YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-----LRPMFTVCGTPTYVAPEILNE 550
I+HRD+KPEN+L+ +++ DFG A+ + + GT YV+PE+L E
Sbjct: 129 IIHRDLKPENILLNEDM----HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610
D+WA G I+Y L+ G PPF + ++ +F I+ +Y FP + +A+
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAG--NEYLIFQKIIKLEYDFP----EKFFPKAR 238
Query: 611 ELISHMLESNPDLRFSAEDVLDHPWL 636
+L+ +L + R E++ + L
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 6e-74
Identities = 76/279 (27%), Positives = 131/279 (46%), Gaps = 17/279 (6%)
Query: 367 ENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEV 426
E++ + + +GDG F V + +K + A K+ID + E+
Sbjct: 2 EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-YMVEI 60
Query: 427 NILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK-FSEEDSKFMTQSLA 485
+IL S +HPNI+KLLD + N L+++IE GG + + + + +E + + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTY 542
AL+YLHDN I+HRD+K N+L + G +K+ DFG++ + R + GTP +
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDG----DIKLADFGVSAKNTRTIQRRDSFIGTPYW 176
Query: 543 VAPEIL-----NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597
+APE++ + Y K DVW+ G+ L + PP + + I +
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH--HELNPMRVLLKIAKSEP-P 233
Query: 598 PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
S K+ + LE N D R++ +L HP++
Sbjct: 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (604), Expect = 2e-73
Identities = 69/302 (22%), Positives = 127/302 (42%), Gaps = 44/302 (14%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
+ +G GN VV +V K + A K+I + I E+ +L N P I
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYI 496
+ + ++ E+ + +E + GG L + K + E+ ++ ++ L+YL + + I
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM-FTVCGTPTYVAPEILNESGYGV 555
+HRD+KP N+LV G +K+ DFG++ +++ M + GT +Y++PE L + Y V
Sbjct: 127 MHRDVKPSNILVNSRG----EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 556 KIDVWAAGVILYILLCGFPPFVSDTNDQDEL-FDDILSGQYGF----------------- 597
+ D+W+ G+ L + G P + EL F + G
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 598 --------------------PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
P S E ++ ++ L NP R + ++ H +++
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 638 RS 639
RS
Sbjct: 303 RS 304
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 5e-72
Identities = 97/280 (34%), Positives = 152/280 (54%), Gaps = 19/280 (6%)
Query: 372 PSKLLQRYSV-GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNIL- 429
+ ++ Y V Q++G G V Q+++K ALK++ EV +
Sbjct: 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHW 59
Query: 430 RSVNHPNIIKLLDEYDT----NNELYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQS 483
R+ P+I++++D Y+ L +V+E + GG+LF I + F+E ++ + +S
Sbjct: 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 119
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV--LRPMFTVCGTPT 541
+ A+ YLH I HRD+KPENLL S +LK+ DFG A+ + T C TP
Sbjct: 120 IGEAIQYLHSINIAHRDVKPENLLY-TSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 178
Query: 542 YVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ--DELFDDILSGQYGFPS 599
YVAPE+L Y D+W+ GVI+YILLCG+PPF S+ + I GQY FP+
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238
Query: 600 PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLERS 639
P W ++SEE K LI ++L++ P R + + ++HPW+ +S
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 7e-72
Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 15/267 (5%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNI 437
IG G+F V + D ++ A + KL ++Q + E +L+ + HPNI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 438 IKLLDEYDT----NNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
++ D +++ + LV EL+ G L + + + + + + L +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 494 N--YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-LRPMFTVCGTPTYVAPEILNE 550
I+HRD+K +N+ + VK+ GD GLA V GTP ++APE+ E
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKI---GDLGLATLKRASFAKAVIGTPEFMAPEMYEE 187
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610
Y +DV+A G+ + + P+ S+ + +++ + SG P+ + E K
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPY-SECQNAAQIYRRVTSGVK--PASFDKVAIPEVK 243
Query: 611 ELISHMLESNPDLRFSAEDVLDHPWLE 637
E+I + N D R+S +D+L+H + +
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 2e-71
Identities = 87/273 (31%), Positives = 133/273 (48%), Gaps = 24/273 (8%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNI 437
Y V IG G++ +++ K K +D + +KQM+ +EVN+LR + HPNI
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 438 IKLLD--EYDTNNELYLVIELIKGGDLFDAISKNVK----FSEEDSKFMTQSLASALSYL 491
++ D TN LY+V+E +GGDL I+K K EE + L AL
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 492 HD-----NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYV 543
H + ++HRD+KP N+ ++ +K+GDFGLA+ + GTP Y+
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQ----NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 544 APEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603
+PE +N Y K D+W+ G +LY L PPF Q EL I G++
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF--TAFSQKELAGKIREGKF---RRIPY 236
Query: 604 DISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
S+E E+I+ ML R S E++L++P +
Sbjct: 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 223 bits (569), Expect = 6e-69
Identities = 61/273 (22%), Positives = 111/273 (40%), Gaps = 10/273 (3%)
Query: 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK--QMIENEVNIL 429
PS L RY +G+I+G G + V D D A+K++ E
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 430 RSVNHPNIIKLLDEYDTNNE----LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLA 485
++NHP I+ + D + Y+V+E + G L D + + + + +
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121
Query: 486 SALSYLHDNYIVHRDIKPENLLVE--MSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYV 543
AL++ H N I+HRD+KP N+++ + + + + V GT Y+
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 544 APEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603
+PE + DV++ G +LY +L G PPF D+ + + PS +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDPIPPSARHE 239
Query: 604 DISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
+S + ++ L NP+ R+ + +
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 4e-67
Identities = 77/268 (28%), Positives = 126/268 (47%), Gaps = 17/268 (6%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNIL-RSV 432
++ + + +++G G+F V K + A+K + K +L + E +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 433 NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492
HP + + + T L+ V+E + GGDL I KF + F + L +LH
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILN 549
IV+RD+K +N+L++ G K+ DFG+ + + T CGTP Y+APEIL
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHI----KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 550 ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
Y +D W+ GV+LY +L G PF D++ELF I +P + +EA
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPF--HGQDEEELFHSIRMDNPFYP----RWLEKEA 230
Query: 610 KELISHMLESNPDLRFSAE-DVLDHPWL 636
K+L+ + P+ R D+ HP
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 218 bits (557), Expect = 1e-66
Identities = 82/269 (30%), Positives = 150/269 (55%), Gaps = 17/269 (6%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVN 433
LQ + + + +G G+F V + +H A+K++ K ++ KQ+ +E +L V
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
HP II++ + +++++++ I+GG+LF + K+ +F +KF + AL YLH
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGY 553
I++RD+KPEN+L++ +G +K+ DFG A+ V +T+CGTP Y+APE+++ Y
Sbjct: 123 KDIIYRDLKPENILLDKNG----HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPY 178
Query: 554 GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613
ID W+ G+++Y +L G+ PF + ++ IL+ + FP +E+ K+L+
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSN--TMKTYEKILNAELRFP----PFFNEDVKDLL 232
Query: 614 SHMLESNPDLRF-----SAEDVLDHPWLE 637
S ++ + R EDV +HPW +
Sbjct: 233 SRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-64
Identities = 72/267 (26%), Positives = 128/267 (47%), Gaps = 20/267 (7%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-KQMIENEVNILRSVNHPN 436
+ +VGQ IG G+F V + K D A+K+++ + + Q +NEV +LR H N
Sbjct: 9 QITVGQRIGSGSFGTVYKG--KWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNY 495
I+ + Y T +L +V + +G L+ + KF + + A + YLH
Sbjct: 66 ILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 496 IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-----PMFTVCGTPTYVAPEIL-- 548
I+HRD+K N+ + +K+GDFGLA R + G+ ++APE++
Sbjct: 125 IIHRDLKSNNIFLHEDL----TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 549 -NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY-GFPSPYWDDIS 606
+++ Y + DV+A G++LY L+ G P+ S+ N++D++ + G S +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPY-SNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 607 EEAKELISHMLESNPDLRFSAEDVLDH 633
+ K L++ L+ D R +L
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 1e-64
Identities = 74/273 (27%), Positives = 131/273 (47%), Gaps = 25/273 (9%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM-----IENEVNIL 429
L +Y VG ++G G F V ++ A+K ++K ++ ++ + EV +L
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 430 RSVN--HPNIIKLLDEYDTNNELYLVIELIKGG-DLFDAISKNVKFSEEDSKFMTQSLAS 486
+ V+ +I+LLD ++ + L++E + DLFD I++ EE ++ +
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 487 ALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-LRPMFTVCGTPTYVAP 545
A+ + H+ ++HRDIK EN+L++++ + K+ DFG + GT Y P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGEL---KLIDFGSGALLKDTVYTDFDGTRVYSPP 178
Query: 546 EILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD 604
E + Y G VW+ G++LY ++CG PF D I+ GQ F
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIRGQVFFR----QR 226
Query: 605 ISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
+S E + LI L P R + E++ +HPW++
Sbjct: 227 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (546), Expect = 1e-64
Identities = 95/294 (32%), Positives = 162/294 (55%), Gaps = 17/294 (5%)
Query: 351 TKTSVARCATATIKRRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKII 410
K +A+ +K+ E + + L ++ + +G G+F V V K A+KI+
Sbjct: 15 VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 411 DKSKLLGKKQM--IENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISK 468
DK K++ KQ+ NE IL++VN P ++KL + N+ LY+V+E + GG++F + +
Sbjct: 75 DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 469 NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528
+FSE ++F + YLH +++RD+KPENLL++ G ++V DFG A+R
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG----YIQVTDFGFAKR 190
Query: 529 VLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFD 588
V +T+CGTP +APEI+ GY +D WA GV++Y + G+PPF +D ++++
Sbjct: 191 VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYE 248
Query: 589 DILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRF-----SAEDVLDHPWLE 637
I+SG+ FP S + K+L+ ++L+ + RF D+ +H W
Sbjct: 249 KIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 214 bits (547), Expect = 2e-64
Identities = 67/273 (24%), Positives = 126/273 (46%), Gaps = 19/273 (6%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIE-----NEVNILR 430
+ +SV +IIG G F V A+K +DK ++ K+ ++++
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 431 SVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSY 490
+ + P I+ + + T ++L +++L+ GGDL +S++ FSE D +F + L +
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 491 LHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-MFTVCGTPTYVAPE-IL 548
+H+ ++V+RD+KP N+L++ G +++ D GLA + GT Y+APE +
Sbjct: 123 MHNRFVVYRDLKPANILLDEHG----HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ 178
Query: 549 NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608
Y D ++ G +L+ LL G PF +I D S E
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMAVELPDSFSPE 235
Query: 609 AKELISHMLESNPDLRFS-----AEDVLDHPWL 636
+ L+ +L+ + + R A++V + P+
Sbjct: 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 3e-63
Identities = 89/271 (32%), Positives = 149/271 (54%), Gaps = 20/271 (7%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQM--IENEVNILRSVN 433
+ + +++G G F V V +K A+KI+ K ++ K ++ E +L++
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
HP + L + T++ L V+E GG+LF +S+ F+EE ++F + SAL YLH
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNE 550
+V+RDIK ENL+++ G +K+ DFGL + + M T CGTP Y+APE+L +
Sbjct: 124 RDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610
+ YG +D W GV++Y ++CG PF + D + LF+ IL + FP +S EAK
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFP----RTLSPEAK 233
Query: 611 ELISHMLESNPDLRFS-----AEDVLDHPWL 636
L++ +L+ +P R A++V++H +
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-61
Identities = 76/286 (26%), Positives = 117/286 (40%), Gaps = 38/286 (13%)
Query: 383 QIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQ----MIENEVNILRSVNHPNII 438
+G+G FA V + DK+ + A+K I K E+ +L+ ++HPNII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVH 498
LLD + + + LV + ++ ++ + K L YLH ++I+H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 499 RDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT---VCGTPTYVAPEILNE-SGYG 554
RD+KP NLL++ +G VLK+ DFGLA+ P T Y APE+L YG
Sbjct: 124 RDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 555 VKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD---------- 604
V +D+WA G IL LL P D++ + I W D
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 605 --------------ISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
++ +LI + NP R +A L +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-60
Identities = 61/267 (22%), Positives = 105/267 (39%), Gaps = 20/267 (7%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP 435
++ + Q IG G F V ++ A+K I Q E +++ + H
Sbjct: 6 MKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHS 60
Query: 436 NIIKLLD-EYDTNNELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLH 492
N+++LL + LY+V E + G L D + + + + + A+ YL
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESG 552
N VHRD+ N+LV V KV DFGL + T + APE L E
Sbjct: 121 GNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKK 176
Query: 553 YGVKIDVWAAGVILYILL-CGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611
+ K DVW+ G++L+ + G P+ ++ + G+ D E
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPY--PRIPLKDVVPRVEK---GYKMDAPDGCPPAVYE 231
Query: 612 LISHMLESNPDLRFSAEDVLDHPWLER 638
++ + + +R S + + LE
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQ--LEH 256
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-58
Identities = 74/280 (26%), Positives = 144/280 (51%), Gaps = 24/280 (8%)
Query: 376 LQRYSVGQIIGDGNFAVV---RQVYDKHKDMDCALKIIDKSKLLGKKQMIE---NEVNIL 429
++ + + +++G G + V R++ A+K++ K+ ++ K + E E +L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 430 RSVNH-PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASAL 488
+ P ++ L + T +L+L+++ I GG+LF +S+ +F+E + + + AL
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL----RPMFTVCGTPTYVA 544
+LH I++RDIK EN+L++ +G + + DFGL++ + + CGT Y+A
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGH----VVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 545 PEIL--NESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602
P+I+ +SG+ +D W+ GV++Y LL G PF D + +I PY
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD--GEKNSQAEISRRILKSEPPYP 256
Query: 603 DDISEEAKELISHMLESNPDLRFS-----AEDVLDHPWLE 637
++S AK+LI +L +P R A+++ +H + +
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 4e-58
Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 43/298 (14%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
RY+ IG+G + +V YD + A+K I + Q E+ IL H NI
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 68
Query: 438 IKLLD-----EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLH 492
I + D + ++YLV L+ G DL+ + S + + + L Y+H
Sbjct: 69 IGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIH 126
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV------LRPMFTVCGTPTYVAPE 546
++HRD+KP NLL+ + LK+ DFGLA+ + T Y APE
Sbjct: 127 SANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 547 IL-NESGYGVKIDVWAAGVILYILLCGFPPFVSDTN----------------DQDELFDD 589
I+ N GY ID+W+ G IL +L P F + +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 590 ILSGQYGFPSPYWD---------DISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
+ + Y P+ + + +A +L+ ML NP R E L HP+LE+
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 194 bits (493), Expect = 1e-57
Identities = 76/292 (26%), Positives = 123/292 (42%), Gaps = 37/292 (12%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNH 434
+++Y + IG+G + VV + + + + ALK I K G E++IL+ + H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494
NI+KL D T L LV E + +K L + ++Y HD
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---MFTVCGTPTYVAPEILNES 551
++HRD+KP+NLL+ G LK+ DFGLA+ P T Y AP++L S
Sbjct: 120 RVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 552 G-YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI----- 605
Y ID+W+ G I ++ G P F + + I S W ++
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 606 --------------------SEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
E +L+S ML+ +P+ R +A+ L+H + +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-57
Identities = 74/308 (24%), Positives = 123/308 (39%), Gaps = 43/308 (13%)
Query: 365 RRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIE 423
R+E ++ Y Q +G G + V D A+K + + +
Sbjct: 6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 65
Query: 424 NEVNILRSVNHPNIIKLLDEYDTNN------ELYLVIELIKGGDLFDAISKNVKFSEEDS 477
E+ +L+ + H N+I LLD + + + YLV+ + G + K+ K E+
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRI 123
Query: 478 KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVC 537
+F+ + L Y+H I+HRD+KP NL V K+ DFGLA++ M
Sbjct: 124 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL----KILDFGLARQADSEMTGYV 179
Query: 538 GTPTYVAPE-ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596
T Y APE ILN Y +D+W+ G I+ ++ G F D + +I+
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS--DHLDQLKEIMKVTGT 237
Query: 597 FPSPYWD---------------------------DISEEAKELISHMLESNPDLRFSAED 629
P+ + + S A L+ ML + + R +A +
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 630 VLDHPWLE 637
L HP+ E
Sbjct: 298 ALAHPYFE 305
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-57
Identities = 74/295 (25%), Positives = 121/295 (41%), Gaps = 43/295 (14%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
Y+ ++IG+G+F VV Q A+K + + K+ E+ I+R ++H NI
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 438 IKLLDEYDTNNE------LYLVIELIKGG---DLFDAISKNVKFSEEDSKFMTQSLASAL 488
++L + ++ E L LV++ + K L +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--PMFTVCGTPTYVAP- 545
+Y+H I HRDIKP+NLL++ + K+ DFG A++++R P + + Y AP
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVL---KLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ-------------DELFDDILS 592
I + Y IDVW+AG +L LL G P F D+ E ++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 593 GQYGFPSP----------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
F P + EA L S +LE P R + + H + +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-57
Identities = 60/261 (22%), Positives = 115/261 (44%), Gaps = 16/261 (6%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
+ Q IG G F +V Y +KD A+K I + + ++ E ++ ++HP +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAM--SEEDFIEEAEVMMKLSHPKL 62
Query: 438 IKLLDEYDTNNELYLVIELIKGGDLFD-AISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
++L + LV E ++ G L D ++ F+ E M + ++YL + +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----LRPMFTVCGTPTYVAPEILNESG 552
+HRD+ N LV + V+KV DFG+ + V + +PE+ + S
Sbjct: 123 IHRDLAARNCLVGENQ----VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 553 YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612
Y K DVW+ GV+++ + + ++ E+ +DI + GF S ++
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDIST---GFRLYKPRLASTHVYQI 234
Query: 613 ISHMLESNPDLRFSAEDVLDH 633
++H + P+ R + +L
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQ 255
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 7e-57
Identities = 73/304 (24%), Positives = 113/304 (37%), Gaps = 51/304 (16%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPN 436
+Y IG G F V + + ALK + G E+ IL+ + H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 437 IIKLLDEYDT--------NNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASAL 488
++ L++ T +YLV + + + VKF+ + K + Q L + L
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 489 SYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-------LRPMFTVCGTPT 541
Y+H N I+HRD+K N+L+ G VLK+ DFGLA+ T
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDG----VLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 542 YVAPE-ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600
Y PE +L E YG ID+W AG I+ + P N + I
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM--QGNTEQHQLALISQLCGSITPE 244
Query: 601 YWDDI----------------------------SEEAKELISHMLESNPDLRFSAEDVLD 632
W ++ A +LI +L +P R ++D L+
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
Query: 633 HPWL 636
H +
Sbjct: 305 HDFF 308
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (487), Expect = 1e-56
Identities = 76/293 (25%), Positives = 116/293 (39%), Gaps = 34/293 (11%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYD-KHKDMDCALKIIDKSKLL-GKKQMIENEVNILR---S 431
Q+Y IG+G + V + D K+ ALK + G EV +LR +
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 432 VNHPNIIKLLD-----EYDTNNELYLVIELIKGGDL-FDAISKNVKFSEEDSKFMTQSLA 485
HPN+++L D D +L LV E + + E K M L
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 486 SALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPTYVAP 545
L +LH + +VHRD+KP+N+LV SG + +V T Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKL--ADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN--------------DQDELFDDIL 591
E+L +S Y +D+W+ G I + P F ++ +++ D+
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 592 SGQYGFPS-------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
+ F S + DI E K+L+ L NP R SA L HP+ +
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-56
Identities = 53/266 (19%), Positives = 112/266 (42%), Gaps = 23/266 (8%)
Query: 385 IGDGNFAVVRQVYDKHKDMD--CALKIIDKSKLLGK-KQMIENEVNILRSVNHPNIIKLL 441
+G GNF V++ Y + K + A+KI+ K + E N+++ +++P I++++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 442 DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
LV+E+ + G L + +N +++ + ++ + YL ++ VHRD+
Sbjct: 75 G-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRV------LRPMFTVCGTPTYVAPEILNESGYGV 555
N+L+ K+ DFGL++ + + + APE +N +
Sbjct: 134 AARNVLLVTQH----YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 556 KIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
K DVW+ GV+++ G P+ E+ + G+ E +L++
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGE---RMGCPAGCPREMYDLMN 244
Query: 615 HMLESNPDLRFSAEDV---LDHPWLE 637
+ + R V L + + +
Sbjct: 245 LCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-56
Identities = 56/266 (21%), Positives = 105/266 (39%), Gaps = 23/266 (8%)
Query: 385 IGDGNFAVVRQVYDKHKD--MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442
+G GNF VRQ + + +D A+K++ + + + E I+ +++P I++L+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 443 EYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDI 501
L LV+E+ GG L + K + + + ++ + YL + VHRD+
Sbjct: 77 -VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135
Query: 502 KPENLLVEMSGCHVKVLKVGDFGLAQRV------LRPMFTVCGTPTYVAPEILNESGYGV 555
N+L+ K+ DFGL++ + + APE +N +
Sbjct: 136 AARNVLLVNRH----YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 556 KIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELIS 614
+ DVW+ GV ++ L G P+ E+ I G+ + E L+S
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGK---RMECPPECPPELYALMS 246
Query: 615 HMLESNPDLRFSAEDV---LDHPWLE 637
+ R V + +
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-56
Identities = 50/262 (19%), Positives = 109/262 (41%), Gaps = 18/262 (6%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+ + + +G G F V Y A+K + + + E N+++ + H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQR 69
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAI--SKNVKFSEEDSKFMTQSLASALSYLHDN 494
+++L T +Y++ E ++ G L D + +K + M +A ++++ +
Sbjct: 70 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----LRPMFTVCGTPTYVAPEILNE 550
+HRD++ N+LV + K+ DFGLA+ + + APE +N
Sbjct: 129 NYIHRDLRAANILVSDTLSC----KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610
+ +K DVW+ G++L ++ + E+ ++ G+ D+ EE
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLER---GYRMVRPDNCPEELY 240
Query: 611 ELISHMLESNPDLRFSAEDVLD 632
+L+ + P+ R + + +
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRS 262
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 8e-56
Identities = 79/293 (26%), Positives = 124/293 (42%), Gaps = 37/293 (12%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNH 434
++ + + IG+G + VV + +K ALK I G E+++L+ +NH
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 435 PNIIKLLDEYDTNNELYLVIELI-KGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
PNI+KLLD T N+LYLV E + + F S K L L++ H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV---LRPMFTVCGTPTYVAPEILNE 550
+ ++HRD+KP+NLL+ G +K+ DFGLA+ +R T Y APEIL
Sbjct: 121 HRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 551 SGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD----- 604
Y +D+W+ G I ++ F D+ + I W
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 605 --------------------ISEEAKELISHMLESNPDLRFSAEDVLDHPWLE 637
+ E+ + L+S ML +P+ R SA+ L HP+ +
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 189 bits (481), Expect = 1e-55
Identities = 64/307 (20%), Positives = 126/307 (41%), Gaps = 48/307 (15%)
Query: 367 ENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEV 426
E+ + Y + + +G G ++ V + + + +KI+ K K+ I+ E+
Sbjct: 25 ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREI 80
Query: 427 NILRSVN-HPNIIKLLD--EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQS 483
IL ++ PNII L D + + LV E + D ++ D +F
Sbjct: 81 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYE 137
Query: 484 LASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV--LRPMFTVCGTPT 541
+ AL Y H I+HRD+KP N++++ + ++ D+GLA+ + +
Sbjct: 138 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL---RLIDWGLAEFYHPGQEYNVRVASRY 194
Query: 542 YVAPEI-LNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDEL-------------- 586
+ PE+ ++ Y +D+W+ G +L ++ PF ++ D+L
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254
Query: 587 ------------FDDILS------GQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAE 628
F+DIL + S +S EA + + +L + R +A
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
Query: 629 DVLDHPW 635
+ ++HP+
Sbjct: 315 EAMEHPY 321
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (474), Expect = 7e-55
Identities = 48/277 (17%), Positives = 98/277 (35%), Gaps = 20/277 (7%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
RY +G+ IG G+F + D + A+K+ K + E I + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVG 64
Query: 438 IKLLDEYDTNNE-LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
I + + +V+EL+ + KFS + + + S + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 497 VHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----------LRPMFTVCGTPTYVAPE 546
+HRD+KP+N L+ + ++ + DFGLA++ R + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 547 ILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQYGFPSP-YWDD 604
+ D+ + G +L G P+ + + ++ I + P
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 605 ISEEAKELISHMLESNPDLRFSAE---DVLDHPWLER 638
E ++ D + + + + +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-54
Identities = 64/266 (24%), Positives = 113/266 (42%), Gaps = 19/266 (7%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVN 433
+R +G+ IG+G F V Q + + A+K ++ E +R +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 434 HPNIIKLLDEYDTNNELYLVIELIKGGDLFD-AISKNVKFSEEDSKFMTQSLASALSYLH 492
HP+I+KL+ T N +++++EL G+L + L++AL+YL
Sbjct: 67 HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 493 DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----LRPMFTVCGTPTYVAPEIL 548
VHRDI N+LV + C +K+GDFGL++ + ++APE +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDC----VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 549 NESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607
N + DVW GV ++ IL+ G PF N +++ I +G+ P +
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGE---RLPMPPNCPP 236
Query: 608 EAKELISHMLESNPDLRFSAEDVLDH 633
L++ +P R ++
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-54
Identities = 53/268 (19%), Positives = 100/268 (37%), Gaps = 20/268 (7%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN 436
+ + +G G F V A+K + + + E +++ + H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM--SPEAFLQEAQVMKKLRHEK 73
Query: 437 IIKLLDEYDTNNELYLVIELIKGGDLFDAI--SKNVKFSEEDSKFMTQSLASALSYLHDN 494
+++L + +Y+V E + G L D + M +AS ++Y+
Sbjct: 74 LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----LRPMFTVCGTPTYVAPEILNE 550
VHRD++ N+LV + V KV DFGLA+ + + APE
Sbjct: 133 NYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 551 SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610
+ +K DVW+ G++L L ++ E+ D + G+ P + E
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVER---GYRMPCPPECPESLH 244
Query: 611 ELISHMLESNPDLRFSAEDVLD--HPWL 636
+L+ P+ R + E + +
Sbjct: 245 DLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 3e-54
Identities = 70/291 (24%), Positives = 116/291 (39%), Gaps = 35/291 (12%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVNH 434
+Q+Y + IG+G + V + ++ ALK + G E+ +L+ + H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494
NI++L D ++ +L LV E S N E K L L + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV---LRPMFTVCGTPTYVAPEILNES 551
++HRD+KP+NLL+ +G K+ +FGLA+ +R T Y P++L +
Sbjct: 121 NVLHRDLKPQNLLINRNGEL----KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 552 G-YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDD------ 604
Y ID+W+AG I L P + D+ I W
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 605 -------------------ISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636
++ ++L+ ++L+ NP R SAE+ L HP+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (474), Expect = 3e-54
Identities = 74/306 (24%), Positives = 120/306 (39%), Gaps = 41/306 (13%)
Query: 365 RRENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIE 423
R+E ++ +RY +G G + V +D + A+K + + + +
Sbjct: 6 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 65
Query: 424 NEVNILRSVNHPNIIKLLDEYDTNNEL-----YLVIELIKGGDLFDAISKNVKFSEEDSK 478
E+ +L+ + H N+I LLD + L ++ + G DL + I K K +++ +
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN-IVKCQKLTDDHVQ 124
Query: 479 FMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCG 538
F+ + L Y+H I+HRD+KP NL V K+ DFGLA+ M
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL----KILDFGLARHTDDEMTGYVA 180
Query: 539 TPTYVAPEI-LNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF 597
T Y APEI LN Y +D+W+ G I+ LL G F D + IL
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLKLILRLVGTP 238
Query: 598 PSPYWD---------------------------DISEEAKELISHMLESNPDLRFSAEDV 630
+ + A +L+ ML + D R +A
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
Query: 631 LDHPWL 636
L H +
Sbjct: 299 LAHAYF 304
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-54
Identities = 59/291 (20%), Positives = 112/291 (38%), Gaps = 43/291 (14%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKD-----MDCALKIIDKSKLLGKKQMIENEVNILRSV 432
G+++G G F V + A+K++ + +++ + +E+ ++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 433 -NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK-------------------- 471
+H NI+ LL + +YL+ E GDL + + +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 472 ---FSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528
+ ED +A + +L VHRD+ N+LV V+K+ DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK----VVKICDFGLARD 213
Query: 529 VLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTND 582
++ ++APE L E Y +K DVW+ G++L+ I G P+
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY--PGIP 271
Query: 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633
D F ++ + P +EE ++ + R S ++
Sbjct: 272 VDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-54
Identities = 60/261 (22%), Positives = 113/261 (43%), Gaps = 18/261 (6%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNII 438
+ + +G G F VV+ + + D A+K+I + + + E ++ +++H ++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLV 62
Query: 439 KLLDEYDTNNELYLVIELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIV 497
+L ++++ E + G L + + +F + M + + A+ YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 498 HRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT----VCGTPTYVAPEILNESGY 553
HRD+ N LV G V+KV DFGL++ VL +T + PE+L S +
Sbjct: 123 HRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 554 GVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612
K D+WA GV+++ I G P+ TN E + I G SE+ +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIAQ---GLRLYRPHLASEKVYTI 233
Query: 613 ISHMLESNPDLRFSAEDVLDH 633
+ D R + + +L +
Sbjct: 234 MYSCWHEKADERPTFKILLSN 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 184 bits (467), Expect = 9e-54
Identities = 57/276 (20%), Positives = 116/276 (42%), Gaps = 24/276 (8%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKH---KDMDCALKIIDKSKLLGKKQMIENEVNILRSV 432
+ + Q+IG G F V + K +++ A+K + +++ +E +I+
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84
Query: 433 NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK-FSEEDSKFMTQSLASALSYL 491
+HPN+I L + + ++ E ++ G L + +N F+ M + +A+ + YL
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA--------QRVLRPMFTVCGTPTYV 543
D VHRD+ N+LV + V KV DFGL+ +
Sbjct: 145 ADMNYVHRDLAARNILVNSNL----VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200
Query: 544 APEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602
APE + + DVW+ G++++ ++ G P+ TN ++ + I + P
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQ---DYRLPPP 255
Query: 603 DDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
D +L+ + + + R +++ L++
Sbjct: 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT--LDK 289
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-53
Identities = 61/271 (22%), Positives = 106/271 (39%), Gaps = 22/271 (8%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDK---HKDMDCALKIIDKSKLLGKKQM--IENEVNILR 430
+ + + +GDG+F VVR+ K + A+K + L + M EVN +
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 431 SVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALS 489
S++H N+I+L + +V EL G L D + K+ F +A +
Sbjct: 67 SLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 490 YLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV------LRPMFTVCGTPTYV 543
YL +HRD+ NLL+ ++K+GDFGL + + +
Sbjct: 126 YLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 544 APEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602
APE L + D W GV L+ + G P++ ++ I P P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQILHKIDKEGERLPRP-- 237
Query: 603 DDISEEAKELISHMLESNPDLRFSAEDVLDH 633
+D ++ ++ P+ R + + D
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (456), Expect = 2e-52
Identities = 56/269 (20%), Positives = 113/269 (42%), Gaps = 18/269 (6%)
Query: 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHP 435
++ +G G + V + K + A+K + + + + + E +++ + HP
Sbjct: 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHP 73
Query: 436 NIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVK--FSEEDSKFMTQSLASALSYLHD 493
N+++LL Y++ E + G+L D + + + S +M ++SA+ YL
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 494 NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV----LRPMFTVCGTPTYVAPEILN 549
+HRD+ N LV + ++KV DFGL++ + + APE L
Sbjct: 134 KNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 550 ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609
+ + +K DVWA GV+L+ + D ++++ + + + E+
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEK---DYRMERPEGCPEKV 245
Query: 610 KELISHMLESNPDLRFSAEDVLDHPWLER 638
EL+ + NP R S ++ E
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQ--AFET 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 7e-52
Identities = 69/282 (24%), Positives = 109/282 (38%), Gaps = 31/282 (10%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKH--KDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NH 434
+IG+GNF V + K MD A+K + + + E+ +L + +H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNV----------------KFSEEDSK 478
PNII LL + LYL IE G+L D + K+ S +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 479 FMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ--RVLRPMFTV 536
+A + YL +HRD+ N+LV V K+ DFGL++ V
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 537 CGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYG 596
++A E LN S Y DVW+ GV+L+ ++ EL++ + G
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLPQ---G 242
Query: 597 FPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
+ + +E +L+ P R S +L L R
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNR 282
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-51
Identities = 56/291 (19%), Positives = 112/291 (38%), Gaps = 38/291 (13%)
Query: 377 QRYSVGQIIGDGNFAVV-----RQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRS 431
R S G+ +G G F V + M A+K++ S L +++ + +E+ +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 432 V-NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN------------------VKF 472
+ NH NI+ LL ++ E GDL + + + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 473 SEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532
ED + +A +++L +HRD+ N+L+ K+ DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT----KICDFGLARDIKND 198
Query: 533 MFT-----VCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF 587
++APE + Y + DVW+ G+ L+ L + +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 588 DDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
I + GF + E +++ +++P R + + ++ +E+
Sbjct: 259 KMI---KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIEK 304
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 5e-50
Identities = 50/265 (18%), Positives = 105/265 (39%), Gaps = 19/265 (7%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKD----MDCALKIIDKSKLLGKKQMIENEVNILRSVNH 434
+ +++G G F V + + + A+K + ++ + I +E ++ SV++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 435 PNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDN 494
P++ +LL T+ + + G L + +A ++YL D
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 495 YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV-----LRPMFTVCGTPTYVAPEILN 549
+VHRD+ N+LV+ +K+ DFGLA+ + ++A E +
Sbjct: 131 RLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 550 ESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608
Y + DVW+ GV ++ L+ G P+ D E+ + G+ P + +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPY--DGIPASEISSILEKGER---LPQPPICTID 241
Query: 609 AKELISHMLESNPDLRFSAEDVLDH 633
++ + D R +++
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 8e-50
Identities = 58/296 (19%), Positives = 110/296 (37%), Gaps = 46/296 (15%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDK-----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSV 432
+ IG+G F V Q A+K++ + + + E ++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 433 NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKN----------------------- 469
++PNI+KLL + L+ E + GDL + +
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 470 -VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528
S + + + +A+ ++YL + VHRD+ N LV + V+K+ DFGL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM----VVKIADFGLSRN 189
Query: 529 V-----LRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTND 582
+ + ++ PE + + Y + DVWA GV+L+ + G P+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 248
Query: 583 QDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
+E+ + G ++ E L+ P R S + L+R
Sbjct: 249 -EEVIYYVRDGN---ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQR 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-48
Identities = 51/274 (18%), Positives = 112/274 (40%), Gaps = 22/274 (8%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMD-----CALKIIDKSKLLGKKQMIENEVNILRS 431
++ ++ + +G G+F +V + K D A+K ++++ + ++ NE ++++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 432 VNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI----------SKNVKFSEEDSKFMT 481
N ++++LL +++EL+ GDL + S M
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 482 QSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR--VLRPMFTVCGT 539
+A ++YL+ N VHRD+ N +V VK+ G R
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 540 PTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599
+++PE L + + DVW+ GV+L+ + ++ +++ ++ G
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFVMEGGL---L 254
Query: 600 PYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633
D+ + EL+ + NP +R S +++
Sbjct: 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 56/287 (19%), Positives = 109/287 (37%), Gaps = 33/287 (11%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMD-------CALKIIDKSKLLGKKQMIENEVNILR 430
R +G+ +G+G F V D D A+K++ + +E+ +++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 431 SV-NHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAI----------------SKNVKFS 473
+ H NII LL + LY+++E G+L + + + + S
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 474 EEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCH-VKVLKVGDFGLAQRVLRP 532
+D +A + YL +HRD+ N+LV + + +
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILY-ILLCGFPPFVSDTNDQDELFDDIL 591
++APE L + Y + DVW+ GV+L+ I G P+ +ELF +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEELFKLLK 251
Query: 592 SGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638
G + + E ++ + P R + + +++ L+R
Sbjct: 252 EGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDR 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-48
Identities = 56/267 (20%), Positives = 105/267 (39%), Gaps = 19/267 (7%)
Query: 377 QRYSVGQIIGDGNFAVVRQVYDKH----KDMDCALKIIDKSKLLGKKQMIENEVNILRSV 432
+ ++IG G F V + K K++ A+K + ++ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 433 NHPNIIKLLDEYDTNNELYLVIELIKGGDLFD-AISKNVKFSEEDSKFMTQSLASALSYL 491
+H NII+L + ++ E ++ G L K+ +FS M + +A+ + YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 492 HDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA------QRVLRPMFTVCGTPTYVAP 545
+ VHRD+ N+LV + V KV DFGL+ + AP
Sbjct: 127 ANMNYVHRDLAARNILVNSNL----VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605
E ++ + DVW+ G++++ ++ + ++ E+ I GF P D
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAIND---GFRLPTPMDC 238
Query: 606 SEEAKELISHMLESNPDLRFSAEDVLD 632
+L+ + R D++
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-48
Identities = 60/283 (21%), Positives = 120/283 (42%), Gaps = 21/283 (7%)
Query: 363 IKRRENLNIPSKLLQRYSVGQIIGDGNFAVV---RQVYDKHKDMDCALKIIDKSKLLGKK 419
++ +++ I L ++IG G+F V + + K + CA+K +++ +G+
Sbjct: 14 VQAVQHVVIGPSSL-IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 72
Query: 420 QMIENEVNILRSVNHPNIIKLLD-EYDTNNELYLVIELIKGGDLFD-AISKNVKFSEEDS 477
E I++ +HPN++ LL + +V+ +K GDL + ++ + +D
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 478 KFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF--- 534
+A + +L VHRD+ N +++ +KV DFGLA+ + F
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK----FTVKVADFGLARDMYDKEFDSV 188
Query: 535 ----TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDI 590
++A E L + K DVW+ GV+L+ L+ P D N D + +
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYL 247
Query: 591 LSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633
L G+ + + E++ ++R S +++
Sbjct: 248 LQGR---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 168 bits (425), Expect = 5e-48
Identities = 47/269 (17%), Positives = 97/269 (36%), Gaps = 17/269 (6%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
Y VG+ IG+G+F V+ + + + A+K + + +E + +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTG 62
Query: 438 IKLLDEY-DTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYI 496
I + + LVI+L+ KFS + + + + + +H+ +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 497 VHRDIKPENLLV-EMSGCHVKVLKVGDFGLAQRV----------LRPMFTVCGTPTYVAP 545
V+RDIKP+N L+ + + ++ V DFG+ + R + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTN-DQDELFDDILSGQYGFPSP-YWD 603
+ D+ A G + L G P+ + ++ I + P
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 604 DISEEAKELISHMLESNPDLRFSAEDVLD 632
EE + + + D + +
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 68/309 (22%), Positives = 125/309 (40%), Gaps = 56/309 (18%)
Query: 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL-LGKKQMIENEVNILRSVN 433
+L+RY + IG G +V YD D + A+K + + + E+ +++ VN
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 434 HPNIIKLLD------EYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASA 487
H NII LL+ + ++YLV+EL+ ++ E ++ +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---IQMELDHERMSYLLYQMLCG 131
Query: 488 LSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFT--VCGTPTYVAP 545
+ +LH I+HRD+KP N++V+ K+ DFGLA+ T Y AP
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTL----KILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 546 EILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605
E++ GY +D+W+ G I+ ++ F D + ++ ++ + +
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR--DYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 606 --------------------------------------SEEAKELISHMLESNPDLRFSA 627
+ +A++L+S ML +P R S
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 628 EDVLDHPWL 636
+D L HP++
Sbjct: 306 DDALQHPYI 314
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 60/296 (20%), Positives = 113/296 (38%), Gaps = 50/296 (16%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI 437
+ + IG G F V + K + + A+KI + + E E+ + H NI
Sbjct: 4 TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENI 59
Query: 438 IKLLDEYDTNN----ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD 493
+ + + +N +L+LV + + G LFD +++ E K AS L++LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHM 118
Query: 494 NY--------IVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR-------VLRPMFTVCG 538
I HRD+K +N+LV+ +G + D GLA R + G
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 539 TPTYVAPEILNES------GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ--------- 583
T Y+APE+L++S + D++A G++ + + + Q
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 584 ----DELFDDILSGQYGFPSP---YWDDISEEAKELISHMLESNPDLRFSAEDVLD 632
+E+ + + P + +++ +N R +A +
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-46
Identities = 51/284 (17%), Positives = 105/284 (36%), Gaps = 35/284 (12%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDC-----ALKIIDKSKLLGKKQMIENEVNILRSV 432
R +G+ +G G F V + D A+K++ + + + + +E+ IL +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 433 NHPNIIKLLDEY--DTNNELYLVIELIKGGDLFDAISKNVK----------------FSE 474
H + L L +++E K G+L + +
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 475 EDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532
E + +A + +L +HRD+ N+L+ V+K+ DFGLA+ + +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN----VVKICDFGLARDIYKDPD 189
Query: 533 ---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDD 589
++APE + + Y ++ DVW+ GV+L+ + +E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 590 ILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633
+ G D + E + + P R + ++++H
Sbjct: 250 LKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (399), Expect = 1e-43
Identities = 66/320 (20%), Positives = 122/320 (38%), Gaps = 63/320 (19%)
Query: 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN- 436
RY + + +G G+F+ V D + A+KI+ K+ + E+E+ +L+ VN +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADN 71
Query: 437 ----------IIKLLDEYDTNNELYLVIELIK-----GGDLFDAISKNVKFSEEDSKFMT 481
I+KLLD ++ + + ++ ++ K ++
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 482 QSLASALSYLHDNY-IVHRDIKPENLLVEMSGCHVKV--LKVGDFGLAQRVLRPMFTVCG 538
+ L L Y+H I+H DIKPEN+L+E+ + +K+ D G A
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 539 TPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDIL------- 591
T Y +PE+L + +G D+W+ +++ L+ G F D DD +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 592 -----------------------------------SGQYGFPSPYWDDISEEAKELISHM 616
+ D ++E + +S M
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 617 LESNPDLRFSAEDVLDHPWL 636
L+ +P R A +++HPWL
Sbjct: 312 LQLDPRKRADAGGLVNHPWL 331
|
| >d1mg4a_ d.15.11.1 (A:) Doublecortin-like kinase Dclk {Human (Homo sapiens) [TaxId: 9606]} Length = 101 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: Doublecortin (DC) family: Doublecortin (DC) domain: Doublecortin-like kinase Dclk species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (283), Expect = 2e-30
Identities = 44/91 (48%), Positives = 75/91 (82%), Gaps = 2/91 (2%)
Query: 98 RRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDG 157
++AK++RF NGD++FKG+V A+ P+R+RSF++LL +LTR L++N+NLP GVR ++T+DG
Sbjct: 1 KKAKKVRFYRNGDRYFKGIVYAISPDRFRSFEALLADLTRTLSDNVNLPQGVRTIYTIDG 60
Query: 158 -QKVTNIDELEDGKFYICSSSGDQFKKVDYA 187
+K++++D+L +G+ Y+C S + FKK++Y
Sbjct: 61 LKKISSLDQLVEGESYVCGSI-EPFKKLEYT 90
|
| >d1mg4a_ d.15.11.1 (A:) Doublecortin-like kinase Dclk {Human (Homo sapiens) [TaxId: 9606]} Length = 101 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: Doublecortin (DC) family: Doublecortin (DC) domain: Doublecortin-like kinase Dclk species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.8 bits (197), Expect = 8e-19
Identities = 15/99 (15%), Positives = 37/99 (37%), Gaps = 3/99 (3%)
Query: 223 RPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDT---GAVRKVYTLNGN 279
+ + + RNG R K + ++ S + + +T + + VR +YT++G
Sbjct: 2 KAKKVRFYRNGDRYFKGIVYAISPDRFRSFEALLADLTRTLSDNVNLPQGVRTIYTIDGL 61
Query: 280 QLARLSDFFKSDDVFFAYGSERVLPDDFELDVEEVKAIQ 318
+ D + + E ++ +V ++
Sbjct: 62 KKISSLDQLVEGESYVCGSIEPFKKLEYTKNVNPNWSVN 100
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 7e-21
Identities = 36/213 (16%), Positives = 72/213 (33%), Gaps = 46/213 (21%)
Query: 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK-----------------QM 421
++G+++G+G + V Y K +C +K KK +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 422 IENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMT 481
NE L+ + + K+ +++ELI +L+ E+ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYR-------VRVENPDEVL 109
Query: 482 QSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMFTVCGTPT 541
+ ++ + IVH D+ N+LV G + + DF + V
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-----IWIIDFPQSVEVGEEG-----WRE 159
Query: 542 YVAPEILN-----ESGYGVKIDVWAAGVILYIL 569
+ ++ N Y + D+ + I IL
Sbjct: 160 ILERDVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 639 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1mg4a_ | 101 | Doublecortin-like kinase Dclk {Human (Homo sapiens | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1mg4a_ | 101 | Doublecortin-like kinase Dclk {Human (Homo sapiens | 99.82 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.25 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.93 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.66 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.56 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.51 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.19 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-58 Score=470.17 Aligned_cols=257 Identities=30% Similarity=0.557 Sum_probs=222.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++++.||+|+||+||+|+++.+++.||+|++.........+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 47899999999999999999999999999999999876655555678899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC----
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---- 531 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---- 531 (639)
||+||+|.+++.+...+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~----~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD----NLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC----CEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC----CEEEccchhheeeccCCcc
Confidence 999999999998888999999999999999999999999999999999999999887 799999999986532
Q ss_pred -CCccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 -PMFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 -~~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.....+||+.|||||++.+..+ +.++|||||||++|||+||+.||........ .+..+..... ....+..+++++
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~~~~~~--~~~~~~~~s~~~ 236 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKT--YLNPWKKIDSAP 236 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHHHTTCT--TSTTGGGSCHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCC--CCCccccCCHHH
Confidence 2346789999999999988776 6789999999999999999999976543333 3333333322 223357899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLERS 639 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~~~ 639 (639)
.+||.+||+.||++|||++|+++||||+++
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 999999999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=465.25 Aligned_cols=253 Identities=36% Similarity=0.663 Sum_probs=230.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
+++|++++.||+|+||+||+|+++.+++.||+|++.+.... ...+.+.+|+.++++++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999765432 2346688999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC-
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP- 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~- 532 (639)
||||++|+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~----~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG----ELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----CEEECCCCSCSCCCCCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC----CEeecccceeeecCCCc
Confidence 99999999999999888999999999999999999999999999999999999999887 7999999999876543
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.. .+..+++..+....+.+| +.+++++++|
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 234 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA--NTYQETYKRISRVEFTFP----DFVTEGARDL 234 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHTTCCCCC----TTSCHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCCCCC----ccCCHHHHHH
Confidence 4567899999999999999999999999999999999999999954 456778888888876665 4689999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 613 ISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
|.+||++||++|||++|+|+||||+.
T Consensus 235 i~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-57 Score=473.83 Aligned_cols=263 Identities=42% Similarity=0.801 Sum_probs=220.7
Q ss_pred cccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 373 SKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 373 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
+.+.+.|++.+.||+|+||+||+|+++.+++.||||++.+.........+.+|+.+|++++|||||++++++.+++.+||
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34567799999999999999999999999999999999877666556678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
|||||+||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||+.... ....+||+|||+|+....
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~-~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCC---------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccC-CCceEEEeccceeEEccCC
Confidence 999999999999999888999999999999999999999999999999999999996421 012799999999976643
Q ss_pred -CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 532 -PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 532 -~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
...+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.+ ....++...+..+...++.+.++.+|++++
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD--ENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC--CCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 24567899999999999999999999999999999999999999964 356778888999988888888889999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||++||++|||++|+++||||++
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 9999999999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-56 Score=459.99 Aligned_cols=262 Identities=34% Similarity=0.670 Sum_probs=237.2
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-----hHHHHHHHHHHHHhcCCCceeeeeeeeecCCc
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-----KKQMIENEVNILRSVNHPNIIKLLDEYDTNNE 449 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 449 (639)
+.++|++++.||+|+||+||+|+++.+++.||||++.+..... ..+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3468999999999999999999999999999999997654432 35778999999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.....+||+|||+|...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 99999999999999999988899999999999999999999999999999999999999887643346999999999876
Q ss_pred cC--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 530 LR--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 530 ~~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.. ...+.+||+.|+|||++.+..|+.++|||||||++|||+||..||.+ .+..+.+..+......++.+.++.+|+
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--DTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC--CCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 43 34567899999999999999999999999999999999999999965 356777888888888877777778999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++++||++||+.||++|||++|+++||||++
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-56 Score=459.43 Aligned_cols=252 Identities=31% Similarity=0.616 Sum_probs=227.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEccccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKL--LGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
++|++++.||+|+||+||+|+++.+++.||||++.+... ....+.+.+|+.+|++++||||+++++++.+++.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999976543 223467889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR--- 531 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~--- 531 (639)
|||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~----~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM----HIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS----CEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc----eEEecccccceecccCCc
Confidence 9999999999999989999999999999999999999999999999999999999888 899999999986642
Q ss_pred --CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 --PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 --~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
...+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.+ .+..+++..+..+.+.+| ..+++++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~ 237 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFP----EKFFPKA 237 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHTTCCCCC----TTCCHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC--cCHHHHHHHHHcCCCCCC----ccCCHHH
Confidence 23456899999999999999999999999999999999999999965 456778888888877665 4689999
Q ss_pred HHHHHHhcccCCCCCCCHHH------HHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAED------VLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~e------iL~HP~f~~ 638 (639)
++||.+||++||++|||++| +++||||++
T Consensus 238 ~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp HHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999999999987 689999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=457.59 Aligned_cols=254 Identities=28% Similarity=0.546 Sum_probs=222.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEe
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIE 455 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 455 (639)
.++|++.+.||+|+||+||+|.++.+++.||||++...... ..+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 36899999999999999999999999999999999765433 35678899999999999999999999999999999999
Q ss_pred eccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---C
Q psy6820 456 LIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---P 532 (639)
Q Consensus 456 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~ 532 (639)
||+||+|.+++.+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... .
T Consensus 98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~----~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----CEEECCCTTCEECCSTTCC
T ss_pred ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC----cEeeccchhheeecccccc
Confidence 9999999998865 4699999999999999999999999999999999999999887 899999999987642 2
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
....+||+.|+|||++.+..|+.++|||||||++|+|+||..||...+ ....+...+......+ +.+..+++++++|
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~~~~~~~~~~--~~~~~~s~~~~~l 249 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-PLRALYLIATNGTPEL--QNPEKLSAIFRDF 249 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHHCSCCC--SSGGGSCHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC-HHHHHHHHHhCCCCCC--CCcccCCHHHHHH
Confidence 446789999999999999999999999999999999999999996532 2233333333333222 3457899999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 613 ISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
|.+||++||++|||++|+|+||||+.
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-55 Score=466.29 Aligned_cols=260 Identities=29% Similarity=0.613 Sum_probs=234.8
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.++++|++++.||+|+||.||+|+++.+++.||||++..... ...+.+.+|+.+|++++|||||++++++.+.+.+|||
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 456799999999999999999999999999999999976543 3456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAIS-KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||+||+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.+.. ..+||+|||+|+.....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~--~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGLTAHLDPK 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTS--CCEEECCCTTCEECCTT
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCC--CeEEEeecchheecccc
Confidence 99999999999985 4567999999999999999999999999999999999999965321 27999999999876533
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
..+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+. +..+++..+......++...+..++++++
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 34578999999999999999999999999999999999999999643 56778888998888888877888999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||+.||++|||++|+|+||||++
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~hp~~~~ 285 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEHPWLTP 285 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-56 Score=465.55 Aligned_cols=256 Identities=26% Similarity=0.433 Sum_probs=220.8
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||+|+||+||+|+++.+++.||+|+++........+.+.+|+.+|++++|||||+++++|.+++.+||||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 67999999999999999999999999999999998765555567788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCCceeeeEEEeeccccccccC-CCc
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-PMF 534 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-~~~ 534 (639)
++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus 86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~----~vkl~DFGla~~~~~~~~~ 161 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG----EIKLCDFGVSGQLIDSMAN 161 (322)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC----CEEECCCCCCHHHHHHTC-
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC----CEEEeeCCCccccCCCccc
Confidence 9999999999988899999999999999999999997 5999999999999999888 899999999986643 345
Q ss_pred cccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHH---------------------------
Q psy6820 535 TVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELF--------------------------- 587 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~--------------------------- 587 (639)
+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence 67999999999999999999999999999999999999999976554322111
Q ss_pred -------------HHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 588 -------------DDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 588 -------------~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+.... .+......++.++++||.+||+.||++|||++|+|+||||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 1111110 011111346899999999999999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-55 Score=462.96 Aligned_cols=253 Identities=35% Similarity=0.674 Sum_probs=231.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
+++|++++.||+|+||.||+|+++.+++.||+|++++.... ...+.+.+|+.+|++++||||+++++++++.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 57899999999999999999999999999999999865432 2346678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC--
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-- 531 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-- 531 (639)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g----~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS----CEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC----CEEEeecccccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999988 899999999986543
Q ss_pred -CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 532 -PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 532 -~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+. +..++++.+..+.+.+| ..++++++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~--~~~~~~~~i~~~~~~~p----~~~s~~~~ 233 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFP----RTLSPEAK 233 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc--CHHHHHHHHhcCCCCCC----ccCCHHHH
Confidence 345689999999999999999999999999999999999999999654 56788888988877666 57899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
+||.+||++||++|++ ++|+++||||++
T Consensus 234 dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 9999999999999994 999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5e-55 Score=465.09 Aligned_cols=260 Identities=32% Similarity=0.616 Sum_probs=234.1
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
.+.++|++++.||+|+||.||+|+++.+++.||||++...... ....+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3457899999999999999999999999999999999865433 346788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||+||+|.+.+.+. .++++.+++.++.||+.||+|||++||+||||||+|||++.... ..+||+|||+|......
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~--~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC--CCEEECCCTTCEECCTT
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCC--CeEEEeecccceecCCC
Confidence 9999999999987654 46999999999999999999999999999999999999984321 27999999999876543
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
..+.+||+.|+|||++.+..|+.++|||||||++|||+||..||.+ .+..+++..+..+...++...+..++++++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG--EDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC--SSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 4457899999999999999999999999999999999999999954 356778888999888888888889999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||++||++|||++|+|+||||++
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 9999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-55 Score=459.20 Aligned_cols=253 Identities=32% Similarity=0.701 Sum_probs=233.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
+++|++++.||+|+||+||+|+++.+++.||||++.+.... ...+.+.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46899999999999999999999999999999999765432 2346788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM 533 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~ 533 (639)
||||+||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g----~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG----HIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS----CEEECCCSSCEECSSCB
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC----CEEEecCccceEecccc
Confidence 99999999999999999999999999999999999999999999999999999999988 89999999999888778
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELI 613 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI 613 (639)
.+.+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+ .+..++...+..+...+| +.++++++++|
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~li 232 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD--SNTMKTYEKILNAELRFP----PFFNEDVKDLL 232 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC--cCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 889999999999999999999999999999999999999999965 456778888888876665 46899999999
Q ss_pred HHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 614 SHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 614 ~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
.+||++||++|+ |++++++||||++
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 999999999996 8999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-55 Score=446.67 Aligned_cols=251 Identities=27% Similarity=0.492 Sum_probs=219.2
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec----CCceEEE
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDT----NNELYLV 453 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~lV 453 (639)
|++.+.||+|+||+||+|.++.+++.||+|++...... ...+.+.+|+++|++++|||||+++++|.+ ...+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 47888999999999999999999999999999766543 334678899999999999999999999864 4568999
Q ss_pred EeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEcc-CCceeeeEEEeecccccccc
Q psy6820 454 IELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNY--IVHRDIKPENLLVEM-SGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~g--ivHrDLKp~NILld~-~g~~~~~vKL~DFGla~~~~ 530 (639)
|||+++|+|.+++.+...+++..++.++.||+.||+|||++| |+||||||+|||++. ++ .+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~----~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG----SVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS----CEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCC----CEEEeecCcceecc
Confidence 999999999999998889999999999999999999999999 999999999999964 55 79999999997654
Q ss_pred CC-CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 531 RP-MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 531 ~~-~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.. ..+.+||+.|+|||++.+ .|+.++|||||||++|||++|+.||... .+...+.+.+..+.. |......+++++
T Consensus 167 ~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~ 242 (270)
T d1t4ha_ 167 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-QNAAQIYRRVTSGVK--PASFDKVAIPEV 242 (270)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-SSHHHHHHHHTTTCC--CGGGGGCCCHHH
T ss_pred CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc-ccHHHHHHHHHcCCC--CcccCccCCHHH
Confidence 33 456789999999999876 5999999999999999999999999654 355666677766532 333446789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCccc
Q psy6820 610 KELISHMLESNPDLRFSAEDVLDHPWLE 637 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~eiL~HP~f~ 637 (639)
++||.+||++||++|||++|+|+||||+
T Consensus 243 ~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 243 KEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-55 Score=452.22 Aligned_cols=254 Identities=30% Similarity=0.488 Sum_probs=222.3
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
+.|++++.||+|+||+||+|+++.+++.||+|++..... ...+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 579999999999999999999999999999999976533 2345678999999999999999999999999999999999
Q ss_pred ccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC---C
Q psy6820 457 IKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR---P 532 (639)
Q Consensus 457 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~---~ 532 (639)
|+||+|.+++.+ .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..... .
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~----~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG----DIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTTCEECHHHHHH
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC----CEEEEechhhhccCCCccc
Confidence 999999999765 56799999999999999999999999999999999999999888 799999999976543 2
Q ss_pred CccccCCCcccCccccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 533 MFTVCGTPTYVAPEILN-----ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~-----~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
..+.+||+.|+|||++. +..|+.++|||||||++|||+||..||... +..+++..+..+.... ...+..+++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~--~~~~~~~~i~~~~~~~-~~~~~~~s~ 243 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL--NPMRVLLKIAKSEPPT-LAQPSRWSS 243 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS--CGGGHHHHHHHSCCCC-CSSGGGSCH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCCC-CCccccCCH
Confidence 34678999999999983 556899999999999999999999999654 3345556666654322 233467899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
++++||.+||+.||++|||++|+++||||+.
T Consensus 244 ~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-55 Score=447.08 Aligned_cols=251 Identities=34% Similarity=0.545 Sum_probs=212.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeec--CCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDT--NNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV 453 (639)
++|++.+.||+|+||+||+|+++.+++.||+|++....... ..+.+.+|+.+|++++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999999999999999998765433 34668899999999999999999998854 4668999
Q ss_pred EeeccCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 454 IELIKGGDLFDAISK----NVKFSEEDSKFMTQSLASALSYLHDNY-----IVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qI~~aL~yLH~~g-----ivHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
||||+||+|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~----~vkl~DFG 159 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ----NVKLGDFG 159 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS----CEEECCHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC----cEEEeecc
Confidence 999999999999854 457999999999999999999999976 99999999999999887 89999999
Q ss_pred ccccccCC---CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy6820 525 LAQRVLRP---MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPY 601 (639)
Q Consensus 525 la~~~~~~---~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~ 601 (639)
+|+..... ..+.+||+.|+|||++.+..|+.++|||||||++|||+||+.||.. .+..++...+..+.... .
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~--~~~~~~~~~i~~~~~~~---~ 234 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA--FSQKELAGKIREGKFRR---I 234 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHTCCCC---C
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC--CCHHHHHHHHHcCCCCC---C
Confidence 99876432 3467899999999999999999999999999999999999999964 35667777887775432 2
Q ss_pred cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 602 ~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
+..+|+++.+||.+||+.||++|||++|+++|||+
T Consensus 235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 35789999999999999999999999999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=457.17 Aligned_cols=259 Identities=26% Similarity=0.580 Sum_probs=235.5
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
++.++|++++.||+|+||+||+|.++.+++.||+|+++.... ....+.+|+.+|+.++|||||++++++++.+.+|||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 467899999999999999999999999999999999976543 345688999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISKNV-KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||++......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~--~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS--STIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC--CCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCc--eEEEEcccchhhccccC
Confidence 99999999999997665 7999999999999999999999999999999999999986542 27999999999876533
Q ss_pred --CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 --MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 --~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
..+.+||+.|+|||.+.+..|+.++|||||||++|+|++|..||.. .+..+++..+..+.+.++.+.++.++++++
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA--ETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 3467899999999999999999999999999999999999999965 456788899999988888777788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+||.+||++||++|||++|+++||||++
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 9999999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.3e-54 Score=442.00 Aligned_cols=257 Identities=41% Similarity=0.747 Sum_probs=232.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--------hHHHHHHHHHHHHhcC-CCceeeeeeeeec
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--------KKQMIENEVNILRSVN-HPNIIKLLDEYDT 446 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--------~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 446 (639)
.++|++.+.||+|+||+||+|++..+++.||||++++..... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999997654321 2345778999999997 9999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 447 NNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
++.+|||||||+||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~----~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM----NIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----CEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC----CeEEccchhe
Confidence 999999999999999999999889999999999999999999999999999999999999999887 8999999999
Q ss_pred ccccC--CCccccCCCcccCccccc------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy6820 527 QRVLR--PMFTVCGTPTYVAPEILN------ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598 (639)
Q Consensus 527 ~~~~~--~~~~~~GT~~Y~APE~l~------~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p 598 (639)
+.... .....+||+.|+|||++. ...++.++||||+||++|||++|+.||.+. +.......+..+...++
T Consensus 158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~--~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCC
T ss_pred eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC--CHHHHHHHHHhCCCCCC
Confidence 87653 244578999999999985 345789999999999999999999999654 56677888888888888
Q ss_pred CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 599 SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 599 ~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.+.+..+|+++++||.+||++||++|||++|+++||||++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 8888899999999999999999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-54 Score=459.86 Aligned_cols=254 Identities=35% Similarity=0.705 Sum_probs=233.3
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.+++|++++.||+|+||.||+|+++.+++.||||++.+.... ...+.+.+|+.+|+.++|||||++++++.+...+++
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 358999999999999999999999999999999999765432 224567899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g----~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG----YIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTTCEECSSC
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC----CEEeeeceeeeecccc
Confidence 999999999999999888999999999999999999999999999999999999999888 8999999999988877
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
..+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+. +...++..+..+...+| ..+++++.+|
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i~~~~~~~p----~~~s~~~~~l 268 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKVRFP----SHFSSDLKDL 268 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC----TTCCHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--CHHHHHHHHhcCCCCCC----ccCCHHHHHH
Confidence 77889999999999999999999999999999999999999999653 56778888888876655 4789999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 613 ISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 613 I~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
|++||++||++|+ |++|+++||||+.
T Consensus 269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 9999999999995 8999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-54 Score=451.19 Aligned_cols=253 Identities=27% Similarity=0.373 Sum_probs=222.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh--HHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK--KQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+.|++.+.||+|+||+||+|++..+++.||||++........ .+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 359999999999999999999999999999999987654332 356889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCCc
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPMF 534 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~~ 534 (639)
|||.+|+|..++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..... ..
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~----~~Kl~DFG~a~~~~~-~~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAP-AN 169 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT----EEEECCCTTCBSSSS-BC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC----CEEEeecccccccCC-CC
Confidence 9999999988888888999999999999999999999999999999999999999888 899999999976543 45
Q ss_pred cccCCCcccCcccccc---CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 535 TVCGTPTYVAPEILNE---SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 535 ~~~GT~~Y~APE~l~~---~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
..+||+.|||||++.+ ..|+.++|||||||++|||++|..||... ...+....+..+.... .....+|+++++
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~--~~~~~~~~i~~~~~~~--~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNESPA--LQSGHWSEYFRN 245 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCCC--CSCTTSCHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCC--CCCCCCCHHHHH
Confidence 6789999999999864 46899999999999999999999999654 3444555555554322 223568999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 612 LISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
||.+||+.||++|||++|+|+||||++
T Consensus 246 li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 999999999999999999999999965
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=445.57 Aligned_cols=253 Identities=30% Similarity=0.576 Sum_probs=225.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc--hhHHHHHHHHHHHH-hcCCCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL--GKKQMIENEVNILR-SVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~--~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~~~~~~l 452 (639)
+++|++++.||+|+||+||+|.++.+++.||||++++.... ...+.+..|..++. .++|||||++++++.+.+.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 36899999999999999999999999999999999765432 22344556666654 6899999999999999999999
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC-
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR- 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~- 531 (639)
|||||++|+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~----~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLG 156 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS----CEEECCCTTCBCCCCT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC----ceeccccchhhhcccc
Confidence 999999999999999989999999999999999999999999999999999999999887 899999999986542
Q ss_pred --CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHH
Q psy6820 532 --PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEA 609 (639)
Q Consensus 532 --~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l 609 (639)
.....+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+ .+..++...+..+.+.+| ..+|+++
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~--~~~~~~~~~i~~~~~~~p----~~~s~~~ 230 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--QDEEELFHSIRMDNPFYP----RWLEKEA 230 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCC----ccCCHHH
Confidence 23457899999999999999999999999999999999999999965 356778888888776555 4689999
Q ss_pred HHHHHHhcccCCCCCCCHH-HHHcCCcccC
Q psy6820 610 KELISHMLESNPDLRFSAE-DVLDHPWLER 638 (639)
Q Consensus 610 ~dLI~~~L~~dP~~Rpta~-eiL~HP~f~~ 638 (639)
++||++||++||++|||+. |+++||||++
T Consensus 231 ~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 9999999999999999995 8999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-53 Score=451.90 Aligned_cols=255 Identities=27% Similarity=0.496 Sum_probs=219.3
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHH---HHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIEN---EVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~---Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
+++|++.+.||+|+||.||+|+++.+++.||||++.+..... ....+.+ |+.+++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 578999999999999999999999999999999997544322 1233333 46667777899999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
|+|||||+||+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g----~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG----HVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS----CEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC----cEEEeeeceeeecC
Confidence 99999999999999999888999999999999999999999999999999999999999888 89999999998765
Q ss_pred C-CCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC-hHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 531 R-PMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTND-QDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 531 ~-~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~-~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
. .....+||+.|+|||++.+ ..|+.++|||||||+||||+||..||...... ...+...+... +...+..+++
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~----~~~~~~~~s~ 234 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----AVELPDSFSP 234 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC----CCCCCSSSCH
T ss_pred CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC----CCCCCCCCCH
Confidence 3 3456789999999999964 57899999999999999999999999765432 33333333333 3344467999
Q ss_pred HHHHHHHHhcccCCCCCCC-----HHHHHcCCcccC
Q psy6820 608 EAKELISHMLESNPDLRFS-----AEDVLDHPWLER 638 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpt-----a~eiL~HP~f~~ 638 (639)
++++||.+||++||++||| |+|+++||||++
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999999 899999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=450.23 Aligned_cols=258 Identities=36% Similarity=0.716 Sum_probs=219.7
Q ss_pred ccCCCeeEEE-EEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeec----C
Q psy6820 374 KLLQRYSVGQ-IIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDT----N 447 (639)
Q Consensus 374 ~~~~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~----~ 447 (639)
.+.++|.+.+ +||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.++ +|||||+++++|++ .
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 4567899874 699999999999999999999999998643 4567899887655 79999999999865 4
Q ss_pred CceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
..+|||||||+||+|++++.+. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ ....+||+|||+
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~-~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-TTCCEEECCCTT
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc-ccccccccccce
Confidence 6789999999999999999764 4699999999999999999999999999999999999998643 123799999999
Q ss_pred cccccC--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC--hHHHHHHHHcCCCCCCCCC
Q psy6820 526 AQRVLR--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND--QDELFDDILSGQYGFPSPY 601 (639)
Q Consensus 526 a~~~~~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~--~~~l~~~i~~~~~~~p~~~ 601 (639)
|+.... .....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.... ...+...+..+.+.+|.+.
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 986643 345678999999999999999999999999999999999999999764432 2334455556667777777
Q ss_pred cccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 602 WDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 602 ~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+..+++++++||++||++||++|||+.|+++||||++
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 7789999999999999999999999999999999965
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=432.17 Aligned_cols=252 Identities=29% Similarity=0.455 Sum_probs=209.5
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhH----HHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 381 VGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKK----QMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 381 i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~----~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
.+++||+|+||+||+|+++.+++.||||+++........ +.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468999999999999999999999999999765443222 3578999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---C
Q psy6820 457 IKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP---M 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~---~ 533 (639)
+.++++..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~----~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----CEEECCCGGGSTTTSCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC----ccccccCccccccCCCcccc
Confidence 99888888877778899999999999999999999999999999999999999887 8999999999776542 3
Q ss_pred ccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC------------
Q psy6820 534 FTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP------------ 600 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~------------ 600 (639)
...+||+.|+|||++.+ ..|+.++|||||||++|||+||.+||...+ ..+....+.......+..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--HHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 45689999999999864 568999999999999999999999996543 344444443221111000
Q ss_pred ------------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 601 ------------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 601 ------------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+.+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 01356899999999999999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=429.61 Aligned_cols=248 Identities=30% Similarity=0.529 Sum_probs=215.9
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchh-----HHHHHHHHHHHHhcC--CCceeeeeeeeecCC
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGK-----KQMIENEVNILRSVN--HPNIIKLLDEYDTNN 448 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~-----~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~ 448 (639)
.++|++++.||+|+||+||+|++..+++.||||++.+...... ...+.+|+.+|++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4689999999999999999999999999999999976543211 133568999999997 899999999999999
Q ss_pred ceEEEEeeccC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 449 ELYLVIELIKG-GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 449 ~~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
..|+||||+.+ +++.+++.+...+++.+++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~---~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR---GELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT---TEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC---CeEEECccccce
Confidence 99999999975 68889998888999999999999999999999999999999999999998653 279999999998
Q ss_pred cccCC-CccccCCCcccCccccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 528 RVLRP-MFTVCGTPTYVAPEILNESGY-GVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 528 ~~~~~-~~~~~GT~~Y~APE~l~~~~~-s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
..... ..+.+||+.|+|||++.+..+ +.++|||||||++|||++|+.||... +.+..+...++ ..+
T Consensus 160 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~i~~~~~~~~----~~~ 227 (273)
T d1xwsa_ 160 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------EEIIRGQVFFR----QRV 227 (273)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------HHHHHCCCCCS----SCC
T ss_pred ecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc--------hHHhhcccCCC----CCC
Confidence 66543 456789999999999987665 67899999999999999999999542 23455555444 578
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
|+++++||.+||+.||++|||++|+++||||++
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999999999999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-51 Score=423.35 Aligned_cols=259 Identities=26% Similarity=0.439 Sum_probs=219.2
Q ss_pred CcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCC-
Q psy6820 372 PSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNN- 448 (639)
Q Consensus 372 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~- 448 (639)
|..+.++|++.+.||+|+||.||+|++..+++.||||++++..... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 2 p~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred CcCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 3456688999999999999999999999999999999998765432 2356889999999999999999999987654
Q ss_pred ---ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccc
Q psy6820 449 ---ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGL 525 (639)
Q Consensus 449 ---~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGl 525 (639)
.+||||||++|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||.
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~----~~~l~d~~~ 157 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN----AVKVMDFGI 157 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS----CEEECCCTT
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc----cceeehhhh
Confidence 4899999999999999999888999999999999999999999999999999999999999887 799999999
Q ss_pred cccccC------CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy6820 526 AQRVLR------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPS 599 (639)
Q Consensus 526 a~~~~~------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~ 599 (639)
+..... .....+||+.|+|||++.+..|+.++|||||||++|||+||.+||... +..+....+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVSVAYQHVREDPIPPS 235 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHCCCCCGG
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc--CHHHHHHHHHhcCCCCCc
Confidence 865432 234568999999999999999999999999999999999999999643 456666777777766666
Q ss_pred CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q psy6820 600 PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWL 636 (639)
Q Consensus 600 ~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f 636 (639)
..++.+|+++.+||.+||++||++||+..+.+.|+|.
T Consensus 236 ~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 6778899999999999999999999954444456664
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=423.38 Aligned_cols=256 Identities=30% Similarity=0.460 Sum_probs=209.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+++|++++.||+|+||+||+|.+..+++.||||+++...... ..+.+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 368999999999999999999999999999999997654322 2356789999999999999999999999999999999
Q ss_pred eeccCCChHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 455 ELIKGGDLFDAIS--KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 455 E~~~ggsL~~~l~--~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||+.+ ++.+++. ....+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~----~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVP 155 (298)
T ss_dssp ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS----CEEECSTTHHHHHCCC
T ss_pred eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC----cceeccCCcceeccCC
Confidence 99965 5554443 345699999999999999999999999999999999999999887 8999999999776533
Q ss_pred ---CccccCCCcccCccccccCC-CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC--------
Q psy6820 533 ---MFTVCGTPTYVAPEILNESG-YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP-------- 600 (639)
Q Consensus 533 ---~~~~~GT~~Y~APE~l~~~~-~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~-------- 600 (639)
.....||+.|+|||++.... ++.++|+|||||++|+|++|+.||...+ ..+....+..........
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--EIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC--HHHHHHHHHHhcCCCchhhccccccc
Confidence 34568999999999987655 5899999999999999999999996542 333333332211111100
Q ss_pred -----------------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 601 -----------------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 601 -----------------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
....+++++++||++||+.||++|||++|+++||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 01246789999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-50 Score=418.46 Aligned_cols=256 Identities=28% Similarity=0.426 Sum_probs=214.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+++|++.+.||+|+||+||+|+++ +++.||||+++...... ..+.+.+|+.+|++++||||+++++++.+++..|++|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 478999999999999999999886 67899999997654332 2467889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|++.++.+..+....+.+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+|.....+
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~----~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPVR 155 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS----CEEECCTTHHHHHCC---
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC----CEEecccccceecccCcc
Confidence 9998888888877788999999999999999999999999999999999999999987 8999999999776543
Q ss_pred -CccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC------------
Q psy6820 533 -MFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP------------ 598 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p------------ 598 (639)
.....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+. ...+....+.......+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV--SEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC--CHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 344578999999999875 45799999999999999999999999654 33333344332111111
Q ss_pred -------------CCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 599 -------------SPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 599 -------------~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
......+++++.|||++||++||++|||++|+++||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0112457899999999999999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=426.29 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=210.0
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCC-----eEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCce
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKD-----MDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 450 (639)
++|++++.||+|+||+||+|++..++ ..||+|.+...........+.+|+.+|+++ +|||||++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 58999999999999999999987654 369999987665555556788999999998 799999999999999999
Q ss_pred EEEEeeccCCChHHHHhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q psy6820 451 YLVIELIKGGDLFDAISKN-----------------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLL 507 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~-----------------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NIL 507 (639)
|+|||||++|+|.++|.+. ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 9999999999999999654 24899999999999999999999999999999999999
Q ss_pred EccCCceeeeEEEeeccccccccCCC-----ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCC
Q psy6820 508 VEMSGCHVKVLKVGDFGLAQRVLRPM-----FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTN 581 (639)
Q Consensus 508 ld~~g~~~~~vKL~DFGla~~~~~~~-----~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~ 581 (639)
++.++ .+||+|||+|+...... .+.+||+.|||||++.+..|+.++|||||||++|||+| |..||.+...
T Consensus 197 l~~~~----~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 197 VTHGK----VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp EETTT----EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cccCC----eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99888 89999999997654322 24568999999999999999999999999999999997 8999976543
Q ss_pred ChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 582 DQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 582 ~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
. ..+ ..+......++ .+..+|+++++||.+||+.||++|||++||++|
T Consensus 273 ~-~~~-~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 D-ANF-YKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp S-HHH-HHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H-HHH-HHHHhcCCCCC--CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 333 34444433333 335789999999999999999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=418.62 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=206.5
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
.++|++++.||+|+||+||+|+... .||||+++..... ...+.+.+|+.+|++++|||||++++++. .+.+|+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence 4679999999999999999997543 5999999765433 33467889999999999999999999875 45789999
Q ss_pred eeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC--
Q psy6820 455 ELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR-- 531 (639)
Q Consensus 455 E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~-- 531 (639)
|||++|+|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~----~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL----TVKIGDFGLATVKSRWS 158 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS----SEEECCCCCSCC-----
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC----CEEEccccceeeccccC
Confidence 99999999999965 45799999999999999999999999999999999999999887 899999999976542
Q ss_pred ---CCccccCCCcccCcccccc---CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC-CCCCccc
Q psy6820 532 ---PMFTVCGTPTYVAPEILNE---SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF-PSPYWDD 604 (639)
Q Consensus 532 ---~~~~~~GT~~Y~APE~l~~---~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~-p~~~~~~ 604 (639)
.....+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.... ....+...+..+.... .......
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcCCCCCcchhcccc
Confidence 2345689999999999864 458999999999999999999999997543 3444444554443221 1234467
Q ss_pred ccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 605 ISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 605 l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+|+++.+||.+||+.||++|||++||+++
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-50 Score=418.48 Aligned_cols=252 Identities=22% Similarity=0.368 Sum_probs=217.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++.+.||+|+||+||+|.++.+++.||||+++.... ..+.+.+|+.+|++++|||||+++++|.+.+.+|+||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 589999999999999999999999999999999976543 346688999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCCC-
Q psy6820 457 IKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRPM- 533 (639)
Q Consensus 457 ~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~~- 533 (639)
|++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~----~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG----CEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC----cEEEccccceeecCCCCc
Confidence 9999999999653 5789999999999999999999999999999999999999887 89999999998765332
Q ss_pred ---ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 534 ---FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 534 ---~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
....||+.|+|||++.+..|+.++|||||||++|||++|..||... .+...+.+.+..+ . ..+.+..+++++.
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-~~~~~~~~~i~~~-~--~~~~~~~~~~~l~ 246 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKD-Y--RMERPEGCPEKVY 246 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTT-C--CCCCCTTCCHHHH
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc-chHHHHHHHHhcC-C--CCCCCccchHHHH
Confidence 2345789999999999999999999999999999999977776443 3455555555543 2 2233467899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHc--CCcccC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLD--HPWLER 638 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~--HP~f~~ 638 (639)
+||.+||+.||++|||++|+++ ..++++
T Consensus 247 ~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999976 244443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-50 Score=418.47 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=205.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCe---EEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDM---DCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.++|++.+.||+|+||+||+|.++.+++ .||||.+.........+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3679999999999999999999876654 5889988766655556778999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
|||||++|+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~----~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL----VCKVSDFGLSRFLED 180 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CEEECCC--------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC----cEEECCcccceEccC
Confidence 99999999999988764 5799999999999999999999999999999999999999887 899999999976542
Q ss_pred C--------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCc
Q psy6820 532 P--------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYW 602 (639)
Q Consensus 532 ~--------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~ 602 (639)
. .....||+.|+|||++.+..|+.++|||||||++|||+| |..||... ...++...+..+. .++ .+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~--~~~~~~~~i~~~~-~~~--~~ 255 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--TNQDVINAIEQDY-RLP--PP 255 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTC-CCC--CC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC-CCC--CC
Confidence 2 122457999999999999999999999999999999998 89999654 4456666666553 222 23
Q ss_pred ccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 603 DDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 603 ~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
..+++++.+||.+||+.||++|||++||+++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 5789999999999999999999999888754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=417.98 Aligned_cols=257 Identities=30% Similarity=0.413 Sum_probs=208.9
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCC-CeEEEEEEEcccccch-hHHHHHHHHHHHHhc---CCCceeeeeeeee-----
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHK-DMDCALKIIDKSKLLG-KKQMIENEVNILRSV---NHPNIIKLLDEYD----- 445 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~----- 445 (639)
.++|++++.||+|+||+||+|++..+ ++.||||++....... ....+.+|+.+|+.| +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999999755 6789999987543322 122345677777666 7999999999884
Q ss_pred cCCceEEEEeeccCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 446 TNNELYLVIELIKGGDLFDAIS-KNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 446 ~~~~~~lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
....+|++|||+.++++..... ....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~----~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----QIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----CEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC----Ceeecchh
Confidence 3457899999998876654443 345699999999999999999999999999999999999999887 89999999
Q ss_pred cccccc--CCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCC-------
Q psy6820 525 LAQRVL--RPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQY------- 595 (639)
Q Consensus 525 la~~~~--~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~------- 595 (639)
++.... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+. +..+....+.....
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--SDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC--CHHHHHHHHHHhhCCCchhcc
Confidence 987654 3345678999999999999999999999999999999999999999654 33444444432100
Q ss_pred ----------------CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 596 ----------------GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 596 ----------------~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
......+..+++++++||.+||++||++|||++|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0001123567899999999999999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=408.57 Aligned_cols=245 Identities=24% Similarity=0.394 Sum_probs=203.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++++.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.++++++|||||+++++|.+++.+|+||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 579999999999999999998764 56799999976543 346788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 457 IKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~----~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ----VIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG----CEEECSCC-----------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC----CeEecccchheeccCCCce
Confidence 9999999998654 5689999999999999999999999999999999999999887 8999999999765432
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcC-CCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCG-FPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG-~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....||+.|+|||++.+..|+.++|||||||++|||+|+ .+||.. ....++...+..+.... .+..+++++.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~~~~~~---~p~~~~~~l~ 232 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--RSNSEVVEDISTGFRLY---KPRLASTHVY 232 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--CCHHHHHHHHHHTCCCC---CCTTSCHHHH
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC--CCHHHHHHHHHhcCCCC---CccccCHHHH
Confidence 2345789999999999999999999999999999999995 555533 34556667776653222 2256899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+||.+||+.||++|||++||++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=412.72 Aligned_cols=257 Identities=19% Similarity=0.350 Sum_probs=216.8
Q ss_pred cccCCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec
Q psy6820 367 ENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT 446 (639)
Q Consensus 367 ~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 446 (639)
+.|+++. ++|++.+.||+|+||.||+|..+ +++.||||+++.... ..+.+.+|+.++++++|||||++++++.+
T Consensus 6 ~~wei~~---~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 6 DEWEVPR---ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp CTTBCCG---GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCeecCH---HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 4455553 68999999999999999999876 567899999976543 34678899999999999999999998854
Q ss_pred CCceEEEEeeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 447 NNELYLVIELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
+.+|+||||+++|+|.+++... .++++..+..++.||+.||+|||++||+||||||+||||+.++ .+||+|||
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~----~~Kl~DFG 154 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL----SCKIADFG 154 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS----CEEECCCT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc----ceeecccc
Confidence 5679999999999999987543 3699999999999999999999999999999999999999887 89999999
Q ss_pred ccccccCC----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy6820 525 LAQRVLRP----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600 (639)
Q Consensus 525 la~~~~~~----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~ 600 (639)
+|+..... .....||+.|+|||++.+..|+.++|||||||++|||+||..|+... ....++...+..+.. .+
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~-~~~~~~~~~i~~~~~---~~ 230 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYR---MV 230 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCC---CC
T ss_pred ceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhcCC---CC
Confidence 99876432 23467899999999999999999999999999999999965555433 345566666666532 22
Q ss_pred CcccccHHHHHHHHHhcccCCCCCCCHHHHHc--CCcccC
Q psy6820 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLD--HPWLER 638 (639)
Q Consensus 601 ~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~--HP~f~~ 638 (639)
....+++++.+||.+||+.||++|||++|+++ |+||..
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 23678999999999999999999999999998 888853
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=414.92 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=214.4
Q ss_pred CCeeEEEE-EccCCceEEEEEEEcC--CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQI-IGDGNFAVVRQVYDKH--KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~-LG~G~fG~Vy~a~~~~--~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
++|.+.+. ||+|+||.||+|..+. ++..||||+++........+.+.+|+.+|++++|||||++++++.+ +.+|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 46888885 9999999999997754 4567999999876655556778999999999999999999999965 468999
Q ss_pred EeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||||++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~----~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT----EEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC----ceeeccchhhhccccc
Confidence 999999999999755 46799999999999999999999999999999999999999887 8999999999866432
Q ss_pred ------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 533 ------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 533 ------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
....+||+.|+|||++.+..++.++|||||||++|||+| |..||.... ..++...+..+.. .+.++.+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~i~~~~~---~~~p~~~ 237 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKR---MECPPEC 237 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTCC---CCCCTTC
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC---CCCCCcC
Confidence 234578999999999999999999999999999999998 999997543 4566667766542 2233679
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHH---HcCCcc
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDV---LDHPWL 636 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~ei---L~HP~f 636 (639)
|+++.+||.+||+.||++|||+.+| |+|+|+
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999888 567776
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=414.33 Aligned_cols=245 Identities=21% Similarity=0.350 Sum_probs=206.5
Q ss_pred EEEccCCceEEEEEEEcC--CCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEeeccC
Q psy6820 383 QIIGDGNFAVVRQVYDKH--KDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIELIKG 459 (639)
Q Consensus 383 ~~LG~G~fG~Vy~a~~~~--~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 459 (639)
+.||+|+||+||+|..+. +++.||||+++..... ...+.+.+|+.+|++++|||||+++++|.+ +..||||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999997653 4678999999754432 234678899999999999999999999965 467899999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC------C
Q psy6820 460 GDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP------M 533 (639)
Q Consensus 460 gsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~------~ 533 (639)
|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~----~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT----EEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC----cccccchhhhhhccccccccccc
Confidence 99999999988999999999999999999999999999999999999999888 8999999999765432 2
Q ss_pred ccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHH
Q psy6820 534 FTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKEL 612 (639)
Q Consensus 534 ~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dL 612 (639)
....||+.|+|||++.+..|+.++|||||||++|||+| |+.||... ...++...+..+.. .+.+..+|+++.+|
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--~~~~~~~~i~~~~~---~~~p~~~~~~~~~l 242 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGER---MGCPAGCPREMYDL 242 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCC---CCCCTTCCHHHHHH
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC--CHHHHHHHHHcCCC---CCCCcccCHHHHHH
Confidence 24578999999999999999999999999999999998 89999654 45566677766532 22336789999999
Q ss_pred HHHhcccCCCCCCCHHHH---HcCCccc
Q psy6820 613 ISHMLESNPDLRFSAEDV---LDHPWLE 637 (639)
Q Consensus 613 I~~~L~~dP~~Rpta~ei---L~HP~f~ 637 (639)
|.+||+.||++|||+++| |+|+|++
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 999999999999999998 5677653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=415.04 Aligned_cols=257 Identities=28% Similarity=0.395 Sum_probs=210.8
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeec--------
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDT-------- 446 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-------- 446 (639)
.++|++++.||+|+||+||+|++..+++.||||++...... .....+.+|+.+|++++||||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 58999999999999999999999999999999998665433 223567899999999999999999998754
Q ss_pred CCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccc
Q psy6820 447 NNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLA 526 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla 526 (639)
.+.+|+||||+.++++.........+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~----~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG----VLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS----CEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC----cEEeeeccee
Confidence 356899999998877776666677899999999999999999999999999999999999999988 8999999999
Q ss_pred ccccC-------CCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy6820 527 QRVLR-------PMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFP 598 (639)
Q Consensus 527 ~~~~~-------~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p 598 (639)
..... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+. +.......+......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~--~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN--TEQHQLALISQLCGSIT 242 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC--CHHHHHHHHHHhcCCCC
Confidence 75542 23456899999999998754 6899999999999999999999999653 33444344333222222
Q ss_pred CCCcc----------------------------cccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 599 SPYWD----------------------------DISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 599 ~~~~~----------------------------~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...+. ..++++.|||.+||+.||++|||++|+|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 22111 13678899999999999999999999999999984
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=405.68 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=220.2
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+++|++++.||+|+||+||+|++..+++.||||+++..... .....+.+|+.+|+.++||||++++++|.+....+++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 46899999999999999999999999999999999765543 33467889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC--
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP-- 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~-- 532 (639)
|++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||.|......
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~----~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG----ELKLANFGLARAFGIPVR 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----CEEECCCTTCEECCSCCS
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC----ceeeeecchhhcccCCCc
Confidence 9999999999998888999999999999999999999999999999999999999887 7999999999876543
Q ss_pred -CccccCCCcccCccccccCC-CChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC-------------
Q psy6820 533 -MFTVCGTPTYVAPEILNESG-YGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF------------- 597 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~-~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~------------- 597 (639)
.....+++.|+|||++.+.. ++.++|||||||++|||++|..||.... +..+....+.......
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-SHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-CHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 23456788999999987654 6999999999999999999999986544 3333334433211111
Q ss_pred ------------CCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 598 ------------PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 598 ------------p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
.......+++++.+||++||+.||++||||+|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 01122457899999999999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=403.07 Aligned_cols=245 Identities=23% Similarity=0.385 Sum_probs=215.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEEEee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLVIEL 456 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 456 (639)
++|++++.||+|+||+||+|+.+ ++..||||++++.... .+.+.+|+.++++++||||++++++|.+++.+++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 67899999999999999999975 6778999999876543 46788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 457 IKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
+++|+|.+++.. ...+++..+..++.||++||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~----~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC----CEEECCCSSCCBCSSSSCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC----cEEECcchhheeccCCCce
Confidence 999999998754 46799999999999999999999999999999999999999887 8999999999765432
Q ss_pred -CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHH
Q psy6820 533 -MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAK 610 (639)
Q Consensus 533 -~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~ 610 (639)
.....||+.|+|||++.+..|+.++|||||||++|||+| |+.||... ...++...+..+.. .+ .+..+++++.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~--~~~~~~~~i~~~~~-~~--~p~~~~~~l~ 231 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--TNSETAEHIAQGLR-LY--RPHLASEKVY 231 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHHHHHTTCC-CC--CCTTCCHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC--CHHHHHHHHHhCCC-CC--CcccccHHHH
Confidence 224568999999999999999999999999999999998 89999654 45667777776532 22 2357899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6820 611 ELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 611 dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+||.+||+.||++|||+++|++|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=419.08 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=210.3
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTNN----- 448 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 448 (639)
+.++|++++.||+|+||+||+|.++.+++.||||++++.... ...+.+.+|+.+|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 457999999999999999999999999999999999765433 22356789999999999999999999997655
Q ss_pred -ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 449 -ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 449 -~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
.+|+||||+ +.+|..+++ ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~----~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC----ELKILDFGLAR 169 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEECCCTTCE
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc----cccccccccee
Confidence 579999999 667777664 45799999999999999999999999999999999999999988 89999999999
Q ss_pred cccCCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCC------------
Q psy6820 528 RVLRPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQ------------ 594 (639)
Q Consensus 528 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~------------ 594 (639)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+ .......+....
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 170 QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--HLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp ECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC--hHHHHHHHHhccCCCcHHHHhhhc
Confidence 88888888899999999999876 457999999999999999999999996543 222222222111
Q ss_pred -----------CCCCC----CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 595 -----------YGFPS----PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 595 -----------~~~p~----~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..... .....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 11111 122457899999999999999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-48 Score=409.46 Aligned_cols=255 Identities=24% Similarity=0.423 Sum_probs=211.6
Q ss_pred ccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeec--CCce
Q psy6820 374 KLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDT--NNEL 450 (639)
Q Consensus 374 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--~~~~ 450 (639)
...++|++++.||+|+||+||+|+++.+++.||||+++... .+.+.+|+.+|++++ ||||+++++++.. ...+
T Consensus 32 ~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 34578999999999999999999999999999999997543 456789999999996 9999999999874 4569
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
++|||||.+++|..+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+|....
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~---~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH---RKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT---TEEEECCGGGCEECC
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC---Ceeeecccccceecc
Confidence 9999999999997764 4699999999999999999999999999999999999998765 269999999997664
Q ss_pred C--CCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHH--HHH----------cCCC
Q psy6820 531 R--PMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFD--DIL----------SGQY 595 (639)
Q Consensus 531 ~--~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~--~i~----------~~~~ 595 (639)
. .....+||+.|+|||.+.+. .++.++|||||||++|||++|..||............ .+. ....
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 3 34567899999999998764 5799999999999999999999999765433221111 000 0000
Q ss_pred --------------------CCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 596 --------------------GFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 596 --------------------~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
..+...+..+++++.|||++||+.||++|||++|+|+||||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0111223457899999999999999999999999999999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=401.74 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=207.5
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCC----eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKD----MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
+.|++.++||+|+||.||+|..+.++ ..||||++...........+.+|+.+|++++|||||++++++.+.+.+++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 57999999999999999999877654 47999999776655556678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
||||+.+++|.+.+... ..+++.++..++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+|+....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~----~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL----VCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CEEECCCCC------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC----eEEEcccchhhcccC
Confidence 99999999999988654 6799999999999999999999999999999999999999987 899999999976542
Q ss_pred C------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 532 P------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 532 ~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||.... ...++.+.+..+. .. +....+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~~~-~~--~~~~~~ 238 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAINDGF-RL--PTPMDC 238 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTTC-CC--CCCTTC
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-CHHHHHHHHhccC-CC--CCchhh
Confidence 2 223568999999999999999999999999999999999766664433 4556666666543 22 233678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++++.+||.+||+.||++|||+.||++
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=404.43 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=213.6
Q ss_pred cccCCCcccCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec
Q psy6820 367 ENLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT 446 (639)
Q Consensus 367 ~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 446 (639)
..|+++ .++|++++.||+|+||.||+|+++.+ +.||||+++.... ..+.+.+|+.++++++|||||++++++.+
T Consensus 10 ~~~~i~---~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 10 DAWEIP---RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TCSBCC---GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceEcC---HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 345554 36899999999999999999998766 5699999976543 35678899999999999999999999854
Q ss_pred CCceEEEEeeccCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 447 NNELYLVIELIKGGDLFDAISK--NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 447 ~~~~~lV~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
+.+|+||||+++|+|..++.. ...+++.++..++.+|+.||+|||++||+||||||+||||+.++ .+||+|||
T Consensus 84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~----~~kl~DfG 158 (285)
T d1fmka3 84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFG 158 (285)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG----CEEECCCC
T ss_pred -CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC----cEEEcccc
Confidence 568999999999999988854 35799999999999999999999999999999999999999887 89999999
Q ss_pred ccccccCC----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy6820 525 LAQRVLRP----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSP 600 (639)
Q Consensus 525 la~~~~~~----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~ 600 (639)
+|+..... .....||+.|+|||++.+..++.++|||||||++|||+||..||.... ...++...+..+. ..+
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-~~~~~~~~i~~~~---~~~ 234 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGY---RMP 234 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTC---CCC
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcC---CCC
Confidence 99765422 234678999999999999999999999999999999999766665443 4455666666543 223
Q ss_pred CcccccHHHHHHHHHhcccCCCCCCCHHHHHc--CCcccC
Q psy6820 601 YWDDISEEAKELISHMLESNPDLRFSAEDVLD--HPWLER 638 (639)
Q Consensus 601 ~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~--HP~f~~ 638 (639)
....+++++++||.+||+.||++|||+++|++ |+||..
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 34689999999999999999999999999998 889864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=414.91 Aligned_cols=257 Identities=29% Similarity=0.478 Sum_probs=208.2
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC----ce
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN----EL 450 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~ 450 (639)
+..+|++++.||+|+||+||+|.+..+++.||||++.+.......+.+.+|+.+|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 34689999999999999999999999999999999987665555567889999999999999999999986653 23
Q ss_pred EEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 451 YLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+++++|+.+|+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~----~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC----CEEEcccCceeecc
Confidence 4455566799999999754 799999999999999999999999999999999999999887 89999999997653
Q ss_pred C------CCccccCCCcccCccccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC--C-------
Q psy6820 531 R------PMFTVCGTPTYVAPEILN-ESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG--Q------- 594 (639)
Q Consensus 531 ~------~~~~~~GT~~Y~APE~l~-~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~--~------- 594 (639)
. .....+||+.|+|||++. +..++.++||||+||++|+|++|..||...+. .......... .
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH--HHHHHHHhhhccCCChhhhh
Confidence 2 134567999999999984 56789999999999999999999999965432 2111111110 0
Q ss_pred -----------CCCCC-------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 595 -----------YGFPS-------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 595 -----------~~~p~-------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...+. ..++.+++++++||.+||+.||++|||++|+|+||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 00010 113457889999999999999999999999999999984
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=401.46 Aligned_cols=247 Identities=24% Similarity=0.399 Sum_probs=205.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCC---CeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 453 (639)
++|++++.||+|+||.||+|.+..+ +..||+|.++........+.+.+|+.+|++++|||||++++++. ++.+|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 5899999999999999999988654 35689999876665555677899999999999999999999995 4678999
Q ss_pred EeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+|+.....
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~----~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----EEEECC----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC----cEEEccchhheeccCC
Confidence 999999999998754 45799999999999999999999999999999999999999988 8999999999765422
Q ss_pred ----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccH
Q psy6820 533 ----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISE 607 (639)
Q Consensus 533 ----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~ 607 (639)
.....||+.|+|||++.+..|+.++|||||||++|||+| |.+||... ...++...+..+.. .+.++.+|+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~--~~~~~~~~i~~~~~---~~~~~~~~~ 236 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGER---LPMPPNCPP 236 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCC---CCCCTTCCH
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCC---CCCCCCCCH
Confidence 234568999999999999999999999999999999998 89999654 34556666766542 234468999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 608 EAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 608 ~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
++.+||.+||+.||++|||++||++|
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=415.04 Aligned_cols=251 Identities=30% Similarity=0.459 Sum_probs=205.5
Q ss_pred CeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec------CCceE
Q psy6820 378 RYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT------NNELY 451 (639)
Q Consensus 378 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~~~~ 451 (639)
+|+.+++||+|+||+||+|++..+++.||||++..... ...+|+.+|++++||||++++++|.. ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 69999999999999999999999999999999976532 23479999999999999999998843 33579
Q ss_pred EEEeeccCCChHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 452 LVIELIKGGDLFDA---ISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 452 lV~E~~~ggsL~~~---l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
||||||+++.+..+ ......+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||++..
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~---~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT---AVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT---CCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC---CceeEecccchhh
Confidence 99999976533332 23456799999999999999999999999999999999999999775 3699999999976
Q ss_pred cc--CCCccccCCCcccCcccccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcC------------
Q psy6820 529 VL--RPMFTVCGTPTYVAPEILNE-SGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSG------------ 593 (639)
Q Consensus 529 ~~--~~~~~~~GT~~Y~APE~l~~-~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~------------ 593 (639)
.. ....+.+||+.|+|||.+.+ ..|+.++|||||||++|||++|..||...+ ..+.+..+...
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~--~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC--HHHHHHHHHHHhCCChHHhhhhh
Confidence 64 33456789999999998765 578999999999999999999999996543 23333333210
Q ss_pred -----CCCCCC--------CCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 594 -----QYGFPS--------PYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 594 -----~~~~p~--------~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
...++. .....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 111111 112457899999999999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=416.53 Aligned_cols=255 Identities=28% Similarity=0.569 Sum_probs=218.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEE---cCCCeEEEEEEEcccccc---hhHHHHHHHHHHHHhcCC-CceeeeeeeeecCC
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYD---KHKDMDCALKIIDKSKLL---GKKQMIENEVNILRSVNH-PNIIKLLDEYDTNN 448 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~---~~~~~~vAiKv~~~~~~~---~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~ 448 (639)
+++|++++.||+|+||+||+|++ +.+++.||||++++.... ...+.+.+|+.+|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 47899999999999999999987 446889999999765432 223567789999999976 89999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 449 ELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
.++++|||+.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~----~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----CEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC----CEEEeeccchhh
Confidence 9999999999999999999999999999999999999999999999999999999999999987 899999999976
Q ss_pred ccC----CCccccCCCcccCccccccC--CCChhhhHHHHHHHHHHHHcCCCCCCCCCC--ChHHHHHHHHcCCCCCCCC
Q psy6820 529 VLR----PMFTVCGTPTYVAPEILNES--GYGVKIDVWAAGVILYILLCGFPPFVSDTN--DQDELFDDILSGQYGFPSP 600 (639)
Q Consensus 529 ~~~----~~~~~~GT~~Y~APE~l~~~--~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~--~~~~l~~~i~~~~~~~p~~ 600 (639)
... ...+..|++.|+|||.+.+. .++.++|||||||+||+|++|..||..... ....+..........+
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~--- 255 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--- 255 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC---
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCC---
Confidence 542 23457899999999999754 468899999999999999999999976432 3334444444443333
Q ss_pred CcccccHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccC
Q psy6820 601 YWDDISEEAKELISHMLESNPDLRF-----SAEDVLDHPWLER 638 (639)
Q Consensus 601 ~~~~l~~~l~dLI~~~L~~dP~~Rp-----ta~eiL~HP~f~~ 638 (639)
+..+++++.+||.+||++||++|| |++|+++||||++
T Consensus 256 -~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 256 -PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred -cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 357899999999999999999999 5899999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=403.70 Aligned_cols=247 Identities=21% Similarity=0.287 Sum_probs=205.8
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCe----EEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCceEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDM----DCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 452 (639)
.+|++++.||+|+||+||+|.+..+++ .||+|.+.........+.+.+|+.++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999887765 58888887655555567789999999999999999999999765 5678
Q ss_pred EEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccC
Q psy6820 453 VIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~ 531 (639)
+|||+.+|+|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~----~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT----EEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC----CeEeeccccceeccc
Confidence 8899999999988865 46799999999999999999999999999999999999999887 899999999986543
Q ss_pred C-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccc
Q psy6820 532 P-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDI 605 (639)
Q Consensus 532 ~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l 605 (639)
. .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+ ..++...+..+.. + +.+..+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~--~~~~~~~i~~~~~-~--~~p~~~ 238 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGER-L--PQPPIC 238 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--GGGHHHHHHHTCC-C--CCCTTB
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCC-C--CCCccc
Confidence 2 223468999999999999999999999999999999998 899996543 3455566655532 2 223678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 606 SEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 606 ~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
++++.+||.+||+.||++|||+.||++|
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=413.51 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=212.0
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Cc
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-GKKQMIENEVNILRSVNHPNIIKLLDEYDTN-----NE 449 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 449 (639)
.++|++++.||+|+||+||+|++..+++.||||++.+.... ...+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999999999999999999865433 2335678999999999999999999998533 34
Q ss_pred eEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccc
Q psy6820 450 LYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRV 529 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~ 529 (639)
.+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~----~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC----ELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----CEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc----cccccccchhccc
Confidence 4666777889999999865 4799999999999999999999999999999999999999988 8999999999888
Q ss_pred cCCCccccCCCcccCccccccC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCC-----------
Q psy6820 530 LRPMFTVCGTPTYVAPEILNES-GYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGF----------- 597 (639)
Q Consensus 530 ~~~~~~~~GT~~Y~APE~l~~~-~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~----------- 597 (639)
.....+..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+. +.......+.......
T Consensus 172 ~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT--DHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHHhcCCCChHHhhhccch
Confidence 7777788999999999987665 4689999999999999999999999654 3333333333221111
Q ss_pred ------------CCC----CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 598 ------------PSP----YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 598 ------------p~~----~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
+.. .+..+++++++||.+||+.||++|||++|+|+||||++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 111 12357899999999999999999999999999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=399.58 Aligned_cols=249 Identities=21% Similarity=0.365 Sum_probs=199.9
Q ss_pred CCeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecC-Cc
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTN-NE 449 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~-~~ 449 (639)
++|++++.||+|+||.||+|.+.. +++.||+|+++........+.+.+|..++.++ +|+||+.+++++... +.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 679999999999999999998754 34689999998766555566677888888777 589999999987654 56
Q ss_pred eEEEEeeccCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCc
Q psy6820 450 LYLVIELIKGGDLFDAISKN----------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC 513 (639)
Q Consensus 450 ~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~ 513 (639)
+++|||||++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~- 171 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN- 171 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC-
Confidence 89999999999999999643 2488999999999999999999999999999999999999887
Q ss_pred eeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcC-CCCCCCCCCChHHHH
Q psy6820 514 HVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCG-FPPFVSDTNDQDELF 587 (639)
Q Consensus 514 ~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG-~~Pf~~~~~~~~~l~ 587 (639)
.+||+|||+|+..... ....+||+.|+|||++.+..++.++|||||||++|||+|| .+||..... .+.+.
T Consensus 172 ---~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~~~~~ 247 (299)
T d1ywna1 172 ---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFC 247 (299)
T ss_dssp ---CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-SHHHH
T ss_pred ---cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-HHHHH
Confidence 8999999999765422 2346799999999999999999999999999999999986 567765433 34444
Q ss_pred HHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 588 DDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 588 ~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
..+..+. .+ +.+..+++++.+||.+||+.||++|||++|+++|
T Consensus 248 ~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 248 RRLKEGT-RM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHTC-CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCC-CC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4444442 22 2335789999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=395.22 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=201.6
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeee-cCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYD-TNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~lV~ 454 (639)
.++|++++.||+|+||.||+|..+ +..||||+++... ..+.+.+|+.++++++||||++++++|. ..+.+|+||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 467999999999999999999874 6689999997653 3467889999999999999999999884 456789999
Q ss_pred eeccCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 455 ELIKGGDLFDAISKN--VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 455 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~----~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASST 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS----CEEECCCCC-------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC----CEeecccccceecCCC
Confidence 999999999999654 3589999999999999999999999999999999999999988 8999999999887766
Q ss_pred CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHHHHH
Q psy6820 533 MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEEAKE 611 (639)
Q Consensus 533 ~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~d 611 (639)
.....+|+.|+|||++.+..++.++|||||||++|||+| |.+||... ...++...+.++. ..+....+++++.+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~---~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGY---KMDAPDGCPPAVYE 231 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTC---CCCCCTTCCHHHHH
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCC---CCCCCccCCHHHHH
Confidence 667789999999999999999999999999999999998 78888543 4455666665542 22233578999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcC
Q psy6820 612 LISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 612 LI~~~L~~dP~~Rpta~eiL~H 633 (639)
||.+||+.||++|||+.+++++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-47 Score=398.58 Aligned_cols=248 Identities=22% Similarity=0.315 Sum_probs=213.9
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCCce
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNNEL 450 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 450 (639)
.++|++.+.||+|+||+||+|+.+. +++.||||+++........+.+.+|+.+|++++||||++++++|.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 3679999999999999999998753 46789999998766555567789999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q psy6820 451 YLVIELIKGGDLFDAISKNV------------------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENL 506 (639)
Q Consensus 451 ~lV~E~~~ggsL~~~l~~~~------------------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NI 506 (639)
+++|||+++|+|.+++.... .+++..+..++.||+.||+|||+++||||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 99999999999999996432 388999999999999999999999999999999999
Q ss_pred EEccCCceeeeEEEeeccccccccC-----CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCC-CCCCCCC
Q psy6820 507 LVEMSGCHVKVLKVGDFGLAQRVLR-----PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGF-PPFVSDT 580 (639)
Q Consensus 507 Lld~~g~~~~~vKL~DFGla~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~-~Pf~~~~ 580 (639)
|++.++ .+||+|||+|+.... ...+.+||+.|+|||.+.+..|+.++|||||||++|||++|. +||..
T Consensus 172 Lld~~~----~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-- 245 (301)
T d1lufa_ 172 LVGENM----VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-- 245 (301)
T ss_dssp EECGGG----CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--
T ss_pred EECCCC----cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC--
Confidence 999887 899999999975532 223567899999999999999999999999999999999995 56744
Q ss_pred CChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 581 NDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 581 ~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+..++...+..+.. .+.+..+++++.+||.+||+.||++|||+.||++
T Consensus 246 ~~~~e~~~~v~~~~~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp SCHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 355667777776653 2234678999999999999999999999999964
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=400.35 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=210.1
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeE--EEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCCceEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMD--CALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 452 (639)
.++|++.+.||+|+||.||+|.++.++.. ||||.++........+.+.+|+.+|+++ +|||||+++++|.+.+.+|+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 46899999999999999999999888764 6777776554444456788999999999 69999999999999999999
Q ss_pred EEeeccCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceee
Q psy6820 453 VIELIKGGDLFDAISKN----------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVK 516 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~ 516 (639)
||||+++|+|.++|++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~---- 164 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY---- 164 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG----
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC----
Confidence 99999999999999654 5699999999999999999999999999999999999999887
Q ss_pred eEEEeeccccccccC--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCC-CCCCCCCCChHHHHHHHHcC
Q psy6820 517 VLKVGDFGLAQRVLR--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGF-PPFVSDTNDQDELFDDILSG 593 (639)
Q Consensus 517 ~vKL~DFGla~~~~~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~-~Pf~~~~~~~~~l~~~i~~~ 593 (639)
.+||+|||+|+.... .....+||+.|+|||.+.+..|+.++|||||||++|||++|. +||.. .+..++...+..+
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~--~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAELYEKLPQG 242 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHGGGT
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC--CCHHHHHHHHHhc
Confidence 899999999976543 233557899999999999999999999999999999999975 56743 3566677776665
Q ss_pred CCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 594 QYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 594 ~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
. ..+.+..+++++++||.+||+.||++|||++||++|
T Consensus 243 ~---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 Y---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp C---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 223346799999999999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=407.57 Aligned_cols=255 Identities=28% Similarity=0.473 Sum_probs=200.8
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccch-hHHHHHHHHHHHHhcCCCceeeeeeeeec------C
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLG-KKQMIENEVNILRSVNHPNIIKLLDEYDT------N 447 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~ 447 (639)
+.++|++++.||+|+||+||+|+++.+++.||||++.+..... ....+.+|+.+|++++||||++++++|.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4588999999999999999999999999999999997655432 33567899999999999999999999853 4
Q ss_pred CceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 448 NELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 448 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
..+|+|||||.+ ++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||++.
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~----~~kl~df~~~~ 167 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLAR 167 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CEEECCCCC--
T ss_pred ceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc----ceeeechhhhh
Confidence 678999999965 5555553 4689999999999999999999999999999999999999887 79999999987
Q ss_pred cccC--CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHH--------------
Q psy6820 528 RVLR--PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDIL-------------- 591 (639)
Q Consensus 528 ~~~~--~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~-------------- 591 (639)
.... .....+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+ .......+.
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~--~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHTTS
T ss_pred ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC--HHHHHHHHHHhccCCCHHHHHHh
Confidence 6653 3345679999999999999999999999999999999999999996543 222222221
Q ss_pred --------cCCCCCCCC----------------CcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q psy6820 592 --------SGQYGFPSP----------------YWDDISEEAKELISHMLESNPDLRFSAEDVLDHPWLER 638 (639)
Q Consensus 592 --------~~~~~~p~~----------------~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~f~~ 638 (639)
......... .....++++.+||++||+.||++||||+|+|+||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 111111100 01225778999999999999999999999999999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=392.12 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=201.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCC---CeEEEEEEEcccccch--hHHHHHHHHHHHHhcCCCceeeeeeeeecCCceE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHK---DMDCALKIIDKSKLLG--KKQMIENEVNILRSVNHPNIIKLLDEYDTNNELY 451 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiKv~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 451 (639)
++|++.+.||+|+||.||+|+.... ...||||++.+..... ..+.+.+|+.+|++++||||+++++++.+ +.++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5799999999999999999976533 3468999987654432 23568899999999999999999999965 5778
Q ss_pred EEEeeccCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeecccccccc
Q psy6820 452 LVIELIKGGDLFDAISK-NVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVL 530 (639)
Q Consensus 452 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~ 530 (639)
+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~----~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT----EEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc----ceeeccchhhhhcc
Confidence 99999999999988754 45799999999999999999999999999999999999999987 89999999998764
Q ss_pred CC------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHHHHHHHcCCCCCCCCCcc
Q psy6820 531 RP------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDELFDDILSGQYGFPSPYWD 603 (639)
Q Consensus 531 ~~------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~ 603 (639)
.. .....||+.|+|||++.+..++.++|||||||++|||+| |..||... +..++...+......++ .++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--~~~~~~~~i~~~~~~~~--~~~ 238 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLP--RPE 238 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTSCCCCC--CCT
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--CHHHHHHHHHhCCCCCC--Ccc
Confidence 32 223567889999999999999999999999999999998 89999643 55667777776654443 346
Q ss_pred cccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 604 DISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 604 ~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.+|+++.+||.+||+.||++|||++||++
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 89999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-47 Score=392.81 Aligned_cols=247 Identities=24% Similarity=0.408 Sum_probs=209.4
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCC-------eEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKD-------MDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLLDEYDTNN 448 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~-------~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 448 (639)
++|.+++.||+|+||.||+|+...++ ..||||+++..........+.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 58999999999999999999876554 479999998766555556778899999888 7999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC
Q psy6820 449 ELYLVIELIKGGDLFDAISKN----------------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG 512 (639)
Q Consensus 449 ~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g 512 (639)
.+++||||+++|+|.+++... ..+++.++..++.||+.||+|||++|||||||||+|||++.++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence 999999999999999999654 3589999999999999999999999999999999999999987
Q ss_pred ceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCChHHH
Q psy6820 513 CHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFVSDTNDQDEL 586 (639)
Q Consensus 513 ~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~~~~~~~~~l 586 (639)
.+||+|||++...... ....+||+.|+|||.+.+..|+.++|||||||++|||+| |.+||.. .....+
T Consensus 173 ----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~--~~~~~~ 246 (299)
T d1fgka_ 173 ----VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--VPVEEL 246 (299)
T ss_dssp ----CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHH
T ss_pred ----CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC--CCHHHH
Confidence 8999999999866432 234678999999999999999999999999999999998 7889854 345667
Q ss_pred HHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 587 ~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
++.+..+. .+ +.+..+++++.+||.+||+.||++|||+.||++
T Consensus 247 ~~~i~~~~-~~--~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEGH-RM--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTC-CC--CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCC-CC--CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 77766643 22 233678999999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=393.07 Aligned_cols=254 Identities=22% Similarity=0.400 Sum_probs=214.7
Q ss_pred ccCCCcccCCCeeEEEEEccCCceEEEEEEEc-----CCCeEEEEEEEcccccchhHHHHHHHHHHHHhc-CCCceeeee
Q psy6820 368 NLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDK-----HKDMDCALKIIDKSKLLGKKQMIENEVNILRSV-NHPNIIKLL 441 (639)
Q Consensus 368 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 441 (639)
+|+++. ++|++++.||+|+||.||+|... .+++.||||+++..........+.+|+.+++++ +|||||+++
T Consensus 17 ~~~~~~---~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 17 KWEFPR---NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGBCCG---GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCH---HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 455543 68999999999999999999763 456789999998776666667788999999999 599999999
Q ss_pred eeeecCCceEEEEeeccCCChHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q psy6820 442 DEYDTNNELYLVIELIKGGDLFDAISKNV------------------KFSEEDSKFMTQSLASALSYLHDNYIVHRDIKP 503 (639)
Q Consensus 442 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp 503 (639)
++|.+.+.+|+|||||++|+|.+++.+.. .+++..+..++.||+.||+|||++|++||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 99999999999999999999999996543 589999999999999999999999999999999
Q ss_pred CceEEccCCceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q psy6820 504 ENLLVEMSGCHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLC-GFPPFV 577 (639)
Q Consensus 504 ~NILld~~g~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLlt-G~~Pf~ 577 (639)
+|||++.++ .+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||+| |.+||.
T Consensus 174 ~NIl~~~~~----~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 174 RNILLTHGR----ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp GGEEEETTT----EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccC----cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 999999887 8999999999866532 224578999999999999999999999999999999999 555554
Q ss_pred CCCCChHHHHHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 578 SDTNDQDELFDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 578 ~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
. ....+.+.+.+..+. .. .....+++++.+||.+||+.||++|||++||++
T Consensus 250 ~-~~~~~~~~~~i~~~~-~~--~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 250 G-MPVDSKFYKMIKEGF-RM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp T-CCSSHHHHHHHHHTC-CC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCHHHHHHHHHhcCC-CC--CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3 333344444444432 22 223568999999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=394.34 Aligned_cols=258 Identities=21% Similarity=0.362 Sum_probs=220.6
Q ss_pred ccCCCcccCCCeeEEEEEccCCceEEEEEEEcC-----CCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeee
Q psy6820 368 NLNIPSKLLQRYSVGQIIGDGNFAVVRQVYDKH-----KDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLD 442 (639)
Q Consensus 368 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 442 (639)
.|+++ .++|.+++.||+|+||.||+|.+.. +++.||||+++..........+.+|+.++++++||||+++++
T Consensus 14 ~~ei~---~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 14 EWEVA---REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp TTBCC---GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ceeec---HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 45554 3689999999999999999998753 357899999987665555567889999999999999999999
Q ss_pred eeecCCceEEEEeeccCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCC
Q psy6820 443 EYDTNNELYLVIELIKGGDLFDAISKN----------VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSG 512 (639)
Q Consensus 443 ~~~~~~~~~lV~E~~~ggsL~~~l~~~----------~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g 512 (639)
++...+..++||||+++|+|.+++... ..+++..+..++.+++.||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 999999999999999999999988532 2478999999999999999999999999999999999999887
Q ss_pred ceeeeEEEeeccccccccCC-----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCC-CCCCCCCCChHHH
Q psy6820 513 CHVKVLKVGDFGLAQRVLRP-----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGF-PPFVSDTNDQDEL 586 (639)
Q Consensus 513 ~~~~~vKL~DFGla~~~~~~-----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~-~Pf~~~~~~~~~l 586 (639)
++||+|||+|+..... .....||+.|+|||.+.+..++.++||||||+++|||+||. +||.. ....+.
T Consensus 171 ----~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~--~~~~~~ 244 (308)
T d1p4oa_ 171 ----TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--LSNEQV 244 (308)
T ss_dssp ----CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--SCHHHH
T ss_pred ----eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC--CCHHHH
Confidence 8999999999765432 23346899999999999999999999999999999999984 77743 355667
Q ss_pred HHHHHcCCCCCCCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHc------CCccc
Q psy6820 587 FDDILSGQYGFPSPYWDDISEEAKELISHMLESNPDLRFSAEDVLD------HPWLE 637 (639)
Q Consensus 587 ~~~i~~~~~~~p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~------HP~f~ 637 (639)
+..+..+... +....+++.+.+||.+||+.||++|||+.+|++ +|+|+
T Consensus 245 ~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 245 LRFVMEGGLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp HHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred HHHHHhCCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 7777765432 223578999999999999999999999999997 77775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=386.24 Aligned_cols=245 Identities=23% Similarity=0.340 Sum_probs=204.3
Q ss_pred EEEEEccCCceEEEEEEEcCCC---eEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeec-CCceEEEEee
Q psy6820 381 VGQIIGDGNFAVVRQVYDKHKD---MDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDT-NNELYLVIEL 456 (639)
Q Consensus 381 i~~~LG~G~fG~Vy~a~~~~~~---~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV~E~ 456 (639)
..++||+|+||+||+|....++ ..||||.+++.......+.+.+|+.+|++++||||+++++++.+ ++.+++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 3688999999999999886543 46899999765555556779999999999999999999998764 5689999999
Q ss_pred ccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC---
Q psy6820 457 IKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP--- 532 (639)
Q Consensus 457 ~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~--- 532 (639)
|++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~----~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF----TVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC----CEEECSSGGGCCTTTTTCC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC----CEEEecccchhhccccccc
Confidence 9999999988754 4578889999999999999999999999999999999999887 8999999999765422
Q ss_pred ----CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHHHHHHHHcCCCCCCCCCcccccHH
Q psy6820 533 ----MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDELFDDILSGQYGFPSPYWDDISEE 608 (639)
Q Consensus 533 ----~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~l~~~i~~~~~~~p~~~~~~l~~~ 608 (639)
.....||+.|+|||.+.+..++.++||||||+++|||+||..||.... ...++...+..+... + ..+.++++
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-~~~~~~~~i~~g~~~-~--~p~~~~~~ 262 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRL-L--QPEYCPDP 262 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC-C--CCTTCCHH
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC-C--CcccCcHH
Confidence 223568999999999999999999999999999999999888886544 333455556655322 2 22578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcC
Q psy6820 609 AKELISHMLESNPDLRFSAEDVLDH 633 (639)
Q Consensus 609 l~dLI~~~L~~dP~~Rpta~eiL~H 633 (639)
+.+||.+||+.||++||++.||++|
T Consensus 263 l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 263 LYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-45 Score=380.13 Aligned_cols=258 Identities=19% Similarity=0.235 Sum_probs=202.8
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCce-eeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI-IKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV 453 (639)
+.++|++++.||+|+||.||+|++..+++.||||++..... .+.+.+|+++++.++|+|+ +.+.+++.+.+..++|
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 34689999999999999999999999999999999876533 2346789999999987665 4555666788889999
Q ss_pred EeeccCCChHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEeeccccccccCC
Q psy6820 454 IELIKGGDLFDAI-SKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQRVLRP 532 (639)
Q Consensus 454 ~E~~~ggsL~~~l-~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~~~~~ 532 (639)
|||+ +++|.+.+ .....+++..+..++.|++.||+|||++||+||||||+|||++..+. ...+||+|||+|+.....
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~-~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK-GNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGG-TTCEEECCCSSCEECBCT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCC-CceeeeeccCcceecccc
Confidence 9999 55666655 44568999999999999999999999999999999999999865431 137999999999866421
Q ss_pred ----------CccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCChHH-HHHHHHcCCCCCC-CC
Q psy6820 533 ----------MFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQDE-LFDDILSGQYGFP-SP 600 (639)
Q Consensus 533 ----------~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~~~-l~~~i~~~~~~~p-~~ 600 (639)
....+||+.|+|||++.+..++.++|||||||++|||+||..||......... ............+ ..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 23567999999999999999999999999999999999999999764432211 1111111111111 11
Q ss_pred CcccccHHHHHHHHHhcccCCCCCCCHH---HHHcCCccc
Q psy6820 601 YWDDISEEAKELISHMLESNPDLRFSAE---DVLDHPWLE 637 (639)
Q Consensus 601 ~~~~l~~~l~dLI~~~L~~dP~~Rpta~---eiL~HP~f~ 637 (639)
....+|+++.++|..||+.||++||+++ ++|+|+|.+
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 2357899999999999999999999987 456777643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=375.96 Aligned_cols=247 Identities=24% Similarity=0.326 Sum_probs=195.2
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCceeeeeeeeecCC----ceEE
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNIIKLLDEYDTNN----ELYL 452 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~~l 452 (639)
++|.+.+.||+|+||.||+|+. +++.||||+++.... .....+.|+..+++++||||+++++++.+.+ .+|+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4688999999999999999975 578999999975432 2233445666667789999999999987553 5899
Q ss_pred EEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCceEEccCCceeeeEEEeecc
Q psy6820 453 VIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD--------NYIVHRDIKPENLLVEMSGCHVKVLKVGDFG 524 (639)
Q Consensus 453 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~--------~givHrDLKp~NILld~~g~~~~~vKL~DFG 524 (639)
|||||++|+|.+++++. .+++..+..++.+++.||+|||+ +||+||||||+||||+.++ .+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~----~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS----CEEECCCT
T ss_pred EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC----CeEEEecC
Confidence 99999999999999765 68999999999999999999996 5999999999999999887 89999999
Q ss_pred ccccccCC-------CccccCCCcccCccccccCC------CChhhhHHHHHHHHHHHHcCCCCCCCCC-----------
Q psy6820 525 LAQRVLRP-------MFTVCGTPTYVAPEILNESG------YGVKIDVWAAGVILYILLCGFPPFVSDT----------- 580 (639)
Q Consensus 525 la~~~~~~-------~~~~~GT~~Y~APE~l~~~~------~s~~sDVwSLGvvL~eLltG~~Pf~~~~----------- 580 (639)
++...... ....+||+.|+|||++.+.. ++.++|||||||+||||+||..||....
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99766432 23467999999999987643 5789999999999999999998874322
Q ss_pred --CChHHHHHHHHcCCCCCCCC-Cc--ccccHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6820 581 --NDQDELFDDILSGQYGFPSP-YW--DDISEEAKELISHMLESNPDLRFSAEDVLD 632 (639)
Q Consensus 581 --~~~~~l~~~i~~~~~~~p~~-~~--~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~ 632 (639)
.....+...+.......+.+ .+ ...+..+.+|+.+||+.||++|||+.||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 12233333443333322111 11 124467999999999999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.4e-44 Score=369.57 Aligned_cols=253 Identities=19% Similarity=0.238 Sum_probs=207.9
Q ss_pred cCCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCC-CceeeeeeeeecCCceEEE
Q psy6820 375 LLQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH-PNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 375 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV 453 (639)
+.++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.++| +|++.+++++......|+|
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 35789999999999999999999999999999999865432 2346789999999975 8999999999999999999
Q ss_pred EeeccCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCc-eeeeEEEeeccccccccC
Q psy6820 454 IELIKGGDLFDAISKN-VKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGC-HVKVLKVGDFGLAQRVLR 531 (639)
Q Consensus 454 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~-~~~~vKL~DFGla~~~~~ 531 (639)
|||+ +++|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++.+.. ....+||+|||+|+....
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999 78999998664 47999999999999999999999999999999999999975321 112799999999976532
Q ss_pred ----------CCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCC-hHHHHHHHHcCCCC-CCC
Q psy6820 532 ----------PMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTND-QDELFDDILSGQYG-FPS 599 (639)
Q Consensus 532 ----------~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~-~~~l~~~i~~~~~~-~p~ 599 (639)
.....+||+.|||||++.+..++.++|||||||++|||+||..||.+.... .......+...... .+.
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 133568999999999999999999999999999999999999999764432 33333333322211 111
Q ss_pred CCcccccHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6820 600 PYWDDISEEAKELISHMLESNPDLRFSAEDVL 631 (639)
Q Consensus 600 ~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL 631 (639)
.....+|+++.+++..|+..+|++||+++.+.
T Consensus 239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 22356899999999999999999999877664
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-43 Score=373.10 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=202.6
Q ss_pred CCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-----------CCceeeeeeeee
Q psy6820 377 QRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-----------HPNIIKLLDEYD 445 (639)
Q Consensus 377 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~~~~~ 445 (639)
++|++++.||+|+||+||+|+++.+++.||||++++... ..+.+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 469999999999999999999999999999999986543 2456678999888875 478999998875
Q ss_pred c--CCceEEEEeeccCCChHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEccCC--ceeee
Q psy6820 446 T--NNELYLVIELIKGGDLFDAI---SKNVKFSEEDSKFMTQSLASALSYLHD-NYIVHRDIKPENLLVEMSG--CHVKV 517 (639)
Q Consensus 446 ~--~~~~~lV~E~~~ggsL~~~l---~~~~~l~~~~~~~i~~qI~~aL~yLH~-~givHrDLKp~NILld~~g--~~~~~ 517 (639)
. ....+++|+++..+...... .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .....
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 4 35667777776555443332 345679999999999999999999998 8999999999999998654 12235
Q ss_pred EEEeeccccccccCCCccccCCCcccCccccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCCh----HHHHHHHHc-
Q psy6820 518 LKVGDFGLAQRVLRPMFTVCGTPTYVAPEILNESGYGVKIDVWAAGVILYILLCGFPPFVSDTNDQ----DELFDDILS- 592 (639)
Q Consensus 518 vKL~DFGla~~~~~~~~~~~GT~~Y~APE~l~~~~~s~~sDVwSLGvvL~eLltG~~Pf~~~~~~~----~~l~~~i~~- 592 (639)
+|++|||.+..........+||+.|+|||++.+..|+.++|+||+||++++|++|+.||....... .........
T Consensus 171 ~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~ 250 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250 (362)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred eeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence 999999999888777778899999999999999999999999999999999999999996543211 111111000
Q ss_pred -CC------------------C----CC--------------CCCCcccccHHHHHHHHHhcccCCCCCCCHHHHHcCCc
Q psy6820 593 -GQ------------------Y----GF--------------PSPYWDDISEEAKELISHMLESNPDLRFSAEDVLDHPW 635 (639)
Q Consensus 593 -~~------------------~----~~--------------p~~~~~~l~~~l~dLI~~~L~~dP~~Rpta~eiL~HP~ 635 (639)
+. . .. ....+...++++.|||.+||+.||.+|||++|+|+|||
T Consensus 251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~ 330 (362)
T d1q8ya_ 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 330 (362)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 00 0 00 00112346789999999999999999999999999999
Q ss_pred ccC
Q psy6820 636 LER 638 (639)
Q Consensus 636 f~~ 638 (639)
|++
T Consensus 331 f~~ 333 (362)
T d1q8ya_ 331 LKD 333 (362)
T ss_dssp GTT
T ss_pred cCC
Confidence 985
|
| >d1mg4a_ d.15.11.1 (A:) Doublecortin-like kinase Dclk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: Doublecortin (DC) family: Doublecortin (DC) domain: Doublecortin-like kinase Dclk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-32 Score=235.72 Aligned_cols=97 Identities=46% Similarity=0.966 Sum_probs=91.1
Q ss_pred cCceEEEEEecCCCCCCcEEEEECCccccCHHHHHHHHHHHHhhcCCCcccceEeecCCC-ceeccccccccCCeEEEec
Q psy6820 98 RRAKRIRFLCNGDKFFKGVVMAVGPERYRSFDSLLEELTRALAENINLPSGVRILFTMDG-QKVTNIDELEDGKFYICSS 176 (639)
Q Consensus 98 ~~~k~v~~~rNgd~~~~g~~~~v~~~~~~~~~~ll~~~t~~l~~~~~l~~~vr~~~t~~g-~~v~~l~~l~~g~~yv~~~ 176 (639)
+|||+|+||||||+||+|++++||+++++|||+||++||++|+.+++||.|||+|||+|| |+|++++||+||+.|||||
T Consensus 1 ~kak~I~~~rNGD~~~~g~~~~i~~r~~~s~d~lL~~lT~~l~~~~~l~~~Vr~lyt~~G~~~V~~l~dl~~g~~yVa~g 80 (101)
T d1mg4a_ 1 KKAKKVRFYRNGDRYFKGIVYAISPDRFRSFEALLADLTRTLSDNVNLPQGVRTIYTIDGLKKISSLDQLVEGESYVCGS 80 (101)
T ss_dssp CCSEEEEEEETTCSSCCCEEEEECTTTCSSHHHHHHHHHHHHCCSSSSTTCCCEEEETTSSCBCCSGGGCCTTCEEEEES
T ss_pred CCccEEEEEeCCCCCCCCEEEEECccccCCHHHHHHHHHHHhccccCCCCCceEEEeCCCCeEeCCHHHhCCCCEEEEEc
Confidence 589999999999999999999999999999999999999999999999999999999998 9999999999999999999
Q ss_pred CCCcccccccccccCCCCCCC
Q psy6820 177 SGDQFKKVDYAILNNNNSSNT 197 (639)
Q Consensus 177 ~~e~f~~~~y~~~~~~~~~~~ 197 (639)
.|+||+++|... ..|+|.
T Consensus 81 -~E~fk~~~Y~~~--~~p~w~ 98 (101)
T d1mg4a_ 81 -IEPFKKLEYTKN--VNPNWS 98 (101)
T ss_dssp -SSCCCCCCTTTT--CCGGGG
T ss_pred -CCCCcccccccc--cCCCCc
Confidence 599999999863 455554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=4.9e-24 Score=205.27 Aligned_cols=165 Identities=19% Similarity=0.246 Sum_probs=122.8
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccc-----------------hhHHHHHHHHHHHHhcCCCceeeee
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLL-----------------GKKQMIENEVNILRSVNHPNIIKLL 441 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~-----------------~~~~~~~~Ei~iL~~l~HpnIv~l~ 441 (639)
+.+++.||+|+||.||+|.+. +++.||||+++..... ........|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468999999999999999875 6789999997532211 0112345689999999999999888
Q ss_pred eeeecCCceEEEEeeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEccCCceeeeEEEe
Q psy6820 442 DEYDTNNELYLVIELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHDNYIVHRDIKPENLLVEMSGCHVKVLKVG 521 (639)
Q Consensus 442 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~~givHrDLKp~NILld~~g~~~~~vKL~ 521 (639)
++. ..+++|||+++..+.+ ++...+..++.|++.||+|||++||+||||||+|||++.++ ++|+
T Consensus 81 ~~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-----~~li 144 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-----IWII 144 (191)
T ss_dssp EEE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-----EEEC
T ss_pred Eec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-----EEEE
Confidence 654 2379999998755432 45566788999999999999999999999999999998664 8999
Q ss_pred eccccccccCCCccccCCCcccCc------cccccCCCChhhhHHHHHHHH
Q psy6820 522 DFGLAQRVLRPMFTVCGTPTYVAP------EILNESGYGVKIDVWAAGVIL 566 (639)
Q Consensus 522 DFGla~~~~~~~~~~~GT~~Y~AP------E~l~~~~~s~~sDVwSLGvvL 566 (639)
|||+|.....+... .|... +.+ ...|+.++|+||+.--+
T Consensus 145 DFG~a~~~~~~~~~-----~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR-----EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH-----HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH-----HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999766433211 12211 111 35578889999986443
|
| >d1mg4a_ d.15.11.1 (A:) Doublecortin-like kinase Dclk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: Doublecortin (DC) family: Doublecortin (DC) domain: Doublecortin-like kinase Dclk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=1.6e-20 Score=161.19 Aligned_cols=85 Identities=16% Similarity=0.293 Sum_probs=79.2
Q ss_pred cceEEEEEEcCCCCcccEEEEecCCCCCCHHHHHHhhhhhccCCC---ccccceeccCC-ccccccccccccCcEEEEcC
Q psy6820 223 RPRIIIVIRNGIRPRKVVRALLNKRNAPSLDQCFSTITDIVKLDT---GAVRKVYTLNG-NQLARLSDFFKSDDVFFAYG 298 (639)
Q Consensus 223 ~p~~i~v~rng~~~~~~~~~~l~~~~~~~~~~~l~~it~~~~~~~---g~v~~lyt~~g-~~v~~~~~~~~~~d~yva~G 298 (639)
+||+|+||||||.+++|++++||+++++|||++|++||++++++. |+||+|||++| ++|.++++ |++++.|||+|
T Consensus 2 kak~I~~~rNGD~~~~g~~~~i~~r~~~s~d~lL~~lT~~l~~~~~l~~~Vr~lyt~~G~~~V~~l~d-l~~g~~yVa~g 80 (101)
T d1mg4a_ 2 KAKKVRFYRNGDRYFKGIVYAISPDRFRSFEALLADLTRTLSDNVNLPQGVRTIYTIDGLKKISSLDQ-LVEGESYVCGS 80 (101)
T ss_dssp CSEEEEEEETTCSSCCCEEEEECTTTCSSHHHHHHHHHHHHCCSSSSTTCCCEEEETTSSCBCCSGGG-CCTTCEEEEES
T ss_pred CccEEEEEeCCCCCCCCEEEEECccccCCHHHHHHHHHHHhccccCCCCCceEEEeCCCCeEeCCHHH-hCCCCEEEEEc
Confidence 589999999999999999999999999999999999999998765 78999999998 89999999 89999999999
Q ss_pred CccccCCccc
Q psy6820 299 SERVLPDDFE 308 (639)
Q Consensus 299 ~e~~~~dd~~ 308 (639)
.|+|.+-+..
T Consensus 81 ~E~fk~~~Y~ 90 (101)
T d1mg4a_ 81 IEPFKKLEYT 90 (101)
T ss_dssp SSCCCCCCTT
T ss_pred CCCCcccccc
Confidence 9999876554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.25 E-value=2e-06 Score=83.86 Aligned_cols=140 Identities=15% Similarity=0.147 Sum_probs=92.7
Q ss_pred CCCeeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEEE
Q psy6820 376 LQRYSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLVI 454 (639)
Q Consensus 376 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 454 (639)
+..|...+..+-++.+.||++. ..+..+.+|+....... ....+.+|...+..+. +--+.+++.+..+++..++||
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 4567777765555567999874 34556788887644322 1234578888888775 333677888888888999999
Q ss_pred eeccCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q psy6820 455 ELIKGGDLFDAISKNVKFSEEDSKFMTQSLASALSYLHD----------------------------------------- 493 (639)
Q Consensus 455 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qI~~aL~yLH~----------------------------------------- 493 (639)
++++|.++.+..... .....++.+++..|+.||+
T Consensus 90 ~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 90 SEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred Eeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 999998776543211 1112223333333333332
Q ss_pred ------------C------CceeccCCCCceEEccCCceeeeEEEeeccccc
Q psy6820 494 ------------N------YIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQ 527 (639)
Q Consensus 494 ------------~------givHrDLKp~NILld~~g~~~~~vKL~DFGla~ 527 (639)
. .++|+|+.|.|||++.++ .+-|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~----~~~lIDwe~a~ 212 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK----VSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE----EEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCc----eEEEeechhcc
Confidence 1 278999999999998664 55699999884
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.93 E-value=1.3e-05 Score=83.49 Aligned_cols=79 Identities=20% Similarity=0.168 Sum_probs=49.6
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEEcccc------cchhHHHHHHHHHHHHhcC-C--CceeeeeeeeecCCceEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSK------LLGKKQMIENEVNILRSVN-H--PNIIKLLDEYDTNNELYL 452 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~------~~~~~~~~~~Ei~iL~~l~-H--pnIv~l~~~~~~~~~~~l 452 (639)
.+.||.|....||++.+..+++.+++|.-.... ......+...|...|+.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999888878889999754211 1111233456787787663 2 345566654 3445679
Q ss_pred EEeeccCCCh
Q psy6820 453 VIELIKGGDL 462 (639)
Q Consensus 453 V~E~~~ggsL 462 (639)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.66 E-value=9.5e-05 Score=71.06 Aligned_cols=75 Identities=16% Similarity=0.080 Sum_probs=52.1
Q ss_pred EEccCCc-eEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCC--CceeeeeeeeecCCceEEEEeeccCC
Q psy6820 384 IIGDGNF-AVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNH--PNIIKLLDEYDTNNELYLVIELIKGG 460 (639)
Q Consensus 384 ~LG~G~f-G~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~gg 460 (639)
.+..|.. +.||+.... .+..+++|...... ...+..|...|+.+.. -.+.+++.+..+++..++|||+++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4445543 688987543 45568889865443 2346678888887753 23567888888888999999999887
Q ss_pred ChH
Q psy6820 461 DLF 463 (639)
Q Consensus 461 sL~ 463 (639)
++.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.56 E-value=0.0052 Score=63.00 Aligned_cols=74 Identities=14% Similarity=0.015 Sum_probs=51.7
Q ss_pred EEEEccCCceEEEEEEEcC-------CCeEEEEEEEcccccchhHHHHHHHHHHHHhcC-CCceeeeeeeeecCCceEEE
Q psy6820 382 GQIIGDGNFAVVRQVYDKH-------KDMDCALKIIDKSKLLGKKQMIENEVNILRSVN-HPNIIKLLDEYDTNNELYLV 453 (639)
Q Consensus 382 ~~~LG~G~fG~Vy~a~~~~-------~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 453 (639)
++.|+.|-.-.+|++.... ..+.+.+++.-.... .....+|..+++.+. +.-..++++++.. .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 4678889999999987653 245678888753221 234568999999886 4444577877743 589
Q ss_pred EeeccCCCh
Q psy6820 454 IELIKGGDL 462 (639)
Q Consensus 454 ~E~~~ggsL 462 (639)
|||++|..|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.51 E-value=0.0039 Score=62.29 Aligned_cols=68 Identities=12% Similarity=0.120 Sum_probs=44.0
Q ss_pred eEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCce--eeeee-----eeecCCceEEEEeeccCCC
Q psy6820 391 AVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPNI--IKLLD-----EYDTNNELYLVIELIKGGD 461 (639)
Q Consensus 391 G~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~HpnI--v~l~~-----~~~~~~~~~lV~E~~~ggs 461 (639)
-.||++.. .+|..|++|+...... ..+.+..|...+..|...++ +..+. .+...+..+.++++++|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 48999855 4567899999875433 24567788888888752222 22221 2344567889999987643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.19 E-value=0.088 Score=51.27 Aligned_cols=141 Identities=13% Similarity=0.062 Sum_probs=72.9
Q ss_pred eeEEEEEccCCceEEEEEEEcCCCeEEEEEEEcccccchhHHHHHHHHHHHHhcCCCc--eeeeee------eeecCCce
Q psy6820 379 YSVGQIIGDGNFAVVRQVYDKHKDMDCALKIIDKSKLLGKKQMIENEVNILRSVNHPN--IIKLLD------EYDTNNEL 450 (639)
Q Consensus 379 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiKv~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~------~~~~~~~~ 450 (639)
..-.+.|..|---+.|.+.... + .|++|++..... .+.+..|+.++..|...+ +...+. ........
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~ 94 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 94 (316)
T ss_dssp EEEEEEECC---EEEEEEEESS-C-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred ceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCCC---HHHHHHHHHHHHhhhhccccccccceecCCCcceeeeccc
Confidence 3445667778778899986554 3 599999865321 234556677777764222 222221 11223445
Q ss_pred EEEEeeccCCChHH-----------HH---h---hc------CCCCHH------------------HHHHHHHHHHHHHH
Q psy6820 451 YLVIELIKGGDLFD-----------AI---S---KN------VKFSEE------------------DSKFMTQSLASALS 489 (639)
Q Consensus 451 ~lV~E~~~ggsL~~-----------~l---~---~~------~~l~~~------------------~~~~i~~qI~~aL~ 489 (639)
..++.++.+..... .+ . .. ...... .....+..+...+.
T Consensus 95 ~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 174 (316)
T d2ppqa1 95 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 174 (316)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred ceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhh
Confidence 66666665543311 00 0 00 000000 11112222222222
Q ss_pred HHH----HCCceeccCCCCceEEccCCceeeeEEEeecccccc
Q psy6820 490 YLH----DNYIVHRDIKPENLLVEMSGCHVKVLKVGDFGLAQR 528 (639)
Q Consensus 490 yLH----~~givHrDLKp~NILld~~g~~~~~vKL~DFGla~~ 528 (639)
..+ ..|+||+|+.++||+++.+. ..-|+||+.+..
T Consensus 175 ~~~~~~L~~giIHgDl~~dNvl~~~~~----v~gvIDF~~~~~ 213 (316)
T d2ppqa1 175 AHWPKDLPAGVIHADLFQDNVFFLGDE----LSGLIDFYFACN 213 (316)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTE----EEEECCCTTCEE
T ss_pred ccCccccccccccCCcchhhhhccccc----ceeEeccccccc
Confidence 222 24699999999999999775 567999999864
|